,CUI1,CUI2,label
0,Dedifferentiated Malignant Infiltrate,Stage IIIA Bladder Cancer AJCC v8,0
1,Mammary Gland Type Features Present,Stage IIIA Bladder Cancer AJCC v8,0
2,Ectopic Tissue,Stage IIIA Bladder Cancer AJCC v8,0
3,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Bladder Cancer AJCC v8,0
4,Dilated Cystic Spaces Present,Stage 0a Urethral Cancer AJCC v8,0
5,Dedifferentiated Malignant Infiltrate,Stage 0a Urethral Cancer AJCC v8,0
6,Mammary Gland Type Features Present,Stage 0a Urethral Cancer AJCC v8,0
7,Ectopic Tissue,Stage 0a Urethral Cancer AJCC v8,0
8,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage 0a Urethral Cancer AJCC v8,0
9,Dilated Cystic Spaces Present,Eyelid Carcinoma by AJCC v7 Stage,0
10,Dedifferentiated Malignant Infiltrate,Eyelid Carcinoma by AJCC v7 Stage,0
11,Mammary Gland Type Features Present,Eyelid Carcinoma by AJCC v7 Stage,0
12,Ectopic Tissue,Eyelid Carcinoma by AJCC v7 Stage,0
13,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Eyelid Carcinoma by AJCC v7 Stage,0
14,Dilated Cystic Spaces Present,Eyelid Carcinoma by AJCC v8 Stage,0
15,Dedifferentiated Malignant Infiltrate,Eyelid Carcinoma by AJCC v8 Stage,0
16,Mammary Gland Type Features Present,Eyelid Carcinoma by AJCC v8 Stage,0
17,Ectopic Tissue,Eyelid Carcinoma by AJCC v8 Stage,0
18,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Eyelid Carcinoma by AJCC v8 Stage,0
19,Dilated Cystic Spaces Present,Stage IB Eyelid Carcinoma AJCC v8,0
20,Dedifferentiated Malignant Infiltrate,Stage IB Eyelid Carcinoma AJCC v8,0
21,Mammary Gland Type Features Present,Stage IB Eyelid Carcinoma AJCC v8,0
22,Ectopic Tissue,Stage IB Eyelid Carcinoma AJCC v8,0
23,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IB Eyelid Carcinoma AJCC v8,0
24,Dilated Cystic Spaces Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,0
25,Dedifferentiated Malignant Infiltrate,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,0
26,Mammary Gland Type Features Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,0
27,Ectopic Tissue,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,0
28,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,0
29,Dilated Cystic Spaces Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
30,Dedifferentiated Malignant Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
31,Mammary Gland Type Features Present,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
32,Ectopic Tissue,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
33,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
34,Dilated Cystic Spaces Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,0
35,Dedifferentiated Malignant Infiltrate,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,0
36,Mammary Gland Type Features Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,0
37,Ectopic Tissue,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,0
38,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,0
39,Dilated Cystic Spaces Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
40,Dedifferentiated Malignant Infiltrate,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
41,Mammary Gland Type Features Present,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
42,Ectopic Tissue,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
43,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
44,Dilated Cystic Spaces Present,Refractory Extensive Stage Lung Small Cell Carcinoma,0
45,Dedifferentiated Malignant Infiltrate,Refractory Extensive Stage Lung Small Cell Carcinoma,0
46,Mammary Gland Type Features Present,Refractory Extensive Stage Lung Small Cell Carcinoma,0
47,Ectopic Tissue,Refractory Extensive Stage Lung Small Cell Carcinoma,0
48,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Extensive Stage Lung Small Cell Carcinoma,0
49,Dilated Cystic Spaces Present,Primary myoepithelial carcinoma of lung,0
50,Dedifferentiated Malignant Infiltrate,Primary myoepithelial carcinoma of lung,0
51,Mammary Gland Type Features Present,Primary myoepithelial carcinoma of lung,0
52,Ectopic Tissue,Primary myoepithelial carcinoma of lung,0
53,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Primary myoepithelial carcinoma of lung,0
54,Coronary Vessel Lesion,Metastatic Bile Duct Carcinoma,0
55,Index Lesion,Metastatic Bile Duct Carcinoma,0
56,Non-Index Lesion,Metastatic Bile Duct Carcinoma,0
57,Mushroom-Shaped Lesion,Metastatic Bile Duct Carcinoma,0
58,Annular Lesion,Metastatic Bile Duct Carcinoma,0
59,Coronary Vessel Lesion,Advanced Bile Duct Carcinoma,0
60,Index Lesion,Advanced Bile Duct Carcinoma,0
61,Non-Index Lesion,Advanced Bile Duct Carcinoma,0
62,Mushroom-Shaped Lesion,Advanced Bile Duct Carcinoma,0
63,Annular Lesion,Advanced Bile Duct Carcinoma,0
64,Dilated Cystic Spaces Present,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,0
65,Dedifferentiated Malignant Infiltrate,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,0
66,Mammary Gland Type Features Present,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,0
67,Ectopic Tissue,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,0
68,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,0
69,Dilated Cystic Spaces Present,Recurrent BRCA-Mutated Ovarian Carcinoma,0
70,Dedifferentiated Malignant Infiltrate,Recurrent BRCA-Mutated Ovarian Carcinoma,0
71,Mammary Gland Type Features Present,Recurrent BRCA-Mutated Ovarian Carcinoma,0
72,Ectopic Tissue,Recurrent BRCA-Mutated Ovarian Carcinoma,0
73,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent BRCA-Mutated Ovarian Carcinoma,0
74,Dilated Cystic Spaces Present,Hormone-Resistant Prostate Carcinoma,0
75,Dedifferentiated Malignant Infiltrate,Hormone-Resistant Prostate Carcinoma,0
76,Mammary Gland Type Features Present,Hormone-Resistant Prostate Carcinoma,0
77,Ectopic Tissue,Hormone-Resistant Prostate Carcinoma,0
78,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hormone-Resistant Prostate Carcinoma,0
79,Dilated Cystic Spaces Present,Stage I Cervical Cancer AJCC v8,0
80,Dedifferentiated Malignant Infiltrate,Stage I Cervical Cancer AJCC v8,0
81,Mammary Gland Type Features Present,Stage I Cervical Cancer AJCC v8,0
82,Ectopic Tissue,Stage I Cervical Cancer AJCC v8,0
83,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Cervical Cancer AJCC v8,0
84,Dilated Cystic Spaces Present,Stage IIA Cervical Cancer AJCC v8,0
85,Dedifferentiated Malignant Infiltrate,Stage IIA Cervical Cancer AJCC v8,0
86,Mammary Gland Type Features Present,Stage IIA Cervical Cancer AJCC v8,0
87,Ectopic Tissue,Stage IIA Cervical Cancer AJCC v8,0
88,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Cervical Cancer AJCC v8,0
89,Dilated Cystic Spaces Present,Stage IIA2 Cervical Cancer AJCC v8,0
90,Dedifferentiated Malignant Infiltrate,Stage IIA2 Cervical Cancer AJCC v8,0
91,Mammary Gland Type Features Present,Stage IIA2 Cervical Cancer AJCC v8,0
92,Ectopic Tissue,Stage IIA2 Cervical Cancer AJCC v8,0
93,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA2 Cervical Cancer AJCC v8,0
94,Dilated Cystic Spaces Present,Stage IIB Ovarian Cancer AJCC v8,0
95,Dedifferentiated Malignant Infiltrate,Stage IIB Ovarian Cancer AJCC v8,0
96,Mammary Gland Type Features Present,Stage IIB Ovarian Cancer AJCC v8,0
97,Ectopic Tissue,Stage IIB Ovarian Cancer AJCC v8,0
98,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIB Ovarian Cancer AJCC v8,0
99,Dilated Cystic Spaces Present,Stage I Fallopian Tube Cancer AJCC v8,0
100,Dedifferentiated Malignant Infiltrate,Stage I Fallopian Tube Cancer AJCC v8,0
101,Mammary Gland Type Features Present,Stage I Fallopian Tube Cancer AJCC v8,0
102,Ectopic Tissue,Stage I Fallopian Tube Cancer AJCC v8,0
103,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Fallopian Tube Cancer AJCC v8,0
104,Dilated Cystic Spaces Present,Stage II Fallopian Tube Cancer AJCC v8,0
105,Dedifferentiated Malignant Infiltrate,Stage II Fallopian Tube Cancer AJCC v8,0
106,Mammary Gland Type Features Present,Stage II Fallopian Tube Cancer AJCC v8,0
107,Ectopic Tissue,Stage II Fallopian Tube Cancer AJCC v8,0
108,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Fallopian Tube Cancer AJCC v8,0
109,Dilated Cystic Spaces Present,Stage IIA Fallopian Tube Cancer AJCC v8,0
110,Dedifferentiated Malignant Infiltrate,Stage IIA Fallopian Tube Cancer AJCC v8,0
111,Mammary Gland Type Features Present,Stage IIA Fallopian Tube Cancer AJCC v8,0
112,Ectopic Tissue,Stage IIA Fallopian Tube Cancer AJCC v8,0
113,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Fallopian Tube Cancer AJCC v8,0
114,Dilated Cystic Spaces Present,Stage IIIA Fallopian Tube Cancer AJCC v8,0
115,Dedifferentiated Malignant Infiltrate,Stage IIIA Fallopian Tube Cancer AJCC v8,0
116,Mammary Gland Type Features Present,Stage IIIA Fallopian Tube Cancer AJCC v8,0
117,Ectopic Tissue,Stage IIIA Fallopian Tube Cancer AJCC v8,0
118,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Fallopian Tube Cancer AJCC v8,0
119,Dilated Cystic Spaces Present,Stage II Primary Peritoneal Cancer AJCC v8,0
120,Dedifferentiated Malignant Infiltrate,Stage II Primary Peritoneal Cancer AJCC v8,0
121,Mammary Gland Type Features Present,Stage II Primary Peritoneal Cancer AJCC v8,0
122,Ectopic Tissue,Stage II Primary Peritoneal Cancer AJCC v8,0
123,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Primary Peritoneal Cancer AJCC v8,0
124,Dilated Cystic Spaces Present,Penile Cancer by AJCC v8 Stage,0
125,Dedifferentiated Malignant Infiltrate,Penile Cancer by AJCC v8 Stage,0
126,Mammary Gland Type Features Present,Penile Cancer by AJCC v8 Stage,0
127,Ectopic Tissue,Penile Cancer by AJCC v8 Stage,0
128,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Penile Cancer by AJCC v8 Stage,0
129,Dilated Cystic Spaces Present,Stage 0 Penile Cancer AJCC v8,0
130,Dedifferentiated Malignant Infiltrate,Stage 0 Penile Cancer AJCC v8,0
131,Mammary Gland Type Features Present,Stage 0 Penile Cancer AJCC v8,0
132,Ectopic Tissue,Stage 0 Penile Cancer AJCC v8,0
133,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage 0 Penile Cancer AJCC v8,0
134,Dilated Cystic Spaces Present,Stage 0a Penile Cancer AJCC v8,0
135,Dedifferentiated Malignant Infiltrate,Stage 0a Penile Cancer AJCC v8,0
136,Mammary Gland Type Features Present,Stage 0a Penile Cancer AJCC v8,0
137,Ectopic Tissue,Stage 0a Penile Cancer AJCC v8,0
138,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage 0a Penile Cancer AJCC v8,0
139,Dilated Cystic Spaces Present,Stage IIIA Penile Cancer AJCC v8,0
140,Dedifferentiated Malignant Infiltrate,Stage IIIA Penile Cancer AJCC v8,0
141,Mammary Gland Type Features Present,Stage IIIA Penile Cancer AJCC v8,0
142,Ectopic Tissue,Stage IIIA Penile Cancer AJCC v8,0
143,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Penile Cancer AJCC v8,0
144,Dilated Cystic Spaces Present,Stage I Ureter Cancer AJCC v8,0
145,Dedifferentiated Malignant Infiltrate,Stage I Ureter Cancer AJCC v8,0
146,Mammary Gland Type Features Present,Stage I Ureter Cancer AJCC v8,0
147,Ectopic Tissue,Stage I Ureter Cancer AJCC v8,0
148,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Ureter Cancer AJCC v8,0
149,Dilated Cystic Spaces Present,Stage II Renal Pelvis Cancer AJCC v8,0
150,Dedifferentiated Malignant Infiltrate,Stage II Renal Pelvis Cancer AJCC v8,0
151,Mammary Gland Type Features Present,Stage II Renal Pelvis Cancer AJCC v8,0
152,Ectopic Tissue,Stage II Renal Pelvis Cancer AJCC v8,0
153,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Renal Pelvis Cancer AJCC v8,0
154,Dilated Cystic Spaces Present,Stage IVA Bladder Cancer AJCC v8,0
155,Dedifferentiated Malignant Infiltrate,Stage IVA Bladder Cancer AJCC v8,0
156,Mammary Gland Type Features Present,Stage IVA Bladder Cancer AJCC v8,0
157,Ectopic Tissue,Stage IVA Bladder Cancer AJCC v8,0
158,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVA Bladder Cancer AJCC v8,0
159,Dilated Cystic Spaces Present,Stage I Urethral Cancer AJCC v8,0
160,Dedifferentiated Malignant Infiltrate,Stage I Urethral Cancer AJCC v8,0
161,Mammary Gland Type Features Present,Stage I Urethral Cancer AJCC v8,0
162,Ectopic Tissue,Stage I Urethral Cancer AJCC v8,0
163,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Urethral Cancer AJCC v8,0
164,Dilated Cystic Spaces Present,Urethral Cancer by AJCC v7 Stage,0
165,Dedifferentiated Malignant Infiltrate,Urethral Cancer by AJCC v7 Stage,0
166,Mammary Gland Type Features Present,Urethral Cancer by AJCC v7 Stage,0
167,Ectopic Tissue,Urethral Cancer by AJCC v7 Stage,0
168,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Urethral Cancer by AJCC v7 Stage,0
169,Dilated Cystic Spaces Present,Stage IIIA Eyelid Carcinoma AJCC v8,0
170,Dedifferentiated Malignant Infiltrate,Stage IIIA Eyelid Carcinoma AJCC v8,0
171,Mammary Gland Type Features Present,Stage IIIA Eyelid Carcinoma AJCC v8,0
172,Ectopic Tissue,Stage IIIA Eyelid Carcinoma AJCC v8,0
173,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Eyelid Carcinoma AJCC v8,0
174,Dilated Cystic Spaces Present,Stage IIIB Eyelid Carcinoma AJCC v8,0
175,Dedifferentiated Malignant Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v8,0
176,Mammary Gland Type Features Present,Stage IIIB Eyelid Carcinoma AJCC v8,0
177,Ectopic Tissue,Stage IIIB Eyelid Carcinoma AJCC v8,0
178,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Eyelid Carcinoma AJCC v8,0
179,Dilated Cystic Spaces Present,Stage IV Eyelid Carcinoma AJCC v8,0
180,Dedifferentiated Malignant Infiltrate,Stage IV Eyelid Carcinoma AJCC v8,0
181,Mammary Gland Type Features Present,Stage IV Eyelid Carcinoma AJCC v8,0
182,Ectopic Tissue,Stage IV Eyelid Carcinoma AJCC v8,0
183,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Eyelid Carcinoma AJCC v8,0
184,Dilated Cystic Spaces Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,0
185,Dedifferentiated Malignant Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,0
186,Mammary Gland Type Features Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,0
187,Ectopic Tissue,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,0
188,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,0
189,Dilated Cystic Spaces Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
190,Dedifferentiated Malignant Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
191,Mammary Gland Type Features Present,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
192,Ectopic Tissue,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
193,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8,0
194,Dilated Cystic Spaces Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,0
195,Dedifferentiated Malignant Infiltrate,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,0
196,Mammary Gland Type Features Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,0
197,Ectopic Tissue,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,0
198,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,0
199,Dilated Cystic Spaces Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
200,Dedifferentiated Malignant Infiltrate,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
201,Mammary Gland Type Features Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
202,Ectopic Tissue,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
203,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,0
204,Dilated Cystic Spaces Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,0
205,Dedifferentiated Malignant Infiltrate,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,0
206,Mammary Gland Type Features Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,0
207,Ectopic Tissue,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,0
208,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,0
209,Dilated Cystic Spaces Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,0
210,Dedifferentiated Malignant Infiltrate,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,0
211,Mammary Gland Type Features Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,0
212,Ectopic Tissue,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,0
213,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v8,0
214,Dilated Cystic Spaces Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,0
215,Dedifferentiated Malignant Infiltrate,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,0
216,Mammary Gland Type Features Present,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,0
217,Ectopic Tissue,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,0
218,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Thyroid Gland Follicular Carcinoma AJCC v8,0
219,Dilated Cystic Spaces Present,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,0
220,Dedifferentiated Malignant Infiltrate,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,0
221,Mammary Gland Type Features Present,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,0
222,Ectopic Tissue,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,0
223,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,0
224,Dilated Cystic Spaces Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
225,Dedifferentiated Malignant Infiltrate,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
226,Mammary Gland Type Features Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
227,Ectopic Tissue,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
228,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
229,Coronary Vessel Lesion,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,0
230,Index Lesion,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,0
231,Non-Index Lesion,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,0
232,Mushroom-Shaped Lesion,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,0
233,Annular Lesion,Thyroid Gland Medullary Carcinoma by AJCC v8 Stage,0
234,Coronary Vessel Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,0
235,Index Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,0
236,Non-Index Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,0
237,Mushroom-Shaped Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,0
238,Annular Lesion,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,0
239,Dilated Cystic Spaces Present,Refractory Lung Carcinoma,0
240,Dedifferentiated Malignant Infiltrate,Refractory Lung Carcinoma,0
241,Mammary Gland Type Features Present,Refractory Lung Carcinoma,0
242,Ectopic Tissue,Refractory Lung Carcinoma,0
243,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Lung Carcinoma,0
244,Dilated Cystic Spaces Present,Refractory Pancreatic Carcinoma,0
245,Dedifferentiated Malignant Infiltrate,Refractory Pancreatic Carcinoma,0
246,Mammary Gland Type Features Present,Refractory Pancreatic Carcinoma,0
247,Ectopic Tissue,Refractory Pancreatic Carcinoma,0
248,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Pancreatic Carcinoma,0
249,Coronary Vessel Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,0
250,Index Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,0
251,Non-Index Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,0
252,Mushroom-Shaped Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,0
253,Annular Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,0
254,Dilated Cystic Spaces Present,BRCA-Mutated Ovarian Carcinoma,0
255,Dedifferentiated Malignant Infiltrate,BRCA-Mutated Ovarian Carcinoma,0
256,Mammary Gland Type Features Present,BRCA-Mutated Ovarian Carcinoma,0
257,Ectopic Tissue,BRCA-Mutated Ovarian Carcinoma,0
258,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,BRCA-Mutated Ovarian Carcinoma,0
259,Dilated Cystic Spaces Present,Stage I Renal Pelvis and Ureter Cancer AJCC v7,0
260,Dedifferentiated Malignant Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v7,0
261,Mammary Gland Type Features Present,Stage I Renal Pelvis and Ureter Cancer AJCC v7,0
262,Ectopic Tissue,Stage I Renal Pelvis and Ureter Cancer AJCC v7,0
263,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Renal Pelvis and Ureter Cancer AJCC v7,0
264,Dilated Cystic Spaces Present,Stage II Vaginal Cancer AJCC v8,0
265,Dedifferentiated Malignant Infiltrate,Stage II Vaginal Cancer AJCC v8,0
266,Mammary Gland Type Features Present,Stage II Vaginal Cancer AJCC v8,0
267,Ectopic Tissue,Stage II Vaginal Cancer AJCC v8,0
268,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Vaginal Cancer AJCC v8,0
269,Dilated Cystic Spaces Present,Stage IA Cervical Cancer AJCC v8,0
270,Dedifferentiated Malignant Infiltrate,Stage IA Cervical Cancer AJCC v8,0
271,Mammary Gland Type Features Present,Stage IA Cervical Cancer AJCC v8,0
272,Ectopic Tissue,Stage IA Cervical Cancer AJCC v8,0
273,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IA Cervical Cancer AJCC v8,0
274,Dilated Cystic Spaces Present,Stage IA2 Cervical Cancer AJCC v8,0
275,Dedifferentiated Malignant Infiltrate,Stage IA2 Cervical Cancer AJCC v8,0
276,Mammary Gland Type Features Present,Stage IA2 Cervical Cancer AJCC v8,0
277,Ectopic Tissue,Stage IA2 Cervical Cancer AJCC v8,0
278,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IA2 Cervical Cancer AJCC v8,0
279,Dilated Cystic Spaces Present,Stage IVB Cervical Cancer AJCC v8,0
280,Dedifferentiated Malignant Infiltrate,Stage IVB Cervical Cancer AJCC v8,0
281,Mammary Gland Type Features Present,Stage IVB Cervical Cancer AJCC v8,0
282,Ectopic Tissue,Stage IVB Cervical Cancer AJCC v8,0
283,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVB Cervical Cancer AJCC v8,0
284,Dilated Cystic Spaces Present,Stage III Fallopian Tube Cancer AJCC v8,0
285,Dedifferentiated Malignant Infiltrate,Stage III Fallopian Tube Cancer AJCC v8,0
286,Mammary Gland Type Features Present,Stage III Fallopian Tube Cancer AJCC v8,0
287,Ectopic Tissue,Stage III Fallopian Tube Cancer AJCC v8,0
288,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Fallopian Tube Cancer AJCC v8,0
289,Dilated Cystic Spaces Present,Stage IIIB Fallopian Tube Cancer AJCC v8,0
290,Dedifferentiated Malignant Infiltrate,Stage IIIB Fallopian Tube Cancer AJCC v8,0
291,Mammary Gland Type Features Present,Stage IIIB Fallopian Tube Cancer AJCC v8,0
292,Ectopic Tissue,Stage IIIB Fallopian Tube Cancer AJCC v8,0
293,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Fallopian Tube Cancer AJCC v8,0
294,Dilated Cystic Spaces Present,Stage IVA Primary Peritoneal Cancer AJCC v8,0
295,Dedifferentiated Malignant Infiltrate,Stage IVA Primary Peritoneal Cancer AJCC v8,0
296,Mammary Gland Type Features Present,Stage IVA Primary Peritoneal Cancer AJCC v8,0
297,Ectopic Tissue,Stage IVA Primary Peritoneal Cancer AJCC v8,0
298,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVA Primary Peritoneal Cancer AJCC v8,0
299,Dilated Cystic Spaces Present,Stage IVB Primary Peritoneal Cancer AJCC v8,0
300,Dedifferentiated Malignant Infiltrate,Stage IVB Primary Peritoneal Cancer AJCC v8,0
301,Mammary Gland Type Features Present,Stage IVB Primary Peritoneal Cancer AJCC v8,0
302,Ectopic Tissue,Stage IVB Primary Peritoneal Cancer AJCC v8,0
303,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVB Primary Peritoneal Cancer AJCC v8,0
304,Dilated Cystic Spaces Present,Prostate Cancer by AJCC v8 Stage,0
305,Dedifferentiated Malignant Infiltrate,Prostate Cancer by AJCC v8 Stage,0
306,Mammary Gland Type Features Present,Prostate Cancer by AJCC v8 Stage,0
307,Ectopic Tissue,Prostate Cancer by AJCC v8 Stage,0
308,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Prostate Cancer by AJCC v8 Stage,0
309,Dilated Cystic Spaces Present,Stage IIA Prostate Cancer AJCC v8,0
310,Dedifferentiated Malignant Infiltrate,Stage IIA Prostate Cancer AJCC v8,0
311,Mammary Gland Type Features Present,Stage IIA Prostate Cancer AJCC v8,0
312,Ectopic Tissue,Stage IIA Prostate Cancer AJCC v8,0
313,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Prostate Cancer AJCC v8,0
314,Dilated Cystic Spaces Present,Stage IV Renal Cell Cancer AJCC v8,0
315,Dedifferentiated Malignant Infiltrate,Stage IV Renal Cell Cancer AJCC v8,0
316,Mammary Gland Type Features Present,Stage IV Renal Cell Cancer AJCC v8,0
317,Ectopic Tissue,Stage IV Renal Cell Cancer AJCC v8,0
318,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Renal Cell Cancer AJCC v8,0
319,Dilated Cystic Spaces Present,Stage 0a Bladder Cancer AJCC v8,0
320,Dedifferentiated Malignant Infiltrate,Stage 0a Bladder Cancer AJCC v8,0
321,Mammary Gland Type Features Present,Stage 0a Bladder Cancer AJCC v8,0
322,Ectopic Tissue,Stage 0a Bladder Cancer AJCC v8,0
323,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage 0a Bladder Cancer AJCC v8,0
324,Dilated Cystic Spaces Present,Stage 0is Bladder Cancer AJCC v8,0
325,Dedifferentiated Malignant Infiltrate,Stage 0is Bladder Cancer AJCC v8,0
326,Mammary Gland Type Features Present,Stage 0is Bladder Cancer AJCC v8,0
327,Ectopic Tissue,Stage 0is Bladder Cancer AJCC v8,0
328,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage 0is Bladder Cancer AJCC v8,0
329,Dilated Cystic Spaces Present,Stage I Bladder Cancer AJCC v8,0
330,Dedifferentiated Malignant Infiltrate,Stage I Bladder Cancer AJCC v8,0
331,Mammary Gland Type Features Present,Stage I Bladder Cancer AJCC v8,0
332,Ectopic Tissue,Stage I Bladder Cancer AJCC v8,0
333,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Bladder Cancer AJCC v8,0
334,Dilated Cystic Spaces Present,Stage II Bladder Cancer AJCC v8,0
335,Dedifferentiated Malignant Infiltrate,Stage II Bladder Cancer AJCC v8,0
336,Mammary Gland Type Features Present,Stage II Bladder Cancer AJCC v8,0
337,Ectopic Tissue,Stage II Bladder Cancer AJCC v8,0
338,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Bladder Cancer AJCC v8,0
339,Dilated Cystic Spaces Present,Stage III Urethral Cancer AJCC v8,0
340,Dedifferentiated Malignant Infiltrate,Stage III Urethral Cancer AJCC v8,0
341,Mammary Gland Type Features Present,Stage III Urethral Cancer AJCC v8,0
342,Ectopic Tissue,Stage III Urethral Cancer AJCC v8,0
343,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Urethral Cancer AJCC v8,0
344,Dilated Cystic Spaces Present,Stage IV Urethral Cancer AJCC v8,0
345,Dedifferentiated Malignant Infiltrate,Stage IV Urethral Cancer AJCC v8,0
346,Mammary Gland Type Features Present,Stage IV Urethral Cancer AJCC v8,0
347,Ectopic Tissue,Stage IV Urethral Cancer AJCC v8,0
348,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Urethral Cancer AJCC v8,0
349,Dilated Cystic Spaces Present,Stage I Eyelid Carcinoma AJCC v8,0
350,Dedifferentiated Malignant Infiltrate,Stage I Eyelid Carcinoma AJCC v8,0
351,Mammary Gland Type Features Present,Stage I Eyelid Carcinoma AJCC v8,0
352,Ectopic Tissue,Stage I Eyelid Carcinoma AJCC v8,0
353,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Eyelid Carcinoma AJCC v8,0
354,Dilated Cystic Spaces Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,0
355,Dedifferentiated Malignant Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,0
356,Mammary Gland Type Features Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,0
357,Ectopic Tissue,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,0
358,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,0
359,Dilated Cystic Spaces Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,0
360,Dedifferentiated Malignant Infiltrate,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,0
361,Mammary Gland Type Features Present,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,0
362,Ectopic Tissue,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,0
363,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Papillary Carcinoma by AJCC v8 Stage,0
364,Dilated Cystic Spaces Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,0
365,Dedifferentiated Malignant Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,0
366,Mammary Gland Type Features Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,0
367,Ectopic Tissue,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,0
368,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,0
369,Dilated Cystic Spaces Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,0
370,Dedifferentiated Malignant Infiltrate,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,0
371,Mammary Gland Type Features Present,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,0
372,Ectopic Tissue,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,0
373,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Thyroid Gland Follicular Carcinoma AJCC v8,0
374,Coronary Vessel Lesion,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,0
375,Index Lesion,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,0
376,Non-Index Lesion,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,0
377,Mushroom-Shaped Lesion,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,0
378,Annular Lesion,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,0
379,Coronary Vessel Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,0
380,Index Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,0
381,Non-Index Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,0
382,Mushroom-Shaped Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,0
383,Annular Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,0
384,Coronary Vessel Lesion,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,0
385,Index Lesion,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,0
386,Non-Index Lesion,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,0
387,Mushroom-Shaped Lesion,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,0
388,Annular Lesion,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,0
389,Dilated Cystic Spaces Present,Stage I Adrenal Cortex Carcinoma AJCC v8,0
390,Dedifferentiated Malignant Infiltrate,Stage I Adrenal Cortex Carcinoma AJCC v8,0
391,Mammary Gland Type Features Present,Stage I Adrenal Cortex Carcinoma AJCC v8,0
392,Ectopic Tissue,Stage I Adrenal Cortex Carcinoma AJCC v8,0
393,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Adrenal Cortex Carcinoma AJCC v8,0
394,Dilated Cystic Spaces Present,Refractory Thyroid Gland Carcinoma,0
395,Dedifferentiated Malignant Infiltrate,Refractory Thyroid Gland Carcinoma,0
396,Mammary Gland Type Features Present,Refractory Thyroid Gland Carcinoma,0
397,Ectopic Tissue,Refractory Thyroid Gland Carcinoma,0
398,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Thyroid Gland Carcinoma,0
399,Dilated Cystic Spaces Present,Stage III Renal Pelvis and Ureter Cancer AJCC v7,0
400,Dedifferentiated Malignant Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v7,0
401,Mammary Gland Type Features Present,Stage III Renal Pelvis and Ureter Cancer AJCC v7,0
402,Ectopic Tissue,Stage III Renal Pelvis and Ureter Cancer AJCC v7,0
403,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Renal Pelvis and Ureter Cancer AJCC v7,0
404,Dilated Cystic Spaces Present,Vaginal Cancer by AJCC v8 Stage,0
405,Dedifferentiated Malignant Infiltrate,Vaginal Cancer by AJCC v8 Stage,0
406,Mammary Gland Type Features Present,Vaginal Cancer by AJCC v8 Stage,0
407,Ectopic Tissue,Vaginal Cancer by AJCC v8 Stage,0
408,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal Cancer by AJCC v8 Stage,0
409,Dilated Cystic Spaces Present,Stage IV Vaginal Cancer AJCC v8,0
410,Dedifferentiated Malignant Infiltrate,Stage IV Vaginal Cancer AJCC v8,0
411,Mammary Gland Type Features Present,Stage IV Vaginal Cancer AJCC v8,0
412,Ectopic Tissue,Stage IV Vaginal Cancer AJCC v8,0
413,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Vaginal Cancer AJCC v8,0
414,Dilated Cystic Spaces Present,Stage II Cervical Cancer AJCC v8,0
415,Dedifferentiated Malignant Infiltrate,Stage II Cervical Cancer AJCC v8,0
416,Mammary Gland Type Features Present,Stage II Cervical Cancer AJCC v8,0
417,Ectopic Tissue,Stage II Cervical Cancer AJCC v8,0
418,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Cervical Cancer AJCC v8,0
419,Dilated Cystic Spaces Present,Stage I Ovarian Cancer AJCC v8,0
420,Dedifferentiated Malignant Infiltrate,Stage I Ovarian Cancer AJCC v8,0
421,Mammary Gland Type Features Present,Stage I Ovarian Cancer AJCC v8,0
422,Ectopic Tissue,Stage I Ovarian Cancer AJCC v8,0
423,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Ovarian Cancer AJCC v8,0
424,Dilated Cystic Spaces Present,Stage IA Ovarian Cancer AJCC v8,0
425,Dedifferentiated Malignant Infiltrate,Stage IA Ovarian Cancer AJCC v8,0
426,Mammary Gland Type Features Present,Stage IA Ovarian Cancer AJCC v8,0
427,Ectopic Tissue,Stage IA Ovarian Cancer AJCC v8,0
428,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IA Ovarian Cancer AJCC v8,0
429,Dilated Cystic Spaces Present,Stage IB Fallopian Tube Cancer AJCC v8,0
430,Dedifferentiated Malignant Infiltrate,Stage IB Fallopian Tube Cancer AJCC v8,0
431,Mammary Gland Type Features Present,Stage IB Fallopian Tube Cancer AJCC v8,0
432,Ectopic Tissue,Stage IB Fallopian Tube Cancer AJCC v8,0
433,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IB Fallopian Tube Cancer AJCC v8,0
434,Dilated Cystic Spaces Present,Stage IIB Fallopian Tube Cancer AJCC v8,0
435,Dedifferentiated Malignant Infiltrate,Stage IIB Fallopian Tube Cancer AJCC v8,0
436,Mammary Gland Type Features Present,Stage IIB Fallopian Tube Cancer AJCC v8,0
437,Ectopic Tissue,Stage IIB Fallopian Tube Cancer AJCC v8,0
438,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIB Fallopian Tube Cancer AJCC v8,0
439,Dilated Cystic Spaces Present,Stage IV Fallopian Tube Cancer AJCC v8,0
440,Dedifferentiated Malignant Infiltrate,Stage IV Fallopian Tube Cancer AJCC v8,0
441,Mammary Gland Type Features Present,Stage IV Fallopian Tube Cancer AJCC v8,0
442,Ectopic Tissue,Stage IV Fallopian Tube Cancer AJCC v8,0
443,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Fallopian Tube Cancer AJCC v8,0
444,Dilated Cystic Spaces Present,Primary Peritoneal Cancer by AJCC v8 Stage,0
445,Dedifferentiated Malignant Infiltrate,Primary Peritoneal Cancer by AJCC v8 Stage,0
446,Mammary Gland Type Features Present,Primary Peritoneal Cancer by AJCC v8 Stage,0
447,Ectopic Tissue,Primary Peritoneal Cancer by AJCC v8 Stage,0
448,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Primary Peritoneal Cancer by AJCC v8 Stage,0
449,Dilated Cystic Spaces Present,Stage IIA Penile Cancer AJCC v8,0
450,Dedifferentiated Malignant Infiltrate,Stage IIA Penile Cancer AJCC v8,0
451,Mammary Gland Type Features Present,Stage IIA Penile Cancer AJCC v8,0
452,Ectopic Tissue,Stage IIA Penile Cancer AJCC v8,0
453,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Penile Cancer AJCC v8,0
454,Dilated Cystic Spaces Present,Stage IV Penile Cancer AJCC v8,0
455,Dedifferentiated Malignant Infiltrate,Stage IV Penile Cancer AJCC v8,0
456,Mammary Gland Type Features Present,Stage IV Penile Cancer AJCC v8,0
457,Ectopic Tissue,Stage IV Penile Cancer AJCC v8,0
458,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Penile Cancer AJCC v8,0
459,Dilated Cystic Spaces Present,Stage II Prostate Cancer AJCC v8,0
460,Dedifferentiated Malignant Infiltrate,Stage II Prostate Cancer AJCC v8,0
461,Mammary Gland Type Features Present,Stage II Prostate Cancer AJCC v8,0
462,Ectopic Tissue,Stage II Prostate Cancer AJCC v8,0
463,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Prostate Cancer AJCC v8,0
464,Dilated Cystic Spaces Present,Stage III Prostate Cancer AJCC v8,0
465,Dedifferentiated Malignant Infiltrate,Stage III Prostate Cancer AJCC v8,0
466,Mammary Gland Type Features Present,Stage III Prostate Cancer AJCC v8,0
467,Ectopic Tissue,Stage III Prostate Cancer AJCC v8,0
468,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Prostate Cancer AJCC v8,0
469,Dilated Cystic Spaces Present,Stage IV Prostate Cancer AJCC v8,0
470,Dedifferentiated Malignant Infiltrate,Stage IV Prostate Cancer AJCC v8,0
471,Mammary Gland Type Features Present,Stage IV Prostate Cancer AJCC v8,0
472,Ectopic Tissue,Stage IV Prostate Cancer AJCC v8,0
473,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Prostate Cancer AJCC v8,0
474,Dilated Cystic Spaces Present,Renal Cell Cancer by AJCC v8 Stage,0
475,Dedifferentiated Malignant Infiltrate,Renal Cell Cancer by AJCC v8 Stage,0
476,Mammary Gland Type Features Present,Renal Cell Cancer by AJCC v8 Stage,0
477,Ectopic Tissue,Renal Cell Cancer by AJCC v8 Stage,0
478,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Renal Cell Cancer by AJCC v8 Stage,0
479,Dilated Cystic Spaces Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,0
480,Dedifferentiated Malignant Infiltrate,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,0
481,Mammary Gland Type Features Present,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,0
482,Ectopic Tissue,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,0
483,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage 0a Renal Pelvis and Ureter Cancer AJCC v8,0
484,Dilated Cystic Spaces Present,Stage 0a Renal Pelvis Cancer AJCC v8,0
485,Dedifferentiated Malignant Infiltrate,Stage 0a Renal Pelvis Cancer AJCC v8,0
486,Mammary Gland Type Features Present,Stage 0a Renal Pelvis Cancer AJCC v8,0
487,Ectopic Tissue,Stage 0a Renal Pelvis Cancer AJCC v8,0
488,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage 0a Renal Pelvis Cancer AJCC v8,0
489,Dilated Cystic Spaces Present,Ureter Cancer by AJCC v7 Stage,0
490,Dedifferentiated Malignant Infiltrate,Ureter Cancer by AJCC v7 Stage,0
491,Mammary Gland Type Features Present,Ureter Cancer by AJCC v7 Stage,0
492,Ectopic Tissue,Ureter Cancer by AJCC v7 Stage,0
493,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ureter Cancer by AJCC v7 Stage,0
494,Dilated Cystic Spaces Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0
495,Dedifferentiated Malignant Infiltrate,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0
496,Mammary Gland Type Features Present,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0
497,Ectopic Tissue,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0
498,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Follicular Carcinoma by AJCC v7 Stage,0
499,Dilated Cystic Spaces Present,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
500,Dedifferentiated Malignant Infiltrate,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
501,Mammary Gland Type Features Present,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
502,Ectopic Tissue,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
503,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,0
504,Dilated Cystic Spaces Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,0
505,Dedifferentiated Malignant Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,0
506,Mammary Gland Type Features Present,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,0
507,Ectopic Tissue,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,0
508,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,0
509,Dilated Cystic Spaces Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0
510,Dedifferentiated Malignant Infiltrate,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0
511,Mammary Gland Type Features Present,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0
512,Ectopic Tissue,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0
513,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,0
514,Dilated Cystic Spaces Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,0
515,Dedifferentiated Malignant Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,0
516,Mammary Gland Type Features Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,0
517,Ectopic Tissue,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,0
518,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,0
519,Dilated Cystic Spaces Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
520,Dedifferentiated Malignant Infiltrate,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
521,Mammary Gland Type Features Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
522,Ectopic Tissue,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
523,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
524,Dilated Cystic Spaces Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
525,Dedifferentiated Malignant Infiltrate,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
526,Mammary Gland Type Features Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
527,Ectopic Tissue,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
528,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,0
529,Dilated Cystic Spaces Present,Thoracic NUT Carcinoma,0
530,Dedifferentiated Malignant Infiltrate,Thoracic NUT Carcinoma,0
531,Mammary Gland Type Features Present,Thoracic NUT Carcinoma,0
532,Ectopic Tissue,Thoracic NUT Carcinoma,0
533,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thoracic NUT Carcinoma,0
534,Dilated Cystic Spaces Present,Skin squamous cell carcinoma recurrent,0
535,Dedifferentiated Malignant Infiltrate,Skin squamous cell carcinoma recurrent,0
536,Mammary Gland Type Features Present,Skin squamous cell carcinoma recurrent,0
537,Ectopic Tissue,Skin squamous cell carcinoma recurrent,0
538,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Skin squamous cell carcinoma recurrent,0
539,Coronary Vessel Lesion,Skin squamous cell carcinoma metastatic,0
540,Index Lesion,Skin squamous cell carcinoma metastatic,0
541,Non-Index Lesion,Skin squamous cell carcinoma metastatic,0
542,Mushroom-Shaped Lesion,Skin squamous cell carcinoma metastatic,0
543,Annular Lesion,Skin squamous cell carcinoma metastatic,0
544,Dilated Cystic Spaces Present,Platinum-Resistant Ovarian Carcinoma,0
545,Dedifferentiated Malignant Infiltrate,Platinum-Resistant Ovarian Carcinoma,0
546,Mammary Gland Type Features Present,Platinum-Resistant Ovarian Carcinoma,0
547,Ectopic Tissue,Platinum-Resistant Ovarian Carcinoma,0
548,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Platinum-Resistant Ovarian Carcinoma,0
549,Dilated Cystic Spaces Present,Stage I Vaginal Cancer AJCC v8,0
550,Dedifferentiated Malignant Infiltrate,Stage I Vaginal Cancer AJCC v8,0
551,Mammary Gland Type Features Present,Stage I Vaginal Cancer AJCC v8,0
552,Ectopic Tissue,Stage I Vaginal Cancer AJCC v8,0
553,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Vaginal Cancer AJCC v8,0
554,Dilated Cystic Spaces Present,Stage IA Vaginal Cancer AJCC v8,0
555,Dedifferentiated Malignant Infiltrate,Stage IA Vaginal Cancer AJCC v8,0
556,Mammary Gland Type Features Present,Stage IA Vaginal Cancer AJCC v8,0
557,Ectopic Tissue,Stage IA Vaginal Cancer AJCC v8,0
558,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IA Vaginal Cancer AJCC v8,0
559,Dilated Cystic Spaces Present,Stage IB Vaginal Cancer AJCC v8,0
560,Dedifferentiated Malignant Infiltrate,Stage IB Vaginal Cancer AJCC v8,0
561,Mammary Gland Type Features Present,Stage IB Vaginal Cancer AJCC v8,0
562,Ectopic Tissue,Stage IB Vaginal Cancer AJCC v8,0
563,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IB Vaginal Cancer AJCC v8,0
564,Dilated Cystic Spaces Present,Stage III Vaginal Cancer AJCC v8,0
565,Dedifferentiated Malignant Infiltrate,Stage III Vaginal Cancer AJCC v8,0
566,Mammary Gland Type Features Present,Stage III Vaginal Cancer AJCC v8,0
567,Ectopic Tissue,Stage III Vaginal Cancer AJCC v8,0
568,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Vaginal Cancer AJCC v8,0
569,Dilated Cystic Spaces Present,Stage IA1 Cervical Cancer AJCC v8,0
570,Dedifferentiated Malignant Infiltrate,Stage IA1 Cervical Cancer AJCC v8,0
571,Mammary Gland Type Features Present,Stage IA1 Cervical Cancer AJCC v8,0
572,Ectopic Tissue,Stage IA1 Cervical Cancer AJCC v8,0
573,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IA1 Cervical Cancer AJCC v8,0
574,Dilated Cystic Spaces Present,Stage IIIB Cervical Cancer AJCC v8,0
575,Dedifferentiated Malignant Infiltrate,Stage IIIB Cervical Cancer AJCC v8,0
576,Mammary Gland Type Features Present,Stage IIIB Cervical Cancer AJCC v8,0
577,Ectopic Tissue,Stage IIIB Cervical Cancer AJCC v8,0
578,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Cervical Cancer AJCC v8,0
579,Dilated Cystic Spaces Present,Stage IV Cervical Cancer AJCC v8,0
580,Dedifferentiated Malignant Infiltrate,Stage IV Cervical Cancer AJCC v8,0
581,Mammary Gland Type Features Present,Stage IV Cervical Cancer AJCC v8,0
582,Ectopic Tissue,Stage IV Cervical Cancer AJCC v8,0
583,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Cervical Cancer AJCC v8,0
584,Dilated Cystic Spaces Present,Ovarian Cancer by AJCC v8 Stage,0
585,Dedifferentiated Malignant Infiltrate,Ovarian Cancer by AJCC v8 Stage,0
586,Mammary Gland Type Features Present,Ovarian Cancer by AJCC v8 Stage,0
587,Ectopic Tissue,Ovarian Cancer by AJCC v8 Stage,0
588,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Cancer by AJCC v8 Stage,0
589,Dilated Cystic Spaces Present,Stage IC Ovarian Cancer AJCC v8,0
590,Dedifferentiated Malignant Infiltrate,Stage IC Ovarian Cancer AJCC v8,0
591,Mammary Gland Type Features Present,Stage IC Ovarian Cancer AJCC v8,0
592,Ectopic Tissue,Stage IC Ovarian Cancer AJCC v8,0
593,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IC Ovarian Cancer AJCC v8,0
594,Dilated Cystic Spaces Present,Stage IIA Ovarian Cancer AJCC v8,0
595,Dedifferentiated Malignant Infiltrate,Stage IIA Ovarian Cancer AJCC v8,0
596,Mammary Gland Type Features Present,Stage IIA Ovarian Cancer AJCC v8,0
597,Ectopic Tissue,Stage IIA Ovarian Cancer AJCC v8,0
598,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Ovarian Cancer AJCC v8,0
599,Dilated Cystic Spaces Present,Stage IIIB Ovarian Cancer AJCC v8,0
600,Dedifferentiated Malignant Infiltrate,Stage IIIB Ovarian Cancer AJCC v8,0
601,Mammary Gland Type Features Present,Stage IIIB Ovarian Cancer AJCC v8,0
602,Ectopic Tissue,Stage IIIB Ovarian Cancer AJCC v8,0
603,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Ovarian Cancer AJCC v8,0
604,Dilated Cystic Spaces Present,Stage IIIC Ovarian Cancer AJCC v8,0
605,Dedifferentiated Malignant Infiltrate,Stage IIIC Ovarian Cancer AJCC v8,0
606,Mammary Gland Type Features Present,Stage IIIC Ovarian Cancer AJCC v8,0
607,Ectopic Tissue,Stage IIIC Ovarian Cancer AJCC v8,0
608,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIC Ovarian Cancer AJCC v8,0
609,Dilated Cystic Spaces Present,Stage IIIC Fallopian Tube Cancer AJCC v8,0
610,Dedifferentiated Malignant Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v8,0
611,Mammary Gland Type Features Present,Stage IIIC Fallopian Tube Cancer AJCC v8,0
612,Ectopic Tissue,Stage IIIC Fallopian Tube Cancer AJCC v8,0
613,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIC Fallopian Tube Cancer AJCC v8,0
614,Dilated Cystic Spaces Present,Primary Peritoneal Cancer by AJCC v7 Stage,0
615,Dedifferentiated Malignant Infiltrate,Primary Peritoneal Cancer by AJCC v7 Stage,0
616,Mammary Gland Type Features Present,Primary Peritoneal Cancer by AJCC v7 Stage,0
617,Ectopic Tissue,Primary Peritoneal Cancer by AJCC v7 Stage,0
618,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Primary Peritoneal Cancer by AJCC v7 Stage,0
619,Dilated Cystic Spaces Present,Stage IIA Primary Peritoneal Cancer AJCC v8,0
620,Dedifferentiated Malignant Infiltrate,Stage IIA Primary Peritoneal Cancer AJCC v8,0
621,Mammary Gland Type Features Present,Stage IIA Primary Peritoneal Cancer AJCC v8,0
622,Ectopic Tissue,Stage IIA Primary Peritoneal Cancer AJCC v8,0
623,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Primary Peritoneal Cancer AJCC v8,0
624,Dilated Cystic Spaces Present,Stage IIB Primary Peritoneal Cancer AJCC v8,0
625,Dedifferentiated Malignant Infiltrate,Stage IIB Primary Peritoneal Cancer AJCC v8,0
626,Mammary Gland Type Features Present,Stage IIB Primary Peritoneal Cancer AJCC v8,0
627,Ectopic Tissue,Stage IIB Primary Peritoneal Cancer AJCC v8,0
628,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIB Primary Peritoneal Cancer AJCC v8,0
629,Dilated Cystic Spaces Present,Stage IIIA Primary Peritoneal Cancer AJCC v8,0
630,Dedifferentiated Malignant Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v8,0
631,Mammary Gland Type Features Present,Stage IIIA Primary Peritoneal Cancer AJCC v8,0
632,Ectopic Tissue,Stage IIIA Primary Peritoneal Cancer AJCC v8,0
633,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Primary Peritoneal Cancer AJCC v8,0
634,Dilated Cystic Spaces Present,Stage IIIB Penile Cancer AJCC v8,0
635,Dedifferentiated Malignant Infiltrate,Stage IIIB Penile Cancer AJCC v8,0
636,Mammary Gland Type Features Present,Stage IIIB Penile Cancer AJCC v8,0
637,Ectopic Tissue,Stage IIIB Penile Cancer AJCC v8,0
638,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Penile Cancer AJCC v8,0
639,Dilated Cystic Spaces Present,Stage I Prostate Cancer AJCC v8,0
640,Dedifferentiated Malignant Infiltrate,Stage I Prostate Cancer AJCC v8,0
641,Mammary Gland Type Features Present,Stage I Prostate Cancer AJCC v8,0
642,Ectopic Tissue,Stage I Prostate Cancer AJCC v8,0
643,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Prostate Cancer AJCC v8,0
644,Dilated Cystic Spaces Present,Stage III Renal Cell Cancer AJCC v8,0
645,Dedifferentiated Malignant Infiltrate,Stage III Renal Cell Cancer AJCC v8,0
646,Mammary Gland Type Features Present,Stage III Renal Cell Cancer AJCC v8,0
647,Ectopic Tissue,Stage III Renal Cell Cancer AJCC v8,0
648,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Renal Cell Cancer AJCC v8,0
649,Dilated Cystic Spaces Present,Ureter Cancer by AJCC v8 Stage,0
650,Dedifferentiated Malignant Infiltrate,Ureter Cancer by AJCC v8 Stage,0
651,Mammary Gland Type Features Present,Ureter Cancer by AJCC v8 Stage,0
652,Ectopic Tissue,Ureter Cancer by AJCC v8 Stage,0
653,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ureter Cancer by AJCC v8 Stage,0
654,Dilated Cystic Spaces Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,0
655,Dedifferentiated Malignant Infiltrate,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,0
656,Mammary Gland Type Features Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,0
657,Ectopic Tissue,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,0
658,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage 0is Renal Pelvis and Ureter Cancer AJCC v8,0
659,Dilated Cystic Spaces Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8,0
660,Dedifferentiated Malignant Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v8,0
661,Mammary Gland Type Features Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8,0
662,Ectopic Tissue,Stage III Renal Pelvis and Ureter Cancer AJCC v8,0
663,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Renal Pelvis and Ureter Cancer AJCC v8,0
664,Dilated Cystic Spaces Present,Stage IV Renal Pelvis Cancer AJCC v8,0
665,Dedifferentiated Malignant Infiltrate,Stage IV Renal Pelvis Cancer AJCC v8,0
666,Mammary Gland Type Features Present,Stage IV Renal Pelvis Cancer AJCC v8,0
667,Ectopic Tissue,Stage IV Renal Pelvis Cancer AJCC v8,0
668,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Renal Pelvis Cancer AJCC v8,0
669,Dilated Cystic Spaces Present,Stage IV Ureter Cancer AJCC v8,0
670,Dedifferentiated Malignant Infiltrate,Stage IV Ureter Cancer AJCC v8,0
671,Mammary Gland Type Features Present,Stage IV Ureter Cancer AJCC v8,0
672,Ectopic Tissue,Stage IV Ureter Cancer AJCC v8,0
673,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Ureter Cancer AJCC v8,0
674,Dilated Cystic Spaces Present,Renal Pelvis Cancer by AJCC v7 Stage,0
675,Dedifferentiated Malignant Infiltrate,Renal Pelvis Cancer by AJCC v7 Stage,0
676,Mammary Gland Type Features Present,Renal Pelvis Cancer by AJCC v7 Stage,0
677,Ectopic Tissue,Renal Pelvis Cancer by AJCC v7 Stage,0
678,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Renal Pelvis Cancer by AJCC v7 Stage,0
679,Dilated Cystic Spaces Present,Stage IIIB Bladder Cancer AJCC v8,0
680,Dedifferentiated Malignant Infiltrate,Stage IIIB Bladder Cancer AJCC v8,0
681,Mammary Gland Type Features Present,Stage IIIB Bladder Cancer AJCC v8,0
682,Ectopic Tissue,Stage IIIB Bladder Cancer AJCC v8,0
683,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Bladder Cancer AJCC v8,0
684,Dilated Cystic Spaces Present,Stage IVB Bladder Cancer AJCC v8,0
685,Dedifferentiated Malignant Infiltrate,Stage IVB Bladder Cancer AJCC v8,0
686,Mammary Gland Type Features Present,Stage IVB Bladder Cancer AJCC v8,0
687,Ectopic Tissue,Stage IVB Bladder Cancer AJCC v8,0
688,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVB Bladder Cancer AJCC v8,0
689,Dilated Cystic Spaces Present,Stage II Eyelid Carcinoma AJCC v8,0
690,Dedifferentiated Malignant Infiltrate,Stage II Eyelid Carcinoma AJCC v8,0
691,Mammary Gland Type Features Present,Stage II Eyelid Carcinoma AJCC v8,0
692,Ectopic Tissue,Stage II Eyelid Carcinoma AJCC v8,0
693,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Eyelid Carcinoma AJCC v8,0
694,Coronary Vessel Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,0
695,Index Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,0
696,Non-Index Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,0
697,Mushroom-Shaped Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,0
698,Annular Lesion,Stage II Thyroid Gland Medullary Carcinoma AJCC v8,0
699,Coronary Vessel Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,0
700,Index Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,0
701,Non-Index Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,0
702,Mushroom-Shaped Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,0
703,Annular Lesion,Stage III Thyroid Gland Medullary Carcinoma AJCC v8,0
704,Dilated Cystic Spaces Present,Stage II Adrenal Cortex Carcinoma AJCC v8,0
705,Dedifferentiated Malignant Infiltrate,Stage II Adrenal Cortex Carcinoma AJCC v8,0
706,Mammary Gland Type Features Present,Stage II Adrenal Cortex Carcinoma AJCC v8,0
707,Ectopic Tissue,Stage II Adrenal Cortex Carcinoma AJCC v8,0
708,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Adrenal Cortex Carcinoma AJCC v8,0
709,Dilated Cystic Spaces Present,Thymic Hepatoid Adenocarcinoma,0
710,Dedifferentiated Malignant Infiltrate,Thymic Hepatoid Adenocarcinoma,0
711,Mammary Gland Type Features Present,Thymic Hepatoid Adenocarcinoma,0
712,Ectopic Tissue,Thymic Hepatoid Adenocarcinoma,0
713,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymic Hepatoid Adenocarcinoma,0
714,Dilated Cystic Spaces Present,Recurrent Thymic Carcinoma,0
715,Dedifferentiated Malignant Infiltrate,Recurrent Thymic Carcinoma,0
716,Mammary Gland Type Features Present,Recurrent Thymic Carcinoma,0
717,Ectopic Tissue,Recurrent Thymic Carcinoma,0
718,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Thymic Carcinoma,0
719,Coronary Vessel Lesion,Locally Advanced Carcinoma,0
720,Index Lesion,Locally Advanced Carcinoma,0
721,Non-Index Lesion,Locally Advanced Carcinoma,0
722,Mushroom-Shaped Lesion,Locally Advanced Carcinoma,0
723,Annular Lesion,Locally Advanced Carcinoma,0
724,Dilated Cystic Spaces Present,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
725,Dedifferentiated Malignant Infiltrate,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
726,Mammary Gland Type Features Present,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
727,Ectopic Tissue,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
728,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
729,Dilated Cystic Spaces Present,Thoracic Esophagus Adenocarcinoma,0
730,Dedifferentiated Malignant Infiltrate,Thoracic Esophagus Adenocarcinoma,0
731,Mammary Gland Type Features Present,Thoracic Esophagus Adenocarcinoma,0
732,Ectopic Tissue,Thoracic Esophagus Adenocarcinoma,0
733,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thoracic Esophagus Adenocarcinoma,0
734,Dilated Cystic Spaces Present,Cervical Esophagus Adenocarcinoma,0
735,Dedifferentiated Malignant Infiltrate,Cervical Esophagus Adenocarcinoma,0
736,Mammary Gland Type Features Present,Cervical Esophagus Adenocarcinoma,0
737,Ectopic Tissue,Cervical Esophagus Adenocarcinoma,0
738,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Esophagus Adenocarcinoma,0
739,Coronary Vessel Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
740,Index Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
741,Non-Index Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
742,Mushroom-Shaped Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
743,Annular Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,0
744,Coronary Vessel Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma,0
745,Index Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma,0
746,Non-Index Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma,0
747,Mushroom-Shaped Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma,0
748,Annular Lesion,Advanced Hypopharyngeal Squamous Cell Carcinoma,0
749,Coronary Vessel Lesion,Metastatic Renal Pelvis Urothelial Carcinoma,0
750,Index Lesion,Metastatic Renal Pelvis Urothelial Carcinoma,0
751,Non-Index Lesion,Metastatic Renal Pelvis Urothelial Carcinoma,0
752,Mushroom-Shaped Lesion,Metastatic Renal Pelvis Urothelial Carcinoma,0
753,Annular Lesion,Metastatic Renal Pelvis Urothelial Carcinoma,0
754,Dilated Cystic Spaces Present,Recurrent Renal Pelvis Urothelial Carcinoma,0
755,Dedifferentiated Malignant Infiltrate,Recurrent Renal Pelvis Urothelial Carcinoma,0
756,Mammary Gland Type Features Present,Recurrent Renal Pelvis Urothelial Carcinoma,0
757,Ectopic Tissue,Recurrent Renal Pelvis Urothelial Carcinoma,0
758,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Renal Pelvis Urothelial Carcinoma,0
759,Dilated Cystic Spaces Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
760,Dedifferentiated Malignant Infiltrate,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
761,Mammary Gland Type Features Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
762,Ectopic Tissue,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
763,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,0
764,Coronary Vessel Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,0
765,Index Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,0
766,Non-Index Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,0
767,Mushroom-Shaped Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,0
768,Annular Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,0
769,Dilated Cystic Spaces Present,Unresectable Adrenal Cortex Carcinoma,0
770,Dedifferentiated Malignant Infiltrate,Unresectable Adrenal Cortex Carcinoma,0
771,Mammary Gland Type Features Present,Unresectable Adrenal Cortex Carcinoma,0
772,Ectopic Tissue,Unresectable Adrenal Cortex Carcinoma,0
773,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Adrenal Cortex Carcinoma,0
774,Dilated Cystic Spaces Present,Refractory Lung Small Cell Carcinoma,0
775,Dedifferentiated Malignant Infiltrate,Refractory Lung Small Cell Carcinoma,0
776,Mammary Gland Type Features Present,Refractory Lung Small Cell Carcinoma,0
777,Ectopic Tissue,Refractory Lung Small Cell Carcinoma,0
778,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Lung Small Cell Carcinoma,0
779,Dilated Cystic Spaces Present,Refractory Fallopian Tube Carcinoma,0
780,Dedifferentiated Malignant Infiltrate,Refractory Fallopian Tube Carcinoma,0
781,Mammary Gland Type Features Present,Refractory Fallopian Tube Carcinoma,0
782,Ectopic Tissue,Refractory Fallopian Tube Carcinoma,0
783,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Fallopian Tube Carcinoma,0
784,Dilated Cystic Spaces Present,Unresectable Pancreatic Neuroendocrine Carcinoma,0
785,Dedifferentiated Malignant Infiltrate,Unresectable Pancreatic Neuroendocrine Carcinoma,0
786,Mammary Gland Type Features Present,Unresectable Pancreatic Neuroendocrine Carcinoma,0
787,Ectopic Tissue,Unresectable Pancreatic Neuroendocrine Carcinoma,0
788,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Pancreatic Neuroendocrine Carcinoma,0
789,Dilated Cystic Spaces Present,Refractory Lung Non-Small Cell Carcinoma,0
790,Dedifferentiated Malignant Infiltrate,Refractory Lung Non-Small Cell Carcinoma,0
791,Mammary Gland Type Features Present,Refractory Lung Non-Small Cell Carcinoma,0
792,Ectopic Tissue,Refractory Lung Non-Small Cell Carcinoma,0
793,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Lung Non-Small Cell Carcinoma,0
794,Coronary Vessel Lesion,Advanced Renal Cell Carcinoma,0
795,Index Lesion,Advanced Renal Cell Carcinoma,0
796,Non-Index Lesion,Advanced Renal Cell Carcinoma,0
797,Mushroom-Shaped Lesion,Advanced Renal Cell Carcinoma,0
798,Annular Lesion,Advanced Renal Cell Carcinoma,0
799,Coronary Vessel Lesion,Metastatic Lung Carcinoma,0
800,Index Lesion,Metastatic Lung Carcinoma,0
801,Non-Index Lesion,Metastatic Lung Carcinoma,0
802,Mushroom-Shaped Lesion,Metastatic Lung Carcinoma,0
803,Annular Lesion,Metastatic Lung Carcinoma,0
804,Dilated Cystic Spaces Present,Refractory Liver Carcinoma,0
805,Dedifferentiated Malignant Infiltrate,Refractory Liver Carcinoma,0
806,Mammary Gland Type Features Present,Refractory Liver Carcinoma,0
807,Ectopic Tissue,Refractory Liver Carcinoma,0
808,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Liver Carcinoma,0
809,Dilated Cystic Spaces Present,Recurrent Acinic Cell Breast Carcinoma,0
810,Dedifferentiated Malignant Infiltrate,Recurrent Acinic Cell Breast Carcinoma,0
811,Mammary Gland Type Features Present,Recurrent Acinic Cell Breast Carcinoma,0
812,Ectopic Tissue,Recurrent Acinic Cell Breast Carcinoma,0
813,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Acinic Cell Breast Carcinoma,0
814,Dilated Cystic Spaces Present,Recurrent Pancreatic Acinar Cell Carcinoma,0
815,Dedifferentiated Malignant Infiltrate,Recurrent Pancreatic Acinar Cell Carcinoma,0
816,Mammary Gland Type Features Present,Recurrent Pancreatic Acinar Cell Carcinoma,0
817,Ectopic Tissue,Recurrent Pancreatic Acinar Cell Carcinoma,0
818,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Pancreatic Acinar Cell Carcinoma,0
819,Dilated Cystic Spaces Present,Recurrent Ovarian Adenocarcinoma,0
820,Dedifferentiated Malignant Infiltrate,Recurrent Ovarian Adenocarcinoma,0
821,Mammary Gland Type Features Present,Recurrent Ovarian Adenocarcinoma,0
822,Ectopic Tissue,Recurrent Ovarian Adenocarcinoma,0
823,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Ovarian Adenocarcinoma,0
824,Coronary Vessel Lesion,Recurrent Thyroid Gland Medullary Carcinoma,0
825,Index Lesion,Recurrent Thyroid Gland Medullary Carcinoma,0
826,Non-Index Lesion,Recurrent Thyroid Gland Medullary Carcinoma,0
827,Mushroom-Shaped Lesion,Recurrent Thyroid Gland Medullary Carcinoma,0
828,Annular Lesion,Recurrent Thyroid Gland Medullary Carcinoma,0
829,Dilated Cystic Spaces Present,Recurrent Parotid Gland Carcinoma,0
830,Dedifferentiated Malignant Infiltrate,Recurrent Parotid Gland Carcinoma,0
831,Mammary Gland Type Features Present,Recurrent Parotid Gland Carcinoma,0
832,Ectopic Tissue,Recurrent Parotid Gland Carcinoma,0
833,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Parotid Gland Carcinoma,0
834,Dilated Cystic Spaces Present,Recurrent Parotid Gland Adenoid Cystic Carcinoma,0
835,Dedifferentiated Malignant Infiltrate,Recurrent Parotid Gland Adenoid Cystic Carcinoma,0
836,Mammary Gland Type Features Present,Recurrent Parotid Gland Adenoid Cystic Carcinoma,0
837,Ectopic Tissue,Recurrent Parotid Gland Adenoid Cystic Carcinoma,0
838,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Parotid Gland Adenoid Cystic Carcinoma,0
839,Coronary Vessel Lesion,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,0
840,Index Lesion,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,0
841,Non-Index Lesion,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,0
842,Mushroom-Shaped Lesion,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,0
843,Annular Lesion,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,0
844,Dilated Cystic Spaces Present,Recurrent Parotid Gland Undifferentiated Carcinoma,0
845,Dedifferentiated Malignant Infiltrate,Recurrent Parotid Gland Undifferentiated Carcinoma,0
846,Mammary Gland Type Features Present,Recurrent Parotid Gland Undifferentiated Carcinoma,0
847,Ectopic Tissue,Recurrent Parotid Gland Undifferentiated Carcinoma,0
848,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Parotid Gland Undifferentiated Carcinoma,0
849,Dilated Cystic Spaces Present,Recurrent Fibrolamellar Carcinoma,0
850,Dedifferentiated Malignant Infiltrate,Recurrent Fibrolamellar Carcinoma,0
851,Mammary Gland Type Features Present,Recurrent Fibrolamellar Carcinoma,0
852,Ectopic Tissue,Recurrent Fibrolamellar Carcinoma,0
853,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Fibrolamellar Carcinoma,0
854,Coronary Vessel Lesion,Locally Advanced Squamous Cell Carcinoma,0
855,Index Lesion,Locally Advanced Squamous Cell Carcinoma,0
856,Non-Index Lesion,Locally Advanced Squamous Cell Carcinoma,0
857,Mushroom-Shaped Lesion,Locally Advanced Squamous Cell Carcinoma,0
858,Annular Lesion,Locally Advanced Squamous Cell Carcinoma,0
859,Dilated Cystic Spaces Present,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,0
860,Dedifferentiated Malignant Infiltrate,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,0
861,Mammary Gland Type Features Present,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,0
862,Ectopic Tissue,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,0
863,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,0
864,Dilated Cystic Spaces Present,Refractory Oral Cavity Squamous Cell Carcinoma,0
865,Dedifferentiated Malignant Infiltrate,Refractory Oral Cavity Squamous Cell Carcinoma,0
866,Mammary Gland Type Features Present,Refractory Oral Cavity Squamous Cell Carcinoma,0
867,Ectopic Tissue,Refractory Oral Cavity Squamous Cell Carcinoma,0
868,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Oral Cavity Squamous Cell Carcinoma,0
869,Dilated Cystic Spaces Present,Refractory Oropharyngeal Squamous Cell Carcinoma,0
870,Dedifferentiated Malignant Infiltrate,Refractory Oropharyngeal Squamous Cell Carcinoma,0
871,Mammary Gland Type Features Present,Refractory Oropharyngeal Squamous Cell Carcinoma,0
872,Ectopic Tissue,Refractory Oropharyngeal Squamous Cell Carcinoma,0
873,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Oropharyngeal Squamous Cell Carcinoma,0
874,Coronary Vessel Lesion,Advanced Laryngeal Squamous Cell Carcinoma,0
875,Index Lesion,Advanced Laryngeal Squamous Cell Carcinoma,0
876,Non-Index Lesion,Advanced Laryngeal Squamous Cell Carcinoma,0
877,Mushroom-Shaped Lesion,Advanced Laryngeal Squamous Cell Carcinoma,0
878,Annular Lesion,Advanced Laryngeal Squamous Cell Carcinoma,0
879,Coronary Vessel Lesion,Metastatic Squamous Cell Carcinoma of the Larynx,0
880,Index Lesion,Metastatic Squamous Cell Carcinoma of the Larynx,0
881,Non-Index Lesion,Metastatic Squamous Cell Carcinoma of the Larynx,0
882,Mushroom-Shaped Lesion,Metastatic Squamous Cell Carcinoma of the Larynx,0
883,Annular Lesion,Metastatic Squamous Cell Carcinoma of the Larynx,0
884,Coronary Vessel Lesion,Urothelial carcinoma ureter metastatic,0
885,Index Lesion,Urothelial carcinoma ureter metastatic,0
886,Non-Index Lesion,Urothelial carcinoma ureter metastatic,0
887,Mushroom-Shaped Lesion,Urothelial carcinoma ureter metastatic,0
888,Annular Lesion,Urothelial carcinoma ureter metastatic,0
889,Dilated Cystic Spaces Present,Unresectable Urothelial Carcinoma,0
890,Dedifferentiated Malignant Infiltrate,Unresectable Urothelial Carcinoma,0
891,Mammary Gland Type Features Present,Unresectable Urothelial Carcinoma,0
892,Ectopic Tissue,Unresectable Urothelial Carcinoma,0
893,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Urothelial Carcinoma,0
894,Dilated Cystic Spaces Present,Refractory Head and Neck Carcinoma,0
895,Dedifferentiated Malignant Infiltrate,Refractory Head and Neck Carcinoma,0
896,Mammary Gland Type Features Present,Refractory Head and Neck Carcinoma,0
897,Ectopic Tissue,Refractory Head and Neck Carcinoma,0
898,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Head and Neck Carcinoma,0
899,Dilated Cystic Spaces Present,Resectable Pancreatic Ductal Adenocarcinoma,0
900,Dedifferentiated Malignant Infiltrate,Resectable Pancreatic Ductal Adenocarcinoma,0
901,Mammary Gland Type Features Present,Resectable Pancreatic Ductal Adenocarcinoma,0
902,Ectopic Tissue,Resectable Pancreatic Ductal Adenocarcinoma,0
903,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Resectable Pancreatic Ductal Adenocarcinoma,0
904,Coronary Vessel Lesion,Locally Advanced Head and Neck Carcinoma,0
905,Index Lesion,Locally Advanced Head and Neck Carcinoma,0
906,Non-Index Lesion,Locally Advanced Head and Neck Carcinoma,0
907,Mushroom-Shaped Lesion,Locally Advanced Head and Neck Carcinoma,0
908,Annular Lesion,Locally Advanced Head and Neck Carcinoma,0
909,Coronary Vessel Lesion,Metastatic gastric adenocarcinoma,0
910,Index Lesion,Metastatic gastric adenocarcinoma,0
911,Non-Index Lesion,Metastatic gastric adenocarcinoma,0
912,Mushroom-Shaped Lesion,Metastatic gastric adenocarcinoma,0
913,Annular Lesion,Metastatic gastric adenocarcinoma,0
914,Dilated Cystic Spaces Present,Refractory Small Intestinal Carcinoma,0
915,Dedifferentiated Malignant Infiltrate,Refractory Small Intestinal Carcinoma,0
916,Mammary Gland Type Features Present,Refractory Small Intestinal Carcinoma,0
917,Ectopic Tissue,Refractory Small Intestinal Carcinoma,0
918,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Small Intestinal Carcinoma,0
919,Dilated Cystic Spaces Present,Recurrent Gastroesophageal Junction Adenocarcinoma,0
920,Dedifferentiated Malignant Infiltrate,Recurrent Gastroesophageal Junction Adenocarcinoma,0
921,Mammary Gland Type Features Present,Recurrent Gastroesophageal Junction Adenocarcinoma,0
922,Ectopic Tissue,Recurrent Gastroesophageal Junction Adenocarcinoma,0
923,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Gastroesophageal Junction Adenocarcinoma,0
924,Coronary Vessel Lesion,Metastatic Cervical Adenocarcinoma,0
925,Index Lesion,Metastatic Cervical Adenocarcinoma,0
926,Non-Index Lesion,Metastatic Cervical Adenocarcinoma,0
927,Mushroom-Shaped Lesion,Metastatic Cervical Adenocarcinoma,0
928,Annular Lesion,Metastatic Cervical Adenocarcinoma,0
929,Dilated Cystic Spaces Present,Recurrent Fallopian Tube Serous Adenocarcinoma,0
930,Dedifferentiated Malignant Infiltrate,Recurrent Fallopian Tube Serous Adenocarcinoma,0
931,Mammary Gland Type Features Present,Recurrent Fallopian Tube Serous Adenocarcinoma,0
932,Ectopic Tissue,Recurrent Fallopian Tube Serous Adenocarcinoma,0
933,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Fallopian Tube Serous Adenocarcinoma,0
934,Dilated Cystic Spaces Present,Recurrent Appendix Carcinoma,0
935,Dedifferentiated Malignant Infiltrate,Recurrent Appendix Carcinoma,0
936,Mammary Gland Type Features Present,Recurrent Appendix Carcinoma,0
937,Ectopic Tissue,Recurrent Appendix Carcinoma,0
938,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Appendix Carcinoma,0
939,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Recurrent Parotid Gland Mucoepidermoid Carcinoma,0
940,Isolated Tumor Cells,Recurrent Parotid Gland Mucoepidermoid Carcinoma,0
941,Pleural/Elastic Layer Invasion,Recurrent Parotid Gland Mucoepidermoid Carcinoma,0
942,Presence of Extravascular Matrix Patterns,Recurrent Parotid Gland Mucoepidermoid Carcinoma,0
943,Ductopenia,Recurrent Parotid Gland Mucoepidermoid Carcinoma,0
944,Dilated Cystic Spaces Present,Unresectable Gastric Adenocarcinoma,0
945,Dedifferentiated Malignant Infiltrate,Unresectable Gastric Adenocarcinoma,0
946,Mammary Gland Type Features Present,Unresectable Gastric Adenocarcinoma,0
947,Ectopic Tissue,Unresectable Gastric Adenocarcinoma,0
948,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Gastric Adenocarcinoma,0
949,Coronary Vessel Lesion,Advanced Urothelial Carcinoma,0
950,Index Lesion,Advanced Urothelial Carcinoma,0
951,Non-Index Lesion,Advanced Urothelial Carcinoma,0
952,Mushroom-Shaped Lesion,Advanced Urothelial Carcinoma,0
953,Annular Lesion,Advanced Urothelial Carcinoma,0
954,Coronary Vessel Lesion,Castration-Naive Prostate Carcinoma,0
955,Index Lesion,Castration-Naive Prostate Carcinoma,0
956,Non-Index Lesion,Castration-Naive Prostate Carcinoma,0
957,Mushroom-Shaped Lesion,Castration-Naive Prostate Carcinoma,0
958,Annular Lesion,Castration-Naive Prostate Carcinoma,0
959,Dilated Cystic Spaces Present,Distal Esophagus Squamous Cell Carcinoma,0
960,Dedifferentiated Malignant Infiltrate,Distal Esophagus Squamous Cell Carcinoma,0
961,Mammary Gland Type Features Present,Distal Esophagus Squamous Cell Carcinoma,0
962,Ectopic Tissue,Distal Esophagus Squamous Cell Carcinoma,0
963,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Distal Esophagus Squamous Cell Carcinoma,0
964,Dilated Cystic Spaces Present,Refractory Endometrial Carcinoma,0
965,Dedifferentiated Malignant Infiltrate,Refractory Endometrial Carcinoma,0
966,Mammary Gland Type Features Present,Refractory Endometrial Carcinoma,0
967,Ectopic Tissue,Refractory Endometrial Carcinoma,0
968,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Endometrial Carcinoma,0
969,Dilated Cystic Spaces Present,Refractory Endometrial Endometrioid Adenocarcinoma,0
970,Dedifferentiated Malignant Infiltrate,Refractory Endometrial Endometrioid Adenocarcinoma,0
971,Mammary Gland Type Features Present,Refractory Endometrial Endometrioid Adenocarcinoma,0
972,Ectopic Tissue,Refractory Endometrial Endometrioid Adenocarcinoma,0
973,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Endometrial Endometrioid Adenocarcinoma,0
974,Coronary Vessel Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx,0
975,Index Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx,0
976,Non-Index Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx,0
977,Mushroom-Shaped Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx,0
978,Annular Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx,0
979,Coronary Vessel Lesion,Metastatic Squamous Cell Carcinoma of the Oropharynx,0
980,Index Lesion,Metastatic Squamous Cell Carcinoma of the Oropharynx,0
981,Non-Index Lesion,Metastatic Squamous Cell Carcinoma of the Oropharynx,0
982,Mushroom-Shaped Lesion,Metastatic Squamous Cell Carcinoma of the Oropharynx,0
983,Annular Lesion,Metastatic Squamous Cell Carcinoma of the Oropharynx,0
984,Coronary Vessel Lesion,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
985,Index Lesion,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
986,Non-Index Lesion,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
987,Mushroom-Shaped Lesion,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
988,Annular Lesion,Metastatic Squamous Cell Carcinoma of the Nasopharynx,0
989,Dilated Cystic Spaces Present,Bilateral Synchronous Sporadic Renal Cell Carcinoma,0
990,Dedifferentiated Malignant Infiltrate,Bilateral Synchronous Sporadic Renal Cell Carcinoma,0
991,Mammary Gland Type Features Present,Bilateral Synchronous Sporadic Renal Cell Carcinoma,0
992,Ectopic Tissue,Bilateral Synchronous Sporadic Renal Cell Carcinoma,0
993,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bilateral Synchronous Sporadic Renal Cell Carcinoma,0
994,Dilated Cystic Spaces Present,Platinum-Resistant Urothelial Carcinoma,0
995,Dedifferentiated Malignant Infiltrate,Platinum-Resistant Urothelial Carcinoma,0
996,Mammary Gland Type Features Present,Platinum-Resistant Urothelial Carcinoma,0
997,Ectopic Tissue,Platinum-Resistant Urothelial Carcinoma,0
998,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Platinum-Resistant Urothelial Carcinoma,0
999,Dilated Cystic Spaces Present,Urothelial carcinoma ureter recurrent,0
1000,Dedifferentiated Malignant Infiltrate,Urothelial carcinoma ureter recurrent,0
1001,Mammary Gland Type Features Present,Urothelial carcinoma ureter recurrent,0
1002,Ectopic Tissue,Urothelial carcinoma ureter recurrent,0
1003,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Urothelial carcinoma ureter recurrent,0
1004,Dilated Cystic Spaces Present,Infiltrating Bladder Carcinoma,0
1005,Dedifferentiated Malignant Infiltrate,Infiltrating Bladder Carcinoma,0
1006,Mammary Gland Type Features Present,Infiltrating Bladder Carcinoma,0
1007,Ectopic Tissue,Infiltrating Bladder Carcinoma,0
1008,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Infiltrating Bladder Carcinoma,0
1009,Dilated Cystic Spaces Present,Refractory Digestive System Carcinoma,0
1010,Dedifferentiated Malignant Infiltrate,Refractory Digestive System Carcinoma,0
1011,Mammary Gland Type Features Present,Refractory Digestive System Carcinoma,0
1012,Ectopic Tissue,Refractory Digestive System Carcinoma,0
1013,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Digestive System Carcinoma,0
1014,Coronary Vessel Lesion,Breast Carcinoma Metastatic in Lymph Node,0
1015,Index Lesion,Breast Carcinoma Metastatic in Lymph Node,0
1016,Non-Index Lesion,Breast Carcinoma Metastatic in Lymph Node,0
1017,Mushroom-Shaped Lesion,Breast Carcinoma Metastatic in Lymph Node,0
1018,Annular Lesion,Breast Carcinoma Metastatic in Lymph Node,0
1019,Dilated Cystic Spaces Present,Recurrent Ovarian Carcinosarcoma,0
1020,Dedifferentiated Malignant Infiltrate,Recurrent Ovarian Carcinosarcoma,0
1021,Mammary Gland Type Features Present,Recurrent Ovarian Carcinosarcoma,0
1022,Ectopic Tissue,Recurrent Ovarian Carcinosarcoma,0
1023,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Ovarian Carcinosarcoma,0
1024,Coronary Vessel Lesion,Locally Advanced Digestive System Carcinoma,0
1025,Index Lesion,Locally Advanced Digestive System Carcinoma,0
1026,Non-Index Lesion,Locally Advanced Digestive System Carcinoma,0
1027,Mushroom-Shaped Lesion,Locally Advanced Digestive System Carcinoma,0
1028,Annular Lesion,Locally Advanced Digestive System Carcinoma,0
1029,Dilated Cystic Spaces Present,Recurrent Minor Salivary Gland Adenocarcinoma,0
1030,Dedifferentiated Malignant Infiltrate,Recurrent Minor Salivary Gland Adenocarcinoma,0
1031,Mammary Gland Type Features Present,Recurrent Minor Salivary Gland Adenocarcinoma,0
1032,Ectopic Tissue,Recurrent Minor Salivary Gland Adenocarcinoma,0
1033,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Minor Salivary Gland Adenocarcinoma,0
1034,Dilated Cystic Spaces Present,Recurrent Ovarian Clear Cell Adenocarcinoma,0
1035,Dedifferentiated Malignant Infiltrate,Recurrent Ovarian Clear Cell Adenocarcinoma,0
1036,Mammary Gland Type Features Present,Recurrent Ovarian Clear Cell Adenocarcinoma,0
1037,Ectopic Tissue,Recurrent Ovarian Clear Cell Adenocarcinoma,0
1038,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Ovarian Clear Cell Adenocarcinoma,0
1039,Dilated Cystic Spaces Present,Recurrent Ovarian Transitional Cell Carcinoma,0
1040,Dedifferentiated Malignant Infiltrate,Recurrent Ovarian Transitional Cell Carcinoma,0
1041,Mammary Gland Type Features Present,Recurrent Ovarian Transitional Cell Carcinoma,0
1042,Ectopic Tissue,Recurrent Ovarian Transitional Cell Carcinoma,0
1043,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Ovarian Transitional Cell Carcinoma,0
1044,Dilated Cystic Spaces Present,Refractory Head and Neck Squamous Cell Carcinoma,0
1045,Dedifferentiated Malignant Infiltrate,Refractory Head and Neck Squamous Cell Carcinoma,0
1046,Mammary Gland Type Features Present,Refractory Head and Neck Squamous Cell Carcinoma,0
1047,Ectopic Tissue,Refractory Head and Neck Squamous Cell Carcinoma,0
1048,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Head and Neck Squamous Cell Carcinoma,0
1049,Coronary Vessel Lesion,Squamous cell carcinoma of head and neck metastatic,0
1050,Index Lesion,Squamous cell carcinoma of head and neck metastatic,0
1051,Non-Index Lesion,Squamous cell carcinoma of head and neck metastatic,0
1052,Mushroom-Shaped Lesion,Squamous cell carcinoma of head and neck metastatic,0
1053,Annular Lesion,Squamous cell carcinoma of head and neck metastatic,0
1054,Dilated Cystic Spaces Present,Refractory Thymic Carcinoma,0
1055,Dedifferentiated Malignant Infiltrate,Refractory Thymic Carcinoma,0
1056,Mammary Gland Type Features Present,Refractory Thymic Carcinoma,0
1057,Ectopic Tissue,Refractory Thymic Carcinoma,0
1058,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Thymic Carcinoma,0
1059,Dilated Cystic Spaces Present,Refractory Nasopharyngeal Carcinoma,0
1060,Dedifferentiated Malignant Infiltrate,Refractory Nasopharyngeal Carcinoma,0
1061,Mammary Gland Type Features Present,Refractory Nasopharyngeal Carcinoma,0
1062,Ectopic Tissue,Refractory Nasopharyngeal Carcinoma,0
1063,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Nasopharyngeal Carcinoma,0
1064,Dilated Cystic Spaces Present,Refractory Ovarian Carcinoma,0
1065,Dedifferentiated Malignant Infiltrate,Refractory Ovarian Carcinoma,0
1066,Mammary Gland Type Features Present,Refractory Ovarian Carcinoma,0
1067,Ectopic Tissue,Refractory Ovarian Carcinoma,0
1068,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Ovarian Carcinoma,0
1069,Dilated Cystic Spaces Present,Recurrent Endometrial Endometrioid Adenocarcinoma,0
1070,Dedifferentiated Malignant Infiltrate,Recurrent Endometrial Endometrioid Adenocarcinoma,0
1071,Mammary Gland Type Features Present,Recurrent Endometrial Endometrioid Adenocarcinoma,0
1072,Ectopic Tissue,Recurrent Endometrial Endometrioid Adenocarcinoma,0
1073,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Endometrial Endometrioid Adenocarcinoma,0
1074,Coronary Vessel Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,0
1075,Index Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,0
1076,Non-Index Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,0
1077,Mushroom-Shaped Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,0
1078,Annular Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,0
1079,Dilated Cystic Spaces Present,Unresectable Gastroesophageal Junction Adenocarcinoma,0
1080,Dedifferentiated Malignant Infiltrate,Unresectable Gastroesophageal Junction Adenocarcinoma,0
1081,Mammary Gland Type Features Present,Unresectable Gastroesophageal Junction Adenocarcinoma,0
1082,Ectopic Tissue,Unresectable Gastroesophageal Junction Adenocarcinoma,0
1083,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Gastroesophageal Junction Adenocarcinoma,0
1084,Coronary Vessel Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,0
1085,Index Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,0
1086,Non-Index Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,0
1087,Mushroom-Shaped Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,0
1088,Annular Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,0
1089,Coronary Vessel Lesion,Locally Advanced Skin Squamous Cell Carcinoma,0
1090,Index Lesion,Locally Advanced Skin Squamous Cell Carcinoma,0
1091,Non-Index Lesion,Locally Advanced Skin Squamous Cell Carcinoma,0
1092,Mushroom-Shaped Lesion,Locally Advanced Skin Squamous Cell Carcinoma,0
1093,Annular Lesion,Locally Advanced Skin Squamous Cell Carcinoma,0
1094,Coronary Vessel Lesion,Metastatic Unresectable Gastric Adenocarcinoma,0
1095,Index Lesion,Metastatic Unresectable Gastric Adenocarcinoma,0
1096,Non-Index Lesion,Metastatic Unresectable Gastric Adenocarcinoma,0
1097,Mushroom-Shaped Lesion,Metastatic Unresectable Gastric Adenocarcinoma,0
1098,Annular Lesion,Metastatic Unresectable Gastric Adenocarcinoma,0
1099,Dilated Cystic Spaces Present,Refractory Colon Carcinoma,0
1100,Dedifferentiated Malignant Infiltrate,Refractory Colon Carcinoma,0
1101,Mammary Gland Type Features Present,Refractory Colon Carcinoma,0
1102,Ectopic Tissue,Refractory Colon Carcinoma,0
1103,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Colon Carcinoma,0
1104,Coronary Vessel Lesion,Metastatic Cervical Adenosquamous Carcinoma,0
1105,Index Lesion,Metastatic Cervical Adenosquamous Carcinoma,0
1106,Non-Index Lesion,Metastatic Cervical Adenosquamous Carcinoma,0
1107,Mushroom-Shaped Lesion,Metastatic Cervical Adenosquamous Carcinoma,0
1108,Annular Lesion,Metastatic Cervical Adenosquamous Carcinoma,0
1109,Dilated Cystic Spaces Present,Recurrent Ampulla of Vater Adenocarcinoma,0
1110,Dedifferentiated Malignant Infiltrate,Recurrent Ampulla of Vater Adenocarcinoma,0
1111,Mammary Gland Type Features Present,Recurrent Ampulla of Vater Adenocarcinoma,0
1112,Ectopic Tissue,Recurrent Ampulla of Vater Adenocarcinoma,0
1113,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Ampulla of Vater Adenocarcinoma,0
1114,Dilated Cystic Spaces Present,Recurrent Appendix Mucinous Adenocarcinoma,0
1115,Dedifferentiated Malignant Infiltrate,Recurrent Appendix Mucinous Adenocarcinoma,0
1116,Mammary Gland Type Features Present,Recurrent Appendix Mucinous Adenocarcinoma,0
1117,Ectopic Tissue,Recurrent Appendix Mucinous Adenocarcinoma,0
1118,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Appendix Mucinous Adenocarcinoma,0
1119,Dilated Cystic Spaces Present,Recurrent Invasive Ductal Breast Carcinoma,0
1120,Dedifferentiated Malignant Infiltrate,Recurrent Invasive Ductal Breast Carcinoma,0
1121,Mammary Gland Type Features Present,Recurrent Invasive Ductal Breast Carcinoma,0
1122,Ectopic Tissue,Recurrent Invasive Ductal Breast Carcinoma,0
1123,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Invasive Ductal Breast Carcinoma,0
1124,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Recurrent Ovarian Cystadenocarcinoma,0
1125,Isolated Tumor Cells,Recurrent Ovarian Cystadenocarcinoma,0
1126,Pleural/Elastic Layer Invasion,Recurrent Ovarian Cystadenocarcinoma,0
1127,Presence of Extravascular Matrix Patterns,Recurrent Ovarian Cystadenocarcinoma,0
1128,Ductopenia,Recurrent Ovarian Cystadenocarcinoma,0
1129,Dilated Cystic Spaces Present,Unresectable Thymic Carcinoma,0
1130,Dedifferentiated Malignant Infiltrate,Unresectable Thymic Carcinoma,0
1131,Mammary Gland Type Features Present,Unresectable Thymic Carcinoma,0
1132,Ectopic Tissue,Unresectable Thymic Carcinoma,0
1133,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Thymic Carcinoma,0
1134,Coronary Vessel Lesion,Locally Advanced Thymic Carcinoma,0
1135,Index Lesion,Locally Advanced Thymic Carcinoma,0
1136,Non-Index Lesion,Locally Advanced Thymic Carcinoma,0
1137,Mushroom-Shaped Lesion,Locally Advanced Thymic Carcinoma,0
1138,Annular Lesion,Locally Advanced Thymic Carcinoma,0
1139,Dilated Cystic Spaces Present,Refractory Hypopharyngeal Squamous Cell Carcinoma,0
1140,Dedifferentiated Malignant Infiltrate,Refractory Hypopharyngeal Squamous Cell Carcinoma,0
1141,Mammary Gland Type Features Present,Refractory Hypopharyngeal Squamous Cell Carcinoma,0
1142,Ectopic Tissue,Refractory Hypopharyngeal Squamous Cell Carcinoma,0
1143,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Hypopharyngeal Squamous Cell Carcinoma,0
1144,Dilated Cystic Spaces Present,Refractory Laryngeal Squamous Cell Carcinoma,0
1145,Dedifferentiated Malignant Infiltrate,Refractory Laryngeal Squamous Cell Carcinoma,0
1146,Mammary Gland Type Features Present,Refractory Laryngeal Squamous Cell Carcinoma,0
1147,Ectopic Tissue,Refractory Laryngeal Squamous Cell Carcinoma,0
1148,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Laryngeal Squamous Cell Carcinoma,0
1149,Dilated Cystic Spaces Present,Refractory Paranasal Sinus Squamous Cell Carcinoma,0
1150,Dedifferentiated Malignant Infiltrate,Refractory Paranasal Sinus Squamous Cell Carcinoma,0
1151,Mammary Gland Type Features Present,Refractory Paranasal Sinus Squamous Cell Carcinoma,0
1152,Ectopic Tissue,Refractory Paranasal Sinus Squamous Cell Carcinoma,0
1153,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Paranasal Sinus Squamous Cell Carcinoma,0
1154,Dilated Cystic Spaces Present,Unresectable Intrahepatic Cholangiocarcinoma,0
1155,Dedifferentiated Malignant Infiltrate,Unresectable Intrahepatic Cholangiocarcinoma,0
1156,Mammary Gland Type Features Present,Unresectable Intrahepatic Cholangiocarcinoma,0
1157,Ectopic Tissue,Unresectable Intrahepatic Cholangiocarcinoma,0
1158,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Intrahepatic Cholangiocarcinoma,0
1159,Dilated Cystic Spaces Present,Refractory Uterine Corpus Carcinoma,0
1160,Dedifferentiated Malignant Infiltrate,Refractory Uterine Corpus Carcinoma,0
1161,Mammary Gland Type Features Present,Refractory Uterine Corpus Carcinoma,0
1162,Ectopic Tissue,Refractory Uterine Corpus Carcinoma,0
1163,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Uterine Corpus Carcinoma,0
1164,Dilated Cystic Spaces Present,Recurrent Endometrial Cancer,0
1165,Dedifferentiated Malignant Infiltrate,Recurrent Endometrial Cancer,0
1166,Mammary Gland Type Features Present,Recurrent Endometrial Cancer,0
1167,Ectopic Tissue,Recurrent Endometrial Cancer,0
1168,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Endometrial Cancer,0
1169,Coronary Vessel Lesion,Metastatic Bladder Urothelial Carcinoma,0
1170,Index Lesion,Metastatic Bladder Urothelial Carcinoma,0
1171,Non-Index Lesion,Metastatic Bladder Urothelial Carcinoma,0
1172,Mushroom-Shaped Lesion,Metastatic Bladder Urothelial Carcinoma,0
1173,Annular Lesion,Metastatic Bladder Urothelial Carcinoma,0
1174,Coronary Vessel Lesion,Recurrent Metastatic Digestive System Carcinoma,0
1175,Index Lesion,Recurrent Metastatic Digestive System Carcinoma,0
1176,Non-Index Lesion,Recurrent Metastatic Digestive System Carcinoma,0
1177,Mushroom-Shaped Lesion,Recurrent Metastatic Digestive System Carcinoma,0
1178,Annular Lesion,Recurrent Metastatic Digestive System Carcinoma,0
1179,Dilated Cystic Spaces Present,Refractory Female Reproductive System Carcinoma,0
1180,Dedifferentiated Malignant Infiltrate,Refractory Female Reproductive System Carcinoma,0
1181,Mammary Gland Type Features Present,Refractory Female Reproductive System Carcinoma,0
1182,Ectopic Tissue,Refractory Female Reproductive System Carcinoma,0
1183,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Female Reproductive System Carcinoma,0
1184,Coronary Vessel Lesion,Advanced Lung Carcinoma,0
1185,Index Lesion,Advanced Lung Carcinoma,0
1186,Non-Index Lesion,Advanced Lung Carcinoma,0
1187,Mushroom-Shaped Lesion,Advanced Lung Carcinoma,0
1188,Annular Lesion,Advanced Lung Carcinoma,0
1189,Coronary Vessel Lesion,Metastatic Gastric Carcinoma,0
1190,Index Lesion,Metastatic Gastric Carcinoma,0
1191,Non-Index Lesion,Metastatic Gastric Carcinoma,0
1192,Mushroom-Shaped Lesion,Metastatic Gastric Carcinoma,0
1193,Annular Lesion,Metastatic Gastric Carcinoma,0
1194,Dilated Cystic Spaces Present,Recurrent Parotid Gland Acinic Cell Carcinoma,0
1195,Dedifferentiated Malignant Infiltrate,Recurrent Parotid Gland Acinic Cell Carcinoma,0
1196,Mammary Gland Type Features Present,Recurrent Parotid Gland Acinic Cell Carcinoma,0
1197,Ectopic Tissue,Recurrent Parotid Gland Acinic Cell Carcinoma,0
1198,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Parotid Gland Acinic Cell Carcinoma,0
1199,Dilated Cystic Spaces Present,Recurrent Paget Disease of the Anal Canal,0
1200,Dedifferentiated Malignant Infiltrate,Recurrent Paget Disease of the Anal Canal,0
1201,Mammary Gland Type Features Present,Recurrent Paget Disease of the Anal Canal,0
1202,Ectopic Tissue,Recurrent Paget Disease of the Anal Canal,0
1203,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Paget Disease of the Anal Canal,0
1204,Dilated Cystic Spaces Present,Recurrent Lobular Breast Carcinoma,0
1205,Dedifferentiated Malignant Infiltrate,Recurrent Lobular Breast Carcinoma,0
1206,Mammary Gland Type Features Present,Recurrent Lobular Breast Carcinoma,0
1207,Ectopic Tissue,Recurrent Lobular Breast Carcinoma,0
1208,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Lobular Breast Carcinoma,0
1209,Dilated Cystic Spaces Present,Recurrent Paget Disease of the Breast,0
1210,Dedifferentiated Malignant Infiltrate,Recurrent Paget Disease of the Breast,0
1211,Mammary Gland Type Features Present,Recurrent Paget Disease of the Breast,0
1212,Ectopic Tissue,Recurrent Paget Disease of the Breast,0
1213,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Paget Disease of the Breast,0
1214,Dilated Cystic Spaces Present,Recurrent Clear Cell Renal Cell Carcinoma,0
1215,Dedifferentiated Malignant Infiltrate,Recurrent Clear Cell Renal Cell Carcinoma,0
1216,Mammary Gland Type Features Present,Recurrent Clear Cell Renal Cell Carcinoma,0
1217,Ectopic Tissue,Recurrent Clear Cell Renal Cell Carcinoma,0
1218,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Clear Cell Renal Cell Carcinoma,0
1219,Dilated Cystic Spaces Present,Recurrent Chromophobe Renal Cell Carcinoma,0
1220,Dedifferentiated Malignant Infiltrate,Recurrent Chromophobe Renal Cell Carcinoma,0
1221,Mammary Gland Type Features Present,Recurrent Chromophobe Renal Cell Carcinoma,0
1222,Ectopic Tissue,Recurrent Chromophobe Renal Cell Carcinoma,0
1223,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Chromophobe Renal Cell Carcinoma,0
1224,Dilated Cystic Spaces Present,Recurrent Ovarian Serous Adenocarcinoma,0
1225,Dedifferentiated Malignant Infiltrate,Recurrent Ovarian Serous Adenocarcinoma,0
1226,Mammary Gland Type Features Present,Recurrent Ovarian Serous Adenocarcinoma,0
1227,Ectopic Tissue,Recurrent Ovarian Serous Adenocarcinoma,0
1228,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Ovarian Serous Adenocarcinoma,0
1229,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Recurrent Pancreatic Cystadenocarcinoma,0
1230,Isolated Tumor Cells,Recurrent Pancreatic Cystadenocarcinoma,0
1231,Pleural/Elastic Layer Invasion,Recurrent Pancreatic Cystadenocarcinoma,0
1232,Presence of Extravascular Matrix Patterns,Recurrent Pancreatic Cystadenocarcinoma,0
1233,Ductopenia,Recurrent Pancreatic Cystadenocarcinoma,0
1234,Dilated Cystic Spaces Present,Recurrent Thyroid Gland Papillary Carcinoma,0
1235,Dedifferentiated Malignant Infiltrate,Recurrent Thyroid Gland Papillary Carcinoma,0
1236,Mammary Gland Type Features Present,Recurrent Thyroid Gland Papillary Carcinoma,0
1237,Ectopic Tissue,Recurrent Thyroid Gland Papillary Carcinoma,0
1238,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Thyroid Gland Papillary Carcinoma,0
1239,Dilated Cystic Spaces Present,Recurrent Thyroid Gland Follicular Carcinoma,0
1240,Dedifferentiated Malignant Infiltrate,Recurrent Thyroid Gland Follicular Carcinoma,0
1241,Mammary Gland Type Features Present,Recurrent Thyroid Gland Follicular Carcinoma,0
1242,Ectopic Tissue,Recurrent Thyroid Gland Follicular Carcinoma,0
1243,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Thyroid Gland Follicular Carcinoma,0
1244,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,0
1245,Isolated Tumor Cells,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,0
1246,Pleural/Elastic Layer Invasion,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,0
1247,Presence of Extravascular Matrix Patterns,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,0
1248,Ductopenia,Recurrent Submandibular Gland Mucoepidermoid Carcinoma,0
1249,Dilated Cystic Spaces Present,Recurrent Submandibular Gland Undifferentiated Carcinoma,0
1250,Dedifferentiated Malignant Infiltrate,Recurrent Submandibular Gland Undifferentiated Carcinoma,0
1251,Mammary Gland Type Features Present,Recurrent Submandibular Gland Undifferentiated Carcinoma,0
1252,Ectopic Tissue,Recurrent Submandibular Gland Undifferentiated Carcinoma,0
1253,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Submandibular Gland Undifferentiated Carcinoma,0
1254,Coronary Vessel Lesion,Metastatic Ureter Carcinoma,0
1255,Index Lesion,Metastatic Ureter Carcinoma,0
1256,Non-Index Lesion,Metastatic Ureter Carcinoma,0
1257,Mushroom-Shaped Lesion,Metastatic Ureter Carcinoma,0
1258,Annular Lesion,Metastatic Ureter Carcinoma,0
1259,Coronary Vessel Lesion,Metastatic Urethral Carcinoma,0
1260,Index Lesion,Metastatic Urethral Carcinoma,0
1261,Non-Index Lesion,Metastatic Urethral Carcinoma,0
1262,Mushroom-Shaped Lesion,Metastatic Urethral Carcinoma,0
1263,Annular Lesion,Metastatic Urethral Carcinoma,0
1264,Dilated Cystic Spaces Present,Unresectable Carcinoma,0
1265,Dedifferentiated Malignant Infiltrate,Unresectable Carcinoma,0
1266,Mammary Gland Type Features Present,Unresectable Carcinoma,0
1267,Ectopic Tissue,Unresectable Carcinoma,0
1268,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Carcinoma,0
1269,Dilated Cystic Spaces Present,Thoracic Esophagus Squamous Cell Carcinoma,0
1270,Dedifferentiated Malignant Infiltrate,Thoracic Esophagus Squamous Cell Carcinoma,0
1271,Mammary Gland Type Features Present,Thoracic Esophagus Squamous Cell Carcinoma,0
1272,Ectopic Tissue,Thoracic Esophagus Squamous Cell Carcinoma,0
1273,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thoracic Esophagus Squamous Cell Carcinoma,0
1274,Dilated Cystic Spaces Present,Gastric Cardia Squamous Cell Carcinoma,0
1275,Dedifferentiated Malignant Infiltrate,Gastric Cardia Squamous Cell Carcinoma,0
1276,Mammary Gland Type Features Present,Gastric Cardia Squamous Cell Carcinoma,0
1277,Ectopic Tissue,Gastric Cardia Squamous Cell Carcinoma,0
1278,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastric Cardia Squamous Cell Carcinoma,0
1279,Dilated Cystic Spaces Present,Refractory Urothelial Carcinoma,0
1280,Dedifferentiated Malignant Infiltrate,Refractory Urothelial Carcinoma,0
1281,Mammary Gland Type Features Present,Refractory Urothelial Carcinoma,0
1282,Ectopic Tissue,Refractory Urothelial Carcinoma,0
1283,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Urothelial Carcinoma,0
1284,Coronary Vessel Lesion,Refractory Metastatic Digestive System Carcinoma,0
1285,Index Lesion,Refractory Metastatic Digestive System Carcinoma,0
1286,Non-Index Lesion,Refractory Metastatic Digestive System Carcinoma,0
1287,Mushroom-Shaped Lesion,Refractory Metastatic Digestive System Carcinoma,0
1288,Annular Lesion,Refractory Metastatic Digestive System Carcinoma,0
1289,Coronary Vessel Lesion,Locally Advanced Bile Duct Carcinoma,0
1290,Index Lesion,Locally Advanced Bile Duct Carcinoma,0
1291,Non-Index Lesion,Locally Advanced Bile Duct Carcinoma,0
1292,Mushroom-Shaped Lesion,Locally Advanced Bile Duct Carcinoma,0
1293,Annular Lesion,Locally Advanced Bile Duct Carcinoma,0
1294,Coronary Vessel Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma,0
1295,Index Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma,0
1296,Non-Index Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma,0
1297,Mushroom-Shaped Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma,0
1298,Annular Lesion,Locally Advanced Pancreatic Ductal Adenocarcinoma,0
1299,Dilated Cystic Spaces Present,Refractory Primary Peritoneal Carcinoma,0
1300,Dedifferentiated Malignant Infiltrate,Refractory Primary Peritoneal Carcinoma,0
1301,Mammary Gland Type Features Present,Refractory Primary Peritoneal Carcinoma,0
1302,Ectopic Tissue,Refractory Primary Peritoneal Carcinoma,0
1303,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Primary Peritoneal Carcinoma,0
1304,Coronary Vessel Lesion,Advanced Carcinoma,0
1305,Index Lesion,Advanced Carcinoma,0
1306,Non-Index Lesion,Advanced Carcinoma,0
1307,Mushroom-Shaped Lesion,Advanced Carcinoma,0
1308,Annular Lesion,Advanced Carcinoma,0
1309,Coronary Vessel Lesion,Advanced Lung Non-Small Cell Squamous Carcinoma,0
1310,Index Lesion,Advanced Lung Non-Small Cell Squamous Carcinoma,0
1311,Non-Index Lesion,Advanced Lung Non-Small Cell Squamous Carcinoma,0
1312,Mushroom-Shaped Lesion,Advanced Lung Non-Small Cell Squamous Carcinoma,0
1313,Annular Lesion,Advanced Lung Non-Small Cell Squamous Carcinoma,0
1314,Coronary Vessel Lesion,Colorectal Carcinoma Metastatic in the Lung,0
1315,Index Lesion,Colorectal Carcinoma Metastatic in the Lung,0
1316,Non-Index Lesion,Colorectal Carcinoma Metastatic in the Lung,0
1317,Mushroom-Shaped Lesion,Colorectal Carcinoma Metastatic in the Lung,0
1318,Annular Lesion,Colorectal Carcinoma Metastatic in the Lung,0
1319,Coronary Vessel Lesion,Breast Carcinoma Metastatic in the Spine,0
1320,Index Lesion,Breast Carcinoma Metastatic in the Spine,0
1321,Non-Index Lesion,Breast Carcinoma Metastatic in the Spine,0
1322,Mushroom-Shaped Lesion,Breast Carcinoma Metastatic in the Spine,0
1323,Annular Lesion,Breast Carcinoma Metastatic in the Spine,0
1324,Coronary Vessel Lesion,Advanced Unresectable Gastric Adenocarcinoma,0
1325,Index Lesion,Advanced Unresectable Gastric Adenocarcinoma,0
1326,Non-Index Lesion,Advanced Unresectable Gastric Adenocarcinoma,0
1327,Mushroom-Shaped Lesion,Advanced Unresectable Gastric Adenocarcinoma,0
1328,Annular Lesion,Advanced Unresectable Gastric Adenocarcinoma,0
1329,Coronary Vessel Lesion,Locally Advanced Small Intestinal Carcinoma,0
1330,Index Lesion,Locally Advanced Small Intestinal Carcinoma,0
1331,Non-Index Lesion,Locally Advanced Small Intestinal Carcinoma,0
1332,Mushroom-Shaped Lesion,Locally Advanced Small Intestinal Carcinoma,0
1333,Annular Lesion,Locally Advanced Small Intestinal Carcinoma,0
1334,Coronary Vessel Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
1335,Index Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
1336,Non-Index Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
1337,Mushroom-Shaped Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
1338,Annular Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",0
1339,Dilated Cystic Spaces Present,Recurrent Prostate Acinar Adenocarcinoma,0
1340,Dedifferentiated Malignant Infiltrate,Recurrent Prostate Acinar Adenocarcinoma,0
1341,Mammary Gland Type Features Present,Recurrent Prostate Acinar Adenocarcinoma,0
1342,Ectopic Tissue,Recurrent Prostate Acinar Adenocarcinoma,0
1343,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Prostate Acinar Adenocarcinoma,0
1344,Dilated Cystic Spaces Present,Recurrent Anal Mucinous Adenocarcinoma,0
1345,Dedifferentiated Malignant Infiltrate,Recurrent Anal Mucinous Adenocarcinoma,0
1346,Mammary Gland Type Features Present,Recurrent Anal Mucinous Adenocarcinoma,0
1347,Ectopic Tissue,Recurrent Anal Mucinous Adenocarcinoma,0
1348,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Anal Mucinous Adenocarcinoma,0
1349,Dilated Cystic Spaces Present,Recurrent Pancreatic Ductal Adenocarcinoma,0
1350,Dedifferentiated Malignant Infiltrate,Recurrent Pancreatic Ductal Adenocarcinoma,0
1351,Mammary Gland Type Features Present,Recurrent Pancreatic Ductal Adenocarcinoma,0
1352,Ectopic Tissue,Recurrent Pancreatic Ductal Adenocarcinoma,0
1353,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Pancreatic Ductal Adenocarcinoma,0
1354,Dilated Cystic Spaces Present,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
1355,Dedifferentiated Malignant Infiltrate,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
1356,Mammary Gland Type Features Present,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
1357,Ectopic Tissue,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
1358,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Submandibular Gland Squamous Cell Carcinoma,0
1359,Coronary Vessel Lesion,Metastatic Fibrolamellar Carcinoma,0
1360,Index Lesion,Metastatic Fibrolamellar Carcinoma,0
1361,Non-Index Lesion,Metastatic Fibrolamellar Carcinoma,0
1362,Mushroom-Shaped Lesion,Metastatic Fibrolamellar Carcinoma,0
1363,Annular Lesion,Metastatic Fibrolamellar Carcinoma,0
1364,Coronary Vessel Lesion,Metastatic hepatocellular carcinoma,0
1365,Index Lesion,Metastatic hepatocellular carcinoma,0
1366,Non-Index Lesion,Metastatic hepatocellular carcinoma,0
1367,Mushroom-Shaped Lesion,Metastatic hepatocellular carcinoma,0
1368,Annular Lesion,Metastatic hepatocellular carcinoma,0
1369,Coronary Vessel Lesion,Metastatic thymic carcinoma,0
1370,Index Lesion,Metastatic thymic carcinoma,0
1371,Non-Index Lesion,Metastatic thymic carcinoma,0
1372,Mushroom-Shaped Lesion,Metastatic thymic carcinoma,0
1373,Annular Lesion,Metastatic thymic carcinoma,0
1374,Dilated Cystic Spaces Present,Recurrent Paranasal Sinus Squamous Cell Carcinoma,0
1375,Dedifferentiated Malignant Infiltrate,Recurrent Paranasal Sinus Squamous Cell Carcinoma,0
1376,Mammary Gland Type Features Present,Recurrent Paranasal Sinus Squamous Cell Carcinoma,0
1377,Ectopic Tissue,Recurrent Paranasal Sinus Squamous Cell Carcinoma,0
1378,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Paranasal Sinus Squamous Cell Carcinoma,0
1379,Dilated Cystic Spaces Present,Recurrent Ovarian Endometrioid Adenocarcinoma,0
1380,Dedifferentiated Malignant Infiltrate,Recurrent Ovarian Endometrioid Adenocarcinoma,0
1381,Mammary Gland Type Features Present,Recurrent Ovarian Endometrioid Adenocarcinoma,0
1382,Ectopic Tissue,Recurrent Ovarian Endometrioid Adenocarcinoma,0
1383,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Ovarian Endometrioid Adenocarcinoma,0
1384,Coronary Vessel Lesion,Metastatic Oral Cavity Squamous Cell Carcinoma,0
1385,Index Lesion,Metastatic Oral Cavity Squamous Cell Carcinoma,0
1386,Non-Index Lesion,Metastatic Oral Cavity Squamous Cell Carcinoma,0
1387,Mushroom-Shaped Lesion,Metastatic Oral Cavity Squamous Cell Carcinoma,0
1388,Annular Lesion,Metastatic Oral Cavity Squamous Cell Carcinoma,0
1389,Dilated Cystic Spaces Present,Refractory Bladder Carcinoma,0
1390,Dedifferentiated Malignant Infiltrate,Refractory Bladder Carcinoma,0
1391,Mammary Gland Type Features Present,Refractory Bladder Carcinoma,0
1392,Ectopic Tissue,Refractory Bladder Carcinoma,0
1393,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Bladder Carcinoma,0
1394,Coronary Vessel Lesion,Metastatic Urethral Urothelial Carcinoma,0
1395,Index Lesion,Metastatic Urethral Urothelial Carcinoma,0
1396,Non-Index Lesion,Metastatic Urethral Urothelial Carcinoma,0
1397,Mushroom-Shaped Lesion,Metastatic Urethral Urothelial Carcinoma,0
1398,Annular Lesion,Metastatic Urethral Urothelial Carcinoma,0
1399,Coronary Vessel Lesion,Metastatic Renal Cell Carcinoma,0
1400,Index Lesion,Metastatic Renal Cell Carcinoma,0
1401,Non-Index Lesion,Metastatic Renal Cell Carcinoma,0
1402,Mushroom-Shaped Lesion,Metastatic Renal Cell Carcinoma,0
1403,Annular Lesion,Metastatic Renal Cell Carcinoma,0
1404,Dilated Cystic Spaces Present,Distal Esophagus Adenocarcinoma,0
1405,Dedifferentiated Malignant Infiltrate,Distal Esophagus Adenocarcinoma,0
1406,Mammary Gland Type Features Present,Distal Esophagus Adenocarcinoma,0
1407,Ectopic Tissue,Distal Esophagus Adenocarcinoma,0
1408,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Distal Esophagus Adenocarcinoma,0
1409,Coronary Vessel Lesion,Metastatic Breast Carcinoma,0
1410,Index Lesion,Metastatic Breast Carcinoma,0
1411,Non-Index Lesion,Metastatic Breast Carcinoma,0
1412,Mushroom-Shaped Lesion,Metastatic Breast Carcinoma,0
1413,Annular Lesion,Metastatic Breast Carcinoma,0
1414,Coronary Vessel Lesion,Metastatic Unresectable Carcinoma,0
1415,Index Lesion,Metastatic Unresectable Carcinoma,0
1416,Non-Index Lesion,Metastatic Unresectable Carcinoma,0
1417,Mushroom-Shaped Lesion,Metastatic Unresectable Carcinoma,0
1418,Annular Lesion,Metastatic Unresectable Carcinoma,0
1419,Dilated Cystic Spaces Present,Refractory Bile Duct Carcinoma,0
1420,Dedifferentiated Malignant Infiltrate,Refractory Bile Duct Carcinoma,0
1421,Mammary Gland Type Features Present,Refractory Bile Duct Carcinoma,0
1422,Ectopic Tissue,Refractory Bile Duct Carcinoma,0
1423,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Bile Duct Carcinoma,0
1424,Dilated Cystic Spaces Present,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",0
1425,Dedifferentiated Malignant Infiltrate,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",0
1426,Mammary Gland Type Features Present,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",0
1427,Ectopic Tissue,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",0
1428,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",0
1429,Dilated Cystic Spaces Present,Recurrent Anal Adenocarcinoma,0
1430,Dedifferentiated Malignant Infiltrate,Recurrent Anal Adenocarcinoma,0
1431,Mammary Gland Type Features Present,Recurrent Anal Adenocarcinoma,0
1432,Ectopic Tissue,Recurrent Anal Adenocarcinoma,0
1433,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Anal Adenocarcinoma,0
1434,Dilated Cystic Spaces Present,Recurrent Salivary Duct Carcinoma,0
1435,Dedifferentiated Malignant Infiltrate,Recurrent Salivary Duct Carcinoma,0
1436,Mammary Gland Type Features Present,Recurrent Salivary Duct Carcinoma,0
1437,Ectopic Tissue,Recurrent Salivary Duct Carcinoma,0
1438,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Salivary Duct Carcinoma,0
1439,Dilated Cystic Spaces Present,Recurrent Thyroid Gland Anaplastic Carcinoma,0
1440,Dedifferentiated Malignant Infiltrate,Recurrent Thyroid Gland Anaplastic Carcinoma,0
1441,Mammary Gland Type Features Present,Recurrent Thyroid Gland Anaplastic Carcinoma,0
1442,Ectopic Tissue,Recurrent Thyroid Gland Anaplastic Carcinoma,0
1443,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Thyroid Gland Anaplastic Carcinoma,0
1444,Dilated Cystic Spaces Present,Recurrent Submandibular Gland Carcinoma,0
1445,Dedifferentiated Malignant Infiltrate,Recurrent Submandibular Gland Carcinoma,0
1446,Mammary Gland Type Features Present,Recurrent Submandibular Gland Carcinoma,0
1447,Ectopic Tissue,Recurrent Submandibular Gland Carcinoma,0
1448,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Submandibular Gland Carcinoma,0
1449,Dilated Cystic Spaces Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,0
1450,Dedifferentiated Malignant Infiltrate,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,0
1451,Mammary Gland Type Features Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,0
1452,Ectopic Tissue,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,0
1453,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,0
1454,Dilated Cystic Spaces Present,Recurrent Parotid Gland Squamous Cell Carcinoma,0
1455,Dedifferentiated Malignant Infiltrate,Recurrent Parotid Gland Squamous Cell Carcinoma,0
1456,Mammary Gland Type Features Present,Recurrent Parotid Gland Squamous Cell Carcinoma,0
1457,Ectopic Tissue,Recurrent Parotid Gland Squamous Cell Carcinoma,0
1458,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Parotid Gland Squamous Cell Carcinoma,0
1459,Dilated Cystic Spaces Present,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,0
1460,Dedifferentiated Malignant Infiltrate,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,0
1461,Mammary Gland Type Features Present,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,0
1462,Ectopic Tissue,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,0
1463,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,0
1464,Dilated Cystic Spaces Present,Cervical Esophagus Squamous Cell Carcinoma,0
1465,Dedifferentiated Malignant Infiltrate,Cervical Esophagus Squamous Cell Carcinoma,0
1466,Mammary Gland Type Features Present,Cervical Esophagus Squamous Cell Carcinoma,0
1467,Ectopic Tissue,Cervical Esophagus Squamous Cell Carcinoma,0
1468,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Esophagus Squamous Cell Carcinoma,0
1469,Dilated Cystic Spaces Present,Refractory Ovarian Endometrioid Adenocarcinoma,0
1470,Dedifferentiated Malignant Infiltrate,Refractory Ovarian Endometrioid Adenocarcinoma,0
1471,Mammary Gland Type Features Present,Refractory Ovarian Endometrioid Adenocarcinoma,0
1472,Ectopic Tissue,Refractory Ovarian Endometrioid Adenocarcinoma,0
1473,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Ovarian Endometrioid Adenocarcinoma,0
1474,Coronary Vessel Lesion,Squamous cell carcinoma of the hypopharynx stage IV,0
1475,Index Lesion,Squamous cell carcinoma of the hypopharynx stage IV,0
1476,Non-Index Lesion,Squamous cell carcinoma of the hypopharynx stage IV,0
1477,Mushroom-Shaped Lesion,Squamous cell carcinoma of the hypopharynx stage IV,0
1478,Annular Lesion,Squamous cell carcinoma of the hypopharynx stage IV,0
1479,Dilated Cystic Spaces Present,Resectable Carcinoma,0
1480,Dedifferentiated Malignant Infiltrate,Resectable Carcinoma,0
1481,Mammary Gland Type Features Present,Resectable Carcinoma,0
1482,Ectopic Tissue,Resectable Carcinoma,0
1483,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Resectable Carcinoma,0
1484,Coronary Vessel Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0
1485,Index Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0
1486,Non-Index Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0
1487,Mushroom-Shaped Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0
1488,Annular Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,0
1489,Coronary Vessel Lesion,Locally Advanced Lung Carcinoma,0
1490,Index Lesion,Locally Advanced Lung Carcinoma,0
1491,Non-Index Lesion,Locally Advanced Lung Carcinoma,0
1492,Mushroom-Shaped Lesion,Locally Advanced Lung Carcinoma,0
1493,Annular Lesion,Locally Advanced Lung Carcinoma,0
1494,Coronary Vessel Lesion,Castration-Sensitive Prostate Carcinoma,0
1495,Index Lesion,Castration-Sensitive Prostate Carcinoma,0
1496,Non-Index Lesion,Castration-Sensitive Prostate Carcinoma,0
1497,Mushroom-Shaped Lesion,Castration-Sensitive Prostate Carcinoma,0
1498,Annular Lesion,Castration-Sensitive Prostate Carcinoma,0
1499,Coronary Vessel Lesion,Metastatic Triple-Negative Breast Carcinoma,0
1500,Index Lesion,Metastatic Triple-Negative Breast Carcinoma,0
1501,Non-Index Lesion,Metastatic Triple-Negative Breast Carcinoma,0
1502,Mushroom-Shaped Lesion,Metastatic Triple-Negative Breast Carcinoma,0
1503,Annular Lesion,Metastatic Triple-Negative Breast Carcinoma,0
1504,Dilated Cystic Spaces Present,Bile duct cancer recurrent,0
1505,Dedifferentiated Malignant Infiltrate,Bile duct cancer recurrent,0
1506,Mammary Gland Type Features Present,Bile duct cancer recurrent,0
1507,Ectopic Tissue,Bile duct cancer recurrent,0
1508,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bile duct cancer recurrent,0
1509,Coronary Vessel Lesion,Metastatic Cervical Carcinoma,0
1510,Index Lesion,Metastatic Cervical Carcinoma,0
1511,Non-Index Lesion,Metastatic Cervical Carcinoma,0
1512,Mushroom-Shaped Lesion,Metastatic Cervical Carcinoma,0
1513,Annular Lesion,Metastatic Cervical Carcinoma,0
1514,Dilated Cystic Spaces Present,Recurrent Submandibular Gland Acinic Cell Carcinoma,0
1515,Dedifferentiated Malignant Infiltrate,Recurrent Submandibular Gland Acinic Cell Carcinoma,0
1516,Mammary Gland Type Features Present,Recurrent Submandibular Gland Acinic Cell Carcinoma,0
1517,Ectopic Tissue,Recurrent Submandibular Gland Acinic Cell Carcinoma,0
1518,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Submandibular Gland Acinic Cell Carcinoma,0
1519,Dilated Cystic Spaces Present,Recurrent Ovarian Mucinous Adenocarcinoma,0
1520,Dedifferentiated Malignant Infiltrate,Recurrent Ovarian Mucinous Adenocarcinoma,0
1521,Mammary Gland Type Features Present,Recurrent Ovarian Mucinous Adenocarcinoma,0
1522,Ectopic Tissue,Recurrent Ovarian Mucinous Adenocarcinoma,0
1523,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Ovarian Mucinous Adenocarcinoma,0
1524,Coronary Vessel Lesion,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,0
1525,Index Lesion,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,0
1526,Non-Index Lesion,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,0
1527,Mushroom-Shaped Lesion,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,0
1528,Annular Lesion,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,0
1529,Coronary Vessel Lesion,Hepatic cancer metastatic,0
1530,Index Lesion,Hepatic cancer metastatic,0
1531,Non-Index Lesion,Hepatic cancer metastatic,0
1532,Mushroom-Shaped Lesion,Hepatic cancer metastatic,0
1533,Annular Lesion,Hepatic cancer metastatic,0
1534,Coronary Vessel Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
1535,Index Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
1536,Non-Index Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
1537,Mushroom-Shaped Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
1538,Annular Lesion,Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,0
1539,Dilated Cystic Spaces Present,Unresectable Digestive System Neuroendocrine Carcinoma,0
1540,Dedifferentiated Malignant Infiltrate,Unresectable Digestive System Neuroendocrine Carcinoma,0
1541,Mammary Gland Type Features Present,Unresectable Digestive System Neuroendocrine Carcinoma,0
1542,Ectopic Tissue,Unresectable Digestive System Neuroendocrine Carcinoma,0
1543,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Digestive System Neuroendocrine Carcinoma,0
1544,Coronary Vessel Lesion,Stage IV Esophageal Squamous Cell Carcinoma,0
1545,Index Lesion,Stage IV Esophageal Squamous Cell Carcinoma,0
1546,Non-Index Lesion,Stage IV Esophageal Squamous Cell Carcinoma,0
1547,Mushroom-Shaped Lesion,Stage IV Esophageal Squamous Cell Carcinoma,0
1548,Annular Lesion,Stage IV Esophageal Squamous Cell Carcinoma,0
1549,Coronary Vessel Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma,0
1550,Index Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma,0
1551,Non-Index Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma,0
1552,Mushroom-Shaped Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma,0
1553,Annular Lesion,Metastatic Nasopharyngeal Undifferentiated Carcinoma,0
1554,Coronary Vessel Lesion,Stage IV Laryngeal Carcinoma,0
1555,Index Lesion,Stage IV Laryngeal Carcinoma,0
1556,Non-Index Lesion,Stage IV Laryngeal Carcinoma,0
1557,Mushroom-Shaped Lesion,Stage IV Laryngeal Carcinoma,0
1558,Annular Lesion,Stage IV Laryngeal Carcinoma,0
1559,Coronary Vessel Lesion,Metastatic Lung Non-Small Cell Carcinoma,0
1560,Index Lesion,Metastatic Lung Non-Small Cell Carcinoma,0
1561,Non-Index Lesion,Metastatic Lung Non-Small Cell Carcinoma,0
1562,Mushroom-Shaped Lesion,Metastatic Lung Non-Small Cell Carcinoma,0
1563,Annular Lesion,Metastatic Lung Non-Small Cell Carcinoma,0
1564,Coronary Vessel Lesion,Metastatic Colon Carcinoma,0
1565,Index Lesion,Metastatic Colon Carcinoma,0
1566,Non-Index Lesion,Metastatic Colon Carcinoma,0
1567,Mushroom-Shaped Lesion,Metastatic Colon Carcinoma,0
1568,Annular Lesion,Metastatic Colon Carcinoma,0
1569,Coronary Vessel Lesion,Metastatic Rectal Carcinoma,0
1570,Index Lesion,Metastatic Rectal Carcinoma,0
1571,Non-Index Lesion,Metastatic Rectal Carcinoma,0
1572,Mushroom-Shaped Lesion,Metastatic Rectal Carcinoma,0
1573,Annular Lesion,Metastatic Rectal Carcinoma,0
1574,Dilated Cystic Spaces Present,Thyroid Gland Mucinous Carcinoma,0
1575,Dedifferentiated Malignant Infiltrate,Thyroid Gland Mucinous Carcinoma,0
1576,Mammary Gland Type Features Present,Thyroid Gland Mucinous Carcinoma,0
1577,Ectopic Tissue,Thyroid Gland Mucinous Carcinoma,0
1578,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Mucinous Carcinoma,0
1579,Coronary Vessel Lesion,Locally Advanced Prostate Carcinoma,0
1580,Index Lesion,Locally Advanced Prostate Carcinoma,0
1581,Non-Index Lesion,Locally Advanced Prostate Carcinoma,0
1582,Mushroom-Shaped Lesion,Locally Advanced Prostate Carcinoma,0
1583,Annular Lesion,Locally Advanced Prostate Carcinoma,0
1584,Coronary Vessel Lesion,Locally Advanced Unresectable Cervical Carcinoma,0
1585,Index Lesion,Locally Advanced Unresectable Cervical Carcinoma,0
1586,Non-Index Lesion,Locally Advanced Unresectable Cervical Carcinoma,0
1587,Mushroom-Shaped Lesion,Locally Advanced Unresectable Cervical Carcinoma,0
1588,Annular Lesion,Locally Advanced Unresectable Cervical Carcinoma,0
1589,Coronary Vessel Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,0
1590,Index Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,0
1591,Non-Index Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,0
1592,Mushroom-Shaped Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,0
1593,Annular Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,0
1594,Coronary Vessel Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0
1595,Index Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0
1596,Non-Index Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0
1597,Mushroom-Shaped Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0
1598,Annular Lesion,Locally Advanced Microsatellite Stable Colorectal Carcinoma,0
1599,Dilated Cystic Spaces Present,Pancreatic adenocarcinoma resectable,0
1600,Dedifferentiated Malignant Infiltrate,Pancreatic adenocarcinoma resectable,0
1601,Mammary Gland Type Features Present,Pancreatic adenocarcinoma resectable,0
1602,Ectopic Tissue,Pancreatic adenocarcinoma resectable,0
1603,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic adenocarcinoma resectable,0
1604,Dilated Cystic Spaces Present,Resectable Intrahepatic Cholangiocarcinoma,0
1605,Dedifferentiated Malignant Infiltrate,Resectable Intrahepatic Cholangiocarcinoma,0
1606,Mammary Gland Type Features Present,Resectable Intrahepatic Cholangiocarcinoma,0
1607,Ectopic Tissue,Resectable Intrahepatic Cholangiocarcinoma,0
1608,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Resectable Intrahepatic Cholangiocarcinoma,0
1609,Dilated Cystic Spaces Present,Unresectable Renal Cell Carcinoma,0
1610,Dedifferentiated Malignant Infiltrate,Unresectable Renal Cell Carcinoma,0
1611,Mammary Gland Type Features Present,Unresectable Renal Cell Carcinoma,0
1612,Ectopic Tissue,Unresectable Renal Cell Carcinoma,0
1613,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Renal Cell Carcinoma,0
1614,Dilated Cystic Spaces Present,Pancreatic adenocarcinoma recurrent,0
1615,Dedifferentiated Malignant Infiltrate,Pancreatic adenocarcinoma recurrent,0
1616,Mammary Gland Type Features Present,Pancreatic adenocarcinoma recurrent,0
1617,Ectopic Tissue,Pancreatic adenocarcinoma recurrent,0
1618,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic adenocarcinoma recurrent,0
1619,Dilated Cystic Spaces Present,Unresectable Lung Non-Small Cell Carcinoma,0
1620,Dedifferentiated Malignant Infiltrate,Unresectable Lung Non-Small Cell Carcinoma,0
1621,Mammary Gland Type Features Present,Unresectable Lung Non-Small Cell Carcinoma,0
1622,Ectopic Tissue,Unresectable Lung Non-Small Cell Carcinoma,0
1623,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Lung Non-Small Cell Carcinoma,0
1624,Coronary Vessel Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,0
1625,Index Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,0
1626,Non-Index Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,0
1627,Mushroom-Shaped Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,0
1628,Annular Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,0
1629,Coronary Vessel Lesion,Metastatic Endometrial Carcinoma,0
1630,Index Lesion,Metastatic Endometrial Carcinoma,0
1631,Non-Index Lesion,Metastatic Endometrial Carcinoma,0
1632,Mushroom-Shaped Lesion,Metastatic Endometrial Carcinoma,0
1633,Annular Lesion,Metastatic Endometrial Carcinoma,0
1634,Coronary Vessel Lesion,Metastatic Adrenal Cortex Carcinoma,0
1635,Index Lesion,Metastatic Adrenal Cortex Carcinoma,0
1636,Non-Index Lesion,Metastatic Adrenal Cortex Carcinoma,0
1637,Mushroom-Shaped Lesion,Metastatic Adrenal Cortex Carcinoma,0
1638,Annular Lesion,Metastatic Adrenal Cortex Carcinoma,0
1639,Coronary Vessel Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,0
1640,Index Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,0
1641,Non-Index Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,0
1642,Mushroom-Shaped Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,0
1643,Annular Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,0
1644,Coronary Vessel Lesion,Metastatic Pharyngeal Carcinoma,0
1645,Index Lesion,Metastatic Pharyngeal Carcinoma,0
1646,Non-Index Lesion,Metastatic Pharyngeal Carcinoma,0
1647,Mushroom-Shaped Lesion,Metastatic Pharyngeal Carcinoma,0
1648,Annular Lesion,Metastatic Pharyngeal Carcinoma,0
1649,Coronary Vessel Lesion,Metastatic Hypopharyngeal Carcinoma,0
1650,Index Lesion,Metastatic Hypopharyngeal Carcinoma,0
1651,Non-Index Lesion,Metastatic Hypopharyngeal Carcinoma,0
1652,Mushroom-Shaped Lesion,Metastatic Hypopharyngeal Carcinoma,0
1653,Annular Lesion,Metastatic Hypopharyngeal Carcinoma,0
1654,Coronary Vessel Lesion,Metastatic Oral Cavity Adenoid Cystic Carcinoma,0
1655,Index Lesion,Metastatic Oral Cavity Adenoid Cystic Carcinoma,0
1656,Non-Index Lesion,Metastatic Oral Cavity Adenoid Cystic Carcinoma,0
1657,Mushroom-Shaped Lesion,Metastatic Oral Cavity Adenoid Cystic Carcinoma,0
1658,Annular Lesion,Metastatic Oral Cavity Adenoid Cystic Carcinoma,0
1659,Coronary Vessel Lesion,Advanced Prostate Carcinoma,0
1660,Index Lesion,Advanced Prostate Carcinoma,0
1661,Non-Index Lesion,Advanced Prostate Carcinoma,0
1662,Mushroom-Shaped Lesion,Advanced Prostate Carcinoma,0
1663,Annular Lesion,Advanced Prostate Carcinoma,0
1664,Coronary Vessel Lesion,Advanced Prostate Adenocarcinoma,0
1665,Index Lesion,Advanced Prostate Adenocarcinoma,0
1666,Non-Index Lesion,Advanced Prostate Adenocarcinoma,0
1667,Mushroom-Shaped Lesion,Advanced Prostate Adenocarcinoma,0
1668,Annular Lesion,Advanced Prostate Adenocarcinoma,0
1669,Coronary Vessel Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma,0
1670,Index Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma,0
1671,Non-Index Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma,0
1672,Mushroom-Shaped Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma,0
1673,Annular Lesion,Locally Advanced Unresectable Cervical Adenocarcinoma,0
1674,Dilated Cystic Spaces Present,Extrapulmonary Small Cell Carcinoma,0
1675,Dedifferentiated Malignant Infiltrate,Extrapulmonary Small Cell Carcinoma,0
1676,Mammary Gland Type Features Present,Extrapulmonary Small Cell Carcinoma,0
1677,Ectopic Tissue,Extrapulmonary Small Cell Carcinoma,0
1678,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Extrapulmonary Small Cell Carcinoma,0
1679,Coronary Vessel Lesion,Advanced Gastric Neuroendocrine Carcinoma,0
1680,Index Lesion,Advanced Gastric Neuroendocrine Carcinoma,0
1681,Non-Index Lesion,Advanced Gastric Neuroendocrine Carcinoma,0
1682,Mushroom-Shaped Lesion,Advanced Gastric Neuroendocrine Carcinoma,0
1683,Annular Lesion,Advanced Gastric Neuroendocrine Carcinoma,0
1684,Coronary Vessel Lesion,Metastatic basal cell carcinoma,0
1685,Index Lesion,Metastatic basal cell carcinoma,0
1686,Non-Index Lesion,Metastatic basal cell carcinoma,0
1687,Mushroom-Shaped Lesion,Metastatic basal cell carcinoma,0
1688,Annular Lesion,Metastatic basal cell carcinoma,0
1689,Coronary Vessel Lesion,Locally Advanced Unresectable Carcinoma,0
1690,Index Lesion,Locally Advanced Unresectable Carcinoma,0
1691,Non-Index Lesion,Locally Advanced Unresectable Carcinoma,0
1692,Mushroom-Shaped Lesion,Locally Advanced Unresectable Carcinoma,0
1693,Annular Lesion,Locally Advanced Unresectable Carcinoma,0
1694,Dilated Cystic Spaces Present,Refractory Digestive System Neuroendocrine Carcinoma,0
1695,Dedifferentiated Malignant Infiltrate,Refractory Digestive System Neuroendocrine Carcinoma,0
1696,Mammary Gland Type Features Present,Refractory Digestive System Neuroendocrine Carcinoma,0
1697,Ectopic Tissue,Refractory Digestive System Neuroendocrine Carcinoma,0
1698,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Digestive System Neuroendocrine Carcinoma,0
1699,Coronary Vessel Lesion,Metastatic Thyroid Gland Follicular Carcinoma,0
1700,Index Lesion,Metastatic Thyroid Gland Follicular Carcinoma,0
1701,Non-Index Lesion,Metastatic Thyroid Gland Follicular Carcinoma,0
1702,Mushroom-Shaped Lesion,Metastatic Thyroid Gland Follicular Carcinoma,0
1703,Annular Lesion,Metastatic Thyroid Gland Follicular Carcinoma,0
1704,Coronary Vessel Lesion,Advanced Cervical Carcinoma,0
1705,Index Lesion,Advanced Cervical Carcinoma,0
1706,Non-Index Lesion,Advanced Cervical Carcinoma,0
1707,Mushroom-Shaped Lesion,Advanced Cervical Carcinoma,0
1708,Annular Lesion,Advanced Cervical Carcinoma,0
1709,Coronary Vessel Lesion,Advanced Cervical Adenocarcinoma,0
1710,Index Lesion,Advanced Cervical Adenocarcinoma,0
1711,Non-Index Lesion,Advanced Cervical Adenocarcinoma,0
1712,Mushroom-Shaped Lesion,Advanced Cervical Adenocarcinoma,0
1713,Annular Lesion,Advanced Cervical Adenocarcinoma,0
1714,Coronary Vessel Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma,0
1715,Index Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma,0
1716,Non-Index Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma,0
1717,Mushroom-Shaped Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma,0
1718,Annular Lesion,Advanced Gastric Small Cell Neuroendocrine Carcinoma,0
1719,Coronary Vessel Lesion,Metastatic Unresectable Basal Cell Carcinoma,0
1720,Index Lesion,Metastatic Unresectable Basal Cell Carcinoma,0
1721,Non-Index Lesion,Metastatic Unresectable Basal Cell Carcinoma,0
1722,Mushroom-Shaped Lesion,Metastatic Unresectable Basal Cell Carcinoma,0
1723,Annular Lesion,Metastatic Unresectable Basal Cell Carcinoma,0
1724,Dilated Cystic Spaces Present,Resectable Digestive System Carcinoma,0
1725,Dedifferentiated Malignant Infiltrate,Resectable Digestive System Carcinoma,0
1726,Mammary Gland Type Features Present,Resectable Digestive System Carcinoma,0
1727,Ectopic Tissue,Resectable Digestive System Carcinoma,0
1728,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Resectable Digestive System Carcinoma,0
1729,Dilated Cystic Spaces Present,Refractory Hormone Receptor Positive Breast Carcinoma,0
1730,Dedifferentiated Malignant Infiltrate,Refractory Hormone Receptor Positive Breast Carcinoma,0
1731,Mammary Gland Type Features Present,Refractory Hormone Receptor Positive Breast Carcinoma,0
1732,Ectopic Tissue,Refractory Hormone Receptor Positive Breast Carcinoma,0
1733,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Hormone Receptor Positive Breast Carcinoma,0
1734,Dilated Cystic Spaces Present,MiT Family Translocation-Associated Renal Cell Carcinoma,0
1735,Dedifferentiated Malignant Infiltrate,MiT Family Translocation-Associated Renal Cell Carcinoma,0
1736,Mammary Gland Type Features Present,MiT Family Translocation-Associated Renal Cell Carcinoma,0
1737,Ectopic Tissue,MiT Family Translocation-Associated Renal Cell Carcinoma,0
1738,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,MiT Family Translocation-Associated Renal Cell Carcinoma,0
1739,Dilated Cystic Spaces Present,Transplant-Related Squamous Cell Carcinoma,0
1740,Dedifferentiated Malignant Infiltrate,Transplant-Related Squamous Cell Carcinoma,0
1741,Mammary Gland Type Features Present,Transplant-Related Squamous Cell Carcinoma,0
1742,Ectopic Tissue,Transplant-Related Squamous Cell Carcinoma,0
1743,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Transplant-Related Squamous Cell Carcinoma,0
1744,Dilated Cystic Spaces Present,Recurrent Endometrial Undifferentiated Carcinoma,0
1745,Dedifferentiated Malignant Infiltrate,Recurrent Endometrial Undifferentiated Carcinoma,0
1746,Mammary Gland Type Features Present,Recurrent Endometrial Undifferentiated Carcinoma,0
1747,Ectopic Tissue,Recurrent Endometrial Undifferentiated Carcinoma,0
1748,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Endometrial Undifferentiated Carcinoma,0
1749,Dilated Cystic Spaces Present,Recurrent Endometrial Mixed Cell Adenocarcinoma,0
1750,Dedifferentiated Malignant Infiltrate,Recurrent Endometrial Mixed Cell Adenocarcinoma,0
1751,Mammary Gland Type Features Present,Recurrent Endometrial Mixed Cell Adenocarcinoma,0
1752,Ectopic Tissue,Recurrent Endometrial Mixed Cell Adenocarcinoma,0
1753,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Endometrial Mixed Cell Adenocarcinoma,0
1754,Coronary Vessel Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,0
1755,Index Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,0
1756,Non-Index Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,0
1757,Mushroom-Shaped Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,0
1758,Annular Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,0
1759,Dilated Cystic Spaces Present,Unresectable Lung Carcinoma,0
1760,Dedifferentiated Malignant Infiltrate,Unresectable Lung Carcinoma,0
1761,Mammary Gland Type Features Present,Unresectable Lung Carcinoma,0
1762,Ectopic Tissue,Unresectable Lung Carcinoma,0
1763,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Lung Carcinoma,0
1764,Coronary Vessel Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,0
1765,Index Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,0
1766,Non-Index Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,0
1767,Mushroom-Shaped Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,0
1768,Annular Lesion,Locally Advanced Pancreatic Neuroendocrine Carcinoma,0
1769,Dilated Cystic Spaces Present,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome,0
1770,Dedifferentiated Malignant Infiltrate,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome,0
1771,Mammary Gland Type Features Present,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome,0
1772,Ectopic Tissue,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome,0
1773,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Chromophobe Renal Cell Carcinoma Associated with Birt-Hogg-Dube Syndrome,0
1774,Dilated Cystic Spaces Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0
1775,Dedifferentiated Malignant Infiltrate,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0
1776,Mammary Gland Type Features Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0
1777,Ectopic Tissue,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0
1778,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,0
1779,Coronary Vessel Lesion,Metastatic Vulvar Carcinoma,0
1780,Index Lesion,Metastatic Vulvar Carcinoma,0
1781,Non-Index Lesion,Metastatic Vulvar Carcinoma,0
1782,Mushroom-Shaped Lesion,Metastatic Vulvar Carcinoma,0
1783,Annular Lesion,Metastatic Vulvar Carcinoma,0
1784,Coronary Vessel Lesion,Metastatic Esophageal Carcinoma,0
1785,Index Lesion,Metastatic Esophageal Carcinoma,0
1786,Non-Index Lesion,Metastatic Esophageal Carcinoma,0
1787,Mushroom-Shaped Lesion,Metastatic Esophageal Carcinoma,0
1788,Annular Lesion,Metastatic Esophageal Carcinoma,0
1789,Coronary Vessel Lesion,Metastatic Oral Cavity Carcinoma,0
1790,Index Lesion,Metastatic Oral Cavity Carcinoma,0
1791,Non-Index Lesion,Metastatic Oral Cavity Carcinoma,0
1792,Mushroom-Shaped Lesion,Metastatic Oral Cavity Carcinoma,0
1793,Annular Lesion,Metastatic Oral Cavity Carcinoma,0
1794,Coronary Vessel Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma,0
1795,Index Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma,0
1796,Non-Index Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma,0
1797,Mushroom-Shaped Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma,0
1798,Annular Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma,0
1799,Coronary Vessel Lesion,Metastatic Lip Squamous Cell Carcinoma,0
1800,Index Lesion,Metastatic Lip Squamous Cell Carcinoma,0
1801,Non-Index Lesion,Metastatic Lip Squamous Cell Carcinoma,0
1802,Mushroom-Shaped Lesion,Metastatic Lip Squamous Cell Carcinoma,0
1803,Annular Lesion,Metastatic Lip Squamous Cell Carcinoma,0
1804,Coronary Vessel Lesion,Metastatic Colorectal Carcinoma,0
1805,Index Lesion,Metastatic Colorectal Carcinoma,0
1806,Non-Index Lesion,Metastatic Colorectal Carcinoma,0
1807,Mushroom-Shaped Lesion,Metastatic Colorectal Carcinoma,0
1808,Annular Lesion,Metastatic Colorectal Carcinoma,0
1809,Coronary Vessel Lesion,Locally Advanced Prostate Adenocarcinoma,0
1810,Index Lesion,Locally Advanced Prostate Adenocarcinoma,0
1811,Non-Index Lesion,Locally Advanced Prostate Adenocarcinoma,0
1812,Mushroom-Shaped Lesion,Locally Advanced Prostate Adenocarcinoma,0
1813,Annular Lesion,Locally Advanced Prostate Adenocarcinoma,0
1814,Dilated Cystic Spaces Present,Recurrent Low Grade Ovarian Serous Adenocarcinoma,0
1815,Dedifferentiated Malignant Infiltrate,Recurrent Low Grade Ovarian Serous Adenocarcinoma,0
1816,Mammary Gland Type Features Present,Recurrent Low Grade Ovarian Serous Adenocarcinoma,0
1817,Ectopic Tissue,Recurrent Low Grade Ovarian Serous Adenocarcinoma,0
1818,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Low Grade Ovarian Serous Adenocarcinoma,0
1819,Dilated Cystic Spaces Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,0
1820,Dedifferentiated Malignant Infiltrate,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,0
1821,Mammary Gland Type Features Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,0
1822,Ectopic Tissue,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,0
1823,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,0
1824,Coronary Vessel Lesion,Metastatic Gastric Neuroendocrine Carcinoma,0
1825,Index Lesion,Metastatic Gastric Neuroendocrine Carcinoma,0
1826,Non-Index Lesion,Metastatic Gastric Neuroendocrine Carcinoma,0
1827,Mushroom-Shaped Lesion,Metastatic Gastric Neuroendocrine Carcinoma,0
1828,Annular Lesion,Metastatic Gastric Neuroendocrine Carcinoma,0
1829,Coronary Vessel Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,0
1830,Index Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,0
1831,Non-Index Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,0
1832,Mushroom-Shaped Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,0
1833,Annular Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,0
1834,Coronary Vessel Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,0
1835,Index Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,0
1836,Non-Index Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,0
1837,Mushroom-Shaped Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,0
1838,Annular Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,0
1839,Coronary Vessel Lesion,Advanced Digestive System Carcinoma,0
1840,Index Lesion,Advanced Digestive System Carcinoma,0
1841,Non-Index Lesion,Advanced Digestive System Carcinoma,0
1842,Mushroom-Shaped Lesion,Advanced Digestive System Carcinoma,0
1843,Annular Lesion,Advanced Digestive System Carcinoma,0
1844,Dilated Cystic Spaces Present,Basal cell carcinoma,0
1845,Dedifferentiated Malignant Infiltrate,Basal cell carcinoma,0
1846,Mammary Gland Type Features Present,Basal cell carcinoma,0
1847,Ectopic Tissue,Basal cell carcinoma,0
1848,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Basal cell carcinoma,0
1849,Dilated Cystic Spaces Present,Biliary Tract Carcinoma,0
1850,Dedifferentiated Malignant Infiltrate,Biliary Tract Carcinoma,0
1851,Mammary Gland Type Features Present,Biliary Tract Carcinoma,0
1852,Ectopic Tissue,Biliary Tract Carcinoma,0
1853,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Biliary Tract Carcinoma,0
1854,Coronary Vessel Lesion,Locally Advanced Unresectable Basal Cell Carcinoma,0
1855,Index Lesion,Locally Advanced Unresectable Basal Cell Carcinoma,0
1856,Non-Index Lesion,Locally Advanced Unresectable Basal Cell Carcinoma,0
1857,Mushroom-Shaped Lesion,Locally Advanced Unresectable Basal Cell Carcinoma,0
1858,Annular Lesion,Locally Advanced Unresectable Basal Cell Carcinoma,0
1859,Dilated Cystic Spaces Present,Digestive System Large Cell Neuroendocrine Carcinoma,0
1860,Dedifferentiated Malignant Infiltrate,Digestive System Large Cell Neuroendocrine Carcinoma,0
1861,Mammary Gland Type Features Present,Digestive System Large Cell Neuroendocrine Carcinoma,0
1862,Ectopic Tissue,Digestive System Large Cell Neuroendocrine Carcinoma,0
1863,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Digestive System Large Cell Neuroendocrine Carcinoma,0
1864,Dilated Cystic Spaces Present,Recurrent Endometrial Clear Cell Adenocarcinoma,0
1865,Dedifferentiated Malignant Infiltrate,Recurrent Endometrial Clear Cell Adenocarcinoma,0
1866,Mammary Gland Type Features Present,Recurrent Endometrial Clear Cell Adenocarcinoma,0
1867,Ectopic Tissue,Recurrent Endometrial Clear Cell Adenocarcinoma,0
1868,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Endometrial Clear Cell Adenocarcinoma,0
1869,Coronary Vessel Lesion,Advanced Neuroendocrine Carcinoma,0
1870,Index Lesion,Advanced Neuroendocrine Carcinoma,0
1871,Non-Index Lesion,Advanced Neuroendocrine Carcinoma,0
1872,Mushroom-Shaped Lesion,Advanced Neuroendocrine Carcinoma,0
1873,Annular Lesion,Advanced Neuroendocrine Carcinoma,0
1874,Coronary Vessel Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,0
1875,Index Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,0
1876,Non-Index Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,0
1877,Mushroom-Shaped Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,0
1878,Annular Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,0
1879,Coronary Vessel Lesion,Stage IV Ovarian Carcinoma,0
1880,Index Lesion,Stage IV Ovarian Carcinoma,0
1881,Non-Index Lesion,Stage IV Ovarian Carcinoma,0
1882,Mushroom-Shaped Lesion,Stage IV Ovarian Carcinoma,0
1883,Annular Lesion,Stage IV Ovarian Carcinoma,0
1884,Coronary Vessel Lesion,Metastatic Vaginal Carcinoma,0
1885,Index Lesion,Metastatic Vaginal Carcinoma,0
1886,Non-Index Lesion,Metastatic Vaginal Carcinoma,0
1887,Mushroom-Shaped Lesion,Metastatic Vaginal Carcinoma,0
1888,Annular Lesion,Metastatic Vaginal Carcinoma,0
1889,Coronary Vessel Lesion,stage IV pancreatic cancer,0
1890,Index Lesion,stage IV pancreatic cancer,0
1891,Non-Index Lesion,stage IV pancreatic cancer,0
1892,Mushroom-Shaped Lesion,stage IV pancreatic cancer,0
1893,Annular Lesion,stage IV pancreatic cancer,0
1894,Coronary Vessel Lesion,Metastatic Oropharyngeal Carcinoma,0
1895,Index Lesion,Metastatic Oropharyngeal Carcinoma,0
1896,Non-Index Lesion,Metastatic Oropharyngeal Carcinoma,0
1897,Mushroom-Shaped Lesion,Metastatic Oropharyngeal Carcinoma,0
1898,Annular Lesion,Metastatic Oropharyngeal Carcinoma,0
1899,Coronary Vessel Lesion,Lung squamous cell carcinoma stage IV,0
1900,Index Lesion,Lung squamous cell carcinoma stage IV,0
1901,Non-Index Lesion,Lung squamous cell carcinoma stage IV,0
1902,Mushroom-Shaped Lesion,Lung squamous cell carcinoma stage IV,0
1903,Annular Lesion,Lung squamous cell carcinoma stage IV,0
1904,Coronary Vessel Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,0
1905,Index Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,0
1906,Non-Index Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,0
1907,Mushroom-Shaped Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,0
1908,Annular Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,0
1909,Dilated Cystic Spaces Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,0
1910,Dedifferentiated Malignant Infiltrate,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,0
1911,Mammary Gland Type Features Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,0
1912,Ectopic Tissue,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,0
1913,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,0
1914,Dilated Cystic Spaces Present,Resectable Pancreatic Acinar Cell Carcinoma,0
1915,Dedifferentiated Malignant Infiltrate,Resectable Pancreatic Acinar Cell Carcinoma,0
1916,Mammary Gland Type Features Present,Resectable Pancreatic Acinar Cell Carcinoma,0
1917,Ectopic Tissue,Resectable Pancreatic Acinar Cell Carcinoma,0
1918,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Resectable Pancreatic Acinar Cell Carcinoma,0
1919,Dilated Cystic Spaces Present,Bile duct adenocarcinoma resectable,0
1920,Dedifferentiated Malignant Infiltrate,Bile duct adenocarcinoma resectable,0
1921,Mammary Gland Type Features Present,Bile duct adenocarcinoma resectable,0
1922,Ectopic Tissue,Bile duct adenocarcinoma resectable,0
1923,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bile duct adenocarcinoma resectable,0
1924,Dilated Cystic Spaces Present,Digestive System Small Cell Neuroendocrine Carcinoma,0
1925,Dedifferentiated Malignant Infiltrate,Digestive System Small Cell Neuroendocrine Carcinoma,0
1926,Mammary Gland Type Features Present,Digestive System Small Cell Neuroendocrine Carcinoma,0
1927,Ectopic Tissue,Digestive System Small Cell Neuroendocrine Carcinoma,0
1928,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Digestive System Small Cell Neuroendocrine Carcinoma,0
1929,Coronary Vessel Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma,0
1930,Index Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma,0
1931,Non-Index Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma,0
1932,Mushroom-Shaped Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma,0
1933,Annular Lesion,Locally Advanced Unresectable Pancreatic Adenocarcinoma,0
1934,Coronary Vessel Lesion,Metastatic Lung Adenocarcinoma,0
1935,Index Lesion,Metastatic Lung Adenocarcinoma,0
1936,Non-Index Lesion,Metastatic Lung Adenocarcinoma,0
1937,Mushroom-Shaped Lesion,Metastatic Lung Adenocarcinoma,0
1938,Annular Lesion,Metastatic Lung Adenocarcinoma,0
1939,Dilated Cystic Spaces Present,Recurrent Digestive System Neuroendocrine Carcinoma,0
1940,Dedifferentiated Malignant Infiltrate,Recurrent Digestive System Neuroendocrine Carcinoma,0
1941,Mammary Gland Type Features Present,Recurrent Digestive System Neuroendocrine Carcinoma,0
1942,Ectopic Tissue,Recurrent Digestive System Neuroendocrine Carcinoma,0
1943,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Digestive System Neuroendocrine Carcinoma,0
1944,Dilated Cystic Spaces Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma,0
1945,Dedifferentiated Malignant Infiltrate,Encapsulated Variant Thyroid Gland Papillary Carcinoma,0
1946,Mammary Gland Type Features Present,Encapsulated Variant Thyroid Gland Papillary Carcinoma,0
1947,Ectopic Tissue,Encapsulated Variant Thyroid Gland Papillary Carcinoma,0
1948,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Encapsulated Variant Thyroid Gland Papillary Carcinoma,0
1949,Coronary Vessel Lesion,Metastatic Lung Small Cell Carcinoma,0
1950,Index Lesion,Metastatic Lung Small Cell Carcinoma,0
1951,Non-Index Lesion,Metastatic Lung Small Cell Carcinoma,0
1952,Mushroom-Shaped Lesion,Metastatic Lung Small Cell Carcinoma,0
1953,Annular Lesion,Metastatic Lung Small Cell Carcinoma,0
1954,Coronary Vessel Lesion,Metastatic Thyroid Gland Papillary Carcinoma,0
1955,Index Lesion,Metastatic Thyroid Gland Papillary Carcinoma,0
1956,Non-Index Lesion,Metastatic Thyroid Gland Papillary Carcinoma,0
1957,Mushroom-Shaped Lesion,Metastatic Thyroid Gland Papillary Carcinoma,0
1958,Annular Lesion,Metastatic Thyroid Gland Papillary Carcinoma,0
1959,Dilated Cystic Spaces Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
1960,Dedifferentiated Malignant Infiltrate,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
1961,Mammary Gland Type Features Present,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
1962,Ectopic Tissue,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
1963,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",0
1964,Dilated Cystic Spaces Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0
1965,Dedifferentiated Malignant Infiltrate,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0
1966,Mammary Gland Type Features Present,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0
1967,Ectopic Tissue,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0
1968,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thyroid Gland Follicular Carcinoma, Widely Invasive",0
1969,Dilated Cystic Spaces Present,Localized Gastroesophageal Junction Adenocarcinoma,0
1970,Dedifferentiated Malignant Infiltrate,Localized Gastroesophageal Junction Adenocarcinoma,0
1971,Mammary Gland Type Features Present,Localized Gastroesophageal Junction Adenocarcinoma,0
1972,Ectopic Tissue,Localized Gastroesophageal Junction Adenocarcinoma,0
1973,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Localized Gastroesophageal Junction Adenocarcinoma,0
1974,Coronary Vessel Lesion,Locally Advanced Pancreatic Adenocarcinoma,0
1975,Index Lesion,Locally Advanced Pancreatic Adenocarcinoma,0
1976,Non-Index Lesion,Locally Advanced Pancreatic Adenocarcinoma,0
1977,Mushroom-Shaped Lesion,Locally Advanced Pancreatic Adenocarcinoma,0
1978,Annular Lesion,Locally Advanced Pancreatic Adenocarcinoma,0
1979,Coronary Vessel Lesion,Locally Advanced Cervical Carcinoma,0
1980,Index Lesion,Locally Advanced Cervical Carcinoma,0
1981,Non-Index Lesion,Locally Advanced Cervical Carcinoma,0
1982,Mushroom-Shaped Lesion,Locally Advanced Cervical Carcinoma,0
1983,Annular Lesion,Locally Advanced Cervical Carcinoma,0
1984,Coronary Vessel Lesion,Locally Advanced Cervical Adenocarcinoma,0
1985,Index Lesion,Locally Advanced Cervical Adenocarcinoma,0
1986,Non-Index Lesion,Locally Advanced Cervical Adenocarcinoma,0
1987,Mushroom-Shaped Lesion,Locally Advanced Cervical Adenocarcinoma,0
1988,Annular Lesion,Locally Advanced Cervical Adenocarcinoma,0
1989,Coronary Vessel Lesion,Locally Advanced Basal Cell Carcinoma,0
1990,Index Lesion,Locally Advanced Basal Cell Carcinoma,0
1991,Non-Index Lesion,Locally Advanced Basal Cell Carcinoma,0
1992,Mushroom-Shaped Lesion,Locally Advanced Basal Cell Carcinoma,0
1993,Annular Lesion,Locally Advanced Basal Cell Carcinoma,0
1994,Dilated Cystic Spaces Present,Resectable Renal Cell Carcinoma,0
1995,Dedifferentiated Malignant Infiltrate,Resectable Renal Cell Carcinoma,0
1996,Mammary Gland Type Features Present,Resectable Renal Cell Carcinoma,0
1997,Ectopic Tissue,Resectable Renal Cell Carcinoma,0
1998,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Resectable Renal Cell Carcinoma,0
1999,Dilated Cystic Spaces Present,Adenocarcinoma gastric recurrent,0
2000,Dedifferentiated Malignant Infiltrate,Adenocarcinoma gastric recurrent,0
2001,Mammary Gland Type Features Present,Adenocarcinoma gastric recurrent,0
2002,Ectopic Tissue,Adenocarcinoma gastric recurrent,0
2003,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adenocarcinoma gastric recurrent,0
2004,Coronary Vessel Lesion,Locally Advanced Unresectable Renal Cell Carcinoma,0
2005,Index Lesion,Locally Advanced Unresectable Renal Cell Carcinoma,0
2006,Non-Index Lesion,Locally Advanced Unresectable Renal Cell Carcinoma,0
2007,Mushroom-Shaped Lesion,Locally Advanced Unresectable Renal Cell Carcinoma,0
2008,Annular Lesion,Locally Advanced Unresectable Renal Cell Carcinoma,0
2009,Coronary Vessel Lesion,"Neuroendocrine carcinoma, metastatic",0
2010,Index Lesion,"Neuroendocrine carcinoma, metastatic",0
2011,Non-Index Lesion,"Neuroendocrine carcinoma, metastatic",0
2012,Mushroom-Shaped Lesion,"Neuroendocrine carcinoma, metastatic",0
2013,Annular Lesion,"Neuroendocrine carcinoma, metastatic",0
2014,Dilated Cystic Spaces Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,0
2015,Dedifferentiated Malignant Infiltrate,Hobnail Variant Thyroid Gland Papillary Carcinoma,0
2016,Mammary Gland Type Features Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,0
2017,Ectopic Tissue,Hobnail Variant Thyroid Gland Papillary Carcinoma,0
2018,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hobnail Variant Thyroid Gland Papillary Carcinoma,0
2019,Coronary Vessel Lesion,Bladder cancer stage IV,0
2020,Index Lesion,Bladder cancer stage IV,0
2021,Non-Index Lesion,Bladder cancer stage IV,0
2022,Mushroom-Shaped Lesion,Bladder cancer stage IV,0
2023,Annular Lesion,Bladder cancer stage IV,0
2024,Coronary Vessel Lesion,Stage IV Nasopharyngeal Carcinoma,0
2025,Index Lesion,Stage IV Nasopharyngeal Carcinoma,0
2026,Non-Index Lesion,Stage IV Nasopharyngeal Carcinoma,0
2027,Mushroom-Shaped Lesion,Stage IV Nasopharyngeal Carcinoma,0
2028,Annular Lesion,Stage IV Nasopharyngeal Carcinoma,0
2029,Coronary Vessel Lesion,Metastatic Lip and Oral Cavity Carcinoma,0
2030,Index Lesion,Metastatic Lip and Oral Cavity Carcinoma,0
2031,Non-Index Lesion,Metastatic Lip and Oral Cavity Carcinoma,0
2032,Mushroom-Shaped Lesion,Metastatic Lip and Oral Cavity Carcinoma,0
2033,Annular Lesion,Metastatic Lip and Oral Cavity Carcinoma,0
2034,Coronary Vessel Lesion,Locally Advanced Unresectable Prostate Carcinoma,0
2035,Index Lesion,Locally Advanced Unresectable Prostate Carcinoma,0
2036,Non-Index Lesion,Locally Advanced Unresectable Prostate Carcinoma,0
2037,Mushroom-Shaped Lesion,Locally Advanced Unresectable Prostate Carcinoma,0
2038,Annular Lesion,Locally Advanced Unresectable Prostate Carcinoma,0
2039,Dilated Cystic Spaces Present,Recurrent Primary Peritoneal Serous Adenocarcinoma,0
2040,Dedifferentiated Malignant Infiltrate,Recurrent Primary Peritoneal Serous Adenocarcinoma,0
2041,Mammary Gland Type Features Present,Recurrent Primary Peritoneal Serous Adenocarcinoma,0
2042,Ectopic Tissue,Recurrent Primary Peritoneal Serous Adenocarcinoma,0
2043,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Primary Peritoneal Serous Adenocarcinoma,0
2044,Dilated Cystic Spaces Present,Resectable Extrahepatic Bile Duct Adenocarcinoma,0
2045,Dedifferentiated Malignant Infiltrate,Resectable Extrahepatic Bile Duct Adenocarcinoma,0
2046,Mammary Gland Type Features Present,Resectable Extrahepatic Bile Duct Adenocarcinoma,0
2047,Ectopic Tissue,Resectable Extrahepatic Bile Duct Adenocarcinoma,0
2048,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Resectable Extrahepatic Bile Duct Adenocarcinoma,0
2049,Dilated Cystic Spaces Present,Hormone Receptor Positive Breast Carcinoma,0
2050,Dedifferentiated Malignant Infiltrate,Hormone Receptor Positive Breast Carcinoma,0
2051,Mammary Gland Type Features Present,Hormone Receptor Positive Breast Carcinoma,0
2052,Ectopic Tissue,Hormone Receptor Positive Breast Carcinoma,0
2053,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hormone Receptor Positive Breast Carcinoma,0
2054,Dilated Cystic Spaces Present,Recurrent Uterine Corpus Carcinosarcoma,0
2055,Dedifferentiated Malignant Infiltrate,Recurrent Uterine Corpus Carcinosarcoma,0
2056,Mammary Gland Type Features Present,Recurrent Uterine Corpus Carcinosarcoma,0
2057,Ectopic Tissue,Recurrent Uterine Corpus Carcinosarcoma,0
2058,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Uterine Corpus Carcinosarcoma,0
2059,Dilated Cystic Spaces Present,Unresectable Digestive System Carcinoma,0
2060,Dedifferentiated Malignant Infiltrate,Unresectable Digestive System Carcinoma,0
2061,Mammary Gland Type Features Present,Unresectable Digestive System Carcinoma,0
2062,Ectopic Tissue,Unresectable Digestive System Carcinoma,0
2063,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Digestive System Carcinoma,0
2064,Coronary Vessel Lesion,Metastatic Fallopian Tube Carcinoma,0
2065,Index Lesion,Metastatic Fallopian Tube Carcinoma,0
2066,Non-Index Lesion,Metastatic Fallopian Tube Carcinoma,0
2067,Mushroom-Shaped Lesion,Metastatic Fallopian Tube Carcinoma,0
2068,Annular Lesion,Metastatic Fallopian Tube Carcinoma,0
2069,Coronary Vessel Lesion,Stage IV Esophageal Adenocarcinoma,0
2070,Index Lesion,Stage IV Esophageal Adenocarcinoma,0
2071,Non-Index Lesion,Stage IV Esophageal Adenocarcinoma,0
2072,Mushroom-Shaped Lesion,Stage IV Esophageal Adenocarcinoma,0
2073,Annular Lesion,Stage IV Esophageal Adenocarcinoma,0
2074,Coronary Vessel Lesion,Metastatic Lip Carcinoma,0
2075,Index Lesion,Metastatic Lip Carcinoma,0
2076,Non-Index Lesion,Metastatic Lip Carcinoma,0
2077,Mushroom-Shaped Lesion,Metastatic Lip Carcinoma,0
2078,Annular Lesion,Metastatic Lip Carcinoma,0
2079,Coronary Vessel Lesion,Metastatic Lung Adenosquamous Carcinoma,0
2080,Index Lesion,Metastatic Lung Adenosquamous Carcinoma,0
2081,Non-Index Lesion,Metastatic Lung Adenosquamous Carcinoma,0
2082,Mushroom-Shaped Lesion,Metastatic Lung Adenosquamous Carcinoma,0
2083,Annular Lesion,Metastatic Lung Adenosquamous Carcinoma,0
2084,Dilated Cystic Spaces Present,Localized Gastric Carcinoma,0
2085,Dedifferentiated Malignant Infiltrate,Localized Gastric Carcinoma,0
2086,Mammary Gland Type Features Present,Localized Gastric Carcinoma,0
2087,Ectopic Tissue,Localized Gastric Carcinoma,0
2088,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Localized Gastric Carcinoma,0
2089,Dilated Cystic Spaces Present,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,0
2090,Dedifferentiated Malignant Infiltrate,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,0
2091,Mammary Gland Type Features Present,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,0
2092,Ectopic Tissue,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,0
2093,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,0
2094,Coronary Vessel Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,0
2095,Index Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,0
2096,Non-Index Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,0
2097,Mushroom-Shaped Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,0
2098,Annular Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,0
2099,Coronary Vessel Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,0
2100,Index Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,0
2101,Non-Index Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,0
2102,Mushroom-Shaped Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,0
2103,Annular Lesion,Metastatic Small Intestinal Neuroendocrine Carcinoma,0
2104,Dilated Cystic Spaces Present,Biochemically Recurrent Prostate Carcinoma,0
2105,Dedifferentiated Malignant Infiltrate,Biochemically Recurrent Prostate Carcinoma,0
2106,Mammary Gland Type Features Present,Biochemically Recurrent Prostate Carcinoma,0
2107,Ectopic Tissue,Biochemically Recurrent Prostate Carcinoma,0
2108,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Biochemically Recurrent Prostate Carcinoma,0
2109,Dilated Cystic Spaces Present,Recurrent Biliary Tract Carcinoma,0
2110,Dedifferentiated Malignant Infiltrate,Recurrent Biliary Tract Carcinoma,0
2111,Mammary Gland Type Features Present,Recurrent Biliary Tract Carcinoma,0
2112,Ectopic Tissue,Recurrent Biliary Tract Carcinoma,0
2113,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Biliary Tract Carcinoma,0
2114,Dilated Cystic Spaces Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,0
2115,Dedifferentiated Malignant Infiltrate,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,0
2116,Mammary Gland Type Features Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,0
2117,Ectopic Tissue,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,0
2118,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,0
2119,Dilated Cystic Spaces Present,Histiocytoid Breast Carcinoma,0
2120,Dedifferentiated Malignant Infiltrate,Histiocytoid Breast Carcinoma,0
2121,Mammary Gland Type Features Present,Histiocytoid Breast Carcinoma,0
2122,Ectopic Tissue,Histiocytoid Breast Carcinoma,0
2123,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Histiocytoid Breast Carcinoma,0
2124,Dilated Cystic Spaces Present,Borderline Resectable Pancreatic Carcinoma,0
2125,Dedifferentiated Malignant Infiltrate,Borderline Resectable Pancreatic Carcinoma,0
2126,Mammary Gland Type Features Present,Borderline Resectable Pancreatic Carcinoma,0
2127,Ectopic Tissue,Borderline Resectable Pancreatic Carcinoma,0
2128,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Resectable Pancreatic Carcinoma,0
2129,Dilated Cystic Spaces Present,Borderline Resectable Pancreatic Adenocarcinoma,0
2130,Dedifferentiated Malignant Infiltrate,Borderline Resectable Pancreatic Adenocarcinoma,0
2131,Mammary Gland Type Features Present,Borderline Resectable Pancreatic Adenocarcinoma,0
2132,Ectopic Tissue,Borderline Resectable Pancreatic Adenocarcinoma,0
2133,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Resectable Pancreatic Adenocarcinoma,0
2134,Dilated Cystic Spaces Present,Recurrent Adenoid Cystic Carcinoma,0
2135,Dedifferentiated Malignant Infiltrate,Recurrent Adenoid Cystic Carcinoma,0
2136,Mammary Gland Type Features Present,Recurrent Adenoid Cystic Carcinoma,0
2137,Ectopic Tissue,Recurrent Adenoid Cystic Carcinoma,0
2138,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Adenoid Cystic Carcinoma,0
2139,Coronary Vessel Lesion,Metastatic Bladder Squamous Cell Carcinoma,0
2140,Index Lesion,Metastatic Bladder Squamous Cell Carcinoma,0
2141,Non-Index Lesion,Metastatic Bladder Squamous Cell Carcinoma,0
2142,Mushroom-Shaped Lesion,Metastatic Bladder Squamous Cell Carcinoma,0
2143,Annular Lesion,Metastatic Bladder Squamous Cell Carcinoma,0
2144,Coronary Vessel Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",0
2145,Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",0
2146,Non-Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",0
2147,Mushroom-Shaped Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",0
2148,Annular Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",0
2149,Dilated Cystic Spaces Present,BAP1-Mutant Clear Cell Renal Cell Carcinoma,0
2150,Dedifferentiated Malignant Infiltrate,BAP1-Mutant Clear Cell Renal Cell Carcinoma,0
2151,Mammary Gland Type Features Present,BAP1-Mutant Clear Cell Renal Cell Carcinoma,0
2152,Ectopic Tissue,BAP1-Mutant Clear Cell Renal Cell Carcinoma,0
2153,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,BAP1-Mutant Clear Cell Renal Cell Carcinoma,0
2154,Coronary Vessel Lesion,Cholangiocarcinoma metastatic,0
2155,Index Lesion,Cholangiocarcinoma metastatic,0
2156,Non-Index Lesion,Cholangiocarcinoma metastatic,0
2157,Mushroom-Shaped Lesion,Cholangiocarcinoma metastatic,0
2158,Annular Lesion,Cholangiocarcinoma metastatic,0
2159,Dilated Cystic Spaces Present,large cell neuroendocrine carcinoma of bladder,0
2160,Dedifferentiated Malignant Infiltrate,large cell neuroendocrine carcinoma of bladder,0
2161,Mammary Gland Type Features Present,large cell neuroendocrine carcinoma of bladder,0
2162,Ectopic Tissue,large cell neuroendocrine carcinoma of bladder,0
2163,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,large cell neuroendocrine carcinoma of bladder,0
2164,Coronary Vessel Lesion,Metastatic Bladder Small Cell Carcinoma,0
2165,Index Lesion,Metastatic Bladder Small Cell Carcinoma,0
2166,Non-Index Lesion,Metastatic Bladder Small Cell Carcinoma,0
2167,Mushroom-Shaped Lesion,Metastatic Bladder Small Cell Carcinoma,0
2168,Annular Lesion,Metastatic Bladder Small Cell Carcinoma,0
2169,Coronary Vessel Lesion,Metastatic Prostate Small Cell Carcinoma,0
2170,Index Lesion,Metastatic Prostate Small Cell Carcinoma,0
2171,Non-Index Lesion,Metastatic Prostate Small Cell Carcinoma,0
2172,Mushroom-Shaped Lesion,Metastatic Prostate Small Cell Carcinoma,0
2173,Annular Lesion,Metastatic Prostate Small Cell Carcinoma,0
2174,Coronary Vessel Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
2175,Index Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
2176,Non-Index Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
2177,Mushroom-Shaped Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
2178,Annular Lesion,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,0
2179,Coronary Vessel Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
2180,Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
2181,Non-Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
2182,Mushroom-Shaped Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
2183,Annular Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",0
2184,Dilated Cystic Spaces Present,Refractory Cholangiocarcinoma,0
2185,Dedifferentiated Malignant Infiltrate,Refractory Cholangiocarcinoma,0
2186,Mammary Gland Type Features Present,Refractory Cholangiocarcinoma,0
2187,Ectopic Tissue,Refractory Cholangiocarcinoma,0
2188,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Cholangiocarcinoma,0
2189,Coronary Vessel Lesion,Advanced Uterine Corpus Carcinosarcoma,0
2190,Index Lesion,Advanced Uterine Corpus Carcinosarcoma,0
2191,Non-Index Lesion,Advanced Uterine Corpus Carcinosarcoma,0
2192,Mushroom-Shaped Lesion,Advanced Uterine Corpus Carcinosarcoma,0
2193,Annular Lesion,Advanced Uterine Corpus Carcinosarcoma,0
2194,Dilated Cystic Spaces Present,Unresectable Skin Basal Cell Carcinoma,0
2195,Dedifferentiated Malignant Infiltrate,Unresectable Skin Basal Cell Carcinoma,0
2196,Mammary Gland Type Features Present,Unresectable Skin Basal Cell Carcinoma,0
2197,Ectopic Tissue,Unresectable Skin Basal Cell Carcinoma,0
2198,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Skin Basal Cell Carcinoma,0
2199,Coronary Vessel Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,0
2200,Index Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,0
2201,Non-Index Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,0
2202,Mushroom-Shaped Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,0
2203,Annular Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,0
2204,Coronary Vessel Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma,0
2205,Index Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma,0
2206,Non-Index Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma,0
2207,Mushroom-Shaped Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma,0
2208,Annular Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma,0
2209,Coronary Vessel Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2210,Index Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2211,Non-Index Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2212,Mushroom-Shaped Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2213,Annular Lesion,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
2214,Coronary Vessel Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,0
2215,Index Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,0
2216,Non-Index Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,0
2217,Mushroom-Shaped Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,0
2218,Annular Lesion,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,0
2219,Coronary Vessel Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,0
2220,Index Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,0
2221,Non-Index Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,0
2222,Mushroom-Shaped Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,0
2223,Annular Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,0
2224,Dilated Cystic Spaces Present,Anal Intraepithelial Neoplasia 3,0
2225,Dedifferentiated Malignant Infiltrate,Anal Intraepithelial Neoplasia 3,0
2226,Mammary Gland Type Features Present,Anal Intraepithelial Neoplasia 3,0
2227,Ectopic Tissue,Anal Intraepithelial Neoplasia 3,0
2228,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anal Intraepithelial Neoplasia 3,0
2229,Dilated Cystic Spaces Present,Urothelial carcinoma recurrent,0
2230,Dedifferentiated Malignant Infiltrate,Urothelial carcinoma recurrent,0
2231,Mammary Gland Type Features Present,Urothelial carcinoma recurrent,0
2232,Ectopic Tissue,Urothelial carcinoma recurrent,0
2233,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Urothelial carcinoma recurrent,0
2234,Coronary Vessel Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",0
2235,Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",0
2236,Non-Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",0
2237,Mushroom-Shaped Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",0
2238,Annular Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",0
2239,Coronary Vessel Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",0
2240,Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",0
2241,Non-Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",0
2242,Mushroom-Shaped Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",0
2243,Annular Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",0
2244,Coronary Vessel Lesion,Metastatic Salivary Gland Carcinoma,0
2245,Index Lesion,Metastatic Salivary Gland Carcinoma,0
2246,Non-Index Lesion,Metastatic Salivary Gland Carcinoma,0
2247,Mushroom-Shaped Lesion,Metastatic Salivary Gland Carcinoma,0
2248,Annular Lesion,Metastatic Salivary Gland Carcinoma,0
2249,Coronary Vessel Lesion,Colorectal Carcinoma Metastatic in the Liver,0
2250,Index Lesion,Colorectal Carcinoma Metastatic in the Liver,0
2251,Non-Index Lesion,Colorectal Carcinoma Metastatic in the Liver,0
2252,Mushroom-Shaped Lesion,Colorectal Carcinoma Metastatic in the Liver,0
2253,Annular Lesion,Colorectal Carcinoma Metastatic in the Liver,0
2254,Coronary Vessel Lesion,Metastatic Kidney Medullary Carcinoma,0
2255,Index Lesion,Metastatic Kidney Medullary Carcinoma,0
2256,Non-Index Lesion,Metastatic Kidney Medullary Carcinoma,0
2257,Mushroom-Shaped Lesion,Metastatic Kidney Medullary Carcinoma,0
2258,Annular Lesion,Metastatic Kidney Medullary Carcinoma,0
2259,Dilated Cystic Spaces Present,Neuroendocrine carcinoma of the bladder,0
2260,Dedifferentiated Malignant Infiltrate,Neuroendocrine carcinoma of the bladder,0
2261,Mammary Gland Type Features Present,Neuroendocrine carcinoma of the bladder,0
2262,Ectopic Tissue,Neuroendocrine carcinoma of the bladder,0
2263,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Neuroendocrine carcinoma of the bladder,0
2264,Coronary Vessel Lesion,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,0
2265,Index Lesion,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,0
2266,Non-Index Lesion,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,0
2267,Mushroom-Shaped Lesion,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,0
2268,Annular Lesion,Metastatic Bladder Large Cell Neuroendocrine Carcinoma,0
2269,Dilated Cystic Spaces Present,Platinum-Resistant Primary Peritoneal Carcinoma,0
2270,Dedifferentiated Malignant Infiltrate,Platinum-Resistant Primary Peritoneal Carcinoma,0
2271,Mammary Gland Type Features Present,Platinum-Resistant Primary Peritoneal Carcinoma,0
2272,Ectopic Tissue,Platinum-Resistant Primary Peritoneal Carcinoma,0
2273,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Platinum-Resistant Primary Peritoneal Carcinoma,0
2274,Coronary Vessel Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,0
2275,Index Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,0
2276,Non-Index Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,0
2277,Mushroom-Shaped Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,0
2278,Annular Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,0
2279,Dilated Cystic Spaces Present,Endometrioid adenocarcinoma recurrent,0
2280,Dedifferentiated Malignant Infiltrate,Endometrioid adenocarcinoma recurrent,0
2281,Mammary Gland Type Features Present,Endometrioid adenocarcinoma recurrent,0
2282,Ectopic Tissue,Endometrioid adenocarcinoma recurrent,0
2283,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Endometrioid adenocarcinoma recurrent,0
2284,Dilated Cystic Spaces Present,Unresectable Skin Squamous Cell Carcinoma,0
2285,Dedifferentiated Malignant Infiltrate,Unresectable Skin Squamous Cell Carcinoma,0
2286,Mammary Gland Type Features Present,Unresectable Skin Squamous Cell Carcinoma,0
2287,Ectopic Tissue,Unresectable Skin Squamous Cell Carcinoma,0
2288,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Skin Squamous Cell Carcinoma,0
2289,Dilated Cystic Spaces Present,Unresectable Basal Cell Carcinoma,0
2290,Dedifferentiated Malignant Infiltrate,Unresectable Basal Cell Carcinoma,0
2291,Mammary Gland Type Features Present,Unresectable Basal Cell Carcinoma,0
2292,Ectopic Tissue,Unresectable Basal Cell Carcinoma,0
2293,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Basal Cell Carcinoma,0
2294,Dilated Cystic Spaces Present,Borderline Resectable Carcinoma,0
2295,Dedifferentiated Malignant Infiltrate,Borderline Resectable Carcinoma,0
2296,Mammary Gland Type Features Present,Borderline Resectable Carcinoma,0
2297,Ectopic Tissue,Borderline Resectable Carcinoma,0
2298,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Resectable Carcinoma,0
2299,Dilated Cystic Spaces Present,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2300,Dedifferentiated Malignant Infiltrate,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2301,Mammary Gland Type Features Present,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2302,Ectopic Tissue,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2303,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2304,Dilated Cystic Spaces Present,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2305,Dedifferentiated Malignant Infiltrate,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2306,Mammary Gland Type Features Present,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2307,Ectopic Tissue,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2308,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Recurrent High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",0
2309,Dilated Cystic Spaces Present,Platinum-Resistant Fallopian Tube Carcinoma,0
2310,Dedifferentiated Malignant Infiltrate,Platinum-Resistant Fallopian Tube Carcinoma,0
2311,Mammary Gland Type Features Present,Platinum-Resistant Fallopian Tube Carcinoma,0
2312,Ectopic Tissue,Platinum-Resistant Fallopian Tube Carcinoma,0
2313,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Platinum-Resistant Fallopian Tube Carcinoma,0
2314,Coronary Vessel Lesion,Metastatic Adenoid Cystic Carcinoma,0
2315,Index Lesion,Metastatic Adenoid Cystic Carcinoma,0
2316,Non-Index Lesion,Metastatic Adenoid Cystic Carcinoma,0
2317,Mushroom-Shaped Lesion,Metastatic Adenoid Cystic Carcinoma,0
2318,Annular Lesion,Metastatic Adenoid Cystic Carcinoma,0
2319,Dilated Cystic Spaces Present,Acquired cystic disease associated renal cell carcinoma,0
2320,Dedifferentiated Malignant Infiltrate,Acquired cystic disease associated renal cell carcinoma,0
2321,Mammary Gland Type Features Present,Acquired cystic disease associated renal cell carcinoma,0
2322,Ectopic Tissue,Acquired cystic disease associated renal cell carcinoma,0
2323,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Acquired cystic disease associated renal cell carcinoma,0
2324,Dilated Cystic Spaces Present,Refractory Uterine Corpus Carcinosarcoma,0
2325,Dedifferentiated Malignant Infiltrate,Refractory Uterine Corpus Carcinosarcoma,0
2326,Mammary Gland Type Features Present,Refractory Uterine Corpus Carcinosarcoma,0
2327,Ectopic Tissue,Refractory Uterine Corpus Carcinosarcoma,0
2328,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Uterine Corpus Carcinosarcoma,0
2329,Dilated Cystic Spaces Present,Platinum-Resistant Lung Small Cell Carcinoma,0
2330,Dedifferentiated Malignant Infiltrate,Platinum-Resistant Lung Small Cell Carcinoma,0
2331,Mammary Gland Type Features Present,Platinum-Resistant Lung Small Cell Carcinoma,0
2332,Ectopic Tissue,Platinum-Resistant Lung Small Cell Carcinoma,0
2333,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Platinum-Resistant Lung Small Cell Carcinoma,0
2334,Dilated Cystic Spaces Present,Unresectable Urethral Urothelial Carcinoma,0
2335,Dedifferentiated Malignant Infiltrate,Unresectable Urethral Urothelial Carcinoma,0
2336,Mammary Gland Type Features Present,Unresectable Urethral Urothelial Carcinoma,0
2337,Ectopic Tissue,Unresectable Urethral Urothelial Carcinoma,0
2338,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Urethral Urothelial Carcinoma,0
2339,Dilated Cystic Spaces Present,Unresectable Ureter Urothelial Carcinoma,0
2340,Dedifferentiated Malignant Infiltrate,Unresectable Ureter Urothelial Carcinoma,0
2341,Mammary Gland Type Features Present,Unresectable Ureter Urothelial Carcinoma,0
2342,Ectopic Tissue,Unresectable Ureter Urothelial Carcinoma,0
2343,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Ureter Urothelial Carcinoma,0
2344,Dilated Cystic Spaces Present,Unresectable Renal Pelvis Urothelial Carcinoma,0
2345,Dedifferentiated Malignant Infiltrate,Unresectable Renal Pelvis Urothelial Carcinoma,0
2346,Mammary Gland Type Features Present,Unresectable Renal Pelvis Urothelial Carcinoma,0
2347,Ectopic Tissue,Unresectable Renal Pelvis Urothelial Carcinoma,0
2348,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Renal Pelvis Urothelial Carcinoma,0
2349,Dilated Cystic Spaces Present,Unresectable Skin Carcinoma,0
2350,Dedifferentiated Malignant Infiltrate,Unresectable Skin Carcinoma,0
2351,Mammary Gland Type Features Present,Unresectable Skin Carcinoma,0
2352,Ectopic Tissue,Unresectable Skin Carcinoma,0
2353,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Skin Carcinoma,0
2354,Coronary Vessel Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",0
2355,Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",0
2356,Non-Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",0
2357,Mushroom-Shaped Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",0
2358,Annular Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",0
2359,Coronary Vessel Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",0
2360,Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",0
2361,Non-Index Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",0
2362,Mushroom-Shaped Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",0
2363,Annular Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",0
2364,Dilated Cystic Spaces Present,Refractory Endometrial Mixed Cell Adenocarcinoma,0
2365,Dedifferentiated Malignant Infiltrate,Refractory Endometrial Mixed Cell Adenocarcinoma,0
2366,Mammary Gland Type Features Present,Refractory Endometrial Mixed Cell Adenocarcinoma,0
2367,Ectopic Tissue,Refractory Endometrial Mixed Cell Adenocarcinoma,0
2368,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Endometrial Mixed Cell Adenocarcinoma,0
2369,Dilated Cystic Spaces Present,Bladder Urothelial Carcinoma in Situ,0
2370,Dedifferentiated Malignant Infiltrate,Bladder Urothelial Carcinoma in Situ,0
2371,Mammary Gland Type Features Present,Bladder Urothelial Carcinoma in Situ,0
2372,Ectopic Tissue,Bladder Urothelial Carcinoma in Situ,0
2373,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Urothelial Carcinoma in Situ,0
2374,Coronary Vessel Lesion,Locally Advanced Urothelial Carcinoma,0
2375,Index Lesion,Locally Advanced Urothelial Carcinoma,0
2376,Non-Index Lesion,Locally Advanced Urothelial Carcinoma,0
2377,Mushroom-Shaped Lesion,Locally Advanced Urothelial Carcinoma,0
2378,Annular Lesion,Locally Advanced Urothelial Carcinoma,0
2379,Dilated Cystic Spaces Present,Refractory Endometrial Serous Adenocarcinoma,0
2380,Dedifferentiated Malignant Infiltrate,Refractory Endometrial Serous Adenocarcinoma,0
2381,Mammary Gland Type Features Present,Refractory Endometrial Serous Adenocarcinoma,0
2382,Ectopic Tissue,Refractory Endometrial Serous Adenocarcinoma,0
2383,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Endometrial Serous Adenocarcinoma,0
2384,Dilated Cystic Spaces Present,Refractory Endometrial Clear Cell Adenocarcinoma,0
2385,Dedifferentiated Malignant Infiltrate,Refractory Endometrial Clear Cell Adenocarcinoma,0
2386,Mammary Gland Type Features Present,Refractory Endometrial Clear Cell Adenocarcinoma,0
2387,Ectopic Tissue,Refractory Endometrial Clear Cell Adenocarcinoma,0
2388,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Endometrial Clear Cell Adenocarcinoma,0
2389,Dilated Cystic Spaces Present,Bladder Non-Invasive Papillary Urothelial Carcinoma,0
2390,Dedifferentiated Malignant Infiltrate,Bladder Non-Invasive Papillary Urothelial Carcinoma,0
2391,Mammary Gland Type Features Present,Bladder Non-Invasive Papillary Urothelial Carcinoma,0
2392,Ectopic Tissue,Bladder Non-Invasive Papillary Urothelial Carcinoma,0
2393,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Non-Invasive Papillary Urothelial Carcinoma,0
2394,Coronary Vessel Lesion,Locally Advanced Salivary Gland Carcinoma,0
2395,Index Lesion,Locally Advanced Salivary Gland Carcinoma,0
2396,Non-Index Lesion,Locally Advanced Salivary Gland Carcinoma,0
2397,Mushroom-Shaped Lesion,Locally Advanced Salivary Gland Carcinoma,0
2398,Annular Lesion,Locally Advanced Salivary Gland Carcinoma,0
2399,Dilated Cystic Spaces Present,Platinum-Sensitive Lung Small Cell Carcinoma,0
2400,Dedifferentiated Malignant Infiltrate,Platinum-Sensitive Lung Small Cell Carcinoma,0
2401,Mammary Gland Type Features Present,Platinum-Sensitive Lung Small Cell Carcinoma,0
2402,Ectopic Tissue,Platinum-Sensitive Lung Small Cell Carcinoma,0
2403,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Platinum-Sensitive Lung Small Cell Carcinoma,0
2404,Dilated Cystic Spaces Present,Unresectable Bladder Urothelial Carcinoma,0
2405,Dedifferentiated Malignant Infiltrate,Unresectable Bladder Urothelial Carcinoma,0
2406,Mammary Gland Type Features Present,Unresectable Bladder Urothelial Carcinoma,0
2407,Ectopic Tissue,Unresectable Bladder Urothelial Carcinoma,0
2408,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Bladder Urothelial Carcinoma,0
2409,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,"Leukemia, Myeloid, Chronic-Phase",0
2410,Myeloblasts Under 2 Percent of Peripheral Blood White Cells,Refractory Cytopenia of Childhood,0
2411,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-0,0
2412,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-0,0
2413,Dilated Cystic Spaces Present,Squamous Lung Dysplasia,0
2414,Dedifferentiated Malignant Infiltrate,Squamous Lung Dysplasia,0
2415,Mammary Gland Type Features Present,Squamous Lung Dysplasia,0
2416,Ectopic Tissue,Squamous Lung Dysplasia,0
2417,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Squamous Lung Dysplasia,0
2418,Dilated Cystic Spaces Present,Gastric Neuroendocrine Neoplasm,0
2419,Dedifferentiated Malignant Infiltrate,Gastric Neuroendocrine Neoplasm,0
2420,Mammary Gland Type Features Present,Gastric Neuroendocrine Neoplasm,0
2421,Ectopic Tissue,Gastric Neuroendocrine Neoplasm,0
2422,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastric Neuroendocrine Neoplasm,0
2423,Dilated Cystic Spaces Present,Respiratory papilloma,0
2424,Dedifferentiated Malignant Infiltrate,Respiratory papilloma,0
2425,Mammary Gland Type Features Present,Respiratory papilloma,0
2426,Ectopic Tissue,Respiratory papilloma,0
2427,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Respiratory papilloma,0
2428,Dilated Cystic Spaces Present,Intestinal Neuroendocrine Tumor,0
2429,Dedifferentiated Malignant Infiltrate,Intestinal Neuroendocrine Tumor,0
2430,Mammary Gland Type Features Present,Intestinal Neuroendocrine Tumor,0
2431,Ectopic Tissue,Intestinal Neuroendocrine Tumor,0
2432,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intestinal Neuroendocrine Tumor,0
2433,Dilated Cystic Spaces Present,Orbit Paraganglioma,0
2434,Dedifferentiated Malignant Infiltrate,Orbit Paraganglioma,0
2435,Mammary Gland Type Features Present,Orbit Paraganglioma,0
2436,Ectopic Tissue,Orbit Paraganglioma,0
2437,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Orbit Paraganglioma,0
2438,Dilated Cystic Spaces Present,Laryngeal Paraganglioma,0
2439,Dedifferentiated Malignant Infiltrate,Laryngeal Paraganglioma,0
2440,Mammary Gland Type Features Present,Laryngeal Paraganglioma,0
2441,Ectopic Tissue,Laryngeal Paraganglioma,0
2442,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Laryngeal Paraganglioma,0
2443,Dilated Cystic Spaces Present,Thyroid stimulating hormone-producing pituitary tumor,0
2444,Dedifferentiated Malignant Infiltrate,Thyroid stimulating hormone-producing pituitary tumor,0
2445,Mammary Gland Type Features Present,Thyroid stimulating hormone-producing pituitary tumor,0
2446,Ectopic Tissue,Thyroid stimulating hormone-producing pituitary tumor,0
2447,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid stimulating hormone-producing pituitary tumor,0
2448,Dilated Cystic Spaces Present,Carcinoid tumor of the duodenum,0
2449,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of the duodenum,0
2450,Mammary Gland Type Features Present,Carcinoid tumor of the duodenum,0
2451,Ectopic Tissue,Carcinoid tumor of the duodenum,0
2452,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of the duodenum,0
2453,Dilated Cystic Spaces Present,Densely Granulated Lactotroph Adenoma,0
2454,Dedifferentiated Malignant Infiltrate,Densely Granulated Lactotroph Adenoma,0
2455,Mammary Gland Type Features Present,Densely Granulated Lactotroph Adenoma,0
2456,Ectopic Tissue,Densely Granulated Lactotroph Adenoma,0
2457,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Densely Granulated Lactotroph Adenoma,0
2458,Dilated Cystic Spaces Present,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,0
2459,Dedifferentiated Malignant Infiltrate,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,0
2460,Mammary Gland Type Features Present,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,0
2461,Ectopic Tissue,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,0
2462,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,0
2463,Dilated Cystic Spaces Present,"Adenoma, Monomorphic",0
2464,Dedifferentiated Malignant Infiltrate,"Adenoma, Monomorphic",0
2465,Mammary Gland Type Features Present,"Adenoma, Monomorphic",0
2466,Ectopic Tissue,"Adenoma, Monomorphic",0
2467,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Adenoma, Monomorphic",0
2468,Dilated Cystic Spaces Present,Malignant tumor of choroid plexus,0
2469,Dedifferentiated Malignant Infiltrate,Malignant tumor of choroid plexus,0
2470,Mammary Gland Type Features Present,Malignant tumor of choroid plexus,0
2471,Ectopic Tissue,Malignant tumor of choroid plexus,0
2472,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant tumor of choroid plexus,0
2473,Dilated Cystic Spaces Present,Well Differentiated Pancreatic Endocrine Tumor,0
2474,Dedifferentiated Malignant Infiltrate,Well Differentiated Pancreatic Endocrine Tumor,0
2475,Mammary Gland Type Features Present,Well Differentiated Pancreatic Endocrine Tumor,0
2476,Ectopic Tissue,Well Differentiated Pancreatic Endocrine Tumor,0
2477,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Well Differentiated Pancreatic Endocrine Tumor,0
2478,Dilated Cystic Spaces Present,Superficial Epithelioma with Sebaceous Differentiation,0
2479,Dedifferentiated Malignant Infiltrate,Superficial Epithelioma with Sebaceous Differentiation,0
2480,Mammary Gland Type Features Present,Superficial Epithelioma with Sebaceous Differentiation,0
2481,Ectopic Tissue,Superficial Epithelioma with Sebaceous Differentiation,0
2482,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Superficial Epithelioma with Sebaceous Differentiation,0
2483,Dilated Cystic Spaces Present,Lung Mixed Squamous Cell and Glandular Papilloma,0
2484,Dedifferentiated Malignant Infiltrate,Lung Mixed Squamous Cell and Glandular Papilloma,0
2485,Mammary Gland Type Features Present,Lung Mixed Squamous Cell and Glandular Papilloma,0
2486,Ectopic Tissue,Lung Mixed Squamous Cell and Glandular Papilloma,0
2487,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Lung Mixed Squamous Cell and Glandular Papilloma,0
2488,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2489,Isolated Tumor Cells,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2490,Pleural/Elastic Layer Invasion,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2491,Presence of Extravascular Matrix Patterns,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2492,Ductopenia,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2493,Dilated Cystic Spaces Present,Frontal Sinus Schneiderian Papilloma,0
2494,Dedifferentiated Malignant Infiltrate,Frontal Sinus Schneiderian Papilloma,0
2495,Mammary Gland Type Features Present,Frontal Sinus Schneiderian Papilloma,0
2496,Ectopic Tissue,Frontal Sinus Schneiderian Papilloma,0
2497,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Frontal Sinus Schneiderian Papilloma,0
2498,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2499,Isolated Tumor Cells,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2500,Pleural/Elastic Layer Invasion,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2501,Presence of Extravascular Matrix Patterns,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2502,Ductopenia,Branch Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
2503,Dilated Cystic Spaces Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,0
2504,Dedifferentiated Malignant Infiltrate,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,0
2505,Mammary Gland Type Features Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,0
2506,Ectopic Tissue,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,0
2507,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,0
2508,Dilated Cystic Spaces Present,Encapsulated Thymoma,0
2509,Dedifferentiated Malignant Infiltrate,Encapsulated Thymoma,0
2510,Mammary Gland Type Features Present,Encapsulated Thymoma,0
2511,Ectopic Tissue,Encapsulated Thymoma,0
2512,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Encapsulated Thymoma,0
2513,Dilated Cystic Spaces Present,Cervical Squamous Intraepithelial Neoplasia 1,0
2514,Dedifferentiated Malignant Infiltrate,Cervical Squamous Intraepithelial Neoplasia 1,0
2515,Mammary Gland Type Features Present,Cervical Squamous Intraepithelial Neoplasia 1,0
2516,Ectopic Tissue,Cervical Squamous Intraepithelial Neoplasia 1,0
2517,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Squamous Intraepithelial Neoplasia 1,0
2518,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Vulvar Papillary Hidradenoma,0
2519,Isolated Tumor Cells,Vulvar Papillary Hidradenoma,0
2520,Pleural/Elastic Layer Invasion,Vulvar Papillary Hidradenoma,0
2521,Presence of Extravascular Matrix Patterns,Vulvar Papillary Hidradenoma,0
2522,Ductopenia,Vulvar Papillary Hidradenoma,0
2523,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Borderline cystadenoma,0
2524,Isolated Tumor Cells,Borderline cystadenoma,0
2525,Pleural/Elastic Layer Invasion,Borderline cystadenoma,0
2526,Presence of Extravascular Matrix Patterns,Borderline cystadenoma,0
2527,Ductopenia,Borderline cystadenoma,0
2528,Dilated Cystic Spaces Present,Small Intestinal Low Grade Intraepithelial Neoplasia,0
2529,Dedifferentiated Malignant Infiltrate,Small Intestinal Low Grade Intraepithelial Neoplasia,0
2530,Mammary Gland Type Features Present,Small Intestinal Low Grade Intraepithelial Neoplasia,0
2531,Ectopic Tissue,Small Intestinal Low Grade Intraepithelial Neoplasia,0
2532,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Low Grade Intraepithelial Neoplasia,0
2533,Coronary Vessel Lesion,Adenoma of ampulla of Vater,0
2534,Index Lesion,Adenoma of ampulla of Vater,0
2535,Non-Index Lesion,Adenoma of ampulla of Vater,0
2536,Mushroom-Shaped Lesion,Adenoma of ampulla of Vater,0
2537,Annular Lesion,Adenoma of ampulla of Vater,0
2538,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Proliferating Brenner Tumor,0
2539,Isolated Tumor Cells,Proliferating Brenner Tumor,0
2540,Pleural/Elastic Layer Invasion,Proliferating Brenner Tumor,0
2541,Presence of Extravascular Matrix Patterns,Proliferating Brenner Tumor,0
2542,Ductopenia,Proliferating Brenner Tumor,0
2543,Coronary Vessel Lesion,Tubulovillous adenoma of rectum,0
2544,Index Lesion,Tubulovillous adenoma of rectum,0
2545,Non-Index Lesion,Tubulovillous adenoma of rectum,0
2546,Mushroom-Shaped Lesion,Tubulovillous adenoma of rectum,0
2547,Annular Lesion,Tubulovillous adenoma of rectum,0
2548,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cystadenofibroma of fallopian tube,0
2549,Isolated Tumor Cells,Cystadenofibroma of fallopian tube,0
2550,Pleural/Elastic Layer Invasion,Cystadenofibroma of fallopian tube,0
2551,Presence of Extravascular Matrix Patterns,Cystadenofibroma of fallopian tube,0
2552,Ductopenia,Cystadenofibroma of fallopian tube,0
2553,Dilated Cystic Spaces Present,Non-Functioning Pituitary Gland Microadenoma,0
2554,Dedifferentiated Malignant Infiltrate,Non-Functioning Pituitary Gland Microadenoma,0
2555,Mammary Gland Type Features Present,Non-Functioning Pituitary Gland Microadenoma,0
2556,Ectopic Tissue,Non-Functioning Pituitary Gland Microadenoma,0
2557,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non-Functioning Pituitary Gland Microadenoma,0
2558,Dilated Cystic Spaces Present,Intraductal papillomatosis,0
2559,Dedifferentiated Malignant Infiltrate,Intraductal papillomatosis,0
2560,Mammary Gland Type Features Present,Intraductal papillomatosis,0
2561,Ectopic Tissue,Intraductal papillomatosis,0
2562,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intraductal papillomatosis,0
2563,Dilated Cystic Spaces Present,Secretory adenoma of pituitary,0
2564,Dedifferentiated Malignant Infiltrate,Secretory adenoma of pituitary,0
2565,Mammary Gland Type Features Present,Secretory adenoma of pituitary,0
2566,Ectopic Tissue,Secretory adenoma of pituitary,0
2567,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Secretory adenoma of pituitary,0
2568,Dilated Cystic Spaces Present,Malignant Thymoma,0
2569,Dedifferentiated Malignant Infiltrate,Malignant Thymoma,0
2570,Mammary Gland Type Features Present,Malignant Thymoma,0
2571,Ectopic Tissue,Malignant Thymoma,0
2572,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Thymoma,0
2573,Dilated Cystic Spaces Present,Carcinoid tumor of the liver,0
2574,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of the liver,0
2575,Mammary Gland Type Features Present,Carcinoid tumor of the liver,0
2576,Ectopic Tissue,Carcinoid tumor of the liver,0
2577,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of the liver,0
2578,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Seminal Vesicle Cystadenoma,0
2579,Isolated Tumor Cells,Seminal Vesicle Cystadenoma,0
2580,Pleural/Elastic Layer Invasion,Seminal Vesicle Cystadenoma,0
2581,Presence of Extravascular Matrix Patterns,Seminal Vesicle Cystadenoma,0
2582,Ductopenia,Seminal Vesicle Cystadenoma,0
2583,Dilated Cystic Spaces Present,Recurrent respiratory papillomatosis,0
2584,Dedifferentiated Malignant Infiltrate,Recurrent respiratory papillomatosis,0
2585,Mammary Gland Type Features Present,Recurrent respiratory papillomatosis,0
2586,Ectopic Tissue,Recurrent respiratory papillomatosis,0
2587,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent respiratory papillomatosis,0
2588,Dilated Cystic Spaces Present,Actinic keratosis,0
2589,Dedifferentiated Malignant Infiltrate,Actinic keratosis,0
2590,Mammary Gland Type Features Present,Actinic keratosis,0
2591,Ectopic Tissue,Actinic keratosis,0
2592,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Actinic keratosis,0
2593,Dilated Cystic Spaces Present,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia,0
2594,Dedifferentiated Malignant Infiltrate,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia,0
2595,Mammary Gland Type Features Present,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia,0
2596,Ectopic Tissue,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia,0
2597,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intraductal papillary neoplasm with low-grade intraepithelial neoplasia,0
2598,Dilated Cystic Spaces Present,Gallbladder Flat Biliary Intraepithelial Neoplasia,0
2599,Dedifferentiated Malignant Infiltrate,Gallbladder Flat Biliary Intraepithelial Neoplasia,0
2600,Mammary Gland Type Features Present,Gallbladder Flat Biliary Intraepithelial Neoplasia,0
2601,Ectopic Tissue,Gallbladder Flat Biliary Intraepithelial Neoplasia,0
2602,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Flat Biliary Intraepithelial Neoplasia,0
2603,Dilated Cystic Spaces Present,Urethral Condyloma Acuminatum,0
2604,Dedifferentiated Malignant Infiltrate,Urethral Condyloma Acuminatum,0
2605,Mammary Gland Type Features Present,Urethral Condyloma Acuminatum,0
2606,Ectopic Tissue,Urethral Condyloma Acuminatum,0
2607,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Urethral Condyloma Acuminatum,0
2608,Dilated Cystic Spaces Present,Urothelial Neoplasm,0
2609,Dedifferentiated Malignant Infiltrate,Urothelial Neoplasm,0
2610,Mammary Gland Type Features Present,Urothelial Neoplasm,0
2611,Ectopic Tissue,Urothelial Neoplasm,0
2612,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Urothelial Neoplasm,0
2613,Dilated Cystic Spaces Present,"Thymoma, type B2, malignant",0
2614,Dedifferentiated Malignant Infiltrate,"Thymoma, type B2, malignant",0
2615,Mammary Gland Type Features Present,"Thymoma, type B2, malignant",0
2616,Ectopic Tissue,"Thymoma, type B2, malignant",0
2617,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thymoma, type B2, malignant",0
2618,Dilated Cystic Spaces Present,Vulvar Squamous Neoplasm,0
2619,Dedifferentiated Malignant Infiltrate,Vulvar Squamous Neoplasm,0
2620,Mammary Gland Type Features Present,Vulvar Squamous Neoplasm,0
2621,Ectopic Tissue,Vulvar Squamous Neoplasm,0
2622,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vulvar Squamous Neoplasm,0
2623,Dilated Cystic Spaces Present,Inverted Squamous Cell Papilloma,0
2624,Dedifferentiated Malignant Infiltrate,Inverted Squamous Cell Papilloma,0
2625,Mammary Gland Type Features Present,Inverted Squamous Cell Papilloma,0
2626,Ectopic Tissue,Inverted Squamous Cell Papilloma,0
2627,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Inverted Squamous Cell Papilloma,0
2628,Dilated Cystic Spaces Present,Gastric dysplasia,0
2629,Dedifferentiated Malignant Infiltrate,Gastric dysplasia,0
2630,Mammary Gland Type Features Present,Gastric dysplasia,0
2631,Ectopic Tissue,Gastric dysplasia,0
2632,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastric dysplasia,0
2633,Dilated Cystic Spaces Present,Bowenoid papulosis of penis,0
2634,Dedifferentiated Malignant Infiltrate,Bowenoid papulosis of penis,0
2635,Mammary Gland Type Features Present,Bowenoid papulosis of penis,0
2636,Ectopic Tissue,Bowenoid papulosis of penis,0
2637,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bowenoid papulosis of penis,0
2638,Dilated Cystic Spaces Present,papillomatosis of extrahepatic bile duct,0
2639,Dedifferentiated Malignant Infiltrate,papillomatosis of extrahepatic bile duct,0
2640,Mammary Gland Type Features Present,papillomatosis of extrahepatic bile duct,0
2641,Ectopic Tissue,papillomatosis of extrahepatic bile duct,0
2642,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,papillomatosis of extrahepatic bile duct,0
2643,Coronary Vessel Lesion,Gastrointestinal tract adenoma,0
2644,Index Lesion,Gastrointestinal tract adenoma,0
2645,Non-Index Lesion,Gastrointestinal tract adenoma,0
2646,Mushroom-Shaped Lesion,Gastrointestinal tract adenoma,0
2647,Annular Lesion,Gastrointestinal tract adenoma,0
2648,Dilated Cystic Spaces Present,mucinous adenocarcinofibroma of ovary,0
2649,Dedifferentiated Malignant Infiltrate,mucinous adenocarcinofibroma of ovary,0
2650,Mammary Gland Type Features Present,mucinous adenocarcinofibroma of ovary,0
2651,Ectopic Tissue,mucinous adenocarcinofibroma of ovary,0
2652,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,mucinous adenocarcinofibroma of ovary,0
2653,Dilated Cystic Spaces Present,Borderline Ovarian Clear Cell Adenofibroma,0
2654,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Clear Cell Adenofibroma,0
2655,Mammary Gland Type Features Present,Borderline Ovarian Clear Cell Adenofibroma,0
2656,Ectopic Tissue,Borderline Ovarian Clear Cell Adenofibroma,0
2657,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Clear Cell Adenofibroma,0
2658,Dilated Cystic Spaces Present,Spindle Cell Oncocytoma of the Adenohypophysis,0
2659,Dedifferentiated Malignant Infiltrate,Spindle Cell Oncocytoma of the Adenohypophysis,0
2660,Mammary Gland Type Features Present,Spindle Cell Oncocytoma of the Adenohypophysis,0
2661,Ectopic Tissue,Spindle Cell Oncocytoma of the Adenohypophysis,0
2662,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Spindle Cell Oncocytoma of the Adenohypophysis,0
2663,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Eccrine hidrocystoma,0
2664,Isolated Tumor Cells,Eccrine hidrocystoma,0
2665,Pleural/Elastic Layer Invasion,Eccrine hidrocystoma,0
2666,Presence of Extravascular Matrix Patterns,Eccrine hidrocystoma,0
2667,Ductopenia,Eccrine hidrocystoma,0
2668,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Serous cystadenoma of pancreas,0
2669,Isolated Tumor Cells,Serous cystadenoma of pancreas,0
2670,Pleural/Elastic Layer Invasion,Serous cystadenoma of pancreas,0
2671,Presence of Extravascular Matrix Patterns,Serous cystadenoma of pancreas,0
2672,Ductopenia,Serous cystadenoma of pancreas,0
2673,Dilated Cystic Spaces Present,Malignant neoplasm of carotid body,0
2674,Dedifferentiated Malignant Infiltrate,Malignant neoplasm of carotid body,0
2675,Mammary Gland Type Features Present,Malignant neoplasm of carotid body,0
2676,Ectopic Tissue,Malignant neoplasm of carotid body,0
2677,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant neoplasm of carotid body,0
2678,Dilated Cystic Spaces Present,Biliary papillomatosis,0
2679,Dedifferentiated Malignant Infiltrate,Biliary papillomatosis,0
2680,Mammary Gland Type Features Present,Biliary papillomatosis,0
2681,Ectopic Tissue,Biliary papillomatosis,0
2682,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Biliary papillomatosis,0
2683,Dilated Cystic Spaces Present,High Grade Lung Neuroendocrine Neoplasm,0
2684,Dedifferentiated Malignant Infiltrate,High Grade Lung Neuroendocrine Neoplasm,0
2685,Mammary Gland Type Features Present,High Grade Lung Neuroendocrine Neoplasm,0
2686,Ectopic Tissue,High Grade Lung Neuroendocrine Neoplasm,0
2687,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Lung Neuroendocrine Neoplasm,0
2688,Dilated Cystic Spaces Present,Intestinal Neuroendocrine Neoplasm,0
2689,Dedifferentiated Malignant Infiltrate,Intestinal Neuroendocrine Neoplasm,0
2690,Mammary Gland Type Features Present,Intestinal Neuroendocrine Neoplasm,0
2691,Ectopic Tissue,Intestinal Neuroendocrine Neoplasm,0
2692,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intestinal Neuroendocrine Neoplasm,0
2693,Coronary Vessel Lesion,Breast Apocrine Adenoma,0
2694,Index Lesion,Breast Apocrine Adenoma,0
2695,Non-Index Lesion,Breast Apocrine Adenoma,0
2696,Mushroom-Shaped Lesion,Breast Apocrine Adenoma,0
2697,Annular Lesion,Breast Apocrine Adenoma,0
2698,Dilated Cystic Spaces Present,Testicular Carcinoid Tumor,0
2699,Dedifferentiated Malignant Infiltrate,Testicular Carcinoid Tumor,0
2700,Mammary Gland Type Features Present,Testicular Carcinoid Tumor,0
2701,Ectopic Tissue,Testicular Carcinoid Tumor,0
2702,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Testicular Carcinoid Tumor,0
2703,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Melanoacanthoma,0
2704,Isolated Tumor Cells,Melanoacanthoma,0
2705,Pleural/Elastic Layer Invasion,Melanoacanthoma,0
2706,Presence of Extravascular Matrix Patterns,Melanoacanthoma,0
2707,Ductopenia,Melanoacanthoma,0
2708,Dilated Cystic Spaces Present,Gonadotroph adenoma,0
2709,Dedifferentiated Malignant Infiltrate,Gonadotroph adenoma,0
2710,Mammary Gland Type Features Present,Gonadotroph adenoma,0
2711,Ectopic Tissue,Gonadotroph adenoma,0
2712,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gonadotroph adenoma,0
2713,Dilated Cystic Spaces Present,Middle Ear Paraganglioma,0
2714,Dedifferentiated Malignant Infiltrate,Middle Ear Paraganglioma,0
2715,Mammary Gland Type Features Present,Middle Ear Paraganglioma,0
2716,Ectopic Tissue,Middle Ear Paraganglioma,0
2717,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Middle Ear Paraganglioma,0
2718,Dilated Cystic Spaces Present,Colorectal Neuroendocrine Tumor G1,0
2719,Dedifferentiated Malignant Infiltrate,Colorectal Neuroendocrine Tumor G1,0
2720,Mammary Gland Type Features Present,Colorectal Neuroendocrine Tumor G1,0
2721,Ectopic Tissue,Colorectal Neuroendocrine Tumor G1,0
2722,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal Neuroendocrine Tumor G1,0
2723,Coronary Vessel Lesion,Colon Sessile Serrated Adenoma/Polyp,0
2724,Index Lesion,Colon Sessile Serrated Adenoma/Polyp,0
2725,Non-Index Lesion,Colon Sessile Serrated Adenoma/Polyp,0
2726,Mushroom-Shaped Lesion,Colon Sessile Serrated Adenoma/Polyp,0
2727,Annular Lesion,Colon Sessile Serrated Adenoma/Polyp,0
2728,Dilated Cystic Spaces Present,High-Grade Prostatic Intraepithelial Neoplasia,0
2729,Dedifferentiated Malignant Infiltrate,High-Grade Prostatic Intraepithelial Neoplasia,0
2730,Mammary Gland Type Features Present,High-Grade Prostatic Intraepithelial Neoplasia,0
2731,Ectopic Tissue,High-Grade Prostatic Intraepithelial Neoplasia,0
2732,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High-Grade Prostatic Intraepithelial Neoplasia,0
2733,Coronary Vessel Lesion,Adenomatous polyp of rectum,0
2734,Index Lesion,Adenomatous polyp of rectum,0
2735,Non-Index Lesion,Adenomatous polyp of rectum,0
2736,Mushroom-Shaped Lesion,Adenomatous polyp of rectum,0
2737,Annular Lesion,Adenomatous polyp of rectum,0
2738,Dilated Cystic Spaces Present,Cervical Squamous Intraepithelial Neoplasia,0
2739,Dedifferentiated Malignant Infiltrate,Cervical Squamous Intraepithelial Neoplasia,0
2740,Mammary Gland Type Features Present,Cervical Squamous Intraepithelial Neoplasia,0
2741,Ectopic Tissue,Cervical Squamous Intraepithelial Neoplasia,0
2742,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Squamous Intraepithelial Neoplasia,0
2743,Dilated Cystic Spaces Present,benign myoepithelioma of salivary gland,0
2744,Dedifferentiated Malignant Infiltrate,benign myoepithelioma of salivary gland,0
2745,Mammary Gland Type Features Present,benign myoepithelioma of salivary gland,0
2746,Ectopic Tissue,benign myoepithelioma of salivary gland,0
2747,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,benign myoepithelioma of salivary gland,0
2748,Dilated Cystic Spaces Present,Widely Invasive Thymoma,0
2749,Dedifferentiated Malignant Infiltrate,Widely Invasive Thymoma,0
2750,Mammary Gland Type Features Present,Widely Invasive Thymoma,0
2751,Ectopic Tissue,Widely Invasive Thymoma,0
2752,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Widely Invasive Thymoma,0
2753,Dilated Cystic Spaces Present,Preinvasive Neoplasm of the Ampullary Region,0
2754,Dedifferentiated Malignant Infiltrate,Preinvasive Neoplasm of the Ampullary Region,0
2755,Mammary Gland Type Features Present,Preinvasive Neoplasm of the Ampullary Region,0
2756,Ectopic Tissue,Preinvasive Neoplasm of the Ampullary Region,0
2757,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Preinvasive Neoplasm of the Ampullary Region,0
2758,Dilated Cystic Spaces Present,Benign pheochromocytoma of adrenal gland,0
2759,Dedifferentiated Malignant Infiltrate,Benign pheochromocytoma of adrenal gland,0
2760,Mammary Gland Type Features Present,Benign pheochromocytoma of adrenal gland,0
2761,Ectopic Tissue,Benign pheochromocytoma of adrenal gland,0
2762,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign pheochromocytoma of adrenal gland,0
2763,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Mucinous Cystadenofibroma,0
2764,Isolated Tumor Cells,Ovarian Mucinous Cystadenofibroma,0
2765,Pleural/Elastic Layer Invasion,Ovarian Mucinous Cystadenofibroma,0
2766,Presence of Extravascular Matrix Patterns,Ovarian Mucinous Cystadenofibroma,0
2767,Ductopenia,Ovarian Mucinous Cystadenofibroma,0
2768,Dilated Cystic Spaces Present,Borderline Ovarian Mucinous Tumor,0
2769,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Mucinous Tumor,0
2770,Mammary Gland Type Features Present,Borderline Ovarian Mucinous Tumor,0
2771,Ectopic Tissue,Borderline Ovarian Mucinous Tumor,0
2772,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Mucinous Tumor,0
2773,Dilated Cystic Spaces Present,Gastric Neuroendocrine Tumor,0
2774,Dedifferentiated Malignant Infiltrate,Gastric Neuroendocrine Tumor,0
2775,Mammary Gland Type Features Present,Gastric Neuroendocrine Tumor,0
2776,Ectopic Tissue,Gastric Neuroendocrine Tumor,0
2777,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastric Neuroendocrine Tumor,0
2778,Coronary Vessel Lesion,Syringofibroadenoma,0
2779,Index Lesion,Syringofibroadenoma,0
2780,Non-Index Lesion,Syringofibroadenoma,0
2781,Mushroom-Shaped Lesion,Syringofibroadenoma,0
2782,Annular Lesion,Syringofibroadenoma,0
2783,Dilated Cystic Spaces Present,Benign neoplasm of sebaceous gland,0
2784,Dedifferentiated Malignant Infiltrate,Benign neoplasm of sebaceous gland,0
2785,Mammary Gland Type Features Present,Benign neoplasm of sebaceous gland,0
2786,Ectopic Tissue,Benign neoplasm of sebaceous gland,0
2787,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign neoplasm of sebaceous gland,0
2788,Dilated Cystic Spaces Present,Atypical Breast Papilloma,0
2789,Dedifferentiated Malignant Infiltrate,Atypical Breast Papilloma,0
2790,Mammary Gland Type Features Present,Atypical Breast Papilloma,0
2791,Ectopic Tissue,Atypical Breast Papilloma,0
2792,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Atypical Breast Papilloma,0
2793,Dilated Cystic Spaces Present,Pituitary Adenoma,0
2794,Dedifferentiated Malignant Infiltrate,Pituitary Adenoma,0
2795,Mammary Gland Type Features Present,Pituitary Adenoma,0
2796,Ectopic Tissue,Pituitary Adenoma,0
2797,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pituitary Adenoma,0
2798,Dilated Cystic Spaces Present,Carcinoid tumor of appendix,0
2799,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of appendix,0
2800,Mammary Gland Type Features Present,Carcinoid tumor of appendix,0
2801,Ectopic Tissue,Carcinoid tumor of appendix,0
2802,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of appendix,0
2803,Dilated Cystic Spaces Present,Multiple Endocrine Neoplasia Type 1,0
2804,Dedifferentiated Malignant Infiltrate,Multiple Endocrine Neoplasia Type 1,0
2805,Mammary Gland Type Features Present,Multiple Endocrine Neoplasia Type 1,0
2806,Ectopic Tissue,Multiple Endocrine Neoplasia Type 1,0
2807,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Multiple Endocrine Neoplasia Type 1,0
2808,Dilated Cystic Spaces Present,Borderline Fallopian Tube Endometrioid Tumor,0
2809,Dedifferentiated Malignant Infiltrate,Borderline Fallopian Tube Endometrioid Tumor,0
2810,Mammary Gland Type Features Present,Borderline Fallopian Tube Endometrioid Tumor,0
2811,Ectopic Tissue,Borderline Fallopian Tube Endometrioid Tumor,0
2812,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Fallopian Tube Endometrioid Tumor,0
2813,Dilated Cystic Spaces Present,Vaginal high grade squamous intraepithelial lesion,0
2814,Dedifferentiated Malignant Infiltrate,Vaginal high grade squamous intraepithelial lesion,0
2815,Mammary Gland Type Features Present,Vaginal high grade squamous intraepithelial lesion,0
2816,Ectopic Tissue,Vaginal high grade squamous intraepithelial lesion,0
2817,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal high grade squamous intraepithelial lesion,0
2818,Dilated Cystic Spaces Present,malignant gastrinoma of pancreas,0
2819,Dedifferentiated Malignant Infiltrate,malignant gastrinoma of pancreas,0
2820,Mammary Gland Type Features Present,malignant gastrinoma of pancreas,0
2821,Ectopic Tissue,malignant gastrinoma of pancreas,0
2822,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,malignant gastrinoma of pancreas,0
2823,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0
2824,Isolated Tumor Cells,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0
2825,Pleural/Elastic Layer Invasion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0
2826,Presence of Extravascular Matrix Patterns,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0
2827,Ductopenia,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Intestinal-Type",0
2828,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",0
2829,Isolated Tumor Cells,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",0
2830,Pleural/Elastic Layer Invasion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",0
2831,Presence of Extravascular Matrix Patterns,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",0
2832,Ductopenia,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type",0
2833,Dilated Cystic Spaces Present,Bladder papilloma,0
2834,Dedifferentiated Malignant Infiltrate,Bladder papilloma,0
2835,Mammary Gland Type Features Present,Bladder papilloma,0
2836,Ectopic Tissue,Bladder papilloma,0
2837,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder papilloma,0
2838,Coronary Vessel Lesion,Colorectal Filiform Serrated Adenoma,0
2839,Index Lesion,Colorectal Filiform Serrated Adenoma,0
2840,Non-Index Lesion,Colorectal Filiform Serrated Adenoma,0
2841,Mushroom-Shaped Lesion,Colorectal Filiform Serrated Adenoma,0
2842,Annular Lesion,Colorectal Filiform Serrated Adenoma,0
2843,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Broad Ligament Serous Cystadenofibroma,0
2844,Isolated Tumor Cells,Broad Ligament Serous Cystadenofibroma,0
2845,Pleural/Elastic Layer Invasion,Broad Ligament Serous Cystadenofibroma,0
2846,Presence of Extravascular Matrix Patterns,Broad Ligament Serous Cystadenofibroma,0
2847,Ductopenia,Broad Ligament Serous Cystadenofibroma,0
2848,Dilated Cystic Spaces Present,Breast Neuroendocrine Neoplasm,0
2849,Dedifferentiated Malignant Infiltrate,Breast Neuroendocrine Neoplasm,0
2850,Mammary Gland Type Features Present,Breast Neuroendocrine Neoplasm,0
2851,Ectopic Tissue,Breast Neuroendocrine Neoplasm,0
2852,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Breast Neuroendocrine Neoplasm,0
2853,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Papillary cystic tumor,0
2854,Isolated Tumor Cells,Papillary cystic tumor,0
2855,Pleural/Elastic Layer Invasion,Papillary cystic tumor,0
2856,Presence of Extravascular Matrix Patterns,Papillary cystic tumor,0
2857,Ductopenia,Papillary cystic tumor,0
2858,Dilated Cystic Spaces Present,Tubular adenoma,0
2859,Dedifferentiated Malignant Infiltrate,Tubular adenoma,0
2860,Mammary Gland Type Features Present,Tubular adenoma,0
2861,Ectopic Tissue,Tubular adenoma,0
2862,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Tubular adenoma,0
2863,Dilated Cystic Spaces Present,Hindgut Carcinoid Tumor,0
2864,Dedifferentiated Malignant Infiltrate,Hindgut Carcinoid Tumor,0
2865,Mammary Gland Type Features Present,Hindgut Carcinoid Tumor,0
2866,Ectopic Tissue,Hindgut Carcinoid Tumor,0
2867,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hindgut Carcinoid Tumor,0
2868,Dilated Cystic Spaces Present,Combined Thymic Epithelial Neoplasm,0
2869,Dedifferentiated Malignant Infiltrate,Combined Thymic Epithelial Neoplasm,0
2870,Mammary Gland Type Features Present,Combined Thymic Epithelial Neoplasm,0
2871,Ectopic Tissue,Combined Thymic Epithelial Neoplasm,0
2872,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Combined Thymic Epithelial Neoplasm,0
2873,Dilated Cystic Spaces Present,Fibroadenoma of breast,0
2874,Dedifferentiated Malignant Infiltrate,Fibroadenoma of breast,0
2875,Mammary Gland Type Features Present,Fibroadenoma of breast,0
2876,Ectopic Tissue,Fibroadenoma of breast,0
2877,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Fibroadenoma of breast,0
2878,Coronary Vessel Lesion,Endocervical polyp,0
2879,Index Lesion,Endocervical polyp,0
2880,Non-Index Lesion,Endocervical polyp,0
2881,Mushroom-Shaped Lesion,Endocervical polyp,0
2882,Annular Lesion,Endocervical polyp,0
2883,Dilated Cystic Spaces Present,Jejunal Neuroendocrine Tumor G1,0
2884,Dedifferentiated Malignant Infiltrate,Jejunal Neuroendocrine Tumor G1,0
2885,Mammary Gland Type Features Present,Jejunal Neuroendocrine Tumor G1,0
2886,Ectopic Tissue,Jejunal Neuroendocrine Tumor G1,0
2887,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Jejunal Neuroendocrine Tumor G1,0
2888,Dilated Cystic Spaces Present,Fallopian Tube Mucinous Neoplasm,0
2889,Dedifferentiated Malignant Infiltrate,Fallopian Tube Mucinous Neoplasm,0
2890,Mammary Gland Type Features Present,Fallopian Tube Mucinous Neoplasm,0
2891,Ectopic Tissue,Fallopian Tube Mucinous Neoplasm,0
2892,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Fallopian Tube Mucinous Neoplasm,0
2893,Dilated Cystic Spaces Present,Glomus vagale tumor,0
2894,Dedifferentiated Malignant Infiltrate,Glomus vagale tumor,0
2895,Mammary Gland Type Features Present,Glomus vagale tumor,0
2896,Ectopic Tissue,Glomus vagale tumor,0
2897,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Glomus vagale tumor,0
2898,Dilated Cystic Spaces Present,Gallbladder Papillary Biliary Intraepithelial Neoplasia,0
2899,Dedifferentiated Malignant Infiltrate,Gallbladder Papillary Biliary Intraepithelial Neoplasia,0
2900,Mammary Gland Type Features Present,Gallbladder Papillary Biliary Intraepithelial Neoplasia,0
2901,Ectopic Tissue,Gallbladder Papillary Biliary Intraepithelial Neoplasia,0
2902,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Papillary Biliary Intraepithelial Neoplasia,0
2903,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Serous papillary cystic tumor of borderline malignancy,0
2904,Isolated Tumor Cells,Serous papillary cystic tumor of borderline malignancy,0
2905,Pleural/Elastic Layer Invasion,Serous papillary cystic tumor of borderline malignancy,0
2906,Presence of Extravascular Matrix Patterns,Serous papillary cystic tumor of borderline malignancy,0
2907,Ductopenia,Serous papillary cystic tumor of borderline malignancy,0
2908,Dilated Cystic Spaces Present,Multiple endocrine neoplasia Type 2,0
2909,Dedifferentiated Malignant Infiltrate,Multiple endocrine neoplasia Type 2,0
2910,Mammary Gland Type Features Present,Multiple endocrine neoplasia Type 2,0
2911,Ectopic Tissue,Multiple endocrine neoplasia Type 2,0
2912,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Multiple endocrine neoplasia Type 2,0
2913,Dilated Cystic Spaces Present,Ampulla of Vater Neuroendocrine Tumor G2,0
2914,Dedifferentiated Malignant Infiltrate,Ampulla of Vater Neuroendocrine Tumor G2,0
2915,Mammary Gland Type Features Present,Ampulla of Vater Neuroendocrine Tumor G2,0
2916,Ectopic Tissue,Ampulla of Vater Neuroendocrine Tumor G2,0
2917,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampulla of Vater Neuroendocrine Tumor G2,0
2918,Dilated Cystic Spaces Present,ACTH-producing pituitary tumor,0
2919,Dedifferentiated Malignant Infiltrate,ACTH-producing pituitary tumor,0
2920,Mammary Gland Type Features Present,ACTH-producing pituitary tumor,0
2921,Ectopic Tissue,ACTH-producing pituitary tumor,0
2922,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,ACTH-producing pituitary tumor,0
2923,Dilated Cystic Spaces Present,High Grade Glandular Intraepithelial Neoplasia,0
2924,Dedifferentiated Malignant Infiltrate,High Grade Glandular Intraepithelial Neoplasia,0
2925,Mammary Gland Type Features Present,High Grade Glandular Intraepithelial Neoplasia,0
2926,Ectopic Tissue,High Grade Glandular Intraepithelial Neoplasia,0
2927,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Glandular Intraepithelial Neoplasia,0
2928,Dilated Cystic Spaces Present,Papilloma of nasal vestibule,0
2929,Dedifferentiated Malignant Infiltrate,Papilloma of nasal vestibule,0
2930,Mammary Gland Type Features Present,Papilloma of nasal vestibule,0
2931,Ectopic Tissue,Papilloma of nasal vestibule,0
2932,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papilloma of nasal vestibule,0
2933,Dilated Cystic Spaces Present,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
2934,Dedifferentiated Malignant Infiltrate,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
2935,Mammary Gland Type Features Present,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
2936,Ectopic Tissue,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
2937,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Cervical Squamous Intraepithelial Neoplasia,0
2938,Dilated Cystic Spaces Present,Low Grade Prostatic Intraepithelial Neoplasia,0
2939,Dedifferentiated Malignant Infiltrate,Low Grade Prostatic Intraepithelial Neoplasia,0
2940,Mammary Gland Type Features Present,Low Grade Prostatic Intraepithelial Neoplasia,0
2941,Ectopic Tissue,Low Grade Prostatic Intraepithelial Neoplasia,0
2942,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Prostatic Intraepithelial Neoplasia,0
2943,Dilated Cystic Spaces Present,Adrenal Gland Composite Pheochromocytoma,0
2944,Dedifferentiated Malignant Infiltrate,Adrenal Gland Composite Pheochromocytoma,0
2945,Mammary Gland Type Features Present,Adrenal Gland Composite Pheochromocytoma,0
2946,Ectopic Tissue,Adrenal Gland Composite Pheochromocytoma,0
2947,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adrenal Gland Composite Pheochromocytoma,0
2948,Dilated Cystic Spaces Present,Ovarian Mucinous Adenofibroma,0
2949,Dedifferentiated Malignant Infiltrate,Ovarian Mucinous Adenofibroma,0
2950,Mammary Gland Type Features Present,Ovarian Mucinous Adenofibroma,0
2951,Ectopic Tissue,Ovarian Mucinous Adenofibroma,0
2952,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Mucinous Adenofibroma,0
2953,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Apocrine cystadenoma,0
2954,Isolated Tumor Cells,Apocrine cystadenoma,0
2955,Pleural/Elastic Layer Invasion,Apocrine cystadenoma,0
2956,Presence of Extravascular Matrix Patterns,Apocrine cystadenoma,0
2957,Ductopenia,Apocrine cystadenoma,0
2958,Coronary Vessel Lesion,Colorectal Adenoma with Moderate Dysplasia,0
2959,Index Lesion,Colorectal Adenoma with Moderate Dysplasia,0
2960,Non-Index Lesion,Colorectal Adenoma with Moderate Dysplasia,0
2961,Mushroom-Shaped Lesion,Colorectal Adenoma with Moderate Dysplasia,0
2962,Annular Lesion,Colorectal Adenoma with Moderate Dysplasia,0
2963,Coronary Vessel Lesion,Tibial adamantinoma,0
2964,Index Lesion,Tibial adamantinoma,0
2965,Non-Index Lesion,Tibial adamantinoma,0
2966,Mushroom-Shaped Lesion,Tibial adamantinoma,0
2967,Annular Lesion,Tibial adamantinoma,0
2968,Dilated Cystic Spaces Present,Pancreatic Intraepithelial Neoplasia-1B,0
2969,Dedifferentiated Malignant Infiltrate,Pancreatic Intraepithelial Neoplasia-1B,0
2970,Mammary Gland Type Features Present,Pancreatic Intraepithelial Neoplasia-1B,0
2971,Ectopic Tissue,Pancreatic Intraepithelial Neoplasia-1B,0
2972,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Intraepithelial Neoplasia-1B,0
2973,Dilated Cystic Spaces Present,ACTH-Secreting Pituitary Adenoma,0
2974,Dedifferentiated Malignant Infiltrate,ACTH-Secreting Pituitary Adenoma,0
2975,Mammary Gland Type Features Present,ACTH-Secreting Pituitary Adenoma,0
2976,Ectopic Tissue,ACTH-Secreting Pituitary Adenoma,0
2977,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,ACTH-Secreting Pituitary Adenoma,0
2978,Coronary Vessel Lesion,"Phyllodes tumor, borderline",0
2979,Index Lesion,"Phyllodes tumor, borderline",0
2980,Non-Index Lesion,"Phyllodes tumor, borderline",0
2981,Mushroom-Shaped Lesion,"Phyllodes tumor, borderline",0
2982,Annular Lesion,"Phyllodes tumor, borderline",0
2983,Dilated Cystic Spaces Present,Thymic Clear Cell Carcinoma,0
2984,Dedifferentiated Malignant Infiltrate,Thymic Clear Cell Carcinoma,0
2985,Mammary Gland Type Features Present,Thymic Clear Cell Carcinoma,0
2986,Ectopic Tissue,Thymic Clear Cell Carcinoma,0
2987,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymic Clear Cell Carcinoma,0
2988,Dilated Cystic Spaces Present,Carcinoid tumor of the prostate,0
2989,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of the prostate,0
2990,Mammary Gland Type Features Present,Carcinoid tumor of the prostate,0
2991,Ectopic Tissue,Carcinoid tumor of the prostate,0
2992,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of the prostate,0
2993,Dilated Cystic Spaces Present,Childhood Carcinoid Tumor,0
2994,Dedifferentiated Malignant Infiltrate,Childhood Carcinoid Tumor,0
2995,Mammary Gland Type Features Present,Childhood Carcinoid Tumor,0
2996,Ectopic Tissue,Childhood Carcinoid Tumor,0
2997,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Childhood Carcinoid Tumor,0
2998,Coronary Vessel Lesion,Benign phyllodes neoplasm of breast,0
2999,Index Lesion,Benign phyllodes neoplasm of breast,0
3000,Non-Index Lesion,Benign phyllodes neoplasm of breast,0
3001,Mushroom-Shaped Lesion,Benign phyllodes neoplasm of breast,0
3002,Annular Lesion,Benign phyllodes neoplasm of breast,0
3003,Dilated Cystic Spaces Present,Borderline serous tumor of ovary,0
3004,Dedifferentiated Malignant Infiltrate,Borderline serous tumor of ovary,0
3005,Mammary Gland Type Features Present,Borderline serous tumor of ovary,0
3006,Ectopic Tissue,Borderline serous tumor of ovary,0
3007,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline serous tumor of ovary,0
3008,Dilated Cystic Spaces Present,"Extra-adrenal paraganglioma, malignant",0
3009,Dedifferentiated Malignant Infiltrate,"Extra-adrenal paraganglioma, malignant",0
3010,Mammary Gland Type Features Present,"Extra-adrenal paraganglioma, malignant",0
3011,Ectopic Tissue,"Extra-adrenal paraganglioma, malignant",0
3012,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Extra-adrenal paraganglioma, malignant",0
3013,Dilated Cystic Spaces Present,Vulvar Ectopic Fibroadenoma,0
3014,Dedifferentiated Malignant Infiltrate,Vulvar Ectopic Fibroadenoma,0
3015,Mammary Gland Type Features Present,Vulvar Ectopic Fibroadenoma,0
3016,Ectopic Tissue,Vulvar Ectopic Fibroadenoma,0
3017,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vulvar Ectopic Fibroadenoma,0
3018,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Erosive Adenomatosis of the Nipple,0
3019,Isolated Tumor Cells,Erosive Adenomatosis of the Nipple,0
3020,Pleural/Elastic Layer Invasion,Erosive Adenomatosis of the Nipple,0
3021,Presence of Extravascular Matrix Patterns,Erosive Adenomatosis of the Nipple,0
3022,Ductopenia,Erosive Adenomatosis of the Nipple,0
3023,Dilated Cystic Spaces Present,Benign Ovarian Clear Cell Tumor,0
3024,Dedifferentiated Malignant Infiltrate,Benign Ovarian Clear Cell Tumor,0
3025,Mammary Gland Type Features Present,Benign Ovarian Clear Cell Tumor,0
3026,Ectopic Tissue,Benign Ovarian Clear Cell Tumor,0
3027,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Ovarian Clear Cell Tumor,0
3028,Dilated Cystic Spaces Present,"Glucagonoma, malignant",0
3029,Dedifferentiated Malignant Infiltrate,"Glucagonoma, malignant",0
3030,Mammary Gland Type Features Present,"Glucagonoma, malignant",0
3031,Ectopic Tissue,"Glucagonoma, malignant",0
3032,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Glucagonoma, malignant",0
3033,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,0
3034,Isolated Tumor Cells,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,0
3035,Pleural/Elastic Layer Invasion,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,0
3036,Presence of Extravascular Matrix Patterns,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,0
3037,Ductopenia,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,0
3038,Dilated Cystic Spaces Present,Malignant Vipoma,0
3039,Dedifferentiated Malignant Infiltrate,Malignant Vipoma,0
3040,Mammary Gland Type Features Present,Malignant Vipoma,0
3041,Ectopic Tissue,Malignant Vipoma,0
3042,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Vipoma,0
3043,Dilated Cystic Spaces Present,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,0
3044,Dedifferentiated Malignant Infiltrate,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,0
3045,Mammary Gland Type Features Present,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,0
3046,Ectopic Tissue,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,0
3047,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,0
3048,Coronary Vessel Lesion,Appendix Tubular Adenoma,0
3049,Index Lesion,Appendix Tubular Adenoma,0
3050,Non-Index Lesion,Appendix Tubular Adenoma,0
3051,Mushroom-Shaped Lesion,Appendix Tubular Adenoma,0
3052,Annular Lesion,Appendix Tubular Adenoma,0
3053,Dilated Cystic Spaces Present,Pancreatic ACTH-Producing Neuroendocrine Tumor,0
3054,Dedifferentiated Malignant Infiltrate,Pancreatic ACTH-Producing Neuroendocrine Tumor,0
3055,Mammary Gland Type Features Present,Pancreatic ACTH-Producing Neuroendocrine Tumor,0
3056,Ectopic Tissue,Pancreatic ACTH-Producing Neuroendocrine Tumor,0
3057,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic ACTH-Producing Neuroendocrine Tumor,0
3058,Dilated Cystic Spaces Present,Gastric Carcinoid Tumor,0
3059,Dedifferentiated Malignant Infiltrate,Gastric Carcinoid Tumor,0
3060,Mammary Gland Type Features Present,Gastric Carcinoid Tumor,0
3061,Ectopic Tissue,Gastric Carcinoid Tumor,0
3062,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastric Carcinoid Tumor,0
3063,Dilated Cystic Spaces Present,Paranasal Sinus Schneiderian Papilloma,0
3064,Dedifferentiated Malignant Infiltrate,Paranasal Sinus Schneiderian Papilloma,0
3065,Mammary Gland Type Features Present,Paranasal Sinus Schneiderian Papilloma,0
3066,Ectopic Tissue,Paranasal Sinus Schneiderian Papilloma,0
3067,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Paranasal Sinus Schneiderian Papilloma,0
3068,Coronary Vessel Lesion,Non-Functioning Adrenal Cortex Adenoma,0
3069,Index Lesion,Non-Functioning Adrenal Cortex Adenoma,0
3070,Non-Index Lesion,Non-Functioning Adrenal Cortex Adenoma,0
3071,Mushroom-Shaped Lesion,Non-Functioning Adrenal Cortex Adenoma,0
3072,Annular Lesion,Non-Functioning Adrenal Cortex Adenoma,0
3073,Dilated Cystic Spaces Present,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
3074,Dedifferentiated Malignant Infiltrate,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
3075,Mammary Gland Type Features Present,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
3076,Ectopic Tissue,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
3077,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Extrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
3078,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0
3079,Isolated Tumor Cells,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0
3080,Pleural/Elastic Layer Invasion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0
3081,Presence of Extravascular Matrix Patterns,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0
3082,Ductopenia,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type",0
3083,Dilated Cystic Spaces Present,Papillary Breast Neoplasm,0
3084,Dedifferentiated Malignant Infiltrate,Papillary Breast Neoplasm,0
3085,Mammary Gland Type Features Present,Papillary Breast Neoplasm,0
3086,Ectopic Tissue,Papillary Breast Neoplasm,0
3087,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papillary Breast Neoplasm,0
3088,Dilated Cystic Spaces Present,Benign Basal Cell Neoplasm,0
3089,Dedifferentiated Malignant Infiltrate,Benign Basal Cell Neoplasm,0
3090,Mammary Gland Type Features Present,Benign Basal Cell Neoplasm,0
3091,Ectopic Tissue,Benign Basal Cell Neoplasm,0
3092,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Basal Cell Neoplasm,0
3093,Dilated Cystic Spaces Present,Bartholin Gland Adenoma,0
3094,Dedifferentiated Malignant Infiltrate,Bartholin Gland Adenoma,0
3095,Mammary Gland Type Features Present,Bartholin Gland Adenoma,0
3096,Ectopic Tissue,Bartholin Gland Adenoma,0
3097,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bartholin Gland Adenoma,0
3098,Dilated Cystic Spaces Present,intraepithelial glandular neoplasia of cervix,0
3099,Dedifferentiated Malignant Infiltrate,intraepithelial glandular neoplasia of cervix,0
3100,Mammary Gland Type Features Present,intraepithelial glandular neoplasia of cervix,0
3101,Ectopic Tissue,intraepithelial glandular neoplasia of cervix,0
3102,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,intraepithelial glandular neoplasia of cervix,0
3103,Dilated Cystic Spaces Present,Thyrotroph adenoma,0
3104,Dedifferentiated Malignant Infiltrate,Thyrotroph adenoma,0
3105,Mammary Gland Type Features Present,Thyrotroph adenoma,0
3106,Ectopic Tissue,Thyrotroph adenoma,0
3107,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyrotroph adenoma,0
3108,Dilated Cystic Spaces Present,Benign tumor of endocrine gland,0
3109,Dedifferentiated Malignant Infiltrate,Benign tumor of endocrine gland,0
3110,Mammary Gland Type Features Present,Benign tumor of endocrine gland,0
3111,Ectopic Tissue,Benign tumor of endocrine gland,0
3112,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign tumor of endocrine gland,0
3113,Coronary Vessel Lesion,Prostate Phyllodes Tumor,0
3114,Index Lesion,Prostate Phyllodes Tumor,0
3115,Non-Index Lesion,Prostate Phyllodes Tumor,0
3116,Mushroom-Shaped Lesion,Prostate Phyllodes Tumor,0
3117,Annular Lesion,Prostate Phyllodes Tumor,0
3118,Dilated Cystic Spaces Present,Gastro-enteropancreatic neuroendocrine tumor,0
3119,Dedifferentiated Malignant Infiltrate,Gastro-enteropancreatic neuroendocrine tumor,0
3120,Mammary Gland Type Features Present,Gastro-enteropancreatic neuroendocrine tumor,0
3121,Ectopic Tissue,Gastro-enteropancreatic neuroendocrine tumor,0
3122,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastro-enteropancreatic neuroendocrine tumor,0
3123,Dilated Cystic Spaces Present,Alveolar adenoma,0
3124,Dedifferentiated Malignant Infiltrate,Alveolar adenoma,0
3125,Mammary Gland Type Features Present,Alveolar adenoma,0
3126,Ectopic Tissue,Alveolar adenoma,0
3127,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Alveolar adenoma,0
3128,Coronary Vessel Lesion,Appendix Villous Adenoma,0
3129,Index Lesion,Appendix Villous Adenoma,0
3130,Non-Index Lesion,Appendix Villous Adenoma,0
3131,Mushroom-Shaped Lesion,Appendix Villous Adenoma,0
3132,Annular Lesion,Appendix Villous Adenoma,0
3133,Dilated Cystic Spaces Present,Acanthoma,0
3134,Dedifferentiated Malignant Infiltrate,Acanthoma,0
3135,Mammary Gland Type Features Present,Acanthoma,0
3136,Ectopic Tissue,Acanthoma,0
3137,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Acanthoma,0
3138,Dilated Cystic Spaces Present,clear cell neoplasm of ovary,0
3139,Dedifferentiated Malignant Infiltrate,clear cell neoplasm of ovary,0
3140,Mammary Gland Type Features Present,clear cell neoplasm of ovary,0
3141,Ectopic Tissue,clear cell neoplasm of ovary,0
3142,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,clear cell neoplasm of ovary,0
3143,Dilated Cystic Spaces Present,Gallbladder Papillomatosis,0
3144,Dedifferentiated Malignant Infiltrate,Gallbladder Papillomatosis,0
3145,Mammary Gland Type Features Present,Gallbladder Papillomatosis,0
3146,Ectopic Tissue,Gallbladder Papillomatosis,0
3147,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Papillomatosis,0
3148,Dilated Cystic Spaces Present,Thymic Carcinoma,0
3149,Dedifferentiated Malignant Infiltrate,Thymic Carcinoma,0
3150,Mammary Gland Type Features Present,Thymic Carcinoma,0
3151,Ectopic Tissue,Thymic Carcinoma,0
3152,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymic Carcinoma,0
3153,Dilated Cystic Spaces Present,Gallbladder Neuroendocrine Tumor G2,0
3154,Dedifferentiated Malignant Infiltrate,Gallbladder Neuroendocrine Tumor G2,0
3155,Mammary Gland Type Features Present,Gallbladder Neuroendocrine Tumor G2,0
3156,Ectopic Tissue,Gallbladder Neuroendocrine Tumor G2,0
3157,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Neuroendocrine Tumor G2,0
3158,Dilated Cystic Spaces Present,Colon Neuroendocrine Tumor G1,0
3159,Dedifferentiated Malignant Infiltrate,Colon Neuroendocrine Tumor G1,0
3160,Mammary Gland Type Features Present,Colon Neuroendocrine Tumor G1,0
3161,Ectopic Tissue,Colon Neuroendocrine Tumor G1,0
3162,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colon Neuroendocrine Tumor G1,0
3163,Dilated Cystic Spaces Present,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,0
3164,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,0
3165,Mammary Gland Type Features Present,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,0
3166,Ectopic Tissue,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,0
3167,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,0
3168,Dilated Cystic Spaces Present,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,0
3169,Dedifferentiated Malignant Infiltrate,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,0
3170,Mammary Gland Type Features Present,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,0
3171,Ectopic Tissue,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,0
3172,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Papillary Neoplasm with High Grade Intraepithelial Neoplasia,0
3173,Dilated Cystic Spaces Present,Mesonephric tumor,0
3174,Dedifferentiated Malignant Infiltrate,Mesonephric tumor,0
3175,Mammary Gland Type Features Present,Mesonephric tumor,0
3176,Ectopic Tissue,Mesonephric tumor,0
3177,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mesonephric tumor,0
3178,Dilated Cystic Spaces Present,Inverting papilloma of the paranasal sinus,0
3179,Dedifferentiated Malignant Infiltrate,Inverting papilloma of the paranasal sinus,0
3180,Mammary Gland Type Features Present,Inverting papilloma of the paranasal sinus,0
3181,Ectopic Tissue,Inverting papilloma of the paranasal sinus,0
3182,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Inverting papilloma of the paranasal sinus,0
3183,Coronary Vessel Lesion,tubular adenoma of stomach,0
3184,Index Lesion,tubular adenoma of stomach,0
3185,Non-Index Lesion,tubular adenoma of stomach,0
3186,Mushroom-Shaped Lesion,tubular adenoma of stomach,0
3187,Annular Lesion,tubular adenoma of stomach,0
3188,Coronary Vessel Lesion,Ampulla of Vater Villous Adenoma,0
3189,Index Lesion,Ampulla of Vater Villous Adenoma,0
3190,Non-Index Lesion,Ampulla of Vater Villous Adenoma,0
3191,Mushroom-Shaped Lesion,Ampulla of Vater Villous Adenoma,0
3192,Annular Lesion,Ampulla of Vater Villous Adenoma,0
3193,Dilated Cystic Spaces Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
3194,Dedifferentiated Malignant Infiltrate,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
3195,Mammary Gland Type Features Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
3196,Ectopic Tissue,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
3197,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,0
3198,Dilated Cystic Spaces Present,Esophageal High Grade Intraepithelial Neoplasia,0
3199,Dedifferentiated Malignant Infiltrate,Esophageal High Grade Intraepithelial Neoplasia,0
3200,Mammary Gland Type Features Present,Esophageal High Grade Intraepithelial Neoplasia,0
3201,Ectopic Tissue,Esophageal High Grade Intraepithelial Neoplasia,0
3202,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Esophageal High Grade Intraepithelial Neoplasia,0
3203,Dilated Cystic Spaces Present,Warty dyskeratoma,0
3204,Dedifferentiated Malignant Infiltrate,Warty dyskeratoma,0
3205,Mammary Gland Type Features Present,Warty dyskeratoma,0
3206,Ectopic Tissue,Warty dyskeratoma,0
3207,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Warty dyskeratoma,0
3208,Dilated Cystic Spaces Present,Recurrent Combined Thymic Epithelial Neoplasm,0
3209,Dedifferentiated Malignant Infiltrate,Recurrent Combined Thymic Epithelial Neoplasm,0
3210,Mammary Gland Type Features Present,Recurrent Combined Thymic Epithelial Neoplasm,0
3211,Ectopic Tissue,Recurrent Combined Thymic Epithelial Neoplasm,0
3212,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Combined Thymic Epithelial Neoplasm,0
3213,Dilated Cystic Spaces Present,Benign Outer Hair Sheath and Infundibulum Neoplasm,0
3214,Dedifferentiated Malignant Infiltrate,Benign Outer Hair Sheath and Infundibulum Neoplasm,0
3215,Mammary Gland Type Features Present,Benign Outer Hair Sheath and Infundibulum Neoplasm,0
3216,Ectopic Tissue,Benign Outer Hair Sheath and Infundibulum Neoplasm,0
3217,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Outer Hair Sheath and Infundibulum Neoplasm,0
3218,Dilated Cystic Spaces Present,Breast Papillomatosis,0
3219,Dedifferentiated Malignant Infiltrate,Breast Papillomatosis,0
3220,Mammary Gland Type Features Present,Breast Papillomatosis,0
3221,Ectopic Tissue,Breast Papillomatosis,0
3222,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Breast Papillomatosis,0
3223,Dilated Cystic Spaces Present,Colorectal Intraepithelial Neoplasia,0
3224,Dedifferentiated Malignant Infiltrate,Colorectal Intraepithelial Neoplasia,0
3225,Mammary Gland Type Features Present,Colorectal Intraepithelial Neoplasia,0
3226,Ectopic Tissue,Colorectal Intraepithelial Neoplasia,0
3227,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal Intraepithelial Neoplasia,0
3228,Coronary Vessel Lesion,HNF1alpha-Inactivated Hepatocellular Adenoma,0
3229,Index Lesion,HNF1alpha-Inactivated Hepatocellular Adenoma,0
3230,Non-Index Lesion,HNF1alpha-Inactivated Hepatocellular Adenoma,0
3231,Mushroom-Shaped Lesion,HNF1alpha-Inactivated Hepatocellular Adenoma,0
3232,Annular Lesion,HNF1alpha-Inactivated Hepatocellular Adenoma,0
3233,Dilated Cystic Spaces Present,Pancreatic Intraepithelial Neoplasia-3,0
3234,Dedifferentiated Malignant Infiltrate,Pancreatic Intraepithelial Neoplasia-3,0
3235,Mammary Gland Type Features Present,Pancreatic Intraepithelial Neoplasia-3,0
3236,Ectopic Tissue,Pancreatic Intraepithelial Neoplasia-3,0
3237,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Intraepithelial Neoplasia-3,0
3238,Dilated Cystic Spaces Present,Bladder Villous Adenoma,0
3239,Dedifferentiated Malignant Infiltrate,Bladder Villous Adenoma,0
3240,Mammary Gland Type Features Present,Bladder Villous Adenoma,0
3241,Ectopic Tissue,Bladder Villous Adenoma,0
3242,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Villous Adenoma,0
3243,Coronary Vessel Lesion,Adenoma of rectum,0
3244,Index Lesion,Adenoma of rectum,0
3245,Non-Index Lesion,Adenoma of rectum,0
3246,Mushroom-Shaped Lesion,Adenoma of rectum,0
3247,Annular Lesion,Adenoma of rectum,0
3248,Dilated Cystic Spaces Present,Benign Adrenal Gland Composite Pheochromocytoma,0
3249,Dedifferentiated Malignant Infiltrate,Benign Adrenal Gland Composite Pheochromocytoma,0
3250,Mammary Gland Type Features Present,Benign Adrenal Gland Composite Pheochromocytoma,0
3251,Ectopic Tissue,Benign Adrenal Gland Composite Pheochromocytoma,0
3252,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Adrenal Gland Composite Pheochromocytoma,0
3253,Dilated Cystic Spaces Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
3254,Dedifferentiated Malignant Infiltrate,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
3255,Mammary Gland Type Features Present,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
3256,Ectopic Tissue,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
3257,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,0
3258,Dilated Cystic Spaces Present,Growth Hormone-Producing Pituitary Gland Neoplasm,0
3259,Dedifferentiated Malignant Infiltrate,Growth Hormone-Producing Pituitary Gland Neoplasm,0
3260,Mammary Gland Type Features Present,Growth Hormone-Producing Pituitary Gland Neoplasm,0
3261,Ectopic Tissue,Growth Hormone-Producing Pituitary Gland Neoplasm,0
3262,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Growth Hormone-Producing Pituitary Gland Neoplasm,0
3263,Dilated Cystic Spaces Present,Carcinoid tumor of intestine,0
3264,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of intestine,0
3265,Mammary Gland Type Features Present,Carcinoid tumor of intestine,0
3266,Ectopic Tissue,Carcinoid tumor of intestine,0
3267,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of intestine,0
3268,Dilated Cystic Spaces Present,Mediastinal Paraganglioma,0
3269,Dedifferentiated Malignant Infiltrate,Mediastinal Paraganglioma,0
3270,Mammary Gland Type Features Present,Mediastinal Paraganglioma,0
3271,Ectopic Tissue,Mediastinal Paraganglioma,0
3272,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mediastinal Paraganglioma,0
3273,Dilated Cystic Spaces Present,Carcinoid tumor of the cecum,0
3274,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of the cecum,0
3275,Mammary Gland Type Features Present,Carcinoid tumor of the cecum,0
3276,Ectopic Tissue,Carcinoid tumor of the cecum,0
3277,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of the cecum,0
3278,Dilated Cystic Spaces Present,Frontal Sinus Inverted Papilloma,0
3279,Dedifferentiated Malignant Infiltrate,Frontal Sinus Inverted Papilloma,0
3280,Mammary Gland Type Features Present,Frontal Sinus Inverted Papilloma,0
3281,Ectopic Tissue,Frontal Sinus Inverted Papilloma,0
3282,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Frontal Sinus Inverted Papilloma,0
3283,Dilated Cystic Spaces Present,"Acanthoma, Pilar Sheath",0
3284,Dedifferentiated Malignant Infiltrate,"Acanthoma, Pilar Sheath",0
3285,Mammary Gland Type Features Present,"Acanthoma, Pilar Sheath",0
3286,Ectopic Tissue,"Acanthoma, Pilar Sheath",0
3287,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Acanthoma, Pilar Sheath",0
3288,Dilated Cystic Spaces Present,"Papilloma, Intraductal",0
3289,Dedifferentiated Malignant Infiltrate,"Papilloma, Intraductal",0
3290,Mammary Gland Type Features Present,"Papilloma, Intraductal",0
3291,Ectopic Tissue,"Papilloma, Intraductal",0
3292,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Papilloma, Intraductal",0
3293,Coronary Vessel Lesion,Fallopian Tube Endometrioid Polyp,0
3294,Index Lesion,Fallopian Tube Endometrioid Polyp,0
3295,Non-Index Lesion,Fallopian Tube Endometrioid Polyp,0
3296,Mushroom-Shaped Lesion,Fallopian Tube Endometrioid Polyp,0
3297,Annular Lesion,Fallopian Tube Endometrioid Polyp,0
3298,Coronary Vessel Lesion,adenoma of extrahepatic bile duct,0
3299,Index Lesion,adenoma of extrahepatic bile duct,0
3300,Non-Index Lesion,adenoma of extrahepatic bile duct,0
3301,Mushroom-Shaped Lesion,adenoma of extrahepatic bile duct,0
3302,Annular Lesion,adenoma of extrahepatic bile duct,0
3303,Dilated Cystic Spaces Present,Oropharyngeal squamous papilloma,0
3304,Dedifferentiated Malignant Infiltrate,Oropharyngeal squamous papilloma,0
3305,Mammary Gland Type Features Present,Oropharyngeal squamous papilloma,0
3306,Ectopic Tissue,Oropharyngeal squamous papilloma,0
3307,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Oropharyngeal squamous papilloma,0
3308,Dilated Cystic Spaces Present,Anal Canal Neuroendocrine Neoplasm,0
3309,Dedifferentiated Malignant Infiltrate,Anal Canal Neuroendocrine Neoplasm,0
3310,Mammary Gland Type Features Present,Anal Canal Neuroendocrine Neoplasm,0
3311,Ectopic Tissue,Anal Canal Neuroendocrine Neoplasm,0
3312,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anal Canal Neuroendocrine Neoplasm,0
3313,Dilated Cystic Spaces Present,Transverse Colon Neuroendocrine Tumor G1,0
3314,Dedifferentiated Malignant Infiltrate,Transverse Colon Neuroendocrine Tumor G1,0
3315,Mammary Gland Type Features Present,Transverse Colon Neuroendocrine Tumor G1,0
3316,Ectopic Tissue,Transverse Colon Neuroendocrine Tumor G1,0
3317,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Transverse Colon Neuroendocrine Tumor G1,0
3318,Dilated Cystic Spaces Present,Pituitary Gland Macroadenoma,0
3319,Dedifferentiated Malignant Infiltrate,Pituitary Gland Macroadenoma,0
3320,Mammary Gland Type Features Present,Pituitary Gland Macroadenoma,0
3321,Ectopic Tissue,Pituitary Gland Macroadenoma,0
3322,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pituitary Gland Macroadenoma,0
3323,Dilated Cystic Spaces Present,Intrapulmonary thymoma,0
3324,Dedifferentiated Malignant Infiltrate,Intrapulmonary thymoma,0
3325,Mammary Gland Type Features Present,Intrapulmonary thymoma,0
3326,Ectopic Tissue,Intrapulmonary thymoma,0
3327,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intrapulmonary thymoma,0
3328,Dilated Cystic Spaces Present,Bladder Non-Invasive Papillary Urothelial Neoplasm,0
3329,Dedifferentiated Malignant Infiltrate,Bladder Non-Invasive Papillary Urothelial Neoplasm,0
3330,Mammary Gland Type Features Present,Bladder Non-Invasive Papillary Urothelial Neoplasm,0
3331,Ectopic Tissue,Bladder Non-Invasive Papillary Urothelial Neoplasm,0
3332,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Non-Invasive Papillary Urothelial Neoplasm,0
3333,Dilated Cystic Spaces Present,Exophytic Schneiderian Papilloma,0
3334,Dedifferentiated Malignant Infiltrate,Exophytic Schneiderian Papilloma,0
3335,Mammary Gland Type Features Present,Exophytic Schneiderian Papilloma,0
3336,Ectopic Tissue,Exophytic Schneiderian Papilloma,0
3337,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Exophytic Schneiderian Papilloma,0
3338,Dilated Cystic Spaces Present,"Thymoma, type AB",0
3339,Dedifferentiated Malignant Infiltrate,"Thymoma, type AB",0
3340,Mammary Gland Type Features Present,"Thymoma, type AB",0
3341,Ectopic Tissue,"Thymoma, type AB",0
3342,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thymoma, type AB",0
3343,Dilated Cystic Spaces Present,Adult Choroid Plexus Neoplasm,0
3344,Dedifferentiated Malignant Infiltrate,Adult Choroid Plexus Neoplasm,0
3345,Mammary Gland Type Features Present,Adult Choroid Plexus Neoplasm,0
3346,Ectopic Tissue,Adult Choroid Plexus Neoplasm,0
3347,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adult Choroid Plexus Neoplasm,0
3348,Dilated Cystic Spaces Present,Syringoma,0
3349,Dedifferentiated Malignant Infiltrate,Syringoma,0
3350,Mammary Gland Type Features Present,Syringoma,0
3351,Ectopic Tissue,Syringoma,0
3352,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Syringoma,0
3353,Dilated Cystic Spaces Present,Vaginal Tubular Adenoma,0
3354,Dedifferentiated Malignant Infiltrate,Vaginal Tubular Adenoma,0
3355,Mammary Gland Type Features Present,Vaginal Tubular Adenoma,0
3356,Ectopic Tissue,Vaginal Tubular Adenoma,0
3357,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal Tubular Adenoma,0
3358,Dilated Cystic Spaces Present,Central Breast Papilloma,0
3359,Dedifferentiated Malignant Infiltrate,Central Breast Papilloma,0
3360,Mammary Gland Type Features Present,Central Breast Papilloma,0
3361,Ectopic Tissue,Central Breast Papilloma,0
3362,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Central Breast Papilloma,0
3363,Dilated Cystic Spaces Present,Skin Papilloma,0
3364,Dedifferentiated Malignant Infiltrate,Skin Papilloma,0
3365,Mammary Gland Type Features Present,Skin Papilloma,0
3366,Ectopic Tissue,Skin Papilloma,0
3367,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Skin Papilloma,0
3368,Dilated Cystic Spaces Present,Midgut Carcinoid Tumor,0
3369,Dedifferentiated Malignant Infiltrate,Midgut Carcinoid Tumor,0
3370,Mammary Gland Type Features Present,Midgut Carcinoid Tumor,0
3371,Ectopic Tissue,Midgut Carcinoid Tumor,0
3372,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Midgut Carcinoid Tumor,0
3373,Dilated Cystic Spaces Present,Carcinoid tumor of lung,0
3374,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of lung,0
3375,Mammary Gland Type Features Present,Carcinoid tumor of lung,0
3376,Ectopic Tissue,Carcinoid tumor of lung,0
3377,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of lung,0
3378,Coronary Vessel Lesion,Tubular adenoma of colon,0
3379,Index Lesion,Tubular adenoma of colon,0
3380,Non-Index Lesion,Tubular adenoma of colon,0
3381,Mushroom-Shaped Lesion,Tubular adenoma of colon,0
3382,Annular Lesion,Tubular adenoma of colon,0
3383,Dilated Cystic Spaces Present,Biliary Intraepithelial Neoplasia-2,0
3384,Dedifferentiated Malignant Infiltrate,Biliary Intraepithelial Neoplasia-2,0
3385,Mammary Gland Type Features Present,Biliary Intraepithelial Neoplasia-2,0
3386,Ectopic Tissue,Biliary Intraepithelial Neoplasia-2,0
3387,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Biliary Intraepithelial Neoplasia-2,0
3388,Dilated Cystic Spaces Present,Benign Breast Adenomyoepithelioma,0
3389,Dedifferentiated Malignant Infiltrate,Benign Breast Adenomyoepithelioma,0
3390,Mammary Gland Type Features Present,Benign Breast Adenomyoepithelioma,0
3391,Ectopic Tissue,Benign Breast Adenomyoepithelioma,0
3392,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Breast Adenomyoepithelioma,0
3393,Dilated Cystic Spaces Present,Low-grade intraurothelial neoplasia,0
3394,Dedifferentiated Malignant Infiltrate,Low-grade intraurothelial neoplasia,0
3395,Mammary Gland Type Features Present,Low-grade intraurothelial neoplasia,0
3396,Ectopic Tissue,Low-grade intraurothelial neoplasia,0
3397,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low-grade intraurothelial neoplasia,0
3398,Dilated Cystic Spaces Present,Vaginal intraepithelial neoplasia grade 2,0
3399,Dedifferentiated Malignant Infiltrate,Vaginal intraepithelial neoplasia grade 2,0
3400,Mammary Gland Type Features Present,Vaginal intraepithelial neoplasia grade 2,0
3401,Ectopic Tissue,Vaginal intraepithelial neoplasia grade 2,0
3402,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal intraepithelial neoplasia grade 2,0
3403,Dilated Cystic Spaces Present,Sclerosing thymoma,0
3404,Dedifferentiated Malignant Infiltrate,Sclerosing thymoma,0
3405,Mammary Gland Type Features Present,Sclerosing thymoma,0
3406,Ectopic Tissue,Sclerosing thymoma,0
3407,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sclerosing thymoma,0
3408,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Acinar Cell Cystadenoma,0
3409,Isolated Tumor Cells,Pancreatic Acinar Cell Cystadenoma,0
3410,Pleural/Elastic Layer Invasion,Pancreatic Acinar Cell Cystadenoma,0
3411,Presence of Extravascular Matrix Patterns,Pancreatic Acinar Cell Cystadenoma,0
3412,Ductopenia,Pancreatic Acinar Cell Cystadenoma,0
3413,Dilated Cystic Spaces Present,"Pheochromocytoma, Extra-Adrenal",0
3414,Dedifferentiated Malignant Infiltrate,"Pheochromocytoma, Extra-Adrenal",0
3415,Mammary Gland Type Features Present,"Pheochromocytoma, Extra-Adrenal",0
3416,Ectopic Tissue,"Pheochromocytoma, Extra-Adrenal",0
3417,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Pheochromocytoma, Extra-Adrenal",0
3418,Coronary Vessel Lesion,Small Intestinal Villous Adenoma,0
3419,Index Lesion,Small Intestinal Villous Adenoma,0
3420,Non-Index Lesion,Small Intestinal Villous Adenoma,0
3421,Mushroom-Shaped Lesion,Small Intestinal Villous Adenoma,0
3422,Annular Lesion,Small Intestinal Villous Adenoma,0
3423,Dilated Cystic Spaces Present,Oral Cavity Adenoma,0
3424,Dedifferentiated Malignant Infiltrate,Oral Cavity Adenoma,0
3425,Mammary Gland Type Features Present,Oral Cavity Adenoma,0
3426,Ectopic Tissue,Oral Cavity Adenoma,0
3427,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Oral Cavity Adenoma,0
3428,Dilated Cystic Spaces Present,Papillary tumor of renal pelvis,0
3429,Dedifferentiated Malignant Infiltrate,Papillary tumor of renal pelvis,0
3430,Mammary Gland Type Features Present,Papillary tumor of renal pelvis,0
3431,Ectopic Tissue,Papillary tumor of renal pelvis,0
3432,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papillary tumor of renal pelvis,0
3433,Dilated Cystic Spaces Present,Papilloma,0
3434,Dedifferentiated Malignant Infiltrate,Papilloma,0
3435,Mammary Gland Type Features Present,Papilloma,0
3436,Ectopic Tissue,Papilloma,0
3437,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papilloma,0
3438,Dilated Cystic Spaces Present,Atypical choroid plexus papilloma,0
3439,Dedifferentiated Malignant Infiltrate,Atypical choroid plexus papilloma,0
3440,Mammary Gland Type Features Present,Atypical choroid plexus papilloma,0
3441,Ectopic Tissue,Atypical choroid plexus papilloma,0
3442,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Atypical choroid plexus papilloma,0
3443,Dilated Cystic Spaces Present,Condyloma acuminata of vulva,0
3444,Dedifferentiated Malignant Infiltrate,Condyloma acuminata of vulva,0
3445,Mammary Gland Type Features Present,Condyloma acuminata of vulva,0
3446,Ectopic Tissue,Condyloma acuminata of vulva,0
3447,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Condyloma acuminata of vulva,0
3448,Dilated Cystic Spaces Present,Malignant Pancreatic Somatostatinoma,0
3449,Dedifferentiated Malignant Infiltrate,Malignant Pancreatic Somatostatinoma,0
3450,Mammary Gland Type Features Present,Malignant Pancreatic Somatostatinoma,0
3451,Ectopic Tissue,Malignant Pancreatic Somatostatinoma,0
3452,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Pancreatic Somatostatinoma,0
3453,Dilated Cystic Spaces Present,High Grade Cervical Intraepithelial Neoplasia,0
3454,Dedifferentiated Malignant Infiltrate,High Grade Cervical Intraepithelial Neoplasia,0
3455,Mammary Gland Type Features Present,High Grade Cervical Intraepithelial Neoplasia,0
3456,Ectopic Tissue,High Grade Cervical Intraepithelial Neoplasia,0
3457,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Cervical Intraepithelial Neoplasia,0
3458,Dilated Cystic Spaces Present,Thyroid Gland Oncocytic Adenoma,0
3459,Dedifferentiated Malignant Infiltrate,Thyroid Gland Oncocytic Adenoma,0
3460,Mammary Gland Type Features Present,Thyroid Gland Oncocytic Adenoma,0
3461,Ectopic Tissue,Thyroid Gland Oncocytic Adenoma,0
3462,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Oncocytic Adenoma,0
3463,Dilated Cystic Spaces Present,Epidermolytic acanthoma,0
3464,Dedifferentiated Malignant Infiltrate,Epidermolytic acanthoma,0
3465,Mammary Gland Type Features Present,Epidermolytic acanthoma,0
3466,Ectopic Tissue,Epidermolytic acanthoma,0
3467,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Epidermolytic acanthoma,0
3468,Dilated Cystic Spaces Present,Intraepithelial Neoplasia,0
3469,Dedifferentiated Malignant Infiltrate,Intraepithelial Neoplasia,0
3470,Mammary Gland Type Features Present,Intraepithelial Neoplasia,0
3471,Ectopic Tissue,Intraepithelial Neoplasia,0
3472,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intraepithelial Neoplasia,0
3473,Coronary Vessel Lesion,Breast adenoma,0
3474,Index Lesion,Breast adenoma,0
3475,Non-Index Lesion,Breast adenoma,0
3476,Mushroom-Shaped Lesion,Breast adenoma,0
3477,Annular Lesion,Breast adenoma,0
3478,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Serous cystadenoma of ovary,0
3479,Isolated Tumor Cells,Serous cystadenoma of ovary,0
3480,Pleural/Elastic Layer Invasion,Serous cystadenoma of ovary,0
3481,Presence of Extravascular Matrix Patterns,Serous cystadenoma of ovary,0
3482,Ductopenia,Serous cystadenoma of ovary,0
3483,Dilated Cystic Spaces Present,Pancreatic Neuroendocrine Microadenoma,0
3484,Dedifferentiated Malignant Infiltrate,Pancreatic Neuroendocrine Microadenoma,0
3485,Mammary Gland Type Features Present,Pancreatic Neuroendocrine Microadenoma,0
3486,Ectopic Tissue,Pancreatic Neuroendocrine Microadenoma,0
3487,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Neuroendocrine Microadenoma,0
3488,Dilated Cystic Spaces Present,Grade II Prostatic Intraepithelial Neoplasia,0
3489,Dedifferentiated Malignant Infiltrate,Grade II Prostatic Intraepithelial Neoplasia,0
3490,Mammary Gland Type Features Present,Grade II Prostatic Intraepithelial Neoplasia,0
3491,Ectopic Tissue,Grade II Prostatic Intraepithelial Neoplasia,0
3492,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Grade II Prostatic Intraepithelial Neoplasia,0
3493,Dilated Cystic Spaces Present,Intraductal papillary breast neoplasm,0
3494,Dedifferentiated Malignant Infiltrate,Intraductal papillary breast neoplasm,0
3495,Mammary Gland Type Features Present,Intraductal papillary breast neoplasm,0
3496,Ectopic Tissue,Intraductal papillary breast neoplasm,0
3497,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intraductal papillary breast neoplasm,0
3498,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Endometrioid Cystadenofibroma,0
3499,Isolated Tumor Cells,Ovarian Endometrioid Cystadenofibroma,0
3500,Pleural/Elastic Layer Invasion,Ovarian Endometrioid Cystadenofibroma,0
3501,Presence of Extravascular Matrix Patterns,Ovarian Endometrioid Cystadenofibroma,0
3502,Ductopenia,Ovarian Endometrioid Cystadenofibroma,0
3503,Dilated Cystic Spaces Present,ductal papilloma of salivary gland,0
3504,Dedifferentiated Malignant Infiltrate,ductal papilloma of salivary gland,0
3505,Mammary Gland Type Features Present,ductal papilloma of salivary gland,0
3506,Ectopic Tissue,ductal papilloma of salivary gland,0
3507,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,ductal papilloma of salivary gland,0
3508,Dilated Cystic Spaces Present,Corneal intraepithelial neoplasia,0
3509,Dedifferentiated Malignant Infiltrate,Corneal intraepithelial neoplasia,0
3510,Mammary Gland Type Features Present,Corneal intraepithelial neoplasia,0
3511,Ectopic Tissue,Corneal intraepithelial neoplasia,0
3512,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Corneal intraepithelial neoplasia,0
3513,Dilated Cystic Spaces Present,Ovarian Surface Papilloma,0
3514,Dedifferentiated Malignant Infiltrate,Ovarian Surface Papilloma,0
3515,Mammary Gland Type Features Present,Ovarian Surface Papilloma,0
3516,Ectopic Tissue,Ovarian Surface Papilloma,0
3517,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Surface Papilloma,0
3518,Coronary Vessel Lesion,Rectal Traditional Serrated Adenoma,0
3519,Index Lesion,Rectal Traditional Serrated Adenoma,0
3520,Non-Index Lesion,Rectal Traditional Serrated Adenoma,0
3521,Mushroom-Shaped Lesion,Rectal Traditional Serrated Adenoma,0
3522,Annular Lesion,Rectal Traditional Serrated Adenoma,0
3523,Dilated Cystic Spaces Present,Malignant Ovarian Transitional Cell Tumor,0
3524,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Transitional Cell Tumor,0
3525,Mammary Gland Type Features Present,Malignant Ovarian Transitional Cell Tumor,0
3526,Ectopic Tissue,Malignant Ovarian Transitional Cell Tumor,0
3527,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Transitional Cell Tumor,0
3528,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Borderline Ovarian Clear Cell Cystadenofibroma,0
3529,Isolated Tumor Cells,Borderline Ovarian Clear Cell Cystadenofibroma,0
3530,Pleural/Elastic Layer Invasion,Borderline Ovarian Clear Cell Cystadenofibroma,0
3531,Presence of Extravascular Matrix Patterns,Borderline Ovarian Clear Cell Cystadenofibroma,0
3532,Ductopenia,Borderline Ovarian Clear Cell Cystadenofibroma,0
3533,Coronary Vessel Lesion,Colorectal Tubulovillous Adenoma,0
3534,Index Lesion,Colorectal Tubulovillous Adenoma,0
3535,Non-Index Lesion,Colorectal Tubulovillous Adenoma,0
3536,Mushroom-Shaped Lesion,Colorectal Tubulovillous Adenoma,0
3537,Annular Lesion,Colorectal Tubulovillous Adenoma,0
3538,Dilated Cystic Spaces Present,"Acanthoma, Clear Cell",0
3539,Dedifferentiated Malignant Infiltrate,"Acanthoma, Clear Cell",0
3540,Mammary Gland Type Features Present,"Acanthoma, Clear Cell",0
3541,Ectopic Tissue,"Acanthoma, Clear Cell",0
3542,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Acanthoma, Clear Cell",0
3543,Dilated Cystic Spaces Present,Classic Type Trichilemmoma,0
3544,Dedifferentiated Malignant Infiltrate,Classic Type Trichilemmoma,0
3545,Mammary Gland Type Features Present,Classic Type Trichilemmoma,0
3546,Ectopic Tissue,Classic Type Trichilemmoma,0
3547,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Classic Type Trichilemmoma,0
3548,Dilated Cystic Spaces Present,Laryngeal Carcinoid Tumor,0
3549,Dedifferentiated Malignant Infiltrate,Laryngeal Carcinoid Tumor,0
3550,Mammary Gland Type Features Present,Laryngeal Carcinoid Tumor,0
3551,Ectopic Tissue,Laryngeal Carcinoid Tumor,0
3552,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Laryngeal Carcinoid Tumor,0
3553,Dilated Cystic Spaces Present,Thymic Atypical Carcinoid Tumor,0
3554,Dedifferentiated Malignant Infiltrate,Thymic Atypical Carcinoid Tumor,0
3555,Mammary Gland Type Features Present,Thymic Atypical Carcinoid Tumor,0
3556,Ectopic Tissue,Thymic Atypical Carcinoid Tumor,0
3557,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymic Atypical Carcinoid Tumor,0
3558,Coronary Vessel Lesion,Rectal Adenoma with Severe Dysplasia,0
3559,Index Lesion,Rectal Adenoma with Severe Dysplasia,0
3560,Non-Index Lesion,Rectal Adenoma with Severe Dysplasia,0
3561,Mushroom-Shaped Lesion,Rectal Adenoma with Severe Dysplasia,0
3562,Annular Lesion,Rectal Adenoma with Severe Dysplasia,0
3563,Dilated Cystic Spaces Present,Adenoma of middle ear,0
3564,Dedifferentiated Malignant Infiltrate,Adenoma of middle ear,0
3565,Mammary Gland Type Features Present,Adenoma of middle ear,0
3566,Ectopic Tissue,Adenoma of middle ear,0
3567,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adenoma of middle ear,0
3568,Coronary Vessel Lesion,papillary adenoma of extrahepatic bile duct,0
3569,Index Lesion,papillary adenoma of extrahepatic bile duct,0
3570,Non-Index Lesion,papillary adenoma of extrahepatic bile duct,0
3571,Mushroom-Shaped Lesion,papillary adenoma of extrahepatic bile duct,0
3572,Annular Lesion,papillary adenoma of extrahepatic bile duct,0
3573,Dilated Cystic Spaces Present,Maxillary Sinus Inverted Papilloma,0
3574,Dedifferentiated Malignant Infiltrate,Maxillary Sinus Inverted Papilloma,0
3575,Mammary Gland Type Features Present,Maxillary Sinus Inverted Papilloma,0
3576,Ectopic Tissue,Maxillary Sinus Inverted Papilloma,0
3577,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Maxillary Sinus Inverted Papilloma,0
3578,Dilated Cystic Spaces Present,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3579,Dedifferentiated Malignant Infiltrate,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3580,Mammary Gland Type Features Present,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3581,Ectopic Tissue,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3582,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3583,Dilated Cystic Spaces Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor,0
3584,Dedifferentiated Malignant Infiltrate,Duodenal Somatostatin-Producing Neuroendocrine Tumor,0
3585,Mammary Gland Type Features Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor,0
3586,Ectopic Tissue,Duodenal Somatostatin-Producing Neuroendocrine Tumor,0
3587,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Duodenal Somatostatin-Producing Neuroendocrine Tumor,0
3588,Dilated Cystic Spaces Present,Epithelial neoplasm of skin,0
3589,Dedifferentiated Malignant Infiltrate,Epithelial neoplasm of skin,0
3590,Mammary Gland Type Features Present,Epithelial neoplasm of skin,0
3591,Ectopic Tissue,Epithelial neoplasm of skin,0
3592,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Epithelial neoplasm of skin,0
3593,Dilated Cystic Spaces Present,Urethral Villous Adenoma,0
3594,Dedifferentiated Malignant Infiltrate,Urethral Villous Adenoma,0
3595,Mammary Gland Type Features Present,Urethral Villous Adenoma,0
3596,Ectopic Tissue,Urethral Villous Adenoma,0
3597,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Urethral Villous Adenoma,0
3598,Dilated Cystic Spaces Present,Thymoma malignant invasive,0
3599,Dedifferentiated Malignant Infiltrate,Thymoma malignant invasive,0
3600,Mammary Gland Type Features Present,Thymoma malignant invasive,0
3601,Ectopic Tissue,Thymoma malignant invasive,0
3602,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymoma malignant invasive,0
3603,Coronary Vessel Lesion,villous adenoma of stomach,0
3604,Index Lesion,villous adenoma of stomach,0
3605,Non-Index Lesion,villous adenoma of stomach,0
3606,Mushroom-Shaped Lesion,villous adenoma of stomach,0
3607,Annular Lesion,villous adenoma of stomach,0
3608,Coronary Vessel Lesion,Adenoma of small intestine,0
3609,Index Lesion,Adenoma of small intestine,0
3610,Non-Index Lesion,Adenoma of small intestine,0
3611,Mushroom-Shaped Lesion,Adenoma of small intestine,0
3612,Annular Lesion,Adenoma of small intestine,0
3613,Dilated Cystic Spaces Present,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,0
3614,Dedifferentiated Malignant Infiltrate,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,0
3615,Mammary Gland Type Features Present,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,0
3616,Ectopic Tissue,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,0
3617,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intraductal papillary neoplasm with high grade intraepithelial neoplasia,0
3618,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Hidradenoma Papilliferum,0
3619,Isolated Tumor Cells,Hidradenoma Papilliferum,0
3620,Pleural/Elastic Layer Invasion,Hidradenoma Papilliferum,0
3621,Presence of Extravascular Matrix Patterns,Hidradenoma Papilliferum,0
3622,Ductopenia,Hidradenoma Papilliferum,0
3623,Coronary Vessel Lesion,Breast Phyllodes Tumor,0
3624,Index Lesion,Breast Phyllodes Tumor,0
3625,Non-Index Lesion,Breast Phyllodes Tumor,0
3626,Mushroom-Shaped Lesion,Breast Phyllodes Tumor,0
3627,Annular Lesion,Breast Phyllodes Tumor,0
3628,Dilated Cystic Spaces Present,Neuroendocrine neoplasm of larynx,0
3629,Dedifferentiated Malignant Infiltrate,Neuroendocrine neoplasm of larynx,0
3630,Mammary Gland Type Features Present,Neuroendocrine neoplasm of larynx,0
3631,Ectopic Tissue,Neuroendocrine neoplasm of larynx,0
3632,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Neuroendocrine neoplasm of larynx,0
3633,Dilated Cystic Spaces Present,Schneiderian papilloma,0
3634,Dedifferentiated Malignant Infiltrate,Schneiderian papilloma,0
3635,Mammary Gland Type Features Present,Schneiderian papilloma,0
3636,Ectopic Tissue,Schneiderian papilloma,0
3637,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Schneiderian papilloma,0
3638,Dilated Cystic Spaces Present,Inverted papilloma of urinary bladder,0
3639,Dedifferentiated Malignant Infiltrate,Inverted papilloma of urinary bladder,0
3640,Mammary Gland Type Features Present,Inverted papilloma of urinary bladder,0
3641,Ectopic Tissue,Inverted papilloma of urinary bladder,0
3642,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Inverted papilloma of urinary bladder,0
3643,Coronary Vessel Lesion,Metastatic Jugulotympanic Paraganglioma,0
3644,Index Lesion,Metastatic Jugulotympanic Paraganglioma,0
3645,Non-Index Lesion,Metastatic Jugulotympanic Paraganglioma,0
3646,Mushroom-Shaped Lesion,Metastatic Jugulotympanic Paraganglioma,0
3647,Annular Lesion,Metastatic Jugulotympanic Paraganglioma,0
3648,Dilated Cystic Spaces Present,Pre-Malignant Skin Epithelial Lesion,0
3649,Dedifferentiated Malignant Infiltrate,Pre-Malignant Skin Epithelial Lesion,0
3650,Mammary Gland Type Features Present,Pre-Malignant Skin Epithelial Lesion,0
3651,Ectopic Tissue,Pre-Malignant Skin Epithelial Lesion,0
3652,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pre-Malignant Skin Epithelial Lesion,0
3653,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
3654,Isolated Tumor Cells,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
3655,Pleural/Elastic Layer Invasion,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
3656,Presence of Extravascular Matrix Patterns,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
3657,Ductopenia,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,0
3658,Dilated Cystic Spaces Present,Hard Palate Monomorphic Adenoma,0
3659,Dedifferentiated Malignant Infiltrate,Hard Palate Monomorphic Adenoma,0
3660,Mammary Gland Type Features Present,Hard Palate Monomorphic Adenoma,0
3661,Ectopic Tissue,Hard Palate Monomorphic Adenoma,0
3662,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hard Palate Monomorphic Adenoma,0
3663,Dilated Cystic Spaces Present,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3664,Dedifferentiated Malignant Infiltrate,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3665,Mammary Gland Type Features Present,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3666,Ectopic Tissue,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3667,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
3668,Dilated Cystic Spaces Present,Extrahepatic Bile Duct Neuroendocrine Tumor,0
3669,Dedifferentiated Malignant Infiltrate,Extrahepatic Bile Duct Neuroendocrine Tumor,0
3670,Mammary Gland Type Features Present,Extrahepatic Bile Duct Neuroendocrine Tumor,0
3671,Ectopic Tissue,Extrahepatic Bile Duct Neuroendocrine Tumor,0
3672,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Extrahepatic Bile Duct Neuroendocrine Tumor,0
3673,Dilated Cystic Spaces Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3674,Dedifferentiated Malignant Infiltrate,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3675,Mammary Gland Type Features Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3676,Ectopic Tissue,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3677,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
3678,Dilated Cystic Spaces Present,Paraganglioma,0
3679,Dedifferentiated Malignant Infiltrate,Paraganglioma,0
3680,Mammary Gland Type Features Present,Paraganglioma,0
3681,Ectopic Tissue,Paraganglioma,0
3682,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Paraganglioma,0
3683,Dilated Cystic Spaces Present,keratoacanthoma,0
3684,Dedifferentiated Malignant Infiltrate,keratoacanthoma,0
3685,Mammary Gland Type Features Present,keratoacanthoma,0
3686,Ectopic Tissue,keratoacanthoma,0
3687,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,keratoacanthoma,0
3688,Dilated Cystic Spaces Present,Digestive System Neuroendocrine Neoplasm,0
3689,Dedifferentiated Malignant Infiltrate,Digestive System Neuroendocrine Neoplasm,0
3690,Mammary Gland Type Features Present,Digestive System Neuroendocrine Neoplasm,0
3691,Ectopic Tissue,Digestive System Neuroendocrine Neoplasm,0
3692,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Digestive System Neuroendocrine Neoplasm,0
3693,Coronary Vessel Lesion,Malignant phyllodes tumor of breast,0
3694,Index Lesion,Malignant phyllodes tumor of breast,0
3695,Non-Index Lesion,Malignant phyllodes tumor of breast,0
3696,Mushroom-Shaped Lesion,Malignant phyllodes tumor of breast,0
3697,Annular Lesion,Malignant phyllodes tumor of breast,0
3698,Dilated Cystic Spaces Present,Thyroid Gland Mucinous Follicular Adenoma,0
3699,Dedifferentiated Malignant Infiltrate,Thyroid Gland Mucinous Follicular Adenoma,0
3700,Mammary Gland Type Features Present,Thyroid Gland Mucinous Follicular Adenoma,0
3701,Ectopic Tissue,Thyroid Gland Mucinous Follicular Adenoma,0
3702,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Mucinous Follicular Adenoma,0
3703,Coronary Vessel Lesion,Colon adenoma,0
3704,Index Lesion,Colon adenoma,0
3705,Non-Index Lesion,Colon adenoma,0
3706,Mushroom-Shaped Lesion,Colon adenoma,0
3707,Annular Lesion,Colon adenoma,0
3708,Dilated Cystic Spaces Present,Intestinal Gangliocytic Paraganglioma,0
3709,Dedifferentiated Malignant Infiltrate,Intestinal Gangliocytic Paraganglioma,0
3710,Mammary Gland Type Features Present,Intestinal Gangliocytic Paraganglioma,0
3711,Ectopic Tissue,Intestinal Gangliocytic Paraganglioma,0
3712,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intestinal Gangliocytic Paraganglioma,0
3713,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Intracystic papillary adenoma,0
3714,Isolated Tumor Cells,Intracystic papillary adenoma,0
3715,Pleural/Elastic Layer Invasion,Intracystic papillary adenoma,0
3716,Presence of Extravascular Matrix Patterns,Intracystic papillary adenoma,0
3717,Ductopenia,Intracystic papillary adenoma,0
3718,Dilated Cystic Spaces Present,Minimally Invasive Thymoma,0
3719,Dedifferentiated Malignant Infiltrate,Minimally Invasive Thymoma,0
3720,Mammary Gland Type Features Present,Minimally Invasive Thymoma,0
3721,Ectopic Tissue,Minimally Invasive Thymoma,0
3722,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Minimally Invasive Thymoma,0
3723,Dilated Cystic Spaces Present,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,0
3724,Dedifferentiated Malignant Infiltrate,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,0
3725,Mammary Gland Type Features Present,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,0
3726,Ectopic Tissue,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,0
3727,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,0
3728,Dilated Cystic Spaces Present,Breast Fibroepithelial Neoplasm,0
3729,Dedifferentiated Malignant Infiltrate,Breast Fibroepithelial Neoplasm,0
3730,Mammary Gland Type Features Present,Breast Fibroepithelial Neoplasm,0
3731,Ectopic Tissue,Breast Fibroepithelial Neoplasm,0
3732,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Breast Fibroepithelial Neoplasm,0
3733,Coronary Vessel Lesion,Cecum Villous Adenoma,0
3734,Index Lesion,Cecum Villous Adenoma,0
3735,Non-Index Lesion,Cecum Villous Adenoma,0
3736,Mushroom-Shaped Lesion,Cecum Villous Adenoma,0
3737,Annular Lesion,Cecum Villous Adenoma,0
3738,Dilated Cystic Spaces Present,Parasympathetic paraganglioma,0
3739,Dedifferentiated Malignant Infiltrate,Parasympathetic paraganglioma,0
3740,Mammary Gland Type Features Present,Parasympathetic paraganglioma,0
3741,Ectopic Tissue,Parasympathetic paraganglioma,0
3742,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Parasympathetic paraganglioma,0
3743,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian serous cystadenofibroma,0
3744,Isolated Tumor Cells,Ovarian serous cystadenofibroma,0
3745,Pleural/Elastic Layer Invasion,Ovarian serous cystadenofibroma,0
3746,Presence of Extravascular Matrix Patterns,Ovarian serous cystadenofibroma,0
3747,Ductopenia,Ovarian serous cystadenofibroma,0
3748,Dilated Cystic Spaces Present,Carcinoid tumor of ileum,0
3749,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of ileum,0
3750,Mammary Gland Type Features Present,Carcinoid tumor of ileum,0
3751,Ectopic Tissue,Carcinoid tumor of ileum,0
3752,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of ileum,0
3753,Dilated Cystic Spaces Present,High Grade Intraepithelial Neoplasia,0
3754,Dedifferentiated Malignant Infiltrate,High Grade Intraepithelial Neoplasia,0
3755,Mammary Gland Type Features Present,High Grade Intraepithelial Neoplasia,0
3756,Ectopic Tissue,High Grade Intraepithelial Neoplasia,0
3757,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Intraepithelial Neoplasia,0
3758,Dilated Cystic Spaces Present,Vulvar Trichoepithelioma,0
3759,Dedifferentiated Malignant Infiltrate,Vulvar Trichoepithelioma,0
3760,Mammary Gland Type Features Present,Vulvar Trichoepithelioma,0
3761,Ectopic Tissue,Vulvar Trichoepithelioma,0
3762,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vulvar Trichoepithelioma,0
3763,Dilated Cystic Spaces Present,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",0
3764,Dedifferentiated Malignant Infiltrate,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",0
3765,Mammary Gland Type Features Present,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",0
3766,Ectopic Tissue,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",0
3767,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",0
3768,Dilated Cystic Spaces Present,Urethral Urothelial Papilloma,0
3769,Dedifferentiated Malignant Infiltrate,Urethral Urothelial Papilloma,0
3770,Mammary Gland Type Features Present,Urethral Urothelial Papilloma,0
3771,Ectopic Tissue,Urethral Urothelial Papilloma,0
3772,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Urethral Urothelial Papilloma,0
3773,Dilated Cystic Spaces Present,Paraganglioma of head and neck,0
3774,Dedifferentiated Malignant Infiltrate,Paraganglioma of head and neck,0
3775,Mammary Gland Type Features Present,Paraganglioma of head and neck,0
3776,Ectopic Tissue,Paraganglioma of head and neck,0
3777,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Paraganglioma of head and neck,0
3778,Dilated Cystic Spaces Present,Mild epithelial dysplasia,0
3779,Dedifferentiated Malignant Infiltrate,Mild epithelial dysplasia,0
3780,Mammary Gland Type Features Present,Mild epithelial dysplasia,0
3781,Ectopic Tissue,Mild epithelial dysplasia,0
3782,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mild epithelial dysplasia,0
3783,Dilated Cystic Spaces Present,Somatostatinoma,0
3784,Dedifferentiated Malignant Infiltrate,Somatostatinoma,0
3785,Mammary Gland Type Features Present,Somatostatinoma,0
3786,Ectopic Tissue,Somatostatinoma,0
3787,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Somatostatinoma,0
3788,Dilated Cystic Spaces Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0
3789,Dedifferentiated Malignant Infiltrate,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0
3790,Mammary Gland Type Features Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0
3791,Ectopic Tissue,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0
3792,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Gastrin-Producing Neuroendocrine Tumor,0
3793,Coronary Vessel Lesion,Inflammatory Hepatocellular Adenoma,0
3794,Index Lesion,Inflammatory Hepatocellular Adenoma,0
3795,Non-Index Lesion,Inflammatory Hepatocellular Adenoma,0
3796,Mushroom-Shaped Lesion,Inflammatory Hepatocellular Adenoma,0
3797,Annular Lesion,Inflammatory Hepatocellular Adenoma,0
3798,Dilated Cystic Spaces Present,Non-Functioning Pituitary Gland Macroadenoma,0
3799,Dedifferentiated Malignant Infiltrate,Non-Functioning Pituitary Gland Macroadenoma,0
3800,Mammary Gland Type Features Present,Non-Functioning Pituitary Gland Macroadenoma,0
3801,Ectopic Tissue,Non-Functioning Pituitary Gland Macroadenoma,0
3802,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non-Functioning Pituitary Gland Macroadenoma,0
3803,Dilated Cystic Spaces Present,Low Grade Penile Intraepithelial Neoplasia,0
3804,Dedifferentiated Malignant Infiltrate,Low Grade Penile Intraepithelial Neoplasia,0
3805,Mammary Gland Type Features Present,Low Grade Penile Intraepithelial Neoplasia,0
3806,Ectopic Tissue,Low Grade Penile Intraepithelial Neoplasia,0
3807,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Penile Intraepithelial Neoplasia,0
3808,Dilated Cystic Spaces Present,Trichoepithelioma,0
3809,Dedifferentiated Malignant Infiltrate,Trichoepithelioma,0
3810,Mammary Gland Type Features Present,Trichoepithelioma,0
3811,Ectopic Tissue,Trichoepithelioma,0
3812,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Trichoepithelioma,0
3813,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,0
3814,Isolated Tumor Cells,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,0
3815,Pleural/Elastic Layer Invasion,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,0
3816,Presence of Extravascular Matrix Patterns,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,0
3817,Ductopenia,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,0
3818,Dilated Cystic Spaces Present,Thymic Carcinoid Tumor,0
3819,Dedifferentiated Malignant Infiltrate,Thymic Carcinoid Tumor,0
3820,Mammary Gland Type Features Present,Thymic Carcinoid Tumor,0
3821,Ectopic Tissue,Thymic Carcinoid Tumor,0
3822,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymic Carcinoid Tumor,0
3823,Dilated Cystic Spaces Present,Regional Adrenal Gland Pheochromocytoma,0
3824,Dedifferentiated Malignant Infiltrate,Regional Adrenal Gland Pheochromocytoma,0
3825,Mammary Gland Type Features Present,Regional Adrenal Gland Pheochromocytoma,0
3826,Ectopic Tissue,Regional Adrenal Gland Pheochromocytoma,0
3827,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Regional Adrenal Gland Pheochromocytoma,0
3828,Dilated Cystic Spaces Present,Common wart,0
3829,Dedifferentiated Malignant Infiltrate,Common wart,0
3830,Mammary Gland Type Features Present,Common wart,0
3831,Ectopic Tissue,Common wart,0
3832,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Common wart,0
3833,Coronary Vessel Lesion,Eccrine acrospiroma,0
3834,Index Lesion,Eccrine acrospiroma,0
3835,Non-Index Lesion,Eccrine acrospiroma,0
3836,Mushroom-Shaped Lesion,Eccrine acrospiroma,0
3837,Annular Lesion,Eccrine acrospiroma,0
3838,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Cystadenoma, Papillary",0
3839,Isolated Tumor Cells,"Cystadenoma, Papillary",0
3840,Pleural/Elastic Layer Invasion,"Cystadenoma, Papillary",0
3841,Presence of Extravascular Matrix Patterns,"Cystadenoma, Papillary",0
3842,Ductopenia,"Cystadenoma, Papillary",0
3843,Dilated Cystic Spaces Present,Borderline Ovarian Serous Tumor with Microinvasion,0
3844,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Serous Tumor with Microinvasion,0
3845,Mammary Gland Type Features Present,Borderline Ovarian Serous Tumor with Microinvasion,0
3846,Ectopic Tissue,Borderline Ovarian Serous Tumor with Microinvasion,0
3847,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Serous Tumor with Microinvasion,0
3848,Coronary Vessel Lesion,Benign Prostate Phyllodes Tumor,0
3849,Index Lesion,Benign Prostate Phyllodes Tumor,0
3850,Non-Index Lesion,Benign Prostate Phyllodes Tumor,0
3851,Mushroom-Shaped Lesion,Benign Prostate Phyllodes Tumor,0
3852,Annular Lesion,Benign Prostate Phyllodes Tumor,0
3853,Dilated Cystic Spaces Present,Intraductal papilloma of breast,0
3854,Dedifferentiated Malignant Infiltrate,Intraductal papilloma of breast,0
3855,Mammary Gland Type Features Present,Intraductal papilloma of breast,0
3856,Ectopic Tissue,Intraductal papilloma of breast,0
3857,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intraductal papilloma of breast,0
3858,Dilated Cystic Spaces Present,Thyroid Gland Clear Cell Follicular Adenoma,0
3859,Dedifferentiated Malignant Infiltrate,Thyroid Gland Clear Cell Follicular Adenoma,0
3860,Mammary Gland Type Features Present,Thyroid Gland Clear Cell Follicular Adenoma,0
3861,Ectopic Tissue,Thyroid Gland Clear Cell Follicular Adenoma,0
3862,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Clear Cell Follicular Adenoma,0
3863,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Serous cystadenoma, borderline malignancy",0
3864,Isolated Tumor Cells,"Serous cystadenoma, borderline malignancy",0
3865,Pleural/Elastic Layer Invasion,"Serous cystadenoma, borderline malignancy",0
3866,Presence of Extravascular Matrix Patterns,"Serous cystadenoma, borderline malignancy",0
3867,Ductopenia,"Serous cystadenoma, borderline malignancy",0
3868,Dilated Cystic Spaces Present,Squamous cell papilloma of eyelid,0
3869,Dedifferentiated Malignant Infiltrate,Squamous cell papilloma of eyelid,0
3870,Mammary Gland Type Features Present,Squamous cell papilloma of eyelid,0
3871,Ectopic Tissue,Squamous cell papilloma of eyelid,0
3872,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Squamous cell papilloma of eyelid,0
3873,Dilated Cystic Spaces Present,Papillomatosis,0
3874,Dedifferentiated Malignant Infiltrate,Papillomatosis,0
3875,Mammary Gland Type Features Present,Papillomatosis,0
3876,Ectopic Tissue,Papillomatosis,0
3877,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papillomatosis,0
3878,Dilated Cystic Spaces Present,Ethmoid Sinus Inverted Papilloma,0
3879,Dedifferentiated Malignant Infiltrate,Ethmoid Sinus Inverted Papilloma,0
3880,Mammary Gland Type Features Present,Ethmoid Sinus Inverted Papilloma,0
3881,Ectopic Tissue,Ethmoid Sinus Inverted Papilloma,0
3882,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ethmoid Sinus Inverted Papilloma,0
3883,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Cystadenoma, Serous",0
3884,Isolated Tumor Cells,"Cystadenoma, Serous",0
3885,Pleural/Elastic Layer Invasion,"Cystadenoma, Serous",0
3886,Presence of Extravascular Matrix Patterns,"Cystadenoma, Serous",0
3887,Ductopenia,"Cystadenoma, Serous",0
3888,Dilated Cystic Spaces Present,Adenoma of rete ovarii,0
3889,Dedifferentiated Malignant Infiltrate,Adenoma of rete ovarii,0
3890,Mammary Gland Type Features Present,Adenoma of rete ovarii,0
3891,Ectopic Tissue,Adenoma of rete ovarii,0
3892,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adenoma of rete ovarii,0
3893,Dilated Cystic Spaces Present,Malignant Paraganglionic Neoplasm,0
3894,Dedifferentiated Malignant Infiltrate,Malignant Paraganglionic Neoplasm,0
3895,Mammary Gland Type Features Present,Malignant Paraganglionic Neoplasm,0
3896,Ectopic Tissue,Malignant Paraganglionic Neoplasm,0
3897,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Paraganglionic Neoplasm,0
3898,Dilated Cystic Spaces Present,Childhood Choroid Plexus Neoplasm,0
3899,Dedifferentiated Malignant Infiltrate,Childhood Choroid Plexus Neoplasm,0
3900,Mammary Gland Type Features Present,Childhood Choroid Plexus Neoplasm,0
3901,Ectopic Tissue,Childhood Choroid Plexus Neoplasm,0
3902,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Childhood Choroid Plexus Neoplasm,0
3903,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,inverted follicular keratosis,0
3904,Isolated Tumor Cells,inverted follicular keratosis,0
3905,Pleural/Elastic Layer Invasion,inverted follicular keratosis,0
3906,Presence of Extravascular Matrix Patterns,inverted follicular keratosis,0
3907,Ductopenia,inverted follicular keratosis,0
3908,Dilated Cystic Spaces Present,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,0
3909,Dedifferentiated Malignant Infiltrate,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,0
3910,Mammary Gland Type Features Present,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,0
3911,Ectopic Tissue,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,0
3912,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,0
3913,Dilated Cystic Spaces Present,Broad Ligament Serous Adenofibroma,0
3914,Dedifferentiated Malignant Infiltrate,Broad Ligament Serous Adenofibroma,0
3915,Mammary Gland Type Features Present,Broad Ligament Serous Adenofibroma,0
3916,Ectopic Tissue,Broad Ligament Serous Adenofibroma,0
3917,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Broad Ligament Serous Adenofibroma,0
3918,Dilated Cystic Spaces Present,Low Grade Conjunctival Intraepithelial Neoplasia,0
3919,Dedifferentiated Malignant Infiltrate,Low Grade Conjunctival Intraepithelial Neoplasia,0
3920,Mammary Gland Type Features Present,Low Grade Conjunctival Intraepithelial Neoplasia,0
3921,Ectopic Tissue,Low Grade Conjunctival Intraepithelial Neoplasia,0
3922,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Conjunctival Intraepithelial Neoplasia,0
3923,Dilated Cystic Spaces Present,Stage III Appendix Neuroendocrine Tumor AJCC v7,0
3924,Dedifferentiated Malignant Infiltrate,Stage III Appendix Neuroendocrine Tumor AJCC v7,0
3925,Mammary Gland Type Features Present,Stage III Appendix Neuroendocrine Tumor AJCC v7,0
3926,Ectopic Tissue,Stage III Appendix Neuroendocrine Tumor AJCC v7,0
3927,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Appendix Neuroendocrine Tumor AJCC v7,0
3928,Dilated Cystic Spaces Present,Appendix Low Grade Intraepithelial Neoplasia,0
3929,Dedifferentiated Malignant Infiltrate,Appendix Low Grade Intraepithelial Neoplasia,0
3930,Mammary Gland Type Features Present,Appendix Low Grade Intraepithelial Neoplasia,0
3931,Ectopic Tissue,Appendix Low Grade Intraepithelial Neoplasia,0
3932,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix Low Grade Intraepithelial Neoplasia,0
3933,Dilated Cystic Spaces Present,Appendix High Grade Intraepithelial Neoplasia,0
3934,Dedifferentiated Malignant Infiltrate,Appendix High Grade Intraepithelial Neoplasia,0
3935,Mammary Gland Type Features Present,Appendix High Grade Intraepithelial Neoplasia,0
3936,Ectopic Tissue,Appendix High Grade Intraepithelial Neoplasia,0
3937,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix High Grade Intraepithelial Neoplasia,0
3938,Dilated Cystic Spaces Present,Squamous Papilloma of the Larynx,0
3939,Dedifferentiated Malignant Infiltrate,Squamous Papilloma of the Larynx,0
3940,Mammary Gland Type Features Present,Squamous Papilloma of the Larynx,0
3941,Ectopic Tissue,Squamous Papilloma of the Larynx,0
3942,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Squamous Papilloma of the Larynx,0
3943,Coronary Vessel Lesion,Esophageal squamous papilloma,0
3944,Index Lesion,Esophageal squamous papilloma,0
3945,Non-Index Lesion,Esophageal squamous papilloma,0
3946,Mushroom-Shaped Lesion,Esophageal squamous papilloma,0
3947,Annular Lesion,Esophageal squamous papilloma,0
3948,Coronary Vessel Lesion,Gastric adenoma,0
3949,Index Lesion,Gastric adenoma,0
3950,Non-Index Lesion,Gastric adenoma,0
3951,Mushroom-Shaped Lesion,Gastric adenoma,0
3952,Annular Lesion,Gastric adenoma,0
3953,Coronary Vessel Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,0
3954,Index Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,0
3955,Non-Index Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,0
3956,Mushroom-Shaped Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,0
3957,Annular Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,0
3958,Coronary Vessel Lesion,Ampulla of Vater Tubular Adenoma,0
3959,Index Lesion,Ampulla of Vater Tubular Adenoma,0
3960,Non-Index Lesion,Ampulla of Vater Tubular Adenoma,0
3961,Mushroom-Shaped Lesion,Ampulla of Vater Tubular Adenoma,0
3962,Annular Lesion,Ampulla of Vater Tubular Adenoma,0
3963,Dilated Cystic Spaces Present,Atypical carcinoid tumor,0
3964,Dedifferentiated Malignant Infiltrate,Atypical carcinoid tumor,0
3965,Mammary Gland Type Features Present,Atypical carcinoid tumor,0
3966,Ectopic Tissue,Atypical carcinoid tumor,0
3967,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Atypical carcinoid tumor,0
3968,Dilated Cystic Spaces Present,Bladder Urothelial Papilloma,0
3969,Dedifferentiated Malignant Infiltrate,Bladder Urothelial Papilloma,0
3970,Mammary Gland Type Features Present,Bladder Urothelial Papilloma,0
3971,Ectopic Tissue,Bladder Urothelial Papilloma,0
3972,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Urothelial Papilloma,0
3973,Dilated Cystic Spaces Present,Serous surface papilloma,0
3974,Dedifferentiated Malignant Infiltrate,Serous surface papilloma,0
3975,Mammary Gland Type Features Present,Serous surface papilloma,0
3976,Ectopic Tissue,Serous surface papilloma,0
3977,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Serous surface papilloma,0
3978,Dilated Cystic Spaces Present,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,0
3979,Dedifferentiated Malignant Infiltrate,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,0
3980,Mammary Gland Type Features Present,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,0
3981,Ectopic Tissue,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,0
3982,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,0
3983,Dilated Cystic Spaces Present,Endolymphatic sac tumor,0
3984,Dedifferentiated Malignant Infiltrate,Endolymphatic sac tumor,0
3985,Mammary Gland Type Features Present,Endolymphatic sac tumor,0
3986,Ectopic Tissue,Endolymphatic sac tumor,0
3987,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Endolymphatic sac tumor,0
3988,Dilated Cystic Spaces Present,High Grade Corneal Intraepithelial Neoplasia,0
3989,Dedifferentiated Malignant Infiltrate,High Grade Corneal Intraepithelial Neoplasia,0
3990,Mammary Gland Type Features Present,High Grade Corneal Intraepithelial Neoplasia,0
3991,Ectopic Tissue,High Grade Corneal Intraepithelial Neoplasia,0
3992,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Corneal Intraepithelial Neoplasia,0
3993,Dilated Cystic Spaces Present,Soft Palate Pleomorphic Adenoma,0
3994,Dedifferentiated Malignant Infiltrate,Soft Palate Pleomorphic Adenoma,0
3995,Mammary Gland Type Features Present,Soft Palate Pleomorphic Adenoma,0
3996,Ectopic Tissue,Soft Palate Pleomorphic Adenoma,0
3997,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Soft Palate Pleomorphic Adenoma,0
3998,Coronary Vessel Lesion,Gallbladder adenoma,0
3999,Index Lesion,Gallbladder adenoma,0
4000,Non-Index Lesion,Gallbladder adenoma,0
4001,Mushroom-Shaped Lesion,Gallbladder adenoma,0
4002,Annular Lesion,Gallbladder adenoma,0
4003,Dilated Cystic Spaces Present,Epithelial tumor of ovary,0
4004,Dedifferentiated Malignant Infiltrate,Epithelial tumor of ovary,0
4005,Mammary Gland Type Features Present,Epithelial tumor of ovary,0
4006,Ectopic Tissue,Epithelial tumor of ovary,0
4007,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Epithelial tumor of ovary,0
4008,Dilated Cystic Spaces Present,"Thymoma, type B3",0
4009,Dedifferentiated Malignant Infiltrate,"Thymoma, type B3",0
4010,Mammary Gland Type Features Present,"Thymoma, type B3",0
4011,Ectopic Tissue,"Thymoma, type B3",0
4012,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thymoma, type B3",0
4013,Coronary Vessel Lesion,Borderline Breast Phyllodes Tumor,0
4014,Index Lesion,Borderline Breast Phyllodes Tumor,0
4015,Non-Index Lesion,Borderline Breast Phyllodes Tumor,0
4016,Mushroom-Shaped Lesion,Borderline Breast Phyllodes Tumor,0
4017,Annular Lesion,Borderline Breast Phyllodes Tumor,0
4018,Dilated Cystic Spaces Present,Inverted Papilloma,0
4019,Dedifferentiated Malignant Infiltrate,Inverted Papilloma,0
4020,Mammary Gland Type Features Present,Inverted Papilloma,0
4021,Ectopic Tissue,Inverted Papilloma,0
4022,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Inverted Papilloma,0
4023,Dilated Cystic Spaces Present,Papillary craniopharyngioma,0
4024,Dedifferentiated Malignant Infiltrate,Papillary craniopharyngioma,0
4025,Mammary Gland Type Features Present,Papillary craniopharyngioma,0
4026,Ectopic Tissue,Papillary craniopharyngioma,0
4027,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papillary craniopharyngioma,0
4028,Dilated Cystic Spaces Present,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma,0
4029,Dedifferentiated Malignant Infiltrate,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma,0
4030,Mammary Gland Type Features Present,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma,0
4031,Ectopic Tissue,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma,0
4032,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma,0
4033,Coronary Vessel Lesion,tubulovillous adenoma of stomach,0
4034,Index Lesion,tubulovillous adenoma of stomach,0
4035,Non-Index Lesion,tubulovillous adenoma of stomach,0
4036,Mushroom-Shaped Lesion,tubulovillous adenoma of stomach,0
4037,Annular Lesion,tubulovillous adenoma of stomach,0
4038,Dilated Cystic Spaces Present,Lung Pleomorphic Adenoma,0
4039,Dedifferentiated Malignant Infiltrate,Lung Pleomorphic Adenoma,0
4040,Mammary Gland Type Features Present,Lung Pleomorphic Adenoma,0
4041,Ectopic Tissue,Lung Pleomorphic Adenoma,0
4042,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Lung Pleomorphic Adenoma,0
4043,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Parotid Gland Warthin Tumor,0
4044,Isolated Tumor Cells,Parotid Gland Warthin Tumor,0
4045,Pleural/Elastic Layer Invasion,Parotid Gland Warthin Tumor,0
4046,Presence of Extravascular Matrix Patterns,Parotid Gland Warthin Tumor,0
4047,Ductopenia,Parotid Gland Warthin Tumor,0
4048,Dilated Cystic Spaces Present,Low Grade Esophageal Glandular Intraepithelial Neoplasia,0
4049,Dedifferentiated Malignant Infiltrate,Low Grade Esophageal Glandular Intraepithelial Neoplasia,0
4050,Mammary Gland Type Features Present,Low Grade Esophageal Glandular Intraepithelial Neoplasia,0
4051,Ectopic Tissue,Low Grade Esophageal Glandular Intraepithelial Neoplasia,0
4052,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Esophageal Glandular Intraepithelial Neoplasia,0
4053,Dilated Cystic Spaces Present,Sparsely Granulated Lactotroph Adenoma,0
4054,Dedifferentiated Malignant Infiltrate,Sparsely Granulated Lactotroph Adenoma,0
4055,Mammary Gland Type Features Present,Sparsely Granulated Lactotroph Adenoma,0
4056,Ectopic Tissue,Sparsely Granulated Lactotroph Adenoma,0
4057,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sparsely Granulated Lactotroph Adenoma,0
4058,Dilated Cystic Spaces Present,Serous adenofibroma,0
4059,Dedifferentiated Malignant Infiltrate,Serous adenofibroma,0
4060,Mammary Gland Type Features Present,Serous adenofibroma,0
4061,Ectopic Tissue,Serous adenofibroma,0
4062,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Serous adenofibroma,0
4063,Dilated Cystic Spaces Present,Thyroid Gland Paraganglioma,0
4064,Dedifferentiated Malignant Infiltrate,Thyroid Gland Paraganglioma,0
4065,Mammary Gland Type Features Present,Thyroid Gland Paraganglioma,0
4066,Ectopic Tissue,Thyroid Gland Paraganglioma,0
4067,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Paraganglioma,0
4068,Dilated Cystic Spaces Present,Atypical Ductal Breast Hyperplasia,0
4069,Dedifferentiated Malignant Infiltrate,Atypical Ductal Breast Hyperplasia,0
4070,Mammary Gland Type Features Present,Atypical Ductal Breast Hyperplasia,0
4071,Ectopic Tissue,Atypical Ductal Breast Hyperplasia,0
4072,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Atypical Ductal Breast Hyperplasia,0
4073,Coronary Vessel Lesion,Filiform Serrated Adenoma,0
4074,Index Lesion,Filiform Serrated Adenoma,0
4075,Non-Index Lesion,Filiform Serrated Adenoma,0
4076,Mushroom-Shaped Lesion,Filiform Serrated Adenoma,0
4077,Annular Lesion,Filiform Serrated Adenoma,0
4078,Dilated Cystic Spaces Present,Neoplasm of aortic body,0
4079,Dedifferentiated Malignant Infiltrate,Neoplasm of aortic body,0
4080,Mammary Gland Type Features Present,Neoplasm of aortic body,0
4081,Ectopic Tissue,Neoplasm of aortic body,0
4082,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Neoplasm of aortic body,0
4083,Coronary Vessel Lesion,Clear cell hidradenoma,0
4084,Index Lesion,Clear cell hidradenoma,0
4085,Non-Index Lesion,Clear cell hidradenoma,0
4086,Mushroom-Shaped Lesion,Clear cell hidradenoma,0
4087,Annular Lesion,Clear cell hidradenoma,0
4088,Dilated Cystic Spaces Present,Bartholin Gland Adenomyoma,0
4089,Dedifferentiated Malignant Infiltrate,Bartholin Gland Adenomyoma,0
4090,Mammary Gland Type Features Present,Bartholin Gland Adenomyoma,0
4091,Ectopic Tissue,Bartholin Gland Adenomyoma,0
4092,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bartholin Gland Adenomyoma,0
4093,Dilated Cystic Spaces Present,Colorectal Neuroendocrine Neoplasm,0
4094,Dedifferentiated Malignant Infiltrate,Colorectal Neuroendocrine Neoplasm,0
4095,Mammary Gland Type Features Present,Colorectal Neuroendocrine Neoplasm,0
4096,Ectopic Tissue,Colorectal Neuroendocrine Neoplasm,0
4097,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal Neuroendocrine Neoplasm,0
4098,Dilated Cystic Spaces Present,Anogenital papillomaviral intraepithelial neoplasia,0
4099,Dedifferentiated Malignant Infiltrate,Anogenital papillomaviral intraepithelial neoplasia,0
4100,Mammary Gland Type Features Present,Anogenital papillomaviral intraepithelial neoplasia,0
4101,Ectopic Tissue,Anogenital papillomaviral intraepithelial neoplasia,0
4102,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anogenital papillomaviral intraepithelial neoplasia,0
4103,Dilated Cystic Spaces Present,Benign Ovarian Mucinous Tumor,0
4104,Dedifferentiated Malignant Infiltrate,Benign Ovarian Mucinous Tumor,0
4105,Mammary Gland Type Features Present,Benign Ovarian Mucinous Tumor,0
4106,Ectopic Tissue,Benign Ovarian Mucinous Tumor,0
4107,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Ovarian Mucinous Tumor,0
4108,Dilated Cystic Spaces Present,Bladder Papillary Urothelial Neoplasm,0
4109,Dedifferentiated Malignant Infiltrate,Bladder Papillary Urothelial Neoplasm,0
4110,Mammary Gland Type Features Present,Bladder Papillary Urothelial Neoplasm,0
4111,Ectopic Tissue,Bladder Papillary Urothelial Neoplasm,0
4112,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Papillary Urothelial Neoplasm,0
4113,Coronary Vessel Lesion,Adenomatous Polyps,0
4114,Index Lesion,Adenomatous Polyps,0
4115,Non-Index Lesion,Adenomatous Polyps,0
4116,Mushroom-Shaped Lesion,Adenomatous Polyps,0
4117,Annular Lesion,Adenomatous Polyps,0
4118,Dilated Cystic Spaces Present,Gallbladder Tubular Carcinoid,0
4119,Dedifferentiated Malignant Infiltrate,Gallbladder Tubular Carcinoid,0
4120,Mammary Gland Type Features Present,Gallbladder Tubular Carcinoid,0
4121,Ectopic Tissue,Gallbladder Tubular Carcinoid,0
4122,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Tubular Carcinoid,0
4123,Dilated Cystic Spaces Present,Biliary Intraepithelial Neoplasia,0
4124,Dedifferentiated Malignant Infiltrate,Biliary Intraepithelial Neoplasia,0
4125,Mammary Gland Type Features Present,Biliary Intraepithelial Neoplasia,0
4126,Ectopic Tissue,Biliary Intraepithelial Neoplasia,0
4127,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Biliary Intraepithelial Neoplasia,0
4128,Dilated Cystic Spaces Present,Ureter Inverted Papilloma,0
4129,Dedifferentiated Malignant Infiltrate,Ureter Inverted Papilloma,0
4130,Mammary Gland Type Features Present,Ureter Inverted Papilloma,0
4131,Ectopic Tissue,Ureter Inverted Papilloma,0
4132,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ureter Inverted Papilloma,0
4133,Coronary Vessel Lesion,Villous adenoma of rectum,0
4134,Index Lesion,Villous adenoma of rectum,0
4135,Non-Index Lesion,Villous adenoma of rectum,0
4136,Mushroom-Shaped Lesion,Villous adenoma of rectum,0
4137,Annular Lesion,Villous adenoma of rectum,0
4138,Dilated Cystic Spaces Present,Ovarian Insular Carcinoid Tumor,0
4139,Dedifferentiated Malignant Infiltrate,Ovarian Insular Carcinoid Tumor,0
4140,Mammary Gland Type Features Present,Ovarian Insular Carcinoid Tumor,0
4141,Ectopic Tissue,Ovarian Insular Carcinoid Tumor,0
4142,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Insular Carcinoid Tumor,0
4143,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Endometrioid Cystadenoma,0
4144,Isolated Tumor Cells,Ovarian Endometrioid Cystadenoma,0
4145,Pleural/Elastic Layer Invasion,Ovarian Endometrioid Cystadenoma,0
4146,Presence of Extravascular Matrix Patterns,Ovarian Endometrioid Cystadenoma,0
4147,Ductopenia,Ovarian Endometrioid Cystadenoma,0
4148,Dilated Cystic Spaces Present,Esophageal Neuroendocrine Neoplasm,0
4149,Dedifferentiated Malignant Infiltrate,Esophageal Neuroendocrine Neoplasm,0
4150,Mammary Gland Type Features Present,Esophageal Neuroendocrine Neoplasm,0
4151,Ectopic Tissue,Esophageal Neuroendocrine Neoplasm,0
4152,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Esophageal Neuroendocrine Neoplasm,0
4153,Coronary Vessel Lesion,Adenomatous polyp of colon,0
4154,Index Lesion,Adenomatous polyp of colon,0
4155,Non-Index Lesion,Adenomatous polyp of colon,0
4156,Mushroom-Shaped Lesion,Adenomatous polyp of colon,0
4157,Annular Lesion,Adenomatous polyp of colon,0
4158,Coronary Vessel Lesion,Colorectal Traditional Serrated Adenoma,0
4159,Index Lesion,Colorectal Traditional Serrated Adenoma,0
4160,Non-Index Lesion,Colorectal Traditional Serrated Adenoma,0
4161,Mushroom-Shaped Lesion,Colorectal Traditional Serrated Adenoma,0
4162,Annular Lesion,Colorectal Traditional Serrated Adenoma,0
4163,Dilated Cystic Spaces Present,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
4164,Dedifferentiated Malignant Infiltrate,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
4165,Mammary Gland Type Features Present,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
4166,Ectopic Tissue,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
4167,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
4168,Dilated Cystic Spaces Present,Ovarian Neuroendocrine Neoplasm,0
4169,Dedifferentiated Malignant Infiltrate,Ovarian Neuroendocrine Neoplasm,0
4170,Mammary Gland Type Features Present,Ovarian Neuroendocrine Neoplasm,0
4171,Ectopic Tissue,Ovarian Neuroendocrine Neoplasm,0
4172,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Neuroendocrine Neoplasm,0
4173,Dilated Cystic Spaces Present,Non-Functioning Endocrine Neoplasm,0
4174,Dedifferentiated Malignant Infiltrate,Non-Functioning Endocrine Neoplasm,0
4175,Mammary Gland Type Features Present,Non-Functioning Endocrine Neoplasm,0
4176,Ectopic Tissue,Non-Functioning Endocrine Neoplasm,0
4177,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non-Functioning Endocrine Neoplasm,0
4178,Dilated Cystic Spaces Present,Familial Paraganglioma,0
4179,Dedifferentiated Malignant Infiltrate,Familial Paraganglioma,0
4180,Mammary Gland Type Features Present,Familial Paraganglioma,0
4181,Ectopic Tissue,Familial Paraganglioma,0
4182,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Familial Paraganglioma,0
4183,Dilated Cystic Spaces Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type",0
4184,Dedifferentiated Malignant Infiltrate,"Borderline Ovarian Mucinous Tumor, Intestinal Type",0
4185,Mammary Gland Type Features Present,"Borderline Ovarian Mucinous Tumor, Intestinal Type",0
4186,Ectopic Tissue,"Borderline Ovarian Mucinous Tumor, Intestinal Type",0
4187,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Borderline Ovarian Mucinous Tumor, Intestinal Type",0
4188,Dilated Cystic Spaces Present,Moderate epithelial dysplasia,0
4189,Dedifferentiated Malignant Infiltrate,Moderate epithelial dysplasia,0
4190,Mammary Gland Type Features Present,Moderate epithelial dysplasia,0
4191,Ectopic Tissue,Moderate epithelial dysplasia,0
4192,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Moderate epithelial dysplasia,0
4193,Dilated Cystic Spaces Present,Pancreatic Intraepithelial Neoplasia-1,0
4194,Dedifferentiated Malignant Infiltrate,Pancreatic Intraepithelial Neoplasia-1,0
4195,Mammary Gland Type Features Present,Pancreatic Intraepithelial Neoplasia-1,0
4196,Ectopic Tissue,Pancreatic Intraepithelial Neoplasia-1,0
4197,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Intraepithelial Neoplasia-1,0
4198,Dilated Cystic Spaces Present,Thymus Lipofibroadenoma,0
4199,Dedifferentiated Malignant Infiltrate,Thymus Lipofibroadenoma,0
4200,Mammary Gland Type Features Present,Thymus Lipofibroadenoma,0
4201,Ectopic Tissue,Thymus Lipofibroadenoma,0
4202,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymus Lipofibroadenoma,0
4203,Dilated Cystic Spaces Present,Thymoma malignant recurrent,0
4204,Dedifferentiated Malignant Infiltrate,Thymoma malignant recurrent,0
4205,Mammary Gland Type Features Present,Thymoma malignant recurrent,0
4206,Ectopic Tissue,Thymoma malignant recurrent,0
4207,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymoma malignant recurrent,0
4208,Dilated Cystic Spaces Present,Central Nervous System Paraganglioma,0
4209,Dedifferentiated Malignant Infiltrate,Central Nervous System Paraganglioma,0
4210,Mammary Gland Type Features Present,Central Nervous System Paraganglioma,0
4211,Ectopic Tissue,Central Nervous System Paraganglioma,0
4212,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Central Nervous System Paraganglioma,0
4213,Dilated Cystic Spaces Present,Lung Squamous Cell Papilloma,0
4214,Dedifferentiated Malignant Infiltrate,Lung Squamous Cell Papilloma,0
4215,Mammary Gland Type Features Present,Lung Squamous Cell Papilloma,0
4216,Ectopic Tissue,Lung Squamous Cell Papilloma,0
4217,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Lung Squamous Cell Papilloma,0
4218,Coronary Vessel Lesion,Ectopic hamartomatous thymoma,0
4219,Index Lesion,Ectopic hamartomatous thymoma,0
4220,Non-Index Lesion,Ectopic hamartomatous thymoma,0
4221,Mushroom-Shaped Lesion,Ectopic hamartomatous thymoma,0
4222,Annular Lesion,Ectopic hamartomatous thymoma,0
4223,Dilated Cystic Spaces Present,Malignant basal cell tumor,0
4224,Dedifferentiated Malignant Infiltrate,Malignant basal cell tumor,0
4225,Mammary Gland Type Features Present,Malignant basal cell tumor,0
4226,Ectopic Tissue,Malignant basal cell tumor,0
4227,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant basal cell tumor,0
4228,Dilated Cystic Spaces Present,Neuroendocrine Tumors,0
4229,Dedifferentiated Malignant Infiltrate,Neuroendocrine Tumors,0
4230,Mammary Gland Type Features Present,Neuroendocrine Tumors,0
4231,Ectopic Tissue,Neuroendocrine Tumors,0
4232,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Neuroendocrine Tumors,0
4233,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,0
4234,Isolated Tumor Cells,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,0
4235,Pleural/Elastic Layer Invasion,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,0
4236,Presence of Extravascular Matrix Patterns,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,0
4237,Ductopenia,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,0
4238,Dilated Cystic Spaces Present,Mixed Somatotroph and Lactotroph Adenoma,0
4239,Dedifferentiated Malignant Infiltrate,Mixed Somatotroph and Lactotroph Adenoma,0
4240,Mammary Gland Type Features Present,Mixed Somatotroph and Lactotroph Adenoma,0
4241,Ectopic Tissue,Mixed Somatotroph and Lactotroph Adenoma,0
4242,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mixed Somatotroph and Lactotroph Adenoma,0
4243,Dilated Cystic Spaces Present,Adamantinous Craniopharyngioma,0
4244,Dedifferentiated Malignant Infiltrate,Adamantinous Craniopharyngioma,0
4245,Mammary Gland Type Features Present,Adamantinous Craniopharyngioma,0
4246,Ectopic Tissue,Adamantinous Craniopharyngioma,0
4247,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adamantinous Craniopharyngioma,0
4248,Coronary Vessel Lesion,Colorectal Adenomatous Polyp,0
4249,Index Lesion,Colorectal Adenomatous Polyp,0
4250,Non-Index Lesion,Colorectal Adenomatous Polyp,0
4251,Mushroom-Shaped Lesion,Colorectal Adenomatous Polyp,0
4252,Annular Lesion,Colorectal Adenomatous Polyp,0
4253,Dilated Cystic Spaces Present,Glandular papilloma,0
4254,Dedifferentiated Malignant Infiltrate,Glandular papilloma,0
4255,Mammary Gland Type Features Present,Glandular papilloma,0
4256,Ectopic Tissue,Glandular papilloma,0
4257,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Glandular papilloma,0
4258,Dilated Cystic Spaces Present,Intermediate Grade Lung Neuroendocrine Neoplasm,0
4259,Dedifferentiated Malignant Infiltrate,Intermediate Grade Lung Neuroendocrine Neoplasm,0
4260,Mammary Gland Type Features Present,Intermediate Grade Lung Neuroendocrine Neoplasm,0
4261,Ectopic Tissue,Intermediate Grade Lung Neuroendocrine Neoplasm,0
4262,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intermediate Grade Lung Neuroendocrine Neoplasm,0
4263,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Papillary mucinous cystadenoma,0
4264,Isolated Tumor Cells,Papillary mucinous cystadenoma,0
4265,Pleural/Elastic Layer Invasion,Papillary mucinous cystadenoma,0
4266,Presence of Extravascular Matrix Patterns,Papillary mucinous cystadenoma,0
4267,Ductopenia,Papillary mucinous cystadenoma,0
4268,Dilated Cystic Spaces Present,Nasopharyngeal Paraganglioma,0
4269,Dedifferentiated Malignant Infiltrate,Nasopharyngeal Paraganglioma,0
4270,Mammary Gland Type Features Present,Nasopharyngeal Paraganglioma,0
4271,Ectopic Tissue,Nasopharyngeal Paraganglioma,0
4272,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Nasopharyngeal Paraganglioma,0
4273,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Papillary cystadenoma, borderline malignancy",0
4274,Isolated Tumor Cells,"Papillary cystadenoma, borderline malignancy",0
4275,Pleural/Elastic Layer Invasion,"Papillary cystadenoma, borderline malignancy",0
4276,Presence of Extravascular Matrix Patterns,"Papillary cystadenoma, borderline malignancy",0
4277,Ductopenia,"Papillary cystadenoma, borderline malignancy",0
4278,Dilated Cystic Spaces Present,Intestinal Intraepithelial Neoplasia,0
4279,Dedifferentiated Malignant Infiltrate,Intestinal Intraepithelial Neoplasia,0
4280,Mammary Gland Type Features Present,Intestinal Intraepithelial Neoplasia,0
4281,Ectopic Tissue,Intestinal Intraepithelial Neoplasia,0
4282,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intestinal Intraepithelial Neoplasia,0
4283,Coronary Vessel Lesion,Breast Ductal Adenoma,0
4284,Index Lesion,Breast Ductal Adenoma,0
4285,Non-Index Lesion,Breast Ductal Adenoma,0
4286,Mushroom-Shaped Lesion,Breast Ductal Adenoma,0
4287,Annular Lesion,Breast Ductal Adenoma,0
4288,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Mucinous cystadenoma of ovary,0
4289,Isolated Tumor Cells,Mucinous cystadenoma of ovary,0
4290,Pleural/Elastic Layer Invasion,Mucinous cystadenoma of ovary,0
4291,Presence of Extravascular Matrix Patterns,Mucinous cystadenoma of ovary,0
4292,Ductopenia,Mucinous cystadenoma of ovary,0
4293,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,cystadenoma of salivary gland,0
4294,Isolated Tumor Cells,cystadenoma of salivary gland,0
4295,Pleural/Elastic Layer Invasion,cystadenoma of salivary gland,0
4296,Presence of Extravascular Matrix Patterns,cystadenoma of salivary gland,0
4297,Ductopenia,cystadenoma of salivary gland,0
4298,Dilated Cystic Spaces Present,Gastrointestinal Carcinoid Tumor,0
4299,Dedifferentiated Malignant Infiltrate,Gastrointestinal Carcinoid Tumor,0
4300,Mammary Gland Type Features Present,Gastrointestinal Carcinoid Tumor,0
4301,Ectopic Tissue,Gastrointestinal Carcinoid Tumor,0
4302,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastrointestinal Carcinoid Tumor,0
4303,Dilated Cystic Spaces Present,High-Grade Squamous Intraepithelial Lesions,0
4304,Dedifferentiated Malignant Infiltrate,High-Grade Squamous Intraepithelial Lesions,0
4305,Mammary Gland Type Features Present,High-Grade Squamous Intraepithelial Lesions,0
4306,Ectopic Tissue,High-Grade Squamous Intraepithelial Lesions,0
4307,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High-Grade Squamous Intraepithelial Lesions,0
4308,Coronary Vessel Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma,0
4309,Index Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma,0
4310,Non-Index Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma,0
4311,Mushroom-Shaped Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma,0
4312,Annular Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma,0
4313,Coronary Vessel Lesion,Pyloric Gland Adenoma,0
4314,Index Lesion,Pyloric Gland Adenoma,0
4315,Non-Index Lesion,Pyloric Gland Adenoma,0
4316,Mushroom-Shaped Lesion,Pyloric Gland Adenoma,0
4317,Annular Lesion,Pyloric Gland Adenoma,0
4318,Coronary Vessel Lesion,Cervical Microglandular Polyp,0
4319,Index Lesion,Cervical Microglandular Polyp,0
4320,Non-Index Lesion,Cervical Microglandular Polyp,0
4321,Mushroom-Shaped Lesion,Cervical Microglandular Polyp,0
4322,Annular Lesion,Cervical Microglandular Polyp,0
4323,Dilated Cystic Spaces Present,Benign Ovarian Transitional Cell Tumor,0
4324,Dedifferentiated Malignant Infiltrate,Benign Ovarian Transitional Cell Tumor,0
4325,Mammary Gland Type Features Present,Benign Ovarian Transitional Cell Tumor,0
4326,Ectopic Tissue,Benign Ovarian Transitional Cell Tumor,0
4327,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Ovarian Transitional Cell Tumor,0
4328,Coronary Vessel Lesion,Parathyroid mixed cell type adenoma,0
4329,Index Lesion,Parathyroid mixed cell type adenoma,0
4330,Non-Index Lesion,Parathyroid mixed cell type adenoma,0
4331,Mushroom-Shaped Lesion,Parathyroid mixed cell type adenoma,0
4332,Annular Lesion,Parathyroid mixed cell type adenoma,0
4333,Coronary Vessel Lesion,Appendix Sessile Serrated Adenoma/Polyp,0
4334,Index Lesion,Appendix Sessile Serrated Adenoma/Polyp,0
4335,Non-Index Lesion,Appendix Sessile Serrated Adenoma/Polyp,0
4336,Mushroom-Shaped Lesion,Appendix Sessile Serrated Adenoma/Polyp,0
4337,Annular Lesion,Appendix Sessile Serrated Adenoma/Polyp,0
4338,Dilated Cystic Spaces Present,Atypical adenoma,0
4339,Dedifferentiated Malignant Infiltrate,Atypical adenoma,0
4340,Mammary Gland Type Features Present,Atypical adenoma,0
4341,Ectopic Tissue,Atypical adenoma,0
4342,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Atypical adenoma,0
4343,Dilated Cystic Spaces Present,Oxyphilic Adenoma,0
4344,Dedifferentiated Malignant Infiltrate,Oxyphilic Adenoma,0
4345,Mammary Gland Type Features Present,Oxyphilic Adenoma,0
4346,Ectopic Tissue,Oxyphilic Adenoma,0
4347,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Oxyphilic Adenoma,0
4348,Dilated Cystic Spaces Present,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,0
4349,Dedifferentiated Malignant Infiltrate,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,0
4350,Mammary Gland Type Features Present,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,0
4351,Ectopic Tissue,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,0
4352,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,0
4353,Dilated Cystic Spaces Present,Small Intestinal VIP-Producing Neuroendocrine Tumor,0
4354,Dedifferentiated Malignant Infiltrate,Small Intestinal VIP-Producing Neuroendocrine Tumor,0
4355,Mammary Gland Type Features Present,Small Intestinal VIP-Producing Neuroendocrine Tumor,0
4356,Ectopic Tissue,Small Intestinal VIP-Producing Neuroendocrine Tumor,0
4357,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal VIP-Producing Neuroendocrine Tumor,0
4358,Coronary Vessel Lesion,Colorectal Adenoma with Mild Dysplasia,0
4359,Index Lesion,Colorectal Adenoma with Mild Dysplasia,0
4360,Non-Index Lesion,Colorectal Adenoma with Mild Dysplasia,0
4361,Mushroom-Shaped Lesion,Colorectal Adenoma with Mild Dysplasia,0
4362,Annular Lesion,Colorectal Adenoma with Mild Dysplasia,0
4363,Coronary Vessel Lesion,Traditional Serrated Adenoma,0
4364,Index Lesion,Traditional Serrated Adenoma,0
4365,Non-Index Lesion,Traditional Serrated Adenoma,0
4366,Mushroom-Shaped Lesion,Traditional Serrated Adenoma,0
4367,Annular Lesion,Traditional Serrated Adenoma,0
4368,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Syringocystadenoma Papilliferum,0
4369,Isolated Tumor Cells,Syringocystadenoma Papilliferum,0
4370,Pleural/Elastic Layer Invasion,Syringocystadenoma Papilliferum,0
4371,Presence of Extravascular Matrix Patterns,Syringocystadenoma Papilliferum,0
4372,Ductopenia,Syringocystadenoma Papilliferum,0
4373,Dilated Cystic Spaces Present,Eccrine spiradenoma,0
4374,Dedifferentiated Malignant Infiltrate,Eccrine spiradenoma,0
4375,Mammary Gland Type Features Present,Eccrine spiradenoma,0
4376,Ectopic Tissue,Eccrine spiradenoma,0
4377,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Eccrine spiradenoma,0
4378,Dilated Cystic Spaces Present,Esophageal Neuroendocrine Tumor,0
4379,Dedifferentiated Malignant Infiltrate,Esophageal Neuroendocrine Tumor,0
4380,Mammary Gland Type Features Present,Esophageal Neuroendocrine Tumor,0
4381,Ectopic Tissue,Esophageal Neuroendocrine Tumor,0
4382,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Esophageal Neuroendocrine Tumor,0
4383,Dilated Cystic Spaces Present,Sporadic Cylindroma,0
4384,Dedifferentiated Malignant Infiltrate,Sporadic Cylindroma,0
4385,Mammary Gland Type Features Present,Sporadic Cylindroma,0
4386,Ectopic Tissue,Sporadic Cylindroma,0
4387,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sporadic Cylindroma,0
4388,Dilated Cystic Spaces Present,Eccrine mixed tumor of skin,0
4389,Dedifferentiated Malignant Infiltrate,Eccrine mixed tumor of skin,0
4390,Mammary Gland Type Features Present,Eccrine mixed tumor of skin,0
4391,Ectopic Tissue,Eccrine mixed tumor of skin,0
4392,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Eccrine mixed tumor of skin,0
4393,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Hidrocystoma,0
4394,Isolated Tumor Cells,Hidrocystoma,0
4395,Pleural/Elastic Layer Invasion,Hidrocystoma,0
4396,Presence of Extravascular Matrix Patterns,Hidrocystoma,0
4397,Ductopenia,Hidrocystoma,0
4398,Dilated Cystic Spaces Present,High Grade Penile Intraepithelial Neoplasia,0
4399,Dedifferentiated Malignant Infiltrate,High Grade Penile Intraepithelial Neoplasia,0
4400,Mammary Gland Type Features Present,High Grade Penile Intraepithelial Neoplasia,0
4401,Ectopic Tissue,High Grade Penile Intraepithelial Neoplasia,0
4402,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Penile Intraepithelial Neoplasia,0
4403,Dilated Cystic Spaces Present,FSH-Producing Gonadotroph Adenoma,0
4404,Dedifferentiated Malignant Infiltrate,FSH-Producing Gonadotroph Adenoma,0
4405,Mammary Gland Type Features Present,FSH-Producing Gonadotroph Adenoma,0
4406,Ectopic Tissue,FSH-Producing Gonadotroph Adenoma,0
4407,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,FSH-Producing Gonadotroph Adenoma,0
4408,Dilated Cystic Spaces Present,Renal Pelvis Urothelial Papilloma,0
4409,Dedifferentiated Malignant Infiltrate,Renal Pelvis Urothelial Papilloma,0
4410,Mammary Gland Type Features Present,Renal Pelvis Urothelial Papilloma,0
4411,Ectopic Tissue,Renal Pelvis Urothelial Papilloma,0
4412,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Renal Pelvis Urothelial Papilloma,0
4413,Coronary Vessel Lesion,Adrenal Cortical Adenoma,0
4414,Index Lesion,Adrenal Cortical Adenoma,0
4415,Non-Index Lesion,Adrenal Cortical Adenoma,0
4416,Mushroom-Shaped Lesion,Adrenal Cortical Adenoma,0
4417,Annular Lesion,Adrenal Cortical Adenoma,0
4418,Dilated Cystic Spaces Present,Condylomata Acuminata,0
4419,Dedifferentiated Malignant Infiltrate,Condylomata Acuminata,0
4420,Mammary Gland Type Features Present,Condylomata Acuminata,0
4421,Ectopic Tissue,Condylomata Acuminata,0
4422,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Condylomata Acuminata,0
4423,Dilated Cystic Spaces Present,Non-Functioning Pituitary Gland Neoplasm,0
4424,Dedifferentiated Malignant Infiltrate,Non-Functioning Pituitary Gland Neoplasm,0
4425,Mammary Gland Type Features Present,Non-Functioning Pituitary Gland Neoplasm,0
4426,Ectopic Tissue,Non-Functioning Pituitary Gland Neoplasm,0
4427,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non-Functioning Pituitary Gland Neoplasm,0
4428,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Borderline Ovarian Serous Cystadenofibroma,0
4429,Isolated Tumor Cells,Borderline Ovarian Serous Cystadenofibroma,0
4430,Pleural/Elastic Layer Invasion,Borderline Ovarian Serous Cystadenofibroma,0
4431,Presence of Extravascular Matrix Patterns,Borderline Ovarian Serous Cystadenofibroma,0
4432,Ductopenia,Borderline Ovarian Serous Cystadenofibroma,0
4433,Dilated Cystic Spaces Present,Bladder Squamous Papilloma,0
4434,Dedifferentiated Malignant Infiltrate,Bladder Squamous Papilloma,0
4435,Mammary Gland Type Features Present,Bladder Squamous Papilloma,0
4436,Ectopic Tissue,Bladder Squamous Papilloma,0
4437,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Squamous Papilloma,0
4438,Dilated Cystic Spaces Present,Metanephric adenoma,0
4439,Dedifferentiated Malignant Infiltrate,Metanephric adenoma,0
4440,Mammary Gland Type Features Present,Metanephric adenoma,0
4441,Ectopic Tissue,Metanephric adenoma,0
4442,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Metanephric adenoma,0
4443,Dilated Cystic Spaces Present,Malignant Ovarian Endometrioid Tumor,0
4444,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Endometrioid Tumor,0
4445,Mammary Gland Type Features Present,Malignant Ovarian Endometrioid Tumor,0
4446,Ectopic Tissue,Malignant Ovarian Endometrioid Tumor,0
4447,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Endometrioid Tumor,0
4448,Dilated Cystic Spaces Present,Malignant neoplasm of endocrine gland,0
4449,Dedifferentiated Malignant Infiltrate,Malignant neoplasm of endocrine gland,0
4450,Mammary Gland Type Features Present,Malignant neoplasm of endocrine gland,0
4451,Ectopic Tissue,Malignant neoplasm of endocrine gland,0
4452,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant neoplasm of endocrine gland,0
4453,Dilated Cystic Spaces Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,0
4454,Dedifferentiated Malignant Infiltrate,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,0
4455,Mammary Gland Type Features Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,0
4456,Ectopic Tissue,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,0
4457,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,0
4458,Coronary Vessel Lesion,Colorectal Adenoma with Severe Dysplasia,0
4459,Index Lesion,Colorectal Adenoma with Severe Dysplasia,0
4460,Non-Index Lesion,Colorectal Adenoma with Severe Dysplasia,0
4461,Mushroom-Shaped Lesion,Colorectal Adenoma with Severe Dysplasia,0
4462,Annular Lesion,Colorectal Adenoma with Severe Dysplasia,0
4463,Dilated Cystic Spaces Present,Pancreatic Somatostatinoma,0
4464,Dedifferentiated Malignant Infiltrate,Pancreatic Somatostatinoma,0
4465,Mammary Gland Type Features Present,Pancreatic Somatostatinoma,0
4466,Ectopic Tissue,Pancreatic Somatostatinoma,0
4467,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Somatostatinoma,0
4468,Dilated Cystic Spaces Present,Papillary adenoma,0
4469,Dedifferentiated Malignant Infiltrate,Papillary adenoma,0
4470,Mammary Gland Type Features Present,Papillary adenoma,0
4471,Ectopic Tissue,Papillary adenoma,0
4472,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papillary adenoma,0
4473,Dilated Cystic Spaces Present,Ancell-Spiegler cylindromas,0
4474,Dedifferentiated Malignant Infiltrate,Ancell-Spiegler cylindromas,0
4475,Mammary Gland Type Features Present,Ancell-Spiegler cylindromas,0
4476,Ectopic Tissue,Ancell-Spiegler cylindromas,0
4477,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ancell-Spiegler cylindromas,0
4478,Dilated Cystic Spaces Present,Oral Cavity Monomorphic Adenoma,0
4479,Dedifferentiated Malignant Infiltrate,Oral Cavity Monomorphic Adenoma,0
4480,Mammary Gland Type Features Present,Oral Cavity Monomorphic Adenoma,0
4481,Ectopic Tissue,Oral Cavity Monomorphic Adenoma,0
4482,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Oral Cavity Monomorphic Adenoma,0
4483,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Malignant Brenner Tumor,0
4484,Isolated Tumor Cells,Malignant Brenner Tumor,0
4485,Pleural/Elastic Layer Invasion,Malignant Brenner Tumor,0
4486,Presence of Extravascular Matrix Patterns,Malignant Brenner Tumor,0
4487,Ductopenia,Malignant Brenner Tumor,0
4488,Dilated Cystic Spaces Present,Vaginal Squamous Papilloma,0
4489,Dedifferentiated Malignant Infiltrate,Vaginal Squamous Papilloma,0
4490,Mammary Gland Type Features Present,Vaginal Squamous Papilloma,0
4491,Ectopic Tissue,Vaginal Squamous Papilloma,0
4492,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal Squamous Papilloma,0
4493,Dilated Cystic Spaces Present,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
4494,Dedifferentiated Malignant Infiltrate,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
4495,Mammary Gland Type Features Present,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
4496,Ectopic Tissue,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
4497,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
4498,Dilated Cystic Spaces Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4499,Dedifferentiated Malignant Infiltrate,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4500,Mammary Gland Type Features Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4501,Ectopic Tissue,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4502,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
4503,Dilated Cystic Spaces Present,"Schneiderian papilloma, inverted",0
4504,Dedifferentiated Malignant Infiltrate,"Schneiderian papilloma, inverted",0
4505,Mammary Gland Type Features Present,"Schneiderian papilloma, inverted",0
4506,Ectopic Tissue,"Schneiderian papilloma, inverted",0
4507,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Schneiderian papilloma, inverted",0
4508,Dilated Cystic Spaces Present,Glomus Tympanicum Tumor,0
4509,Dedifferentiated Malignant Infiltrate,Glomus Tympanicum Tumor,0
4510,Mammary Gland Type Features Present,Glomus Tympanicum Tumor,0
4511,Ectopic Tissue,Glomus Tympanicum Tumor,0
4512,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Glomus Tympanicum Tumor,0
4513,Dilated Cystic Spaces Present,Low Grade Lung Neuroendocrine Neoplasm,0
4514,Dedifferentiated Malignant Infiltrate,Low Grade Lung Neuroendocrine Neoplasm,0
4515,Mammary Gland Type Features Present,Low Grade Lung Neuroendocrine Neoplasm,0
4516,Ectopic Tissue,Low Grade Lung Neuroendocrine Neoplasm,0
4517,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Lung Neuroendocrine Neoplasm,0
4518,Dilated Cystic Spaces Present,Tubulovillous adenoma,0
4519,Dedifferentiated Malignant Infiltrate,Tubulovillous adenoma,0
4520,Mammary Gland Type Features Present,Tubulovillous adenoma,0
4521,Ectopic Tissue,Tubulovillous adenoma,0
4522,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Tubulovillous adenoma,0
4523,Dilated Cystic Spaces Present,Urethral Inverted Papilloma,0
4524,Dedifferentiated Malignant Infiltrate,Urethral Inverted Papilloma,0
4525,Mammary Gland Type Features Present,Urethral Inverted Papilloma,0
4526,Ectopic Tissue,Urethral Inverted Papilloma,0
4527,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Urethral Inverted Papilloma,0
4528,Coronary Vessel Lesion,"Gastric Adenoma, Gastric-Type",0
4529,Index Lesion,"Gastric Adenoma, Gastric-Type",0
4530,Non-Index Lesion,"Gastric Adenoma, Gastric-Type",0
4531,Mushroom-Shaped Lesion,"Gastric Adenoma, Gastric-Type",0
4532,Annular Lesion,"Gastric Adenoma, Gastric-Type",0
4533,Dilated Cystic Spaces Present,Anal Canal Neuroendocrine Tumor G2,0
4534,Dedifferentiated Malignant Infiltrate,Anal Canal Neuroendocrine Tumor G2,0
4535,Mammary Gland Type Features Present,Anal Canal Neuroendocrine Tumor G2,0
4536,Ectopic Tissue,Anal Canal Neuroendocrine Tumor G2,0
4537,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anal Canal Neuroendocrine Tumor G2,0
4538,Dilated Cystic Spaces Present,Pancreatic Neuroendocrine Tumor G2,0
4539,Dedifferentiated Malignant Infiltrate,Pancreatic Neuroendocrine Tumor G2,0
4540,Mammary Gland Type Features Present,Pancreatic Neuroendocrine Tumor G2,0
4541,Ectopic Tissue,Pancreatic Neuroendocrine Tumor G2,0
4542,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Neuroendocrine Tumor G2,0
4543,Dilated Cystic Spaces Present,Extrahepatic Bile Duct Neuroendocrine Tumor G2,0
4544,Dedifferentiated Malignant Infiltrate,Extrahepatic Bile Duct Neuroendocrine Tumor G2,0
4545,Mammary Gland Type Features Present,Extrahepatic Bile Duct Neuroendocrine Tumor G2,0
4546,Ectopic Tissue,Extrahepatic Bile Duct Neuroendocrine Tumor G2,0
4547,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Extrahepatic Bile Duct Neuroendocrine Tumor G2,0
4548,Dilated Cystic Spaces Present,Fallopian Tube Serous Adenofibroma,0
4549,Dedifferentiated Malignant Infiltrate,Fallopian Tube Serous Adenofibroma,0
4550,Mammary Gland Type Features Present,Fallopian Tube Serous Adenofibroma,0
4551,Ectopic Tissue,Fallopian Tube Serous Adenofibroma,0
4552,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Fallopian Tube Serous Adenofibroma,0
4553,Dilated Cystic Spaces Present,Breast Complex Fibroadenoma,0
4554,Dedifferentiated Malignant Infiltrate,Breast Complex Fibroadenoma,0
4555,Mammary Gland Type Features Present,Breast Complex Fibroadenoma,0
4556,Ectopic Tissue,Breast Complex Fibroadenoma,0
4557,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Breast Complex Fibroadenoma,0
4558,Dilated Cystic Spaces Present,Neuroendocrine neoplasm of appendix,0
4559,Dedifferentiated Malignant Infiltrate,Neuroendocrine neoplasm of appendix,0
4560,Mammary Gland Type Features Present,Neuroendocrine neoplasm of appendix,0
4561,Ectopic Tissue,Neuroendocrine neoplasm of appendix,0
4562,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Neuroendocrine neoplasm of appendix,0
4563,Coronary Vessel Lesion,Duodenal Adenoma,0
4564,Index Lesion,Duodenal Adenoma,0
4565,Non-Index Lesion,Duodenal Adenoma,0
4566,Mushroom-Shaped Lesion,Duodenal Adenoma,0
4567,Annular Lesion,Duodenal Adenoma,0
4568,Dilated Cystic Spaces Present,Intestinal Neuroendocrine Tumor G2,0
4569,Dedifferentiated Malignant Infiltrate,Intestinal Neuroendocrine Tumor G2,0
4570,Mammary Gland Type Features Present,Intestinal Neuroendocrine Tumor G2,0
4571,Ectopic Tissue,Intestinal Neuroendocrine Tumor G2,0
4572,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intestinal Neuroendocrine Tumor G2,0
4573,Dilated Cystic Spaces Present,Squamous Cell Neoplasms,0
4574,Dedifferentiated Malignant Infiltrate,Squamous Cell Neoplasms,0
4575,Mammary Gland Type Features Present,Squamous Cell Neoplasms,0
4576,Ectopic Tissue,Squamous Cell Neoplasms,0
4577,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Squamous Cell Neoplasms,0
4578,Dilated Cystic Spaces Present,Endocrine Gland Neoplasms,0
4579,Dedifferentiated Malignant Infiltrate,Endocrine Gland Neoplasms,0
4580,Mammary Gland Type Features Present,Endocrine Gland Neoplasms,0
4581,Ectopic Tissue,Endocrine Gland Neoplasms,0
4582,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Endocrine Gland Neoplasms,0
4583,Dilated Cystic Spaces Present,Condyloma acuminata of cervix,0
4584,Dedifferentiated Malignant Infiltrate,Condyloma acuminata of cervix,0
4585,Mammary Gland Type Features Present,Condyloma acuminata of cervix,0
4586,Ectopic Tissue,Condyloma acuminata of cervix,0
4587,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Condyloma acuminata of cervix,0
4588,Dilated Cystic Spaces Present,Esophageal Neuroendocrine Tumor G2,0
4589,Dedifferentiated Malignant Infiltrate,Esophageal Neuroendocrine Tumor G2,0
4590,Mammary Gland Type Features Present,Esophageal Neuroendocrine Tumor G2,0
4591,Ectopic Tissue,Esophageal Neuroendocrine Tumor G2,0
4592,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Esophageal Neuroendocrine Tumor G2,0
4593,Dilated Cystic Spaces Present,Eccrine Poroma,0
4594,Dedifferentiated Malignant Infiltrate,Eccrine Poroma,0
4595,Mammary Gland Type Features Present,Eccrine Poroma,0
4596,Ectopic Tissue,Eccrine Poroma,0
4597,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Eccrine Poroma,0
4598,Coronary Vessel Lesion,Colon Traditional Serrated Adenoma,0
4599,Index Lesion,Colon Traditional Serrated Adenoma,0
4600,Non-Index Lesion,Colon Traditional Serrated Adenoma,0
4601,Mushroom-Shaped Lesion,Colon Traditional Serrated Adenoma,0
4602,Annular Lesion,Colon Traditional Serrated Adenoma,0
4603,Dilated Cystic Spaces Present,Sphenoid Sinus Inverted Papilloma,0
4604,Dedifferentiated Malignant Infiltrate,Sphenoid Sinus Inverted Papilloma,0
4605,Mammary Gland Type Features Present,Sphenoid Sinus Inverted Papilloma,0
4606,Ectopic Tissue,Sphenoid Sinus Inverted Papilloma,0
4607,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sphenoid Sinus Inverted Papilloma,0
4608,Dilated Cystic Spaces Present,Water-clear cell adenoma,0
4609,Dedifferentiated Malignant Infiltrate,Water-clear cell adenoma,0
4610,Mammary Gland Type Features Present,Water-clear cell adenoma,0
4611,Ectopic Tissue,Water-clear cell adenoma,0
4612,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Water-clear cell adenoma,0
4613,Dilated Cystic Spaces Present,Cervical Intraepithelial Neoplasia,0
4614,Dedifferentiated Malignant Infiltrate,Cervical Intraepithelial Neoplasia,0
4615,Mammary Gland Type Features Present,Cervical Intraepithelial Neoplasia,0
4616,Ectopic Tissue,Cervical Intraepithelial Neoplasia,0
4617,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Intraepithelial Neoplasia,0
4618,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Rete Ovarii Cystadenoma,0
4619,Isolated Tumor Cells,Rete Ovarii Cystadenoma,0
4620,Pleural/Elastic Layer Invasion,Rete Ovarii Cystadenoma,0
4621,Presence of Extravascular Matrix Patterns,Rete Ovarii Cystadenoma,0
4622,Ductopenia,Rete Ovarii Cystadenoma,0
4623,Dilated Cystic Spaces Present,Vaginal intraepithelial neoplasia grade 1,0
4624,Dedifferentiated Malignant Infiltrate,Vaginal intraepithelial neoplasia grade 1,0
4625,Mammary Gland Type Features Present,Vaginal intraepithelial neoplasia grade 1,0
4626,Ectopic Tissue,Vaginal intraepithelial neoplasia grade 1,0
4627,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal intraepithelial neoplasia grade 1,0
4628,Dilated Cystic Spaces Present,Renal Adenoma,0
4629,Dedifferentiated Malignant Infiltrate,Renal Adenoma,0
4630,Mammary Gland Type Features Present,Renal Adenoma,0
4631,Ectopic Tissue,Renal Adenoma,0
4632,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Renal Adenoma,0
4633,Dilated Cystic Spaces Present,Anal Canal Squamous Intraepithelial Neoplasia,0
4634,Dedifferentiated Malignant Infiltrate,Anal Canal Squamous Intraepithelial Neoplasia,0
4635,Mammary Gland Type Features Present,Anal Canal Squamous Intraepithelial Neoplasia,0
4636,Ectopic Tissue,Anal Canal Squamous Intraepithelial Neoplasia,0
4637,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anal Canal Squamous Intraepithelial Neoplasia,0
4638,Dilated Cystic Spaces Present,Small Intestinal High Grade Intraepithelial Neoplasia,0
4639,Dedifferentiated Malignant Infiltrate,Small Intestinal High Grade Intraepithelial Neoplasia,0
4640,Mammary Gland Type Features Present,Small Intestinal High Grade Intraepithelial Neoplasia,0
4641,Ectopic Tissue,Small Intestinal High Grade Intraepithelial Neoplasia,0
4642,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal High Grade Intraepithelial Neoplasia,0
4643,Dilated Cystic Spaces Present,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,0
4644,Dedifferentiated Malignant Infiltrate,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,0
4645,Mammary Gland Type Features Present,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,0
4646,Ectopic Tissue,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,0
4647,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Anal Canal Squamous Intraepithelial Neoplasia,0
4648,Dilated Cystic Spaces Present,"Thymoma, type A, malignant",0
4649,Dedifferentiated Malignant Infiltrate,"Thymoma, type A, malignant",0
4650,Mammary Gland Type Features Present,"Thymoma, type A, malignant",0
4651,Ectopic Tissue,"Thymoma, type A, malignant",0
4652,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thymoma, type A, malignant",0
4653,Dilated Cystic Spaces Present,Malignant Pancreatic Insulinoma,0
4654,Dedifferentiated Malignant Infiltrate,Malignant Pancreatic Insulinoma,0
4655,Mammary Gland Type Features Present,Malignant Pancreatic Insulinoma,0
4656,Ectopic Tissue,Malignant Pancreatic Insulinoma,0
4657,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Pancreatic Insulinoma,0
4658,Dilated Cystic Spaces Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,0
4659,Dedifferentiated Malignant Infiltrate,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,0
4660,Mammary Gland Type Features Present,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,0
4661,Ectopic Tissue,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,0
4662,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,0
4663,Dilated Cystic Spaces Present,Prostate Neuroendocrine Neoplasm,0
4664,Dedifferentiated Malignant Infiltrate,Prostate Neuroendocrine Neoplasm,0
4665,Mammary Gland Type Features Present,Prostate Neuroendocrine Neoplasm,0
4666,Ectopic Tissue,Prostate Neuroendocrine Neoplasm,0
4667,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Prostate Neuroendocrine Neoplasm,0
4668,Dilated Cystic Spaces Present,Carcinoid tumor of rectum,0
4669,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of rectum,0
4670,Mammary Gland Type Features Present,Carcinoid tumor of rectum,0
4671,Ectopic Tissue,Carcinoid tumor of rectum,0
4672,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of rectum,0
4673,Dilated Cystic Spaces Present,Inverted urothelial papilloma,0
4674,Dedifferentiated Malignant Infiltrate,Inverted urothelial papilloma,0
4675,Mammary Gland Type Features Present,Inverted urothelial papilloma,0
4676,Ectopic Tissue,Inverted urothelial papilloma,0
4677,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Inverted urothelial papilloma,0
4678,Dilated Cystic Spaces Present,Pituitary Gland Oncocytic Adenoma,0
4679,Dedifferentiated Malignant Infiltrate,Pituitary Gland Oncocytic Adenoma,0
4680,Mammary Gland Type Features Present,Pituitary Gland Oncocytic Adenoma,0
4681,Ectopic Tissue,Pituitary Gland Oncocytic Adenoma,0
4682,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pituitary Gland Oncocytic Adenoma,0
4683,Dilated Cystic Spaces Present,serous adenocarcinofibroma of ovary,0
4684,Dedifferentiated Malignant Infiltrate,serous adenocarcinofibroma of ovary,0
4685,Mammary Gland Type Features Present,serous adenocarcinofibroma of ovary,0
4686,Ectopic Tissue,serous adenocarcinofibroma of ovary,0
4687,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,serous adenocarcinofibroma of ovary,0
4688,Dilated Cystic Spaces Present,Fallopian Tube Papilloma,0
4689,Dedifferentiated Malignant Infiltrate,Fallopian Tube Papilloma,0
4690,Mammary Gland Type Features Present,Fallopian Tube Papilloma,0
4691,Ectopic Tissue,Fallopian Tube Papilloma,0
4692,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Fallopian Tube Papilloma,0
4693,Dilated Cystic Spaces Present,Ovarian Seromucinous Adenofibroma,0
4694,Dedifferentiated Malignant Infiltrate,Ovarian Seromucinous Adenofibroma,0
4695,Mammary Gland Type Features Present,Ovarian Seromucinous Adenofibroma,0
4696,Ectopic Tissue,Ovarian Seromucinous Adenofibroma,0
4697,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Seromucinous Adenofibroma,0
4698,Dilated Cystic Spaces Present,Pancreatic Neuroendocrine Tumor G1,0
4699,Dedifferentiated Malignant Infiltrate,Pancreatic Neuroendocrine Tumor G1,0
4700,Mammary Gland Type Features Present,Pancreatic Neuroendocrine Tumor G1,0
4701,Ectopic Tissue,Pancreatic Neuroendocrine Tumor G1,0
4702,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Neuroendocrine Tumor G1,0
4703,Dilated Cystic Spaces Present,Mammosomatotroph Adenoma,0
4704,Dedifferentiated Malignant Infiltrate,Mammosomatotroph Adenoma,0
4705,Mammary Gland Type Features Present,Mammosomatotroph Adenoma,0
4706,Ectopic Tissue,Mammosomatotroph Adenoma,0
4707,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mammosomatotroph Adenoma,0
4708,Coronary Vessel Lesion,Clear Cell Adrenal Cortical Adenoma,0
4709,Index Lesion,Clear Cell Adrenal Cortical Adenoma,0
4710,Non-Index Lesion,Clear Cell Adrenal Cortical Adenoma,0
4711,Mushroom-Shaped Lesion,Clear Cell Adrenal Cortical Adenoma,0
4712,Annular Lesion,Clear Cell Adrenal Cortical Adenoma,0
4713,Dilated Cystic Spaces Present,Stage I Digestive System Neuroendocrine Tumor AJCC v7,0
4714,Dedifferentiated Malignant Infiltrate,Stage I Digestive System Neuroendocrine Tumor AJCC v7,0
4715,Mammary Gland Type Features Present,Stage I Digestive System Neuroendocrine Tumor AJCC v7,0
4716,Ectopic Tissue,Stage I Digestive System Neuroendocrine Tumor AJCC v7,0
4717,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Digestive System Neuroendocrine Tumor AJCC v7,0
4718,Dilated Cystic Spaces Present,Vaginal Squamous Neoplasm,0
4719,Dedifferentiated Malignant Infiltrate,Vaginal Squamous Neoplasm,0
4720,Mammary Gland Type Features Present,Vaginal Squamous Neoplasm,0
4721,Ectopic Tissue,Vaginal Squamous Neoplasm,0
4722,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal Squamous Neoplasm,0
4723,Coronary Vessel Lesion,Metastatic Breast Carcinoid Tumor,0
4724,Index Lesion,Metastatic Breast Carcinoid Tumor,0
4725,Non-Index Lesion,Metastatic Breast Carcinoid Tumor,0
4726,Mushroom-Shaped Lesion,Metastatic Breast Carcinoid Tumor,0
4727,Annular Lesion,Metastatic Breast Carcinoid Tumor,0
4728,Dilated Cystic Spaces Present,Thymic Typical Carcinoid Tumor,0
4729,Dedifferentiated Malignant Infiltrate,Thymic Typical Carcinoid Tumor,0
4730,Mammary Gland Type Features Present,Thymic Typical Carcinoid Tumor,0
4731,Ectopic Tissue,Thymic Typical Carcinoid Tumor,0
4732,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymic Typical Carcinoid Tumor,0
4733,Dilated Cystic Spaces Present,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,0
4734,Dedifferentiated Malignant Infiltrate,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,0
4735,Mammary Gland Type Features Present,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,0
4736,Ectopic Tissue,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,0
4737,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,0
4738,Dilated Cystic Spaces Present,Rectal Neuroendocrine Neoplasm,0
4739,Dedifferentiated Malignant Infiltrate,Rectal Neuroendocrine Neoplasm,0
4740,Mammary Gland Type Features Present,Rectal Neuroendocrine Neoplasm,0
4741,Ectopic Tissue,Rectal Neuroendocrine Neoplasm,0
4742,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Rectal Neuroendocrine Neoplasm,0
4743,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Papillary serous cystadenoma,0
4744,Isolated Tumor Cells,Papillary serous cystadenoma,0
4745,Pleural/Elastic Layer Invasion,Papillary serous cystadenoma,0
4746,Presence of Extravascular Matrix Patterns,Papillary serous cystadenoma,0
4747,Ductopenia,Papillary serous cystadenoma,0
4748,Dilated Cystic Spaces Present,Pancreatic Vipoma,0
4749,Dedifferentiated Malignant Infiltrate,Pancreatic Vipoma,0
4750,Mammary Gland Type Features Present,Pancreatic Vipoma,0
4751,Ectopic Tissue,Pancreatic Vipoma,0
4752,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Vipoma,0
4753,Coronary Vessel Lesion,Flat adenoma,0
4754,Index Lesion,Flat adenoma,0
4755,Non-Index Lesion,Flat adenoma,0
4756,Mushroom-Shaped Lesion,Flat adenoma,0
4757,Annular Lesion,Flat adenoma,0
4758,Dilated Cystic Spaces Present,Prolactin-producing pituitary tumor,0
4759,Dedifferentiated Malignant Infiltrate,Prolactin-producing pituitary tumor,0
4760,Mammary Gland Type Features Present,Prolactin-producing pituitary tumor,0
4761,Ectopic Tissue,Prolactin-producing pituitary tumor,0
4762,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Prolactin-producing pituitary tumor,0
4763,Coronary Vessel Lesion,Foveolar-Type Adenoma,0
4764,Index Lesion,Foveolar-Type Adenoma,0
4765,Non-Index Lesion,Foveolar-Type Adenoma,0
4766,Mushroom-Shaped Lesion,Foveolar-Type Adenoma,0
4767,Annular Lesion,Foveolar-Type Adenoma,0
4768,Dilated Cystic Spaces Present,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,0
4769,Dedifferentiated Malignant Infiltrate,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,0
4770,Mammary Gland Type Features Present,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,0
4771,Ectopic Tissue,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,0
4772,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,0
4773,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Seromucinous Cystadenoma,0
4774,Isolated Tumor Cells,Ovarian Seromucinous Cystadenoma,0
4775,Pleural/Elastic Layer Invasion,Ovarian Seromucinous Cystadenoma,0
4776,Presence of Extravascular Matrix Patterns,Ovarian Seromucinous Cystadenoma,0
4777,Ductopenia,Ovarian Seromucinous Cystadenoma,0
4778,Dilated Cystic Spaces Present,Benign Breast Eccrine Spiradenoma,0
4779,Dedifferentiated Malignant Infiltrate,Benign Breast Eccrine Spiradenoma,0
4780,Mammary Gland Type Features Present,Benign Breast Eccrine Spiradenoma,0
4781,Ectopic Tissue,Benign Breast Eccrine Spiradenoma,0
4782,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Breast Eccrine Spiradenoma,0
4783,Dilated Cystic Spaces Present,Sympathetic paraganglioma,0
4784,Dedifferentiated Malignant Infiltrate,Sympathetic paraganglioma,0
4785,Mammary Gland Type Features Present,Sympathetic paraganglioma,0
4786,Ectopic Tissue,Sympathetic paraganglioma,0
4787,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sympathetic paraganglioma,0
4788,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Intraductal Papillary Mucinous Neoplasm,0
4789,Isolated Tumor Cells,Pancreatic Intraductal Papillary Mucinous Neoplasm,0
4790,Pleural/Elastic Layer Invasion,Pancreatic Intraductal Papillary Mucinous Neoplasm,0
4791,Presence of Extravascular Matrix Patterns,Pancreatic Intraductal Papillary Mucinous Neoplasm,0
4792,Ductopenia,Pancreatic Intraductal Papillary Mucinous Neoplasm,0
4793,Dilated Cystic Spaces Present,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,0
4794,Dedifferentiated Malignant Infiltrate,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,0
4795,Mammary Gland Type Features Present,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,0
4796,Ectopic Tissue,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,0
4797,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Von Hippel-Lindau Syndrome-Associated Pancreatic Serous Adenoma,0
4798,Coronary Vessel Lesion,tubulopapillary adenoma of extrahepatic bile duct,0
4799,Index Lesion,tubulopapillary adenoma of extrahepatic bile duct,0
4800,Non-Index Lesion,tubulopapillary adenoma of extrahepatic bile duct,0
4801,Mushroom-Shaped Lesion,tubulopapillary adenoma of extrahepatic bile duct,0
4802,Annular Lesion,tubulopapillary adenoma of extrahepatic bile duct,0
4803,Coronary Vessel Lesion,Compact Cell Adrenal Cortical Adenoma,0
4804,Index Lesion,Compact Cell Adrenal Cortical Adenoma,0
4805,Non-Index Lesion,Compact Cell Adrenal Cortical Adenoma,0
4806,Mushroom-Shaped Lesion,Compact Cell Adrenal Cortical Adenoma,0
4807,Annular Lesion,Compact Cell Adrenal Cortical Adenoma,0
4808,Dilated Cystic Spaces Present,Borderline Ovarian Serous Adenofibroma,0
4809,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Serous Adenofibroma,0
4810,Mammary Gland Type Features Present,Borderline Ovarian Serous Adenofibroma,0
4811,Ectopic Tissue,Borderline Ovarian Serous Adenofibroma,0
4812,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Serous Adenofibroma,0
4813,Dilated Cystic Spaces Present,Ovarian mixed epithelial carcinoma,0
4814,Dedifferentiated Malignant Infiltrate,Ovarian mixed epithelial carcinoma,0
4815,Mammary Gland Type Features Present,Ovarian mixed epithelial carcinoma,0
4816,Ectopic Tissue,Ovarian mixed epithelial carcinoma,0
4817,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian mixed epithelial carcinoma,0
4818,Dilated Cystic Spaces Present,Condyloma acuminata of vagina,0
4819,Dedifferentiated Malignant Infiltrate,Condyloma acuminata of vagina,0
4820,Mammary Gland Type Features Present,Condyloma acuminata of vagina,0
4821,Ectopic Tissue,Condyloma acuminata of vagina,0
4822,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Condyloma acuminata of vagina,0
4823,Dilated Cystic Spaces Present,Fallopian Tube Serous Neoplasm,0
4824,Dedifferentiated Malignant Infiltrate,Fallopian Tube Serous Neoplasm,0
4825,Mammary Gland Type Features Present,Fallopian Tube Serous Neoplasm,0
4826,Ectopic Tissue,Fallopian Tube Serous Neoplasm,0
4827,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Fallopian Tube Serous Neoplasm,0
4828,Dilated Cystic Spaces Present,Malignant Intrathoracic Paravertebral Paraganglioma,0
4829,Dedifferentiated Malignant Infiltrate,Malignant Intrathoracic Paravertebral Paraganglioma,0
4830,Mammary Gland Type Features Present,Malignant Intrathoracic Paravertebral Paraganglioma,0
4831,Ectopic Tissue,Malignant Intrathoracic Paravertebral Paraganglioma,0
4832,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Intrathoracic Paravertebral Paraganglioma,0
4833,Dilated Cystic Spaces Present,Malignant carcinoid tumor of lung,0
4834,Dedifferentiated Malignant Infiltrate,Malignant carcinoid tumor of lung,0
4835,Mammary Gland Type Features Present,Malignant carcinoid tumor of lung,0
4836,Ectopic Tissue,Malignant carcinoid tumor of lung,0
4837,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant carcinoid tumor of lung,0
4838,Dilated Cystic Spaces Present,Parathyroid Gland Lipoadenoma,0
4839,Dedifferentiated Malignant Infiltrate,Parathyroid Gland Lipoadenoma,0
4840,Mammary Gland Type Features Present,Parathyroid Gland Lipoadenoma,0
4841,Ectopic Tissue,Parathyroid Gland Lipoadenoma,0
4842,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Parathyroid Gland Lipoadenoma,0
4843,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cystic Oncocytic Neoplasm,0
4844,Isolated Tumor Cells,Cystic Oncocytic Neoplasm,0
4845,Pleural/Elastic Layer Invasion,Cystic Oncocytic Neoplasm,0
4846,Presence of Extravascular Matrix Patterns,Cystic Oncocytic Neoplasm,0
4847,Ductopenia,Cystic Oncocytic Neoplasm,0
4848,Dilated Cystic Spaces Present,Ureter Urothelial Papilloma,0
4849,Dedifferentiated Malignant Infiltrate,Ureter Urothelial Papilloma,0
4850,Mammary Gland Type Features Present,Ureter Urothelial Papilloma,0
4851,Ectopic Tissue,Ureter Urothelial Papilloma,0
4852,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ureter Urothelial Papilloma,0
4853,Dilated Cystic Spaces Present,"Transitional cell papilloma, benign",0
4854,Dedifferentiated Malignant Infiltrate,"Transitional cell papilloma, benign",0
4855,Mammary Gland Type Features Present,"Transitional cell papilloma, benign",0
4856,Ectopic Tissue,"Transitional cell papilloma, benign",0
4857,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Transitional cell papilloma, benign",0
4858,Dilated Cystic Spaces Present,Vaginal Mullerian Papilloma,0
4859,Dedifferentiated Malignant Infiltrate,Vaginal Mullerian Papilloma,0
4860,Mammary Gland Type Features Present,Vaginal Mullerian Papilloma,0
4861,Ectopic Tissue,Vaginal Mullerian Papilloma,0
4862,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal Mullerian Papilloma,0
4863,Dilated Cystic Spaces Present,Esophageal dysplasia,0
4864,Dedifferentiated Malignant Infiltrate,Esophageal dysplasia,0
4865,Mammary Gland Type Features Present,Esophageal dysplasia,0
4866,Ectopic Tissue,Esophageal dysplasia,0
4867,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Esophageal dysplasia,0
4868,Dilated Cystic Spaces Present,inverted ductal papilloma of salivary gland,0
4869,Dedifferentiated Malignant Infiltrate,inverted ductal papilloma of salivary gland,0
4870,Mammary Gland Type Features Present,inverted ductal papilloma of salivary gland,0
4871,Ectopic Tissue,inverted ductal papilloma of salivary gland,0
4872,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,inverted ductal papilloma of salivary gland,0
4873,Dilated Cystic Spaces Present,Hormone secreting pituitary neoplasms,0
4874,Dedifferentiated Malignant Infiltrate,Hormone secreting pituitary neoplasms,0
4875,Mammary Gland Type Features Present,Hormone secreting pituitary neoplasms,0
4876,Ectopic Tissue,Hormone secreting pituitary neoplasms,0
4877,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hormone secreting pituitary neoplasms,0
4878,Dilated Cystic Spaces Present,High Grade Gastric Intraepithelial Neoplasia,0
4879,Dedifferentiated Malignant Infiltrate,High Grade Gastric Intraepithelial Neoplasia,0
4880,Mammary Gland Type Features Present,High Grade Gastric Intraepithelial Neoplasia,0
4881,Ectopic Tissue,High Grade Gastric Intraepithelial Neoplasia,0
4882,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Gastric Intraepithelial Neoplasia,0
4883,Dilated Cystic Spaces Present,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,0
4884,Dedifferentiated Malignant Infiltrate,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,0
4885,Mammary Gland Type Features Present,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,0
4886,Ectopic Tissue,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,0
4887,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Digestive System Neuroendocrine Tumor AJCC v7,0
4888,Dilated Cystic Spaces Present,Giant fibroadenoma of breast,0
4889,Dedifferentiated Malignant Infiltrate,Giant fibroadenoma of breast,0
4890,Mammary Gland Type Features Present,Giant fibroadenoma of breast,0
4891,Ectopic Tissue,Giant fibroadenoma of breast,0
4892,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Giant fibroadenoma of breast,0
4893,Dilated Cystic Spaces Present,Ovarian Mucinous Carcinoid Tumor,0
4894,Dedifferentiated Malignant Infiltrate,Ovarian Mucinous Carcinoid Tumor,0
4895,Mammary Gland Type Features Present,Ovarian Mucinous Carcinoid Tumor,0
4896,Ectopic Tissue,Ovarian Mucinous Carcinoid Tumor,0
4897,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Mucinous Carcinoid Tumor,0
4898,Dilated Cystic Spaces Present,Thyroid Gland Follicular Adenoma,0
4899,Dedifferentiated Malignant Infiltrate,Thyroid Gland Follicular Adenoma,0
4900,Mammary Gland Type Features Present,Thyroid Gland Follicular Adenoma,0
4901,Ectopic Tissue,Thyroid Gland Follicular Adenoma,0
4902,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Follicular Adenoma,0
4903,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Borderline Ovarian Endometrioid Cystadenofibroma,0
4904,Isolated Tumor Cells,Borderline Ovarian Endometrioid Cystadenofibroma,0
4905,Pleural/Elastic Layer Invasion,Borderline Ovarian Endometrioid Cystadenofibroma,0
4906,Presence of Extravascular Matrix Patterns,Borderline Ovarian Endometrioid Cystadenofibroma,0
4907,Ductopenia,Borderline Ovarian Endometrioid Cystadenofibroma,0
4908,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Adenolymphoma,0
4909,Isolated Tumor Cells,Adenolymphoma,0
4910,Pleural/Elastic Layer Invasion,Adenolymphoma,0
4911,Presence of Extravascular Matrix Patterns,Adenolymphoma,0
4912,Ductopenia,Adenolymphoma,0
4913,Dilated Cystic Spaces Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4914,Dedifferentiated Malignant Infiltrate,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4915,Mammary Gland Type Features Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4916,Ectopic Tissue,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4917,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
4918,Dilated Cystic Spaces Present,"Thymoma, type B1, malignant",0
4919,Dedifferentiated Malignant Infiltrate,"Thymoma, type B1, malignant",0
4920,Mammary Gland Type Features Present,"Thymoma, type B1, malignant",0
4921,Ectopic Tissue,"Thymoma, type B1, malignant",0
4922,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thymoma, type B1, malignant",0
4923,Dilated Cystic Spaces Present,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4924,Dedifferentiated Malignant Infiltrate,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4925,Mammary Gland Type Features Present,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4926,Ectopic Tissue,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4927,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4928,Dilated Cystic Spaces Present,Malignant Ovarian Surface Epithelial-Stromal Tumor,0
4929,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Surface Epithelial-Stromal Tumor,0
4930,Mammary Gland Type Features Present,Malignant Ovarian Surface Epithelial-Stromal Tumor,0
4931,Ectopic Tissue,Malignant Ovarian Surface Epithelial-Stromal Tumor,0
4932,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Surface Epithelial-Stromal Tumor,0
4933,Dilated Cystic Spaces Present,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4934,Dedifferentiated Malignant Infiltrate,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4935,Mammary Gland Type Features Present,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4936,Ectopic Tissue,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4937,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,0
4938,Dilated Cystic Spaces Present,Neuroendocrine neoplasm of lung,0
4939,Dedifferentiated Malignant Infiltrate,Neuroendocrine neoplasm of lung,0
4940,Mammary Gland Type Features Present,Neuroendocrine neoplasm of lung,0
4941,Ectopic Tissue,Neuroendocrine neoplasm of lung,0
4942,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Neuroendocrine neoplasm of lung,0
4943,Dilated Cystic Spaces Present,Islet Cell Tumor,0
4944,Dedifferentiated Malignant Infiltrate,Islet Cell Tumor,0
4945,Mammary Gland Type Features Present,Islet Cell Tumor,0
4946,Ectopic Tissue,Islet Cell Tumor,0
4947,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Islet Cell Tumor,0
4948,Dilated Cystic Spaces Present,Adenoma of lung,0
4949,Dedifferentiated Malignant Infiltrate,Adenoma of lung,0
4950,Mammary Gland Type Features Present,Adenoma of lung,0
4951,Ectopic Tissue,Adenoma of lung,0
4952,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adenoma of lung,0
4953,Coronary Vessel Lesion,Apocrine adenoma,0
4954,Index Lesion,Apocrine adenoma,0
4955,Non-Index Lesion,Apocrine adenoma,0
4956,Mushroom-Shaped Lesion,Apocrine adenoma,0
4957,Annular Lesion,Apocrine adenoma,0
4958,Dilated Cystic Spaces Present,Ampulla of Vater Neuroendocrine Tumor G1,0
4959,Dedifferentiated Malignant Infiltrate,Ampulla of Vater Neuroendocrine Tumor G1,0
4960,Mammary Gland Type Features Present,Ampulla of Vater Neuroendocrine Tumor G1,0
4961,Ectopic Tissue,Ampulla of Vater Neuroendocrine Tumor G1,0
4962,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampulla of Vater Neuroendocrine Tumor G1,0
4963,Dilated Cystic Spaces Present,Benign Ovarian Serous Tumor,0
4964,Dedifferentiated Malignant Infiltrate,Benign Ovarian Serous Tumor,0
4965,Mammary Gland Type Features Present,Benign Ovarian Serous Tumor,0
4966,Ectopic Tissue,Benign Ovarian Serous Tumor,0
4967,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Ovarian Serous Tumor,0
4968,Dilated Cystic Spaces Present,Vaginal Tubulovillous Adenoma,0
4969,Dedifferentiated Malignant Infiltrate,Vaginal Tubulovillous Adenoma,0
4970,Mammary Gland Type Features Present,Vaginal Tubulovillous Adenoma,0
4971,Ectopic Tissue,Vaginal Tubulovillous Adenoma,0
4972,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal Tubulovillous Adenoma,0
4973,Coronary Vessel Lesion,Colorectal Villous Adenoma,0
4974,Index Lesion,Colorectal Villous Adenoma,0
4975,Non-Index Lesion,Colorectal Villous Adenoma,0
4976,Mushroom-Shaped Lesion,Colorectal Villous Adenoma,0
4977,Annular Lesion,Colorectal Villous Adenoma,0
4978,Dilated Cystic Spaces Present,Conjunctival intraepithelial neoplasia,0
4979,Dedifferentiated Malignant Infiltrate,Conjunctival intraepithelial neoplasia,0
4980,Mammary Gland Type Features Present,Conjunctival intraepithelial neoplasia,0
4981,Ectopic Tissue,Conjunctival intraepithelial neoplasia,0
4982,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Conjunctival intraepithelial neoplasia,0
4983,Dilated Cystic Spaces Present,Parathyroid Gland Oncocytic Adenoma,0
4984,Dedifferentiated Malignant Infiltrate,Parathyroid Gland Oncocytic Adenoma,0
4985,Mammary Gland Type Features Present,Parathyroid Gland Oncocytic Adenoma,0
4986,Ectopic Tissue,Parathyroid Gland Oncocytic Adenoma,0
4987,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Parathyroid Gland Oncocytic Adenoma,0
4988,Dilated Cystic Spaces Present,Grade II Glandular Intraepithelial Neoplasia,0
4989,Dedifferentiated Malignant Infiltrate,Grade II Glandular Intraepithelial Neoplasia,0
4990,Mammary Gland Type Features Present,Grade II Glandular Intraepithelial Neoplasia,0
4991,Ectopic Tissue,Grade II Glandular Intraepithelial Neoplasia,0
4992,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Grade II Glandular Intraepithelial Neoplasia,0
4993,Coronary Vessel Lesion,Androgen-Producing Adrenal Cortex Adenoma,0
4994,Index Lesion,Androgen-Producing Adrenal Cortex Adenoma,0
4995,Non-Index Lesion,Androgen-Producing Adrenal Cortex Adenoma,0
4996,Mushroom-Shaped Lesion,Androgen-Producing Adrenal Cortex Adenoma,0
4997,Annular Lesion,Androgen-Producing Adrenal Cortex Adenoma,0
4998,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Benign Brenner Tumor,0
4999,Isolated Tumor Cells,Benign Brenner Tumor,0
5000,Pleural/Elastic Layer Invasion,Benign Brenner Tumor,0
5001,Presence of Extravascular Matrix Patterns,Benign Brenner Tumor,0
5002,Ductopenia,Benign Brenner Tumor,0
5003,Dilated Cystic Spaces Present,Cauda Equina Paraganglioma,0
5004,Dedifferentiated Malignant Infiltrate,Cauda Equina Paraganglioma,0
5005,Mammary Gland Type Features Present,Cauda Equina Paraganglioma,0
5006,Ectopic Tissue,Cauda Equina Paraganglioma,0
5007,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cauda Equina Paraganglioma,0
5008,Dilated Cystic Spaces Present,Pedunculated conjunctival papilloma,0
5009,Dedifferentiated Malignant Infiltrate,Pedunculated conjunctival papilloma,0
5010,Mammary Gland Type Features Present,Pedunculated conjunctival papilloma,0
5011,Ectopic Tissue,Pedunculated conjunctival papilloma,0
5012,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pedunculated conjunctival papilloma,0
5013,Dilated Cystic Spaces Present,Malignant Ovarian Mucinous Tumor,0
5014,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Mucinous Tumor,0
5015,Mammary Gland Type Features Present,Malignant Ovarian Mucinous Tumor,0
5016,Ectopic Tissue,Malignant Ovarian Mucinous Tumor,0
5017,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Mucinous Tumor,0
5018,Coronary Vessel Lesion,Mixed Cell Adrenal Cortical Adenoma,0
5019,Index Lesion,Mixed Cell Adrenal Cortical Adenoma,0
5020,Non-Index Lesion,Mixed Cell Adrenal Cortical Adenoma,0
5021,Mushroom-Shaped Lesion,Mixed Cell Adrenal Cortical Adenoma,0
5022,Annular Lesion,Mixed Cell Adrenal Cortical Adenoma,0
5023,Dilated Cystic Spaces Present,Papilloma of buccal mucosa,0
5024,Dedifferentiated Malignant Infiltrate,Papilloma of buccal mucosa,0
5025,Mammary Gland Type Features Present,Papilloma of buccal mucosa,0
5026,Ectopic Tissue,Papilloma of buccal mucosa,0
5027,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papilloma of buccal mucosa,0
5028,Dilated Cystic Spaces Present,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",0
5029,Dedifferentiated Malignant Infiltrate,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",0
5030,Mammary Gland Type Features Present,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",0
5031,Ectopic Tissue,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",0
5032,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",0
5033,Coronary Vessel Lesion,Adenoma of large intestine,0
5034,Index Lesion,Adenoma of large intestine,0
5035,Non-Index Lesion,Adenoma of large intestine,0
5036,Mushroom-Shaped Lesion,Adenoma of large intestine,0
5037,Annular Lesion,Adenoma of large intestine,0
5038,Dilated Cystic Spaces Present,Large cell acanthoma,0
5039,Dedifferentiated Malignant Infiltrate,Large cell acanthoma,0
5040,Mammary Gland Type Features Present,Large cell acanthoma,0
5041,Ectopic Tissue,Large cell acanthoma,0
5042,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Large cell acanthoma,0
5043,Dilated Cystic Spaces Present,Appendix Tubular Carcinoid,0
5044,Dedifferentiated Malignant Infiltrate,Appendix Tubular Carcinoid,0
5045,Mammary Gland Type Features Present,Appendix Tubular Carcinoid,0
5046,Ectopic Tissue,Appendix Tubular Carcinoid,0
5047,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix Tubular Carcinoid,0
5048,Dilated Cystic Spaces Present,Lung Mucous Gland Adenoma,0
5049,Dedifferentiated Malignant Infiltrate,Lung Mucous Gland Adenoma,0
5050,Mammary Gland Type Features Present,Lung Mucous Gland Adenoma,0
5051,Ectopic Tissue,Lung Mucous Gland Adenoma,0
5052,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Lung Mucous Gland Adenoma,0
5053,Dilated Cystic Spaces Present,Benign neuroendocrine tumor,0
5054,Dedifferentiated Malignant Infiltrate,Benign neuroendocrine tumor,0
5055,Mammary Gland Type Features Present,Benign neuroendocrine tumor,0
5056,Ectopic Tissue,Benign neuroendocrine tumor,0
5057,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign neuroendocrine tumor,0
5058,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Seborrheic keratosis of eyelid,0
5059,Isolated Tumor Cells,Seborrheic keratosis of eyelid,0
5060,Pleural/Elastic Layer Invasion,Seborrheic keratosis of eyelid,0
5061,Presence of Extravascular Matrix Patterns,Seborrheic keratosis of eyelid,0
5062,Ductopenia,Seborrheic keratosis of eyelid,0
5063,Dilated Cystic Spaces Present,Peripheral Breast Papilloma,0
5064,Dedifferentiated Malignant Infiltrate,Peripheral Breast Papilloma,0
5065,Mammary Gland Type Features Present,Peripheral Breast Papilloma,0
5066,Ectopic Tissue,Peripheral Breast Papilloma,0
5067,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Peripheral Breast Papilloma,0
5068,Dilated Cystic Spaces Present,Nephrogenic adenofibroma,0
5069,Dedifferentiated Malignant Infiltrate,Nephrogenic adenofibroma,0
5070,Mammary Gland Type Features Present,Nephrogenic adenofibroma,0
5071,Ectopic Tissue,Nephrogenic adenofibroma,0
5072,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Nephrogenic adenofibroma,0
5073,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pilomatrixoma,0
5074,Isolated Tumor Cells,Pilomatrixoma,0
5075,Pleural/Elastic Layer Invasion,Pilomatrixoma,0
5076,Presence of Extravascular Matrix Patterns,Pilomatrixoma,0
5077,Ductopenia,Pilomatrixoma,0
5078,Dilated Cystic Spaces Present,Ovarian Endometrioid Tumor,0
5079,Dedifferentiated Malignant Infiltrate,Ovarian Endometrioid Tumor,0
5080,Mammary Gland Type Features Present,Ovarian Endometrioid Tumor,0
5081,Ectopic Tissue,Ovarian Endometrioid Tumor,0
5082,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Endometrioid Tumor,0
5083,Dilated Cystic Spaces Present,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5084,Dedifferentiated Malignant Infiltrate,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5085,Mammary Gland Type Features Present,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5086,Ectopic Tissue,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5087,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5088,Dilated Cystic Spaces Present,Colorectal Low Grade Intraepithelial Neoplasia,0
5089,Dedifferentiated Malignant Infiltrate,Colorectal Low Grade Intraepithelial Neoplasia,0
5090,Mammary Gland Type Features Present,Colorectal Low Grade Intraepithelial Neoplasia,0
5091,Ectopic Tissue,Colorectal Low Grade Intraepithelial Neoplasia,0
5092,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal Low Grade Intraepithelial Neoplasia,0
5093,Dilated Cystic Spaces Present,Colorectal High Grade Intraepithelial Neoplasia,0
5094,Dedifferentiated Malignant Infiltrate,Colorectal High Grade Intraepithelial Neoplasia,0
5095,Mammary Gland Type Features Present,Colorectal High Grade Intraepithelial Neoplasia,0
5096,Ectopic Tissue,Colorectal High Grade Intraepithelial Neoplasia,0
5097,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal High Grade Intraepithelial Neoplasia,0
5098,Dilated Cystic Spaces Present,canalicular adenoma of salivary gland,0
5099,Dedifferentiated Malignant Infiltrate,canalicular adenoma of salivary gland,0
5100,Mammary Gland Type Features Present,canalicular adenoma of salivary gland,0
5101,Ectopic Tissue,canalicular adenoma of salivary gland,0
5102,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,canalicular adenoma of salivary gland,0
5103,Dilated Cystic Spaces Present,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5104,Dedifferentiated Malignant Infiltrate,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5105,Mammary Gland Type Features Present,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5106,Ectopic Tissue,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5107,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5108,Dilated Cystic Spaces Present,Oncocytic Neoplasm,0
5109,Dedifferentiated Malignant Infiltrate,Oncocytic Neoplasm,0
5110,Mammary Gland Type Features Present,Oncocytic Neoplasm,0
5111,Ectopic Tissue,Oncocytic Neoplasm,0
5112,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Oncocytic Neoplasm,0
5113,Dilated Cystic Spaces Present,Borderline Fallopian Tube Mucinous Tumor,0
5114,Dedifferentiated Malignant Infiltrate,Borderline Fallopian Tube Mucinous Tumor,0
5115,Mammary Gland Type Features Present,Borderline Fallopian Tube Mucinous Tumor,0
5116,Ectopic Tissue,Borderline Fallopian Tube Mucinous Tumor,0
5117,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Fallopian Tube Mucinous Tumor,0
5118,Dilated Cystic Spaces Present,Lung Typical Carcinoid Tumor,0
5119,Dedifferentiated Malignant Infiltrate,Lung Typical Carcinoid Tumor,0
5120,Mammary Gland Type Features Present,Lung Typical Carcinoid Tumor,0
5121,Ectopic Tissue,Lung Typical Carcinoid Tumor,0
5122,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Lung Typical Carcinoid Tumor,0
5123,Dilated Cystic Spaces Present,Intraepithelial Neoplasia in Barrett Esophagus,0
5124,Dedifferentiated Malignant Infiltrate,Intraepithelial Neoplasia in Barrett Esophagus,0
5125,Mammary Gland Type Features Present,Intraepithelial Neoplasia in Barrett Esophagus,0
5126,Ectopic Tissue,Intraepithelial Neoplasia in Barrett Esophagus,0
5127,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intraepithelial Neoplasia in Barrett Esophagus,0
5128,Dilated Cystic Spaces Present,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5129,Dedifferentiated Malignant Infiltrate,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5130,Mammary Gland Type Features Present,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5131,Ectopic Tissue,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5132,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5133,Dilated Cystic Spaces Present,Duodenal Gastrin-Producing Neuroendocrine Tumor,0
5134,Dedifferentiated Malignant Infiltrate,Duodenal Gastrin-Producing Neuroendocrine Tumor,0
5135,Mammary Gland Type Features Present,Duodenal Gastrin-Producing Neuroendocrine Tumor,0
5136,Ectopic Tissue,Duodenal Gastrin-Producing Neuroendocrine Tumor,0
5137,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Duodenal Gastrin-Producing Neuroendocrine Tumor,0
5138,Dilated Cystic Spaces Present,Gastric Neuroendocrine Tumor G2,0
5139,Dedifferentiated Malignant Infiltrate,Gastric Neuroendocrine Tumor G2,0
5140,Mammary Gland Type Features Present,Gastric Neuroendocrine Tumor G2,0
5141,Ectopic Tissue,Gastric Neuroendocrine Tumor G2,0
5142,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastric Neuroendocrine Tumor G2,0
5143,Dilated Cystic Spaces Present,Prostatic Adenoma,0
5144,Dedifferentiated Malignant Infiltrate,Prostatic Adenoma,0
5145,Mammary Gland Type Features Present,Prostatic Adenoma,0
5146,Ectopic Tissue,Prostatic Adenoma,0
5147,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Prostatic Adenoma,0
5148,Dilated Cystic Spaces Present,Prolactinoma,0
5149,Dedifferentiated Malignant Infiltrate,Prolactinoma,0
5150,Mammary Gland Type Features Present,Prolactinoma,0
5151,Ectopic Tissue,Prolactinoma,0
5152,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Prolactinoma,0
5153,Dilated Cystic Spaces Present,Esophageal Neuroendocrine Tumor G1,0
5154,Dedifferentiated Malignant Infiltrate,Esophageal Neuroendocrine Tumor G1,0
5155,Mammary Gland Type Features Present,Esophageal Neuroendocrine Tumor G1,0
5156,Ectopic Tissue,Esophageal Neuroendocrine Tumor G1,0
5157,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Esophageal Neuroendocrine Tumor G1,0
5158,Dilated Cystic Spaces Present,Somatotroph/Lactotroph Adenoma,0
5159,Dedifferentiated Malignant Infiltrate,Somatotroph/Lactotroph Adenoma,0
5160,Mammary Gland Type Features Present,Somatotroph/Lactotroph Adenoma,0
5161,Ectopic Tissue,Somatotroph/Lactotroph Adenoma,0
5162,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Somatotroph/Lactotroph Adenoma,0
5163,Dilated Cystic Spaces Present,Thyroid Gland Lipoadenoma,0
5164,Dedifferentiated Malignant Infiltrate,Thyroid Gland Lipoadenoma,0
5165,Mammary Gland Type Features Present,Thyroid Gland Lipoadenoma,0
5166,Ectopic Tissue,Thyroid Gland Lipoadenoma,0
5167,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Lipoadenoma,0
5168,Dilated Cystic Spaces Present,Ovarian Transitional Cell Tumor,0
5169,Dedifferentiated Malignant Infiltrate,Ovarian Transitional Cell Tumor,0
5170,Mammary Gland Type Features Present,Ovarian Transitional Cell Tumor,0
5171,Ectopic Tissue,Ovarian Transitional Cell Tumor,0
5172,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Transitional Cell Tumor,0
5173,Dilated Cystic Spaces Present,Gastrinoma,0
5174,Dedifferentiated Malignant Infiltrate,Gastrinoma,0
5175,Mammary Gland Type Features Present,Gastrinoma,0
5176,Ectopic Tissue,Gastrinoma,0
5177,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastrinoma,0
5178,Dilated Cystic Spaces Present,Oncocytic Schneiderian papilloma,0
5179,Dedifferentiated Malignant Infiltrate,Oncocytic Schneiderian papilloma,0
5180,Mammary Gland Type Features Present,Oncocytic Schneiderian papilloma,0
5181,Ectopic Tissue,Oncocytic Schneiderian papilloma,0
5182,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Oncocytic Schneiderian papilloma,0
5183,Dilated Cystic Spaces Present,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
5184,Dedifferentiated Malignant Infiltrate,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
5185,Mammary Gland Type Features Present,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
5186,Ectopic Tissue,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
5187,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Vulvar Intraepithelial Neoplasia, Differentiated Type",0
5188,Dilated Cystic Spaces Present,Ampulla of Vater Neuroendocrine Neoplasm,0
5189,Dedifferentiated Malignant Infiltrate,Ampulla of Vater Neuroendocrine Neoplasm,0
5190,Mammary Gland Type Features Present,Ampulla of Vater Neuroendocrine Neoplasm,0
5191,Ectopic Tissue,Ampulla of Vater Neuroendocrine Neoplasm,0
5192,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampulla of Vater Neuroendocrine Neoplasm,0
5193,Dilated Cystic Spaces Present,Cervical intraepithelial neoplasia grade 1,0
5194,Dedifferentiated Malignant Infiltrate,Cervical intraepithelial neoplasia grade 1,0
5195,Mammary Gland Type Features Present,Cervical intraepithelial neoplasia grade 1,0
5196,Ectopic Tissue,Cervical intraepithelial neoplasia grade 1,0
5197,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical intraepithelial neoplasia grade 1,0
5198,Dilated Cystic Spaces Present,Sphenoid Sinus Schneiderian Papilloma,0
5199,Dedifferentiated Malignant Infiltrate,Sphenoid Sinus Schneiderian Papilloma,0
5200,Mammary Gland Type Features Present,Sphenoid Sinus Schneiderian Papilloma,0
5201,Ectopic Tissue,Sphenoid Sinus Schneiderian Papilloma,0
5202,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sphenoid Sinus Schneiderian Papilloma,0
5203,Dilated Cystic Spaces Present,Papillary transitional cell neoplasm of low malignant potential,0
5204,Dedifferentiated Malignant Infiltrate,Papillary transitional cell neoplasm of low malignant potential,0
5205,Mammary Gland Type Features Present,Papillary transitional cell neoplasm of low malignant potential,0
5206,Ectopic Tissue,Papillary transitional cell neoplasm of low malignant potential,0
5207,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papillary transitional cell neoplasm of low malignant potential,0
5208,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Vulvar Seborrheic Keratosis,0
5209,Isolated Tumor Cells,Vulvar Seborrheic Keratosis,0
5210,Pleural/Elastic Layer Invasion,Vulvar Seborrheic Keratosis,0
5211,Presence of Extravascular Matrix Patterns,Vulvar Seborrheic Keratosis,0
5212,Ductopenia,Vulvar Seborrheic Keratosis,0
5213,Dilated Cystic Spaces Present,Glandular cell neoplasm,0
5214,Dedifferentiated Malignant Infiltrate,Glandular cell neoplasm,0
5215,Mammary Gland Type Features Present,Glandular cell neoplasm,0
5216,Ectopic Tissue,Glandular cell neoplasm,0
5217,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Glandular cell neoplasm,0
5218,Dilated Cystic Spaces Present,Mixed epithelial tumor of ovary,0
5219,Dedifferentiated Malignant Infiltrate,Mixed epithelial tumor of ovary,0
5220,Mammary Gland Type Features Present,Mixed epithelial tumor of ovary,0
5221,Ectopic Tissue,Mixed epithelial tumor of ovary,0
5222,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mixed epithelial tumor of ovary,0
5223,Dilated Cystic Spaces Present,Densely Granulated Somatotroph Adenoma,0
5224,Dedifferentiated Malignant Infiltrate,Densely Granulated Somatotroph Adenoma,0
5225,Mammary Gland Type Features Present,Densely Granulated Somatotroph Adenoma,0
5226,Ectopic Tissue,Densely Granulated Somatotroph Adenoma,0
5227,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Densely Granulated Somatotroph Adenoma,0
5228,Dilated Cystic Spaces Present,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,0
5229,Dedifferentiated Malignant Infiltrate,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,0
5230,Mammary Gland Type Features Present,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,0
5231,Ectopic Tissue,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,0
5232,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,0
5233,Dilated Cystic Spaces Present,Localized Adrenal Gland Pheochromocytoma,0
5234,Dedifferentiated Malignant Infiltrate,Localized Adrenal Gland Pheochromocytoma,0
5235,Mammary Gland Type Features Present,Localized Adrenal Gland Pheochromocytoma,0
5236,Ectopic Tissue,Localized Adrenal Gland Pheochromocytoma,0
5237,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Localized Adrenal Gland Pheochromocytoma,0
5238,Coronary Vessel Lesion,Bile duct adenoma,0
5239,Index Lesion,Bile duct adenoma,0
5240,Non-Index Lesion,Bile duct adenoma,0
5241,Mushroom-Shaped Lesion,Bile duct adenoma,0
5242,Annular Lesion,Bile duct adenoma,0
5243,Dilated Cystic Spaces Present,Hereditary Kidney Oncocytoma,0
5244,Dedifferentiated Malignant Infiltrate,Hereditary Kidney Oncocytoma,0
5245,Mammary Gland Type Features Present,Hereditary Kidney Oncocytoma,0
5246,Ectopic Tissue,Hereditary Kidney Oncocytoma,0
5247,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hereditary Kidney Oncocytoma,0
5248,Dilated Cystic Spaces Present,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0
5249,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0
5250,Mammary Gland Type Features Present,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0
5251,Ectopic Tissue,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0
5252,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,0
5253,Coronary Vessel Lesion,Malignant Cystosarcoma Phyllodes,0
5254,Index Lesion,Malignant Cystosarcoma Phyllodes,0
5255,Non-Index Lesion,Malignant Cystosarcoma Phyllodes,0
5256,Mushroom-Shaped Lesion,Malignant Cystosarcoma Phyllodes,0
5257,Annular Lesion,Malignant Cystosarcoma Phyllodes,0
5258,Dilated Cystic Spaces Present,Childhood Craniopharyngioma,0
5259,Dedifferentiated Malignant Infiltrate,Childhood Craniopharyngioma,0
5260,Mammary Gland Type Features Present,Childhood Craniopharyngioma,0
5261,Ectopic Tissue,Childhood Craniopharyngioma,0
5262,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Childhood Craniopharyngioma,0
5263,Coronary Vessel Lesion,Intrahepatic Bile Duct Microcystic Adenoma,0
5264,Index Lesion,Intrahepatic Bile Duct Microcystic Adenoma,0
5265,Non-Index Lesion,Intrahepatic Bile Duct Microcystic Adenoma,0
5266,Mushroom-Shaped Lesion,Intrahepatic Bile Duct Microcystic Adenoma,0
5267,Annular Lesion,Intrahepatic Bile Duct Microcystic Adenoma,0
5268,Dilated Cystic Spaces Present,Vulval intraepithelial neoplasia,0
5269,Dedifferentiated Malignant Infiltrate,Vulval intraepithelial neoplasia,0
5270,Mammary Gland Type Features Present,Vulval intraepithelial neoplasia,0
5271,Ectopic Tissue,Vulval intraepithelial neoplasia,0
5272,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vulval intraepithelial neoplasia,0
5273,Dilated Cystic Spaces Present,Malignant Pancreatic Vipoma,0
5274,Dedifferentiated Malignant Infiltrate,Malignant Pancreatic Vipoma,0
5275,Mammary Gland Type Features Present,Malignant Pancreatic Vipoma,0
5276,Ectopic Tissue,Malignant Pancreatic Vipoma,0
5277,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Pancreatic Vipoma,0
5278,Dilated Cystic Spaces Present,Mucinous neoplasm,0
5279,Dedifferentiated Malignant Infiltrate,Mucinous neoplasm,0
5280,Mammary Gland Type Features Present,Mucinous neoplasm,0
5281,Ectopic Tissue,Mucinous neoplasm,0
5282,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mucinous neoplasm,0
5283,Dilated Cystic Spaces Present,Colon Neuroendocrine Neoplasm,0
5284,Dedifferentiated Malignant Infiltrate,Colon Neuroendocrine Neoplasm,0
5285,Mammary Gland Type Features Present,Colon Neuroendocrine Neoplasm,0
5286,Ectopic Tissue,Colon Neuroendocrine Neoplasm,0
5287,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colon Neuroendocrine Neoplasm,0
5288,Coronary Vessel Lesion,Appendix Traditional Serrated Adenoma,0
5289,Index Lesion,Appendix Traditional Serrated Adenoma,0
5290,Non-Index Lesion,Appendix Traditional Serrated Adenoma,0
5291,Mushroom-Shaped Lesion,Appendix Traditional Serrated Adenoma,0
5292,Annular Lesion,Appendix Traditional Serrated Adenoma,0
5293,Dilated Cystic Spaces Present,Vaginal Villous Adenoma,0
5294,Dedifferentiated Malignant Infiltrate,Vaginal Villous Adenoma,0
5295,Mammary Gland Type Features Present,Vaginal Villous Adenoma,0
5296,Ectopic Tissue,Vaginal Villous Adenoma,0
5297,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal Villous Adenoma,0
5298,Dilated Cystic Spaces Present,Glucagonoma,0
5299,Dedifferentiated Malignant Infiltrate,Glucagonoma,0
5300,Mammary Gland Type Features Present,Glucagonoma,0
5301,Ectopic Tissue,Glucagonoma,0
5302,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Glucagonoma,0
5303,Coronary Vessel Lesion,Ampulla of Vater Tubulovillous Adenoma,0
5304,Index Lesion,Ampulla of Vater Tubulovillous Adenoma,0
5305,Non-Index Lesion,Ampulla of Vater Tubulovillous Adenoma,0
5306,Mushroom-Shaped Lesion,Ampulla of Vater Tubulovillous Adenoma,0
5307,Annular Lesion,Ampulla of Vater Tubulovillous Adenoma,0
5308,Dilated Cystic Spaces Present,Adrenal Gland Pheochromocytoma,0
5309,Dedifferentiated Malignant Infiltrate,Adrenal Gland Pheochromocytoma,0
5310,Mammary Gland Type Features Present,Adrenal Gland Pheochromocytoma,0
5311,Ectopic Tissue,Adrenal Gland Pheochromocytoma,0
5312,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adrenal Gland Pheochromocytoma,0
5313,Dilated Cystic Spaces Present,Functioning Pituitary Gland Macroadenoma,0
5314,Dedifferentiated Malignant Infiltrate,Functioning Pituitary Gland Macroadenoma,0
5315,Mammary Gland Type Features Present,Functioning Pituitary Gland Macroadenoma,0
5316,Ectopic Tissue,Functioning Pituitary Gland Macroadenoma,0
5317,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Functioning Pituitary Gland Macroadenoma,0
5318,Dilated Cystic Spaces Present,Small Intestinal Neuroendocrine Tumor,0
5319,Dedifferentiated Malignant Infiltrate,Small Intestinal Neuroendocrine Tumor,0
5320,Mammary Gland Type Features Present,Small Intestinal Neuroendocrine Tumor,0
5321,Ectopic Tissue,Small Intestinal Neuroendocrine Tumor,0
5322,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Neuroendocrine Tumor,0
5323,Dilated Cystic Spaces Present,Multiple Endocrine Neoplasia Type 2b,0
5324,Dedifferentiated Malignant Infiltrate,Multiple Endocrine Neoplasia Type 2b,0
5325,Mammary Gland Type Features Present,Multiple Endocrine Neoplasia Type 2b,0
5326,Ectopic Tissue,Multiple Endocrine Neoplasia Type 2b,0
5327,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Multiple Endocrine Neoplasia Type 2b,0
5328,Coronary Vessel Lesion,Tubular adenoma of breast,0
5329,Index Lesion,Tubular adenoma of breast,0
5330,Non-Index Lesion,Tubular adenoma of breast,0
5331,Mushroom-Shaped Lesion,Tubular adenoma of breast,0
5332,Annular Lesion,Tubular adenoma of breast,0
5333,Dilated Cystic Spaces Present,Transitional Cell Intraepithelial Neoplasia,0
5334,Dedifferentiated Malignant Infiltrate,Transitional Cell Intraepithelial Neoplasia,0
5335,Mammary Gland Type Features Present,Transitional Cell Intraepithelial Neoplasia,0
5336,Ectopic Tissue,Transitional Cell Intraepithelial Neoplasia,0
5337,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Transitional Cell Intraepithelial Neoplasia,0
5338,Dilated Cystic Spaces Present,clear cell adenocarcinofibroma of ovary,0
5339,Dedifferentiated Malignant Infiltrate,clear cell adenocarcinofibroma of ovary,0
5340,Mammary Gland Type Features Present,clear cell adenocarcinofibroma of ovary,0
5341,Ectopic Tissue,clear cell adenocarcinofibroma of ovary,0
5342,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,clear cell adenocarcinofibroma of ovary,0
5343,Dilated Cystic Spaces Present,Childhood Adrenal Gland Pheochromocytoma,0
5344,Dedifferentiated Malignant Infiltrate,Childhood Adrenal Gland Pheochromocytoma,0
5345,Mammary Gland Type Features Present,Childhood Adrenal Gland Pheochromocytoma,0
5346,Ectopic Tissue,Childhood Adrenal Gland Pheochromocytoma,0
5347,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Childhood Adrenal Gland Pheochromocytoma,0
5348,Dilated Cystic Spaces Present,Stage II Appendix Neuroendocrine Tumor AJCC v7,0
5349,Dedifferentiated Malignant Infiltrate,Stage II Appendix Neuroendocrine Tumor AJCC v7,0
5350,Mammary Gland Type Features Present,Stage II Appendix Neuroendocrine Tumor AJCC v7,0
5351,Ectopic Tissue,Stage II Appendix Neuroendocrine Tumor AJCC v7,0
5352,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Appendix Neuroendocrine Tumor AJCC v7,0
5353,Dilated Cystic Spaces Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,0
5354,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,0
5355,Mammary Gland Type Features Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,0
5356,Ectopic Tissue,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,0
5357,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,0
5358,Coronary Vessel Lesion,Hepatocellular Adenoma,0
5359,Index Lesion,Hepatocellular Adenoma,0
5360,Non-Index Lesion,Hepatocellular Adenoma,0
5361,Mushroom-Shaped Lesion,Hepatocellular Adenoma,0
5362,Annular Lesion,Hepatocellular Adenoma,0
5363,Dilated Cystic Spaces Present,Uterine Corpus Carcinoid Tumor,0
5364,Dedifferentiated Malignant Infiltrate,Uterine Corpus Carcinoid Tumor,0
5365,Mammary Gland Type Features Present,Uterine Corpus Carcinoid Tumor,0
5366,Ectopic Tissue,Uterine Corpus Carcinoid Tumor,0
5367,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Uterine Corpus Carcinoid Tumor,0
5368,Dilated Cystic Spaces Present,Ovarian Carcinoid Tumor,0
5369,Dedifferentiated Malignant Infiltrate,Ovarian Carcinoid Tumor,0
5370,Mammary Gland Type Features Present,Ovarian Carcinoid Tumor,0
5371,Ectopic Tissue,Ovarian Carcinoid Tumor,0
5372,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Carcinoid Tumor,0
5373,Dilated Cystic Spaces Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5374,Dedifferentiated Malignant Infiltrate,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5375,Mammary Gland Type Features Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5376,Ectopic Tissue,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5377,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
5378,Dilated Cystic Spaces Present,Growth Hormone-Secreting Pituitary Adenoma,0
5379,Dedifferentiated Malignant Infiltrate,Growth Hormone-Secreting Pituitary Adenoma,0
5380,Mammary Gland Type Features Present,Growth Hormone-Secreting Pituitary Adenoma,0
5381,Ectopic Tissue,Growth Hormone-Secreting Pituitary Adenoma,0
5382,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Growth Hormone-Secreting Pituitary Adenoma,0
5383,Dilated Cystic Spaces Present,Transitional Cell Neoplasm,0
5384,Dedifferentiated Malignant Infiltrate,Transitional Cell Neoplasm,0
5385,Mammary Gland Type Features Present,Transitional Cell Neoplasm,0
5386,Ectopic Tissue,Transitional Cell Neoplasm,0
5387,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Transitional Cell Neoplasm,0
5388,Dilated Cystic Spaces Present,Biliary Intraepithelial Neoplasia-1,0
5389,Dedifferentiated Malignant Infiltrate,Biliary Intraepithelial Neoplasia-1,0
5390,Mammary Gland Type Features Present,Biliary Intraepithelial Neoplasia-1,0
5391,Ectopic Tissue,Biliary Intraepithelial Neoplasia-1,0
5392,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Biliary Intraepithelial Neoplasia-1,0
5393,Dilated Cystic Spaces Present,Low Grade Gastric Intraepithelial Neoplasia,0
5394,Dedifferentiated Malignant Infiltrate,Low Grade Gastric Intraepithelial Neoplasia,0
5395,Mammary Gland Type Features Present,Low Grade Gastric Intraepithelial Neoplasia,0
5396,Ectopic Tissue,Low Grade Gastric Intraepithelial Neoplasia,0
5397,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Gastric Intraepithelial Neoplasia,0
5398,Dilated Cystic Spaces Present,Wolffian tumor,0
5399,Dedifferentiated Malignant Infiltrate,Wolffian tumor,0
5400,Mammary Gland Type Features Present,Wolffian tumor,0
5401,Ectopic Tissue,Wolffian tumor,0
5402,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Wolffian tumor,0
5403,Dilated Cystic Spaces Present,Chief cell adenoma,0
5404,Dedifferentiated Malignant Infiltrate,Chief cell adenoma,0
5405,Mammary Gland Type Features Present,Chief cell adenoma,0
5406,Ectopic Tissue,Chief cell adenoma,0
5407,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Chief cell adenoma,0
5408,Dilated Cystic Spaces Present,"Adenoma, Villous",0
5409,Dedifferentiated Malignant Infiltrate,"Adenoma, Villous",0
5410,Mammary Gland Type Features Present,"Adenoma, Villous",0
5411,Ectopic Tissue,"Adenoma, Villous",0
5412,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Adenoma, Villous",0
5413,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Mucinous Cystic Tumor with Mural Nodules,0
5414,Isolated Tumor Cells,Ovarian Mucinous Cystic Tumor with Mural Nodules,0
5415,Pleural/Elastic Layer Invasion,Ovarian Mucinous Cystic Tumor with Mural Nodules,0
5416,Presence of Extravascular Matrix Patterns,Ovarian Mucinous Cystic Tumor with Mural Nodules,0
5417,Ductopenia,Ovarian Mucinous Cystic Tumor with Mural Nodules,0
5418,Dilated Cystic Spaces Present,Renal Pelvis Inverted Papilloma,0
5419,Dedifferentiated Malignant Infiltrate,Renal Pelvis Inverted Papilloma,0
5420,Mammary Gland Type Features Present,Renal Pelvis Inverted Papilloma,0
5421,Ectopic Tissue,Renal Pelvis Inverted Papilloma,0
5422,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Renal Pelvis Inverted Papilloma,0
5423,Coronary Vessel Lesion,Unclassified Hepatocellular Adenoma,0
5424,Index Lesion,Unclassified Hepatocellular Adenoma,0
5425,Non-Index Lesion,Unclassified Hepatocellular Adenoma,0
5426,Mushroom-Shaped Lesion,Unclassified Hepatocellular Adenoma,0
5427,Annular Lesion,Unclassified Hepatocellular Adenoma,0
5428,Dilated Cystic Spaces Present,Maxillary Sinus Schneiderian Papilloma,0
5429,Dedifferentiated Malignant Infiltrate,Maxillary Sinus Schneiderian Papilloma,0
5430,Mammary Gland Type Features Present,Maxillary Sinus Schneiderian Papilloma,0
5431,Ectopic Tissue,Maxillary Sinus Schneiderian Papilloma,0
5432,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Maxillary Sinus Schneiderian Papilloma,0
5433,Dilated Cystic Spaces Present,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,0
5434,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,0
5435,Mammary Gland Type Features Present,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,0
5436,Ectopic Tissue,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,0
5437,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,0
5438,Dilated Cystic Spaces Present,High Grade Conjunctival Intraepithelial Neoplasia,0
5439,Dedifferentiated Malignant Infiltrate,High Grade Conjunctival Intraepithelial Neoplasia,0
5440,Mammary Gland Type Features Present,High Grade Conjunctival Intraepithelial Neoplasia,0
5441,Ectopic Tissue,High Grade Conjunctival Intraepithelial Neoplasia,0
5442,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Conjunctival Intraepithelial Neoplasia,0
5443,Dilated Cystic Spaces Present,Benign Apocrine Neoplasm,0
5444,Dedifferentiated Malignant Infiltrate,Benign Apocrine Neoplasm,0
5445,Mammary Gland Type Features Present,Benign Apocrine Neoplasm,0
5446,Ectopic Tissue,Benign Apocrine Neoplasm,0
5447,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Apocrine Neoplasm,0
5448,Dilated Cystic Spaces Present,Cervical intraepithelial neoplasia grade 2,0
5449,Dedifferentiated Malignant Infiltrate,Cervical intraepithelial neoplasia grade 2,0
5450,Mammary Gland Type Features Present,Cervical intraepithelial neoplasia grade 2,0
5451,Ectopic Tissue,Cervical intraepithelial neoplasia grade 2,0
5452,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical intraepithelial neoplasia grade 2,0
5453,Dilated Cystic Spaces Present,Vaginal intraepithelial neoplasia,0
5454,Dedifferentiated Malignant Infiltrate,Vaginal intraepithelial neoplasia,0
5455,Mammary Gland Type Features Present,Vaginal intraepithelial neoplasia,0
5456,Ectopic Tissue,Vaginal intraepithelial neoplasia,0
5457,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal intraepithelial neoplasia,0
5458,Dilated Cystic Spaces Present,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5459,Dedifferentiated Malignant Infiltrate,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5460,Mammary Gland Type Features Present,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5461,Ectopic Tissue,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5462,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
5463,Dilated Cystic Spaces Present,Trichilemmoma,0
5464,Dedifferentiated Malignant Infiltrate,Trichilemmoma,0
5465,Mammary Gland Type Features Present,Trichilemmoma,0
5466,Ectopic Tissue,Trichilemmoma,0
5467,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Trichilemmoma,0
5468,Dilated Cystic Spaces Present,Childhood Atypical Choroid Plexus Papilloma,0
5469,Dedifferentiated Malignant Infiltrate,Childhood Atypical Choroid Plexus Papilloma,0
5470,Mammary Gland Type Features Present,Childhood Atypical Choroid Plexus Papilloma,0
5471,Ectopic Tissue,Childhood Atypical Choroid Plexus Papilloma,0
5472,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Childhood Atypical Choroid Plexus Papilloma,0
5473,Dilated Cystic Spaces Present,Perianal Squamous Intraepithelial Neoplasia,0
5474,Dedifferentiated Malignant Infiltrate,Perianal Squamous Intraepithelial Neoplasia,0
5475,Mammary Gland Type Features Present,Perianal Squamous Intraepithelial Neoplasia,0
5476,Ectopic Tissue,Perianal Squamous Intraepithelial Neoplasia,0
5477,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Perianal Squamous Intraepithelial Neoplasia,0
5478,Dilated Cystic Spaces Present,Sparsely Granulated Somatotroph Adenoma,0
5479,Dedifferentiated Malignant Infiltrate,Sparsely Granulated Somatotroph Adenoma,0
5480,Mammary Gland Type Features Present,Sparsely Granulated Somatotroph Adenoma,0
5481,Ectopic Tissue,Sparsely Granulated Somatotroph Adenoma,0
5482,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sparsely Granulated Somatotroph Adenoma,0
5483,Dilated Cystic Spaces Present,Thymic epithelial tumor,0
5484,Dedifferentiated Malignant Infiltrate,Thymic epithelial tumor,0
5485,Mammary Gland Type Features Present,Thymic epithelial tumor,0
5486,Ectopic Tissue,Thymic epithelial tumor,0
5487,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymic epithelial tumor,0
5488,Dilated Cystic Spaces Present,Thymoma,0
5489,Dedifferentiated Malignant Infiltrate,Thymoma,0
5490,Mammary Gland Type Features Present,Thymoma,0
5491,Ectopic Tissue,Thymoma,0
5492,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymoma,0
5493,Dilated Cystic Spaces Present,Neuroendocrine neoplasm of gallbladder,0
5494,Dedifferentiated Malignant Infiltrate,Neuroendocrine neoplasm of gallbladder,0
5495,Mammary Gland Type Features Present,Neuroendocrine neoplasm of gallbladder,0
5496,Ectopic Tissue,Neuroendocrine neoplasm of gallbladder,0
5497,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Neuroendocrine neoplasm of gallbladder,0
5498,Dilated Cystic Spaces Present,Gallbladder Biliary Intraepithelial Neoplasia,0
5499,Dedifferentiated Malignant Infiltrate,Gallbladder Biliary Intraepithelial Neoplasia,0
5500,Mammary Gland Type Features Present,Gallbladder Biliary Intraepithelial Neoplasia,0
5501,Ectopic Tissue,Gallbladder Biliary Intraepithelial Neoplasia,0
5502,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Biliary Intraepithelial Neoplasia,0
5503,Dilated Cystic Spaces Present,Atrial Paraganglioma,0
5504,Dedifferentiated Malignant Infiltrate,Atrial Paraganglioma,0
5505,Mammary Gland Type Features Present,Atrial Paraganglioma,0
5506,Ectopic Tissue,Atrial Paraganglioma,0
5507,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Atrial Paraganglioma,0
5508,Dilated Cystic Spaces Present,Cervical Mullerian Papilloma,0
5509,Dedifferentiated Malignant Infiltrate,Cervical Mullerian Papilloma,0
5510,Mammary Gland Type Features Present,Cervical Mullerian Papilloma,0
5511,Ectopic Tissue,Cervical Mullerian Papilloma,0
5512,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Mullerian Papilloma,0
5513,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Fundic gland polyp,0
5514,Isolated Tumor Cells,Fundic gland polyp,0
5515,Pleural/Elastic Layer Invasion,Fundic gland polyp,0
5516,Presence of Extravascular Matrix Patterns,Fundic gland polyp,0
5517,Ductopenia,Fundic gland polyp,0
5518,Dilated Cystic Spaces Present,"Oncocytoma, renal",0
5519,Dedifferentiated Malignant Infiltrate,"Oncocytoma, renal",0
5520,Mammary Gland Type Features Present,"Oncocytoma, renal",0
5521,Ectopic Tissue,"Oncocytoma, renal",0
5522,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Oncocytoma, renal",0
5523,Dilated Cystic Spaces Present,Clear cell adenoma,0
5524,Dedifferentiated Malignant Infiltrate,Clear cell adenoma,0
5525,Mammary Gland Type Features Present,Clear cell adenoma,0
5526,Ectopic Tissue,Clear cell adenoma,0
5527,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Clear cell adenoma,0
5528,Coronary Vessel Lesion,Metastatic Adrenal Gland Pheochromocytoma,0
5529,Index Lesion,Metastatic Adrenal Gland Pheochromocytoma,0
5530,Non-Index Lesion,Metastatic Adrenal Gland Pheochromocytoma,0
5531,Mushroom-Shaped Lesion,Metastatic Adrenal Gland Pheochromocytoma,0
5532,Annular Lesion,Metastatic Adrenal Gland Pheochromocytoma,0
5533,Dilated Cystic Spaces Present,External Ear Actinic Keratosis,0
5534,Dedifferentiated Malignant Infiltrate,External Ear Actinic Keratosis,0
5535,Mammary Gland Type Features Present,External Ear Actinic Keratosis,0
5536,Ectopic Tissue,External Ear Actinic Keratosis,0
5537,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,External Ear Actinic Keratosis,0
5538,Dilated Cystic Spaces Present,Papilloma of eyelid,0
5539,Dedifferentiated Malignant Infiltrate,Papilloma of eyelid,0
5540,Mammary Gland Type Features Present,Papilloma of eyelid,0
5541,Ectopic Tissue,Papilloma of eyelid,0
5542,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papilloma of eyelid,0
5543,Dilated Cystic Spaces Present,Glandular Cell Intraepithelial Neoplasia,0
5544,Dedifferentiated Malignant Infiltrate,Glandular Cell Intraepithelial Neoplasia,0
5545,Mammary Gland Type Features Present,Glandular Cell Intraepithelial Neoplasia,0
5546,Ectopic Tissue,Glandular Cell Intraepithelial Neoplasia,0
5547,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Glandular Cell Intraepithelial Neoplasia,0
5548,Dilated Cystic Spaces Present,Eccrine dermal cylindroma,0
5549,Dedifferentiated Malignant Infiltrate,Eccrine dermal cylindroma,0
5550,Mammary Gland Type Features Present,Eccrine dermal cylindroma,0
5551,Ectopic Tissue,Eccrine dermal cylindroma,0
5552,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Eccrine dermal cylindroma,0
5553,Dilated Cystic Spaces Present,Desmoplastic trichilemmoma,0
5554,Dedifferentiated Malignant Infiltrate,Desmoplastic trichilemmoma,0
5555,Mammary Gland Type Features Present,Desmoplastic trichilemmoma,0
5556,Ectopic Tissue,Desmoplastic trichilemmoma,0
5557,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Desmoplastic trichilemmoma,0
5558,Coronary Vessel Lesion,Malignant Vulvar Phyllodes Tumor,0
5559,Index Lesion,Malignant Vulvar Phyllodes Tumor,0
5560,Non-Index Lesion,Malignant Vulvar Phyllodes Tumor,0
5561,Mushroom-Shaped Lesion,Malignant Vulvar Phyllodes Tumor,0
5562,Annular Lesion,Malignant Vulvar Phyllodes Tumor,0
5563,Dilated Cystic Spaces Present,Dermal Duct Tumor,0
5564,Dedifferentiated Malignant Infiltrate,Dermal Duct Tumor,0
5565,Mammary Gland Type Features Present,Dermal Duct Tumor,0
5566,Ectopic Tissue,Dermal Duct Tumor,0
5567,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Dermal Duct Tumor,0
5568,Dilated Cystic Spaces Present,Recurrent Inverted Schneiderian Papilloma,0
5569,Dedifferentiated Malignant Infiltrate,Recurrent Inverted Schneiderian Papilloma,0
5570,Mammary Gland Type Features Present,Recurrent Inverted Schneiderian Papilloma,0
5571,Ectopic Tissue,Recurrent Inverted Schneiderian Papilloma,0
5572,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Inverted Schneiderian Papilloma,0
5573,Dilated Cystic Spaces Present,Gastrointestinal Intraepithelial Neoplasia,0
5574,Dedifferentiated Malignant Infiltrate,Gastrointestinal Intraepithelial Neoplasia,0
5575,Mammary Gland Type Features Present,Gastrointestinal Intraepithelial Neoplasia,0
5576,Ectopic Tissue,Gastrointestinal Intraepithelial Neoplasia,0
5577,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastrointestinal Intraepithelial Neoplasia,0
5578,Coronary Vessel Lesion,Cortisol-Producing Adrenal Cortex Adenoma,0
5579,Index Lesion,Cortisol-Producing Adrenal Cortex Adenoma,0
5580,Non-Index Lesion,Cortisol-Producing Adrenal Cortex Adenoma,0
5581,Mushroom-Shaped Lesion,Cortisol-Producing Adrenal Cortex Adenoma,0
5582,Annular Lesion,Cortisol-Producing Adrenal Cortex Adenoma,0
5583,Coronary Vessel Lesion,Lactating adenoma,0
5584,Index Lesion,Lactating adenoma,0
5585,Non-Index Lesion,Lactating adenoma,0
5586,Mushroom-Shaped Lesion,Lactating adenoma,0
5587,Annular Lesion,Lactating adenoma,0
5588,Dilated Cystic Spaces Present,Ascending Colon Neuroendocrine Tumor G1,0
5589,Dedifferentiated Malignant Infiltrate,Ascending Colon Neuroendocrine Tumor G1,0
5590,Mammary Gland Type Features Present,Ascending Colon Neuroendocrine Tumor G1,0
5591,Ectopic Tissue,Ascending Colon Neuroendocrine Tumor G1,0
5592,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ascending Colon Neuroendocrine Tumor G1,0
5593,Dilated Cystic Spaces Present,Non-Functioning Pancreatic Neuroendocrine Tumor G1,0
5594,Dedifferentiated Malignant Infiltrate,Non-Functioning Pancreatic Neuroendocrine Tumor G1,0
5595,Mammary Gland Type Features Present,Non-Functioning Pancreatic Neuroendocrine Tumor G1,0
5596,Ectopic Tissue,Non-Functioning Pancreatic Neuroendocrine Tumor G1,0
5597,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non-Functioning Pancreatic Neuroendocrine Tumor G1,0
5598,Dilated Cystic Spaces Present,Pituitary Gland Microadenoma,0
5599,Dedifferentiated Malignant Infiltrate,Pituitary Gland Microadenoma,0
5600,Mammary Gland Type Features Present,Pituitary Gland Microadenoma,0
5601,Ectopic Tissue,Pituitary Gland Microadenoma,0
5602,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pituitary Gland Microadenoma,0
5603,Dilated Cystic Spaces Present,Ovarian Clear Cell Adenofibroma,0
5604,Dedifferentiated Malignant Infiltrate,Ovarian Clear Cell Adenofibroma,0
5605,Mammary Gland Type Features Present,Ovarian Clear Cell Adenofibroma,0
5606,Ectopic Tissue,Ovarian Clear Cell Adenofibroma,0
5607,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Clear Cell Adenofibroma,0
5608,Dilated Cystic Spaces Present,Vaginal Glandular Neoplasm,0
5609,Dedifferentiated Malignant Infiltrate,Vaginal Glandular Neoplasm,0
5610,Mammary Gland Type Features Present,Vaginal Glandular Neoplasm,0
5611,Ectopic Tissue,Vaginal Glandular Neoplasm,0
5612,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal Glandular Neoplasm,0
5613,Dilated Cystic Spaces Present,Microfollicular adenoma,0
5614,Dedifferentiated Malignant Infiltrate,Microfollicular adenoma,0
5615,Mammary Gland Type Features Present,Microfollicular adenoma,0
5616,Ectopic Tissue,Microfollicular adenoma,0
5617,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Microfollicular adenoma,0
5618,Dilated Cystic Spaces Present,Macrofollicular adenoma,0
5619,Dedifferentiated Malignant Infiltrate,Macrofollicular adenoma,0
5620,Mammary Gland Type Features Present,Macrofollicular adenoma,0
5621,Ectopic Tissue,Macrofollicular adenoma,0
5622,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Macrofollicular adenoma,0
5623,Dilated Cystic Spaces Present,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5624,Dedifferentiated Malignant Infiltrate,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5625,Mammary Gland Type Features Present,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5626,Ectopic Tissue,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5627,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor,0
5628,Dilated Cystic Spaces Present,Ampulla of Vater Neuroendocrine Tumor,0
5629,Dedifferentiated Malignant Infiltrate,Ampulla of Vater Neuroendocrine Tumor,0
5630,Mammary Gland Type Features Present,Ampulla of Vater Neuroendocrine Tumor,0
5631,Ectopic Tissue,Ampulla of Vater Neuroendocrine Tumor,0
5632,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampulla of Vater Neuroendocrine Tumor,0
5633,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Papillary mucinous cystadenoma, borderline malignancy",0
5634,Isolated Tumor Cells,"Papillary mucinous cystadenoma, borderline malignancy",0
5635,Pleural/Elastic Layer Invasion,"Papillary mucinous cystadenoma, borderline malignancy",0
5636,Presence of Extravascular Matrix Patterns,"Papillary mucinous cystadenoma, borderline malignancy",0
5637,Ductopenia,"Papillary mucinous cystadenoma, borderline malignancy",0
5638,Coronary Vessel Lesion,tubular adenoma of gallbladder,0
5639,Index Lesion,tubular adenoma of gallbladder,0
5640,Non-Index Lesion,tubular adenoma of gallbladder,0
5641,Mushroom-Shaped Lesion,tubular adenoma of gallbladder,0
5642,Annular Lesion,tubular adenoma of gallbladder,0
5643,Dilated Cystic Spaces Present,Anal Canal Neuroendocrine Tumor,0
5644,Dedifferentiated Malignant Infiltrate,Anal Canal Neuroendocrine Tumor,0
5645,Mammary Gland Type Features Present,Anal Canal Neuroendocrine Tumor,0
5646,Ectopic Tissue,Anal Canal Neuroendocrine Tumor,0
5647,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anal Canal Neuroendocrine Tumor,0
5648,Dilated Cystic Spaces Present,Benign Epithelioma,0
5649,Dedifferentiated Malignant Infiltrate,Benign Epithelioma,0
5650,Mammary Gland Type Features Present,Benign Epithelioma,0
5651,Ectopic Tissue,Benign Epithelioma,0
5652,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Epithelioma,0
5653,Dilated Cystic Spaces Present,insulinoma,0
5654,Dedifferentiated Malignant Infiltrate,insulinoma,0
5655,Mammary Gland Type Features Present,insulinoma,0
5656,Ectopic Tissue,insulinoma,0
5657,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,insulinoma,0
5658,Dilated Cystic Spaces Present,Digestive System Neuroendocrine Tumor G2,0
5659,Dedifferentiated Malignant Infiltrate,Digestive System Neuroendocrine Tumor G2,0
5660,Mammary Gland Type Features Present,Digestive System Neuroendocrine Tumor G2,0
5661,Ectopic Tissue,Digestive System Neuroendocrine Tumor G2,0
5662,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Digestive System Neuroendocrine Tumor G2,0
5663,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cystadenoma,0
5664,Isolated Tumor Cells,Cystadenoma,0
5665,Pleural/Elastic Layer Invasion,Cystadenoma,0
5666,Presence of Extravascular Matrix Patterns,Cystadenoma,0
5667,Ductopenia,Cystadenoma,0
5668,Dilated Cystic Spaces Present,Benign Germinative Follicular Epithelium Neoplasm,0
5669,Dedifferentiated Malignant Infiltrate,Benign Germinative Follicular Epithelium Neoplasm,0
5670,Mammary Gland Type Features Present,Benign Germinative Follicular Epithelium Neoplasm,0
5671,Ectopic Tissue,Benign Germinative Follicular Epithelium Neoplasm,0
5672,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Germinative Follicular Epithelium Neoplasm,0
5673,Dilated Cystic Spaces Present,Mediastinal Thymoma,0
5674,Dedifferentiated Malignant Infiltrate,Mediastinal Thymoma,0
5675,Mammary Gland Type Features Present,Mediastinal Thymoma,0
5676,Ectopic Tissue,Mediastinal Thymoma,0
5677,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mediastinal Thymoma,0
5678,Dilated Cystic Spaces Present,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",0
5679,Dedifferentiated Malignant Infiltrate,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",0
5680,Mammary Gland Type Features Present,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",0
5681,Ectopic Tissue,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",0
5682,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"High Grade Prostatic Intraepithelial Neoplasia, Mucinous Variant",0
5683,Dilated Cystic Spaces Present,Anterior Pituitary Gland Endocrine Neoplasm,0
5684,Dedifferentiated Malignant Infiltrate,Anterior Pituitary Gland Endocrine Neoplasm,0
5685,Mammary Gland Type Features Present,Anterior Pituitary Gland Endocrine Neoplasm,0
5686,Ectopic Tissue,Anterior Pituitary Gland Endocrine Neoplasm,0
5687,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anterior Pituitary Gland Endocrine Neoplasm,0
5688,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,0
5689,Isolated Tumor Cells,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,0
5690,Pleural/Elastic Layer Invasion,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,0
5691,Presence of Extravascular Matrix Patterns,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,0
5692,Ductopenia,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,0
5693,Dilated Cystic Spaces Present,sebaceous adenoma of salivary gland,0
5694,Dedifferentiated Malignant Infiltrate,sebaceous adenoma of salivary gland,0
5695,Mammary Gland Type Features Present,sebaceous adenoma of salivary gland,0
5696,Ectopic Tissue,sebaceous adenoma of salivary gland,0
5697,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,sebaceous adenoma of salivary gland,0
5698,Dilated Cystic Spaces Present,Regional Digestive System Neuroendocrine Tumor G1,0
5699,Dedifferentiated Malignant Infiltrate,Regional Digestive System Neuroendocrine Tumor G1,0
5700,Mammary Gland Type Features Present,Regional Digestive System Neuroendocrine Tumor G1,0
5701,Ectopic Tissue,Regional Digestive System Neuroendocrine Tumor G1,0
5702,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Regional Digestive System Neuroendocrine Tumor G1,0
5703,Coronary Vessel Lesion,adenomatous polyp of stomach,0
5704,Index Lesion,adenomatous polyp of stomach,0
5705,Non-Index Lesion,adenomatous polyp of stomach,0
5706,Mushroom-Shaped Lesion,adenomatous polyp of stomach,0
5707,Annular Lesion,adenomatous polyp of stomach,0
5708,Dilated Cystic Spaces Present,Intrahepatic Bile Duct Papillary Neoplasm,0
5709,Dedifferentiated Malignant Infiltrate,Intrahepatic Bile Duct Papillary Neoplasm,0
5710,Mammary Gland Type Features Present,Intrahepatic Bile Duct Papillary Neoplasm,0
5711,Ectopic Tissue,Intrahepatic Bile Duct Papillary Neoplasm,0
5712,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intrahepatic Bile Duct Papillary Neoplasm,0
5713,Dilated Cystic Spaces Present,Plantar wart,0
5714,Dedifferentiated Malignant Infiltrate,Plantar wart,0
5715,Mammary Gland Type Features Present,Plantar wart,0
5716,Ectopic Tissue,Plantar wart,0
5717,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Plantar wart,0
5718,Dilated Cystic Spaces Present,Cervical Squamous Neoplasm,0
5719,Dedifferentiated Malignant Infiltrate,Cervical Squamous Neoplasm,0
5720,Mammary Gland Type Features Present,Cervical Squamous Neoplasm,0
5721,Ectopic Tissue,Cervical Squamous Neoplasm,0
5722,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Squamous Neoplasm,0
5723,Dilated Cystic Spaces Present,Epithelioma,0
5724,Dedifferentiated Malignant Infiltrate,Epithelioma,0
5725,Mammary Gland Type Features Present,Epithelioma,0
5726,Ectopic Tissue,Epithelioma,0
5727,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Epithelioma,0
5728,Dilated Cystic Spaces Present,Inverting papilloma of the nasal cavity,0
5729,Dedifferentiated Malignant Infiltrate,Inverting papilloma of the nasal cavity,0
5730,Mammary Gland Type Features Present,Inverting papilloma of the nasal cavity,0
5731,Ectopic Tissue,Inverting papilloma of the nasal cavity,0
5732,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Inverting papilloma of the nasal cavity,0
5733,Dilated Cystic Spaces Present,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,0
5734,Dedifferentiated Malignant Infiltrate,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,0
5735,Mammary Gland Type Features Present,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,0
5736,Ectopic Tissue,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,0
5737,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,0
5738,Dilated Cystic Spaces Present,Breast Carcinoid Tumor,0
5739,Dedifferentiated Malignant Infiltrate,Breast Carcinoid Tumor,0
5740,Mammary Gland Type Features Present,Breast Carcinoid Tumor,0
5741,Ectopic Tissue,Breast Carcinoid Tumor,0
5742,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Breast Carcinoid Tumor,0
5743,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0
5744,Isolated Tumor Cells,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0
5745,Pleural/Elastic Layer Invasion,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0
5746,Presence of Extravascular Matrix Patterns,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0
5747,Ductopenia,"Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type",0
5748,Dilated Cystic Spaces Present,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",0
5749,Dedifferentiated Malignant Infiltrate,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",0
5750,Mammary Gland Type Features Present,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",0
5751,Ectopic Tissue,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",0
5752,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",0
5753,Dilated Cystic Spaces Present,Hurthle Cell Tumor,0
5754,Dedifferentiated Malignant Infiltrate,Hurthle Cell Tumor,0
5755,Mammary Gland Type Features Present,Hurthle Cell Tumor,0
5756,Ectopic Tissue,Hurthle Cell Tumor,0
5757,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hurthle Cell Tumor,0
5758,Dilated Cystic Spaces Present,Small Intestinal Carcinoid Tumor,0
5759,Dedifferentiated Malignant Infiltrate,Small Intestinal Carcinoid Tumor,0
5760,Mammary Gland Type Features Present,Small Intestinal Carcinoid Tumor,0
5761,Ectopic Tissue,Small Intestinal Carcinoid Tumor,0
5762,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Carcinoid Tumor,0
5763,Dilated Cystic Spaces Present,Non functioning pancreatic endocrine tumor,0
5764,Dedifferentiated Malignant Infiltrate,Non functioning pancreatic endocrine tumor,0
5765,Mammary Gland Type Features Present,Non functioning pancreatic endocrine tumor,0
5766,Ectopic Tissue,Non functioning pancreatic endocrine tumor,0
5767,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non functioning pancreatic endocrine tumor,0
5768,Dilated Cystic Spaces Present,Benign Eccrine Neoplasm,0
5769,Dedifferentiated Malignant Infiltrate,Benign Eccrine Neoplasm,0
5770,Mammary Gland Type Features Present,Benign Eccrine Neoplasm,0
5771,Ectopic Tissue,Benign Eccrine Neoplasm,0
5772,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Eccrine Neoplasm,0
5773,Coronary Vessel Lesion,Metastatic carcinoid tumor,0
5774,Index Lesion,Metastatic carcinoid tumor,0
5775,Non-Index Lesion,Metastatic carcinoid tumor,0
5776,Mushroom-Shaped Lesion,Metastatic carcinoid tumor,0
5777,Annular Lesion,Metastatic carcinoid tumor,0
5778,Dilated Cystic Spaces Present,High grade cervical glandular intraepithelial neoplasia,0
5779,Dedifferentiated Malignant Infiltrate,High grade cervical glandular intraepithelial neoplasia,0
5780,Mammary Gland Type Features Present,High grade cervical glandular intraepithelial neoplasia,0
5781,Ectopic Tissue,High grade cervical glandular intraepithelial neoplasia,0
5782,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High grade cervical glandular intraepithelial neoplasia,0
5783,Dilated Cystic Spaces Present,Acidophil Stem Cell Pituitary Gland Adenoma,0
5784,Dedifferentiated Malignant Infiltrate,Acidophil Stem Cell Pituitary Gland Adenoma,0
5785,Mammary Gland Type Features Present,Acidophil Stem Cell Pituitary Gland Adenoma,0
5786,Ectopic Tissue,Acidophil Stem Cell Pituitary Gland Adenoma,0
5787,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Acidophil Stem Cell Pituitary Gland Adenoma,0
5788,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei,0
5789,Isolated Tumor Cells,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei,0
5790,Pleural/Elastic Layer Invasion,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei,0
5791,Presence of Extravascular Matrix Patterns,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei,0
5792,Ductopenia,Ovarian Mucinous Cystic Tumor Associated with Pseudomyxoma Peritonei,0
5793,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Mucinous-Cystic Neoplasm,0
5794,Isolated Tumor Cells,Pancreatic Mucinous-Cystic Neoplasm,0
5795,Pleural/Elastic Layer Invasion,Pancreatic Mucinous-Cystic Neoplasm,0
5796,Presence of Extravascular Matrix Patterns,Pancreatic Mucinous-Cystic Neoplasm,0
5797,Ductopenia,Pancreatic Mucinous-Cystic Neoplasm,0
5798,Dilated Cystic Spaces Present,Primary malignant neoplasm of glomus jugulare,0
5799,Dedifferentiated Malignant Infiltrate,Primary malignant neoplasm of glomus jugulare,0
5800,Mammary Gland Type Features Present,Primary malignant neoplasm of glomus jugulare,0
5801,Ectopic Tissue,Primary malignant neoplasm of glomus jugulare,0
5802,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Primary malignant neoplasm of glomus jugulare,0
5803,Coronary Vessel Lesion,Gallbladder Papillary Adenoma,0
5804,Index Lesion,Gallbladder Papillary Adenoma,0
5805,Non-Index Lesion,Gallbladder Papillary Adenoma,0
5806,Mushroom-Shaped Lesion,Gallbladder Papillary Adenoma,0
5807,Annular Lesion,Gallbladder Papillary Adenoma,0
5808,Coronary Vessel Lesion,tubulopapillary adenoma of gallbladder,0
5809,Index Lesion,tubulopapillary adenoma of gallbladder,0
5810,Non-Index Lesion,tubulopapillary adenoma of gallbladder,0
5811,Mushroom-Shaped Lesion,tubulopapillary adenoma of gallbladder,0
5812,Annular Lesion,tubulopapillary adenoma of gallbladder,0
5813,Dilated Cystic Spaces Present,Malignant Adrenal Gland Composite Pheochromocytoma,0
5814,Dedifferentiated Malignant Infiltrate,Malignant Adrenal Gland Composite Pheochromocytoma,0
5815,Mammary Gland Type Features Present,Malignant Adrenal Gland Composite Pheochromocytoma,0
5816,Ectopic Tissue,Malignant Adrenal Gland Composite Pheochromocytoma,0
5817,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Adrenal Gland Composite Pheochromocytoma,0
5818,Coronary Vessel Lesion,Sebaceous adenoma,0
5819,Index Lesion,Sebaceous adenoma,0
5820,Non-Index Lesion,Sebaceous adenoma,0
5821,Mushroom-Shaped Lesion,Sebaceous adenoma,0
5822,Annular Lesion,Sebaceous adenoma,0
5823,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cystadenoma of pancreas,0
5824,Isolated Tumor Cells,Cystadenoma of pancreas,0
5825,Pleural/Elastic Layer Invasion,Cystadenoma of pancreas,0
5826,Presence of Extravascular Matrix Patterns,Cystadenoma of pancreas,0
5827,Ductopenia,Cystadenoma of pancreas,0
5828,Dilated Cystic Spaces Present,High Grade Esophageal Squamous Intraepithelial Neoplasia,0
5829,Dedifferentiated Malignant Infiltrate,High Grade Esophageal Squamous Intraepithelial Neoplasia,0
5830,Mammary Gland Type Features Present,High Grade Esophageal Squamous Intraepithelial Neoplasia,0
5831,Ectopic Tissue,High Grade Esophageal Squamous Intraepithelial Neoplasia,0
5832,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Esophageal Squamous Intraepithelial Neoplasia,0
5833,Dilated Cystic Spaces Present,Cervical Glandular Neoplasm,0
5834,Dedifferentiated Malignant Infiltrate,Cervical Glandular Neoplasm,0
5835,Mammary Gland Type Features Present,Cervical Glandular Neoplasm,0
5836,Ectopic Tissue,Cervical Glandular Neoplasm,0
5837,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Glandular Neoplasm,0
5838,Dilated Cystic Spaces Present,"Glandular intraepithelial neoplasia, low grade",0
5839,Dedifferentiated Malignant Infiltrate,"Glandular intraepithelial neoplasia, low grade",0
5840,Mammary Gland Type Features Present,"Glandular intraepithelial neoplasia, low grade",0
5841,Ectopic Tissue,"Glandular intraepithelial neoplasia, low grade",0
5842,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Glandular intraepithelial neoplasia, low grade",0
5843,Dilated Cystic Spaces Present,Liver Neuroendocrine Neoplasm,0
5844,Dedifferentiated Malignant Infiltrate,Liver Neuroendocrine Neoplasm,0
5845,Mammary Gland Type Features Present,Liver Neuroendocrine Neoplasm,0
5846,Ectopic Tissue,Liver Neuroendocrine Neoplasm,0
5847,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Liver Neuroendocrine Neoplasm,0
5848,Dilated Cystic Spaces Present,Cervical high grade squamous intraepithelial lesion,0
5849,Dedifferentiated Malignant Infiltrate,Cervical high grade squamous intraepithelial lesion,0
5850,Mammary Gland Type Features Present,Cervical high grade squamous intraepithelial lesion,0
5851,Ectopic Tissue,Cervical high grade squamous intraepithelial lesion,0
5852,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical high grade squamous intraepithelial lesion,0
5853,Coronary Vessel Lesion,Aldosterone-Producing Adrenal Cortex Adenoma,0
5854,Index Lesion,Aldosterone-Producing Adrenal Cortex Adenoma,0
5855,Non-Index Lesion,Aldosterone-Producing Adrenal Cortex Adenoma,0
5856,Mushroom-Shaped Lesion,Aldosterone-Producing Adrenal Cortex Adenoma,0
5857,Annular Lesion,Aldosterone-Producing Adrenal Cortex Adenoma,0
5858,Coronary Vessel Lesion,Breast Pleomorphic Adenoma,0
5859,Index Lesion,Breast Pleomorphic Adenoma,0
5860,Non-Index Lesion,Breast Pleomorphic Adenoma,0
5861,Mushroom-Shaped Lesion,Breast Pleomorphic Adenoma,0
5862,Annular Lesion,Breast Pleomorphic Adenoma,0
5863,Dilated Cystic Spaces Present,Pancreatic Delta Cell Neoplasm,0
5864,Dedifferentiated Malignant Infiltrate,Pancreatic Delta Cell Neoplasm,0
5865,Mammary Gland Type Features Present,Pancreatic Delta Cell Neoplasm,0
5866,Ectopic Tissue,Pancreatic Delta Cell Neoplasm,0
5867,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Delta Cell Neoplasm,0
5868,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Papillary Cystadenoma,0
5869,Isolated Tumor Cells,Ovarian Papillary Cystadenoma,0
5870,Pleural/Elastic Layer Invasion,Ovarian Papillary Cystadenoma,0
5871,Presence of Extravascular Matrix Patterns,Ovarian Papillary Cystadenoma,0
5872,Ductopenia,Ovarian Papillary Cystadenoma,0
5873,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Trichoadenoma,0
5874,Isolated Tumor Cells,Trichoadenoma,0
5875,Pleural/Elastic Layer Invasion,Trichoadenoma,0
5876,Presence of Extravascular Matrix Patterns,Trichoadenoma,0
5877,Ductopenia,Trichoadenoma,0
5878,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Cystadenoma,0
5879,Isolated Tumor Cells,Ovarian Cystadenoma,0
5880,Pleural/Elastic Layer Invasion,Ovarian Cystadenoma,0
5881,Presence of Extravascular Matrix Patterns,Ovarian Cystadenoma,0
5882,Ductopenia,Ovarian Cystadenoma,0
5883,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,0
5884,Isolated Tumor Cells,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,0
5885,Pleural/Elastic Layer Invasion,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,0
5886,Presence of Extravascular Matrix Patterns,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,0
5887,Ductopenia,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,0
5888,Dilated Cystic Spaces Present,Null Cell Pituitary Gland Adenoma,0
5889,Dedifferentiated Malignant Infiltrate,Null Cell Pituitary Gland Adenoma,0
5890,Mammary Gland Type Features Present,Null Cell Pituitary Gland Adenoma,0
5891,Ectopic Tissue,Null Cell Pituitary Gland Adenoma,0
5892,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Null Cell Pituitary Gland Adenoma,0
5893,Dilated Cystic Spaces Present,Pancreatic Acinar Cell Neoplasm,0
5894,Dedifferentiated Malignant Infiltrate,Pancreatic Acinar Cell Neoplasm,0
5895,Mammary Gland Type Features Present,Pancreatic Acinar Cell Neoplasm,0
5896,Ectopic Tissue,Pancreatic Acinar Cell Neoplasm,0
5897,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Acinar Cell Neoplasm,0
5898,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Testicular Brenner Tumor,0
5899,Isolated Tumor Cells,Testicular Brenner Tumor,0
5900,Pleural/Elastic Layer Invasion,Testicular Brenner Tumor,0
5901,Presence of Extravascular Matrix Patterns,Testicular Brenner Tumor,0
5902,Ductopenia,Testicular Brenner Tumor,0
5903,Dilated Cystic Spaces Present,Superior and Inferior Paraaortic Paraganglioma,0
5904,Dedifferentiated Malignant Infiltrate,Superior and Inferior Paraaortic Paraganglioma,0
5905,Mammary Gland Type Features Present,Superior and Inferior Paraaortic Paraganglioma,0
5906,Ectopic Tissue,Superior and Inferior Paraaortic Paraganglioma,0
5907,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Superior and Inferior Paraaortic Paraganglioma,0
5908,Coronary Vessel Lesion,Multiple adenomatous polyps,0
5909,Index Lesion,Multiple adenomatous polyps,0
5910,Non-Index Lesion,Multiple adenomatous polyps,0
5911,Mushroom-Shaped Lesion,Multiple adenomatous polyps,0
5912,Annular Lesion,Multiple adenomatous polyps,0
5913,Dilated Cystic Spaces Present,Recurrent Digestive System Neuroendocrine Tumor G1,0
5914,Dedifferentiated Malignant Infiltrate,Recurrent Digestive System Neuroendocrine Tumor G1,0
5915,Mammary Gland Type Features Present,Recurrent Digestive System Neuroendocrine Tumor G1,0
5916,Ectopic Tissue,Recurrent Digestive System Neuroendocrine Tumor G1,0
5917,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Digestive System Neuroendocrine Tumor G1,0
5918,Dilated Cystic Spaces Present,Ovarian mucinous tumor,0
5919,Dedifferentiated Malignant Infiltrate,Ovarian mucinous tumor,0
5920,Mammary Gland Type Features Present,Ovarian mucinous tumor,0
5921,Ectopic Tissue,Ovarian mucinous tumor,0
5922,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian mucinous tumor,0
5923,Dilated Cystic Spaces Present,Urinary System Paraganglioma,0
5924,Dedifferentiated Malignant Infiltrate,Urinary System Paraganglioma,0
5925,Mammary Gland Type Features Present,Urinary System Paraganglioma,0
5926,Ectopic Tissue,Urinary System Paraganglioma,0
5927,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Urinary System Paraganglioma,0
5928,Dilated Cystic Spaces Present,Parotid monomorphic adenoma,0
5929,Dedifferentiated Malignant Infiltrate,Parotid monomorphic adenoma,0
5930,Mammary Gland Type Features Present,Parotid monomorphic adenoma,0
5931,Ectopic Tissue,Parotid monomorphic adenoma,0
5932,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Parotid monomorphic adenoma,0
5933,Dilated Cystic Spaces Present,Pancreatic intraepithelial neoplasia,0
5934,Dedifferentiated Malignant Infiltrate,Pancreatic intraepithelial neoplasia,0
5935,Mammary Gland Type Features Present,Pancreatic intraepithelial neoplasia,0
5936,Ectopic Tissue,Pancreatic intraepithelial neoplasia,0
5937,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic intraepithelial neoplasia,0
5938,Dilated Cystic Spaces Present,Non-Functioning Pancreatic Neuroendocrine Tumor G2,0
5939,Dedifferentiated Malignant Infiltrate,Non-Functioning Pancreatic Neuroendocrine Tumor G2,0
5940,Mammary Gland Type Features Present,Non-Functioning Pancreatic Neuroendocrine Tumor G2,0
5941,Ectopic Tissue,Non-Functioning Pancreatic Neuroendocrine Tumor G2,0
5942,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non-Functioning Pancreatic Neuroendocrine Tumor G2,0
5943,Dilated Cystic Spaces Present,Malignant Ovarian Clear Cell Tumor,0
5944,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Clear Cell Tumor,0
5945,Mammary Gland Type Features Present,Malignant Ovarian Clear Cell Tumor,0
5946,Ectopic Tissue,Malignant Ovarian Clear Cell Tumor,0
5947,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Clear Cell Tumor,0
5948,Dilated Cystic Spaces Present,Multiple Endocrine Neoplasia,0
5949,Dedifferentiated Malignant Infiltrate,Multiple Endocrine Neoplasia,0
5950,Mammary Gland Type Features Present,Multiple Endocrine Neoplasia,0
5951,Ectopic Tissue,Multiple Endocrine Neoplasia,0
5952,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Multiple Endocrine Neoplasia,0
5953,Dilated Cystic Spaces Present,Endometrioid tumor,0
5954,Dedifferentiated Malignant Infiltrate,Endometrioid tumor,0
5955,Mammary Gland Type Features Present,Endometrioid tumor,0
5956,Ectopic Tissue,Endometrioid tumor,0
5957,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Endometrioid tumor,0
5958,Dilated Cystic Spaces Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,0
5959,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,0
5960,Mammary Gland Type Features Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,0
5961,Ectopic Tissue,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,0
5962,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,0
5963,Dilated Cystic Spaces Present,Low Grade Corneal Intraepithelial Neoplasia,0
5964,Dedifferentiated Malignant Infiltrate,Low Grade Corneal Intraepithelial Neoplasia,0
5965,Mammary Gland Type Features Present,Low Grade Corneal Intraepithelial Neoplasia,0
5966,Ectopic Tissue,Low Grade Corneal Intraepithelial Neoplasia,0
5967,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Corneal Intraepithelial Neoplasia,0
5968,Dilated Cystic Spaces Present,Vulval intraepithelial neoplasia grade 2,0
5969,Dedifferentiated Malignant Infiltrate,Vulval intraepithelial neoplasia grade 2,0
5970,Mammary Gland Type Features Present,Vulval intraepithelial neoplasia grade 2,0
5971,Ectopic Tissue,Vulval intraepithelial neoplasia grade 2,0
5972,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vulval intraepithelial neoplasia grade 2,0
5973,Dilated Cystic Spaces Present,Malignant Ovarian Serous Tumor,0
5974,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Serous Tumor,0
5975,Mammary Gland Type Features Present,Malignant Ovarian Serous Tumor,0
5976,Ectopic Tissue,Malignant Ovarian Serous Tumor,0
5977,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Serous Tumor,0
5978,Dilated Cystic Spaces Present,Serous Neoplasm,0
5979,Dedifferentiated Malignant Infiltrate,Serous Neoplasm,0
5980,Mammary Gland Type Features Present,Serous Neoplasm,0
5981,Ectopic Tissue,Serous Neoplasm,0
5982,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Serous Neoplasm,0
5983,Dilated Cystic Spaces Present,Hidroacanthoma simplex,0
5984,Dedifferentiated Malignant Infiltrate,Hidroacanthoma simplex,0
5985,Mammary Gland Type Features Present,Hidroacanthoma simplex,0
5986,Ectopic Tissue,Hidroacanthoma simplex,0
5987,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hidroacanthoma simplex,0
5988,Coronary Vessel Lesion,Gardner Syndrome,0
5989,Index Lesion,Gardner Syndrome,0
5990,Non-Index Lesion,Gardner Syndrome,0
5991,Mushroom-Shaped Lesion,Gardner Syndrome,0
5992,Annular Lesion,Gardner Syndrome,0
5993,Dilated Cystic Spaces Present,Apudoma,0
5994,Dedifferentiated Malignant Infiltrate,Apudoma,0
5995,Mammary Gland Type Features Present,Apudoma,0
5996,Ectopic Tissue,Apudoma,0
5997,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Apudoma,0
5998,Dilated Cystic Spaces Present,High Grade Esophageal Glandular Intraepithelial Neoplasia,0
5999,Dedifferentiated Malignant Infiltrate,High Grade Esophageal Glandular Intraepithelial Neoplasia,0
6000,Mammary Gland Type Features Present,High Grade Esophageal Glandular Intraepithelial Neoplasia,0
6001,Ectopic Tissue,High Grade Esophageal Glandular Intraepithelial Neoplasia,0
6002,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Esophageal Glandular Intraepithelial Neoplasia,0
6003,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Appendix Mucinous Cystadenoma,0
6004,Isolated Tumor Cells,Appendix Mucinous Cystadenoma,0
6005,Pleural/Elastic Layer Invasion,Appendix Mucinous Cystadenoma,0
6006,Presence of Extravascular Matrix Patterns,Appendix Mucinous Cystadenoma,0
6007,Ductopenia,Appendix Mucinous Cystadenoma,0
6008,Dilated Cystic Spaces Present,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,0
6009,Dedifferentiated Malignant Infiltrate,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,0
6010,Mammary Gland Type Features Present,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,0
6011,Ectopic Tissue,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,0
6012,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7,0
6013,Dilated Cystic Spaces Present,Esophageal Glandular Intraepithelial Neoplasia,0
6014,Dedifferentiated Malignant Infiltrate,Esophageal Glandular Intraepithelial Neoplasia,0
6015,Mammary Gland Type Features Present,Esophageal Glandular Intraepithelial Neoplasia,0
6016,Ectopic Tissue,Esophageal Glandular Intraepithelial Neoplasia,0
6017,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Esophageal Glandular Intraepithelial Neoplasia,0
6018,Dilated Cystic Spaces Present,LH-Producing Gonadotroph Adenoma,0
6019,Dedifferentiated Malignant Infiltrate,LH-Producing Gonadotroph Adenoma,0
6020,Mammary Gland Type Features Present,LH-Producing Gonadotroph Adenoma,0
6021,Ectopic Tissue,LH-Producing Gonadotroph Adenoma,0
6022,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,LH-Producing Gonadotroph Adenoma,0
6023,Dilated Cystic Spaces Present,Ovarian Papillary Tumor,0
6024,Dedifferentiated Malignant Infiltrate,Ovarian Papillary Tumor,0
6025,Mammary Gland Type Features Present,Ovarian Papillary Tumor,0
6026,Ectopic Tissue,Ovarian Papillary Tumor,0
6027,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Papillary Tumor,0
6028,Dilated Cystic Spaces Present,Extrahepatic Bile Duct Neuroendocrine Neoplasm,0
6029,Dedifferentiated Malignant Infiltrate,Extrahepatic Bile Duct Neuroendocrine Neoplasm,0
6030,Mammary Gland Type Features Present,Extrahepatic Bile Duct Neuroendocrine Neoplasm,0
6031,Ectopic Tissue,Extrahepatic Bile Duct Neuroendocrine Neoplasm,0
6032,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Extrahepatic Bile Duct Neuroendocrine Neoplasm,0
6033,Dilated Cystic Spaces Present,Squamous Papilloma of the Nasopharynx,0
6034,Dedifferentiated Malignant Infiltrate,Squamous Papilloma of the Nasopharynx,0
6035,Mammary Gland Type Features Present,Squamous Papilloma of the Nasopharynx,0
6036,Ectopic Tissue,Squamous Papilloma of the Nasopharynx,0
6037,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Squamous Papilloma of the Nasopharynx,0
6038,Dilated Cystic Spaces Present,Extrahepatic Bile Duct Carcinoid Tumor,0
6039,Dedifferentiated Malignant Infiltrate,Extrahepatic Bile Duct Carcinoid Tumor,0
6040,Mammary Gland Type Features Present,Extrahepatic Bile Duct Carcinoid Tumor,0
6041,Ectopic Tissue,Extrahepatic Bile Duct Carcinoid Tumor,0
6042,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Extrahepatic Bile Duct Carcinoid Tumor,0
6043,Dilated Cystic Spaces Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6044,Dedifferentiated Malignant Infiltrate,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6045,Mammary Gland Type Features Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6046,Ectopic Tissue,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6047,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6048,Dilated Cystic Spaces Present,Adult Craniopharyngioma,0
6049,Dedifferentiated Malignant Infiltrate,Adult Craniopharyngioma,0
6050,Mammary Gland Type Features Present,Adult Craniopharyngioma,0
6051,Ectopic Tissue,Adult Craniopharyngioma,0
6052,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adult Craniopharyngioma,0
6053,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Vulvar Inverted Follicular Keratosis,0
6054,Isolated Tumor Cells,Vulvar Inverted Follicular Keratosis,0
6055,Pleural/Elastic Layer Invasion,Vulvar Inverted Follicular Keratosis,0
6056,Presence of Extravascular Matrix Patterns,Vulvar Inverted Follicular Keratosis,0
6057,Ductopenia,Vulvar Inverted Follicular Keratosis,0
6058,Dilated Cystic Spaces Present,Endometrial intraepithelial neoplasia,0
6059,Dedifferentiated Malignant Infiltrate,Endometrial intraepithelial neoplasia,0
6060,Mammary Gland Type Features Present,Endometrial intraepithelial neoplasia,0
6061,Ectopic Tissue,Endometrial intraepithelial neoplasia,0
6062,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Endometrial intraepithelial neoplasia,0
6063,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Clear Cell Cystadenofibroma,0
6064,Isolated Tumor Cells,Ovarian Clear Cell Cystadenofibroma,0
6065,Pleural/Elastic Layer Invasion,Ovarian Clear Cell Cystadenofibroma,0
6066,Presence of Extravascular Matrix Patterns,Ovarian Clear Cell Cystadenofibroma,0
6067,Ductopenia,Ovarian Clear Cell Cystadenofibroma,0
6068,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Macrocystic Serous Cystadenoma,0
6069,Isolated Tumor Cells,Pancreatic Macrocystic Serous Cystadenoma,0
6070,Pleural/Elastic Layer Invasion,Pancreatic Macrocystic Serous Cystadenoma,0
6071,Presence of Extravascular Matrix Patterns,Pancreatic Macrocystic Serous Cystadenoma,0
6072,Ductopenia,Pancreatic Macrocystic Serous Cystadenoma,0
6073,Dilated Cystic Spaces Present,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",0
6074,Dedifferentiated Malignant Infiltrate,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",0
6075,Mammary Gland Type Features Present,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",0
6076,Ectopic Tissue,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",0
6077,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",0
6078,Dilated Cystic Spaces Present,Pancreatic Serous Neoplasm,0
6079,Dedifferentiated Malignant Infiltrate,Pancreatic Serous Neoplasm,0
6080,Mammary Gland Type Features Present,Pancreatic Serous Neoplasm,0
6081,Ectopic Tissue,Pancreatic Serous Neoplasm,0
6082,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Serous Neoplasm,0
6083,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Intraductal Papillary-Mucinous Adenoma,0
6084,Isolated Tumor Cells,Pancreatic Intraductal Papillary-Mucinous Adenoma,0
6085,Pleural/Elastic Layer Invasion,Pancreatic Intraductal Papillary-Mucinous Adenoma,0
6086,Presence of Extravascular Matrix Patterns,Pancreatic Intraductal Papillary-Mucinous Adenoma,0
6087,Ductopenia,Pancreatic Intraductal Papillary-Mucinous Adenoma,0
6088,Dilated Cystic Spaces Present,Cerebellar Paraganglioma,0
6089,Dedifferentiated Malignant Infiltrate,Cerebellar Paraganglioma,0
6090,Mammary Gland Type Features Present,Cerebellar Paraganglioma,0
6091,Ectopic Tissue,Cerebellar Paraganglioma,0
6092,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cerebellar Paraganglioma,0
6093,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Brenner Tumor,0
6094,Isolated Tumor Cells,Brenner Tumor,0
6095,Pleural/Elastic Layer Invasion,Brenner Tumor,0
6096,Presence of Extravascular Matrix Patterns,Brenner Tumor,0
6097,Ductopenia,Brenner Tumor,0
6098,Dilated Cystic Spaces Present,"Transitional cell papilloma, inverted",0
6099,Dedifferentiated Malignant Infiltrate,"Transitional cell papilloma, inverted",0
6100,Mammary Gland Type Features Present,"Transitional cell papilloma, inverted",0
6101,Ectopic Tissue,"Transitional cell papilloma, inverted",0
6102,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Transitional cell papilloma, inverted",0
6103,Dilated Cystic Spaces Present,Benign Carotid Body Paraganglioma,0
6104,Dedifferentiated Malignant Infiltrate,Benign Carotid Body Paraganglioma,0
6105,Mammary Gland Type Features Present,Benign Carotid Body Paraganglioma,0
6106,Ectopic Tissue,Benign Carotid Body Paraganglioma,0
6107,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Carotid Body Paraganglioma,0
6108,Dilated Cystic Spaces Present,Moderate pancreatic duct dysplasia,0
6109,Dedifferentiated Malignant Infiltrate,Moderate pancreatic duct dysplasia,0
6110,Mammary Gland Type Features Present,Moderate pancreatic duct dysplasia,0
6111,Ectopic Tissue,Moderate pancreatic duct dysplasia,0
6112,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Moderate pancreatic duct dysplasia,0
6113,Dilated Cystic Spaces Present,Acinar cell tumor,0
6114,Dedifferentiated Malignant Infiltrate,Acinar cell tumor,0
6115,Mammary Gland Type Features Present,Acinar cell tumor,0
6116,Ectopic Tissue,Acinar cell tumor,0
6117,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Acinar cell tumor,0
6118,Dilated Cystic Spaces Present,Penile intraepithelial neoplasia,0
6119,Dedifferentiated Malignant Infiltrate,Penile intraepithelial neoplasia,0
6120,Mammary Gland Type Features Present,Penile intraepithelial neoplasia,0
6121,Ectopic Tissue,Penile intraepithelial neoplasia,0
6122,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Penile intraepithelial neoplasia,0
6123,Dilated Cystic Spaces Present,Borderline Ovarian Transitional Cell Tumor,0
6124,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Transitional Cell Tumor,0
6125,Mammary Gland Type Features Present,Borderline Ovarian Transitional Cell Tumor,0
6126,Ectopic Tissue,Borderline Ovarian Transitional Cell Tumor,0
6127,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Transitional Cell Tumor,0
6128,Dilated Cystic Spaces Present,Prostatic Intraepithelial Neoplasias,0
6129,Dedifferentiated Malignant Infiltrate,Prostatic Intraepithelial Neoplasias,0
6130,Mammary Gland Type Features Present,Prostatic Intraepithelial Neoplasias,0
6131,Ectopic Tissue,Prostatic Intraepithelial Neoplasias,0
6132,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Prostatic Intraepithelial Neoplasias,0
6133,Dilated Cystic Spaces Present,Appendix Intraepithelial Neoplasia,0
6134,Dedifferentiated Malignant Infiltrate,Appendix Intraepithelial Neoplasia,0
6135,Mammary Gland Type Features Present,Appendix Intraepithelial Neoplasia,0
6136,Ectopic Tissue,Appendix Intraepithelial Neoplasia,0
6137,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix Intraepithelial Neoplasia,0
6138,Coronary Vessel Lesion,Rectal Tubular Adenoma,0
6139,Index Lesion,Rectal Tubular Adenoma,0
6140,Non-Index Lesion,Rectal Tubular Adenoma,0
6141,Mushroom-Shaped Lesion,Rectal Tubular Adenoma,0
6142,Annular Lesion,Rectal Tubular Adenoma,0
6143,Dilated Cystic Spaces Present,Ectopic Cervical Thymoma,0
6144,Dedifferentiated Malignant Infiltrate,Ectopic Cervical Thymoma,0
6145,Mammary Gland Type Features Present,Ectopic Cervical Thymoma,0
6146,Ectopic Tissue,Ectopic Cervical Thymoma,0
6147,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ectopic Cervical Thymoma,0
6148,Dilated Cystic Spaces Present,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,0
6149,Dedifferentiated Malignant Infiltrate,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,0
6150,Mammary Gland Type Features Present,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,0
6151,Ectopic Tissue,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,0
6152,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,0
6153,Dilated Cystic Spaces Present,Thymoma malignant noninvasive,0
6154,Dedifferentiated Malignant Infiltrate,Thymoma malignant noninvasive,0
6155,Mammary Gland Type Features Present,Thymoma malignant noninvasive,0
6156,Ectopic Tissue,Thymoma malignant noninvasive,0
6157,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymoma malignant noninvasive,0
6158,Dilated Cystic Spaces Present,Squamous intraepithelial neoplasia grade 2,0
6159,Dedifferentiated Malignant Infiltrate,Squamous intraepithelial neoplasia grade 2,0
6160,Mammary Gland Type Features Present,Squamous intraepithelial neoplasia grade 2,0
6161,Ectopic Tissue,Squamous intraepithelial neoplasia grade 2,0
6162,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Squamous intraepithelial neoplasia grade 2,0
6163,Dilated Cystic Spaces Present,Cervical Squamous Papilloma,0
6164,Dedifferentiated Malignant Infiltrate,Cervical Squamous Papilloma,0
6165,Mammary Gland Type Features Present,Cervical Squamous Papilloma,0
6166,Ectopic Tissue,Cervical Squamous Papilloma,0
6167,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Squamous Papilloma,0
6168,Dilated Cystic Spaces Present,Small Intestinal Neuroendocrine Tumor G2,0
6169,Dedifferentiated Malignant Infiltrate,Small Intestinal Neuroendocrine Tumor G2,0
6170,Mammary Gland Type Features Present,Small Intestinal Neuroendocrine Tumor G2,0
6171,Ectopic Tissue,Small Intestinal Neuroendocrine Tumor G2,0
6172,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Neuroendocrine Tumor G2,0
6173,Dilated Cystic Spaces Present,Functioning Pancreatic Neuroendocrine Tumor,0
6174,Dedifferentiated Malignant Infiltrate,Functioning Pancreatic Neuroendocrine Tumor,0
6175,Mammary Gland Type Features Present,Functioning Pancreatic Neuroendocrine Tumor,0
6176,Ectopic Tissue,Functioning Pancreatic Neuroendocrine Tumor,0
6177,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Functioning Pancreatic Neuroendocrine Tumor,0
6178,Dilated Cystic Spaces Present,Bile Duct Biliary Intraepithelial Neoplasia,0
6179,Dedifferentiated Malignant Infiltrate,Bile Duct Biliary Intraepithelial Neoplasia,0
6180,Mammary Gland Type Features Present,Bile Duct Biliary Intraepithelial Neoplasia,0
6181,Ectopic Tissue,Bile Duct Biliary Intraepithelial Neoplasia,0
6182,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bile Duct Biliary Intraepithelial Neoplasia,0
6183,Dilated Cystic Spaces Present,Dysplasia of anus,0
6184,Dedifferentiated Malignant Infiltrate,Dysplasia of anus,0
6185,Mammary Gland Type Features Present,Dysplasia of anus,0
6186,Ectopic Tissue,Dysplasia of anus,0
6187,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Dysplasia of anus,0
6188,Dilated Cystic Spaces Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6189,Dedifferentiated Malignant Infiltrate,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6190,Mammary Gland Type Features Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6191,Ectopic Tissue,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6192,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,0
6193,Dilated Cystic Spaces Present,Gastric Gastrin-Producing Neuroendocrine Tumor,0
6194,Dedifferentiated Malignant Infiltrate,Gastric Gastrin-Producing Neuroendocrine Tumor,0
6195,Mammary Gland Type Features Present,Gastric Gastrin-Producing Neuroendocrine Tumor,0
6196,Ectopic Tissue,Gastric Gastrin-Producing Neuroendocrine Tumor,0
6197,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastric Gastrin-Producing Neuroendocrine Tumor,0
6198,Dilated Cystic Spaces Present,benign endometrioid tumor of ovary,0
6199,Dedifferentiated Malignant Infiltrate,benign endometrioid tumor of ovary,0
6200,Mammary Gland Type Features Present,benign endometrioid tumor of ovary,0
6201,Ectopic Tissue,benign endometrioid tumor of ovary,0
6202,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,benign endometrioid tumor of ovary,0
6203,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,0
6204,Isolated Tumor Cells,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,0
6205,Pleural/Elastic Layer Invasion,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,0
6206,Presence of Extravascular Matrix Patterns,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,0
6207,Ductopenia,intraductal papillary-mucinous neoplasm of pancreas with moderate dysplasia,0
6208,Coronary Vessel Lesion,Villous adenoma of duodenum,0
6209,Index Lesion,Villous adenoma of duodenum,0
6210,Non-Index Lesion,Villous adenoma of duodenum,0
6211,Mushroom-Shaped Lesion,Villous adenoma of duodenum,0
6212,Annular Lesion,Villous adenoma of duodenum,0
6213,Dilated Cystic Spaces Present,Benign neoplasm of sweat gland,0
6214,Dedifferentiated Malignant Infiltrate,Benign neoplasm of sweat gland,0
6215,Mammary Gland Type Features Present,Benign neoplasm of sweat gland,0
6216,Ectopic Tissue,Benign neoplasm of sweat gland,0
6217,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign neoplasm of sweat gland,0
6218,Dilated Cystic Spaces Present,Low Grade Esophageal Squamous Intraepithelial Neoplasia,0
6219,Dedifferentiated Malignant Infiltrate,Low Grade Esophageal Squamous Intraepithelial Neoplasia,0
6220,Mammary Gland Type Features Present,Low Grade Esophageal Squamous Intraepithelial Neoplasia,0
6221,Ectopic Tissue,Low Grade Esophageal Squamous Intraepithelial Neoplasia,0
6222,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Esophageal Squamous Intraepithelial Neoplasia,0
6223,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Cystadenoma, Mucinous",0
6224,Isolated Tumor Cells,"Cystadenoma, Mucinous",0
6225,Pleural/Elastic Layer Invasion,"Cystadenoma, Mucinous",0
6226,Presence of Extravascular Matrix Patterns,"Cystadenoma, Mucinous",0
6227,Ductopenia,"Cystadenoma, Mucinous",0
6228,Coronary Vessel Lesion,Sessile Serrated Adenoma/Polyp,0
6229,Index Lesion,Sessile Serrated Adenoma/Polyp,0
6230,Non-Index Lesion,Sessile Serrated Adenoma/Polyp,0
6231,Mushroom-Shaped Lesion,Sessile Serrated Adenoma/Polyp,0
6232,Annular Lesion,Sessile Serrated Adenoma/Polyp,0
6233,Dilated Cystic Spaces Present,Pancreatic Serous Adenoma,0
6234,Dedifferentiated Malignant Infiltrate,Pancreatic Serous Adenoma,0
6235,Mammary Gland Type Features Present,Pancreatic Serous Adenoma,0
6236,Ectopic Tissue,Pancreatic Serous Adenoma,0
6237,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Serous Adenoma,0
6238,Coronary Vessel Lesion,Sebaceoma,0
6239,Index Lesion,Sebaceoma,0
6240,Non-Index Lesion,Sebaceoma,0
6241,Mushroom-Shaped Lesion,Sebaceoma,0
6242,Annular Lesion,Sebaceoma,0
6243,Coronary Vessel Lesion,Beta-Catenin-Activated Hepatocellular Adenoma,0
6244,Index Lesion,Beta-Catenin-Activated Hepatocellular Adenoma,0
6245,Non-Index Lesion,Beta-Catenin-Activated Hepatocellular Adenoma,0
6246,Mushroom-Shaped Lesion,Beta-Catenin-Activated Hepatocellular Adenoma,0
6247,Annular Lesion,Beta-Catenin-Activated Hepatocellular Adenoma,0
6248,Dilated Cystic Spaces Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,0
6249,Dedifferentiated Malignant Infiltrate,Thyroid Gland Signet Ring Cell Follicular Adenoma,0
6250,Mammary Gland Type Features Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,0
6251,Ectopic Tissue,Thyroid Gland Signet Ring Cell Follicular Adenoma,0
6252,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Signet Ring Cell Follicular Adenoma,0
6253,Coronary Vessel Lesion,Small Intestinal Tubulovillous Adenoma,0
6254,Index Lesion,Small Intestinal Tubulovillous Adenoma,0
6255,Non-Index Lesion,Small Intestinal Tubulovillous Adenoma,0
6256,Mushroom-Shaped Lesion,Small Intestinal Tubulovillous Adenoma,0
6257,Annular Lesion,Small Intestinal Tubulovillous Adenoma,0
6258,Dilated Cystic Spaces Present,"Ampullary Flat Intraepithelial Neoplasia, High Grade",0
6259,Dedifferentiated Malignant Infiltrate,"Ampullary Flat Intraepithelial Neoplasia, High Grade",0
6260,Mammary Gland Type Features Present,"Ampullary Flat Intraepithelial Neoplasia, High Grade",0
6261,Ectopic Tissue,"Ampullary Flat Intraepithelial Neoplasia, High Grade",0
6262,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Ampullary Flat Intraepithelial Neoplasia, High Grade",0
6263,Dilated Cystic Spaces Present,"Thymoma, type B1",0
6264,Dedifferentiated Malignant Infiltrate,"Thymoma, type B1",0
6265,Mammary Gland Type Features Present,"Thymoma, type B1",0
6266,Ectopic Tissue,"Thymoma, type B1",0
6267,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thymoma, type B1",0
6268,Dilated Cystic Spaces Present,Cervical Intraepithelial Neoplasia Grade 2/3,0
6269,Dedifferentiated Malignant Infiltrate,Cervical Intraepithelial Neoplasia Grade 2/3,0
6270,Mammary Gland Type Features Present,Cervical Intraepithelial Neoplasia Grade 2/3,0
6271,Ectopic Tissue,Cervical Intraepithelial Neoplasia Grade 2/3,0
6272,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Intraepithelial Neoplasia Grade 2/3,0
6273,Dilated Cystic Spaces Present,Multiple Endocrine Neoplasia Type 2a,0
6274,Dedifferentiated Malignant Infiltrate,Multiple Endocrine Neoplasia Type 2a,0
6275,Mammary Gland Type Features Present,Multiple Endocrine Neoplasia Type 2a,0
6276,Ectopic Tissue,Multiple Endocrine Neoplasia Type 2a,0
6277,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Multiple Endocrine Neoplasia Type 2a,0
6278,Dilated Cystic Spaces Present,Intraductal Breast Papillomatosis,0
6279,Dedifferentiated Malignant Infiltrate,Intraductal Breast Papillomatosis,0
6280,Mammary Gland Type Features Present,Intraductal Breast Papillomatosis,0
6281,Ectopic Tissue,Intraductal Breast Papillomatosis,0
6282,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intraductal Breast Papillomatosis,0
6283,Dilated Cystic Spaces Present,Stage I Appendix Neuroendocrine Tumor AJCC v7,0
6284,Dedifferentiated Malignant Infiltrate,Stage I Appendix Neuroendocrine Tumor AJCC v7,0
6285,Mammary Gland Type Features Present,Stage I Appendix Neuroendocrine Tumor AJCC v7,0
6286,Ectopic Tissue,Stage I Appendix Neuroendocrine Tumor AJCC v7,0
6287,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Appendix Neuroendocrine Tumor AJCC v7,0
6288,Dilated Cystic Spaces Present,Fallopian Tube Endometrioid Tumor,0
6289,Dedifferentiated Malignant Infiltrate,Fallopian Tube Endometrioid Tumor,0
6290,Mammary Gland Type Features Present,Fallopian Tube Endometrioid Tumor,0
6291,Ectopic Tissue,Fallopian Tube Endometrioid Tumor,0
6292,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Fallopian Tube Endometrioid Tumor,0
6293,Coronary Vessel Lesion,estrogen-producing adrenal cortical adenoma,0
6294,Index Lesion,estrogen-producing adrenal cortical adenoma,0
6295,Non-Index Lesion,estrogen-producing adrenal cortical adenoma,0
6296,Mushroom-Shaped Lesion,estrogen-producing adrenal cortical adenoma,0
6297,Annular Lesion,estrogen-producing adrenal cortical adenoma,0
6298,Dilated Cystic Spaces Present,Lipoadenoma,0
6299,Dedifferentiated Malignant Infiltrate,Lipoadenoma,0
6300,Mammary Gland Type Features Present,Lipoadenoma,0
6301,Ectopic Tissue,Lipoadenoma,0
6302,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Lipoadenoma,0
6303,Dilated Cystic Spaces Present,Malignant Germinative Follicular Epithelium Neoplasm,0
6304,Dedifferentiated Malignant Infiltrate,Malignant Germinative Follicular Epithelium Neoplasm,0
6305,Mammary Gland Type Features Present,Malignant Germinative Follicular Epithelium Neoplasm,0
6306,Ectopic Tissue,Malignant Germinative Follicular Epithelium Neoplasm,0
6307,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Germinative Follicular Epithelium Neoplasm,0
6308,Dilated Cystic Spaces Present,Sclerosing Breast Papilloma,0
6309,Dedifferentiated Malignant Infiltrate,Sclerosing Breast Papilloma,0
6310,Mammary Gland Type Features Present,Sclerosing Breast Papilloma,0
6311,Ectopic Tissue,Sclerosing Breast Papilloma,0
6312,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sclerosing Breast Papilloma,0
6313,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Anal Papillary Hidradenoma,0
6314,Isolated Tumor Cells,Anal Papillary Hidradenoma,0
6315,Pleural/Elastic Layer Invasion,Anal Papillary Hidradenoma,0
6316,Presence of Extravascular Matrix Patterns,Anal Papillary Hidradenoma,0
6317,Ductopenia,Anal Papillary Hidradenoma,0
6318,Dilated Cystic Spaces Present,Vulvar Syringoma,0
6319,Dedifferentiated Malignant Infiltrate,Vulvar Syringoma,0
6320,Mammary Gland Type Features Present,Vulvar Syringoma,0
6321,Ectopic Tissue,Vulvar Syringoma,0
6322,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vulvar Syringoma,0
6323,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,cystic mucinous tumor of pancreas with moderate dysplasia,0
6324,Isolated Tumor Cells,cystic mucinous tumor of pancreas with moderate dysplasia,0
6325,Pleural/Elastic Layer Invasion,cystic mucinous tumor of pancreas with moderate dysplasia,0
6326,Presence of Extravascular Matrix Patterns,cystic mucinous tumor of pancreas with moderate dysplasia,0
6327,Ductopenia,cystic mucinous tumor of pancreas with moderate dysplasia,0
6328,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Intraductal Tubulopapillary Neoplasm,0
6329,Isolated Tumor Cells,Pancreatic Intraductal Tubulopapillary Neoplasm,0
6330,Pleural/Elastic Layer Invasion,Pancreatic Intraductal Tubulopapillary Neoplasm,0
6331,Presence of Extravascular Matrix Patterns,Pancreatic Intraductal Tubulopapillary Neoplasm,0
6332,Ductopenia,Pancreatic Intraductal Tubulopapillary Neoplasm,0
6333,Dilated Cystic Spaces Present,Desmoplastic trichoepithelioma,0
6334,Dedifferentiated Malignant Infiltrate,Desmoplastic trichoepithelioma,0
6335,Mammary Gland Type Features Present,Desmoplastic trichoepithelioma,0
6336,Ectopic Tissue,Desmoplastic trichoepithelioma,0
6337,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Desmoplastic trichoepithelioma,0
6338,Dilated Cystic Spaces Present,Lung Glandular Papilloma,0
6339,Dedifferentiated Malignant Infiltrate,Lung Glandular Papilloma,0
6340,Mammary Gland Type Features Present,Lung Glandular Papilloma,0
6341,Ectopic Tissue,Lung Glandular Papilloma,0
6342,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Lung Glandular Papilloma,0
6343,Dilated Cystic Spaces Present,"Papilloma, Squamous Cell",0
6344,Dedifferentiated Malignant Infiltrate,"Papilloma, Squamous Cell",0
6345,Mammary Gland Type Features Present,"Papilloma, Squamous Cell",0
6346,Ectopic Tissue,"Papilloma, Squamous Cell",0
6347,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Papilloma, Squamous Cell",0
6348,Coronary Vessel Lesion,Appendix Tubulovillous Adenoma,0
6349,Index Lesion,Appendix Tubulovillous Adenoma,0
6350,Non-Index Lesion,Appendix Tubulovillous Adenoma,0
6351,Mushroom-Shaped Lesion,Appendix Tubulovillous Adenoma,0
6352,Annular Lesion,Appendix Tubulovillous Adenoma,0
6353,Dilated Cystic Spaces Present,"Thymoma, type AB, malignant",0
6354,Dedifferentiated Malignant Infiltrate,"Thymoma, type AB, malignant",0
6355,Mammary Gland Type Features Present,"Thymoma, type AB, malignant",0
6356,Ectopic Tissue,"Thymoma, type AB, malignant",0
6357,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thymoma, type AB, malignant",0
6358,Dilated Cystic Spaces Present,Pericanalicular fibroadenoma,0
6359,Dedifferentiated Malignant Infiltrate,Pericanalicular fibroadenoma,0
6360,Mammary Gland Type Features Present,Pericanalicular fibroadenoma,0
6361,Ectopic Tissue,Pericanalicular fibroadenoma,0
6362,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pericanalicular fibroadenoma,0
6363,Dilated Cystic Spaces Present,"Adenoma, Microcystic",0
6364,Dedifferentiated Malignant Infiltrate,"Adenoma, Microcystic",0
6365,Mammary Gland Type Features Present,"Adenoma, Microcystic",0
6366,Ectopic Tissue,"Adenoma, Microcystic",0
6367,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Adenoma, Microcystic",0
6368,Dilated Cystic Spaces Present,"Pheochromocytoma, malignant",0
6369,Dedifferentiated Malignant Infiltrate,"Pheochromocytoma, malignant",0
6370,Mammary Gland Type Features Present,"Pheochromocytoma, malignant",0
6371,Ectopic Tissue,"Pheochromocytoma, malignant",0
6372,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Pheochromocytoma, malignant",0
6373,Dilated Cystic Spaces Present,Condyloma anal,0
6374,Dedifferentiated Malignant Infiltrate,Condyloma anal,0
6375,Mammary Gland Type Features Present,Condyloma anal,0
6376,Ectopic Tissue,Condyloma anal,0
6377,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Condyloma anal,0
6378,Dilated Cystic Spaces Present,Small Intestinal Neuroendocrine Neoplasm,0
6379,Dedifferentiated Malignant Infiltrate,Small Intestinal Neuroendocrine Neoplasm,0
6380,Mammary Gland Type Features Present,Small Intestinal Neuroendocrine Neoplasm,0
6381,Ectopic Tissue,Small Intestinal Neuroendocrine Neoplasm,0
6382,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Neuroendocrine Neoplasm,0
6383,Dilated Cystic Spaces Present,Squamous papillomatosis,0
6384,Dedifferentiated Malignant Infiltrate,Squamous papillomatosis,0
6385,Mammary Gland Type Features Present,Squamous papillomatosis,0
6386,Ectopic Tissue,Squamous papillomatosis,0
6387,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Squamous papillomatosis,0
6388,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Broad Ligament Serous Cystadenoma,0
6389,Isolated Tumor Cells,Broad Ligament Serous Cystadenoma,0
6390,Pleural/Elastic Layer Invasion,Broad Ligament Serous Cystadenoma,0
6391,Presence of Extravascular Matrix Patterns,Broad Ligament Serous Cystadenoma,0
6392,Ductopenia,Broad Ligament Serous Cystadenoma,0
6393,Dilated Cystic Spaces Present,Ovarian Squamous Cell Tumor,0
6394,Dedifferentiated Malignant Infiltrate,Ovarian Squamous Cell Tumor,0
6395,Mammary Gland Type Features Present,Ovarian Squamous Cell Tumor,0
6396,Ectopic Tissue,Ovarian Squamous Cell Tumor,0
6397,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Squamous Cell Tumor,0
6398,Dilated Cystic Spaces Present,Gallbladder Neuroendocrine Tumor G1,0
6399,Dedifferentiated Malignant Infiltrate,Gallbladder Neuroendocrine Tumor G1,0
6400,Mammary Gland Type Features Present,Gallbladder Neuroendocrine Tumor G1,0
6401,Ectopic Tissue,Gallbladder Neuroendocrine Tumor G1,0
6402,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gallbladder Neuroendocrine Tumor G1,0
6403,Dilated Cystic Spaces Present,"Gastrinoma, malignant",0
6404,Dedifferentiated Malignant Infiltrate,"Gastrinoma, malignant",0
6405,Mammary Gland Type Features Present,"Gastrinoma, malignant",0
6406,Ectopic Tissue,"Gastrinoma, malignant",0
6407,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Gastrinoma, malignant",0
6408,Dilated Cystic Spaces Present,Benign oncocytoma of salivary gland,0
6409,Dedifferentiated Malignant Infiltrate,Benign oncocytoma of salivary gland,0
6410,Mammary Gland Type Features Present,Benign oncocytoma of salivary gland,0
6411,Ectopic Tissue,Benign oncocytoma of salivary gland,0
6412,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign oncocytoma of salivary gland,0
6413,Dilated Cystic Spaces Present,Localized Digestive System Neuroendocrine Tumor G1,0
6414,Dedifferentiated Malignant Infiltrate,Localized Digestive System Neuroendocrine Tumor G1,0
6415,Mammary Gland Type Features Present,Localized Digestive System Neuroendocrine Tumor G1,0
6416,Ectopic Tissue,Localized Digestive System Neuroendocrine Tumor G1,0
6417,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Localized Digestive System Neuroendocrine Tumor G1,0
6418,Dilated Cystic Spaces Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor,0
6419,Dedifferentiated Malignant Infiltrate,Jejunal Somatostatin-Producing Neuroendocrine Tumor,0
6420,Mammary Gland Type Features Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor,0
6421,Ectopic Tissue,Jejunal Somatostatin-Producing Neuroendocrine Tumor,0
6422,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Jejunal Somatostatin-Producing Neuroendocrine Tumor,0
6423,Dilated Cystic Spaces Present,Tumor of follicular infundibulum,0
6424,Dedifferentiated Malignant Infiltrate,Tumor of follicular infundibulum,0
6425,Mammary Gland Type Features Present,Tumor of follicular infundibulum,0
6426,Ectopic Tissue,Tumor of follicular infundibulum,0
6427,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Tumor of follicular infundibulum,0
6428,Dilated Cystic Spaces Present,"Adenoma, Trabecular",0
6429,Dedifferentiated Malignant Infiltrate,"Adenoma, Trabecular",0
6430,Mammary Gland Type Features Present,"Adenoma, Trabecular",0
6431,Ectopic Tissue,"Adenoma, Trabecular",0
6432,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Adenoma, Trabecular",0
6433,Coronary Vessel Lesion,Colon Adenoma with Severe Dysplasia,0
6434,Index Lesion,Colon Adenoma with Severe Dysplasia,0
6435,Non-Index Lesion,Colon Adenoma with Severe Dysplasia,0
6436,Mushroom-Shaped Lesion,Colon Adenoma with Severe Dysplasia,0
6437,Annular Lesion,Colon Adenoma with Severe Dysplasia,0
6438,Dilated Cystic Spaces Present,Papillary Urothelial Neoplasm,0
6439,Dedifferentiated Malignant Infiltrate,Papillary Urothelial Neoplasm,0
6440,Mammary Gland Type Features Present,Papillary Urothelial Neoplasm,0
6441,Ectopic Tissue,Papillary Urothelial Neoplasm,0
6442,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papillary Urothelial Neoplasm,0
6443,Dilated Cystic Spaces Present,Recurrent Adrenal Gland Pheochromocytoma,0
6444,Dedifferentiated Malignant Infiltrate,Recurrent Adrenal Gland Pheochromocytoma,0
6445,Mammary Gland Type Features Present,Recurrent Adrenal Gland Pheochromocytoma,0
6446,Ectopic Tissue,Recurrent Adrenal Gland Pheochromocytoma,0
6447,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Adrenal Gland Pheochromocytoma,0
6448,Dilated Cystic Spaces Present,Buschke-Lowenstein Tumor,0
6449,Dedifferentiated Malignant Infiltrate,Buschke-Lowenstein Tumor,0
6450,Mammary Gland Type Features Present,Buschke-Lowenstein Tumor,0
6451,Ectopic Tissue,Buschke-Lowenstein Tumor,0
6452,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Buschke-Lowenstein Tumor,0
6453,Dilated Cystic Spaces Present,Benign epithelial neoplasm of skin,0
6454,Dedifferentiated Malignant Infiltrate,Benign epithelial neoplasm of skin,0
6455,Mammary Gland Type Features Present,Benign epithelial neoplasm of skin,0
6456,Ectopic Tissue,Benign epithelial neoplasm of skin,0
6457,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign epithelial neoplasm of skin,0
6458,Dilated Cystic Spaces Present,Microscopic Thymoma,0
6459,Dedifferentiated Malignant Infiltrate,Microscopic Thymoma,0
6460,Mammary Gland Type Features Present,Microscopic Thymoma,0
6461,Ectopic Tissue,Microscopic Thymoma,0
6462,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Microscopic Thymoma,0
6463,Dilated Cystic Spaces Present,Pancreatic Intraepithelial Neoplasia-1A,0
6464,Dedifferentiated Malignant Infiltrate,Pancreatic Intraepithelial Neoplasia-1A,0
6465,Mammary Gland Type Features Present,Pancreatic Intraepithelial Neoplasia-1A,0
6466,Ectopic Tissue,Pancreatic Intraepithelial Neoplasia-1A,0
6467,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Intraepithelial Neoplasia-1A,0
6468,Dilated Cystic Spaces Present,Benign tumor of choroid plexus,0
6469,Dedifferentiated Malignant Infiltrate,Benign tumor of choroid plexus,0
6470,Mammary Gland Type Features Present,Benign tumor of choroid plexus,0
6471,Ectopic Tissue,Benign tumor of choroid plexus,0
6472,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign tumor of choroid plexus,0
6473,Dilated Cystic Spaces Present,Appendix Neuroendocrine Tumor G2,0
6474,Dedifferentiated Malignant Infiltrate,Appendix Neuroendocrine Tumor G2,0
6475,Mammary Gland Type Features Present,Appendix Neuroendocrine Tumor G2,0
6476,Ectopic Tissue,Appendix Neuroendocrine Tumor G2,0
6477,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix Neuroendocrine Tumor G2,0
6478,Dilated Cystic Spaces Present,Juvenile papillomatosis of breast,0
6479,Dedifferentiated Malignant Infiltrate,Juvenile papillomatosis of breast,0
6480,Mammary Gland Type Features Present,Juvenile papillomatosis of breast,0
6481,Ectopic Tissue,Juvenile papillomatosis of breast,0
6482,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Juvenile papillomatosis of breast,0
6483,Dilated Cystic Spaces Present,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
6484,Dedifferentiated Malignant Infiltrate,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
6485,Mammary Gland Type Features Present,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
6486,Ectopic Tissue,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
6487,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
6488,Coronary Vessel Lesion,Adamantinoma,0
6489,Index Lesion,Adamantinoma,0
6490,Non-Index Lesion,Adamantinoma,0
6491,Mushroom-Shaped Lesion,Adamantinoma,0
6492,Annular Lesion,Adamantinoma,0
6493,Dilated Cystic Spaces Present,Borderline Ovarian Endometrioid Adenofibroma,0
6494,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Endometrioid Adenofibroma,0
6495,Mammary Gland Type Features Present,Borderline Ovarian Endometrioid Adenofibroma,0
6496,Ectopic Tissue,Borderline Ovarian Endometrioid Adenofibroma,0
6497,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Endometrioid Adenofibroma,0
6498,Dilated Cystic Spaces Present,Benign epithelial tumor of ovary,0
6499,Dedifferentiated Malignant Infiltrate,Benign epithelial tumor of ovary,0
6500,Mammary Gland Type Features Present,Benign epithelial tumor of ovary,0
6501,Ectopic Tissue,Benign epithelial tumor of ovary,0
6502,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign epithelial tumor of ovary,0
6503,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Clear Cell Papillary Cystadenoma,0
6504,Isolated Tumor Cells,Clear Cell Papillary Cystadenoma,0
6505,Pleural/Elastic Layer Invasion,Clear Cell Papillary Cystadenoma,0
6506,Presence of Extravascular Matrix Patterns,Clear Cell Papillary Cystadenoma,0
6507,Ductopenia,Clear Cell Papillary Cystadenoma,0
6508,Dilated Cystic Spaces Present,Germinative Follicular Epithelium Neoplasm,0
6509,Dedifferentiated Malignant Infiltrate,Germinative Follicular Epithelium Neoplasm,0
6510,Mammary Gland Type Features Present,Germinative Follicular Epithelium Neoplasm,0
6511,Ectopic Tissue,Germinative Follicular Epithelium Neoplasm,0
6512,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Germinative Follicular Epithelium Neoplasm,0
6513,Dilated Cystic Spaces Present,Ovarian Trabecular Carcinoid Tumor,0
6514,Dedifferentiated Malignant Infiltrate,Ovarian Trabecular Carcinoid Tumor,0
6515,Mammary Gland Type Features Present,Ovarian Trabecular Carcinoid Tumor,0
6516,Ectopic Tissue,Ovarian Trabecular Carcinoid Tumor,0
6517,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Trabecular Carcinoid Tumor,0
6518,Dilated Cystic Spaces Present,Hard Palate Pleomorphic Adenoma,0
6519,Dedifferentiated Malignant Infiltrate,Hard Palate Pleomorphic Adenoma,0
6520,Mammary Gland Type Features Present,Hard Palate Pleomorphic Adenoma,0
6521,Ectopic Tissue,Hard Palate Pleomorphic Adenoma,0
6522,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hard Palate Pleomorphic Adenoma,0
6523,Coronary Vessel Lesion,External Auditory Canal Ceruminous Adenoma,0
6524,Index Lesion,External Auditory Canal Ceruminous Adenoma,0
6525,Non-Index Lesion,External Auditory Canal Ceruminous Adenoma,0
6526,Mushroom-Shaped Lesion,External Auditory Canal Ceruminous Adenoma,0
6527,Annular Lesion,External Auditory Canal Ceruminous Adenoma,0
6528,Dilated Cystic Spaces Present,Oral Cavity Pleomorphic Adenoma,0
6529,Dedifferentiated Malignant Infiltrate,Oral Cavity Pleomorphic Adenoma,0
6530,Mammary Gland Type Features Present,Oral Cavity Pleomorphic Adenoma,0
6531,Ectopic Tissue,Oral Cavity Pleomorphic Adenoma,0
6532,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Oral Cavity Pleomorphic Adenoma,0
6533,Dilated Cystic Spaces Present,Condyloma Acuminatum with Dysplasia,0
6534,Dedifferentiated Malignant Infiltrate,Condyloma Acuminatum with Dysplasia,0
6535,Mammary Gland Type Features Present,Condyloma Acuminatum with Dysplasia,0
6536,Ectopic Tissue,Condyloma Acuminatum with Dysplasia,0
6537,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Condyloma Acuminatum with Dysplasia,0
6538,Dilated Cystic Spaces Present,Classical Poroma,0
6539,Dedifferentiated Malignant Infiltrate,Classical Poroma,0
6540,Mammary Gland Type Features Present,Classical Poroma,0
6541,Ectopic Tissue,Classical Poroma,0
6542,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Classical Poroma,0
6543,Dilated Cystic Spaces Present,Functioning Pancreatic Neuroendocrine Tumor G2,0
6544,Dedifferentiated Malignant Infiltrate,Functioning Pancreatic Neuroendocrine Tumor G2,0
6545,Mammary Gland Type Features Present,Functioning Pancreatic Neuroendocrine Tumor G2,0
6546,Ectopic Tissue,Functioning Pancreatic Neuroendocrine Tumor G2,0
6547,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Functioning Pancreatic Neuroendocrine Tumor G2,0
6548,Dilated Cystic Spaces Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6549,Dedifferentiated Malignant Infiltrate,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6550,Mammary Gland Type Features Present,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6551,Ectopic Tissue,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6552,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
6553,Dilated Cystic Spaces Present,Parathyroid Adenoma,0
6554,Dedifferentiated Malignant Infiltrate,Parathyroid Adenoma,0
6555,Mammary Gland Type Features Present,Parathyroid Adenoma,0
6556,Ectopic Tissue,Parathyroid Adenoma,0
6557,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Parathyroid Adenoma,0
6558,Dilated Cystic Spaces Present,Vestibular Papilloma,0
6559,Dedifferentiated Malignant Infiltrate,Vestibular Papilloma,0
6560,Mammary Gland Type Features Present,Vestibular Papilloma,0
6561,Ectopic Tissue,Vestibular Papilloma,0
6562,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vestibular Papilloma,0
6563,Dilated Cystic Spaces Present,Vestibular Micropapillomatosis,0
6564,Dedifferentiated Malignant Infiltrate,Vestibular Micropapillomatosis,0
6565,Mammary Gland Type Features Present,Vestibular Micropapillomatosis,0
6566,Ectopic Tissue,Vestibular Micropapillomatosis,0
6567,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vestibular Micropapillomatosis,0
6568,Dilated Cystic Spaces Present,Functioning Endocrine Neoplasm,0
6569,Dedifferentiated Malignant Infiltrate,Functioning Endocrine Neoplasm,0
6570,Mammary Gland Type Features Present,Functioning Endocrine Neoplasm,0
6571,Ectopic Tissue,Functioning Endocrine Neoplasm,0
6572,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Functioning Endocrine Neoplasm,0
6573,Coronary Vessel Lesion,Vulvar Nodular Hidradenoma,0
6574,Index Lesion,Vulvar Nodular Hidradenoma,0
6575,Non-Index Lesion,Vulvar Nodular Hidradenoma,0
6576,Mushroom-Shaped Lesion,Vulvar Nodular Hidradenoma,0
6577,Annular Lesion,Vulvar Nodular Hidradenoma,0
6578,Coronary Vessel Lesion,Malignant Phyllodes Tumor of Prostate,0
6579,Index Lesion,Malignant Phyllodes Tumor of Prostate,0
6580,Non-Index Lesion,Malignant Phyllodes Tumor of Prostate,0
6581,Mushroom-Shaped Lesion,Malignant Phyllodes Tumor of Prostate,0
6582,Annular Lesion,Malignant Phyllodes Tumor of Prostate,0
6583,Dilated Cystic Spaces Present,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant",0
6584,Dedifferentiated Malignant Infiltrate,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant",0
6585,Mammary Gland Type Features Present,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant",0
6586,Ectopic Tissue,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant",0
6587,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant",0
6588,Dilated Cystic Spaces Present,"Mesonephroma, benign",0
6589,Dedifferentiated Malignant Infiltrate,"Mesonephroma, benign",0
6590,Mammary Gland Type Features Present,"Mesonephroma, benign",0
6591,Ectopic Tissue,"Mesonephroma, benign",0
6592,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Mesonephroma, benign",0
6593,Dilated Cystic Spaces Present,Bowenoid papulosis,0
6594,Dedifferentiated Malignant Infiltrate,Bowenoid papulosis,0
6595,Mammary Gland Type Features Present,Bowenoid papulosis,0
6596,Ectopic Tissue,Bowenoid papulosis,0
6597,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bowenoid papulosis,0
6598,Dilated Cystic Spaces Present,Ethmoid Sinus Schneiderian Papilloma,0
6599,Dedifferentiated Malignant Infiltrate,Ethmoid Sinus Schneiderian Papilloma,0
6600,Mammary Gland Type Features Present,Ethmoid Sinus Schneiderian Papilloma,0
6601,Ectopic Tissue,Ethmoid Sinus Schneiderian Papilloma,0
6602,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ethmoid Sinus Schneiderian Papilloma,0
6603,Dilated Cystic Spaces Present,"Adenoma, Basal Cell",0
6604,Dedifferentiated Malignant Infiltrate,"Adenoma, Basal Cell",0
6605,Mammary Gland Type Features Present,"Adenoma, Basal Cell",0
6606,Ectopic Tissue,"Adenoma, Basal Cell",0
6607,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Adenoma, Basal Cell",0
6608,Dilated Cystic Spaces Present,Bladder Paraganglioma,0
6609,Dedifferentiated Malignant Infiltrate,Bladder Paraganglioma,0
6610,Mammary Gland Type Features Present,Bladder Paraganglioma,0
6611,Ectopic Tissue,Bladder Paraganglioma,0
6612,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Paraganglioma,0
6613,Coronary Vessel Lesion,Anal Canal Squamous Papilloma,0
6614,Index Lesion,Anal Canal Squamous Papilloma,0
6615,Non-Index Lesion,Anal Canal Squamous Papilloma,0
6616,Mushroom-Shaped Lesion,Anal Canal Squamous Papilloma,0
6617,Annular Lesion,Anal Canal Squamous Papilloma,0
6618,Dilated Cystic Spaces Present,Ovarian Serous Tumor,0
6619,Dedifferentiated Malignant Infiltrate,Ovarian Serous Tumor,0
6620,Mammary Gland Type Features Present,Ovarian Serous Tumor,0
6621,Ectopic Tissue,Ovarian Serous Tumor,0
6622,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Serous Tumor,0
6623,Dilated Cystic Spaces Present,Thymoma Type B,0
6624,Dedifferentiated Malignant Infiltrate,Thymoma Type B,0
6625,Mammary Gland Type Features Present,Thymoma Type B,0
6626,Ectopic Tissue,Thymoma Type B,0
6627,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymoma Type B,0
6628,Dilated Cystic Spaces Present,Vipoma,0
6629,Dedifferentiated Malignant Infiltrate,Vipoma,0
6630,Mammary Gland Type Features Present,Vipoma,0
6631,Ectopic Tissue,Vipoma,0
6632,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vipoma,0
6633,Dilated Cystic Spaces Present,Ovarian Serous Adenofibroma,0
6634,Dedifferentiated Malignant Infiltrate,Ovarian Serous Adenofibroma,0
6635,Mammary Gland Type Features Present,Ovarian Serous Adenofibroma,0
6636,Ectopic Tissue,Ovarian Serous Adenofibroma,0
6637,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Serous Adenofibroma,0
6638,Coronary Vessel Lesion,Choroid Plexus Papilloma,0
6639,Index Lesion,Choroid Plexus Papilloma,0
6640,Non-Index Lesion,Choroid Plexus Papilloma,0
6641,Mushroom-Shaped Lesion,Choroid Plexus Papilloma,0
6642,Annular Lesion,Choroid Plexus Papilloma,0
6643,Dilated Cystic Spaces Present,Craniopharyngioma,0
6644,Dedifferentiated Malignant Infiltrate,Craniopharyngioma,0
6645,Mammary Gland Type Features Present,Craniopharyngioma,0
6646,Ectopic Tissue,Craniopharyngioma,0
6647,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Craniopharyngioma,0
6648,Dilated Cystic Spaces Present,Micronodular thymoma with lymphoid stroma,0
6649,Dedifferentiated Malignant Infiltrate,Micronodular thymoma with lymphoid stroma,0
6650,Mammary Gland Type Features Present,Micronodular thymoma with lymphoid stroma,0
6651,Ectopic Tissue,Micronodular thymoma with lymphoid stroma,0
6652,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Micronodular thymoma with lymphoid stroma,0
6653,Coronary Vessel Lesion,Colorectal Tubular Adenoma,0
6654,Index Lesion,Colorectal Tubular Adenoma,0
6655,Non-Index Lesion,Colorectal Tubular Adenoma,0
6656,Mushroom-Shaped Lesion,Colorectal Tubular Adenoma,0
6657,Annular Lesion,Colorectal Tubular Adenoma,0
6658,Dilated Cystic Spaces Present,Extra-Adrenal Retroperitoneal Paraganglioma,0
6659,Dedifferentiated Malignant Infiltrate,Extra-Adrenal Retroperitoneal Paraganglioma,0
6660,Mammary Gland Type Features Present,Extra-Adrenal Retroperitoneal Paraganglioma,0
6661,Ectopic Tissue,Extra-Adrenal Retroperitoneal Paraganglioma,0
6662,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Extra-Adrenal Retroperitoneal Paraganglioma,0
6663,Dilated Cystic Spaces Present,Intrathoracic Paravertebral Paraganglioma,0
6664,Dedifferentiated Malignant Infiltrate,Intrathoracic Paravertebral Paraganglioma,0
6665,Mammary Gland Type Features Present,Intrathoracic Paravertebral Paraganglioma,0
6666,Ectopic Tissue,Intrathoracic Paravertebral Paraganglioma,0
6667,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intrathoracic Paravertebral Paraganglioma,0
6668,Dilated Cystic Spaces Present,Acantholytic acanthoma,0
6669,Dedifferentiated Malignant Infiltrate,Acantholytic acanthoma,0
6670,Mammary Gland Type Features Present,Acantholytic acanthoma,0
6671,Ectopic Tissue,Acantholytic acanthoma,0
6672,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Acantholytic acanthoma,0
6673,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Lung Mucinous Cystadenoma,0
6674,Isolated Tumor Cells,Lung Mucinous Cystadenoma,0
6675,Pleural/Elastic Layer Invasion,Lung Mucinous Cystadenoma,0
6676,Presence of Extravascular Matrix Patterns,Lung Mucinous Cystadenoma,0
6677,Ductopenia,Lung Mucinous Cystadenoma,0
6678,Dilated Cystic Spaces Present,High Grade Anal Canal Squamous Intraepithelial Neoplasia,0
6679,Dedifferentiated Malignant Infiltrate,High Grade Anal Canal Squamous Intraepithelial Neoplasia,0
6680,Mammary Gland Type Features Present,High Grade Anal Canal Squamous Intraepithelial Neoplasia,0
6681,Ectopic Tissue,High Grade Anal Canal Squamous Intraepithelial Neoplasia,0
6682,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,High Grade Anal Canal Squamous Intraepithelial Neoplasia,0
6683,Dilated Cystic Spaces Present,Vaginal Adenoma,0
6684,Dedifferentiated Malignant Infiltrate,Vaginal Adenoma,0
6685,Mammary Gland Type Features Present,Vaginal Adenoma,0
6686,Ectopic Tissue,Vaginal Adenoma,0
6687,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vaginal Adenoma,0
6688,Dilated Cystic Spaces Present,intraductal papilloma of salivary gland,0
6689,Dedifferentiated Malignant Infiltrate,intraductal papilloma of salivary gland,0
6690,Mammary Gland Type Features Present,intraductal papilloma of salivary gland,0
6691,Ectopic Tissue,intraductal papilloma of salivary gland,0
6692,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,intraductal papilloma of salivary gland,0
6693,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,sialadenoma papilliferum of salivary gland,0
6694,Isolated Tumor Cells,sialadenoma papilliferum of salivary gland,0
6695,Pleural/Elastic Layer Invasion,sialadenoma papilliferum of salivary gland,0
6696,Presence of Extravascular Matrix Patterns,sialadenoma papilliferum of salivary gland,0
6697,Ductopenia,sialadenoma papilliferum of salivary gland,0
6698,Dilated Cystic Spaces Present,Grade II Penile Intraepithelial Neoplasia,0
6699,Dedifferentiated Malignant Infiltrate,Grade II Penile Intraepithelial Neoplasia,0
6700,Mammary Gland Type Features Present,Grade II Penile Intraepithelial Neoplasia,0
6701,Ectopic Tissue,Grade II Penile Intraepithelial Neoplasia,0
6702,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Grade II Penile Intraepithelial Neoplasia,0
6703,Dilated Cystic Spaces Present,Malignant Bladder Paraganglioma,0
6704,Dedifferentiated Malignant Infiltrate,Malignant Bladder Paraganglioma,0
6705,Mammary Gland Type Features Present,Malignant Bladder Paraganglioma,0
6706,Ectopic Tissue,Malignant Bladder Paraganglioma,0
6707,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Bladder Paraganglioma,0
6708,Coronary Vessel Lesion,"Phyllodes tumor, benign",0
6709,Index Lesion,"Phyllodes tumor, benign",0
6710,Non-Index Lesion,"Phyllodes tumor, benign",0
6711,Mushroom-Shaped Lesion,"Phyllodes tumor, benign",0
6712,Annular Lesion,"Phyllodes tumor, benign",0
6713,Coronary Vessel Lesion,adenoma of intrahepatic bile duct,0
6714,Index Lesion,adenoma of intrahepatic bile duct,0
6715,Non-Index Lesion,adenoma of intrahepatic bile duct,0
6716,Mushroom-Shaped Lesion,adenoma of intrahepatic bile duct,0
6717,Annular Lesion,adenoma of intrahepatic bile duct,0
6718,Dilated Cystic Spaces Present,"Neoplasms, Fibroepithelial",0
6719,Dedifferentiated Malignant Infiltrate,"Neoplasms, Fibroepithelial",0
6720,Mammary Gland Type Features Present,"Neoplasms, Fibroepithelial",0
6721,Ectopic Tissue,"Neoplasms, Fibroepithelial",0
6722,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Neoplasms, Fibroepithelial",0
6723,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Seborrheic keratosis,0
6724,Isolated Tumor Cells,Seborrheic keratosis,0
6725,Pleural/Elastic Layer Invasion,Seborrheic keratosis,0
6726,Presence of Extravascular Matrix Patterns,Seborrheic keratosis,0
6727,Ductopenia,Seborrheic keratosis,0
6728,Dilated Cystic Spaces Present,Vulvar Glandular Neoplasm,0
6729,Dedifferentiated Malignant Infiltrate,Vulvar Glandular Neoplasm,0
6730,Mammary Gland Type Features Present,Vulvar Glandular Neoplasm,0
6731,Ectopic Tissue,Vulvar Glandular Neoplasm,0
6732,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vulvar Glandular Neoplasm,0
6733,Dilated Cystic Spaces Present,Adenoma of Minor Vestibular Glands,0
6734,Dedifferentiated Malignant Infiltrate,Adenoma of Minor Vestibular Glands,0
6735,Mammary Gland Type Features Present,Adenoma of Minor Vestibular Glands,0
6736,Ectopic Tissue,Adenoma of Minor Vestibular Glands,0
6737,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adenoma of Minor Vestibular Glands,0
6738,Dilated Cystic Spaces Present,Small Intestinal Intraepithelial Neoplasia,0
6739,Dedifferentiated Malignant Infiltrate,Small Intestinal Intraepithelial Neoplasia,0
6740,Mammary Gland Type Features Present,Small Intestinal Intraepithelial Neoplasia,0
6741,Ectopic Tissue,Small Intestinal Intraepithelial Neoplasia,0
6742,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Intraepithelial Neoplasia,0
6743,Coronary Vessel Lesion,"Adenoma, Sweat Gland",0
6744,Index Lesion,"Adenoma, Sweat Gland",0
6745,Non-Index Lesion,"Adenoma, Sweat Gland",0
6746,Mushroom-Shaped Lesion,"Adenoma, Sweat Gland",0
6747,Annular Lesion,"Adenoma, Sweat Gland",0
6748,Dilated Cystic Spaces Present,Appendix Neuroendocrine Tumor,0
6749,Dedifferentiated Malignant Infiltrate,Appendix Neuroendocrine Tumor,0
6750,Mammary Gland Type Features Present,Appendix Neuroendocrine Tumor,0
6751,Ectopic Tissue,Appendix Neuroendocrine Tumor,0
6752,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix Neuroendocrine Tumor,0
6753,Coronary Vessel Lesion,Colonic tubulovillous adenoma,0
6754,Index Lesion,Colonic tubulovillous adenoma,0
6755,Non-Index Lesion,Colonic tubulovillous adenoma,0
6756,Mushroom-Shaped Lesion,Colonic tubulovillous adenoma,0
6757,Annular Lesion,Colonic tubulovillous adenoma,0
6758,Dilated Cystic Spaces Present,Cardiac Paraganglioma,0
6759,Dedifferentiated Malignant Infiltrate,Cardiac Paraganglioma,0
6760,Mammary Gland Type Features Present,Cardiac Paraganglioma,0
6761,Ectopic Tissue,Cardiac Paraganglioma,0
6762,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cardiac Paraganglioma,0
6763,Dilated Cystic Spaces Present,Papillary Epithelial Neoplasm,0
6764,Dedifferentiated Malignant Infiltrate,Papillary Epithelial Neoplasm,0
6765,Mammary Gland Type Features Present,Papillary Epithelial Neoplasm,0
6766,Ectopic Tissue,Papillary Epithelial Neoplasm,0
6767,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Papillary Epithelial Neoplasm,0
6768,Dilated Cystic Spaces Present,Bronchial adenoma,0
6769,Dedifferentiated Malignant Infiltrate,Bronchial adenoma,0
6770,Mammary Gland Type Features Present,Bronchial adenoma,0
6771,Ectopic Tissue,Bronchial adenoma,0
6772,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bronchial adenoma,0
6773,Dilated Cystic Spaces Present,Non-Invasive Urothelial Neoplasm,0
6774,Dedifferentiated Malignant Infiltrate,Non-Invasive Urothelial Neoplasm,0
6775,Mammary Gland Type Features Present,Non-Invasive Urothelial Neoplasm,0
6776,Ectopic Tissue,Non-Invasive Urothelial Neoplasm,0
6777,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non-Invasive Urothelial Neoplasm,0
6778,Dilated Cystic Spaces Present,"Thymoma, type B2",0
6779,Dedifferentiated Malignant Infiltrate,"Thymoma, type B2",0
6780,Mammary Gland Type Features Present,"Thymoma, type B2",0
6781,Ectopic Tissue,"Thymoma, type B2",0
6782,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thymoma, type B2",0
6783,Dilated Cystic Spaces Present,Meckel Diverticulum Neuroendocrine Tumor G1,0
6784,Dedifferentiated Malignant Infiltrate,Meckel Diverticulum Neuroendocrine Tumor G1,0
6785,Mammary Gland Type Features Present,Meckel Diverticulum Neuroendocrine Tumor G1,0
6786,Ectopic Tissue,Meckel Diverticulum Neuroendocrine Tumor G1,0
6787,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Meckel Diverticulum Neuroendocrine Tumor G1,0
6788,Dilated Cystic Spaces Present,Adenoma of the nipple,0
6789,Dedifferentiated Malignant Infiltrate,Adenoma of the nipple,0
6790,Mammary Gland Type Features Present,Adenoma of the nipple,0
6791,Ectopic Tissue,Adenoma of the nipple,0
6792,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adenoma of the nipple,0
6793,Dilated Cystic Spaces Present,Borderline epithelial tumor of ovary,0
6794,Dedifferentiated Malignant Infiltrate,Borderline epithelial tumor of ovary,0
6795,Mammary Gland Type Features Present,Borderline epithelial tumor of ovary,0
6796,Ectopic Tissue,Borderline epithelial tumor of ovary,0
6797,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline epithelial tumor of ovary,0
6798,Dilated Cystic Spaces Present,Extra-Adrenal Paraganglioma,0
6799,Dedifferentiated Malignant Infiltrate,Extra-Adrenal Paraganglioma,0
6800,Mammary Gland Type Features Present,Extra-Adrenal Paraganglioma,0
6801,Ectopic Tissue,Extra-Adrenal Paraganglioma,0
6802,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Extra-Adrenal Paraganglioma,0
6803,Dilated Cystic Spaces Present,Descending Colon Neuroendocrine Tumor G1,0
6804,Dedifferentiated Malignant Infiltrate,Descending Colon Neuroendocrine Tumor G1,0
6805,Mammary Gland Type Features Present,Descending Colon Neuroendocrine Tumor G1,0
6806,Ectopic Tissue,Descending Colon Neuroendocrine Tumor G1,0
6807,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Descending Colon Neuroendocrine Tumor G1,0
6808,Dilated Cystic Spaces Present,"Thymoma, type A",0
6809,Dedifferentiated Malignant Infiltrate,"Thymoma, type A",0
6810,Mammary Gland Type Features Present,"Thymoma, type A",0
6811,Ectopic Tissue,"Thymoma, type A",0
6812,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thymoma, type A",0
6813,Coronary Vessel Lesion,Glomerulosa Cell Adrenal Cortical Adenoma,0
6814,Index Lesion,Glomerulosa Cell Adrenal Cortical Adenoma,0
6815,Non-Index Lesion,Glomerulosa Cell Adrenal Cortical Adenoma,0
6816,Mushroom-Shaped Lesion,Glomerulosa Cell Adrenal Cortical Adenoma,0
6817,Annular Lesion,Glomerulosa Cell Adrenal Cortical Adenoma,0
6818,Dilated Cystic Spaces Present,Cervical Neuroendocrine Neoplasm,0
6819,Dedifferentiated Malignant Infiltrate,Cervical Neuroendocrine Neoplasm,0
6820,Mammary Gland Type Features Present,Cervical Neuroendocrine Neoplasm,0
6821,Ectopic Tissue,Cervical Neuroendocrine Neoplasm,0
6822,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Neuroendocrine Neoplasm,0
6823,Dilated Cystic Spaces Present,Carotid Body Paraganglioma,0
6824,Dedifferentiated Malignant Infiltrate,Carotid Body Paraganglioma,0
6825,Mammary Gland Type Features Present,Carotid Body Paraganglioma,0
6826,Ectopic Tissue,Carotid Body Paraganglioma,0
6827,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carotid Body Paraganglioma,0
6828,Dilated Cystic Spaces Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,0
6829,Dedifferentiated Malignant Infiltrate,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,0
6830,Mammary Gland Type Features Present,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,0
6831,Ectopic Tissue,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,0
6832,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,0
6833,Dilated Cystic Spaces Present,Intra-Abdominal Paraganglioma,0
6834,Dedifferentiated Malignant Infiltrate,Intra-Abdominal Paraganglioma,0
6835,Mammary Gland Type Features Present,Intra-Abdominal Paraganglioma,0
6836,Ectopic Tissue,Intra-Abdominal Paraganglioma,0
6837,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intra-Abdominal Paraganglioma,0
6838,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pancreatic Intraductal Neoplasms,0
6839,Isolated Tumor Cells,Pancreatic Intraductal Neoplasms,0
6840,Pleural/Elastic Layer Invasion,Pancreatic Intraductal Neoplasms,0
6841,Presence of Extravascular Matrix Patterns,Pancreatic Intraductal Neoplasms,0
6842,Ductopenia,Pancreatic Intraductal Neoplasms,0
6843,Dilated Cystic Spaces Present,Malignant Cardiac Paraganglioma,0
6844,Dedifferentiated Malignant Infiltrate,Malignant Cardiac Paraganglioma,0
6845,Mammary Gland Type Features Present,Malignant Cardiac Paraganglioma,0
6846,Ectopic Tissue,Malignant Cardiac Paraganglioma,0
6847,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Cardiac Paraganglioma,0
6848,Dilated Cystic Spaces Present,Uterine Corpus Neuroendocrine Neoplasm,0
6849,Dedifferentiated Malignant Infiltrate,Uterine Corpus Neuroendocrine Neoplasm,0
6850,Mammary Gland Type Features Present,Uterine Corpus Neuroendocrine Neoplasm,0
6851,Ectopic Tissue,Uterine Corpus Neuroendocrine Neoplasm,0
6852,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Uterine Corpus Neuroendocrine Neoplasm,0
6853,Dilated Cystic Spaces Present,"Somatostatinoma, malignant",0
6854,Dedifferentiated Malignant Infiltrate,"Somatostatinoma, malignant",0
6855,Mammary Gland Type Features Present,"Somatostatinoma, malignant",0
6856,Ectopic Tissue,"Somatostatinoma, malignant",0
6857,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Somatostatinoma, malignant",0
6858,Dilated Cystic Spaces Present,Foregut Carcinoid Tumor,0
6859,Dedifferentiated Malignant Infiltrate,Foregut Carcinoid Tumor,0
6860,Mammary Gland Type Features Present,Foregut Carcinoid Tumor,0
6861,Ectopic Tissue,Foregut Carcinoid Tumor,0
6862,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Foregut Carcinoid Tumor,0
6863,Dilated Cystic Spaces Present,Thyroid Gland Hyperfunctioning Adenoma,0
6864,Dedifferentiated Malignant Infiltrate,Thyroid Gland Hyperfunctioning Adenoma,0
6865,Mammary Gland Type Features Present,Thyroid Gland Hyperfunctioning Adenoma,0
6866,Ectopic Tissue,Thyroid Gland Hyperfunctioning Adenoma,0
6867,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Hyperfunctioning Adenoma,0
6868,Dilated Cystic Spaces Present,Intracanalicular fibroadenoma,0
6869,Dedifferentiated Malignant Infiltrate,Intracanalicular fibroadenoma,0
6870,Mammary Gland Type Features Present,Intracanalicular fibroadenoma,0
6871,Ectopic Tissue,Intracanalicular fibroadenoma,0
6872,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intracanalicular fibroadenoma,0
6873,Dilated Cystic Spaces Present,Benign squamous cell tumor,0
6874,Dedifferentiated Malignant Infiltrate,Benign squamous cell tumor,0
6875,Mammary Gland Type Features Present,Benign squamous cell tumor,0
6876,Ectopic Tissue,Benign squamous cell tumor,0
6877,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign squamous cell tumor,0
6878,Dilated Cystic Spaces Present,Skin appendage adenoma,0
6879,Dedifferentiated Malignant Infiltrate,Skin appendage adenoma,0
6880,Mammary Gland Type Features Present,Skin appendage adenoma,0
6881,Ectopic Tissue,Skin appendage adenoma,0
6882,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Skin appendage adenoma,0
6883,Coronary Vessel Lesion,tubular adenoma of extrahepatic bile duct,0
6884,Index Lesion,tubular adenoma of extrahepatic bile duct,0
6885,Non-Index Lesion,tubular adenoma of extrahepatic bile duct,0
6886,Mushroom-Shaped Lesion,tubular adenoma of extrahepatic bile duct,0
6887,Annular Lesion,tubular adenoma of extrahepatic bile duct,0
6888,Dilated Cystic Spaces Present,"Endometrioid adenoma, borderline malignancy",0
6889,Dedifferentiated Malignant Infiltrate,"Endometrioid adenoma, borderline malignancy",0
6890,Mammary Gland Type Features Present,"Endometrioid adenoma, borderline malignancy",0
6891,Ectopic Tissue,"Endometrioid adenoma, borderline malignancy",0
6892,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Endometrioid adenoma, borderline malignancy",0
6893,Dilated Cystic Spaces Present,Plurihormonal Pituitary Gland Adenoma,0
6894,Dedifferentiated Malignant Infiltrate,Plurihormonal Pituitary Gland Adenoma,0
6895,Mammary Gland Type Features Present,Plurihormonal Pituitary Gland Adenoma,0
6896,Ectopic Tissue,Plurihormonal Pituitary Gland Adenoma,0
6897,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Plurihormonal Pituitary Gland Adenoma,0
6898,Coronary Vessel Lesion,Childhood Choroid Plexus Papilloma,0
6899,Index Lesion,Childhood Choroid Plexus Papilloma,0
6900,Non-Index Lesion,Childhood Choroid Plexus Papilloma,0
6901,Mushroom-Shaped Lesion,Childhood Choroid Plexus Papilloma,0
6902,Annular Lesion,Childhood Choroid Plexus Papilloma,0
6903,Dilated Cystic Spaces Present,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
6904,Dedifferentiated Malignant Infiltrate,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
6905,Mammary Gland Type Features Present,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
6906,Ectopic Tissue,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
6907,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,0
6908,Coronary Vessel Lesion,Metaplastic thymoma,0
6909,Index Lesion,Metaplastic thymoma,0
6910,Non-Index Lesion,Metaplastic thymoma,0
6911,Mushroom-Shaped Lesion,Metaplastic thymoma,0
6912,Annular Lesion,Metaplastic thymoma,0
6913,Dilated Cystic Spaces Present,Strumal carcinoid,0
6914,Dedifferentiated Malignant Infiltrate,Strumal carcinoid,0
6915,Mammary Gland Type Features Present,Strumal carcinoid,0
6916,Ectopic Tissue,Strumal carcinoid,0
6917,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Strumal carcinoid,0
6918,Coronary Vessel Lesion,Appendix adenoma,0
6919,Index Lesion,Appendix adenoma,0
6920,Non-Index Lesion,Appendix adenoma,0
6921,Mushroom-Shaped Lesion,Appendix adenoma,0
6922,Annular Lesion,Appendix adenoma,0
6923,Dilated Cystic Spaces Present,Ampulla of Vater Gangliocytic Paraganglioma,0
6924,Dedifferentiated Malignant Infiltrate,Ampulla of Vater Gangliocytic Paraganglioma,0
6925,Mammary Gland Type Features Present,Ampulla of Vater Gangliocytic Paraganglioma,0
6926,Ectopic Tissue,Ampulla of Vater Gangliocytic Paraganglioma,0
6927,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampulla of Vater Gangliocytic Paraganglioma,0
6928,Dilated Cystic Spaces Present,Parathyroid Gland Atypical Adenoma,0
6929,Dedifferentiated Malignant Infiltrate,Parathyroid Gland Atypical Adenoma,0
6930,Mammary Gland Type Features Present,Parathyroid Gland Atypical Adenoma,0
6931,Ectopic Tissue,Parathyroid Gland Atypical Adenoma,0
6932,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Parathyroid Gland Atypical Adenoma,0
6933,Dilated Cystic Spaces Present,Flat Ductal Epithelial Atypia of the Breast,0
6934,Dedifferentiated Malignant Infiltrate,Flat Ductal Epithelial Atypia of the Breast,0
6935,Mammary Gland Type Features Present,Flat Ductal Epithelial Atypia of the Breast,0
6936,Ectopic Tissue,Flat Ductal Epithelial Atypia of the Breast,0
6937,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Flat Ductal Epithelial Atypia of the Breast,0
6938,Dilated Cystic Spaces Present,Vulvar Keratoacanthoma,0
6939,Dedifferentiated Malignant Infiltrate,Vulvar Keratoacanthoma,0
6940,Mammary Gland Type Features Present,Vulvar Keratoacanthoma,0
6941,Ectopic Tissue,Vulvar Keratoacanthoma,0
6942,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Vulvar Keratoacanthoma,0
6943,Dilated Cystic Spaces Present,Acinar cell adenoma,0
6944,Dedifferentiated Malignant Infiltrate,Acinar cell adenoma,0
6945,Mammary Gland Type Features Present,Acinar cell adenoma,0
6946,Ectopic Tissue,Acinar cell adenoma,0
6947,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Acinar cell adenoma,0
6948,Dilated Cystic Spaces Present,Esophageal Squamous Intraepithelial Neoplasia,0
6949,Dedifferentiated Malignant Infiltrate,Esophageal Squamous Intraepithelial Neoplasia,0
6950,Mammary Gland Type Features Present,Esophageal Squamous Intraepithelial Neoplasia,0
6951,Ectopic Tissue,Esophageal Squamous Intraepithelial Neoplasia,0
6952,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Esophageal Squamous Intraepithelial Neoplasia,0
6953,Coronary Vessel Lesion,Adrenal Cortex Oncocytic Adenoma,0
6954,Index Lesion,Adrenal Cortex Oncocytic Adenoma,0
6955,Non-Index Lesion,Adrenal Cortex Oncocytic Adenoma,0
6956,Mushroom-Shaped Lesion,Adrenal Cortex Oncocytic Adenoma,0
6957,Annular Lesion,Adrenal Cortex Oncocytic Adenoma,0
6958,Dilated Cystic Spaces Present,Choroid Plexus Neoplasms,0
6959,Dedifferentiated Malignant Infiltrate,Choroid Plexus Neoplasms,0
6960,Mammary Gland Type Features Present,Choroid Plexus Neoplasms,0
6961,Ectopic Tissue,Choroid Plexus Neoplasms,0
6962,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Choroid Plexus Neoplasms,0
6963,Dilated Cystic Spaces Present,Renal papillary adenoma,0
6964,Dedifferentiated Malignant Infiltrate,Renal papillary adenoma,0
6965,Mammary Gland Type Features Present,Renal papillary adenoma,0
6966,Ectopic Tissue,Renal papillary adenoma,0
6967,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Renal papillary adenoma,0
6968,Dilated Cystic Spaces Present,Bladder Urothelial Proliferation of Uncertain Malignant Potential,0
6969,Dedifferentiated Malignant Infiltrate,Bladder Urothelial Proliferation of Uncertain Malignant Potential,0
6970,Mammary Gland Type Features Present,Bladder Urothelial Proliferation of Uncertain Malignant Potential,0
6971,Ectopic Tissue,Bladder Urothelial Proliferation of Uncertain Malignant Potential,0
6972,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Urothelial Proliferation of Uncertain Malignant Potential,0
6973,Dilated Cystic Spaces Present,Carcinoid Tumor,0
6974,Dedifferentiated Malignant Infiltrate,Carcinoid Tumor,0
6975,Mammary Gland Type Features Present,Carcinoid Tumor,0
6976,Ectopic Tissue,Carcinoid Tumor,0
6977,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid Tumor,0
6978,Dilated Cystic Spaces Present,Parathyroid transitional clear cell adenoma,0
6979,Dedifferentiated Malignant Infiltrate,Parathyroid transitional clear cell adenoma,0
6980,Mammary Gland Type Features Present,Parathyroid transitional clear cell adenoma,0
6981,Ectopic Tissue,Parathyroid transitional clear cell adenoma,0
6982,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Parathyroid transitional clear cell adenoma,0
6983,Coronary Vessel Lesion,Pancreatic Solid Serous Adenoma,0
6984,Index Lesion,Pancreatic Solid Serous Adenoma,0
6985,Non-Index Lesion,Pancreatic Solid Serous Adenoma,0
6986,Mushroom-Shaped Lesion,Pancreatic Solid Serous Adenoma,0
6987,Annular Lesion,Pancreatic Solid Serous Adenoma,0
6988,Coronary Vessel Lesion,Heavily Pigmented Adrenal Cortical Adenoma,0
6989,Index Lesion,Heavily Pigmented Adrenal Cortical Adenoma,0
6990,Non-Index Lesion,Heavily Pigmented Adrenal Cortical Adenoma,0
6991,Mushroom-Shaped Lesion,Heavily Pigmented Adrenal Cortical Adenoma,0
6992,Annular Lesion,Heavily Pigmented Adrenal Cortical Adenoma,0
6993,Dilated Cystic Spaces Present,Borderline Ovarian Mucinous Adenofibroma,0
6994,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Mucinous Adenofibroma,0
6995,Mammary Gland Type Features Present,Borderline Ovarian Mucinous Adenofibroma,0
6996,Ectopic Tissue,Borderline Ovarian Mucinous Adenofibroma,0
6997,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Mucinous Adenofibroma,0
6998,Dilated Cystic Spaces Present,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",0
6999,Dedifferentiated Malignant Infiltrate,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",0
7000,Mammary Gland Type Features Present,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",0
7001,Ectopic Tissue,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",0
7002,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",0
7003,Dilated Cystic Spaces Present,"Papillomatosis, glandular",0
7004,Dedifferentiated Malignant Infiltrate,"Papillomatosis, glandular",0
7005,Mammary Gland Type Features Present,"Papillomatosis, glandular",0
7006,Ectopic Tissue,"Papillomatosis, glandular",0
7007,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Papillomatosis, glandular",0
7008,Coronary Vessel Lesion,Adenomatous Polyposis Coli,0
7009,Index Lesion,Adenomatous Polyposis Coli,0
7010,Non-Index Lesion,Adenomatous Polyposis Coli,0
7011,Mushroom-Shaped Lesion,Adenomatous Polyposis Coli,0
7012,Annular Lesion,Adenomatous Polyposis Coli,0
7013,Dilated Cystic Spaces Present,Mild esophageal dysplasia,0
7014,Dedifferentiated Malignant Infiltrate,Mild esophageal dysplasia,0
7015,Mammary Gland Type Features Present,Mild esophageal dysplasia,0
7016,Ectopic Tissue,Mild esophageal dysplasia,0
7017,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mild esophageal dysplasia,0
7018,Dilated Cystic Spaces Present,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,0
7019,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,0
7020,Mammary Gland Type Features Present,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,0
7021,Ectopic Tissue,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,0
7022,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,0
7023,Dilated Cystic Spaces Present,Juvenile fibroadenoma of breast,0
7024,Dedifferentiated Malignant Infiltrate,Juvenile fibroadenoma of breast,0
7025,Mammary Gland Type Features Present,Juvenile fibroadenoma of breast,0
7026,Ectopic Tissue,Juvenile fibroadenoma of breast,0
7027,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Juvenile fibroadenoma of breast,0
7028,Dilated Cystic Spaces Present,Low Grade Squamous Intraepithelial Neoplasia,0
7029,Dedifferentiated Malignant Infiltrate,Low Grade Squamous Intraepithelial Neoplasia,0
7030,Mammary Gland Type Features Present,Low Grade Squamous Intraepithelial Neoplasia,0
7031,Ectopic Tissue,Low Grade Squamous Intraepithelial Neoplasia,0
7032,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low Grade Squamous Intraepithelial Neoplasia,0
7033,Dilated Cystic Spaces Present,Fallopian Tube Metaplastic Papillary Tumor,0
7034,Dedifferentiated Malignant Infiltrate,Fallopian Tube Metaplastic Papillary Tumor,0
7035,Mammary Gland Type Features Present,Fallopian Tube Metaplastic Papillary Tumor,0
7036,Ectopic Tissue,Fallopian Tube Metaplastic Papillary Tumor,0
7037,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Fallopian Tube Metaplastic Papillary Tumor,0
7038,Dilated Cystic Spaces Present,Basal Cell Neoplasm,0
7039,Dedifferentiated Malignant Infiltrate,Basal Cell Neoplasm,0
7040,Mammary Gland Type Features Present,Basal Cell Neoplasm,0
7041,Ectopic Tissue,Basal Cell Neoplasm,0
7042,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Basal Cell Neoplasm,0
7043,Dilated Cystic Spaces Present,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
7044,Dedifferentiated Malignant Infiltrate,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
7045,Mammary Gland Type Features Present,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
7046,Ectopic Tissue,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
7047,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Intrahepatic Bile Duct Biliary Intraepithelial Neoplasia,0
7048,Dilated Cystic Spaces Present,endometrioid adenofibroma of ovary,0
7049,Dedifferentiated Malignant Infiltrate,endometrioid adenofibroma of ovary,0
7050,Mammary Gland Type Features Present,endometrioid adenofibroma of ovary,0
7051,Ectopic Tissue,endometrioid adenofibroma of ovary,0
7052,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,endometrioid adenofibroma of ovary,0
7053,Dilated Cystic Spaces Present,Adenoma,0
7054,Dedifferentiated Malignant Infiltrate,Adenoma,0
7055,Mammary Gland Type Features Present,Adenoma,0
7056,Ectopic Tissue,Adenoma,0
7057,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adenoma,0
7058,Dilated Cystic Spaces Present,Colorectal Neuroendocrine Tumor G2,0
7059,Dedifferentiated Malignant Infiltrate,Colorectal Neuroendocrine Tumor G2,0
7060,Mammary Gland Type Features Present,Colorectal Neuroendocrine Tumor G2,0
7061,Ectopic Tissue,Colorectal Neuroendocrine Tumor G2,0
7062,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal Neuroendocrine Tumor G2,0
7063,Dilated Cystic Spaces Present,Borderline Ovarian Clear Cell Tumor,0
7064,Dedifferentiated Malignant Infiltrate,Borderline Ovarian Clear Cell Tumor,0
7065,Mammary Gland Type Features Present,Borderline Ovarian Clear Cell Tumor,0
7066,Ectopic Tissue,Borderline Ovarian Clear Cell Tumor,0
7067,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Borderline Ovarian Clear Cell Tumor,0
7068,Coronary Vessel Lesion,Phyllodes Tumor,0
7069,Index Lesion,Phyllodes Tumor,0
7070,Non-Index Lesion,Phyllodes Tumor,0
7071,Mushroom-Shaped Lesion,Phyllodes Tumor,0
7072,Annular Lesion,Phyllodes Tumor,0
7073,Dilated Cystic Spaces Present,Cervical Atypical Carcinoid Tumor,0
7074,Dedifferentiated Malignant Infiltrate,Cervical Atypical Carcinoid Tumor,0
7075,Mammary Gland Type Features Present,Cervical Atypical Carcinoid Tumor,0
7076,Ectopic Tissue,Cervical Atypical Carcinoid Tumor,0
7077,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Cervical Atypical Carcinoid Tumor,0
7078,Dilated Cystic Spaces Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",0
7079,Dedifferentiated Malignant Infiltrate,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",0
7080,Mammary Gland Type Features Present,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",0
7081,Ectopic Tissue,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",0
7082,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Borderline Ovarian Mucinous Tumor, Endocervical-Like",0
7083,Coronary Vessel Lesion,Villous adenoma of colon,0
7084,Index Lesion,Villous adenoma of colon,0
7085,Non-Index Lesion,Villous adenoma of colon,0
7086,Mushroom-Shaped Lesion,Villous adenoma of colon,0
7087,Annular Lesion,Villous adenoma of colon,0
7088,Dilated Cystic Spaces Present,Glomus Jugulare Tumor,0
7089,Dedifferentiated Malignant Infiltrate,Glomus Jugulare Tumor,0
7090,Mammary Gland Type Features Present,Glomus Jugulare Tumor,0
7091,Ectopic Tissue,Glomus Jugulare Tumor,0
7092,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Glomus Jugulare Tumor,0
7093,Dilated Cystic Spaces Present,Small Intestinal Gangliocytic Paraganglioma,0
7094,Dedifferentiated Malignant Infiltrate,Small Intestinal Gangliocytic Paraganglioma,0
7095,Mammary Gland Type Features Present,Small Intestinal Gangliocytic Paraganglioma,0
7096,Ectopic Tissue,Small Intestinal Gangliocytic Paraganglioma,0
7097,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Small Intestinal Gangliocytic Paraganglioma,0
7098,Dilated Cystic Spaces Present,Squamous intraepithelial lesion,0
7099,Dedifferentiated Malignant Infiltrate,Squamous intraepithelial lesion,0
7100,Mammary Gland Type Features Present,Squamous intraepithelial lesion,0
7101,Ectopic Tissue,Squamous intraepithelial lesion,0
7102,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Squamous intraepithelial lesion,0
7103,Dilated Cystic Spaces Present,Anal Canal Neuroendocrine Tumor G1,0
7104,Dedifferentiated Malignant Infiltrate,Anal Canal Neuroendocrine Tumor G1,0
7105,Mammary Gland Type Features Present,Anal Canal Neuroendocrine Tumor G1,0
7106,Ectopic Tissue,Anal Canal Neuroendocrine Tumor G1,0
7107,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anal Canal Neuroendocrine Tumor G1,0
7108,Coronary Vessel Lesion,Mixed cell adenoma,0
7109,Index Lesion,Mixed cell adenoma,0
7110,Non-Index Lesion,Mixed cell adenoma,0
7111,Mushroom-Shaped Lesion,Mixed cell adenoma,0
7112,Annular Lesion,Mixed cell adenoma,0
7113,Dilated Cystic Spaces Present,Functioning Pituitary Gland Microadenoma,0
7114,Dedifferentiated Malignant Infiltrate,Functioning Pituitary Gland Microadenoma,0
7115,Mammary Gland Type Features Present,Functioning Pituitary Gland Microadenoma,0
7116,Ectopic Tissue,Functioning Pituitary Gland Microadenoma,0
7117,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Functioning Pituitary Gland Microadenoma,0
7118,Coronary Vessel Lesion,Colorectal Sessile Serrated Adenoma/Polyp,0
7119,Index Lesion,Colorectal Sessile Serrated Adenoma/Polyp,0
7120,Non-Index Lesion,Colorectal Sessile Serrated Adenoma/Polyp,0
7121,Mushroom-Shaped Lesion,Colorectal Sessile Serrated Adenoma/Polyp,0
7122,Annular Lesion,Colorectal Sessile Serrated Adenoma/Polyp,0
7123,Coronary Vessel Lesion,Rectal Sessile Serrated Adenoma/Polyp,0
7124,Index Lesion,Rectal Sessile Serrated Adenoma/Polyp,0
7125,Non-Index Lesion,Rectal Sessile Serrated Adenoma/Polyp,0
7126,Mushroom-Shaped Lesion,Rectal Sessile Serrated Adenoma/Polyp,0
7127,Annular Lesion,Rectal Sessile Serrated Adenoma/Polyp,0
7128,Dilated Cystic Spaces Present,Carcinoid tumor of pancreas,0
7129,Dedifferentiated Malignant Infiltrate,Carcinoid tumor of pancreas,0
7130,Mammary Gland Type Features Present,Carcinoid tumor of pancreas,0
7131,Ectopic Tissue,Carcinoid tumor of pancreas,0
7132,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Carcinoid tumor of pancreas,0
7133,Dilated Cystic Spaces Present,Low grade cervical glandular intraepithelial neoplasia,0
7134,Dedifferentiated Malignant Infiltrate,Low grade cervical glandular intraepithelial neoplasia,0
7135,Mammary Gland Type Features Present,Low grade cervical glandular intraepithelial neoplasia,0
7136,Ectopic Tissue,Low grade cervical glandular intraepithelial neoplasia,0
7137,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Low grade cervical glandular intraepithelial neoplasia,0
7138,Dilated Cystic Spaces Present,Squamous cell papilloma of skin,0
7139,Dedifferentiated Malignant Infiltrate,Squamous cell papilloma of skin,0
7140,Mammary Gland Type Features Present,Squamous cell papilloma of skin,0
7141,Ectopic Tissue,Squamous cell papilloma of skin,0
7142,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Squamous cell papilloma of skin,0
7143,Dilated Cystic Spaces Present,Colorectal Neuroendocrine Tumor,0
7144,Dedifferentiated Malignant Infiltrate,Colorectal Neuroendocrine Tumor,0
7145,Mammary Gland Type Features Present,Colorectal Neuroendocrine Tumor,0
7146,Ectopic Tissue,Colorectal Neuroendocrine Tumor,0
7147,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal Neuroendocrine Tumor,0
7148,Dilated Cystic Spaces Present,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,0
7149,Dedifferentiated Malignant Infiltrate,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,0
7150,Mammary Gland Type Features Present,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,0
7151,Ectopic Tissue,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,0
7152,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,0
7153,Dilated Cystic Spaces Present,Benign Ovarian Seromucinous Tumor,0
7154,Dedifferentiated Malignant Infiltrate,Benign Ovarian Seromucinous Tumor,0
7155,Mammary Gland Type Features Present,Benign Ovarian Seromucinous Tumor,0
7156,Ectopic Tissue,Benign Ovarian Seromucinous Tumor,0
7157,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Ovarian Seromucinous Tumor,0
7158,Coronary Vessel Lesion,Small Intestinal Tubular Adenoma,0
7159,Index Lesion,Small Intestinal Tubular Adenoma,0
7160,Non-Index Lesion,Small Intestinal Tubular Adenoma,0
7161,Mushroom-Shaped Lesion,Small Intestinal Tubular Adenoma,0
7162,Annular Lesion,Small Intestinal Tubular Adenoma,0
7163,Dilated Cystic Spaces Present,Testicular gonadoblastoma,0
7164,Dedifferentiated Malignant Infiltrate,Testicular gonadoblastoma,0
7165,Mammary Gland Type Features Present,Testicular gonadoblastoma,0
7166,Ectopic Tissue,Testicular gonadoblastoma,0
7167,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Testicular gonadoblastoma,0
7168,Dilated Cystic Spaces Present,Leydig Cell Tumor,0
7169,Dedifferentiated Malignant Infiltrate,Leydig Cell Tumor,0
7170,Mammary Gland Type Features Present,Leydig Cell Tumor,0
7171,Ectopic Tissue,Leydig Cell Tumor,0
7172,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Leydig Cell Tumor,0
7173,Dilated Cystic Spaces Present,Ovarian Sclerosing Stromal Tumor,0
7174,Dedifferentiated Malignant Infiltrate,Ovarian Sclerosing Stromal Tumor,0
7175,Mammary Gland Type Features Present,Ovarian Sclerosing Stromal Tumor,0
7176,Ectopic Tissue,Ovarian Sclerosing Stromal Tumor,0
7177,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Sclerosing Stromal Tumor,0
7178,Dilated Cystic Spaces Present,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0
7179,Dedifferentiated Malignant Infiltrate,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0
7180,Mammary Gland Type Features Present,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0
7181,Ectopic Tissue,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0
7182,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,0
7183,Coronary Vessel Lesion,"Leydig cell tumor, benign",0
7184,Index Lesion,"Leydig cell tumor, benign",0
7185,Non-Index Lesion,"Leydig cell tumor, benign",0
7186,Mushroom-Shaped Lesion,"Leydig cell tumor, benign",0
7187,Annular Lesion,"Leydig cell tumor, benign",0
7188,Dilated Cystic Spaces Present,Ovarian Microcystic Stromal Tumor,0
7189,Dedifferentiated Malignant Infiltrate,Ovarian Microcystic Stromal Tumor,0
7190,Mammary Gland Type Features Present,Ovarian Microcystic Stromal Tumor,0
7191,Ectopic Tissue,Ovarian Microcystic Stromal Tumor,0
7192,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Microcystic Stromal Tumor,0
7193,Dilated Cystic Spaces Present,Stromal tumor of ovary,0
7194,Dedifferentiated Malignant Infiltrate,Stromal tumor of ovary,0
7195,Mammary Gland Type Features Present,Stromal tumor of ovary,0
7196,Ectopic Tissue,Stromal tumor of ovary,0
7197,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stromal tumor of ovary,0
7198,Dilated Cystic Spaces Present,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",0
7199,Dedifferentiated Malignant Infiltrate,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",0
7200,Mammary Gland Type Features Present,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",0
7201,Ectopic Tissue,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",0
7202,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",0
7203,Dilated Cystic Spaces Present,Testicular Large Cell Calcifying Sertoli Cell Tumor,0
7204,Dedifferentiated Malignant Infiltrate,Testicular Large Cell Calcifying Sertoli Cell Tumor,0
7205,Mammary Gland Type Features Present,Testicular Large Cell Calcifying Sertoli Cell Tumor,0
7206,Ectopic Tissue,Testicular Large Cell Calcifying Sertoli Cell Tumor,0
7207,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Testicular Large Cell Calcifying Sertoli Cell Tumor,0
7208,Dilated Cystic Spaces Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7209,Dedifferentiated Malignant Infiltrate,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7210,Mammary Gland Type Features Present,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7211,Ectopic Tissue,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7212,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Ovarian Retiform Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7213,Dilated Cystic Spaces Present,Juvenile type ovarian granulosa cell tumor,0
7214,Dedifferentiated Malignant Infiltrate,Juvenile type ovarian granulosa cell tumor,0
7215,Mammary Gland Type Features Present,Juvenile type ovarian granulosa cell tumor,0
7216,Ectopic Tissue,Juvenile type ovarian granulosa cell tumor,0
7217,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Juvenile type ovarian granulosa cell tumor,0
7218,Dilated Cystic Spaces Present,Tumor of the Thecoma/Fibroma Group,0
7219,Dedifferentiated Malignant Infiltrate,Tumor of the Thecoma/Fibroma Group,0
7220,Mammary Gland Type Features Present,Tumor of the Thecoma/Fibroma Group,0
7221,Ectopic Tissue,Tumor of the Thecoma/Fibroma Group,0
7222,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Tumor of the Thecoma/Fibroma Group,0
7223,Dilated Cystic Spaces Present,Testicular Thecoma,0
7224,Dedifferentiated Malignant Infiltrate,Testicular Thecoma,0
7225,Mammary Gland Type Features Present,Testicular Thecoma,0
7226,Ectopic Tissue,Testicular Thecoma,0
7227,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Testicular Thecoma,0
7228,Dilated Cystic Spaces Present,Ovarian Thecoma,0
7229,Dedifferentiated Malignant Infiltrate,Ovarian Thecoma,0
7230,Mammary Gland Type Features Present,Ovarian Thecoma,0
7231,Ectopic Tissue,Ovarian Thecoma,0
7232,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Thecoma,0
7233,Poorly Formed Pattern,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0
7234,Multinodular and Vacuolated Pattern,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0
7235,Reticular Growth Pattern,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0
7236,Microcystic Growth Pattern,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0
7237,Labyrinthine Growth Pattern,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",0
7238,Dilated Cystic Spaces Present,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7239,Dedifferentiated Malignant Infiltrate,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7240,Mammary Gland Type Features Present,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7241,Ectopic Tissue,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7242,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7243,Dilated Cystic Spaces Present,Benign Testicular Sertoli Cell Tumor,0
7244,Dedifferentiated Malignant Infiltrate,Benign Testicular Sertoli Cell Tumor,0
7245,Mammary Gland Type Features Present,Benign Testicular Sertoli Cell Tumor,0
7246,Ectopic Tissue,Benign Testicular Sertoli Cell Tumor,0
7247,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Testicular Sertoli Cell Tumor,0
7248,Dilated Cystic Spaces Present,Ovarian Sex Cord Tumor with Annular Tubules,0
7249,Dedifferentiated Malignant Infiltrate,Ovarian Sex Cord Tumor with Annular Tubules,0
7250,Mammary Gland Type Features Present,Ovarian Sex Cord Tumor with Annular Tubules,0
7251,Ectopic Tissue,Ovarian Sex Cord Tumor with Annular Tubules,0
7252,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Sex Cord Tumor with Annular Tubules,0
7253,Dilated Cystic Spaces Present,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7254,Dedifferentiated Malignant Infiltrate,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7255,Mammary Gland Type Features Present,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7256,Ectopic Tissue,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7257,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7258,Dilated Cystic Spaces Present,Juvenile granulosa cell tumor,0
7259,Dedifferentiated Malignant Infiltrate,Juvenile granulosa cell tumor,0
7260,Mammary Gland Type Features Present,Juvenile granulosa cell tumor,0
7261,Ectopic Tissue,Juvenile granulosa cell tumor,0
7262,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Juvenile granulosa cell tumor,0
7263,Dilated Cystic Spaces Present,Ovarian gonadoblastoma,0
7264,Dedifferentiated Malignant Infiltrate,Ovarian gonadoblastoma,0
7265,Mammary Gland Type Features Present,Ovarian gonadoblastoma,0
7266,Ectopic Tissue,Ovarian gonadoblastoma,0
7267,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian gonadoblastoma,0
7268,Dilated Cystic Spaces Present,Malignant Ovarian Sex Cord-Stromal Tumor,0
7269,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Sex Cord-Stromal Tumor,0
7270,Mammary Gland Type Features Present,Malignant Ovarian Sex Cord-Stromal Tumor,0
7271,Ectopic Tissue,Malignant Ovarian Sex Cord-Stromal Tumor,0
7272,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Sex Cord-Stromal Tumor,0
7273,Dilated Cystic Spaces Present,Benign Ovarian Thecoma,0
7274,Dedifferentiated Malignant Infiltrate,Benign Ovarian Thecoma,0
7275,Mammary Gland Type Features Present,Benign Ovarian Thecoma,0
7276,Ectopic Tissue,Benign Ovarian Thecoma,0
7277,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Ovarian Thecoma,0
7278,Dilated Cystic Spaces Present,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,0
7279,Dedifferentiated Malignant Infiltrate,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,0
7280,Mammary Gland Type Features Present,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,0
7281,Ectopic Tissue,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,0
7282,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Sertoli-Leydig Cell Tumor with Heterologous Elements,0
7283,Dilated Cystic Spaces Present,"Ovarian Leydig Cell Tumor, Non-Hilar Type",0
7284,Dedifferentiated Malignant Infiltrate,"Ovarian Leydig Cell Tumor, Non-Hilar Type",0
7285,Mammary Gland Type Features Present,"Ovarian Leydig Cell Tumor, Non-Hilar Type",0
7286,Ectopic Tissue,"Ovarian Leydig Cell Tumor, Non-Hilar Type",0
7287,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Ovarian Leydig Cell Tumor, Non-Hilar Type",0
7288,Dilated Cystic Spaces Present,Reproductive Endocrine Neoplasm,0
7289,Dedifferentiated Malignant Infiltrate,Reproductive Endocrine Neoplasm,0
7290,Mammary Gland Type Features Present,Reproductive Endocrine Neoplasm,0
7291,Ectopic Tissue,Reproductive Endocrine Neoplasm,0
7292,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Reproductive Endocrine Neoplasm,0
7293,Dilated Cystic Spaces Present,Atypical Pituitary Gland Adenoma,0
7294,Dedifferentiated Malignant Infiltrate,Atypical Pituitary Gland Adenoma,0
7295,Mammary Gland Type Features Present,Atypical Pituitary Gland Adenoma,0
7296,Ectopic Tissue,Atypical Pituitary Gland Adenoma,0
7297,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Atypical Pituitary Gland Adenoma,0
7298,Dilated Cystic Spaces Present,Testicular Tumor of the Thecoma/Fibroma Group,0
7299,Dedifferentiated Malignant Infiltrate,Testicular Tumor of the Thecoma/Fibroma Group,0
7300,Mammary Gland Type Features Present,Testicular Tumor of the Thecoma/Fibroma Group,0
7301,Ectopic Tissue,Testicular Tumor of the Thecoma/Fibroma Group,0
7302,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Testicular Tumor of the Thecoma/Fibroma Group,0
7303,Dilated Cystic Spaces Present,Malignant Testicular Sex Cord-Stromal Tumor,0
7304,Dedifferentiated Malignant Infiltrate,Malignant Testicular Sex Cord-Stromal Tumor,0
7305,Mammary Gland Type Features Present,Malignant Testicular Sex Cord-Stromal Tumor,0
7306,Ectopic Tissue,Malignant Testicular Sex Cord-Stromal Tumor,0
7307,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Testicular Sex Cord-Stromal Tumor,0
7308,Dilated Cystic Spaces Present,Sex Cord-Stromal Tumor,0
7309,Dedifferentiated Malignant Infiltrate,Sex Cord-Stromal Tumor,0
7310,Mammary Gland Type Features Present,Sex Cord-Stromal Tumor,0
7311,Ectopic Tissue,Sex Cord-Stromal Tumor,0
7312,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sex Cord-Stromal Tumor,0
7313,Dilated Cystic Spaces Present,Ovarian Granulosa-Stromal Cell Tumor,0
7314,Dedifferentiated Malignant Infiltrate,Ovarian Granulosa-Stromal Cell Tumor,0
7315,Mammary Gland Type Features Present,Ovarian Granulosa-Stromal Cell Tumor,0
7316,Ectopic Tissue,Ovarian Granulosa-Stromal Cell Tumor,0
7317,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Granulosa-Stromal Cell Tumor,0
7318,Dilated Cystic Spaces Present,Benign Sertoli Cell Tumor,0
7319,Dedifferentiated Malignant Infiltrate,Benign Sertoli Cell Tumor,0
7320,Mammary Gland Type Features Present,Benign Sertoli Cell Tumor,0
7321,Ectopic Tissue,Benign Sertoli Cell Tumor,0
7322,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Sertoli Cell Tumor,0
7323,Dilated Cystic Spaces Present,Ovarian Sertoli Cell Tumor with Lipid Storage,0
7324,Dedifferentiated Malignant Infiltrate,Ovarian Sertoli Cell Tumor with Lipid Storage,0
7325,Mammary Gland Type Features Present,Ovarian Sertoli Cell Tumor with Lipid Storage,0
7326,Ectopic Tissue,Ovarian Sertoli Cell Tumor with Lipid Storage,0
7327,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Sertoli Cell Tumor with Lipid Storage,0
7328,Dilated Cystic Spaces Present,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
7329,Dedifferentiated Malignant Infiltrate,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
7330,Mammary Gland Type Features Present,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
7331,Ectopic Tissue,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
7332,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Juvenile Type Bilateral Ovarian Granulosa Cell Tumor,0
7333,Dilated Cystic Spaces Present,Hilus cell tumor of ovary,0
7334,Dedifferentiated Malignant Infiltrate,Hilus cell tumor of ovary,0
7335,Mammary Gland Type Features Present,Hilus cell tumor of ovary,0
7336,Ectopic Tissue,Hilus cell tumor of ovary,0
7337,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Hilus cell tumor of ovary,0
7338,Dilated Cystic Spaces Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7339,Dedifferentiated Malignant Infiltrate,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7340,Mammary Gland Type Features Present,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7341,Ectopic Tissue,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7342,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7343,Dilated Cystic Spaces Present,Thecoma,0
7344,Dedifferentiated Malignant Infiltrate,Thecoma,0
7345,Mammary Gland Type Features Present,Thecoma,0
7346,Ectopic Tissue,Thecoma,0
7347,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thecoma,0
7348,Dilated Cystic Spaces Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",0
7349,Dedifferentiated Malignant Infiltrate,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",0
7350,Mammary Gland Type Features Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",0
7351,Ectopic Tissue,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",0
7352,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",0
7353,Dilated Cystic Spaces Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",0
7354,Dedifferentiated Malignant Infiltrate,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",0
7355,Mammary Gland Type Features Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",0
7356,Ectopic Tissue,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",0
7357,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Testicular Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated",0
7358,Dilated Cystic Spaces Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",0
7359,Dedifferentiated Malignant Infiltrate,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",0
7360,Mammary Gland Type Features Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",0
7361,Ectopic Tissue,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",0
7362,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",0
7363,Dilated Cystic Spaces Present,granulosa cell tumor,0
7364,Dedifferentiated Malignant Infiltrate,granulosa cell tumor,0
7365,Mammary Gland Type Features Present,granulosa cell tumor,0
7366,Ectopic Tissue,granulosa cell tumor,0
7367,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,granulosa cell tumor,0
7368,Dilated Cystic Spaces Present,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,0
7369,Dedifferentiated Malignant Infiltrate,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,0
7370,Mammary Gland Type Features Present,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,0
7371,Ectopic Tissue,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,0
7372,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements,0
7373,Dilated Cystic Spaces Present,"Leydig cell tumor, malignant",0
7374,Dedifferentiated Malignant Infiltrate,"Leydig cell tumor, malignant",0
7375,Mammary Gland Type Features Present,"Leydig cell tumor, malignant",0
7376,Ectopic Tissue,"Leydig cell tumor, malignant",0
7377,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Leydig cell tumor, malignant",0
7378,Dilated Cystic Spaces Present,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
7379,Dedifferentiated Malignant Infiltrate,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
7380,Mammary Gland Type Features Present,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
7381,Ectopic Tissue,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
7382,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types,0
7383,Dilated Cystic Spaces Present,Malignant Testicular Sertoli Cell Tumor,0
7384,Dedifferentiated Malignant Infiltrate,Malignant Testicular Sertoli Cell Tumor,0
7385,Mammary Gland Type Features Present,Malignant Testicular Sertoli Cell Tumor,0
7386,Ectopic Tissue,Malignant Testicular Sertoli Cell Tumor,0
7387,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Testicular Sertoli Cell Tumor,0
7388,Dilated Cystic Spaces Present,Ovarian Retiform Sertoli-Leydig Cell Tumor,0
7389,Dedifferentiated Malignant Infiltrate,Ovarian Retiform Sertoli-Leydig Cell Tumor,0
7390,Mammary Gland Type Features Present,Ovarian Retiform Sertoli-Leydig Cell Tumor,0
7391,Ectopic Tissue,Ovarian Retiform Sertoli-Leydig Cell Tumor,0
7392,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Retiform Sertoli-Leydig Cell Tumor,0
7393,Dilated Cystic Spaces Present,Testicular Sclerosing Sertoli Cell Tumor,0
7394,Dedifferentiated Malignant Infiltrate,Testicular Sclerosing Sertoli Cell Tumor,0
7395,Mammary Gland Type Features Present,Testicular Sclerosing Sertoli Cell Tumor,0
7396,Ectopic Tissue,Testicular Sclerosing Sertoli Cell Tumor,0
7397,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Testicular Sclerosing Sertoli Cell Tumor,0
7398,Dilated Cystic Spaces Present,Adult Type Ovarian Granulosa Cell Tumor,0
7399,Dedifferentiated Malignant Infiltrate,Adult Type Ovarian Granulosa Cell Tumor,0
7400,Mammary Gland Type Features Present,Adult Type Ovarian Granulosa Cell Tumor,0
7401,Ectopic Tissue,Adult Type Ovarian Granulosa Cell Tumor,0
7402,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adult Type Ovarian Granulosa Cell Tumor,0
7403,Dilated Cystic Spaces Present,Leydig cell neoplasm of testis,0
7404,Dedifferentiated Malignant Infiltrate,Leydig cell neoplasm of testis,0
7405,Mammary Gland Type Features Present,Leydig cell neoplasm of testis,0
7406,Ectopic Tissue,Leydig cell neoplasm of testis,0
7407,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Leydig cell neoplasm of testis,0
7408,Dilated Cystic Spaces Present,Ovarian Fibromata,0
7409,Dedifferentiated Malignant Infiltrate,Ovarian Fibromata,0
7410,Mammary Gland Type Features Present,Ovarian Fibromata,0
7411,Ectopic Tissue,Ovarian Fibromata,0
7412,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Fibromata,0
7413,Dilated Cystic Spaces Present,Malignant Granulosa Cell Tumor,0
7414,Dedifferentiated Malignant Infiltrate,Malignant Granulosa Cell Tumor,0
7415,Mammary Gland Type Features Present,Malignant Granulosa Cell Tumor,0
7416,Ectopic Tissue,Malignant Granulosa Cell Tumor,0
7417,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Granulosa Cell Tumor,0
7418,Dilated Cystic Spaces Present,Benign Ovarian Luteinized Thecoma,0
7419,Dedifferentiated Malignant Infiltrate,Benign Ovarian Luteinized Thecoma,0
7420,Mammary Gland Type Features Present,Benign Ovarian Luteinized Thecoma,0
7421,Ectopic Tissue,Benign Ovarian Luteinized Thecoma,0
7422,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Ovarian Luteinized Thecoma,0
7423,Dilated Cystic Spaces Present,Ovarian Stromal-Leydig Cell Tumor,0
7424,Dedifferentiated Malignant Infiltrate,Ovarian Stromal-Leydig Cell Tumor,0
7425,Mammary Gland Type Features Present,Ovarian Stromal-Leydig Cell Tumor,0
7426,Ectopic Tissue,Ovarian Stromal-Leydig Cell Tumor,0
7427,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Stromal-Leydig Cell Tumor,0
7428,Dilated Cystic Spaces Present,Lipid cell tumor of ovary,0
7429,Dedifferentiated Malignant Infiltrate,Lipid cell tumor of ovary,0
7430,Mammary Gland Type Features Present,Lipid cell tumor of ovary,0
7431,Ectopic Tissue,Lipid cell tumor of ovary,0
7432,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Lipid cell tumor of ovary,0
7433,Dilated Cystic Spaces Present,Ovarian Stromal Tumor with Minor Sex Cord Elements,0
7434,Dedifferentiated Malignant Infiltrate,Ovarian Stromal Tumor with Minor Sex Cord Elements,0
7435,Mammary Gland Type Features Present,Ovarian Stromal Tumor with Minor Sex Cord Elements,0
7436,Ectopic Tissue,Ovarian Stromal Tumor with Minor Sex Cord Elements,0
7437,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Stromal Tumor with Minor Sex Cord Elements,0
7438,Dilated Cystic Spaces Present,malignant steroid cell tumor of ovary,0
7439,Dedifferentiated Malignant Infiltrate,malignant steroid cell tumor of ovary,0
7440,Mammary Gland Type Features Present,malignant steroid cell tumor of ovary,0
7441,Ectopic Tissue,malignant steroid cell tumor of ovary,0
7442,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,malignant steroid cell tumor of ovary,0
7443,Dilated Cystic Spaces Present,Malignant Sertoli Cell Tumor,0
7444,Dedifferentiated Malignant Infiltrate,Malignant Sertoli Cell Tumor,0
7445,Mammary Gland Type Features Present,Malignant Sertoli Cell Tumor,0
7446,Ectopic Tissue,Malignant Sertoli Cell Tumor,0
7447,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Sertoli Cell Tumor,0
7448,Dilated Cystic Spaces Present,Gonadoblastoma,0
7449,Dedifferentiated Malignant Infiltrate,Gonadoblastoma,0
7450,Mammary Gland Type Features Present,Gonadoblastoma,0
7451,Ectopic Tissue,Gonadoblastoma,0
7452,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gonadoblastoma,0
7453,Dilated Cystic Spaces Present,Sertoli cell tumor of testis,0
7454,Dedifferentiated Malignant Infiltrate,Sertoli cell tumor of testis,0
7455,Mammary Gland Type Features Present,Sertoli cell tumor of testis,0
7456,Ectopic Tissue,Sertoli cell tumor of testis,0
7457,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sertoli cell tumor of testis,0
7458,Dilated Cystic Spaces Present,Ovarian gynandroblastoma,0
7459,Dedifferentiated Malignant Infiltrate,Ovarian gynandroblastoma,0
7460,Mammary Gland Type Features Present,Ovarian gynandroblastoma,0
7461,Ectopic Tissue,Ovarian gynandroblastoma,0
7462,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian gynandroblastoma,0
7463,Dilated Cystic Spaces Present,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0
7464,Dedifferentiated Malignant Infiltrate,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0
7465,Mammary Gland Type Features Present,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0
7466,Ectopic Tissue,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0
7467,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Sex Cord-Stromal Tumor Associated with Peutz-Jeghers Syndrome,0
7468,Dilated Cystic Spaces Present,Typical Ovarian Thecoma,0
7469,Dedifferentiated Malignant Infiltrate,Typical Ovarian Thecoma,0
7470,Mammary Gland Type Features Present,Typical Ovarian Thecoma,0
7471,Ectopic Tissue,Typical Ovarian Thecoma,0
7472,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Typical Ovarian Thecoma,0
7473,Dilated Cystic Spaces Present,Ovarian Signet Ring Stromal Tumor,0
7474,Dedifferentiated Malignant Infiltrate,Ovarian Signet Ring Stromal Tumor,0
7475,Mammary Gland Type Features Present,Ovarian Signet Ring Stromal Tumor,0
7476,Ectopic Tissue,Ovarian Signet Ring Stromal Tumor,0
7477,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Signet Ring Stromal Tumor,0
7478,Dilated Cystic Spaces Present,Ovarian Sertoli-Stromal Cell Tumor,0
7479,Dedifferentiated Malignant Infiltrate,Ovarian Sertoli-Stromal Cell Tumor,0
7480,Mammary Gland Type Features Present,Ovarian Sertoli-Stromal Cell Tumor,0
7481,Ectopic Tissue,Ovarian Sertoli-Stromal Cell Tumor,0
7482,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Sertoli-Stromal Cell Tumor,0
7483,Dilated Cystic Spaces Present,Benign Ovarian Sex Cord-Stromal Tumor,0
7484,Dedifferentiated Malignant Infiltrate,Benign Ovarian Sex Cord-Stromal Tumor,0
7485,Mammary Gland Type Features Present,Benign Ovarian Sex Cord-Stromal Tumor,0
7486,Ectopic Tissue,Benign Ovarian Sex Cord-Stromal Tumor,0
7487,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Ovarian Sex Cord-Stromal Tumor,0
7488,Dilated Cystic Spaces Present,Adult Type Granulosa Cell Tumor,0
7489,Dedifferentiated Malignant Infiltrate,Adult Type Granulosa Cell Tumor,0
7490,Mammary Gland Type Features Present,Adult Type Granulosa Cell Tumor,0
7491,Ectopic Tissue,Adult Type Granulosa Cell Tumor,0
7492,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adult Type Granulosa Cell Tumor,0
7493,Dilated Cystic Spaces Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7494,Dedifferentiated Malignant Infiltrate,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7495,Mammary Gland Type Features Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7496,Ectopic Tissue,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7497,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",0
7498,Dilated Cystic Spaces Present,Luteoma,0
7499,Dedifferentiated Malignant Infiltrate,Luteoma,0
7500,Mammary Gland Type Features Present,Luteoma,0
7501,Ectopic Tissue,Luteoma,0
7502,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Luteoma,0
7503,Coronary Vessel Lesion,Adult Type Testicular Granulosa Cell Tumor,0
7504,Index Lesion,Adult Type Testicular Granulosa Cell Tumor,0
7505,Non-Index Lesion,Adult Type Testicular Granulosa Cell Tumor,0
7506,Mushroom-Shaped Lesion,Adult Type Testicular Granulosa Cell Tumor,0
7507,Annular Lesion,Adult Type Testicular Granulosa Cell Tumor,0
7508,Dilated Cystic Spaces Present,Juvenile Type Testicular Granulosa Cell Tumor,0
7509,Dedifferentiated Malignant Infiltrate,Juvenile Type Testicular Granulosa Cell Tumor,0
7510,Mammary Gland Type Features Present,Juvenile Type Testicular Granulosa Cell Tumor,0
7511,Ectopic Tissue,Juvenile Type Testicular Granulosa Cell Tumor,0
7512,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Juvenile Type Testicular Granulosa Cell Tumor,0
7513,Dilated Cystic Spaces Present,Ovarian Tumor of the Thecoma/Fibroma Group,0
7514,Dedifferentiated Malignant Infiltrate,Ovarian Tumor of the Thecoma/Fibroma Group,0
7515,Mammary Gland Type Features Present,Ovarian Tumor of the Thecoma/Fibroma Group,0
7516,Ectopic Tissue,Ovarian Tumor of the Thecoma/Fibroma Group,0
7517,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Tumor of the Thecoma/Fibroma Group,0
7518,Dilated Cystic Spaces Present,Ovarian Cellular Fibroma,0
7519,Dedifferentiated Malignant Infiltrate,Ovarian Cellular Fibroma,0
7520,Mammary Gland Type Features Present,Ovarian Cellular Fibroma,0
7521,Ectopic Tissue,Ovarian Cellular Fibroma,0
7522,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Cellular Fibroma,0
7523,Dilated Cystic Spaces Present,fibroma of testis,0
7524,Dedifferentiated Malignant Infiltrate,fibroma of testis,0
7525,Mammary Gland Type Features Present,fibroma of testis,0
7526,Ectopic Tissue,fibroma of testis,0
7527,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,fibroma of testis,0
7528,Dilated Cystic Spaces Present,Mixed germ cell-sex cord-stromal tumor,0
7529,Dedifferentiated Malignant Infiltrate,Mixed germ cell-sex cord-stromal tumor,0
7530,Mammary Gland Type Features Present,Mixed germ cell-sex cord-stromal tumor,0
7531,Ectopic Tissue,Mixed germ cell-sex cord-stromal tumor,0
7532,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Mixed germ cell-sex cord-stromal tumor,0
7533,Dilated Cystic Spaces Present,Sex cord stromal tumor of testis,0
7534,Dedifferentiated Malignant Infiltrate,Sex cord stromal tumor of testis,0
7535,Mammary Gland Type Features Present,Sex cord stromal tumor of testis,0
7536,Ectopic Tissue,Sex cord stromal tumor of testis,0
7537,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sex cord stromal tumor of testis,0
7538,Dilated Cystic Spaces Present,Sertoli-Leydig cell tumor of ovary,0
7539,Dedifferentiated Malignant Infiltrate,Sertoli-Leydig cell tumor of ovary,0
7540,Mammary Gland Type Features Present,Sertoli-Leydig cell tumor of ovary,0
7541,Ectopic Tissue,Sertoli-Leydig cell tumor of ovary,0
7542,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sertoli-Leydig cell tumor of ovary,0
7543,Dilated Cystic Spaces Present,"Thecoma, luteinized",0
7544,Dedifferentiated Malignant Infiltrate,"Thecoma, luteinized",0
7545,Mammary Gland Type Features Present,"Thecoma, luteinized",0
7546,Ectopic Tissue,"Thecoma, luteinized",0
7547,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Thecoma, luteinized",0
7548,Dilated Cystic Spaces Present,Ovarian Granulosa Cell Tumor,0
7549,Dedifferentiated Malignant Infiltrate,Ovarian Granulosa Cell Tumor,0
7550,Mammary Gland Type Features Present,Ovarian Granulosa Cell Tumor,0
7551,Ectopic Tissue,Ovarian Granulosa Cell Tumor,0
7552,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Granulosa Cell Tumor,0
7553,Dilated Cystic Spaces Present,Malignant Ovarian Luteinized Thecoma,0
7554,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Luteinized Thecoma,0
7555,Mammary Gland Type Features Present,Malignant Ovarian Luteinized Thecoma,0
7556,Ectopic Tissue,Malignant Ovarian Luteinized Thecoma,0
7557,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Luteinized Thecoma,0
7558,Dilated Cystic Spaces Present,Ovarian Sertoli Cell Tumor,0
7559,Dedifferentiated Malignant Infiltrate,Ovarian Sertoli Cell Tumor,0
7560,Mammary Gland Type Features Present,Ovarian Sertoli Cell Tumor,0
7561,Ectopic Tissue,Ovarian Sertoli Cell Tumor,0
7562,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Sertoli Cell Tumor,0
7563,Dilated Cystic Spaces Present,Malignant Ovarian Granulosa Cell Tumor,0
7564,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Granulosa Cell Tumor,0
7565,Mammary Gland Type Features Present,Malignant Ovarian Granulosa Cell Tumor,0
7566,Ectopic Tissue,Malignant Ovarian Granulosa Cell Tumor,0
7567,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Granulosa Cell Tumor,0
7568,Dilated Cystic Spaces Present,Malignant Testicular Leydig Cell Tumor,0
7569,Dedifferentiated Malignant Infiltrate,Malignant Testicular Leydig Cell Tumor,0
7570,Mammary Gland Type Features Present,Malignant Testicular Leydig Cell Tumor,0
7571,Ectopic Tissue,Malignant Testicular Leydig Cell Tumor,0
7572,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Testicular Leydig Cell Tumor,0
7573,Dilated Cystic Spaces Present,Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis,0
7574,Dedifferentiated Malignant Infiltrate,Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis,0
7575,Mammary Gland Type Features Present,Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis,0
7576,Ectopic Tissue,Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis,0
7577,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ovarian Luteinized Thecoma Associated with Sclerosing Peritonitis,0
7578,Dilated Cystic Spaces Present,Malignant sex-cord stromal tumor,0
7579,Dedifferentiated Malignant Infiltrate,Malignant sex-cord stromal tumor,0
7580,Mammary Gland Type Features Present,Malignant sex-cord stromal tumor,0
7581,Ectopic Tissue,Malignant sex-cord stromal tumor,0
7582,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant sex-cord stromal tumor,0
7583,Dilated Cystic Spaces Present,Granulosa cell tumor of the testis,0
7584,Dedifferentiated Malignant Infiltrate,Granulosa cell tumor of the testis,0
7585,Mammary Gland Type Features Present,Granulosa cell tumor of the testis,0
7586,Ectopic Tissue,Granulosa cell tumor of the testis,0
7587,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Granulosa cell tumor of the testis,0
7588,Dilated Cystic Spaces Present,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7589,Dedifferentiated Malignant Infiltrate,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7590,Mammary Gland Type Features Present,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7591,Ectopic Tissue,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7592,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Well Differentiated Ovarian Sertoli-Leydig Cell Tumor,0
7593,Dilated Cystic Spaces Present,Sertoli Cell Tumor,0
7594,Dedifferentiated Malignant Infiltrate,Sertoli Cell Tumor,0
7595,Mammary Gland Type Features Present,Sertoli Cell Tumor,0
7596,Ectopic Tissue,Sertoli Cell Tumor,0
7597,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sertoli Cell Tumor,0
7598,Dilated Cystic Spaces Present,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0
7599,Dedifferentiated Malignant Infiltrate,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0
7600,Mammary Gland Type Features Present,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0
7601,Ectopic Tissue,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0
7602,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,"Ovarian Steroid Cell Tumor, Not Otherwise Specified",0
7603,Dilated Cystic Spaces Present,Well Differentiated Ovarian Steroid Cell Tumor,0
7604,Dedifferentiated Malignant Infiltrate,Well Differentiated Ovarian Steroid Cell Tumor,0
7605,Mammary Gland Type Features Present,Well Differentiated Ovarian Steroid Cell Tumor,0
7606,Ectopic Tissue,Well Differentiated Ovarian Steroid Cell Tumor,0
7607,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Well Differentiated Ovarian Steroid Cell Tumor,0
7608,Dilated Cystic Spaces Present,Malignant Ovarian Thecoma,0
7609,Dedifferentiated Malignant Infiltrate,Malignant Ovarian Thecoma,0
7610,Mammary Gland Type Features Present,Malignant Ovarian Thecoma,0
7611,Ectopic Tissue,Malignant Ovarian Thecoma,0
7612,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Malignant Ovarian Thecoma,0
7613,Dilated Cystic Spaces Present,Stage II Gastric Neuroendocrine Tumor AJCC v8,0
7614,Dedifferentiated Malignant Infiltrate,Stage II Gastric Neuroendocrine Tumor AJCC v8,0
7615,Mammary Gland Type Features Present,Stage II Gastric Neuroendocrine Tumor AJCC v8,0
7616,Ectopic Tissue,Stage II Gastric Neuroendocrine Tumor AJCC v8,0
7617,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Gastric Neuroendocrine Tumor AJCC v8,0
7618,Dilated Cystic Spaces Present,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
7619,Dedifferentiated Malignant Infiltrate,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
7620,Mammary Gland Type Features Present,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
7621,Ectopic Tissue,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
7622,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
7623,Dilated Cystic Spaces Present,Stage II Jejunal Neuroendocrine Tumor AJCC v8,0
7624,Dedifferentiated Malignant Infiltrate,Stage II Jejunal Neuroendocrine Tumor AJCC v8,0
7625,Mammary Gland Type Features Present,Stage II Jejunal Neuroendocrine Tumor AJCC v8,0
7626,Ectopic Tissue,Stage II Jejunal Neuroendocrine Tumor AJCC v8,0
7627,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Jejunal Neuroendocrine Tumor AJCC v8,0
7628,Dilated Cystic Spaces Present,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,0
7629,Dedifferentiated Malignant Infiltrate,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,0
7630,Mammary Gland Type Features Present,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,0
7631,Ectopic Tissue,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,0
7632,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,0
7633,Dilated Cystic Spaces Present,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
7634,Dedifferentiated Malignant Infiltrate,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
7635,Mammary Gland Type Features Present,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
7636,Ectopic Tissue,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
7637,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colon Neuroendocrine Tumor by AJCC v8 Stage,0
7638,Dilated Cystic Spaces Present,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage,0
7639,Dedifferentiated Malignant Infiltrate,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage,0
7640,Mammary Gland Type Features Present,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage,0
7641,Ectopic Tissue,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage,0
7642,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage,0
7643,Dilated Cystic Spaces Present,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,0
7644,Dedifferentiated Malignant Infiltrate,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,0
7645,Mammary Gland Type Features Present,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,0
7646,Ectopic Tissue,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,0
7647,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,0
7648,Dilated Cystic Spaces Present,Anal Ectopic Fibroadenoma,0
7649,Dedifferentiated Malignant Infiltrate,Anal Ectopic Fibroadenoma,0
7650,Mammary Gland Type Features Present,Anal Ectopic Fibroadenoma,0
7651,Ectopic Tissue,Anal Ectopic Fibroadenoma,0
7652,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anal Ectopic Fibroadenoma,0
7653,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,0
7654,Isolated Tumor Cells,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,0
7655,Pleural/Elastic Layer Invasion,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,0
7656,Presence of Extravascular Matrix Patterns,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,0
7657,Ductopenia,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,0
7658,Coronary Vessel Lesion,Metastatic Paraganglioma,0
7659,Index Lesion,Metastatic Paraganglioma,0
7660,Non-Index Lesion,Metastatic Paraganglioma,0
7661,Mushroom-Shaped Lesion,Metastatic Paraganglioma,0
7662,Annular Lesion,Metastatic Paraganglioma,0
7663,Dilated Cystic Spaces Present,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7664,Dedifferentiated Malignant Infiltrate,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7665,Mammary Gland Type Features Present,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7666,Ectopic Tissue,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7667,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
7668,Dilated Cystic Spaces Present,Stage IV Gastric Neuroendocrine Tumor AJCC v8,0
7669,Dedifferentiated Malignant Infiltrate,Stage IV Gastric Neuroendocrine Tumor AJCC v8,0
7670,Mammary Gland Type Features Present,Stage IV Gastric Neuroendocrine Tumor AJCC v8,0
7671,Ectopic Tissue,Stage IV Gastric Neuroendocrine Tumor AJCC v8,0
7672,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Gastric Neuroendocrine Tumor AJCC v8,0
7673,Dilated Cystic Spaces Present,Stage II Duodenal Neuroendocrine Tumor AJCC v8,0
7674,Dedifferentiated Malignant Infiltrate,Stage II Duodenal Neuroendocrine Tumor AJCC v8,0
7675,Mammary Gland Type Features Present,Stage II Duodenal Neuroendocrine Tumor AJCC v8,0
7676,Ectopic Tissue,Stage II Duodenal Neuroendocrine Tumor AJCC v8,0
7677,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Duodenal Neuroendocrine Tumor AJCC v8,0
7678,Dilated Cystic Spaces Present,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7679,Dedifferentiated Malignant Infiltrate,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7680,Mammary Gland Type Features Present,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7681,Ectopic Tissue,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7682,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7683,Dilated Cystic Spaces Present,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7684,Dedifferentiated Malignant Infiltrate,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7685,Mammary Gland Type Features Present,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7686,Ectopic Tissue,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7687,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7688,Dilated Cystic Spaces Present,Ileal Neuroendocrine Tumor by AJCC v8 Stage,0
7689,Dedifferentiated Malignant Infiltrate,Ileal Neuroendocrine Tumor by AJCC v8 Stage,0
7690,Mammary Gland Type Features Present,Ileal Neuroendocrine Tumor by AJCC v8 Stage,0
7691,Ectopic Tissue,Ileal Neuroendocrine Tumor by AJCC v8 Stage,0
7692,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ileal Neuroendocrine Tumor by AJCC v8 Stage,0
7693,Dilated Cystic Spaces Present,Stage IV Appendix Neuroendocrine Tumor AJCC v8,0
7694,Dedifferentiated Malignant Infiltrate,Stage IV Appendix Neuroendocrine Tumor AJCC v8,0
7695,Mammary Gland Type Features Present,Stage IV Appendix Neuroendocrine Tumor AJCC v8,0
7696,Ectopic Tissue,Stage IV Appendix Neuroendocrine Tumor AJCC v8,0
7697,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Appendix Neuroendocrine Tumor AJCC v8,0
7698,Dilated Cystic Spaces Present,Stage I Colorectal Neuroendocrine Tumor AJCC v8,0
7699,Dedifferentiated Malignant Infiltrate,Stage I Colorectal Neuroendocrine Tumor AJCC v8,0
7700,Mammary Gland Type Features Present,Stage I Colorectal Neuroendocrine Tumor AJCC v8,0
7701,Ectopic Tissue,Stage I Colorectal Neuroendocrine Tumor AJCC v8,0
7702,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Colorectal Neuroendocrine Tumor AJCC v8,0
7703,Dilated Cystic Spaces Present,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,0
7704,Dedifferentiated Malignant Infiltrate,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,0
7705,Mammary Gland Type Features Present,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,0
7706,Ectopic Tissue,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,0
7707,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,0
7708,Dilated Cystic Spaces Present,Colon Neuroendocrine Tumor,0
7709,Dedifferentiated Malignant Infiltrate,Colon Neuroendocrine Tumor,0
7710,Mammary Gland Type Features Present,Colon Neuroendocrine Tumor,0
7711,Ectopic Tissue,Colon Neuroendocrine Tumor,0
7712,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colon Neuroendocrine Tumor,0
7713,Dilated Cystic Spaces Present,Rectal Neuroendocrine Tumor,0
7714,Dedifferentiated Malignant Infiltrate,Rectal Neuroendocrine Tumor,0
7715,Mammary Gland Type Features Present,Rectal Neuroendocrine Tumor,0
7716,Ectopic Tissue,Rectal Neuroendocrine Tumor,0
7717,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Rectal Neuroendocrine Tumor,0
7718,Dilated Cystic Spaces Present,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
7719,Dedifferentiated Malignant Infiltrate,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
7720,Mammary Gland Type Features Present,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
7721,Ectopic Tissue,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
7722,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,0
7723,Dilated Cystic Spaces Present,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7724,Dedifferentiated Malignant Infiltrate,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7725,Mammary Gland Type Features Present,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7726,Ectopic Tissue,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7727,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
7728,Dilated Cystic Spaces Present,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7729,Dedifferentiated Malignant Infiltrate,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7730,Mammary Gland Type Features Present,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7731,Ectopic Tissue,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7732,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7733,Dilated Cystic Spaces Present,Stage III Jejunal Neuroendocrine Tumor AJCC v8,0
7734,Dedifferentiated Malignant Infiltrate,Stage III Jejunal Neuroendocrine Tumor AJCC v8,0
7735,Mammary Gland Type Features Present,Stage III Jejunal Neuroendocrine Tumor AJCC v8,0
7736,Ectopic Tissue,Stage III Jejunal Neuroendocrine Tumor AJCC v8,0
7737,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Jejunal Neuroendocrine Tumor AJCC v8,0
7738,Dilated Cystic Spaces Present,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,0
7739,Dedifferentiated Malignant Infiltrate,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,0
7740,Mammary Gland Type Features Present,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,0
7741,Ectopic Tissue,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,0
7742,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,0
7743,Dilated Cystic Spaces Present,Stage I Ileal Neuroendocrine Tumor AJCC v8,0
7744,Dedifferentiated Malignant Infiltrate,Stage I Ileal Neuroendocrine Tumor AJCC v8,0
7745,Mammary Gland Type Features Present,Stage I Ileal Neuroendocrine Tumor AJCC v8,0
7746,Ectopic Tissue,Stage I Ileal Neuroendocrine Tumor AJCC v8,0
7747,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Ileal Neuroendocrine Tumor AJCC v8,0
7748,Dilated Cystic Spaces Present,Stage III Ileal Neuroendocrine Tumor AJCC v8,0
7749,Dedifferentiated Malignant Infiltrate,Stage III Ileal Neuroendocrine Tumor AJCC v8,0
7750,Mammary Gland Type Features Present,Stage III Ileal Neuroendocrine Tumor AJCC v8,0
7751,Ectopic Tissue,Stage III Ileal Neuroendocrine Tumor AJCC v8,0
7752,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Ileal Neuroendocrine Tumor AJCC v8,0
7753,Dilated Cystic Spaces Present,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7754,Dedifferentiated Malignant Infiltrate,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7755,Mammary Gland Type Features Present,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7756,Ectopic Tissue,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7757,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
7758,Dilated Cystic Spaces Present,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,0
7759,Dedifferentiated Malignant Infiltrate,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,0
7760,Mammary Gland Type Features Present,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,0
7761,Ectopic Tissue,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,0
7762,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,0
7763,Dilated Cystic Spaces Present,Stage IV Colon Neuroendocrine Tumor AJCC v8,0
7764,Dedifferentiated Malignant Infiltrate,Stage IV Colon Neuroendocrine Tumor AJCC v8,0
7765,Mammary Gland Type Features Present,Stage IV Colon Neuroendocrine Tumor AJCC v8,0
7766,Ectopic Tissue,Stage IV Colon Neuroendocrine Tumor AJCC v8,0
7767,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Colon Neuroendocrine Tumor AJCC v8,0
7768,Dilated Cystic Spaces Present,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,0
7769,Dedifferentiated Malignant Infiltrate,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,0
7770,Mammary Gland Type Features Present,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,0
7771,Ectopic Tissue,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,0
7772,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIB Rectal Neuroendocrine Tumor AJCC v8,0
7773,Dilated Cystic Spaces Present,Stage III Thymoma AJCC v8,0
7774,Dedifferentiated Malignant Infiltrate,Stage III Thymoma AJCC v8,0
7775,Mammary Gland Type Features Present,Stage III Thymoma AJCC v8,0
7776,Ectopic Tissue,Stage III Thymoma AJCC v8,0
7777,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Thymoma AJCC v8,0
7778,Dilated Cystic Spaces Present,Stage IV Thymoma AJCC v8,0
7779,Dedifferentiated Malignant Infiltrate,Stage IV Thymoma AJCC v8,0
7780,Mammary Gland Type Features Present,Stage IV Thymoma AJCC v8,0
7781,Ectopic Tissue,Stage IV Thymoma AJCC v8,0
7782,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Thymoma AJCC v8,0
7783,Dilated Cystic Spaces Present,Stage IVA Thymoma AJCC v8,0
7784,Dedifferentiated Malignant Infiltrate,Stage IVA Thymoma AJCC v8,0
7785,Mammary Gland Type Features Present,Stage IVA Thymoma AJCC v8,0
7786,Ectopic Tissue,Stage IVA Thymoma AJCC v8,0
7787,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVA Thymoma AJCC v8,0
7788,Dilated Cystic Spaces Present,Gastric Neuroendocrine Tumor by AJCC v8 Stage,0
7789,Dedifferentiated Malignant Infiltrate,Gastric Neuroendocrine Tumor by AJCC v8 Stage,0
7790,Mammary Gland Type Features Present,Gastric Neuroendocrine Tumor by AJCC v8 Stage,0
7791,Ectopic Tissue,Gastric Neuroendocrine Tumor by AJCC v8 Stage,0
7792,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Gastric Neuroendocrine Tumor by AJCC v8 Stage,0
7793,Dilated Cystic Spaces Present,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7794,Dedifferentiated Malignant Infiltrate,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7795,Mammary Gland Type Features Present,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7796,Ectopic Tissue,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7797,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,0
7798,Dilated Cystic Spaces Present,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,0
7799,Dedifferentiated Malignant Infiltrate,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,0
7800,Mammary Gland Type Features Present,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,0
7801,Ectopic Tissue,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,0
7802,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,0
7803,Dilated Cystic Spaces Present,Stage IIA Colon Neuroendocrine Tumor AJCC v8,0
7804,Dedifferentiated Malignant Infiltrate,Stage IIA Colon Neuroendocrine Tumor AJCC v8,0
7805,Mammary Gland Type Features Present,Stage IIA Colon Neuroendocrine Tumor AJCC v8,0
7806,Ectopic Tissue,Stage IIA Colon Neuroendocrine Tumor AJCC v8,0
7807,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Colon Neuroendocrine Tumor AJCC v8,0
7808,Dilated Cystic Spaces Present,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,0
7809,Dedifferentiated Malignant Infiltrate,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,0
7810,Mammary Gland Type Features Present,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,0
7811,Ectopic Tissue,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,0
7812,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Colon Neuroendocrine Tumor AJCC v8,0
7813,Dilated Cystic Spaces Present,Rectal Neuroendocrine Tumor by AJCC v8 Stage,0
7814,Dedifferentiated Malignant Infiltrate,Rectal Neuroendocrine Tumor by AJCC v8 Stage,0
7815,Mammary Gland Type Features Present,Rectal Neuroendocrine Tumor by AJCC v8 Stage,0
7816,Ectopic Tissue,Rectal Neuroendocrine Tumor by AJCC v8 Stage,0
7817,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Rectal Neuroendocrine Tumor by AJCC v8 Stage,0
7818,Dilated Cystic Spaces Present,Stage I Rectal Neuroendocrine Tumor AJCC v8,0
7819,Dedifferentiated Malignant Infiltrate,Stage I Rectal Neuroendocrine Tumor AJCC v8,0
7820,Mammary Gland Type Features Present,Stage I Rectal Neuroendocrine Tumor AJCC v8,0
7821,Ectopic Tissue,Stage I Rectal Neuroendocrine Tumor AJCC v8,0
7822,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Rectal Neuroendocrine Tumor AJCC v8,0
7823,Dilated Cystic Spaces Present,Stage II Thymus Epithelial Neoplasm AJCC v8,0
7824,Dedifferentiated Malignant Infiltrate,Stage II Thymus Epithelial Neoplasm AJCC v8,0
7825,Mammary Gland Type Features Present,Stage II Thymus Epithelial Neoplasm AJCC v8,0
7826,Ectopic Tissue,Stage II Thymus Epithelial Neoplasm AJCC v8,0
7827,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Thymus Epithelial Neoplasm AJCC v8,0
7828,Dilated Cystic Spaces Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,0
7829,Dedifferentiated Malignant Infiltrate,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,0
7830,Mammary Gland Type Features Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,0
7831,Ectopic Tissue,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,0
7832,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,0
7833,Dilated Cystic Spaces Present,Stage IV Thymus Epithelial Neoplasm AJCC v8,0
7834,Dedifferentiated Malignant Infiltrate,Stage IV Thymus Epithelial Neoplasm AJCC v8,0
7835,Mammary Gland Type Features Present,Stage IV Thymus Epithelial Neoplasm AJCC v8,0
7836,Ectopic Tissue,Stage IV Thymus Epithelial Neoplasm AJCC v8,0
7837,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Thymus Epithelial Neoplasm AJCC v8,0
7838,Dilated Cystic Spaces Present,Stage IIIB Thymoma AJCC v8,0
7839,Dedifferentiated Malignant Infiltrate,Stage IIIB Thymoma AJCC v8,0
7840,Mammary Gland Type Features Present,Stage IIIB Thymoma AJCC v8,0
7841,Ectopic Tissue,Stage IIIB Thymoma AJCC v8,0
7842,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Thymoma AJCC v8,0
7843,Dilated Cystic Spaces Present,Refractory Abdominal Neuroendocrine Neoplasm,0
7844,Dedifferentiated Malignant Infiltrate,Refractory Abdominal Neuroendocrine Neoplasm,0
7845,Mammary Gland Type Features Present,Refractory Abdominal Neuroendocrine Neoplasm,0
7846,Ectopic Tissue,Refractory Abdominal Neuroendocrine Neoplasm,0
7847,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Abdominal Neuroendocrine Neoplasm,0
7848,Coronary Vessel Lesion,Locally Advanced Paraganglioma,0
7849,Index Lesion,Locally Advanced Paraganglioma,0
7850,Non-Index Lesion,Locally Advanced Paraganglioma,0
7851,Mushroom-Shaped Lesion,Locally Advanced Paraganglioma,0
7852,Annular Lesion,Locally Advanced Paraganglioma,0
7853,Dilated Cystic Spaces Present,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,0
7854,Dedifferentiated Malignant Infiltrate,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,0
7855,Mammary Gland Type Features Present,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,0
7856,Ectopic Tissue,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,0
7857,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,0
7858,Dilated Cystic Spaces Present,Stage II Ileal Neuroendocrine Tumor AJCC v8,0
7859,Dedifferentiated Malignant Infiltrate,Stage II Ileal Neuroendocrine Tumor AJCC v8,0
7860,Mammary Gland Type Features Present,Stage II Ileal Neuroendocrine Tumor AJCC v8,0
7861,Ectopic Tissue,Stage II Ileal Neuroendocrine Tumor AJCC v8,0
7862,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Ileal Neuroendocrine Tumor AJCC v8,0
7863,Dilated Cystic Spaces Present,Stage IV Ileal Neuroendocrine Tumor AJCC v8,0
7864,Dedifferentiated Malignant Infiltrate,Stage IV Ileal Neuroendocrine Tumor AJCC v8,0
7865,Mammary Gland Type Features Present,Stage IV Ileal Neuroendocrine Tumor AJCC v8,0
7866,Ectopic Tissue,Stage IV Ileal Neuroendocrine Tumor AJCC v8,0
7867,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Ileal Neuroendocrine Tumor AJCC v8,0
7868,Dilated Cystic Spaces Present,Stage II Appendix Neuroendocrine Tumor AJCC v8,0
7869,Dedifferentiated Malignant Infiltrate,Stage II Appendix Neuroendocrine Tumor AJCC v8,0
7870,Mammary Gland Type Features Present,Stage II Appendix Neuroendocrine Tumor AJCC v8,0
7871,Ectopic Tissue,Stage II Appendix Neuroendocrine Tumor AJCC v8,0
7872,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Appendix Neuroendocrine Tumor AJCC v8,0
7873,Dilated Cystic Spaces Present,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,0
7874,Dedifferentiated Malignant Infiltrate,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,0
7875,Mammary Gland Type Features Present,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,0
7876,Ectopic Tissue,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,0
7877,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Rectal Neuroendocrine Tumor AJCC v8,0
7878,Dilated Cystic Spaces Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8,0
7879,Dedifferentiated Malignant Infiltrate,Stage IV Rectal Neuroendocrine Tumor AJCC v8,0
7880,Mammary Gland Type Features Present,Stage IV Rectal Neuroendocrine Tumor AJCC v8,0
7881,Ectopic Tissue,Stage IV Rectal Neuroendocrine Tumor AJCC v8,0
7882,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Rectal Neuroendocrine Tumor AJCC v8,0
7883,Dilated Cystic Spaces Present,Thymus Epithelial Neoplasm by AJCC v8 Stage,0
7884,Dedifferentiated Malignant Infiltrate,Thymus Epithelial Neoplasm by AJCC v8 Stage,0
7885,Mammary Gland Type Features Present,Thymus Epithelial Neoplasm by AJCC v8 Stage,0
7886,Ectopic Tissue,Thymus Epithelial Neoplasm by AJCC v8 Stage,0
7887,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymus Epithelial Neoplasm by AJCC v8 Stage,0
7888,Dilated Cystic Spaces Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
7889,Dedifferentiated Malignant Infiltrate,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
7890,Mammary Gland Type Features Present,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
7891,Ectopic Tissue,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
7892,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVB Thymus Epithelial Neoplasm AJCC v8,0
7893,Dilated Cystic Spaces Present,Stage IIIA Thymoma AJCC v8,0
7894,Dedifferentiated Malignant Infiltrate,Stage IIIA Thymoma AJCC v8,0
7895,Mammary Gland Type Features Present,Stage IIIA Thymoma AJCC v8,0
7896,Ectopic Tissue,Stage IIIA Thymoma AJCC v8,0
7897,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIA Thymoma AJCC v8,0
7898,Dilated Cystic Spaces Present,Stage IVB Thymoma AJCC v8,0
7899,Dedifferentiated Malignant Infiltrate,Stage IVB Thymoma AJCC v8,0
7900,Mammary Gland Type Features Present,Stage IVB Thymoma AJCC v8,0
7901,Ectopic Tissue,Stage IVB Thymoma AJCC v8,0
7902,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVB Thymoma AJCC v8,0
7903,Dilated Cystic Spaces Present,Perineal Ectopic Fibroadenoma,0
7904,Dedifferentiated Malignant Infiltrate,Perineal Ectopic Fibroadenoma,0
7905,Mammary Gland Type Features Present,Perineal Ectopic Fibroadenoma,0
7906,Ectopic Tissue,Perineal Ectopic Fibroadenoma,0
7907,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Perineal Ectopic Fibroadenoma,0
7908,Dilated Cystic Spaces Present,Lung Adenofibroma,0
7909,Dedifferentiated Malignant Infiltrate,Lung Adenofibroma,0
7910,Mammary Gland Type Features Present,Lung Adenofibroma,0
7911,Ectopic Tissue,Lung Adenofibroma,0
7912,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Lung Adenofibroma,0
7913,Dilated Cystic Spaces Present,Stage I Duodenal Neuroendocrine Tumor AJCC v8,0
7914,Dedifferentiated Malignant Infiltrate,Stage I Duodenal Neuroendocrine Tumor AJCC v8,0
7915,Mammary Gland Type Features Present,Stage I Duodenal Neuroendocrine Tumor AJCC v8,0
7916,Ectopic Tissue,Stage I Duodenal Neuroendocrine Tumor AJCC v8,0
7917,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Duodenal Neuroendocrine Tumor AJCC v8,0
7918,Dilated Cystic Spaces Present,Duodenal Neuroendocrine Tumor,0
7919,Dedifferentiated Malignant Infiltrate,Duodenal Neuroendocrine Tumor,0
7920,Mammary Gland Type Features Present,Duodenal Neuroendocrine Tumor,0
7921,Ectopic Tissue,Duodenal Neuroendocrine Tumor,0
7922,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Duodenal Neuroendocrine Tumor,0
7923,Dilated Cystic Spaces Present,Stage I Jejunal Neuroendocrine Tumor AJCC v8,0
7924,Dedifferentiated Malignant Infiltrate,Stage I Jejunal Neuroendocrine Tumor AJCC v8,0
7925,Mammary Gland Type Features Present,Stage I Jejunal Neuroendocrine Tumor AJCC v8,0
7926,Ectopic Tissue,Stage I Jejunal Neuroendocrine Tumor AJCC v8,0
7927,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Jejunal Neuroendocrine Tumor AJCC v8,0
7928,Dilated Cystic Spaces Present,Stage I Appendix Neuroendocrine Tumor AJCC v8,0
7929,Dedifferentiated Malignant Infiltrate,Stage I Appendix Neuroendocrine Tumor AJCC v8,0
7930,Mammary Gland Type Features Present,Stage I Appendix Neuroendocrine Tumor AJCC v8,0
7931,Ectopic Tissue,Stage I Appendix Neuroendocrine Tumor AJCC v8,0
7932,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Appendix Neuroendocrine Tumor AJCC v8,0
7933,Dilated Cystic Spaces Present,Stage III Appendix Neuroendocrine Tumor AJCC v8,0
7934,Dedifferentiated Malignant Infiltrate,Stage III Appendix Neuroendocrine Tumor AJCC v8,0
7935,Mammary Gland Type Features Present,Stage III Appendix Neuroendocrine Tumor AJCC v8,0
7936,Ectopic Tissue,Stage III Appendix Neuroendocrine Tumor AJCC v8,0
7937,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Appendix Neuroendocrine Tumor AJCC v8,0
7938,Dilated Cystic Spaces Present,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,0
7939,Dedifferentiated Malignant Infiltrate,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,0
7940,Mammary Gland Type Features Present,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,0
7941,Ectopic Tissue,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,0
7942,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,0
7943,Dilated Cystic Spaces Present,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,0
7944,Dedifferentiated Malignant Infiltrate,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,0
7945,Mammary Gland Type Features Present,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,0
7946,Ectopic Tissue,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,0
7947,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,0
7948,Dilated Cystic Spaces Present,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,0
7949,Dedifferentiated Malignant Infiltrate,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,0
7950,Mammary Gland Type Features Present,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,0
7951,Ectopic Tissue,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,0
7952,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Colorectal Neuroendocrine Tumor AJCC v8,0
7953,Dilated Cystic Spaces Present,Stage I Colon Neuroendocrine Tumor AJCC v8,0
7954,Dedifferentiated Malignant Infiltrate,Stage I Colon Neuroendocrine Tumor AJCC v8,0
7955,Mammary Gland Type Features Present,Stage I Colon Neuroendocrine Tumor AJCC v8,0
7956,Ectopic Tissue,Stage I Colon Neuroendocrine Tumor AJCC v8,0
7957,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Colon Neuroendocrine Tumor AJCC v8,0
7958,Dilated Cystic Spaces Present,Stage I Pancreatic Neuroendocrine Tumor AJCC v8,0
7959,Dedifferentiated Malignant Infiltrate,Stage I Pancreatic Neuroendocrine Tumor AJCC v8,0
7960,Mammary Gland Type Features Present,Stage I Pancreatic Neuroendocrine Tumor AJCC v8,0
7961,Ectopic Tissue,Stage I Pancreatic Neuroendocrine Tumor AJCC v8,0
7962,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Pancreatic Neuroendocrine Tumor AJCC v8,0
7963,Dilated Cystic Spaces Present,Stage I Thymus Epithelial Neoplasm AJCC v8,0
7964,Dedifferentiated Malignant Infiltrate,Stage I Thymus Epithelial Neoplasm AJCC v8,0
7965,Mammary Gland Type Features Present,Stage I Thymus Epithelial Neoplasm AJCC v8,0
7966,Ectopic Tissue,Stage I Thymus Epithelial Neoplasm AJCC v8,0
7967,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Thymus Epithelial Neoplasm AJCC v8,0
7968,Dilated Cystic Spaces Present,Stage IIIB Thymus Epithelial Neoplasm AJCC v8,0
7969,Dedifferentiated Malignant Infiltrate,Stage IIIB Thymus Epithelial Neoplasm AJCC v8,0
7970,Mammary Gland Type Features Present,Stage IIIB Thymus Epithelial Neoplasm AJCC v8,0
7971,Ectopic Tissue,Stage IIIB Thymus Epithelial Neoplasm AJCC v8,0
7972,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Thymus Epithelial Neoplasm AJCC v8,0
7973,Dilated Cystic Spaces Present,Stage IVA Thymus Epithelial Neoplasm AJCC v8,0
7974,Dedifferentiated Malignant Infiltrate,Stage IVA Thymus Epithelial Neoplasm AJCC v8,0
7975,Mammary Gland Type Features Present,Stage IVA Thymus Epithelial Neoplasm AJCC v8,0
7976,Ectopic Tissue,Stage IVA Thymus Epithelial Neoplasm AJCC v8,0
7977,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IVA Thymus Epithelial Neoplasm AJCC v8,0
7978,Dilated Cystic Spaces Present,Stage II Thymoma AJCC v8,0
7979,Dedifferentiated Malignant Infiltrate,Stage II Thymoma AJCC v8,0
7980,Mammary Gland Type Features Present,Stage II Thymoma AJCC v8,0
7981,Ectopic Tissue,Stage II Thymoma AJCC v8,0
7982,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Thymoma AJCC v8,0
7983,Dilated Cystic Spaces Present,Oral Intraepithelial Neoplasia,0
7984,Dedifferentiated Malignant Infiltrate,Oral Intraepithelial Neoplasia,0
7985,Mammary Gland Type Features Present,Oral Intraepithelial Neoplasia,0
7986,Ectopic Tissue,Oral Intraepithelial Neoplasia,0
7987,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Oral Intraepithelial Neoplasia,0
7988,Dilated Cystic Spaces Present,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,0
7989,Dedifferentiated Malignant Infiltrate,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,0
7990,Mammary Gland Type Features Present,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,0
7991,Ectopic Tissue,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,0
7992,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,0
7993,Dilated Cystic Spaces Present,Stage III Thymus Epithelial Neoplasm AJCC v8,0
7994,Dedifferentiated Malignant Infiltrate,Stage III Thymus Epithelial Neoplasm AJCC v8,0
7995,Mammary Gland Type Features Present,Stage III Thymus Epithelial Neoplasm AJCC v8,0
7996,Ectopic Tissue,Stage III Thymus Epithelial Neoplasm AJCC v8,0
7997,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Thymus Epithelial Neoplasm AJCC v8,0
7998,Dilated Cystic Spaces Present,Thymoma by AJCC v8 Stage,0
7999,Dedifferentiated Malignant Infiltrate,Thymoma by AJCC v8 Stage,0
8000,Mammary Gland Type Features Present,Thymoma by AJCC v8 Stage,0
8001,Ectopic Tissue,Thymoma by AJCC v8 Stage,0
8002,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymoma by AJCC v8 Stage,0
8003,Dilated Cystic Spaces Present,Stage I Thymoma AJCC v8,0
8004,Dedifferentiated Malignant Infiltrate,Stage I Thymoma AJCC v8,0
8005,Mammary Gland Type Features Present,Stage I Thymoma AJCC v8,0
8006,Ectopic Tissue,Stage I Thymoma AJCC v8,0
8007,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Thymoma AJCC v8,0
8008,Dilated Cystic Spaces Present,Recurrent Abdominal Neuroendocrine Neoplasm,0
8009,Dedifferentiated Malignant Infiltrate,Recurrent Abdominal Neuroendocrine Neoplasm,0
8010,Mammary Gland Type Features Present,Recurrent Abdominal Neuroendocrine Neoplasm,0
8011,Ectopic Tissue,Recurrent Abdominal Neuroendocrine Neoplasm,0
8012,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Abdominal Neuroendocrine Neoplasm,0
8013,Dilated Cystic Spaces Present,Stage III Duodenal Neuroendocrine Tumor AJCC v8,0
8014,Dedifferentiated Malignant Infiltrate,Stage III Duodenal Neuroendocrine Tumor AJCC v8,0
8015,Mammary Gland Type Features Present,Stage III Duodenal Neuroendocrine Tumor AJCC v8,0
8016,Ectopic Tissue,Stage III Duodenal Neuroendocrine Tumor AJCC v8,0
8017,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Duodenal Neuroendocrine Tumor AJCC v8,0
8018,Dilated Cystic Spaces Present,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,0
8019,Dedifferentiated Malignant Infiltrate,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,0
8020,Mammary Gland Type Features Present,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,0
8021,Ectopic Tissue,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,0
8022,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,0
8023,Dilated Cystic Spaces Present,Jejunal Neuroendocrine Tumor,0
8024,Dedifferentiated Malignant Infiltrate,Jejunal Neuroendocrine Tumor,0
8025,Mammary Gland Type Features Present,Jejunal Neuroendocrine Tumor,0
8026,Ectopic Tissue,Jejunal Neuroendocrine Tumor,0
8027,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Jejunal Neuroendocrine Tumor,0
8028,Dilated Cystic Spaces Present,Ileal Neuroendocrine Tumor,0
8029,Dedifferentiated Malignant Infiltrate,Ileal Neuroendocrine Tumor,0
8030,Mammary Gland Type Features Present,Ileal Neuroendocrine Tumor,0
8031,Ectopic Tissue,Ileal Neuroendocrine Tumor,0
8032,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ileal Neuroendocrine Tumor,0
8033,Dilated Cystic Spaces Present,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,0
8034,Dedifferentiated Malignant Infiltrate,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,0
8035,Mammary Gland Type Features Present,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,0
8036,Ectopic Tissue,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,0
8037,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,0
8038,Dilated Cystic Spaces Present,Appendix Neuroendocrine Tumor by AJCC v7 Stage,0
8039,Dedifferentiated Malignant Infiltrate,Appendix Neuroendocrine Tumor by AJCC v7 Stage,0
8040,Mammary Gland Type Features Present,Appendix Neuroendocrine Tumor by AJCC v7 Stage,0
8041,Ectopic Tissue,Appendix Neuroendocrine Tumor by AJCC v7 Stage,0
8042,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix Neuroendocrine Tumor by AJCC v7 Stage,0
8043,Dilated Cystic Spaces Present,Appendix Neuroendocrine Tumor by AJCC v8 Stage,0
8044,Dedifferentiated Malignant Infiltrate,Appendix Neuroendocrine Tumor by AJCC v8 Stage,0
8045,Mammary Gland Type Features Present,Appendix Neuroendocrine Tumor by AJCC v8 Stage,0
8046,Ectopic Tissue,Appendix Neuroendocrine Tumor by AJCC v8 Stage,0
8047,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Appendix Neuroendocrine Tumor by AJCC v8 Stage,0
8048,Dilated Cystic Spaces Present,Stage IIB Colon Neuroendocrine Tumor AJCC v8,0
8049,Dedifferentiated Malignant Infiltrate,Stage IIB Colon Neuroendocrine Tumor AJCC v8,0
8050,Mammary Gland Type Features Present,Stage IIB Colon Neuroendocrine Tumor AJCC v8,0
8051,Ectopic Tissue,Stage IIB Colon Neuroendocrine Tumor AJCC v8,0
8052,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIB Colon Neuroendocrine Tumor AJCC v8,0
8053,Dilated Cystic Spaces Present,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,0
8054,Dedifferentiated Malignant Infiltrate,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,0
8055,Mammary Gland Type Features Present,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,0
8056,Ectopic Tissue,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,0
8057,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IIIB Rectal Neuroendocrine Tumor AJCC v8,0
8058,Dilated Cystic Spaces Present,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,0
8059,Dedifferentiated Malignant Infiltrate,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,0
8060,Mammary Gland Type Features Present,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,0
8061,Ectopic Tissue,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,0
8062,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,0
8063,Dilated Cystic Spaces Present,Refractory Malignant Thymoma,0
8064,Dedifferentiated Malignant Infiltrate,Refractory Malignant Thymoma,0
8065,Mammary Gland Type Features Present,Refractory Malignant Thymoma,0
8066,Ectopic Tissue,Refractory Malignant Thymoma,0
8067,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Malignant Thymoma,0
8068,Dilated Cystic Spaces Present,Masaoka-Koga Stage III,0
8069,Dedifferentiated Malignant Infiltrate,Masaoka-Koga Stage III,0
8070,Mammary Gland Type Features Present,Masaoka-Koga Stage III,0
8071,Ectopic Tissue,Masaoka-Koga Stage III,0
8072,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Masaoka-Koga Stage III,0
8073,Dilated Cystic Spaces Present,Thymoma by Masaoka-Koga Stage,0
8074,Dedifferentiated Malignant Infiltrate,Thymoma by Masaoka-Koga Stage,0
8075,Mammary Gland Type Features Present,Thymoma by Masaoka-Koga Stage,0
8076,Ectopic Tissue,Thymoma by Masaoka-Koga Stage,0
8077,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thymoma by Masaoka-Koga Stage,0
8078,Dilated Cystic Spaces Present,Masaoka-Koga Stage I,0
8079,Dedifferentiated Malignant Infiltrate,Masaoka-Koga Stage I,0
8080,Mammary Gland Type Features Present,Masaoka-Koga Stage I,0
8081,Ectopic Tissue,Masaoka-Koga Stage I,0
8082,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Masaoka-Koga Stage I,0
8083,Dilated Cystic Spaces Present,Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage,0
8084,Dedifferentiated Malignant Infiltrate,Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage,0
8085,Mammary Gland Type Features Present,Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage,0
8086,Ectopic Tissue,Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage,0
8087,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage,0
8088,Dilated Cystic Spaces Present,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8089,Dedifferentiated Malignant Infiltrate,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8090,Mammary Gland Type Features Present,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8091,Ectopic Tissue,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8092,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8093,Dilated Cystic Spaces Present,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8094,Dedifferentiated Malignant Infiltrate,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8095,Mammary Gland Type Features Present,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8096,Ectopic Tissue,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8097,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage III Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8098,Dilated Cystic Spaces Present,Masaoka-Koga Stage IVb,0
8099,Dedifferentiated Malignant Infiltrate,Masaoka-Koga Stage IVb,0
8100,Mammary Gland Type Features Present,Masaoka-Koga Stage IVb,0
8101,Ectopic Tissue,Masaoka-Koga Stage IVb,0
8102,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Masaoka-Koga Stage IVb,0
8103,Dilated Cystic Spaces Present,Masaoka-Koga Stage II,0
8104,Dedifferentiated Malignant Infiltrate,Masaoka-Koga Stage II,0
8105,Mammary Gland Type Features Present,Masaoka-Koga Stage II,0
8106,Ectopic Tissue,Masaoka-Koga Stage II,0
8107,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Masaoka-Koga Stage II,0
8108,Dilated Cystic Spaces Present,Masaoka-Koga Stage IV,0
8109,Dedifferentiated Malignant Infiltrate,Masaoka-Koga Stage IV,0
8110,Mammary Gland Type Features Present,Masaoka-Koga Stage IV,0
8111,Ectopic Tissue,Masaoka-Koga Stage IV,0
8112,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Masaoka-Koga Stage IV,0
8113,Dilated Cystic Spaces Present,Atypical Type A Thymoma,0
8114,Dedifferentiated Malignant Infiltrate,Atypical Type A Thymoma,0
8115,Mammary Gland Type Features Present,Atypical Type A Thymoma,0
8116,Ectopic Tissue,Atypical Type A Thymoma,0
8117,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Atypical Type A Thymoma,0
8118,Coronary Vessel Lesion,Pulmonary Sclerosing Hemangioma,0
8119,Index Lesion,Pulmonary Sclerosing Hemangioma,0
8120,Non-Index Lesion,Pulmonary Sclerosing Hemangioma,0
8121,Mushroom-Shaped Lesion,Pulmonary Sclerosing Hemangioma,0
8122,Annular Lesion,Pulmonary Sclerosing Hemangioma,0
8123,Coronary Vessel Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,0
8124,Index Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,0
8125,Non-Index Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,0
8126,Mushroom-Shaped Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,0
8127,Annular Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,0
8128,Dilated Cystic Spaces Present,Unresectable Craniopharyngioma,0
8129,Dedifferentiated Malignant Infiltrate,Unresectable Craniopharyngioma,0
8130,Mammary Gland Type Features Present,Unresectable Craniopharyngioma,0
8131,Ectopic Tissue,Unresectable Craniopharyngioma,0
8132,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Craniopharyngioma,0
8133,Dilated Cystic Spaces Present,Masaoka-Koga Stage IIa,0
8134,Dedifferentiated Malignant Infiltrate,Masaoka-Koga Stage IIa,0
8135,Mammary Gland Type Features Present,Masaoka-Koga Stage IIa,0
8136,Ectopic Tissue,Masaoka-Koga Stage IIa,0
8137,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Masaoka-Koga Stage IIa,0
8138,Dilated Cystic Spaces Present,Masaoka-Koga Stage IIb,0
8139,Dedifferentiated Malignant Infiltrate,Masaoka-Koga Stage IIb,0
8140,Mammary Gland Type Features Present,Masaoka-Koga Stage IIb,0
8141,Ectopic Tissue,Masaoka-Koga Stage IIb,0
8142,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Masaoka-Koga Stage IIb,0
8143,Dilated Cystic Spaces Present,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8144,Dedifferentiated Malignant Infiltrate,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8145,Mammary Gland Type Features Present,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8146,Ectopic Tissue,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8147,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage II Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8148,Dilated Cystic Spaces Present,Masaoka-Koga Stage IVa,0
8149,Dedifferentiated Malignant Infiltrate,Masaoka-Koga Stage IVa,0
8150,Mammary Gland Type Features Present,Masaoka-Koga Stage IVa,0
8151,Ectopic Tissue,Masaoka-Koga Stage IVa,0
8152,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Masaoka-Koga Stage IVa,0
8153,Coronary Vessel Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8154,Index Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8155,Non-Index Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8156,Mushroom-Shaped Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8157,Annular Lesion,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8158,Coronary Vessel Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8159,Index Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8160,Non-Index Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8161,Mushroom-Shaped Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8162,Annular Lesion,Metastatic Non-Functioning Well Differentiated Neuroendocrine Neoplasm,0
8163,Dilated Cystic Spaces Present,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8164,Dedifferentiated Malignant Infiltrate,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8165,Mammary Gland Type Features Present,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8166,Ectopic Tissue,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8167,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,0
8168,Dilated Cystic Spaces Present,Recurrent Craniopharyngioma,0
8169,Dedifferentiated Malignant Infiltrate,Recurrent Craniopharyngioma,0
8170,Mammary Gland Type Features Present,Recurrent Craniopharyngioma,0
8171,Ectopic Tissue,Recurrent Craniopharyngioma,0
8172,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Craniopharyngioma,0
8173,Dilated Cystic Spaces Present,Crooke Cell Adenoma,0
8174,Dedifferentiated Malignant Infiltrate,Crooke Cell Adenoma,0
8175,Mammary Gland Type Features Present,Crooke Cell Adenoma,0
8176,Ectopic Tissue,Crooke Cell Adenoma,0
8177,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Crooke Cell Adenoma,0
8178,Dilated Cystic Spaces Present,Refractory Malignant Endocrine Neoplasm,0
8179,Dedifferentiated Malignant Infiltrate,Refractory Malignant Endocrine Neoplasm,0
8180,Mammary Gland Type Features Present,Refractory Malignant Endocrine Neoplasm,0
8181,Ectopic Tissue,Refractory Malignant Endocrine Neoplasm,0
8182,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Malignant Endocrine Neoplasm,0
8183,Dilated Cystic Spaces Present,Densely Granulated Corticotroph Adenoma,0
8184,Dedifferentiated Malignant Infiltrate,Densely Granulated Corticotroph Adenoma,0
8185,Mammary Gland Type Features Present,Densely Granulated Corticotroph Adenoma,0
8186,Ectopic Tissue,Densely Granulated Corticotroph Adenoma,0
8187,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Densely Granulated Corticotroph Adenoma,0
8188,Dilated Cystic Spaces Present,Unresectable Carcinoid Tumor,0
8189,Dedifferentiated Malignant Infiltrate,Unresectable Carcinoid Tumor,0
8190,Mammary Gland Type Features Present,Unresectable Carcinoid Tumor,0
8191,Ectopic Tissue,Unresectable Carcinoid Tumor,0
8192,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Carcinoid Tumor,0
8193,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Recurrent Malignant Ovarian Brenner Tumor,0
8194,Isolated Tumor Cells,Recurrent Malignant Ovarian Brenner Tumor,0
8195,Pleural/Elastic Layer Invasion,Recurrent Malignant Ovarian Brenner Tumor,0
8196,Presence of Extravascular Matrix Patterns,Recurrent Malignant Ovarian Brenner Tumor,0
8197,Ductopenia,Recurrent Malignant Ovarian Brenner Tumor,0
8198,Dilated Cystic Spaces Present,Recurrent Malignant Ovarian Transitional Cell Tumor,0
8199,Dedifferentiated Malignant Infiltrate,Recurrent Malignant Ovarian Transitional Cell Tumor,0
8200,Mammary Gland Type Features Present,Recurrent Malignant Ovarian Transitional Cell Tumor,0
8201,Ectopic Tissue,Recurrent Malignant Ovarian Transitional Cell Tumor,0
8202,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Malignant Ovarian Transitional Cell Tumor,0
8203,Dilated Cystic Spaces Present,Sparsely Granulated Corticotroph Adenoma,0
8204,Dedifferentiated Malignant Infiltrate,Sparsely Granulated Corticotroph Adenoma,0
8205,Mammary Gland Type Features Present,Sparsely Granulated Corticotroph Adenoma,0
8206,Ectopic Tissue,Sparsely Granulated Corticotroph Adenoma,0
8207,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sparsely Granulated Corticotroph Adenoma,0
8208,Dilated Cystic Spaces Present,Recurrent Malignant Endocrine Neoplasm,0
8209,Dedifferentiated Malignant Infiltrate,Recurrent Malignant Endocrine Neoplasm,0
8210,Mammary Gland Type Features Present,Recurrent Malignant Endocrine Neoplasm,0
8211,Ectopic Tissue,Recurrent Malignant Endocrine Neoplasm,0
8212,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Malignant Endocrine Neoplasm,0
8213,Dilated Cystic Spaces Present,Plurimorphous Plurihormonal Pituitary Gland Adenoma,0
8214,Dedifferentiated Malignant Infiltrate,Plurimorphous Plurihormonal Pituitary Gland Adenoma,0
8215,Mammary Gland Type Features Present,Plurimorphous Plurihormonal Pituitary Gland Adenoma,0
8216,Ectopic Tissue,Plurimorphous Plurihormonal Pituitary Gland Adenoma,0
8217,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Plurimorphous Plurihormonal Pituitary Gland Adenoma,0
8218,Dilated Cystic Spaces Present,Pituitary Gland Paraganglioma,0
8219,Dedifferentiated Malignant Infiltrate,Pituitary Gland Paraganglioma,0
8220,Mammary Gland Type Features Present,Pituitary Gland Paraganglioma,0
8221,Ectopic Tissue,Pituitary Gland Paraganglioma,0
8222,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pituitary Gland Paraganglioma,0
8223,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Epididymal Papillary Cystadenoma,0
8224,Isolated Tumor Cells,Epididymal Papillary Cystadenoma,0
8225,Pleural/Elastic Layer Invasion,Epididymal Papillary Cystadenoma,0
8226,Presence of Extravascular Matrix Patterns,Epididymal Papillary Cystadenoma,0
8227,Ductopenia,Epididymal Papillary Cystadenoma,0
8228,Dilated Cystic Spaces Present,Thyroid Gland Spindle Cell Follicular Adenoma,0
8229,Dedifferentiated Malignant Infiltrate,Thyroid Gland Spindle Cell Follicular Adenoma,0
8230,Mammary Gland Type Features Present,Thyroid Gland Spindle Cell Follicular Adenoma,0
8231,Ectopic Tissue,Thyroid Gland Spindle Cell Follicular Adenoma,0
8232,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Spindle Cell Follicular Adenoma,0
8233,Coronary Vessel Lesion,Metastatic Neuroendocrine Neoplasm,0
8234,Index Lesion,Metastatic Neuroendocrine Neoplasm,0
8235,Non-Index Lesion,Metastatic Neuroendocrine Neoplasm,0
8236,Mushroom-Shaped Lesion,Metastatic Neuroendocrine Neoplasm,0
8237,Annular Lesion,Metastatic Neuroendocrine Neoplasm,0
8238,Coronary Vessel Lesion,Metastatic Breast Neuroendocrine Neoplasm,0
8239,Index Lesion,Metastatic Breast Neuroendocrine Neoplasm,0
8240,Non-Index Lesion,Metastatic Breast Neuroendocrine Neoplasm,0
8241,Mushroom-Shaped Lesion,Metastatic Breast Neuroendocrine Neoplasm,0
8242,Annular Lesion,Metastatic Breast Neuroendocrine Neoplasm,0
8243,Dilated Cystic Spaces Present,Non-Functioning Corticotroph Adenoma,0
8244,Dedifferentiated Malignant Infiltrate,Non-Functioning Corticotroph Adenoma,0
8245,Mammary Gland Type Features Present,Non-Functioning Corticotroph Adenoma,0
8246,Ectopic Tissue,Non-Functioning Corticotroph Adenoma,0
8247,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Non-Functioning Corticotroph Adenoma,0
8248,Dilated Cystic Spaces Present,Pituitary Gland Double Adenomas,0
8249,Dedifferentiated Malignant Infiltrate,Pituitary Gland Double Adenomas,0
8250,Mammary Gland Type Features Present,Pituitary Gland Double Adenomas,0
8251,Ectopic Tissue,Pituitary Gland Double Adenomas,0
8252,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pituitary Gland Double Adenomas,0
8253,Dilated Cystic Spaces Present,Adrenal Cortex Sex Cord-Stromal Tumor,0
8254,Dedifferentiated Malignant Infiltrate,Adrenal Cortex Sex Cord-Stromal Tumor,0
8255,Mammary Gland Type Features Present,Adrenal Cortex Sex Cord-Stromal Tumor,0
8256,Ectopic Tissue,Adrenal Cortex Sex Cord-Stromal Tumor,0
8257,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Adrenal Cortex Sex Cord-Stromal Tumor,0
8258,Dilated Cystic Spaces Present,Pituitary Gland Multiple Adenomas,0
8259,Dedifferentiated Malignant Infiltrate,Pituitary Gland Multiple Adenomas,0
8260,Mammary Gland Type Features Present,Pituitary Gland Multiple Adenomas,0
8261,Ectopic Tissue,Pituitary Gland Multiple Adenomas,0
8262,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pituitary Gland Multiple Adenomas,0
8263,Coronary Vessel Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
8264,Index Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
8265,Non-Index Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
8266,Mushroom-Shaped Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
8267,Annular Lesion,Advanced Well Differentiated Neuroendocrine Neoplasm,0
8268,Dilated Cystic Spaces Present,Pituitary Gland Mixed Gangliocytoma-Adenoma,0
8269,Dedifferentiated Malignant Infiltrate,Pituitary Gland Mixed Gangliocytoma-Adenoma,0
8270,Mammary Gland Type Features Present,Pituitary Gland Mixed Gangliocytoma-Adenoma,0
8271,Ectopic Tissue,Pituitary Gland Mixed Gangliocytoma-Adenoma,0
8272,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Pituitary Gland Mixed Gangliocytoma-Adenoma,0
8273,Coronary Vessel Lesion,Advanced Carcinoid Tumor,0
8274,Index Lesion,Advanced Carcinoid Tumor,0
8275,Non-Index Lesion,Advanced Carcinoid Tumor,0
8276,Mushroom-Shaped Lesion,Advanced Carcinoid Tumor,0
8277,Annular Lesion,Advanced Carcinoid Tumor,0
8278,Coronary Vessel Lesion,Pancreatic neuroendocrine tumor metastatic,0
8279,Index Lesion,Pancreatic neuroendocrine tumor metastatic,0
8280,Non-Index Lesion,Pancreatic neuroendocrine tumor metastatic,0
8281,Mushroom-Shaped Lesion,Pancreatic neuroendocrine tumor metastatic,0
8282,Annular Lesion,Pancreatic neuroendocrine tumor metastatic,0
8283,Coronary Vessel Lesion,Advanced Pancreatic Neuroendocrine Tumor,0
8284,Index Lesion,Advanced Pancreatic Neuroendocrine Tumor,0
8285,Non-Index Lesion,Advanced Pancreatic Neuroendocrine Tumor,0
8286,Mushroom-Shaped Lesion,Advanced Pancreatic Neuroendocrine Tumor,0
8287,Annular Lesion,Advanced Pancreatic Neuroendocrine Tumor,0
8288,Dilated Cystic Spaces Present,Densely Granulated Non-Functioning Corticotroph Adenoma,0
8289,Dedifferentiated Malignant Infiltrate,Densely Granulated Non-Functioning Corticotroph Adenoma,0
8290,Mammary Gland Type Features Present,Densely Granulated Non-Functioning Corticotroph Adenoma,0
8291,Ectopic Tissue,Densely Granulated Non-Functioning Corticotroph Adenoma,0
8292,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Densely Granulated Non-Functioning Corticotroph Adenoma,0
8293,Dilated Cystic Spaces Present,Thyroid Gland Black Follicular Adenoma,0
8294,Dedifferentiated Malignant Infiltrate,Thyroid Gland Black Follicular Adenoma,0
8295,Mammary Gland Type Features Present,Thyroid Gland Black Follicular Adenoma,0
8296,Ectopic Tissue,Thyroid Gland Black Follicular Adenoma,0
8297,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Thyroid Gland Black Follicular Adenoma,0
8298,Dilated Cystic Spaces Present,Benign Parathyroid Gland Adenoma,0
8299,Dedifferentiated Malignant Infiltrate,Benign Parathyroid Gland Adenoma,0
8300,Mammary Gland Type Features Present,Benign Parathyroid Gland Adenoma,0
8301,Ectopic Tissue,Benign Parathyroid Gland Adenoma,0
8302,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Benign Parathyroid Gland Adenoma,0
8303,Dilated Cystic Spaces Present,Ectopic Thyroid Gland Thymoma,0
8304,Dedifferentiated Malignant Infiltrate,Ectopic Thyroid Gland Thymoma,0
8305,Mammary Gland Type Features Present,Ectopic Thyroid Gland Thymoma,0
8306,Ectopic Tissue,Ectopic Thyroid Gland Thymoma,0
8307,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Ectopic Thyroid Gland Thymoma,0
8308,Coronary Vessel Lesion,Advanced Neuroendocrine Neoplasm,0
8309,Index Lesion,Advanced Neuroendocrine Neoplasm,0
8310,Non-Index Lesion,Advanced Neuroendocrine Neoplasm,0
8311,Mushroom-Shaped Lesion,Advanced Neuroendocrine Neoplasm,0
8312,Annular Lesion,Advanced Neuroendocrine Neoplasm,0
8313,Dilated Cystic Spaces Present,Sparsely Granulated Non-Functioning Corticotroph Adenoma,0
8314,Dedifferentiated Malignant Infiltrate,Sparsely Granulated Non-Functioning Corticotroph Adenoma,0
8315,Mammary Gland Type Features Present,Sparsely Granulated Non-Functioning Corticotroph Adenoma,0
8316,Ectopic Tissue,Sparsely Granulated Non-Functioning Corticotroph Adenoma,0
8317,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Sparsely Granulated Non-Functioning Corticotroph Adenoma,0
8318,Dilated Cystic Spaces Present,Monomorphous Plurihormonal Pituitary Gland Adenoma,0
8319,Dedifferentiated Malignant Infiltrate,Monomorphous Plurihormonal Pituitary Gland Adenoma,0
8320,Mammary Gland Type Features Present,Monomorphous Plurihormonal Pituitary Gland Adenoma,0
8321,Ectopic Tissue,Monomorphous Plurihormonal Pituitary Gland Adenoma,0
8322,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Monomorphous Plurihormonal Pituitary Gland Adenoma,0
8323,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Broad Ligament Papillary Cystadenoma,0
8324,Isolated Tumor Cells,Broad Ligament Papillary Cystadenoma,0
8325,Pleural/Elastic Layer Invasion,Broad Ligament Papillary Cystadenoma,0
8326,Presence of Extravascular Matrix Patterns,Broad Ligament Papillary Cystadenoma,0
8327,Ductopenia,Broad Ligament Papillary Cystadenoma,0
8328,Coronary Vessel Lesion,Metastatic Digestive System Neuroendocrine Neoplasm,0
8329,Index Lesion,Metastatic Digestive System Neuroendocrine Neoplasm,0
8330,Non-Index Lesion,Metastatic Digestive System Neuroendocrine Neoplasm,0
8331,Mushroom-Shaped Lesion,Metastatic Digestive System Neuroendocrine Neoplasm,0
8332,Annular Lesion,Metastatic Digestive System Neuroendocrine Neoplasm,0
8333,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Clear cell papillary renal cell carcinoma,0
8334,Isolated Tumor Cells,Clear cell papillary renal cell carcinoma,0
8335,Pleural/Elastic Layer Invasion,Clear cell papillary renal cell carcinoma,0
8336,Presence of Extravascular Matrix Patterns,Clear cell papillary renal cell carcinoma,0
8337,Ductopenia,Clear cell papillary renal cell carcinoma,0
8338,Dilated Cystic Spaces Present,Refractory Adrenal Gland Pheochromocytoma,0
8339,Dedifferentiated Malignant Infiltrate,Refractory Adrenal Gland Pheochromocytoma,0
8340,Mammary Gland Type Features Present,Refractory Adrenal Gland Pheochromocytoma,0
8341,Ectopic Tissue,Refractory Adrenal Gland Pheochromocytoma,0
8342,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Adrenal Gland Pheochromocytoma,0
8343,Coronary Vessel Lesion,Metastatic Lung Neuroendocrine Neoplasm,0
8344,Index Lesion,Metastatic Lung Neuroendocrine Neoplasm,0
8345,Non-Index Lesion,Metastatic Lung Neuroendocrine Neoplasm,0
8346,Mushroom-Shaped Lesion,Metastatic Lung Neuroendocrine Neoplasm,0
8347,Annular Lesion,Metastatic Lung Neuroendocrine Neoplasm,0
8348,Dilated Cystic Spaces Present,Bladder Non-Invasive Urothelial Neoplasm,0
8349,Dedifferentiated Malignant Infiltrate,Bladder Non-Invasive Urothelial Neoplasm,0
8350,Mammary Gland Type Features Present,Bladder Non-Invasive Urothelial Neoplasm,0
8351,Ectopic Tissue,Bladder Non-Invasive Urothelial Neoplasm,0
8352,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Non-Invasive Urothelial Neoplasm,0
8353,Dilated Cystic Spaces Present,Unresectable Adrenal Gland Pheochromocytoma,0
8354,Dedifferentiated Malignant Infiltrate,Unresectable Adrenal Gland Pheochromocytoma,0
8355,Mammary Gland Type Features Present,Unresectable Adrenal Gland Pheochromocytoma,0
8356,Ectopic Tissue,Unresectable Adrenal Gland Pheochromocytoma,0
8357,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Adrenal Gland Pheochromocytoma,0
8358,Coronary Vessel Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,0
8359,Index Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,0
8360,Non-Index Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,0
8361,Mushroom-Shaped Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,0
8362,Annular Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,0
8363,Dilated Cystic Spaces Present,Familial Adrenal Gland Pheochromocytoma,0
8364,Dedifferentiated Malignant Infiltrate,Familial Adrenal Gland Pheochromocytoma,0
8365,Mammary Gland Type Features Present,Familial Adrenal Gland Pheochromocytoma,0
8366,Ectopic Tissue,Familial Adrenal Gland Pheochromocytoma,0
8367,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Familial Adrenal Gland Pheochromocytoma,0
8368,Dilated Cystic Spaces Present,Multiple endocrine neoplasia type 4,0
8369,Dedifferentiated Malignant Infiltrate,Multiple endocrine neoplasia type 4,0
8370,Mammary Gland Type Features Present,Multiple endocrine neoplasia type 4,0
8371,Ectopic Tissue,Multiple endocrine neoplasia type 4,0
8372,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Multiple endocrine neoplasia type 4,0
8373,Dilated Cystic Spaces Present,Laryngeal papillomatosis,0
8374,Dedifferentiated Malignant Infiltrate,Laryngeal papillomatosis,0
8375,Mammary Gland Type Features Present,Laryngeal papillomatosis,0
8376,Ectopic Tissue,Laryngeal papillomatosis,0
8377,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Laryngeal papillomatosis,0
8378,Dilated Cystic Spaces Present,Metanephric stromal tumor,0
8379,Dedifferentiated Malignant Infiltrate,Metanephric stromal tumor,0
8380,Mammary Gland Type Features Present,Metanephric stromal tumor,0
8381,Ectopic Tissue,Metanephric stromal tumor,0
8382,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Metanephric stromal tumor,0
8383,Dilated Cystic Spaces Present,Refractory Neuroendocrine Neoplasm,0
8384,Dedifferentiated Malignant Infiltrate,Refractory Neuroendocrine Neoplasm,0
8385,Mammary Gland Type Features Present,Refractory Neuroendocrine Neoplasm,0
8386,Ectopic Tissue,Refractory Neuroendocrine Neoplasm,0
8387,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Neuroendocrine Neoplasm,0
8388,Dilated Cystic Spaces Present,Anal Intraepithelial Neoplasia 2,0
8389,Dedifferentiated Malignant Infiltrate,Anal Intraepithelial Neoplasia 2,0
8390,Mammary Gland Type Features Present,Anal Intraepithelial Neoplasia 2,0
8391,Ectopic Tissue,Anal Intraepithelial Neoplasia 2,0
8392,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anal Intraepithelial Neoplasia 2,0
8393,Dilated Cystic Spaces Present,Metanephric Tumor,0
8394,Dedifferentiated Malignant Infiltrate,Metanephric Tumor,0
8395,Mammary Gland Type Features Present,Metanephric Tumor,0
8396,Ectopic Tissue,Metanephric Tumor,0
8397,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Metanephric Tumor,0
8398,Coronary Vessel Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,0
8399,Index Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,0
8400,Non-Index Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,0
8401,Mushroom-Shaped Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,0
8402,Annular Lesion,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,0
8403,Dilated Cystic Spaces Present,'Refractory Paraganglioma',0
8404,Dedifferentiated Malignant Infiltrate,'Refractory Paraganglioma',0
8405,Mammary Gland Type Features Present,'Refractory Paraganglioma',0
8406,Ectopic Tissue,'Refractory Paraganglioma',0
8407,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,'Refractory Paraganglioma',0
8408,Dilated Cystic Spaces Present,Recurrent Paraganglioma,0
8409,Dedifferentiated Malignant Infiltrate,Recurrent Paraganglioma,0
8410,Mammary Gland Type Features Present,Recurrent Paraganglioma,0
8411,Ectopic Tissue,Recurrent Paraganglioma,0
8412,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Paraganglioma,0
8413,Dilated Cystic Spaces Present,Anal Intraepithelial Neoplasia 1,0
8414,Dedifferentiated Malignant Infiltrate,Anal Intraepithelial Neoplasia 1,0
8415,Mammary Gland Type Features Present,Anal Intraepithelial Neoplasia 1,0
8416,Ectopic Tissue,Anal Intraepithelial Neoplasia 1,0
8417,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Anal Intraepithelial Neoplasia 1,0
8418,Dilated Cystic Spaces Present,Refractory Digestive System Neuroendocrine Neoplasm,0
8419,Dedifferentiated Malignant Infiltrate,Refractory Digestive System Neuroendocrine Neoplasm,0
8420,Mammary Gland Type Features Present,Refractory Digestive System Neuroendocrine Neoplasm,0
8421,Ectopic Tissue,Refractory Digestive System Neuroendocrine Neoplasm,0
8422,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Refractory Digestive System Neuroendocrine Neoplasm,0
8423,Coronary Vessel Lesion,Advanced Digestive System Neuroendocrine Neoplasm,0
8424,Index Lesion,Advanced Digestive System Neuroendocrine Neoplasm,0
8425,Non-Index Lesion,Advanced Digestive System Neuroendocrine Neoplasm,0
8426,Mushroom-Shaped Lesion,Advanced Digestive System Neuroendocrine Neoplasm,0
8427,Annular Lesion,Advanced Digestive System Neuroendocrine Neoplasm,0
8428,Dilated Cystic Spaces Present,Composite Paraganglioma,0
8429,Dedifferentiated Malignant Infiltrate,Composite Paraganglioma,0
8430,Mammary Gland Type Features Present,Composite Paraganglioma,0
8431,Ectopic Tissue,Composite Paraganglioma,0
8432,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Composite Paraganglioma,0
8433,Dilated Cystic Spaces Present,Unresectable Paraganglioma,0
8434,Dedifferentiated Malignant Infiltrate,Unresectable Paraganglioma,0
8435,Mammary Gland Type Features Present,Unresectable Paraganglioma,0
8436,Ectopic Tissue,Unresectable Paraganglioma,0
8437,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Unresectable Paraganglioma,0
8438,Dilated Cystic Spaces Present,Recurrent Neuroendocrine Neoplasm,0
8439,Dedifferentiated Malignant Infiltrate,Recurrent Neuroendocrine Neoplasm,0
8440,Mammary Gland Type Features Present,Recurrent Neuroendocrine Neoplasm,0
8441,Ectopic Tissue,Recurrent Neuroendocrine Neoplasm,0
8442,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Recurrent Neuroendocrine Neoplasm,0
8443,Dilated Cystic Spaces Present,Bladder Neuroendocrine Neoplasm,0
8444,Dedifferentiated Malignant Infiltrate,Bladder Neuroendocrine Neoplasm,0
8445,Mammary Gland Type Features Present,Bladder Neuroendocrine Neoplasm,0
8446,Ectopic Tissue,Bladder Neuroendocrine Neoplasm,0
8447,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Bladder Neuroendocrine Neoplasm,0
8448,Dilated Cystic Spaces Present,Kidney Neuroendocrine Neoplasm,0
8449,Dedifferentiated Malignant Infiltrate,Kidney Neuroendocrine Neoplasm,0
8450,Mammary Gland Type Features Present,Kidney Neuroendocrine Neoplasm,0
8451,Ectopic Tissue,Kidney Neuroendocrine Neoplasm,0
8452,Barrett Esophagus With Metaplastic Goblet Cell Columnar Epithelium,Kidney Neuroendocrine Neoplasm,0
8453,Poorly Formed Pattern,Childhood Diffuse Astrocytoma,0
8454,Multinodular and Vacuolated Pattern,Childhood Diffuse Astrocytoma,0
8455,Reticular Growth Pattern,Childhood Diffuse Astrocytoma,0
8456,Microcystic Growth Pattern,Childhood Diffuse Astrocytoma,0
8457,Labyrinthine Growth Pattern,Childhood Diffuse Astrocytoma,0
8458,Poorly Formed Pattern,T-cell/histiocyte rich large B-cell lymphoma,0
8459,Multinodular and Vacuolated Pattern,T-cell/histiocyte rich large B-cell lymphoma,0
8460,Reticular Growth Pattern,T-cell/histiocyte rich large B-cell lymphoma,0
8461,Microcystic Growth Pattern,T-cell/histiocyte rich large B-cell lymphoma,0
8462,Labyrinthine Growth Pattern,T-cell/histiocyte rich large B-cell lymphoma,0
8463,Poorly Formed Pattern,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,0
8464,Multinodular and Vacuolated Pattern,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,0
8465,Reticular Growth Pattern,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,0
8466,Microcystic Growth Pattern,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,0
8467,Labyrinthine Growth Pattern,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,0
8468,Poorly Formed Pattern,Adult Anaplastic Oligodendroglioma,0
8469,Multinodular and Vacuolated Pattern,Adult Anaplastic Oligodendroglioma,0
8470,Reticular Growth Pattern,Adult Anaplastic Oligodendroglioma,0
8471,Microcystic Growth Pattern,Adult Anaplastic Oligodendroglioma,0
8472,Labyrinthine Growth Pattern,Adult Anaplastic Oligodendroglioma,0
8473,Poorly Formed Pattern,Cerebral Glioblastoma,0
8474,Multinodular and Vacuolated Pattern,Cerebral Glioblastoma,0
8475,Reticular Growth Pattern,Cerebral Glioblastoma,0
8476,Microcystic Growth Pattern,Cerebral Glioblastoma,0
8477,Labyrinthine Growth Pattern,Cerebral Glioblastoma,0
8478,Poorly Formed Pattern,Anaplastic Oligodendroglioma,0
8479,Multinodular and Vacuolated Pattern,Anaplastic Oligodendroglioma,0
8480,Reticular Growth Pattern,Anaplastic Oligodendroglioma,0
8481,Microcystic Growth Pattern,Anaplastic Oligodendroglioma,0
8482,Labyrinthine Growth Pattern,Anaplastic Oligodendroglioma,0
8483,Poorly Formed Pattern,Desmoplastic mesothelioma,0
8484,Multinodular and Vacuolated Pattern,Desmoplastic mesothelioma,0
8485,Reticular Growth Pattern,Desmoplastic mesothelioma,0
8486,Microcystic Growth Pattern,Desmoplastic mesothelioma,0
8487,Labyrinthine Growth Pattern,Desmoplastic mesothelioma,0
8488,Poorly Formed Pattern,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8489,Multinodular and Vacuolated Pattern,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8490,Reticular Growth Pattern,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8491,Microcystic Growth Pattern,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8492,Labyrinthine Growth Pattern,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8493,Poorly Formed Pattern,Childhood Anaplastic Oligoastrocytoma,0
8494,Multinodular and Vacuolated Pattern,Childhood Anaplastic Oligoastrocytoma,0
8495,Reticular Growth Pattern,Childhood Anaplastic Oligoastrocytoma,0
8496,Microcystic Growth Pattern,Childhood Anaplastic Oligoastrocytoma,0
8497,Labyrinthine Growth Pattern,Childhood Anaplastic Oligoastrocytoma,0
8498,Poorly Formed Pattern,Thyroid Immunoblastic Lymphoma,0
8499,Multinodular and Vacuolated Pattern,Thyroid Immunoblastic Lymphoma,0
8500,Reticular Growth Pattern,Thyroid Immunoblastic Lymphoma,0
8501,Microcystic Growth Pattern,Thyroid Immunoblastic Lymphoma,0
8502,Labyrinthine Growth Pattern,Thyroid Immunoblastic Lymphoma,0
8503,Poorly Formed Pattern,Childhood Malignant Peripheral Nerve Sheath Tumor,0
8504,Multinodular and Vacuolated Pattern,Childhood Malignant Peripheral Nerve Sheath Tumor,0
8505,Reticular Growth Pattern,Childhood Malignant Peripheral Nerve Sheath Tumor,0
8506,Microcystic Growth Pattern,Childhood Malignant Peripheral Nerve Sheath Tumor,0
8507,Labyrinthine Growth Pattern,Childhood Malignant Peripheral Nerve Sheath Tumor,0
8508,Poorly Formed Pattern,Adult Brain Stem Mixed Glioma,0
8509,Multinodular and Vacuolated Pattern,Adult Brain Stem Mixed Glioma,0
8510,Reticular Growth Pattern,Adult Brain Stem Mixed Glioma,0
8511,Microcystic Growth Pattern,Adult Brain Stem Mixed Glioma,0
8512,Labyrinthine Growth Pattern,Adult Brain Stem Mixed Glioma,0
8513,Poorly Formed Pattern,Centroblastic lymphoma recurrent,0
8514,Multinodular and Vacuolated Pattern,Centroblastic lymphoma recurrent,0
8515,Reticular Growth Pattern,Centroblastic lymphoma recurrent,0
8516,Microcystic Growth Pattern,Centroblastic lymphoma recurrent,0
8517,Labyrinthine Growth Pattern,Centroblastic lymphoma recurrent,0
8518,Poorly Formed Pattern,Childhood Cerebellar Anaplastic Astrocytoma,0
8519,Multinodular and Vacuolated Pattern,Childhood Cerebellar Anaplastic Astrocytoma,0
8520,Reticular Growth Pattern,Childhood Cerebellar Anaplastic Astrocytoma,0
8521,Microcystic Growth Pattern,Childhood Cerebellar Anaplastic Astrocytoma,0
8522,Labyrinthine Growth Pattern,Childhood Cerebellar Anaplastic Astrocytoma,0
8523,Poorly Formed Pattern,AIDS-Related Diffuse Large B-cell Lymphoma,0
8524,Multinodular and Vacuolated Pattern,AIDS-Related Diffuse Large B-cell Lymphoma,0
8525,Reticular Growth Pattern,AIDS-Related Diffuse Large B-cell Lymphoma,0
8526,Microcystic Growth Pattern,AIDS-Related Diffuse Large B-cell Lymphoma,0
8527,Labyrinthine Growth Pattern,AIDS-Related Diffuse Large B-cell Lymphoma,0
8528,Poorly Formed Pattern,Brain Glioblastoma,0
8529,Multinodular and Vacuolated Pattern,Brain Glioblastoma,0
8530,Reticular Growth Pattern,Brain Glioblastoma,0
8531,Microcystic Growth Pattern,Brain Glioblastoma,0
8532,Labyrinthine Growth Pattern,Brain Glioblastoma,0
8533,Poorly Formed Pattern,Well Differentiated Oligodendroglioma,0
8534,Multinodular and Vacuolated Pattern,Well Differentiated Oligodendroglioma,0
8535,Reticular Growth Pattern,Well Differentiated Oligodendroglioma,0
8536,Microcystic Growth Pattern,Well Differentiated Oligodendroglioma,0
8537,Labyrinthine Growth Pattern,Well Differentiated Oligodendroglioma,0
8538,Poorly Formed Pattern,ALK positive large B-cell lymphoma,0
8539,Multinodular and Vacuolated Pattern,ALK positive large B-cell lymphoma,0
8540,Reticular Growth Pattern,ALK positive large B-cell lymphoma,0
8541,Microcystic Growth Pattern,ALK positive large B-cell lymphoma,0
8542,Labyrinthine Growth Pattern,ALK positive large B-cell lymphoma,0
8543,Poorly Formed Pattern,Melanotic malignant nerve sheath tumor,0
8544,Multinodular and Vacuolated Pattern,Melanotic malignant nerve sheath tumor,0
8545,Reticular Growth Pattern,Melanotic malignant nerve sheath tumor,0
8546,Microcystic Growth Pattern,Melanotic malignant nerve sheath tumor,0
8547,Labyrinthine Growth Pattern,Melanotic malignant nerve sheath tumor,0
8548,Poorly Formed Pattern,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,0
8549,Multinodular and Vacuolated Pattern,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,0
8550,Reticular Growth Pattern,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,0
8551,Microcystic Growth Pattern,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,0
8552,Labyrinthine Growth Pattern,Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma,0
8553,Poorly Formed Pattern,"Diffuse large B-cell lymphoma, unclassifiable, NOS",0
8554,Multinodular and Vacuolated Pattern,"Diffuse large B-cell lymphoma, unclassifiable, NOS",0
8555,Reticular Growth Pattern,"Diffuse large B-cell lymphoma, unclassifiable, NOS",0
8556,Microcystic Growth Pattern,"Diffuse large B-cell lymphoma, unclassifiable, NOS",0
8557,Labyrinthine Growth Pattern,"Diffuse large B-cell lymphoma, unclassifiable, NOS",0
8558,Poorly Formed Pattern,Glandular malignant peripheral nerve sheath tumor,0
8559,Multinodular and Vacuolated Pattern,Glandular malignant peripheral nerve sheath tumor,0
8560,Reticular Growth Pattern,Glandular malignant peripheral nerve sheath tumor,0
8561,Microcystic Growth Pattern,Glandular malignant peripheral nerve sheath tumor,0
8562,Labyrinthine Growth Pattern,Glandular malignant peripheral nerve sheath tumor,0
8563,Poorly Formed Pattern,Diffuse Astrocytoma,0
8564,Multinodular and Vacuolated Pattern,Diffuse Astrocytoma,0
8565,Reticular Growth Pattern,Diffuse Astrocytoma,0
8566,Microcystic Growth Pattern,Diffuse Astrocytoma,0
8567,Labyrinthine Growth Pattern,Diffuse Astrocytoma,0
8568,Poorly Formed Pattern,Adult Diffuse Large B-Cell Lymphoma,0
8569,Multinodular and Vacuolated Pattern,Adult Diffuse Large B-Cell Lymphoma,0
8570,Reticular Growth Pattern,Adult Diffuse Large B-Cell Lymphoma,0
8571,Microcystic Growth Pattern,Adult Diffuse Large B-Cell Lymphoma,0
8572,Labyrinthine Growth Pattern,Adult Diffuse Large B-Cell Lymphoma,0
8573,Poorly Formed Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma,0
8574,Multinodular and Vacuolated Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma,0
8575,Reticular Growth Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma,0
8576,Microcystic Growth Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma,0
8577,Labyrinthine Growth Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma,0
8578,Poorly Formed Pattern,Stage I Diffuse Large B-Cell Lymphoma,0
8579,Multinodular and Vacuolated Pattern,Stage I Diffuse Large B-Cell Lymphoma,0
8580,Reticular Growth Pattern,Stage I Diffuse Large B-Cell Lymphoma,0
8581,Microcystic Growth Pattern,Stage I Diffuse Large B-Cell Lymphoma,0
8582,Labyrinthine Growth Pattern,Stage I Diffuse Large B-Cell Lymphoma,0
8583,Poorly Formed Pattern,Oligodendroglioma of spinal cord,0
8584,Multinodular and Vacuolated Pattern,Oligodendroglioma of spinal cord,0
8585,Reticular Growth Pattern,Oligodendroglioma of spinal cord,0
8586,Microcystic Growth Pattern,Oligodendroglioma of spinal cord,0
8587,Labyrinthine Growth Pattern,Oligodendroglioma of spinal cord,0
8588,Poorly Formed Pattern,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8589,Multinodular and Vacuolated Pattern,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8590,Reticular Growth Pattern,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8591,Microcystic Growth Pattern,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8592,Labyrinthine Growth Pattern,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8593,Poorly Formed Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,0
8594,Multinodular and Vacuolated Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,0
8595,Reticular Growth Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,0
8596,Microcystic Growth Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,0
8597,Labyrinthine Growth Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,0
8598,Poorly Formed Pattern,Proneural Glioblastoma,0
8599,Multinodular and Vacuolated Pattern,Proneural Glioblastoma,0
8600,Reticular Growth Pattern,Proneural Glioblastoma,0
8601,Microcystic Growth Pattern,Proneural Glioblastoma,0
8602,Labyrinthine Growth Pattern,Proneural Glioblastoma,0
8603,Poorly Formed Pattern,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
8604,Multinodular and Vacuolated Pattern,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
8605,Reticular Growth Pattern,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
8606,Microcystic Growth Pattern,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
8607,Labyrinthine Growth Pattern,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
8608,Poorly Formed Pattern,Anaplastic Brain Stem Astrocytoma,0
8609,Multinodular and Vacuolated Pattern,Anaplastic Brain Stem Astrocytoma,0
8610,Reticular Growth Pattern,Anaplastic Brain Stem Astrocytoma,0
8611,Microcystic Growth Pattern,Anaplastic Brain Stem Astrocytoma,0
8612,Labyrinthine Growth Pattern,Anaplastic Brain Stem Astrocytoma,0
8613,Poorly Formed Pattern,Recurrent Adult Immunoblastic Lymphoma,0
8614,Multinodular and Vacuolated Pattern,Recurrent Adult Immunoblastic Lymphoma,0
8615,Reticular Growth Pattern,Recurrent Adult Immunoblastic Lymphoma,0
8616,Microcystic Growth Pattern,Recurrent Adult Immunoblastic Lymphoma,0
8617,Labyrinthine Growth Pattern,Recurrent Adult Immunoblastic Lymphoma,0
8618,Poorly Formed Pattern,Primary mediastinal large B-cell lymphoma stage III,0
8619,Multinodular and Vacuolated Pattern,Primary mediastinal large B-cell lymphoma stage III,0
8620,Reticular Growth Pattern,Primary mediastinal large B-cell lymphoma stage III,0
8621,Microcystic Growth Pattern,Primary mediastinal large B-cell lymphoma stage III,0
8622,Labyrinthine Growth Pattern,Primary mediastinal large B-cell lymphoma stage III,0
8623,Poorly Formed Pattern,Adult Glioblastoma,0
8624,Multinodular and Vacuolated Pattern,Adult Glioblastoma,0
8625,Reticular Growth Pattern,Adult Glioblastoma,0
8626,Microcystic Growth Pattern,Adult Glioblastoma,0
8627,Labyrinthine Growth Pattern,Adult Glioblastoma,0
8628,Poorly Formed Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",0
8629,Multinodular and Vacuolated Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",0
8630,Reticular Growth Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",0
8631,Microcystic Growth Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",0
8632,Labyrinthine Growth Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",0
8633,Coronary Vessel Lesion,Metastatic Malignant Peripheral Nerve Sheath Tumor,0
8634,Index Lesion,Metastatic Malignant Peripheral Nerve Sheath Tumor,0
8635,Non-Index Lesion,Metastatic Malignant Peripheral Nerve Sheath Tumor,0
8636,Mushroom-Shaped Lesion,Metastatic Malignant Peripheral Nerve Sheath Tumor,0
8637,Annular Lesion,Metastatic Malignant Peripheral Nerve Sheath Tumor,0
8638,Poorly Formed Pattern,Recurrent Childhood Fibrillary Astrocytoma,0
8639,Multinodular and Vacuolated Pattern,Recurrent Childhood Fibrillary Astrocytoma,0
8640,Reticular Growth Pattern,Recurrent Childhood Fibrillary Astrocytoma,0
8641,Microcystic Growth Pattern,Recurrent Childhood Fibrillary Astrocytoma,0
8642,Labyrinthine Growth Pattern,Recurrent Childhood Fibrillary Astrocytoma,0
8643,Poorly Formed Pattern,"Diffuse Astrocytoma, IDH-Wildtype",0
8644,Multinodular and Vacuolated Pattern,"Diffuse Astrocytoma, IDH-Wildtype",0
8645,Reticular Growth Pattern,"Diffuse Astrocytoma, IDH-Wildtype",0
8646,Microcystic Growth Pattern,"Diffuse Astrocytoma, IDH-Wildtype",0
8647,Labyrinthine Growth Pattern,"Diffuse Astrocytoma, IDH-Wildtype",0
8648,Poorly Formed Pattern,Mixed astrocytoma-ependymoma,0
8649,Multinodular and Vacuolated Pattern,Mixed astrocytoma-ependymoma,0
8650,Reticular Growth Pattern,Mixed astrocytoma-ependymoma,0
8651,Microcystic Growth Pattern,Mixed astrocytoma-ependymoma,0
8652,Labyrinthine Growth Pattern,Mixed astrocytoma-ependymoma,0
8653,Poorly Formed Pattern,Childhood Cerebral Diffuse Astrocytoma,0
8654,Multinodular and Vacuolated Pattern,Childhood Cerebral Diffuse Astrocytoma,0
8655,Reticular Growth Pattern,Childhood Cerebral Diffuse Astrocytoma,0
8656,Microcystic Growth Pattern,Childhood Cerebral Diffuse Astrocytoma,0
8657,Labyrinthine Growth Pattern,Childhood Cerebral Diffuse Astrocytoma,0
8658,Poorly Formed Pattern,Gliomatosis Cerebri Type I,0
8659,Multinodular and Vacuolated Pattern,Gliomatosis Cerebri Type I,0
8660,Reticular Growth Pattern,Gliomatosis Cerebri Type I,0
8661,Microcystic Growth Pattern,Gliomatosis Cerebri Type I,0
8662,Labyrinthine Growth Pattern,Gliomatosis Cerebri Type I,0
8663,Poorly Formed Pattern,Diffuse large B-cell lymphoma refractory,0
8664,Multinodular and Vacuolated Pattern,Diffuse large B-cell lymphoma refractory,0
8665,Reticular Growth Pattern,Diffuse large B-cell lymphoma refractory,0
8666,Microcystic Growth Pattern,Diffuse large B-cell lymphoma refractory,0
8667,Labyrinthine Growth Pattern,Diffuse large B-cell lymphoma refractory,0
8668,Poorly Formed Pattern,Grade III Lymphomatoid Granulomatosis,0
8669,Multinodular and Vacuolated Pattern,Grade III Lymphomatoid Granulomatosis,0
8670,Reticular Growth Pattern,Grade III Lymphomatoid Granulomatosis,0
8671,Microcystic Growth Pattern,Grade III Lymphomatoid Granulomatosis,0
8672,Labyrinthine Growth Pattern,Grade III Lymphomatoid Granulomatosis,0
8673,Poorly Formed Pattern,Childhood Giant Cell Glioblastoma,0
8674,Multinodular and Vacuolated Pattern,Childhood Giant Cell Glioblastoma,0
8675,Reticular Growth Pattern,Childhood Giant Cell Glioblastoma,0
8676,Microcystic Growth Pattern,Childhood Giant Cell Glioblastoma,0
8677,Labyrinthine Growth Pattern,Childhood Giant Cell Glioblastoma,0
8678,Poorly Formed Pattern,Recurrent Childhood Diffuse Astrocytoma,0
8679,Multinodular and Vacuolated Pattern,Recurrent Childhood Diffuse Astrocytoma,0
8680,Reticular Growth Pattern,Recurrent Childhood Diffuse Astrocytoma,0
8681,Microcystic Growth Pattern,Recurrent Childhood Diffuse Astrocytoma,0
8682,Labyrinthine Growth Pattern,Recurrent Childhood Diffuse Astrocytoma,0
8683,Poorly Formed Pattern,Adult Giant Cell Glioblastoma,0
8684,Multinodular and Vacuolated Pattern,Adult Giant Cell Glioblastoma,0
8685,Reticular Growth Pattern,Adult Giant Cell Glioblastoma,0
8686,Microcystic Growth Pattern,Adult Giant Cell Glioblastoma,0
8687,Labyrinthine Growth Pattern,Adult Giant Cell Glioblastoma,0
8688,Poorly Formed Pattern,gliosarcoma,0
8689,Multinodular and Vacuolated Pattern,gliosarcoma,0
8690,Reticular Growth Pattern,gliosarcoma,0
8691,Microcystic Growth Pattern,gliosarcoma,0
8692,Labyrinthine Growth Pattern,gliosarcoma,0
8693,Poorly Formed Pattern,Stage III Adult Immunoblastic Lymphoma,0
8694,Multinodular and Vacuolated Pattern,Stage III Adult Immunoblastic Lymphoma,0
8695,Reticular Growth Pattern,Stage III Adult Immunoblastic Lymphoma,0
8696,Microcystic Growth Pattern,Stage III Adult Immunoblastic Lymphoma,0
8697,Labyrinthine Growth Pattern,Stage III Adult Immunoblastic Lymphoma,0
8698,Poorly Formed Pattern,Childhood Cerebral Anaplastic Astrocytoma,0
8699,Multinodular and Vacuolated Pattern,Childhood Cerebral Anaplastic Astrocytoma,0
8700,Reticular Growth Pattern,Childhood Cerebral Anaplastic Astrocytoma,0
8701,Microcystic Growth Pattern,Childhood Cerebral Anaplastic Astrocytoma,0
8702,Labyrinthine Growth Pattern,Childhood Cerebral Anaplastic Astrocytoma,0
8703,Poorly Formed Pattern,Brain Stem Glioblastoma,0
8704,Multinodular and Vacuolated Pattern,Brain Stem Glioblastoma,0
8705,Reticular Growth Pattern,Brain Stem Glioblastoma,0
8706,Microcystic Growth Pattern,Brain Stem Glioblastoma,0
8707,Labyrinthine Growth Pattern,Brain Stem Glioblastoma,0
8708,Poorly Formed Pattern,Adult Diffuse Astrocytoma,0
8709,Multinodular and Vacuolated Pattern,Adult Diffuse Astrocytoma,0
8710,Reticular Growth Pattern,Adult Diffuse Astrocytoma,0
8711,Microcystic Growth Pattern,Adult Diffuse Astrocytoma,0
8712,Labyrinthine Growth Pattern,Adult Diffuse Astrocytoma,0
8713,Poorly Formed Pattern,Activated B-cell type diffuse large B-cell lymphoma,0
8714,Multinodular and Vacuolated Pattern,Activated B-cell type diffuse large B-cell lymphoma,0
8715,Reticular Growth Pattern,Activated B-cell type diffuse large B-cell lymphoma,0
8716,Microcystic Growth Pattern,Activated B-cell type diffuse large B-cell lymphoma,0
8717,Labyrinthine Growth Pattern,Activated B-cell type diffuse large B-cell lymphoma,0
8718,Poorly Formed Pattern,Centroblastic lymphoma stage I,0
8719,Multinodular and Vacuolated Pattern,Centroblastic lymphoma stage I,0
8720,Reticular Growth Pattern,Centroblastic lymphoma stage I,0
8721,Microcystic Growth Pattern,Centroblastic lymphoma stage I,0
8722,Labyrinthine Growth Pattern,Centroblastic lymphoma stage I,0
8723,Poorly Formed Pattern,Immunoblastic Large-Cell Lymphoma,0
8724,Multinodular and Vacuolated Pattern,Immunoblastic Large-Cell Lymphoma,0
8725,Reticular Growth Pattern,Immunoblastic Large-Cell Lymphoma,0
8726,Microcystic Growth Pattern,Immunoblastic Large-Cell Lymphoma,0
8727,Labyrinthine Growth Pattern,Immunoblastic Large-Cell Lymphoma,0
8728,Poorly Formed Pattern,Stage II Adult Immunoblastic Lymphoma,0
8729,Multinodular and Vacuolated Pattern,Stage II Adult Immunoblastic Lymphoma,0
8730,Reticular Growth Pattern,Stage II Adult Immunoblastic Lymphoma,0
8731,Microcystic Growth Pattern,Stage II Adult Immunoblastic Lymphoma,0
8732,Labyrinthine Growth Pattern,Stage II Adult Immunoblastic Lymphoma,0
8733,Poorly Formed Pattern,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8734,Multinodular and Vacuolated Pattern,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8735,Reticular Growth Pattern,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8736,Microcystic Growth Pattern,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8737,Labyrinthine Growth Pattern,Centroblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,0
8738,Poorly Formed Pattern,Thyroid Diffuse Large B-Cell Lymphoma,0
8739,Multinodular and Vacuolated Pattern,Thyroid Diffuse Large B-Cell Lymphoma,0
8740,Reticular Growth Pattern,Thyroid Diffuse Large B-Cell Lymphoma,0
8741,Microcystic Growth Pattern,Thyroid Diffuse Large B-Cell Lymphoma,0
8742,Labyrinthine Growth Pattern,Thyroid Diffuse Large B-Cell Lymphoma,0
8743,Poorly Formed Pattern,Plasmablastic Lymphoma of Mucosa Site,0
8744,Multinodular and Vacuolated Pattern,Plasmablastic Lymphoma of Mucosa Site,0
8745,Reticular Growth Pattern,Plasmablastic Lymphoma of Mucosa Site,0
8746,Microcystic Growth Pattern,Plasmablastic Lymphoma of Mucosa Site,0
8747,Labyrinthine Growth Pattern,Plasmablastic Lymphoma of Mucosa Site,0
8748,Poorly Formed Pattern,Mixed Oligodendroglioma-Astrocytoma,0
8749,Multinodular and Vacuolated Pattern,Mixed Oligodendroglioma-Astrocytoma,0
8750,Reticular Growth Pattern,Mixed Oligodendroglioma-Astrocytoma,0
8751,Microcystic Growth Pattern,Mixed Oligodendroglioma-Astrocytoma,0
8752,Labyrinthine Growth Pattern,Mixed Oligodendroglioma-Astrocytoma,0
8753,Poorly Formed Pattern,Stage II Diffuse Large B-Cell Lymphoma,0
8754,Multinodular and Vacuolated Pattern,Stage II Diffuse Large B-Cell Lymphoma,0
8755,Reticular Growth Pattern,Stage II Diffuse Large B-Cell Lymphoma,0
8756,Microcystic Growth Pattern,Stage II Diffuse Large B-Cell Lymphoma,0
8757,Labyrinthine Growth Pattern,Stage II Diffuse Large B-Cell Lymphoma,0
8758,Poorly Formed Pattern,large B-cell diffuse lymphoma of accessory sinus,0
8759,Multinodular and Vacuolated Pattern,large B-cell diffuse lymphoma of accessory sinus,0
8760,Reticular Growth Pattern,large B-cell diffuse lymphoma of accessory sinus,0
8761,Microcystic Growth Pattern,large B-cell diffuse lymphoma of accessory sinus,0
8762,Labyrinthine Growth Pattern,large B-cell diffuse lymphoma of accessory sinus,0
8763,Poorly Formed Pattern,Primary mediastinal large B-cell lymphoma stage IV,0
8764,Multinodular and Vacuolated Pattern,Primary mediastinal large B-cell lymphoma stage IV,0
8765,Reticular Growth Pattern,Primary mediastinal large B-cell lymphoma stage IV,0
8766,Microcystic Growth Pattern,Primary mediastinal large B-cell lymphoma stage IV,0
8767,Labyrinthine Growth Pattern,Primary mediastinal large B-cell lymphoma stage IV,0
8768,Poorly Formed Pattern,Multifocal Glioblastomas,0
8769,Multinodular and Vacuolated Pattern,Multifocal Glioblastomas,0
8770,Reticular Growth Pattern,Multifocal Glioblastomas,0
8771,Microcystic Growth Pattern,Multifocal Glioblastomas,0
8772,Labyrinthine Growth Pattern,Multifocal Glioblastomas,0
8773,Coronary Vessel Lesion,Gliomatosis Cerebri Type II,0
8774,Index Lesion,Gliomatosis Cerebri Type II,0
8775,Non-Index Lesion,Gliomatosis Cerebri Type II,0
8776,Mushroom-Shaped Lesion,Gliomatosis Cerebri Type II,0
8777,Annular Lesion,Gliomatosis Cerebri Type II,0
8778,Poorly Formed Pattern,Adult Gliosarcoma,0
8779,Multinodular and Vacuolated Pattern,Adult Gliosarcoma,0
8780,Reticular Growth Pattern,Adult Gliosarcoma,0
8781,Microcystic Growth Pattern,Adult Gliosarcoma,0
8782,Labyrinthine Growth Pattern,Adult Gliosarcoma,0
8783,Poorly Formed Pattern,mixed gliomas,0
8784,Multinodular and Vacuolated Pattern,mixed gliomas,0
8785,Reticular Growth Pattern,mixed gliomas,0
8786,Microcystic Growth Pattern,mixed gliomas,0
8787,Labyrinthine Growth Pattern,mixed gliomas,0
8788,Poorly Formed Pattern,Classical Glioblastoma,0
8789,Multinodular and Vacuolated Pattern,Classical Glioblastoma,0
8790,Reticular Growth Pattern,Classical Glioblastoma,0
8791,Microcystic Growth Pattern,Classical Glioblastoma,0
8792,Labyrinthine Growth Pattern,Classical Glioblastoma,0
8793,Poorly Formed Pattern,"Glioblastoma, IDH-Wildtype",0
8794,Multinodular and Vacuolated Pattern,"Glioblastoma, IDH-Wildtype",0
8795,Reticular Growth Pattern,"Glioblastoma, IDH-Wildtype",0
8796,Microcystic Growth Pattern,"Glioblastoma, IDH-Wildtype",0
8797,Labyrinthine Growth Pattern,"Glioblastoma, IDH-Wildtype",0
8798,Poorly Formed Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
8799,Multinodular and Vacuolated Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
8800,Reticular Growth Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
8801,Microcystic Growth Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
8802,Labyrinthine Growth Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
8803,Poorly Formed Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
8804,Multinodular and Vacuolated Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
8805,Reticular Growth Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
8806,Microcystic Growth Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
8807,Labyrinthine Growth Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
8808,Poorly Formed Pattern,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,0
8809,Multinodular and Vacuolated Pattern,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,0
8810,Reticular Growth Pattern,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,0
8811,Microcystic Growth Pattern,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,0
8812,Labyrinthine Growth Pattern,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,0
8813,Poorly Formed Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
8814,Multinodular and Vacuolated Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
8815,Reticular Growth Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
8816,Microcystic Growth Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
8817,Labyrinthine Growth Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified by Gene Expression Profile",0
8818,Poorly Formed Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,0
8819,Multinodular and Vacuolated Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,0
8820,Reticular Growth Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,0
8821,Microcystic Growth Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,0
8822,Labyrinthine Growth Pattern,Recurrent Adult Grade III Lymphomatoid Granulomatosis,0
8823,Poorly Formed Pattern,Giant Cell Glioblastoma,0
8824,Multinodular and Vacuolated Pattern,Giant Cell Glioblastoma,0
8825,Reticular Growth Pattern,Giant Cell Glioblastoma,0
8826,Microcystic Growth Pattern,Giant Cell Glioblastoma,0
8827,Labyrinthine Growth Pattern,Giant Cell Glioblastoma,0
8828,Poorly Formed Pattern,Centroblastic lymphoma stage IV,0
8829,Multinodular and Vacuolated Pattern,Centroblastic lymphoma stage IV,0
8830,Reticular Growth Pattern,Centroblastic lymphoma stage IV,0
8831,Microcystic Growth Pattern,Centroblastic lymphoma stage IV,0
8832,Labyrinthine Growth Pattern,Centroblastic lymphoma stage IV,0
8833,Poorly Formed Pattern,Recurrent Childhood Glioblastoma,0
8834,Multinodular and Vacuolated Pattern,Recurrent Childhood Glioblastoma,0
8835,Reticular Growth Pattern,Recurrent Childhood Glioblastoma,0
8836,Microcystic Growth Pattern,Recurrent Childhood Glioblastoma,0
8837,Labyrinthine Growth Pattern,Recurrent Childhood Glioblastoma,0
8838,Poorly Formed Pattern,Childhood Brain Anaplastic Astrocytoma,0
8839,Multinodular and Vacuolated Pattern,Childhood Brain Anaplastic Astrocytoma,0
8840,Reticular Growth Pattern,Childhood Brain Anaplastic Astrocytoma,0
8841,Microcystic Growth Pattern,Childhood Brain Anaplastic Astrocytoma,0
8842,Labyrinthine Growth Pattern,Childhood Brain Anaplastic Astrocytoma,0
8843,Poorly Formed Pattern,large B-cell diffuse lymphoma of kidney,0
8844,Multinodular and Vacuolated Pattern,large B-cell diffuse lymphoma of kidney,0
8845,Reticular Growth Pattern,large B-cell diffuse lymphoma of kidney,0
8846,Microcystic Growth Pattern,large B-cell diffuse lymphoma of kidney,0
8847,Labyrinthine Growth Pattern,large B-cell diffuse lymphoma of kidney,0
8848,Poorly Formed Pattern,Childhood Oligodendroglioma,0
8849,Multinodular and Vacuolated Pattern,Childhood Oligodendroglioma,0
8850,Reticular Growth Pattern,Childhood Oligodendroglioma,0
8851,Microcystic Growth Pattern,Childhood Oligodendroglioma,0
8852,Labyrinthine Growth Pattern,Childhood Oligodendroglioma,0
8853,Poorly Formed Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,0
8854,Multinodular and Vacuolated Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,0
8855,Reticular Growth Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,0
8856,Microcystic Growth Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,0
8857,Labyrinthine Growth Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,0
8858,Poorly Formed Pattern,Stage I Adult Immunoblastic Lymphoma,0
8859,Multinodular and Vacuolated Pattern,Stage I Adult Immunoblastic Lymphoma,0
8860,Reticular Growth Pattern,Stage I Adult Immunoblastic Lymphoma,0
8861,Microcystic Growth Pattern,Stage I Adult Immunoblastic Lymphoma,0
8862,Labyrinthine Growth Pattern,Stage I Adult Immunoblastic Lymphoma,0
8863,Poorly Formed Pattern,Primary Cutaneous Intravascular Large B-Cell Lymphoma,0
8864,Multinodular and Vacuolated Pattern,Primary Cutaneous Intravascular Large B-Cell Lymphoma,0
8865,Reticular Growth Pattern,Primary Cutaneous Intravascular Large B-Cell Lymphoma,0
8866,Microcystic Growth Pattern,Primary Cutaneous Intravascular Large B-Cell Lymphoma,0
8867,Labyrinthine Growth Pattern,Primary Cutaneous Intravascular Large B-Cell Lymphoma,0
8868,Poorly Formed Pattern,Neural Glioblastoma,0
8869,Multinodular and Vacuolated Pattern,Neural Glioblastoma,0
8870,Reticular Growth Pattern,Neural Glioblastoma,0
8871,Microcystic Growth Pattern,Neural Glioblastoma,0
8872,Labyrinthine Growth Pattern,Neural Glioblastoma,0
8873,Poorly Formed Pattern,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,0
8874,Multinodular and Vacuolated Pattern,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,0
8875,Reticular Growth Pattern,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,0
8876,Microcystic Growth Pattern,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,0
8877,Labyrinthine Growth Pattern,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,0
8878,Poorly Formed Pattern,Stage III Diffuse Large B-Cell Lymphoma,0
8879,Multinodular and Vacuolated Pattern,Stage III Diffuse Large B-Cell Lymphoma,0
8880,Reticular Growth Pattern,Stage III Diffuse Large B-Cell Lymphoma,0
8881,Microcystic Growth Pattern,Stage III Diffuse Large B-Cell Lymphoma,0
8882,Labyrinthine Growth Pattern,Stage III Diffuse Large B-Cell Lymphoma,0
8883,Poorly Formed Pattern,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
8884,Multinodular and Vacuolated Pattern,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
8885,Reticular Growth Pattern,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
8886,Microcystic Growth Pattern,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
8887,Labyrinthine Growth Pattern,Primary Cutaneous T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
8888,Poorly Formed Pattern,Recurrent Childhood Oligodendroglioma,0
8889,Multinodular and Vacuolated Pattern,Recurrent Childhood Oligodendroglioma,0
8890,Reticular Growth Pattern,Recurrent Childhood Oligodendroglioma,0
8891,Microcystic Growth Pattern,Recurrent Childhood Oligodendroglioma,0
8892,Labyrinthine Growth Pattern,Recurrent Childhood Oligodendroglioma,0
8893,Poorly Formed Pattern,Gemistocytic astrocytoma,0
8894,Multinodular and Vacuolated Pattern,Gemistocytic astrocytoma,0
8895,Reticular Growth Pattern,Gemistocytic astrocytoma,0
8896,Microcystic Growth Pattern,Gemistocytic astrocytoma,0
8897,Labyrinthine Growth Pattern,Gemistocytic astrocytoma,0
8898,Poorly Formed Pattern,Diffuse large B-cell lymphoma associated with chronic inflammation,0
8899,Multinodular and Vacuolated Pattern,Diffuse large B-cell lymphoma associated with chronic inflammation,0
8900,Reticular Growth Pattern,Diffuse large B-cell lymphoma associated with chronic inflammation,0
8901,Microcystic Growth Pattern,Diffuse large B-cell lymphoma associated with chronic inflammation,0
8902,Labyrinthine Growth Pattern,Diffuse large B-cell lymphoma associated with chronic inflammation,0
8903,Poorly Formed Pattern,Recurrent Childhood Anaplastic Astrocytoma,0
8904,Multinodular and Vacuolated Pattern,Recurrent Childhood Anaplastic Astrocytoma,0
8905,Reticular Growth Pattern,Recurrent Childhood Anaplastic Astrocytoma,0
8906,Microcystic Growth Pattern,Recurrent Childhood Anaplastic Astrocytoma,0
8907,Labyrinthine Growth Pattern,Recurrent Childhood Anaplastic Astrocytoma,0
8908,Poorly Formed Pattern,Childhood Brain Stem Gliosarcoma,0
8909,Multinodular and Vacuolated Pattern,Childhood Brain Stem Gliosarcoma,0
8910,Reticular Growth Pattern,Childhood Brain Stem Gliosarcoma,0
8911,Microcystic Growth Pattern,Childhood Brain Stem Gliosarcoma,0
8912,Labyrinthine Growth Pattern,Childhood Brain Stem Gliosarcoma,0
8913,Poorly Formed Pattern,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,0
8914,Multinodular and Vacuolated Pattern,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,0
8915,Reticular Growth Pattern,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,0
8916,Microcystic Growth Pattern,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,0
8917,Labyrinthine Growth Pattern,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,0
8918,Poorly Formed Pattern,"Anaplastic Astrocytoma, IDH-Mutant",0
8919,Multinodular and Vacuolated Pattern,"Anaplastic Astrocytoma, IDH-Mutant",0
8920,Reticular Growth Pattern,"Anaplastic Astrocytoma, IDH-Mutant",0
8921,Microcystic Growth Pattern,"Anaplastic Astrocytoma, IDH-Mutant",0
8922,Labyrinthine Growth Pattern,"Anaplastic Astrocytoma, IDH-Mutant",0
8923,Poorly Formed Pattern,Angioendotheliomatosis,0
8924,Multinodular and Vacuolated Pattern,Angioendotheliomatosis,0
8925,Reticular Growth Pattern,Angioendotheliomatosis,0
8926,Microcystic Growth Pattern,Angioendotheliomatosis,0
8927,Labyrinthine Growth Pattern,Angioendotheliomatosis,0
8928,Poorly Formed Pattern,large B-cell diffuse lymphoma of spleen,0
8929,Multinodular and Vacuolated Pattern,large B-cell diffuse lymphoma of spleen,0
8930,Reticular Growth Pattern,large B-cell diffuse lymphoma of spleen,0
8931,Microcystic Growth Pattern,large B-cell diffuse lymphoma of spleen,0
8932,Labyrinthine Growth Pattern,large B-cell diffuse lymphoma of spleen,0
8933,Poorly Formed Pattern,Childhood Immunoblastic Lymphoma,0
8934,Multinodular and Vacuolated Pattern,Childhood Immunoblastic Lymphoma,0
8935,Reticular Growth Pattern,Childhood Immunoblastic Lymphoma,0
8936,Microcystic Growth Pattern,Childhood Immunoblastic Lymphoma,0
8937,Labyrinthine Growth Pattern,Childhood Immunoblastic Lymphoma,0
8938,Poorly Formed Pattern,Protoplasmic astrocytoma,0
8939,Multinodular and Vacuolated Pattern,Protoplasmic astrocytoma,0
8940,Reticular Growth Pattern,Protoplasmic astrocytoma,0
8941,Microcystic Growth Pattern,Protoplasmic astrocytoma,0
8942,Labyrinthine Growth Pattern,Protoplasmic astrocytoma,0
8943,Poorly Formed Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,0
8944,Multinodular and Vacuolated Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,0
8945,Reticular Growth Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,0
8946,Microcystic Growth Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,0
8947,Labyrinthine Growth Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,0
8948,Coronary Vessel Lesion,"Glioblastoma, IDH-Mutant",0
8949,Index Lesion,"Glioblastoma, IDH-Mutant",0
8950,Non-Index Lesion,"Glioblastoma, IDH-Mutant",0
8951,Mushroom-Shaped Lesion,"Glioblastoma, IDH-Mutant",0
8952,Annular Lesion,"Glioblastoma, IDH-Mutant",0
8953,Poorly Formed Pattern,Childhood Glioblastoma,0
8954,Multinodular and Vacuolated Pattern,Childhood Glioblastoma,0
8955,Reticular Growth Pattern,Childhood Glioblastoma,0
8956,Microcystic Growth Pattern,Childhood Glioblastoma,0
8957,Labyrinthine Growth Pattern,Childhood Glioblastoma,0
8958,Poorly Formed Pattern,Primary mediastinal large B-cell lymphoma recurrent,0
8959,Multinodular and Vacuolated Pattern,Primary mediastinal large B-cell lymphoma recurrent,0
8960,Reticular Growth Pattern,Primary mediastinal large B-cell lymphoma recurrent,0
8961,Microcystic Growth Pattern,Primary mediastinal large B-cell lymphoma recurrent,0
8962,Labyrinthine Growth Pattern,Primary mediastinal large B-cell lymphoma recurrent,0
8963,Poorly Formed Pattern,Primary cutaneous diffuse large cell B-cell lymphoma,0
8964,Multinodular and Vacuolated Pattern,Primary cutaneous diffuse large cell B-cell lymphoma,0
8965,Reticular Growth Pattern,Primary cutaneous diffuse large cell B-cell lymphoma,0
8966,Microcystic Growth Pattern,Primary cutaneous diffuse large cell B-cell lymphoma,0
8967,Labyrinthine Growth Pattern,Primary cutaneous diffuse large cell B-cell lymphoma,0
8968,Poorly Formed Pattern,Stage IV Adult Immunoblastic Lymphoma,0
8969,Multinodular and Vacuolated Pattern,Stage IV Adult Immunoblastic Lymphoma,0
8970,Reticular Growth Pattern,Stage IV Adult Immunoblastic Lymphoma,0
8971,Microcystic Growth Pattern,Stage IV Adult Immunoblastic Lymphoma,0
8972,Labyrinthine Growth Pattern,Stage IV Adult Immunoblastic Lymphoma,0
8973,Poorly Formed Pattern,Gastric Diffuse Large B-Cell Lymphoma,0
8974,Multinodular and Vacuolated Pattern,Gastric Diffuse Large B-Cell Lymphoma,0
8975,Reticular Growth Pattern,Gastric Diffuse Large B-Cell Lymphoma,0
8976,Microcystic Growth Pattern,Gastric Diffuse Large B-Cell Lymphoma,0
8977,Labyrinthine Growth Pattern,Gastric Diffuse Large B-Cell Lymphoma,0
8978,Poorly Formed Pattern,Childhood Diffuse Large B-Cell Lymphoma,0
8979,Multinodular and Vacuolated Pattern,Childhood Diffuse Large B-Cell Lymphoma,0
8980,Reticular Growth Pattern,Childhood Diffuse Large B-Cell Lymphoma,0
8981,Microcystic Growth Pattern,Childhood Diffuse Large B-Cell Lymphoma,0
8982,Labyrinthine Growth Pattern,Childhood Diffuse Large B-Cell Lymphoma,0
8983,Poorly Formed Pattern,Centroblastic lymphoma refractory,0
8984,Multinodular and Vacuolated Pattern,Centroblastic lymphoma refractory,0
8985,Reticular Growth Pattern,Centroblastic lymphoma refractory,0
8986,Microcystic Growth Pattern,Centroblastic lymphoma refractory,0
8987,Labyrinthine Growth Pattern,Centroblastic lymphoma refractory,0
8988,Poorly Formed Pattern,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,0
8989,Multinodular and Vacuolated Pattern,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,0
8990,Reticular Growth Pattern,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,0
8991,Microcystic Growth Pattern,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,0
8992,Labyrinthine Growth Pattern,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,0
8993,Poorly Formed Pattern,Grade 2 Diffuse Follicular Lymphoma,0
8994,Multinodular and Vacuolated Pattern,Grade 2 Diffuse Follicular Lymphoma,0
8995,Reticular Growth Pattern,Grade 2 Diffuse Follicular Lymphoma,0
8996,Microcystic Growth Pattern,Grade 2 Diffuse Follicular Lymphoma,0
8997,Labyrinthine Growth Pattern,Grade 2 Diffuse Follicular Lymphoma,0
8998,Poorly Formed Pattern,Anaplastic astrocytoma,0
8999,Multinodular and Vacuolated Pattern,Anaplastic astrocytoma,0
9000,Reticular Growth Pattern,Anaplastic astrocytoma,0
9001,Microcystic Growth Pattern,Anaplastic astrocytoma,0
9002,Labyrinthine Growth Pattern,Anaplastic astrocytoma,0
9003,Poorly Formed Pattern,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
9004,Multinodular and Vacuolated Pattern,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
9005,Reticular Growth Pattern,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
9006,Microcystic Growth Pattern,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
9007,Labyrinthine Growth Pattern,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,0
9008,Poorly Formed Pattern,Glioblastoma,0
9009,Multinodular and Vacuolated Pattern,Glioblastoma,0
9010,Reticular Growth Pattern,Glioblastoma,0
9011,Microcystic Growth Pattern,Glioblastoma,0
9012,Labyrinthine Growth Pattern,Glioblastoma,0
9013,Poorly Formed Pattern,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,0
9014,Multinodular and Vacuolated Pattern,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,0
9015,Reticular Growth Pattern,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,0
9016,Microcystic Growth Pattern,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,0
9017,Labyrinthine Growth Pattern,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,0
9018,Poorly Formed Pattern,Recurrent Childhood Anaplastic Oligoastrocytoma,0
9019,Multinodular and Vacuolated Pattern,Recurrent Childhood Anaplastic Oligoastrocytoma,0
9020,Reticular Growth Pattern,Recurrent Childhood Anaplastic Oligoastrocytoma,0
9021,Microcystic Growth Pattern,Recurrent Childhood Anaplastic Oligoastrocytoma,0
9022,Labyrinthine Growth Pattern,Recurrent Childhood Anaplastic Oligoastrocytoma,0
9023,Poorly Formed Pattern,Anaplastic Diencephalic Astrocytoma,0
9024,Multinodular and Vacuolated Pattern,Anaplastic Diencephalic Astrocytoma,0
9025,Reticular Growth Pattern,Anaplastic Diencephalic Astrocytoma,0
9026,Microcystic Growth Pattern,Anaplastic Diencephalic Astrocytoma,0
9027,Labyrinthine Growth Pattern,Anaplastic Diencephalic Astrocytoma,0
9028,Poorly Formed Pattern,Primary Pulmonary Diffuse Large B-Cell Lymphoma,0
9029,Multinodular and Vacuolated Pattern,Primary Pulmonary Diffuse Large B-Cell Lymphoma,0
9030,Reticular Growth Pattern,Primary Pulmonary Diffuse Large B-Cell Lymphoma,0
9031,Microcystic Growth Pattern,Primary Pulmonary Diffuse Large B-Cell Lymphoma,0
9032,Labyrinthine Growth Pattern,Primary Pulmonary Diffuse Large B-Cell Lymphoma,0
9033,Poorly Formed Pattern,Breast Diffuse Large B-Cell Lymphoma,0
9034,Multinodular and Vacuolated Pattern,Breast Diffuse Large B-Cell Lymphoma,0
9035,Reticular Growth Pattern,Breast Diffuse Large B-Cell Lymphoma,0
9036,Microcystic Growth Pattern,Breast Diffuse Large B-Cell Lymphoma,0
9037,Labyrinthine Growth Pattern,Breast Diffuse Large B-Cell Lymphoma,0
9038,Poorly Formed Pattern,Diffuse follicle center lymphoma,0
9039,Multinodular and Vacuolated Pattern,Diffuse follicle center lymphoma,0
9040,Reticular Growth Pattern,Diffuse follicle center lymphoma,0
9041,Microcystic Growth Pattern,Diffuse follicle center lymphoma,0
9042,Labyrinthine Growth Pattern,Diffuse follicle center lymphoma,0
9043,Poorly Formed Pattern,Plasmablastic lymphoma,0
9044,Multinodular and Vacuolated Pattern,Plasmablastic lymphoma,0
9045,Reticular Growth Pattern,Plasmablastic lymphoma,0
9046,Microcystic Growth Pattern,Plasmablastic lymphoma,0
9047,Labyrinthine Growth Pattern,Plasmablastic lymphoma,0
9048,Poorly Formed Pattern,Recurrent Grade III Lymphomatoid Granulomatosis,0
9049,Multinodular and Vacuolated Pattern,Recurrent Grade III Lymphomatoid Granulomatosis,0
9050,Reticular Growth Pattern,Recurrent Grade III Lymphomatoid Granulomatosis,0
9051,Microcystic Growth Pattern,Recurrent Grade III Lymphomatoid Granulomatosis,0
9052,Labyrinthine Growth Pattern,Recurrent Grade III Lymphomatoid Granulomatosis,0
9053,Poorly Formed Pattern,Childhood Mixed Glioma,0
9054,Multinodular and Vacuolated Pattern,Childhood Mixed Glioma,0
9055,Reticular Growth Pattern,Childhood Mixed Glioma,0
9056,Microcystic Growth Pattern,Childhood Mixed Glioma,0
9057,Labyrinthine Growth Pattern,Childhood Mixed Glioma,0
9058,Poorly Formed Pattern,Adult Immunoblastic Lymphoma,0
9059,Multinodular and Vacuolated Pattern,Adult Immunoblastic Lymphoma,0
9060,Reticular Growth Pattern,Adult Immunoblastic Lymphoma,0
9061,Microcystic Growth Pattern,Adult Immunoblastic Lymphoma,0
9062,Labyrinthine Growth Pattern,Adult Immunoblastic Lymphoma,0
9063,Poorly Formed Pattern,Lymphohistiocytoid Mesothelioma,0
9064,Multinodular and Vacuolated Pattern,Lymphohistiocytoid Mesothelioma,0
9065,Reticular Growth Pattern,Lymphohistiocytoid Mesothelioma,0
9066,Microcystic Growth Pattern,Lymphohistiocytoid Mesothelioma,0
9067,Labyrinthine Growth Pattern,Lymphohistiocytoid Mesothelioma,0
9068,Poorly Formed Pattern,Esophageal Malignant Peripheral Nerve Sheath Tumor,0
9069,Multinodular and Vacuolated Pattern,Esophageal Malignant Peripheral Nerve Sheath Tumor,0
9070,Reticular Growth Pattern,Esophageal Malignant Peripheral Nerve Sheath Tumor,0
9071,Microcystic Growth Pattern,Esophageal Malignant Peripheral Nerve Sheath Tumor,0
9072,Labyrinthine Growth Pattern,Esophageal Malignant Peripheral Nerve Sheath Tumor,0
9073,Poorly Formed Pattern,Recurrent Childhood Gemistocytic Astrocytoma,0
9074,Multinodular and Vacuolated Pattern,Recurrent Childhood Gemistocytic Astrocytoma,0
9075,Reticular Growth Pattern,Recurrent Childhood Gemistocytic Astrocytoma,0
9076,Microcystic Growth Pattern,Recurrent Childhood Gemistocytic Astrocytoma,0
9077,Labyrinthine Growth Pattern,Recurrent Childhood Gemistocytic Astrocytoma,0
9078,Poorly Formed Pattern,Recurrent Childhood Oligoastrocytoma,0
9079,Multinodular and Vacuolated Pattern,Recurrent Childhood Oligoastrocytoma,0
9080,Reticular Growth Pattern,Recurrent Childhood Oligoastrocytoma,0
9081,Microcystic Growth Pattern,Recurrent Childhood Oligoastrocytoma,0
9082,Labyrinthine Growth Pattern,Recurrent Childhood Oligoastrocytoma,0
9083,Poorly Formed Pattern,Adult Brain Glioblastoma,0
9084,Multinodular and Vacuolated Pattern,Adult Brain Glioblastoma,0
9085,Reticular Growth Pattern,Adult Brain Glioblastoma,0
9086,Microcystic Growth Pattern,Adult Brain Glioblastoma,0
9087,Labyrinthine Growth Pattern,Adult Brain Glioblastoma,0
9088,Poorly Formed Pattern,Diffuse large B-cell lymphoma recurrent,0
9089,Multinodular and Vacuolated Pattern,Diffuse large B-cell lymphoma recurrent,0
9090,Reticular Growth Pattern,Diffuse large B-cell lymphoma recurrent,0
9091,Microcystic Growth Pattern,Diffuse large B-cell lymphoma recurrent,0
9092,Labyrinthine Growth Pattern,Diffuse large B-cell lymphoma recurrent,0
9093,Poorly Formed Pattern,Stage IV Diffuse Large B-Cell Lymphoma,0
9094,Multinodular and Vacuolated Pattern,Stage IV Diffuse Large B-Cell Lymphoma,0
9095,Reticular Growth Pattern,Stage IV Diffuse Large B-Cell Lymphoma,0
9096,Microcystic Growth Pattern,Stage IV Diffuse Large B-Cell Lymphoma,0
9097,Labyrinthine Growth Pattern,Stage IV Diffuse Large B-Cell Lymphoma,0
9098,Poorly Formed Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,0
9099,Multinodular and Vacuolated Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,0
9100,Reticular Growth Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,0
9101,Microcystic Growth Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,0
9102,Labyrinthine Growth Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,0
9103,Poorly Formed Pattern,Diencephalic Glioblastoma,0
9104,Multinodular and Vacuolated Pattern,Diencephalic Glioblastoma,0
9105,Reticular Growth Pattern,Diencephalic Glioblastoma,0
9106,Microcystic Growth Pattern,Diencephalic Glioblastoma,0
9107,Labyrinthine Growth Pattern,Diencephalic Glioblastoma,0
9108,Poorly Formed Pattern,oligodendroglioma,0
9109,Multinodular and Vacuolated Pattern,oligodendroglioma,0
9110,Reticular Growth Pattern,oligodendroglioma,0
9111,Microcystic Growth Pattern,oligodendroglioma,0
9112,Labyrinthine Growth Pattern,oligodendroglioma,0
9113,Poorly Formed Pattern,Recurrent Childhood Protoplasmic Astrocytoma,0
9114,Multinodular and Vacuolated Pattern,Recurrent Childhood Protoplasmic Astrocytoma,0
9115,Reticular Growth Pattern,Recurrent Childhood Protoplasmic Astrocytoma,0
9116,Microcystic Growth Pattern,Recurrent Childhood Protoplasmic Astrocytoma,0
9117,Labyrinthine Growth Pattern,Recurrent Childhood Protoplasmic Astrocytoma,0
9118,Poorly Formed Pattern,Colorectal Diffuse Large B-Cell Lymphoma,0
9119,Multinodular and Vacuolated Pattern,Colorectal Diffuse Large B-Cell Lymphoma,0
9120,Reticular Growth Pattern,Colorectal Diffuse Large B-Cell Lymphoma,0
9121,Microcystic Growth Pattern,Colorectal Diffuse Large B-Cell Lymphoma,0
9122,Labyrinthine Growth Pattern,Colorectal Diffuse Large B-Cell Lymphoma,0
9123,Poorly Formed Pattern,Sarcomatoid Mesothelioma,0
9124,Multinodular and Vacuolated Pattern,Sarcomatoid Mesothelioma,0
9125,Reticular Growth Pattern,Sarcomatoid Mesothelioma,0
9126,Microcystic Growth Pattern,Sarcomatoid Mesothelioma,0
9127,Labyrinthine Growth Pattern,Sarcomatoid Mesothelioma,0
9128,Poorly Formed Pattern,Malignant Peripheral Nerve Sheath Tumor,0
9129,Multinodular and Vacuolated Pattern,Malignant Peripheral Nerve Sheath Tumor,0
9130,Reticular Growth Pattern,Malignant Peripheral Nerve Sheath Tumor,0
9131,Microcystic Growth Pattern,Malignant Peripheral Nerve Sheath Tumor,0
9132,Labyrinthine Growth Pattern,Malignant Peripheral Nerve Sheath Tumor,0
9133,Poorly Formed Pattern,Childhood Grade III Lymphomatoid Granulomatosis,0
9134,Multinodular and Vacuolated Pattern,Childhood Grade III Lymphomatoid Granulomatosis,0
9135,Reticular Growth Pattern,Childhood Grade III Lymphomatoid Granulomatosis,0
9136,Microcystic Growth Pattern,Childhood Grade III Lymphomatoid Granulomatosis,0
9137,Labyrinthine Growth Pattern,Childhood Grade III Lymphomatoid Granulomatosis,0
9138,Poorly Formed Pattern,Cardiac Malignant Peripheral Nerve Sheath Tumor,0
9139,Multinodular and Vacuolated Pattern,Cardiac Malignant Peripheral Nerve Sheath Tumor,0
9140,Reticular Growth Pattern,Cardiac Malignant Peripheral Nerve Sheath Tumor,0
9141,Microcystic Growth Pattern,Cardiac Malignant Peripheral Nerve Sheath Tumor,0
9142,Labyrinthine Growth Pattern,Cardiac Malignant Peripheral Nerve Sheath Tumor,0
9143,Poorly Formed Pattern,Diffuse large B-cell lymphoma of central nervous system,0
9144,Multinodular and Vacuolated Pattern,Diffuse large B-cell lymphoma of central nervous system,0
9145,Reticular Growth Pattern,Diffuse large B-cell lymphoma of central nervous system,0
9146,Microcystic Growth Pattern,Diffuse large B-cell lymphoma of central nervous system,0
9147,Labyrinthine Growth Pattern,Diffuse large B-cell lymphoma of central nervous system,0
9148,Poorly Formed Pattern,Cerebellar Glioblastoma,0
9149,Multinodular and Vacuolated Pattern,Cerebellar Glioblastoma,0
9150,Reticular Growth Pattern,Cerebellar Glioblastoma,0
9151,Microcystic Growth Pattern,Cerebellar Glioblastoma,0
9152,Labyrinthine Growth Pattern,Cerebellar Glioblastoma,0
9153,Poorly Formed Pattern,Childhood Gliosarcoma,0
9154,Multinodular and Vacuolated Pattern,Childhood Gliosarcoma,0
9155,Reticular Growth Pattern,Childhood Gliosarcoma,0
9156,Microcystic Growth Pattern,Childhood Gliosarcoma,0
9157,Labyrinthine Growth Pattern,Childhood Gliosarcoma,0
9158,Poorly Formed Pattern,Recurrent Childhood Giant Cell Glioblastoma,0
9159,Multinodular and Vacuolated Pattern,Recurrent Childhood Giant Cell Glioblastoma,0
9160,Reticular Growth Pattern,Recurrent Childhood Giant Cell Glioblastoma,0
9161,Microcystic Growth Pattern,Recurrent Childhood Giant Cell Glioblastoma,0
9162,Labyrinthine Growth Pattern,Recurrent Childhood Giant Cell Glioblastoma,0
9163,Poorly Formed Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0
9164,Multinodular and Vacuolated Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0
9165,Reticular Growth Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0
9166,Microcystic Growth Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0
9167,Labyrinthine Growth Pattern,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Other",0
9168,Poorly Formed Pattern,Epithelioid glioblastoma,0
9169,Multinodular and Vacuolated Pattern,Epithelioid glioblastoma,0
9170,Reticular Growth Pattern,Epithelioid glioblastoma,0
9171,Microcystic Growth Pattern,Epithelioid glioblastoma,0
9172,Labyrinthine Growth Pattern,Epithelioid glioblastoma,0
9173,Poorly Formed Pattern,Pleural Biphasic Mesothelioma,0
9174,Multinodular and Vacuolated Pattern,Pleural Biphasic Mesothelioma,0
9175,Reticular Growth Pattern,Pleural Biphasic Mesothelioma,0
9176,Microcystic Growth Pattern,Pleural Biphasic Mesothelioma,0
9177,Labyrinthine Growth Pattern,Pleural Biphasic Mesothelioma,0
9178,Poorly Formed Pattern,Low Grade Malignant Peripheral Nerve Sheath Tumor,0
9179,Multinodular and Vacuolated Pattern,Low Grade Malignant Peripheral Nerve Sheath Tumor,0
9180,Reticular Growth Pattern,Low Grade Malignant Peripheral Nerve Sheath Tumor,0
9181,Microcystic Growth Pattern,Low Grade Malignant Peripheral Nerve Sheath Tumor,0
9182,Labyrinthine Growth Pattern,Low Grade Malignant Peripheral Nerve Sheath Tumor,0
9183,Poorly Formed Pattern,Pyothorax-Associated Lymphoma,0
9184,Multinodular and Vacuolated Pattern,Pyothorax-Associated Lymphoma,0
9185,Reticular Growth Pattern,Pyothorax-Associated Lymphoma,0
9186,Microcystic Growth Pattern,Pyothorax-Associated Lymphoma,0
9187,Labyrinthine Growth Pattern,Pyothorax-Associated Lymphoma,0
9188,Poorly Formed Pattern,Pleural Epithelioid Mesothelioma,0
9189,Multinodular and Vacuolated Pattern,Pleural Epithelioid Mesothelioma,0
9190,Reticular Growth Pattern,Pleural Epithelioid Mesothelioma,0
9191,Microcystic Growth Pattern,Pleural Epithelioid Mesothelioma,0
9192,Labyrinthine Growth Pattern,Pleural Epithelioid Mesothelioma,0
9193,Poorly Formed Pattern,Glioblastoma with Primitive Neuronal Component,0
9194,Multinodular and Vacuolated Pattern,Glioblastoma with Primitive Neuronal Component,0
9195,Reticular Growth Pattern,Glioblastoma with Primitive Neuronal Component,0
9196,Microcystic Growth Pattern,Glioblastoma with Primitive Neuronal Component,0
9197,Labyrinthine Growth Pattern,Glioblastoma with Primitive Neuronal Component,0
9198,Poorly Formed Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
9199,Multinodular and Vacuolated Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
9200,Reticular Growth Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
9201,Microcystic Growth Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
9202,Labyrinthine Growth Pattern,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",0
9203,Poorly Formed Pattern,Recurrent Childhood Gliomatosis Cerebri,0
9204,Multinodular and Vacuolated Pattern,Recurrent Childhood Gliomatosis Cerebri,0
9205,Reticular Growth Pattern,Recurrent Childhood Gliomatosis Cerebri,0
9206,Microcystic Growth Pattern,Recurrent Childhood Gliomatosis Cerebri,0
9207,Labyrinthine Growth Pattern,Recurrent Childhood Gliomatosis Cerebri,0
9208,Poorly Formed Pattern,Primary mediastinal large B-cell lymphoma refractory,0
9209,Multinodular and Vacuolated Pattern,Primary mediastinal large B-cell lymphoma refractory,0
9210,Reticular Growth Pattern,Primary mediastinal large B-cell lymphoma refractory,0
9211,Microcystic Growth Pattern,Primary mediastinal large B-cell lymphoma refractory,0
9212,Labyrinthine Growth Pattern,Primary mediastinal large B-cell lymphoma refractory,0
9213,Poorly Formed Pattern,Brain Oligodendroglioma,0
9214,Multinodular and Vacuolated Pattern,Brain Oligodendroglioma,0
9215,Reticular Growth Pattern,Brain Oligodendroglioma,0
9216,Microcystic Growth Pattern,Brain Oligodendroglioma,0
9217,Labyrinthine Growth Pattern,Brain Oligodendroglioma,0
9218,Poorly Formed Pattern,Esophageal Diffuse Large B-Cell Lymphoma,0
9219,Multinodular and Vacuolated Pattern,Esophageal Diffuse Large B-Cell Lymphoma,0
9220,Reticular Growth Pattern,Esophageal Diffuse Large B-Cell Lymphoma,0
9221,Microcystic Growth Pattern,Esophageal Diffuse Large B-Cell Lymphoma,0
9222,Labyrinthine Growth Pattern,Esophageal Diffuse Large B-Cell Lymphoma,0
9223,Poorly Formed Pattern,Immunoblastic lymphoma associated with AIDS,0
9224,Multinodular and Vacuolated Pattern,Immunoblastic lymphoma associated with AIDS,0
9225,Reticular Growth Pattern,Immunoblastic lymphoma associated with AIDS,0
9226,Microcystic Growth Pattern,Immunoblastic lymphoma associated with AIDS,0
9227,Labyrinthine Growth Pattern,Immunoblastic lymphoma associated with AIDS,0
9228,Poorly Formed Pattern,"Trophoblastic Tumor, Placental Site",0
9229,Multinodular and Vacuolated Pattern,"Trophoblastic Tumor, Placental Site",0
9230,Reticular Growth Pattern,"Trophoblastic Tumor, Placental Site",0
9231,Microcystic Growth Pattern,"Trophoblastic Tumor, Placental Site",0
9232,Labyrinthine Growth Pattern,"Trophoblastic Tumor, Placental Site",0
9233,Poorly Formed Pattern,Adult Malignant Peripheral Nerve Sheath Tumor,0
9234,Multinodular and Vacuolated Pattern,Adult Malignant Peripheral Nerve Sheath Tumor,0
9235,Reticular Growth Pattern,Adult Malignant Peripheral Nerve Sheath Tumor,0
9236,Microcystic Growth Pattern,Adult Malignant Peripheral Nerve Sheath Tumor,0
9237,Labyrinthine Growth Pattern,Adult Malignant Peripheral Nerve Sheath Tumor,0
9238,Coronary Vessel Lesion,Secondary Supratentorial Anaplastic Astrocytoma,0
9239,Index Lesion,Secondary Supratentorial Anaplastic Astrocytoma,0
9240,Non-Index Lesion,Secondary Supratentorial Anaplastic Astrocytoma,0
9241,Mushroom-Shaped Lesion,Secondary Supratentorial Anaplastic Astrocytoma,0
9242,Annular Lesion,Secondary Supratentorial Anaplastic Astrocytoma,0
9243,Poorly Formed Pattern,Pleural Desmoplastic Mesothelioma,0
9244,Multinodular and Vacuolated Pattern,Pleural Desmoplastic Mesothelioma,0
9245,Reticular Growth Pattern,Pleural Desmoplastic Mesothelioma,0
9246,Microcystic Growth Pattern,Pleural Desmoplastic Mesothelioma,0
9247,Labyrinthine Growth Pattern,Pleural Desmoplastic Mesothelioma,0
9248,Poorly Formed Pattern,Infratentorial Glioblastoma,0
9249,Multinodular and Vacuolated Pattern,Infratentorial Glioblastoma,0
9250,Reticular Growth Pattern,Infratentorial Glioblastoma,0
9251,Microcystic Growth Pattern,Infratentorial Glioblastoma,0
9252,Labyrinthine Growth Pattern,Infratentorial Glioblastoma,0
9253,Poorly Formed Pattern,Adult Brain Stem Gliosarcoma,0
9254,Multinodular and Vacuolated Pattern,Adult Brain Stem Gliosarcoma,0
9255,Reticular Growth Pattern,Adult Brain Stem Gliosarcoma,0
9256,Microcystic Growth Pattern,Adult Brain Stem Gliosarcoma,0
9257,Labyrinthine Growth Pattern,Adult Brain Stem Gliosarcoma,0
9258,Poorly Formed Pattern,Adult Brain Oligodendroglioma,0
9259,Multinodular and Vacuolated Pattern,Adult Brain Oligodendroglioma,0
9260,Reticular Growth Pattern,Adult Brain Oligodendroglioma,0
9261,Microcystic Growth Pattern,Adult Brain Oligodendroglioma,0
9262,Labyrinthine Growth Pattern,Adult Brain Oligodendroglioma,0
9263,Poorly Formed Pattern,Adult Mixed Glioma,0
9264,Multinodular and Vacuolated Pattern,Adult Mixed Glioma,0
9265,Reticular Growth Pattern,Adult Mixed Glioma,0
9266,Microcystic Growth Pattern,Adult Mixed Glioma,0
9267,Labyrinthine Growth Pattern,Adult Mixed Glioma,0
9268,Poorly Formed Pattern,Adult Anaplastic Astrocytoma,0
9269,Multinodular and Vacuolated Pattern,Adult Anaplastic Astrocytoma,0
9270,Reticular Growth Pattern,Adult Anaplastic Astrocytoma,0
9271,Microcystic Growth Pattern,Adult Anaplastic Astrocytoma,0
9272,Labyrinthine Growth Pattern,Adult Anaplastic Astrocytoma,0
9273,Poorly Formed Pattern,Primary Cutaneous Plasmablastic Lymphoma,0
9274,Multinodular and Vacuolated Pattern,Primary Cutaneous Plasmablastic Lymphoma,0
9275,Reticular Growth Pattern,Primary Cutaneous Plasmablastic Lymphoma,0
9276,Microcystic Growth Pattern,Primary Cutaneous Plasmablastic Lymphoma,0
9277,Labyrinthine Growth Pattern,Primary Cutaneous Plasmablastic Lymphoma,0
9278,Poorly Formed Pattern,"Anaplastic Astrocytoma, IDH-Wildtype",0
9279,Multinodular and Vacuolated Pattern,"Anaplastic Astrocytoma, IDH-Wildtype",0
9280,Reticular Growth Pattern,"Anaplastic Astrocytoma, IDH-Wildtype",0
9281,Microcystic Growth Pattern,"Anaplastic Astrocytoma, IDH-Wildtype",0
9282,Labyrinthine Growth Pattern,"Anaplastic Astrocytoma, IDH-Wildtype",0
9283,Poorly Formed Pattern,Anaplastic Oligoastrocytoma,0
9284,Multinodular and Vacuolated Pattern,Anaplastic Oligoastrocytoma,0
9285,Reticular Growth Pattern,Anaplastic Oligoastrocytoma,0
9286,Microcystic Growth Pattern,Anaplastic Oligoastrocytoma,0
9287,Labyrinthine Growth Pattern,Anaplastic Oligoastrocytoma,0
9288,Poorly Formed Pattern,Childhood Protoplasmic Astrocytoma,0
9289,Multinodular and Vacuolated Pattern,Childhood Protoplasmic Astrocytoma,0
9290,Reticular Growth Pattern,Childhood Protoplasmic Astrocytoma,0
9291,Microcystic Growth Pattern,Childhood Protoplasmic Astrocytoma,0
9292,Labyrinthine Growth Pattern,Childhood Protoplasmic Astrocytoma,0
9293,Poorly Formed Pattern,Low grade myofibroblastic sarcoma,0
9294,Multinodular and Vacuolated Pattern,Low grade myofibroblastic sarcoma,0
9295,Reticular Growth Pattern,Low grade myofibroblastic sarcoma,0
9296,Microcystic Growth Pattern,Low grade myofibroblastic sarcoma,0
9297,Labyrinthine Growth Pattern,Low grade myofibroblastic sarcoma,0
9298,Poorly Formed Pattern,Childhood Oligoastrocytoma,0
9299,Multinodular and Vacuolated Pattern,Childhood Oligoastrocytoma,0
9300,Reticular Growth Pattern,Childhood Oligoastrocytoma,0
9301,Microcystic Growth Pattern,Childhood Oligoastrocytoma,0
9302,Labyrinthine Growth Pattern,Childhood Oligoastrocytoma,0
9303,Poorly Formed Pattern,Childhood Anaplastic Oligodendroglioma,0
9304,Multinodular and Vacuolated Pattern,Childhood Anaplastic Oligodendroglioma,0
9305,Reticular Growth Pattern,Childhood Anaplastic Oligodendroglioma,0
9306,Microcystic Growth Pattern,Childhood Anaplastic Oligodendroglioma,0
9307,Labyrinthine Growth Pattern,Childhood Anaplastic Oligodendroglioma,0
9308,Poorly Formed Pattern,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,0
9309,Multinodular and Vacuolated Pattern,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,0
9310,Reticular Growth Pattern,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,0
9311,Microcystic Growth Pattern,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,0
9312,Labyrinthine Growth Pattern,AIDS-Related Plasmablastic Lymphoma of the Oral Mucosa,0
9313,Poorly Formed Pattern,Recurrent Childhood Gliosarcoma,0
9314,Multinodular and Vacuolated Pattern,Recurrent Childhood Gliosarcoma,0
9315,Reticular Growth Pattern,Recurrent Childhood Gliosarcoma,0
9316,Microcystic Growth Pattern,Recurrent Childhood Gliosarcoma,0
9317,Labyrinthine Growth Pattern,Recurrent Childhood Gliosarcoma,0
9318,Poorly Formed Pattern,"Malignant lymphoma centroblastic, diffuse",0
9319,Multinodular and Vacuolated Pattern,"Malignant lymphoma centroblastic, diffuse",0
9320,Reticular Growth Pattern,"Malignant lymphoma centroblastic, diffuse",0
9321,Microcystic Growth Pattern,"Malignant lymphoma centroblastic, diffuse",0
9322,Labyrinthine Growth Pattern,"Malignant lymphoma centroblastic, diffuse",0
9323,Poorly Formed Pattern,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0
9324,Multinodular and Vacuolated Pattern,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0
9325,Reticular Growth Pattern,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0
9326,Microcystic Growth Pattern,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0
9327,Labyrinthine Growth Pattern,Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type,0
9328,Poorly Formed Pattern,Glioblastoma by Gene Expression Profile,0
9329,Multinodular and Vacuolated Pattern,Glioblastoma by Gene Expression Profile,0
9330,Reticular Growth Pattern,Glioblastoma by Gene Expression Profile,0
9331,Microcystic Growth Pattern,Glioblastoma by Gene Expression Profile,0
9332,Labyrinthine Growth Pattern,Glioblastoma by Gene Expression Profile,0
9333,Poorly Formed Pattern,Anaplastic large B-cell lymphoma,0
9334,Multinodular and Vacuolated Pattern,Anaplastic large B-cell lymphoma,0
9335,Reticular Growth Pattern,Anaplastic large B-cell lymphoma,0
9336,Microcystic Growth Pattern,Anaplastic large B-cell lymphoma,0
9337,Labyrinthine Growth Pattern,Anaplastic large B-cell lymphoma,0
9338,Poorly Formed Pattern,Mediastinal (Thymic) Large B-Cell Lymphoma,0
9339,Multinodular and Vacuolated Pattern,Mediastinal (Thymic) Large B-Cell Lymphoma,0
9340,Reticular Growth Pattern,Mediastinal (Thymic) Large B-Cell Lymphoma,0
9341,Microcystic Growth Pattern,Mediastinal (Thymic) Large B-Cell Lymphoma,0
9342,Labyrinthine Growth Pattern,Mediastinal (Thymic) Large B-Cell Lymphoma,0
9343,Poorly Formed Pattern,Childhood Brain Oligodendroglioma,0
9344,Multinodular and Vacuolated Pattern,Childhood Brain Oligodendroglioma,0
9345,Reticular Growth Pattern,Childhood Brain Oligodendroglioma,0
9346,Microcystic Growth Pattern,Childhood Brain Oligodendroglioma,0
9347,Labyrinthine Growth Pattern,Childhood Brain Oligodendroglioma,0
9348,Poorly Formed Pattern,Plasmablastic Lymphoma of the Oral Mucosa,0
9349,Multinodular and Vacuolated Pattern,Plasmablastic Lymphoma of the Oral Mucosa,0
9350,Reticular Growth Pattern,Plasmablastic Lymphoma of the Oral Mucosa,0
9351,Microcystic Growth Pattern,Plasmablastic Lymphoma of the Oral Mucosa,0
9352,Labyrinthine Growth Pattern,Plasmablastic Lymphoma of the Oral Mucosa,0
9353,Poorly Formed Pattern,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,0
9354,Multinodular and Vacuolated Pattern,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,0
9355,Reticular Growth Pattern,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,0
9356,Microcystic Growth Pattern,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,0
9357,Labyrinthine Growth Pattern,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,0
9358,Poorly Formed Pattern,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
9359,Multinodular and Vacuolated Pattern,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
9360,Reticular Growth Pattern,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
9361,Microcystic Growth Pattern,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
9362,Labyrinthine Growth Pattern,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
9363,Poorly Formed Pattern,Diffuse malignant mesothelioma,0
9364,Multinodular and Vacuolated Pattern,Diffuse malignant mesothelioma,0
9365,Reticular Growth Pattern,Diffuse malignant mesothelioma,0
9366,Microcystic Growth Pattern,Diffuse malignant mesothelioma,0
9367,Labyrinthine Growth Pattern,Diffuse malignant mesothelioma,0
9368,Poorly Formed Pattern,Mesenchymal Glioblastoma,0
9369,Multinodular and Vacuolated Pattern,Mesenchymal Glioblastoma,0
9370,Reticular Growth Pattern,Mesenchymal Glioblastoma,0
9371,Microcystic Growth Pattern,Mesenchymal Glioblastoma,0
9372,Labyrinthine Growth Pattern,Mesenchymal Glioblastoma,0
9373,Poorly Formed Pattern,"Diffuse Astrocytoma, IDH-Mutant",0
9374,Multinodular and Vacuolated Pattern,"Diffuse Astrocytoma, IDH-Mutant",0
9375,Reticular Growth Pattern,"Diffuse Astrocytoma, IDH-Mutant",0
9376,Microcystic Growth Pattern,"Diffuse Astrocytoma, IDH-Mutant",0
9377,Labyrinthine Growth Pattern,"Diffuse Astrocytoma, IDH-Mutant",0
9378,Poorly Formed Pattern,Grade III Childhood Astrocytoma,0
9379,Multinodular and Vacuolated Pattern,Grade III Childhood Astrocytoma,0
9380,Reticular Growth Pattern,Grade III Childhood Astrocytoma,0
9381,Microcystic Growth Pattern,Grade III Childhood Astrocytoma,0
9382,Labyrinthine Growth Pattern,Grade III Childhood Astrocytoma,0
9383,Poorly Formed Pattern,Primary mediastinal large B-cell lymphoma stage I,0
9384,Multinodular and Vacuolated Pattern,Primary mediastinal large B-cell lymphoma stage I,0
9385,Reticular Growth Pattern,Primary mediastinal large B-cell lymphoma stage I,0
9386,Microcystic Growth Pattern,Primary mediastinal large B-cell lymphoma stage I,0
9387,Labyrinthine Growth Pattern,Primary mediastinal large B-cell lymphoma stage I,0
9388,Poorly Formed Pattern,Fibrillary Astrocytoma,0
9389,Multinodular and Vacuolated Pattern,Fibrillary Astrocytoma,0
9390,Reticular Growth Pattern,Fibrillary Astrocytoma,0
9391,Microcystic Growth Pattern,Fibrillary Astrocytoma,0
9392,Labyrinthine Growth Pattern,Fibrillary Astrocytoma,0
9393,Poorly Formed Pattern,Pleural Sarcomatoid Mesothelioma,0
9394,Multinodular and Vacuolated Pattern,Pleural Sarcomatoid Mesothelioma,0
9395,Reticular Growth Pattern,Pleural Sarcomatoid Mesothelioma,0
9396,Microcystic Growth Pattern,Pleural Sarcomatoid Mesothelioma,0
9397,Labyrinthine Growth Pattern,Pleural Sarcomatoid Mesothelioma,0
9398,Poorly Formed Pattern,"Perineurioma, malignant",0
9399,Multinodular and Vacuolated Pattern,"Perineurioma, malignant",0
9400,Reticular Growth Pattern,"Perineurioma, malignant",0
9401,Microcystic Growth Pattern,"Perineurioma, malignant",0
9402,Labyrinthine Growth Pattern,"Perineurioma, malignant",0
9403,Poorly Formed Pattern,"Epithelioid mesothelioma, malignant",0
9404,Multinodular and Vacuolated Pattern,"Epithelioid mesothelioma, malignant",0
9405,Reticular Growth Pattern,"Epithelioid mesothelioma, malignant",0
9406,Microcystic Growth Pattern,"Epithelioid mesothelioma, malignant",0
9407,Labyrinthine Growth Pattern,"Epithelioid mesothelioma, malignant",0
9408,Poorly Formed Pattern,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,0
9409,Multinodular and Vacuolated Pattern,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,0
9410,Reticular Growth Pattern,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,0
9411,Microcystic Growth Pattern,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,0
9412,Labyrinthine Growth Pattern,Methotrexate-Associated Diffuse Large B-Cell Lymphoma,0
9413,Poorly Formed Pattern,Glioblastoma multiforme of spinal cord,0
9414,Multinodular and Vacuolated Pattern,Glioblastoma multiforme of spinal cord,0
9415,Reticular Growth Pattern,Glioblastoma multiforme of spinal cord,0
9416,Microcystic Growth Pattern,Glioblastoma multiforme of spinal cord,0
9417,Labyrinthine Growth Pattern,Glioblastoma multiforme of spinal cord,0
9418,Poorly Formed Pattern,Primary Effusion Lymphoma,0
9419,Multinodular and Vacuolated Pattern,Primary Effusion Lymphoma,0
9420,Reticular Growth Pattern,Primary Effusion Lymphoma,0
9421,Microcystic Growth Pattern,Primary Effusion Lymphoma,0
9422,Labyrinthine Growth Pattern,Primary Effusion Lymphoma,0
9423,Poorly Formed Pattern,AIDS-Related Primary Effusion Lymphoma,0
9424,Multinodular and Vacuolated Pattern,AIDS-Related Primary Effusion Lymphoma,0
9425,Reticular Growth Pattern,AIDS-Related Primary Effusion Lymphoma,0
9426,Microcystic Growth Pattern,AIDS-Related Primary Effusion Lymphoma,0
9427,Labyrinthine Growth Pattern,AIDS-Related Primary Effusion Lymphoma,0
9428,Poorly Formed Pattern,Supratentorial Glioblastoma,0
9429,Multinodular and Vacuolated Pattern,Supratentorial Glioblastoma,0
9430,Reticular Growth Pattern,Supratentorial Glioblastoma,0
9431,Microcystic Growth Pattern,Supratentorial Glioblastoma,0
9432,Labyrinthine Growth Pattern,Supratentorial Glioblastoma,0
9433,Poorly Formed Pattern,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,0
9434,Multinodular and Vacuolated Pattern,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,0
9435,Reticular Growth Pattern,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,0
9436,Microcystic Growth Pattern,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,0
9437,Labyrinthine Growth Pattern,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,0
9438,Poorly Formed Pattern,Recurrent Malignant Peripheral Nerve Sheath Tumor,0
9439,Multinodular and Vacuolated Pattern,Recurrent Malignant Peripheral Nerve Sheath Tumor,0
9440,Reticular Growth Pattern,Recurrent Malignant Peripheral Nerve Sheath Tumor,0
9441,Microcystic Growth Pattern,Recurrent Malignant Peripheral Nerve Sheath Tumor,0
9442,Labyrinthine Growth Pattern,Recurrent Malignant Peripheral Nerve Sheath Tumor,0
9443,Poorly Formed Pattern,Childhood Fibrillary Astrocytoma,0
9444,Multinodular and Vacuolated Pattern,Childhood Fibrillary Astrocytoma,0
9445,Reticular Growth Pattern,Childhood Fibrillary Astrocytoma,0
9446,Microcystic Growth Pattern,Childhood Fibrillary Astrocytoma,0
9447,Labyrinthine Growth Pattern,Childhood Fibrillary Astrocytoma,0
9448,Poorly Formed Pattern,Diffuse Glioma,0
9449,Multinodular and Vacuolated Pattern,Diffuse Glioma,0
9450,Reticular Growth Pattern,Diffuse Glioma,0
9451,Microcystic Growth Pattern,Diffuse Glioma,0
9452,Labyrinthine Growth Pattern,Diffuse Glioma,0
9453,Poorly Formed Pattern,Adult Grade III Lymphomatoid Granulomatosis,0
9454,Multinodular and Vacuolated Pattern,Adult Grade III Lymphomatoid Granulomatosis,0
9455,Reticular Growth Pattern,Adult Grade III Lymphomatoid Granulomatosis,0
9456,Microcystic Growth Pattern,Adult Grade III Lymphomatoid Granulomatosis,0
9457,Labyrinthine Growth Pattern,Adult Grade III Lymphomatoid Granulomatosis,0
9458,Poorly Formed Pattern,Gliomatosis cerebri,0
9459,Multinodular and Vacuolated Pattern,Gliomatosis cerebri,0
9460,Reticular Growth Pattern,Gliomatosis cerebri,0
9461,Microcystic Growth Pattern,Gliomatosis cerebri,0
9462,Labyrinthine Growth Pattern,Gliomatosis cerebri,0
9463,Poorly Formed Pattern,Primary mediastinal large B-cell lymphoma stage II,0
9464,Multinodular and Vacuolated Pattern,Primary mediastinal large B-cell lymphoma stage II,0
9465,Reticular Growth Pattern,Primary mediastinal large B-cell lymphoma stage II,0
9466,Microcystic Growth Pattern,Primary mediastinal large B-cell lymphoma stage II,0
9467,Labyrinthine Growth Pattern,Primary mediastinal large B-cell lymphoma stage II,0
9468,Poorly Formed Pattern,Anaplastic Hemispheric Astrocytoma,0
9469,Multinodular and Vacuolated Pattern,Anaplastic Hemispheric Astrocytoma,0
9470,Reticular Growth Pattern,Anaplastic Hemispheric Astrocytoma,0
9471,Microcystic Growth Pattern,Anaplastic Hemispheric Astrocytoma,0
9472,Labyrinthine Growth Pattern,Anaplastic Hemispheric Astrocytoma,0
9473,Poorly Formed Pattern,AIDS-Related Plasmablastic Lymphoma,0
9474,Multinodular and Vacuolated Pattern,AIDS-Related Plasmablastic Lymphoma,0
9475,Reticular Growth Pattern,AIDS-Related Plasmablastic Lymphoma,0
9476,Microcystic Growth Pattern,AIDS-Related Plasmablastic Lymphoma,0
9477,Labyrinthine Growth Pattern,AIDS-Related Plasmablastic Lymphoma,0
9478,Poorly Formed Pattern,Small cell glioblastoma,0
9479,Multinodular and Vacuolated Pattern,Small cell glioblastoma,0
9480,Reticular Growth Pattern,Small cell glioblastoma,0
9481,Microcystic Growth Pattern,Small cell glioblastoma,0
9482,Labyrinthine Growth Pattern,Small cell glioblastoma,0
9483,Poorly Formed Pattern,Grade 1 Diffuse Follicular Lymphoma,0
9484,Multinodular and Vacuolated Pattern,Grade 1 Diffuse Follicular Lymphoma,0
9485,Reticular Growth Pattern,Grade 1 Diffuse Follicular Lymphoma,0
9486,Microcystic Growth Pattern,Grade 1 Diffuse Follicular Lymphoma,0
9487,Labyrinthine Growth Pattern,Grade 1 Diffuse Follicular Lymphoma,0
9488,Poorly Formed Pattern,Recurrent Glioblastoma,0
9489,Multinodular and Vacuolated Pattern,Recurrent Glioblastoma,0
9490,Reticular Growth Pattern,Recurrent Glioblastoma,0
9491,Microcystic Growth Pattern,Recurrent Glioblastoma,0
9492,Labyrinthine Growth Pattern,Recurrent Glioblastoma,0
9493,Poorly Formed Pattern,Adult Oligodendroglioma,0
9494,Multinodular and Vacuolated Pattern,Adult Oligodendroglioma,0
9495,Reticular Growth Pattern,Adult Oligodendroglioma,0
9496,Microcystic Growth Pattern,Adult Oligodendroglioma,0
9497,Labyrinthine Growth Pattern,Adult Oligodendroglioma,0
9498,Poorly Formed Pattern,Centroblastic lymphoma stage II,0
9499,Multinodular and Vacuolated Pattern,Centroblastic lymphoma stage II,0
9500,Reticular Growth Pattern,Centroblastic lymphoma stage II,0
9501,Microcystic Growth Pattern,Centroblastic lymphoma stage II,0
9502,Labyrinthine Growth Pattern,Centroblastic lymphoma stage II,0
9503,Poorly Formed Pattern,Diffuse Intrinsic Pontine Glioma,0
9504,Multinodular and Vacuolated Pattern,Diffuse Intrinsic Pontine Glioma,0
9505,Reticular Growth Pattern,Diffuse Intrinsic Pontine Glioma,0
9506,Microcystic Growth Pattern,Diffuse Intrinsic Pontine Glioma,0
9507,Labyrinthine Growth Pattern,Diffuse Intrinsic Pontine Glioma,0
9508,Poorly Formed Pattern,"Diffuse midline glioma, point mutation K27M in histone H3",0
9509,Multinodular and Vacuolated Pattern,"Diffuse midline glioma, point mutation K27M in histone H3",0
9510,Reticular Growth Pattern,"Diffuse midline glioma, point mutation K27M in histone H3",0
9511,Microcystic Growth Pattern,"Diffuse midline glioma, point mutation K27M in histone H3",0
9512,Labyrinthine Growth Pattern,"Diffuse midline glioma, point mutation K27M in histone H3",0
9513,Poorly Formed Pattern,Childhood Gliomatosis Cerebri,0
9514,Multinodular and Vacuolated Pattern,Childhood Gliomatosis Cerebri,0
9515,Reticular Growth Pattern,Childhood Gliomatosis Cerebri,0
9516,Microcystic Growth Pattern,Childhood Gliomatosis Cerebri,0
9517,Labyrinthine Growth Pattern,Childhood Gliomatosis Cerebri,0
9518,Poorly Formed Pattern,High Grade Malignant Peripheral Nerve Sheath Tumor,0
9519,Multinodular and Vacuolated Pattern,High Grade Malignant Peripheral Nerve Sheath Tumor,0
9520,Reticular Growth Pattern,High Grade Malignant Peripheral Nerve Sheath Tumor,0
9521,Microcystic Growth Pattern,High Grade Malignant Peripheral Nerve Sheath Tumor,0
9522,Labyrinthine Growth Pattern,High Grade Malignant Peripheral Nerve Sheath Tumor,0
9523,Poorly Formed Pattern,Centroblastic lymphoma stage III,0
9524,Multinodular and Vacuolated Pattern,Centroblastic lymphoma stage III,0
9525,Reticular Growth Pattern,Centroblastic lymphoma stage III,0
9526,Microcystic Growth Pattern,Centroblastic lymphoma stage III,0
9527,Labyrinthine Growth Pattern,Centroblastic lymphoma stage III,0
9528,Poorly Formed Pattern,Diffuse Large B-Cell Lymphoma,0
9529,Multinodular and Vacuolated Pattern,Diffuse Large B-Cell Lymphoma,0
9530,Reticular Growth Pattern,Diffuse Large B-Cell Lymphoma,0
9531,Microcystic Growth Pattern,Diffuse Large B-Cell Lymphoma,0
9532,Labyrinthine Growth Pattern,Diffuse Large B-Cell Lymphoma,0
9533,Poorly Formed Pattern,Childhood Gemistocytic Astrocytoma,0
9534,Multinodular and Vacuolated Pattern,Childhood Gemistocytic Astrocytoma,0
9535,Reticular Growth Pattern,Childhood Gemistocytic Astrocytoma,0
9536,Microcystic Growth Pattern,Childhood Gemistocytic Astrocytoma,0
9537,Labyrinthine Growth Pattern,Childhood Gemistocytic Astrocytoma,0
9538,Poorly Formed Pattern,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,0
9539,Multinodular and Vacuolated Pattern,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,0
9540,Reticular Growth Pattern,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,0
9541,Microcystic Growth Pattern,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,0
9542,Labyrinthine Growth Pattern,Large B-cell lymphoma arising in HHV8 associated multicentric Castleman disease,0
9543,Poorly Formed Pattern,Splenic diffuse red pulp small B-cell lymphoma,0
9544,Multinodular and Vacuolated Pattern,Splenic diffuse red pulp small B-cell lymphoma,0
9545,Reticular Growth Pattern,Splenic diffuse red pulp small B-cell lymphoma,0
9546,Microcystic Growth Pattern,Splenic diffuse red pulp small B-cell lymphoma,0
9547,Labyrinthine Growth Pattern,Splenic diffuse red pulp small B-cell lymphoma,0
9548,Poorly Formed Pattern,Childhood Brain Stem Mixed Glioma,0
9549,Multinodular and Vacuolated Pattern,Childhood Brain Stem Mixed Glioma,0
9550,Reticular Growth Pattern,Childhood Brain Stem Mixed Glioma,0
9551,Microcystic Growth Pattern,Childhood Brain Stem Mixed Glioma,0
9552,Labyrinthine Growth Pattern,Childhood Brain Stem Mixed Glioma,0
9553,Poorly Formed Pattern,Colon Diffuse Large B-Cell Lymphoma,0
9554,Multinodular and Vacuolated Pattern,Colon Diffuse Large B-Cell Lymphoma,0
9555,Reticular Growth Pattern,Colon Diffuse Large B-Cell Lymphoma,0
9556,Microcystic Growth Pattern,Colon Diffuse Large B-Cell Lymphoma,0
9557,Labyrinthine Growth Pattern,Colon Diffuse Large B-Cell Lymphoma,0
9558,Poorly Formed Pattern,large B-cell diffuse lymphoma of liver,0
9559,Multinodular and Vacuolated Pattern,large B-cell diffuse lymphoma of liver,0
9560,Reticular Growth Pattern,large B-cell diffuse lymphoma of liver,0
9561,Microcystic Growth Pattern,large B-cell diffuse lymphoma of liver,0
9562,Labyrinthine Growth Pattern,large B-cell diffuse lymphoma of liver,0
9563,Poorly Formed Pattern,"Mesothelioma, biphasic, malignant",0
9564,Multinodular and Vacuolated Pattern,"Mesothelioma, biphasic, malignant",0
9565,Reticular Growth Pattern,"Mesothelioma, biphasic, malignant",0
9566,Microcystic Growth Pattern,"Mesothelioma, biphasic, malignant",0
9567,Labyrinthine Growth Pattern,"Mesothelioma, biphasic, malignant",0
9568,Poorly Formed Pattern,Recurrent Childhood Anaplastic Oligodendroglioma,0
9569,Multinodular and Vacuolated Pattern,Recurrent Childhood Anaplastic Oligodendroglioma,0
9570,Reticular Growth Pattern,Recurrent Childhood Anaplastic Oligodendroglioma,0
9571,Microcystic Growth Pattern,Recurrent Childhood Anaplastic Oligodendroglioma,0
9572,Labyrinthine Growth Pattern,Recurrent Childhood Anaplastic Oligodendroglioma,0
9573,Poorly Formed Pattern,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0
9574,Multinodular and Vacuolated Pattern,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0
9575,Reticular Growth Pattern,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0
9576,Microcystic Growth Pattern,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0
9577,Labyrinthine Growth Pattern,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,0
9578,Poorly Formed Pattern,Triple hit lymphoma,0
9579,Multinodular and Vacuolated Pattern,Triple hit lymphoma,0
9580,Reticular Growth Pattern,Triple hit lymphoma,0
9581,Microcystic Growth Pattern,Triple hit lymphoma,0
9582,Labyrinthine Growth Pattern,Triple hit lymphoma,0
9583,Poorly Formed Pattern,Recurrent Gliosarcoma,0
9584,Multinodular and Vacuolated Pattern,Recurrent Gliosarcoma,0
9585,Reticular Growth Pattern,Recurrent Gliosarcoma,0
9586,Microcystic Growth Pattern,Recurrent Gliosarcoma,0
9587,Labyrinthine Growth Pattern,Recurrent Gliosarcoma,0
9588,Poorly Formed Pattern,Double-Hit Lymphoma,0
9589,Multinodular and Vacuolated Pattern,Double-Hit Lymphoma,0
9590,Reticular Growth Pattern,Double-Hit Lymphoma,0
9591,Microcystic Growth Pattern,Double-Hit Lymphoma,0
9592,Labyrinthine Growth Pattern,Double-Hit Lymphoma,0
9593,Poorly Formed Pattern,MGMT-Unmethylated Glioblastoma,0
9594,Multinodular and Vacuolated Pattern,MGMT-Unmethylated Glioblastoma,0
9595,Reticular Growth Pattern,MGMT-Unmethylated Glioblastoma,0
9596,Microcystic Growth Pattern,MGMT-Unmethylated Glioblastoma,0
9597,Labyrinthine Growth Pattern,MGMT-Unmethylated Glioblastoma,0
9598,Poorly Formed Pattern,Central Nervous System Intravascular Large B-Cell Lymphoma,0
9599,Multinodular and Vacuolated Pattern,Central Nervous System Intravascular Large B-Cell Lymphoma,0
9600,Reticular Growth Pattern,Central Nervous System Intravascular Large B-Cell Lymphoma,0
9601,Microcystic Growth Pattern,Central Nervous System Intravascular Large B-Cell Lymphoma,0
9602,Labyrinthine Growth Pattern,Central Nervous System Intravascular Large B-Cell Lymphoma,0
9603,Poorly Formed Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,0
9604,Multinodular and Vacuolated Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,0
9605,Reticular Growth Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,0
9606,Microcystic Growth Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,0
9607,Labyrinthine Growth Pattern,High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements,0
9608,Poorly Formed Pattern,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9609,Multinodular and Vacuolated Pattern,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9610,Reticular Growth Pattern,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9611,Microcystic Growth Pattern,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9612,Labyrinthine Growth Pattern,"High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9613,Poorly Formed Pattern,Refractory Intravascular Large B-Cell Lymphoma,0
9614,Multinodular and Vacuolated Pattern,Refractory Intravascular Large B-Cell Lymphoma,0
9615,Reticular Growth Pattern,Refractory Intravascular Large B-Cell Lymphoma,0
9616,Microcystic Growth Pattern,Refractory Intravascular Large B-Cell Lymphoma,0
9617,Labyrinthine Growth Pattern,Refractory Intravascular Large B-Cell Lymphoma,0
9618,Poorly Formed Pattern,High grade B-cell lymphoma,0
9619,Multinodular and Vacuolated Pattern,High grade B-cell lymphoma,0
9620,Reticular Growth Pattern,High grade B-cell lymphoma,0
9621,Microcystic Growth Pattern,High grade B-cell lymphoma,0
9622,Labyrinthine Growth Pattern,High grade B-cell lymphoma,0
9623,Poorly Formed Pattern,Double expressor lymphoma,0
9624,Multinodular and Vacuolated Pattern,Double expressor lymphoma,0
9625,Reticular Growth Pattern,Double expressor lymphoma,0
9626,Microcystic Growth Pattern,Double expressor lymphoma,0
9627,Labyrinthine Growth Pattern,Double expressor lymphoma,0
9628,Poorly Formed Pattern,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9629,Multinodular and Vacuolated Pattern,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9630,Reticular Growth Pattern,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9631,Microcystic Growth Pattern,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9632,Labyrinthine Growth Pattern,"Small Intestinal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9633,Poorly Formed Pattern,Refractory Extranodal Diffuse Large B-cell Lymphoma,0
9634,Multinodular and Vacuolated Pattern,Refractory Extranodal Diffuse Large B-cell Lymphoma,0
9635,Reticular Growth Pattern,Refractory Extranodal Diffuse Large B-cell Lymphoma,0
9636,Microcystic Growth Pattern,Refractory Extranodal Diffuse Large B-cell Lymphoma,0
9637,Labyrinthine Growth Pattern,Refractory Extranodal Diffuse Large B-cell Lymphoma,0
9638,Poorly Formed Pattern,Recurrent Intravascular Large B-Cell Lymphoma,0
9639,Multinodular and Vacuolated Pattern,Recurrent Intravascular Large B-Cell Lymphoma,0
9640,Reticular Growth Pattern,Recurrent Intravascular Large B-Cell Lymphoma,0
9641,Microcystic Growth Pattern,Recurrent Intravascular Large B-Cell Lymphoma,0
9642,Labyrinthine Growth Pattern,Recurrent Intravascular Large B-Cell Lymphoma,0
9643,Poorly Formed Pattern,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9644,Multinodular and Vacuolated Pattern,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9645,Reticular Growth Pattern,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9646,Microcystic Growth Pattern,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9647,Labyrinthine Growth Pattern,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9648,Poorly Formed Pattern,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,0
9649,Multinodular and Vacuolated Pattern,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,0
9650,Reticular Growth Pattern,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,0
9651,Microcystic Growth Pattern,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,0
9652,Labyrinthine Growth Pattern,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,0
9653,Poorly Formed Pattern,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9654,Multinodular and Vacuolated Pattern,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9655,Reticular Growth Pattern,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9656,Microcystic Growth Pattern,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9657,Labyrinthine Growth Pattern,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",0
9658,Poorly Formed Pattern,Recurrent Anaplastic Astrocytoma,0
9659,Multinodular and Vacuolated Pattern,Recurrent Anaplastic Astrocytoma,0
9660,Reticular Growth Pattern,Recurrent Anaplastic Astrocytoma,0
9661,Microcystic Growth Pattern,Recurrent Anaplastic Astrocytoma,0
9662,Labyrinthine Growth Pattern,Recurrent Anaplastic Astrocytoma,0
9663,Poorly Formed Pattern,Recurrent Diffuse Intrinsic Pontine Glioma,0
9664,Multinodular and Vacuolated Pattern,Recurrent Diffuse Intrinsic Pontine Glioma,0
9665,Reticular Growth Pattern,Recurrent Diffuse Intrinsic Pontine Glioma,0
9666,Microcystic Growth Pattern,Recurrent Diffuse Intrinsic Pontine Glioma,0
9667,Labyrinthine Growth Pattern,Recurrent Diffuse Intrinsic Pontine Glioma,0
9668,Poorly Formed Pattern,Recurrent Extranodal Diffuse Large B-cell Lymphoma,0
9669,Multinodular and Vacuolated Pattern,Recurrent Extranodal Diffuse Large B-cell Lymphoma,0
9670,Reticular Growth Pattern,Recurrent Extranodal Diffuse Large B-cell Lymphoma,0
9671,Microcystic Growth Pattern,Recurrent Extranodal Diffuse Large B-cell Lymphoma,0
9672,Labyrinthine Growth Pattern,Recurrent Extranodal Diffuse Large B-cell Lymphoma,0
9673,Poorly Formed Pattern,Diffuse Blastoid B-Cell Lymphoma,0
9674,Multinodular and Vacuolated Pattern,Diffuse Blastoid B-Cell Lymphoma,0
9675,Reticular Growth Pattern,Diffuse Blastoid B-Cell Lymphoma,0
9676,Microcystic Growth Pattern,Diffuse Blastoid B-Cell Lymphoma,0
9677,Labyrinthine Growth Pattern,Diffuse Blastoid B-Cell Lymphoma,0
9678,Poorly Formed Pattern,Refractory Diffuse Intrinsic Pontine Glioma,0
9679,Multinodular and Vacuolated Pattern,Refractory Diffuse Intrinsic Pontine Glioma,0
9680,Reticular Growth Pattern,Refractory Diffuse Intrinsic Pontine Glioma,0
9681,Microcystic Growth Pattern,Refractory Diffuse Intrinsic Pontine Glioma,0
9682,Labyrinthine Growth Pattern,Refractory Diffuse Intrinsic Pontine Glioma,0
9683,Poorly Formed Pattern,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9684,Multinodular and Vacuolated Pattern,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9685,Reticular Growth Pattern,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9686,Microcystic Growth Pattern,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9687,Labyrinthine Growth Pattern,"Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified",0
9688,Poorly Formed Pattern,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9689,Multinodular and Vacuolated Pattern,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9690,Reticular Growth Pattern,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9691,Microcystic Growth Pattern,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9692,Labyrinthine Growth Pattern,"HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9693,Poorly Formed Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,0
9694,Multinodular and Vacuolated Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,0
9695,Reticular Growth Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,0
9696,Microcystic Growth Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,0
9697,Labyrinthine Growth Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,0
9698,Poorly Formed Pattern,Recurrent Anaplastic Oligodendroglioma,0
9699,Multinodular and Vacuolated Pattern,Recurrent Anaplastic Oligodendroglioma,0
9700,Reticular Growth Pattern,Recurrent Anaplastic Oligodendroglioma,0
9701,Microcystic Growth Pattern,Recurrent Anaplastic Oligodendroglioma,0
9702,Labyrinthine Growth Pattern,Recurrent Anaplastic Oligodendroglioma,0
9703,Poorly Formed Pattern,Refractory Glioblastoma,0
9704,Multinodular and Vacuolated Pattern,Refractory Glioblastoma,0
9705,Reticular Growth Pattern,Refractory Glioblastoma,0
9706,Microcystic Growth Pattern,Refractory Glioblastoma,0
9707,Labyrinthine Growth Pattern,Refractory Glioblastoma,0
9708,Poorly Formed Pattern,Childhood Brain Glioblastoma,0
9709,Multinodular and Vacuolated Pattern,Childhood Brain Glioblastoma,0
9710,Reticular Growth Pattern,Childhood Brain Glioblastoma,0
9711,Microcystic Growth Pattern,Childhood Brain Glioblastoma,0
9712,Labyrinthine Growth Pattern,Childhood Brain Glioblastoma,0
9713,Poorly Formed Pattern,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage,0
9714,Multinodular and Vacuolated Pattern,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage,0
9715,Reticular Growth Pattern,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage,0
9716,Microcystic Growth Pattern,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage,0
9717,Labyrinthine Growth Pattern,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage,0
9718,Poorly Formed Pattern,Recurrent Anaplastic Oligoastrocytoma,0
9719,Multinodular and Vacuolated Pattern,Recurrent Anaplastic Oligoastrocytoma,0
9720,Reticular Growth Pattern,Recurrent Anaplastic Oligoastrocytoma,0
9721,Microcystic Growth Pattern,Recurrent Anaplastic Oligoastrocytoma,0
9722,Labyrinthine Growth Pattern,Recurrent Anaplastic Oligoastrocytoma,0
9723,Poorly Formed Pattern,Centroblastic Lymphoma by Ann Arbor Stage,0
9724,Multinodular and Vacuolated Pattern,Centroblastic Lymphoma by Ann Arbor Stage,0
9725,Reticular Growth Pattern,Centroblastic Lymphoma by Ann Arbor Stage,0
9726,Microcystic Growth Pattern,Centroblastic Lymphoma by Ann Arbor Stage,0
9727,Labyrinthine Growth Pattern,Centroblastic Lymphoma by Ann Arbor Stage,0
9728,Poorly Formed Pattern,MCD Diffuse Large B-Cell Lymphoma,0
9729,Multinodular and Vacuolated Pattern,MCD Diffuse Large B-Cell Lymphoma,0
9730,Reticular Growth Pattern,MCD Diffuse Large B-Cell Lymphoma,0
9731,Microcystic Growth Pattern,MCD Diffuse Large B-Cell Lymphoma,0
9732,Labyrinthine Growth Pattern,MCD Diffuse Large B-Cell Lymphoma,0
9733,Poorly Formed Pattern,BN2 Diffuse Large B-Cell Lymphoma,0
9734,Multinodular and Vacuolated Pattern,BN2 Diffuse Large B-Cell Lymphoma,0
9735,Reticular Growth Pattern,BN2 Diffuse Large B-Cell Lymphoma,0
9736,Microcystic Growth Pattern,BN2 Diffuse Large B-Cell Lymphoma,0
9737,Labyrinthine Growth Pattern,BN2 Diffuse Large B-Cell Lymphoma,0
9738,Poorly Formed Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0
9739,Multinodular and Vacuolated Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0
9740,Reticular Growth Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0
9741,Microcystic Growth Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0
9742,Labyrinthine Growth Pattern,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes",0
9743,Poorly Formed Pattern,N1 Diffuse Large B-Cell Lymphoma,0
9744,Multinodular and Vacuolated Pattern,N1 Diffuse Large B-Cell Lymphoma,0
9745,Reticular Growth Pattern,N1 Diffuse Large B-Cell Lymphoma,0
9746,Microcystic Growth Pattern,N1 Diffuse Large B-Cell Lymphoma,0
9747,Labyrinthine Growth Pattern,N1 Diffuse Large B-Cell Lymphoma,0
9748,Poorly Formed Pattern,EZB Diffuse Large B-Cell Lymphoma,0
9749,Multinodular and Vacuolated Pattern,EZB Diffuse Large B-Cell Lymphoma,0
9750,Reticular Growth Pattern,EZB Diffuse Large B-Cell Lymphoma,0
9751,Microcystic Growth Pattern,EZB Diffuse Large B-Cell Lymphoma,0
9752,Labyrinthine Growth Pattern,EZB Diffuse Large B-Cell Lymphoma,0
9753,Poorly Formed Pattern,Body Cavity Primary Effusion Lymphoma,0
9754,Multinodular and Vacuolated Pattern,Body Cavity Primary Effusion Lymphoma,0
9755,Reticular Growth Pattern,Body Cavity Primary Effusion Lymphoma,0
9756,Microcystic Growth Pattern,Body Cavity Primary Effusion Lymphoma,0
9757,Labyrinthine Growth Pattern,Body Cavity Primary Effusion Lymphoma,0
9758,Poorly Formed Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9759,Multinodular and Vacuolated Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9760,Reticular Growth Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9761,Microcystic Growth Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9762,Labyrinthine Growth Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9763,Poorly Formed Pattern,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9764,Multinodular and Vacuolated Pattern,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9765,Reticular Growth Pattern,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9766,Microcystic Growth Pattern,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9767,Labyrinthine Growth Pattern,"Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9768,Poorly Formed Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,0
9769,Multinodular and Vacuolated Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,0
9770,Reticular Growth Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,0
9771,Microcystic Growth Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,0
9772,Labyrinthine Growth Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,0
9773,Poorly Formed Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma,0
9774,Multinodular and Vacuolated Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma,0
9775,Reticular Growth Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma,0
9776,Microcystic Growth Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma,0
9777,Labyrinthine Growth Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma,0
9778,Poorly Formed Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9779,Multinodular and Vacuolated Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9780,Reticular Growth Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9781,Microcystic Growth Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9782,Labyrinthine Growth Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,0
9783,Poorly Formed Pattern,MGMT-Methylated Glioblastoma,0
9784,Multinodular and Vacuolated Pattern,MGMT-Methylated Glioblastoma,0
9785,Reticular Growth Pattern,MGMT-Methylated Glioblastoma,0
9786,Microcystic Growth Pattern,MGMT-Methylated Glioblastoma,0
9787,Labyrinthine Growth Pattern,MGMT-Methylated Glioblastoma,0
9788,Poorly Formed Pattern,Extracavitary Primary Effusion Lymphoma,0
9789,Multinodular and Vacuolated Pattern,Extracavitary Primary Effusion Lymphoma,0
9790,Reticular Growth Pattern,Extracavitary Primary Effusion Lymphoma,0
9791,Microcystic Growth Pattern,Extracavitary Primary Effusion Lymphoma,0
9792,Labyrinthine Growth Pattern,Extracavitary Primary Effusion Lymphoma,0
9793,Poorly Formed Pattern,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9794,Multinodular and Vacuolated Pattern,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9795,Reticular Growth Pattern,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9796,Microcystic Growth Pattern,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9797,Labyrinthine Growth Pattern,"Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",0
9798,Poorly Formed Pattern,Refractory Malignant Peripheral Nerve Sheath Tumor,0
9799,Multinodular and Vacuolated Pattern,Refractory Malignant Peripheral Nerve Sheath Tumor,0
9800,Reticular Growth Pattern,Refractory Malignant Peripheral Nerve Sheath Tumor,0
9801,Microcystic Growth Pattern,Refractory Malignant Peripheral Nerve Sheath Tumor,0
9802,Labyrinthine Growth Pattern,Refractory Malignant Peripheral Nerve Sheath Tumor,0
9803,Poorly Formed Pattern,Temporal Lobe Anaplastic Astrocytoma,0
9804,Multinodular and Vacuolated Pattern,Temporal Lobe Anaplastic Astrocytoma,0
9805,Reticular Growth Pattern,Temporal Lobe Anaplastic Astrocytoma,0
9806,Microcystic Growth Pattern,Temporal Lobe Anaplastic Astrocytoma,0
9807,Labyrinthine Growth Pattern,Temporal Lobe Anaplastic Astrocytoma,0
9808,Poorly Formed Pattern,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9809,Multinodular and Vacuolated Pattern,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9810,Reticular Growth Pattern,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9811,Microcystic Growth Pattern,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9812,Labyrinthine Growth Pattern,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9813,Poorly Formed Pattern,Frontal Lobe Anaplastic Astrocytoma,0
9814,Multinodular and Vacuolated Pattern,Frontal Lobe Anaplastic Astrocytoma,0
9815,Reticular Growth Pattern,Frontal Lobe Anaplastic Astrocytoma,0
9816,Microcystic Growth Pattern,Frontal Lobe Anaplastic Astrocytoma,0
9817,Labyrinthine Growth Pattern,Frontal Lobe Anaplastic Astrocytoma,0
9818,Poorly Formed Pattern,Frontal Lobe Anaplastic Oligodendroglioma,0
9819,Multinodular and Vacuolated Pattern,Frontal Lobe Anaplastic Oligodendroglioma,0
9820,Reticular Growth Pattern,Frontal Lobe Anaplastic Oligodendroglioma,0
9821,Microcystic Growth Pattern,Frontal Lobe Anaplastic Oligodendroglioma,0
9822,Labyrinthine Growth Pattern,Frontal Lobe Anaplastic Oligodendroglioma,0
9823,Poorly Formed Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,0
9824,Multinodular and Vacuolated Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,0
9825,Reticular Growth Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,0
9826,Microcystic Growth Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,0
9827,Labyrinthine Growth Pattern,Pituitary Gland Diffuse Large B-Cell Lymphoma,0
9828,Poorly Formed Pattern,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,0
9829,Multinodular and Vacuolated Pattern,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,0
9830,Reticular Growth Pattern,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,0
9831,Microcystic Growth Pattern,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,0
9832,Labyrinthine Growth Pattern,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,0
9833,Poorly Formed Pattern,Refractory Primary Effusion Lymphoma,0
9834,Multinodular and Vacuolated Pattern,Refractory Primary Effusion Lymphoma,0
9835,Reticular Growth Pattern,Refractory Primary Effusion Lymphoma,0
9836,Microcystic Growth Pattern,Refractory Primary Effusion Lymphoma,0
9837,Labyrinthine Growth Pattern,Refractory Primary Effusion Lymphoma,0
9838,Poorly Formed Pattern,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9839,Multinodular and Vacuolated Pattern,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9840,Reticular Growth Pattern,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9841,Microcystic Growth Pattern,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9842,Labyrinthine Growth Pattern,Recurrent Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9843,Poorly Formed Pattern,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9844,Multinodular and Vacuolated Pattern,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9845,Reticular Growth Pattern,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9846,Microcystic Growth Pattern,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9847,Labyrinthine Growth Pattern,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,0
9848,Poorly Formed Pattern,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9849,Multinodular and Vacuolated Pattern,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9850,Reticular Growth Pattern,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9851,Microcystic Growth Pattern,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9852,Labyrinthine Growth Pattern,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9853,Poorly Formed Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9854,Multinodular and Vacuolated Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9855,Reticular Growth Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9856,Microcystic Growth Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9857,Labyrinthine Growth Pattern,Refractory Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System,0
9858,Poorly Formed Pattern,Recurrent Plasmablastic Lymphoma,0
9859,Multinodular and Vacuolated Pattern,Recurrent Plasmablastic Lymphoma,0
9860,Reticular Growth Pattern,Recurrent Plasmablastic Lymphoma,0
9861,Microcystic Growth Pattern,Recurrent Plasmablastic Lymphoma,0
9862,Labyrinthine Growth Pattern,Recurrent Plasmablastic Lymphoma,0
9863,Poorly Formed Pattern,Refractory Plasmablastic Lymphoma,0
9864,Multinodular and Vacuolated Pattern,Refractory Plasmablastic Lymphoma,0
9865,Reticular Growth Pattern,Refractory Plasmablastic Lymphoma,0
9866,Microcystic Growth Pattern,Refractory Plasmablastic Lymphoma,0
9867,Labyrinthine Growth Pattern,Refractory Plasmablastic Lymphoma,0
9868,Poorly Formed Pattern,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9869,Multinodular and Vacuolated Pattern,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9870,Reticular Growth Pattern,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9871,Microcystic Growth Pattern,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9872,Labyrinthine Growth Pattern,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9873,Poorly Formed Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9874,Multinodular and Vacuolated Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9875,Reticular Growth Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9876,Microcystic Growth Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9877,Labyrinthine Growth Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,0
9878,Poorly Formed Pattern,Recurrent Primary Effusion Lymphoma,0
9879,Multinodular and Vacuolated Pattern,Recurrent Primary Effusion Lymphoma,0
9880,Reticular Growth Pattern,Recurrent Primary Effusion Lymphoma,0
9881,Microcystic Growth Pattern,Recurrent Primary Effusion Lymphoma,0
9882,Labyrinthine Growth Pattern,Recurrent Primary Effusion Lymphoma,0
9883,Poorly Formed Pattern,Recurrent Giant Cell Glioblastoma,0
9884,Multinodular and Vacuolated Pattern,Recurrent Giant Cell Glioblastoma,0
9885,Reticular Growth Pattern,Recurrent Giant Cell Glioblastoma,0
9886,Microcystic Growth Pattern,Recurrent Giant Cell Glioblastoma,0
9887,Labyrinthine Growth Pattern,Recurrent Giant Cell Glioblastoma,0
9888,CD5-Positive Blast Cells Greater than 50 Percent,Acute biphenotypic leukemia,0
9889,Blasts Less than or Equal to 10000/mm3,Acute biphenotypic leukemia,0
9890,Lymphoblasts with Surface Immunoglobulin Present,Acute biphenotypic leukemia,0
9891,Blasts Increased by Greater than or Equal to 50 Percent,Acute biphenotypic leukemia,0
9892,Decrease in Blasts,Acute biphenotypic leukemia,0
9893,CD5-Positive Blast Cells Greater than 50 Percent,Infant Acute Biphenotypic Leukemia,0
9894,Blasts Less than or Equal to 10000/mm3,Infant Acute Biphenotypic Leukemia,0
9895,Lymphoblasts with Surface Immunoglobulin Present,Infant Acute Biphenotypic Leukemia,0
9896,Blasts Increased by Greater than or Equal to 50 Percent,Infant Acute Biphenotypic Leukemia,0
9897,Decrease in Blasts,Infant Acute Biphenotypic Leukemia,0
9898,CD5-Positive Blast Cells Greater than 50 Percent,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,0
9899,Blasts Less than or Equal to 10000/mm3,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,0
9900,Lymphoblasts with Surface Immunoglobulin Present,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,0
9901,Blasts Increased by Greater than or Equal to 50 Percent,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,0
9902,Decrease in Blasts,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1,0
9903,CD5-Positive Blast Cells Greater than 50 Percent,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,0
9904,Blasts Less than or Equal to 10000/mm3,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,0
9905,Lymphoblasts with Surface Immunoglobulin Present,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,0
9906,Blasts Increased by Greater than or Equal to 50 Percent,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,0
9907,Decrease in Blasts,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged,0
9908,CD5-Positive Blast Cells Greater than 50 Percent,Mixed phenotype acute leukemia B/myeloid,0
9909,Blasts Less than or Equal to 10000/mm3,Mixed phenotype acute leukemia B/myeloid,0
9910,Lymphoblasts with Surface Immunoglobulin Present,Mixed phenotype acute leukemia B/myeloid,0
9911,Blasts Increased by Greater than or Equal to 50 Percent,Mixed phenotype acute leukemia B/myeloid,0
9912,Decrease in Blasts,Mixed phenotype acute leukemia B/myeloid,0
9913,CD5-Positive Blast Cells Greater than 50 Percent,Mixed phenotype acute leukemia T/myeloid,0
9914,Blasts Less than or Equal to 10000/mm3,Mixed phenotype acute leukemia T/myeloid,0
9915,Lymphoblasts with Surface Immunoglobulin Present,Mixed phenotype acute leukemia T/myeloid,0
9916,Blasts Increased by Greater than or Equal to 50 Percent,Mixed phenotype acute leukemia T/myeloid,0
9917,Decrease in Blasts,Mixed phenotype acute leukemia T/myeloid,0
9918,CD5-Positive Blast Cells Greater than 50 Percent,Mixed phenotype acute leukemia,0
9919,Blasts Less than or Equal to 10000/mm3,Mixed phenotype acute leukemia,0
9920,Lymphoblasts with Surface Immunoglobulin Present,Mixed phenotype acute leukemia,0
9921,Blasts Increased by Greater than or Equal to 50 Percent,Mixed phenotype acute leukemia,0
9922,Decrease in Blasts,Mixed phenotype acute leukemia,0
9923,CD5-Positive Blast Cells Greater than 50 Percent,Acute bilineal leukemia,0
9924,Blasts Less than or Equal to 10000/mm3,Acute bilineal leukemia,0
9925,Lymphoblasts with Surface Immunoglobulin Present,Acute bilineal leukemia,0
9926,Blasts Increased by Greater than or Equal to 50 Percent,Acute bilineal leukemia,0
9927,Decrease in Blasts,Acute bilineal leukemia,0
9928,CD5-Positive Blast Cells Greater than 50 Percent,acute biphenotypic leukemia in relapse,0
9929,Blasts Less than or Equal to 10000/mm3,acute biphenotypic leukemia in relapse,0
9930,Lymphoblasts with Surface Immunoglobulin Present,acute biphenotypic leukemia in relapse,0
9931,Blasts Increased by Greater than or Equal to 50 Percent,acute biphenotypic leukemia in relapse,0
9932,Decrease in Blasts,acute biphenotypic leukemia in relapse,0
9933,CD5-Positive Blast Cells Greater than 50 Percent,Recurrent Mixed Phenotype Acute Leukemia,0
9934,Blasts Less than or Equal to 10000/mm3,Recurrent Mixed Phenotype Acute Leukemia,0
9935,Lymphoblasts with Surface Immunoglobulin Present,Recurrent Mixed Phenotype Acute Leukemia,0
9936,Blasts Increased by Greater than or Equal to 50 Percent,Recurrent Mixed Phenotype Acute Leukemia,0
9937,Decrease in Blasts,Recurrent Mixed Phenotype Acute Leukemia,0
9938,CD5-Positive Blast Cells Greater than 50 Percent,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified",0
9939,Blasts Less than or Equal to 10000/mm3,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified",0
9940,Lymphoblasts with Surface Immunoglobulin Present,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified",0
9941,Blasts Increased by Greater than or Equal to 50 Percent,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified",0
9942,Decrease in Blasts,"Mixed Phenotype Acute Leukemia, B/T/Myeloid, Not Otherwise Specified",0
9943,CD5-Positive Blast Cells Greater than 50 Percent,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",0
9944,Blasts Less than or Equal to 10000/mm3,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",0
9945,Lymphoblasts with Surface Immunoglobulin Present,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",0
9946,Blasts Increased by Greater than or Equal to 50 Percent,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",0
9947,Decrease in Blasts,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",0
9948,CD5-Positive Blast Cells Greater than 50 Percent,Refractory Mixed Phenotype Acute Leukemia,0
9949,Blasts Less than or Equal to 10000/mm3,Refractory Mixed Phenotype Acute Leukemia,0
9950,Lymphoblasts with Surface Immunoglobulin Present,Refractory Mixed Phenotype Acute Leukemia,0
9951,Blasts Increased by Greater than or Equal to 50 Percent,Refractory Mixed Phenotype Acute Leukemia,0
9952,Decrease in Blasts,Refractory Mixed Phenotype Acute Leukemia,0
9953,CD5-Positive Blast Cells Greater than 50 Percent,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",0
9954,Blasts Less than or Equal to 10000/mm3,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",0
9955,Lymphoblasts with Surface Immunoglobulin Present,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",0
9956,Blasts Increased by Greater than or Equal to 50 Percent,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",0
9957,Decrease in Blasts,"Mixed Phenotype Acute Leukemia, B/T, Not Otherwise Specified",0
9958,Poorly Formed Pattern,Adult Infiltrating Astrocytoma,0
9959,Multinodular and Vacuolated Pattern,Adult Infiltrating Astrocytoma,0
9960,Reticular Growth Pattern,Adult Infiltrating Astrocytoma,0
9961,Microcystic Growth Pattern,Adult Infiltrating Astrocytoma,0
9962,Labyrinthine Growth Pattern,Adult Infiltrating Astrocytoma,0
9963,Poorly Formed Pattern,Infantile digital fibromatosis,0
9964,Multinodular and Vacuolated Pattern,Infantile digital fibromatosis,0
9965,Reticular Growth Pattern,Infantile digital fibromatosis,0
9966,Microcystic Growth Pattern,Infantile digital fibromatosis,0
9967,Labyrinthine Growth Pattern,Infantile digital fibromatosis,0
9968,Poorly Formed Pattern,Fibromatosis,0
9969,Multinodular and Vacuolated Pattern,Fibromatosis,0
9970,Reticular Growth Pattern,Fibromatosis,0
9971,Microcystic Growth Pattern,Fibromatosis,0
9972,Labyrinthine Growth Pattern,Fibromatosis,0
9973,Poorly Formed Pattern,Dupuytren Contracture,0
9974,Multinodular and Vacuolated Pattern,Dupuytren Contracture,0
9975,Reticular Growth Pattern,Dupuytren Contracture,0
9976,Microcystic Growth Pattern,Dupuytren Contracture,0
9977,Labyrinthine Growth Pattern,Dupuytren Contracture,0
9978,Poorly Formed Pattern,Malignant Uterine Corpus PEComa,0
9979,Multinodular and Vacuolated Pattern,Malignant Uterine Corpus PEComa,0
9980,Reticular Growth Pattern,Malignant Uterine Corpus PEComa,0
9981,Microcystic Growth Pattern,Malignant Uterine Corpus PEComa,0
9982,Labyrinthine Growth Pattern,Malignant Uterine Corpus PEComa,0
9983,Poorly Formed Pattern,"Perivascular epithelioid tumor, malignant",0
9984,Multinodular and Vacuolated Pattern,"Perivascular epithelioid tumor, malignant",0
9985,Reticular Growth Pattern,"Perivascular epithelioid tumor, malignant",0
9986,Microcystic Growth Pattern,"Perivascular epithelioid tumor, malignant",0
9987,Labyrinthine Growth Pattern,"Perivascular epithelioid tumor, malignant",0
9988,Poorly Formed Pattern,Pigmented villonodular synovitis,0
9989,Multinodular and Vacuolated Pattern,Pigmented villonodular synovitis,0
9990,Reticular Growth Pattern,Pigmented villonodular synovitis,0
9991,Microcystic Growth Pattern,Pigmented villonodular synovitis,0
9992,Labyrinthine Growth Pattern,Pigmented villonodular synovitis,0
9993,Poorly Formed Pattern,"Fibromatosis, Aggressive",0
9994,Multinodular and Vacuolated Pattern,"Fibromatosis, Aggressive",0
9995,Reticular Growth Pattern,"Fibromatosis, Aggressive",0
9996,Microcystic Growth Pattern,"Fibromatosis, Aggressive",0
9997,Labyrinthine Growth Pattern,"Fibromatosis, Aggressive",0
9998,Poorly Formed Pattern,Lipofibromatosis,0
9999,Multinodular and Vacuolated Pattern,Lipofibromatosis,0
10000,Reticular Growth Pattern,Lipofibromatosis,0
10001,Microcystic Growth Pattern,Lipofibromatosis,0
10002,Labyrinthine Growth Pattern,Lipofibromatosis,0
10003,Poorly Formed Pattern,Diffuse neurofibroma,0
10004,Multinodular and Vacuolated Pattern,Diffuse neurofibroma,0
10005,Reticular Growth Pattern,Diffuse neurofibroma,0
10006,Microcystic Growth Pattern,Diffuse neurofibroma,0
10007,Labyrinthine Growth Pattern,Diffuse neurofibroma,0
10008,Poorly Formed Pattern,"Fibromatosis, Abdominal",0
10009,Multinodular and Vacuolated Pattern,"Fibromatosis, Abdominal",0
10010,Reticular Growth Pattern,"Fibromatosis, Abdominal",0
10011,Microcystic Growth Pattern,"Fibromatosis, Abdominal",0
10012,Labyrinthine Growth Pattern,"Fibromatosis, Abdominal",0
10013,Poorly Formed Pattern,Pelvic Fibromatosis,0
10014,Multinodular and Vacuolated Pattern,Pelvic Fibromatosis,0
10015,Reticular Growth Pattern,Pelvic Fibromatosis,0
10016,Microcystic Growth Pattern,Pelvic Fibromatosis,0
10017,Labyrinthine Growth Pattern,Pelvic Fibromatosis,0
10018,Poorly Formed Pattern,Fibromatosis colli,0
10019,Multinodular and Vacuolated Pattern,Fibromatosis colli,0
10020,Reticular Growth Pattern,Fibromatosis colli,0
10021,Microcystic Growth Pattern,Fibromatosis colli,0
10022,Labyrinthine Growth Pattern,Fibromatosis colli,0
10023,Poorly Formed Pattern,Peyronie Disease,0
10024,Multinodular and Vacuolated Pattern,Peyronie Disease,0
10025,Reticular Growth Pattern,Peyronie Disease,0
10026,Microcystic Growth Pattern,Peyronie Disease,0
10027,Labyrinthine Growth Pattern,Peyronie Disease,0
10028,Poorly Formed Pattern,"Fibromatosis, Plantar",0
10029,Multinodular and Vacuolated Pattern,"Fibromatosis, Plantar",0
10030,Reticular Growth Pattern,"Fibromatosis, Plantar",0
10031,Microcystic Growth Pattern,"Fibromatosis, Plantar",0
10032,Labyrinthine Growth Pattern,"Fibromatosis, Plantar",0
10033,Poorly Formed Pattern,Chest Wall Fibromatosis,0
10034,Multinodular and Vacuolated Pattern,Chest Wall Fibromatosis,0
10035,Reticular Growth Pattern,Chest Wall Fibromatosis,0
10036,Microcystic Growth Pattern,Chest Wall Fibromatosis,0
10037,Labyrinthine Growth Pattern,Chest Wall Fibromatosis,0
10038,Poorly Formed Pattern,Superficial fibromatosis,0
10039,Multinodular and Vacuolated Pattern,Superficial fibromatosis,0
10040,Reticular Growth Pattern,Superficial fibromatosis,0
10041,Microcystic Growth Pattern,Superficial fibromatosis,0
10042,Labyrinthine Growth Pattern,Superficial fibromatosis,0
10043,Poorly Formed Pattern,Extra-abdominal fibromatosis,0
10044,Multinodular and Vacuolated Pattern,Extra-abdominal fibromatosis,0
10045,Reticular Growth Pattern,Extra-abdominal fibromatosis,0
10046,Microcystic Growth Pattern,Extra-abdominal fibromatosis,0
10047,Labyrinthine Growth Pattern,Extra-abdominal fibromatosis,0
10048,Poorly Formed Pattern,Central Nervous System Desmoid-Type Fibromatosis,0
10049,Multinodular and Vacuolated Pattern,Central Nervous System Desmoid-Type Fibromatosis,0
10050,Reticular Growth Pattern,Central Nervous System Desmoid-Type Fibromatosis,0
10051,Microcystic Growth Pattern,Central Nervous System Desmoid-Type Fibromatosis,0
10052,Labyrinthine Growth Pattern,Central Nervous System Desmoid-Type Fibromatosis,0
10053,Poorly Formed Pattern,Malignant Lung PEComa,0
10054,Multinodular and Vacuolated Pattern,Malignant Lung PEComa,0
10055,Reticular Growth Pattern,Malignant Lung PEComa,0
10056,Microcystic Growth Pattern,Malignant Lung PEComa,0
10057,Labyrinthine Growth Pattern,Malignant Lung PEComa,0
10058,Poorly Formed Pattern,Unresectable Desmoid-Type Fibromatosis,0
10059,Multinodular and Vacuolated Pattern,Unresectable Desmoid-Type Fibromatosis,0
10060,Reticular Growth Pattern,Unresectable Desmoid-Type Fibromatosis,0
10061,Microcystic Growth Pattern,Unresectable Desmoid-Type Fibromatosis,0
10062,Labyrinthine Growth Pattern,Unresectable Desmoid-Type Fibromatosis,0
10063,Poorly Formed Pattern,Recurrent Desmoid-Type Fibromatosis,0
10064,Multinodular and Vacuolated Pattern,Recurrent Desmoid-Type Fibromatosis,0
10065,Reticular Growth Pattern,Recurrent Desmoid-Type Fibromatosis,0
10066,Microcystic Growth Pattern,Recurrent Desmoid-Type Fibromatosis,0
10067,Labyrinthine Growth Pattern,Recurrent Desmoid-Type Fibromatosis,0
10068,Open wound of penis due to bite,Old Burn Scar-Related Neoplasm,0
10069,Open wound of tongue due to bite,Old Burn Scar-Related Neoplasm,0
10070,Open wound of face due to bite,Old Burn Scar-Related Neoplasm,0
10071,Open wound of finger of right hand due to bite,Old Burn Scar-Related Neoplasm,0
10072,Open wound of finger of left hand due to bite,Old Burn Scar-Related Neoplasm,0
10073,Open wound of penis due to bite,Old Burn Scar-Related Cutaneous Melanoma,0
10074,Open wound of tongue due to bite,Old Burn Scar-Related Cutaneous Melanoma,0
10075,Open wound of face due to bite,Old Burn Scar-Related Cutaneous Melanoma,0
10076,Open wound of finger of right hand due to bite,Old Burn Scar-Related Cutaneous Melanoma,0
10077,Open wound of finger of left hand due to bite,Old Burn Scar-Related Cutaneous Melanoma,0
10078,Coronary Vessel Lesion,Cellular Myxoma,0
10079,Index Lesion,Cellular Myxoma,0
10080,Non-Index Lesion,Cellular Myxoma,0
10081,Mushroom-Shaped Lesion,Cellular Myxoma,0
10082,Annular Lesion,Cellular Myxoma,0
10083,Coronary Vessel Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma,0
10084,Index Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma,0
10085,Non-Index Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma,0
10086,Mushroom-Shaped Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma,0
10087,Annular Lesion,Intracranial Extraskeletal Myxoid Chondrosarcoma,0
10088,Coronary Vessel Lesion,Ovarian Myxoid Liposarcoma,0
10089,Index Lesion,Ovarian Myxoid Liposarcoma,0
10090,Non-Index Lesion,Ovarian Myxoid Liposarcoma,0
10091,Mushroom-Shaped Lesion,Ovarian Myxoid Liposarcoma,0
10092,Annular Lesion,Ovarian Myxoid Liposarcoma,0
10093,Coronary Vessel Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,0
10094,Index Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,0
10095,Non-Index Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,0
10096,Mushroom-Shaped Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,0
10097,Annular Lesion,Metastatic Extraskeletal Myxoid Chondrosarcoma,0
10098,Coronary Vessel Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,0
10099,Index Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,0
10100,Non-Index Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,0
10101,Mushroom-Shaped Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,0
10102,Annular Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,0
10103,Coronary Vessel Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,0
10104,Index Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,0
10105,Non-Index Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,0
10106,Mushroom-Shaped Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,0
10107,Annular Lesion,Conventional Extraskeletal Myxoid Chondrosarcoma,0
10108,Coronary Vessel Lesion,Classic Rhabdomyoma,0
10109,Index Lesion,Classic Rhabdomyoma,0
10110,Non-Index Lesion,Classic Rhabdomyoma,0
10111,Mushroom-Shaped Lesion,Classic Rhabdomyoma,0
10112,Annular Lesion,Classic Rhabdomyoma,0
10113,Coronary Vessel Lesion,Intramuscular Myxoma,0
10114,Index Lesion,Intramuscular Myxoma,0
10115,Non-Index Lesion,Intramuscular Myxoma,0
10116,Mushroom-Shaped Lesion,Intramuscular Myxoma,0
10117,Annular Lesion,Intramuscular Myxoma,0
10118,Coronary Vessel Lesion,Cervical Rhabdomyoma,0
10119,Index Lesion,Cervical Rhabdomyoma,0
10120,Non-Index Lesion,Cervical Rhabdomyoma,0
10121,Mushroom-Shaped Lesion,Cervical Rhabdomyoma,0
10122,Annular Lesion,Cervical Rhabdomyoma,0
10123,Coronary Vessel Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma,0
10124,Index Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma,0
10125,Non-Index Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma,0
10126,Mushroom-Shaped Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma,0
10127,Annular Lesion,Recurrent Extraskeletal Myxoid Chondrosarcoma,0
10128,Coronary Vessel Lesion,Locally Advanced Epithelioid Hemangioendothelioma,0
10129,Index Lesion,Locally Advanced Epithelioid Hemangioendothelioma,0
10130,Non-Index Lesion,Locally Advanced Epithelioid Hemangioendothelioma,0
10131,Mushroom-Shaped Lesion,Locally Advanced Epithelioid Hemangioendothelioma,0
10132,Annular Lesion,Locally Advanced Epithelioid Hemangioendothelioma,0
10133,Coronary Vessel Lesion,Metastatic Epithelioid Hemangioendothelioma,0
10134,Index Lesion,Metastatic Epithelioid Hemangioendothelioma,0
10135,Non-Index Lesion,Metastatic Epithelioid Hemangioendothelioma,0
10136,Mushroom-Shaped Lesion,Metastatic Epithelioid Hemangioendothelioma,0
10137,Annular Lesion,Metastatic Epithelioid Hemangioendothelioma,0
10138,Coronary Vessel Lesion,Recurrent Myxoid Liposarcoma,0
10139,Index Lesion,Recurrent Myxoid Liposarcoma,0
10140,Non-Index Lesion,Recurrent Myxoid Liposarcoma,0
10141,Mushroom-Shaped Lesion,Recurrent Myxoid Liposarcoma,0
10142,Annular Lesion,Recurrent Myxoid Liposarcoma,0
10143,Coronary Vessel Lesion,Metastatic Chordoma,0
10144,Index Lesion,Metastatic Chordoma,0
10145,Non-Index Lesion,Metastatic Chordoma,0
10146,Mushroom-Shaped Lesion,Metastatic Chordoma,0
10147,Annular Lesion,Metastatic Chordoma,0
10148,Coronary Vessel Lesion,Locally Advanced Chordoma,0
10149,Index Lesion,Locally Advanced Chordoma,0
10150,Non-Index Lesion,Locally Advanced Chordoma,0
10151,Mushroom-Shaped Lesion,Locally Advanced Chordoma,0
10152,Annular Lesion,Locally Advanced Chordoma,0
10153,Coronary Vessel Lesion,Myxoid liposarcoma metastatic,0
10154,Index Lesion,Myxoid liposarcoma metastatic,0
10155,Non-Index Lesion,Myxoid liposarcoma metastatic,0
10156,Mushroom-Shaped Lesion,Myxoid liposarcoma metastatic,0
10157,Annular Lesion,Myxoid liposarcoma metastatic,0
10158,Coronary Vessel Lesion,Refractory Myxoid Liposarcoma,0
10159,Index Lesion,Refractory Myxoid Liposarcoma,0
10160,Non-Index Lesion,Refractory Myxoid Liposarcoma,0
10161,Mushroom-Shaped Lesion,Refractory Myxoid Liposarcoma,0
10162,Annular Lesion,Refractory Myxoid Liposarcoma,0
10163,Venous insufficiency of leg,Hypertensive crisis,0
10164,Ventricular tachycardia,Hypertensive crisis,0
10165,Finding of heart rate,Hypertensive crisis,0
10166,Pulse rate finding,Hypertensive crisis,0
10167,Vascular measurements - finding,Hypertensive crisis,0
10168,Venous insufficiency of leg,Hypertensive episode,0
10169,Ventricular tachycardia,Hypertensive episode,0
10170,Finding of heart rate,Hypertensive episode,0
10171,Pulse rate finding,Hypertensive episode,0
10172,Vascular measurements - finding,Hypertensive episode,0
10173,Venous insufficiency of leg,Hypertensive Encephalopathy,0
10174,Ventricular tachycardia,Hypertensive Encephalopathy,0
10175,Finding of heart rate,Hypertensive Encephalopathy,0
10176,Pulse rate finding,Hypertensive Encephalopathy,0
10177,Vascular measurements - finding,Hypertensive Encephalopathy,0
10178,Coronary Vessel Lesion,Juxtaglomerular tumor,0
10179,Index Lesion,Juxtaglomerular tumor,0
10180,Non-Index Lesion,Juxtaglomerular tumor,0
10181,Mushroom-Shaped Lesion,Juxtaglomerular tumor,0
10182,Annular Lesion,Juxtaglomerular tumor,0
10183,Coronary Vessel Lesion,Large Bowel Juvenile Polyp,0
10184,Index Lesion,Large Bowel Juvenile Polyp,0
10185,Non-Index Lesion,Large Bowel Juvenile Polyp,0
10186,Mushroom-Shaped Lesion,Large Bowel Juvenile Polyp,0
10187,Annular Lesion,Large Bowel Juvenile Polyp,0
10188,Coronary Vessel Lesion,Hereditary Kidney Wilms Tumor,0
10189,Index Lesion,Hereditary Kidney Wilms Tumor,0
10190,Non-Index Lesion,Hereditary Kidney Wilms Tumor,0
10191,Mushroom-Shaped Lesion,Hereditary Kidney Wilms Tumor,0
10192,Annular Lesion,Hereditary Kidney Wilms Tumor,0
10193,Coronary Vessel Lesion,Gallbladder Hyperplastic Polyp,0
10194,Index Lesion,Gallbladder Hyperplastic Polyp,0
10195,Non-Index Lesion,Gallbladder Hyperplastic Polyp,0
10196,Mushroom-Shaped Lesion,Gallbladder Hyperplastic Polyp,0
10197,Annular Lesion,Gallbladder Hyperplastic Polyp,0
10198,Coronary Vessel Lesion,Ovarian Wilms Tumor,0
10199,Index Lesion,Ovarian Wilms Tumor,0
10200,Non-Index Lesion,Ovarian Wilms Tumor,0
10201,Mushroom-Shaped Lesion,Ovarian Wilms Tumor,0
10202,Annular Lesion,Ovarian Wilms Tumor,0
10203,Coronary Vessel Lesion,Giant Cell Tumor of Soft Tissue,0
10204,Index Lesion,Giant Cell Tumor of Soft Tissue,0
10205,Non-Index Lesion,Giant Cell Tumor of Soft Tissue,0
10206,Mushroom-Shaped Lesion,Giant Cell Tumor of Soft Tissue,0
10207,Annular Lesion,Giant Cell Tumor of Soft Tissue,0
10208,Coronary Vessel Lesion,Vulvar Angiomyofibroblastoma,0
10209,Index Lesion,Vulvar Angiomyofibroblastoma,0
10210,Non-Index Lesion,Vulvar Angiomyofibroblastoma,0
10211,Mushroom-Shaped Lesion,Vulvar Angiomyofibroblastoma,0
10212,Annular Lesion,Vulvar Angiomyofibroblastoma,0
10213,Coronary Vessel Lesion,Conventional Cardiac Rhabdomyoma,0
10214,Index Lesion,Conventional Cardiac Rhabdomyoma,0
10215,Non-Index Lesion,Conventional Cardiac Rhabdomyoma,0
10216,Mushroom-Shaped Lesion,Conventional Cardiac Rhabdomyoma,0
10217,Annular Lesion,Conventional Cardiac Rhabdomyoma,0
10218,Coronary Vessel Lesion,Polyp of ethmoidal sinus,0
10219,Index Lesion,Polyp of ethmoidal sinus,0
10220,Non-Index Lesion,Polyp of ethmoidal sinus,0
10221,Mushroom-Shaped Lesion,Polyp of ethmoidal sinus,0
10222,Annular Lesion,Polyp of ethmoidal sinus,0
10223,Coronary Vessel Lesion,Skin tag,0
10224,Index Lesion,Skin tag,0
10225,Non-Index Lesion,Skin tag,0
10226,Mushroom-Shaped Lesion,Skin tag,0
10227,Annular Lesion,Skin tag,0
10228,Coronary Vessel Lesion,Polyp of vocal cord,0
10229,Index Lesion,Polyp of vocal cord,0
10230,Non-Index Lesion,Polyp of vocal cord,0
10231,Mushroom-Shaped Lesion,Polyp of vocal cord,0
10232,Annular Lesion,Polyp of vocal cord,0
10233,Coronary Vessel Lesion,Colorectal Perineurioma,0
10234,Index Lesion,Colorectal Perineurioma,0
10235,Non-Index Lesion,Colorectal Perineurioma,0
10236,Mushroom-Shaped Lesion,Colorectal Perineurioma,0
10237,Annular Lesion,Colorectal Perineurioma,0
10238,Coronary Vessel Lesion,Cavernous Angioleiomyoma,0
10239,Index Lesion,Cavernous Angioleiomyoma,0
10240,Non-Index Lesion,Cavernous Angioleiomyoma,0
10241,Mushroom-Shaped Lesion,Cavernous Angioleiomyoma,0
10242,Annular Lesion,Cavernous Angioleiomyoma,0
10243,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cystic Partially Differentiated Nephroblastoma,0
10244,Isolated Tumor Cells,Cystic Partially Differentiated Nephroblastoma,0
10245,Pleural/Elastic Layer Invasion,Cystic Partially Differentiated Nephroblastoma,0
10246,Presence of Extravascular Matrix Patterns,Cystic Partially Differentiated Nephroblastoma,0
10247,Ductopenia,Cystic Partially Differentiated Nephroblastoma,0
10248,Coronary Vessel Lesion,Polyp of gallbladder,0
10249,Index Lesion,Polyp of gallbladder,0
10250,Non-Index Lesion,Polyp of gallbladder,0
10251,Mushroom-Shaped Lesion,Polyp of gallbladder,0
10252,Annular Lesion,Polyp of gallbladder,0
10253,Coronary Vessel Lesion,Pericardial Adenomatoid Tumor,0
10254,Index Lesion,Pericardial Adenomatoid Tumor,0
10255,Non-Index Lesion,Pericardial Adenomatoid Tumor,0
10256,Mushroom-Shaped Lesion,Pericardial Adenomatoid Tumor,0
10257,Annular Lesion,Pericardial Adenomatoid Tumor,0
10258,Coronary Vessel Lesion,Myofibroblastoma,0
10259,Index Lesion,Myofibroblastoma,0
10260,Non-Index Lesion,Myofibroblastoma,0
10261,Mushroom-Shaped Lesion,Myofibroblastoma,0
10262,Annular Lesion,Myofibroblastoma,0
10263,Coronary Vessel Lesion,Polyp of small intestine,0
10264,Index Lesion,Polyp of small intestine,0
10265,Non-Index Lesion,Polyp of small intestine,0
10266,Mushroom-Shaped Lesion,Polyp of small intestine,0
10267,Annular Lesion,Polyp of small intestine,0
10268,Coronary Vessel Lesion,Rectal Juvenile Polyp,0
10269,Index Lesion,Rectal Juvenile Polyp,0
10270,Non-Index Lesion,Rectal Juvenile Polyp,0
10271,Mushroom-Shaped Lesion,Rectal Juvenile Polyp,0
10272,Annular Lesion,Rectal Juvenile Polyp,0
10273,Coronary Vessel Lesion,Metachronous Wilms Tumor,0
10274,Index Lesion,Metachronous Wilms Tumor,0
10275,Non-Index Lesion,Metachronous Wilms Tumor,0
10276,Mushroom-Shaped Lesion,Metachronous Wilms Tumor,0
10277,Annular Lesion,Metachronous Wilms Tumor,0
10278,Coronary Vessel Lesion,Nasopharyngeal Angiofibroma,0
10279,Index Lesion,Nasopharyngeal Angiofibroma,0
10280,Non-Index Lesion,Nasopharyngeal Angiofibroma,0
10281,Mushroom-Shaped Lesion,Nasopharyngeal Angiofibroma,0
10282,Annular Lesion,Nasopharyngeal Angiofibroma,0
10283,Coronary Vessel Lesion,Fetal rhabdomyoma,0
10284,Index Lesion,Fetal rhabdomyoma,0
10285,Non-Index Lesion,Fetal rhabdomyoma,0
10286,Mushroom-Shaped Lesion,Fetal rhabdomyoma,0
10287,Annular Lesion,Fetal rhabdomyoma,0
10288,Coronary Vessel Lesion,Vaginal Myofibroblastoma,0
10289,Index Lesion,Vaginal Myofibroblastoma,0
10290,Non-Index Lesion,Vaginal Myofibroblastoma,0
10291,Mushroom-Shaped Lesion,Vaginal Myofibroblastoma,0
10292,Annular Lesion,Vaginal Myofibroblastoma,0
10293,Coronary Vessel Lesion,Hemangioblastoma,0
10294,Index Lesion,Hemangioblastoma,0
10295,Non-Index Lesion,Hemangioblastoma,0
10296,Mushroom-Shaped Lesion,Hemangioblastoma,0
10297,Annular Lesion,Hemangioblastoma,0
10298,Coronary Vessel Lesion,Cervical Fibroepithelial Polyp,0
10299,Index Lesion,Cervical Fibroepithelial Polyp,0
10300,Non-Index Lesion,Cervical Fibroepithelial Polyp,0
10301,Mushroom-Shaped Lesion,Cervical Fibroepithelial Polyp,0
10302,Annular Lesion,Cervical Fibroepithelial Polyp,0
10303,Coronary Vessel Lesion,Polyp of sphenoidal sinus,0
10304,Index Lesion,Polyp of sphenoidal sinus,0
10305,Non-Index Lesion,Polyp of sphenoidal sinus,0
10306,Mushroom-Shaped Lesion,Polyp of sphenoidal sinus,0
10307,Annular Lesion,Polyp of sphenoidal sinus,0
10308,Coronary Vessel Lesion,Endometrial Polyp,0
10309,Index Lesion,Endometrial Polyp,0
10310,Non-Index Lesion,Endometrial Polyp,0
10311,Mushroom-Shaped Lesion,Endometrial Polyp,0
10312,Annular Lesion,Endometrial Polyp,0
10313,Coronary Vessel Lesion,Gastric Hamartoma,0
10314,Index Lesion,Gastric Hamartoma,0
10315,Non-Index Lesion,Gastric Hamartoma,0
10316,Mushroom-Shaped Lesion,Gastric Hamartoma,0
10317,Annular Lesion,Gastric Hamartoma,0
10318,Coronary Vessel Lesion,Rectal polyp,0
10319,Index Lesion,Rectal polyp,0
10320,Non-Index Lesion,Rectal polyp,0
10321,Mushroom-Shaped Lesion,Rectal polyp,0
10322,Annular Lesion,Rectal polyp,0
10323,Coronary Vessel Lesion,Myopericytoma,0
10324,Index Lesion,Myopericytoma,0
10325,Non-Index Lesion,Myopericytoma,0
10326,Mushroom-Shaped Lesion,Myopericytoma,0
10327,Annular Lesion,Myopericytoma,0
10328,Coronary Vessel Lesion,Peutz-Jeghers polyps of small bowel,0
10329,Index Lesion,Peutz-Jeghers polyps of small bowel,0
10330,Non-Index Lesion,Peutz-Jeghers polyps of small bowel,0
10331,Mushroom-Shaped Lesion,Peutz-Jeghers polyps of small bowel,0
10332,Annular Lesion,Peutz-Jeghers polyps of small bowel,0
10333,Coronary Vessel Lesion,Polyp of external auditory meatus,0
10334,Index Lesion,Polyp of external auditory meatus,0
10335,Non-Index Lesion,Polyp of external auditory meatus,0
10336,Mushroom-Shaped Lesion,Polyp of external auditory meatus,0
10337,Annular Lesion,Polyp of external auditory meatus,0
10338,Coronary Vessel Lesion,Ureteric polyp,0
10339,Index Lesion,Ureteric polyp,0
10340,Non-Index Lesion,Ureteric polyp,0
10341,Mushroom-Shaped Lesion,Ureteric polyp,0
10342,Annular Lesion,Ureteric polyp,0
10343,Coronary Vessel Lesion,Peutz-Jeghers Polyp of the Stomach,0
10344,Index Lesion,Peutz-Jeghers Polyp of the Stomach,0
10345,Non-Index Lesion,Peutz-Jeghers Polyp of the Stomach,0
10346,Mushroom-Shaped Lesion,Peutz-Jeghers Polyp of the Stomach,0
10347,Annular Lesion,Peutz-Jeghers Polyp of the Stomach,0
10348,Coronary Vessel Lesion,Rectal hyperplastic polyp,0
10349,Index Lesion,Rectal hyperplastic polyp,0
10350,Non-Index Lesion,Rectal hyperplastic polyp,0
10351,Mushroom-Shaped Lesion,Rectal hyperplastic polyp,0
10352,Annular Lesion,Rectal hyperplastic polyp,0
10353,Coronary Vessel Lesion,Clear cell sarcoma of kidney,0
10354,Index Lesion,Clear cell sarcoma of kidney,0
10355,Non-Index Lesion,Clear cell sarcoma of kidney,0
10356,Mushroom-Shaped Lesion,Clear cell sarcoma of kidney,0
10357,Annular Lesion,Clear cell sarcoma of kidney,0
10358,Coronary Vessel Lesion,Fibrous polyp,0
10359,Index Lesion,Fibrous polyp,0
10360,Non-Index Lesion,Fibrous polyp,0
10361,Mushroom-Shaped Lesion,Fibrous polyp,0
10362,Annular Lesion,Fibrous polyp,0
10363,Coronary Vessel Lesion,Vulvar Superficial Myofibroblastoma,0
10364,Index Lesion,Vulvar Superficial Myofibroblastoma,0
10365,Non-Index Lesion,Vulvar Superficial Myofibroblastoma,0
10366,Mushroom-Shaped Lesion,Vulvar Superficial Myofibroblastoma,0
10367,Annular Lesion,Vulvar Superficial Myofibroblastoma,0
10368,Coronary Vessel Lesion,Cellular angiofibroma,0
10369,Index Lesion,Cellular angiofibroma,0
10370,Non-Index Lesion,Cellular angiofibroma,0
10371,Mushroom-Shaped Lesion,Cellular angiofibroma,0
10372,Annular Lesion,Cellular angiofibroma,0
10373,Coronary Vessel Lesion,Benign Vaginal Mixed Tumor,0
10374,Index Lesion,Benign Vaginal Mixed Tumor,0
10375,Non-Index Lesion,Benign Vaginal Mixed Tumor,0
10376,Mushroom-Shaped Lesion,Benign Vaginal Mixed Tumor,0
10377,Annular Lesion,Benign Vaginal Mixed Tumor,0
10378,Coronary Vessel Lesion,Soft tissue perineurioma,0
10379,Index Lesion,Soft tissue perineurioma,0
10380,Non-Index Lesion,Soft tissue perineurioma,0
10381,Mushroom-Shaped Lesion,Soft tissue perineurioma,0
10382,Annular Lesion,Soft tissue perineurioma,0
10383,Coronary Vessel Lesion,Gastric Juvenile Polyp,0
10384,Index Lesion,Gastric Juvenile Polyp,0
10385,Non-Index Lesion,Gastric Juvenile Polyp,0
10386,Mushroom-Shaped Lesion,Gastric Juvenile Polyp,0
10387,Annular Lesion,Gastric Juvenile Polyp,0
10388,Coronary Vessel Lesion,Mammary-Type Myofibroblastoma,0
10389,Index Lesion,Mammary-Type Myofibroblastoma,0
10390,Non-Index Lesion,Mammary-Type Myofibroblastoma,0
10391,Mushroom-Shaped Lesion,Mammary-Type Myofibroblastoma,0
10392,Annular Lesion,Mammary-Type Myofibroblastoma,0
10393,Coronary Vessel Lesion,Brain Stem Hemangioblastoma,0
10394,Index Lesion,Brain Stem Hemangioblastoma,0
10395,Non-Index Lesion,Brain Stem Hemangioblastoma,0
10396,Mushroom-Shaped Lesion,Brain Stem Hemangioblastoma,0
10397,Annular Lesion,Brain Stem Hemangioblastoma,0
10398,Coronary Vessel Lesion,Vaginal Fibroepithelial Polyp,0
10399,Index Lesion,Vaginal Fibroepithelial Polyp,0
10400,Non-Index Lesion,Vaginal Fibroepithelial Polyp,0
10401,Mushroom-Shaped Lesion,Vaginal Fibroepithelial Polyp,0
10402,Annular Lesion,Vaginal Fibroepithelial Polyp,0
10403,Coronary Vessel Lesion,Extracardiac Rhabdomyoma,0
10404,Index Lesion,Extracardiac Rhabdomyoma,0
10405,Non-Index Lesion,Extracardiac Rhabdomyoma,0
10406,Mushroom-Shaped Lesion,Extracardiac Rhabdomyoma,0
10407,Annular Lesion,Extracardiac Rhabdomyoma,0
10408,Coronary Vessel Lesion,Polyp of maxillary sinus,0
10409,Index Lesion,Polyp of maxillary sinus,0
10410,Non-Index Lesion,Polyp of maxillary sinus,0
10411,Mushroom-Shaped Lesion,Polyp of maxillary sinus,0
10412,Annular Lesion,Polyp of maxillary sinus,0
10413,Coronary Vessel Lesion,Peutz Jehgers polyp,0
10414,Index Lesion,Peutz Jehgers polyp,0
10415,Non-Index Lesion,Peutz Jehgers polyp,0
10416,Mushroom-Shaped Lesion,Peutz Jehgers polyp,0
10417,Annular Lesion,Peutz Jehgers polyp,0
10418,Coronary Vessel Lesion,Sclerosing Polycystic Adenosis,0
10419,Index Lesion,Sclerosing Polycystic Adenosis,0
10420,Non-Index Lesion,Sclerosing Polycystic Adenosis,0
10421,Mushroom-Shaped Lesion,Sclerosing Polycystic Adenosis,0
10422,Annular Lesion,Sclerosing Polycystic Adenosis,0
10423,Coronary Vessel Lesion,Polyp of vagina,0
10424,Index Lesion,Polyp of vagina,0
10425,Non-Index Lesion,Polyp of vagina,0
10426,Mushroom-Shaped Lesion,Polyp of vagina,0
10427,Annular Lesion,Polyp of vagina,0
10428,Coronary Vessel Lesion,Stromal Predominant Kidney Wilms Tumor,0
10429,Index Lesion,Stromal Predominant Kidney Wilms Tumor,0
10430,Non-Index Lesion,Stromal Predominant Kidney Wilms Tumor,0
10431,Mushroom-Shaped Lesion,Stromal Predominant Kidney Wilms Tumor,0
10432,Annular Lesion,Stromal Predominant Kidney Wilms Tumor,0
10433,Coronary Vessel Lesion,Mixed Cell Type Kidney Wilms Tumor,0
10434,Index Lesion,Mixed Cell Type Kidney Wilms Tumor,0
10435,Non-Index Lesion,Mixed Cell Type Kidney Wilms Tumor,0
10436,Mushroom-Shaped Lesion,Mixed Cell Type Kidney Wilms Tumor,0
10437,Annular Lesion,Mixed Cell Type Kidney Wilms Tumor,0
10438,Coronary Vessel Lesion,Anal Inflammatory Cloacogenic Polyp,0
10439,Index Lesion,Anal Inflammatory Cloacogenic Polyp,0
10440,Non-Index Lesion,Anal Inflammatory Cloacogenic Polyp,0
10441,Mushroom-Shaped Lesion,Anal Inflammatory Cloacogenic Polyp,0
10442,Annular Lesion,Anal Inflammatory Cloacogenic Polyp,0
10443,Coronary Vessel Lesion,Colorectal Microvesicular Hyperplastic Polyp,0
10444,Index Lesion,Colorectal Microvesicular Hyperplastic Polyp,0
10445,Non-Index Lesion,Colorectal Microvesicular Hyperplastic Polyp,0
10446,Mushroom-Shaped Lesion,Colorectal Microvesicular Hyperplastic Polyp,0
10447,Annular Lesion,Colorectal Microvesicular Hyperplastic Polyp,0
10448,Coronary Vessel Lesion,Stage IV Kidney Wilms Tumor,0
10449,Index Lesion,Stage IV Kidney Wilms Tumor,0
10450,Non-Index Lesion,Stage IV Kidney Wilms Tumor,0
10451,Mushroom-Shaped Lesion,Stage IV Kidney Wilms Tumor,0
10452,Annular Lesion,Stage IV Kidney Wilms Tumor,0
10453,Coronary Vessel Lesion,Central Nervous System Chondroma,0
10454,Index Lesion,Central Nervous System Chondroma,0
10455,Non-Index Lesion,Central Nervous System Chondroma,0
10456,Mushroom-Shaped Lesion,Central Nervous System Chondroma,0
10457,Annular Lesion,Central Nervous System Chondroma,0
10458,Coronary Vessel Lesion,Vaginal Angiomyofibroblastoma,0
10459,Index Lesion,Vaginal Angiomyofibroblastoma,0
10460,Non-Index Lesion,Vaginal Angiomyofibroblastoma,0
10461,Mushroom-Shaped Lesion,Vaginal Angiomyofibroblastoma,0
10462,Annular Lesion,Vaginal Angiomyofibroblastoma,0
10463,Coronary Vessel Lesion,Uterine Polyp,0
10464,Index Lesion,Uterine Polyp,0
10465,Non-Index Lesion,Uterine Polyp,0
10466,Mushroom-Shaped Lesion,Uterine Polyp,0
10467,Annular Lesion,Uterine Polyp,0
10468,Coronary Vessel Lesion,polyps,0
10469,Index Lesion,polyps,0
10470,Non-Index Lesion,polyps,0
10471,Mushroom-Shaped Lesion,polyps,0
10472,Annular Lesion,polyps,0
10473,Coronary Vessel Lesion,Anal skin tag,0
10474,Index Lesion,Anal skin tag,0
10475,Non-Index Lesion,Anal skin tag,0
10476,Mushroom-Shaped Lesion,Anal skin tag,0
10477,Annular Lesion,Anal skin tag,0
10478,Coronary Vessel Lesion,Nephroblastoma,0
10479,Index Lesion,Nephroblastoma,0
10480,Non-Index Lesion,Nephroblastoma,0
10481,Mushroom-Shaped Lesion,Nephroblastoma,0
10482,Annular Lesion,Nephroblastoma,0
10483,Coronary Vessel Lesion,Polyp of vulva,0
10484,Index Lesion,Polyp of vulva,0
10485,Non-Index Lesion,Polyp of vulva,0
10486,Mushroom-Shaped Lesion,Polyp of vulva,0
10487,Annular Lesion,Polyp of vulva,0
10488,Coronary Vessel Lesion,Desmoplastic fibroblastoma,0
10489,Index Lesion,Desmoplastic fibroblastoma,0
10490,Non-Index Lesion,Desmoplastic fibroblastoma,0
10491,Mushroom-Shaped Lesion,Desmoplastic fibroblastoma,0
10492,Annular Lesion,Desmoplastic fibroblastoma,0
10493,Coronary Vessel Lesion,Preauricular skin tag,0
10494,Index Lesion,Preauricular skin tag,0
10495,Non-Index Lesion,Preauricular skin tag,0
10496,Mushroom-Shaped Lesion,Preauricular skin tag,0
10497,Annular Lesion,Preauricular skin tag,0
10498,Coronary Vessel Lesion,Anaplastic Kidney Wilms Tumor,0
10499,Index Lesion,Anaplastic Kidney Wilms Tumor,0
10500,Non-Index Lesion,Anaplastic Kidney Wilms Tumor,0
10501,Mushroom-Shaped Lesion,Anaplastic Kidney Wilms Tumor,0
10502,Annular Lesion,Anaplastic Kidney Wilms Tumor,0
10503,Coronary Vessel Lesion,Colon Hyperplastic Polyp,0
10504,Index Lesion,Colon Hyperplastic Polyp,0
10505,Non-Index Lesion,Colon Hyperplastic Polyp,0
10506,Mushroom-Shaped Lesion,Colon Hyperplastic Polyp,0
10507,Annular Lesion,Colon Hyperplastic Polyp,0
10508,Coronary Vessel Lesion,Precancerous Polyp,0
10509,Index Lesion,Precancerous Polyp,0
10510,Non-Index Lesion,Precancerous Polyp,0
10511,Mushroom-Shaped Lesion,Precancerous Polyp,0
10512,Annular Lesion,Precancerous Polyp,0
10513,Coronary Vessel Lesion,Gingival Angiofibroma,0
10514,Index Lesion,Gingival Angiofibroma,0
10515,Non-Index Lesion,Gingival Angiofibroma,0
10516,Mushroom-Shaped Lesion,Gingival Angiofibroma,0
10517,Annular Lesion,Gingival Angiofibroma,0
10518,Coronary Vessel Lesion,Adult Pineocytoma,0
10519,Index Lesion,Adult Pineocytoma,0
10520,Non-Index Lesion,Adult Pineocytoma,0
10521,Mushroom-Shaped Lesion,Adult Pineocytoma,0
10522,Annular Lesion,Adult Pineocytoma,0
10523,Coronary Vessel Lesion,Hibernoma,0
10524,Index Lesion,Hibernoma,0
10525,Non-Index Lesion,Hibernoma,0
10526,Mushroom-Shaped Lesion,Hibernoma,0
10527,Annular Lesion,Hibernoma,0
10528,Coronary Vessel Lesion,Pleomorphic Rhabdomyosarcoma,0
10529,Index Lesion,Pleomorphic Rhabdomyosarcoma,0
10530,Non-Index Lesion,Pleomorphic Rhabdomyosarcoma,0
10531,Mushroom-Shaped Lesion,Pleomorphic Rhabdomyosarcoma,0
10532,Annular Lesion,Pleomorphic Rhabdomyosarcoma,0
10533,Coronary Vessel Lesion,Vaginal Rhabdomyoma,0
10534,Index Lesion,Vaginal Rhabdomyoma,0
10535,Non-Index Lesion,Vaginal Rhabdomyoma,0
10536,Mushroom-Shaped Lesion,Vaginal Rhabdomyoma,0
10537,Annular Lesion,Vaginal Rhabdomyoma,0
10538,Coronary Vessel Lesion,Gastric hyperplastic polyp,0
10539,Index Lesion,Gastric hyperplastic polyp,0
10540,Non-Index Lesion,Gastric hyperplastic polyp,0
10541,Mushroom-Shaped Lesion,Gastric hyperplastic polyp,0
10542,Annular Lesion,Gastric hyperplastic polyp,0
10543,Coronary Vessel Lesion,Nodular tenosynovitis,0
10544,Index Lesion,Nodular tenosynovitis,0
10545,Non-Index Lesion,Nodular tenosynovitis,0
10546,Mushroom-Shaped Lesion,Nodular tenosynovitis,0
10547,Annular Lesion,Nodular tenosynovitis,0
10548,Coronary Vessel Lesion,Soft tissue chondroma,0
10549,Index Lesion,Soft tissue chondroma,0
10550,Non-Index Lesion,Soft tissue chondroma,0
10551,Mushroom-Shaped Lesion,Soft tissue chondroma,0
10552,Annular Lesion,Soft tissue chondroma,0
10553,Coronary Vessel Lesion,Mediastinal Chondroma,0
10554,Index Lesion,Mediastinal Chondroma,0
10555,Non-Index Lesion,Mediastinal Chondroma,0
10556,Mushroom-Shaped Lesion,Mediastinal Chondroma,0
10557,Annular Lesion,Mediastinal Chondroma,0
10558,Coronary Vessel Lesion,Oropharyngeal Polyp,0
10559,Index Lesion,Oropharyngeal Polyp,0
10560,Non-Index Lesion,Oropharyngeal Polyp,0
10561,Mushroom-Shaped Lesion,Oropharyngeal Polyp,0
10562,Annular Lesion,Oropharyngeal Polyp,0
10563,Coronary Vessel Lesion,Central Nervous System Hemangioblastoma,0
10564,Index Lesion,Central Nervous System Hemangioblastoma,0
10565,Non-Index Lesion,Central Nervous System Hemangioblastoma,0
10566,Mushroom-Shaped Lesion,Central Nervous System Hemangioblastoma,0
10567,Annular Lesion,Central Nervous System Hemangioblastoma,0
10568,Coronary Vessel Lesion,Breast Myofibroblastoma,0
10569,Index Lesion,Breast Myofibroblastoma,0
10570,Non-Index Lesion,Breast Myofibroblastoma,0
10571,Mushroom-Shaped Lesion,Breast Myofibroblastoma,0
10572,Annular Lesion,Breast Myofibroblastoma,0
10573,Coronary Vessel Lesion,Urethra Fibroepithelial Polyp,0
10574,Index Lesion,Urethra Fibroepithelial Polyp,0
10575,Non-Index Lesion,Urethra Fibroepithelial Polyp,0
10576,Mushroom-Shaped Lesion,Urethra Fibroepithelial Polyp,0
10577,Annular Lesion,Urethra Fibroepithelial Polyp,0
10578,Coronary Vessel Lesion,Polyp of large intestine,0
10579,Index Lesion,Polyp of large intestine,0
10580,Non-Index Lesion,Polyp of large intestine,0
10581,Mushroom-Shaped Lesion,Polyp of large intestine,0
10582,Annular Lesion,Polyp of large intestine,0
10583,Coronary Vessel Lesion,Polyp of esophagus,0
10584,Index Lesion,Polyp of esophagus,0
10585,Non-Index Lesion,Polyp of esophagus,0
10586,Mushroom-Shaped Lesion,Polyp of esophagus,0
10587,Annular Lesion,Polyp of esophagus,0
10588,Coronary Vessel Lesion,Uterine Corpus Adenomatoid Tumor,0
10589,Index Lesion,Uterine Corpus Adenomatoid Tumor,0
10590,Non-Index Lesion,Uterine Corpus Adenomatoid Tumor,0
10591,Mushroom-Shaped Lesion,Uterine Corpus Adenomatoid Tumor,0
10592,Annular Lesion,Uterine Corpus Adenomatoid Tumor,0
10593,Coronary Vessel Lesion,Colorectal Inflammatory Polyp,0
10594,Index Lesion,Colorectal Inflammatory Polyp,0
10595,Non-Index Lesion,Colorectal Inflammatory Polyp,0
10596,Mushroom-Shaped Lesion,Colorectal Inflammatory Polyp,0
10597,Annular Lesion,Colorectal Inflammatory Polyp,0
10598,Coronary Vessel Lesion,Stage V Kidney Wilms Tumor,0
10599,Index Lesion,Stage V Kidney Wilms Tumor,0
10600,Non-Index Lesion,Stage V Kidney Wilms Tumor,0
10601,Mushroom-Shaped Lesion,Stage V Kidney Wilms Tumor,0
10602,Annular Lesion,Stage V Kidney Wilms Tumor,0
10603,Coronary Vessel Lesion,Epithelial Predominant Kidney Wilms Tumor,0
10604,Index Lesion,Epithelial Predominant Kidney Wilms Tumor,0
10605,Non-Index Lesion,Epithelial Predominant Kidney Wilms Tumor,0
10606,Mushroom-Shaped Lesion,Epithelial Predominant Kidney Wilms Tumor,0
10607,Annular Lesion,Epithelial Predominant Kidney Wilms Tumor,0
10608,Coronary Vessel Lesion,"Histiocytoma, Angiomatoid Fibrous",0
10609,Index Lesion,"Histiocytoma, Angiomatoid Fibrous",0
10610,Non-Index Lesion,"Histiocytoma, Angiomatoid Fibrous",0
10611,Mushroom-Shaped Lesion,"Histiocytoma, Angiomatoid Fibrous",0
10612,Annular Lesion,"Histiocytoma, Angiomatoid Fibrous",0
10613,Coronary Vessel Lesion,Angiofibroma,0
10614,Index Lesion,Angiofibroma,0
10615,Non-Index Lesion,Angiofibroma,0
10616,Mushroom-Shaped Lesion,Angiofibroma,0
10617,Annular Lesion,Angiofibroma,0
10618,Coronary Vessel Lesion,Childhood Pleomorphic Rhabdomyosarcoma,0
10619,Index Lesion,Childhood Pleomorphic Rhabdomyosarcoma,0
10620,Non-Index Lesion,Childhood Pleomorphic Rhabdomyosarcoma,0
10621,Mushroom-Shaped Lesion,Childhood Pleomorphic Rhabdomyosarcoma,0
10622,Annular Lesion,Childhood Pleomorphic Rhabdomyosarcoma,0
10623,Coronary Vessel Lesion,Gastric Cronkhite Canada Polyposis,0
10624,Index Lesion,Gastric Cronkhite Canada Polyposis,0
10625,Non-Index Lesion,Gastric Cronkhite Canada Polyposis,0
10626,Mushroom-Shaped Lesion,Gastric Cronkhite Canada Polyposis,0
10627,Annular Lesion,Gastric Cronkhite Canada Polyposis,0
10628,Coronary Vessel Lesion,Polyp of middle ear,0
10629,Index Lesion,Polyp of middle ear,0
10630,Non-Index Lesion,Polyp of middle ear,0
10631,Mushroom-Shaped Lesion,Polyp of middle ear,0
10632,Annular Lesion,Polyp of middle ear,0
10633,Coronary Vessel Lesion,Colorectal hyperplastic polyp,0
10634,Index Lesion,Colorectal hyperplastic polyp,0
10635,Non-Index Lesion,Colorectal hyperplastic polyp,0
10636,Mushroom-Shaped Lesion,Colorectal hyperplastic polyp,0
10637,Annular Lesion,Colorectal hyperplastic polyp,0
10638,Coronary Vessel Lesion,Frontal sinus polyp,0
10639,Index Lesion,Frontal sinus polyp,0
10640,Non-Index Lesion,Frontal sinus polyp,0
10641,Mushroom-Shaped Lesion,Frontal sinus polyp,0
10642,Annular Lesion,Frontal sinus polyp,0
10643,Coronary Vessel Lesion,Stage III Kidney Wilms Tumor,0
10644,Index Lesion,Stage III Kidney Wilms Tumor,0
10645,Non-Index Lesion,Stage III Kidney Wilms Tumor,0
10646,Mushroom-Shaped Lesion,Stage III Kidney Wilms Tumor,0
10647,Annular Lesion,Stage III Kidney Wilms Tumor,0
10648,Coronary Vessel Lesion,Osteoid osteoma,0
10649,Index Lesion,Osteoid osteoma,0
10650,Non-Index Lesion,Osteoid osteoma,0
10651,Mushroom-Shaped Lesion,Osteoid osteoma,0
10652,Annular Lesion,Osteoid osteoma,0
10653,Coronary Vessel Lesion,Polyp of nasal sinus,0
10654,Index Lesion,Polyp of nasal sinus,0
10655,Non-Index Lesion,Polyp of nasal sinus,0
10656,Mushroom-Shaped Lesion,Polyp of nasal sinus,0
10657,Annular Lesion,Polyp of nasal sinus,0
10658,Coronary Vessel Lesion,Gingival fibroepithelial polyp,0
10659,Index Lesion,Gingival fibroepithelial polyp,0
10660,Non-Index Lesion,Gingival fibroepithelial polyp,0
10661,Mushroom-Shaped Lesion,Gingival fibroepithelial polyp,0
10662,Annular Lesion,Gingival fibroepithelial polyp,0
10663,Coronary Vessel Lesion,Lipoblastoma,0
10664,Index Lesion,Lipoblastoma,0
10665,Non-Index Lesion,Lipoblastoma,0
10666,Mushroom-Shaped Lesion,Lipoblastoma,0
10667,Annular Lesion,Lipoblastoma,0
10668,Coronary Vessel Lesion,Vulvar Fibroepithelial Stromal Polyp,0
10669,Index Lesion,Vulvar Fibroepithelial Stromal Polyp,0
10670,Non-Index Lesion,Vulvar Fibroepithelial Stromal Polyp,0
10671,Mushroom-Shaped Lesion,Vulvar Fibroepithelial Stromal Polyp,0
10672,Annular Lesion,Vulvar Fibroepithelial Stromal Polyp,0
10673,Coronary Vessel Lesion,Adult Pleomorphic Rhabdomyosarcoma,0
10674,Index Lesion,Adult Pleomorphic Rhabdomyosarcoma,0
10675,Non-Index Lesion,Adult Pleomorphic Rhabdomyosarcoma,0
10676,Mushroom-Shaped Lesion,Adult Pleomorphic Rhabdomyosarcoma,0
10677,Annular Lesion,Adult Pleomorphic Rhabdomyosarcoma,0
10678,Coronary Vessel Lesion,Angiomyoma,0
10679,Index Lesion,Angiomyoma,0
10680,Non-Index Lesion,Angiomyoma,0
10681,Mushroom-Shaped Lesion,Angiomyoma,0
10682,Annular Lesion,Angiomyoma,0
10683,Coronary Vessel Lesion,Calcifying Fibrous Pseudotumor,0
10684,Index Lesion,Calcifying Fibrous Pseudotumor,0
10685,Non-Index Lesion,Calcifying Fibrous Pseudotumor,0
10686,Mushroom-Shaped Lesion,Calcifying Fibrous Pseudotumor,0
10687,Annular Lesion,Calcifying Fibrous Pseudotumor,0
10688,Coronary Vessel Lesion,Recurrent Kidney Wilms Tumor,0
10689,Index Lesion,Recurrent Kidney Wilms Tumor,0
10690,Non-Index Lesion,Recurrent Kidney Wilms Tumor,0
10691,Mushroom-Shaped Lesion,Recurrent Kidney Wilms Tumor,0
10692,Annular Lesion,Recurrent Kidney Wilms Tumor,0
10693,Coronary Vessel Lesion,Anal polyp,0
10694,Index Lesion,Anal polyp,0
10695,Non-Index Lesion,Anal polyp,0
10696,Mushroom-Shaped Lesion,Anal polyp,0
10697,Annular Lesion,Anal polyp,0
10698,Coronary Vessel Lesion,Pituicytoma,0
10699,Index Lesion,Pituicytoma,0
10700,Non-Index Lesion,Pituicytoma,0
10701,Mushroom-Shaped Lesion,Pituicytoma,0
10702,Annular Lesion,Pituicytoma,0
10703,Coronary Vessel Lesion,Adult Cardiac Cellular Rhabdomyoma,0
10704,Index Lesion,Adult Cardiac Cellular Rhabdomyoma,0
10705,Non-Index Lesion,Adult Cardiac Cellular Rhabdomyoma,0
10706,Mushroom-Shaped Lesion,Adult Cardiac Cellular Rhabdomyoma,0
10707,Annular Lesion,Adult Cardiac Cellular Rhabdomyoma,0
10708,Coronary Vessel Lesion,Appendix Hyperplastic Polyp,0
10709,Index Lesion,Appendix Hyperplastic Polyp,0
10710,Non-Index Lesion,Appendix Hyperplastic Polyp,0
10711,Mushroom-Shaped Lesion,Appendix Hyperplastic Polyp,0
10712,Annular Lesion,Appendix Hyperplastic Polyp,0
10713,Coronary Vessel Lesion,Deep histiocytoma,0
10714,Index Lesion,Deep histiocytoma,0
10715,Non-Index Lesion,Deep histiocytoma,0
10716,Mushroom-Shaped Lesion,Deep histiocytoma,0
10717,Annular Lesion,Deep histiocytoma,0
10718,Coronary Vessel Lesion,Otic polyp,0
10719,Index Lesion,Otic polyp,0
10720,Non-Index Lesion,Otic polyp,0
10721,Mushroom-Shaped Lesion,Otic polyp,0
10722,Annular Lesion,Otic polyp,0
10723,Coronary Vessel Lesion,Juvenile Polyp of the Small Intestine,0
10724,Index Lesion,Juvenile Polyp of the Small Intestine,0
10725,Non-Index Lesion,Juvenile Polyp of the Small Intestine,0
10726,Mushroom-Shaped Lesion,Juvenile Polyp of the Small Intestine,0
10727,Annular Lesion,Juvenile Polyp of the Small Intestine,0
10728,Coronary Vessel Lesion,Spindle cell lipoma,0
10729,Index Lesion,Spindle cell lipoma,0
10730,Non-Index Lesion,Spindle cell lipoma,0
10731,Mushroom-Shaped Lesion,Spindle cell lipoma,0
10732,Annular Lesion,Spindle cell lipoma,0
10733,Coronary Vessel Lesion,Adenomatoid Tumor,0
10734,Index Lesion,Adenomatoid Tumor,0
10735,Non-Index Lesion,Adenomatoid Tumor,0
10736,Mushroom-Shaped Lesion,Adenomatoid Tumor,0
10737,Annular Lesion,Adenomatoid Tumor,0
10738,Coronary Vessel Lesion,Adult Kidney Wilms Tumor,0
10739,Index Lesion,Adult Kidney Wilms Tumor,0
10740,Non-Index Lesion,Adult Kidney Wilms Tumor,0
10741,Mushroom-Shaped Lesion,Adult Kidney Wilms Tumor,0
10742,Annular Lesion,Adult Kidney Wilms Tumor,0
10743,Coronary Vessel Lesion,Fibroma of tendon sheath,0
10744,Index Lesion,Fibroma of tendon sheath,0
10745,Non-Index Lesion,Fibroma of tendon sheath,0
10746,Mushroom-Shaped Lesion,Fibroma of tendon sheath,0
10747,Annular Lesion,Fibroma of tendon sheath,0
10748,Coronary Vessel Lesion,Rhabdomyoma,0
10749,Index Lesion,Rhabdomyoma,0
10750,Non-Index Lesion,Rhabdomyoma,0
10751,Mushroom-Shaped Lesion,Rhabdomyoma,0
10752,Annular Lesion,Rhabdomyoma,0
10753,Coronary Vessel Lesion,Cervix adenomatous polyp,0
10754,Index Lesion,Cervix adenomatous polyp,0
10755,Non-Index Lesion,Cervix adenomatous polyp,0
10756,Mushroom-Shaped Lesion,Cervix adenomatous polyp,0
10757,Annular Lesion,Cervix adenomatous polyp,0
10758,Coronary Vessel Lesion,Nonanaplastic Kidney Wilms Tumor,0
10759,Index Lesion,Nonanaplastic Kidney Wilms Tumor,0
10760,Non-Index Lesion,Nonanaplastic Kidney Wilms Tumor,0
10761,Mushroom-Shaped Lesion,Nonanaplastic Kidney Wilms Tumor,0
10762,Annular Lesion,Nonanaplastic Kidney Wilms Tumor,0
10763,Coronary Vessel Lesion,Colorectal Hamartoma,0
10764,Index Lesion,Colorectal Hamartoma,0
10765,Non-Index Lesion,Colorectal Hamartoma,0
10766,Mushroom-Shaped Lesion,Colorectal Hamartoma,0
10767,Annular Lesion,Colorectal Hamartoma,0
10768,Coronary Vessel Lesion,Hamartomatous polyposis,0
10769,Index Lesion,Hamartomatous polyposis,0
10770,Non-Index Lesion,Hamartomatous polyposis,0
10771,Mushroom-Shaped Lesion,Hamartomatous polyposis,0
10772,Annular Lesion,Hamartomatous polyposis,0
10773,Coronary Vessel Lesion,Epulides,0
10774,Index Lesion,Epulides,0
10775,Non-Index Lesion,Epulides,0
10776,Mushroom-Shaped Lesion,Epulides,0
10777,Annular Lesion,Epulides,0
10778,Coronary Vessel Lesion,Colonic Polyps,0
10779,Index Lesion,Colonic Polyps,0
10780,Non-Index Lesion,Colonic Polyps,0
10781,Mushroom-Shaped Lesion,Colonic Polyps,0
10782,Annular Lesion,Colonic Polyps,0
10783,Coronary Vessel Lesion,Angiomyofibroblastoma,0
10784,Index Lesion,Angiomyofibroblastoma,0
10785,Non-Index Lesion,Angiomyofibroblastoma,0
10786,Mushroom-Shaped Lesion,Angiomyofibroblastoma,0
10787,Annular Lesion,Angiomyofibroblastoma,0
10788,Coronary Vessel Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,0
10789,Index Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,0
10790,Non-Index Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,0
10791,Mushroom-Shaped Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,0
10792,Annular Lesion,Colorectal Goblet Cell Rich Hyperplastic Polyp,0
10793,Coronary Vessel Lesion,Gastrointestinal polyps,0
10794,Index Lesion,Gastrointestinal polyps,0
10795,Non-Index Lesion,Gastrointestinal polyps,0
10796,Mushroom-Shaped Lesion,Gastrointestinal polyps,0
10797,Annular Lesion,Gastrointestinal polyps,0
10798,Coronary Vessel Lesion,Blastema Predominant Kidney Wilms Tumor,0
10799,Index Lesion,Blastema Predominant Kidney Wilms Tumor,0
10800,Non-Index Lesion,Blastema Predominant Kidney Wilms Tumor,0
10801,Mushroom-Shaped Lesion,Blastema Predominant Kidney Wilms Tumor,0
10802,Annular Lesion,Blastema Predominant Kidney Wilms Tumor,0
10803,Coronary Vessel Lesion,Hyperplastic Polyp,0
10804,Index Lesion,Hyperplastic Polyp,0
10805,Non-Index Lesion,Hyperplastic Polyp,0
10806,Mushroom-Shaped Lesion,Hyperplastic Polyp,0
10807,Annular Lesion,Hyperplastic Polyp,0
10808,Coronary Vessel Lesion,Cerebellar hemangioblastoma,0
10809,Index Lesion,Cerebellar hemangioblastoma,0
10810,Non-Index Lesion,Cerebellar hemangioblastoma,0
10811,Mushroom-Shaped Lesion,Cerebellar hemangioblastoma,0
10812,Annular Lesion,Cerebellar hemangioblastoma,0
10813,Coronary Vessel Lesion,Pineocytoma,0
10814,Index Lesion,Pineocytoma,0
10815,Non-Index Lesion,Pineocytoma,0
10816,Mushroom-Shaped Lesion,Pineocytoma,0
10817,Annular Lesion,Pineocytoma,0
10818,Coronary Vessel Lesion,Juvenile polyp,0
10819,Index Lesion,Juvenile polyp,0
10820,Non-Index Lesion,Juvenile polyp,0
10821,Mushroom-Shaped Lesion,Juvenile polyp,0
10822,Annular Lesion,Juvenile polyp,0
10823,Coronary Vessel Lesion,Intravascular Angioleiomyoma,0
10824,Index Lesion,Intravascular Angioleiomyoma,0
10825,Non-Index Lesion,Intravascular Angioleiomyoma,0
10826,Mushroom-Shaped Lesion,Intravascular Angioleiomyoma,0
10827,Annular Lesion,Intravascular Angioleiomyoma,0
10828,Coronary Vessel Lesion,Cystadenocarcinoma of kidney,0
10829,Index Lesion,Cystadenocarcinoma of kidney,0
10830,Non-Index Lesion,Cystadenocarcinoma of kidney,0
10831,Mushroom-Shaped Lesion,Cystadenocarcinoma of kidney,0
10832,Annular Lesion,Cystadenocarcinoma of kidney,0
10833,Coronary Vessel Lesion,Colon Serrated Polyposis,0
10834,Index Lesion,Colon Serrated Polyposis,0
10835,Non-Index Lesion,Colon Serrated Polyposis,0
10836,Mushroom-Shaped Lesion,Colon Serrated Polyposis,0
10837,Annular Lesion,Colon Serrated Polyposis,0
10838,Coronary Vessel Lesion,"Polyposis, Gastric",0
10839,Index Lesion,"Polyposis, Gastric",0
10840,Non-Index Lesion,"Polyposis, Gastric",0
10841,Mushroom-Shaped Lesion,"Polyposis, Gastric",0
10842,Annular Lesion,"Polyposis, Gastric",0
10843,Coronary Vessel Lesion,Nasal Polyps,0
10844,Index Lesion,Nasal Polyps,0
10845,Non-Index Lesion,Nasal Polyps,0
10846,Mushroom-Shaped Lesion,Nasal Polyps,0
10847,Annular Lesion,Nasal Polyps,0
10848,Coronary Vessel Lesion,Pseudopolyposis of colon,0
10849,Index Lesion,Pseudopolyposis of colon,0
10850,Non-Index Lesion,Pseudopolyposis of colon,0
10851,Mushroom-Shaped Lesion,Pseudopolyposis of colon,0
10852,Annular Lesion,Pseudopolyposis of colon,0
10853,Coronary Vessel Lesion,Benign neoplasm of mesothelial tissue of peritoneum,0
10854,Index Lesion,Benign neoplasm of mesothelial tissue of peritoneum,0
10855,Non-Index Lesion,Benign neoplasm of mesothelial tissue of peritoneum,0
10856,Mushroom-Shaped Lesion,Benign neoplasm of mesothelial tissue of peritoneum,0
10857,Annular Lesion,Benign neoplasm of mesothelial tissue of peritoneum,0
10858,Coronary Vessel Lesion,Multiple polyps,0
10859,Index Lesion,Multiple polyps,0
10860,Non-Index Lesion,Multiple polyps,0
10861,Mushroom-Shaped Lesion,Multiple polyps,0
10862,Annular Lesion,Multiple polyps,0
10863,Coronary Vessel Lesion,Venous Angioleiomyoma,0
10864,Index Lesion,Venous Angioleiomyoma,0
10865,Non-Index Lesion,Venous Angioleiomyoma,0
10866,Mushroom-Shaped Lesion,Venous Angioleiomyoma,0
10867,Annular Lesion,Venous Angioleiomyoma,0
10868,Coronary Vessel Lesion,Pleomorphic Lipoma,0
10869,Index Lesion,Pleomorphic Lipoma,0
10870,Non-Index Lesion,Pleomorphic Lipoma,0
10871,Mushroom-Shaped Lesion,Pleomorphic Lipoma,0
10872,Annular Lesion,Pleomorphic Lipoma,0
10873,Coronary Vessel Lesion,Colorectal Peutz-Jeghers Polyp,0
10874,Index Lesion,Colorectal Peutz-Jeghers Polyp,0
10875,Non-Index Lesion,Colorectal Peutz-Jeghers Polyp,0
10876,Mushroom-Shaped Lesion,Colorectal Peutz-Jeghers Polyp,0
10877,Annular Lesion,Colorectal Peutz-Jeghers Polyp,0
10878,Coronary Vessel Lesion,Solid Angioleiomyoma,0
10879,Index Lesion,Solid Angioleiomyoma,0
10880,Non-Index Lesion,Solid Angioleiomyoma,0
10881,Mushroom-Shaped Lesion,Solid Angioleiomyoma,0
10882,Annular Lesion,Solid Angioleiomyoma,0
10883,Coronary Vessel Lesion,Adrenal Cortex Adenomatoid Tumor,0
10884,Index Lesion,Adrenal Cortex Adenomatoid Tumor,0
10885,Non-Index Lesion,Adrenal Cortex Adenomatoid Tumor,0
10886,Mushroom-Shaped Lesion,Adrenal Cortex Adenomatoid Tumor,0
10887,Annular Lesion,Adrenal Cortex Adenomatoid Tumor,0
10888,Coronary Vessel Lesion,Giant Fibrovascular Esophageal Polyp,0
10889,Index Lesion,Giant Fibrovascular Esophageal Polyp,0
10890,Non-Index Lesion,Giant Fibrovascular Esophageal Polyp,0
10891,Mushroom-Shaped Lesion,Giant Fibrovascular Esophageal Polyp,0
10892,Annular Lesion,Giant Fibrovascular Esophageal Polyp,0
10893,Coronary Vessel Lesion,Adult Extracardiac Rhabdomyoma,0
10894,Index Lesion,Adult Extracardiac Rhabdomyoma,0
10895,Non-Index Lesion,Adult Extracardiac Rhabdomyoma,0
10896,Mushroom-Shaped Lesion,Adult Extracardiac Rhabdomyoma,0
10897,Annular Lesion,Adult Extracardiac Rhabdomyoma,0
10898,Coronary Vessel Lesion,Central Nervous System Rhabdomyoma,0
10899,Index Lesion,Central Nervous System Rhabdomyoma,0
10900,Non-Index Lesion,Central Nervous System Rhabdomyoma,0
10901,Mushroom-Shaped Lesion,Central Nervous System Rhabdomyoma,0
10902,Annular Lesion,Central Nervous System Rhabdomyoma,0
10903,Coronary Vessel Lesion,Stage I Kidney Wilms Tumor,0
10904,Index Lesion,Stage I Kidney Wilms Tumor,0
10905,Non-Index Lesion,Stage I Kidney Wilms Tumor,0
10906,Mushroom-Shaped Lesion,Stage I Kidney Wilms Tumor,0
10907,Annular Lesion,Stage I Kidney Wilms Tumor,0
10908,Coronary Vessel Lesion,Mediastinal Rhabdomyoma,0
10909,Index Lesion,Mediastinal Rhabdomyoma,0
10910,Non-Index Lesion,Mediastinal Rhabdomyoma,0
10911,Mushroom-Shaped Lesion,Mediastinal Rhabdomyoma,0
10912,Annular Lesion,Mediastinal Rhabdomyoma,0
10913,Coronary Vessel Lesion,Intermediate Rhabdomyoma,0
10914,Index Lesion,Intermediate Rhabdomyoma,0
10915,Non-Index Lesion,Intermediate Rhabdomyoma,0
10916,Mushroom-Shaped Lesion,Intermediate Rhabdomyoma,0
10917,Annular Lesion,Intermediate Rhabdomyoma,0
10918,Coronary Vessel Lesion,Stage II Kidney Wilms Tumor,0
10919,Index Lesion,Stage II Kidney Wilms Tumor,0
10920,Non-Index Lesion,Stage II Kidney Wilms Tumor,0
10921,Mushroom-Shaped Lesion,Stage II Kidney Wilms Tumor,0
10922,Annular Lesion,Stage II Kidney Wilms Tumor,0
10923,Coronary Vessel Lesion,Gastric Non-Neoplastic Polyp,0
10924,Index Lesion,Gastric Non-Neoplastic Polyp,0
10925,Non-Index Lesion,Gastric Non-Neoplastic Polyp,0
10926,Mushroom-Shaped Lesion,Gastric Non-Neoplastic Polyp,0
10927,Annular Lesion,Gastric Non-Neoplastic Polyp,0
10928,Coronary Vessel Lesion,Neoplastic Polyp,0
10929,Index Lesion,Neoplastic Polyp,0
10930,Non-Index Lesion,Neoplastic Polyp,0
10931,Mushroom-Shaped Lesion,Neoplastic Polyp,0
10932,Annular Lesion,Neoplastic Polyp,0
10933,Coronary Vessel Lesion,Adenomatoid tumor of epididymis,0
10934,Index Lesion,Adenomatoid tumor of epididymis,0
10935,Non-Index Lesion,Adenomatoid tumor of epididymis,0
10936,Mushroom-Shaped Lesion,Adenomatoid tumor of epididymis,0
10937,Annular Lesion,Adenomatoid tumor of epididymis,0
10938,Coronary Vessel Lesion,Central Nervous System Hibernoma,0
10939,Index Lesion,Central Nervous System Hibernoma,0
10940,Non-Index Lesion,Central Nervous System Hibernoma,0
10941,Mushroom-Shaped Lesion,Central Nervous System Hibernoma,0
10942,Annular Lesion,Central Nervous System Hibernoma,0
10943,Coronary Vessel Lesion,chondroma of lung,0
10944,Index Lesion,chondroma of lung,0
10945,Non-Index Lesion,chondroma of lung,0
10946,Mushroom-Shaped Lesion,chondroma of lung,0
10947,Annular Lesion,chondroma of lung,0
10948,Coronary Vessel Lesion,Colorectal Cowden-Associated Polyp,0
10949,Index Lesion,Colorectal Cowden-Associated Polyp,0
10950,Non-Index Lesion,Colorectal Cowden-Associated Polyp,0
10951,Mushroom-Shaped Lesion,Colorectal Cowden-Associated Polyp,0
10952,Annular Lesion,Colorectal Cowden-Associated Polyp,0
10953,Coronary Vessel Lesion,Ovarian Adenomatoid Tumor,0
10954,Index Lesion,Ovarian Adenomatoid Tumor,0
10955,Non-Index Lesion,Ovarian Adenomatoid Tumor,0
10956,Mushroom-Shaped Lesion,Ovarian Adenomatoid Tumor,0
10957,Annular Lesion,Ovarian Adenomatoid Tumor,0
10958,Coronary Vessel Lesion,Colon Juvenile Polyp,0
10959,Index Lesion,Colon Juvenile Polyp,0
10960,Non-Index Lesion,Colon Juvenile Polyp,0
10961,Mushroom-Shaped Lesion,Colon Juvenile Polyp,0
10962,Annular Lesion,Colon Juvenile Polyp,0
10963,Coronary Vessel Lesion,Genital rhabdomyoma,0
10964,Index Lesion,Genital rhabdomyoma,0
10965,Non-Index Lesion,Genital rhabdomyoma,0
10966,Mushroom-Shaped Lesion,Genital rhabdomyoma,0
10967,Annular Lesion,Genital rhabdomyoma,0
10968,Coronary Vessel Lesion,Renal Pelvis Fibroepithelial Polyp,0
10969,Index Lesion,Renal Pelvis Fibroepithelial Polyp,0
10970,Non-Index Lesion,Renal Pelvis Fibroepithelial Polyp,0
10971,Mushroom-Shaped Lesion,Renal Pelvis Fibroepithelial Polyp,0
10972,Annular Lesion,Renal Pelvis Fibroepithelial Polyp,0
10973,Coronary Vessel Lesion,Hamartomatous polyp,0
10974,Index Lesion,Hamartomatous polyp,0
10975,Non-Index Lesion,Hamartomatous polyp,0
10976,Mushroom-Shaped Lesion,Hamartomatous polyp,0
10977,Annular Lesion,Hamartomatous polyp,0
10978,Coronary Vessel Lesion,Cervical Wilms Tumor,0
10979,Index Lesion,Cervical Wilms Tumor,0
10980,Non-Index Lesion,Cervical Wilms Tumor,0
10981,Mushroom-Shaped Lesion,Cervical Wilms Tumor,0
10982,Annular Lesion,Cervical Wilms Tumor,0
10983,Coronary Vessel Lesion,Colorectal Sporadic Serrated Polyp,0
10984,Index Lesion,Colorectal Sporadic Serrated Polyp,0
10985,Non-Index Lesion,Colorectal Sporadic Serrated Polyp,0
10986,Mushroom-Shaped Lesion,Colorectal Sporadic Serrated Polyp,0
10987,Annular Lesion,Colorectal Sporadic Serrated Polyp,0
10988,Coronary Vessel Lesion,Retinal hemangioblastoma,0
10989,Index Lesion,Retinal hemangioblastoma,0
10990,Non-Index Lesion,Retinal hemangioblastoma,0
10991,Mushroom-Shaped Lesion,Retinal hemangioblastoma,0
10992,Annular Lesion,Retinal hemangioblastoma,0
10993,Coronary Vessel Lesion,Conventional Lipoma,0
10994,Index Lesion,Conventional Lipoma,0
10995,Non-Index Lesion,Conventional Lipoma,0
10996,Mushroom-Shaped Lesion,Conventional Lipoma,0
10997,Annular Lesion,Conventional Lipoma,0
10998,Coronary Vessel Lesion,Colorectal Mucin Poor Hyperplastic Polyp,0
10999,Index Lesion,Colorectal Mucin Poor Hyperplastic Polyp,0
11000,Non-Index Lesion,Colorectal Mucin Poor Hyperplastic Polyp,0
11001,Mushroom-Shaped Lesion,Colorectal Mucin Poor Hyperplastic Polyp,0
11002,Annular Lesion,Colorectal Mucin Poor Hyperplastic Polyp,0
11003,Coronary Vessel Lesion,Polyp in nasopharynx,0
11004,Index Lesion,Polyp in nasopharynx,0
11005,Non-Index Lesion,Polyp in nasopharynx,0
11006,Mushroom-Shaped Lesion,Polyp in nasopharynx,0
11007,Annular Lesion,Polyp in nasopharynx,0
11008,Coronary Vessel Lesion,Placental polyp,0
11009,Index Lesion,Placental polyp,0
11010,Non-Index Lesion,Placental polyp,0
11011,Mushroom-Shaped Lesion,Placental polyp,0
11012,Annular Lesion,Placental polyp,0
11013,Coronary Vessel Lesion,Palisaded Lymph Node Myofibroblastoma,0
11014,Index Lesion,Palisaded Lymph Node Myofibroblastoma,0
11015,Non-Index Lesion,Palisaded Lymph Node Myofibroblastoma,0
11016,Mushroom-Shaped Lesion,Palisaded Lymph Node Myofibroblastoma,0
11017,Annular Lesion,Palisaded Lymph Node Myofibroblastoma,0
11018,Coronary Vessel Lesion,Benign Mixed Tumor of the Vulva,0
11019,Index Lesion,Benign Mixed Tumor of the Vulva,0
11020,Non-Index Lesion,Benign Mixed Tumor of the Vulva,0
11021,Mushroom-Shaped Lesion,Benign Mixed Tumor of the Vulva,0
11022,Annular Lesion,Benign Mixed Tumor of the Vulva,0
11023,Coronary Vessel Lesion,Childhood Kidney Wilms Tumor,0
11024,Index Lesion,Childhood Kidney Wilms Tumor,0
11025,Non-Index Lesion,Childhood Kidney Wilms Tumor,0
11026,Mushroom-Shaped Lesion,Childhood Kidney Wilms Tumor,0
11027,Annular Lesion,Childhood Kidney Wilms Tumor,0
11028,Coronary Vessel Lesion,Ossifying Fibroma,0
11029,Index Lesion,Ossifying Fibroma,0
11030,Non-Index Lesion,Ossifying Fibroma,0
11031,Mushroom-Shaped Lesion,Ossifying Fibroma,0
11032,Annular Lesion,Ossifying Fibroma,0
11033,Coronary Vessel Lesion,Cyst of Skene's duct,0
11034,Index Lesion,Cyst of Skene's duct,0
11035,Non-Index Lesion,Cyst of Skene's duct,0
11036,Mushroom-Shaped Lesion,Cyst of Skene's duct,0
11037,Annular Lesion,Cyst of Skene's duct,0
11038,Coronary Vessel Lesion,Benign neoplasm of mesothelial tissue of pleura,0
11039,Index Lesion,Benign neoplasm of mesothelial tissue of pleura,0
11040,Non-Index Lesion,Benign neoplasm of mesothelial tissue of pleura,0
11041,Mushroom-Shaped Lesion,Benign neoplasm of mesothelial tissue of pleura,0
11042,Annular Lesion,Benign neoplasm of mesothelial tissue of pleura,0
11043,Coronary Vessel Lesion,Spindle Cell/Pleomorphic Lipoma,0
11044,Index Lesion,Spindle Cell/Pleomorphic Lipoma,0
11045,Non-Index Lesion,Spindle Cell/Pleomorphic Lipoma,0
11046,Mushroom-Shaped Lesion,Spindle Cell/Pleomorphic Lipoma,0
11047,Annular Lesion,Spindle Cell/Pleomorphic Lipoma,0
11048,Coronary Vessel Lesion,Vulvar Cellular Angiofibroma,0
11049,Index Lesion,Vulvar Cellular Angiofibroma,0
11050,Non-Index Lesion,Vulvar Cellular Angiofibroma,0
11051,Mushroom-Shaped Lesion,Vulvar Cellular Angiofibroma,0
11052,Annular Lesion,Vulvar Cellular Angiofibroma,0
11053,Coronary Vessel Lesion,Focal nodular hyperplasia of liver,0
11054,Index Lesion,Focal nodular hyperplasia of liver,0
11055,Non-Index Lesion,Focal nodular hyperplasia of liver,0
11056,Mushroom-Shaped Lesion,Focal nodular hyperplasia of liver,0
11057,Annular Lesion,Focal nodular hyperplasia of liver,0
11058,Coronary Vessel Lesion,Fallopian Tube Adenomatoid Tumor,0
11059,Index Lesion,Fallopian Tube Adenomatoid Tumor,0
11060,Non-Index Lesion,Fallopian Tube Adenomatoid Tumor,0
11061,Mushroom-Shaped Lesion,Fallopian Tube Adenomatoid Tumor,0
11062,Annular Lesion,Fallopian Tube Adenomatoid Tumor,0
11063,Coronary Vessel Lesion,Cardiac rhabdomyoma,0
11064,Index Lesion,Cardiac rhabdomyoma,0
11065,Non-Index Lesion,Cardiac rhabdomyoma,0
11066,Mushroom-Shaped Lesion,Cardiac rhabdomyoma,0
11067,Annular Lesion,Cardiac rhabdomyoma,0
11068,Coronary Vessel Lesion,Giant cell angiofibroma,0
11069,Index Lesion,Giant cell angiofibroma,0
11070,Non-Index Lesion,Giant cell angiofibroma,0
11071,Mushroom-Shaped Lesion,Giant cell angiofibroma,0
11072,Annular Lesion,Giant cell angiofibroma,0
11073,Coronary Vessel Lesion,Central Nervous System Myofibroblastoma,0
11074,Index Lesion,Central Nervous System Myofibroblastoma,0
11075,Non-Index Lesion,Central Nervous System Myofibroblastoma,0
11076,Mushroom-Shaped Lesion,Central Nervous System Myofibroblastoma,0
11077,Annular Lesion,Central Nervous System Myofibroblastoma,0
11078,Coronary Vessel Lesion,Spinal hemangioblastoma,0
11079,Index Lesion,Spinal hemangioblastoma,0
11080,Non-Index Lesion,Spinal hemangioblastoma,0
11081,Mushroom-Shaped Lesion,Spinal hemangioblastoma,0
11082,Annular Lesion,Spinal hemangioblastoma,0
11083,Coronary Vessel Lesion,Cerebral Hemangioblastoma,0
11084,Index Lesion,Cerebral Hemangioblastoma,0
11085,Non-Index Lesion,Cerebral Hemangioblastoma,0
11086,Mushroom-Shaped Lesion,Cerebral Hemangioblastoma,0
11087,Annular Lesion,Cerebral Hemangioblastoma,0
11088,Coronary Vessel Lesion,Medullary Hemangioblastoma,0
11089,Index Lesion,Medullary Hemangioblastoma,0
11090,Non-Index Lesion,Medullary Hemangioblastoma,0
11091,Mushroom-Shaped Lesion,Medullary Hemangioblastoma,0
11092,Annular Lesion,Medullary Hemangioblastoma,0
11093,Coronary Vessel Lesion,Peripheral Hemangioblastoma,0
11094,Index Lesion,Peripheral Hemangioblastoma,0
11095,Non-Index Lesion,Peripheral Hemangioblastoma,0
11096,Mushroom-Shaped Lesion,Peripheral Hemangioblastoma,0
11097,Annular Lesion,Peripheral Hemangioblastoma,0
11098,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11099,Isolated Tumor Cells,Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11100,Pleural/Elastic Layer Invasion,Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11101,Presence of Extravascular Matrix Patterns,Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11102,Ductopenia,Bile Duct Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11103,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Testicular Dermoid Cyst,0
11104,Isolated Tumor Cells,Testicular Dermoid Cyst,0
11105,Pleural/Elastic Layer Invasion,Testicular Dermoid Cyst,0
11106,Presence of Extravascular Matrix Patterns,Testicular Dermoid Cyst,0
11107,Ductopenia,Testicular Dermoid Cyst,0
11108,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Mucinous cystadenofibroma,0
11109,Isolated Tumor Cells,Mucinous cystadenofibroma,0
11110,Pleural/Elastic Layer Invasion,Mucinous cystadenofibroma,0
11111,Presence of Extravascular Matrix Patterns,Mucinous cystadenofibroma,0
11112,Ductopenia,Mucinous cystadenofibroma,0
11113,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cystic tumor of atrio-ventricular node,0
11114,Isolated Tumor Cells,Cystic tumor of atrio-ventricular node,0
11115,Pleural/Elastic Layer Invasion,Cystic tumor of atrio-ventricular node,0
11116,Presence of Extravascular Matrix Patterns,Cystic tumor of atrio-ventricular node,0
11117,Ductopenia,Cystic tumor of atrio-ventricular node,0
11118,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Polycystic liver disease,0
11119,Isolated Tumor Cells,Polycystic liver disease,0
11120,Pleural/Elastic Layer Invasion,Polycystic liver disease,0
11121,Presence of Extravascular Matrix Patterns,Polycystic liver disease,0
11122,Ductopenia,Polycystic liver disease,0
11123,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Ovarian Cystic Teratoma,0
11124,Isolated Tumor Cells,Ovarian Cystic Teratoma,0
11125,Pleural/Elastic Layer Invasion,Ovarian Cystic Teratoma,0
11126,Presence of Extravascular Matrix Patterns,Ovarian Cystic Teratoma,0
11127,Ductopenia,Ovarian Cystic Teratoma,0
11128,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11129,Isolated Tumor Cells,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11130,Pleural/Elastic Layer Invasion,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11131,Presence of Extravascular Matrix Patterns,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11132,Ductopenia,Gallbladder Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11133,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Benign mixed epithelial and stromal tumor of kidney,0
11134,Isolated Tumor Cells,Benign mixed epithelial and stromal tumor of kidney,0
11135,Pleural/Elastic Layer Invasion,Benign mixed epithelial and stromal tumor of kidney,0
11136,Presence of Extravascular Matrix Patterns,Benign mixed epithelial and stromal tumor of kidney,0
11137,Ductopenia,Benign mixed epithelial and stromal tumor of kidney,0
11138,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,cystadenoma of intrahepatic bile duct,0
11139,Isolated Tumor Cells,cystadenoma of intrahepatic bile duct,0
11140,Pleural/Elastic Layer Invasion,cystadenoma of intrahepatic bile duct,0
11141,Presence of Extravascular Matrix Patterns,cystadenoma of intrahepatic bile duct,0
11142,Ductopenia,cystadenoma of intrahepatic bile duct,0
11143,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11144,Isolated Tumor Cells,Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11145,Pleural/Elastic Layer Invasion,Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11146,Presence of Extravascular Matrix Patterns,Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11147,Ductopenia,Gallbladder Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11148,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Malignant ovarian cyst,0
11149,Isolated Tumor Cells,Malignant ovarian cyst,0
11150,Pleural/Elastic Layer Invasion,Malignant ovarian cyst,0
11151,Presence of Extravascular Matrix Patterns,Malignant ovarian cyst,0
11152,Ductopenia,Malignant ovarian cyst,0
11153,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Childhood Multilocular Cystic Renal Neoplasm,0
11154,Isolated Tumor Cells,Childhood Multilocular Cystic Renal Neoplasm,0
11155,Pleural/Elastic Layer Invasion,Childhood Multilocular Cystic Renal Neoplasm,0
11156,Presence of Extravascular Matrix Patterns,Childhood Multilocular Cystic Renal Neoplasm,0
11157,Ductopenia,Childhood Multilocular Cystic Renal Neoplasm,0
11158,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Dermoid Cyst of the Spinal Cord,0
11159,Isolated Tumor Cells,Dermoid Cyst of the Spinal Cord,0
11160,Pleural/Elastic Layer Invasion,Dermoid Cyst of the Spinal Cord,0
11161,Presence of Extravascular Matrix Patterns,Dermoid Cyst of the Spinal Cord,0
11162,Ductopenia,Dermoid Cyst of the Spinal Cord,0
11163,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Malignant Kidney Mixed Epithelial and Stromal Tumor,0
11164,Isolated Tumor Cells,Malignant Kidney Mixed Epithelial and Stromal Tumor,0
11165,Pleural/Elastic Layer Invasion,Malignant Kidney Mixed Epithelial and Stromal Tumor,0
11166,Presence of Extravascular Matrix Patterns,Malignant Kidney Mixed Epithelial and Stromal Tumor,0
11167,Ductopenia,Malignant Kidney Mixed Epithelial and Stromal Tumor,0
11168,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Rete Ovarii Cystadenofibroma,0
11169,Isolated Tumor Cells,Rete Ovarii Cystadenofibroma,0
11170,Pleural/Elastic Layer Invasion,Rete Ovarii Cystadenofibroma,0
11171,Presence of Extravascular Matrix Patterns,Rete Ovarii Cystadenofibroma,0
11172,Ductopenia,Rete Ovarii Cystadenofibroma,0
11173,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Vaginal Dermoid Cyst,0
11174,Isolated Tumor Cells,Vaginal Dermoid Cyst,0
11175,Pleural/Elastic Layer Invasion,Vaginal Dermoid Cyst,0
11176,Presence of Extravascular Matrix Patterns,Vaginal Dermoid Cyst,0
11177,Ductopenia,Vaginal Dermoid Cyst,0
11178,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Pleuropulmonary blastoma type I,0
11179,Isolated Tumor Cells,Pleuropulmonary blastoma type I,0
11180,Pleural/Elastic Layer Invasion,Pleuropulmonary blastoma type I,0
11181,Presence of Extravascular Matrix Patterns,Pleuropulmonary blastoma type I,0
11182,Ductopenia,Pleuropulmonary blastoma type I,0
11183,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Adult cystic teratoma,0
11184,Isolated Tumor Cells,Adult cystic teratoma,0
11185,Pleural/Elastic Layer Invasion,Adult cystic teratoma,0
11186,Presence of Extravascular Matrix Patterns,Adult cystic teratoma,0
11187,Ductopenia,Adult cystic teratoma,0
11188,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Dermoid cyst of skin,0
11189,Isolated Tumor Cells,Dermoid cyst of skin,0
11190,Pleural/Elastic Layer Invasion,Dermoid cyst of skin,0
11191,Presence of Extravascular Matrix Patterns,Dermoid cyst of skin,0
11192,Ductopenia,Dermoid cyst of skin,0
11193,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Gallbladder Mucinous Cystic Neoplasm,0
11194,Isolated Tumor Cells,Gallbladder Mucinous Cystic Neoplasm,0
11195,Pleural/Elastic Layer Invasion,Gallbladder Mucinous Cystic Neoplasm,0
11196,Presence of Extravascular Matrix Patterns,Gallbladder Mucinous Cystic Neoplasm,0
11197,Ductopenia,Gallbladder Mucinous Cystic Neoplasm,0
11198,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Nipple Syringomatous Adenoma,0
11199,Isolated Tumor Cells,Nipple Syringomatous Adenoma,0
11200,Pleural/Elastic Layer Invasion,Nipple Syringomatous Adenoma,0
11201,Presence of Extravascular Matrix Patterns,Nipple Syringomatous Adenoma,0
11202,Ductopenia,Nipple Syringomatous Adenoma,0
11203,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Dermoid Cyst,0
11204,Isolated Tumor Cells,Dermoid Cyst,0
11205,Pleural/Elastic Layer Invasion,Dermoid Cyst,0
11206,Presence of Extravascular Matrix Patterns,Dermoid Cyst,0
11207,Ductopenia,Dermoid Cyst,0
11208,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,cystadenoma of extrahepatic bile duct,0
11209,Isolated Tumor Cells,cystadenoma of extrahepatic bile duct,0
11210,Pleural/Elastic Layer Invasion,cystadenoma of extrahepatic bile duct,0
11211,Presence of Extravascular Matrix Patterns,cystadenoma of extrahepatic bile duct,0
11212,Ductopenia,cystadenoma of extrahepatic bile duct,0
11213,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cystic Neoplasm,0
11214,Isolated Tumor Cells,Cystic Neoplasm,0
11215,Pleural/Elastic Layer Invasion,Cystic Neoplasm,0
11216,Presence of Extravascular Matrix Patterns,Cystic Neoplasm,0
11217,Ductopenia,Cystic Neoplasm,0
11218,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Testicular Yolk Sac Tumor, Macrocystic Pattern",0
11219,Isolated Tumor Cells,"Testicular Yolk Sac Tumor, Macrocystic Pattern",0
11220,Pleural/Elastic Layer Invasion,"Testicular Yolk Sac Tumor, Macrocystic Pattern",0
11221,Presence of Extravascular Matrix Patterns,"Testicular Yolk Sac Tumor, Macrocystic Pattern",0
11222,Ductopenia,"Testicular Yolk Sac Tumor, Macrocystic Pattern",0
11223,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11224,Isolated Tumor Cells,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11225,Pleural/Elastic Layer Invasion,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11226,Presence of Extravascular Matrix Patterns,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11227,Ductopenia,Bile Duct Mucinous Cystic Neoplasm with Low Grade Intraepithelial Neoplasia,0
11228,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11229,Isolated Tumor Cells,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11230,Pleural/Elastic Layer Invasion,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11231,Presence of Extravascular Matrix Patterns,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11232,Ductopenia,Bile Duct Mucinous Cystic Neoplasm with Intermediate Grade Intraepithelial Neoplasia,0
11233,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11234,Isolated Tumor Cells,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11235,Pleural/Elastic Layer Invasion,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11236,Presence of Extravascular Matrix Patterns,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11237,Ductopenia,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,0
11238,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Telangiectatic osteosarcoma,0
11239,Isolated Tumor Cells,Telangiectatic osteosarcoma,0
11240,Pleural/Elastic Layer Invasion,Telangiectatic osteosarcoma,0
11241,Presence of Extravascular Matrix Patterns,Telangiectatic osteosarcoma,0
11242,Ductopenia,Telangiectatic osteosarcoma,0
11243,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Clear cell cystadenofibroma,0
11244,Isolated Tumor Cells,Clear cell cystadenofibroma,0
11245,Pleural/Elastic Layer Invasion,Clear cell cystadenofibroma,0
11246,Presence of Extravascular Matrix Patterns,Clear cell cystadenofibroma,0
11247,Ductopenia,Clear cell cystadenofibroma,0
11248,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Central Nervous System Dermoid Cyst,0
11249,Isolated Tumor Cells,Central Nervous System Dermoid Cyst,0
11250,Pleural/Elastic Layer Invasion,Central Nervous System Dermoid Cyst,0
11251,Presence of Extravascular Matrix Patterns,Central Nervous System Dermoid Cyst,0
11252,Ductopenia,Central Nervous System Dermoid Cyst,0
11253,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cystadenofibroma,0
11254,Isolated Tumor Cells,Cystadenofibroma,0
11255,Pleural/Elastic Layer Invasion,Cystadenofibroma,0
11256,Presence of Extravascular Matrix Patterns,Cystadenofibroma,0
11257,Ductopenia,Cystadenofibroma,0
11258,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Dermoid cyst of ovary,0
11259,Isolated Tumor Cells,Dermoid cyst of ovary,0
11260,Pleural/Elastic Layer Invasion,Dermoid cyst of ovary,0
11261,Presence of Extravascular Matrix Patterns,Dermoid cyst of ovary,0
11262,Ductopenia,Dermoid cyst of ovary,0
11263,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Benign cystic nephroma,0
11264,Isolated Tumor Cells,Benign cystic nephroma,0
11265,Pleural/Elastic Layer Invasion,Benign cystic nephroma,0
11266,Presence of Extravascular Matrix Patterns,Benign cystic nephroma,0
11267,Ductopenia,Benign cystic nephroma,0
11268,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cystic teratoma,0
11269,Isolated Tumor Cells,Cystic teratoma,0
11270,Pleural/Elastic Layer Invasion,Cystic teratoma,0
11271,Presence of Extravascular Matrix Patterns,Cystic teratoma,0
11272,Ductopenia,Cystic teratoma,0
11273,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Dermoid cyst of orbit,0
11274,Isolated Tumor Cells,Dermoid cyst of orbit,0
11275,Pleural/Elastic Layer Invasion,Dermoid cyst of orbit,0
11276,Presence of Extravascular Matrix Patterns,Dermoid cyst of orbit,0
11277,Ductopenia,Dermoid cyst of orbit,0
11278,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Bile duct cystadenoma,0
11279,Isolated Tumor Cells,Bile duct cystadenoma,0
11280,Pleural/Elastic Layer Invasion,Bile duct cystadenoma,0
11281,Presence of Extravascular Matrix Patterns,Bile duct cystadenoma,0
11282,Ductopenia,Bile duct cystadenoma,0
11283,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Calcifying Odontogenic Cyst,0
11284,Isolated Tumor Cells,Calcifying Odontogenic Cyst,0
11285,Pleural/Elastic Layer Invasion,Calcifying Odontogenic Cyst,0
11286,Presence of Extravascular Matrix Patterns,Calcifying Odontogenic Cyst,0
11287,Ductopenia,Calcifying Odontogenic Cyst,0
11288,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Solid pseudopapillary tumor of the pancreas,0
11289,Isolated Tumor Cells,Solid pseudopapillary tumor of the pancreas,0
11290,Pleural/Elastic Layer Invasion,Solid pseudopapillary tumor of the pancreas,0
11291,Presence of Extravascular Matrix Patterns,Solid pseudopapillary tumor of the pancreas,0
11292,Ductopenia,Solid pseudopapillary tumor of the pancreas,0
11293,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Keratocystic Odontogenic Tumor,0
11294,Isolated Tumor Cells,Keratocystic Odontogenic Tumor,0
11295,Pleural/Elastic Layer Invasion,Keratocystic Odontogenic Tumor,0
11296,Presence of Extravascular Matrix Patterns,Keratocystic Odontogenic Tumor,0
11297,Ductopenia,Keratocystic Odontogenic Tumor,0
11298,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Childhood Cystic Nephroma,0
11299,Isolated Tumor Cells,Childhood Cystic Nephroma,0
11300,Pleural/Elastic Layer Invasion,Childhood Cystic Nephroma,0
11301,Presence of Extravascular Matrix Patterns,Childhood Cystic Nephroma,0
11302,Ductopenia,Childhood Cystic Nephroma,0
11303,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Kidney Mixed Epithelial and Stromal Tumor Family,0
11304,Isolated Tumor Cells,Kidney Mixed Epithelial and Stromal Tumor Family,0
11305,Pleural/Elastic Layer Invasion,Kidney Mixed Epithelial and Stromal Tumor Family,0
11306,Presence of Extravascular Matrix Patterns,Kidney Mixed Epithelial and Stromal Tumor Family,0
11307,Ductopenia,Kidney Mixed Epithelial and Stromal Tumor Family,0
11308,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,GIANT PIGMENTED HAIRY NEVUS,0
11309,Isolated Tumor Cells,GIANT PIGMENTED HAIRY NEVUS,0
11310,Pleural/Elastic Layer Invasion,GIANT PIGMENTED HAIRY NEVUS,0
11311,Presence of Extravascular Matrix Patterns,GIANT PIGMENTED HAIRY NEVUS,0
11312,Ductopenia,GIANT PIGMENTED HAIRY NEVUS,0
11313,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,"Nevus, Blue",0
11314,Isolated Tumor Cells,"Nevus, Blue",0
11315,Pleural/Elastic Layer Invasion,"Nevus, Blue",0
11316,Presence of Extravascular Matrix Patterns,"Nevus, Blue",0
11317,Ductopenia,"Nevus, Blue",0
11318,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Vaginal Blue Nevus,0
11319,Isolated Tumor Cells,Vaginal Blue Nevus,0
11320,Pleural/Elastic Layer Invasion,Vaginal Blue Nevus,0
11321,Presence of Extravascular Matrix Patterns,Vaginal Blue Nevus,0
11322,Ductopenia,Vaginal Blue Nevus,0
11323,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cervical Blue Nevus,0
11324,Isolated Tumor Cells,Cervical Blue Nevus,0
11325,Pleural/Elastic Layer Invasion,Cervical Blue Nevus,0
11326,Presence of Extravascular Matrix Patterns,Cervical Blue Nevus,0
11327,Ductopenia,Cervical Blue Nevus,0
11328,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Common blue nevus of skin,0
11329,Isolated Tumor Cells,Common blue nevus of skin,0
11330,Pleural/Elastic Layer Invasion,Common blue nevus of skin,0
11331,Presence of Extravascular Matrix Patterns,Common blue nevus of skin,0
11332,Ductopenia,Common blue nevus of skin,0
11333,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Vulvar Blue Nevus,0
11334,Isolated Tumor Cells,Vulvar Blue Nevus,0
11335,Pleural/Elastic Layer Invasion,Vulvar Blue Nevus,0
11336,Presence of Extravascular Matrix Patterns,Vulvar Blue Nevus,0
11337,Ductopenia,Vulvar Blue Nevus,0
11338,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Melanotic neurofibroma,0
11339,Isolated Tumor Cells,Melanotic neurofibroma,0
11340,Pleural/Elastic Layer Invasion,Melanotic neurofibroma,0
11341,Presence of Extravascular Matrix Patterns,Melanotic neurofibroma,0
11342,Ductopenia,Melanotic neurofibroma,0
11343,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Spindle cell nevus of Reed,0
11344,Isolated Tumor Cells,Spindle cell nevus of Reed,0
11345,Pleural/Elastic Layer Invasion,Spindle cell nevus of Reed,0
11346,Presence of Extravascular Matrix Patterns,Spindle cell nevus of Reed,0
11347,Ductopenia,Spindle cell nevus of Reed,0
11348,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Cellular Blue Nevus,0
11349,Isolated Tumor Cells,Cellular Blue Nevus,0
11350,Pleural/Elastic Layer Invasion,Cellular Blue Nevus,0
11351,Presence of Extravascular Matrix Patterns,Cellular Blue Nevus,0
11352,Ductopenia,Cellular Blue Nevus,0
11353,Cytoplasm Presence of Less than or Equal to Twenty Five Percent,Melanocytic nevus of skin,0
11354,Isolated Tumor Cells,Melanocytic nevus of skin,0
11355,Pleural/Elastic Layer Invasion,Melanocytic nevus of skin,0
11356,Presence of Extravascular Matrix Patterns,Melanocytic nevus of skin,0
11357,Ductopenia,Melanocytic nevus of skin,0
11358,Coronary Vessel Lesion,Secondary malignant neoplasm of lymph node,0
11359,Index Lesion,Secondary malignant neoplasm of lymph node,0
11360,Non-Index Lesion,Secondary malignant neoplasm of lymph node,0
11361,Mushroom-Shaped Lesion,Secondary malignant neoplasm of lymph node,0
11362,Annular Lesion,Secondary malignant neoplasm of lymph node,0
11363,Coronary Vessel Lesion,Secondary malignant neoplasm of peritoneum,0
11364,Index Lesion,Secondary malignant neoplasm of peritoneum,0
11365,Non-Index Lesion,Secondary malignant neoplasm of peritoneum,0
11366,Mushroom-Shaped Lesion,Secondary malignant neoplasm of peritoneum,0
11367,Annular Lesion,Secondary malignant neoplasm of peritoneum,0
11368,Coronary Vessel Lesion,Secondary malignant neoplasm of pericardium,0
11369,Index Lesion,Secondary malignant neoplasm of pericardium,0
11370,Non-Index Lesion,Secondary malignant neoplasm of pericardium,0
11371,Mushroom-Shaped Lesion,Secondary malignant neoplasm of pericardium,0
11372,Annular Lesion,Secondary malignant neoplasm of pericardium,0
11373,Coronary Vessel Lesion,Metastatic Malignant Neoplasm in the Soft Tissues,0
11374,Index Lesion,Metastatic Malignant Neoplasm in the Soft Tissues,0
11375,Non-Index Lesion,Metastatic Malignant Neoplasm in the Soft Tissues,0
11376,Mushroom-Shaped Lesion,Metastatic Malignant Neoplasm in the Soft Tissues,0
11377,Annular Lesion,Metastatic Malignant Neoplasm in the Soft Tissues,0
11378,Coronary Vessel Lesion,Metastatic Malignant Neoplasm to the Leptomeninges,0
11379,Index Lesion,Metastatic Malignant Neoplasm to the Leptomeninges,0
11380,Non-Index Lesion,Metastatic Malignant Neoplasm to the Leptomeninges,0
11381,Mushroom-Shaped Lesion,Metastatic Malignant Neoplasm to the Leptomeninges,0
11382,Annular Lesion,Metastatic Malignant Neoplasm to the Leptomeninges,0
11383,Coronary Vessel Lesion,Secondary malignant neoplasm of anus,0
11384,Index Lesion,Secondary malignant neoplasm of anus,0
11385,Non-Index Lesion,Secondary malignant neoplasm of anus,0
11386,Mushroom-Shaped Lesion,Secondary malignant neoplasm of anus,0
11387,Annular Lesion,Secondary malignant neoplasm of anus,0
11388,Coronary Vessel Lesion,Secondary Acute Myeloid Leukemia,0
11389,Index Lesion,Secondary Acute Myeloid Leukemia,0
11390,Non-Index Lesion,Secondary Acute Myeloid Leukemia,0
11391,Mushroom-Shaped Lesion,Secondary Acute Myeloid Leukemia,0
11392,Annular Lesion,Secondary Acute Myeloid Leukemia,0
11393,Coronary Vessel Lesion,Distantly Metastatic Malignant Neoplasm,0
11394,Index Lesion,Distantly Metastatic Malignant Neoplasm,0
11395,Non-Index Lesion,Distantly Metastatic Malignant Neoplasm,0
11396,Mushroom-Shaped Lesion,Distantly Metastatic Malignant Neoplasm,0
11397,Annular Lesion,Distantly Metastatic Malignant Neoplasm,0
11398,Coronary Vessel Lesion,Metastatic Neoplasm to the Gallbladder,0
11399,Index Lesion,Metastatic Neoplasm to the Gallbladder,0
11400,Non-Index Lesion,Metastatic Neoplasm to the Gallbladder,0
11401,Mushroom-Shaped Lesion,Metastatic Neoplasm to the Gallbladder,0
11402,Annular Lesion,Metastatic Neoplasm to the Gallbladder,0
11403,Coronary Vessel Lesion,Secondary malignant neoplasm of large intestine,0
11404,Index Lesion,Secondary malignant neoplasm of large intestine,0
11405,Non-Index Lesion,Secondary malignant neoplasm of large intestine,0
11406,Mushroom-Shaped Lesion,Secondary malignant neoplasm of large intestine,0
11407,Annular Lesion,Secondary malignant neoplasm of large intestine,0
11408,Coronary Vessel Lesion,Metastatic Neoplasm to the Placenta,0
11409,Index Lesion,Metastatic Neoplasm to the Placenta,0
11410,Non-Index Lesion,Metastatic Neoplasm to the Placenta,0
11411,Mushroom-Shaped Lesion,Metastatic Neoplasm to the Placenta,0
11412,Annular Lesion,Metastatic Neoplasm to the Placenta,0
11413,Coronary Vessel Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,0
11414,Index Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,0
11415,Non-Index Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,0
11416,Mushroom-Shaped Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,0
11417,Annular Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,0
11418,Coronary Vessel Lesion,Secondary malignant neoplasm of small intestine,0
11419,Index Lesion,Secondary malignant neoplasm of small intestine,0
11420,Non-Index Lesion,Secondary malignant neoplasm of small intestine,0
11421,Mushroom-Shaped Lesion,Secondary malignant neoplasm of small intestine,0
11422,Annular Lesion,Secondary malignant neoplasm of small intestine,0
11423,Coronary Vessel Lesion,Alkylating Agent-Related Acute Myeloid Leukemia,0
11424,Index Lesion,Alkylating Agent-Related Acute Myeloid Leukemia,0
11425,Non-Index Lesion,Alkylating Agent-Related Acute Myeloid Leukemia,0
11426,Mushroom-Shaped Lesion,Alkylating Agent-Related Acute Myeloid Leukemia,0
11427,Annular Lesion,Alkylating Agent-Related Acute Myeloid Leukemia,0
11428,Coronary Vessel Lesion,Metastases to abdominal cavity,0
11429,Index Lesion,Metastases to abdominal cavity,0
11430,Non-Index Lesion,Metastases to abdominal cavity,0
11431,Mushroom-Shaped Lesion,Metastases to abdominal cavity,0
11432,Annular Lesion,Metastases to abdominal cavity,0
11433,Coronary Vessel Lesion,Secondary malignant neoplasm of heart,0
11434,Index Lesion,Secondary malignant neoplasm of heart,0
11435,Non-Index Lesion,Secondary malignant neoplasm of heart,0
11436,Mushroom-Shaped Lesion,Secondary malignant neoplasm of heart,0
11437,Annular Lesion,Secondary malignant neoplasm of heart,0
11438,Coronary Vessel Lesion,Secondary Neoplasm,0
11439,Index Lesion,Secondary Neoplasm,0
11440,Non-Index Lesion,Secondary Neoplasm,0
11441,Mushroom-Shaped Lesion,Secondary Neoplasm,0
11442,Annular Lesion,Secondary Neoplasm,0
11443,Coronary Vessel Lesion,Secondary malignant neoplasm of retina,0
11444,Index Lesion,Secondary malignant neoplasm of retina,0
11445,Non-Index Lesion,Secondary malignant neoplasm of retina,0
11446,Mushroom-Shaped Lesion,Secondary malignant neoplasm of retina,0
11447,Annular Lesion,Secondary malignant neoplasm of retina,0
11448,Coronary Vessel Lesion,Chondrosarcoma metastatic,0
11449,Index Lesion,Chondrosarcoma metastatic,0
11450,Non-Index Lesion,Chondrosarcoma metastatic,0
11451,Mushroom-Shaped Lesion,Chondrosarcoma metastatic,0
11452,Annular Lesion,Chondrosarcoma metastatic,0
11453,Coronary Vessel Lesion,Metastatic Ewing's Sarcoma,0
11454,Index Lesion,Metastatic Ewing's Sarcoma,0
11455,Non-Index Lesion,Metastatic Ewing's Sarcoma,0
11456,Mushroom-Shaped Lesion,Metastatic Ewing's Sarcoma,0
11457,Annular Lesion,Metastatic Ewing's Sarcoma,0
11458,Coronary Vessel Lesion,Radiation-Related Osteosarcoma,0
11459,Index Lesion,Radiation-Related Osteosarcoma,0
11460,Non-Index Lesion,Radiation-Related Osteosarcoma,0
11461,Mushroom-Shaped Lesion,Radiation-Related Osteosarcoma,0
11462,Annular Lesion,Radiation-Related Osteosarcoma,0
11463,Coronary Vessel Lesion,Extraskeletal osteosarcoma metastatic,0
11464,Index Lesion,Extraskeletal osteosarcoma metastatic,0
11465,Non-Index Lesion,Extraskeletal osteosarcoma metastatic,0
11466,Mushroom-Shaped Lesion,Extraskeletal osteosarcoma metastatic,0
11467,Annular Lesion,Extraskeletal osteosarcoma metastatic,0
11468,Coronary Vessel Lesion,Metastatic malignant neoplasm to brain,0
11469,Index Lesion,Metastatic malignant neoplasm to brain,0
11470,Non-Index Lesion,Metastatic malignant neoplasm to brain,0
11471,Mushroom-Shaped Lesion,Metastatic malignant neoplasm to brain,0
11472,Annular Lesion,Metastatic malignant neoplasm to brain,0
11473,Coronary Vessel Lesion,Secondary malignant neoplasm of hypopharynx,0
11474,Index Lesion,Secondary malignant neoplasm of hypopharynx,0
11475,Non-Index Lesion,Secondary malignant neoplasm of hypopharynx,0
11476,Mushroom-Shaped Lesion,Secondary malignant neoplasm of hypopharynx,0
11477,Annular Lesion,Secondary malignant neoplasm of hypopharynx,0
11478,Coronary Vessel Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,0
11479,Index Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,0
11480,Non-Index Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,0
11481,Mushroom-Shaped Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,0
11482,Annular Lesion,Secondary malignant neoplasm of extrahepatic bile ducts,0
11483,Coronary Vessel Lesion,Secondary malignant neoplasm of kidney,0
11484,Index Lesion,Secondary malignant neoplasm of kidney,0
11485,Non-Index Lesion,Secondary malignant neoplasm of kidney,0
11486,Mushroom-Shaped Lesion,Secondary malignant neoplasm of kidney,0
11487,Annular Lesion,Secondary malignant neoplasm of kidney,0
11488,Coronary Vessel Lesion,Meningeal Leukemia,0
11489,Index Lesion,Meningeal Leukemia,0
11490,Non-Index Lesion,Meningeal Leukemia,0
11491,Mushroom-Shaped Lesion,Meningeal Leukemia,0
11492,Annular Lesion,Meningeal Leukemia,0
11493,Coronary Vessel Lesion,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11494,Index Lesion,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11495,Non-Index Lesion,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11496,Mushroom-Shaped Lesion,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11497,Annular Lesion,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
11498,Coronary Vessel Lesion,Locally Metastatic Malignant Neoplasm,0
11499,Index Lesion,Locally Metastatic Malignant Neoplasm,0
11500,Non-Index Lesion,Locally Metastatic Malignant Neoplasm,0
11501,Mushroom-Shaped Lesion,Locally Metastatic Malignant Neoplasm,0
11502,Annular Lesion,Locally Metastatic Malignant Neoplasm,0
11503,Coronary Vessel Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
11504,Index Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
11505,Non-Index Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
11506,Mushroom-Shaped Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
11507,Annular Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0
11508,Coronary Vessel Lesion,Metastatic Childhood Soft Tissue Sarcoma,0
11509,Index Lesion,Metastatic Childhood Soft Tissue Sarcoma,0
11510,Non-Index Lesion,Metastatic Childhood Soft Tissue Sarcoma,0
11511,Mushroom-Shaped Lesion,Metastatic Childhood Soft Tissue Sarcoma,0
11512,Annular Lesion,Metastatic Childhood Soft Tissue Sarcoma,0
11513,Coronary Vessel Lesion,Metastatic melanoma,0
11514,Index Lesion,Metastatic melanoma,0
11515,Non-Index Lesion,Metastatic melanoma,0
11516,Mushroom-Shaped Lesion,Metastatic melanoma,0
11517,Annular Lesion,Metastatic melanoma,0
11518,Coronary Vessel Lesion,Secondary malignant neoplasm of sternum,0
11519,Index Lesion,Secondary malignant neoplasm of sternum,0
11520,Non-Index Lesion,Secondary malignant neoplasm of sternum,0
11521,Mushroom-Shaped Lesion,Secondary malignant neoplasm of sternum,0
11522,Annular Lesion,Secondary malignant neoplasm of sternum,0
11523,Coronary Vessel Lesion,Secondary malignant neoplasm of stomach,0
11524,Index Lesion,Secondary malignant neoplasm of stomach,0
11525,Non-Index Lesion,Secondary malignant neoplasm of stomach,0
11526,Mushroom-Shaped Lesion,Secondary malignant neoplasm of stomach,0
11527,Annular Lesion,Secondary malignant neoplasm of stomach,0
11528,Coronary Vessel Lesion,Metastatic Malignant Neoplasm in the Adult Brain,0
11529,Index Lesion,Metastatic Malignant Neoplasm in the Adult Brain,0
11530,Non-Index Lesion,Metastatic Malignant Neoplasm in the Adult Brain,0
11531,Mushroom-Shaped Lesion,Metastatic Malignant Neoplasm in the Adult Brain,0
11532,Annular Lesion,Metastatic Malignant Neoplasm in the Adult Brain,0
11533,Coronary Vessel Lesion,Secondary malignant neoplasm of urethra,0
11534,Index Lesion,Secondary malignant neoplasm of urethra,0
11535,Non-Index Lesion,Secondary malignant neoplasm of urethra,0
11536,Mushroom-Shaped Lesion,Secondary malignant neoplasm of urethra,0
11537,Annular Lesion,Secondary malignant neoplasm of urethra,0
11538,Coronary Vessel Lesion,Metastatic Neoplasm to the Bladder,0
11539,Index Lesion,Metastatic Neoplasm to the Bladder,0
11540,Non-Index Lesion,Metastatic Neoplasm to the Bladder,0
11541,Mushroom-Shaped Lesion,Metastatic Neoplasm to the Bladder,0
11542,Annular Lesion,Metastatic Neoplasm to the Bladder,0
11543,Coronary Vessel Lesion,Metastatic Bone Ewing Sarcoma,0
11544,Index Lesion,Metastatic Bone Ewing Sarcoma,0
11545,Non-Index Lesion,Metastatic Bone Ewing Sarcoma,0
11546,Mushroom-Shaped Lesion,Metastatic Bone Ewing Sarcoma,0
11547,Annular Lesion,Metastatic Bone Ewing Sarcoma,0
11548,Coronary Vessel Lesion,Secondary malignant neoplasm of brain stem,0
11549,Index Lesion,Secondary malignant neoplasm of brain stem,0
11550,Non-Index Lesion,Secondary malignant neoplasm of brain stem,0
11551,Mushroom-Shaped Lesion,Secondary malignant neoplasm of brain stem,0
11552,Annular Lesion,Secondary malignant neoplasm of brain stem,0
11553,Coronary Vessel Lesion,Secondary Peripheral Chondrosarcoma,0
11554,Index Lesion,Secondary Peripheral Chondrosarcoma,0
11555,Non-Index Lesion,Secondary Peripheral Chondrosarcoma,0
11556,Mushroom-Shaped Lesion,Secondary Peripheral Chondrosarcoma,0
11557,Annular Lesion,Secondary Peripheral Chondrosarcoma,0
11558,Coronary Vessel Lesion,Secondary Central Chondrosarcoma,0
11559,Index Lesion,Secondary Central Chondrosarcoma,0
11560,Non-Index Lesion,Secondary Central Chondrosarcoma,0
11561,Mushroom-Shaped Lesion,Secondary Central Chondrosarcoma,0
11562,Annular Lesion,Secondary Central Chondrosarcoma,0
11563,Coronary Vessel Lesion,Secondary malignant neoplasm of ciliary body,0
11564,Index Lesion,Secondary malignant neoplasm of ciliary body,0
11565,Non-Index Lesion,Secondary malignant neoplasm of ciliary body,0
11566,Mushroom-Shaped Lesion,Secondary malignant neoplasm of ciliary body,0
11567,Annular Lesion,Secondary malignant neoplasm of ciliary body,0
11568,Coronary Vessel Lesion,Secondary malignant neoplasm of neck,0
11569,Index Lesion,Secondary malignant neoplasm of neck,0
11570,Non-Index Lesion,Secondary malignant neoplasm of neck,0
11571,Mushroom-Shaped Lesion,Secondary malignant neoplasm of neck,0
11572,Annular Lesion,Secondary malignant neoplasm of neck,0
11573,Coronary Vessel Lesion,Benzene-Related Acute Myeloid Leukemia,0
11574,Index Lesion,Benzene-Related Acute Myeloid Leukemia,0
11575,Non-Index Lesion,Benzene-Related Acute Myeloid Leukemia,0
11576,Mushroom-Shaped Lesion,Benzene-Related Acute Myeloid Leukemia,0
11577,Annular Lesion,Benzene-Related Acute Myeloid Leukemia,0
11578,Coronary Vessel Lesion,Secondary Central Nervous System Lymphoma,0
11579,Index Lesion,Secondary Central Nervous System Lymphoma,0
11580,Non-Index Lesion,Secondary Central Nervous System Lymphoma,0
11581,Mushroom-Shaped Lesion,Secondary Central Nervous System Lymphoma,0
11582,Annular Lesion,Secondary Central Nervous System Lymphoma,0
11583,Coronary Vessel Lesion,Secondary malignant neoplasm of choroid,0
11584,Index Lesion,Secondary malignant neoplasm of choroid,0
11585,Non-Index Lesion,Secondary malignant neoplasm of choroid,0
11586,Mushroom-Shaped Lesion,Secondary malignant neoplasm of choroid,0
11587,Annular Lesion,Secondary malignant neoplasm of choroid,0
11588,Coronary Vessel Lesion,Metastatic Malignant Solid Neoplasm,0
11589,Index Lesion,Metastatic Malignant Solid Neoplasm,0
11590,Non-Index Lesion,Metastatic Malignant Solid Neoplasm,0
11591,Mushroom-Shaped Lesion,Metastatic Malignant Solid Neoplasm,0
11592,Annular Lesion,Metastatic Malignant Solid Neoplasm,0
11593,Coronary Vessel Lesion,Secondary malignant neoplasm of pharynx,0
11594,Index Lesion,Secondary malignant neoplasm of pharynx,0
11595,Non-Index Lesion,Secondary malignant neoplasm of pharynx,0
11596,Mushroom-Shaped Lesion,Secondary malignant neoplasm of pharynx,0
11597,Annular Lesion,Secondary malignant neoplasm of pharynx,0
11598,Coronary Vessel Lesion,Metastatic malignant neoplasm to nasopharynx,0
11599,Index Lesion,Metastatic malignant neoplasm to nasopharynx,0
11600,Non-Index Lesion,Metastatic malignant neoplasm to nasopharynx,0
11601,Mushroom-Shaped Lesion,Metastatic malignant neoplasm to nasopharynx,0
11602,Annular Lesion,Metastatic malignant neoplasm to nasopharynx,0
11603,Coronary Vessel Lesion,Secondary malignant neoplasm of ovary,0
11604,Index Lesion,Secondary malignant neoplasm of ovary,0
11605,Non-Index Lesion,Secondary malignant neoplasm of ovary,0
11606,Mushroom-Shaped Lesion,Secondary malignant neoplasm of ovary,0
11607,Annular Lesion,Secondary malignant neoplasm of ovary,0
11608,Coronary Vessel Lesion,Secondary osteosarcoma,0
11609,Index Lesion,Secondary osteosarcoma,0
11610,Non-Index Lesion,Secondary osteosarcoma,0
11611,Mushroom-Shaped Lesion,Secondary osteosarcoma,0
11612,Annular Lesion,Secondary osteosarcoma,0
11613,Coronary Vessel Lesion,Secondary malignant neoplasm of larynx,0
11614,Index Lesion,Secondary malignant neoplasm of larynx,0
11615,Non-Index Lesion,Secondary malignant neoplasm of larynx,0
11616,Mushroom-Shaped Lesion,Secondary malignant neoplasm of larynx,0
11617,Annular Lesion,Secondary malignant neoplasm of larynx,0
11618,Coronary Vessel Lesion,CNS metastases,0
11619,Index Lesion,CNS metastases,0
11620,Non-Index Lesion,CNS metastases,0
11621,Mushroom-Shaped Lesion,CNS metastases,0
11622,Annular Lesion,CNS metastases,0
11623,Coronary Vessel Lesion,Secondary malignant neoplasm of rectum,0
11624,Index Lesion,Secondary malignant neoplasm of rectum,0
11625,Non-Index Lesion,Secondary malignant neoplasm of rectum,0
11626,Mushroom-Shaped Lesion,Secondary malignant neoplasm of rectum,0
11627,Annular Lesion,Secondary malignant neoplasm of rectum,0
11628,Coronary Vessel Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
11629,Index Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
11630,Non-Index Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
11631,Mushroom-Shaped Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
11632,Annular Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",0
11633,Coronary Vessel Lesion,Secondary malignant neoplasm of vulva,0
11634,Index Lesion,Secondary malignant neoplasm of vulva,0
11635,Non-Index Lesion,Secondary malignant neoplasm of vulva,0
11636,Mushroom-Shaped Lesion,Secondary malignant neoplasm of vulva,0
11637,Annular Lesion,Secondary malignant neoplasm of vulva,0
11638,Coronary Vessel Lesion,"Neoplasms, Unknown Primary",0
11639,Index Lesion,"Neoplasms, Unknown Primary",0
11640,Non-Index Lesion,"Neoplasms, Unknown Primary",0
11641,Mushroom-Shaped Lesion,"Neoplasms, Unknown Primary",0
11642,Annular Lesion,"Neoplasms, Unknown Primary",0
11643,Coronary Vessel Lesion,Secondary malignant neoplasm of bone,0
11644,Index Lesion,Secondary malignant neoplasm of bone,0
11645,Non-Index Lesion,Secondary malignant neoplasm of bone,0
11646,Mushroom-Shaped Lesion,Secondary malignant neoplasm of bone,0
11647,Annular Lesion,Secondary malignant neoplasm of bone,0
11648,Coronary Vessel Lesion,Secondary malignant neoplasm of mediastinum,0
11649,Index Lesion,Secondary malignant neoplasm of mediastinum,0
11650,Non-Index Lesion,Secondary malignant neoplasm of mediastinum,0
11651,Mushroom-Shaped Lesion,Secondary malignant neoplasm of mediastinum,0
11652,Annular Lesion,Secondary malignant neoplasm of mediastinum,0
11653,Coronary Vessel Lesion,Osteosarcoma Arising in Paget Disease of Bone,0
11654,Index Lesion,Osteosarcoma Arising in Paget Disease of Bone,0
11655,Non-Index Lesion,Osteosarcoma Arising in Paget Disease of Bone,0
11656,Mushroom-Shaped Lesion,Osteosarcoma Arising in Paget Disease of Bone,0
11657,Annular Lesion,Osteosarcoma Arising in Paget Disease of Bone,0
11658,Coronary Vessel Lesion,Secondary malignant neoplasm of epididymis,0
11659,Index Lesion,Secondary malignant neoplasm of epididymis,0
11660,Non-Index Lesion,Secondary malignant neoplasm of epididymis,0
11661,Mushroom-Shaped Lesion,Secondary malignant neoplasm of epididymis,0
11662,Annular Lesion,Secondary malignant neoplasm of epididymis,0
11663,Coronary Vessel Lesion,Secondary malignant neoplasm of vertebral column,0
11664,Index Lesion,Secondary malignant neoplasm of vertebral column,0
11665,Non-Index Lesion,Secondary malignant neoplasm of vertebral column,0
11666,Mushroom-Shaped Lesion,Secondary malignant neoplasm of vertebral column,0
11667,Annular Lesion,Secondary malignant neoplasm of vertebral column,0
11668,Coronary Vessel Lesion,Secondary malignant neoplasm of female breast,0
11669,Index Lesion,Secondary malignant neoplasm of female breast,0
11670,Non-Index Lesion,Secondary malignant neoplasm of female breast,0
11671,Mushroom-Shaped Lesion,Secondary malignant neoplasm of female breast,0
11672,Annular Lesion,Secondary malignant neoplasm of female breast,0
11673,Coronary Vessel Lesion,Secondary malignant neoplasm of lung,0
11674,Index Lesion,Secondary malignant neoplasm of lung,0
11675,Non-Index Lesion,Secondary malignant neoplasm of lung,0
11676,Mushroom-Shaped Lesion,Secondary malignant neoplasm of lung,0
11677,Annular Lesion,Secondary malignant neoplasm of lung,0
11678,Coronary Vessel Lesion,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,0
11679,Index Lesion,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,0
11680,Non-Index Lesion,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,0
11681,Mushroom-Shaped Lesion,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,0
11682,Annular Lesion,Therapy-related acute myeloid leukemia and myelodysplastic syndrome,0
11683,Coronary Vessel Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",0
11684,Index Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",0
11685,Non-Index Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",0
11686,Mushroom-Shaped Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",0
11687,Annular Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",0
11688,Coronary Vessel Lesion,Chemotherapy-Related Leukemia,0
11689,Index Lesion,Chemotherapy-Related Leukemia,0
11690,Non-Index Lesion,Chemotherapy-Related Leukemia,0
11691,Mushroom-Shaped Lesion,Chemotherapy-Related Leukemia,0
11692,Annular Lesion,Chemotherapy-Related Leukemia,0
11693,Coronary Vessel Lesion,Secondary Cerebral Hodgkin Lymphoma,0
11694,Index Lesion,Secondary Cerebral Hodgkin Lymphoma,0
11695,Non-Index Lesion,Secondary Cerebral Hodgkin Lymphoma,0
11696,Mushroom-Shaped Lesion,Secondary Cerebral Hodgkin Lymphoma,0
11697,Annular Lesion,Secondary Cerebral Hodgkin Lymphoma,0
11698,Coronary Vessel Lesion,Metastatic Malignant Neoplasm to the Cervix,0
11699,Index Lesion,Metastatic Malignant Neoplasm to the Cervix,0
11700,Non-Index Lesion,Metastatic Malignant Neoplasm to the Cervix,0
11701,Mushroom-Shaped Lesion,Metastatic Malignant Neoplasm to the Cervix,0
11702,Annular Lesion,Metastatic Malignant Neoplasm to the Cervix,0
11703,Coronary Vessel Lesion,Metastatic Non-Cutaneous Melanoma,0
11704,Index Lesion,Metastatic Non-Cutaneous Melanoma,0
11705,Non-Index Lesion,Metastatic Non-Cutaneous Melanoma,0
11706,Mushroom-Shaped Lesion,Metastatic Non-Cutaneous Melanoma,0
11707,Annular Lesion,Metastatic Non-Cutaneous Melanoma,0
11708,Coronary Vessel Lesion,Alkylating Agent-Related Myelodysplastic Syndrome,0
11709,Index Lesion,Alkylating Agent-Related Myelodysplastic Syndrome,0
11710,Non-Index Lesion,Alkylating Agent-Related Myelodysplastic Syndrome,0
11711,Mushroom-Shaped Lesion,Alkylating Agent-Related Myelodysplastic Syndrome,0
11712,Annular Lesion,Alkylating Agent-Related Myelodysplastic Syndrome,0
11713,Coronary Vessel Lesion,Secondary malignant neoplasm of colon,0
11714,Index Lesion,Secondary malignant neoplasm of colon,0
11715,Non-Index Lesion,Secondary malignant neoplasm of colon,0
11716,Mushroom-Shaped Lesion,Secondary malignant neoplasm of colon,0
11717,Annular Lesion,Secondary malignant neoplasm of colon,0
11718,Coronary Vessel Lesion,Secondary malignant neoplasm of spinal cord,0
11719,Index Lesion,Secondary malignant neoplasm of spinal cord,0
11720,Non-Index Lesion,Secondary malignant neoplasm of spinal cord,0
11721,Mushroom-Shaped Lesion,Secondary malignant neoplasm of spinal cord,0
11722,Annular Lesion,Secondary malignant neoplasm of spinal cord,0
11723,Coronary Vessel Lesion,Secondary malignant neoplasm of chest wall,0
11724,Index Lesion,Secondary malignant neoplasm of chest wall,0
11725,Non-Index Lesion,Secondary malignant neoplasm of chest wall,0
11726,Mushroom-Shaped Lesion,Secondary malignant neoplasm of chest wall,0
11727,Annular Lesion,Secondary malignant neoplasm of chest wall,0
11728,Coronary Vessel Lesion,Secondary Malignant Neoplasm,0
11729,Index Lesion,Secondary Malignant Neoplasm,0
11730,Non-Index Lesion,Secondary Malignant Neoplasm,0
11731,Mushroom-Shaped Lesion,Secondary Malignant Neoplasm,0
11732,Annular Lesion,Secondary Malignant Neoplasm,0
11733,Coronary Vessel Lesion,Metastatic osteosarcoma,0
11734,Index Lesion,Metastatic osteosarcoma,0
11735,Non-Index Lesion,Metastatic osteosarcoma,0
11736,Mushroom-Shaped Lesion,Metastatic osteosarcoma,0
11737,Annular Lesion,Metastatic osteosarcoma,0
11738,Coronary Vessel Lesion,Drop Metastasis in the Spinal Cord,0
11739,Index Lesion,Drop Metastasis in the Spinal Cord,0
11740,Non-Index Lesion,Drop Metastasis in the Spinal Cord,0
11741,Mushroom-Shaped Lesion,Drop Metastasis in the Spinal Cord,0
11742,Annular Lesion,Drop Metastasis in the Spinal Cord,0
11743,Coronary Vessel Lesion,Secondary malignant neoplasm of testis,0
11744,Index Lesion,Secondary malignant neoplasm of testis,0
11745,Non-Index Lesion,Secondary malignant neoplasm of testis,0
11746,Mushroom-Shaped Lesion,Secondary malignant neoplasm of testis,0
11747,Annular Lesion,Secondary malignant neoplasm of testis,0
11748,Coronary Vessel Lesion,Advanced cancer,0
11749,Index Lesion,Advanced cancer,0
11750,Non-Index Lesion,Advanced cancer,0
11751,Mushroom-Shaped Lesion,Advanced cancer,0
11752,Annular Lesion,Advanced cancer,0
11753,Coronary Vessel Lesion,Secondary malignant neoplasm of lip,0
11754,Index Lesion,Secondary malignant neoplasm of lip,0
11755,Non-Index Lesion,Secondary malignant neoplasm of lip,0
11756,Mushroom-Shaped Lesion,Secondary malignant neoplasm of lip,0
11757,Annular Lesion,Secondary malignant neoplasm of lip,0
11758,Coronary Vessel Lesion,Secondary malignant neoplasm of liver,0
11759,Index Lesion,Secondary malignant neoplasm of liver,0
11760,Non-Index Lesion,Secondary malignant neoplasm of liver,0
11761,Mushroom-Shaped Lesion,Secondary malignant neoplasm of liver,0
11762,Annular Lesion,Secondary malignant neoplasm of liver,0
11763,Coronary Vessel Lesion,Secondary malignant neoplasm of orbit,0
11764,Index Lesion,Secondary malignant neoplasm of orbit,0
11765,Non-Index Lesion,Secondary malignant neoplasm of orbit,0
11766,Mushroom-Shaped Lesion,Secondary malignant neoplasm of orbit,0
11767,Annular Lesion,Secondary malignant neoplasm of orbit,0
11768,Coronary Vessel Lesion,Peripheral neuroepithelioma of bone metastatic,0
11769,Index Lesion,Peripheral neuroepithelioma of bone metastatic,0
11770,Non-Index Lesion,Peripheral neuroepithelioma of bone metastatic,0
11771,Mushroom-Shaped Lesion,Peripheral neuroepithelioma of bone metastatic,0
11772,Annular Lesion,Peripheral neuroepithelioma of bone metastatic,0
11773,Coronary Vessel Lesion,Secondary malignant neoplasm of axilla,0
11774,Index Lesion,Secondary malignant neoplasm of axilla,0
11775,Non-Index Lesion,Secondary malignant neoplasm of axilla,0
11776,Mushroom-Shaped Lesion,Secondary malignant neoplasm of axilla,0
11777,Annular Lesion,Secondary malignant neoplasm of axilla,0
11778,Coronary Vessel Lesion,Metachronous Osteosarcoma,0
11779,Index Lesion,Metachronous Osteosarcoma,0
11780,Non-Index Lesion,Metachronous Osteosarcoma,0
11781,Mushroom-Shaped Lesion,Metachronous Osteosarcoma,0
11782,Annular Lesion,Metachronous Osteosarcoma,0
11783,Coronary Vessel Lesion,Secondary malignant neoplasm of pancreas,0
11784,Index Lesion,Secondary malignant neoplasm of pancreas,0
11785,Non-Index Lesion,Secondary malignant neoplasm of pancreas,0
11786,Mushroom-Shaped Lesion,Secondary malignant neoplasm of pancreas,0
11787,Annular Lesion,Secondary malignant neoplasm of pancreas,0
11788,Coronary Vessel Lesion,Secondary Myelodysplastic Syndrome,0
11789,Index Lesion,Secondary Myelodysplastic Syndrome,0
11790,Non-Index Lesion,Secondary Myelodysplastic Syndrome,0
11791,Mushroom-Shaped Lesion,Secondary Myelodysplastic Syndrome,0
11792,Annular Lesion,Secondary Myelodysplastic Syndrome,0
11793,Coronary Vessel Lesion,Secondary malignant neoplasm of trachea,0
11794,Index Lesion,Secondary malignant neoplasm of trachea,0
11795,Non-Index Lesion,Secondary malignant neoplasm of trachea,0
11796,Mushroom-Shaped Lesion,Secondary malignant neoplasm of trachea,0
11797,Annular Lesion,Secondary malignant neoplasm of trachea,0
11798,Coronary Vessel Lesion,Secondary malignant neoplasm of nervous system,0
11799,Index Lesion,Secondary malignant neoplasm of nervous system,0
11800,Non-Index Lesion,Secondary malignant neoplasm of nervous system,0
11801,Mushroom-Shaped Lesion,Secondary malignant neoplasm of nervous system,0
11802,Annular Lesion,Secondary malignant neoplasm of nervous system,0
11803,Coronary Vessel Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,0
11804,Index Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,0
11805,Non-Index Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,0
11806,Mushroom-Shaped Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,0
11807,Annular Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,0
11808,Coronary Vessel Lesion,Secondary Heart Lymphoma,0
11809,Index Lesion,Secondary Heart Lymphoma,0
11810,Non-Index Lesion,Secondary Heart Lymphoma,0
11811,Mushroom-Shaped Lesion,Secondary Heart Lymphoma,0
11812,Annular Lesion,Secondary Heart Lymphoma,0
11813,Coronary Vessel Lesion,Secondary malignant neoplasm of parathyroid gland,0
11814,Index Lesion,Secondary malignant neoplasm of parathyroid gland,0
11815,Non-Index Lesion,Secondary malignant neoplasm of parathyroid gland,0
11816,Mushroom-Shaped Lesion,Secondary malignant neoplasm of parathyroid gland,0
11817,Annular Lesion,Secondary malignant neoplasm of parathyroid gland,0
11818,Coronary Vessel Lesion,Disseminated Malignant Neoplasm,0
11819,Index Lesion,Disseminated Malignant Neoplasm,0
11820,Non-Index Lesion,Disseminated Malignant Neoplasm,0
11821,Mushroom-Shaped Lesion,Disseminated Malignant Neoplasm,0
11822,Annular Lesion,Disseminated Malignant Neoplasm,0
11823,Coronary Vessel Lesion,Secondary malignant neoplasm of prostate,0
11824,Index Lesion,Secondary malignant neoplasm of prostate,0
11825,Non-Index Lesion,Secondary malignant neoplasm of prostate,0
11826,Mushroom-Shaped Lesion,Secondary malignant neoplasm of prostate,0
11827,Annular Lesion,Secondary malignant neoplasm of prostate,0
11828,Coronary Vessel Lesion,Secondary malignant neoplasm of esophagus,0
11829,Index Lesion,Secondary malignant neoplasm of esophagus,0
11830,Non-Index Lesion,Secondary malignant neoplasm of esophagus,0
11831,Mushroom-Shaped Lesion,Secondary malignant neoplasm of esophagus,0
11832,Annular Lesion,Secondary malignant neoplasm of esophagus,0
11833,Coronary Vessel Lesion,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0
11834,Index Lesion,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0
11835,Non-Index Lesion,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0
11836,Mushroom-Shaped Lesion,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0
11837,Annular Lesion,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,0
11838,Coronary Vessel Lesion,Metastases to adrenals,0
11839,Index Lesion,Metastases to adrenals,0
11840,Non-Index Lesion,Metastases to adrenals,0
11841,Mushroom-Shaped Lesion,Metastases to adrenals,0
11842,Annular Lesion,Metastases to adrenals,0
11843,Coronary Vessel Lesion,Secondary malignant neoplasm of ureter,0
11844,Index Lesion,Secondary malignant neoplasm of ureter,0
11845,Non-Index Lesion,Secondary malignant neoplasm of ureter,0
11846,Mushroom-Shaped Lesion,Secondary malignant neoplasm of ureter,0
11847,Annular Lesion,Secondary malignant neoplasm of ureter,0
11848,Coronary Vessel Lesion,Secondary malignant neoplasm of skin,0
11849,Index Lesion,Secondary malignant neoplasm of skin,0
11850,Non-Index Lesion,Secondary malignant neoplasm of skin,0
11851,Mushroom-Shaped Lesion,Secondary malignant neoplasm of skin,0
11852,Annular Lesion,Secondary malignant neoplasm of skin,0
11853,Coronary Vessel Lesion,Secondary malignant neoplasm of pituitary gland,0
11854,Index Lesion,Secondary malignant neoplasm of pituitary gland,0
11855,Non-Index Lesion,Secondary malignant neoplasm of pituitary gland,0
11856,Mushroom-Shaped Lesion,Secondary malignant neoplasm of pituitary gland,0
11857,Annular Lesion,Secondary malignant neoplasm of pituitary gland,0
11858,Coronary Vessel Lesion,Secondary malignant neoplasm of thymus,0
11859,Index Lesion,Secondary malignant neoplasm of thymus,0
11860,Non-Index Lesion,Secondary malignant neoplasm of thymus,0
11861,Mushroom-Shaped Lesion,Secondary malignant neoplasm of thymus,0
11862,Annular Lesion,Secondary malignant neoplasm of thymus,0
11863,Coronary Vessel Lesion,Secondary Central Nervous System Hodgkin Lymphoma,0
11864,Index Lesion,Secondary Central Nervous System Hodgkin Lymphoma,0
11865,Non-Index Lesion,Secondary Central Nervous System Hodgkin Lymphoma,0
11866,Mushroom-Shaped Lesion,Secondary Central Nervous System Hodgkin Lymphoma,0
11867,Annular Lesion,Secondary Central Nervous System Hodgkin Lymphoma,0
11868,Coronary Vessel Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma,0
11869,Index Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma,0
11870,Non-Index Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma,0
11871,Mushroom-Shaped Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma,0
11872,Annular Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma,0
11873,Coronary Vessel Lesion,Reactive systemic amyloidosis,0
11874,Index Lesion,Reactive systemic amyloidosis,0
11875,Non-Index Lesion,Reactive systemic amyloidosis,0
11876,Mushroom-Shaped Lesion,Reactive systemic amyloidosis,0
11877,Annular Lesion,Reactive systemic amyloidosis,0
11878,Coronary Vessel Lesion,Secondary Prostate Urothelial Carcinoma,0
11879,Index Lesion,Secondary Prostate Urothelial Carcinoma,0
11880,Non-Index Lesion,Secondary Prostate Urothelial Carcinoma,0
11881,Mushroom-Shaped Lesion,Secondary Prostate Urothelial Carcinoma,0
11882,Annular Lesion,Secondary Prostate Urothelial Carcinoma,0
11883,Coronary Vessel Lesion,Secondary malignant neoplasm of bone marrow,0
11884,Index Lesion,Secondary malignant neoplasm of bone marrow,0
11885,Non-Index Lesion,Secondary malignant neoplasm of bone marrow,0
11886,Mushroom-Shaped Lesion,Secondary malignant neoplasm of bone marrow,0
11887,Annular Lesion,Secondary malignant neoplasm of bone marrow,0
11888,Coronary Vessel Lesion,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,0
11889,Index Lesion,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,0
11890,Non-Index Lesion,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,0
11891,Mushroom-Shaped Lesion,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,0
11892,Annular Lesion,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,0
11893,Coronary Vessel Lesion,Treatment related leukaemia,0
11894,Index Lesion,Treatment related leukaemia,0
11895,Non-Index Lesion,Treatment related leukaemia,0
11896,Mushroom-Shaped Lesion,Treatment related leukaemia,0
11897,Annular Lesion,Treatment related leukaemia,0
11898,Coronary Vessel Lesion,Metastatic Malignant Neoplasm in the Iris,0
11899,Index Lesion,Metastatic Malignant Neoplasm in the Iris,0
11900,Non-Index Lesion,Metastatic Malignant Neoplasm in the Iris,0
11901,Mushroom-Shaped Lesion,Metastatic Malignant Neoplasm in the Iris,0
11902,Annular Lesion,Metastatic Malignant Neoplasm in the Iris,0
11903,Coronary Vessel Lesion,Secondary malignant neoplasm of eye,0
11904,Index Lesion,Secondary malignant neoplasm of eye,0
11905,Non-Index Lesion,Secondary malignant neoplasm of eye,0
11906,Mushroom-Shaped Lesion,Secondary malignant neoplasm of eye,0
11907,Annular Lesion,Secondary malignant neoplasm of eye,0
11908,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,0
11909,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,0
11910,Coronary Vessel Lesion,Locally Advanced Malignant Neoplasm,0
11911,Index Lesion,Locally Advanced Malignant Neoplasm,0
11912,Non-Index Lesion,Locally Advanced Malignant Neoplasm,0
11913,Mushroom-Shaped Lesion,Locally Advanced Malignant Neoplasm,0
11914,Annular Lesion,Locally Advanced Malignant Neoplasm,0
11915,Coronary Vessel Lesion,Treatment related acute myeloid leukaemia,0
11916,Index Lesion,Treatment related acute myeloid leukaemia,0
11917,Non-Index Lesion,Treatment related acute myeloid leukaemia,0
11918,Mushroom-Shaped Lesion,Treatment related acute myeloid leukaemia,0
11919,Annular Lesion,Treatment related acute myeloid leukaemia,0
11920,Coronary Vessel Lesion,Medulloblastoma with Leptomeningeal Spread,0
11921,Index Lesion,Medulloblastoma with Leptomeningeal Spread,0
11922,Non-Index Lesion,Medulloblastoma with Leptomeningeal Spread,0
11923,Mushroom-Shaped Lesion,Medulloblastoma with Leptomeningeal Spread,0
11924,Annular Lesion,Medulloblastoma with Leptomeningeal Spread,0
11925,Coronary Vessel Lesion,Secondary Chondrosarcoma,0
11926,Index Lesion,Secondary Chondrosarcoma,0
11927,Non-Index Lesion,Secondary Chondrosarcoma,0
11928,Mushroom-Shaped Lesion,Secondary Chondrosarcoma,0
11929,Annular Lesion,Secondary Chondrosarcoma,0
11930,Coronary Vessel Lesion,Metastatic malignant neoplasm to oropharynx,0
11931,Index Lesion,Metastatic malignant neoplasm to oropharynx,0
11932,Non-Index Lesion,Metastatic malignant neoplasm to oropharynx,0
11933,Mushroom-Shaped Lesion,Metastatic malignant neoplasm to oropharynx,0
11934,Annular Lesion,Metastatic malignant neoplasm to oropharynx,0
11935,Coronary Vessel Lesion,Secondary malignant neoplasm of vagina,0
11936,Index Lesion,Secondary malignant neoplasm of vagina,0
11937,Non-Index Lesion,Secondary malignant neoplasm of vagina,0
11938,Mushroom-Shaped Lesion,Secondary malignant neoplasm of vagina,0
11939,Annular Lesion,Secondary malignant neoplasm of vagina,0
11940,Coronary Vessel Lesion,Therapy-related myelodysplastic syndrome,0
11941,Index Lesion,Therapy-related myelodysplastic syndrome,0
11942,Non-Index Lesion,Therapy-related myelodysplastic syndrome,0
11943,Mushroom-Shaped Lesion,Therapy-related myelodysplastic syndrome,0
11944,Annular Lesion,Therapy-related myelodysplastic syndrome,0
11945,Coronary Vessel Lesion,Metastatic Malignant Neoplasm to the Thyroid,0
11946,Index Lesion,Metastatic Malignant Neoplasm to the Thyroid,0
11947,Non-Index Lesion,Metastatic Malignant Neoplasm to the Thyroid,0
11948,Mushroom-Shaped Lesion,Metastatic Malignant Neoplasm to the Thyroid,0
11949,Annular Lesion,Metastatic Malignant Neoplasm to the Thyroid,0
11950,Coronary Vessel Lesion,Extra-osseous Ewing's sarcoma metastatic,0
11951,Index Lesion,Extra-osseous Ewing's sarcoma metastatic,0
11952,Non-Index Lesion,Extra-osseous Ewing's sarcoma metastatic,0
11953,Mushroom-Shaped Lesion,Extra-osseous Ewing's sarcoma metastatic,0
11954,Annular Lesion,Extra-osseous Ewing's sarcoma metastatic,0
11955,Coronary Vessel Lesion,Secondary malignant neoplasm of pleura,0
11956,Index Lesion,Secondary malignant neoplasm of pleura,0
11957,Non-Index Lesion,Secondary malignant neoplasm of pleura,0
11958,Mushroom-Shaped Lesion,Secondary malignant neoplasm of pleura,0
11959,Annular Lesion,Secondary malignant neoplasm of pleura,0
11960,Coronary Vessel Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11961,Index Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11962,Non-Index Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11963,Mushroom-Shaped Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11964,Annular Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11965,Coronary Vessel Lesion,Peritoneal mesothelioma malignant advanced,0
11966,Index Lesion,Peritoneal mesothelioma malignant advanced,0
11967,Non-Index Lesion,Peritoneal mesothelioma malignant advanced,0
11968,Mushroom-Shaped Lesion,Peritoneal mesothelioma malignant advanced,0
11969,Annular Lesion,Peritoneal mesothelioma malignant advanced,0
11970,Coronary Vessel Lesion,Advanced Unfavorable Hodgkin Lymphoma,0
11971,Index Lesion,Advanced Unfavorable Hodgkin Lymphoma,0
11972,Non-Index Lesion,Advanced Unfavorable Hodgkin Lymphoma,0
11973,Mushroom-Shaped Lesion,Advanced Unfavorable Hodgkin Lymphoma,0
11974,Annular Lesion,Advanced Unfavorable Hodgkin Lymphoma,0
11975,Coronary Vessel Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11976,Index Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11977,Non-Index Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11978,Mushroom-Shaped Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11979,Annular Lesion,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11980,Coronary Vessel Lesion,Metastatic Malignant Germ Cell Tumor,0
11981,Index Lesion,Metastatic Malignant Germ Cell Tumor,0
11982,Non-Index Lesion,Metastatic Malignant Germ Cell Tumor,0
11983,Mushroom-Shaped Lesion,Metastatic Malignant Germ Cell Tumor,0
11984,Annular Lesion,Metastatic Malignant Germ Cell Tumor,0
11985,Coronary Vessel Lesion,Pericardial mesothelioma malignant advanced,0
11986,Index Lesion,Pericardial mesothelioma malignant advanced,0
11987,Non-Index Lesion,Pericardial mesothelioma malignant advanced,0
11988,Mushroom-Shaped Lesion,Pericardial mesothelioma malignant advanced,0
11989,Annular Lesion,Pericardial mesothelioma malignant advanced,0
11990,Coronary Vessel Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,0
11991,Index Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,0
11992,Non-Index Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,0
11993,Mushroom-Shaped Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,0
11994,Annular Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,0
11995,Coronary Vessel Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11996,Index Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11997,Non-Index Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11998,Mushroom-Shaped Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
11999,Annular Lesion,Stage IVA Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
12000,Coronary Vessel Lesion,Advanced Favorable Hodgkin Lymphoma,0
12001,Index Lesion,Advanced Favorable Hodgkin Lymphoma,0
12002,Non-Index Lesion,Advanced Favorable Hodgkin Lymphoma,0
12003,Mushroom-Shaped Lesion,Advanced Favorable Hodgkin Lymphoma,0
12004,Annular Lesion,Advanced Favorable Hodgkin Lymphoma,0
12005,Coronary Vessel Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,0
12006,Index Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,0
12007,Non-Index Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,0
12008,Mushroom-Shaped Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,0
12009,Annular Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,0
12010,Coronary Vessel Lesion,Advanced Malignant Solid Neoplasm,0
12011,Index Lesion,Advanced Malignant Solid Neoplasm,0
12012,Non-Index Lesion,Advanced Malignant Solid Neoplasm,0
12013,Mushroom-Shaped Lesion,Advanced Malignant Solid Neoplasm,0
12014,Annular Lesion,Advanced Malignant Solid Neoplasm,0
12015,Coronary Vessel Lesion,Pleural mesothelioma malignant advanced,0
12016,Index Lesion,Pleural mesothelioma malignant advanced,0
12017,Non-Index Lesion,Pleural mesothelioma malignant advanced,0
12018,Mushroom-Shaped Lesion,Pleural mesothelioma malignant advanced,0
12019,Annular Lesion,Pleural mesothelioma malignant advanced,0
12020,Coronary Vessel Lesion,Advanced Favorable Non-Hodgkin Lymphoma,0
12021,Index Lesion,Advanced Favorable Non-Hodgkin Lymphoma,0
12022,Non-Index Lesion,Advanced Favorable Non-Hodgkin Lymphoma,0
12023,Mushroom-Shaped Lesion,Advanced Favorable Non-Hodgkin Lymphoma,0
12024,Annular Lesion,Advanced Favorable Non-Hodgkin Lymphoma,0
12025,Coronary Vessel Lesion,Mesothelioma malignant advanced,0
12026,Index Lesion,Mesothelioma malignant advanced,0
12027,Non-Index Lesion,Mesothelioma malignant advanced,0
12028,Mushroom-Shaped Lesion,Mesothelioma malignant advanced,0
12029,Annular Lesion,Mesothelioma malignant advanced,0
12030,Coronary Vessel Lesion,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
12031,Index Lesion,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
12032,Non-Index Lesion,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
12033,Mushroom-Shaped Lesion,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
12034,Annular Lesion,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,0
12035,Coronary Vessel Lesion,Locally Advanced Malignant Solid Neoplasm,0
12036,Index Lesion,Locally Advanced Malignant Solid Neoplasm,0
12037,Non-Index Lesion,Locally Advanced Malignant Solid Neoplasm,0
12038,Mushroom-Shaped Lesion,Locally Advanced Malignant Solid Neoplasm,0
12039,Annular Lesion,Locally Advanced Malignant Solid Neoplasm,0
12040,Coronary Vessel Lesion,Melanoma Metastatic in the Central Nervous System,0
12041,Index Lesion,Melanoma Metastatic in the Central Nervous System,0
12042,Non-Index Lesion,Melanoma Metastatic in the Central Nervous System,0
12043,Mushroom-Shaped Lesion,Melanoma Metastatic in the Central Nervous System,0
12044,Annular Lesion,Melanoma Metastatic in the Central Nervous System,0
12045,Coronary Vessel Lesion,Locally Advanced Angiosarcoma,0
12046,Index Lesion,Locally Advanced Angiosarcoma,0
12047,Non-Index Lesion,Locally Advanced Angiosarcoma,0
12048,Mushroom-Shaped Lesion,Locally Advanced Angiosarcoma,0
12049,Annular Lesion,Locally Advanced Angiosarcoma,0
12050,Coronary Vessel Lesion,Advanced B-Cell Neoplasm,0
12051,Index Lesion,Advanced B-Cell Neoplasm,0
12052,Non-Index Lesion,Advanced B-Cell Neoplasm,0
12053,Mushroom-Shaped Lesion,Advanced B-Cell Neoplasm,0
12054,Annular Lesion,Advanced B-Cell Neoplasm,0
12055,Coronary Vessel Lesion,Metastatic angiosarcoma,0
12056,Index Lesion,Metastatic angiosarcoma,0
12057,Non-Index Lesion,Metastatic angiosarcoma,0
12058,Mushroom-Shaped Lesion,Metastatic angiosarcoma,0
12059,Annular Lesion,Metastatic angiosarcoma,0
12060,Coronary Vessel Lesion,Advanced Uveal Melanoma,0
12061,Index Lesion,Advanced Uveal Melanoma,0
12062,Non-Index Lesion,Advanced Uveal Melanoma,0
12063,Mushroom-Shaped Lesion,Advanced Uveal Melanoma,0
12064,Annular Lesion,Advanced Uveal Melanoma,0
12065,Coronary Vessel Lesion,Advanced Lymphoma,0
12066,Index Lesion,Advanced Lymphoma,0
12067,Non-Index Lesion,Advanced Lymphoma,0
12068,Mushroom-Shaped Lesion,Advanced Lymphoma,0
12069,Annular Lesion,Advanced Lymphoma,0
12070,Coronary Vessel Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,0
12071,Index Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,0
12072,Non-Index Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,0
12073,Mushroom-Shaped Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,0
12074,Annular Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,0
12075,Coronary Vessel Lesion,Liposarcoma metastatic,0
12076,Index Lesion,Liposarcoma metastatic,0
12077,Non-Index Lesion,Liposarcoma metastatic,0
12078,Mushroom-Shaped Lesion,Liposarcoma metastatic,0
12079,Annular Lesion,Liposarcoma metastatic,0
12080,Coronary Vessel Lesion,Advanced Sarcoma,0
12081,Index Lesion,Advanced Sarcoma,0
12082,Non-Index Lesion,Advanced Sarcoma,0
12083,Mushroom-Shaped Lesion,Advanced Sarcoma,0
12084,Annular Lesion,Advanced Sarcoma,0
12085,Coronary Vessel Lesion,Alveolar soft part sarcoma metastatic,0
12086,Index Lesion,Alveolar soft part sarcoma metastatic,0
12087,Non-Index Lesion,Alveolar soft part sarcoma metastatic,0
12088,Mushroom-Shaped Lesion,Alveolar soft part sarcoma metastatic,0
12089,Annular Lesion,Alveolar soft part sarcoma metastatic,0
12090,Coronary Vessel Lesion,Metastatic Malignant Neoplasm in the Viscera,0
12091,Index Lesion,Metastatic Malignant Neoplasm in the Viscera,0
12092,Non-Index Lesion,Metastatic Malignant Neoplasm in the Viscera,0
12093,Mushroom-Shaped Lesion,Metastatic Malignant Neoplasm in the Viscera,0
12094,Annular Lesion,Metastatic Malignant Neoplasm in the Viscera,0
12095,Coronary Vessel Lesion,Locally Advanced Bone Sarcoma,0
12096,Index Lesion,Locally Advanced Bone Sarcoma,0
12097,Non-Index Lesion,Locally Advanced Bone Sarcoma,0
12098,Mushroom-Shaped Lesion,Locally Advanced Bone Sarcoma,0
12099,Annular Lesion,Locally Advanced Bone Sarcoma,0
12100,Coronary Vessel Lesion,Metastatic Unresectable Malignant Neoplasm,0
12101,Index Lesion,Metastatic Unresectable Malignant Neoplasm,0
12102,Non-Index Lesion,Metastatic Unresectable Malignant Neoplasm,0
12103,Mushroom-Shaped Lesion,Metastatic Unresectable Malignant Neoplasm,0
12104,Annular Lesion,Metastatic Unresectable Malignant Neoplasm,0
12105,Coronary Vessel Lesion,Malignant fibrous histiocytoma metastatic,0
12106,Index Lesion,Malignant fibrous histiocytoma metastatic,0
12107,Non-Index Lesion,Malignant fibrous histiocytoma metastatic,0
12108,Mushroom-Shaped Lesion,Malignant fibrous histiocytoma metastatic,0
12109,Annular Lesion,Malignant fibrous histiocytoma metastatic,0
12110,Coronary Vessel Lesion,Metastatic Uveal Melanoma,0
12111,Index Lesion,Metastatic Uveal Melanoma,0
12112,Non-Index Lesion,Metastatic Uveal Melanoma,0
12113,Mushroom-Shaped Lesion,Metastatic Uveal Melanoma,0
12114,Annular Lesion,Metastatic Uveal Melanoma,0
12115,Coronary Vessel Lesion,Uveal Melanoma Metastatic in the Liver,0
12116,Index Lesion,Uveal Melanoma Metastatic in the Liver,0
12117,Non-Index Lesion,Uveal Melanoma Metastatic in the Liver,0
12118,Mushroom-Shaped Lesion,Uveal Melanoma Metastatic in the Liver,0
12119,Annular Lesion,Uveal Melanoma Metastatic in the Liver,0
12120,Coronary Vessel Lesion,Metastatic Gastrointestinal Stromal Tumor,0
12121,Index Lesion,Metastatic Gastrointestinal Stromal Tumor,0
12122,Non-Index Lesion,Metastatic Gastrointestinal Stromal Tumor,0
12123,Mushroom-Shaped Lesion,Metastatic Gastrointestinal Stromal Tumor,0
12124,Annular Lesion,Metastatic Gastrointestinal Stromal Tumor,0
12125,Coronary Vessel Lesion,Metastatic Unresectable Sarcoma,0
12126,Index Lesion,Metastatic Unresectable Sarcoma,0
12127,Non-Index Lesion,Metastatic Unresectable Sarcoma,0
12128,Mushroom-Shaped Lesion,Metastatic Unresectable Sarcoma,0
12129,Annular Lesion,Metastatic Unresectable Sarcoma,0
12130,Coronary Vessel Lesion,Locally Advanced Soft Tissue Sarcoma,0
12131,Index Lesion,Locally Advanced Soft Tissue Sarcoma,0
12132,Non-Index Lesion,Locally Advanced Soft Tissue Sarcoma,0
12133,Mushroom-Shaped Lesion,Locally Advanced Soft Tissue Sarcoma,0
12134,Annular Lesion,Locally Advanced Soft Tissue Sarcoma,0
12135,Coronary Vessel Lesion,Advanced Synovial Sarcoma,0
12136,Index Lesion,Advanced Synovial Sarcoma,0
12137,Non-Index Lesion,Advanced Synovial Sarcoma,0
12138,Mushroom-Shaped Lesion,Advanced Synovial Sarcoma,0
12139,Annular Lesion,Advanced Synovial Sarcoma,0
12140,Coronary Vessel Lesion,Locally Advanced Unresectable Malignant Neoplasm,0
12141,Index Lesion,Locally Advanced Unresectable Malignant Neoplasm,0
12142,Non-Index Lesion,Locally Advanced Unresectable Malignant Neoplasm,0
12143,Mushroom-Shaped Lesion,Locally Advanced Unresectable Malignant Neoplasm,0
12144,Annular Lesion,Locally Advanced Unresectable Malignant Neoplasm,0
12145,Coronary Vessel Lesion,Locally Advanced Unresectable Sarcoma,0
12146,Index Lesion,Locally Advanced Unresectable Sarcoma,0
12147,Non-Index Lesion,Locally Advanced Unresectable Sarcoma,0
12148,Mushroom-Shaped Lesion,Locally Advanced Unresectable Sarcoma,0
12149,Annular Lesion,Locally Advanced Unresectable Sarcoma,0
12150,Coronary Vessel Lesion,Locally Advanced Sarcoma,0
12151,Index Lesion,Locally Advanced Sarcoma,0
12152,Non-Index Lesion,Locally Advanced Sarcoma,0
12153,Mushroom-Shaped Lesion,Locally Advanced Sarcoma,0
12154,Annular Lesion,Locally Advanced Sarcoma,0
12155,Coronary Vessel Lesion,Locally Advanced Gastrointestinal Stromal Tumor,0
12156,Index Lesion,Locally Advanced Gastrointestinal Stromal Tumor,0
12157,Non-Index Lesion,Locally Advanced Gastrointestinal Stromal Tumor,0
12158,Mushroom-Shaped Lesion,Locally Advanced Gastrointestinal Stromal Tumor,0
12159,Annular Lesion,Locally Advanced Gastrointestinal Stromal Tumor,0
12160,Coronary Vessel Lesion,"Sarcoma, metastatic",0
12161,Index Lesion,"Sarcoma, metastatic",0
12162,Non-Index Lesion,"Sarcoma, metastatic",0
12163,Mushroom-Shaped Lesion,"Sarcoma, metastatic",0
12164,Annular Lesion,"Sarcoma, metastatic",0
12165,Coronary Vessel Lesion,Metastatic Soft Tissue Sarcoma,0
12166,Index Lesion,Metastatic Soft Tissue Sarcoma,0
12167,Non-Index Lesion,Metastatic Soft Tissue Sarcoma,0
12168,Mushroom-Shaped Lesion,Metastatic Soft Tissue Sarcoma,0
12169,Annular Lesion,Metastatic Soft Tissue Sarcoma,0
12170,Coronary Vessel Lesion,Metastatic Bone Sarcoma,0
12171,Index Lesion,Metastatic Bone Sarcoma,0
12172,Non-Index Lesion,Metastatic Bone Sarcoma,0
12173,Mushroom-Shaped Lesion,Metastatic Bone Sarcoma,0
12174,Annular Lesion,Metastatic Bone Sarcoma,0
12175,Coronary Vessel Lesion,Epithelioid sarcoma metastatic,0
12176,Index Lesion,Epithelioid sarcoma metastatic,0
12177,Non-Index Lesion,Epithelioid sarcoma metastatic,0
12178,Mushroom-Shaped Lesion,Epithelioid sarcoma metastatic,0
12179,Annular Lesion,Epithelioid sarcoma metastatic,0
12180,Coronary Vessel Lesion,Synovial sarcoma metastatic,0
12181,Index Lesion,Synovial sarcoma metastatic,0
12182,Non-Index Lesion,Synovial sarcoma metastatic,0
12183,Mushroom-Shaped Lesion,Synovial sarcoma metastatic,0
12184,Annular Lesion,Synovial sarcoma metastatic,0
12185,Coronary Vessel Lesion,Locally Advanced Melanoma,0
12186,Index Lesion,Locally Advanced Melanoma,0
12187,Non-Index Lesion,Locally Advanced Melanoma,0
12188,Mushroom-Shaped Lesion,Locally Advanced Melanoma,0
12189,Annular Lesion,Locally Advanced Melanoma,0
12190,Coronary Vessel Lesion,Advanced Melanoma,0
12191,Index Lesion,Advanced Melanoma,0
12192,Non-Index Lesion,Advanced Melanoma,0
12193,Mushroom-Shaped Lesion,Advanced Melanoma,0
12194,Annular Lesion,Advanced Melanoma,0
12195,Coronary Vessel Lesion,Locally Advanced Unresectable Bone Sarcoma,0
12196,Index Lesion,Locally Advanced Unresectable Bone Sarcoma,0
12197,Non-Index Lesion,Locally Advanced Unresectable Bone Sarcoma,0
12198,Mushroom-Shaped Lesion,Locally Advanced Unresectable Bone Sarcoma,0
12199,Annular Lesion,Locally Advanced Unresectable Bone Sarcoma,0
12200,Coronary Vessel Lesion,Advanced Sarcoma of the Extremity,0
12201,Index Lesion,Advanced Sarcoma of the Extremity,0
12202,Non-Index Lesion,Advanced Sarcoma of the Extremity,0
12203,Mushroom-Shaped Lesion,Advanced Sarcoma of the Extremity,0
12204,Annular Lesion,Advanced Sarcoma of the Extremity,0
12205,Coronary Vessel Lesion,Metastatic Malignant Pancreatic Neoplasm,0
12206,Index Lesion,Metastatic Malignant Pancreatic Neoplasm,0
12207,Non-Index Lesion,Metastatic Malignant Pancreatic Neoplasm,0
12208,Mushroom-Shaped Lesion,Metastatic Malignant Pancreatic Neoplasm,0
12209,Annular Lesion,Metastatic Malignant Pancreatic Neoplasm,0
12210,Coronary Vessel Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,0
12211,Index Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,0
12212,Non-Index Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,0
12213,Mushroom-Shaped Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,0
12214,Annular Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,0
12215,Coronary Vessel Lesion,Metastatic Malignant Neoplasm in the Sellar Region,0
12216,Index Lesion,Metastatic Malignant Neoplasm in the Sellar Region,0
12217,Non-Index Lesion,Metastatic Malignant Neoplasm in the Sellar Region,0
12218,Mushroom-Shaped Lesion,Metastatic Malignant Neoplasm in the Sellar Region,0
12219,Annular Lesion,Metastatic Malignant Neoplasm in the Sellar Region,0
12220,Coronary Vessel Lesion,Metastatic Meningioma,0
12221,Index Lesion,Metastatic Meningioma,0
12222,Non-Index Lesion,Metastatic Meningioma,0
12223,Mushroom-Shaped Lesion,Metastatic Meningioma,0
12224,Annular Lesion,Metastatic Meningioma,0
12225,Coronary Vessel Lesion,Melanoma of Unknown Primary,0
12226,Index Lesion,Melanoma of Unknown Primary,0
12227,Non-Index Lesion,Melanoma of Unknown Primary,0
12228,Mushroom-Shaped Lesion,Melanoma of Unknown Primary,0
12229,Annular Lesion,Melanoma of Unknown Primary,0
12230,Coronary Vessel Lesion,Stage IV adult soft tissue sarcoma,0
12231,Index Lesion,Stage IV adult soft tissue sarcoma,0
12232,Non-Index Lesion,Stage IV adult soft tissue sarcoma,0
12233,Mushroom-Shaped Lesion,Stage IV adult soft tissue sarcoma,0
12234,Annular Lesion,Stage IV adult soft tissue sarcoma,0
12235,Coronary Vessel Lesion,Stage IV Skin Melanoma,0
12236,Index Lesion,Stage IV Skin Melanoma,0
12237,Non-Index Lesion,Stage IV Skin Melanoma,0
12238,Mushroom-Shaped Lesion,Stage IV Skin Melanoma,0
12239,Annular Lesion,Stage IV Skin Melanoma,0
12240,Coronary Vessel Lesion,Advanced Kaposi Sarcoma,0
12241,Index Lesion,Advanced Kaposi Sarcoma,0
12242,Non-Index Lesion,Advanced Kaposi Sarcoma,0
12243,Mushroom-Shaped Lesion,Advanced Kaposi Sarcoma,0
12244,Annular Lesion,Advanced Kaposi Sarcoma,0
12245,Coronary Vessel Lesion,Recurrent Metastatic Malignant Neoplasm,0
12246,Index Lesion,Recurrent Metastatic Malignant Neoplasm,0
12247,Non-Index Lesion,Recurrent Metastatic Malignant Neoplasm,0
12248,Mushroom-Shaped Lesion,Recurrent Metastatic Malignant Neoplasm,0
12249,Annular Lesion,Recurrent Metastatic Malignant Neoplasm,0
12250,Coronary Vessel Lesion,"Kaposi's sarcoma, metastatic",0
12251,Index Lesion,"Kaposi's sarcoma, metastatic",0
12252,Non-Index Lesion,"Kaposi's sarcoma, metastatic",0
12253,Mushroom-Shaped Lesion,"Kaposi's sarcoma, metastatic",0
12254,Annular Lesion,"Kaposi's sarcoma, metastatic",0
12255,Coronary Vessel Lesion,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
12256,Index Lesion,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
12257,Non-Index Lesion,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
12258,Mushroom-Shaped Lesion,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
12259,Annular Lesion,Metastatic Human Papillomavirus-Related Malignant Neoplasm,0
12260,Coronary Vessel Lesion,Testicular cancer metastatic,0
12261,Index Lesion,Testicular cancer metastatic,0
12262,Non-Index Lesion,Testicular cancer metastatic,0
12263,Mushroom-Shaped Lesion,Testicular cancer metastatic,0
12264,Annular Lesion,Testicular cancer metastatic,0
12265,Coronary Vessel Lesion,Metastatic leiomyosarcoma,0
12266,Index Lesion,Metastatic leiomyosarcoma,0
12267,Non-Index Lesion,Metastatic leiomyosarcoma,0
12268,Mushroom-Shaped Lesion,Metastatic leiomyosarcoma,0
12269,Annular Lesion,Metastatic leiomyosarcoma,0
12270,Coronary Vessel Lesion,Metastatic Neuroblastoma,0
12271,Index Lesion,Metastatic Neuroblastoma,0
12272,Non-Index Lesion,Metastatic Neuroblastoma,0
12273,Mushroom-Shaped Lesion,Metastatic Neuroblastoma,0
12274,Annular Lesion,Metastatic Neuroblastoma,0
12275,Coronary Vessel Lesion,Fibrosarcoma metastatic,0
12276,Index Lesion,Fibrosarcoma metastatic,0
12277,Non-Index Lesion,Fibrosarcoma metastatic,0
12278,Mushroom-Shaped Lesion,Fibrosarcoma metastatic,0
12279,Annular Lesion,Fibrosarcoma metastatic,0
12280,Coronary Vessel Lesion,Advanced Cutaneous Melanoma of the Extremity,0
12281,Index Lesion,Advanced Cutaneous Melanoma of the Extremity,0
12282,Non-Index Lesion,Advanced Cutaneous Melanoma of the Extremity,0
12283,Mushroom-Shaped Lesion,Advanced Cutaneous Melanoma of the Extremity,0
12284,Annular Lesion,Advanced Cutaneous Melanoma of the Extremity,0
12285,Coronary Vessel Lesion,Metastatic Malignant Genitourinary System Neoplasm,0
12286,Index Lesion,Metastatic Malignant Genitourinary System Neoplasm,0
12287,Non-Index Lesion,Metastatic Malignant Genitourinary System Neoplasm,0
12288,Mushroom-Shaped Lesion,Metastatic Malignant Genitourinary System Neoplasm,0
12289,Annular Lesion,Metastatic Malignant Genitourinary System Neoplasm,0
12290,Coronary Vessel Lesion,Advanced Extracranial Malignant Solid Neoplasm,0
12291,Index Lesion,Advanced Extracranial Malignant Solid Neoplasm,0
12292,Non-Index Lesion,Advanced Extracranial Malignant Solid Neoplasm,0
12293,Mushroom-Shaped Lesion,Advanced Extracranial Malignant Solid Neoplasm,0
12294,Annular Lesion,Advanced Extracranial Malignant Solid Neoplasm,0
12295,Coronary Vessel Lesion,Metastatic Extracranial Malignant Solid Neoplasm,0
12296,Index Lesion,Metastatic Extracranial Malignant Solid Neoplasm,0
12297,Non-Index Lesion,Metastatic Extracranial Malignant Solid Neoplasm,0
12298,Mushroom-Shaped Lesion,Metastatic Extracranial Malignant Solid Neoplasm,0
12299,Annular Lesion,Metastatic Extracranial Malignant Solid Neoplasm,0
12300,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Juvenile Myelomonocytic Leukemia,0
12301,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Juvenile Myelomonocytic Leukemia,0
12302,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Chronic eosinophilic leukemia,0
12303,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic eosinophilic leukemia,0
12304,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,"Leukemia, Myelomonocytic, Chronic",0
12305,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myelomonocytic, Chronic",0
12306,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,0
12307,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,0
12308,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-2,0
12309,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-2,0
12310,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Myelodysplastic-Myeloproliferative Diseases,0
12311,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic-Myeloproliferative Diseases,0
12312,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",0
12313,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Myelodysplastic/myeloproliferative neoplasm, unclassifiable",0
12314,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-1,0
12315,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-1,0
12316,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",0
12317,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",0
12318,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia with Eosinophilia,0
12319,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia with Eosinophilia,0
12320,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Recurrent Chronic Myelomonocytic Leukemia,0
12321,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Recurrent Chronic Myelomonocytic Leukemia,0
12322,Blasts 20 Percent or Less of Bone Marrow Nucleated Cells,Refractory Chronic Myelomonocytic Leukemia,0
12323,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Chronic Myelomonocytic Leukemia,0
12324,Links List,Heavy Chain Deposition Disease,0
12325,Term (temporal),Childhood Fibrillary Astrocytoma,0
12326,Different,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12327,Human papilloma virus infection,BRCA2 Syndrome,0
12328,Common (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
12329,Determined by,Microcystic meningioma,0
12330,Chemical Association,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12331,Ibrutinib,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12332,Childhood Lymphoma,Unresectable Rhabdomyosarcoma,0
12333,Definitely Related to Intervention,Diffuse malignant mesothelioma,0
12334,Poverty,Uterine Cancer,0
12335,How Much Distress Itching,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12336,13q12,Acute lymphadenitis,0
12337,Head - Component of Device,Undifferentiated Endocervical Sarcoma,0
12338,suggestion,Kaposi's sarcoma of extrahepatic bile duct,0
12339,Ulceration,Leptomeningeal sarcoma,0
12340,Etiology aspects,Human Papillomavirus-Related Carcinoma,0
12341,biopsy characteristics,Tonsillar Carcinoma,0
12342,Onset of (contextual qualifier),Platinum-Resistant Lung Small Cell Carcinoma,0
12343,research subject screening,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12344,Malignant Meningioma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12345,Therapeutic procedure,Blepharal carcinoma,0
12346,Common (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12347,Have Shortness of Breath question,Adenocarcinoma of the prostate metastatic,0
12348,Adrenocortical carcinoma,Intestinal Metaplasia of Bladder Urothelium,0
12349,Adult Non-Hodgkin Lymphoma,Multiple Skull Base Meningiomas,0
12350,In Cerebrospinal Fluid,Stage II Carcinoma of Penis,0
12351,Subependymal Giant Cell Astrocytoma,Cherubism,0
12352,Obesity,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
12353,Multifocal,FIGO Stage IVA Ovarian Cancer,0
12354,Affecting,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
12355,Back,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12356,Personal appearance,Cartilaginous exostosis,0
12357,Lifetime,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12358,Gingiva,Benign tumor of eyelid,0
12359,30%,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
12360,Primary malignant neoplasm,Human Papillomavirus-Related Carcinoma,0
12361,Malignant Neoplasms,Trabecular adenocarcinoma,0
12362,Study of epidemiology,Mixed astrocytoma-ependymoma,0
12363,Remaining,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12364,Low Grade,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12365,Shin,Intraepithelial Melanocytic Hyperplasia,0
12366,Protruding,Cerebral Primitive Neuroectodermal Tumor,0
12367,20s,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
12368,Cell Device,Human Papillomavirus-Related Carcinoma,0
12369,Classification,Familial Adenomatous Polyposis Associated Medulloblastoma,0
12370,Ability,Stage IV Childhood Non-Hodgkin Lymphoma,0
12371,Unexplained weight loss,Tubal Hyperplasia,0
12372,Usual,Kaposi's sarcoma of extrahepatic bile duct,0
12373,Benign Neoplasm,Colorectal Neuroendocrine Tumor G2,0
12374,Rare Diseases,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12375,combination - answer to question,Cartilaginous exostosis,0
12376,Variable (uniformity),Gallbladder Adenocarcinoma,0
12377,Usually,Larynx carcinoma recurrent,0
12378,Back structure,Blepharal carcinoma,0
12379,white blood cell type,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12380,Hemangioma,Mucinous adenocarcinoma gastric,0
12381,Symptoms aspect,Benign tumor of eyelid,0
12382,Smear - instruction imperative,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12383,Portion of urine,Adult Acute Eosinophilic Leukemia,0
12384,Numbers,Recurrent Testicular Lymphoma,0
12385,peripheral blood,Recurrent Uveal Melanoma,0
12386,School Grade,Mucinous adenocarcinoma gastric,0
12387,Malignant epithelioma,Refractory Barrett Esophagus,0
12388,Very,Stage 0 Penile Cancer AJCC v8,0
12389,Third,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12390,Source,Pancreatic Intraepithelial Neoplasia-3,0
12391,Experimental Finding,Airway Hemangioma,0
12392,Geographic Locations,Thyroid Hurthle Cell Carcinoma,0
12393,Infection,ROSE Cluster 3,0
12394,Entity Determiner - specific,Rhabdomyosarcoma with ganglionic differentiation,0
12395,Removed,Ampulla of Vater Tubular Adenoma,0
12396,Genetic,High Grade Glandular Intraepithelial Neoplasia,0
12397,Specimen Source Codes - Tube,Localized Ewing Sarcoma,0
12398,Latin America,Recurrent Uveal Melanoma,0
12399,best (quality),Stage IB Pancreatic Cancer AJCC v8,0
12400,Assortment,Mucinous adenocarcinoma gastric,0
12401,Including (qualifier),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12402,low exposure,Acantholytic squamous cell carcinoma,0
12403,Measures,Localized Askin Tumor,0
12404,Malignant Neoplasms,Neonatal leukemia,0
12405,Deeply,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12406,Cervix Uteri,Splenic Manifestation of Hairy Cell Leukemia,0
12407,Involvement with,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12408,Case unit dose,Recurrent Rhabdomyosarcoma,0
12409,Affect (mental function),Ampulla of Vater Tubular Adenoma,0
12410,Form:Finding:Point in time:{Setting}:Document:{Role},Spermatocytic seminoma,0
12411,>5,Mixed astrocytoma-ependymoma,0
12412,Occur (action),Acantholytic squamous cell carcinoma,0
12413,MOSTLY,Noninfiltrating Intraductal Carcinoma,0
12414,Etiology aspects,Refractory Ependymoma,0
12415,Treating,Nasal cavity carcinoma,0
12416,Result,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12417,Breast Cancer Type 1 Susceptibility Protein Measurement,Engraftment syndrome,0
12418,Condition,Vaginal Adenoma,0
12419,Recombinant Immune Globulin,Unresectable Rhabdomyosarcoma,0
12420,Body structure,Metaplastic carcinoma of breast,0
12421,Daily Living,Grade 3a Malignant Neoplasm,0
12422,Device Cord,Anaplastic large cell lymphoma,0
12423,Covers (device),Papillary cystic tumor,0
12424,High,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12425,Undescended testis (body structure),Liver Lymphangioma,0
12426,Personal appearance,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12427,Representation (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
12428,Family illness,Vaginal Adenoma,0
12429,Zone,Undifferentiated Endocervical Sarcoma,0
12430,Present,Congenital hamartoma,0
12431,Persons,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12432,Definition,Lipoma of small intestine,0
12433,Death NOS,Vaginal Adenoma,0
12434,Nasal sinus,embryonal rhabdomyosarcoma of prostate,0
12435,Malignant - descriptor,Choroid Epithelioid Cell Melanoma,0
12436,Muscle Contraction,embryonal rhabdomyosarcoma of prostate,0
12437,1000000,Engraftment syndrome,0
12438,Include (action),Blood Vessel Tumors,0
12439,Worker,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12440,Occur (action),Squamous cell carcinoma of lip,0
12441,Colon <insect>,Pleomorphic adenoma of parotid gland,0
12442,Malignant neoplasm of skin,Testicular cancer metastatic,0
12443,Microvolt,Vaginal Adenoma,0
12444,Meaning,Mucinous adenocarcinoma gastric,0
12445,Membrane Device,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12446,foreign,Malignant neoplasm of choroid,0
12447,Biomaterial Treatment,Congenital hamartoma,0
12448,described,ROSE Cluster 3,0
12449,Smear - instruction imperative,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12450,Lead,Papillary squamous cell carcinoma,0
12451,Unknown GENC,Thymic Atypical Carcinoid Tumor,0
12452,Penetration,FIGO Stage II Ovarian Cancer,0
12453,leukemia,Locally Advanced Squamous Cell Carcinoma,0
12454,Vaginal wall,Peripheral primitive neuroectodermal tumor of soft tissue,0
12455,Responsible to,Bladder adenocarcinoma stage IV,0
12456,Disease,Leptomeningeal sarcoma,0
12457,Yolk Sac Tumor,Benign Apocrine Neoplasm,0
12458,Weight Loss,Liver Cavernous Hemangioma,0
12459,Bone marrow aspiration procedure,Type II Endometrial Adenocarcinoma,0
12460,Occurrence,Noninfiltrating Intraductal Carcinoma,0
12461,risk factors - observation list,Pancreatic carcinoma,0
12462,Obesity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12463,Microplate Well,Angiosarcoma of liver,0
12464,regional,Type II Endometrial Adenocarcinoma,0
12465,Malignant Bone Neoplasm,Secondary malignant neoplasm of lymph node,0
12466,Gestational trophoblastic disease,Mixed astrocytoma-ependymoma,0
12467,True primary (qualifier value),Refractory Ependymoma,0
12468,Frequently,Secondary malignant neoplasm of lymph node,0
12469,Linear,Uterine Cancer,0
12470,Liver Flavor,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12471,Antimicrobial Intermediate Susceptibility Result,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12472,Initially,Pilocytic astrocytoma of cerebellum,0
12473,Time,sarcoma of spinal cord,0
12474,Line Unit of Length,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12475,depend,Stage I Adult Non-Hodgkin Lymphoma,0
12476,Type - attribute,mucinous adenocarcinoma of gallbladder,0
12477,Condition:Find:Pt:^Patient:Nom,Stage IV Penile Cancer AJCC v7,0
12478,Hardness,Refractory Barrett Esophagus,0
12479,Pediculus humanus capitis (eukaryote),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12480,Cancer Genus,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
12481,Ductal Breast Carcinoma,Recurrent Primary Lymphoma of Bone,0
12482,Communicable Diseases,Unresectable Rhabdomyosarcoma,0
12483,Including (qualifier),Childhood Lymphoma,0
12484,Arising,Thyroid Hurthle Cell Carcinoma,0
12485,Resolution,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12486,radiotherapeutic,Childhood Central Nervous System Ganglioneuroblastoma,0
12487,How Often Nausea,Small Intestinal Villous Adenoma,0
12488,Preventive intent,Female Breast Carcinoma,0
12489,Special,Noninfiltrating Intraductal Carcinoma,0
12490,Grains,Mixed astrocytoma-ependymoma,0
12491,Elderly (population group),Deep Leiomyoma,0
12492,Small,Trichilemmocarcinoma,0
12493,Phonation,Endometrial Small Cell Carcinoma,0
12494,With intensity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12495,Collagen,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
12496,Specimen Source Codes - tumor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12497,Inspiration function,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12498,risk factors,Acantholytic squamous cell carcinoma,0
12499,Occur (action),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
12500,Sweating,Acantholytic squamous cell carcinoma,0
12501,Make - Instruction Imperative,Metastatic Lung Small Cell Carcinoma,0
12502,Sufficient,Congenital hamartoma,0
12503,Biomaterial Treatment,Liver Lymphangioma,0
12504,Duct (organ) structure,Melanomatosis,0
12505,Smear - instruction imperative,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
12506,Classification,Locally Advanced Epithelioid Hemangioendothelioma,0
12507,Tumor Antigens,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12508,Free of (attribute),Thymic Clear Cell Carcinoma,0
12509,Phase,Anaplastic large cell lymphoma,0
12510,New Zealand Rabbits,Precursor B-lymphoblastic lymphoma stage II,0
12511,shared attribute,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12512,Following,Childhood Central Nervous System Immature Teratoma,0
12513,Retinoic Acid Response Element,FIGO Stage IVA Ovarian Cancer,0
12514,Anterior thoracic region,Neonatal leukemia,0
12515,Physical findings,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12516,Often - answer to question,Non-Metastatic Gestational Trophoblastic Tumor,0
12517,Presentation,Refractory Bladder Carcinoma,0
12518,Painful intercourse female,Cervical Squamous Intraepithelial Neoplasia,0
12519,Arising,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12520,Square Mile,Lipoma of small intestine,0
12521,Bayer Visual Acuity Changes Grade 3,Acantholytic squamous cell carcinoma,0
12522,Aspects of disease screening,Ectomesenchymal Chondromyxoid Tumor,0
12523,Indication of (contextual qualifier),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
12524,Muscle Tissue,Childhood Extragonadal Malignant Germ Cell Tumor,0
12525,Liver,Brain Tumor,0
12526,Adult Non-Hodgkin Lymphoma,Unicystic ameloblastoma,0
12527,Cell Count,Benign Carotid Body Paraganglioma,0
12528,Site,Malignant Testicular Sertoli Cell Tumor,0
12529,Group A (qualifier value),Tumorlet,0
12530,Blood Circulation,Anterior Urethral Malignant Neoplasm,0
12531,Females,Liver Lymphangioma,0
12532,Diagnosis,Papillary squamous cell carcinoma,0
12533,Unit device,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12534,Pilocytic Astrocytoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12535,Associated topography,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12536,high - ActExposureLevelCode,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12537,Third revision,Blepharal carcinoma,0
12538,shared attribute,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12539,Benign,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12540,Organ,Microcystic meningioma,0
12541,<90,Unicystic ameloblastoma,0
12542,Childhood Rhabdomyosarcoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12543,Therapeutic radiology procedure,Plexosarcoma,0
12544,Pineal germinoma,Diffuse malignant mesothelioma,0
12545,Academic degree,Adenocarcinoma,0
12546,Red Blood Cell Count measurement,Anterior Urethral Malignant Neoplasm,0
12547,Supportive assistance,Tonsillar Carcinoma,0
12548,Skin,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12549,Then,Granular Cell Leiomyosarcoma,0
12550,Positive Selection,Adult Anaplastic Oligodendroglioma,0
12551,Malignant Vaginal Neoplasm,Urethral Carcinoma,0
12552,Diffuse,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12553,Peritoneum,Female Breast Carcinoma,0
12554,Cumulative,Acinar cell carcinoma of pancreas,0
12555,month,Clonal Hematopoiesis of Indeterminate Potential,0
12556,Painless,Undifferentiated Endocervical Sarcoma,0
12557,increasing incidence,Xeroderma pigmentosum,0
12558,Occurrence,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12559,Carcinoma of lung,Epithelioid Sarcoma NCI Grade 3,0
12560,second (number),Transitional cell carcinoma,0
12561,One,Intestinal Metaplasia of Bladder Urothelium,0
12562,Frequently,Primary Cutaneous Plasmablastic Lymphoma,0
12563,prevention aspects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12564,Eye Color,Central Nervous System Yolk Sac Tumor,0
12565,Condition:Find:Pt:^Patient:Nom,Refractory Ependymoma,0
12566,Stomach,Vaginal Adenoma,0
12567,Neck,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12568,Lung,Multiple Skull Base Meningiomas,0
12569,Neoplasms,Malignant Neoplasm with Regional Lymph Node Involvement,0
12570,Melanins,Adult Alveolar Soft Part Sarcoma,0
12571,Cyst,Acute Undifferentiated Leukemia,0
12572,Unconscious State,Cervical Squamous Intraepithelial Neoplasia,0
12573,Upper arm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12574,Decision,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
12575,Long Term Survivorship,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12576,Specific qualifier value,FIGO Stage IVA Ovarian Cancer,0
12577,Long-term Follow-up,Acute Undifferentiated Leukemia,0
12578,Major <insect>,Blepharal carcinoma,0
12579,Extrinsic,Primary Cutaneous Plasmablastic Lymphoma,0
12580,Behavior:-:Point in time:^Patient:-,Placental aromatase deficiency,0
12581,3+ Score,Non-Metastatic Gestational Trophoblastic Tumor,0
12582,Phenomenon,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12583,Base - General Qualifier,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12584,Pain,Nasal cavity carcinoma,0
12585,Containing (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12586,Small,Mixed astrocytoma-ependymoma,0
12587,Cell Count,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12588,bony process,Engraftment syndrome,0
12589,Body part,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12590,Area,Stage IV Colorectal Cancer AJCC v8,0
12591,Deep (qualifier value),Choroid Epithelioid Cell Melanoma,0
12592,Smoking,Stage I Adult Non-Hodgkin Lymphoma,0
12593,Including (qualifier),Neonatal leukemia,0
12594,To,Engraftment syndrome,0
12595,Case (situation),Localized Askin Tumor,0
12596,Pleomorphic,Mucosal Melanoma,0
12597,Pressure (finding),sarcoma of spinal cord,0
12598,Treating,Stage 0 Lip Carcinoma,0
12599,Stop brand of fluoride,Bladder squamous cell carcinoma stage I,0
12600,Males,Malignant Testicular Sertoli Cell Tumor,0
12601,eTMF Content Model Code,Cartilaginous exostosis,0
12602,Prostate,clear cell adenocarcinoma of gallbladder,0
12603,Etiology aspects,Mucinous adenocarcinoma gastric,0
12604,Neoplasms,Hodgkin lymphoma,0
12605,More,Refractory Ependymoma,0
12606,Unknown,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12607,Complete,Benign Anal Granular Cell Tumor,0
12608,Known,Type II Endometrial Adenocarcinoma,0
12609,Followed by,Hereditary corneal dystrophy,0
12610,Repair,papillary carcinoma of penis,0
12611,Surface of bone,Advanced Uterine Corpus Carcinosarcoma,0
12612,Lactation,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
12613,Joints,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
12614,Providing presence (regime/therapy),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12615,Frequently,Metastatic Lung Small Cell Carcinoma,0
12616,Percent of Abnormal Cells,Collecting Duct Carcinoma of the Kidney,0
12617,Nutrients,Benign Anal Granular Cell Tumor,0
12618,Removed,Localized Ewing Sarcoma,0
12619,Classification,Cerebral Primitive Neuroectodermal Tumor,0
12620,Manufactured sign,Astrocytoma of brain,0
12621,International Classification of Disease for Oncology,Mucosal Melanoma,0
12622,transmission process,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
12623,Glycation End Products,Testicular cancer metastatic,0
12624,SLC6A2 protein,Thyroid Hurthle Cell Carcinoma,0
12625,Tryptophanase,Colorectal High Grade B-Cell Lymphoma,0
12626,How Much Distress Vomiting,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12627,17th century,Chondrosarcoma,0
12628,Options,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12629,Semilunar fold of fauces,Cancer of Urinary Tract,0
12630,biopsy characteristics,Malignant melanoma of eyelid,0
12631,Pharmacotherapy,Female Breast Carcinoma,0
12632,Medullary - body parts,Cerebral Primitive Neuroectodermal Tumor,0
12633,Roman Numeral III,Cherubism,0
12634,Shortness of breath:-:Point in time:^Patient:-,sarcoma of spinal cord,0
12635,Absent,Thyroid Hurthle Cell Carcinoma,0
12636,Malignant Neoplasms,Activated B-cell type diffuse large B-cell lymphoma,0
12637,Pineal gland,Giant cell angiofibroma,0
12638,Epithelium of vagina,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12639,Classification,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12640,shared attribute,Engraftment syndrome,0
12641,Manufactured form,Fibroadenoma of breast,0
12642,Hormone replacement therapy,Benign squamous cell tumor,0
12643,Involvement with,Refractory Bladder Carcinoma,0
12644,Bone Marrow,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12645,Tumor Suppressor Genes,Childhood Lung Non-Small Cell Carcinoma,0
12646,Well defined,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12647,Smooth muscle (tissue),Childhood Lymphoma,0
12648,Event Seriousness - Significant,Vaginal Adenoid Cystic Carcinoma,0
12649,Oral cavity,Acute Undifferentiated Leukemia,0
12650,Telencephalon,Locally Advanced Epithelioid Hemangioendothelioma,0
12651,Diagnosis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12652,Administration procedure,Ovarian germ cell choriocarcinoma stage IV,0
12653,Make - Instruction Imperative,Childhood Fibrillary Astrocytoma,0
12654,Grade,clear cell adenocarcinoma of gallbladder,0
12655,Retained,Small cell neuroendocrine carcinoma of bladder,0
12656,Involvement with,Metastatic Malignant Neoplasm in the Sellar Region,0
12657,Fertility Domain,Adenocarcinoma of duodenum,0
12658,200,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12659,Bothered by Vomiting,Maxillary Sinus Adenoid Cystic Carcinoma,0
12660,3+ Score,Recurrent Uveal Melanoma,0
12661,Science of Morphology,Hereditary corneal dystrophy,0
12662,Newly Diagnosed Childhood Ependymoma,Fibroadenoma of breast,0
12663,Image Feature,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
12664,Mass,Benign tumor of eyelid,0
12665,Affect (mental function),Fourth Ventricle and Brain Stem Ependymal Tumor,0
12666,Tumor cells,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12667,65,Acantholytic squamous cell carcinoma,0
12668,Levels (qualifier value),Primary Cutaneous Plasmablastic Lymphoma,0
12669,Firstly,Liver Lymphangioma,0
12670,Vascular,Thymic Clear Cell Carcinoma,0
12671,Response (statement),Bladder squamous cell carcinoma stage I,0
12672,Liver,Gallbladder Adenocarcinoma,0
12673,Negation,Small Intestinal Villous Adenoma,0
12674,Neuroglia,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
12675,Blink Reflexes,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12676,fish - non-drug agent,Intestinal Metaplasia of Bladder Urothelium,0
12677,Tonsil,Recurrent Testicular Lymphoma,0
12678,Skeletal bone,Recurrent Testicular Lymphoma,0
12679,To,Liver Lymphangioma,0
12680,Present,FIGO Stage IVA Ovarian Cancer,0
12681,Lung,adenosquamous carcinoma of breast,0
12682,Malignant neoplasm of soft tissue,Transitional cell carcinoma,0
12683,B-Lymphocytes,Cystadenocarcinoma,0
12684,Malignant Neoplasms,Malignant neoplasm of thalamus,0
12685,Smudge cell,Refractory Barrett Esophagus,0
12686,History of tobacco use,Trichilemmocarcinoma,0
12687,Rating (action),Childhood Lymphoma,0
12688,Natural Killer Cells,Diffuse malignant mesothelioma,0
12689,Lymph,High Grade Glandular Intraepithelial Neoplasia,0
12690,Changing,Carcinoma ex pleomorphic adenoma of parotid gland,0
12691,Site of,Multiple Endocrine Neoplasia,0
12692,Usual Severity Sweats,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12693,Wound Healing,Astrocytoma of brain,0
12694,Varies,Astrocytoma of brain,0
12695,Person Name,Small intestine carcinoma,0
12696,Stem of Organ,Acute Undifferentiated Leukemia,0
12697,Soluble (qualifier),Intraepithelial Melanocytic Hyperplasia,0
12698,Extravasation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12699,Usual,Testicular cancer metastatic,0
12700,Name (property) (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12701,second (number),Thyroid carcinoma,0
12702,Both ovaries,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12703,Polycythemia,Pancreatic carcinoma,0
12704,include - SetOperator,FIGO Stage IVA Ovarian Cancer,0
12705,mesodermal,papillary carcinoma of penis,0
12706,Immunoglobulin Heavy Chain Variable Domain,Maxillary Sinus Adenocarcinoma,0
12707,cell growth,embryonal rhabdomyosarcoma of prostate,0
12708,Point,Collecting Duct Carcinoma of the Kidney,0
12709,Chest Pain,Maxillary Sinus Adenocarcinoma,0
12710,Less Than,Benign squamous cell tumor,0
12711,newly,Xeroderma pigmentosum,0
12712,Cystitis,Human Papillomavirus-Related Carcinoma,0
12713,Lymphoid system structure,Diffuse malignant mesothelioma,0
12714,Percent of Bacteria,Epithelioid Sarcoma NCI Grade 3,0
12715,include - SetOperator,Angiosarcoma of liver,0
12716,Characteristics,Unresectable Rhabdomyosarcoma,0
12717,algorithm,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
12718,Malignant Neoplasms,Diffuse malignant mesothelioma,0
12719,therapeutic aspects,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12720,Offspring,Gallbladder Adenocarcinoma,0
12721,Used by,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12722,Chemotherapy,Recurrent Rhabdomyosarcoma,0
12723,Primary,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12724,genetic risk factors,Secondary malignant neoplasm of lymph node,0
12725,BRCA1 wt Allele,Placental aromatase deficiency,0
12726,Liver and Intrahepatic Biliary Tract Carcinoma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
12727,Tumor Necrosis Factor Receptor Superfamily Member 8,Benign squamous cell tumor,0
12728,With shape,Carcinoma of urinary bladder,0
12729,90%,Childhood Thyroid Gland Follicular Carcinoma,0
12730,Part of,Adult Anaplastic Oligodendroglioma,0
12731,Fever symptoms (finding),Collecting Duct Carcinoma of the Kidney,0
12732,Worse,Benign squamous cell tumor,0
12733,Entity,Choroid Epithelioid Cell Melanoma,0
12734,Site of,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12735,Range,Diffuse malignant mesothelioma,0
12736,Fatigue,Undifferentiated Endocervical Sarcoma,0
12737,Fatigue,Testicular cancer metastatic,0
12738,Oral epithelium (specimen),Carcinoma,0
12739,Body part,Malignant melanoma of eyelid,0
12740,North America,Vaginal Adenoma,0
12741,Descent,Mucinous adenocarcinoma gastric,0
12742,Often - answer to question,Unicystic ameloblastoma,0
12743,Evidence,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12744,Decision,Adult Acute Eosinophilic Leukemia,0
12745,Treating,Recurrent Diffuse Intrinsic Pontine Glioma,0
12746,Hiatal Hernia,Uterine Cancer,0
12747,Mechanism Component of Device,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12748,Used by,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12749,Gene Cluster Text Format,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12750,2+ Score,Leiomyoma of Gallbladder,0
12751,One,Pancreatic Intraepithelial Neoplasia-3,0
12752,Glioblastoma Multiforme Pathway,Vaginal Adenoid Cystic Carcinoma,0
12753,Stomach structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12754,Malignant neoplasm of skin,Gallbladder adenoma,0
12755,Pressure (property),Malignant melanoma of eyelid,0
12756,66,Intestinal Metaplasia of Bladder Urothelium,0
12757,Gastroesophageal reflux disease,Basal Cell Ameloblastoma,0
12758,fluid - substance,Cerebral Primitive Neuroectodermal Tumor,0
12759,Primary malignant neoplasm,Anaplastic large cell lymphoma,0
12760,Rare,Hemangioma,0
12761,Aspects of signs,Lipoma of small intestine,0
12762,Confirmed by,Malignant Testicular Sertoli Cell Tumor,0
12763,Position of phenotypic abnormality,Methotrexate-Associated Hodgkin Lymphoma,0
12764,Abdominal mass,Refractory Bladder Carcinoma,0
12765,Make - Instruction Imperative,Childhood Lymphoma,0
12766,Teratoma,Advanced Uterine Corpus Carcinosarcoma,0
12767,Manufactured form,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
12768,Cerebrum,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12769,therapeutic aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12770,2+ Score,benign mature teratoma of pancreas,0
12771,Primary,Platinum-Resistant Lung Small Cell Carcinoma,0
12772,Testicular mass,Benign squamous cell tumor,0
12773,Type A,Mastocytosis,0
12774,associated disease,Transitional cell carcinoma,0
12775,Type A,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12776,include - SetOperator,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12777,Raised,Grade 3a Malignant Neoplasm,0
12778,Overall,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12779,Enlargement procedure,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
12780,Physical findings:Finding:Point in time:^Patient:Nominal:Observed,Ichthyosis,0
12781,Age at cancer Dx:Number:Point in time:Cancer.To be specified in another part of the message:Quantitative,Intraepithelial Melanocytic Hyperplasia,0
12782,Reflux,Choroid Necrotic Melanoma,0
12783,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12784,Three,Mixed astrocytoma-ependymoma,0
12785,Development,Urethral Carcinoma,0
12786,Mammal liver preparation,Transitional cell carcinoma,0
12787,Viola tricolor extract,Leptomeningeal sarcoma,0
12788,primary tumor,Clonal Hematopoiesis of Indeterminate Potential,0
12789,Covered (qualifier value),Advanced Uterine Corpus Carcinosarcoma,0
12790,Incidence Rate,Colorectal Neuroendocrine Tumor G2,0
12791,Primary,Carcinoma,0
12792,Table Cell Horizontal Align - left,Malignant Neoplasm with Regional Lymph Node Involvement,0
12793,Certain (qualifier value),Splenic Manifestation of Hairy Cell Leukemia,0
12794,Radiation Oncologists,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12795,Lesion,non-Hodgkin's lymphoma of spleen,0
12796,Salivary Gland Neoplasms,Malignant neoplasm of thalamus,0
12797,Increased cerebrospinal fluid production,Refractory WHO Grade III Glioma,0
12798,Alcohol consumption,Peripheral primitive neuroectodermal tumor of soft tissue,0
12799,Family (taxonomic),Stage IB Pancreatic Cancer AJCC v8,0
12800,Occurrence Indicator,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
12801,Urine,Human Papillomavirus-Related Carcinoma,0
12802,Tobacco smoking behavior,Peripheral primitive neuroectodermal tumor of soft tissue,0
12803,Poliosis,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
12804,Squamous Epithelial Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12805,Occurrence,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12806,Seventh,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12807,acute,Liver Lymphangioma,0
12808,Speaking (activity),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12809,Common (qualifier value),papillary carcinoma of penis,0
12810,Grade,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
12811,Removing (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12812,Brain,Heavy Chain Deposition Disease,0
12813,Manufactured form,Childhood Anaplastic Large Cell Lymphoma,0
12814,Chromosome band,Stage III Cutaneous Melanoma AJCC v6,0
12815,Benign Teratoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12816,Greeks,Benign Ovarian Thecoma,0
12817,1000000,Benign neoplasm of thorax,0
12818,Narrowed structure,Liver Lymphangioma,0
12819,A Codes,Mixed astrocytoma-ependymoma,0
12820,Bone marrow: lymphocytes (finding),Malignant Neoplasm with Regional Lymph Node Involvement,0
12821,SLC35G1 gene,Nasal cavity carcinoma,0
12822,Tumor cells,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
12823,Sharing (Social Behavior),Low Grade Squamous Intraepithelial Neoplasia,0
12824,Shortened,Hodgkin Disease,0
12825,Spreading (qualifier value),Mucinous adenocarcinoma gastric,0
12826,Pure Spanish horse breed (organism),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
12827,Surgery specialty,Localized Askin Tumor,0
12828,Pleural Effusion,Intraepithelial Melanocytic Hyperplasia,0
12829,Specific qualifier value,Human Papillomavirus-Related Carcinoma,0
12830,Abnormal,Pancreatic carcinoma,0
12831,Oils,Cervical Fibroepithelial Polyp,0
12832,Male population group,Cervical Adenomyoma,0
12833,Dictionary [Publication Type],Small intestine carcinoma,0
12834,PSA Level Less than Two,Leiomyoma of Gallbladder,0
12835,Squamous cell carcinoma - category,Childhood Extragonadal Malignant Germ Cell Tumor,0
12836,peripheral blood,Acute Undifferentiated Leukemia,0
12837,Family member,Cervical Adenomyoma,0
12838,Including (qualifier),Endometrial Small Cell Carcinoma,0
12839,Malignant Neoplasms,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
12840,Poorly differentiated,Melanomatosis,0
12841,United States,FIGO Stage IVA Ovarian Cancer,0
12842,Complete,Mucosal Melanoma,0
12843,Has difficulty doing (qualifier value),Malignant melanoma of eyelid,0
12844,Neoplasms,Spongiotic dermatitis,0
12845,day,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12846,Fever symptoms (finding),Uterine Cancer,0
12847,Form of bone,Bladder Neuroendocrine Neoplasm,0
12848,mesodermal,Mucinous adenocarcinoma gastric,0
12849,Greater than one,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
12850,Two,Central Nervous System Yolk Sac Tumor,0
12851,Chest,Pancreatic Endocrine Carcinoma,0
12852,Secondary Neoplasm,Benign Anal Granular Cell Tumor,0
12853,Cancer Other,papillary carcinoma of penis,0
12854,Image Feature,Undifferentiated Endocervical Sarcoma,0
12855,Most,Malignant melanoma of eyelid,0
12856,Prognostic Factors,Adult Hepatocellular Carcinoma,0
12857,Female Phenotype,Childhood Central Nervous System Ganglioneuroblastoma,0
12858,2+,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12859,Duct Device,Precursor B-lymphoblastic lymphoma stage II,0
12860,Administration procedure,adenoid cystic carcinoma of lung,0
12861,Chew (administration method),Diffuse malignant mesothelioma,0
12862,Including (qualifier),Malignant neoplasm of thalamus,0
12863,Call (Instruction),Localized Malignant Neoplasm,0
12864,Round cell tumor,FIGO Stage IVA Ovarian Cancer,0
12865,shared attribute,Acantholytic squamous cell carcinoma,0
12866,Infrequent,Refractory Barrett Esophagus,0
12867,Fasting Status Indicator,embryonal rhabdomyosarcoma of prostate,0
12868,therapeutic aspects,Adult Alveolar Soft Part Sarcoma,0
12869,Lymphatic System,Congenital hamartoma,0
12870,Name Given at Birth,Stage IB Pancreatic Cancer AJCC v8,0
12871,Blue color,Tonsillar Carcinoma,0
12872,Sample Range,Benign Anal Granular Cell Tumor,0
12873,Much,Maxillary Sinus Adenoid Cystic Carcinoma,0
12874,Cover - action,Stage IV Penile Cancer AJCC v7,0
12875,Fast Growing,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
12876,Together,Xeroderma pigmentosum,0
12877,Case unit dose,Hereditary Diffuse Gastric Adenocarcinoma,0
12878,Treating,Blepharal carcinoma,0
12879,NCI CTEP SDC Small Cell Lung Cancer Sub-Category Terminology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12880,Cord - Body Parts,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
12881,Affecting,Chondrosarcoma,0
12882,Medical Imaging,Childhood Central Nervous System Ganglioneuroblastoma,0
12883,Primary malignant neoplasm,Cervical Squamous Intraepithelial Neoplasia,0
12884,Treatment Epoch,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12885,Second edition,Acute Undifferentiated Leukemia,0
12886,Physical Medical Procedure,Unicystic ameloblastoma,0
12887,Personal appearance,squamous cell carcinoma of the thyroid gland,0
12888,Molecular Mass,Stage IV Colorectal Cancer AJCC v8,0
12889,Complication Aspects,Cervical Fibroepithelial Polyp,0
12890,Tumor Mass,Nasal cavity carcinoma,0
12891,Headache,Refractory Bladder Carcinoma,0
12892,Cardiac Lead Procedure,Primary Cutaneous Plasmablastic Lymphoma,0
12893,Concept model domain,Cerebral Primitive Neuroectodermal Tumor,0
12894,Usual Severity Itching,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
12895,GORAB gene,Basal Cell Ameloblastoma,0
12896,Unknown GENC,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
12897,risk factors,Melanomatosis,0
12898,treatment - ActInformationManagementReason,Acute Undifferentiated Leukemia,0
12899,Cyclin A,Malignant neoplasm of olfactory nerve,0
12900,Participation Type - origin,Type II Endometrial Adenocarcinoma,0
12901,Primary malignant neoplasm,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
12902,Primary,Hyperplasia of pituitary gland,0
12903,incidence of cases,Botryoid-Type Embryonal Rhabdomyosarcoma,0
12904,Spreading (qualifier value),Pancreatic carcinoma,0
12905,Cardiovascular system,Adult Acute Eosinophilic Leukemia,0
12906,Specimen Source Codes - tumor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
12907,Drain device,Choroid Necrotic Melanoma,0
12908,Therapeutic radiology procedure,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
12909,Tired,GIANT PIGMENTED HAIRY NEVUS,0
12910,Shortness of Breath Visual Analogue Scale,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12911,risk factors,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
12912,Blood Vessel,Clinical Stage I Cutaneous Melanoma AJCC v8,0
12913,Pediculus humanus capitis (eukaryote),Childhood Lymphoma,0
12914,Occurrence,Malignant melanoma of eyelid,0
12915,Include (action),Uterine Cancer,0
12916,Including (qualifier),ROSE Cluster 3,0
12917,True primary (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12918,Major,Astrocytoma of brain,0
12919,Most,Bladder Neuroendocrine Neoplasm,0
12920,Form:Finding:Point in time:{Setting}:Document:{Role},Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
12921,per second,Extra-Adrenal Paraganglioma,0
12922,Study Variable,Trabecular adenocarcinoma,0
12923,Prevalence aspects,Thymoma malignant recurrent,0
12924,Occur (action),Adult Anaplastic Oligodendroglioma,0
12925,Unknown,Methotrexate-Associated Hodgkin Lymphoma,0
12926,100%,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12927,Occurrence Indicator,Intraepithelial Melanocytic Hyperplasia,0
12928,Participation Type - origin,Anaplastic large cell lymphoma,0
12929,Mechanism Component of Device,Childhood Fibrillary Astrocytoma,0
12930,Tests (qualifier value),Clinical Stage I Cutaneous Melanoma AJCC v8,0
12931,Most,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12932,Along edge (qualifier value),Liver Cavernous Hemangioma,0
12933,Firstly,Carcinomatosis of peritoneal cavity,0
12934,3+ Score,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
12935,Occur (action),Maxillary Sinus Adenocarcinoma,0
12936,Occur (action),Stage III Cutaneous Melanoma AJCC v6,0
12937,Diagnosis Study,Activated B-cell type diffuse large B-cell lymphoma,0
12938,Various patch test substance,FIGO Stage IVA Ovarian Cancer,0
12939,Have Weight Loss,Granular Cell Leiomyosarcoma,0
12940,Cancer Genus,Brain Ependymoma,0
12941,Precancerous Conditions,Funisitis (disorder),0
12942,Connective Tissue,Malignant Testicular Sertoli Cell Tumor,0
12943,Individual,Locally Advanced Carcinoma,0
12944,Residential flat,clear cell adenocarcinoma of gallbladder,0
12945,Hyperplastic Polyp,Anterior Urethral Malignant Neoplasm,0
12946,Internal,Hodgkin lymphoma,0
12947,Rocky,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
12948,Glioma,Cervical Fibroepithelial Polyp,0
12949,Pregnancy,Stage IB Pancreatic Cancer AJCC v8,0
12950,Decision,papillary carcinoma of penis,0
12951,acute,Papillary cystic tumor,0
12952,Include (action),Stage II Hepatocellular Carcinoma AJCC v8,0
12953,More Often than Once a Day,Spongiotic dermatitis,0
12954,year,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
12955,Chemotherapy,Acantholytic squamous cell carcinoma,0
12956,Early stage,Tonsillar Carcinoma,0
12957,Secondary Neoplasm,Acantholytic squamous cell carcinoma,0
12958,Increased,Small cell neuroendocrine carcinoma of bladder,0
12959,Naive Pregerminal Center B-Lymphocyte,Adrenal Rest Tumor,0
12960,Retinoic Acid Response Element,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
12961,First Intercourse,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
12962,CDISC SEND Tumor Findings Results Terminology,Spongiotic dermatitis,0
12963,Reduction (chemical),Cerebral Primitive Neuroectodermal Tumor,0
12964,High,Childhood Lung Non-Small Cell Carcinoma,0
12965,Rare,Multiple Endocrine Neoplasia,0
12966,Biogenic Amines,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
12967,Two,Uterine Cancer,0
12968,Areas <moth>,Leptomeningeal sarcoma,0
12969,Obesity,Kaposi's sarcoma of extrahepatic bile duct,0
12970,unknown vaccine or immune globulin,papillary carcinoma of penis,0
12971,Surgical extraction,Carcinoma of urinary bladder,0
12972,Greater Than,Astrocytoma of brain,0
12973,Present,Vaginal Adenoid Cystic Carcinoma,0
12974,Subtype (attribute),Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
12975,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,sarcoma of spinal cord,0
12976,Males,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
12977,Symptoms,Liver Lymphangioma,0
12978,Negation,Refractory Bladder Carcinoma,0
12979,Squamous cell carcinoma - category,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
12980,Lung,Recurrent Uveal Melanoma,0
12981,Squamous Epithelial Cells,Stage I Adult Non-Hodgkin Lymphoma,0
12982,Neoplasms,Collecting Duct Carcinoma of the Kidney,0
12983,Time,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
12984,Pituitary Gland,Adult Anaplastic Oligodendroglioma,0
12985,metaplastic cell transformation,Papillary squamous cell carcinoma,0
12986,Diameter (qualifier value),Cervical Adenomyoma,0
12987,transport (device),Precursor B-lymphoblastic lymphoma stage II,0
12988,Skin lesion,Pancreatic carcinoma,0
12989,Endocrine Cells,Malignant Testicular Sertoli Cell Tumor,0
12990,A Codes,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
12991,Skin Specimen,Type II Endometrial Adenocarcinoma,0
12992,avoidance,Microcystic meningioma,0
12993,Etoposide,FIGO Stage II Ovarian Cancer,0
12994,Small,Methotrexate-Associated Hodgkin Lymphoma,0
12995,Greasy skin,Thyroid Hurthle Cell Carcinoma,0
12996,Skin Angiosarcoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
12997,Base - General Qualifier,embryonal rhabdomyosarcoma of prostate,0
12998,Relationships,Primary Cutaneous Plasmablastic Lymphoma,0
12999,Feelings,adenoid cystic carcinoma of lung,0
13000,Togo,FIGO Stage II Ovarian Cancer,0
13001,Relational and Item-Specific Encoding Task,Methotrexate-Associated Hodgkin Lymphoma,0
13002,Mucous Membrane,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13003,Presentation,Squamous cell carcinoma of lip,0
13004,Referring,Benign tumor of eyelid,0
13005,Odontogenic Tumors,Malignant melanoma of eyelid,0
13006,Used by,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13007,Weight Loss,Thymic Clear Cell Carcinoma,0
13008,Skull,Type II Endometrial Adenocarcinoma,0
13009,Body site,Grade 3a Malignant Neoplasm,0
13010,Appearance,Type II Endometrial Adenocarcinoma,0
13011,Magnetic Resonance Imaging,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13012,Cancer Genus,Malignant Neoplasm of Lung - Multiple Primary Sites,0
13013,include - SetOperator,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13014,Developed Countries,Diffuse malignant mesothelioma,0
13015,Location,sarcoma of spinal cord,0
13016,Internal,Peripheral primitive neuroectodermal tumor of soft tissue,0
13017,Squamous Epithelial Cells,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13018,Hepatitis C,FIGO Stage II Ovarian Cancer,0
13019,Case unit dose,Human Papillomavirus-Related Carcinoma,0
13020,Complete Trisomy 21 Syndrome,Hereditary Diffuse Gastric Adenocarcinoma,0
13021,Smear - instruction imperative,Non-Metastatic Gestational Trophoblastic Tumor,0
13022,Immature,Ovarian germ cell choriocarcinoma stage IV,0
13023,Epithelium of large intestine,Fibroadenoma of breast,0
13024,Procedure Domain,Airway Hemangioma,0
13025,The Sun,Localized Ewing Sarcoma,0
13026,Type - attribute,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13027,Inguinal part of abdomen,Bladder squamous cell carcinoma stage I,0
13028,Separate,Mucinous adenocarcinoma gastric,0
13029,Heterogeneity,Testicular cancer metastatic,0
13030,Perianal Squamous Intraepithelial Neoplasia,Carcinoma ex pleomorphic adenoma of parotid gland,0
13031,Topical form corticosteroids,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13032,Fever,Human Papillomavirus-Related Carcinoma,0
13033,Financial Account,Methotrexate-Associated Hodgkin Lymphoma,0
13034,Person Observer,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13035,Set scale,Fibroadenoma of breast,0
13036,Used by,Cervical Fibroepithelial Polyp,0
13037,Often - answer to question,Testicular cancer metastatic,0
13038,Disease,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13039,NCI CTEP SDC Melanoma Sub-Category Terminology,Unfavorable Non-Hodgkin Lymphoma,0
13040,melanoma,Unicystic ameloblastoma,0
13041,Classification,embryonal rhabdomyosarcoma of prostate,0
13042,Endometrial biopsy,Brain Tumor,0
13043,Renal Cell Carcinoma,Human Papillomavirus-Related Carcinoma,0
13044,FAT1 wt Allele,Thyroid Hurthle Cell Carcinoma,0
13045,Person present,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13046,Surface of cervix,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13047,Manufactured form,Carcinoma ex pleomorphic adenoma of parotid gland,0
13048,intent,Bladder adenocarcinoma stage IV,0
13049,Determined by,Benign Anal Granular Cell Tumor,0
13050,Rare,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
13051,Benign melanocytic nevus,Unresectable Rhabdomyosarcoma,0
13052,Contain (action),Childhood Central Nervous System Ganglioneuroblastoma,0
13053,Cell Count,Stage III Cutaneous Melanoma AJCC v6,0
13054,Hypokinesia,embryonal rhabdomyosarcoma of prostate,0
13055,Nodule,Malignant melanoma of eyelid,0
13056,Biological Response Modifiers,Trabecular adenocarcinoma,0
13057,Cause of death:Find:Pt:^Patient:Nom,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13058,Effective,Placental aromatase deficiency,0
13059,Ultrasonic,Adult Hepatocellular Carcinoma,0
13060,Feature,Vaginal Adenoma,0
13061,Approximate,Unfavorable Non-Hodgkin Lymphoma,0
13062,Only - dosing instruction fragment,Platinum-Resistant Lung Small Cell Carcinoma,0
13063,Primary malignant neoplasm of lung,Trichilemmocarcinoma,0
13064,Surgical extraction,Vaginal Adenoid Cystic Carcinoma,0
13065,Condition,Benign Anal Granular Cell Tumor,0
13066,Spreading (qualifier value),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13067,Brain Neoplasms,Locally Advanced Epithelioid Hemangioendothelioma,0
13068,Tryptophanase,Mucinous adenocarcinoma gastric,0
13069,Relative Survival,Recurrent Primary Lymphoma of Bone,0
13070,To,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13071,metaplastic cell transformation,Human Papillomavirus-Related Carcinoma,0
13072,Term Birth,Benign tumor of eyelid,0
13073,Use - dosing instruction imperative,Lipoma of small intestine,0
13074,Removed,Methotrexate-Associated Hodgkin Lymphoma,0
13075,Subtype (attribute),Female Breast Carcinoma,0
13076,Often - answer to question,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13077,combination - answer to question,Anterior Urethral Malignant Neoplasm,0
13078,high - ActExposureLevelCode,Hyperplasia of pituitary gland,0
13079,Specimen Source Codes - Infiltrate,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13080,Lymph,Cerebral Primitive Neuroectodermal Tumor,0
13081,IPSS Risk Category High,Vaginal Adenoid Cystic Carcinoma,0
13082,Treating,Cancer of Urinary Tract,0
13083,Malignant neoplasm of kidney,Refractory Bladder Carcinoma,0
13084,Formation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13085,Dyspnea,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13086,Borg Category-Ratio 10 Perceived Exertion Score 5,Female Breast Carcinoma,0
13087,Lung,Digestive System Hodgkin Lymphoma,0
13088,40%,Diffuse malignant mesothelioma,0
13089,Component object,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13090,World Health Organization,Extracranial Neuroblastoma,0
13091,More Often than Once a Day,Cancer of Urinary Tract,0
13092,Western World,Heavy Chain Deposition Disease,0
13093,Nose Diseases,Neoplasms,0
13094,foreign,Maxillary Sinus Adenocarcinoma,0
13095,Togo,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13096,Used by,Stage III Adult Immunoblastic Lymphoma,0
13097,Splenomegaly,Placental aromatase deficiency,0
13098,Anatomic Structure,Intestinal Metaplasia of Bladder Urothelium,0
13099,Genitalia,Pancreatic Intraepithelial Neoplasia-3,0
13100,Enneking High Surgical Grade,Human Papillomavirus-Related Carcinoma,0
13101,Causing,Blood Vessel Tumors,0
13102,Frequently,Xeroderma pigmentosum,0
13103,Account number:Identifier:Point in time:^Patient:Nominal,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13104,Immune System Finding,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13105,Diagnostic Imaging,Stage IB Lung Cancer AJCC v7,0
13106,floor (object),Recurrent Uveal Melanoma,0
13107,Effectiveness,Colorectal Neuroendocrine Tumor G2,0
13108,Mutation Abnormality,Mucinous adenocarcinoma gastric,0
13109,% volume (qualifier value),Diffuse malignant mesothelioma,0
13110,200,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13111,Vasopressin (USP),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13112,Childhood Myelodysplastic Syndrome,Acinar cell carcinoma of pancreas,0
13113,Diagnosis,Cancer of Urinary Tract,0
13114,Worsening pattern,Female Breast Carcinoma,0
13115,Diagnosis Study,Fourth Ventricle and Brain Stem Ependymal Tumor,0
13116,Treatment Epoch,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13117,Adult Diffuse Large B-Cell Lymphoma,Recurrent Rhabdomyosarcoma,0
13118,Scheme,embryonal rhabdomyosarcoma of prostate,0
13119,Manufactured form,Liver Lymphangioma,0
13120,risk factors - observation list,Noninfiltrating Intraductal Carcinoma,0
13121,Screening Study,Adult Brain Stem Mixed Glioma,0
13122,Cessation of life,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13123,Immature Cell Count (laboratory procedure),FIGO Stage IVA Ovarian Cancer,0
13124,Advanced phase,Cervical Fibroepithelial Polyp,0
13125,Mature,Neonatal leukemia,0
13126,N+ (tumor staging),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13127,Magnetic Resonance Imaging,FIGO Stage II Ovarian Cancer,0
13128,Tonsil,Metaplastic carcinoma of breast,0
13129,Presentation,Acute Undifferentiated Leukemia,0
13130,Hormones,Cartilaginous exostosis,0
13131,Age,Malignant neoplasm of olfactory nerve,0
13132,Family member,Intraepithelial Melanocytic Hyperplasia,0
13133,Smear - instruction imperative,Basal Cell Ameloblastoma,0
13134,Form:Finding:Point in time:{Setting}:Document:{Role},Endometrial Small Cell Carcinoma,0
13135,Behavior:-:Point in time:^Patient:-,Diffuse malignant mesothelioma,0
13136,Few,Adult Hepatocellular Carcinoma,0
13137,Including (qualifier),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13138,Account number:Identifier:Point in time:^Patient:Nominal,Breast Ductal Adenoma,0
13139,Leads (device),Adult Anaplastic Oligodendroglioma,0
13140,Count of entities,Recurrent Uveal Melanoma,0
13141,Common Specifications in HL7 V3 Publishing,Adenocarcinoma of the prostate metastatic,0
13142,Hereditary,Malignant Testicular Sertoli Cell Tumor,0
13143,Diagnosis Study,Childhood Central Nervous System Ganglioneuroblastoma,0
13144,Smear test,Kaposi's sarcoma of extrahepatic bile duct,0
13145,Hodgkin Disease,Pancreatic carcinoma,0
13146,Characteristics,Refractory Ependymoma,0
13147,Disease,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13148,Lymphoproliferation,Hair nevus,0
13149,NCI CTEP SDC Melanoma Sub-Category Terminology,Basal Cell Ameloblastoma,0
13150,Approximate,Thyroid Hurthle Cell Carcinoma,0
13151,Occur (action),Multiple Skull Base Meningiomas,0
13152,Admission Level of Care Code - Improved,Malignant Testicular Sertoli Cell Tumor,0
13153,Solar Erythema,Grade 3a Malignant Neoplasm,0
13154,Tryptophanase,Anaplastic large cell lymphoma,0
13155,Growth action,Refractory Barrett Esophagus,0
13156,Retinoic Acid Response Element,Locally Advanced Epithelioid Hemangioendothelioma,0
13157,Acquired Name,Benign squamous cell tumor,0
13158,1000000,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13159,Frequently,Human Papillomavirus-Related Carcinoma,0
13160,Adult human body,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13161,Removed,Female Breast Carcinoma,0
13162,Certain (qualifier value),Malignant Neoplasm of Lung - Multiple Primary Sites,0
13163,Japan,Peripheral primitive neuroectodermal tumor of soft tissue,0
13164,Angiolymphoid hyperplasia,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13165,Occur (action),Stage IB Pancreatic Cancer AJCC v8,0
13166,Estimated,embryonal rhabdomyosarcoma of prostate,0
13167,Cells,Papillary squamous cell carcinoma,0
13168,Process,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13169,Lifetime,Intraepithelial Melanocytic Hyperplasia,0
13170,Thymic Tissue,Advanced Uterine Corpus Carcinosarcoma,0
13171,Togo,Maxillary Sinus Adenocarcinoma,0
13172,Fertility Agents,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
13173,Singular,Heavy Chain Deposition Disease,0
13174,Neoplasms by Site,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13175,Half,Liver Lymphangioma,0
13176,status - In progress,FIGO Stage II Ovarian Cancer,0
13177,Manufactured form,Pilocytic astrocytoma of cerebellum,0
13178,Anterior portion of neck,FIGO Stage IVA Ovarian Cancer,0
13179,Death (finding),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13180,Including (qualifier),Adult Fibrolamellar Carcinoma,0
13181,Cosmetics,Pancreatic Endocrine Carcinoma,0
13182,nonmyeloablative allogeneic hematopoietic stem cell transplantation,Basal Cell Ameloblastoma,0
13183,Value Above Reference Range,Small cell neuroendocrine carcinoma of bladder,0
13184,Males,Refractory Barrett Esophagus,0
13185,Qualitative form,Metastatic Carcinoma in the Lung,0
13186,Carcinoma,Cancer of Urinary Tract,0
13187,radioactive iodine,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13188,Females,Cartilaginous exostosis,0
13189,Etiology aspects,Acantholytic squamous cell carcinoma,0
13190,Group A (qualifier value),Spongiotic dermatitis,0
13191,High Risk Acute Leukemia,BRCA2 Syndrome,0
13192,Virus,Cartilaginous exostosis,0
13193,Publications,Kaposi's sarcoma of extrahepatic bile duct,0
13194,United States,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13195,Genetic Risk,Stage IB Pancreatic Cancer AJCC v8,0
13196,Bounded by,Ovarian germ cell choriocarcinoma stage IV,0
13197,Liquid substance,Benign neoplasm of eye,0
13198,Benign Neoplasm,Undifferentiated Neuroblastoma,0
13199,Cell Count,BRCA2 Syndrome,0
13200,What subject filter - Result,Localized Askin Tumor,0
13201,GORAB gene,Pancreatic carcinoma,0
13202,Entity,Stage IV Colorectal Cancer AJCC v8,0
13203,Changing,Extracranial Neuroblastoma,0
13204,Experimental Result,Mucinous cystadenofibroma,0
13205,Intracranial,Testicular cancer metastatic,0
13206,Subtype (attribute),Botryoid-Type Embryonal Rhabdomyosarcoma,0
13207,Tryptophanase,Tubal Hyperplasia,0
13208,Occurrence,Platinum-Resistant Lung Small Cell Carcinoma,0
13209,Aggressive course,Grade 3a Malignant Neoplasm,0
13210,Aromatase,Adrenal Rest Tumor,0
13211,VARIOUS DRUG CLASSES IN ATC,Squamous cell carcinoma of lip,0
13212,Form:Finding:Point in time:{Setting}:Document:{Role},Testicular cancer metastatic,0
13213,T-Lymphocyte,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13214,Fallopian Tubes,Mucinous cystadenofibroma,0
13215,Symptoms,Stage IV Childhood Non-Hodgkin Lymphoma,0
13216,Bacteria present,Cervical Fibroepithelial Polyp,0
13217,Increased,Intracortical osteosarcoma,0
13218,Sarcoma,Xeroderma pigmentosum,0
13219,Poverty,Pancreatic carcinoma,0
13220,Drop - Unit of Volume,Cancer of Urinary Tract,0
13221,Obesity,Blepharal carcinoma,0
13222,operate <remove>,FIGO Stage IVA Ovarian Cancer,0
13223,Did not receive therapy or drug for,Adult Hepatocellular Carcinoma,0
13224,Occur (action),Localized Ewing Sarcoma,0
13225,*Type - Kind of quantity,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
13226,Chemotherapy,Carcinoma of submandibular gland,0
13227,Primary malignant neoplasm,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
13228,Body structure,Bladder squamous cell carcinoma stage I,0
13229,Definitely Related to Intervention,Tubal Hyperplasia,0
13230,therapeutic aspects,Parathyroid Gland Adenocarcinoma,0
13231,High,Locally Advanced Soft Tissue Sarcoma,0
13232,Appearance of eyelid,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13233,Tissue Specimen Code,Cervical Squamous Intraepithelial Neoplasia,0
13234,Systemic disease,Stage III Cutaneous Melanoma AJCC v6,0
13235,Mutation,Multiple Endocrine Neoplasia,0
13236,Floor - story of building,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13237,High,Stage III Adult Immunoblastic Lymphoma,0
13238,Include (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13239,Shapes,Liver Lymphangioma,0
13240,Increased,Fibroadenoma of breast,0
13241,Testis,adenosquamous carcinoma of breast,0
13242,Gait normal,Refractory Barrett Esophagus,0
13243,Bile duct carcinoma,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
13244,Cancer Genus,Colorectal High Grade B-Cell Lymphoma,0
13245,Body tissue,Central Nervous System Yolk Sac Tumor,0
13246,Drop (unit of presentation),Intraepithelial Melanocytic Hyperplasia,0
13247,Term (temporal),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13248,Secretory Vesicles,Small cell neuroendocrine carcinoma of bladder,0
13249,Definition,Kaposi's sarcoma of extrahepatic bile duct,0
13250,70%,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13251,Body tissue,Central Nervous System Yolk Sac Tumor,0
13252,Tumor stage,Brain Tumor,0
13253,Sounding,Spermatocytic seminoma,0
13254,Qualitative form,Acute Undifferentiated Leukemia,0
13255,combination - answer to question,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13256,Septicemia,Splenic Manifestation of Hairy Cell Leukemia,0
13257,Therapeutic radiology procedure,Cerebral hemangioma,0
13258,Hemoptysis,Maxillary Sinus Adenoid Cystic Carcinoma,0
13259,Togo,Nasal cavity carcinoma,0
13260,Diffuse,Kaposi's sarcoma of skin,0
13261,Inguinal part of abdomen,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13262,Mental association,Malignant Testicular Sertoli Cell Tumor,0
13263,Concern,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13264,Rare,Mixed astrocytoma-ependymoma,0
13265,Pain NOS,Anaplastic large cell lymphoma,0
13266,Breast Feeding,Malignant neoplasm of gallbladder,0
13267,Disease,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13268,Significant,Mucinous neoplasm,0
13269,Group A (blood group),Adrenal Rest Tumor,0
13270,Human body,Stage III Cutaneous Melanoma AJCC v6,0
13271,Reflecting,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13272,Rhabdomyosarcoma,Melanomatosis,0
13273,Sectioning technique,Splenic Manifestation of Hairy Cell Leukemia,0
13274,Erythrocytes,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13275,Documented,Metastatic Carcinoma in the Lung,0
13276,Sharing (Social Behavior),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
13277,Stomach Carcinoma,FIGO Stage IVA Ovarian Cancer,0
13278,Help document,Basal Cell Ameloblastoma,0
13279,Menopause,Recurrent Uveal Melanoma,0
13280,Occur (action),Bladder squamous cell carcinoma stage I,0
13281,Chemotherapy Regimen,Advanced Uterine Corpus Carcinosarcoma,0
13282,Time,Cerebral hemangioma,0
13283,Apply,Kaposi's sarcoma of extrahepatic bile duct,0
13284,Neoplasms,Colorectal High Grade B-Cell Lymphoma,0
13285,Manufactured form,Neonatal leukemia,0
13286,Classification of information,Serous cystadenocarcinoma ovary,0
13287,Radiation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13288,Antibiotics,ROSE Cluster 3,0
13289,Thyroid Neoplasm,Ovarian germ cell choriocarcinoma stage IV,0
13290,Childhood Ependymoma,Ovarian germ cell choriocarcinoma stage IV,0
13291,Dyspareunia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13292,head of bed,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13293,Recommendation,Testicular cancer metastatic,0
13294,Macrophage count,Acantholytic squamous cell carcinoma,0
13295,Singular,FIGO Stage II Ovarian Cancer,0
13296,majority,Choroid Necrotic Melanoma,0
13297,Tumor of exocrine pancreas,Precursor B-lymphoblastic lymphoma stage II,0
13298,Spinal Cord Injuries,Human Papillomavirus-Related Carcinoma,0
13299,System (unit of presentation),Spongiotic dermatitis,0
13300,Suspected qualifier,clear cell adenocarcinoma of gallbladder,0
13301,Decision,gliosarcoma,0
13302,rapid diagnosis,Recurrent Uveal Melanoma,0
13303,Used by,Cervical Fibroepithelial Polyp,0
13304,Frequently,Stage IB Lung Cancer AJCC v7,0
13305,pharmacotherapeutic,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13306,Exposure to asbestos,Neonatal leukemia,0
13307,Tissue Specimen Code,Kaposi's sarcoma of extrahepatic bile duct,0
13308,dendritic spine neck,Recurrent Primary Lymphoma of Bone,0
13309,Albumins,Airway Hemangioma,0
13310,Adult Lymphoma,Benign Anal Granular Cell Tumor,0
13311,Gastrointestinal tract structure,Blepharal carcinoma,0
13312,Bothered by Night Sweats,Extra-Adrenal Paraganglioma,0
13313,Testis present,Stage IV Penile Cancer AJCC v7,0
13314,Stem of Organ,Bladder squamous cell carcinoma stage I,0
13315,Show,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13316,Occur (action),Childhood Thyroid Gland Follicular Carcinoma,0
13317,Hemopoietic stem cell transplant,Childhood Central Nervous System Ganglioneuroblastoma,0
13318,Experimental Result,Tongue Alveolar Soft Part Sarcoma,0
13319,Neuroendocrine Tumors,Chronic Myelomonocytic Leukemia-2,0
13320,Symptoms aspect,Anterior Urethral Malignant Neoplasm,0
13321,Blood,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13322,Head - Component of Device,Pancreatic Endocrine Carcinoma,0
13323,Mixed (qualifier value),Microcystic meningioma,0
13324,Malignant Neoplasms,Liver Lymphangioma,0
13325,Lymphoma,Peripheral primitive neuroectodermal tumor of soft tissue,0
13326,Nursing interventions,Ovarian germ cell choriocarcinoma stage IV,0
13327,Skin,Endometrial Small Cell Carcinoma,0
13328,High,Human Papillomavirus-Related Carcinoma,0
13329,Time (foundation metadata concept),Brain Tumor,0
13330,Oncogene ErbB2,Fibroadenoma of breast,0
13331,Esthesia,ROSE Cluster 3,0
13332,Nausea:Presence or Threshold:Point in time:^Patient:Ordinal,Refractory Barrett Esophagus,0
13333,Polyp of large intestine,Childhood Lung Non-Small Cell Carcinoma,0
13334,Surgical service,Parathyroid Gland Adenocarcinoma,0
13335,Determined by,Bladder squamous cell carcinoma stage I,0
13336,Cell positive for CD34 antigen,Thymic Clear Cell Carcinoma,0
13337,Duplicate,Stage 0 Lip Carcinoma,0
13338,tuber cinereum,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13339,Time,Basal Cell Ameloblastoma,0
13340,Symptoms aspect,Adult Acute Eosinophilic Leukemia,0
13341,Population Median,Stage IB Pancreatic Cancer AJCC v8,0
13342,Either,Recurrent Testicular Lymphoma,0
13343,Antibiotics for systemic use,Stage IB Pancreatic Cancer AJCC v8,0
13344,Congenital phimosis,Localized Ewing Sarcoma,0
13345,Localized,Acute lymphadenitis,0
13346,Child,Human Papillomavirus-Related Carcinoma,0
13347,Frequently,Thyroid Hurthle Cell Carcinoma,0
13348,Adult Glioblastoma,Bladder adenocarcinoma stage IV,0
13349,Lymphoid Tissue,Contact dermatitis due to alkali,0
13350,Percent normal,Recurrent Testicular Lymphoma,0
13351,Stomach Carcinoma,ALK positive large B-cell lymphoma,0
13352,Published Comment,Intracortical osteosarcoma,0
13353,Occur (action),Refractory Ependymoma,0
13354,Usual,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13355,Gestational trophoblastic disease,Benign squamous cell tumor,0
13356,Reduced,Unfavorable Non-Hodgkin Lymphoma,0
13357,Techniques,FIGO Stage IVA Ovarian Cancer,0
13358,CEL gene,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13359,british,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13360,Approach,Refractory Ependymoma,0
13361,leukemia,Intestinal Neuroendocrine Carcinoma,0
13362,lobe,Childhood Anaplastic Large Cell Lymphoma,0
13363,1000000,Human Papillomavirus-Related Carcinoma,0
13364,Usual,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13365,Occurrence Indicator,Recurrent Rhabdomyosarcoma,0
13366,Characteristics,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13367,Pain,Malignant melanoma of eyelid,0
13368,Human Papilloma Virus Vaccine,Medulloblastoma,0
13369,Togo,adenosquamous carcinoma of breast,0
13370,low confidentiality,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13371,Anterior portion of neck,Basal Cell Ameloblastoma,0
13372,radiotherapeutic,Colorectal Neuroendocrine Tumor G2,0
13373,Africa,Unicystic ameloblastoma,0
13374,Adulthood,Recurrent Testicular Lymphoma,0
13375,2+ Score,Carcinoma of urinary bladder,0
13376,colon function,Precursor B-lymphoblastic lymphoma stage II,0
13377,High Level,Pilocytic astrocytoma of cerebellum,0
13378,Only - dosing instruction fragment,Extra-Adrenal Paraganglioma,0
13379,Include (action),Botryoid-Type Embryonal Rhabdomyosarcoma,0
13380,Usually,Benign squamous cell tumor,0
13381,Constant (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13382,include - SetOperator,Childhood Central Nervous System Ganglioneuroblastoma,0
13383,Neoplasm Metastasis,Acute Undifferentiated Leukemia,0
13384,Adult human body,Benign squamous cell tumor,0
13385,Derived value,Toxic Epidermal Necrolysis,0
13386,red Patches,Hyperplasia of pituitary gland,0
13387,Homo sapiens,Primary Cutaneous Plasmablastic Lymphoma,0
13388,Group A (blood group),Diffuse malignant mesothelioma,0
13389,Entity Determiner - specific,Uterine Cancer,0
13390,Abnormal result,Testicular cancer metastatic,0
13391,Known,Clonal Hematopoiesis of Indeterminate Potential,0
13392,allowing,Extra-Adrenal Paraganglioma,0
13393,Autumn,Microcystic meningioma,0
13394,Intestines,Spermatocytic seminoma,0
13395,Meaning,Bladder squamous cell carcinoma stage I,0
13396,Cell Count,sarcoma of spinal cord,0
13397,Hepatic Involvement,Bladder adenocarcinoma stage IV,0
13398,Assortment,Angiosarcoma of liver,0
13399,Tissue Specimen Code,Intraepithelial Melanocytic Hyperplasia,0
13400,Present,Adult Acute Eosinophilic Leukemia,0
13401,Indication of (contextual qualifier),Benign squamous cell tumor,0
13402,Type of complication:Type:Pt:^Patient:Nom,Mixed parotid tumor,0
13403,Dental Cavity Lining,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13404,risk factors - observation list,Cystadenocarcinoma,0
13405,Spreading (qualifier value),Neonatal leukemia,0
13406,Infrequent,Childhood Choriocarcinoma,0
13407,Cancer Genus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
13408,Germ,Serous cystadenocarcinoma ovary,0
13409,Mental blocking,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13410,Joints,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13411,Vaginal (intended site),Recurrent Uveal Melanoma,0
13412,Physical findings,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13413,EPO protein,Refractory Barrett Esophagus,0
13414,10%,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
13415,Sometimes,FIGO Stage II Ovarian Cancer,0
13416,Hematology+Oncology,Engraftment syndrome,0
13417,Help document,embryonal rhabdomyosarcoma of prostate,0
13418,Mixed Neoplasm,Multiple Skull Base Meningiomas,0
13419,combination of objects,Benign Apocrine Neoplasm,0
13420,Lymphocyte Activation,Cervical Squamous Intraepithelial Neoplasia,0
13421,Rest,Pancreatic Intraepithelial Neoplasia-3,0
13422,Cervix carcinoma,Small intestine carcinoma,0
13423,Logical Condition,Medulloblastoma,0
13424,Four,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13425,Common Specifications in HL7 V3 Publishing,Blepharal carcinoma,0
13426,Due to,Mucinous cystadenofibroma,0
13427,Less Than,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13428,Primary mucinous cystadenocarcinoma of lung,Recurrent Testicular Lymphoma,0
13429,Evaluation procedure,Stage 0 Lip Carcinoma,0
13430,Back,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13431,Administration procedure,Type II Endometrial Adenocarcinoma,0
13432,Poor - grade value,Diffuse malignant mesothelioma,0
13433,IPSS Risk Category Low,Bladder adenocarcinoma stage IV,0
13434,Inferior,Choroid Necrotic Melanoma,0
13435,Persons,Cartilaginous exostosis,0
13436,Process (qualifier value),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
13437,Onset of (contextual qualifier),Locally Advanced Carcinoma,0
13438,treatment options,Adult Anaplastic Oligodendroglioma,0
13439,Retraction (finding),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13440,Hematology procedure,Breast Ductal Adenoma,0
13441,Rare,Mixed astrocytoma-ependymoma,0
13442,Exogenous Factors,Cervical Fibroepithelial Polyp,0
13443,Retinoic Acid Response Element,Ovarian germ cell choriocarcinoma stage IV,0
13444,Body structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13445,Manufactured form,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13446,Identical,Thyroid Hurthle Cell Carcinoma,0
13447,Cause of Death,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13448,New Zealand Rabbits,Microcystic meningioma,0
13449,Singular,Lipoma of small intestine,0
13450,Carcinoma,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13451,Common (qualifier value),Tongue Alveolar Soft Part Sarcoma,0
13452,Form:Finding:Point in time:{Setting}:Document:{Role},Ovarian germ cell choriocarcinoma stage IV,0
13453,Fever,Refractory Barrett Esophagus,0
13454,Chromosomal translocation,Cancer of Urinary Tract,0
13455,Immune,Refractory Bladder Carcinoma,0
13456,Advanced phase,Noninfiltrating Intraductal Carcinoma,0
13457,Primary malignant neoplasm,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
13458,Recurrence (disease attribute),Recurrent Uveal Melanoma,0
13459,Chemotherapy Regimen,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13460,Urine looks dark,Recurrent Uveal Melanoma,0
13461,Full,squamous cell carcinoma of the thyroid gland,0
13462,Blood Circulation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13463,Biological Transport,Clonal Hematopoiesis of Indeterminate Potential,0
13464,Adult Ependymoma,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
13465,Hormone replacement therapy,Pancreatic carcinoma,0
13466,Cause of Death,Refractory Ependymoma,0
13467,Benzene,Refractory Ependymoma,0
13468,Feature,Malignant neoplasm of thalamus,0
13469,Blood Vessel,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13470,Qualitative form,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13471,depend,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13472,Treatment Effectiveness,Nasal cavity carcinoma,0
13473,low confidentiality,Melanomatosis,0
13474,History of previous events,Localized Askin Tumor,0
13475,Leading,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13476,MOSTLY,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13477,Slow,Thyroid Hurthle Cell Carcinoma,0
13478,4+ Answer to question,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
13479,Administration procedure,Stage III Cutaneous Melanoma AJCC v6,0
13480,Light Microscopy,Acute Undifferentiated Leukemia,0
13481,Weight measurement scales,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13482,Body Site Modifier - Lower,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13483,Usual,gliosarcoma,0
13484,Possible,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13485,Medical Imaging,Clonal Hematopoiesis of Indeterminate Potential,0
13486,antibiotics,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13487,Delta (difference),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13488,cancer risk,Refractory Bladder Carcinoma,0
13489,Lymphocyte,Peripheral primitive neuroectodermal tumor of soft tissue,0
13490,Occurrence Indicator,Adult Acute Eosinophilic Leukemia,0
13491,Olfactory system,Ovarian germ cell choriocarcinoma stage IV,0
13492,Irregular,Testicular cancer metastatic,0
13493,Take,Adult Hepatocellular Carcinoma,0
13494,Exception - Property or Attribute,FIGO Stage IVA Ovarian Cancer,0
13495,Pharmaceutical Preparations,Small cell neuroendocrine carcinoma of bladder,0
13496,Dorsal,Malignant Testicular Sertoli Cell Tumor,0
13497,Qualitative form,Ichthyosis,0
13498,Pure Spanish horse breed (organism),Refractory Bladder Carcinoma,0
13499,Treating,Airway Hemangioma,0
13500,Itchiness,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13501,Thyroid Gland Tissue,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13502,Diagnosis Study,Refractory Bladder Carcinoma,0
13503,Leakage,Stage IV Childhood Non-Hodgkin Lymphoma,0
13504,unknown vaccine or immune globulin,Brain Tumor,0
13505,Exposure to radiation,Childhood Central Nervous System Ganglioneuroblastoma,0
13506,therapeutic aspects,High Grade Glandular Intraepithelial Neoplasia,0
13507,Usual Severity Vomiting,Splenic Manifestation of Hairy Cell Leukemia,0
13508,Prostate,Splenic Manifestation of Hairy Cell Leukemia,0
13509,Inferior esophageal sphincter structure,Giant cell angiofibroma,0
13510,High Mitosis-Karyorrhexis Index,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13511,Formation,Benign squamous cell tumor,0
13512,Base - General Qualifier,Small cell neuroendocrine carcinoma of bladder,0
13513,Medical Device Emits Smoke,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13514,Pathological Dilatation,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13515,Biomaterial Treatment,Adult Acute Eosinophilic Leukemia,0
13516,Diffuse Large B-Cell Lymphoma,Intestinal Neuroendocrine Carcinoma,0
13517,Latch Device,Childhood Choriocarcinoma,0
13518,eTMF Content Model Code,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
13519,To,Vaginal Adenoid Cystic Carcinoma,0
13520,Science of Morphology,Basal Cell Ameloblastoma,0
13521,Causing,Malignant Neoplasm with Regional Lymph Node Involvement,0
13522,Uterus,Medulloblastoma,0
13523,Females,Choroid Epithelioid Cell Melanoma,0
13524,Pruritus,Non-Metastatic Gestational Trophoblastic Tumor,0
13525,Hematological Disease,Basal Cell Ameloblastoma,0
13526,Body cavities,Cancer of Urinary Tract,0
13527,SPINK5 gene,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13528,Signet ring cell,Locally Advanced Carcinoma,0
13529,Have Shortness of Breath question,Childhood Central Nervous System Immature Teratoma,0
13530,Autosomal hereditary disorder,Metastatic Lung Neuroendocrine Neoplasm,0
13531,Five-year Survival Rate,Squamous cell carcinoma of lip,0
13532,Sore to touch,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13533,Occurrence Indicator,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13534,Formation,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13535,Solid Dose Form,Stage IB Lung Cancer AJCC v7,0
13536,Negation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13537,Present,Platinum-Resistant Lung Small Cell Carcinoma,0
13538,Science of Etiology,Acute Undifferentiated Leukemia,0
13539,Abnormal Cell Count,Engraftment syndrome,0
13540,Secretory Vesicles,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13541,Immunotherapy,Colorectal High Grade B-Cell Lymphoma,0
13542,respiratory,Cystadenocarcinoma,0
13543,Tentorium cerebelli,Splenic Manifestation of Hairy Cell Leukemia,0
13544,Ultrasonics (sound),Childhood Fibrillary Astrocytoma,0
13545,Status post,Unresectable Rhabdomyosarcoma,0
13546,Immunotherapy,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13547,Occurrence,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13548,Occur (action),gliosarcoma,0
13549,diagnosis aspect,Childhood Central Nervous System Ganglioneuroblastoma,0
13550,Four,Carcinomatosis of peritoneal cavity,0
13551,low confidentiality,Chest Wall Fibromatosis,0
13552,1000000,ROSE Cluster 3,0
13553,Neoplasms,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13554,Treating,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13555,CD44 wt Allele,FIGO Stage II Ovarian Cancer,0
13556,Malignant neoplasm of testis,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13557,Characteristics,embryonal rhabdomyosarcoma of prostate,0
13558,Muscle (organ),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13559,Pharmacotherapy,Chondrosarcoma,0
13560,True,Recurrent Testicular Lymphoma,0
13561,To,Precursor B-lymphoblastic lymphoma stage II,0
13562,Common Specifications in HL7 V3 Publishing,Unresectable Rhabdomyosarcoma,0
13563,Examination,Gallbladder Adenocarcinoma,0
13564,Difficulty walking,Refractory Ependymoma,0
13565,Compressing (action),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13566,Gland,Adult Brain Stem Mixed Glioma,0
13567,Common Specifications in HL7 V3 Publishing,Engraftment syndrome,0
13568,Biological Response Modifiers,Refractory Barrett Esophagus,0
13569,Progress,Hyperplasia of pituitary gland,0
13570,Biopsy,Stage I Adult Non-Hodgkin Lymphoma,0
13571,Lacking,Cervical Adenomyoma,0
13572,Secondary to,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
13573,Common (qualifier value),Metastatic Ductal Breast Carcinoma,0
13574,diagnosis aspect,Tonsillar Carcinoma,0
13575,World,Malignant neoplasm of choroid,0
13576,Sunburn,Kaposi's sarcoma of extrahepatic bile duct,0
13577,Skin,sarcoma of spinal cord,0
13578,Milliampere second,Carcinomatosis of peritoneal cavity,0
13579,Exploratory incision,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13580,800,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13581,survival aspects,GIANT PIGMENTED HAIRY NEVUS,0
13582,combination - answer to question,Airway Hemangioma,0
13583,Singular,Thyroid Hurthle Cell Carcinoma,0
13584,Lower lip structure,Thyroid carcinoma,0
13585,Sarcoma - category (morphologic abnormality),Endometrial Small Cell Carcinoma,0
13586,Adult Pilocytic Astrocytoma,Bladder Neuroendocrine Neoplasm,0
13587,Adrenal Cortex Hormones,Hyperplasia of pituitary gland,0
13588,include - SetOperator,Cancer of Urinary Tract,0
13589,Malignant neoplasm of soft tissue,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13590,[AA000] INTRODUCTION,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
13591,shared attribute,Platinum-Resistant Lung Small Cell Carcinoma,0
13592,Myasthenia Gravis,Stage III Cutaneous Melanoma AJCC v6,0
13593,Structure of collecting tubule,FIGO Stage II Ovarian Cancer,0
13594,IPSS Risk Category High,embryonal rhabdomyosarcoma of prostate,0
13595,CDISC SEND Tumor Findings Results Terminology,Malignant melanoma of eyelid,0
13596,Ionizing radiation,Giant cell angiofibroma,0
13597,second (number),Noninfiltrating Intraductal Carcinoma,0
13598,Tired,Non-Hodgkin Lymphoma During Pregnancy,0
13599,Cause of death:Find:Pt:^Patient:Nom,Squamous cell carcinoma of lip,0
13600,Include (action),Cervical Squamous Intraepithelial Neoplasia,0
13601,serotonin secretion,Malignant neoplasm of thalamus,0
13602,Child,Stage III Cutaneous Melanoma AJCC v6,0
13603,Thrombopoietin,Recurrent Testicular Lymphoma,0
13604,treatment - ActInformationManagementReason,Mucinous adenocarcinoma gastric,0
13605,Estimated,Adult Hepatocellular Carcinoma,0
13606,SPACA9 gene,Secondary malignant neoplasm of lymph node,0
13607,Grouping,Ovarian germ cell choriocarcinoma stage IV,0
13608,radiotherapeutic,FIGO Stage IVA Ovarian Cancer,0
13609,1000000,Tumorlet,0
13610,Mast Cell Count,Acute Undifferentiated Leukemia,0
13611,Rectum,Gallbladder Adenocarcinoma,0
13612,Primary operation,Fibroadenoma of breast,0
13613,Neoplastic disease,Localized Ewing Sarcoma,0
13614,Plasma,Localized Malignant Neoplasm,0
13615,Derivation,Basal Cell Ameloblastoma,0
13616,How Often Weight Loss,Digestive System Hodgkin Lymphoma,0
13617,Adult Glioblastoma,Refractory Bladder Carcinoma,0
13618,depend,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13619,Genus Homo,Small cell neuroendocrine carcinoma of bladder,0
13620,Root body part,Benign squamous cell tumor,0
13621,Neuroglia,Type II Endometrial Adenocarcinoma,0
13622,Cystic,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13623,PCYT1A wt Allele,Platinum-Resistant Lung Small Cell Carcinoma,0
13624,Hypoalbuminemia,ROSE Cluster 3,0
13625,Tumor stage,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13626,Advanced phase,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13627,Mild pain,Digestive System Hodgkin Lymphoma,0
13628,Surgical advancement - action,Locally Advanced Squamous Cell Carcinoma,0
13629,Forecast of outcome,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
13630,Make - Instruction Imperative,Undifferentiated Endocervical Sarcoma,0
13631,Immune System Finding,Splenic Manifestation of Hairy Cell Leukemia,0
13632,common types,Malignant neoplasm of olfactory nerve,0
13633,65+,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13634,Adenocarcinoma,Stage I Adult Non-Hodgkin Lymphoma,0
13635,Case (situation),Digestive System Hodgkin Lymphoma,0
13636,Nicotiana,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13637,leukemia,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
13638,stem cell factor receptor activity,Basal Cell Ameloblastoma,0
13639,Neoplasms,Refractory Ependymoma,0
13640,VARIOUS DRUG CLASSES IN ATC,Carcinoma,0
13641,Tissue Growth,Intestinal Metaplasia of Bladder Urothelium,0
13642,Personal appearance,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13643,NCI CTEP SDC Penile Cancer Sub-Category Terminology,Rhabdomyosarcoma with ganglionic differentiation,0
13644,Negation,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
13645,Smaller,Stage I Adult Non-Hodgkin Lymphoma,0
13646,Disease remission,Epithelioid Sarcoma NCI Grade 3,0
13647,Complete Trisomy 21 Syndrome,Clinical Stage I Cutaneous Melanoma AJCC v8,0
13648,Recurrence,Digestive System Hodgkin Lymphoma,0
13649,Including (qualifier),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13650,Specimen Source Codes - tumor,Pancreatic Endocrine Carcinoma,0
13651,Number of birth,Clonal Hematopoiesis of Indeterminate Potential,0
13652,Fever,Small cell neuroendocrine carcinoma of bladder,0
13653,Tryptophanase,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13654,Growth abnormality,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13655,Specimen Source Codes - tumor,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13656,Annual,Mucinous neoplasm,0
13657,pharmacotherapeutic,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
13658,Blood,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13659,Usual Severity Itching,Adenocarcinoma,0
13660,Sinus - general anatomical term,Low Grade Squamous Intraepithelial Neoplasia,0
13661,Combined,Diffuse malignant mesothelioma,0
13662,inflammatory,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13663,Cisplatin,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13664,Blood,Xeroderma pigmentosum,0
13665,Diameter (qualifier value),Microcystic meningioma,0
13666,Proton Pump Inhibitors [MoA],Tubal Hyperplasia,0
13667,pharmacotherapeutic,Childhood Extragonadal Malignant Germ Cell Tumor,0
13668,Fine needle aspiration biopsy,Adenocarcinoma,0
13669,Persons,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13670,10%,Mucinous cystadenofibroma,0
13671,Child,Kaposi's sarcoma of extrahepatic bile duct,0
13672,Specimen Source Codes - tumor,Acinar cell carcinoma of pancreas,0
13673,cell transformation,Transitional cell carcinoma,0
13674,Chemotherapy Regimen,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13675,Eye protection,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13676,Biopsy,Prostate Lymphoma,0
13677,Rapid,Stage II Hepatocellular Carcinoma AJCC v8,0
13678,include - SetOperator,Recurrent Testicular Lymphoma,0
13679,Estrogen Receptor Measurement,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13680,Malignancy,Recurrent Testicular Lymphoma,0
13681,Related personal status,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13682,Histopathology,Non-Metastatic Gestational Trophoblastic Tumor,0
13683,Tumor Cell Invasion,Locally Advanced Squamous Cell Carcinoma,0
13684,Plumbum metallicum,Breast Apocrine Adenoma,0
13685,To,Small intestine carcinoma,0
13686,Very rare,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13687,Consequence of,Adult Alveolar Soft Part Sarcoma,0
13688,Patients,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13689,International Classification of Disease for Oncology,Digestive System Hodgkin Lymphoma,0
13690,Sexually active,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13691,Concept model domain,Adult Alveolar Soft Part Sarcoma,0
13692,Have Pain,Splenic Manifestation of Hairy Cell Leukemia,0
13693,Death (finding),Recurrent Uveal Melanoma,0
13694,T lymphocyte marker,Endometrial Small Cell Carcinoma,0
13695,Symptoms,Primary Cutaneous Plasmablastic Lymphoma,0
13696,To,Engraftment syndrome,0
13697,Neoplasms,Female Breast Carcinoma,0
13698,2+ Score,Vaginal Adenoma,0
13699,Blood group A (finding),Tongue Alveolar Soft Part Sarcoma,0
13700,Child,Cerebral Primitive Neuroectodermal Tumor,0
13701,Reduced,ROSE Cluster 3,0
13702,Colon structure (body structure),Benign neoplasm of thorax,0
13703,Cessation of life,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13704,Percent (qualifier value),Testicular cancer metastatic,0
13705,Therapeutic procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13706,Shortness of Breath Visual Analogue Scale,Rhabdomyosarcoma with ganglionic differentiation,0
13707,Covers (device),Stage IB Pancreatic Cancer AJCC v8,0
13708,International Classification of Diseases,Multiple Skull Base Meningiomas,0
13709,Upper urinary tract structure,Colorectal High Grade B-Cell Lymphoma,0
13710,Decade,Clinical Stage I Cutaneous Melanoma AJCC v8,0
13711,Swollen Lymph Node,Vaginal Adenoma,0
13712,Indication of (contextual qualifier),Leiomyoma of Gallbladder,0
13713,Young Child [Disease/Finding],Squamous cell carcinoma of lip,0
13714,2+,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13715,Extension,Cancer of Urinary Tract,0
13716,Name,Benign neoplasm of thorax,0
13717,Symptoms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
13718,Persons,Cancer of Urinary Tract,0
13719,Mutation,Metastatic Ductal Breast Carcinoma,0
13720,day,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13721,Exposure to radiation,Clinical Stage I Cutaneous Melanoma AJCC v8,0
13722,include - SetOperator,Stage III Cutaneous Melanoma AJCC v6,0
13723,Used by,Angiosarcoma of liver,0
13724,Urethral Carcinoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13725,shared attribute,Squamous cell carcinoma of lip,0
13726,Sepsis,Metaplastic carcinoma of breast,0
13727,Placement action,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
13728,Skin,Refractory Bladder Carcinoma,0
13729,Skin Specimen,Benign squamous cell tumor,0
13730,International Classification of Disease for Oncology,Gallbladder adenoma,0
13731,Mammal liver preparation,Splenic Manifestation of Hairy Cell Leukemia,0
13732,Risk,Diffuse malignant mesothelioma,0
13733,Linear,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
13734,Time (foundation metadata concept),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13735,List,Adult Acute Eosinophilic Leukemia,0
13736,Including (qualifier),Squamous cell carcinoma of lip,0
13737,Did not receive therapy or drug for,Metastatic Neoplasm to the Gallbladder,0
13738,Australia,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13739,Increase,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
13740,Body Parts - Canal,Microcystic meningioma,0
13741,Call (Instruction),Anterior Urethral Malignant Neoplasm,0
13742,Lung,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13743,Therapeutic radiology procedure,ROSE Cluster 3,0
13744,Drop British,Mucinous neoplasm,0
13745,member,adenosquamous carcinoma of breast,0
13746,peripheral blood,papillary carcinoma of penis,0
13747,Numerous,Small cell neuroendocrine carcinoma of bladder,0
13748,Period (temporal qualifier),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13749,include - SetOperator,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13750,Out (direction),Collecting Duct Carcinoma of the Kidney,0
13751,Used by,Vaginal Adenoma,0
13752,Togo,Anterior Urethral Malignant Neoplasm,0
13753,Skin Erosion,Hyperplasia of pituitary gland,0
13754,Females,Acute lymphadenitis,0
13755,Viola tricolor,Intraepithelial Melanocytic Hyperplasia,0
13756,Obesity,Stage III Adult Immunoblastic Lymphoma,0
13757,consider,Stage IB Lung Cancer AJCC v7,0
13758,Active License,embryonal rhabdomyosarcoma of prostate,0
13759,Cessation of life,Cancer of Urinary Tract,0
13760,Clinical Observation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13761,Nerve,Blepharal carcinoma,0
13762,Metastasis,Cartilaginous exostosis,0
13763,Include (action),Refractory Ependymoma,0
13764,Colon <insect>,Deep Leiomyoma,0
13765,Skeletal bone,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13766,Lymphocyte component of blood,Locally Advanced Squamous Cell Carcinoma,0
13767,Human body structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13768,90%,Adult Acute Eosinophilic Leukemia,0
13769,Biologic Development,High Grade Glandular Intraepithelial Neoplasia,0
13770,Tobacco smoking behavior,Intraepithelial Melanocytic Hyperplasia,0
13771,Early,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
13772,Mutation,Bladder squamous cell carcinoma stage I,0
13773,How Often Weight Loss,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
13774,Neoplasm Metastasis,Parathyroid Gland Adenocarcinoma,0
13775,Immature,Kaposi's sarcoma of skin,0
13776,Active License,Bladder Neuroendocrine Neoplasm,0
13777,Blood,Larynx carcinoma recurrent,0
13778,Symptoms aspect,Metastatic Lung Small Cell Carcinoma,0
13779,Common (qualifier value),Adenocarcinoma,0
13780,Face,Blepharal carcinoma,0
13781,Sweating,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13782,avoidance,Extracranial Neuroblastoma,0
13783,Presentation,Metastatic Lung Neuroendocrine Neoplasm,0
13784,Diagnosis Study,Refractory Bladder Carcinoma,0
13785,Exposure to,Stage III Cutaneous Melanoma AJCC v6,0
13786,Neoplasms,non-Hodgkin's lymphoma of spleen,0
13787,Clear,Undifferentiated Neuroblastoma,0
13788,low exposure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
13789,Cell Count,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13790,Therapeutic procedure,Recurrent Uveal Melanoma,0
13791,Divide,Placental aromatase deficiency,0
13792,Cell Count,Multiple Endocrine Neoplasia,0
13793,depend,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13794,CDISC SEND Tumor Findings Results Terminology,Xeroderma pigmentosum,0
13795,Cause of death:Find:Pt:^Patient:Nom,Neoplasms,0
13796,Retraction (finding),Extra-abdominal fibromatosis,0
13797,Known,Primary Cutaneous Plasmablastic Lymphoma,0
13798,Mass,Benign Apocrine Neoplasm,0
13799,Physical findings,Benign Anal Granular Cell Tumor,0
13800,Intermediate Mitosis-Karyorrhexis Index,Squamous cell carcinoma of lip,0
13801,Malignant Neoplasms,Localized Ewing Sarcoma,0
13802,Cellular Debris,Childhood Central Nervous System Ganglioneuroblastoma,0
13803,Aim,Childhood Central Nervous System Ganglioneuroblastoma,0
13804,combination of objects,Small Intestinal Villous Adenoma,0
13805,Relative (related person),benign mature teratoma of pancreas,0
13806,Human body,Ichthyosis,0
13807,Body tissue,Basal Cell Ameloblastoma,0
13808,Numerous,Platinum-Resistant Lung Small Cell Carcinoma,0
13809,Therapeutic radiology procedure,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13810,United States,Malignant Neoplasm of Lung - Multiple Primary Sites,0
13811,Acetaminophen [EPC],Stage III Adult Immunoblastic Lymphoma,0
13812,Ultra-violet,Acute Undifferentiated Leukemia,0
13813,Body Site Modifier - Lower,Methotrexate-Associated Hodgkin Lymphoma,0
13814,Primary operation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13815,Engraftment syndrome,Nasal cavity carcinoma,0
13816,In situ,Grade 1 Clear Cell Renal Cell Carcinoma,0
13817,+2,Breast Ductal Adenoma,0
13818,Acid reflux,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13819,How Often Vomiting,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13820,Benign neoplasm of paraganglion,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
13821,Mixed Cell Morphology,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
13822,Occurrence,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13823,Primary operation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13824,Entity Determiner - specific,Ampulla of Vater Tubular Adenoma,0
13825,Cells,Hodgkin Disease,0
13826,Active,Choroid Epithelioid Cell Melanoma,0
13827,Absent,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13828,Funds,Benign tumor of eyelid,0
13829,Transection (procedure),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
13830,Occur (action),sarcoma of spinal cord,0
13831,Unmarried,Refractory Bladder Carcinoma,0
13832,Malignant - descriptor,Localized Ewing Sarcoma,0
13833,Free of (attribute),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13834,Occur (action),Kaposi's sarcoma of extrahepatic bile duct,0
13835,Feelings,Atypical Lobular Breast Hyperplasia,0
13836,Pediatrics,Chronic Myelomonocytic Leukemia-2,0
13837,Person Observer,Vaginal Adenoma,0
13838,Experimental Result,Stage IB Lung Cancer AJCC v7,0
13839,63,Granular Cell Leiomyosarcoma,0
13840,Togo,Benign squamous cell tumor,0
13841,Paraneoplastic Syndromes,FIGO Stage IVA Ovarian Cancer,0
13842,Dust,Lung Mucinous Cystadenoma,0
13843,Class,Clonal Hematopoiesis of Indeterminate Potential,0
13844,Most,Nasal cavity carcinoma,0
13845,N not otherwise specified Antibody,Cervical Squamous Intraepithelial Neoplasia,0
13846,Proximal,Mucinous adenocarcinoma gastric,0
13847,Squamocolumnar junction of cervix,Intestinal Metaplasia of Bladder Urothelium,0
13848,Rating (action),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
13849,Eye,Botryoid-Type Embryonal Rhabdomyosarcoma,0
13850,Immune System Finding,Pilocytic astrocytoma of cerebellum,0
13851,Fever symptoms (finding),Engraftment syndrome,0
13852,Surgical aspects,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13853,Screening procedure,Type II Endometrial Adenocarcinoma,0
13854,Operative Surgical Procedures,Stage 0 Lip Carcinoma,0
13855,Palatine Tonsil,Chronic Myelomonocytic Leukemia-2,0
13856,+2,Low Grade Squamous Intraepithelial Neoplasia,0
13857,Cardiac Lead Procedure,Xeroderma pigmentosum,0
13858,Severe (severity modifier),BRCA2 Syndrome,0
13859,Image Feature,Medulloblastoma,0
13860,Time,Ichthyosis,0
13861,Papillomavirus,Localized Askin Tumor,0
13862,respiratory,Pancreatic Intraepithelial Neoplasia-3,0
13863,Place,Small cell neuroendocrine carcinoma of bladder,0
13864,Rating (action),Hodgkin lymphoma,0
13865,2+,Splenic Manifestation of Hairy Cell Leukemia,0
13866,Weight measurement scales,Uterine Cancer,0
13867,Bone Marrow,Thyroid Hurthle Cell Carcinoma,0
13868,Therapeutic procedure,Digestive System Hodgkin Lymphoma,0
13869,year,Acute Undifferentiated Leukemia,0
13870,Less Than,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13871,Neoplasms,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
13872,Science of Etiology,Spermatocytic seminoma,0
13873,Heart,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
13874,Call (Instruction),Small cell neuroendocrine carcinoma of bladder,0
13875,spindle assembly checkpoint,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13876,Decrease,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13877,include - SetOperator,Digestive System Hodgkin Lymphoma,0
13878,per year,clear cell adenocarcinoma of gallbladder,0
13879,Call (Instruction),Carcinoma of urinary bladder,0
13880,Presentation,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13881,African race,Malignant melanoma of eyelid,0
13882,Excessive,Type II Endometrial Adenocarcinoma,0
13883,Internal,Occult Lung Adenosquamous Carcinoma,0
13884,Medical Imaging,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13885,Percent of Abnormal Cells,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13886,Including (qualifier),Cherubism,0
13887,Stage 3B,Adult Acute Eosinophilic Leukemia,0
13888,Cessation of life,Cancer of Urinary Tract,0
13889,Young Adult,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
13890,Tired,Cervical Fibroepithelial Polyp,0
13891,alpha 1-Antitrypsin Deficiency,Acantholytic squamous cell carcinoma,0
13892,Dependent - ability,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
13893,West Haven Hepatic Encephalopathy Grade 3,Atypical Lobular Breast Hyperplasia,0
13894,Primary operation,Intraepithelial Melanocytic Hyperplasia,0
13895,Chemotherapy,Acinar cell carcinoma of pancreas,0
13896,Science of Morphology,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13897,Neoplasm Metastasis,Recurrent Testicular Lymphoma,0
13898,General surgery specialty,Stage III Adult Immunoblastic Lymphoma,0
13899,Beginning,Unresectable Rhabdomyosarcoma,0
13900,GUCY2C wt Allele,Familial Adenomatous Polyposis Associated Medulloblastoma,0
13901,Breast Carcinoma,Tonsillar Carcinoma,0
13902,Case unit dose,Cancer of Urinary Tract,0
13903,Eye,Occult Lung Adenosquamous Carcinoma,0
13904,Specimen Type - Serum,Tubal Hyperplasia,0
13905,Cancer Genus,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13906,Endocrine Cells,malignant lymphoma of pancreatic lymph nodes,0
13907,Human body structure,Lung squamous cell carcinoma stage I,0
13908,Homo sapiens,Neonatal leukemia,0
13909,Table Cell Horizontal Align - left,Leiomyoma of Gallbladder,0
13910,survival aspects,Colorectal cancer,0
13911,Laboratory Procedures,Xeroderma pigmentosum,0
13912,Table Cell Horizontal Align - left,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
13913,To,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
13914,More,Testicular cancer metastatic,0
13915,Decrease,Pancreatic Endocrine Carcinoma,0
13916,Medical Imaging,Refractory Barrett Esophagus,0
13917,Formation,Refractory Ependymoma,0
13918,Intermediate Mitosis-Karyorrhexis Index,Adult Hepatocellular Carcinoma,0
13919,Absence (morphologic abnormality),Childhood Central Nervous System Ganglioneuroblastoma,0
13920,Talpidae,Adult Alveolar Soft Part Sarcoma,0
13921,Melanoma Pathway,Benign Anal Granular Cell Tumor,0
13922,Pure Spanish horse breed (organism),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
13923,Primary malignant neoplasm,Splenic Manifestation of Hairy Cell Leukemia,0
13924,Usual,Choroid Necrotic Melanoma,0
13925,Controlling (action),Acute lymphadenitis,0
13926,Experimental Result,Kaposi's sarcoma of extrahepatic bile duct,0
13927,100%,Gallbladder Adenocarcinoma,0
13928,Ephrin Type-B Receptor 1,Benign squamous cell tumor,0
13929,10%,Endometrial Small Cell Carcinoma,0
13930,Time (foundation metadata concept),Human Papillomavirus-Related Carcinoma,0
13931,More Often than Once a Day,FIGO Stage IVA Ovarian Cancer,0
13932,Borg Category-Ratio 10 Perceived Exertion Score 5,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
13933,Sometimes,Giant cell angiofibroma,0
13934,Affecting,Mucinous adenocarcinoma gastric,0
13935,Only - dosing instruction fragment,Airway Hemangioma,0
13936,per second,Mucinous adenocarcinoma gastric,0
13937,Antimicrobial Intermediate Susceptibility Result,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13938,Western Europe,Intraepithelial Melanocytic Hyperplasia,0
13939,Breaking down,Xeroderma pigmentosum,0
13940,Severities,Childhood Anaplastic Large Cell Lymphoma,0
13941,Limited stage (cancer stage),Methotrexate-Associated Hodgkin Lymphoma,0
13942,Referring,Mucinous adenocarcinoma gastric,0
13943,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
13944,Tryptophanase,non-Hodgkin's lymphoma of spleen,0
13945,III (suffix),Extra-abdominal fibromatosis,0
13946,Decreased,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
13947,Presentation,Thyroid Hurthle Cell Carcinoma,0
13948,Surgical aspects,Extra-abdominal fibromatosis,0
13949,Cessation of life,Werner Syndrome,0
13950,Following,Grade 3a Malignant Neoplasm,0
13951,Apply,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
13952,2+,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
13953,Lung,Kaposi's sarcoma of skin,0
13954,Slightly (qualifier value),Adult Hepatocellular Carcinoma,0
13955,Limited (extensiveness),Anterior Urethral Malignant Neoplasm,0
13956,Togo,Liver Lymphangioma,0
13957,>90,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13958,Infiltration,Bladder Neuroendocrine Neoplasm,0
13959,Body Fluids,Hodgkin lymphoma,0
13960,Forecast of outcome,Small cell neuroendocrine carcinoma of bladder,0
13961,Empty (qualifier),Undifferentiated Endocervical Sarcoma,0
13962,Vaginal,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
13963,Suspected diagnosis,Anaplastic large cell lymphoma,0
13964,mole changes,Unicystic ameloblastoma,0
13965,Singular,Metastatic Lung Neuroendocrine Neoplasm,0
13966,Two,Benign tumor of eyelid,0
13967,Homo sapiens,Choroid Epithelioid Cell Melanoma,0
13968,MOSTLY,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13969,Malignant - descriptor,Congenital hamartoma,0
13970,milliliter,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
13971,Cessation of life,Cerebral Primitive Neuroectodermal Tumor,0
13972,Group A (qualifier value),Thymic Clear Cell Carcinoma,0
13973,Visible,Localized Askin Tumor,0
13974,Type - attribute,Refractory Ependymoma,0
13975,Contain (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
13976,Primary,Diffuse malignant mesothelioma,0
13977,Scaling,Adult Alveolar Soft Part Sarcoma,0
13978,Code,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
13979,Result,Breast Apocrine Adenoma,0
13980,Language Ability - Sign,Epithelioid Sarcoma NCI Grade 3,0
13981,Placenta,Papillary squamous cell carcinoma,0
13982,Follicle,FIGO Stage II Ovarian Cancer,0
13983,survive,Colorectal High Grade B-Cell Lymphoma,0
13984,Frequently,Brain Tumor,0
13985,Tissue Growth,Ovarian Dermoid Cyst with Secondary Carcinoma,0
13986,Progress,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
13987,Life Threatening,Squamous cell carcinoma of lip,0
13988,Tryptophanase,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
13989,How Often Weight Loss,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
13990,Weight decreased,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
13991,Name (property) (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
13992,Treating,Refractory Ependymoma,0
13993,Olfactory Mucosa,Small Intestinal Villous Adenoma,0
13994,therapeutic aspects,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
13995,Patient Reported Outcome Stem,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
13996,Extracellular Vesicles,Metastatic Lung Small Cell Carcinoma,0
13997,First (number),Germinoma,0
13998,NCI CTEP SDC Neuroblastoma Sub-Category Terminology,Recurrent Testicular Lymphoma,0
13999,Five,Cervical Fibroepithelial Polyp,0
14000,Magnetic Resonance Imaging Study File,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14001,Mathematical Factor,FIGO Stage IVA Ovarian Cancer,0
14002,Small,Benign neoplasm of thorax,0
14003,Skin Specimen,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
14004,second (number),Recurrent Primary Lymphoma of Bone,0
14005,Consistency,Choroid Epithelioid Cell Melanoma,0
14006,Two,Maxillary Sinus Adenoid Cystic Carcinoma,0
14007,In Blood,Digestive System Hodgkin Lymphoma,0
14008,Approximate,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14009,Including (qualifier),Papillary squamous cell carcinoma,0
14010,Group Object,Diffuse malignant mesothelioma,0
14011,Frequently,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
14012,Manufactured sign,Uterine Cancer,0
14013,survival aspects,Primary Cutaneous Plasmablastic Lymphoma,0
14014,Extent of disease,Multiple Skull Base Meningiomas,0
14015,Death Related to Adverse Event,Serous cystadenocarcinoma ovary,0
14016,Enzyme (disposition),Childhood Lymphoma,0
14017,survival aspects,papillary carcinoma of penis,0
14018,Plumbum metallicum,Mucosal Melanoma,0
14019,Golden retriever,Adenocarcinoma of duodenum,0
14020,Tryptophanase,Childhood Central Nervous System Ganglioneuroblastoma,0
14021,peripheral blood,Mucosal Melanoma,0
14022,Including (qualifier),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14023,Problems - What subject filter,Tonsillar Carcinoma,0
14024,Cancer Genus,Epithelioid Sarcoma NCI Grade 3,0
14025,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14026,Vocal cord structure,Locally Advanced Epithelioid Hemangioendothelioma,0
14027,activate - Data Operation,Cervical Adenomyoma,0
14028,In Urine,Brain Ependymoma,0
14029,Decrease,Clonal Hematopoiesis of Indeterminate Potential,0
14030,Smear test,Hodgkin Disease,0
14031,Often - answer to question,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14032,Appearance,Cervical Fibroepithelial Polyp,0
14033,cell growth,Testicular cancer metastatic,0
14034,Mammal liver preparation,Pancreatic carcinoma,0
14035,dependent,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
14036,Leading,Recurrent Testicular Lymphoma,0
14037,Body structure,Acantholytic squamous cell carcinoma,0
14038,Smaller,Malignant Neoplasm with Regional Lymph Node Involvement,0
14039,Presumed Benign,Benign neoplasm of thorax,0
14040,Increased risk for cancer,Type II Endometrial Adenocarcinoma,0
14041,red Patches,Basal Cell Ameloblastoma,0
14042,One,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14043,Symptoms aspect,BRCA2 Syndrome,0
14044,Stomach,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14045,Brain Neoplasms,Thyroid Hurthle Cell Carcinoma,0
14046,Form:Finding:Point in time:{Setting}:Document:{Role},Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14047,Copy (object),Cherubism,0
14048,Geographic Locations,Pancreatic Intraepithelial Neoplasia-3,0
14049,First (number),Advanced Lung Carcinoma,0
14050,Melanocytic nevus,Xeroderma pigmentosum,0
14051,intent,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14052,+2,Childhood Central Nervous System Ganglioneuroblastoma,0
14053,Term Birth,High Grade Glandular Intraepithelial Neoplasia,0
14054,Combined,Recurrent Testicular Lymphoma,0
14055,Device Motor,adenoid cystic carcinoma of lung,0
14056,Retinoic Acid Response Element,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14057,Removed,Hodgkin Disease,0
14058,Spreading (qualifier value),Bladder squamous cell carcinoma stage I,0
14059,Microplate Well,embryonal rhabdomyosarcoma of prostate,0
14060,Unmarried person,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14061,Point,Benign Anal Granular Cell Tumor,0
14062,Positive Finding,Recurrent Rhabdomyosarcoma,0
14063,Human papilloma virus infection,Nasal cavity carcinoma,0
14064,Occur (action),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14065,Neoplasms,Larynx carcinoma recurrent,0
14066,Scar Tissue,Anterior Urethral Malignant Neoplasm,0
14067,To,Angiosarcoma of liver,0
14068,Ultrasonic,clear cell adenocarcinoma of gallbladder,0
14069,Togo,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14070,Formation,Human Papillomavirus-Related Carcinoma,0
14071,depend,Refractory Barrett Esophagus,0
14072,Weight Loss,Breast Apocrine Adenoma,0
14073,Location,Breast Ductal Adenoma,0
14074,Biological Response Modifiers,Childhood Central Nervous System Ganglioneuroblastoma,0
14075,Result,Metastatic Ductal Breast Carcinoma,0
14076,Chemotherapy,Mucinous cystadenofibroma,0
14077,PSA Level Less than Two,Acute Undifferentiated Leukemia,0
14078,Rare,Squamous cell carcinoma of lip,0
14079,Packaging Case,Breast Ductal Adenoma,0
14080,Hyperlink,Airway Hemangioma,0
14081,Mass of body structure,clear cell adenocarcinoma of gallbladder,0
14082,Aspects of disease screening,Malignant Neoplasm with Regional Lymph Node Involvement,0
14083,Before,Stage 0 Penile Cancer AJCC v8,0
14084,Science of Anatomy,Human Papillomavirus-Related Carcinoma,0
14085,Rare,Toxic Epidermal Necrolysis,0
14086,Immature,Advanced Uterine Corpus Carcinosarcoma,0
14087,Formation,Rhabdomyosarcoma with ganglionic differentiation,0
14088,Hospice and Palliative Care Nursing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14089,Blood,Benign squamous cell tumor,0
14090,Used by,Kaposi's sarcoma of skin,0
14091,Li-Fraumeni Syndrome,Microcystic meningioma,0
14092,Order (taxonomic),Female Breast Carcinoma,0
14093,H2 receptor blockers,Hemangioma,0
14094,Death (finding),Unicystic ameloblastoma,0
14095,Milliampere second,Kaposi's sarcoma of skin,0
14096,shared attribute,Trabecular adenocarcinoma,0
14097,Testing,Placental aromatase deficiency,0
14098,Form of muscle,ICHTHYOSIS,0
14099,Smear - instruction imperative,Cerebral Primitive Neuroectodermal Tumor,0
14100,potential,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
14101,Experimental Result,mucinous adenocarcinoma of gallbladder,0
14102,Cervical lymph node group,Precursor B-lymphoblastic lymphoma stage II,0
14103,BRCA1 protein,Necrotizing Funisitis,0
14104,National origin,Recurrent Primary Lymphoma of Bone,0
14105,Homo sapiens,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14106,Taxonomic,Type II Endometrial Adenocarcinoma,0
14107,insensitivity,Recurrent Uveal Melanoma,0
14108,Skin,Localized Malignant Neoplasm,0
14109,Cervix carcinoma,Testicular cancer metastatic,0
14110,Childhood Lymphoma,Testicular cancer metastatic,0
14111,Fever,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14112,Qualitative form,mucinous adenocarcinoma of gallbladder,0
14113,Genetic,Splenic Manifestation of Hairy Cell Leukemia,0
14114,Limited stage (cancer stage),Collecting Duct Carcinoma of the Kidney,0
14115,Malignant Vaginal Neoplasm,Small Intestinal Villous Adenoma,0
14116,Woman,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14117,removal technique,Benign Anal Granular Cell Tumor,0
14118,Affecting,mucinous adenocarcinoma of gallbladder,0
14119,Behavior,Larynx carcinoma recurrent,0
14120,Stop (qualifier value),Vaginal Adenoid Cystic Carcinoma,0
14121,Often - answer to question,Mucinous adenocarcinoma gastric,0
14122,research subject screening,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14123,Fraction of,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14124,Course,Cerebral Primitive Neuroectodermal Tumor,0
14125,Diagnosis,Bladder squamous cell carcinoma stage I,0
14126,Desiccation,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14127,Treating,Malignant neoplasm of thalamus,0
14128,Reported Term,Acinar cell carcinoma of pancreas,0
14129,Lymph,Diffuse malignant mesothelioma,0
14130,Arising in,Pancreatic Intraepithelial Neoplasia-3,0
14131,T prime,Giant cell angiofibroma,0
14132,Unknown,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14133,Function (attribute),Botryoid-Type Embryonal Rhabdomyosarcoma,0
14134,Aspects of signs,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14135,Unknown,Secondary malignant neoplasm of lymph node,0
14136,Classical (qualifier value),Localized Ewing Sarcoma,0
14137,Urinary Bladder,Recurrent Uveal Melanoma,0
14138,Line Unit of Length,Localized Ewing Sarcoma,0
14139,Beginning,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14140,Classification,Stage III Cutaneous Melanoma AJCC v6,0
14141,Telephone Extension Number,Metastatic Kidney Carcinoma,0
14142,Usual,Occult Lung Adenosquamous Carcinoma,0
14143,Include (action),Cervical Fibroepithelial Polyp,0
14144,American College of Cardiology/American Heart Association Lesion Complexity Score A,Malignant Testicular Sertoli Cell Tumor,0
14145,Treatment Epoch,Papillary squamous cell carcinoma,0
14146,Endometrial scraping,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14147,Cover (physical object),Benign squamous cell tumor,0
14148,Absent,Placental aromatase deficiency,0
14149,Togo,Stage 0 Penile Cancer AJCC v8,0
14150,Grade IV Childhood Astrocytic Neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14151,Rare Diseases,Childhood Central Nervous System Ganglioneuroblastoma,0
14152,Clinical Study Case,Stage I Colon Neuroendocrine Tumor AJCC v8,0
14153,symbol,Medulloblastoma,0
14154,Including (qualifier),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
14155,Colon structure (body structure),Childhood Fibrillary Astrocytoma,0
14156,Needs,Stage IB Pancreatic Cancer AJCC v8,0
14157,To,Peripheral primitive neuroectodermal tumor of soft tissue,0
14158,Classification,Malignant melanoma of eyelid,0
14159,Spreading (qualifier value),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
14160,Cancer Genus,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14161,Arsenic measurement,Familial Adenomatous Polyposis Associated Medulloblastoma,0
14162,Most,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14163,How Often Weight Loss,Localized Ewing Sarcoma,0
14164,Histologic type,High Grade Glandular Intraepithelial Neoplasia,0
14165,Treatment Epoch,Mucinous adenocarcinoma gastric,0
14166,Formation,Squamous cell carcinoma of lip,0
14167,Pisum sativum (pea) extract,Recurrent Uveal Melanoma,0
14168,Qualitative form,Melanomatosis,0
14169,Sun Exposure,Trabecular adenocarcinoma,0
14170,Percent (qualifier value),FIGO Stage IVA Ovarian Cancer,0
14171,Recommendation,Benign squamous cell tumor,0
14172,Usually,Diffuse malignant mesothelioma,0
14173,Indication,Diffuse malignant mesothelioma,0
14174,Intercellular Junctions,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14175,Include (action),Maxillary Sinus Adenoid Cystic Carcinoma,0
14176,Replacement,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14177,metastatic qualifier,Localized Ewing Sarcoma,0
14178,1000000,Metaplastic carcinoma of breast,0
14179,Mass of body region,Metastatic Malignant Neoplasm in the Sellar Region,0
14180,various other intestinal adsorbents in ATC,Melanomatosis,0
14181,melanoma,Activated B-cell type diffuse large B-cell lymphoma,0
14182,Malignant Neoplasms,Childhood Central Nervous System Immature Teratoma,0
14183,Involvement with,Leptomeningeal sarcoma,0
14184,<90,Recurrent Uveal Melanoma,0
14185,Pages,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
14186,Symptoms,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14187,Feel Tired question,Giant cell angiofibroma,0
14188,Fever,Endometrial Small Cell Carcinoma,0
14189,Immune system,Metastatic Lung Neuroendocrine Neoplasm,0
14190,Aspects of disease screening,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14191,Togo,Stage III Cutaneous Melanoma AJCC v6,0
14192,Stent,Ovarian germ cell choriocarcinoma stage IV,0
14193,Primary malignant neoplasm,Bladder adenocarcinoma stage IV,0
14194,Smear test,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14195,Process,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14196,Aspect - Kind of quantity,Non-Metastatic Gestational Trophoblastic Tumor,0
14197,Normal,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
14198,Pediculus humanus capitis (eukaryote),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14199,Classical Hodgkin's Lymphoma,Precursor B-lymphoblastic lymphoma stage II,0
14200,Status post,Fibroadenoma of breast,0
14201,Obesity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14202,spells (neurological symptom),Adult Hepatocellular Carcinoma,0
14203,Duct system,Splenic Manifestation of Hairy Cell Leukemia,0
14204,Physical findings,Adult Acute Eosinophilic Leukemia,0
14205,Highest,Kaposi's sarcoma of skin,0
14206,Formation,Clonal Hematopoiesis of Indeterminate Potential,0
14207,Childhood Alveolar Rhabdomyosarcoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14208,Sometimes,Metastatic Neoplasm to the Gallbladder,0
14209,Papillomavirus,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14210,2+ Score,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14211,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Childhood Lymphoma,0
14212,Account number:Identifier:Point in time:^Patient:Nominal,Localized Malignant Neoplasm,0
14213,Experimental Result,Intracortical osteosarcoma,0
14214,Interventional procedure,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14215,Manifest,Low Grade Squamous Intraepithelial Neoplasia,0
14216,Protective Clothing,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14217,shared attribute,Choroid Epithelioid Cell Melanoma,0
14218,2000,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14219,General Health:Find:Pt:^Patient:Ord,Diffuse malignant mesothelioma,0
14220,Use of,Cancer of Urinary Tract,0
14221,Cell Count,Ampulla of Vater Tubular Adenoma,0
14222,Smear - instruction imperative,Acute Undifferentiated Leukemia,0
14223,Container status - Identified,Angiosarcoma of liver,0
14224,Treating,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
14225,Call (Instruction),Acute Undifferentiated Leukemia,0
14226,Intention - mental process,Atypical Mesothelial Hyperplasia,0
14227,Xeroderma Pigmentosum,Neonatal leukemia,0
14228,Basis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14229,The Sun,Malignant Testicular Sertoli Cell Tumor,0
14230,Large,Endometrial Small Cell Carcinoma,0
14231,Deoxyribonucleic Acid Measurement,Benign tumor of eyelid,0
14232,bony process,Intraepithelial Melanocytic Hyperplasia,0
14233,Count of entities,Squamous cell carcinoma of lip,0
14234,Array Feature,Kaposi's sarcoma of extrahepatic bile duct,0
14235,United States,Angiosarcoma of liver,0
14236,Ultrasonics (sound),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14237,Ephrin Type-B Receptor 1,High Grade Glandular Intraepithelial Neoplasia,0
14238,Child,Stage IB Pancreatic Cancer AJCC v8,0
14239,Biopsy,Carcinomatosis of peritoneal cavity,0
14240,Cell Differentiation process,Stage III Cutaneous Melanoma AJCC v6,0
14241,Adult,Recurrent Uveal Melanoma,0
14242,Spreading (qualifier value),Malignant neoplasm of gallbladder,0
14243,Singular,Benign Anal Granular Cell Tumor,0
14244,Two,Mucinous adenocarcinoma gastric,0
14245,Immature,Unicystic ameloblastoma,0
14246,Therapeutic radiology procedure,Kaposi's sarcoma of skin,0
14247,set (group),Stage IV Penile Cancer AJCC v7,0
14248,Taxonomic,Placental aromatase deficiency,0
14249,Increased tendency to bruise,Undifferentiated Endocervical Sarcoma,0
14250,Only - dosing instruction fragment,Type II Endometrial Adenocarcinoma,0
14251,Medications,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14252,Occurrence,Undifferentiated Endocervical Sarcoma,0
14253,Including (qualifier),Adult Fibrolamellar Carcinoma,0
14254,Did not receive therapy or drug for,Epithelioid Sarcoma NCI Grade 3,0
14255,Angioma,Chest Wall Fibromatosis,0
14256,Conditional,Metastatic Malignant Neoplasm in the Sellar Region,0
14257,Hereditary,Primary Cutaneous Plasmablastic Lymphoma,0
14258,Macrophage Activation Syndrome,Childhood Anaplastic Large Cell Lymphoma,0
14259,drug companies,Noninfiltrating Intraductal Carcinoma,0
14260,Heterogeneity,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14261,Operative Surgical Procedures,Adult Hepatocellular Carcinoma,0
14262,Residue on Palate,Malignant neoplasm of choroid,0
14263,Skin lesion,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14264,Feel Pain,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
14265,Reported Term,Chondrosarcoma,0
14266,Treating,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
14267,Deterioration of status,Neoplasms,0
14268,Does stand alone,Carcinoma of urinary bladder,0
14269,Tryptophanase,clear cell adenocarcinoma of gallbladder,0
14270,Contain (action),Locally Advanced Carcinoma,0
14271,Reported Term,Digestive System Hodgkin Lymphoma,0
14272,Case (situation),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14273,Adult Glioblastoma,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
14274,Chemotherapy Regimen,Engraftment syndrome,0
14275,Interventional procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14276,Absence (morphologic abnormality),Acute lymphadenitis,0
14277,Trachea (moth),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14278,Malignant melanoma of eye,Malignant melanoma of eyelid,0
14279,Reporting,Benign tumor of eyelid,0
14280,Blood group antibody I,Type II Endometrial Adenocarcinoma,0
14281,radiotherapeutic,Childhood Fibrillary Astrocytoma,0
14282,90%,Microcystic meningioma,0
14283,include - SetOperator,Plexosarcoma,0
14284,Progestins,Undifferentiated Endocervical Sarcoma,0
14285,Spreading (qualifier value),Multiple Skull Base Meningiomas,0
14286,>40 years,Basal Cell Ameloblastoma,0
14287,Normal menstruation - observation,Neonatal leukemia,0
14288,Symptoms,Lipoma of small intestine,0
14289,Process (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14290,Two,Chronic Myelomonocytic Leukemia-2,0
14291,member,clear cell adenocarcinoma of gallbladder,0
14292,N+ (tumor staging),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14293,30%,Locally Advanced Carcinoma,0
14294,Second Suffix,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14295,Point in time,Spindle Cell Melanoma,0
14296,National origin,Recurrent Testicular Lymphoma,0
14297,Grouped (qualifier value),Cancer of Urinary Tract,0
14298,Associated with,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
14299,User Group,Nasal cavity carcinoma,0
14300,Lung,Lung squamous cell carcinoma stage I,0
14301,Perianal Squamous Intraepithelial Neoplasia,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14302,Symptoms aspect,Metastatic Lung Neuroendocrine Neoplasm,0
14303,various antiinfectives and antiseptics for local oral treatment,Anterior Urethral Malignant Neoplasm,0
14304,Cell Count,Kaposi's sarcoma of extrahepatic bile duct,0
14305,Sharing (Social Behavior),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
14306,Hypertensive disease,Advanced Uterine Corpus Carcinosarcoma,0
14307,Vaginal Sarcoma,Undifferentiated Endocervical Sarcoma,0
14308,Subgroup A Nepoviruses,Acute Undifferentiated Leukemia,0
14309,Patients,Acute Undifferentiated Leukemia,0
14310,Plumbum metallicum,Cervical Adenomyoma,0
14311,Probable diagnosis,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14312,Arterial system,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14313,Often - answer to question,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14314,Term (temporal),Childhood Central Nervous System Ganglioneuroblastoma,0
14315,Narrow,Childhood Lymphoma,0
14316,Premalignant,Cartilaginous exostosis,0
14317,Over (spatial),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14318,Most,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14319,Descending,Squamous cell carcinoma of lip,0
14320,Carcinoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14321,Combined,Vaginal Adenoma,0
14322,sequelae aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14323,Rest,Kaposi's sarcoma of extrahepatic bile duct,0
14324,Common (qualifier value),Human Papillomavirus-Related Carcinoma,0
14325,Liver Flavor,Childhood Thyroid Gland Follicular Carcinoma,0
14326,Occurrence Indicator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14327,Personal appearance,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14328,Biologic Development,embryonal rhabdomyosarcoma of prostate,0
14329,Symptoms,Choroid Epithelioid Cell Melanoma,0
14330,Common (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14331,Appearance Distress Question,Cerebral hemangioma,0
14332,Classical Hodgkin's Lymphoma,Cartilaginous exostosis,0
14333,Swelling,Ovarian germ cell choriocarcinoma stage IV,0
14334,Magnetic Resonance Imaging Study File,Digestive System Hodgkin Lymphoma,0
14335,Protein Glycosylation,Funisitis (disorder),0
14336,Females,Stage III Adult Immunoblastic Lymphoma,0
14337,Percent (qualifier value),Liver Cavernous Hemangioma,0
14338,Cancer Other,Giant cell angiofibroma,0
14339,Academic degree,Colorectal High Grade B-Cell Lymphoma,0
14340,Pancreatic Cancer Pathway,Medulloblastoma,0
14341,Salvage Therapy,Angiosarcoma of liver,0
14342,How Much Distress Weight Loss,Vaginal Adenoma,0
14343,Pharyngeal area structure,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14344,CD96 gene,Chest Wall Fibromatosis,0
14345,Low Level,Mixed astrocytoma-ependymoma,0
14346,Often - answer to question,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14347,Iodides,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14348,Retinoic Acid Response Element,Engraftment syndrome,0
14349,Sequence Data Type,Neonatal leukemia,0
14350,Adamantinoma,Mucosal Melanoma,0
14351,Person 1,Microcystic meningioma,0
14352,Papillary Thyroid Carcinoma Pathway,Ovarian Carcinoid Tumor,0
14353,Continuance of life,malignant lymphoma of pancreatic lymph nodes,0
14354,Malignant - descriptor,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14355,Functional Relationship,FIGO Stage IVA Ovarian Cancer,0
14356,Disease,Recurrent Primary Lymphoma of Bone,0
14357,risk factors - observation list,Nasal cavity carcinoma,0
14358,Skin Pigmentation Disorder,Intestinal Metaplasia of Bladder Urothelium,0
14359,Formation,Occult Lung Adenosquamous Carcinoma,0
14360,Five,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14361,Physical findings:Finding:Point in time:^Patient:Nominal:Observed,Gallbladder Adenocarcinoma,0
14362,Logical Condition,Human Papillomavirus-Related Carcinoma,0
14363,risk factors,Non-Metastatic Gestational Trophoblastic Tumor,0
14364,Chew (administration method),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14365,Stem cells,Locally Advanced Squamous Cell Carcinoma,0
14366,IPSS Risk Category High,Extra-Adrenal Paraganglioma,0
14367,Urine,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14368,Evaluation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14369,Death (finding),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14370,Normal,Lipoma of small intestine,0
14371,Development,Cerebral hemangioma,0
14372,majority,Xeroderma pigmentosum,0
14373,Specific qualifier value,Thymic Clear Cell Carcinoma,0
14374,Classification,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
14375,Show,Childhood Fibrillary Astrocytoma,0
14376,Recommendation,Mucinous adenocarcinoma gastric,0
14377,Neoplasms,Adult Brain Stem Mixed Glioma,0
14378,Melanocytic nevus,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14379,Mandible,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14380,Females,Childhood Central Nervous System Ganglioneuroblastoma,0
14381,Protection,Ovarian Carcinoid Tumor,0
14382,Wound Healing,Metastatic Malignant Neoplasm in the Sellar Region,0
14383,Tobacco smoking behavior,Carcinoma of urinary bladder,0
14384,Lymphoid organ structure,Localized Malignant Neoplasm,0
14385,SLC6A2 wt Allele,Recurrent Uveal Melanoma,0
14386,Lymphocyte component of blood,Adult Alveolar Soft Part Sarcoma,0
14387,Cultured Cell Line,Small Intestinal Villous Adenoma,0
14388,Long Variable,Spongiotic dermatitis,0
14389,1+ Score,Transitional cell carcinoma,0
14390,Tetrachloroethylene,Fibroadenoma of breast,0
14391,Hemorrhagic,Chest Wall Fibromatosis,0
14392,Lymphoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14393,Pediculus (eukaryote),Anaplastic large cell lymphoma,0
14394,Lead,Kaposi's sarcoma of extrahepatic bile duct,0
14395,Cell Count,Melanomatosis,0
14396,In the past,Hereditary Diffuse Gastric Adenocarcinoma,0
14397,Arising,Engraftment syndrome,0
14398,South,Bladder squamous cell carcinoma stage I,0
14399,Usually,Noninfiltrating Intraductal Carcinoma,0
14400,Widening,Localized Askin Tumor,0
14401,Decision,Adult Acute Eosinophilic Leukemia,0
14402,Age at menopause,FIGO Stage IVA Ovarian Cancer,0
14403,How Much Distress Pain,Adult Alveolar Soft Part Sarcoma,0
14404,Lung,Malignant Testicular Sertoli Cell Tumor,0
14405,Formation,Pancreatic carcinoma,0
14406,Progress,FIGO Stage II Ovarian Cancer,0
14407,Cancer Biology,FIGO Stage II Ovarian Cancer,0
14408,True Control Status,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14409,unknown vaccine or immune globulin,Intraepithelial Melanocytic Hyperplasia,0
14410,Hematologic Tests,Refractory Bladder Carcinoma,0
14411,Myeloproliferation,FIGO Stage II Ovarian Cancer,0
14412,Borg Category-Ratio 10 Perceived Exertion Score 5,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14413,International Classification of Diseases,Adult Acute Eosinophilic Leukemia,0
14414,High Risk Acute Leukemia,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14415,Follicular thyroid carcinoma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
14416,Neck Pain Score 2,Periosteal Osteosarcoma,0
14417,Contain (action),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14418,Complete,Mixed astrocytoma-ependymoma,0
14419,Traumatic injury,Colorectal High Grade B-Cell Lymphoma,0
14420,Poverty,Hyperplasia of pituitary gland,0
14421,Nevus,Engraftment syndrome,0
14422,Type - attribute,Intracortical osteosarcoma,0
14423,Lymphadenopathy,Acinar cell carcinoma of pancreas,0
14424,Imbrication (procedure),Trichilemmocarcinoma,0
14425,Human body,Stage IB Pancreatic Cancer AJCC v8,0
14426,Make - Instruction Imperative,Airway Hemangioma,0
14427,Breast Cancer Type 1 Susceptibility Protein Measurement,Stage II Carcinoma of Penis,0
14428,Used by,Cystadenocarcinoma,0
14429,Epstein-Barr Virus,Blepharal carcinoma,0
14430,treatment - ActInformationManagementReason,Stage I Colon Neuroendocrine Tumor AJCC v8,0
14431,Medical Devices,Malignant melanoma of eyelid,0
14432,preference,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
14433,Malignant neoplasm of pancreas,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14434,Management procedure,adenoid cystic carcinoma of lung,0
14435,include - SetOperator,Mucinous adenocarcinoma gastric,0
14436,Adrenal Cortex,Extracranial Neuroblastoma,0
14437,Legal Adult,Extracranial Neuroblastoma,0
14438,growth aspects,Malignant Neoplasm with Regional Lymph Node Involvement,0
14439,per year,Ichthyoses,0
14440,genetic risk factors,Mixed parotid tumor,0
14441,PREVENT (product),Locally Advanced Soft Tissue Sarcoma,0
14442,Biological Response Modifier Therapy,Unresectable Rhabdomyosarcoma,0
14443,Excision,Intraepithelial Melanocytic Hyperplasia,0
14444,Ductal,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14445,Ethanol,Xeroderma pigmentosum,0
14446,Etiology,Adult Acute Eosinophilic Leukemia,0
14447,To,Kaposi's sarcoma of extrahepatic bile duct,0
14448,Immediate,Localized Ewing Sarcoma,0
14449,Carcinoma of bladder,FIGO Stage II Ovarian Cancer,0
14450,Muscle (organ),Pilocytic astrocytoma of cerebellum,0
14451,Magnetic Resonance Imaging,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14452,Cutaneous Melanoma,Nasal cavity carcinoma,0
14453,Age of Onset,Carcinoma of urinary bladder,0
14454,Often - answer to question,Chondrosarcoma,0
14455,Surgery specialty,Type II Endometrial Adenocarcinoma,0
14456,Severe (severity modifier),Benign squamous cell tumor,0
14457,suggestion,Bladder squamous cell carcinoma stage I,0
14458,Formation,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
14459,Central Nervous System Neoplasms,Unicystic ameloblastoma,0
14460,Negation,Atypical Lobular Breast Hyperplasia,0
14461,Vagina Carcinoma,Benign squamous cell tumor,0
14462,Consistency,squamous cell carcinoma of the thyroid gland,0
14463,Account number:Identifier:Point in time:^Patient:Nominal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14464,Including (qualifier),Xeroderma pigmentosum,0
14465,Delta (difference),Engraftment syndrome,0
14466,Limited Walking Ability,Mixed astrocytoma-ependymoma,0
14467,Severe (severity modifier),Blepharal carcinoma,0
14468,Cell Count,malignant lymphoma of pancreatic lymph nodes,0
14469,Filter - medical device,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14470,Carcinomatosis of peritoneal cavity,Melanomatosis,0
14471,Changing,Carcinoma of submandibular gland,0
14472,Sebum,Chronic Myelomonocytic Leukemia-2,0
14473,Table - furniture,Collecting Duct Carcinoma of the Kidney,0
14474,Type - attribute,benign mature teratoma of pancreas,0
14475,White blood cell count normal,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14476,Slow,Endometrial Small Cell Carcinoma,0
14477,Cells,Benign tumor of eyelid,0
14478,Thought,Maxillary Sinus Adenoid Cystic Carcinoma,0
14479,Surrounding (qualifier value),Malignant neoplasm of gallbladder,0
14480,Pigmentary Change in Skin,Tongue Alveolar Soft Part Sarcoma,0
14481,800,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14482,Sequence Data Type,Metastatic Ductal Breast Carcinoma,0
14483,gene therapy,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
14484,Experimental Organism Basal Cell Carcinoma,Parathyroid Gland Adenocarcinoma,0
14485,2+ Score,Periosteal Osteosarcoma,0
14486,Line Unit of Length,Carcinoma of urinary bladder,0
14487,Tryptophanase,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14488,diagnosis aspect,Melanomatosis,0
14489,Current (present time),Metastatic Neoplasm to the Gallbladder,0
14490,Age,Basal Cell Ameloblastoma,0
14491,Meaning,Lung squamous cell carcinoma stage I,0
14492,Main,Childhood Lung Non-Small Cell Carcinoma,0
14493,Characterization,Stage IB Pancreatic Cancer AJCC v8,0
14494,Condyloma,Benign Anal Granular Cell Tumor,0
14495,Standard Treatment,Intraepithelial Melanocytic Hyperplasia,0
14496,Spreading (qualifier value),Ovarian Carcinoid Tumor,0
14497,Feel Tired question,Childhood Lymphoma,0
14498,Cystic,Fibroadenoma of breast,0
14499,Scar Tissue,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14500,Biomaterial Treatment,Cervical Squamous Intraepithelial Neoplasia,0
14501,Gender,Occult Lung Adenosquamous Carcinoma,0
14502,Testing,Stage 0 Penile Cancer AJCC v8,0
14503,Persons,Stage III Cutaneous Melanoma AJCC v6,0
14504,65,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14505,Tears body substance,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
14506,Local disease,Methotrexate-Associated Hodgkin Lymphoma,0
14507,Network,Diffuse malignant mesothelioma,0
14508,Aggressive course,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14509,Lymphoma,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14510,Cell Count,Benign Anal Granular Cell Tumor,0
14511,Others - Allergy,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
14512,Case (situation),Neoplasms,0
14513,Arising,Carcinoma of urinary bladder,0
14514,Type - attribute,Recurrent Uveal Melanoma,0
14515,Type of vessel,Digestive System Hodgkin Lymphoma,0
14516,Direct (qualifier),Xeroderma pigmentosum,0
14517,Symptoms aspect,Grade 3a Malignant Neoplasm,0
14518,Age at menopause:Time:Point in time:^Patient:Quantitative,Carcinoma ex pleomorphic adenoma of parotid gland,0
14519,Aim,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14520,Primitive,Childhood Anaplastic Large Cell Lymphoma,0
14521,Genetic Heterogeneity,Benign tumor of eyelid,0
14522,Carcinoma in Situ,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
14523,Manufactured form,Type II Endometrial Adenocarcinoma,0
14524,Image Feature,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14525,Supportive assistance,Grade 3a Malignant Neoplasm,0
14526,Adult human body,Lipoma of small intestine,0
14527,Medulloblastoma,Precursor B-lymphoblastic lymphoma stage II,0
14528,Continuance of life,Stage III Adult Immunoblastic Lymphoma,0
14529,Leading,Mucinous adenocarcinoma gastric,0
14530,High risk of,Stage IV Colorectal Cancer AJCC v8,0
14531,described,Anterior Urethral Malignant Neoplasm,0
14532,Thin (qualifier value),Endometrial Small Cell Carcinoma,0
14533,Science of Etiology,Mixed parotid tumor,0
14534,Population Group,Tonsillar Carcinoma,0
14535,GUCY2C wt Allele,Locally Advanced Carcinoma,0
14536,Secondary Neoplasm,Intraepithelial Melanocytic Hyperplasia,0
14537,Togo,Blood Vessel Tumors,0
14538,Often - answer to question,Epithelioid Sarcoma NCI Grade 3,0
14539,Type A,Testicular cancer metastatic,0
14540,What subject filter - Result,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14541,Lead,Mucinous adenocarcinoma gastric,0
14542,More,ROSE Cluster 3,0
14543,Abdominal Cavity,Bladder adenocarcinoma stage IV,0
14544,Specimen Source Codes - tumor,Uterine Cancer,0
14545,Liquid substance,Childhood Anaplastic Large Cell Lymphoma,0
14546,Type A,Vaginal Adenoma,0
14547,Left sided,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14548,unknown vaccine or immune globulin,Mucosal Melanoma,0
14549,Localized skin lesion,Cerebral hemangioma,0
14550,risk factors,Stage IV Penile Cancer AJCC v7,0
14551,Goes <invertebrate>,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14552,Neoplasms,Peripheral primitive neuroectodermal tumor of soft tissue,0
14553,PREMATURE CHROMATID SEPARATION TRAIT,Heavy Chain Deposition Disease,0
14554,Skin pigmentation - finding,Digestive System Hodgkin Lymphoma,0
14555,Improving (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14556,Linear,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14557,Infection,Carcinoma,0
14558,Metastatic to,Localized Ewing Sarcoma,0
14559,Chemotherapy Regimen,GIANT PIGMENTED HAIRY NEVUS,0
14560,Carcinoma,Small intestine carcinoma,0
14561,Image Feature,Melanomatosis,0
14562,Device system,Recurrent Uveal Melanoma,0
14563,solid Ovarian mass,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14564,Smooth muscle (tissue),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14565,Cavern,Refractory Ependymoma,0
14566,protrusion,Stage IV Penile Cancer AJCC v7,0
14567,Mass of body region,Acute Undifferentiated Leukemia,0
14568,Entity Determiner - specific,Peripheral primitive neuroectodermal tumor of soft tissue,0
14569,Analysis of substances,Peripheral primitive neuroectodermal tumor of soft tissue,0
14570,Surface,Stage IV Colorectal Cancer AJCC v8,0
14571,Biopsy,Hemangioma,0
14572,Immune system,Maxillary Sinus Adenoid Cystic Carcinoma,0
14573,Retinoids,Benign Anal Granular Cell Tumor,0
14574,Chemotherapy,Cerebral hemangioma,0
14575,Does carry,Cervical Squamous Intraepithelial Neoplasia,0
14576,Certain (qualifier value),Intraepithelial Melanocytic Hyperplasia,0
14577,Name (property) (qualifier value),Diffuse malignant mesothelioma,0
14578,Skin,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14579,Including (qualifier),Engraftment syndrome,0
14580,Natural,Peripheral primitive neuroectodermal tumor of soft tissue,0
14581,Neoplastic disease of uncertain behavior,Peripheral primitive neuroectodermal tumor of soft tissue,0
14582,65,Trabecular adenocarcinoma,0
14583,Publications,Lipoma of small intestine,0
14584,Manifest,Thymic Clear Cell Carcinoma,0
14585,Fluid behavior,Breast Apocrine Adenoma,0
14586,Disseminated Malignant Neoplasm,Squamous cell carcinoma of lip,0
14587,Certain (qualifier value),Adult Hepatocellular Carcinoma,0
14588,Morning,Acute lymphadenitis,0
14589,Result,Pancreatic Endocrine Carcinoma,0
14590,Aspects of signs,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
14591,Entity Determiner - specific,Extracranial Neuroblastoma,0
14592,Present,Pancreatic carcinoma,0
14593,Cells,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14594,United States,Benign Anal Granular Cell Tumor,0
14595,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
14596,Fever symptoms (finding),Tonsillar Carcinoma,0
14597,Classification of information,Digestive System Hodgkin Lymphoma,0
14598,Increased,Localized Askin Tumor,0
14599,Less Than,Cervical Adenomyoma,0
14600,Ovulation,Lipoma of small intestine,0
14601,Severe (severity modifier),Occult Lung Adenosquamous Carcinoma,0
14602,Lip and Oral Cavity Carcinoma,Vaginal Adenoid Cystic Carcinoma,0
14603,Poliosis,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14604,How Much Distress Weight Loss,Kaposi's sarcoma of extrahepatic bile duct,0
14605,Surgery specialty,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
14606,Context,Unicystic ameloblastoma,0
14607,Plumbum metallicum,Intracortical osteosarcoma,0
14608,Two,Choroid Necrotic Melanoma,0
14609,Aspects of signs,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14610,shared attribute,Choroid Epithelioid Cell Melanoma,0
14611,low confidentiality,Stage IV Colorectal Cancer AJCC v8,0
14612,Adenocarcinoma of large intestine,Diffuse malignant mesothelioma,0
14613,Malignant - descriptor,Acute lymphadenitis,0
14614,Common Specifications in HL7 V3 Publishing,FIGO Stage II Ovarian Cancer,0
14615,What subject filter - Result,Hyperplasia of pituitary gland,0
14616,Not Otherwise Specified,Localized Askin Tumor,0
14617,Capsule (unit of presentation),Atypical Mesothelial Hyperplasia,0
14618,3+ Score,Hair nevus,0
14619,Specimen Source Codes - Mucus,Medulloblastoma,0
14620,Usually,Splenic Manifestation of Hairy Cell Leukemia,0
14621,Usual Severity Sweats,FIGO Stage II Ovarian Cancer,0
14622,English Language,Cerebral Primitive Neuroectodermal Tumor,0
14623,Usually,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14624,Eighth,Benign neoplasm of eye,0
14625,Positron-Emission Tomography,Stage III Cutaneous Melanoma AJCC v6,0
14626,Thyroid Gland,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14627,Formation,Pleomorphic adenoma of parotid gland,0
14628,Carcinoid Tumor,Recurrent Testicular Lymphoma,0
14629,Ultrasonography,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
14630,National origin,Digestive System Hodgkin Lymphoma,0
14631,Manufactured form,Recurrent Diffuse Intrinsic Pontine Glioma,0
14632,french race,Refractory Bladder Carcinoma,0
14633,Birth defects diagnosis:Find:Pt:^Patient:Nar,Liver Cavernous Hemangioma,0
14634,*Type - Kind of quantity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14635,Term Birth,Endometrial Small Cell Carcinoma,0
14636,True primary (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14637,skin color,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14638,Groups,Primary Cutaneous Plasmablastic Lymphoma,0
14639,Perform,Localized Askin Tumor,0
14640,Therapeutic procedure,Spindle Cell Melanoma,0
14641,seen,Mastocytosis,0
14642,MYOT gene,Female Breast Carcinoma,0
14643,Expiration,Liver Lymphangioma,0
14644,Response (communication),Female Breast Carcinoma,0
14645,Immunotherapy,Tonsillar Carcinoma,0
14646,Rare,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14647,Malignant - descriptor,Diffuse malignant mesothelioma,0
14648,Neoplasms,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14649,Term (lexical),Uterine Cancer,0
14650,Sarcoma,Cerebral Primitive Neuroectodermal Tumor,0
14651,Manufactured sign,Tongue Alveolar Soft Part Sarcoma,0
14652,Pelvic pain female,Intestinal Metaplasia of Bladder Urothelium,0
14653,Niobium,Unicystic ameloblastoma,0
14654,Primary malignant neoplasm,Pilocytic astrocytoma of cerebellum,0
14655,Burkina Faso,Testicular cancer metastatic,0
14656,Skin Specimen,Metastatic Lung Neuroendocrine Neoplasm,0
14657,HLA Class II Histocompatibility Antigen Gamma Chain,Primary Cutaneous Plasmablastic Lymphoma,0
14658,Females,Transitional cell carcinoma,0
14659,Early,Recurrent Uveal Melanoma,0
14660,Common Specifications in HL7 V3 Publishing,Stage IV Penile Cancer AJCC v7,0
14661,Intestines,Hodgkin lymphoma,0
14662,Tooth root structure,Neonatal leukemia,0
14663,Body site,Recurrent Testicular Lymphoma,0
14664,therapeutic aspects,Trabecular adenocarcinoma,0
14665,Europe,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
14666,Characteristics,FIGO Stage II Ovarian Cancer,0
14667,Associated with,Squamous cell carcinoma of lip,0
14668,Ultraviolet Light Sterilization,Fibroadenoma of breast,0
14669,Primary malignant neoplasm,Childhood Lung Non-Small Cell Carcinoma,0
14670,Young,Cerebral Primitive Neuroectodermal Tumor,0
14671,Science of Statistics,Stage IB Pancreatic Cancer AJCC v8,0
14672,List,Cerebral Primitive Neuroectodermal Tumor,0
14673,Fever symptoms (finding),Squamous cell carcinoma of lip,0
14674,Diet Code Specification Type - Preference,FIGO Stage IVA Ovarian Cancer,0
14675,Occurrence Indicator,Thymoma malignant recurrent,0
14676,Intestines,Gallbladder adenoma,0
14677,Early,Gallbladder Adenocarcinoma,0
14678,Congenital phimosis,Digestive System Hodgkin Lymphoma,0
14679,include - SetOperator,Gallbladder Adenocarcinoma,0
14680,Fatal,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14681,Array Feature,Choroid Necrotic Melanoma,0
14682,Major,Childhood Lung Non-Small Cell Carcinoma,0
14683,Childhood Lymphoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
14684,Cure (remedy),Stage IB Lung Cancer AJCC v7,0
14685,Device system,Childhood Central Nervous System Ganglioneuroblastoma,0
14686,*Type - Kind of quantity,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14687,Myelodysplastic Syndrome,Intraepithelial Melanocytic Hyperplasia,0
14688,Present,Gallbladder Adenocarcinoma,0
14689,Pancreatic carcinoma,Fibroadenoma of breast,0
14690,Categories,Benign neoplasm of eye,0
14691,Main,Medulloblastoma,0
14692,Oral region,Stage I Colon Neuroendocrine Tumor AJCC v8,0
14693,year,Colorectal Neuroendocrine Tumor G2,0
14694,Atypical,Cerebral Primitive Neuroectodermal Tumor,0
14695,Type - attribute,Benign Ovarian Thecoma,0
14696,Chemotherapy,Cerebral hemangioma,0
14697,Pain,Brain Tumor,0
14698,Adult Classical Hodgkin Lymphoma,Acantholytic squamous cell carcinoma,0
14699,Most,Unicystic ameloblastoma,0
14700,Age,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14701,Melanoma Pathway,Choroid Epithelioid Cell Melanoma,0
14702,Mathematical Operator,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
14703,Relative Survival,Malignant neoplasm of thalamus,0
14704,Combined,FIGO Stage II Ovarian Cancer,0
14705,Vision,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14706,Active License,non-Hodgkin's lymphoma of spleen,0
14707,Clinical,Vaginal Adenoid Cystic Carcinoma,0
14708,Adult human body,Digestive System Hodgkin Lymphoma,0
14709,Hollow shape,Gallbladder Adenocarcinoma,0
14710,Submandibular,Splenic Manifestation of Hairy Cell Leukemia,0
14711,Treatment Epoch,Fibroadenoma of breast,0
14712,First (number),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14713,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Locally Advanced Squamous Cell Carcinoma,0
14714,Malignant Neoplasms,Giant cell angiofibroma,0
14715,Squamous Epithelial Cells,Mucinous adenocarcinoma gastric,0
14716,Derivation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14717,Five-year Survival Rate,Trabecular adenocarcinoma,0
14718,Small,Microcystic meningioma,0
14719,Occurrence,Intestinal Metaplasia of Bladder Urothelium,0
14720,Alcohol consumption,Malignant Neoplasm with Regional Lymph Node Involvement,0
14721,Percent of Abnormal Cells,papillary carcinoma of penis,0
14722,Body structure,Unicystic ameloblastoma,0
14723,Neuroendocrine Tumors,Airway Hemangioma,0
14724,Case (situation),Platinum-Resistant Lung Small Cell Carcinoma,0
14725,Sore to touch,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
14726,Manufactured sign,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
14727,Accepted,Familial Hemophagocytic Lymphocytosis,0
14728,Obesity,Carcinomatosis of peritoneal cavity,0
14729,Drop British,Trichilemmocarcinoma,0
14730,Cancer Genus,Neonatal leukemia,0
14731,First sign,Locally Advanced Squamous Cell Carcinoma,0
14732,Type of complication,Type II Endometrial Adenocarcinoma,0
14733,95,Stage 0 Penile Cancer AJCC v8,0
14734,include - SetOperator,Cerebral Primitive Neuroectodermal Tumor,0
14735,Negation,Ovarian Dermoid Cyst with Secondary Carcinoma,0
14736,What subject filter - Result,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14737,Good,Methotrexate-Associated Hodgkin Lymphoma,0
14738,Basis - conceptual entity,Cervical Squamous Intraepithelial Neoplasia,0
14739,Suspected qualifier,Stage III Cutaneous Melanoma AJCC v6,0
14740,Blue color,Childhood Fibrillary Astrocytoma,0
14741,Retinoic Acid Response Element,Spindle Cell Melanoma,0
14742,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Acinar cell carcinoma of pancreas,0
14743,Eye,Cervical Squamous Intraepithelial Neoplasia,0
14744,Oral,Localized Askin Tumor,0
14745,80%,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14746,Qualitative form,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
14747,Frequently,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14748,Chest wall pain,Childhood Lymphoma,0
14749,African race,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
14750,200,Malignant Testicular Sertoli Cell Tumor,0
14751,Return to (contextual qualifier) (qualifier value),Xeroderma pigmentosum,0
14752,Present,Breast Ductal Adenoma,0
14753,Gait normal,Gallbladder adenoma,0
14754,Patterns,Adenocarcinoma,0
14755,Common Specifications in HL7 V3 Publishing,Locally Advanced Soft Tissue Sarcoma,0
14756,Median Statistical Measurement,Serous cystadenocarcinoma ovary,0
14757,Known,Werner Syndrome,0
14758,Call (Instruction),Squamous cell carcinoma of lip,0
14759,Sharing (Social Behavior),Chronic Myelomonocytic Leukemia-2,0
14760,diagnosis aspect,Malignant melanoma of eyelid,0
14761,French Catheter Gauge,Brain Tumor,0
14762,transport (device),Ovarian Dermoid Cyst with Secondary Carcinoma,0
14763,Breaking down,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14764,Main,Liver Cavernous Hemangioma,0
14765,Value Above Reference Range,Xeroderma pigmentosum,0
14766,Possible diagnosis,Mucinous adenocarcinoma gastric,0
14767,List,Childhood Thyroid Gland Follicular Carcinoma,0
14768,Assortment,Benign Anal Granular Cell Tumor,0
14769,Value Above Reference Range,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14770,Imaging Techniques,Urethral Carcinoma,0
14771,North America,Methotrexate-Associated Hodgkin Lymphoma,0
14772,Contain (action),Localized Askin Tumor,0
14773,Fracture,Neonatal leukemia,0
14774,Surgery specialty,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14775,United States Military Commissioned Officer O4,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
14776,Biliary Tract Cancer,Unresectable Rhabdomyosarcoma,0
14777,Condition,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14778,lymph nodes,Transitional cell carcinoma,0
14779,Teratoma,Benign Ovarian Thecoma,0
14780,What subject filter - Result,Ovarian germ cell choriocarcinoma stage IV,0
14781,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14782,Comfort,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14783,Name (property) (qualifier value),Medulloblastoma,0
14784,Qualitative form,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14785,Neoplasms,Spermatocytic seminoma,0
14786,Stomach,Adult Acute Eosinophilic Leukemia,0
14787,Outward,Metastatic Carcinoma in the Lung,0
14788,Nodulus cerebelli,Chondrosarcoma,0
14789,Attenuated by (contextual qualifier),Chondrosarcoma,0
14790,risk factors,Benign tumor of eyelid,0
14791,Cells,Locally Advanced Carcinoma,0
14792,Rare,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
14793,Initially,Colorectal High Grade B-Cell Lymphoma,0
14794,Unknown GENC,FIGO Stage II Ovarian Cancer,0
14795,Favorable,Malignant neoplasm of gallbladder,0
14796,Brain,Bladder squamous cell carcinoma stage I,0
14797,National origin,Kaposi's sarcoma of extrahepatic bile duct,0
14798,Operative Surgical Procedures,High Grade Glandular Intraepithelial Neoplasia,0
14799,2+ Score,ROSE Cluster 3,0
14800,Relationships,Pilocytic astrocytoma of cerebellum,0
14801,Non-invasive,Serous cystadenocarcinoma ovary,0
14802,With frequency,Lipoma of small intestine,0
14803,>90,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
14804,Therapeutic procedure,Refractory Barrett Esophagus,0
14805,Interventional procedure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
14806,What subject filter - Result,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14807,Pathology,Ovarian germ cell choriocarcinoma stage IV,0
14808,Risk,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14809,Therapeutic procedure,Leiomyoma of Gallbladder,0
14810,Primary malignant neoplasm,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
14811,<50,Intestinal Neuroendocrine Carcinoma,0
14812,Meningitis,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14813,Usual Severity Sweats,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14814,Constipation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14815,Main,Cerebral Primitive Neuroectodermal Tumor,0
14816,Aerosol Dose Form,benign mature teratoma of pancreas,0
14817,combination of objects,Ovarian Carcinoid Tumor,0
14818,Reduction procedure,Benign neoplasm of thorax,0
14819,Infrequent,Metastatic Neoplasm to the Gallbladder,0
14820,Experimental Result,Giant cell angiofibroma,0
14821,Rate,Colorectal High Grade B-Cell Lymphoma,0
14822,Special,Human Papillomavirus-Related Carcinoma,0
14823,Cervix carcinoma,Occult Lung Adenosquamous Carcinoma,0
14824,Togo,Recurrent Testicular Lymphoma,0
14825,Cells,Trichilemmocarcinoma,0
14826,Broken skin,Melanomatosis,0
14827,Platelets Product,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14828,Pancreas,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14829,Better than Others,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14830,Qualitative form,Engraftment syndrome,0
14831,Progress,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14832,Tryptophanase,FIGO Stage IVA Ovarian Cancer,0
14833,Color change,Adult Acute Eosinophilic Leukemia,0
14834,Common Specifications in HL7 V3 Publishing,Papillary squamous cell carcinoma,0
14835,Nausea Visual Analogue Scale,Nasal cavity carcinoma,0
14836,Intestines,Ovarian germ cell choriocarcinoma stage IV,0
14837,Anorexia,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14838,Including (qualifier),Cerebral Primitive Neuroectodermal Tumor,0
14839,Survival Rate,Digestive System Hodgkin Lymphoma,0
14840,Presence (property),Benign neoplasm of eye,0
14841,therapeutic aspects,Lipoma of small intestine,0
14842,School Grade,Hodgkin Disease,0
14843,Enlargement procedure,Mucinous adenocarcinoma gastric,0
14844,Neuroglia,Brain Tumor,0
14845,Precipitating Factors,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14846,Proximal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14847,Symptoms aspect,Cervical Fibroepithelial Polyp,0
14848,Genetic Heterogeneity,Stage I Colon Neuroendocrine Tumor AJCC v8,0
14849,Astrocytoma,Undifferentiated Neuroblastoma,0
14850,Pesticides,Lipoma of small intestine,0
14851,Rest,Bladder adenocarcinoma stage IV,0
14852,Childhood Lymphoma,Acute Undifferentiated Leukemia,0
14853,Obesity,Refractory Barrett Esophagus,0
14854,kidneys and collecting system,Occult Lung Adenosquamous Carcinoma,0
14855,Body tissue,Engraftment syndrome,0
14856,spinal,Angiosarcoma of liver,0
14857,Derivative,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
14858,described,Malignant melanoma of eyelid,0
14859,Cell Count,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14860,Object Attribute,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
14861,Gastrointestinal Leak NOS,Stage I Adult Non-Hodgkin Lymphoma,0
14862,Ductal Carcinoma,Papillary squamous cell carcinoma,0
14863,Biomaterial Treatment,Unfavorable Non-Hodgkin Lymphoma,0
14864,fluid - substance,Stage I Adult Non-Hodgkin Lymphoma,0
14865,Three,Basal Cell Ameloblastoma,0
14866,Sunlight,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14867,New Zealand,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
14868,Mean Percent of Normal,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
14869,Second edition,Squamous cell carcinoma of lip,0
14870,Relationships,Vaginal Adenoid Cystic Carcinoma,0
14871,Negation,Granular Cell Leiomyosarcoma,0
14872,Neck,Stage III Cutaneous Melanoma AJCC v6,0
14873,risk factors,Diffuse malignant mesothelioma,0
14874,Affect (mental function),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14875,NCI CTEP SDC Melanoma Sub-Category Terminology,Chronic Myelomonocytic Leukemia-2,0
14876,Does carry,Testicular cancer metastatic,0
14877,Cancer Genus,Brain Tumor,0
14878,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Chondrosarcoma,0
14879,Malignant Neoplasms,Diffuse malignant mesothelioma,0
14880,Free (available (qualifier)),Clinical Stage I Cutaneous Melanoma AJCC v8,0
14881,Risk,Splenic Manifestation of Hairy Cell Leukemia,0
14882,Malignant neoplasm of liver,FIGO Stage II Ovarian Cancer,0
14883,POEMS Syndrome,Adult Alveolar Soft Part Sarcoma,0
14884,SLC6A2 protein,Lipoma of small intestine,0
14885,survival aspects,Malignant neoplasm of subglottis,0
14886,Ephrin Type-B Receptor 1,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14887,Polypeptide Hormones,Gallbladder Adenocarcinoma,0
14888,Responsible to,Tongue Alveolar Soft Part Sarcoma,0
14889,Frequently,Colorectal High Grade B-Cell Lymphoma,0
14890,Hormone Therapy,Type II Endometrial Adenocarcinoma,0
14891,Malignant Neoplasms,clear cell adenocarcinoma of gallbladder,0
14892,Secreted,Stage IV Penile Cancer AJCC v7,0
14893,Money or percentage indicator - Percentage,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
14894,Set of regional lymph nodes,Liver Lymphangioma,0
14895,transport (device),Thymic Clear Cell Carcinoma,0
14896,Childhood Alveolar Soft Part Sarcoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
14897,International Classification of Diseases,adenosquamous carcinoma of breast,0
14898,Speaking (activity),Unicystic ameloblastoma,0
14899,Experimental Result,Sarcomatoid Renal Cell Carcinoma,0
14900,How Much Distress Sweats,FIGO Stage IVA Ovarian Cancer,0
14901,Tumor stage,Angiosarcoma of liver,0
14902,Morphology,Keratoderma,0
14903,Classification,Liver Cavernous Hemangioma,0
14904,physiological aspects,Papillary squamous cell carcinoma,0
14905,Usually Need Help from Another Person for Reach,Adult Hepatocellular Carcinoma,0
14906,Minerals,FIGO Stage II Ovarian Cancer,0
14907,Two,Digestive System Hodgkin Lymphoma,0
14908,Lymphadenopathy,Contact dermatitis due to alkali,0
14909,respiratory gaseous exchange in organisms,Vaginal Adenoid Cystic Carcinoma,0
14910,Usually,Stage III Cutaneous Melanoma AJCC v6,0
14911,Classification,Undifferentiated Endocervical Sarcoma,0
14912,Inflammatory Breast Carcinoma,Extracranial Neuroblastoma,0
14913,Ks Antibody,Granular Cell Leiomyosarcoma,0
14914,Important,Malignant neoplasm of choroid,0
14915,Squamous cell carcinoma,Benign tumor of eyelid,0
14916,Surgery specialty,Nasal cavity carcinoma,0
14917,Various patch test substance,Chondrosarcoma,0
14918,Biomaterial Treatment,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14919,Domain (area of knowledge),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
14920,Administration procedure,Kaposi's sarcoma of extrahepatic bile duct,0
14921,Ovary,embryonal rhabdomyosarcoma of prostate,0
14922,Including (qualifier),Papillary squamous cell carcinoma,0
14923,Proto-Oncogene Proteins B-raf,Trabecular adenocarcinoma,0
14924,Formation,Splenic Manifestation of Hairy Cell Leukemia,0
14925,Transformation,Engraftment syndrome,0
14926,Involvement with,Undifferentiated Neuroblastoma,0
14927,gene therapy,Stage II Carcinoma of Penis,0
14928,Normal,Clinical Stage I Cutaneous Melanoma AJCC v8,0
14929,Colorectal Carcinoma,Kaposi's sarcoma of skin,0
14930,Estimated,Medulloblastoma,0
14931,Assessed,Recurrent Uveal Melanoma,0
14932,Notable,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
14933,Vaginal (intended site),Female Breast Carcinoma,0
14934,Left sided,Stage II Carcinoma of Penis,0
14935,shared attribute,Thymic Clear Cell Carcinoma,0
14936,Usual Severity Pain,Epithelioid Sarcoma NCI Grade 3,0
14937,Occurrence,Neoplasms,0
14938,Array Feature,Digestive System Hodgkin Lymphoma,0
14939,Specimen Source Codes - tumor,Cerebral Primitive Neuroectodermal Tumor,0
14940,Ocular orbit,Giant cell angiofibroma,0
14941,76,Stage III Cutaneous Melanoma AJCC v6,0
14942,Fever,Mucinous adenocarcinoma gastric,0
14943,Persons,Childhood Thyroid Gland Follicular Carcinoma,0
14944,Study Subject,Childhood Lymphoma,0
14945,Cure (remedy),Benign Anal Granular Cell Tumor,0
14946,Neutral - answer to question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
14947,Biomaterial Treatment,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
14948,treatment - ActInformationManagementReason,Necrotizing Funisitis,0
14949,Physical findings,Unresectable Rhabdomyosarcoma,0
14950,Worried,Toxic Epidermal Necrolysis,0
14951,1960s,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
14952,Negative Surgical Margin,Kaposi's sarcoma of skin,0
14953,How Often Shortness of Breath,Stage I Adult Non-Hodgkin Lymphoma,0
14954,Paraganglioma,Xeroderma pigmentosum,0
14955,Morphology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
14956,+2,Non-Metastatic Gestational Trophoblastic Tumor,0
14957,Congenital meningocele,Childhood Anaplastic Large Cell Lymphoma,0
14958,Histologic,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14959,Agreement,Mucinous adenocarcinoma gastric,0
14960,Have Weight Loss,gliosarcoma,0
14961,Diagnosis Study,Anaplastic large cell lymphoma,0
14962,Case unit dose,embryonal rhabdomyosarcoma of prostate,0
14963,diagnosis aspect,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
14964,Left sided,Malignant Neoplasm of Lung - Multiple Primary Sites,0
14965,Widening,Stage 0 Penile Cancer AJCC v8,0
14966,Packaging Case,Diffuse malignant mesothelioma,0
14967,Total thymectomy,Multiple Skull Base Meningiomas,0
14968,Circumscribe (action),Chronic Myelomonocytic Leukemia-2,0
14969,Fasting Status Indicator,Stage III Cutaneous Melanoma AJCC v6,0
14970,Abdominal bloating,Kaposi's sarcoma of extrahepatic bile duct,0
14971,defects aspect,Cartilaginous exostosis,0
14972,Lip structure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
14973,Contrast Media,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
14974,risk factors,Leptomeningeal sarcoma,0
14975,Umbilical stump observable,Clonal Hematopoiesis of Indeterminate Potential,0
14976,Third revision,Gallbladder Adenocarcinoma,0
14977,depend,Digestive System Hodgkin Lymphoma,0
14978,Decision,Secondary malignant neoplasm of lymph node,0
14979,Including (qualifier),Mucinous adenocarcinoma gastric,0
14980,cell growth,Kaposi's sarcoma of skin,0
14981,Therapeutic radiology procedure,Neonatal leukemia,0
14982,Symptoms,Refractory Ependymoma,0
14983,general population,Recurrent Testicular Lymphoma,0
14984,Occurrence Indicator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
14985,Guarded prognosis,Heavy Chain Deposition Disease,0
14986,Cellular infiltrate,Stage III Adult Immunoblastic Lymphoma,0
14987,risk factors - observation list,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
14988,Common Specifications in HL7 V3 Publishing,Vaginal Adenoma,0
14989,Methods aspects,Xeroderma pigmentosum,0
14990,Young Adult,Botryoid-Type Embryonal Rhabdomyosarcoma,0
14991,Fever symptoms (finding),Adenocarcinoma of the prostate metastatic,0
14992,Pressure - action,Thymic Clear Cell Carcinoma,0
14993,Inflammatory Bowel Diseases,Recurrent Testicular Lymphoma,0
14994,1000000,Adult Acute Eosinophilic Leukemia,0
14995,Adult human body,mucinous adenocarcinoma of gallbladder,0
14996,Body tissue,Melanomatosis,0
14997,Nose,Unicystic ameloblastoma,0
14998,Type A,Acantholytic squamous cell carcinoma,0
14999,year,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
15000,Constant (qualifier),Hodgkin Disease,0
15001,Childhood Lymphoma,Small cell neuroendocrine carcinoma of bladder,0
15002,shared attribute,benign mature teratoma of pancreas,0
15003,Administration procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15004,Ultrasonic,Endometrial Small Cell Carcinoma,0
15005,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,Human Papillomavirus-Related Carcinoma,0
15006,Genus Homo,Thyroid Hurthle Cell Carcinoma,0
15007,Smoking,Rhabdomyosarcoma with ganglionic differentiation,0
15008,Cancer Etiology,Hodgkin lymphoma,0
15009,In Blood,Benign neoplasm of thorax,0
15010,Used by,Methotrexate-Associated Hodgkin Lymphoma,0
15011,Percent (qualifier value),Cervical Squamous Intraepithelial Neoplasia,0
15012,Transection (procedure),Neonatal leukemia,0
15013,2000,Recurrent Rhabdomyosarcoma,0
15014,Historical aspects qualifier,Benign Anal Granular Cell Tumor,0
15015,Skin,Liver Lymphangioma,0
15016,Neoadjuvant Therapy,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15017,Skin Specimen,Intestinal Metaplasia of Bladder Urothelium,0
15018,PXN wt Allele,Anaplastic large cell lymphoma,0
15019,Manufactured form,Brain Tumor,0
15020,Myasthenia Gravis,Intestinal Metaplasia of Bladder Urothelium,0
15021,Face,Cervical Adenomyoma,0
15022,Vocal cord structure,Cancer of Urinary Tract,0
15023,Including (qualifier),Intracortical osteosarcoma,0
15024,Growth,Localized Askin Tumor,0
15025,Childhood Teratoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15026,Historical aspects qualifier,Childhood Thyroid Gland Follicular Carcinoma,0
15027,Major,Malignant Neoplasm of Lung - Multiple Primary Sites,0
15028,Result,Refractory Ependymoma,0
15029,Site of primary lesion,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15030,Frequently,Unfavorable Non-Hodgkin Lymphoma,0
15031,Often - answer to question,embryonal rhabdomyosarcoma of prostate,0
15032,Organ,Unicystic ameloblastoma,0
15033,Therapeutic procedure,Diffuse malignant mesothelioma,0
15034,Neoplasms,Chondrosarcoma,0
15035,Usual,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15036,NR0B1 wt Allele,Stage I Colon Neuroendocrine Tumor AJCC v8,0
15037,Continuance of life,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15038,3+ Answer to Question,Transitional cell carcinoma,0
15039,Removed,Splenic Manifestation of Hairy Cell Leukemia,0
15040,Back Pain,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
15041,Antifungal Antibiotics,Cancer of Urinary Tract,0
15042,Possibly Related to Intervention,Intestinal Metaplasia of Bladder Urothelium,0
15043,Tobacco smoking behavior,FIGO Stage II Ovarian Cancer,0
15044,Main,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15045,Blood Vessel,Parathyroid Gland Adenocarcinoma,0
15046,Neoplasm Metastasis,Pilocytic astrocytoma of cerebellum,0
15047,Genes,Mucinous adenocarcinoma gastric,0
15048,Financial Account,Testicular cancer metastatic,0
15049,Rare,Liver Cavernous Hemangioma,0
15050,risk factors - observation list,Stage IB Lung Cancer AJCC v7,0
15051,Common (qualifier value),Cherubism,0
15052,Interventional procedure,Chondrosarcoma,0
15053,Cessation of life,Recurrent Testicular Lymphoma,0
15054,Base - General Qualifier,Recurrent Uveal Melanoma,0
15055,Count of entities,Thymic Clear Cell Carcinoma,0
15056,Location of Oral Residue Following Swallowing,FIGO Stage IVA Ovarian Cancer,0
15057,Lymphoid Cells,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15058,Tumor cells,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15059,low,Testicular cancer metastatic,0
15060,Tissue damage,Ectomesenchymal Chondromyxoid Tumor,0
15061,Possible,Basal Cell Ameloblastoma,0
15062,High Level,embryonal rhabdomyosarcoma of prostate,0
15063,Gestational trophoblastic disease,Hemangioma,0
15064,Symptoms,Epithelioid Sarcoma NCI Grade 3,0
15065,Folded structure,Primary Cutaneous Plasmablastic Lymphoma,0
15066,Combined,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
15067,Ovarian Cysts,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15068,Singular,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15069,Leg,Locally Advanced Soft Tissue Sarcoma,0
15070,sex,Uterine Cancer,0
15071,Fever symptoms (finding),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
15072,Monoclonal Gammapathies,Vaginal Adenoid Cystic Carcinoma,0
15073,Neoplastic disease,Uterine Cancer,0
15074,Accident due to exposure to weather conditions,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15075,Diabetes Mellitus,Uterine Cancer,0
15076,Known,BRCA2 Syndrome,0
15077,Diagnosis,Gallbladder Adenocarcinoma,0
15078,Grade,Chest Wall Fibromatosis,0
15079,Articular system,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15080,Biomaterial Treatment,Stage III Adult Immunoblastic Lymphoma,0
15081,Used by,Cerebral Primitive Neuroectodermal Tumor,0
15082,Plasma Product,Bladder Neuroendocrine Neoplasm,0
15083,Malignant Neoplasms,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15084,Daily,Refractory Barrett Esophagus,0
15085,Distant,Intraepithelial Melanocytic Hyperplasia,0
15086,Different,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15087,Target Awareness - partial,Tongue Alveolar Soft Part Sarcoma,0
15088,Diagnostic Imaging,Locally Advanced Squamous Cell Carcinoma,0
15089,Abdominal mass,Recurrent Uveal Melanoma,0
15090,Human body,Carcinoma,0
15091,Screening,Neoplasms,0
15092,Negation,Serous cystadenocarcinoma ovary,0
15093,200,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15094,The Sun,Cerebral Primitive Neuroectodermal Tumor,0
15095,Interferes with,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15096,Hereditary Diffuse Gastric Cancer,Metaplastic carcinoma of breast,0
15097,Biological Response Modifiers,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15098,Case unit dose,Cancer of Urinary Tract,0
15099,Males,Anterior Urethral Malignant Neoplasm,0
15100,Type - attribute,Maxillary Sinus Adenoid Cystic Carcinoma,0
15101,Human Papillomavirus,Carcinomatosis of peritoneal cavity,0
15102,Due to,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
15103,Lymphoid system structure,Peripheral primitive neuroectodermal tumor of soft tissue,0
15104,Cover - action,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15105,Contain (action),Ovarian germ cell choriocarcinoma stage IV,0
15106,Secondary Neoplasm,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15107,Ameloblasts,mucinous adenocarcinoma of gallbladder,0
15108,More,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
15109,anatomical layer,Neonatal leukemia,0
15110,Malignant Neoplasms,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
15111,Two,Unfavorable Non-Hodgkin Lymphoma,0
15112,Involvement with,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15113,Human papillomavirus 16,Recurrent Diffuse Intrinsic Pontine Glioma,0
15114,Division (action),Stage III Adult Immunoblastic Lymphoma,0
15115,NCI CTEP SDC Melanoma Sub-Category Terminology,Kaposi's sarcoma of skin,0
15116,To,Stage IB Pancreatic Cancer AJCC v8,0
15117,Skin tanning,Diffuse malignant mesothelioma,0
15118,Sore to touch,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15119,Natural,Mixed astrocytoma-ependymoma,0
15120,Most,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15121,physiological aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15122,Disease remission,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
15123,Tissue Specimen Code,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
15124,Type - attribute,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15125,Intestines,Basal Cell Ameloblastoma,0
15126,Lymphocyte,Kaposi's sarcoma of skin,0
15127,Cells,ROSE Cluster 3,0
15128,1000000,clear cell adenocarcinoma of gallbladder,0
15129,fibroma,Cervical Fibroepithelial Polyp,0
15130,Type - attribute,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15131,Age of Onset,Benign squamous cell tumor,0
15132,intrathecal chemotherapy,Chondrosarcoma,0
15133,Pharmacotherapy,Recurrent Testicular Lymphoma,0
15134,Milliampere second,Adenoma,0
15135,Case unit dose,Adult Alveolar Soft Part Sarcoma,0
15136,Treating,Recurrent Testicular Lymphoma,0
15137,Treatment Epoch,Liver Cavernous Hemangioma,0
15138,Tumor Mass,Malignant Neoplasm with Regional Lymph Node Involvement,0
15139,Thinking,Kaposi's sarcoma of extrahepatic bile duct,0
15140,Rare,embryonal rhabdomyosarcoma of prostate,0
15141,Special,Human Papillomavirus-Related Carcinoma,0
15142,Stomach,Colorectal Neuroendocrine Tumor G2,0
15143,Anorexia,Recurrent Uveal Melanoma,0
15144,Increased,Bladder adenocarcinoma stage IV,0
15145,Persons,Thymic Clear Cell Carcinoma,0
15146,diagnosis aspect,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15147,Vulva,Metastatic Lung Neuroendocrine Neoplasm,0
15148,Human body,Neonatal leukemia,0
15149,Viola <angiosperm>,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
15150,Receive,Extra-Adrenal Paraganglioma,0
15151,Combined,Locally Advanced Epithelioid Hemangioendothelioma,0
15152,Polypeptide Hormones,Tubal Hyperplasia,0
15153,Common Specifications in HL7 V3 Publishing,Mixed astrocytoma-ependymoma,0
15154,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Benign Anal Granular Cell Tumor,0
15155,Feelings,embryonal rhabdomyosarcoma of prostate,0
15156,Epithelial cell count (procedure),Benign squamous cell tumor,0
15157,Treatment Epoch,Giant cell angiofibroma,0
15158,Pediculus (eukaryote),Adult Alveolar Soft Part Sarcoma,0
15159,Term (temporal),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
15160,include - SetOperator,de novo Myelodysplastic Syndrome,0
15161,Liver,Stage I Colon Neuroendocrine Tumor AJCC v8,0
15162,Type - attribute,Bladder squamous cell carcinoma stage I,0
15163,Skin Specimen,Carcinomatosis of peritoneal cavity,0
15164,cervical cancer,Breast Ductal Adenoma,0
15165,Frequently,Cerebral Primitive Neuroectodermal Tumor,0
15166,Dog family,Diffuse malignant mesothelioma,0
15167,Consistency,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15168,Labium,Kaposi's sarcoma of extrahepatic bile duct,0
15169,Childhood Lymphoma,Testicular cancer metastatic,0
15170,Plumbum metallicum,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15171,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15172,Feelings,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15173,Negation,Angiosarcoma of liver,0
15174,Brain part,Refractory Bladder Carcinoma,0
15175,Occur (action),Stage I Colon Neuroendocrine Tumor AJCC v8,0
15176,Lung,Hodgkin Disease,0
15177,Genetic Risk,Stage IB Pancreatic Cancer AJCC v8,0
15178,Chromosomes,Recurrent Testicular Lymphoma,0
15179,<3 (qualifier value),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15180,Neuroendocrine Tumors,Uterine Cancer,0
15181,Telencephalon,Melanomatosis,0
15182,Dietary Lead,Small Intestinal Villous Adenoma,0
15183,Location of Oral Residue Following Swallowing,Benign Apocrine Neoplasm,0
15184,device aspects,Brain Tumor,0
15185,potential,Uterine Cancer,0
15186,3+ Score,Type II Endometrial Adenocarcinoma,0
15187,biopsy characteristics,Malignant neoplasm of choroid,0
15188,Adverse Event Associated with Vascular,Cerebral Primitive Neuroectodermal Tumor,0
15189,Amount type - Percentage,Heavy Chain Deposition Disease,0
15190,Providing presence (regime/therapy),Hyperplasia of pituitary gland,0
15191,Biogenic Amines,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
15192,Infrequent,Vaginal Adenoma,0
15193,Usual,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15194,Molecular Mass,Collecting Duct Carcinoma of the Kidney,0
15195,Magnetic Resonance Imaging,Carcinomatosis of peritoneal cavity,0
15196,Area,Adult Acute Eosinophilic Leukemia,0
15197,Close,Metaplastic carcinoma of breast,0
15198,Togo,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15199,Well Differentiated,Atypical Mesothelial Hyperplasia,0
15200,Type - attribute,Refractory Bladder Carcinoma,0
15201,Tryptophanase,Childhood Anaplastic Large Cell Lymphoma,0
15202,Case unit dose,Sarcomatoid Renal Cell Carcinoma,0
15203,Cancer Genus,Xeroderma pigmentosum,0
15204,Malignant neoplasm of penis,Benign Anal Granular Cell Tumor,0
15205,Lymphoid Tissue,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15206,Certain (qualifier value),Mucinous adenocarcinoma,0
15207,Infected,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
15208,Therapeutic procedure,Digestive System Hodgkin Lymphoma,0
15209,National origin,Choroid Necrotic Melanoma,0
15210,Etiology aspects,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
15211,motor movement,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15212,Long,Cartilaginous exostosis,0
15213,Predominate,Localized Askin Tumor,0
15214,Pharmacotherapy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15215,United States,Anterior Urethral Malignant Neoplasm,0
15216,NCI CTEP SDC Melanoma Sub-Category Terminology,Human Papillomavirus-Related Carcinoma,0
15217,Socket Device,Childhood Anaplastic Large Cell Lymphoma,0
15218,PSA Level Less than Two,Methotrexate-Associated Hodgkin Lymphoma,0
15219,Symptoms aspect,Hodgkin Disease,0
15220,65+,Recurrent Rhabdomyosarcoma,0
15221,Skin,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15222,Qualitative form,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15223,Routine Contract,Engraftment syndrome,0
15224,Shoulder,Localized Ewing Sarcoma,0
15225,Decision,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15226,gene therapy,Angiosarcoma of liver,0
15227,Persons,embryonal rhabdomyosarcoma of prostate,0
15228,Swollen Lymph Node,Tumorlet,0
15229,Able (finding),Choroid Epithelioid Cell Melanoma,0
15230,Hair Diseases,Stage 0 Penile Cancer AJCC v8,0
15231,Levels (qualifier value),Stage 0 Penile Cancer AJCC v8,0
15232,Symptoms aspect,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
15233,Case (situation),Ovarian Dermoid Cyst with Secondary Carcinoma,0
15234,Cancer Genus,Childhood Lymphoma,0
15235,Spreading (qualifier value),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15236,per year,Refractory Ependymoma,0
15237,Woman,Pancreatic carcinoma,0
15238,Form:Finding:Point in time:{Setting}:Document:{Role},Thyroid carcinoma,0
15239,diagnosis aspect,Childhood Lung Non-Small Cell Carcinoma,0
15240,Immunoproliferative Disorders,Astrocytoma of brain,0
15241,20%,Childhood Central Nervous System Ganglioneuroblastoma,0
15242,Small cell carcinoma of lung,Mucinous adenocarcinoma gastric,0
15243,Iodides,Anaplastic large cell lymphoma,0
15244,Physicians,Parathyroid Gland Adenocarcinoma,0
15245,Neck,Cancer of Urinary Tract,0
15246,Usual Severity Vomiting,Breast Ductal Adenoma,0
15247,Chemotherapy Regimen,Noninfiltrating Intraductal Carcinoma,0
15248,Term (lexical),Mucinous adenocarcinoma gastric,0
15249,Intestines,Stage I Colon Neuroendocrine Tumor AJCC v8,0
15250,Neoplasm Metastasis,FIGO Stage II Ovarian Cancer,0
15251,Groups,Papillary squamous cell carcinoma,0
15252,Decreased vascular flow,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15253,Occurrence Indicator,Tonsillar Carcinoma,0
15254,Life,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15255,Etiology,Xeroderma pigmentosum,0
15256,New,Kaposi's sarcoma of extrahepatic bile duct,0
15257,Small,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15258,Approximate,Localized Ewing Sarcoma,0
15259,Confirmation,High Grade Glandular Intraepithelial Neoplasia,0
15260,Smaller,Intestinal Neuroendocrine Carcinoma,0
15261,Term (lexical),Angiosarcoma of liver,0
15262,Decreasing,Engraftment syndrome,0
15263,diagnosis aspect,Xeroderma pigmentosum,0
15264,Help document,Rhabdomyosarcoma with ganglionic differentiation,0
15265,Concentration measurement,Metaplastic carcinoma of breast,0
15266,Combined,Stage 0 Penile Cancer AJCC v8,0
15267,Venous system,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
15268,X-Ray Computed Tomography,Papillary squamous cell carcinoma,0
15269,Malignant neoplasm of soft tissue,Pancreatic Endocrine Carcinoma,0
15270,Dietary Lead,Human Papillomavirus-Related Carcinoma,0
15271,Forecast of outcome,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15272,Primary malignant neoplasm,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15273,20%,Cartilaginous exostosis,0
15274,Cover - action,Melanomatosis,0
15275,Known,Adult Alveolar Soft Part Sarcoma,0
15276,Numerous,Unresectable Rhabdomyosarcoma,0
15277,Therapeutic procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15278,Type - attribute,Stage IB Pancreatic Cancer AJCC v8,0
15279,Table Cell Horizontal Align - left,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15280,Wealthy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15281,Formation,Liver Lymphangioma,0
15282,Infertility study,FIGO Stage II Ovarian Cancer,0
15283,Occur (action),Breast Ductal Adenoma,0
15284,Stomach,Recurrent Uveal Melanoma,0
15285,Nodular (qualifier value),Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
15286,SPINK5 gene,Childhood Central Nervous System Ganglioneuroblastoma,0
15287,Lymphoma,Adenocarcinoma,0
15288,Severe (severity modifier),Bladder Neuroendocrine Neoplasm,0
15289,body system,Type II Endometrial Adenocarcinoma,0
15290,B-Cell Lymphomas,Malignant melanoma of eyelid,0
15291,Retinoic Acid Response Element,Recurrent Rhabdomyosarcoma,0
15292,How Often Weight Loss,Adrenal Rest Tumor,0
15293,Highest,Metaplastic carcinoma of breast,0
15294,Pharmacotherapy,Fibroadenoma of breast,0
15295,Often - answer to question,Malignant neoplasm of olfactory nerve,0
15296,Clinical Trials,Clonal Hematopoiesis of Indeterminate Potential,0
15297,Weight decreased,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15298,Firstly,High Grade Glandular Intraepithelial Neoplasia,0
15299,Abdominal Pain,Thymic Clear Cell Carcinoma,0
15300,shared attribute,Hereditary Diffuse Gastric Adenocarcinoma,0
15301,To,Intraepithelial Melanocytic Hyperplasia,0
15302,Living Alone,embryonal rhabdomyosarcoma of prostate,0
15303,Covered (qualifier value),Refractory Barrett Esophagus,0
15304,Individual,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
15305,Then,Chest Wall Fibromatosis,0
15306,Location,Localized Ewing Sarcoma,0
15307,Laboratory method,Recurrent Rhabdomyosarcoma,0
15308,Prolonged menses,Cervical Squamous Intraepithelial Neoplasia,0
15309,Site,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15310,Fluid behavior,Benign Anal Granular Cell Tumor,0
15311,Sometimes,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15312,Entity Determiner - specific,Breast Apocrine Adenoma,0
15313,Ephrin Type-B Receptor 1,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
15314,Specimen Source Codes - Respiratory,Intraepithelial Melanocytic Hyperplasia,0
15315,Capillary Leak Syndrome,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15316,Chemicals,Mucinous cystadenofibroma,0
15317,Intervention regimes,Tonsillar Carcinoma,0
15318,set (group),Gallbladder Adenocarcinoma,0
15319,Condition:Find:Pt:^Patient:Nom,Recurrent Primary Lymphoma of Bone,0
15320,Ability to balance,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15321,Capillary vessel,Tonsillar Carcinoma,0
15322,Prognosis bad,Adult Anaplastic Oligodendroglioma,0
15323,Lymphoma,Epithelioid Sarcoma NCI Grade 3,0
15324,Weight Loss,Thyroid Hurthle Cell Carcinoma,0
15325,Malignant Vaginal Neoplasm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15326,heterochromatin domain,Leptomeningeal sarcoma,0
15327,Crystals,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15328,Operative Surgical Procedures,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15329,Kissing,Thymic Clear Cell Carcinoma,0
15330,Anterior,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15331,Common Specifications in HL7 V3 Publishing,Peripheral primitive neuroectodermal tumor of soft tissue,0
15332,Abnormal cell,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
15333,Elderly (population group),Thyroid Hurthle Cell Carcinoma,0
15334,Formation,High Grade Glandular Intraepithelial Neoplasia,0
15335,Occurrence,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
15336,Malignant neoplasm of urinary bladder,Malignant Testicular Sertoli Cell Tumor,0
15337,Most,Diffuse malignant mesothelioma,0
15338,Basis - conceptual entity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15339,General surgery specialty,Occult Lung Adenosquamous Carcinoma,0
15340,Togo,Vaginal Adenoid Cystic Carcinoma,0
15341,Health,Precursor B-lymphoblastic lymphoma stage II,0
15342,Frequently,Childhood Central Nervous System Immature Teratoma,0
15343,Vaginal,Endometrial Small Cell Carcinoma,0
15344,Oral contraception,Thymic Clear Cell Carcinoma,0
15345,Account number:Identifier:Point in time:^Patient:Nominal,Fibroadenoma of breast,0
15346,Genus Anemia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15347,Illness (finding),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15348,Esophageal,Unicystic ameloblastoma,0
15349,99,Childhood Anaplastic Large Cell Lymphoma,0
15350,Code System Type - Internal,Vaginal Adenoma,0
15351,Endometrial Carcinoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
15352,cell type,adenosquamous carcinoma of breast,0
15353,Epidemic,Thyroid Hurthle Cell Carcinoma,0
15354,Liver Flavor,Vaginal Adenoid Cystic Carcinoma,0
15355,epithelial,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
15356,government - ActInformationManagementReason,Kaposi's sarcoma of skin,0
15357,Ovarian Hyperstimulation Syndrome,Larynx carcinoma recurrent,0
15358,Ovary,Localized Ewing Sarcoma,0
15359,Asia,Thymoma malignant recurrent,0
15360,Well,Bladder squamous cell carcinoma stage I,0
15361,Immunization Programs,Cerebral hemangioma,0
15362,Telephone Extension Number,Liver Lymphangioma,0
15363,Known,Pilocytic astrocytoma of cerebellum,0
15364,Example,Liver Lymphangioma,0
15365,Platelet Glycoprotein 4,Non-Metastatic Gestational Trophoblastic Tumor,0
15366,low confidentiality,Spongiotic dermatitis,0
15367,Carbohydrates,Small cell neuroendocrine carcinoma of bladder,0
15368,Strong,Primary Cutaneous Plasmablastic Lymphoma,0
15369,Negation,FIGO Stage IVA Ovarian Cancer,0
15370,Autosomal recessive inheritance,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15371,Chest wall structure,Platinum-Resistant Lung Small Cell Carcinoma,0
15372,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15373,Percent (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
15374,Five,Cancer of Urinary Tract,0
15375,Granulation Tissue,Ovarian germ cell choriocarcinoma stage IV,0
15376,treatment - ActInformationManagementReason,FIGO Stage II Ovarian Cancer,0
15377,Surrounding (qualifier value),Benign Carotid Body Paraganglioma,0
15378,Net (qualifier),Adenocarcinoma of the prostate metastatic,0
15379,Cerebrum,Human Papillomavirus-Related Carcinoma,0
15380,NCI CTEP SDC Melanoma Sub-Category Terminology,Malignant melanoma of eyelid,0
15381,Area,Engraftment syndrome,0
15382,Cause of death:Find:Pt:^Patient:Nom,Vaginal Adenoma,0
15383,Requirement,Neoplasms,0
15384,Large blood vessel structure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15385,Workplace,Liver Lymphangioma,0
15386,Malignant Neoplasms,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15387,Carcinoma,adenosquamous carcinoma of breast,0
15388,Vaginal Hemorrhage,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15389,Common Specifications in HL7 V3 Publishing,Diffuse malignant mesothelioma,0
15390,Sore Throat,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
15391,Muscle Tissue,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15392,various antiseptic throat preparations,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
15393,Smear - instruction imperative,Leptomeningeal sarcoma,0
15394,Class,Liver Lymphangioma,0
15395,Slow,Benign Anal Granular Cell Tumor,0
15396,New Zealand,Advanced Uterine Corpus Carcinosarcoma,0
15397,Either,Xeroderma pigmentosum,0
15398,70%,Congenital hamartoma,0
15399,high - ActExposureLevelCode,Gallbladder Adenocarcinoma,0
15400,Fever,Tongue Alveolar Soft Part Sarcoma,0
15401,Age,Acute lymphadenitis,0
15402,International Statistical Classification of Diseases and Related Health Problems,Thyroid Hurthle Cell Carcinoma,0
15403,Haemoconcentration,Refractory Bladder Carcinoma,0
15404,Function Axis,Microcystic meningioma,0
15405,Clone Cells,Cartilaginous exostosis,0
15406,700,Thyroid Hurthle Cell Carcinoma,0
15407,Including (qualifier),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15408,Borg Category-Ratio 10 Perceived Exertion Score 5,Refractory Ependymoma,0
15409,Primary malignant neoplasm,Cartilaginous exostosis,0
15410,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Lipoma of small intestine,0
15411,Rating (action),Hemangioma,0
15412,International Classification of Diseases for Oncology,Metastatic Kidney Carcinoma,0
15413,More,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15414,Disease Screening,Recurrent Testicular Lymphoma,0
15415,/40,Lung Mucinous Cystadenoma,0
15416,Asthma Control Test Questionnaire,Malignant melanoma of eyelid,0
15417,Cancer Etiology,Pancreatic carcinoma,0
15418,Malignant Cell Count,clear cell adenocarcinoma of gallbladder,0
15419,Rare,Cervical Squamous Intraepithelial Neoplasia,0
15420,Soft Tissue Route of Drug Administration,Xeroderma pigmentosum,0
15421,Lymphatic System,Benign tumor of eyelid,0
15422,Malignant Cell Count,Childhood Fibrillary Astrocytoma,0
15423,Unit of radiation dose,Blood Vessel Tumors,0
15424,Actinic keratosis,Stage 0 Lip Carcinoma,0
15425,Able (finding),Small cell neuroendocrine carcinoma of bladder,0
15426,Biospecimen,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15427,World,Adult Alveolar Soft Part Sarcoma,0
15428,CEL gene,Benign Apocrine Neoplasm,0
15429,DNA,Nasal cavity carcinoma,0
15430,<90,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15431,Cystic,Locally Advanced Epithelioid Hemangioendothelioma,0
15432,HUGO Gene Nomenclature Committee,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15433,CEL gene,Childhood Fibrillary Astrocytoma,0
15434,Availability of,Choroid Epithelioid Cell Melanoma,0
15435,84,embryonal rhabdomyosarcoma of prostate,0
15436,Classification,Mucinous adenocarcinoma gastric,0
15437,Surgery specialty,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15438,Poor oral hygiene,Childhood Central Nervous System Ganglioneuroblastoma,0
15439,Taxonomic,Tongue Alveolar Soft Part Sarcoma,0
15440,Only - dosing instruction fragment,Gallbladder Adenocarcinoma,0
15441,Area,Localized Askin Tumor,0
15442,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Human Papillomavirus-Related Carcinoma,0
15443,North America,Fourth Ventricle and Brain Stem Ependymal Tumor,0
15444,Symptoms aspect,Clonal Hematopoiesis of Indeterminate Potential,0
15445,Reported Term,Human Papillomavirus-Related Carcinoma,0
15446,Certain (qualifier value),Human Papillomavirus-Related Carcinoma,0
15447,Linear,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15448,Percent of Abnormal Cells,Human Papillomavirus-Related Carcinoma,0
15449,Lymphoma,Mixed parotid tumor,0
15450,United States,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
15451,Biologic Development,Kaposi's sarcoma of extrahepatic bile duct,0
15452,Rate,Childhood Anaplastic Large Cell Lymphoma,0
15453,Tumor Mass,Recurrent Uveal Melanoma,0
15454,Times,Giant cell angiofibroma,0
15455,Certain (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
15456,Administrative Division,Adrenal Rest Tumor,0
15457,Person Observer,Cerebral Primitive Neuroectodermal Tumor,0
15458,Qualitative form,Ovarian germ cell choriocarcinoma stage IV,0
15459,Benign,Tubal Hyperplasia,0
15460,Glioblastoma,Plexosarcoma,0
15461,Major,FIGO Stage IVA Ovarian Cancer,0
15462,Pituitary Hormones,Benign Anal Granular Cell Tumor,0
15463,Location,Mucinous adenocarcinoma gastric,0
15464,With staging,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15465,Does turn (finding),Benign Anal Granular Cell Tumor,0
15466,per year,Refractory Ependymoma,0
15467,Rarely malignant,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15468,Formation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15469,Slow,Childhood Central Nervous System Ganglioneuroblastoma,0
15470,Major,FIGO Stage II Ovarian Cancer,0
15471,Needs,Pancreatic carcinoma,0
15472,CDISC SEND Tumor Findings Results Terminology,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15473,Offspring,Refractory Barrett Esophagus,0
15474,Expression procedure,Multiple Skull Base Meningiomas,0
15475,Greater Than,Uterine Cancer,0
15476,Carcinoma breast stage IV,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15477,Mass of body structure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15478,Present,Type II Endometrial Adenocarcinoma,0
15479,Responsible to,malignant lymphoma of pancreatic lymph nodes,0
15480,Comparison,Intraepithelial Melanocytic Hyperplasia,0
15481,Menopause present (finding),Recurrent Uveal Melanoma,0
15482,Country number,Kaposi's sarcoma of extrahepatic bile duct,0
15483,Occur (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15484,Pain,Refractory Bladder Carcinoma,0
15485,Color change,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15486,Sequence Arm,Advanced Lung Carcinoma,0
15487,human papilloma virus type 16,Cystadenocarcinoma,0
15488,Group A (qualifier value),adenoid cystic carcinoma of lung,0
15489,Anatomy aspects,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15490,+5,embryonal rhabdomyosarcoma of prostate,0
15491,Hereditary,Acute Undifferentiated Leukemia,0
15492,Aspects of signs,Germinoma,0
15493,Usually Need Help from Another Person for Arising,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15494,Body tissue,Neoplasms,0
15495,Medullary carcinoma of thyroid,Multiple Skull Base Meningiomas,0
15496,Neoplastic disease,Unicystic ameloblastoma,0
15497,Identified,Stage IB Pancreatic Cancer AJCC v8,0
15498,Test Method,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
15499,Basis - conceptual entity,Platinum-Resistant Lung Small Cell Carcinoma,0
15500,In addition to,Stage I Colon Neuroendocrine Tumor AJCC v8,0
15501,Term (temporal),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15502,Clonality,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15503,Child,Cerebral Primitive Neuroectodermal Tumor,0
15504,Neuroepithelial,Necrotizing Funisitis,0
15505,Tryptophanase,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15506,Entire dorsal spinal cord,Extracranial Neuroblastoma,0
15507,PSA Level Greater than Fifty,Multiple Endocrine Neoplasia,0
15508,Thick,Benign Anal Granular Cell Tumor,0
15509,Expression (foundation metadata concept),Squamous cell carcinoma of lip,0
15510,Negative,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15511,Childhood Hodgkin Lymphoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15512,Temporal Lobe,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15513,Impaired skin integrity,Epithelioid Sarcoma NCI Grade 3,0
15514,Smear - instruction imperative,Intracortical osteosarcoma,0
15515,Tobacco,Medulloblastoma,0
15516,Abdomen+,Benign neoplasm of eye,0
15517,Imaging Techniques,Stage IB Lung Cancer AJCC v7,0
15518,Talpidae,Stage II Hepatocellular Carcinoma AJCC v8,0
15519,Teens,Giant cell angiofibroma,0
15520,Radiation Ionizing Radiotherapy,Mucinous adenocarcinoma gastric,0
15521,North America,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15522,Cancer Genus,Undifferentiated Endocervical Sarcoma,0
15523,Period Circadian Protein Homolog 1,Heavy Chain Deposition Disease,0
15524,Family history,Placental aromatase deficiency,0
15525,Cause of Death,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15526,Hematology procedure,Kaposi's sarcoma of skin,0
15527,Africa,Tubal Hyperplasia,0
15528,Efficacy Study,Adult Acute Eosinophilic Leukemia,0
15529,Linear,Uterine Cancer,0
15530,Sufficiently defined concept definition status (core metadata concept),Localized Ewing Sarcoma,0
15531,Maintaining (action),Methotrexate-Associated Hodgkin Lymphoma,0
15532,In Blood,Intraepithelial Melanocytic Hyperplasia,0
15533,risk factors - observation list,Kaposi's sarcoma of extrahepatic bile duct,0
15534,Increasing,Refractory Barrett Esophagus,0
15535,peripheral blood,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
15536,Type - attribute,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15537,Standard Treatment,Intestinal Metaplasia of Bladder Urothelium,0
15538,Entity,Ichthyoses,0
15539,Poor function,Carcinoma of urinary bladder,0
15540,Pain Distress Question,Bladder squamous cell carcinoma stage I,0
15541,Diffuse Large B-Cell Lymphoma,Benign Anal Granular Cell Tumor,0
15542,Patient Discharge,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
15543,Decade,carcinoma of middle ear,0
15544,Administration Method - Infiltrate,Uterine Cancer,0
15545,New,Bladder Neuroendocrine Neoplasm,0
15546,Chemotherapy Regimen,Xeroderma pigmentosum,0
15547,human herpesvirus 8,Low Grade Squamous Intraepithelial Neoplasia,0
15548,Specimen Source Codes - Mucus,Malignant melanoma of eyelid,0
15549,Blood Transfusion,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15550,Time,Low Grade Squamous Intraepithelial Neoplasia,0
15551,Mutation,Pilocytic astrocytoma of cerebellum,0
15552,Cerebellum,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15553,Growth abnormality,Astrocytoma of brain,0
15554,What subject filter - Result,Undifferentiated Endocervical Sarcoma,0
15555,Physical findings,Thymic Atypical Carcinoid Tumor,0
15556,Most,Lipoma of small intestine,0
15557,Occurrence,Pancreatic Endocrine Carcinoma,0
15558,Tryptophanase,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
15559,Form of bone,Unicystic ameloblastoma,0
15560,Neoplasm Metastasis,Diffuse malignant mesothelioma,0
15561,Increase,Trichilemmocarcinoma,0
15562,Hormones,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15563,ca increase,Pancreatic Intraepithelial Neoplasia-3,0
15564,Felis catus,Stage IV Penile Cancer AJCC v7,0
15565,Contact with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15566,Relationships,Melanomatosis,0
15567,Manufactured form,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
15568,Injury due to exposure to external cause,Precursor B-lymphoblastic lymphoma stage II,0
15569,Secondary Neoplasm,Primary Cutaneous Plasmablastic Lymphoma,0
15570,Body Site Modifier - Lower,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
15571,Females,Lipoma of small intestine,0
15572,Epithelial ovarian cancer,Serous cystadenocarcinoma ovary,0
15573,Fever,Mixed parotid tumor,0
15574,Hemangioma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15575,Percent normal,Xeroderma pigmentosum,0
15576,KAT5 wt Allele,Placental aromatase deficiency,0
15577,include - SetOperator,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15578,Percent (qualifier value),Unicystic ameloblastoma,0
15579,Colorectal Carcinoma,Nasal cavity carcinoma,0
15580,Tobacco smoking behavior,Precursor B-lymphoblastic lymphoma stage II,0
15581,Incidence,Recurrent Testicular Lymphoma,0
15582,Salivary Glands,Liver Lymphangioma,0
15583,Either,Germinoma,0
15584,Administration procedure,Granular Cell Leiomyosarcoma,0
15585,Average of Value Derivation Technique,Cerebral Primitive Neuroectodermal Tumor,0
15586,Near,Thyroid Hurthle Cell Carcinoma,0
15587,Seed entity,Extra-abdominal fibromatosis,0
15588,Frequently,Small cell neuroendocrine carcinoma of bladder,0
15589,SMG1 wt Allele,Female Breast Carcinoma,0
15590,Pediculus (eukaryote),Extra-Adrenal Paraganglioma,0
15591,research subject screening,Localized Malignant Neoplasm,0
15592,Part of,Engraftment syndrome,0
15593,Symptoms aspect,Benign squamous cell tumor,0
15594,Fatigue,Uterine Cancer,0
15595,Group A (qualifier value),Gallbladder Adenocarcinoma,0
15596,Established,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15597,Ki67 Measurement,Cystadenocarcinoma,0
15598,Usual Severity Weight Loss,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15599,Hemorrhagic Fevers,Recurrent Uveal Melanoma,0
15600,Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15601,Cause of Death,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15602,Skin,Childhood Anaplastic Large Cell Lymphoma,0
15603,Diagnosis,Undifferentiated Endocervical Sarcoma,0
15604,Bone Pain,Clonal Hematopoiesis of Indeterminate Potential,0
15605,Process (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15606,Unknown,Female Breast Carcinoma,0
15607,Less often,FIGO Stage IVA Ovarian Cancer,0
15608,Benign,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
15609,95,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15610,Disease,Pancreatic Endocrine Carcinoma,0
15611,Feelings,Deep Leiomyoma,0
15612,Occurrence,Choroid Necrotic Melanoma,0
15613,Infrequent,Malignant neoplasm of olfactory nerve,0
15614,Include (action),Pancreatic Intraepithelial Neoplasia-3,0
15615,Injury due to exposure to external cause,clear cell adenocarcinoma of gallbladder,0
15616,Term (lexical),Recurrent Testicular Lymphoma,0
15617,Secondary Neoplasm,Pancreatic Endocrine Carcinoma,0
15618,Unknown GENC,Cancer of Urinary Tract,0
15619,Administration procedure,BRCA2 Syndrome,0
15620,Present,Gallbladder Adenocarcinoma,0
15621,Order (arrangement),Benign tumor of eyelid,0
15622,melanoma,Astrocytoma of brain,0
15623,Computed Tomography Study File,Malignant neoplasm of choroid,0
15624,Series - set of composite instances,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15625,degree of relationship - exchange,Bladder squamous cell carcinoma stage I,0
15626,Reported Term,Melanomatosis,0
15627,Symptoms,Familial Hemophagocytic Lymphocytosis,0
15628,Result,Malignant melanoma of eyelid,0
15629,combination of objects,Hodgkin lymphoma,0
15630,Aspect (characteristic),Familial Adenomatous Polyposis Associated Medulloblastoma,0
15631,include - SetOperator,Acute Undifferentiated Leukemia,0
15632,NCI CTEP SDC Melanoma Sub-Category Terminology,Breast Ductal Adenoma,0
15633,Small cell carcinoma of lung,Chest Wall Fibromatosis,0
15634,Case Study,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15635,Ultraviolet Rays,Diffuse malignant mesothelioma,0
15636,Slow,Nasal cavity carcinoma,0
15637,More,Multiple Skull Base Meningiomas,0
15638,Worse,BRCA2 Syndrome,0
15639,Target Lesion Identification,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15640,Undifferentiated Neuroblastoma,Undifferentiated Endocervical Sarcoma,0
15641,Carcinoma,gliosarcoma,0
15642,Uncontrolled,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15643,Form of uterus,gliosarcoma,0
15644,Lower - spatial qualifier,Human Papillomavirus-Related Carcinoma,0
15645,Medulloblastoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15646,Two,Malignant Neoplasm of Lung - Multiple Primary Sites,0
15647,AKR1A1 wt Allele,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15648,Common (qualifier value),Tumorlet,0
15649,Centrocytic lymphoma,gliosarcoma,0
15650,Present,Hereditary Diffuse Gastric Adenocarcinoma,0
15651,Cervical Squamous Cell Carcinoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15652,Science of Etiology,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15653,Zone,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15654,TRIM33 wt Allele,Localized Ewing Sarcoma,0
15655,English Language,Pancreatic Intraepithelial Neoplasia-3,0
15656,Treatment Epoch,Stage IV Childhood Non-Hodgkin Lymphoma,0
15657,Less Than,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15658,Location of Oral Residue Following Swallowing,papillary carcinoma of penis,0
15659,Pharyngeal structure,Stage IB Pancreatic Cancer AJCC v8,0
15660,Pleomorphism,Ectomesenchymal Chondromyxoid Tumor,0
15661,Abnormal,Clonal Hematopoiesis of Indeterminate Potential,0
15662,Antibiotics,Thymic Atypical Carcinoid Tumor,0
15663,Spreading (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
15664,combination of objects,Stage IB Pancreatic Cancer AJCC v8,0
15665,Feelings,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15666,Rare,Placental aromatase deficiency,0
15667,Percent of Abnormal Cells,Mucosal Melanoma,0
15668,World,Hemangioma,0
15669,Magnetic Resonance Imaging,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
15670,Colorectal Cancer Pathway,Familial Hemophagocytic Lymphocytosis,0
15671,Case unit dose,Vaginal Adenoma,0
15672,Carrying,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15673,Operative Surgical Procedures,Testicular cancer metastatic,0
15674,Occur (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
15675,Frequently,Neonatal leukemia,0
15676,Malignant neoplasm of urinary bladder,Kaposi's sarcoma of extrahepatic bile duct,0
15677,Cure (remedy),Undifferentiated Endocervical Sarcoma,0
15678,Fever,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
15679,Scientific Study,Platinum-Resistant Lung Small Cell Carcinoma,0
15680,Y base,Recurrent Rhabdomyosarcoma,0
15681,How Much Distress Weight Loss,Vaginal Adenoma,0
15682,User Group,Testicular cancer metastatic,0
15683,Presentation,Tongue Alveolar Soft Part Sarcoma,0
15684,Two,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15685,Growth pattern,Atypical Lobular Breast Hyperplasia,0
15686,80%,Cerebral Primitive Neuroectodermal Tumor,0
15687,combination - answer to question,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15688,Persons,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
15689,Due to,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15690,artesunate,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15691,Normal pregnancy,Tubal Hyperplasia,0
15692,Pregnancy,Glomeruloid hemangioma,0
15693,Include (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15694,Administration procedure,Placental aromatase deficiency,0
15695,Usually Need Help from Another Person for Arising,Peripheral primitive neuroectodermal tumor of soft tissue,0
15696,IPSS Risk Category Low,Heavy Chain Deposition Disease,0
15697,Main,Benign Ovarian Thecoma,0
15698,Increasing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15699,Back Pain,Type II Endometrial Adenocarcinoma,0
15700,Catch - Finding of sensory dimension of pain,Stage III Cutaneous Melanoma AJCC v6,0
15701,Mediate,FIGO Stage II Ovarian Cancer,0
15702,Initially,Clonal Hematopoiesis of Indeterminate Potential,0
15703,Experimental Organism Basal Cell Carcinoma,sarcoma of spinal cord,0
15704,Child,Diffuse malignant mesothelioma,0
15705,Mature,Cerebral hemangioma,0
15706,DNA,Malignant Neoplasm with Regional Lymph Node Involvement,0
15707,English race,Carcinoma of submandibular gland,0
15708,Continuance of life,Squamous cell carcinoma of lip,0
15709,Include (action),Adenocarcinoma,0
15710,Choose (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
15711,Cornea,Atypical Lobular Breast Hyperplasia,0
15712,Before values,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15713,Less Than,Neonatal leukemia,0
15714,Manufactured form,Diffuse malignant mesothelioma,0
15715,Breast Carcinoma,Nasal cavity carcinoma,0
15716,Pelvic Pain,Adult Acute Eosinophilic Leukemia,0
15717,Include (action),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
15718,Image Feature,Childhood Fibrillary Astrocytoma,0
15719,Occurrence,Endometrial Small Cell Carcinoma,0
15720,Fourth,Intestinal Neuroendocrine Carcinoma,0
15721,Excision biopsy,Maxillary Sinus Adenocarcinoma,0
15722,1000000,Ovarian Carcinoid Tumor,0
15723,Decision,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15724,Left,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15725,Science of Etiology,Liver Lymphangioma,0
15726,Late,Metastatic Ductal Breast Carcinoma,0
15727,Glioblastoma Multiforme Pathway,Melanomatosis,0
15728,Edema,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15729,More,Pilocytic astrocytoma of cerebellum,0
15730,Management procedure,Lung squamous cell carcinoma stage I,0
15731,high - ActExposureLevelCode,Uterine Cancer,0
15732,Group A (blood group),Astrocytoma of brain,0
15733,Brain Neoplasms,Ovarian germ cell choriocarcinoma stage IV,0
15734,include - SetOperator,Anterior Urethral Malignant Neoplasm,0
15735,Responsible to,Melanomatosis,0
15736,Cardiac Arrest,Endometrial Small Cell Carcinoma,0
15737,Structure of left half of body,Adenocarcinoma,0
15738,Rate,Splenic Manifestation of Hairy Cell Leukemia,0
15739,Infection,Cervical Fibroepithelial Polyp,0
15740,Strikes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15741,Fishes,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15742,Tryptophanase,adenoid cystic carcinoma of lung,0
15743,Dietary Lead,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15744,Persons,Malignant Testicular Sertoli Cell Tumor,0
15745,Slide (glass microscope),Mucinous adenocarcinoma gastric,0
15746,Cure (remedy),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15747,Pleomorphic Xanthoastrocytoma,Malignant Testicular Sertoli Cell Tumor,0
15748,Progress,Refractory Ependymoma,0
15749,Offspring,Contact dermatitis due to alkali,0
15750,Injury due to exposure to external cause,Blepharal carcinoma,0
15751,Person Observer,Anterior Urethral Malignant Neoplasm,0
15752,suggestion,Malignant Neoplasm with Regional Lymph Node Involvement,0
15753,Optic Nerve,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
15754,World,Transitional cell carcinoma,0
15755,Affect (mental function),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15756,gene therapy,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
15757,Term (lexical),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15758,Mass,Malignant Neoplasm with Regional Lymph Node Involvement,0
15759,Linear,Locally Advanced Squamous Cell Carcinoma,0
15760,Imaging Techniques,Familial Adenomatous Polyposis Associated Medulloblastoma,0
15761,Image Feature,Adult Fibrolamellar Carcinoma,0
15762,Egg of order Phthiraptera,Adult Anaplastic Oligodendroglioma,0
15763,Severe (severity modifier),Atypical Mesothelial Hyperplasia,0
15764,Weight decreased,Recurrent Uveal Melanoma,0
15765,radiotherapeutic,ICHTHYOSIS,0
15766,Nucleotide Excision Repair,Metastatic Lung Small Cell Carcinoma,0
15767,Mesenchymal Cell Neoplasm,Leiomyoma of Gallbladder,0
15768,Adult Children,gliosarcoma,0
15769,Primary malignant neoplasm,Adult Acute Eosinophilic Leukemia,0
15770,Spreading (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15771,Body Site Modifier - Lower,Cancer of Urinary Tract,0
15772,Mesenchymal Stem Cells,Stage IV Penile Cancer AJCC v7,0
15773,various other intestinal adsorbents in ATC,Refractory Ependymoma,0
15774,Night sweats,Childhood Fibrillary Astrocytoma,0
15775,Stage Grouping,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
15776,Cyst,Ovarian Dermoid Cyst with Secondary Carcinoma,0
15777,Genital infection,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
15778,Pleomorphism (morphologic abnormality),High Grade Salivary Gland Mucoepidermoid Carcinoma,0
15779,Pediatric Neoplasm,Thyroid Hurthle Cell Carcinoma,0
15780,Array Feature,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15781,Diagnostic Imaging,Malignant Testicular Sertoli Cell Tumor,0
15782,Negation,Type II Endometrial Adenocarcinoma,0
15783,Leads (device),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15784,Interstitial Fluid,Chondrosarcoma,0
15785,White blood cell count normal,Mucinous adenocarcinoma gastric,0
15786,Dysuria,Stage 0 Penile Cancer AJCC v8,0
15787,PSA Level Greater than Fifty,Benign tumor of eyelid,0
15788,HLA Complex,Unicystic ameloblastoma,0
15789,Fibroid Tumor,Melanomatosis,0
15790,activate biological process,Methotrexate-Associated Hodgkin Lymphoma,0
15791,risk factors,Carcinoma of urinary bladder,0
15792,Net (qualifier),Malignant neoplasm of choroid,0
15793,Follicle,adenoid cystic carcinoma of lung,0
15794,presently,Angiosarcoma of liver,0
15795,Rare,Epithelioid Sarcoma NCI Grade 3,0
15796,Primary malignant neoplasm,Ovarian germ cell choriocarcinoma stage IV,0
15797,Usually,Blood Vessel Tumors,0
15798,Associated with,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
15799,various other agents for local oral treatment in ATC,Metastatic Lung Small Cell Carcinoma,0
15800,Death NOS,Cancer of Urinary Tract,0
15801,Exposure to ionizing radiation,High Grade Glandular Intraepithelial Neoplasia,0
15802,99,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
15803,Inguinal region,Blood Vessel Tumors,0
15804,Only - dosing instruction fragment,Adenocarcinoma of the prostate metastatic,0
15805,Northern Europe,Astrocytoma of brain,0
15806,Possibly Related to Intervention,Non-Hodgkin Lymphoma During Pregnancy,0
15807,consideration,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15808,Carcinoma of larynx,Uterine Cancer,0
15809,63,Maxillary Sinus Adenocarcinoma,0
15810,Papillary Thyroid Carcinoma Pathway,Primary Cutaneous Plasmablastic Lymphoma,0
15811,Can Do Very Little,High Grade Glandular Intraepithelial Neoplasia,0
15812,Liver Flavor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15813,Early,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15814,Congenital qualifier,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15815,Tissue Specimen Code,squamous cell carcinoma of the thyroid gland,0
15816,Calcium Channel Blockers,Cancer of Urinary Tract,0
15817,Mobility aid,embryonal rhabdomyosarcoma of prostate,0
15818,Spreading (qualifier value),Kaposi's sarcoma of skin,0
15819,Due to,Locally Advanced Squamous Cell Carcinoma,0
15820,Germ cell tumor,Diffuse malignant mesothelioma,0
15821,Taxonomic,Botryoid-Type Embryonal Rhabdomyosarcoma,0
15822,Liver,Childhood Lung Non-Small Cell Carcinoma,0
15823,Abnormal Reference Range,Maxillary Sinus Adenocarcinoma,0
15824,Related personal status,Recurrent Testicular Lymphoma,0
15825,Late,Bladder adenocarcinoma stage IV,0
15826,Symptoms,Lipoma of small intestine,0
15827,Known,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15828,Sexually Transmitted Diseases,Carcinoma ex pleomorphic adenoma of parotid gland,0
15829,Occur (action),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
15830,Active,FIGO Stage IVA Ovarian Cancer,0
15831,Affect (mental function),Chondrosarcoma,0
15832,Anterior,adenosquamous carcinoma of breast,0
15833,Account number:Identifier:Point in time:^Patient:Nominal,Rhabdomyosarcoma with ganglionic differentiation,0
15834,Weight decreased,Childhood Choriocarcinoma,0
15835,Prognosis:Find:Pt:^Patient:Nom,FIGO Stage IVA Ovarian Cancer,0
15836,Object Class,Benign Carotid Body Paraganglioma,0
15837,3+ Answer to Question,BRCA2 Syndrome,0
15838,Jack Device,Granular Cell Leiomyosarcoma,0
15839,Group A (qualifier value),Squamous cell carcinoma of lip,0
15840,Arranged (transportation),Cervical Fibroepithelial Polyp,0
15841,Cell Count,Clonal Hematopoiesis of Indeterminate Potential,0
15842,Smear - instruction imperative,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15843,Part of,Mucinous neoplasm,0
15844,Treating,Undifferentiated Neuroblastoma,0
15845,Usually,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15846,Manufactured sign,Locally Advanced Carcinoma,0
15847,Rare,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15848,Infiltration Route of Drug Administration,gliosarcoma,0
15849,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Uterine Cancer,0
15850,Mathematical Operator,Locally Advanced Epithelioid Hemangioendothelioma,0
15851,Transformation,Unicystic ameloblastoma,0
15852,Obesity,Gallbladder Adenocarcinoma,0
15853,treatment - ActInformationManagementReason,Stage IB Pancreatic Cancer AJCC v8,0
15854,Vagina Carcinoma,Vaginal Adenoma,0
15855,Indexes,Uterine Cancer,0
15856,lobe,Lipoma of small intestine,0
15857,Much,Brain Ependymoma,0
15858,Cure (remedy),Adult Acute Eosinophilic Leukemia,0
15859,use of ultrasonography,Adult Alveolar Soft Part Sarcoma,0
15860,Unintentional,Stage II Hepatocellular Carcinoma AJCC v8,0
15861,Response to treatment,Chronic Myelomonocytic Leukemia-2,0
15862,Malignant Neoplasms,Precursor B-lymphoblastic lymphoma stage II,0
15863,Beginning,Tubal Hyperplasia,0
15864,Cervical lymph node group,Astrocytoma of brain,0
15865,Stensen's duct,Mucosal Melanoma,0
15866,Childhood Lymphoma,malignant lymphoma of pancreatic lymph nodes,0
15867,Does carry,Childhood Anaplastic Large Cell Lymphoma,0
15868,Qualitative form,Localized Askin Tumor,0
15869,Drain number:ID:Pt:^Patient:Nom,Noninfiltrating Intraductal Carcinoma,0
15870,Usual Severity Vomiting,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15871,Aggressive course,Hodgkin lymphoma,0
15872,How Often Weight Loss,Adult Alveolar Soft Part Sarcoma,0
15873,entry - cluster,Bladder adenocarcinoma stage IV,0
15874,Tobacco smoking behavior,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
15875,Lymphatic System,Choroid Epithelioid Cell Melanoma,0
15876,Mean Percent of Normal,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15877,Hereditary Diseases,Thymic Clear Cell Carcinoma,0
15878,Body part,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
15879,Lung,Undifferentiated Endocervical Sarcoma,0
15880,Germ cell tumor,Stage III Cutaneous Melanoma AJCC v6,0
15881,Support,Maxillary Sinus Adenoid Cystic Carcinoma,0
15882,Rosette formation,Bladder squamous cell carcinoma stage I,0
15883,Palmitic Acid,Cervical Fibroepithelial Polyp,0
15884,Dyspnea,Periosteal Osteosarcoma,0
15885,Numbers,papillary carcinoma of penis,0
15886,Mature Lymphocyte,Recurrent Testicular Lymphoma,0
15887,Egg of order Phthiraptera,Peripheral primitive neuroectodermal tumor of soft tissue,0
15888,Responsible to,Benign Anal Granular Cell Tumor,0
15889,Alcohols,Airway Hemangioma,0
15890,Pax (eukaryote),Carcinoma of urinary bladder,0
15891,Therapeutic procedure,Maxillary Sinus Adenocarcinoma,0
15892,Long Variable,Chest Wall Fibromatosis,0
15893,Cell Invasion,Stage III Cutaneous Melanoma AJCC v6,0
15894,Pharmacologic Substance,Hodgkin lymphoma,0
15895,Diffuse Large B-Cell Lymphoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
15896,World Health Organization,Plexosarcoma,0
15897,International Classification of Diseases for Oncology,Recurrent Uveal Melanoma,0
15898,Retained,Diffuse malignant mesothelioma,0
15899,Spreading (qualifier value),Non-Metastatic Gestational Trophoblastic Tumor,0
15900,In Blood,Adenocarcinoma,0
15901,insensitivity,Chondrosarcoma,0
15902,Cessation of life,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
15903,White Blood Cell Count procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
15904,Occur (action),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
15905,Family history,Childhood Anaplastic Large Cell Lymphoma,0
15906,Diagnostic Neoplasm Staging,Kaposi's sarcoma of extrahepatic bile duct,0
15907,Affect (mental function),Malignant melanoma of eyelid,0
15908,Notch Receptor Intracellular Domain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15909,Retraction (finding),Ovarian germ cell choriocarcinoma stage IV,0
15910,Rare,Recurrent Testicular Lymphoma,0
15911,Name (property) (qualifier value),Acute lymphadenitis,0
15912,Administration procedure,FIGO Stage IVA Ovarian Cancer,0
15913,Enhance (action),Malignant Testicular Sertoli Cell Tumor,0
15914,Mohs Surgery,Intestinal Neuroendocrine Carcinoma,0
15915,Malignant - descriptor,gliosarcoma,0
15916,Susceptible,Carcinoma,0
15917,Increasing,Recurrent Testicular Lymphoma,0
15918,Malignant - descriptor,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
15919,Diagnostic Imaging,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
15920,Maxilla,Kaposi's sarcoma of extrahepatic bile duct,0
15921,Version,Colorectal Neuroendocrine Tumor G2,0
15922,Infrequent,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
15923,Main,FIGO Stage IVA Ovarian Cancer,0
15924,Sometimes,Basal Cell Ameloblastoma,0
15925,Dyspareunia,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
15926,Fibromatosis,embryonal rhabdomyosarcoma of prostate,0
15927,Present,Childhood Fibrillary Astrocytoma,0
15928,Smear - instruction imperative,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
15929,Air (substance),mucinous adenocarcinoma of gallbladder,0
15930,Defense,Clinical Stage I Cutaneous Melanoma AJCC v8,0
15931,HER-2-neu peptide vaccine,Intraepithelial Melanocytic Hyperplasia,0
15932,Administrative Division,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
15933,Pain Distress Question,Contact dermatitis due to alkali,0
15934,Genetic,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
15935,Two,Benign Anal Granular Cell Tumor,0
15936,Both ovaries,Adult Acute Eosinophilic Leukemia,0
15937,Symptoms,Small intestine carcinoma,0
15938,Referring,Astrocytoma of brain,0
15939,Ovary,Atypical Lobular Breast Hyperplasia,0
15940,Techniques,Cerebral Primitive Neuroectodermal Tumor,0
15941,Hematogenous spread,Melanomatosis,0
15942,NCI CTEP SDC Adrenal Cancer Sub-Category Terminology,Undifferentiated Endocervical Sarcoma,0
15943,Subtype (attribute),Nasal cavity carcinoma,0
15944,Persons,Thymic Clear Cell Carcinoma,0
15945,Rare,Stage II Carcinoma of Penis,0
15946,Include (action),Platinum-Resistant Lung Small Cell Carcinoma,0
15947,Personal appearance,clear cell adenocarcinoma of gallbladder,0
15948,Constant (qualifier),Digestive System Hodgkin Lymphoma,0
15949,Death (finding),Cervical Adenomyoma,0
15950,Include (action),Hereditary Diffuse Gastric Adenocarcinoma,0
15951,Main,Familial Hemophagocytic Lymphocytosis,0
15952,Extrinsic,Carcinoma of urinary bladder,0
15953,Gram per Deciliter,Diffuse malignant mesothelioma,0
15954,Classification of information,Anterior Urethral Malignant Neoplasm,0
15955,Case (situation),Cystadenocarcinoma,0
15956,More,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
15957,Malignant - descriptor,Kaposi's sarcoma of extrahepatic bile duct,0
15958,Amount type - Percentage,Advanced Uterine Corpus Carcinosarcoma,0
15959,Less Than,Diffuse malignant mesothelioma,0
15960,Five-year Survival Rate,Refractory Barrett Esophagus,0
15961,Misdiagnosis,Non-Metastatic Gestational Trophoblastic Tumor,0
15962,Impaired skin integrity,Hodgkin lymphoma,0
15963,Adenocarcinoma,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
15964,Object Class,Benign Carotid Body Paraganglioma,0
15965,Iris <angiosperm>,Type II Endometrial Adenocarcinoma,0
15966,Proline,Localized Ewing Sarcoma,0
15967,Inferior,Non-Metastatic Gestational Trophoblastic Tumor,0
15968,Most,Benign Apocrine Neoplasm,0
15969,depend,sarcoma of spinal cord,0
15970,Positive Charge,Childhood Thyroid Gland Follicular Carcinoma,0
15971,Primary,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
15972,Local,Primary Cutaneous Plasmablastic Lymphoma,0
15973,Use of,Small cell neuroendocrine carcinoma of bladder,0
15974,status - In progress,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
15975,Histologic,Stage III Adult Immunoblastic Lymphoma,0
15976,Adult Diffuse Large B-Cell Lymphoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
15977,Ligaments,Kaposi's sarcoma of extrahepatic bile duct,0
15978,Cold Sensation,Pleomorphic adenoma of parotid gland,0
15979,Sharing (Social Behavior),Occult Lung Adenosquamous Carcinoma,0
15980,Severe Extremity Pain,Stage III Cutaneous Melanoma AJCC v6,0
15981,Fever,Intraepithelial Melanocytic Hyperplasia,0
15982,Code,Werner Syndrome,0
15983,Including (qualifier),Liver Lymphangioma,0
15984,Condition,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
15985,Fever symptoms (finding),Trabecular adenocarcinoma,0
15986,Thymic epithelial tumor,Refractory Barrett Esophagus,0
15987,Unintentional Material Aspiration,benign mature teratoma of pancreas,0
15988,Subtype (attribute),Funisitis (disorder),0
15989,Death (finding),Childhood Lymphoma,0
15990,Common (qualifier value),Medulloblastoma,0
15991,Continuance of life,Kaposi's sarcoma of extrahepatic bile duct,0
15992,Body site,Acantholytic squamous cell carcinoma,0
15993,Feature,Rhabdomyosarcoma with ganglionic differentiation,0
15994,Ascites,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
15995,Primary,Microcystic meningioma,0
15996,include - SetOperator,Vaginal Adenoma,0
15997,Aggressive behavior,Benign neoplasm of eye,0
15998,Confusion,Microcystic meningioma,0
15999,Same,Stage IB Lung Cancer AJCC v7,0
16000,Lifetime,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16001,Qualitative form,Giant cell angiofibroma,0
16002,Diffuse Large B-Cell Lymphoma,Digestive System Hodgkin Lymphoma,0
16003,Average,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
16004,Cancer of Lip,Carcinoma of urinary bladder,0
16005,Chewing,Stage 0 Lip Carcinoma,0
16006,Case (situation),Heavy Chain Deposition Disease,0
16007,Have Weight Loss,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16008,N+ (tumor staging),FIGO Stage II Ovarian Cancer,0
16009,Greater,Angiosarcoma of liver,0
16010,Smaller,Locally Advanced Epithelioid Hemangioendothelioma,0
16011,Adrenal Cancer,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16012,atypia morphology,Malignant Neoplasm with Regional Lymph Node Involvement,0
16013,Financial Account,embryonal rhabdomyosarcoma of prostate,0
16014,Specialized Stand Alone Plan - Vision,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16015,Melanocytic nevus,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16016,Sharing (Social Behavior),Ovarian Dermoid Cyst with Secondary Carcinoma,0
16017,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16018,Osteoporosis,Chest Wall Fibromatosis,0
16019,Physical shape,Tonsillar Carcinoma,0
16020,Pancreas,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16021,Body part,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16022,Time,Malignant neoplasm of subglottis,0
16023,Formation,Familial Hemophagocytic Lymphocytosis,0
16024,Fatigue,Stage II Carcinoma of Penis,0
16025,Abnormal cell,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16026,common types,FIGO Stage IVA Ovarian Cancer,0
16027,Detached,Pilocytic astrocytoma of cerebellum,0
16028,Carcinoma of lung,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
16029,VARIOUS DRUG CLASSES IN ATC,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16030,Aggressive course,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
16031,Pale feces (finding),Placental aromatase deficiency,0
16032,Immune system,Endometrial Small Cell Carcinoma,0
16033,Primary malignant neoplasm,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16034,Left,Angiosarcoma of liver,0
16035,diagnosis aspect,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16036,Malignant Neoplasms,Mucinous adenocarcinoma gastric,0
16037,High,Giant cell angiofibroma,0
16038,Diagnosis Study,Testicular cancer metastatic,0
16039,Type A,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16040,Mutation,Acinar cell carcinoma of pancreas,0
16041,Common Specifications in HL7 V3 Publishing,Acute Undifferentiated Leukemia,0
16042,A Codes,Stage IV Colorectal Cancer AJCC v8,0
16043,Australia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16044,Presence (property),Lung squamous cell carcinoma stage I,0
16045,Related personal status,Mixed astrocytoma-ependymoma,0
16046,Reaching,benign mature teratoma of pancreas,0
16047,Decreasing,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16048,shared attribute,Mixed astrocytoma-ependymoma,0
16049,therapeutic aspects,Precursor B-lymphoblastic lymphoma stage II,0
16050,Base of the Brain,Mucinous adenocarcinoma gastric,0
16051,Primary,Blepharal carcinoma,0
16052,Skin Specimen,Hodgkin lymphoma,0
16053,Smoking,Papillary squamous cell carcinoma,0
16054,High Level,Intracortical osteosarcoma,0
16055,Spreading (qualifier value),Cerebral Primitive Neuroectodermal Tumor,0
16056,Identified,Malignant melanoma of eyelid,0
16057,Feel Tired question,Intraepithelial Melanocytic Hyperplasia,0
16058,Occur (action),Metastatic Malignant Neoplasm in the Sellar Region,0
16059,Fibrous,Intraepithelial Melanocytic Hyperplasia,0
16060,Blood flow,Anaplastic large cell lymphoma,0
16061,Name (property) (qualifier value),FIGO Stage II Ovarian Cancer,0
16062,Platelet Glycoprotein 4,Intestinal Metaplasia of Bladder Urothelium,0
16063,Ultraviolet Light Sterilization,Pancreatic Intraepithelial Neoplasia-3,0
16064,International Classification of Disease for Oncology,Ovarian Dermoid Cyst with Secondary Carcinoma,0
16065,Death (finding),Carcinoma ex pleomorphic adenoma of parotid gland,0
16066,80%,ROSE Cluster 3,0
16067,Immature Lymphocytes Measurement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16068,Nervous system structure,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16069,Person 1,Hair nevus,0
16070,Precision - second,Pancreatic Endocrine Carcinoma,0
16071,Urine looks dark,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16072,Peripheral T-Cell Lymphoma,Malignant melanoma of eyelid,0
16073,AKR1A1 wt Allele,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16074,Two,Intestinal Metaplasia of Bladder Urothelium,0
16075,Primary malignant neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16076,Before,Primary Cutaneous Plasmablastic Lymphoma,0
16077,Carcinoma,Mucinous adenocarcinoma gastric,0
16078,Covers (device),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16079,Pap smear,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16080,Options,Heavy Chain Deposition Disease,0
16081,Biopsy,Recurrent Testicular Lymphoma,0
16082,Diabetes,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16083,high - ActExposureLevelCode,Human Papillomavirus-Related Carcinoma,0
16084,Poor function,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16085,Neoplasms,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16086,Acquired lymphangioma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16087,Active License,Benign Anal Granular Cell Tumor,0
16088,65+,Liver Lymphangioma,0
16089,respiratory,Metastatic Lung Neuroendocrine Neoplasm,0
16090,Formation,Stage IB Pancreatic Cancer AJCC v8,0
16091,Body tissue,Metastatic Malignant Neoplasm in the Sellar Region,0
16092,Well Differentiated,Recurrent Rhabdomyosarcoma,0
16093,Neuroectodermal Tumor,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16094,Adverse Event Associated with Vascular,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16095,<90,Adenocarcinoma of duodenum,0
16096,Malignant - descriptor,Breast Apocrine Adenoma,0
16097,Etiology,Metastatic Neoplasm to the Gallbladder,0
16098,Tryptophanase,Congenital hamartoma,0
16099,Neoplasm Metastasis,Secondary malignant neoplasm of lymph node,0
16100,False Discovery Rate,Pancreatic Intraepithelial Neoplasia-3,0
16101,avoidance,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16102,Sensation quality,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
16103,Basis - conceptual entity,Tubal Hyperplasia,0
16104,Malignant Neoplasms,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
16105,Therapeutic radiology procedure,Refractory Ependymoma,0
16106,Tryptophanase,Kaposi's sarcoma of extrahepatic bile duct,0
16107,Armpit,Cartilaginous exostosis,0
16108,Gland,Localized Malignant Neoplasm,0
16109,Cavitation,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16110,Biopsy,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
16111,Example,Stage I Adult Non-Hodgkin Lymphoma,0
16112,High Mitosis-Karyorrhexis Index,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16113,Overall Publication Type,Plexosarcoma,0
16114,Feature,Metaplastic carcinoma of breast,0
16115,Family,Localized Askin Tumor,0
16116,Etiology aspects,Mucosal Melanoma,0
16117,Specimen Source Codes - tumor,Adult Anaplastic Oligodendroglioma,0
16118,Oral (intended site),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16119,What subject filter - Result,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16120,Third grade in elementary school,Maxillary Sinus Adenocarcinoma,0
16121,Location,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16122,Togo,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16123,Melanoma Pathway,Intestinal Metaplasia of Bladder Urothelium,0
16124,Observation of color of skin,Mucinous adenocarcinoma gastric,0
16125,treatment - ActInformationManagementReason,Melanomatosis,0
16126,Throat,Choroid Epithelioid Cell Melanoma,0
16127,Usual Severity Shortness of Breath,Hemangioma,0
16128,Admixture,Cancer of Urinary Tract,0
16129,Enlarged,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16130,Infection,Intracortical osteosarcoma,0
16131,Germ,Endometrial Small Cell Carcinoma,0
16132,Supportive assistance,Bladder adenocarcinoma stage IV,0
16133,Metastasis,Cancer of Urinary Tract,0
16134,seen,Ovarian Carcinoid Tumor,0
16135,Nearly,Acute Undifferentiated Leukemia,0
16136,60%,Stage 0 Lip Carcinoma,0
16137,General surgery specialty,Bladder adenocarcinoma stage IV,0
16138,Area,Childhood Central Nervous System Immature Teratoma,0
16139,Screening,Precursor B-lymphoblastic lymphoma stage II,0
16140,Condition,Malignant neoplasm of choroid,0
16141,MOSTLY,Atypical Mesothelial Hyperplasia,0
16142,Evaluation,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16143,Lymphoid Cells,Acantholytic squamous cell carcinoma,0
16144,Including (qualifier),Recurrent Uveal Melanoma,0
16145,Pelvic Pain,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16146,Appearance,Astrocytoma of brain,0
16147,Death (finding),Neonatal leukemia,0
16148,Present,squamous cell carcinoma of the thyroid gland,0
16149,Age,Stage I Colon Neuroendocrine Tumor AJCC v8,0
16150,Second Primary Cancers,Multiple Endocrine Neoplasia,0
16151,Skin Pigmentation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16152,pathologic fistula,Childhood Extragonadal Malignant Germ Cell Tumor,0
16153,Adrenal Gland Pheochromocytoma,Undifferentiated Endocervical Sarcoma,0
16154,PCYT1A wt Allele,Carcinoma ex pleomorphic adenoma of parotid gland,0
16155,Lung,Pancreatic Intraepithelial Neoplasia-3,0
16156,Squamous cell carcinoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
16157,Etiology aspects,Tongue Alveolar Soft Part Sarcoma,0
16158,Lethal,Cervical Fibroepithelial Polyp,0
16159,More,Non-Metastatic Gestational Trophoblastic Tumor,0
16160,geographic population,Intestinal Metaplasia of Bladder Urothelium,0
16161,SLC6A2 protein,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16162,Clear,Chronic Myelomonocytic Leukemia-2,0
16163,Manufactured form,Extra-abdominal fibromatosis,0
16164,Rate,Mucosal Melanoma,0
16165,Suspected diagnosis,Astrocytoma of brain,0
16166,Case (situation),Platinum-Resistant Lung Small Cell Carcinoma,0
16167,+2,Intraepithelial Melanocytic Hyperplasia,0
16168,Collections (publication),Cerebral Primitive Neuroectodermal Tumor,0
16169,Lymphocyte production,Unicystic ameloblastoma,0
16170,include - SetOperator,Nasal cavity carcinoma,0
16171,Overall,Mucinous cystadenofibroma,0
16172,Togo,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
16173,Assortment,Female Breast Carcinoma,0
16174,Finding,Neoplasms,0
16175,Third,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16176,Science of Etiology,Recurrent Uveal Melanoma,0
16177,<90,Intestinal Neuroendocrine Carcinoma,0
16178,Histology,Undifferentiated Endocervical Sarcoma,0
16179,Hemopoietic tissue,Melanomatosis,0
16180,Data Type - Point In Time,Fourth Ventricle and Brain Stem Ependymal Tumor,0
16181,Togo,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
16182,Hodgkin Disease,Precursor B-lymphoblastic lymphoma stage II,0
16183,Long Variable,Refractory Bladder Carcinoma,0
16184,Present,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16185,Administration procedure,Intestinal Metaplasia of Bladder Urothelium,0
16186,Odontogenic Epithelium,Small cell neuroendocrine carcinoma of bladder,0
16187,Occur (action),Refractory Ependymoma,0
16188,Group A (blood group),BRCA2 Syndrome,0
16189,Race,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16190,Form:Finding:Point in time:{Setting}:Document:{Role},Mucosal Melanoma,0
16191,Palmitic Acid,Locally Advanced Squamous Cell Carcinoma,0
16192,Tumor Mass,Extra-abdominal fibromatosis,0
16193,Lung,Acantholytic squamous cell carcinoma,0
16194,Morphology,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16195,Tanning of leather,Noninfiltrating Intraductal Carcinoma,0
16196,Brain,Nasal cavity carcinoma,0
16197,Differential Diagnosis,Adult Alveolar Soft Part Sarcoma,0
16198,High risk of,mucinous adenocarcinoma of gallbladder,0
16199,Malignant Neoplasms,Brain Ependymoma,0
16200,Kit device,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16201,Age,Extra-abdominal fibromatosis,0
16202,Small Cell Lung Cancer Pathway,Childhood Fibrillary Astrocytoma,0
16203,Azacitidine,Granular Cell Leiomyosarcoma,0
16204,potential,Female Breast Carcinoma,0
16205,Surgical aspects,Epithelioid Sarcoma NCI Grade 3,0
16206,Beginning,Malignant neoplasm of gallbladder,0
16207,Unknown GENC,Sarcomatoid Renal Cell Carcinoma,0
16208,Mast Cell Count,Cervical Adenomyoma,0
16209,Confirmed by,Localized Malignant Neoplasm,0
16210,Often - answer to question,Liver Cavernous Hemangioma,0
16211,Excision,Pancreatic carcinoma,0
16212,Therapeutic procedure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16213,Malignant neoplasm of breast,BRCA2 Syndrome,0
16214,Gram per Deciliter,Giant cell angiofibroma,0
16215,Food,Intraepithelial Melanocytic Hyperplasia,0
16216,High,Pancreatic carcinoma,0
16217,Well Being Visual Analogue Scale,Metastatic Lung Neuroendocrine Neoplasm,0
16218,Sex Cord-Stromal Tumor,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16219,Links List,Anaplastic large cell lymphoma,0
16220,Urinary system,Gallbladder Adenocarcinoma,0
16221,Include (action),Melanomatosis,0
16222,Treating,Liver Lymphangioma,0
16223,Others - Allergy,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16224,Persons,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16225,Tissue Specimen Code,Pancreatic carcinoma,0
16226,Administration procedure,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16227,Histopathologic Grade,Intestinal Metaplasia of Bladder Urothelium,0
16228,Soft Tissue Route of Drug Administration,Mucinous adenocarcinoma gastric,0
16229,High risk of,Cerebral Primitive Neuroectodermal Tumor,0
16230,Diagnosis,Basal Cell Ameloblastoma,0
16231,Therapeutic procedure,Human Papillomavirus-Related Carcinoma,0
16232,Primary,Stage IB Pancreatic Cancer AJCC v8,0
16233,900,Brain Ependymoma,0
16234,Before,Acantholytic squamous cell carcinoma,0
16235,Statistical mean,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16236,MOSTLY,Acute lymphadenitis,0
16237,Glioblastoma Multiforme Pathway,Ichthyosis,0
16238,Possibly Related to Intervention,Breast Ductal Adenoma,0
16239,59,Metastatic Lung Small Cell Carcinoma,0
16240,Condition:Find:Pt:^Patient:Nom,FIGO Stage IVA Ovarian Cancer,0
16241,Used by,Childhood Central Nervous System Ganglioneuroblastoma,0
16242,Southern Europe,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
16243,Adult Subependymal Giant Cell Astrocytoma,Hyperplasia of pituitary gland,0
16244,Case unit dose,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16245,Case unit dose,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
16246,Skin tanning,Primary Cutaneous Plasmablastic Lymphoma,0
16247,Following,Mixed astrocytoma-ependymoma,0
16248,Most,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16249,Endothelial Cells,Blepharal carcinoma,0
16250,Lineage,Stage I Colon Neuroendocrine Tumor AJCC v8,0
16251,artesunate,Colorectal cancer,0
16252,Pallor of skin,Lipoma of small intestine,0
16253,How Often Weight Loss,High Grade Glandular Intraepithelial Neoplasia,0
16254,1000000,FIGO Stage IVA Ovarian Cancer,0
16255,Body tissue,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16256,depend,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16257,Forecast of outcome,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16258,Relative to,Acute Undifferentiated Leukemia,0
16259,Smooth Muscle Tumor,Chronic Myelomonocytic Leukemia-2,0
16260,Skin,mucinous adenocarcinoma of gallbladder,0
16261,Striated muscle cell,Testicular cancer metastatic,0
16262,Negation,Cerebral Primitive Neuroectodermal Tumor,0
16263,Experimental Result,Human Papillomavirus-Related Carcinoma,0
16264,Spinal Cord,Cervical Fibroepithelial Polyp,0
16265,Lung,Vaginal Adenoid Cystic Carcinoma,0
16266,described,FIGO Stage IVA Ovarian Cancer,0
16267,Adenocarcinoma,Blood Vessel Tumors,0
16268,Illness: Cannot describe symptoms,Mucinous adenocarcinoma gastric,0
16269,Breast Feeding,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16270,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Lipoma of small intestine,0
16271,Fever,gliosarcoma,0
16272,Sequence Data Type,Squamous cell carcinoma of lip,0
16273,Tubal Ligation,Blepharal carcinoma,0
16274,Confirmation,mucinous adenocarcinoma of gallbladder,0
16275,White blood cells urine (lab test),Diffuse malignant mesothelioma,0
16276,shared attribute,Liver Cavernous Hemangioma,0
16277,Formation,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
16278,Therapeutic immunosuppression,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16279,Include (action),Intraepithelial Melanocytic Hyperplasia,0
16280,True Control Status,Gallbladder Adenocarcinoma,0
16281,month,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16282,Damage,Recurrent Diffuse Intrinsic Pontine Glioma,0
16283,Disease remission,Spindle Cell Melanoma,0
16284,Operative Surgical Procedures,Xeroderma pigmentosum,0
16285,Code System Type - Internal,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16286,1000000,Ectomesenchymal Chondromyxoid Tumor,0
16287,Nodulus cerebelli,Thyroid Hurthle Cell Carcinoma,0
16288,Orbital region,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16289,WHO tumor classification,Locally Advanced Soft Tissue Sarcoma,0
16290,Designated,Ovarian Dermoid Cyst with Secondary Carcinoma,0
16291,Solid Neoplasm,Acute Undifferentiated Leukemia,0
16292,Count of entities,Uterine Cancer,0
16293,Melanoma Pathway,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16294,Condition,Intracortical osteosarcoma,0
16295,Transmitted by,BRCA2 Syndrome,0
16296,Histologic,Funisitis (disorder),0
16297,Closed,papillary carcinoma of penis,0
16298,99,Cerebral Primitive Neuroectodermal Tumor,0
16299,New,Primary Cutaneous Plasmablastic Lymphoma,0
16300,Oral cavity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16301,Magnetic Resonance Imaging Study File,Lipoma of small intestine,0
16302,Primary malignant neoplasm,Heavy Chain Deposition Disease,0
16303,Malignant - descriptor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16304,Medulloepithelioma,Vaginal Adenoma,0
16305,Act Relationship Subset - previous,Metastatic Neoplasm to the Gallbladder,0
16306,Medications:-:Point in time:^Patient:-,Trabecular adenocarcinoma,0
16307,Disease,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
16308,To,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
16309,removal technique,Hodgkin Disease,0
16310,Increase,Gallbladder Adenocarcinoma,0
16311,Process (qualifier value),Benign Ovarian Thecoma,0
16312,Rating (action),Ampulla of Vater Tubular Adenoma,0
16313,Incomplete spinal cord injury,Adenoma,0
16314,physiological aspects,Childhood Extragonadal Malignant Germ Cell Tumor,0
16315,Beginning,Blepharal carcinoma,0
16316,Infrequent,Metaplastic carcinoma of breast,0
16317,Base - General Qualifier,Mucinous adenocarcinoma gastric,0
16318,Including (qualifier),Childhood Fibrillary Astrocytoma,0
16319,Type - attribute,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16320,Secondary Neoplasm,Malignant Neoplasm with Regional Lymph Node Involvement,0
16321,Mesenchymal Cell Neoplasm,Hair nevus,0
16322,Symptoms,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16323,Participation Type - origin,adenosquamous carcinoma of breast,0
16324,Very,Intestinal Neuroendocrine Carcinoma,0
16325,Status post,Stage III Cutaneous Melanoma AJCC v6,0
16326,metastatic qualifier,Unfavorable Non-Hodgkin Lymphoma,0
16327,Benign tumor of salivary gland,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16328,Cell secretion,sarcoma of spinal cord,0
16329,Diagnosis Study,Transitional cell carcinoma,0
16330,Have Difficulty Swallowing,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16331,Common (qualifier value),Tonsillar Carcinoma,0
16332,Gonadal structure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16333,Group Object,papillary carcinoma of penis,0
16334,Cancer Histology,Metastatic Carcinoma in the Lung,0
16335,Sodium Chloride,Spermatocytic seminoma,0
16336,{Setting},Thyroid Hurthle Cell Carcinoma,0
16337,Form of breast,Localized Askin Tumor,0
16338,obsolete,Trichilemmocarcinoma,0
16339,Infrequent,Maxillary Sinus Adenoid Cystic Carcinoma,0
16340,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Endometrial Small Cell Carcinoma,0
16341,shared attribute,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16342,Tissue Growth,Childhood Lymphoma,0
16343,Image Feature,Recurrent Uveal Melanoma,0
16344,Human papilloma virus infection,Undifferentiated Endocervical Sarcoma,0
16345,Affecting,Childhood Anaplastic Large Cell Lymphoma,0
16346,2+,Recurrent Testicular Lymphoma,0
16347,Medical Device Emits Smoke,Adult Hepatocellular Carcinoma,0
16348,Term (temporal),mucinous adenocarcinoma of gallbladder,0
16349,Often - answer to question,High Grade Glandular Intraepithelial Neoplasia,0
16350,Removed,Brain Ependymoma,0
16351,General health,Localized Ewing Sarcoma,0
16352,Rest,Unfavorable Non-Hodgkin Lymphoma,0
16353,Poor - qualifier,Malignant melanoma of eyelid,0
16354,risk factors - observation list,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16355,Polypeptide Hormones,Testicular cancer metastatic,0
16356,Type - attribute,Plexosarcoma,0
16357,How Much Distress Sweats,Refractory Barrett Esophagus,0
16358,research subject screening,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16359,How Often Felt Normal question,Cancer of Urinary Tract,0
16360,Present,Malignant melanoma of eyelid,0
16361,Formation,Childhood Extragonadal Malignant Germ Cell Tumor,0
16362,dendritic spine neck,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16363,Face,Low Grade Squamous Intraepithelial Neoplasia,0
16364,treatment - ActInformationManagementReason,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
16365,described,Malignant neoplasm of subglottis,0
16366,Secretory Vesicles,Benign Anal Granular Cell Tumor,0
16367,Lip and Oral Cavity Carcinoma,Hyperplasia of pituitary gland,0
16368,neural,Granular Cell Leiomyosarcoma,0
16369,Aim,Malignant Testicular Sertoli Cell Tumor,0
16370,Known,Engraftment syndrome,0
16371,Primary malignant neoplasm,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16372,Occur (action),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16373,Site,Extra-Adrenal Paraganglioma,0
16374,1960s,Low Grade Squamous Intraepithelial Neoplasia,0
16375,Leukemia,malignant lymphoma of pancreatic lymph nodes,0
16376,Absent,Human Papillomavirus-Related Carcinoma,0
16377,Back,ROSE Cluster 3,0
16378,Malignant Neoplasms,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16379,Subject Risk,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16380,device aspects,Localized Askin Tumor,0
16381,Advanced phase,Engraftment syndrome,0
16382,Wounds and Injuries,Childhood Central Nervous System Ganglioneuroblastoma,0
16383,Rhabdomyosarcoma,Childhood Extragonadal Malignant Germ Cell Tumor,0
16384,Physical Appearance,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16385,Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16386,Weight Loss,Extra-abdominal fibromatosis,0
16387,Symptoms aspect,Breast Ductal Adenoma,0
16388,Case (situation),Bladder squamous cell carcinoma stage I,0
16389,How Much Distress Cough,Cerebral hemangioma,0
16390,NCI CTEP SDC Small Cell Lung Cancer Sub-Category Terminology,Childhood Central Nervous System Ganglioneuroblastoma,0
16391,Make - Instruction Imperative,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16392,Surrounding (qualifier value),Mixed astrocytoma-ependymoma,0
16393,Adult Non-Hodgkin Lymphoma,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
16394,shared attribute,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
16395,Tests (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16396,regional,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16397,Local,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16398,Use of,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16399,Extent of disease,Acantholytic squamous cell carcinoma,0
16400,Most,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
16401,Cure (remedy),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16402,Treatment Epoch,Benign Apocrine Neoplasm,0
16403,Referring,Platinum-Resistant Lung Small Cell Carcinoma,0
16404,Palliative Care,Adult Hepatocellular Carcinoma,0
16405,Science of Etiology,Digestive System Hodgkin Lymphoma,0
16406,B-Cell Activation,Refractory Ependymoma,0
16407,Thyroid carcinoma,Malignant neoplasm of thalamus,0
16408,morphological,Unresectable Rhabdomyosarcoma,0
16409,Malignant Neoplasms,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16410,Coitus,Congenital hamartoma,0
16411,laparoscopy (therapeutic),Gallbladder Adenocarcinoma,0
16412,400,Mastocytosis,0
16413,Weight decreased,Chronic Myelomonocytic Leukemia-2,0
16414,Completely - dosing instruction fragment,Advanced Uterine Corpus Carcinosarcoma,0
16415,second (number),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
16416,Definitely Related to Intervention,Undifferentiated Neuroblastoma,0
16417,Possibly Related to Intervention,Melanomatosis,0
16418,FDA Establishment Activity Terminology,Ampulla of Vater Tubular Adenoma,0
16419,Togo,Acantholytic squamous cell carcinoma,0
16420,Malignant tumor of cervix,Contact dermatitis due to alkali,0
16421,intrathecal chemotherapy,Refractory Ependymoma,0
16422,Germ Layers,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16423,Human body,Bladder Neuroendocrine Neoplasm,0
16424,United States,Low Grade Squamous Intraepithelial Neoplasia,0
16425,System,Thyroid Hurthle Cell Carcinoma,0
16426,Bleomycin,Carcinoma of submandibular gland,0
16427,63,Peripheral primitive neuroectodermal tumor of soft tissue,0
16428,Tissue damage,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16429,Mass,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
16430,Site of,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
16431,Prominent,Multiple Endocrine Neoplasia,0
16432,include - SetOperator,Vaginal Adenoma,0
16433,Known,Grade 3a Malignant Neoplasm,0
16434,Risk,clear cell adenocarcinoma of gallbladder,0
16435,Type - attribute,Refractory Barrett Esophagus,0
16436,To,Hemangioma,0
16437,Vaginal,Giant cell angiofibroma,0
16438,Object Relationship,Metastatic Neoplasm to the Gallbladder,0
16439,United States Military Commissioned Officer O4,Recurrent Uveal Melanoma,0
16440,Brain,Stage IB Pancreatic Cancer AJCC v8,0
16441,Manufactured form,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16442,Japan,Benign squamous cell tumor,0
16443,Descent,Malignant neoplasm of olfactory nerve,0
16444,Containing (qualifier),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
16445,Human Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16446,Occurrence Indicator,Noninfiltrating Intraductal Carcinoma,0
16447,DNA Damage,Cerebral hemangioma,0
16448,Adult,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16449,Premalignant,Carcinoma,0
16450,Referring,Serous cystadenocarcinoma ovary,0
16451,Status post,Peripheral primitive neuroectodermal tumor of soft tissue,0
16452,31,Choroid Necrotic Melanoma,0
16453,Case unit dose,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16454,False Discovery Rate,Transitional cell carcinoma,0
16455,Etiology aspects,Adult Alveolar Soft Part Sarcoma,0
16456,Cytologic,Tonsillar Carcinoma,0
16457,Manufactured form,Adult Fibrolamellar Carcinoma,0
16458,Surgery specialty,Locally Advanced Squamous Cell Carcinoma,0
16459,mole changes,Neoplasms,0
16460,Weight decreased,Keratoderma,0
16461,Part of,Stage III Cutaneous Melanoma AJCC v6,0
16462,Supportive assistance,Localized Askin Tumor,0
16463,Hollow shape,FIGO Stage IVA Ovarian Cancer,0
16464,Woman,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
16465,biopsy characteristics,Anterior Urethral Malignant Neoplasm,0
16466,*Type - Kind of quantity,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
16467,Term Birth,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16468,Tissue Specimen Code,Basal Cell Ameloblastoma,0
16469,Distal (qualifier value),clear cell adenocarcinoma of gallbladder,0
16470,Malignant neoplasm of penis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16471,Granulocyte component of blood,Mucinous neoplasm,0
16472,Precancerous Conditions,Stage IV Childhood Non-Hodgkin Lymphoma,0
16473,Often - answer to question,FIGO Stage IVA Ovarian Cancer,0
16474,Factory,Gallbladder adenoma,0
16475,Present,Nasal cavity carcinoma,0
16476,Cessation of life,Mucinous adenocarcinoma gastric,0
16477,With intensity,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16478,Tumor site,Extra-Adrenal Paraganglioma,0
16479,International Statistical Classification of Diseases and Related Health Problems,Stage III Adult Immunoblastic Lymphoma,0
16480,6000,FIGO Stage II Ovarian Cancer,0
16481,Participation Type - origin,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16482,Involvement with,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
16483,Form:Finding:Point in time:{Setting}:Document:{Role},Pancreatic carcinoma,0
16484,76,Melanomatosis,0
16485,Inguinal part of abdomen,Malignant Neoplasm of Lung - Multiple Primary Sites,0
16486,Invasive,Ovarian germ cell choriocarcinoma stage IV,0
16487,Anatomic structures,Advanced Uterine Corpus Carcinosarcoma,0
16488,Tissue Specimen Code,Carcinoma of urinary bladder,0
16489,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,clear cell adenocarcinoma of gallbladder,0
16490,Term (temporal),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16491,risk factors - observation list,sarcoma of spinal cord,0
16492,Etiology aspects,Localized Askin Tumor,0
16493,Formations,Localized Ewing Sarcoma,0
16494,Cells,Stage III Cutaneous Melanoma AJCC v6,0
16495,Circumscribe (action),Vaginal Adenoid Cystic Carcinoma,0
16496,High Level,Leptomeningeal sarcoma,0
16497,Probably,Giant cell angiofibroma,0
16498,Morphology,Pancreatic carcinoma,0
16499,Distal (qualifier value),Malignant melanoma of eyelid,0
16500,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Hyperplasia of pituitary gland,0
16501,Hematologic Tests,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16502,Cheek structure,Malignant neoplasm of thalamus,0
16503,Formation,Benign neoplasm of eye,0
16504,Embryonic Development,Stage III Cutaneous Melanoma AJCC v6,0
16505,Useful,Granular Cell Leiomyosarcoma,0
16506,Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16507,Name,Stage III Cutaneous Melanoma AJCC v6,0
16508,Associated with,Colorectal cancer,0
16509,Only - dosing instruction fragment,Giant cell angiofibroma,0
16510,Used by,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
16511,Multiplication,Brain Ependymoma,0
16512,Cancer Genus,Unicystic ameloblastoma,0
16513,Definitely Related to Intervention,Female Breast Carcinoma,0
16514,Asia,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16515,Obesity,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16516,Lymphoma,Kaposi's sarcoma of extrahepatic bile duct,0
16517,common types,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16518,Extension,Uterine Cancer,0
16519,Surgical repair,Placental aromatase deficiency,0
16520,New,BRCA2 Syndrome,0
16521,Means,Childhood Anaplastic Large Cell Lymphoma,0
16522,Males,Adenocarcinoma of the prostate metastatic,0
16523,Stage Grouping,Congenital hamartoma,0
16524,Factor,Locally Advanced Squamous Cell Carcinoma,0
16525,Digital Content Category,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
16526,CEL gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16527,Infrequent,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16528,mole changes,Ampulla of Vater Tubular Adenoma,0
16529,Device Motor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16530,Adipose tissue,squamous cell carcinoma of the thyroid gland,0
16531,Good,Choroid Necrotic Melanoma,0
16532,Classic Histology,Medulloblastoma,0
16533,shared attribute,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16534,Has difficulty doing (qualifier value),Female Breast Carcinoma,0
16535,Young Adult,Familial Adenomatous Polyposis Associated Medulloblastoma,0
16536,combination of objects,Benign Anal Granular Cell Tumor,0
16537,Legal Adult,Xeroderma pigmentosum,0
16538,Science of Etiology,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
16539,Numbers,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16540,Burkitt Lymphoma,Kaposi's sarcoma of extrahepatic bile duct,0
16541,Down Syndrome,Peripheral primitive neuroectodermal tumor of soft tissue,0
16542,Orbit (brand of fungicide),Spermatocytic seminoma,0
16543,Cavitation,Intestinal Metaplasia of Bladder Urothelium,0
16544,Professional guide,Melanomatosis,0
16545,More,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
16546,<3 (qualifier value),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16547,One,BRCA2 Syndrome,0
16548,veterans alcoholism screening test (VAST),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
16549,Hyperlink,Breast Ductal Adenoma,0
16550,Myeloma Proteins,FIGO Stage IVA Ovarian Cancer,0
16551,Sixty,Mixed astrocytoma-ependymoma,0
16552,Headache,Benign tumor of eyelid,0
16553,Pancreatic Hormones,Nasal cavity carcinoma,0
16554,size,Small cell neuroendocrine carcinoma of bladder,0
16555,Nine,Familial Adenomatous Polyposis Associated Medulloblastoma,0
16556,Chemotherapy,Childhood Fibrillary Astrocytoma,0
16557,Bilateral,Benign tumor of eyelid,0
16558,Subject Risk,BRCA2 Syndrome,0
16559,Togo,Chest Wall Fibromatosis,0
16560,Treating,benign mature teratoma of pancreas,0
16561,Hollow shape,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16562,Physical findings,Melanomatosis,0
16563,Taxonomic,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
16564,Packaging Case,Maxillary Sinus Adenoid Cystic Carcinoma,0
16565,Primary malignant neoplasm,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16566,control aspects,squamous cell carcinoma of the thyroid gland,0
16567,Formation,Non-Metastatic Gestational Trophoblastic Tumor,0
16568,Spreading (qualifier value),Malignant Testicular Sertoli Cell Tumor,0
16569,Malignant Cell Count,Trabecular adenocarcinoma,0
16570,Continuance of life,Melanomatosis,0
16571,Include (action),FIGO Stage II Ovarian Cancer,0
16572,Hepatic Involvement,BRCA2 Syndrome,0
16573,Thin (qualifier value),adenoid cystic carcinoma of lung,0
16574,Gland,Gallbladder Adenocarcinoma,0
16575,Involvement with,Stage IV Penile Cancer AJCC v7,0
16576,Histology Procedure,Endometrial Small Cell Carcinoma,0
16577,year,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
16578,Average,Sarcomatoid Renal Cell Carcinoma,0
16579,Late,Vaginal Adenoid Cystic Carcinoma,0
16580,Disease Outcome,Intraepithelial Melanocytic Hyperplasia,0
16581,Type A,Low Grade Squamous Intraepithelial Neoplasia,0
16582,Usually,Atypical Lobular Breast Hyperplasia,0
16583,ancestors,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16584,AKR1A1 wt Allele,Pancreatic Intraepithelial Neoplasia-3,0
16585,condom use,Colorectal High Grade B-Cell Lymphoma,0
16586,Common (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
16587,Growth abnormality,Primary Cutaneous Plasmablastic Lymphoma,0
16588,shared attribute,embryonal rhabdomyosarcoma of prostate,0
16589,Term (temporal),Localized Ewing Sarcoma,0
16590,Liver,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
16591,RBC count low,Atypical Lobular Breast Hyperplasia,0
16592,survival aspects,Heavy Chain Deposition Disease,0
16593,physiological aspects,Testicular cancer metastatic,0
16594,Tract,Stage III Adult Immunoblastic Lymphoma,0
16595,per year,Small intestine carcinoma,0
16596,Hemorrhage,Stage 0 Lip Carcinoma,0
16597,Death (finding),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16598,Only - dosing instruction fragment,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
16599,Entity Name Part Type - given,Squamous cell carcinoma of lip,0
16600,General surgery specialty,Childhood Lung Non-Small Cell Carcinoma,0
16601,NCI CTEP SDC Melanoma Sub-Category Terminology,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16602,Symptoms aspect,Choroid Necrotic Melanoma,0
16603,Disease,Endometrial Small Cell Carcinoma,0
16604,Chemotherapy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16605,Sequence Data Type,Precursor B-lymphoblastic lymphoma stage II,0
16606,Patient Discharge,Intraepithelial Melanocytic Hyperplasia,0
16607,Cessation of life,Non-Metastatic Gestational Trophoblastic Tumor,0
16608,Spinal Cord,Extracranial Neuroblastoma,0
16609,Relational and Item-Specific Encoding Task,Localized Malignant Neoplasm,0
16610,Function Axis,Endometrial Small Cell Carcinoma,0
16611,Data (eukaryote),Benign Anal Granular Cell Tumor,0
16612,Removing (action),Occult Lung Adenosquamous Carcinoma,0
16613,Usually,Mixed astrocytoma-ependymoma,0
16614,Hoods,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16615,BRCA2 protein,Bladder adenocarcinoma stage IV,0
16616,Lynch Syndrome,Anterior Urethral Malignant Neoplasm,0
16617,Analysis,Digestive System Hodgkin Lymphoma,0
16618,Collection (action),Female Breast Carcinoma,0
16619,Form:Finding:Point in time:{Setting}:Document:{Role},Primary Cutaneous Plasmablastic Lymphoma,0
16620,Response to treatment,Blepharal carcinoma,0
16621,Average of Value Derivation Technique,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16622,EntityNameUseR2 <temporary>,Human Papillomavirus-Related Carcinoma,0
16623,Membrane,Platinum-Resistant Lung Small Cell Carcinoma,0
16624,Orbital,Mixed astrocytoma-ependymoma,0
16625,Eye,Cancer of Urinary Tract,0
16626,Liver carcinoma,Malignant Testicular Sertoli Cell Tumor,0
16627,Decrease,Cervical Adenomyoma,0
16628,diagnostic image,Stage III Cutaneous Melanoma AJCC v6,0
16629,Most,Mastocytosis,0
16630,Status post,Refractory Barrett Esophagus,0
16631,English race,Cerebral Primitive Neuroectodermal Tumor,0
16632,Persons,Stage IB Lung Cancer AJCC v7,0
16633,Peritoneal Surface Malignancy,Mucinous adenocarcinoma gastric,0
16634,Inflammation,non-Hodgkin's lymphoma of spleen,0
16635,Chemotherapy Regimen,Recurrent Testicular Lymphoma,0
16636,Age at diagnosis,Trabecular adenocarcinoma,0
16637,Precursor,Vaginal Adenoma,0
16638,High Grade Astrocytic Tumor,High Grade Glandular Intraepithelial Neoplasia,0
16639,Shortened,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16640,Bacteria present,Bladder squamous cell carcinoma stage I,0
16641,Dropping,Non-Metastatic Gestational Trophoblastic Tumor,0
16642,Others - Allergy,Refractory Bladder Carcinoma,0
16643,35,Malignant melanoma of eyelid,0
16644,Very,Medulloblastoma,0
16645,Followed by,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16646,Oral cavity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16647,Surgery specialty,Hodgkin lymphoma,0
16648,Group A (blood group),Digestive System Hodgkin Lymphoma,0
16649,Net (qualifier),non-Hodgkin's lymphoma of spleen,0
16650,Tentorium cerebelli,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
16651,Count of entities,Squamous cell carcinoma of lip,0
16652,Presentation,squamous cell carcinoma of the thyroid gland,0
16653,include - SetOperator,Papillary cystic tumor,0
16654,betel quid,Breast Ductal Adenoma,0
16655,Body tissue,Stage III Cutaneous Melanoma AJCC v6,0
16656,To,Gallbladder Adenocarcinoma,0
16657,Rest,Small cell neuroendocrine carcinoma of bladder,0
16658,Case (situation),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
16659,Genitalia,Bladder squamous cell carcinoma stage I,0
16660,Cause of death:Find:Pt:^Patient:Nom,Tonsillar Carcinoma,0
16661,SLC35G1 gene,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16662,Associated with,Intraepithelial Melanocytic Hyperplasia,0
16663,Reported Term,Childhood Anaplastic Large Cell Lymphoma,0
16664,Usually,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16665,Use - dosing instruction imperative,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16666,Continuance of life,FIGO Stage IVA Ovarian Cancer,0
16667,Enlarged,Recurrent Primary Lymphoma of Bone,0
16668,therapeutic aspects,Diffuse malignant mesothelioma,0
16669,Subgroup A Nepoviruses,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16670,Responsible to,Splenic Manifestation of Hairy Cell Leukemia,0
16671,Estimated,Peripheral primitive neuroectodermal tumor of soft tissue,0
16672,Original,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
16673,french race,Stage IB Pancreatic Cancer AJCC v8,0
16674,Science of Etiology,Carcinoma ex pleomorphic adenoma of parotid gland,0
16675,Tryptophanase,non-Hodgkin's lymphoma of spleen,0
16676,Subject Risk,Diffuse malignant mesothelioma,0
16677,Most,Type II Endometrial Adenocarcinoma,0
16678,Leads (device),Plexosarcoma,0
16679,Liquid substance,Malignant neoplasm of olfactory nerve,0
16680,Lymphatic System,Recurrent Testicular Lymphoma,0
16681,Childhood Leukemia,FIGO Stage IVA Ovarian Cancer,0
16682,0%,Benign tumor of eyelid,0
16683,Malignant Neoplasms,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16684,Clinician,Acantholytic squamous cell carcinoma,0
16685,Definitely Related to Intervention,Childhood Lymphoma,0
16686,Frequency of Pain Question,BRCA2 Syndrome,0
16687,Skin,Familial Adenomatous Polyposis Associated Medulloblastoma,0
16688,Urothelium,Refractory Barrett Esophagus,0
16689,Cell Count,Undifferentiated Endocervical Sarcoma,0
16690,Eighth,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16691,Biopsy,Advanced Uterine Corpus Carcinosarcoma,0
16692,Type A,Ichthyosis,0
16693,Image Feature,Acantholytic squamous cell carcinoma,0
16694,Cancer Genus,Mucinous adenocarcinoma gastric,0
16695,Lower - spatial qualifier,Stage II Hepatocellular Carcinoma AJCC v8,0
16696,<90,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
16697,ATLAS Score Clinical Classification,Cartilaginous exostosis,0
16698,Immune System Part,Refractory Bladder Carcinoma,0
16699,Tissue Specimen Code,Benign Anal Granular Cell Tumor,0
16700,Retinoic Acid Response Element,Stage IB Pancreatic Cancer AJCC v8,0
16701,Vestigium,Localized Askin Tumor,0
16702,Legal Adult,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16703,Continuous,Spongiotic dermatitis,0
16704,Amount type - Percentage,Mucinous adenocarcinoma gastric,0
16705,Cure (remedy),Extracranial Neuroblastoma,0
16706,Time,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
16707,Adult Classical Hodgkin Lymphoma,Leiomyoma of Gallbladder,0
16708,Numbers,Anterior Urethral Malignant Neoplasm,0
16709,Version (morphologic abnormality),Cartilaginous exostosis,0
16710,shared attribute,Malignant Testicular Sertoli Cell Tumor,0
16711,Epithelium of vagina,Bladder adenocarcinoma stage IV,0
16712,Administration procedure,Melanomatosis,0
16713,Contain (action),Benign neoplasm of eye,0
16714,Cancer Genus,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16715,Back Pain,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16716,Categories,Adult Hepatocellular Carcinoma,0
16717,Disease,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16718,aspects of adverse effects,Vaginal Adenoma,0
16719,Exacerbations of Chronic Pulmonary Disease Tool Patient-Reported Outcome Questionnaire,clear cell adenocarcinoma of gallbladder,0
16720,Pain,Female Breast Carcinoma,0
16721,include - SetOperator,Localized Ewing Sarcoma,0
16722,Including (qualifier),Papillary squamous cell carcinoma,0
16723,Well Differentiated,Kaposi's sarcoma of extrahepatic bile duct,0
16724,Common Specifications in HL7 V3 Publishing,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
16725,BRCA2 gene,Refractory Bladder Carcinoma,0
16726,Usually,Leptomeningeal sarcoma,0
16727,Pancreas,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
16728,Gross (qualifier value),Choroid Epithelioid Cell Melanoma,0
16729,Skeletal bone,Parathyroid Gland Adenocarcinoma,0
16730,Retinoic Acid Response Element,Mucinous adenocarcinoma gastric,0
16731,Epithelial ovarian cancer,FIGO Stage IVA Ovarian Cancer,0
16732,Third,Nasal cavity carcinoma,0
16733,chapter,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
16734,Infrequent,Anterior Urethral Malignant Neoplasm,0
16735,Symptoms aspect,Melanomatosis,0
16736,Rate,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16737,Negation,Necrotizing Funisitis,0
16738,Only - dosing instruction fragment,Refractory Ependymoma,0
16739,Derivative,squamous cell carcinoma of the thyroid gland,0
16740,Malignant Neoplasms,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16741,One,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16742,Greater,Adult Acute Eosinophilic Leukemia,0
16743,NIN gene,Grade 3a Malignant Neoplasm,0
16744,Firstly,Carcinoma of urinary bladder,0
16745,Fever symptoms (finding),Mucinous adenocarcinoma gastric,0
16746,2+ Score,Thymic Atypical Carcinoid Tumor,0
16747,Cell Count,Childhood Central Nervous System Ganglioneuroblastoma,0
16748,AKR1A1 wt Allele,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
16749,Linear,Localized Ewing Sarcoma,0
16750,Woman,Refractory Bladder Carcinoma,0
16751,Bottom,Sarcomatoid Renal Cell Carcinoma,0
16752,Primary malignant neoplasm,Nasal cavity carcinoma,0
16753,Palmitic Acid,Cartilaginous exostosis,0
16754,/hour,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
16755,In Blood,Papillary squamous cell carcinoma,0
16756,Obstructed,Recurrent Primary Lymphoma of Bone,0
16757,Uterus,Stage I Adult Non-Hodgkin Lymphoma,0
16758,Most,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
16759,Molecular Mass,Cerebral hemangioma,0
16760,Tissue Specimen Code,Angiosarcoma of liver,0
16761,Tryptophanase,Stage I Adult Non-Hodgkin Lymphoma,0
16762,Malignant Head and Neck Neoplasm,Stage IV Colorectal Cancer AJCC v8,0
16763,Type - attribute,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
16764,Similarity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16765,Diagnosis,ROSE Cluster 3,0
16766,Swollen Lymph Node,Cervical Fibroepithelial Polyp,0
16767,various other agents for local oral treatment in ATC,Localized Askin Tumor,0
16768,Australia,mucinous adenocarcinoma of gallbladder,0
16769,Cause of death.secondary:Find:Pt:^Patient:Nom,Gallbladder Adenocarcinoma,0
16770,Make - Instruction Imperative,Thyroid Hurthle Cell Carcinoma,0
16771,Type A,GIANT PIGMENTED HAIRY NEVUS,0
16772,Term (lexical),Squamous cell carcinoma of lip,0
16773,700,Recurrent Uveal Melanoma,0
16774,Involvement with,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16775,Well Differentiated,Squamous cell carcinoma of lip,0
16776,size,Tubal Hyperplasia,0
16777,Individual,squamous cell carcinoma of the thyroid gland,0
16778,Special,Stage IV Childhood Non-Hodgkin Lymphoma,0
16779,Platelets Product,Human Papillomavirus-Related Carcinoma,0
16780,Morphology,Stage III Adult Immunoblastic Lymphoma,0
16781,Risk,Childhood Central Nervous System Ganglioneuroblastoma,0
16782,Cell Count,Stage III Cutaneous Melanoma AJCC v6,0
16783,Only - dosing instruction fragment,Pancreatic Intraepithelial Neoplasia-3,0
16784,Science of Etiology,Neoplasms,0
16785,Patient Outcome,Stage II Carcinoma of Penis,0
16786,MM genotype,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
16787,Leukemia,Melanomatosis,0
16788,Appearance,Anterior Urethral Malignant Neoplasm,0
16789,Smoking,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16790,Palmitic Acid,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16791,Definition,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16792,Negation,Nasal cavity carcinoma,0
16793,Sarcoma - category (morphologic abnormality),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16794,Autosomal dominant hereditary disorder,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16795,Squamous cell carcinoma - category,Fibroadenoma of breast,0
16796,Qualitative form,Neonatal leukemia,0
16797,Appearance,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16798,Patient Problem,Recurrent Uveal Melanoma,0
16799,Major <insect>,Hodgkin lymphoma,0
16800,Genus Homo,Refractory Ependymoma,0
16801,Feature,Thyroid Hurthle Cell Carcinoma,0
16802,Body Regions,Malignant Neoplasm with Regional Lymph Node Involvement,0
16803,Weight decreased,Bladder squamous cell carcinoma stage I,0
16804,Science of Etiology,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
16805,Common Specifications in HL7 V3 Publishing,Angiosarcoma of liver,0
16806,Aspects of signs,Plexosarcoma,0
16807,Stomach structure,Malignant neoplasm of thalamus,0
16808,Bone Marrow,FIGO Stage IVA Ovarian Cancer,0
16809,To,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16810,Old,Malignant Testicular Sertoli Cell Tumor,0
16811,Togo,Malignant neoplasm of choroid,0
16812,Science of Etiology,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16813,Premalignant,Neonatal leukemia,0
16814,Disease,Squamous cell carcinoma of lip,0
16815,Bloating,Breast Ductal Adenoma,0
16816,Etiology aspects,Extra-abdominal fibromatosis,0
16817,Common (qualifier value),Mucinous adenocarcinoma gastric,0
16818,include - SetOperator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
16819,Trauma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
16820,Tryptophanase,Diffuse malignant mesothelioma,0
16821,Genes,Tonsillar Carcinoma,0
16822,Contain (action),Childhood Fibrillary Astrocytoma,0
16823,Nicotiana,Brain Tumor,0
16824,Further,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
16825,Glycation End Products,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16826,Feelings,Localized Ewing Sarcoma,0
16827,Five-year Survival Rate,Benign squamous cell tumor,0
16828,pharmacotherapeutic,Larynx carcinoma recurrent,0
16829,Show,Kaposi's sarcoma of skin,0
16830,Liver Flavor,Transitional cell carcinoma,0
16831,radiotherapeutic,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
16832,pharmacotherapeutic,Mucinous adenocarcinoma gastric,0
16833,Dangerousness,Small Intestinal Villous Adenoma,0
16834,Cells,adenoid cystic carcinoma of lung,0
16835,Case unit dose,Deep Leiomyoma,0
16836,Complication,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16837,Part Dosing Unit,Stage III Cutaneous Melanoma AJCC v6,0
16838,Cessation of life,Lung Mucinous Cystadenoma,0
16839,Lead,Testicular cancer metastatic,0
16840,Primary malignant neoplasm,Diffuse malignant mesothelioma,0
16841,Enlargement procedure,Kaposi's sarcoma of extrahepatic bile duct,0
16842,Benign Neoplasm,Mucinous adenocarcinoma gastric,0
16843,Histologic,Liver Lymphangioma,0
16844,History,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16845,Superior mediastinum,clear cell adenocarcinoma of gallbladder,0
16846,Stage,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
16847,Bone Infection,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16848,Tryptophanase,squamous cell carcinoma of the thyroid gland,0
16849,Severe (severity modifier),Mucosal Melanoma,0
16850,Continuance of life,Metastatic Carcinoma in the Lung,0
16851,Nuclear (nucleus),Non-Metastatic Gestational Trophoblastic Tumor,0
16852,Linear,Colorectal Neuroendocrine Tumor G2,0
16853,Screening,Locally Advanced Squamous Cell Carcinoma,0
16854,Pharmacotherapy,BRCA2 Syndrome,0
16855,Firstly,Congenital hamartoma,0
16856,Occur (action),Thyroid Hurthle Cell Carcinoma,0
16857,Methods aspects,Fibroadenoma of breast,0
16858,Lymphoma,Type II Endometrial Adenocarcinoma,0
16859,Third grade in elementary school,Ichthyosis,0
16860,Tanning of leather,Refractory Ependymoma,0
16861,Malignant Neoplasms,Tongue Alveolar Soft Part Sarcoma,0
16862,Valid,Refractory Barrett Esophagus,0
16863,Experimental Result,Clonal Hematopoiesis of Indeterminate Potential,0
16864,Affect (mental function),Splenic Manifestation of Hairy Cell Leukemia,0
16865,Representation (action),Pancreatic Intraepithelial Neoplasia-3,0
16866,Rare Diseases,Tonsillar Carcinoma,0
16867,Overall Publication Type,Digestive System Hodgkin Lymphoma,0
16868,Did not receive therapy or drug for,non-Hodgkin's lymphoma of spleen,0
16869,Feelings,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16870,Cancer Genus,Acantholytic squamous cell carcinoma,0
16871,Kinked,Hereditary Diffuse Gastric Adenocarcinoma,0
16872,Less Than,Central Nervous System Anaplastic Large Cell Lymphoma,0
16873,Manufactured form,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
16874,Malignant neoplasm of thyroid,Blepharal carcinoma,0
16875,Neoplasms,Advanced Lung Carcinoma,0
16876,Primary malignant neoplasm,Recurrent Testicular Lymphoma,0
16877,Smallest,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16878,Complication Aspects,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16879,Nail plate,Female Breast Carcinoma,0
16880,include - SetOperator,FIGO Stage II Ovarian Cancer,0
16881,Tissue Growth,Cancer of Urinary Tract,0
16882,Usually,Cancer of Urinary Tract,0
16883,Followed by,Malignant neoplasm of subglottis,0
16884,Abnormal Reference Range,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
16885,How Often Weight Loss,Stage III Cutaneous Melanoma AJCC v6,0
16886,Most,Plexosarcoma,0
16887,Medications:-:Point in time:^Patient:-,Metastatic Malignant Neoplasm in the Sellar Region,0
16888,pharmacotherapeutic,Stage IB Lung Cancer AJCC v7,0
16889,FOXO1 gene,Childhood Choriocarcinoma,0
16890,suffix,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
16891,Infrequent,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
16892,Prostate,Heavy Chain Deposition Disease,0
16893,Malignant neoplasm of mouth,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
16894,Congenital Abnormality,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
16895,Linear,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16896,Category Type,Metaplastic carcinoma of breast,0
16897,shared attribute,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
16898,Oral contraception,Platinum-Resistant Lung Small Cell Carcinoma,0
16899,Cancer Genus,Vaginal Adenoma,0
16900,National origin,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
16901,Firstly,Methotrexate-Associated Hodgkin Lymphoma,0
16902,Neoplasms,Human Papillomavirus-Related Carcinoma,0
16903,Wounds - qualifier,Kaposi's sarcoma of extrahepatic bile duct,0
16904,Clear,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
16905,Group A (blood group),Endometrial Small Cell Carcinoma,0
16906,Lung,Chondrosarcoma,0
16907,Event Seriousness - Significant,Epithelioid Sarcoma NCI Grade 3,0
16908,Excision,Fibroadenoma of breast,0
16909,Human body structure,Peripheral primitive neuroectodermal tumor of soft tissue,0
16910,International Statistical Classification of Diseases and Related Health Problems,Malignant neoplasm of thalamus,0
16911,Screening procedure,Malignant neoplasm of subglottis,0
16912,Disc - Body Part,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
16913,Chemotherapy Regimen,Unfavorable Non-Hodgkin Lymphoma,0
16914,Common Specifications in HL7 V3 Publishing,FIGO Stage II Ovarian Cancer,0
16915,Barrett Esophagus,Localized Askin Tumor,0
16916,survival aspects,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
16917,Marketing basis - Transitional,Human Papillomavirus-Related Carcinoma,0
16918,Data operation - complete,Cervical Fibroepithelial Polyp,0
16919,Biomaterial Treatment,Botryoid-Type Embryonal Rhabdomyosarcoma,0
16920,Common Specifications in HL7 V3 Publishing,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16921,Melanoma Pathway,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
16922,Intravenous,Malignant Neoplasm with Regional Lymph Node Involvement,0
16923,Percent (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16924,Vomiting,clear cell adenocarcinoma of gallbladder,0
16925,Togo,Medulloblastoma,0
16926,risk factors - observation list,Acantholytic squamous cell carcinoma,0
16927,Leg,clear cell adenocarcinoma of gallbladder,0
16928,Code System Type - Internal,Stage III Cutaneous Melanoma AJCC v6,0
16929,Upper Extremity,Localized Ewing Sarcoma,0
16930,Vaginal Neoplasms,Neonatal leukemia,0
16931,Logical Condition,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
16932,Family (taxonomic),Gallbladder Adenocarcinoma,0
16933,Appearance Distress Question,Clinical Stage I Cutaneous Melanoma AJCC v8,0
16934,Used by,Locally Advanced Epithelioid Hemangioendothelioma,0
16935,include - SetOperator,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16936,structure,Cerebral Primitive Neuroectodermal Tumor,0
16937,American College of Cardiology/American Heart Association Lesion Complexity Score C,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16938,Ichthyoses,Intracortical osteosarcoma,0
16939,Sweat,Bladder adenocarcinoma stage IV,0
16940,Elderly (population group),Recurrent Uveal Melanoma,0
16941,Group A (blood group),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
16942,Hereditary Diffuse Gastric Cancer,Stage IV Penile Cancer AJCC v7,0
16943,Chemotherapy Regimen,Human Papillomavirus-Related Carcinoma,0
16944,Human body,Malignant neoplasm of olfactory nerve,0
16945,Include (action),Cherubism,0
16946,Catabolism,Lipoma of small intestine,0
16947,*Activity (kind of quantity),Contact dermatitis due to alkali,0
16948,Fibrolamellar Hepatocellular Carcinoma,Non-Metastatic Gestational Trophoblastic Tumor,0
16949,Sweat,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16950,Array Feature,Endometrial Small Cell Carcinoma,0
16951,Abdominal Cavity,Glomeruloid hemangioma,0
16952,Compartments [PK],Intestinal Neuroendocrine Carcinoma,0
16953,External exotoses,Trichilemmocarcinoma,0
16954,Singular,FIGO Stage IVA Ovarian Cancer,0
16955,Togo,Stage IV Penile Cancer AJCC v7,0
16956,Abnormal cell,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
16957,various antiinfectives and antiseptics for local oral treatment,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
16958,Abdominal Cavity,Intestinal Metaplasia of Bladder Urothelium,0
16959,Effectiveness,Peripheral primitive neuroectodermal tumor of soft tissue,0
16960,How Often Weight Loss,mucinous adenocarcinoma of gallbladder,0
16961,High risk of,Heavy Chain Deposition Disease,0
16962,Symptoms aspect,Maxillary Sinus Adenocarcinoma,0
16963,Additional,Vaginal Adenoma,0
16964,second (number),Squamous cell carcinoma of lip,0
16965,Excision,Stage 0 Penile Cancer AJCC v8,0
16966,Age-Years,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
16967,Pharmacotherapy,Non-Metastatic Gestational Trophoblastic Tumor,0
16968,Academic degree,Benign Anal Granular Cell Tumor,0
16969,Make - Instruction Imperative,Testicular cancer metastatic,0
16970,Type A,Recurrent Primary Lymphoma of Bone,0
16971,New Zealand,Recurrent Uveal Melanoma,0
16972,Options,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
16973,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
16974,Cause of death.underlying,Periosteal Osteosarcoma,0
16975,Microvolt,Diffuse malignant mesothelioma,0
16976,Malignant - descriptor,FIGO Stage II Ovarian Cancer,0
16977,Sharing (Social Behavior),Carcinoma,0
16978,Case unit dose,embryonal rhabdomyosarcoma of prostate,0
16979,Malignant neoplasm of breast,Stage III Cutaneous Melanoma AJCC v6,0
16980,Persons,Neoplasms,0
16981,Chemotherapy Regimen,benign mature teratoma of pancreas,0
16982,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Recurrent Diffuse Intrinsic Pontine Glioma,0
16983,To,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
16984,Pharmacotherapy,Uterine Cancer,0
16985,1000000,Prostate Lymphoma,0
16986,Blood,Hodgkin lymphoma,0
16987,Specimen Source Codes - tumor,Pancreatic carcinoma,0
16988,Pathologic,Cancer of Urinary Tract,0
16989,consider,Transitional cell carcinoma,0
16990,SPINK5 gene,Metastatic Kidney Carcinoma,0
16991,Leading,Splenic Manifestation of Hairy Cell Leukemia,0
16992,Orthologous Gene,Pleomorphic adenoma of parotid gland,0
16993,Difficult (qualifier value),Neoplasms,0
16994,Known,Carcinoma,0
16995,Affect (mental function),Anterior Urethral Malignant Neoplasm,0
16996,depend,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
16997,Feelings,Gallbladder Adenocarcinoma,0
16998,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Mucinous adenocarcinoma,0
16999,Malignant Neoplasms,Necrotizing Funisitis,0
17000,Presentation,Malignant melanoma of eyelid,0
17001,Status post,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17002,Anatomy aspects,Cartilaginous exostosis,0
17003,Usual Severity Itching,Cerebral Primitive Neuroectodermal Tumor,0
17004,described,Vaginal Adenoid Cystic Carcinoma,0
17005,Small cell carcinoma of lung,FIGO Stage IVA Ovarian Cancer,0
17006,Two,Mucinous adenocarcinoma gastric,0
17007,Telephone Extension Number,Mucinous adenocarcinoma gastric,0
17008,Process (qualifier value),Childhood Central Nervous System Ganglioneuroblastoma,0
17009,Most,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
17010,Neoplasm Metastasis,Ovarian germ cell choriocarcinoma stage IV,0
17011,Times,Chest Wall Fibromatosis,0
17012,Science of Etiology,Mixed astrocytoma-ependymoma,0
17013,Greeks,Childhood Central Nervous System Ganglioneuroblastoma,0
17014,Negation,Stage III Cutaneous Melanoma AJCC v6,0
17015,Molecular Mass,Refractory Bladder Carcinoma,0
17016,Malignant Neoplasms,Breast Ductal Adenoma,0
17017,Abnormal cell,Spongiotic dermatitis,0
17018,Several,Locally Advanced Epithelioid Hemangioendothelioma,0
17019,1+ Score,Secondary malignant neoplasm of lymph node,0
17020,Classification of information,Localized Ewing Sarcoma,0
17021,Japanese language,FIGO Stage II Ovarian Cancer,0
17022,Condition:Find:Pt:^Patient:Nom,Adrenal Rest Tumor,0
17023,Biologic Development,Localized Malignant Neoplasm,0
17024,Protocols documentation,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
17025,survival aspects,Non-Metastatic Gestational Trophoblastic Tumor,0
17026,Mass of body region,Primary Cutaneous Plasmablastic Lymphoma,0
17027,Body part,High Grade Glandular Intraepithelial Neoplasia,0
17028,Act Relationship Subset - previous,Melanomatosis,0
17029,Medial collateral ligament,Carcinoma of submandibular gland,0
17030,Primary malignant neoplasm of endometrium,Benign Anal Granular Cell Tumor,0
17031,Less Than,Adult Hepatocellular Carcinoma,0
17032,Saint Lucia,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17033,removal technique,Rhabdomyosarcoma with ganglionic differentiation,0
17034,International Classification of Diseases,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17035,Tired,Type II Endometrial Adenocarcinoma,0
17036,Approximate,Tubal Hyperplasia,0
17037,Low Back Pain,Mucinous cystadenofibroma,0
17038,Logical Condition,Tumorlet,0
17039,Malignant neoplasm of ovary,Nasal cavity carcinoma,0
17040,Initial Usage,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17041,Process (qualifier value),Hodgkin lymphoma,0
17042,Chemotherapy Regimen,Maxillary Sinus Adenoid Cystic Carcinoma,0
17043,include - SetOperator,Trabecular adenocarcinoma,0
17044,First (number),Anterior Urethral Malignant Neoplasm,0
17045,Hematopoietic Neoplasms,Metastatic Lung Small Cell Carcinoma,0
17046,Smear - instruction imperative,Gallbladder Adenocarcinoma,0
17047,Pharmaceutical Preparations,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17048,Common Specifications in HL7 V3 Publishing,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17049,Account number:Identifier:Point in time:^Patient:Nominal,clear cell adenocarcinoma of gallbladder,0
17050,Malignant Vaginal Neoplasm,embryonal rhabdomyosarcoma of prostate,0
17051,Anal (qualifier value),Childhood Fibrillary Astrocytoma,0
17052,Extreme Response,Congenital hamartoma,0
17053,Body tissue,Methotrexate-Associated Hodgkin Lymphoma,0
17054,Emotional,Maxillary Sinus Adenoid Cystic Carcinoma,0
17055,Shortness of Breath Visual Analogue Scale,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17056,Common (qualifier value),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17057,Third,Occult Lung Adenosquamous Carcinoma,0
17058,Observation Interpretation - intermediate,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
17059,SLC35G1 gene,Stage III Cutaneous Melanoma AJCC v6,0
17060,Endocrine Cells,Benign tumor of eyelid,0
17061,Including (qualifier),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17062,N not otherwise specified Antibody,Maxillary Sinus Adenocarcinoma,0
17063,Case (situation),Funisitis (disorder),0
17064,Deglutition Disorders,Childhood Anaplastic Large Cell Lymphoma,0
17065,Lesion,Pancreatic carcinoma,0
17066,Taken,Lipoma of small intestine,0
17067,Out (direction),Cerebral Primitive Neuroectodermal Tumor,0
17068,Characterization,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17069,3+ Score,Extra-abdominal fibromatosis,0
17070,Location,gliosarcoma,0
17071,metastatic qualifier,Refractory Barrett Esophagus,0
17072,Covers (device),Engraftment syndrome,0
17073,Axilla,Carcinoma of submandibular gland,0
17074,Administration procedure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17075,Very High Level,Unresectable Rhabdomyosarcoma,0
17076,Methods aspects,FIGO Stage IVA Ovarian Cancer,0
17077,Qualitative form,embryonal rhabdomyosarcoma of prostate,0
17078,Platelets Product,Pancreatic carcinoma,0
17079,Myeloid,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17080,Glioblastoma Multiforme,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
17081,Lacrimal gland structure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17082,Etiology,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17083,Colonic Polyps,Cerebral Primitive Neuroectodermal Tumor,0
17084,Greater,FIGO Stage II Ovarian Cancer,0
17085,High Mitotic Activity,mucinous adenocarcinoma of gallbladder,0
17086,Infrequent,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17087,EPRS gene,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17088,NCI CTEP SDC Astrocytoma,Astrocytoma of brain,0
17089,Term (temporal),Metastatic Lung Small Cell Carcinoma,0
17090,treatment - ActInformationManagementReason,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17091,Tears body substance,Parathyroid Gland Adenocarcinoma,0
17092,Estrogens,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17093,Classes - encounter,ROSE Cluster 3,0
17094,Item Collection,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
17095,Disease Screening,Recurrent Testicular Lymphoma,0
17096,Beginning,Testicular cancer metastatic,0
17097,Congenital ichthyosis,Malignant neoplasm of thalamus,0
17098,*Type - Kind of quantity,Malignant neoplasm of subglottis,0
17099,Nerve,Pancreatic Intraepithelial Neoplasia-3,0
17100,Most,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17101,Orbital content,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17102,Science of Etiology,Stage III Cutaneous Melanoma AJCC v6,0
17103,Estimated,Kaposi's sarcoma of skin,0
17104,Diagnostic Imaging,Metastatic Carcinoma in the Lung,0
17105,Manufactured form,Liver Lymphangioma,0
17106,Neoplasms,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17107,Treatment Epoch,Adult Acute Eosinophilic Leukemia,0
17108,Contain (action),papillary carcinoma of penis,0
17109,Low Grade,Mucinous adenocarcinoma,0
17110,Freezing,Low Grade Squamous Intraepithelial Neoplasia,0
17111,Cell Count,Cartilaginous exostosis,0
17112,Immune System Finding,Engraftment syndrome,0
17113,Sufficiently defined concept definition status (core metadata concept),Precursor B-lymphoblastic lymphoma stage II,0
17114,Adult Lymphoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17115,Abnormal Cell Count,Malignant neoplasm of thalamus,0
17116,Varies,Mucinous adenocarcinoma gastric,0
17117,Hemochromatosis,Methotrexate-Associated Hodgkin Lymphoma,0
17118,Leading,Stage III Adult Immunoblastic Lymphoma,0
17119,Increase,Unfavorable Non-Hodgkin Lymphoma,0
17120,morphological,Stage III Cutaneous Melanoma AJCC v6,0
17121,Include (action),Stage III Cutaneous Melanoma AJCC v6,0
17122,Death (finding),Localized Askin Tumor,0
17123,Version (morphologic abnormality),Mixed parotid tumor,0
17124,Disease,Diffuse malignant mesothelioma,0
17125,Approach,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17126,Togo,Angiosarcoma of liver,0
17127,Therapeutic procedure,Unfavorable Non-Hodgkin Lymphoma,0
17128,Frequently,Adenocarcinoma of duodenum,0
17129,Staining (finding),Adenocarcinoma of the prostate metastatic,0
17130,Fertility Agents,clear cell adenocarcinoma of gallbladder,0
17131,Males,Grade 1 Clear Cell Renal Cell Carcinoma,0
17132,Formation,Refractory Bladder Carcinoma,0
17133,United States,Platinum-Resistant Lung Small Cell Carcinoma,0
17134,Symptoms aspect,benign mature teratoma of pancreas,0
17135,Gram per Deciliter,Adult Anaplastic Oligodendroglioma,0
17136,soft tissue,Small cell neuroendocrine carcinoma of bladder,0
17137,Manual pelvic examination (procedure),Stage I Colon Neuroendocrine Tumor AJCC v8,0
17138,Low Level,FIGO Stage IVA Ovarian Cancer,0
17139,Primary malignant neoplasm,Unicystic ameloblastoma,0
17140,Case unit dose,Localized Ewing Sarcoma,0
17141,Presentation,Extracranial Neuroblastoma,0
17142,Therapeutic procedure,High Grade Glandular Intraepithelial Neoplasia,0
17143,Abdominal hysterectomy,Refractory Bladder Carcinoma,0
17144,Connective Tissue,Splenic Manifestation of Hairy Cell Leukemia,0
17145,Particle,Choroid Epithelioid Cell Melanoma,0
17146,Tumor cells,High Grade Glandular Intraepithelial Neoplasia,0
17147,Five-year Survival Rate,Basal Cell Ameloblastoma,0
17148,Malignant neoplasm of breast,Nasal cavity carcinoma,0
17149,Determined by,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
17150,Endodermal,Endometrial Small Cell Carcinoma,0
17151,Autosomal dominant inheritance,Pancreatic carcinoma,0
17152,Does stand alone,Recurrent Uveal Melanoma,0
17153,per year,Epithelioid Sarcoma NCI Grade 3,0
17154,More,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17155,Treating,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
17156,Involvement with,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17157,Controlled by,Malignant melanoma of eyelid,0
17158,Affecting,Human Papillomavirus-Related Carcinoma,0
17159,Rare Diseases,squamous cell carcinoma of the thyroid gland,0
17160,Injury due to exposure to external cause,Metastatic Lung Neuroendocrine Neoplasm,0
17161,Positive,Breast Ductal Adenoma,0
17162,Negative Number,High Grade Glandular Intraepithelial Neoplasia,0
17163,Adolescent (age group),Small cell neuroendocrine carcinoma of bladder,0
17164,Followed by,Testicular cancer metastatic,0
17165,Biological Response Modifiers,Childhood Lymphoma,0
17166,Metastatic to,Tongue Alveolar Soft Part Sarcoma,0
17167,Pharmacotherapy,Adenocarcinoma of the prostate metastatic,0
17168,Collection (action),Trabecular adenocarcinoma,0
17169,Type - attribute,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17170,Pleural effusion disorder,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17171,Condition:Find:Pt:^Patient:Nom,Cherubism,0
17172,Physical findings,Small Intestinal Villous Adenoma,0
17173,Anabolism,Malignant neoplasm of thalamus,0
17174,Stomach structure,Benign neoplasm of eye,0
17175,Extrinsic,embryonal rhabdomyosarcoma of prostate,0
17176,Cell Count,Gallbladder adenoma,0
17177,Destruction (action),Cancer of Urinary Tract,0
17178,LMNA wt Allele,Methotrexate-Associated Hodgkin Lymphoma,0
17179,Primary malignant neoplasm,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17180,World Health Organization,Peripheral primitive neuroectodermal tumor of soft tissue,0
17181,Pap smear,Diffuse malignant mesothelioma,0
17182,Brain part,Peripheral primitive neuroectodermal tumor of soft tissue,0
17183,include - SetOperator,Papillary squamous cell carcinoma,0
17184,Thickened,squamous cell carcinoma of the thyroid gland,0
17185,Childhood Extracranial Germ Cell Tumor,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17186,Laboratory Procedures,Unresectable Rhabdomyosarcoma,0
17187,Primary malignant neoplasm,Diffuse malignant mesothelioma,0
17188,Before,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17189,Distention,Grade 1 Clear Cell Renal Cell Carcinoma,0
17190,Call (Instruction),Malignant Neoplasm with Regional Lymph Node Involvement,0
17191,various allergen extracts,Unresectable Rhabdomyosarcoma,0
17192,Cancer Etiology,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
17193,Double eyelid,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17194,Spreading (qualifier value),adenoid cystic carcinoma of lung,0
17195,Malignant epithelioma,Intracortical osteosarcoma,0
17196,Chemotherapy,Stage IV Childhood Non-Hodgkin Lymphoma,0
17197,Hyperplasia,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17198,Stage Grouping,Primary Cutaneous Plasmablastic Lymphoma,0
17199,Together,Xeroderma pigmentosum,0
17200,Difficulty walking,Neonatal leukemia,0
17201,Asleep,Bladder Neuroendocrine Neoplasm,0
17202,Occur (action),Recurrent Testicular Lymphoma,0
17203,Include (action),Human Papillomavirus-Related Carcinoma,0
17204,Blood Circulation,Metastatic Lung Neuroendocrine Neoplasm,0
17205,Type - attribute,Recurrent Uveal Melanoma,0
17206,Surgical aspects,Familial Hemophagocytic Lymphocytosis,0
17207,Chemotherapy,Clonal Hematopoiesis of Indeterminate Potential,0
17208,Tests (qualifier value),Squamous cell carcinoma of lip,0
17209,month,FIGO Stage IVA Ovarian Cancer,0
17210,product,Neonatal leukemia,0
17211,Excision,Malignant Neoplasm with Regional Lymph Node Involvement,0
17212,shared attribute,Ectomesenchymal Chondromyxoid Tumor,0
17213,Occurrence Indicator,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17214,Retinoic Acid Response Element,Thyroid Hurthle Cell Carcinoma,0
17215,Physical findings,Liver Lymphangioma,0
17216,Sacrifice,Mucinous adenocarcinoma gastric,0
17217,Regurgitation,Undifferentiated Endocervical Sarcoma,0
17218,Evidence,Benign squamous cell tumor,0
17219,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17220,Gram per Deciliter,Intestinal Metaplasia of Bladder Urothelium,0
17221,Anterior portion of neck,embryonal rhabdomyosarcoma of prostate,0
17222,Trial Screening,Spongiotic dermatitis,0
17223,Cancer Genus,Lipoma of small intestine,0
17224,Only - dosing instruction fragment,Clonal Hematopoiesis of Indeterminate Potential,0
17225,Bone Pain,Adult Anaplastic Oligodendroglioma,0
17226,List,Liver Lymphangioma,0
17227,Table Rules - groups,Non-Metastatic Gestational Trophoblastic Tumor,0
17228,Lymphoma,Engraftment syndrome,0
17229,Child,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
17230,Bio-Informatics,Adult Alveolar Soft Part Sarcoma,0
17231,Body structure,Childhood Fibrillary Astrocytoma,0
17232,Vital (qualifier value),Testicular cancer metastatic,0
17233,Oral,Kaposi's sarcoma of skin,0
17234,Symptoms,Astrocytoma of brain,0
17235,seconds,Xeroderma pigmentosum,0
17236,Have Weight Loss,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17237,Science of Etiology,Tonsillar Carcinoma,0
17238,Walled,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17239,National origin,adenosquamous carcinoma of breast,0
17240,Times,FIGO Stage II Ovarian Cancer,0
17241,Complication,Testicular cancer metastatic,0
17242,Usually Need Help from Another Person for Arising,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17243,Growth action,mucinous adenocarcinoma of gallbladder,0
17244,Representation (action),Microcystic meningioma,0
17245,include - SetOperator,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17246,Central,Childhood Lymphoma,0
17247,Discharge,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17248,health and disease,BRCA2 Syndrome,0
17249,year,Malignant melanoma of eyelid,0
17250,Left,Undifferentiated Endocervical Sarcoma,0
17251,Contact with,Adenocarcinoma,0
17252,Major <insect>,Mastocytosis,0
17253,Macrophage Activation Syndrome,Human Papillomavirus-Related Carcinoma,0
17254,Colon structure (body structure),Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17255,Function Axis,Adult Brain Stem Mixed Glioma,0
17256,Adult Hodgkin Lymphoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17257,Often - answer to question,Cancer of Urinary Tract,0
17258,Most,Methotrexate-Associated Hodgkin Lymphoma,0
17259,Number of birth,Platinum-Resistant Lung Small Cell Carcinoma,0
17260,Second Suffix,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17261,Life Expectancy,Vaginal Adenoma,0
17262,Infected,Cancer of Urinary Tract,0
17263,Removing (action),Undifferentiated Neuroblastoma,0
17264,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
17265,Cells,Pancreatic Intraepithelial Neoplasia-3,0
17266,Involvement with,embryonal rhabdomyosarcoma of prostate,0
17267,THYROID DIAGNOSTIC RADIOPHARMACEUTICALS,Transitional cell carcinoma,0
17268,Greater than one,Thyroid Hurthle Cell Carcinoma,0
17269,Include (action),Basal Cell Ameloblastoma,0
17270,Abdominal Cavity,Stage III Cutaneous Melanoma AJCC v6,0
17271,Stage IV Breast Cancer AJCC v6 and v7,Ichthyosis,0
17272,Base - General Qualifier,Childhood Fibrillary Astrocytoma,0
17273,NCI CTEP SDC Wilms Tumor Sub-Category Terminology,Adrenal Rest Tumor,0
17274,Very High Level,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17275,Infant,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
17276,Neuroendocrine Tumors,FIGO Stage II Ovarian Cancer,0
17277,G2 stage (tumor staging),Stage IV Colorectal Cancer AJCC v8,0
17278,Removed,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17279,Tryptophanase,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17280,Non-Seminomatous Lesion,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17281,Term Birth,Necrotizing Funisitis,0
17282,Appearance,Recurrent Testicular Lymphoma,0
17283,Disease,Microcystic meningioma,0
17284,How Often Felt Normal question,GIANT PIGMENTED HAIRY NEVUS,0
17285,Important,Anaplastic large cell lymphoma,0
17286,Type A,Metastatic Ductal Breast Carcinoma,0
17287,Symptoms,Trabecular adenocarcinoma,0
17288,Colorectal Carcinoma,Basal Cell Ameloblastoma,0
17289,The Sun,Human Papillomavirus-Related Carcinoma,0
17290,Class,Localized Ewing Sarcoma,0
17291,Asia,Thyroid Hurthle Cell Carcinoma,0
17292,Order (arrangement),Splenic Manifestation of Hairy Cell Leukemia,0
17293,Occurrence,adenosquamous carcinoma of breast,0
17294,Childhood Leukemia,Adult Acute Eosinophilic Leukemia,0
17295,Affect (mental function),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17296,General surgery specialty,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17297,Genetic syndrome,FIGO Stage IVA Ovarian Cancer,0
17298,Occurrence Indicator,Digestive System Hodgkin Lymphoma,0
17299,Smaller,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17300,Screens (device),Recurrent Primary Lymphoma of Bone,0
17301,Providing (action),Stage III Cutaneous Melanoma AJCC v6,0
17302,International Statistical Classification of Diseases and Related Health Problems,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17303,Lower - spatial qualifier,Benign squamous cell tumor,0
17304,Japan,Pancreatic Intraepithelial Neoplasia-3,0
17305,Time,Thymic Clear Cell Carcinoma,0
17306,Testing,Granular Cell Leiomyosarcoma,0
17307,second (number),Stage IV Penile Cancer AJCC v7,0
17308,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17309,Human body structure,Type II Endometrial Adenocarcinoma,0
17310,NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17311,Cyclophosphamide,non-Hodgkin's lymphoma of spleen,0
17312,Infiltration Route of Drug Administration,Undifferentiated Neuroblastoma,0
17313,Adenoma,Splenic Manifestation of Hairy Cell Leukemia,0
17314,Body structure,Papillary cystic tumor,0
17315,Age at diagnosis:Time:Pt:^Patient:Qn,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17316,Success,Giant cell angiofibroma,0
17317,*Type - Kind of quantity,Thymic Clear Cell Carcinoma,0
17318,Adult Hodgkin Lymphoma,Atypical Lobular Breast Hyperplasia,0
17319,Swelling,Undifferentiated Neuroblastoma,0
17320,Cell Count,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17321,Adult Subependymal Giant Cell Astrocytoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17322,Borg Category-Ratio 10 Perceived Exertion Score 5,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17323,Prevention Study,Malignant Neoplasm with Regional Lymph Node Involvement,0
17324,Monocytes,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
17325,List,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17326,Medical Device Emits Smoke,Cerebral hemangioma,0
17327,Cells,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17328,Web Site,Undifferentiated Neuroblastoma,0
17329,Ultrasonography,Mucinous adenocarcinoma gastric,0
17330,Present,Xeroderma pigmentosum,0
17331,Pancreas part,Low Grade Squamous Intraepithelial Neoplasia,0
17332,Most,Locally Advanced Carcinoma,0
17333,Malignant Neoplasms,Gallbladder Adenocarcinoma,0
17334,Primary,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17335,Middle,Female Breast Carcinoma,0
17336,Cancer Genus,Recurrent Uveal Melanoma,0
17337,Usually Need Help from Another Person for Reach,Kaposi's sarcoma of skin,0
17338,2+ Score,Stage IV Penile Cancer AJCC v7,0
17339,Specimen Source Codes - tumor,Diffuse malignant mesothelioma,0
17340,Tryptophanase,squamous cell carcinoma of the thyroid gland,0
17341,Neoplasms,Uterine Cancer,0
17342,Death Related to Adverse Event,Xeroderma pigmentosum,0
17343,Targeted Therapy,Stage III Cutaneous Melanoma AJCC v6,0
17344,United States,Transitional cell carcinoma,0
17345,Weight Loss,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17346,CDISC SEND Tumor Findings Results Terminology,Endometrial Small Cell Carcinoma,0
17347,Retrobulbar Route of Drug Administration,Testicular cancer metastatic,0
17348,Disease Screening,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17349,FAT1 wt Allele,Cartilaginous exostosis,0
17350,1870s,adenosquamous carcinoma of breast,0
17351,Appearance Distress Question,Thyroid Hurthle Cell Carcinoma,0
17352,Abnormal host response,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17353,Person 3,Lipoma of small intestine,0
17354,Entire great blood vessel (organ),sarcoma of spinal cord,0
17355,Value Above Reference Range,Xeroderma pigmentosum,0
17356,Contract agreement,Neonatal leukemia,0
17357,More Often than Once a Day,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17358,Count of entities,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17359,Sacrifice,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17360,physiological aspects,Recurrent Testicular Lymphoma,0
17361,*Type - Kind of quantity,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17362,Involvement with,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17363,Cell Device,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17364,include - SetOperator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17365,Areas <moth>,Undifferentiated Endocervical Sarcoma,0
17366,Metastatic Neoplasm,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17367,Metaplastic carcinoma of breast,Locally Advanced Soft Tissue Sarcoma,0
17368,Formation,Carcinoma of urinary bladder,0
17369,risk factors,Unicystic ameloblastoma,0
17370,Percent of Abnormal Cells,Blepharal carcinoma,0
17371,70%,Cartilaginous exostosis,0
17372,Better,Familial Adenomatous Polyposis Associated Medulloblastoma,0
17373,Treatment Epoch,Childhood Central Nervous System Ganglioneuroblastoma,0
17374,Short Value,Malignant melanoma of eyelid,0
17375,melanocyte,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17376,>5,Blood Vessel Tumors,0
17377,Diabetes,Acute Undifferentiated Leukemia,0
17378,Array Feature,Peripheral primitive neuroectodermal tumor of soft tissue,0
17379,High,Locally Advanced Carcinoma,0
17380,Pediculus (eukaryote),Small cell neuroendocrine carcinoma of bladder,0
17381,Adult Soft Tissue Sarcoma,Malignant neoplasm of olfactory nerve,0
17382,Pain Distress Question,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17383,Nicotiana,Stage III Cutaneous Melanoma AJCC v6,0
17384,pharmacotherapeutic,Localized Malignant Neoplasm,0
17385,Amount type - Percentage,Basal Cell Ameloblastoma,0
17386,diagnosis aspect,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17387,Malignant - descriptor,FIGO Stage II Ovarian Cancer,0
17388,cell growth,Malignant neoplasm of gallbladder,0
17389,Cancer Other,Methotrexate-Associated Hodgkin Lymphoma,0
17390,Third,Adult Acute Eosinophilic Leukemia,0
17391,Type - attribute,Primary Cutaneous Plasmablastic Lymphoma,0
17392,Endometrial Carcinoma,Pancreatic carcinoma,0
17393,Occurrence Indicator,Cervical Squamous Intraepithelial Neoplasia,0
17394,Ricin poisoning,BRCA2 Syndrome,0
17395,Beds,Vaginal Adenoid Cystic Carcinoma,0
17396,Significant,Malignant neoplasm of choroid,0
17397,1+ Score,Acute lymphadenitis,0
17398,Axis,Peripheral primitive neuroectodermal tumor of soft tissue,0
17399,Cervical Intraepithelial Neoplasia,Testicular cancer metastatic,0
17400,Several,Squamous cell carcinoma of lip,0
17401,AMINO ACIDS/PROTEINS,Intraepithelial Melanocytic Hyperplasia,0
17402,Persons,Low Grade Squamous Intraepithelial Neoplasia,0
17403,Microplate Well,Intraepithelial Melanocytic Hyperplasia,0
17404,Stable status,Plexosarcoma,0
17405,Adult human body,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17406,Often - answer to question,Neoplasms,0
17407,Count of entities,Methotrexate-Associated Hodgkin Lymphoma,0
17408,Difficult (qualifier value),Fibroadenoma of breast,0
17409,Object Class,Testicular cancer metastatic,0
17410,Arrested progression,Ovarian Carcinoid Tumor,0
17411,CDISC SEND Tumor Findings Results Terminology,Platinum-Resistant Lung Small Cell Carcinoma,0
17412,Value Above Reference Range,Trichilemmocarcinoma,0
17413,*Type - Kind of quantity,Intraepithelial Melanocytic Hyperplasia,0
17414,Chronic inflammation,Unresectable Rhabdomyosarcoma,0
17415,Make - Instruction Imperative,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17416,Continuance of life,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17417,System - kit,Testicular cancer metastatic,0
17418,Epithelial Cells,Recurrent Uveal Melanoma,0
17419,Administration procedure,Peripheral primitive neuroectodermal tumor of soft tissue,0
17420,Liver Flavor,Pancreatic Intraepithelial Neoplasia-3,0
17421,Rubbery,adenosquamous carcinoma of breast,0
17422,Consistency,Deep Leiomyoma,0
17423,Front of neck,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17424,Sarcoma,Bladder adenocarcinoma stage IV,0
17425,Thick,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
17426,20%,Benign Anal Granular Cell Tumor,0
17427,Aspect (characteristic),Mixed parotid tumor,0
17428,Loss of Appetite question,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17429,Inhibition,Benign Carotid Body Paraganglioma,0
17430,Anterior chest wall structure,sarcoma of spinal cord,0
17431,Associated topography,Engraftment syndrome,0
17432,body system,Uterine Cancer,0
17433,Electromagnetic Fields,Parathyroid Gland Adenocarcinoma,0
17434,Symptoms aspect,Childhood Anaplastic Large Cell Lymphoma,0
17435,Recurrence,Metastatic Kidney Carcinoma,0
17436,leukemia,Stage IV Colorectal Cancer AJCC v8,0
17437,Internal,Undifferentiated Neuroblastoma,0
17438,Liquid substance,Xeroderma pigmentosum,0
17439,treatment - ActInformationManagementReason,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17440,Data Transformation,Cervical Fibroepithelial Polyp,0
17441,Autoimmune Diseases,Pilocytic astrocytoma of cerebellum,0
17442,Result,Benign Carotid Body Paraganglioma,0
17443,Neoplasm Metastasis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17444,Mutation Abnormality,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17445,therapeutic aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17446,Xeroderma Pigmentosum,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17447,Active,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17448,South,Squamous cell carcinoma of lip,0
17449,Therapeutic radiology procedure,Hemangioma,0
17450,Beginning,Type II Endometrial Adenocarcinoma,0
17451,Abdominal Cavity,squamous cell carcinoma of the thyroid gland,0
17452,All extremities,Giant cell angiofibroma,0
17453,50%,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17454,Malignant lymphoma,Squamous cell carcinoma of lip,0
17455,Characterization,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
17456,BRCA2 Protein,Stage IV Colorectal Cancer AJCC v8,0
17457,Cover (physical object),Recurrent Uveal Melanoma,0
17458,Reflecting,FIGO Stage II Ovarian Cancer,0
17459,early disease,Childhood Fibrillary Astrocytoma,0
17460,Exposure to radiation,Extra-Adrenal Paraganglioma,0
17461,Pathogenic organism,Choroid Necrotic Melanoma,0
17462,Use of,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
17463,Most,Localized Ewing Sarcoma,0
17464,Laryngeal part,Breast Apocrine Adenoma,0
17465,Swollen Lymph Node,Melanomatosis,0
17466,Can Do Very Little,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17467,Mode of inheritance,Hair nevus,0
17468,N not otherwise specified Antibody,Benign squamous cell tumor,0
17469,To,Recurrent Uveal Melanoma,0
17470,More,Childhood Fibrillary Astrocytoma,0
17471,Certainties,Noninfiltrating Intraductal Carcinoma,0
17472,Local disease,Acute lymphadenitis,0
17473,Primary malignant neoplasm,Pancreatic Endocrine Carcinoma,0
17474,Containing (qualifier),Intraepithelial Melanocytic Hyperplasia,0
17475,Germ Layers,Contact dermatitis due to alkali,0
17476,Body tissue,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17477,Structure of primordial sex cell,Stage IB Pancreatic Cancer AJCC v8,0
17478,Carbon Dioxide,Recurrent Testicular Lymphoma,0
17479,Common Specifications in HL7 V3 Publishing,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17480,SLC6A2 wt Allele,Intestinal Metaplasia of Bladder Urothelium,0
17481,3+ Answer to Question,Digestive System Hodgkin Lymphoma,0
17482,GIVEN,Endometrial Small Cell Carcinoma,0
17483,Serving,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17484,Teens,Carcinoma of urinary bladder,0
17485,Usually Need Help from Another Person for Reach,clear cell adenocarcinoma of gallbladder,0
17486,Decision,Human Papillomavirus-Related Carcinoma,0
17487,aggressive cancer,Stage 0 Penile Cancer AJCC v8,0
17488,Never (frequency),Spindle Cell Melanoma,0
17489,Tumor site,Benign squamous cell tumor,0
17490,Image Feature,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17491,High Risk Acute Leukemia,Undifferentiated Neuroblastoma,0
17492,Cerebrum,Small cell neuroendocrine carcinoma of bladder,0
17493,peripheral blood,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17494,True primary (qualifier value),Refractory WHO Grade III Glioma,0
17495,Result,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
17496,include - SetOperator,Deep Leiomyoma,0
17497,Age,Hodgkin lymphoma,0
17498,63,Undifferentiated Neuroblastoma,0
17499,Dental Enamel,Nasal cavity carcinoma,0
17500,Benign,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17501,Primary,Xeroderma pigmentosum,0
17502,include - SetOperator,Placental aromatase deficiency,0
17503,Net (qualifier),Mucinous neoplasm,0
17504,Administration procedure,Astrocytoma of brain,0
17505,Life Threatening or Disabling Adverse Event,Mixed astrocytoma-ependymoma,0
17506,shared attribute,embryonal rhabdomyosarcoma of prostate,0
17507,Entity Determiner - specific,Unfavorable Non-Hodgkin Lymphoma,0
17508,Elderly (population group),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17509,Mammary Gland Parenchyma,Localized Askin Tumor,0
17510,Telephone Extension Number,Carcinoma of urinary bladder,0
17511,Process,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17512,2+ Score,Childhood Central Nervous System Ganglioneuroblastoma,0
17513,Combined,Pancreatic Intraepithelial Neoplasia-3,0
17514,Western Europe,Chronic Myelomonocytic Leukemia-2,0
17515,Minor (person),Stage III Cutaneous Melanoma AJCC v6,0
17516,Fertility Agents,benign mature teratoma of pancreas,0
17517,Upper aerodigestive tract,Papillary squamous cell carcinoma,0
17518,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17519,Times,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17520,Oral cavity,Trabecular adenocarcinoma,0
17521,Derivation,Acute Undifferentiated Leukemia,0
17522,Tumor stage,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17523,IPSS Risk Category High,Papillary squamous cell carcinoma,0
17524,Stomach,Cervical Fibroepithelial Polyp,0
17525,Treating,Malignant neoplasm of thalamus,0
17526,Examination,Vaginal Adenoid Cystic Carcinoma,0
17527,60%,Blepharal carcinoma,0
17528,Body tissue,Childhood Thyroid Gland Follicular Carcinoma,0
17529,PREVENT (product),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17530,Fasting,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17531,Usual,Trichilemmocarcinoma,0
17532,Diagnosis,Squamous cell carcinoma of lip,0
17533,Inferior,Gallbladder adenoma,0
17534,Common (qualifier value),Mastocytosis,0
17535,Frequently,Mastocytosis,0
17536,Nerve Tissue,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17537,Facial edema,FIGO Stage II Ovarian Cancer,0
17538,radiotherapeutic,Acute Undifferentiated Leukemia,0
17539,Breathing Distress Question,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17540,Congenital Abnormality,Malignant melanoma of eyelid,0
17541,More,Colorectal High Grade B-Cell Lymphoma,0
17542,Rest,FIGO Stage IVA Ovarian Cancer,0
17543,How Often Vomiting,Brain Tumor,0
17544,Diagnosis Study,Hyperplasia of pituitary gland,0
17545,Abnormally high,Stage III Cutaneous Melanoma AJCC v6,0
17546,Prevalence aspects,Cartilaginous exostosis,0
17547,Often - answer to question,Stage II Hepatocellular Carcinoma AJCC v8,0
17548,Age,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17549,Three,Benign Apocrine Neoplasm,0
17550,Treating,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17551,Respiration,Refractory Barrett Esophagus,0
17552,Due to,Refractory Barrett Esophagus,0
17553,Disease,Female Breast Carcinoma,0
17554,How Much Distress Itching,Cancer of Urinary Tract,0
17555,Form:Finding:Point in time:{Setting}:Document:{Role},Benign Ovarian Thecoma,0
17556,Study,Astrocytoma of brain,0
17557,Primary,Mucinous adenocarcinoma gastric,0
17558,Unmarried person,Locally Advanced Carcinoma,0
17559,More,High Grade Glandular Intraepithelial Neoplasia,0
17560,Sectioning technique,Astrocytoma of brain,0
17561,Body tissue,Trichilemmocarcinoma,0
17562,Including (qualifier),malignant lymphoma of pancreatic lymph nodes,0
17563,Intermediate,Cherubism,0
17564,Manufactured form,Acinar cell carcinoma of pancreas,0
17565,Pediculus humanus capitis (eukaryote),Digestive System Hodgkin Lymphoma,0
17566,Disorder of lymph node,Diffuse malignant mesothelioma,0
17567,Togo,Adult Alveolar Soft Part Sarcoma,0
17568,Time,Childhood Choriocarcinoma,0
17569,2+ Score,Trabecular adenocarcinoma,0
17570,Malignant neoplasm of endometrium,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17571,Primary malignant neoplasm,Splenic Manifestation of Hairy Cell Leukemia,0
17572,Did not receive therapy or drug for,Methotrexate-Associated Hodgkin Lymphoma,0
17573,Accounting (activity),Recurrent Testicular Lymphoma,0
17574,Germ,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17575,Abdomen,Low Grade Squamous Intraepithelial Neoplasia,0
17576,body system,Heavy Chain Deposition Disease,0
17577,Central Minus,Cherubism,0
17578,radiotherapeutic,Intraepithelial Melanocytic Hyperplasia,0
17579,DNA Breaks,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17580,BRCA1 protein,Fibroadenoma of breast,0
17581,Togo,sarcoma of spinal cord,0
17582,Enneking Low Surgical Grade,Refractory Barrett Esophagus,0
17583,Make - Instruction Imperative,Endometrial Small Cell Carcinoma,0
17584,Case unit dose,Adult Acute Eosinophilic Leukemia,0
17585,Human body,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17586,combination - answer to question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17587,various other nasal preparations in ATC,Undifferentiated Neuroblastoma,0
17588,Esophageal,Colorectal High Grade B-Cell Lymphoma,0
17589,Infection,Xeroderma pigmentosum,0
17590,Swab,Thymic Clear Cell Carcinoma,0
17591,Erythrocytes,Adult Alveolar Soft Part Sarcoma,0
17592,include - SetOperator,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
17593,Occur (action),Metastatic Carcinoma in the Lung,0
17594,Occurrence,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
17595,Fraction of,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
17596,Neuroendocrine Tumors,Kaposi's sarcoma of skin,0
17597,Feelings,Neonatal leukemia,0
17598,Smear - instruction imperative,Small Intestinal Villous Adenoma,0
17599,Occur (action),Kaposi's sarcoma of extrahepatic bile duct,0
17600,Malignant Neoplasms,Hyperplasia of pituitary gland,0
17601,United States,Cancer of Urinary Tract,0
17602,Abnormal uterine bleeding,Unresectable Rhabdomyosarcoma,0
17603,Head and neck structure,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17604,Short Value,Trichilemmocarcinoma,0
17605,Oropharyngeal,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17606,Occurrence Indicator,Engraftment syndrome,0
17607,gemcitabine,FIGO Stage II Ovarian Cancer,0
17608,Stem of Organ,Benign squamous cell tumor,0
17609,ICD-9,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17610,treatment options,Lung squamous cell carcinoma stage I,0
17611,Increased risk,Malignant Neoplasm with Regional Lymph Node Involvement,0
17612,Group A (qualifier value),Localized Ewing Sarcoma,0
17613,primary tumor,Kaposi's sarcoma of skin,0
17614,Headache,ROSE Cluster 3,0
17615,Severe (severity modifier),Unicystic ameloblastoma,0
17616,Life threatening - Event Consequence,Acute lymphadenitis,0
17617,Beginning,Peripheral primitive neuroectodermal tumor of soft tissue,0
17618,Version,Benign Anal Granular Cell Tumor,0
17619,Pregnancy,Acantholytic squamous cell carcinoma,0
17620,low confidentiality,Tubal Hyperplasia,0
17621,Associated with,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17622,Known,Angiosarcoma of liver,0
17623,Cellular fibroma,benign mature teratoma of pancreas,0
17624,Oral cavity,Nasal cavity carcinoma,0
17625,include - SetOperator,Chest Wall Fibromatosis,0
17626,Bone Marrow Cells,Ichthyoses,0
17627,To,Localized Ewing Sarcoma,0
17628,transport (device),Recurrent Testicular Lymphoma,0
17629,Similarity,Peripheral primitive neuroectodermal tumor of soft tissue,0
17630,Primary,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17631,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,FIGO Stage IVA Ovarian Cancer,0
17632,Room of building - Study,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
17633,Aggressive course,Stage 0 Lip Carcinoma,0
17634,Referral placed,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17635,Lymphoid Tissue,Basal Cell Ameloblastoma,0
17636,High risk,Acantholytic squamous cell carcinoma,0
17637,Adenocarcinoma of pancreas,Malignant neoplasm of olfactory nerve,0
17638,Smear - instruction imperative,Astrocytoma of brain,0
17639,Aggressive course,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17640,Mus,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17641,Bone Tissue,Benign neoplasm of eye,0
17642,Most,Ovarian germ cell choriocarcinoma stage IV,0
17643,described,ROSE Cluster 3,0
17644,Preventive intent,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
17645,Neoplasms,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
17646,International Statistical Classification of Diseases and Related Health Problems,Localized Malignant Neoplasm,0
17647,Diagnosis Study,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17648,brain cell,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17649,Subcutaneous Tissue,Undifferentiated Neuroblastoma,0
17650,Tryptophanase,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17651,Person Name,Gallbladder Adenocarcinoma,0
17652,Seizures,Vaginal Adenoid Cystic Carcinoma,0
17653,Comparison,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
17654,macromolecule,Childhood Thyroid Gland Follicular Carcinoma,0
17655,Major,Colorectal Neuroendocrine Tumor G2,0
17656,Frequently,embryonal rhabdomyosarcoma of prostate,0
17657,Specific qualifier value,Kaposi's sarcoma of skin,0
17658,risk factors - observation list,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17659,Free of (attribute),Familial Adenomatous Polyposis Associated Medulloblastoma,0
17660,*Type - Kind of quantity,Urethral Carcinoma,0
17661,Retinoic Acid Response Element,Microcystic meningioma,0
17662,Time,Chondrosarcoma,0
17663,Smear - instruction imperative,Cerebral Primitive Neuroectodermal Tumor,0
17664,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Stage II Hepatocellular Carcinoma AJCC v8,0
17665,High Mitosis-Karyorrhexis Index,de novo Myelodysplastic Syndrome,0
17666,Unique,Localized Ewing Sarcoma,0
17667,Concept model range (foundation metadata concept),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
17668,Sweat Glands,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17669,Plumbum metallicum,Stage II Hepatocellular Carcinoma AJCC v8,0
17670,Disease remission,Childhood Choriocarcinoma,0
17671,Referring,Neoplasms,0
17672,More,Undifferentiated Endocervical Sarcoma,0
17673,Togo,FIGO Stage II Ovarian Cancer,0
17674,Sunlight,Hyperplasia of pituitary gland,0
17675,NBL1 gene,Malignant melanoma of eyelid,0
17676,Person Name,Mucinous neoplasm,0
17677,High risk of,Recurrent Testicular Lymphoma,0
17678,Malignant Neoplasms,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17679,Targeted Therapy,FIGO Stage II Ovarian Cancer,0
17680,Neoplasms,Nasal cavity carcinoma,0
17681,Occurrence,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17682,Parameterized Data Type - Set,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
17683,pharmacotherapeutic,Leiomyoma of Gallbladder,0
17684,Common Specifications in HL7 V3 Publishing,Mixed astrocytoma-ependymoma,0
17685,Pruritus,Diffuse malignant mesothelioma,0
17686,Hyperplasia,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
17687,Bone Tissue,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17688,Form:Finding:Point in time:{Setting}:Document:{Role},Vaginal Adenoid Cystic Carcinoma,0
17689,Age at menopause,Type II Endometrial Adenocarcinoma,0
17690,Definition,Hemangioma,0
17691,In situ neoplasm (morphology),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17692,Following,mucinous adenocarcinoma of gallbladder,0
17693,Natural immunosuppression,Intraepithelial Melanocytic Hyperplasia,0
17694,Increase in size since previous mammogram,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17695,Pharyngeal structure,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17696,Negative Number,Human Papillomavirus-Related Carcinoma,0
17697,Include (action),Periosteal Osteosarcoma,0
17698,geographic population,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
17699,Symptoms,Breast Ductal Adenoma,0
17700,Case (situation),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
17701,Surgery specialty,Refractory WHO Grade III Glioma,0
17702,Critical,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17703,Call (Instruction),Colorectal cancer,0
17704,Common (qualifier value),Diffuse malignant mesothelioma,0
17705,PSA Level Less than Two,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17706,Part of,Clonal Hematopoiesis of Indeterminate Potential,0
17707,Antimicrobial Susceptibility Result,Locally Advanced Carcinoma,0
17708,Arsenic measurement,Tongue Alveolar Soft Part Sarcoma,0
17709,Half,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17710,{Setting},Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17711,Cervical Squamous Cell Carcinoma,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
17712,Lower - spatial qualifier,Cancer of Urinary Tract,0
17713,treatment - ActInformationManagementReason,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17714,World,Bladder adenocarcinoma stage IV,0
17715,Milliampere second,Benign Apocrine Neoplasm,0
17716,Togo,Colorectal High Grade B-Cell Lymphoma,0
17717,Histologic,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17718,Two,FIGO Stage IVA Ovarian Cancer,0
17719,Count of entities,embryonal rhabdomyosarcoma of prostate,0
17720,mesodermal,Childhood Central Nervous System Ganglioneuroblastoma,0
17721,Pluripotent,Familial Adenomatous Polyposis Associated Medulloblastoma,0
17722,Neoplasms,Trabecular adenocarcinoma,0
17723,Immune System Processes,Endometrial Small Cell Carcinoma,0
17724,Necrotic changes (finding),Refractory Bladder Carcinoma,0
17725,Linear,Small intestine carcinoma,0
17726,Four,Adenocarcinoma of duodenum,0
17727,predictive factor,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
17728,The Cancer Genome Atlas,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17729,Gastrointestinal tract structure,Thymic Clear Cell Carcinoma,0
17730,Carcinoma,papillary carcinoma of penis,0
17731,Inguinal region,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17732,Bone Marrow,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
17733,Frequently,Parathyroid Gland Adenocarcinoma,0
17734,Cancer Genus,squamous cell carcinoma of the thyroid gland,0
17735,Disease Response,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
17736,Round shape,Intestinal Metaplasia of Bladder Urothelium,0
17737,Function (attribute),non-Hodgkin's lymphoma of spleen,0
17738,Affecting,Hereditary Diffuse Gastric Adenocarcinoma,0
17739,Affecting,Mucinous adenocarcinoma gastric,0
17740,Most,Bladder adenocarcinoma stage IV,0
17741,Appearance,Acantholytic squamous cell carcinoma,0
17742,Cell Device,Stage III Cutaneous Melanoma AJCC v6,0
17743,Benign tumor of salivary gland,embryonal rhabdomyosarcoma of prostate,0
17744,Old age,Mucinous adenocarcinoma gastric,0
17745,Histologic,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17746,Upper jaw region,Squamous cell carcinoma of lip,0
17747,Class,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17748,morphological,Intraepithelial Melanocytic Hyperplasia,0
17749,Manufactured form,Epithelioid Sarcoma NCI Grade 3,0
17750,Population Group,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17751,Act Relationship Type - occurrence,Childhood Thyroid Gland Follicular Carcinoma,0
17752,Location of Oral Residue Following Swallowing,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17753,PAX3 gene,Benign tumor of eyelid,0
17754,Homo sapiens,Cervical Fibroepithelial Polyp,0
17755,Law enforcement arrest,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
17756,Translocation of object,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17757,Pharmacotherapy,Type II Endometrial Adenocarcinoma,0
17758,Call (Instruction),Primary Cutaneous Plasmablastic Lymphoma,0
17759,75,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17760,Proline measurement,Lipoma of small intestine,0
17761,Clinical Study Case,ROSE Cluster 3,0
17762,Known,Cerebral Primitive Neuroectodermal Tumor,0
17763,Act Mood - intent,Rhabdomyosarcoma with ganglionic differentiation,0
17764,Premature aging syndrome,Larynx carcinoma recurrent,0
17765,Tobacco smoking behavior,Maxillary Sinus Adenoid Cystic Carcinoma,0
17766,Cancer Genus,Lipoma of small intestine,0
17767,Abnormal Reference Range,ROSE Cluster 3,0
17768,Prostate,Mucinous adenocarcinoma gastric,0
17769,Brain,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17770,Greater Than,Mucinous neoplasm,0
17771,High,Childhood Central Nervous System Ganglioneuroblastoma,0
17772,Usually,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17773,200,Kaposi's sarcoma of extrahepatic bile duct,0
17774,health and disease,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
17775,Frequently,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
17776,combination - answer to question,adenoid cystic carcinoma of lung,0
17777,Malignant Neoplasms,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
17778,Pathological Dilatation,Childhood Central Nervous System Ganglioneuroblastoma,0
17779,Percent (qualifier value),Chest Wall Fibromatosis,0
17780,Manufactured form,Gallbladder Adenocarcinoma,0
17781,Mass of body region,Lipoma of small intestine,0
17782,Range,Refractory Bladder Carcinoma,0
17783,Negation,Astrocytoma of brain,0
17784,Medical Imaging,Acantholytic squamous cell carcinoma,0
17785,95,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17786,Worsening pattern,Chronic Myelomonocytic Leukemia-2,0
17787,Structure of cortex of kidney,Refractory Bladder Carcinoma,0
17788,various other agents for local oral treatment in ATC,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17789,artesunate,embryonal rhabdomyosarcoma of prostate,0
17790,Childhood Non-Hodgkin Lymphoma,Cancer of Urinary Tract,0
17791,Most,Cartilaginous exostosis,0
17792,Fever,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17793,World,sarcoma of spinal cord,0
17794,Unconscious State,Stage II Carcinoma of Penis,0
17795,Autosome,Recurrent Testicular Lymphoma,0
17796,Body tissue,Non-Metastatic Gestational Trophoblastic Tumor,0
17797,Head,Tonsillar Carcinoma,0
17798,Operative Surgical Procedures,Refractory Bladder Carcinoma,0
17799,Floor (anatomic),Bladder adenocarcinoma stage IV,0
17800,Chemotherapy Regimen,Neonatal leukemia,0
17801,Specimen obtained by fine needle aspiration procedure,Collecting Duct Carcinoma of the Kidney,0
17802,United States Military Commissioned Officer O4,Liver Lymphangioma,0
17803,Secondary Neoplasm,Endometrial Small Cell Carcinoma,0
17804,cancer classification,Engraftment syndrome,0
17805,Polycythemia Vera,Benign tumor of eyelid,0
17806,Skin Specimen,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17807,More Often than Once a Day,Digestive System Hodgkin Lymphoma,0
17808,Effect,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17809,Diagnosis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
17810,Frequently,Congenital hamartoma,0
17811,shared attribute,Unicystic ameloblastoma,0
17812,CDISC Relationship Class,Locally Advanced Carcinoma,0
17813,Classification,Extra-abdominal fibromatosis,0
17814,How Often Felt Normal question,Transitional cell carcinoma,0
17815,Present,Maxillary Sinus Adenoid Cystic Carcinoma,0
17816,Fetal,Epithelioid Sarcoma NCI Grade 3,0
17817,Call (Instruction),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
17818,Diagnostic Imaging,Refractory Barrett Esophagus,0
17819,Primary,Metastatic Neoplasm to the Gallbladder,0
17820,growth aspects,Cervical Fibroepithelial Polyp,0
17821,Online Mendelian Inheritance In Man,Epithelioid Sarcoma NCI Grade 3,0
17822,Along edge (qualifier value),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
17823,Bony,Stage IB Pancreatic Cancer AJCC v8,0
17824,Persons,Acantholytic squamous cell carcinoma,0
17825,Classification,Metaplastic carcinoma of breast,0
17826,Precancerous Conditions,Extra-abdominal fibromatosis,0
17827,Form of nose,Engraftment syndrome,0
17828,Classification,Nasal cavity carcinoma,0
17829,Taxonomic,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17830,Family,Malignant Neoplasm of Lung - Multiple Primary Sites,0
17831,Cells,Congenital hamartoma,0
17832,Qualitative form,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17833,Pharyngeal structure,adenoid cystic carcinoma of lung,0
17834,VIPR1 wt Allele,Stage 0 Penile Cancer AJCC v8,0
17835,Night sweats,Kaposi's sarcoma of skin,0
17836,Portion of urine,squamous cell carcinoma of the thyroid gland,0
17837,IPSS Risk Category High,Ovarian germ cell choriocarcinoma stage IV,0
17838,Chemotherapy Regimen,Malignant Neoplasm of Lung - Multiple Primary Sites,0
17839,Decision,Fourth Ventricle and Brain Stem Ependymal Tumor,0
17840,cns lymphoma,Malignant neoplasm of gallbladder,0
17841,Ovulation,Benign squamous cell tumor,0
17842,Singular,embryonal rhabdomyosarcoma of prostate,0
17843,Family member,Precursor B-lymphoblastic lymphoma stage II,0
17844,Hemorrhage,Advanced Uterine Corpus Carcinosarcoma,0
17845,Carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17846,Uterine Fibroids,Stage IB Pancreatic Cancer AJCC v8,0
17847,Body Site Modifier - Lower,Clonal Hematopoiesis of Indeterminate Potential,0
17848,Pink color,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
17849,Glioma,Acantholytic squamous cell carcinoma,0
17850,Much,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
17851,Specimen Source Codes - tumor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17852,Case (situation),Papillary squamous cell carcinoma,0
17853,Characterization,FIGO Stage II Ovarian Cancer,0
17854,Genetic,Intraepithelial Melanocytic Hyperplasia,0
17855,Treatment intent,Atypical Lobular Breast Hyperplasia,0
17856,Name (property) (qualifier value),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17857,Levator palpebrae superioris structure,Rhabdomyosarcoma with ganglionic differentiation,0
17858,Symptoms aspect,Metastatic Malignant Neoplasm in the Sellar Region,0
17859,Bone Marrow,Kaposi's sarcoma of skin,0
17860,Table Rules - groups,Refractory Barrett Esophagus,0
17861,Fever,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
17862,Trachea (moth),Spongiotic dermatitis,0
17863,Fluid overload,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17864,Infrequent,Parathyroid Gland Adenocarcinoma,0
17865,Mesenchymal Stem Cells,Werner Syndrome,0
17866,Birth defects diagnosis:Find:Pt:^Patient:Nar,Localized Askin Tumor,0
17867,GDF15 protein,Recurrent Uveal Melanoma,0
17868,Intention - mental process,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17869,Malignant - descriptor,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17870,Common (qualifier value),Engraftment syndrome,0
17871,Subtype (attribute),Adult Alveolar Soft Part Sarcoma,0
17872,dendritic spine neck,Malignant neoplasm of olfactory nerve,0
17873,Species,Hemangioma,0
17874,biopsy characteristics,Clinical Stage I Cutaneous Melanoma AJCC v8,0
17875,Evaluation,Stage 0 Penile Cancer AJCC v8,0
17876,growth aspects,Benign Anal Granular Cell Tumor,0
17877,failed,Lipoma of small intestine,0
17878,320,Recurrent Testicular Lymphoma,0
17879,To,Malignant neoplasm of choroid,0
17880,Diagnosis,Squamous cell carcinoma of lip,0
17881,PDGFRA gene,Hereditary Diffuse Gastric Adenocarcinoma,0
17882,cell growth,Recurrent Testicular Lymphoma,0
17883,Group A (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17884,Malignant Neoplasms,Stage II Carcinoma of Penis,0
17885,Structure of subclavian vein,Angiosarcoma of liver,0
17886,radiotherapeutic,Localized Malignant Neoplasm,0
17887,Special,sarcoma of spinal cord,0
17888,Cone-Rod Dystrophy 2,Refractory Barrett Esophagus,0
17889,Injury cause:Type:Point in time:^Patient:Nominal,Pancreatic carcinoma,0
17890,Occurrence,Malignant neoplasm of olfactory nerve,0
17891,Retinoic Acid Response Element,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
17892,Five-year Survival Rate,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17893,Melanocytic nevus,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
17894,Mass of neck,Familial Adenomatous Polyposis Associated Medulloblastoma,0
17895,therapeutic aspects,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
17896,Due to,mucinous adenocarcinoma of gallbladder,0
17897,Intraperitoneal,Tongue Alveolar Soft Part Sarcoma,0
17898,Target Awareness - partial,Atypical Lobular Breast Hyperplasia,0
17899,various other intestinal adsorbents in ATC,Recurrent Testicular Lymphoma,0
17900,CD69 protein,Childhood Anaplastic Large Cell Lymphoma,0
17901,structure,adenosquamous carcinoma of breast,0
17902,Widening,Thymic Clear Cell Carcinoma,0
17903,Ovary,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
17904,Followed by,Chest Wall Fibromatosis,0
17905,transcription factor activity,Benign tumor of eyelid,0
17906,diagnosis aspect,Hemangioma,0
17907,Benign,Xeroderma pigmentosum,0
17908,Daily Living,Hereditary Diffuse Gastric Adenocarcinoma,0
17909,Bilateral salpingectomy with oophorectomy,Endometrial Small Cell Carcinoma,0
17910,Including (qualifier),Malignant melanoma of eyelid,0
17911,Common Specifications in HL7 V3 Publishing,Trabecular adenocarcinoma,0
17912,Ethanol,Intraepithelial Melanocytic Hyperplasia,0
17913,Urinary tract,Contact dermatitis due to alkali,0
17914,Greeks,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
17915,Target Awareness - partial,clear cell adenocarcinoma of gallbladder,0
17916,Related personal status,Chest Wall Fibromatosis,0
17917,Singular,Malignant melanoma of eyelid,0
17918,Tryptophanase,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17919,Malignant - descriptor,Cerebral hemangioma,0
17920,Toxic Epidermal Necrolysis,Melanomatosis,0
17921,Science of Etiology,Carcinoma,0
17922,Formed,Vaginal Adenoid Cystic Carcinoma,0
17923,High Grade Cervical Squamous Intraepithelial Neoplasia,Adult Alveolar Soft Part Sarcoma,0
17924,Type - attribute,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17925,Form:Finding:Point in time:{Setting}:Document:{Role},Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
17926,Body tissue,Hereditary Diffuse Gastric Adenocarcinoma,0
17927,Entity Determiner - specific,Stage IV Penile Cancer AJCC v7,0
17928,High risk of,Mucosal Melanoma,0
17929,Occurrence,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17930,3+ Score,Cervical Fibroepithelial Polyp,0
17931,Term (lexical),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
17932,Usually,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
17933,Natural History,Malignant neoplasm of subglottis,0
17934,Occur (action),High Grade Glandular Intraepithelial Neoplasia,0
17935,Toxic Epidermal Necrolysis,Colorectal High Grade B-Cell Lymphoma,0
17936,Sample Range,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
17937,Person Name,Platinum-Resistant Lung Small Cell Carcinoma,0
17938,Human body,Adult Acute Eosinophilic Leukemia,0
17939,Reside,Human Papillomavirus-Related Carcinoma,0
17940,kill - ActRelationshipJoin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
17941,Blood group A (finding),Nasal cavity carcinoma,0
17942,Abnormal Virilization,Tonsillar Carcinoma,0
17943,Biomaterial Treatment,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17944,Malignant Childhood Neoplasm,Peripheral primitive neuroectodermal tumor of soft tissue,0
17945,Type - attribute,Carcinoma of urinary bladder,0
17946,Immature Lymphocytes Measurement,Refractory Barrett Esophagus,0
17947,Third revision,Unresectable Rhabdomyosarcoma,0
17948,Left sided,Refractory Barrett Esophagus,0
17949,Salivary Glands,embryonal rhabdomyosarcoma of prostate,0
17950,Neoplastic disease,Benign squamous cell tumor,0
17951,New,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
17952,pharmacotherapeutic,Familial Hemophagocytic Lymphocytosis,0
17953,Previously Treated Childhood Rhabdomyosarcoma,Childhood Lymphoma,0
17954,Surgical aspects,Pancreatic carcinoma,0
17955,Often - answer to question,Recurrent Testicular Lymphoma,0
17956,Singular,Tonsillar Carcinoma,0
17957,More,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
17958,Both ovaries,Granular Cell Leiomyosarcoma,0
17959,Result,Maxillary Sinus Adenoid Cystic Carcinoma,0
17960,Never (frequency),Digestive System Hodgkin Lymphoma,0
17961,Myeloproliferative disease,Type II Endometrial Adenocarcinoma,0
17962,Experimental Result,gliosarcoma,0
17963,20%,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17964,Diagnosis,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
17965,Progress,mucinous adenocarcinoma of gallbladder,0
17966,risk factors - observation list,Adenocarcinoma of duodenum,0
17967,Classical Hodgkin's Lymphoma,Thymic Clear Cell Carcinoma,0
17968,SLC35G1 gene,Nasal cavity carcinoma,0
17969,Trial Screening,Pancreatic Intraepithelial Neoplasia-3,0
17970,ethnic european,Engraftment syndrome,0
17971,Adult Lymphoma,Acantholytic squamous cell carcinoma,0
17972,Tryptophanase,Malignant Neoplasm of Lung - Multiple Primary Sites,0
17973,Smaller,Occult Lung Adenosquamous Carcinoma,0
17974,Increase,Benign Anal Granular Cell Tumor,0
17975,diagnosis aspect,Xeroderma pigmentosum,0
17976,Adult human body,Fourth Ventricle and Brain Stem Ependymal Tumor,0
17977,Relationships,Advanced Uterine Corpus Carcinosarcoma,0
17978,Associated with,Botryoid-Type Embryonal Rhabdomyosarcoma,0
17979,Domain (area of knowledge),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
17980,Malignant Neoplasms,Low Grade Squamous Intraepithelial Neoplasia,0
17981,Human Papillomavirus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
17982,All,Splenic Manifestation of Hairy Cell Leukemia,0
17983,Qualitative form,Blepharal carcinoma,0
17984,Skin,Mixed parotid tumor,0
17985,status - In progress,Cervical Squamous Intraepithelial Neoplasia,0
17986,Persons,Medulloblastoma,0
17987,Include (action),Mucinous adenocarcinoma gastric,0
17988,Numbness,Vaginal Adenoma,0
17989,Specimen Source Codes - tumor,Benign tumor of eyelid,0
17990,Tryptophanase,FIGO Stage II Ovarian Cancer,0
17991,Histopathological aspects,Giant cell angiofibroma,0
17992,Risk,Vaginal Adenoid Cystic Carcinoma,0
17993,Hour,Adenocarcinoma,0
17994,Cervical lymph node group,High Grade Glandular Intraepithelial Neoplasia,0
17995,Melanoma Pathway,Malignant neoplasm of olfactory nerve,0
17996,Alcohols,Refractory Bladder Carcinoma,0
17997,Vaginal neoplasia,Stage II Carcinoma of Penis,0
17998,Valid,Undifferentiated Endocervical Sarcoma,0
17999,Removed,Breast Ductal Adenoma,0
18000,Hematologic Neoplasms,Ichthyosis,0
18001,Frequently,Clonal Hematopoiesis of Indeterminate Potential,0
18002,Financial Account,embryonal rhabdomyosarcoma of prostate,0
18003,Worse,Metastatic Carcinoma in the Lung,0
18004,Immune System Processes,Kaposi's sarcoma of extrahepatic bile duct,0
18005,Optic Chiasms,Mastocytosis,0
18006,Sample Range,Childhood Fibrillary Astrocytoma,0
18007,Basis - conceptual entity,Stage IV Penile Cancer AJCC v7,0
18008,Color,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
18009,100%,Stage 0 Penile Cancer AJCC v8,0
18010,Type - attribute,Kaposi's sarcoma of extrahepatic bile duct,0
18011,Age at menopause,Acantholytic squamous cell carcinoma,0
18012,consider,Splenic Manifestation of Hairy Cell Leukemia,0
18013,Primary malignant neoplasm,FIGO Stage IVA Ovarian Cancer,0
18014,Biomaterial Treatment,Brain Tumor,0
18015,epithelial,Carcinomatosis of peritoneal cavity,0
18016,Ancestry-Informative Marker,Advanced Lung Carcinoma,0
18017,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Refractory Ependymoma,0
18018,Infiltration (procedure),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18019,Activation action,Stage 0 Penile Cancer AJCC v8,0
18020,Developed Countries,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
18021,Negative - answer,Childhood Anaplastic Large Cell Lymphoma,0
18022,Vaginal neoplasia,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18023,Occurrence,Unicystic ameloblastoma,0
18024,Including (qualifier),Cancer of Urinary Tract,0
18025,Case (situation),Thyroid Hurthle Cell Carcinoma,0
18026,Imaging Techniques,Malignant neoplasm of olfactory nerve,0
18027,Aspect (characteristic),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18028,Affecting,Mucosal Melanoma,0
18029,Mammary Gland Parenchyma,Locally Advanced Carcinoma,0
18030,Radiotherapy Research,Bladder adenocarcinoma stage IV,0
18031,size,Unfavorable Non-Hodgkin Lymphoma,0
18032,Symptoms aspect,Benign Ovarian Thecoma,0
18033,Wall of colon,Stage IV Colorectal Cancer AJCC v8,0
18034,<3 (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18035,Heartburn,Low Grade Squamous Intraepithelial Neoplasia,0
18036,Cancer Genus,Metastatic Kidney Carcinoma,0
18037,Adult Pilocytic Astrocytoma,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18038,Anterior portion of neck,Placental aromatase deficiency,0
18039,Most,Papillary squamous cell carcinoma,0
18040,Deglutition,Stage IB Pancreatic Cancer AJCC v8,0
18041,various allergen extracts,Benign Anal Granular Cell Tumor,0
18042,Occurrence Indicator,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
18043,Critical,Occult Lung Adenosquamous Carcinoma,0
18044,School Grade,Neonatal leukemia,0
18045,Beginning,Digestive System Hodgkin Lymphoma,0
18046,Liver Flavor,Thyroid Hurthle Cell Carcinoma,0
18047,therapeutic aspects,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18048,Complication,Cervical Adenomyoma,0
18049,Microscopes,Acute Undifferentiated Leukemia,0
18050,Removed,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18051,Increased,Astrocytoma of brain,0
18052,Hand,Astrocytoma of brain,0
18053,Then,Acute Undifferentiated Leukemia,0
18054,Connective Tissue,Placental aromatase deficiency,0
18055,Cancer Genus,embryonal rhabdomyosarcoma of prostate,0
18056,Lymphoma,Recurrent Testicular Lymphoma,0
18057,Long,Intraepithelial Melanocytic Hyperplasia,0
18058,Upper,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
18059,Inguinal region,Low Grade Squamous Intraepithelial Neoplasia,0
18060,Most,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18061,Ability,Precursor B-lymphoblastic lymphoma stage II,0
18062,Process (qualifier value),Mixed parotid tumor,0
18063,Affecting,Childhood Central Nervous System Ganglioneuroblastoma,0
18064,Primary malignant neoplasm,Blood Vessel Tumors,0
18065,Cosmetic surgery,Anterior Urethral Malignant Neoplasm,0
18066,Multiple malignancy,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18067,Needs,Precursor B-lymphoblastic lymphoma stage II,0
18068,diagnosis aspect,Chondrosarcoma,0
18069,Ulceration,embryonal rhabdomyosarcoma of prostate,0
18070,Occurrence Indicator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18071,To,Adult Hepatocellular Carcinoma,0
18072,Sacral dysgenesis,Small cell neuroendocrine carcinoma of bladder,0
18073,Tryptophanase,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18074,Uncontrolled,Congenital hamartoma,0
18075,Protocol Agent,Adult Fibrolamellar Carcinoma,0
18076,Damage,adenosquamous carcinoma of breast,0
18077,operate <remove>,Malignant Testicular Sertoli Cell Tumor,0
18078,Common (qualifier value),Metastatic Malignant Neoplasm in the Sellar Region,0
18079,Offspring,embryonal rhabdomyosarcoma of prostate,0
18080,Exposure to,Stage IV Colorectal Cancer AJCC v8,0
18081,Occurrence,Xeroderma pigmentosum,0
18082,Usual,Testicular cancer metastatic,0
18083,Lock - Remote control command,High Grade Glandular Intraepithelial Neoplasia,0
18084,Childhood Lymphoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18085,Superkingdom (taxonomic category),Occult Lung Adenosquamous Carcinoma,0
18086,Ulcer,Malignant melanoma of eyelid,0
18087,Unknown,Cervical Squamous Intraepithelial Neoplasia,0
18088,Row (arrangement),Hodgkin Disease,0
18089,Tissue Growth,mucinous adenocarcinoma of gallbladder,0
18090,Exons,Cervical Fibroepithelial Polyp,0
18091,Widening,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
18092,lymph nodes,Cerebral hemangioma,0
18093,Include (action),Thymic Clear Cell Carcinoma,0
18094,Precision - temporal,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18095,59,Recurrent Uveal Melanoma,0
18096,shared attribute,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
18097,Numerous,Diffuse malignant mesothelioma,0
18098,1960s,Engraftment syndrome,0
18099,Cell Count,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18100,Cause of death.underlying,Breast Ductal Adenoma,0
18101,Usual Severity Sweats,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18102,Three,Tonsillar Carcinoma,0
18103,Sample Mean,Liver Lymphangioma,0
18104,Rapid,Refractory Bladder Carcinoma,0
18105,Secondary to,Malignant melanoma of eyelid,0
18106,Usual,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18107,Malignant Vaginal Neoplasm,Xeroderma pigmentosum,0
18108,Often - answer to question,Undifferentiated Endocervical Sarcoma,0
18109,Desiccation,Testicular cancer metastatic,0
18110,per year,Acute lymphadenitis,0
18111,Locally,Human Papillomavirus-Related Carcinoma,0
18112,<90,Spongiotic dermatitis,0
18113,Take,Female Breast Carcinoma,0
18114,solid substance,Recurrent Uveal Melanoma,0
18115,Involvement with,Basal Cell Ameloblastoma,0
18116,Dilated,Locally Advanced Carcinoma,0
18117,Coding Subtest (WISC-V),non-Hodgkin's lymphoma of spleen,0
18118,Common (qualifier value),Breast Ductal Adenoma,0
18119,Manufactured form,FIGO Stage IVA Ovarian Cancer,0
18120,Including (qualifier),Kaposi's sarcoma of extrahepatic bile duct,0
18121,Dominant,Adenocarcinoma of the prostate metastatic,0
18122,Version,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18123,Frequently,benign mature teratoma of pancreas,0
18124,Definitely Related to Intervention,Testicular cancer metastatic,0
18125,Occur (action),Blepharal carcinoma,0
18126,Abnormal Reference Range,Thymic Clear Cell Carcinoma,0
18127,One,Recurrent Uveal Melanoma,0
18128,Diagnosis,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18129,Males,Endometrial Small Cell Carcinoma,0
18130,Males,Splenic Manifestation of Hairy Cell Leukemia,0
18131,General surgery specialty,Mucinous adenocarcinoma,0
18132,Use of,mucinous adenocarcinoma of gallbladder,0
18133,Gait normal,Recurrent Primary Lymphoma of Bone,0
18134,Future,Diffuse malignant mesothelioma,0
18135,Decision,Chest Wall Fibromatosis,0
18136,One,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18137,risk factors - observation list,Squamous cell carcinoma of lip,0
18138,Stable status,Blood Vessel Tumors,0
18139,Mixed Tumor,Benign neoplasm of thorax,0
18140,Surgical aspects,Ichthyosis,0
18141,Curative - procedure intent,Metastatic Malignant Neoplasm in the Sellar Region,0
18142,Occurrence,Giant cell angiofibroma,0
18143,Tryptophanase,FIGO Stage II Ovarian Cancer,0
18144,Surgical extraction,Colorectal cancer,0
18145,Building caretaker,Thymic Atypical Carcinoid Tumor,0
18146,Type - attribute,Intraepithelial Melanocytic Hyperplasia,0
18147,Bone Pain,Acute Undifferentiated Leukemia,0
18148,Spreading (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18149,SLC6A2 wt Allele,Kaposi's sarcoma of extrahepatic bile duct,0
18150,Location of Pharyngeal Residue Following Swallowing,Fourth Ventricle and Brain Stem Ependymal Tumor,0
18151,Combined,Malignant Testicular Sertoli Cell Tumor,0
18152,Chemical or Textual Reference to Actual Test or Parameter,Metastatic Ductal Breast Carcinoma,0
18153,Weight Loss,Metaplastic carcinoma of breast,0
18154,Functional,Engraftment syndrome,0
18155,Lumpectomy of breast,Childhood Central Nervous System Ganglioneuroblastoma,0
18156,Spreading (qualifier value),Kaposi's sarcoma of skin,0
18157,Corner Minus,Advanced Uterine Corpus Carcinosarcoma,0
18158,Egg of order Phthiraptera,de novo Myelodysplastic Syndrome,0
18159,Vaginal wall,Childhood Extragonadal Malignant Germ Cell Tumor,0
18160,Life,Ectomesenchymal Chondromyxoid Tumor,0
18161,Multiplication,Placental aromatase deficiency,0
18162,Have Shortness of Breath question,Benign Anal Granular Cell Tumor,0
18163,Cancer Etiology,Lipoma of small intestine,0
18164,Management procedure,Stage I Adult Non-Hodgkin Lymphoma,0
18165,Pancreatic Cancer Pathway,Werner Syndrome,0
18166,Specimen Source Codes - Respiratory,Benign neoplasm of thorax,0
18167,Cancer Genus,Blood Vessel Tumors,0
18168,Present,Angiosarcoma of liver,0
18169,Asians,Malignant Neoplasm with Regional Lymph Node Involvement,0
18170,Variant,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
18171,Togo,Lipoma of small intestine,0
18172,How Often Sweats,BRCA2 Syndrome,0
18173,Second edition,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
18174,General surgery specialty,Occult Lung Adenosquamous Carcinoma,0
18175,Synonym,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
18176,Science of Etiology,Benign Carotid Body Paraganglioma,0
18177,Weight Loss,Thyroid Hurthle Cell Carcinoma,0
18178,Rare,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
18179,Diabetes,Chronic Myelomonocytic Leukemia-2,0
18180,Malignant neoplasm of soft tissue,Mucinous adenocarcinoma gastric,0
18181,Approximate,Undifferentiated Neuroblastoma,0
18182,seen,Recurrent Primary Lymphoma of Bone,0
18183,Patch (unit of presentation),Benign Ovarian Thecoma,0
18184,Polypeptide Hormones,Stage II Carcinoma of Penis,0
18185,trends qualifier,Cancer of Urinary Tract,0
18186,FLT3LG wt Allele,Choroid Epithelioid Cell Melanoma,0
18187,Code,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
18188,Feel Tired question,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18189,Most,Acute Undifferentiated Leukemia,0
18190,Rare,Choroid Necrotic Melanoma,0
18191,Negation,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
18192,Blood Platelets,Chest Wall Fibromatosis,0
18193,Mumps virus,Cartilaginous exostosis,0
18194,Volume (publication),Childhood Lung Non-Small Cell Carcinoma,0
18195,Derived value,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
18196,Singular,Refractory Barrett Esophagus,0
18197,Disruptive,Adult Alveolar Soft Part Sarcoma,0
18198,Occur (action),Congenital hamartoma,0
18199,<90,Squamous cell carcinoma of lip,0
18200,Estimated,Neoplasms,0
18201,Asia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18202,95,Female Breast Carcinoma,0
18203,1+,Benign Anal Granular Cell Tumor,0
18204,Call (Instruction),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18205,Malignant Neoplasms,Astrocytoma of brain,0
18206,Anal Sex,Stage IV Childhood Non-Hodgkin Lymphoma,0
18207,Adult human body,Colorectal High Grade B-Cell Lymphoma,0
18208,TP53 gene,Acantholytic squamous cell carcinoma,0
18209,pre-surgery,Engraftment syndrome,0
18210,IPSS Risk Category High,Botryoid-Type Embryonal Rhabdomyosarcoma,0
18211,Lung,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18212,Group A (qualifier value),Childhood Fibrillary Astrocytoma,0
18213,Connective Tissue,Uterine Cancer,0
18214,Cancer Genus,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
18215,Edema,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18216,Benign Neoplasm,Bladder adenocarcinoma stage IV,0
18217,Deep (qualifier value),Peripheral primitive neuroectodermal tumor of soft tissue,0
18218,status - In progress,papillary carcinoma of penis,0
18219,Hearing,High Grade Glandular Intraepithelial Neoplasia,0
18220,History of present illness,Airway Hemangioma,0
18221,Science of Etiology,Refractory Ependymoma,0
18222,Leg,Metastatic Lung Small Cell Carcinoma,0
18223,IPSS Risk Category High,Lipoma of small intestine,0
18224,Persons,Granular Cell Leiomyosarcoma,0
18225,Infection,Benign Anal Granular Cell Tumor,0
18226,Nephroblastoma,Kaposi's sarcoma of skin,0
18227,One,Kaposi's sarcoma of extrahepatic bile duct,0
18228,melanocyte,Diffuse malignant mesothelioma,0
18229,Set (Psychology),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
18230,Include (action),Precursor B-lymphoblastic lymphoma stage II,0
18231,Exposure to,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18232,Embryonal Rhabdomyosarcoma,Thyroid carcinoma,0
18233,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Giant cell angiofibroma,0
18234,What subject filter - Result,benign mature teratoma of pancreas,0
18235,Body tissue,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18236,bacteria aspects,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18237,Abnormally high,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
18238,Liver carcinoma,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
18239,Aryepiglottic fold structure,Carcinoma,0
18240,Approximate,Stage II Carcinoma of Penis,0
18241,Medical,Choroid Necrotic Melanoma,0
18242,Surgical aspects,Stage IB Pancreatic Cancer AJCC v8,0
18243,Mass,Refractory Bladder Carcinoma,0
18244,Contraceptives,Endometrial Small Cell Carcinoma,0
18245,Paraganglioma,Angiosarcoma of liver,0
18246,Secondary Cause of Death,Stage IB Lung Cancer AJCC v7,0
18247,Good,Pancreatic Intraepithelial Neoplasia-3,0
18248,Uncertainty,FIGO Stage II Ovarian Cancer,0
18249,Specimen Source Codes - tumor,Localized Ewing Sarcoma,0
18250,Including (qualifier),Carcinoma of urinary bladder,0
18251,World Health Organization,Colorectal cancer,0
18252,CD40LG wt Allele,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18253,Certain (qualifier value),Undifferentiated Neuroblastoma,0
18254,Old,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
18255,Supportive assistance,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
18256,Logical Condition,Non-Metastatic Gestational Trophoblastic Tumor,0
18257,Benign Teratoma,Methotrexate-Associated Hodgkin Lymphoma,0
18258,Case unit dose,Medulloblastoma,0
18259,Options,Acute Undifferentiated Leukemia,0
18260,A Codes,clear cell adenocarcinoma of gallbladder,0
18261,Hearing Loss,ROSE Cluster 3,0
18262,Involvement with,Refractory Ependymoma,0
18263,Possibly Related to Intervention,Ichthyoses,0
18264,therapeutic aspects,Intracortical osteosarcoma,0
18265,Frequently,Childhood Fibrillary Astrocytoma,0
18266,TNFRSF8 Positive,Giant cell angiofibroma,0
18267,Tumor cells,Malignant melanoma of eyelid,0
18268,Fixation - action,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
18269,Hypoalbuminemia,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18270,Science of Etiology,Female Breast Carcinoma,0
18271,Include (action),Leptomeningeal sarcoma,0
18272,Living quarters,Acantholytic squamous cell carcinoma,0
18273,Occur (action),Type II Endometrial Adenocarcinoma,0
18274,70%,FIGO Stage II Ovarian Cancer,0
18275,Adjacent,Clonal Hematopoiesis of Indeterminate Potential,0
18276,Structure of tubal tonsil,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18277,seconds,ROSE Cluster 3,0
18278,pharmacotherapeutic,Familial Adenomatous Polyposis Associated Medulloblastoma,0
18279,Round cell tumor,Mucinous adenocarcinoma gastric,0
18280,10%,Locally Advanced Soft Tissue Sarcoma,0
18281,Frequently,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18282,Negative Number,Stage I Adult Non-Hodgkin Lymphoma,0
18283,Extension,Ovarian germ cell choriocarcinoma stage IV,0
18284,macrophage,Benign squamous cell tumor,0
18285,Probability,Plexosarcoma,0
18286,Contrast Media,Acantholytic squamous cell carcinoma,0
18287,status - In progress,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18288,Affect (mental function),Primary Cutaneous Plasmablastic Lymphoma,0
18289,Set of muscles,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
18290,Area,Cystadenocarcinoma,0
18291,Base Pair Unit,Malignant Neoplasm with Regional Lymph Node Involvement,0
18292,BRCA1 protein,Malignant neoplasm of thalamus,0
18293,Occurrence Indicator,Spindle Cell Melanoma,0
18294,Human papilloma virus infection,Choroid Epithelioid Cell Melanoma,0
18295,Two,Advanced Uterine Corpus Carcinosarcoma,0
18296,Surrounding (qualifier value),Childhood Central Nervous System Immature Teratoma,0
18297,Common (qualifier value),clear cell adenocarcinoma of gallbladder,0
18298,Signs and Symptoms,Stage IB Pancreatic Cancer AJCC v8,0
18299,TP53 gene,Tumorlet,0
18300,Often - answer to question,Blepharal carcinoma,0
18301,Severe (severity modifier),Maxillary Sinus Adenoid Cystic Carcinoma,0
18302,FAMILIAL ADENOMATOUS POLYPOSIS,Splenic Manifestation of Hairy Cell Leukemia,0
18303,Common Specifications in HL7 V3 Publishing,Bladder adenocarcinoma stage IV,0
18304,Term (temporal),Breast Ductal Adenoma,0
18305,Vision,Mucinous adenocarcinoma gastric,0
18306,Presence (property),Low Grade Squamous Intraepithelial Neoplasia,0
18307,Two,Adult Acute Eosinophilic Leukemia,0
18308,other medicated shampoos in ATC,Intestinal Metaplasia of Bladder Urothelium,0
18309,Age of Onset,Chronic Myelomonocytic Leukemia-2,0
18310,With shape,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18311,Group A (qualifier value),papillary carcinoma of penis,0
18312,Retinoic Acid Response Element,Mixed astrocytoma-ependymoma,0
18313,Basis - conceptual entity,Familial Adenomatous Polyposis Associated Medulloblastoma,0
18314,Target Lesion Identification,Thyroid Hurthle Cell Carcinoma,0
18315,Group A (blood group),Type II Endometrial Adenocarcinoma,0
18316,Personal appearance,Metastatic Ductal Breast Carcinoma,0
18317,Specific qualifier value,Anaplastic large cell lymphoma,0
18318,Science of Statistics,Adrenal Rest Tumor,0
18319,Present,Recurrent Rhabdomyosarcoma,0
18320,Diagnosis Study,Ovarian germ cell choriocarcinoma stage IV,0
18321,Skeletal bone,Recurrent Testicular Lymphoma,0
18322,Categories,Spongiotic dermatitis,0
18323,Europe,Refractory Ependymoma,0
18324,English race,Placental aromatase deficiency,0
18325,75,Benign Ovarian Thecoma,0
18326,Body tissue,Familial Adenomatous Polyposis Associated Medulloblastoma,0
18327,Scab,Malignant neoplasm of gallbladder,0
18328,Smear - instruction imperative,Xeroderma pigmentosum,0
18329,HL7PublishingSubSection <practice>,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
18330,Vagina,Malignant Neoplasm with Regional Lymph Node Involvement,0
18331,Structure of parenchyma of lung,Malignant melanoma of eyelid,0
18332,Obesity,Endometrial Small Cell Carcinoma,0
18333,Various patch test substance,Benign Anal Granular Cell Tumor,0
18334,End,papillary carcinoma of penis,0
18335,low,Localized Ewing Sarcoma,0
18336,Layer of dermis,Breast Ductal Adenoma,0
18337,Include (action),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
18338,Treating,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18339,Covers (device),Cherubism,0
18340,Pain,Adult Brain Stem Mixed Glioma,0
18341,Three,Medulloblastoma,0
18342,Treating,Localized Malignant Neoplasm,0
18343,Cause of Death,Mixed astrocytoma-ependymoma,0
18344,Group A (blood group),Type II Endometrial Adenocarcinoma,0
18345,Hydatidiform Mole,Low Grade Squamous Intraepithelial Neoplasia,0
18346,Fever,Malignant melanoma of eyelid,0
18347,Fan (physical object),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18348,Taken,High Grade Glandular Intraepithelial Neoplasia,0
18349,Half,Squamous cell carcinoma of lip,0
18350,Tryptophanase,Nasal cavity carcinoma,0
18351,include - SetOperator,Atypical Lobular Breast Hyperplasia,0
18352,Constant (qualifier),Undifferentiated Endocervical Sarcoma,0
18353,Malignant neoplasm of skin,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
18354,per year,Localized Ewing Sarcoma,0
18355,Numbers,Acute Undifferentiated Leukemia,0
18356,Normal,Tonsillar Carcinoma,0
18357,Skin,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18358,Widespread,Papillary squamous cell carcinoma,0
18359,Portion of urine,Serous cystadenocarcinoma ovary,0
18360,Clinical,Liver Lymphangioma,0
18361,Human body,Childhood Central Nervous System Immature Teratoma,0
18362,Treating,Uterine Cancer,0
18363,Two,Metastatic Ductal Breast Carcinoma,0
18364,Persons,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18365,Diagnosis,Neonatal leukemia,0
18366,Odontogenesis,Adenocarcinoma,0
18367,How Often Weight Loss,Recurrent Testicular Lymphoma,0
18368,Version,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18369,Malignant neoplasm of lung,Recurrent Primary Lymphoma of Bone,0
18370,B-Lymphocytes,FIGO Stage II Ovarian Cancer,0
18371,radiotherapeutic,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18372,Paraneoplastic Syndromes,Grade 3a Malignant Neoplasm,0
18373,Taxonomic,Carcinoma of urinary bladder,0
18374,High risk,Refractory Bladder Carcinoma,0
18375,Lymphoma,Lipoma of small intestine,0
18376,Chemotherapy Regimen,Cartilaginous exostosis,0
18377,Obesity,Methotrexate-Associated Hodgkin Lymphoma,0
18378,Back structure,Mucinous adenocarcinoma gastric,0
18379,Solid Dose Form,Liver Lymphangioma,0
18380,Known,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18381,Ankle,Cerebral hemangioma,0
18382,PSA Level Greater than Fifty,Periosteal Osteosarcoma,0
18383,Occur (action),Undifferentiated Neuroblastoma,0
18384,Neurons,Female Breast Carcinoma,0
18385,In Urine,Ichthyosis,0
18386,Abnormal Reference Range,de novo Myelodysplastic Syndrome,0
18387,Hereditary Diseases,Splenic Manifestation of Hairy Cell Leukemia,0
18388,Most,Endometrial Small Cell Carcinoma,0
18389,Skin Specimen,Mucinous adenocarcinoma gastric,0
18390,Tumor Mass,Metastatic Lung Small Cell Carcinoma,0
18391,Malignant neoplasm of lung,Benign squamous cell tumor,0
18392,Genetic Selection,Acute Undifferentiated Leukemia,0
18393,Diagnosis,Refractory Barrett Esophagus,0
18394,radiotherapeutic,Acute lymphadenitis,0
18395,Have Sweats,Childhood Lymphoma,0
18396,Bladder Cancer Pathway,Hyperplasia of pituitary gland,0
18397,Autosomal recessive inheritance,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18398,Valid,Trabecular adenocarcinoma,0
18399,Malignant Neoplasms,Primary Cutaneous Plasmablastic Lymphoma,0
18400,Organ,Mucinous cystadenofibroma,0
18401,Experimental Result,Occult Lung Adenosquamous Carcinoma,0
18402,Posterior cord syndrome,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
18403,Precision - second,Hyperplasia of pituitary gland,0
18404,Cell Proliferation,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
18405,Presence of cells,Multiple Skull Base Meningiomas,0
18406,Togo,Metaplastic carcinoma of breast,0
18407,Population Median,Tongue Alveolar Soft Part Sarcoma,0
18408,Referring,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18409,Reported Term,Malignant Neoplasm with Regional Lymph Node Involvement,0
18410,Late stage,Choroid Necrotic Melanoma,0
18411,Class (taxonomic),Hodgkin Disease,0
18412,Perianal,Spindle Cell Melanoma,0
18413,Usual,Stage IV Childhood Non-Hodgkin Lymphoma,0
18414,Cardiovascular system,Carcinoma ex pleomorphic adenoma of parotid gland,0
18415,Granulomatous,Diffuse malignant mesothelioma,0
18416,Cardiovascular System Part,Unfavorable Non-Hodgkin Lymphoma,0
18417,Renal collecting tube,Intraepithelial Melanocytic Hyperplasia,0
18418,Derivation,Childhood Fibrillary Astrocytoma,0
18419,Negation,Stage III Cutaneous Melanoma AJCC v6,0
18420,research subject screening,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18421,Table Cell Horizontal Align - left,Astrocytoma of brain,0
18422,therapeutic aspects,Cervical Fibroepithelial Polyp,0
18423,Alcohol consumption,Digestive System Hodgkin Lymphoma,0
18424,Accumulation of fluid,Small cell neuroendocrine carcinoma of bladder,0
18425,anatomical layer,Benign Anal Granular Cell Tumor,0
18426,include - SetOperator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18427,Bladder Continence Question,Heavy Chain Deposition Disease,0
18428,Biologic Development,Nasal cavity carcinoma,0
18429,Appearance,Peripheral primitive neuroectodermal tumor of soft tissue,0
18430,Upper,Colorectal High Grade B-Cell Lymphoma,0
18431,change (in) bowel movements,Precursor B-lymphoblastic lymphoma stage II,0
18432,Malignant - descriptor,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18433,Veins,FIGO Stage IVA Ovarian Cancer,0
18434,Administration procedure,Blepharal carcinoma,0
18435,Qualitative form,gliosarcoma,0
18436,Anatomic Site,Refractory Ependymoma,0
18437,Usual Severity Sweats,Intraepithelial Melanocytic Hyperplasia,0
18438,Function (attribute),Refractory Ependymoma,0
18439,Intraepidermal vesicles,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18440,Case unit dose,Pilocytic astrocytoma of cerebellum,0
18441,Formation,Human Papillomavirus-Related Carcinoma,0
18442,Increase,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18443,Onset of (contextual qualifier),Malignant Neoplasm with Regional Lymph Node Involvement,0
18444,Endocrine Cells,Engraftment syndrome,0
18445,Females,Maxillary Sinus Adenoid Cystic Carcinoma,0
18446,Average,FIGO Stage IVA Ovarian Cancer,0
18447,Shortened,Malignant Testicular Sertoli Cell Tumor,0
18448,Intravascular line,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18449,Possible diagnosis,Keratoderma,0
18450,Probability,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18451,Occurrence,Intestinal Neuroendocrine Carcinoma,0
18452,Variable (uniformity),Trichilemmocarcinoma,0
18453,Neuroepithelial Cells,Metaplastic carcinoma of breast,0
18454,Appearance Distress Question,Splenic Manifestation of Hairy Cell Leukemia,0
18455,Fused structure,Kaposi's sarcoma of skin,0
18456,utilization qualifier,Female Breast Carcinoma,0
18457,Analysis,Malignant neoplasm of olfactory nerve,0
18458,Social group,Mucinous adenocarcinoma gastric,0
18459,Cancer Genus,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
18460,Smear - instruction imperative,Childhood Fibrillary Astrocytoma,0
18461,Route of Administration - Mucous Membrane,Stage 0 Penile Cancer AJCC v8,0
18462,Cancer Remission,FIGO Stage II Ovarian Cancer,0
18463,Intention - mental process,Methotrexate-Associated Hodgkin Lymphoma,0
18464,treatment - ActInformationManagementReason,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
18465,Cardiac Lead Procedure,Recurrent Testicular Lymphoma,0
18466,Ectoderm,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
18467,Biopsy,Cerebral Primitive Neuroectodermal Tumor,0
18468,Polypeptide Hormones,Acute lymphadenitis,0
18469,Name,Mixed astrocytoma-ependymoma,0
18470,ovarian neoplasm,adenosquamous carcinoma of breast,0
18471,Type - attribute,Choroid Necrotic Melanoma,0
18472,Risk,Chondrosarcoma,0
18473,Diagnosis Study,Adrenal Rest Tumor,0
18474,End,High Grade Glandular Intraepithelial Neoplasia,0
18475,oncology field,Transitional cell carcinoma,0
18476,Falls,Recurrent Diffuse Intrinsic Pontine Glioma,0
18477,Usual Severity Weight Loss,Advanced Lung Carcinoma,0
18478,Variety (taxon),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
18479,Pharmacokinetics: Excretion,Childhood Anaplastic Large Cell Lymphoma,0
18480,Derived value,Pancreatic Endocrine Carcinoma,0
18481,Skin,Occult Lung Adenosquamous Carcinoma,0
18482,Malignant neoplasm of gallbladder,FIGO Stage II Ovarian Cancer,0
18483,Container status - Identified,Benign Anal Granular Cell Tumor,0
18484,bacteria aspects,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
18485,Microscopes,Benign Anal Granular Cell Tumor,0
18486,risk factors - observation list,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
18487,Primary malignant neoplasm,Angiosarcoma of liver,0
18488,Reported Term,Refractory Ependymoma,0
18489,Edema,Benign tumor of eyelid,0
18490,sex,Liver Cavernous Hemangioma,0
18491,Back structure,Adult Alveolar Soft Part Sarcoma,0
18492,Fever,Nasal cavity carcinoma,0
18493,Responsible to,Recurrent Uveal Melanoma,0
18494,radiotherapeutic,Cartilaginous exostosis,0
18495,Melanins,Stage IB Pancreatic Cancer AJCC v8,0
18496,Type - attribute,Bladder adenocarcinoma stage IV,0
18497,Time,Childhood Fibrillary Astrocytoma,0
18498,Pass (indicator),Precursor B-lymphoblastic lymphoma stage II,0
18499,Continuous,Squamous cell carcinoma of lip,0
18500,CYREN gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18501,Medications:-:Point in time:^Patient:-,Benign squamous cell tumor,0
18502,Multilaminar epithelium,Intraepithelial Melanocytic Hyperplasia,0
18503,Covers (device),FIGO Stage IVA Ovarian Cancer,0
18504,VIPR1 wt Allele,Fibroadenoma of breast,0
18505,Include (action),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18506,Qualitative form,Congenital hamartoma,0
18507,Major <insect>,Carcinoma of urinary bladder,0
18508,Rating (action),Testicular cancer metastatic,0
18509,Combined,Squamous cell carcinoma of lip,0
18510,Death (finding),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18511,Group A (blood group),Locally Advanced Epithelioid Hemangioendothelioma,0
18512,Asia,Malignant Neoplasm of Lung - Multiple Primary Sites,0
18513,Part,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18514,National Human Genome Research Institute (U.S.),Platinum-Resistant Lung Small Cell Carcinoma,0
18515,Affecting,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
18516,Pharmacotherapy,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18517,PREVENT (product),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18518,Excision,Basal Cell Ameloblastoma,0
18519,growth aspects,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18520,chance,Low Grade Squamous Intraepithelial Neoplasia,0
18521,Polypeptide Hormones,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
18522,Removed,Localized Malignant Neoplasm,0
18523,Greater than one,Malignant melanoma of eyelid,0
18524,Clone Cells,Adult Fibrolamellar Carcinoma,0
18525,CDISC SDTM Route of Administration Terminology,Intracortical osteosarcoma,0
18526,Early,sarcoma of spinal cord,0
18527,Tumor Mass,FIGO Stage II Ovarian Cancer,0
18528,Certain (qualifier value),High Grade Glandular Intraepithelial Neoplasia,0
18529,Lymphadenopathy,Testicular cancer metastatic,0
18530,Descending,embryonal rhabdomyosarcoma of prostate,0
18531,Tanning of leather,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18532,80%,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18533,Approximate,Female Breast Carcinoma,0
18534,Basal cell carcinoma,Refractory WHO Grade III Glioma,0
18535,Tumor Mass,Endometrial Small Cell Carcinoma,0
18536,Diffuse Large B-Cell Lymphoma,Childhood Central Nervous System Ganglioneuroblastoma,0
18537,Include (action),Testicular cancer metastatic,0
18538,Childhood diseases,Benign Apocrine Neoplasm,0
18539,described,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
18540,English race,Adult Hepatocellular Carcinoma,0
18541,shared attribute,Kaposi's sarcoma of skin,0
18542,Peeling of skin,Vaginal Adenoma,0
18543,Targeted Therapy,Adrenal Rest Tumor,0
18544,Numerous,Carcinoma of urinary bladder,0
18545,Mucous Membrane,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18546,Death (finding),Non-Metastatic Gestational Trophoblastic Tumor,0
18547,Greater,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18548,Structure of choroid plexus,Metastatic Neoplasm to the Gallbladder,0
18549,Time (foundation metadata concept),Acinar cell carcinoma of pancreas,0
18550,Trauma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18551,Containing (qualifier),Acantholytic squamous cell carcinoma,0
18552,Country number:Find:Pt:^Patient:Nom,Ovarian germ cell choriocarcinoma stage IV,0
18553,Swyer Syndrome,Tongue Alveolar Soft Part Sarcoma,0
18554,Often - answer to question,Localized Askin Tumor,0
18555,Neuronal heterotopia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
18556,Specific qualifier value,Splenic Manifestation of Hairy Cell Leukemia,0
18557,Increase,Extra-abdominal fibromatosis,0
18558,Chorioamnionitis,mucinous adenocarcinoma of gallbladder,0
18559,Test - temporal region,Cervical Squamous Intraepithelial Neoplasia,0
18560,cell type,Intestinal Metaplasia of Bladder Urothelium,0
18561,75,Refractory Ependymoma,0
18562,Along edge (qualifier value),Peripheral primitive neuroectodermal tumor of soft tissue,0
18563,Spatial Frequency,Intracortical osteosarcoma,0
18564,Presence (property),Pancreatic Intraepithelial Neoplasia-3,0
18565,diagnosis aspect,Granular Cell Leiomyosarcoma,0
18566,60%,Engraftment syndrome,0
18567,Most Recent,Bladder adenocarcinoma stage IV,0
18568,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
18569,non-recurrent,Lipoma of small intestine,0
18570,Sebaceous Glands,Breast Ductal Adenoma,0
18571,Group A (blood group),Childhood Central Nervous System Ganglioneuroblastoma,0
18572,include - SetOperator,Noninfiltrating Intraductal Carcinoma,0
18573,35,Nasal cavity carcinoma,0
18574,Males,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18575,Including (qualifier),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18576,Risk,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
18577,Confirmation,Female Breast Carcinoma,0
18578,Graph Node,Maxillary Sinus Adenocarcinoma,0
18579,Hypesthesia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18580,peripheral blood,Engraftment syndrome,0
18581,Subject Risk,Testicular cancer metastatic,0
18582,Including (qualifier),Vaginal Adenoma,0
18583,risk factors,Kaposi's sarcoma of skin,0
18584,Used by,Fibroadenoma of breast,0
18585,Operative Surgical Procedures,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18586,gene therapy,adenoid cystic carcinoma of lung,0
18587,Numbers,Botryoid-Type Embryonal Rhabdomyosarcoma,0
18588,Oral region,Endometrial Small Cell Carcinoma,0
18589,Oral cavity,clear cell adenocarcinoma of gallbladder,0
18590,Condition,Endometrial Small Cell Carcinoma,0
18591,Common (qualifier value),Spongiotic dermatitis,0
18592,Primary malignant neoplasm,Extra-Adrenal Paraganglioma,0
18593,Salivary Glands,adenoid cystic carcinoma of lung,0
18594,Cystadenocarcinoma,Cancer of Urinary Tract,0
18595,Medical Device Material Separation,Undifferentiated Endocervical Sarcoma,0
18596,Complete,Cervical Fibroepithelial Polyp,0
18597,Frequently,Anterior Urethral Malignant Neoplasm,0
18598,Seminoma,Refractory Ependymoma,0
18599,Gonadal structure,Acantholytic squamous cell carcinoma,0
18600,Fever,Ovarian germ cell choriocarcinoma stage IV,0
18601,Etiology aspects,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
18602,Disease,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18603,Most,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18604,Obesity,Deep Leiomyoma,0
18605,Diagnosis,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18606,Publishing,embryonal rhabdomyosarcoma of prostate,0
18607,Skin Specimen,Metastatic Malignant Neoplasm in the Sellar Region,0
18608,analysis aspect,Contact dermatitis due to alkali,0
18609,Young Adult,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18610,Cells,mucinous adenocarcinoma of gallbladder,0
18611,Cell Count,Neonatal leukemia,0
18612,Tissue Specimen Code,Female Breast Carcinoma,0
18613,Body part,Ovarian Carcinoid Tumor,0
18614,Melanins,Cerebral Primitive Neuroectodermal Tumor,0
18615,Statistical Prevalence,Deep Leiomyoma,0
18616,Person Observer,Platinum-Resistant Lung Small Cell Carcinoma,0
18617,Covered (qualifier value),Locally Advanced Soft Tissue Sarcoma,0
18618,Multiply - dosing instruction fragment,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18619,Less Than,Collecting Duct Carcinoma of the Kidney,0
18620,Vascular Neoplasms,papillary carcinoma of penis,0
18621,Smear - instruction imperative,Undifferentiated Endocervical Sarcoma,0
18622,Administration procedure,Childhood Central Nervous System Ganglioneuroblastoma,0
18623,Mass of body structure,Malignant melanoma of eyelid,0
18624,floor (object),Malignant Testicular Sertoli Cell Tumor,0
18625,Genitourinary system,Recurrent Testicular Lymphoma,0
18626,Moved from,Kaposi's sarcoma of skin,0
18627,Nicotiana tabacum,Papillary squamous cell carcinoma,0
18628,Surgery specialty,Malignant melanoma of eyelid,0
18629,Severe (severity modifier),Locally Advanced Soft Tissue Sarcoma,0
18630,Biomaterial Treatment,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
18631,Occurrence Indicator,Liver Lymphangioma,0
18632,Environmental risk factor,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18633,75,Human Papillomavirus-Related Carcinoma,0
18634,Singular,Recurrent Testicular Lymphoma,0
18635,pharmacotherapeutic,Placental aromatase deficiency,0
18636,Specimen Source Codes - tumor,Adult Anaplastic Oligodendroglioma,0
18637,Screening Study,Recurrent Uveal Melanoma,0
18638,Singular,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18639,Either,Adult Anaplastic Oligodendroglioma,0
18640,Administration procedure,Thymic Clear Cell Carcinoma,0
18641,Slightly Able,BRCA2 Syndrome,0
18642,Benign,Recurrent Testicular Lymphoma,0
18643,Abnormal Reference Range,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18644,Type - attribute,Blood Vessel Tumors,0
18645,Result,Metastatic Ductal Breast Carcinoma,0
18646,Simulate composite resin,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18647,Primary malignant neoplasm,Intracortical osteosarcoma,0
18648,hearing impairment,Tongue Alveolar Soft Part Sarcoma,0
18649,Epstein-Barr Virus,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
18650,Carcinoma of lung,Stage IV Childhood Non-Hodgkin Lymphoma,0
18651,Weight Loss,clear cell adenocarcinoma of gallbladder,0
18652,Primary operation,Maxillary Sinus Adenoid Cystic Carcinoma,0
18653,United States,Vaginal Adenoma,0
18654,Neoplasms,Testicular cancer metastatic,0
18655,Negation,Stage I Adult Non-Hodgkin Lymphoma,0
18656,Malignant Neoplasms,Adult Fibrolamellar Carcinoma,0
18657,Indeterminate,Localized Ewing Sarcoma,0
18658,Infratentorial,Metastatic Lung Small Cell Carcinoma,0
18659,Affecting,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
18660,Neoplasms,Acantholytic squamous cell carcinoma,0
18661,Variety (taxon),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18662,Growth,Kaposi's sarcoma of extrahepatic bile duct,0
18663,Chemotherapy Regimen,Recurrent Uveal Melanoma,0
18664,Spreading (qualifier value),Fibroadenoma of breast,0
18665,Malignant neoplasm of pancreas,Ovarian germ cell choriocarcinoma stage IV,0
18666,Low Back Pain,Leptomeningeal sarcoma,0
18667,Medical Devices,Periosteal Osteosarcoma,0
18668,Hodgkin Disease,gliosarcoma,0
18669,World Health Organization,Intestinal Metaplasia of Bladder Urothelium,0
18670,Qualitative form,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
18671,EHD1 wt Allele,FIGO Stage IVA Ovarian Cancer,0
18672,Mechanism Component of Device,Xeroderma pigmentosum,0
18673,Steroids,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18674,skin color,GIANT PIGMENTED HAIRY NEVUS,0
18675,Ephrin Type-B Receptor 1,Bladder adenocarcinoma stage IV,0
18676,Feelings,Carcinoma of urinary bladder,0
18677,Case (situation),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18678,Usually,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18679,Chemotherapy Regimen,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18680,Precision - temporal,Xeroderma pigmentosum,0
18681,Thigh structure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18682,Liver and Intrahepatic Biliary Tract Carcinoma,adenoid cystic carcinoma of lung,0
18683,Extrinsic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18684,Contrast,Female Breast Carcinoma,0
18685,corticosteroids cream,Diffuse malignant mesothelioma,0
18686,HL7PublishingSubSection <practice>,Bladder squamous cell carcinoma stage I,0
18687,combination - answer to question,Adult Alveolar Soft Part Sarcoma,0
18688,Chemotherapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18689,Term Birth,Benign Anal Granular Cell Tumor,0
18690,Formation,Microcystic meningioma,0
18691,Relational and Item-Specific Encoding Task,Breast Ductal Adenoma,0
18692,10%,Locally Advanced Squamous Cell Carcinoma,0
18693,Poor - qualifier,Advanced Lung Carcinoma,0
18694,Lower eyelid,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18695,Removed,Childhood Central Nervous System Immature Teratoma,0
18696,Liver Cirrhosis,Intestinal Neuroendocrine Carcinoma,0
18697,Mesenchymal Stem Cells,Vaginal Adenoma,0
18698,Pharmacotherapy,Stage II Hepatocellular Carcinoma AJCC v8,0
18699,Helping Behavior,Kaposi's sarcoma of extrahepatic bile duct,0
18700,Entity,Splenic Manifestation of Hairy Cell Leukemia,0
18701,0%,Nasal cavity carcinoma,0
18702,Before values,Recurrent Rhabdomyosarcoma,0
18703,antibody (non-specific) abnormal,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18704,Specimen Source Codes - tumor,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18705,Clear fluid,Malignant neoplasm of subglottis,0
18706,Confirmed by,Refractory Ependymoma,0
18707,Financial Account,Vaginal Adenoma,0
18708,Mass,adenoid cystic carcinoma of lung,0
18709,Did not receive therapy or drug for,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
18710,Original,Mucinous adenocarcinoma gastric,0
18711,Obesity,Leiomyoma of Gallbladder,0
18712,Synonym (core metadata concept),FIGO Stage IVA Ovarian Cancer,0
18713,Cerebral cortex,Recurrent Testicular Lymphoma,0
18714,Malignant neoplasm of penis,adenoid cystic carcinoma of lung,0
18715,Involvement with,Granular Cell Leiomyosarcoma,0
18716,Lysergic acid diethylamide measurement,Type II Endometrial Adenocarcinoma,0
18717,Treatment Epoch,Intraepithelial Melanocytic Hyperplasia,0
18718,Papillary,Nasal cavity carcinoma,0
18719,Worse,Recurrent Uveal Melanoma,0
18720,Limited (extensiveness),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
18721,Cancer Genus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18722,Skin Specimen,Childhood Fibrillary Astrocytoma,0
18723,NCI CTEP SDC Acute Lymphoblastic Leukemia Sub-Category Terminology,BRCA2 Syndrome,0
18724,Disease,Cancer of Urinary Tract,0
18725,High risk of,Breast Apocrine Adenoma,0
18726,metastatic qualifier,Undifferentiated Endocervical Sarcoma,0
18727,1000000,Giant cell angiofibroma,0
18728,Lymphoma,Locally Advanced Epithelioid Hemangioendothelioma,0
18729,Bone Pain,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18730,Undifferentiated Sex,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18731,Adult Pilocytic Astrocytoma,Methotrexate-Associated Hodgkin Lymphoma,0
18732,Artificial (qualifier value),Human Papillomavirus-Related Carcinoma,0
18733,Science of Etiology,Acute lymphadenitis,0
18734,Myasthenia Gravis,Astrocytoma of brain,0
18735,Classes - encounter,Locally Advanced Epithelioid Hemangioendothelioma,0
18736,Confirmed by,Botryoid-Type Embryonal Rhabdomyosarcoma,0
18737,Malignant - descriptor,Recurrent Rhabdomyosarcoma,0
18738,Talpidae,Contact dermatitis due to alkali,0
18739,photoreactivating enzyme activity,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18740,World Health Organization,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18741,atypia morphology,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18742,Male population group,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18743,Obesity,Stage IV Colorectal Cancer AJCC v8,0
18744,operate <remove>,Intestinal Metaplasia of Bladder Urothelium,0
18745,Primary operation,Neoplasms,0
18746,Approximate,Clonal Hematopoiesis of Indeterminate Potential,0
18747,Liver,Advanced Uterine Corpus Carcinosarcoma,0
18748,What subject filter - Result,FIGO Stage IVA Ovarian Cancer,0
18749,What subject filter - Result,Non-Hodgkin Lymphoma During Pregnancy,0
18750,Including (qualifier),Adenocarcinoma,0
18751,Tryptophanase,Stage IB Pancreatic Cancer AJCC v8,0
18752,Driven,Stage 0 Penile Cancer AJCC v8,0
18753,Psyche structure,Mucinous adenocarcinoma gastric,0
18754,CEL gene,Refractory Barrett Esophagus,0
18755,Esophageal,Vaginal Adenoid Cystic Carcinoma,0
18756,Concept Relationship,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18757,Ganglioneuroblastoma,Giant cell angiofibroma,0
18758,Time,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
18759,Etiology aspects,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18760,Encode (action),Acute Undifferentiated Leukemia,0
18761,Feel Tired question,Acute lymphadenitis,0
18762,Screening procedure,Childhood Thyroid Gland Follicular Carcinoma,0
18763,Surgical aspects,Childhood Thyroid Gland Follicular Carcinoma,0
18764,Visual Impairment,Blepharal carcinoma,0
18765,English [International Organization for Standardization 639-1 code en] language reference set,Stage IV Penile Cancer AJCC v7,0
18766,Qualitative form,Breast Apocrine Adenoma,0
18767,Good,High Grade Glandular Intraepithelial Neoplasia,0
18768,Abdomen,BRCA2 Syndrome,0
18769,Experimental Result,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18770,Sharing (Social Behavior),Carcinoma of urinary bladder,0
18771,Adult Non-Hodgkin Lymphoma,Localized Ewing Sarcoma,0
18772,Onset of (contextual qualifier),Adult Hepatocellular Carcinoma,0
18773,Condition,Refractory Ependymoma,0
18774,Liquid Tumor,Spongiotic dermatitis,0
18775,Beginning,Benign Anal Granular Cell Tumor,0
18776,Abnormally high,Stage I Colon Neuroendocrine Tumor AJCC v8,0
18777,Occurrence,Refractory Bladder Carcinoma,0
18778,Growth,Benign tumor of eyelid,0
18779,Early,ICHTHYOSIS,0
18780,Lymphocyte component of blood,Liver Lymphangioma,0
18781,Form:Finding:Point in time:{Setting}:Document:{Role},Thyroid Hurthle Cell Carcinoma,0
18782,Term Birth,Benign tumor of eyelid,0
18783,Near,Kaposi's sarcoma of skin,0
18784,Feelings,Multiple Skull Base Meningiomas,0
18785,Protein complex,Female Breast Carcinoma,0
18786,Primary,Localized Malignant Neoplasm,0
18787,Neuroglia,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18788,Pelvic pain female,Recurrent Testicular Lymphoma,0
18789,antibiotics,Fourth Ventricle and Brain Stem Ependymal Tumor,0
18790,History of present illness,Low Grade Squamous Intraepithelial Neoplasia,0
18791,Present,FIGO Stage IVA Ovarian Cancer,0
18792,Spreading (qualifier value),Choroid Necrotic Melanoma,0
18793,Increased,Vaginal Adenoid Cystic Carcinoma,0
18794,Term (temporal),Localized Malignant Neoplasm,0
18795,Resulting in,Human Papillomavirus-Related Carcinoma,0
18796,Including (qualifier),Acantholytic squamous cell carcinoma,0
18797,Type - attribute,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18798,ovarian,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18799,Sometimes,Diffuse malignant mesothelioma,0
18800,Papanicolaou Test,Gallbladder Adenocarcinoma,0
18801,Combined,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
18802,Unknown,FIGO Stage II Ovarian Cancer,0
18803,Xp,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
18804,Site of,Childhood Central Nervous System Immature Teratoma,0
18805,other medicated shampoos in ATC,Acantholytic squamous cell carcinoma,0
18806,Oral cavity,Anaplastic large cell lymphoma,0
18807,Continuous,Heavy Chain Deposition Disease,0
18808,2+ Score,Cervical Fibroepithelial Polyp,0
18809,Adult Teratoma,Childhood Fibrillary Astrocytoma,0
18810,Cover - action,Acantholytic squamous cell carcinoma,0
18811,800,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
18812,Occurrence,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
18813,Sunscreening Agents,FIGO Stage II Ovarian Cancer,0
18814,Very Much,Neoplasms,0
18815,Primary operation,Squamous cell carcinoma of lip,0
18816,Urine looks dark,Refractory Glioma,0
18817,Case (situation),ROSE Cluster 3,0
18818,Disease Screening,Splenic Manifestation of Hairy Cell Leukemia,0
18819,Palmitic Acid,Intraepithelial Melanocytic Hyperplasia,0
18820,Malignant Neoplasms,Sarcomatoid Renal Cell Carcinoma,0
18821,Manufactured form,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18822,Sharing (Social Behavior),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
18823,treatment - ActInformationManagementReason,BRCA2 Syndrome,0
18824,Present,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18825,Meaning,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18826,Permutation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18827,MILDLY,Human Papillomavirus-Related Carcinoma,0
18828,Term (lexical),Childhood Fibrillary Astrocytoma,0
18829,Cicatrix,Acantholytic squamous cell carcinoma,0
18830,Negation,Splenic Manifestation of Hairy Cell Leukemia,0
18831,Cancer Genus,Spongiotic dermatitis,0
18832,depend,Pancreatic Intraepithelial Neoplasia-3,0
18833,Protocol - answer to question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
18834,True primary (qualifier value),Multiple Skull Base Meningiomas,0
18835,Make - Instruction Imperative,GIANT PIGMENTED HAIRY NEVUS,0
18836,Sore sensation,Carcinoma ex pleomorphic adenoma of parotid gland,0
18837,NCI CTEP SDC Vaginal Cancer Sub-Category Terminology,Adult Hepatocellular Carcinoma,0
18838,Carcinoma,Uterine Cancer,0
18839,spinal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
18840,To,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
18841,Chemicals,Parathyroid Gland Adenocarcinoma,0
18842,Definitive,Ectomesenchymal Chondromyxoid Tumor,0
18843,Obese build,Gallbladder Adenocarcinoma,0
18844,biopsy characteristics,Hyperplasia of pituitary gland,0
18845,Links List,Anaplastic large cell lymphoma,0
18846,per second,Blepharal carcinoma,0
18847,Curative - procedure intent,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
18848,Retrobulbar space (body structure),squamous cell carcinoma of the thyroid gland,0
18849,Continuance of life,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18850,Source (property) (qualifier value),Testicular cancer metastatic,0
18851,Combined,Localized Askin Tumor,0
18852,Aspects of signs,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
18853,Ependymoblastoma,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18854,Data operation - complete,Metastatic Ductal Breast Carcinoma,0
18855,Mixed Salivary Gland Tumor,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
18856,Chemotherapy Regimen,Ovarian Carcinoid Tumor,0
18857,Weight Loss,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
18858,Circulating,Brain Ependymoma,0
18859,Poverty,Squamous cell carcinoma of lip,0
18860,Beginning,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18861,Neoplastic disease,BRCA2 Syndrome,0
18862,Togo,Recurrent Testicular Lymphoma,0
18863,Togo,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
18864,Primary malignant neoplasm,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
18865,Neoplasms,Squamous cell carcinoma of lip,0
18866,Individual,Benign Anal Granular Cell Tumor,0
18867,Common (qualifier value),Lung squamous cell carcinoma stage I,0
18868,Smear - instruction imperative,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
18869,Tubal Ligation,Stage I Adult Non-Hodgkin Lymphoma,0
18870,various antiinfectives and antiseptics for local oral treatment,Acute Undifferentiated Leukemia,0
18871,Mass of body structure,Stage IB Lung Cancer AJCC v7,0
18872,Painless,Stage 0 Lip Carcinoma,0
18873,Formation,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
18874,Cure (remedy),Locally Advanced Soft Tissue Sarcoma,0
18875,Leg,BRCA2 Syndrome,0
18876,Base - General Qualifier,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18877,Well,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18878,Pleomorphic,Peripheral primitive neuroectodermal tumor of soft tissue,0
18879,Anemia,Benign squamous cell tumor,0
18880,include - SetOperator,Stage I Adult Non-Hodgkin Lymphoma,0
18881,N not otherwise specified Antibody,Ovarian Carcinoid Tumor,0
18882,Most,Grade 1 Clear Cell Renal Cell Carcinoma,0
18883,RBM12 gene,Thymic Clear Cell Carcinoma,0
18884,Containing (qualifier),Bladder squamous cell carcinoma stage I,0
18885,Bacteria,Hereditary Diffuse Gastric Adenocarcinoma,0
18886,Formation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
18887,Chemotherapy,Chondrosarcoma,0
18888,Condition:Find:Pt:^Patient:Nom,Vaginal Adenoid Cystic Carcinoma,0
18889,Adult human body,Childhood Anaplastic Large Cell Lymphoma,0
18890,Skull,Recurrent Diffuse Intrinsic Pontine Glioma,0
18891,Acquired (qualifier value),FIGO Stage IVA Ovarian Cancer,0
18892,South Korea,Benign Apocrine Neoplasm,0
18893,Common Specifications in HL7 V3 Publishing,Hemangioma,0
18894,Ulcer,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18895,Make - Instruction Imperative,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
18896,genetic risk factors,Malignant Neoplasm with Regional Lymph Node Involvement,0
18897,Cell (compartment),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18898,World Health Organization,Bladder squamous cell carcinoma stage I,0
18899,Usual Severity Weight Loss,GIANT PIGMENTED HAIRY NEVUS,0
18900,Publishing,Malignant neoplasm of subglottis,0
18901,GORAB gene,Primary Cutaneous Plasmablastic Lymphoma,0
18902,Publications,Localized Malignant Neoplasm,0
18903,lymph nodes,Diffuse malignant mesothelioma,0
18904,Route of Administration - Mucous Membrane,Squamous cell carcinoma of lip,0
18905,various other intestinal adsorbents in ATC,Fibroadenoma of breast,0
18906,SMIM10L2A gene,Bladder squamous cell carcinoma stage I,0
18907,Occur (action),Hereditary corneal dystrophy,0
18908,Name,Metastatic Lung Neuroendocrine Neoplasm,0
18909,Dermis,Neonatal leukemia,0
18910,Leukemia,Vaginal Adenoid Cystic Carcinoma,0
18911,Neoplasms,Stage I Colon Neuroendocrine Tumor AJCC v8,0
18912,High Grade Astrocytic Tumor,Microcystic meningioma,0
18913,Adult human body,Human Papillomavirus-Related Carcinoma,0
18914,Nervous system structure,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
18915,Severe (severity modifier),Gallbladder adenoma,0
18916,Nasal sinus,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
18917,60%,embryonal rhabdomyosarcoma of prostate,0
18918,Pelvic Pain,Locally Advanced Carcinoma,0
18919,3+ Score,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
18920,Nasal (intended site),Bladder squamous cell carcinoma stage I,0
18921,Future,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
18922,Usual,Malignant Neoplasm of Lung - Multiple Primary Sites,0
18923,Include (action),Kaposi's sarcoma of extrahepatic bile duct,0
18924,Drop measurement,Basal Cell Ameloblastoma,0
18925,Megakaryocyte Count,Cervical Fibroepithelial Polyp,0
18926,Neoplasms,Extra-Adrenal Paraganglioma,0
18927,Anaphylactic shock,Benign tumor of eyelid,0
18928,Lung,Contact dermatitis due to alkali,0
18929,Sacrifice,Peripheral primitive neuroectodermal tumor of soft tissue,0
18930,Universal - VocabularyDomainQualifier,papillary carcinoma of penis,0
18931,Scrotum,Stage III Adult Immunoblastic Lymphoma,0
18932,Scheme,Mucinous adenocarcinoma gastric,0
18933,Common (qualifier value),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
18934,Qualitative form,Type II Endometrial Adenocarcinoma,0
18935,Infrequent,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
18936,Choroid,Recurrent Testicular Lymphoma,0
18937,Decision,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
18938,Form:Finding:Point in time:{Setting}:Document:{Role},Acute Undifferentiated Leukemia,0
18939,What subject filter - Result,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
18940,bacteria aspects,FIGO Stage IVA Ovarian Cancer,0
18941,Removed,Locally Advanced Carcinoma,0
18942,Hemoptysis,Adult Brain Stem Mixed Glioma,0
18943,Nearly,Methotrexate-Associated Hodgkin Lymphoma,0
18944,Second Suffix,Testicular cancer metastatic,0
18945,4+ Answer to question,Stage III Cutaneous Melanoma AJCC v6,0
18946,Tired,Pancreatic Endocrine Carcinoma,0
18947,Term (lexical),Melanomatosis,0
18948,Malignant Neoplasms,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
18949,Black color,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
18950,Two,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
18951,Term (temporal),Ichthyosis,0
18952,Part of,Unresectable Rhabdomyosarcoma,0
18953,Esophageal,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
18954,point - UnitsOfMeasure,Small intestine carcinoma,0
18955,Palate,Mixed parotid tumor,0
18956,Development,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
18957,Occur (action),Ichthyoses,0
18958,Lower - spatial qualifier,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
18959,Abdomen+,Low Grade Squamous Intraepithelial Neoplasia,0
18960,Precision - characteristic,adenoid cystic carcinoma of lung,0
18961,Common Specifications in HL7 V3 Publishing,Chest Wall Fibromatosis,0
18962,Reparative closure,FIGO Stage IVA Ovarian Cancer,0
18963,Malignant neoplasm of endometrium,Trichilemmocarcinoma,0
18964,Type A,Ovarian germ cell choriocarcinoma stage IV,0
18965,Cancer Genus,Locally Advanced Epithelioid Hemangioendothelioma,0
18966,Class (taxonomic),gliosarcoma,0
18967,Visual Impairment,Gallbladder adenoma,0
18968,Average of Value Derivation Technique,Botryoid-Type Embryonal Rhabdomyosarcoma,0
18969,Infrequent,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
18970,Encounter due to tobacco use,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
18971,color additive,Childhood Lymphoma,0
18972,Non-Small Cell Lung Carcinoma,Childhood Fibrillary Astrocytoma,0
18973,Spinal Cord,Colorectal Neuroendocrine Tumor G2,0
18974,Entity,Squamous cell carcinoma of lip,0
18975,Singular,Heavy Chain Deposition Disease,0
18976,Filter (function),Occult Lung Adenosquamous Carcinoma,0
18977,Clavien-Dindo Grade II,Metaplastic carcinoma of breast,0
18978,Fever,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
18979,About The Same,Stage 0 Lip Carcinoma,0
18980,Bruising,Bladder squamous cell carcinoma stage I,0
18981,Exposure to,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
18982,Tobacco smoking behavior,Ovarian Dermoid Cyst with Secondary Carcinoma,0
18983,Related personal status,Recurrent Testicular Lymphoma,0
18984,Lymphoid organ structure,Familial Hemophagocytic Lymphocytosis,0
18985,Excision,Mixed astrocytoma-ependymoma,0
18986,90%,Recurrent Testicular Lymphoma,0
18987,Bothered by Vomiting,Cystadenocarcinoma,0
18988,Value Above Reference Range,Female Breast Carcinoma,0
18989,2+ Score,Airway Hemangioma,0
18990,Tryptophanase,Clinical Stage I Cutaneous Melanoma AJCC v8,0
18991,various antiseptic throat preparations,Intraepithelial Melanocytic Hyperplasia,0
18992,Evidence,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
18993,Replaced by,Kaposi's sarcoma of extrahepatic bile duct,0
18994,United States,Bladder squamous cell carcinoma stage I,0
18995,Case (situation),Benign Anal Granular Cell Tumor,0
18996,Antifungal Antibiotics,Primary Cutaneous Plasmablastic Lymphoma,0
18997,Sample Range,Mucinous adenocarcinoma gastric,0
18998,Case unit dose,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
18999,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Splenic Manifestation of Hairy Cell Leukemia,0
19000,Certain (qualifier value),Spermatocytic seminoma,0
19001,Descending,Malignant melanoma of eyelid,0
19002,Shortened,Vaginal Adenoid Cystic Carcinoma,0
19003,Immunoglobulins,Pancreatic carcinoma,0
19004,Symptoms aspect,Leiomyoma of Gallbladder,0
19005,Adenocarcinoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19006,Primary malignant neoplasm,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19007,Options,FIGO Stage II Ovarian Cancer,0
19008,Adult Glioblastoma,Diffuse malignant mesothelioma,0
19009,76,FIGO Stage IVA Ovarian Cancer,0
19010,E-Cadherin,Gallbladder Adenocarcinoma,0
19011,Retina,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
19012,SLC6A2 protein,Ovarian germ cell choriocarcinoma stage IV,0
19013,Fever,Low Grade Squamous Intraepithelial Neoplasia,0
19014,Have Weight Loss,Carcinomatosis of peritoneal cavity,0
19015,Marketing basis - Transitional,Metaplastic carcinoma of breast,0
19016,Poor - grade value,Epithelioid Sarcoma NCI Grade 3,0
19017,Surgical extraction,Malignant Testicular Sertoli Cell Tumor,0
19018,Dorsal,Thymic Atypical Carcinoid Tumor,0
19019,Body Fluid Discharge,Multiple Endocrine Neoplasia,0
19020,Adult Rhabdomyosarcoma,Thymic Atypical Carcinoid Tumor,0
19021,Specific qualifier value,Refractory Barrett Esophagus,0
19022,Sample Range,Ovarian germ cell choriocarcinoma stage IV,0
19023,Cancer Genus,Vaginal Adenoid Cystic Carcinoma,0
19024,Skin Pigmentation,Periosteal Osteosarcoma,0
19025,Location,Benign neoplasm of eye,0
19026,Capillary vessel,clear cell adenocarcinoma of gallbladder,0
19027,Specimen Source Codes - tumor,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19028,Negation,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19029,Symptoms aspect,Extra-abdominal fibromatosis,0
19030,Etiology aspects,Unresectable Rhabdomyosarcoma,0
19031,Thyroid carcinoma,Nasal cavity carcinoma,0
19032,Bacterial shell rot,Gallbladder Adenocarcinoma,0
19033,Body part,FIGO Stage IVA Ovarian Cancer,0
19034,Treatment Epoch,Mucinous adenocarcinoma gastric,0
19035,Singular,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19036,Lymphatic Capillaries,Hereditary Diffuse Gastric Adenocarcinoma,0
19037,Common (qualifier value),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19038,Occur (action),Low Grade Squamous Intraepithelial Neoplasia,0
19039,Analysis,Anterior Urethral Malignant Neoplasm,0
19040,Usually,Methotrexate-Associated Hodgkin Lymphoma,0
19041,40%,gliosarcoma,0
19042,include - SetOperator,Adenocarcinoma,0
19043,Tissue Specimen Code,benign mature teratoma of pancreas,0
19044,Form of uterus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19045,status - In progress,Squamous cell carcinoma of lip,0
19046,Adult Lymphoma,Mucinous adenocarcinoma gastric,0
19047,Neoplasms,Engraftment syndrome,0
19048,Involvement with,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19049,alone - group size,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
19050,Orbital region,Carcinoma ex pleomorphic adenoma of parotid gland,0
19051,Primary malignant neoplasm,Giant cell angiofibroma,0
19052,Case (situation),Cerebral Primitive Neuroectodermal Tumor,0
19053,Person 1,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19054,Gastroesophageal Reflux Disease,Anterior Urethral Malignant Neoplasm,0
19055,Therapeutic procedure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19056,Pancreas,Stage III Adult Immunoblastic Lymphoma,0
19057,Fatigue,Type II Endometrial Adenocarcinoma,0
19058,Related personal status,Epithelioid Sarcoma NCI Grade 3,0
19059,depend,Malignant melanoma of eyelid,0
19060,Actinic keratosis,Refractory Ependymoma,0
19061,Melanins,Vaginal Adenoid Cystic Carcinoma,0
19062,Asians,Noninfiltrating Intraductal Carcinoma,0
19063,Several,FIGO Stage IVA Ovarian Cancer,0
19064,Aspects of signs,Cancer of Urinary Tract,0
19065,Occlusion of artery (disorder),Bladder squamous cell carcinoma stage I,0
19066,Object Class,Endometrial Small Cell Carcinoma,0
19067,Tears body substance,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19068,Antibiotics,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19069,Classification of information,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19070,Linear,Adenocarcinoma of duodenum,0
19071,Worse,Placental aromatase deficiency,0
19072,Referring,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
19073,Chemotherapy,Malignant Testicular Sertoli Cell Tumor,0
19074,Primary malignant neoplasm,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
19075,Experimental Result,Extracranial Neuroblastoma,0
19076,60%,Maxillary Sinus Adenocarcinoma,0
19077,Pediatric Neoplasm,Bladder adenocarcinoma stage IV,0
19078,Call (Instruction),Gallbladder adenoma,0
19079,Ultrasonography,mucinous adenocarcinoma of gallbladder,0
19080,Mutation,Diffuse malignant mesothelioma,0
19081,Genes,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19082,Sunlight,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19083,Neoplasm Metastasis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19084,Carcinoma,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
19085,Blast Cell,Kaposi's sarcoma of skin,0
19086,High Risk Acute Leukemia,Microcystic meningioma,0
19087,Then,Type II Endometrial Adenocarcinoma,0
19088,Neoplasms,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19089,System (unit of presentation),Stage IV Childhood Non-Hodgkin Lymphoma,0
19090,Tissue Specimen Code,Stage IV Childhood Non-Hodgkin Lymphoma,0
19091,Decreasing,Lipoma of small intestine,0
19092,Frequently,Digestive System Hodgkin Lymphoma,0
19093,Sometimes,non-Hodgkin's lymphoma of spleen,0
19094,Genetic,Serous cystadenocarcinoma ovary,0
19095,Family history,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
19096,Stress,Peripheral primitive neuroectodermal tumor of soft tissue,0
19097,Telencephalon,papillary carcinoma of penis,0
19098,Treatment intent,Refractory Ependymoma,0
19099,Containing (qualifier),Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
19100,Descent,Carcinoma of urinary bladder,0
19101,Mixed (qualifier value),Glomeruloid hemangioma,0
19102,T prime,Ichthyosis,0
19103,Etiology aspects,Colorectal cancer,0
19104,Usual Severity Weight Loss,Neonatal leukemia,0
19105,Examination,Acantholytic squamous cell carcinoma,0
19106,thymocyte,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19107,Examination,Carcinoma of urinary bladder,0
19108,Tissue Type Code - Basal cell carcinoma,Human Papillomavirus-Related Carcinoma,0
19109,Etiology,Childhood Lymphoma,0
19110,Autosomal dominant hereditary disorder,Adenocarcinoma,0
19111,Very High Level,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19112,Anatomic Site,Periosteal Osteosarcoma,0
19113,Obesity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19114,Common Specifications in HL7 V3 Publishing,Brain Tumor,0
19115,Abdominal Cavity,Tonsillar Carcinoma,0
19116,Within,Mucinous adenocarcinoma gastric,0
19117,Negation,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19118,Primary,Adult Hepatocellular Carcinoma,0
19119,Term (lexical),Primary Cutaneous Plasmablastic Lymphoma,0
19120,Childhood Non-Hodgkin Lymphoma,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
19121,biopsy characteristics,Fibroadenoma of breast,0
19122,Common (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19123,Support,Mucinous adenocarcinoma gastric,0
19124,Blood group antibody I,Breast Ductal Adenoma,0
19125,Skin fold,Ovarian Carcinoid Tumor,0
19126,Renal pelvis,Stage I Adult Non-Hodgkin Lymphoma,0
19127,Few minutes,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
19128,Thoracic Duct,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19129,Operation excision,Low Grade Squamous Intraepithelial Neoplasia,0
19130,Age,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19131,Before,Placental aromatase deficiency,0
19132,Smear - instruction imperative,Kaposi's sarcoma of extrahepatic bile duct,0
19133,Areas <moth>,High Grade Glandular Intraepithelial Neoplasia,0
19134,shared attribute,Recurrent Uveal Melanoma,0
19135,Papillary transitional cell carcinoma,Bladder squamous cell carcinoma stage I,0
19136,Leads (device),Engraftment syndrome,0
19137,Macrophage Activation Syndrome,Cerebral Primitive Neuroectodermal Tumor,0
19138,Endocrine Cells,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19139,Structure of isthmus of thyroid gland,Carcinomatosis of peritoneal cavity,0
19140,Intervention regimes,Medulloblastoma,0
19141,Reported Term,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19142,Fallopian Tubes,Pancreatic Intraepithelial Neoplasia-3,0
19143,melanoma,Localized Askin Tumor,0
19144,Cells,Nasal cavity carcinoma,0
19145,Control function,Blepharal carcinoma,0
19146,Laboratory Procedures,Airway Hemangioma,0
19147,Diagnosis,Acute Undifferentiated Leukemia,0
19148,Togo,Maxillary Sinus Adenoid Cystic Carcinoma,0
19149,Frequently,Blood Vessel Tumors,0
19150,Contain (action),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
19151,Due to,Cartilaginous exostosis,0
19152,fluid ounce,Papillary squamous cell carcinoma,0
19153,Thymus Gland,Thymic Clear Cell Carcinoma,0
19154,Able (finding),mucinous adenocarcinoma of gallbladder,0
19155,Ultrasonic Shockwave,Primary Cutaneous Plasmablastic Lymphoma,0
19156,35,Intestinal Metaplasia of Bladder Urothelium,0
19157,Ovary,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19158,Pharmacotherapy,Stage III Cutaneous Melanoma AJCC v6,0
19159,Unmarried person,Childhood Anaplastic Large Cell Lymphoma,0
19160,Endometrial biopsy,Liver Lymphangioma,0
19161,Measurement,Liver Lymphangioma,0
19162,Manufactured form,Malignant melanoma of eyelid,0
19163,Nipples,Heavy Chain Deposition Disease,0
19164,Probability,Squamous cell carcinoma of lip,0
19165,Following,Liver Lymphangioma,0
19166,Genes,Extra-Adrenal Paraganglioma,0
19167,Lymphocyte,Recurrent Uveal Melanoma,0
19168,Decision,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19169,Smear - instruction imperative,Adult Hepatocellular Carcinoma,0
19170,Spreading (qualifier value),Thymic Clear Cell Carcinoma,0
19171,Monitor Device,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19172,Diffuse Large B-Cell Lymphoma,Benign squamous cell tumor,0
19173,Plasma,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
19174,Sometimes,Anterior Urethral Malignant Neoplasm,0
19175,heart inflammation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19176,Brain,Microcystic meningioma,0
19177,various other agents for local oral treatment in ATC,Medulloblastoma,0
19178,Case unit dose,Blepharal carcinoma,0
19179,Neoadjuvant Therapy Clinical Trial Setting,Cerebral Primitive Neuroectodermal Tumor,0
19180,Pediculus (eukaryote),Microcystic meningioma,0
19181,Extrinsic,Cancer of Urinary Tract,0
19182,Screening,Uterine Cancer,0
19183,Severe (severity modifier),papillary carcinoma of penis,0
19184,Oral (intended site),FIGO Stage IVA Ovarian Cancer,0
19185,gene therapy,Adult Acute Eosinophilic Leukemia,0
19186,PSA Level Less than Two,Choroid Epithelioid Cell Melanoma,0
19187,7.2,Recurrent Primary Lymphoma of Bone,0
19188,Term (lexical),Type II Endometrial Adenocarcinoma,0
19189,Benign Neoplasm,Blepharal carcinoma,0
19190,Comprehension,Acantholytic squamous cell carcinoma,0
19191,*Type - Kind of quantity,Acute Undifferentiated Leukemia,0
19192,Case (situation),Heavy Chain Deposition Disease,0
19193,Age of Onset,Colorectal High Grade B-Cell Lymphoma,0
19194,Togo,Localized Ewing Sarcoma,0
19195,North America,Nasal cavity carcinoma,0
19196,Childhood Non-Hodgkin Lymphoma,Chondrosarcoma,0
19197,35,Kaposi's sarcoma of extrahepatic bile duct,0
19198,Occurrence,Extracranial Neuroblastoma,0
19199,Histocompatibility Testing,Mixed astrocytoma-ependymoma,0
19200,Unknown,Childhood Central Nervous System Ganglioneuroblastoma,0
19201,ferric oxide,Unresectable Rhabdomyosarcoma,0
19202,Plant Roots,Malignant Testicular Sertoli Cell Tumor,0
19203,Milliampere second,Bladder Neuroendocrine Neoplasm,0
19204,Negation,Refractory Ependymoma,0
19205,Tissue Specimen Code,Neonatal leukemia,0
19206,Secondary Neoplasm,Acantholytic squamous cell carcinoma,0
19207,Part of,Angiosarcoma of liver,0
19208,Horns,Neoplasms,0
19209,Often - answer to question,Thymic Clear Cell Carcinoma,0
19210,Vagina,Trichilemmocarcinoma,0
19211,Neoplasms,Adult Hepatocellular Carcinoma,0
19212,Due to,Benign Apocrine Neoplasm,0
19213,Occurrence Indicator,Refractory Barrett Esophagus,0
19214,Abdomen,Refractory Ependymoma,0
19215,Usual Severity Weight Loss,Testicular cancer metastatic,0
19216,Microvolt,Precursor B-lymphoblastic lymphoma stage II,0
19217,World,Tubal Hyperplasia,0
19218,Male Phenotype,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19219,Group A (qualifier value),Spongiotic dermatitis,0
19220,Dorsal,Kaposi's sarcoma of extrahepatic bile duct,0
19221,Africa,Advanced Lung Carcinoma,0
19222,Cancer Other,Childhood Thyroid Gland Follicular Carcinoma,0
19223,treatment - ActInformationManagementReason,Uterine Cancer,0
19224,Decade,Clonal Hematopoiesis of Indeterminate Potential,0
19225,Rate,Kaposi's sarcoma of skin,0
19226,risk factors,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19227,Main,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19228,Leakage,Localized Ewing Sarcoma,0
19229,risk factors,Unresectable Rhabdomyosarcoma,0
19230,include - SetOperator,Metaplastic carcinoma of breast,0
19231,Square Mile,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19232,Symptoms aspect,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19233,1+ Score,Medulloblastoma,0
19234,Hormonal Contraception,Leptomeningeal sarcoma,0
19235,Geographic Locations,Vaginal Adenoma,0
19236,Adverse Event Associated with Syndromes,Lung Inflammatory Myofibroblastic Tumor,0
19237,Average,Recurrent Uveal Melanoma,0
19238,Abdomen,Peripheral primitive neuroectodermal tumor of soft tissue,0
19239,complex (molecular entity),Kaposi's sarcoma of extrahepatic bile duct,0
19240,Hypothalamic hamartomas,Unicystic ameloblastoma,0
19241,Occurrence,Kaposi's sarcoma of extrahepatic bile duct,0
19242,Premalignant,Bladder adenocarcinoma stage IV,0
19243,Diagnosis,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
19244,Cause of Death,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
19245,Support,mucinous adenocarcinoma of gallbladder,0
19246,Colorectal Carcinoma,embryonal rhabdomyosarcoma of prostate,0
19247,Much,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19248,Non-Small Cell Lung Carcinoma,Peripheral primitive neuroectodermal tumor of soft tissue,0
19249,Known,Stage III Cutaneous Melanoma AJCC v6,0
19250,Location of Pharyngeal Residue Following Swallowing,Chondrosarcoma,0
19251,Physical findings,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
19252,year,Thyroid Hurthle Cell Carcinoma,0
19253,Take,Refractory Barrett Esophagus,0
19254,Support,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19255,Severe (severity modifier),embryonal rhabdomyosarcoma of prostate,0
19256,Growth,Localized Ewing Sarcoma,0
19257,Usually,Childhood Central Nervous System Ganglioneuroblastoma,0
19258,Cessation of life,Central Nervous System Anaplastic Large Cell Lymphoma,0
19259,Administration procedure,Benign neoplasm of eye,0
19260,Then,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19261,Immature cells,Lung squamous cell carcinoma stage I,0
19262,Dental caries,Recurrent Testicular Lymphoma,0
19263,Growth abnormality,Vaginal Adenoid Cystic Carcinoma,0
19264,Common (qualifier value),Gastric Diffuse Large B-Cell Lymphoma,0
19265,United States,Uterine Cancer,0
19266,Pelvic cavity structure,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
19267,triclocarban,Malignant melanoma of eyelid,0
19268,Manual pelvic examination (procedure),Non-Metastatic Gestational Trophoblastic Tumor,0
19269,Administration procedure,Stage III Cutaneous Melanoma AJCC v6,0
19270,United States,Benign Carotid Body Paraganglioma,0
19271,Blood,Xeroderma pigmentosum,0
19272,Chemotherapy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19273,Proliferation (morphologic abnormality),Bladder adenocarcinoma stage IV,0
19274,Science of Etiology,Cartilaginous exostosis,0
19275,Primary malignant neoplasm,Medulloblastoma,0
19276,Gastric Gastrointestinal Stromal Tumor,Pilocytic astrocytoma of cerebellum,0
19277,Term (lexical),Botryoid-Type Embryonal Rhabdomyosarcoma,0
19278,Skin,Benign squamous cell tumor,0
19279,Only - dosing instruction fragment,Pancreatic Intraepithelial Neoplasia-3,0
19280,Deterioration of status,Lung Mucinous Cystadenoma,0
19281,Nasolacrimal duct structure,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19282,Hydatidiform Mole,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19283,Feelings,Splenic Manifestation of Hairy Cell Leukemia,0
19284,Classification,Neoplasms,0
19285,United States,Locally Advanced Carcinoma,0
19286,Singular,Acute Undifferentiated Leukemia,0
19287,Exposure to,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
19288,Suspected qualifier,Trabecular adenocarcinoma,0
19289,During,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
19290,Progress,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19291,Therapeutic procedure,Airway Hemangioma,0
19292,Malignant neoplasm of pancreas,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19293,Linear,Choroid Epithelioid Cell Melanoma,0
19294,Structure of lower lobe of lung,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19295,contents - HtmlLinkType,Ichthyoses,0
19296,Perfusion (procedure),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19297,Usual,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19298,Talc,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19299,Beginning,Human Papillomavirus-Related Carcinoma,0
19300,Fibrous nodule,Pancreatic Intraepithelial Neoplasia-3,0
19301,High Mitosis-Karyorrhexis Index,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19302,Skin,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19303,500,Mucosal Melanoma,0
19304,Recommendation,Spermatocytic seminoma,0
19305,percent positive cells,Precursor B-lymphoblastic lymphoma stage II,0
19306,Exist,sarcoma of spinal cord,0
19307,90%,Acute Undifferentiated Leukemia,0
19308,Person Name,Intracortical osteosarcoma,0
19309,Materials,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19310,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Unresectable Rhabdomyosarcoma,0
19311,Malignant neoplasm of ovary,Leptomeningeal sarcoma,0
19312,Ultraviolet Light Sterilization,Human Papillomavirus-Related Carcinoma,0
19313,hormone problem,Acute Undifferentiated Leukemia,0
19314,Have Sweats,Stage IV Penile Cancer AJCC v7,0
19315,size,FIGO Stage II Ovarian Cancer,0
19316,Lymphocyte,Astrocytoma of brain,0
19317,Beginning,Metaplastic carcinoma of breast,0
19318,Primary operation,Kaposi's sarcoma of extrahepatic bile duct,0
19319,Case unit dose,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19320,Fatigue,Stage IB Pancreatic Cancer AJCC v8,0
19321,apply - action,Vaginal Adenoma,0
19322,Active,Chronic Myelomonocytic Leukemia-2,0
19323,As Much as Desired,Cerebral Primitive Neuroectodermal Tumor,0
19324,Portion of urine,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19325,Possible diagnosis,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19326,Vulva,Collecting Duct Carcinoma of the Kidney,0
19327,Pediculus (eukaryote),Cervical Squamous Intraepithelial Neoplasia,0
19328,Common (qualifier value),FIGO Stage IVA Ovarian Cancer,0
19329,*Type - Kind of quantity,Colorectal cancer,0
19330,Gastrointestinal tract structure,Undifferentiated Endocervical Sarcoma,0
19331,Aggressive behavior,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
19332,Life,Astrocytoma of brain,0
19333,Malignant neoplasm of thyroid,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
19334,Assisted (qualifier value),Noninfiltrating Intraductal Carcinoma,0
19335,Application (Document),Botryoid-Type Embryonal Rhabdomyosarcoma,0
19336,Spreading (qualifier value),Fibroadenoma of breast,0
19337,Oral cavity,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19338,Glandular,Vaginal Adenoid Cystic Carcinoma,0
19339,Immune,Ichthyosis,0
19340,Lymphoma,GIANT PIGMENTED HAIRY NEVUS,0
19341,Often - answer to question,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
19342,Diagnosis Study,Familial Hemophagocytic Lymphocytosis,0
19343,World Health Organization,Chest Wall Fibromatosis,0
19344,In Urine,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
19345,Asymptomatic Diseases,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
19346,How Much Distress Itching,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19347,Worsening pattern,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19348,Use of,Brain Tumor,0
19349,cell type,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19350,Deposition,Cancer of Urinary Tract,0
19351,Pruritus,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
19352,Sunlight,Undifferentiated Neuroblastoma,0
19353,71,Cartilaginous exostosis,0
19354,CEL gene,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19355,20%,Cervical Fibroepithelial Polyp,0
19356,Count of entities,Squamous cell carcinoma of lip,0
19357,Following,Anterior Urethral Malignant Neoplasm,0
19358,Cell division,Cancer of Urinary Tract,0
19359,Togo,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19360,Primary malignant neoplasm,Unresectable Rhabdomyosarcoma,0
19361,Areas <moth>,Mastocytosis,0
19362,Western Europe,Adult Fibrolamellar Carcinoma,0
19363,Characteristics,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
19364,Main,Bladder adenocarcinoma stage IV,0
19365,Often - answer to question,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19366,New,Benign Anal Granular Cell Tumor,0
19367,Cell Count,Splenic Manifestation of Hairy Cell Leukemia,0
19368,Include (action),Diffuse malignant mesothelioma,0
19369,Pelvic Pain,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19370,Young,Malignant melanoma of eyelid,0
19371,Classical Hodgkin's Lymphoma,Vaginal Adenoma,0
19372,adaptive,Metastatic Ductal Breast Carcinoma,0
19373,Term Birth,Cervical Fibroepithelial Polyp,0
19374,status - In progress,Engraftment syndrome,0
19375,Diagnosis,FIGO Stage II Ovarian Cancer,0
19376,Application procedure,BRCA2 Syndrome,0
19377,Lymphoma,Extracranial Neuroblastoma,0
19378,Obesity,Cancer of Urinary Tract,0
19379,Degree or extent,Mucosal Melanoma,0
19380,Togo,Thyroid Hurthle Cell Carcinoma,0
19381,Malignant Neoplasms,Pancreatic carcinoma,0
19382,Include (action),sarcoma of spinal cord,0
19383,Neoplasm Metastasis,Benign tumor of eyelid,0
19384,Call (Instruction),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19385,Oral cavity,Methotrexate-Associated Hodgkin Lymphoma,0
19386,Liquid substance,Benign squamous cell tumor,0
19387,Surgery specialty,Carcinomatosis of peritoneal cavity,0
19388,Average of Value Derivation Technique,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19389,Stomach,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
19390,Formation,Pancreatic Intraepithelial Neoplasia-3,0
19391,Australia,Thymic Clear Cell Carcinoma,0
19392,Less Than,Benign Apocrine Neoplasm,0
19393,Scab,Squamous cell carcinoma of lip,0
19394,Evaluation procedure,Liver Lymphangioma,0
19395,How Much Distress Weight Loss,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19396,Person Name,Chondrosarcoma,0
19397,Pelvic pain female,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19398,Covered (qualifier value),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
19399,Free (available (qualifier)),Malignant neoplasm of olfactory nerve,0
19400,Symptoms,Rhabdomyosarcoma with ganglionic differentiation,0
19401,H NOS Antibodies,Acantholytic squamous cell carcinoma,0
19402,shared attribute,Melanomatosis,0
19403,Pathological Dilatation,FIGO Stage II Ovarian Cancer,0
19404,Lower jaw region,Intraepithelial Melanocytic Hyperplasia,0
19405,Abnormal vaginal bleeding,Primary Cutaneous Plasmablastic Lymphoma,0
19406,Effective,Hereditary Diffuse Gastric Adenocarcinoma,0
19407,Mechanism (attribute),Maxillary Sinus Adenoid Cystic Carcinoma,0
19408,Chickenpox Vaccine,Methotrexate-Associated Hodgkin Lymphoma,0
19409,Known,BRCA2 Syndrome,0
19410,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
19411,Neoplasms,Childhood Central Nervous System Immature Teratoma,0
19412,Expression (foundation metadata concept),Recurrent Uveal Melanoma,0
19413,Observed,Melanomatosis,0
19414,depend,Unfavorable Non-Hodgkin Lymphoma,0
19415,Person 2,Metastatic Neoplasm to the Gallbladder,0
19416,Professional guide,Adenocarcinoma of duodenum,0
19417,Follow-Up Report,Familial Hemophagocytic Lymphocytosis,0
19418,Common Specifications in HL7 V3 Publishing,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19419,Swelling,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
19420,Easy bleeding,Giant cell angiofibroma,0
19421,Case unit dose,Locally Advanced Soft Tissue Sarcoma,0
19422,Building process,Benign tumor of eyelid,0
19423,Human Cells,Tongue Alveolar Soft Part Sarcoma,0
19424,95,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19425,Aggressive Non-Hodgkin Lymphoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19426,Collagen Type III,Adult Hepatocellular Carcinoma,0
19427,Malignant neoplasm of urinary bladder,Acute Undifferentiated Leukemia,0
19428,Exposure to Agent Orange,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
19429,Poly(ADP-ribose) Polymerases,Kaposi's sarcoma of extrahepatic bile duct,0
19430,Formation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19431,Case (situation),Breast Ductal Adenoma,0
19432,Treating,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
19433,Neoplasms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19434,brain shape,Intraepithelial Melanocytic Hyperplasia,0
19435,Egg of order Phthiraptera,Mucinous adenocarcinoma gastric,0
19436,TP53 protein,Adult Alveolar Soft Part Sarcoma,0
19437,Therapeutic procedure,Heavy Chain Deposition Disease,0
19438,Science of Morphology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
19439,Wall of lymphatic vessel,Acute Undifferentiated Leukemia,0
19440,Skin,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19441,body system,Extra-abdominal fibromatosis,0
19442,History of present illness,Blepharal carcinoma,0
19443,Palmitic Acid,Childhood Anaplastic Large Cell Lymphoma,0
19444,Most,Cerebral Primitive Neuroectodermal Tumor,0
19445,Enneking High Surgical Grade,Carcinoma of urinary bladder,0
19446,Twice (Numerical Qualifier),Advanced Uterine Corpus Carcinosarcoma,0
19447,Vagina Carcinoma,mucinous adenocarcinoma of gallbladder,0
19448,medication - HL7 publishing domain,Recurrent Testicular Lymphoma,0
19449,Treatment Epoch,Refractory Bladder Carcinoma,0
19450,Short,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
19451,Body structure,Undifferentiated Endocervical Sarcoma,0
19452,Diagnosis,Acinar cell carcinoma of pancreas,0
19453,include - SetOperator,Nasal cavity carcinoma,0
19454,Very Much,BRCA2 Syndrome,0
19455,Malignant Neoplasms,gliosarcoma,0
19456,Tryptophanase,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19457,Manufactured sign,Nasal cavity carcinoma,0
19458,Biomaterial Treatment,Recurrent Uveal Melanoma,0
19459,Cells,Toxic Epidermal Necrolysis,0
19460,Most,Benign Apocrine Neoplasm,0
19461,Blood Vessel,Splenic Manifestation of Hairy Cell Leukemia,0
19462,Cause of Death,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19463,General health,FIGO Stage II Ovarian Cancer,0
19464,Rating (action),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19465,Known,Noninfiltrating Intraductal Carcinoma,0
19466,Frequently,Cancer of Urinary Tract,0
19467,Biological Response Modifiers,Refractory Glioma,0
19468,True Control Status,Undifferentiated Endocervical Sarcoma,0
19469,Pelvic Pain,Malignant Neoplasm of Lung - Multiple Primary Sites,0
19470,Uncontrolled,Stage IB Pancreatic Cancer AJCC v8,0
19471,Angiofibroma,Engraftment syndrome,0
19472,Array Feature,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19473,exception - ResponseLevel,Mucinous adenocarcinoma gastric,0
19474,Artificial Airways,Nasal cavity carcinoma,0
19475,Cessation of life,Undifferentiated Endocervical Sarcoma,0
19476,Contrast,Benign Carotid Body Paraganglioma,0
19477,Coding,Uterine Cancer,0
19478,Offspring,Benign neoplasm of eye,0
19479,described,Colorectal High Grade B-Cell Lymphoma,0
19480,Chemotherapy,Acantholytic squamous cell carcinoma,0
19481,Pharmacotherapy,Intraepithelial Melanocytic Hyperplasia,0
19482,year,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
19483,GUCY2C protein,Ichthyosis,0
19484,Divide,Xeroderma pigmentosum,0
19485,Hereditary,Diffuse malignant mesothelioma,0
19486,First (number),Fibroadenoma of breast,0
19487,Lip structure,Nasal cavity carcinoma,0
19488,Make - Instruction Imperative,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19489,Pain,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19490,Cell Device,Anaplastic large cell lymphoma,0
19491,Result,Childhood Anaplastic Large Cell Lymphoma,0
19492,Human Cells,Peripheral primitive neuroectodermal tumor of soft tissue,0
19493,Primary malignant neoplasm of bladder,Childhood Anaplastic Large Cell Lymphoma,0
19494,Cavitation,Hereditary corneal dystrophy,0
19495,Usual,Basal Cell Ameloblastoma,0
19496,Complete Pharyngeal Contraction,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19497,Adult human body,Undifferentiated Endocervical Sarcoma,0
19498,therapeutic aspects,embryonal rhabdomyosarcoma of prostate,0
19499,Myeloid,Liver Lymphangioma,0
19500,One,Spongiotic dermatitis,0
19501,Hair follicle structure,Locally Advanced Epithelioid Hemangioendothelioma,0
19502,Africa,Refractory Bladder Carcinoma,0
19503,erbB-2 Receptor,embryonal rhabdomyosarcoma of prostate,0
19504,Primary operation,Pancreatic carcinoma,0
19505,CSNK1D wt Allele,Adult Acute Eosinophilic Leukemia,0
19506,Head - Component of Device,Squamous cell carcinoma of lip,0
19507,Bacteria,Anterior Urethral Malignant Neoplasm,0
19508,Known,clear cell adenocarcinoma of gallbladder,0
19509,Histopathologic Grade differentiation,Cervical Adenomyoma,0
19510,Complete excision,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19511,development aspects,Grade 1 Clear Cell Renal Cell Carcinoma,0
19512,Pain,Multiple Skull Base Meningiomas,0
19513,Lymphoid Tissue,Trabecular adenocarcinoma,0
19514,Tissue Specimen Code,Acantholytic squamous cell carcinoma,0
19515,cell type,Malignant Testicular Sertoli Cell Tumor,0
19516,Frequently,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19517,per year,Locally Advanced Soft Tissue Sarcoma,0
19518,Sequence Arm,Testicular cancer metastatic,0
19519,Name (property) (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
19520,Manufactured form,Recurrent Primary Lymphoma of Bone,0
19521,Front of neck,Human Papillomavirus-Related Carcinoma,0
19522,Intravascular line,Benign squamous cell tumor,0
19523,Pelvic cavity structure,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19524,Most,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19525,Interpretation:Impression/interpretation of study:Point in time:^Patient:Nominal,Malignant neoplasm of thalamus,0
19526,Childhood Burkitt Lymphoma,Fourth Ventricle and Brain Stem Ependymal Tumor,0
19527,Non-Small Cell Lung Carcinoma,Mixed astrocytoma-ependymoma,0
19528,Value Above Reference Range,Thymoma malignant recurrent,0
19529,Silicon Dioxide,Mucinous cystadenofibroma,0
19530,Firstly,Adenocarcinoma of duodenum,0
19531,Rating (action),Malignant neoplasm of choroid,0
19532,Right,Localized Ewing Sarcoma,0
19533,Research Activities,Urethral Carcinoma,0
19534,Progress,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
19535,Survival Rate,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19536,Glandular,embryonal rhabdomyosarcoma of prostate,0
19537,Congenital qualifier,Cartilaginous exostosis,0
19538,Offspring,Angiosarcoma of liver,0
19539,2+ Score,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19540,Vagina,Liver Lymphangioma,0
19541,year,Carcinoma of urinary bladder,0
19542,Decrease,Childhood Fibrillary Astrocytoma,0
19543,Metastatic Neoplasm,Gallbladder Adenocarcinoma,0
19544,Usually,Diffuse malignant mesothelioma,0
19545,Common (qualifier value),Bladder adenocarcinoma stage IV,0
19546,Before,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19547,Including (qualifier),Recurrent Primary Lymphoma of Bone,0
19548,Function (attribute),Clonal Hematopoiesis of Indeterminate Potential,0
19549,Including (qualifier),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
19550,Term Birth,Engraftment syndrome,0
19551,Referring,Transitional cell carcinoma,0
19552,Dietary Lead,Ampulla of Vater Tubular Adenoma,0
19553,Detected (finding),Benign neoplasm of eye,0
19554,Use of,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19555,therapeutic aspects,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19556,Progress,Tongue Alveolar Soft Part Sarcoma,0
19557,How Often Sweats,Benign Carotid Body Paraganglioma,0
19558,Offspring,Thyroid Hurthle Cell Carcinoma,0
19559,Child,Kaposi's sarcoma of extrahepatic bile duct,0
19560,Less Than,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19561,Neoplasms,Type II Endometrial Adenocarcinoma,0
19562,Malignant - descriptor,Nasal cavity carcinoma,0
19563,Squamous cell carcinoma,Childhood Central Nervous System Ganglioneuroblastoma,0
19564,Removing (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19565,Secondary Neoplasm,Human Papillomavirus-Related Carcinoma,0
19566,Aldosterone,Werner Syndrome,0
19567,Used by,Hereditary Diffuse Gastric Adenocarcinoma,0
19568,Abnormal Cell Count,Nasal cavity carcinoma,0
19569,Treatment Epoch,Benign Anal Granular Cell Tumor,0
19570,Reaching,Undifferentiated Endocervical Sarcoma,0
19571,Gene Mutation,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19572,Specialized Stand Alone Plan - Vision,Recurrent Testicular Lymphoma,0
19573,High Mitosis-Karyorrhexis Index,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19574,General health,Angiosarcoma of liver,0
19575,Usual,Digestive System Hodgkin Lymphoma,0
19576,lymph nodes,Hereditary corneal dystrophy,0
19577,Various patch test substance,squamous cell carcinoma of the thyroid gland,0
19578,Cancer Genus,Fourth Ventricle and Brain Stem Ependymal Tumor,0
19579,Pain,Stage III Cutaneous Melanoma AJCC v6,0
19580,Affecting,FIGO Stage IVA Ovarian Cancer,0
19581,Different,Refractory Ependymoma,0
19582,Malignant Childhood Neoplasm,Neonatal leukemia,0
19583,Statistical Prevalence,Stage I Colon Neuroendocrine Tumor AJCC v8,0
19584,Causing,Colorectal High Grade B-Cell Lymphoma,0
19585,Occurrence,Stage IV Colorectal Cancer AJCC v8,0
19586,Providing presence (regime/therapy),Anterior Urethral Malignant Neoplasm,0
19587,Possible,Giant cell angiofibroma,0
19588,Unintentional,Locally Advanced Squamous Cell Carcinoma,0
19589,Administration procedure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
19590,Common Specifications in HL7 V3 Publishing,Neonatal leukemia,0
19591,factor A,GIANT PIGMENTED HAIRY NEVUS,0
19592,More,Cerebral hemangioma,0
19593,Useful,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19594,Germ Cells,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
19595,Food allergenic extracts,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19596,Beginning,BRCA2 Syndrome,0
19597,Lymphoma,Hodgkin Disease,0
19598,Human Papilloma Virus Vaccine,Chest Wall Fibromatosis,0
19599,Delta (difference),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
19600,Tests (qualifier value),Ovarian germ cell choriocarcinoma stage IV,0
19601,Childhood Embryonal Rhabdomyosarcoma,Cancer of Urinary Tract,0
19602,Hemorrhage,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19603,Clear,Low Grade Squamous Intraepithelial Neoplasia,0
19604,Symptoms aspect,Blepharal carcinoma,0
19605,Common Specifications in HL7 V3 Publishing,Occult Lung Adenosquamous Carcinoma,0
19606,factor A,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19607,Abnormal degeneration,sarcoma of spinal cord,0
19608,Result,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19609,Smell Perception,Undifferentiated Endocervical Sarcoma,0
19610,Swelling,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19611,Assisted (qualifier value),Primary Cutaneous Plasmablastic Lymphoma,0
19612,status - In progress,Splenic Manifestation of Hairy Cell Leukemia,0
19613,Oropharyngeal,Mixed astrocytoma-ependymoma,0
19614,Cell Count,Precursor B-lymphoblastic lymphoma stage II,0
19615,Rating (action),Nasal cavity carcinoma,0
19616,Benign melanocytic nevus,Recurrent Testicular Lymphoma,0
19617,Malignant neoplasm of thyroid,non-Hodgkin's lymphoma of spleen,0
19618,High Level,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19619,Pleomorphic carcinoma,Kaposi's sarcoma of skin,0
19620,Carcinoma of lung,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19621,day,Vaginal Adenoma,0
19622,Compressing (action),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19623,Leukocytes,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19624,Process,Secondary malignant neoplasm of lymph node,0
19625,Aspects of signs,Brain Tumor,0
19626,Including (qualifier),Engraftment syndrome,0
19627,Pharmacotherapy,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
19628,Times,Malignant neoplasm of subglottis,0
19629,Personal appearance,Non-Metastatic Gestational Trophoblastic Tumor,0
19630,Enlargement procedure,Benign Carotid Body Paraganglioma,0
19631,Immune system,BRCA2 Syndrome,0
19632,Form:Finding:Point in time:{Setting}:Document:{Role},High Grade Glandular Intraepithelial Neoplasia,0
19633,MUTYH gene,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19634,Blood Vessel,Metaplastic carcinoma of breast,0
19635,Malignant Childhood Neoplasm,Stage IV Penile Cancer AJCC v7,0
19636,Cell secretion,Neonatal leukemia,0
19637,Traumatic injury,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19638,Measurement,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19639,Cancer Remission,Adult Hepatocellular Carcinoma,0
19640,Presumed,ROSE Cluster 3,0
19641,Rare,embryonal rhabdomyosarcoma of prostate,0
19642,Cancer Genus,benign mature teratoma of pancreas,0
19643,Science of Etiology,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19644,Abdominal Distension,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19645,Smudge Cell Count,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19646,Glycoproteins,Acantholytic squamous cell carcinoma,0
19647,40%,Localized Ewing Sarcoma,0
19648,Differentiation,Cancer of Urinary Tract,0
19649,Targeted Therapy,Recurrent Primary Lymphoma of Bone,0
19650,Left,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19651,Reported Term,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19652,chapter,Adult Alveolar Soft Part Sarcoma,0
19653,To,Ectomesenchymal Chondromyxoid Tumor,0
19654,Geographic Locations,Malignant Neoplasm of Lung - Multiple Primary Sites,0
19655,Name (property) (qualifier value),Chest Wall Fibromatosis,0
19656,Specific qualifier value,Intraepithelial Melanocytic Hyperplasia,0
19657,Pediculus humanus capitis (eukaryote),Thymoma malignant recurrent,0
19658,Thrombocythemia,Stage III Cutaneous Melanoma AJCC v6,0
19659,Disseminated,Spongiotic dermatitis,0
19660,Both ovaries,Choroid Necrotic Melanoma,0
19661,Form:Finding:Point in time:{Setting}:Document:{Role},clear cell adenocarcinoma of gallbladder,0
19662,Obesity,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19663,Subtype (attribute),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19664,Partial,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19665,Binding (Molecular Function),Cervical Fibroepithelial Polyp,0
19666,High risk of,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19667,Anatomic Site,Non-Metastatic Gestational Trophoblastic Tumor,0
19668,Offspring,Clonal Hematopoiesis of Indeterminate Potential,0
19669,Surgical aspects,Human Papillomavirus-Related Carcinoma,0
19670,Slightly Agree,Colorectal High Grade B-Cell Lymphoma,0
19671,overview,Splenic Manifestation of Hairy Cell Leukemia,0
19672,Carcinoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19673,Direct type of relationship,Cherubism,0
19674,Severe (severity modifier),Non-Metastatic Gestational Trophoblastic Tumor,0
19675,Bone pain,Granular Cell Leiomyosarcoma,0
19676,Science of Etiology,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
19677,Analysis,Adrenal Rest Tumor,0
19678,Part,Metastatic Lung Neuroendocrine Neoplasm,0
19679,Neoplasms,Liver Lymphangioma,0
19680,various other nasal preparations in ATC,Chest Wall Fibromatosis,0
19681,Type - attribute,Acute Undifferentiated Leukemia,0
19682,therapeutic aspects,Malignant neoplasm of thalamus,0
19683,Cystadenoma,Primary Cutaneous Plasmablastic Lymphoma,0
19684,Time (foundation metadata concept),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19685,Case Study,Intraepithelial Melanocytic Hyperplasia,0
19686,Type - attribute,Chest Wall Fibromatosis,0
19687,Cervical lymph node group,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19688,Therapeutic radiology procedure,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
19689,Major,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
19690,Table Cell Horizontal Align - left,Refractory Barrett Esophagus,0
19691,Bladder Neoplasm,Childhood Thyroid Gland Follicular Carcinoma,0
19692,Vaginal,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19693,Smoking,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19694,Two,Trichilemmocarcinoma,0
19695,Reported Term,Serous cystadenocarcinoma ovary,0
19696,Diagnosis Study,embryonal rhabdomyosarcoma of prostate,0
19697,Abdomen,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
19698,Secondary to,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
19699,Stratified squamous epithelium,Placental aromatase deficiency,0
19700,Administration procedure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
19701,Obesity,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19702,Upper gastrointestinal tract series,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19703,disease transmission,Thyroid Hurthle Cell Carcinoma,0
19704,Location,Thyroid Hurthle Cell Carcinoma,0
19705,Epithelial ovarian cancer,Hodgkin Disease,0
19706,Cancer Genus,Familial Adenomatous Polyposis Associated Medulloblastoma,0
19707,SLC6A2 protein,Childhood Lung Non-Small Cell Carcinoma,0
19708,PSA Level Less than Two,Pilocytic astrocytoma of cerebellum,0
19709,Occur (action),Malignant neoplasm of subglottis,0
19710,Weight Loss,Bladder squamous cell carcinoma stage I,0
19711,80%,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19712,Limb structure,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
19713,Sarcoma - category (morphologic abnormality),Acute lymphadenitis,0
19714,First sign,Lung squamous cell carcinoma stage I,0
19715,Lymphocyte component of blood,Digestive System Hodgkin Lymphoma,0
19716,Dietary Lead,Lipoma of small intestine,0
19717,Term Birth,Digestive System Hodgkin Lymphoma,0
19718,Surgery specialty,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
19719,High risk,Mastocytosis,0
19720,gene therapy,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19721,Make - Instruction Imperative,Acantholytic squamous cell carcinoma,0
19722,Beginning,gliosarcoma,0
19723,Generic Role,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19724,white blood cell type,Refractory Barrett Esophagus,0
19725,Symptoms,Adult Hepatocellular Carcinoma,0
19726,Treatment Epoch,Splenic Manifestation of Hairy Cell Leukemia,0
19727,Healed,Stage IB Pancreatic Cancer AJCC v8,0
19728,Possible diagnosis,Xeroderma pigmentosum,0
19729,Vaginal Hemorrhage,Tubal Hyperplasia,0
19730,Bronchi,Carcinomatosis of peritoneal cavity,0
19731,Therapeutic procedure,Childhood Central Nervous System Immature Teratoma,0
19732,Singular,Benign Carotid Body Paraganglioma,0
19733,Greatly,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
19734,Only - dosing instruction fragment,Adrenal Rest Tumor,0
19735,Including (qualifier),Testicular cancer metastatic,0
19736,Experimental Result,Mucinous adenocarcinoma gastric,0
19737,Science of Etiology,Methotrexate-Associated Hodgkin Lymphoma,0
19738,Symptoms aspect,Liver Lymphangioma,0
19739,High,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19740,diagnosis aspect,Recurrent Uveal Melanoma,0
19741,Related personal status,mucinous adenocarcinoma of gallbladder,0
19742,Microplate Well,gliosarcoma,0
19743,Togo,Female Breast Carcinoma,0
19744,Involvement with,Cervical Fibroepithelial Polyp,0
19745,Infection caused by Helicobacter pylori,Thyroid Hurthle Cell Carcinoma,0
19746,Occur (action),Adult Anaplastic Oligodendroglioma,0
19747,Basal Cell Carcinoma Pathway,Primary Cutaneous Plasmablastic Lymphoma,0
19748,Closed,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19749,Call (Instruction),Stage III Cutaneous Melanoma AJCC v6,0
19750,Organ,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19751,Abnormal cell,embryonal rhabdomyosarcoma of prostate,0
19752,epithelial,Engraftment syndrome,0
19753,Common Specifications in HL7 V3 Publishing,Adult Acute Eosinophilic Leukemia,0
19754,Follicular,Extra-abdominal fibromatosis,0
19755,What subject filter - Result,Rhabdomyosarcoma with ganglionic differentiation,0
19756,Incised wound,Occult Lung Adenosquamous Carcinoma,0
19757,Rapid,Colorectal High Grade B-Cell Lymphoma,0
19758,Referral placed,Chest Wall Fibromatosis,0
19759,% of total,Adult Hepatocellular Carcinoma,0
19760,Intestines,Advanced Lung Carcinoma,0
19761,Social group,Human Papillomavirus-Related Carcinoma,0
19762,Hypertensive disease,Fourth Ventricle and Brain Stem Ependymal Tumor,0
19763,Statistical Prevalence,Congenital hamartoma,0
19764,Chemotherapy Regimen,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
19765,Abnormally high,Grade 3a Malignant Neoplasm,0
19766,Non-Clinical Gestation Trial Phase,Locally Advanced Soft Tissue Sarcoma,0
19767,Malignant Neoplasms,Kaposi's sarcoma of extrahepatic bile duct,0
19768,Individual,Cartilaginous exostosis,0
19769,Aspects of signs,Xeroderma pigmentosum,0
19770,Occurrence Indicator,Cervical Adenomyoma,0
19771,pharmacotherapeutic,Splenic Manifestation of Hairy Cell Leukemia,0
19772,Related personal status,Gallbladder Adenocarcinoma,0
19773,Decision,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19774,Pharmaceutical Preparations,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19775,Neuroendocrine Tumors,Metaplastic carcinoma of breast,0
19776,Gland,Diffuse malignant mesothelioma,0
19777,Percent of Abnormal Cells,Childhood Central Nervous System Ganglioneuroblastoma,0
19778,Etiology aspects,Benign squamous cell tumor,0
19779,Death NOS,Benign neoplasm of thorax,0
19780,Categories,Childhood Central Nervous System Ganglioneuroblastoma,0
19781,Primary,Mucinous adenocarcinoma gastric,0
19782,Central Nervous System,Basal Cell Ameloblastoma,0
19783,Age,Recurrent Testicular Lymphoma,0
19784,Sunscreening Agents,Placental aromatase deficiency,0
19785,Options,Cancer of Urinary Tract,0
19786,View Tunnel,Refractory Ependymoma,0
19787,Symptoms,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
19788,Part Dosing Unit,Lipoma of small intestine,0
19789,Coding,FIGO Stage IVA Ovarian Cancer,0
19790,Eating,Adult Alveolar Soft Part Sarcoma,0
19791,Including (qualifier),Spindle Cell Melanoma,0
19792,Intraepithelial Neoplasia,Malignant neoplasm of gallbladder,0
19793,Area,Hemangioma,0
19794,Retinoic Acid Response Element,BRCA2 Syndrome,0
19795,Testis,Metaplastic carcinoma of breast,0
19796,Common (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
19797,Various patch test substance,Xeroderma pigmentosum,0
19798,Medulla Oblongata,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
19799,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Stage IV Childhood Non-Hodgkin Lymphoma,0
19800,Renal Cell Carcinoma,Malignant neoplasm of subglottis,0
19801,Coding,Testicular cancer metastatic,0
19802,Selenite,Localized Askin Tumor,0
19803,Cure (remedy),Melanomatosis,0
19804,Low Mitosis-Karyorrhexis Index,Diffuse malignant mesothelioma,0
19805,Common (qualifier value),ROSE Cluster 3,0
19806,Antibiotics,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
19807,Affecting,Funisitis (disorder),0
19808,Trauma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19809,status - In progress,Acantholytic squamous cell carcinoma,0
19810,Red blood cells,Neonatal leukemia,0
19811,Valid,Fibroadenoma of breast,0
19812,Life Expectancy Less than Five Years,Kaposi's sarcoma of extrahepatic bile duct,0
19813,Hereditary,Medulloblastoma,0
19814,Have Weight Loss,Childhood Fibrillary Astrocytoma,0
19815,Body structure,Papillary squamous cell carcinoma,0
19816,Reduced,mucinous adenocarcinoma of gallbladder,0
19817,Diagnosis Study,Recurrent Uveal Melanoma,0
19818,Cells,Leptomeningeal sarcoma,0
19819,Net (qualifier),Malignant Neoplasm of Lung - Multiple Primary Sites,0
19820,Tryptophanase,Tonsillar Carcinoma,0
19821,Female of child bearing age,Necrotizing Funisitis,0
19822,PSA Level Less than Two,Nasal cavity carcinoma,0
19823,Response process,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
19824,Patient Reported Outcome Stem,Peripheral primitive neuroectodermal tumor of soft tissue,0
19825,First (number),Spongiotic dermatitis,0
19826,Include (action),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
19827,Anatomic Site,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
19828,Groups,squamous cell carcinoma of the thyroid gland,0
19829,Immunotherapy,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19830,suggestion,Mucinous adenocarcinoma gastric,0
19831,Common (qualifier value),Metaplastic carcinoma of breast,0
19832,Biospecimen,Astrocytoma of brain,0
19833,Acute leukemia,Intraepithelial Melanocytic Hyperplasia,0
19834,Clothing,Childhood Lymphoma,0
19835,Leukemic Cells Measurement,embryonal rhabdomyosarcoma of prostate,0
19836,Singular,FIGO Stage IVA Ovarian Cancer,0
19837,Mass of body region,Collecting Duct Carcinoma of the Kidney,0
19838,section sample,Chondrosarcoma,0
19839,Discover,FIGO Stage II Ovarian Cancer,0
19840,Botswana,Intestinal Metaplasia of Bladder Urothelium,0
19841,Percent normal,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
19842,Dysuria,Melanomatosis,0
19843,Primary malignant neoplasm,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
19844,Pharmaceutical Preparations,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19845,Science of Etiology,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19846,Etiology aspects,Lung squamous cell carcinoma stage I,0
19847,United States,Blood Vessel Tumors,0
19848,Enzyme (disposition),Small Intestinal Villous Adenoma,0
19849,Rare,Non-Metastatic Gestational Trophoblastic Tumor,0
19850,Qualitative form,Carcinoma,0
19851,Biological Response Modifiers,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
19852,Spreading (qualifier value),Malignant melanoma of eyelid,0
19853,Covers (device),Bladder adenocarcinoma stage IV,0
19854,Death (finding),Metastatic Kidney Carcinoma,0
19855,Malignant Neoplasms,Hemangioma,0
19856,Pharmacotherapy,Astrocytoma of brain,0
19857,Benign Neoplasm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19858,Squamous cell carcinoma,Maxillary Sinus Adenocarcinoma,0
19859,Primary malignant neoplasm,benign mature teratoma of pancreas,0
19860,Including (qualifier),Diffuse malignant mesothelioma,0
19861,85,Childhood Thyroid Gland Follicular Carcinoma,0
19862,Congenital Abnormality,Small Intestinal Villous Adenoma,0
19863,Burkina Faso,Maxillary Sinus Adenoid Cystic Carcinoma,0
19864,Persons,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19865,Disease,Advanced Uterine Corpus Carcinosarcoma,0
19866,Person Name,Blood Vessel Tumors,0
19867,Tobacco smoking behavior,Neoplasms,0
19868,Tail,Medulloblastoma,0
19869,Case (situation),Malignant Neoplasm with Regional Lymph Node Involvement,0
19870,Frequently,Splenic Manifestation of Hairy Cell Leukemia,0
19871,Ultraviolet Light Sterilization,Clonal Hematopoiesis of Indeterminate Potential,0
19872,therapeutic aspects,Benign neoplasm of eye,0
19873,high - ActExposureLevelCode,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
19874,3+ Answer to Question,embryonal rhabdomyosarcoma of prostate,0
19875,Low Level,Malignant Neoplasm with Regional Lymph Node Involvement,0
19876,Major,Mucinous neoplasm,0
19877,Patient observation,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19878,Occurrence Indicator,de novo Myelodysplastic Syndrome,0
19879,newly,Benign neoplasm of eye,0
19880,Death NOS,Refractory Bladder Carcinoma,0
19881,Etiology aspects,Grade 3a Malignant Neoplasm,0
19882,Common Specifications in HL7 V3 Publishing,Benign Carotid Body Paraganglioma,0
19883,Rating (action),Extra-abdominal fibromatosis,0
19884,Common Specifications in HL7 V3 Publishing,Bladder Neuroendocrine Neoplasm,0
19885,combination of objects,Adult Fibrolamellar Carcinoma,0
19886,Case unit dose,Localized Malignant Neoplasm,0
19887,Central Nervous System,Deep Leiomyoma,0
19888,Dysgerminoma,Undifferentiated Endocervical Sarcoma,0
19889,Skin cell,Gallbladder Adenocarcinoma,0
19890,Common (qualifier value),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
19891,Including (qualifier),Refractory Ependymoma,0
19892,cervical cancer,Anaplastic large cell lymphoma,0
19893,Night sweats,Malignant melanoma of eyelid,0
19894,Main,Cervical Squamous Intraepithelial Neoplasia,0
19895,Critical,Metastatic Lung Small Cell Carcinoma,0
19896,Mucosal Melanoma,Malignant neoplasm of subglottis,0
19897,White color,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
19898,Myeloid Cells,Cervical Squamous Intraepithelial Neoplasia,0
19899,Adult Burkitt Lymphoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19900,Adult Lymphoma,Uterine Cancer,0
19901,Impaired skin integrity,Anaplastic large cell lymphoma,0
19902,Telephone Extension Number,Parathyroid Gland Adenocarcinoma,0
19903,Notable,Human Papillomavirus-Related Carcinoma,0
19904,various other agents for local oral treatment in ATC,Human Papillomavirus-Related Carcinoma,0
19905,Antidepressant Measurement,Mucinous neoplasm,0
19906,Management procedure,Intraepithelial Melanocytic Hyperplasia,0
19907,Feelings,Granular Cell Leiomyosarcoma,0
19908,Frequently,Benign Anal Granular Cell Tumor,0
19909,AKR1A1 wt Allele,Xeroderma pigmentosum,0
19910,Classification of information,Plexosarcoma,0
19911,Gland,Stage IB Pancreatic Cancer AJCC v8,0
19912,Call (Instruction),Chronic Myelomonocytic Leukemia-2,0
19913,Surface of skin,Brain Tumor,0
19914,Operative Surgical Procedures,Digestive System Hodgkin Lymphoma,0
19915,Body tissue,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19916,Others - Allergy,Childhood Cerebellar Neoplasm,0
19917,Rapid,Trichilemmocarcinoma,0
19918,American College of Cardiology/American Heart Association Lesion Complexity Score C,Botryoid-Type Embryonal Rhabdomyosarcoma,0
19919,Symptoms,Benign Anal Granular Cell Tumor,0
19920,Surgery specialty,Cancer of Urinary Tract,0
19921,History of previous events,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
19922,various antiinfectives and antiseptics for local oral treatment,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19923,Measurement,Benign squamous cell tumor,0
19924,high - ActExposureLevelCode,Lung squamous cell carcinoma stage I,0
19925,Only - dosing instruction fragment,Recurrent Testicular Lymphoma,0
19926,Tumor site,Localized Askin Tumor,0
19927,Legal Adult,Endometrial Small Cell Carcinoma,0
19928,Surgical Replantation,Xeroderma pigmentosum,0
19929,Damage,Undifferentiated Endocervical Sarcoma,0
19930,Gram per Deciliter,Stage IV Colorectal Cancer AJCC v8,0
19931,BRCA2 protein,Splenic Manifestation of Hairy Cell Leukemia,0
19932,Often - answer to question,Non-Metastatic Gestational Trophoblastic Tumor,0
19933,Exostosis,Papillary squamous cell carcinoma,0
19934,Diagnosis Study,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
19935,Dental caries,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
19936,shared attribute,Bladder adenocarcinoma stage IV,0
19937,Heterogeneity,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19938,Tumor Mass,Parathyroid Gland Adenocarcinoma,0
19939,United States Military Commissioned Officer O4,Blepharal carcinoma,0
19940,Include (action),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19941,2+,Neonatal leukemia,0
19942,Werner Syndrome,Malignant Testicular Sertoli Cell Tumor,0
19943,Vagina,FIGO Stage II Ovarian Cancer,0
19944,Infection of bone,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
19945,include - SetOperator,Gallbladder adenoma,0
19946,Present,Leptomeningeal sarcoma,0
19947,Image Feature,Primary Cutaneous Plasmablastic Lymphoma,0
19948,Known,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
19949,Occurrence Indicator,Airway Hemangioma,0
19950,Biopsy,Cervical Fibroepithelial Polyp,0
19951,High,non-Hodgkin's lymphoma of spleen,0
19952,SLC6A2 wt Allele,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
19953,Consequence of,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
19954,Reporting,benign mature teratoma of pancreas,0
19955,Classification of information,Liver Lymphangioma,0
19956,Benign,Atypical Lobular Breast Hyperplasia,0
19957,Acute leukemia,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
19958,TARSAL-CARPAL COALITION SYNDROME,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
19959,The Sun,Chest Wall Fibromatosis,0
19960,Patient need for (contextual qualifier),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
19961,Mucous body substance,Bladder squamous cell carcinoma stage I,0
19962,Five-year Survival Rate,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
19963,Abundance,Pancreatic Intraepithelial Neoplasia-3,0
19964,Complication Aspects,Stage IV Childhood Non-Hodgkin Lymphoma,0
19965,Cancer Genus,Xeroderma pigmentosum,0
19966,biopsy characteristics,FIGO Stage II Ovarian Cancer,0
19967,North America,FIGO Stage II Ovarian Cancer,0
19968,Varies,FIGO Stage IVA Ovarian Cancer,0
19969,newly,Endometrial Small Cell Carcinoma,0
19970,Dietary Factors,Peripheral primitive neuroectodermal tumor of soft tissue,0
19971,Pelvic Pain,Squamous cell carcinoma of lip,0
19972,radiotherapeutic,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
19973,Togo,Liver Lymphangioma,0
19974,Descent,Type II Endometrial Adenocarcinoma,0
19975,Etiology aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
19976,Deletion Mutation,Cystadenocarcinoma,0
19977,Malignant Neoplasms,Cerebral Primitive Neuroectodermal Tumor,0
19978,Histology,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19979,Neuroendocrine Tumors,Cervical Fibroepithelial Polyp,0
19980,Skin lesion,Childhood Anaplastic Large Cell Lymphoma,0
19981,Tumor cells,Non-Hodgkin Lymphoma During Pregnancy,0
19982,Platelet Glycoprotein 4,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
19983,Social Role,Thymoma malignant recurrent,0
19984,therapeutic aspects,Colorectal Neuroendocrine Tumor G2,0
19985,Hereditary Nonpolyposis Colorectal Cancer,Ovarian Dermoid Cyst with Secondary Carcinoma,0
19986,Rating (action),Human Papillomavirus-Related Carcinoma,0
19987,Related personal status,Benign neoplasm of thorax,0
19988,Cells,Adult Hepatocellular Carcinoma,0
19989,Cancer Genus,Low Grade Squamous Intraepithelial Neoplasia,0
19990,Sweating,Childhood Fibrillary Astrocytoma,0
19991,>90,Chronic Myelomonocytic Leukemia-2,0
19992,Highest,Fibroadenoma of breast,0
19993,Type - attribute,Ichthyosis,0
19994,Choriocarcinoma,ICHTHYOSIS,0
19995,Lymphocyte component of blood,FIGO Stage IVA Ovarian Cancer,0
19996,Different,Childhood Anaplastic Large Cell Lymphoma,0
19997,Ependyma,Airway Hemangioma,0
19998,Grade three rank,Metastatic Lung Small Cell Carcinoma,0
19999,Fever,Leptomeningeal sarcoma,0
20000,Vaginal Sarcoma,Acute Undifferentiated Leukemia,0
20001,Malignant Neoplasms,Cervical Squamous Intraepithelial Neoplasia,0
20002,Cells,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
20003,Occur (action),Thyroid Hurthle Cell Carcinoma,0
20004,Cells,Bladder squamous cell carcinoma stage I,0
20005,Negative Surgical Margin,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20006,Usually Need Help from Another Person for Reach,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20007,Occur (action),Spongiotic dermatitis,0
20008,Net (qualifier),Carcinoma of urinary bladder,0
20009,Receive,Refractory WHO Grade III Glioma,0
20010,intrathecal chemotherapy,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
20011,Category Type,Stage I Adult Non-Hodgkin Lymphoma,0
20012,Biomaterial Treatment,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
20013,Common Specifications in HL7 V3 Publishing,Childhood Central Nervous System Ganglioneuroblastoma,0
20014,Severe (severity modifier),Pancreatic carcinoma,0
20015,Causing,Fibroadenoma of breast,0
20016,Operative Surgical Procedures,Breast Ductal Adenoma,0
20017,Similarity,Recurrent Uveal Melanoma,0
20018,North America,Recurrent Uveal Melanoma,0
20019,Chest,Testicular cancer metastatic,0
20020,CEL gene,Low Grade Squamous Intraepithelial Neoplasia,0
20021,Usual,BRCA2 Syndrome,0
20022,size,Benign Anal Granular Cell Tumor,0
20023,Manifestation of,Kaposi's sarcoma of extrahepatic bile duct,0
20024,Vaginal wall,Breast Ductal Adenoma,0
20025,% volume (qualifier value),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20026,Lymphocyte component of blood,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20027,Subgroup A Nepoviruses,Congenital hamartoma,0
20028,Combined,Basal Cell Ameloblastoma,0
20029,Neoplasms,Giant cell angiofibroma,0
20030,include - SetOperator,Kaposi's sarcoma of extrahepatic bile duct,0
20031,Canis familiaris,Carcinomatosis of peritoneal cavity,0
20032,Crystal - human material,Undifferentiated Neuroblastoma,0
20033,In Blood,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20034,Malignant neoplasm of skin,Stage I Adult Non-Hodgkin Lymphoma,0
20035,Main,Cervical Squamous Intraepithelial Neoplasia,0
20036,Exposure to radiation,Colorectal High Grade B-Cell Lymphoma,0
20037,Chemotherapy,Metastatic Lung Small Cell Carcinoma,0
20038,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Carcinomatosis of peritoneal cavity,0
20039,Benign,Choroid Epithelioid Cell Melanoma,0
20040,Cancer Genus,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
20041,Tissue Specimen Code,Stage IV Childhood Non-Hodgkin Lymphoma,0
20042,ultrasound device,Congenital hamartoma,0
20043,Structure of ciliary ganglion,Familial Adenomatous Polyposis Associated Medulloblastoma,0
20044,Primary,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20045,Childhood Lymphoma,Childhood Anaplastic Large Cell Lymphoma,0
20046,Due to,Metastatic Lung Small Cell Carcinoma,0
20047,Two,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20048,Cancer,Stage III Adult Immunoblastic Lymphoma,0
20049,Study Site,benign mature teratoma of pancreas,0
20050,Night sweats,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
20051,Flank Pain,Mucinous adenocarcinoma gastric,0
20052,cell growth,ALK positive large B-cell lymphoma,0
20053,Elderly (population group),Bladder adenocarcinoma stage IV,0
20054,Associated topography,Childhood Choriocarcinoma,0
20055,Largest,Human Papillomavirus-Related Carcinoma,0
20056,Childhood Myelodysplastic Syndrome,Benign Apocrine Neoplasm,0
20057,Degree Unit of Plane Angle,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
20058,Human papilloma virus infection,Angiosarcoma of liver,0
20059,risk factors - observation list,FIGO Stage II Ovarian Cancer,0
20060,Tissue Specimen Code,Adult Anaplastic Oligodendroglioma,0
20061,Etiology aspects,Atypical Mesothelial Hyperplasia,0
20062,Decreasing,Benign neoplasm of eye,0
20063,Widening,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
20064,Involvement with,Childhood Lung Non-Small Cell Carcinoma,0
20065,Spinal Cord,Stage III Cutaneous Melanoma AJCC v6,0
20066,Female Reproductive System,Grade 3a Malignant Neoplasm,0
20067,Biological Transport,Refractory Bladder Carcinoma,0
20068,Neck,Bladder Neuroendocrine Neoplasm,0
20069,Primary malignant neoplasm,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20070,Occurrence Indicator,Localized Askin Tumor,0
20071,Treating,Refractory Bladder Carcinoma,0
20072,Flushing,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20073,One,Pilocytic astrocytoma of cerebellum,0
20074,Unconscious State,Central Nervous System Yolk Sac Tumor,0
20075,Males,Occult Lung Adenosquamous Carcinoma,0
20076,Metabolic Syndrome X,Adult Hepatocellular Carcinoma,0
20077,Mild (qualifier value),Nasal cavity carcinoma,0
20078,Astrocytes,Primary Cutaneous Plasmablastic Lymphoma,0
20079,Management Occupations,Primary Cutaneous Plasmablastic Lymphoma,0
20080,Body part,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20081,Array Feature,Medulloblastoma,0
20082,Forecast of outcome,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20083,Component object,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20084,PSA Level Less than Two,Cerebral hemangioma,0
20085,Bone Marrow,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20086,Low Back Pain,Acute Undifferentiated Leukemia,0
20087,Platelet Glycoprotein 4,Pancreatic Intraepithelial Neoplasia-3,0
20088,Spreading (qualifier value),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20089,Human papillomavirus 16,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
20090,Neonatal (qualifier value),Thymic Clear Cell Carcinoma,0
20091,Adult Ependymoma,Contact dermatitis due to alkali,0
20092,Third revision,Brain Tumor,0
20093,Progress,Benign squamous cell tumor,0
20094,Shapes,Engraftment syndrome,0
20095,Set of short ciliary nerves,Benign squamous cell tumor,0
20096,Usual,Familial Hemophagocytic Lymphocytosis,0
20097,Eyelid structure,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20098,Two,Precursor B-lymphoblastic lymphoma stage II,0
20099,Carcinoma of lung,Non-Hodgkin Lymphoma During Pregnancy,0
20100,human AVP protein,Small intestine carcinoma,0
20101,Irritation,Benign Anal Granular Cell Tumor,0
20102,In Blood,Atypical Mesothelial Hyperplasia,0
20103,Heart,Ovarian germ cell choriocarcinoma stage IV,0
20104,Symptoms,BRCA2 Syndrome,0
20105,Immune System Processes,Adult Acute Eosinophilic Leukemia,0
20106,Order (document),Stage 0 Penile Cancer AJCC v8,0
20107,Therapeutic procedure,Sarcomatoid Renal Cell Carcinoma,0
20108,Singular,sarcoma of spinal cord,0
20109,Multiple Myeloma,Precursor B-lymphoblastic lymphoma stage II,0
20110,2+ Score,Lung squamous cell carcinoma stage I,0
20111,Frequently,Refractory Ependymoma,0
20112,Mutation,Endometrial Small Cell Carcinoma,0
20113,Referring,Kaposi's sarcoma of skin,0
20114,Elderly (population group),Chronic Myelomonocytic Leukemia-2,0
20115,Pain control,Extra-abdominal fibromatosis,0
20116,Mental concentration,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20117,Five,Unresectable Rhabdomyosarcoma,0
20118,Menopause,embryonal rhabdomyosarcoma of prostate,0
20119,shared attribute,Chest Wall Fibromatosis,0
20120,Cancer Genus,embryonal rhabdomyosarcoma of prostate,0
20121,data type - ratio,Bladder squamous cell carcinoma stage I,0
20122,Very,Extra-Adrenal Paraganglioma,0
20123,Mathematical Factor,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20124,Result,Mucinous cystadenofibroma,0
20125,stage,Periosteal Osteosarcoma,0
20126,Tissue damage,benign mature teratoma of pancreas,0
20127,Laser plant,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20128,Carcinoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20129,Specimen Source Codes - Lesion,Benign neoplasm of eye,0
20130,Diffuse Large B-Cell Lymphoma,Acantholytic squamous cell carcinoma,0
20131,Seizures,Breast Apocrine Adenoma,0
20132,Progress,Hereditary corneal dystrophy,0
20133,ovarian,Clonal Hematopoiesis of Indeterminate Potential,0
20134,1000000,Cerebral Primitive Neuroectodermal Tumor,0
20135,Less Than,Astrocytoma of brain,0
20136,West (direction),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20137,Age-Years,Undifferentiated Neuroblastoma,0
20138,Exposure to,Vaginal Adenoma,0
20139,*Type - Kind of quantity,Anterior Urethral Malignant Neoplasm,0
20140,Debris,Cervical Adenomyoma,0
20141,Spreading (qualifier value),Refractory Bladder Carcinoma,0
20142,Connect,Benign squamous cell tumor,0
20143,Common (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
20144,Low Mitosis-Karyorrhexis Index,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20145,Skin,Malignant Testicular Sertoli Cell Tumor,0
20146,Tumor Mass,Stage III Adult Immunoblastic Lymphoma,0
20147,Common Specifications in HL7 V3 Publishing,adenosquamous carcinoma of breast,0
20148,Chemotherapy Regimen,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
20149,Treatment Epoch,Stage 0 Lip Carcinoma,0
20150,melanoma,Anaplastic large cell lymphoma,0
20151,Occur (action),papillary carcinoma of penis,0
20152,peripheral blood,Kaposi's sarcoma of extrahepatic bile duct,0
20153,Beginning,Cancer of Urinary Tract,0
20154,Affect (mental function),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
20155,Usually Need Help from Another Person for Reach,Acute Undifferentiated Leukemia,0
20156,>90,Unfavorable Non-Hodgkin Lymphoma,0
20157,Affecting,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20158,Reproduction,Keratoderma,0
20159,Spreading (qualifier value),Localized Malignant Neoplasm,0
20160,Page (document),Unfavorable Non-Hodgkin Lymphoma,0
20161,Leading,Mucinous adenocarcinoma,0
20162,Greater,Cerebral Primitive Neuroectodermal Tumor,0
20163,GUCY2C wt Allele,Colorectal cancer,0
20164,International Aspects,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20165,Daily,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20166,PDGFRB gene,Locally Advanced Squamous Cell Carcinoma,0
20167,Compressed structure,Leiomyoma of Gallbladder,0
20168,75,Grade 3a Malignant Neoplasm,0
20169,Complication,Type II Endometrial Adenocarcinoma,0
20170,Urine,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20171,Blood Vessel,Spermatocytic seminoma,0
20172,year,Adrenal Rest Tumor,0
20173,Birthmark,Small intestine carcinoma,0
20174,Cell Count,Cancer of Urinary Tract,0
20175,Glycation End Products,Undifferentiated Endocervical Sarcoma,0
20176,Portion of urine,Diffuse malignant mesothelioma,0
20177,Cervical dysplasia,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20178,Low Back Pain,Thyroid Hurthle Cell Carcinoma,0
20179,Brain,Transitional cell carcinoma,0
20180,First (number),Squamous cell carcinoma of lip,0
20181,Including (qualifier),Clinical Stage I Cutaneous Melanoma AJCC v8,0
20182,Infrequent,Carcinoma of urinary bladder,0
20183,Overall Publication Type,Recurrent Primary Lymphoma of Bone,0
20184,Treating,Endometrial Small Cell Carcinoma,0
20185,Adult human body,Mixed parotid tumor,0
20186,Blood,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20187,Tanning of leather,Thyroid Hurthle Cell Carcinoma,0
20188,Malignant Neoplasms,Undifferentiated Endocervical Sarcoma,0
20189,Infrequent,Pancreatic Intraepithelial Neoplasia-3,0
20190,Mass,Astrocytoma of brain,0
20191,84,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20192,Risk,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20193,<50,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20194,Senile Plaques,Leiomyoma of Gallbladder,0
20195,Hematologic Tests,Recurrent Uveal Melanoma,0
20196,Papillary serous cystadenocarcinoma,Endometrial Small Cell Carcinoma,0
20197,Cicatrix,carcinoma of middle ear,0
20198,N not otherwise specified Antibody,Granular Cell Leiomyosarcoma,0
20199,Person 1,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20200,First (number),Undifferentiated Endocervical Sarcoma,0
20201,Referring,Nasal cavity carcinoma,0
20202,Leading,Nasal cavity carcinoma,0
20203,Relational and Item-Specific Encoding Task,Cervical Fibroepithelial Polyp,0
20204,Injection of therapeutic agent,sarcoma of spinal cord,0
20205,World Health Organization,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20206,Screening for cancer,Xeroderma pigmentosum,0
20207,Benign Smooth Muscle Neoplasm,Acantholytic squamous cell carcinoma,0
20208,Different,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20209,Common Specifications in HL7 V3 Publishing,embryonal rhabdomyosarcoma of prostate,0
20210,Shortness of breath:-:Point in time:^Patient:-,Refractory Bladder Carcinoma,0
20211,Usually Need Help from Another Person for Reach,Anterior Urethral Malignant Neoplasm,0
20212,include - SetOperator,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20213,Tryptophanase,Metastatic Carcinoma in the Lung,0
20214,Malignant neoplasm of duodenum,mucinous adenocarcinoma of gallbladder,0
20215,New,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
20216,1000000,Refractory Bladder Carcinoma,0
20217,biopsy characteristics,Peripheral primitive neuroectodermal tumor of soft tissue,0
20218,Decision,Refractory Ependymoma,0
20219,Site of,Localized Ewing Sarcoma,0
20220,All of the Time,Spindle Cell Melanoma,0
20221,Delayed Puberty,Mucinous adenocarcinoma,0
20222,bony process,sarcoma of spinal cord,0
20223,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Mucinous adenocarcinoma gastric,0
20224,Type - attribute,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
20225,Feelings,Stage IB Pancreatic Cancer AJCC v8,0
20226,Imbrication (procedure),Vaginal Adenoma,0
20227,Adult Lymphoma,Clonal Hematopoiesis of Indeterminate Potential,0
20228,Adult human body,Malignant Testicular Sertoli Cell Tumor,0
20229,Intestines,Refractory Ependymoma,0
20230,Uveal melanoma,Lipoma of small intestine,0
20231,Measures (attribute),Adult Hepatocellular Carcinoma,0
20232,Detection,clear cell adenocarcinoma of gallbladder,0
20233,Body structure,Benign squamous cell tumor,0
20234,Appearance,clear cell adenocarcinoma of gallbladder,0
20235,Congenital defects,Kaposi's sarcoma of extrahepatic bile duct,0
20236,device aspects,Benign tumor of eyelid,0
20237,Tryptophanase,Astrocytoma of brain,0
20238,cell type,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20239,Evaluation,GIANT PIGMENTED HAIRY NEVUS,0
20240,newly,Carcinoma,0
20241,Biomaterial Treatment,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
20242,Expected,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20243,Morphology,Childhood Choriocarcinoma,0
20244,Type A,Benign Anal Granular Cell Tumor,0
20245,Character String Data Type,Giant cell angiofibroma,0
20246,Salivary Glands,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
20247,Tryptophanase,Type II Endometrial Adenocarcinoma,0
20248,Bladder Continence Question,Cervical Adenomyoma,0
20249,Induce (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
20250,Occurrence,Angiosarcoma of liver,0
20251,80%,Recurrent Primary Lymphoma of Bone,0
20252,Stage Grouping,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20253,Squamous cell carcinoma - category,Collecting Duct Carcinoma of the Kidney,0
20254,Tryptophanase,Mixed astrocytoma-ependymoma,0
20255,Superkingdom (taxonomic category),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20256,Good,Stage 0 Lip Carcinoma,0
20257,Tryptophanase,Maxillary Sinus Adenocarcinoma,0
20258,Embryonal Rhabdomyosarcoma,Airway Hemangioma,0
20259,All nervous tissue,Leiomyoma of Gallbladder,0
20260,Infection,Diffuse malignant mesothelioma,0
20261,Overlap,Chest Wall Fibromatosis,0
20262,Lymphocyte,Malignant melanoma of eyelid,0
20263,AS virus,Recurrent Primary Lymphoma of Bone,0
20264,Family history,Intestinal Metaplasia of Bladder Urothelium,0
20265,Common Specifications in HL7 V3 Publishing,Diffuse malignant mesothelioma,0
20266,borderline ovarian tumor,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20267,Affect (mental function),Xeroderma pigmentosum,0
20268,Common Specifications in HL7 V3 Publishing,Fourth Ventricle and Brain Stem Ependymal Tumor,0
20269,What subject filter - Result,Carcinoma ex pleomorphic adenoma of parotid gland,0
20270,Logical Condition,Localized Askin Tumor,0
20271,General surgery specialty,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20272,Spreading (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20273,Malignant - descriptor,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
20274,Case (situation),Cherubism,0
20275,Late,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
20276,Treatment Epoch,Secondary malignant neoplasm of lymph node,0
20277,Account number:Identifier:Point in time:^Patient:Nominal,Type II Endometrial Adenocarcinoma,0
20278,Chemotherapy Regimen,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
20279,Interstitial Route of Drug Administration,Cervical Fibroepithelial Polyp,0
20280,Study Element,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20281,Arising in,Bladder squamous cell carcinoma stage I,0
20282,Organ Transplantation,Placental aromatase deficiency,0
20283,Cancer Genus,papillary carcinoma of penis,0
20284,Ventricle,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
20285,One,Bladder adenocarcinoma stage IV,0
20286,Section - Geographic Area,Gallbladder Adenocarcinoma,0
20287,Interpretation Process,Acantholytic squamous cell carcinoma,0
20288,List,Gallbladder Adenocarcinoma,0
20289,Visit,Intraepithelial Melanocytic Hyperplasia,0
20290,Exclude,Splenic Manifestation of Hairy Cell Leukemia,0
20291,Multiple Myeloma,Kaposi's sarcoma of extrahepatic bile duct,0
20292,Therapeutic radiology procedure,Clonal Hematopoiesis of Indeterminate Potential,0
20293,Electrolyte [EPC],Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20294,95,Trabecular adenocarcinoma,0
20295,Body structure,Brain Tumor,0
20296,Morphology,Acute Undifferentiated Leukemia,0
20297,Publishing,Localized Malignant Neoplasm,0
20298,Childhood Lymphoma,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20299,Tryptophanase,FIGO Stage IVA Ovarian Cancer,0
20300,Colon structure (body structure),Secondary malignant neoplasm of lymph node,0
20301,Body tissue,Diffuse malignant mesothelioma,0
20302,Distal (qualifier value),Benign neoplasm of eye,0
20303,Effectiveness,Papillary squamous cell carcinoma,0
20304,other medicated shampoos in ATC,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20305,Side,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20306,United States,Metaplastic carcinoma of breast,0
20307,Unknown GENC,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
20308,Upper,Female Breast Carcinoma,0
20309,IPSS Risk Category High,Maxillary Sinus Adenoid Cystic Carcinoma,0
20310,United States,Adenocarcinoma,0
20311,1980s,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
20312,Two,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
20313,High risk of,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20314,Established,Neonatal leukemia,0
20315,Persons,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20316,Main,Benign neoplasm of eye,0
20317,Persistent,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
20318,Case (situation),ROSE Cluster 3,0
20319,Forecast of outcome,Intraepithelial Melanocytic Hyperplasia,0
20320,treatment - ActInformationManagementReason,Diffuse malignant mesothelioma,0
20321,Intervention regimes,Childhood Thyroid Gland Follicular Carcinoma,0
20322,Occurrence,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20323,Fungal,Primary Cutaneous Plasmablastic Lymphoma,0
20324,Symptoms,FIGO Stage IVA Ovarian Cancer,0
20325,Poverty,Refractory Ependymoma,0
20326,Occur (action),Anterior Urethral Malignant Neoplasm,0
20327,Lung diseases,Stage IB Pancreatic Cancer AJCC v8,0
20328,Infrequent,Thymic Clear Cell Carcinoma,0
20329,Adult Teratoma,High Grade Glandular Intraepithelial Neoplasia,0
20330,Primary,Medulloblastoma,0
20331,Metastatic malignant neoplasm to brain,Chest Wall Fibromatosis,0
20332,Serous,Engraftment syndrome,0
20333,diagnosis aspect,sarcoma of spinal cord,0
20334,Often - answer to question,Pleomorphic adenoma of parotid gland,0
20335,cell transformation,Larynx carcinoma recurrent,0
20336,Neoadjuvant Therapy Clinical Trial Setting,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20337,Separate,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20338,research,Chronic Myelomonocytic Leukemia-2,0
20339,Surgical aspects,Stage I Colon Neuroendocrine Tumor AJCC v8,0
20340,Symptoms,adenoid cystic carcinoma of lung,0
20341,Reside,Malignant melanoma of eyelid,0
20342,10%,Childhood Central Nervous System Ganglioneuroblastoma,0
20343,Greater Than,Heavy Chain Deposition Disease,0
20344,Have Been Coughing,Brain Tumor,0
20345,Slow,Intestinal Metaplasia of Bladder Urothelium,0
20346,United States,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
20347,Html Link Type - index,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20348,Astrocytes,Metastatic Kidney Carcinoma,0
20349,Woman,Benign tumor of eyelid,0
20350,Give - dosing instruction imperative,Benign neoplasm of thorax,0
20351,Person Observer,Mixed astrocytoma-ependymoma,0
20352,development aspects,Primary Cutaneous Plasmablastic Lymphoma,0
20353,Carcinoid Tumor,Intestinal Neuroendocrine Carcinoma,0
20354,Decreasing,Mixed parotid tumor,0
20355,Cervical Atlas,Localized Askin Tumor,0
20356,Surgical aspects,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20357,Known,Occult Lung Adenosquamous Carcinoma,0
20358,Neoplasms,Endometrial Small Cell Carcinoma,0
20359,Tryptophanase,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20360,Woman,embryonal rhabdomyosarcoma of prostate,0
20361,Persons,Congenital hamartoma,0
20362,Injury due to exposure to external cause,Locally Advanced Soft Tissue Sarcoma,0
20363,Beginning,Fibroadenoma of breast,0
20364,Peritoneum,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20365,Social Networks,Hodgkin Disease,0
20366,Hematologic Tests,Diffuse malignant mesothelioma,0
20367,Liver carcinoma,Trichilemmocarcinoma,0
20368,Blood,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20369,*Type - Kind of quantity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20370,Precision - characteristic,Platinum-Resistant Lung Small Cell Carcinoma,0
20371,various allergen extracts,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20372,Tryptophanase,Clonal Hematopoiesis of Indeterminate Potential,0
20373,Etiology aspects,Pancreatic Intraepithelial Neoplasia-3,0
20374,General surgery specialty,Stage IB Lung Cancer AJCC v7,0
20375,Occurrence Indicator,Peripheral primitive neuroectodermal tumor of soft tissue,0
20376,Techniques,Hemangioma,0
20377,Primary malignant neoplasm,Uterine Cancer,0
20378,1.1,Localized Askin Tumor,0
20379,Recommendation,Adenocarcinoma,0
20380,Diagnosis Study,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20381,900,squamous cell carcinoma of the thyroid gland,0
20382,Per Millimeter,gliosarcoma,0
20383,H/O: malignant neoplasm,Stage IV Colorectal Cancer AJCC v8,0
20384,Long-term,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20385,british,Pancreatic Intraepithelial Neoplasia-3,0
20386,Groups,Childhood Fibrillary Astrocytoma,0
20387,metaplastic cell transformation,Extra-abdominal fibromatosis,0
20388,Disease,Granular Cell Leiomyosarcoma,0
20389,pharmacotherapeutic,Malignant neoplasm of subglottis,0
20390,Microscopes,Recurrent Rhabdomyosarcoma,0
20391,Severe (severity modifier),embryonal rhabdomyosarcoma of prostate,0
20392,Event Seriousness - Significant,Localized Malignant Neoplasm,0
20393,Subgroup,Malignant melanoma of eyelid,0
20394,Band form,FIGO Stage II Ovarian Cancer,0
20395,Occurrence Indicator,Trichilemmocarcinoma,0
20396,External lower lip,Maxillary Sinus Adenoid Cystic Carcinoma,0
20397,N+ (tumor staging),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20398,Symptoms aspect,Medulloblastoma,0
20399,Formation,Kaposi's sarcoma of extrahepatic bile duct,0
20400,*Type - Kind of quantity,Low Grade Squamous Intraepithelial Neoplasia,0
20401,Transitional cell morphology,Neoplasms,0
20402,Anterior portion of neck,Unicystic ameloblastoma,0
20403,Myalgia,Nasal cavity carcinoma,0
20404,Result,Bladder squamous cell carcinoma stage I,0
20405,Tobacco smoking behavior,Heavy Chain Deposition Disease,0
20406,Uvea,Sarcomatoid Renal Cell Carcinoma,0
20407,Possible diagnosis,Clonal Hematopoiesis of Indeterminate Potential,0
20408,Smear - instruction imperative,Serous cystadenocarcinoma ovary,0
20409,Sporadically,Endometrial Small Cell Carcinoma,0
20410,Meaning,Malignant neoplasm of gallbladder,0
20411,Drugs used in migraine prophylaxis,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
20412,Loss of appetite (finding),Chondrosarcoma,0
20413,Include (action),Heavy Chain Deposition Disease,0
20414,Lymphocyte,Undifferentiated Neuroblastoma,0
20415,Minor (value),Malignant neoplasm of gallbladder,0
20416,Overall,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
20417,Derivation,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20418,Small,Stage I Colon Neuroendocrine Tumor AJCC v8,0
20419,Include (action),Ovarian Dermoid Cyst with Secondary Carcinoma,0
20420,Often - answer to question,Pancreatic carcinoma,0
20421,Lymphocyte component of blood,Localized Malignant Neoplasm,0
20422,Confirmed by,Human Papillomavirus-Related Carcinoma,0
20423,Adult Angiosarcoma,Metastatic Kidney Carcinoma,0
20424,Overall,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20425,CDISC SDTM Procedure Terminology,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
20426,Active,Trabecular adenocarcinoma,0
20427,Face,Refractory Ependymoma,0
20428,Esophagus,Adult Acute Eosinophilic Leukemia,0
20429,Occurrence Indicator,Xeroderma pigmentosum,0
20430,Vertebral column,Acute Undifferentiated Leukemia,0
20431,Overall Publication Type,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20432,Disease,Platinum-Resistant Lung Small Cell Carcinoma,0
20433,Areas <moth>,Diffuse malignant mesothelioma,0
20434,Malignant neoplasm of urinary bladder,Recurrent Uveal Melanoma,0
20435,Solid,Adenocarcinoma,0
20436,Referring,Locally Advanced Carcinoma,0
20437,*Type - Kind of quantity,FIGO Stage II Ovarian Cancer,0
20438,Smear - instruction imperative,Testicular cancer metastatic,0
20439,Solid,Methotrexate-Associated Hodgkin Lymphoma,0
20440,Microscopic,Benign Carotid Body Paraganglioma,0
20441,Usual,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
20442,Insecticides,Splenic Manifestation of Hairy Cell Leukemia,0
20443,Immature Cell Count (laboratory procedure),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20444,Time,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20445,Skin,Melanomatosis,0
20446,Publications,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20447,Neoplasm Metastasis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
20448,Literature,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20449,pharmacotherapeutic,Pancreatic Intraepithelial Neoplasia-3,0
20450,preference,Chronic Myelomonocytic Leukemia-2,0
20451,Most,Melanomatosis,0
20452,Often - answer to question,Metastatic Ductal Breast Carcinoma,0
20453,Dosing Days to Detection,Stage 0 Penile Cancer AJCC v8,0
20454,Process (qualifier value),Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
20455,Most,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20456,veterans alcoholism screening test (VAST),Kaposi's sarcoma of extrahepatic bile duct,0
20457,Survival Rate,Mucinous adenocarcinoma gastric,0
20458,Pale color,Mucinous adenocarcinoma,0
20459,Adult Alveolar Soft Part Sarcoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20460,Symptoms aspect,Acute Undifferentiated Leukemia,0
20461,Very High Level,FIGO Stage II Ovarian Cancer,0
20462,Odontogenesis,Intraepithelial Melanocytic Hyperplasia,0
20463,One,Mucinous adenocarcinoma gastric,0
20464,Only - dosing instruction fragment,Ovarian Carcinoid Tumor,0
20465,site-specific telomere resolvase activity,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20466,Europe,Testicular cancer metastatic,0
20467,IPSS Risk Category High,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
20468,Malignant Neoplasms,papillary carcinoma of penis,0
20469,Case unit dose,Refractory WHO Grade III Glioma,0
20470,Fatigue,Childhood Extragonadal Malignant Germ Cell Tumor,0
20471,75,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
20472,Males,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20473,Hematuria,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20474,*Type - Kind of quantity,adenosquamous carcinoma of breast,0
20475,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Stage IV Penile Cancer AJCC v7,0
20476,cell type,clear cell adenocarcinoma of gallbladder,0
20477,Affecting,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20478,Guide device,Type II Endometrial Adenocarcinoma,0
20479,status - In progress,Kaposi's sarcoma of extrahepatic bile duct,0
20480,Cessation of life,Rhabdomyosarcoma with ganglionic differentiation,0
20481,Most,Melanomatosis,0
20482,Administration Method - Infiltrate,Stage IV Colorectal Cancer AJCC v8,0
20483,Hormonal,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20484,solid substance,Diffuse malignant mesothelioma,0
20485,Gait normal,embryonal rhabdomyosarcoma of prostate,0
20486,90%,Familial Hemophagocytic Lymphocytosis,0
20487,CEL gene,Neonatal leukemia,0
20488,Frequently,Adult Alveolar Soft Part Sarcoma,0
20489,Tissue Specimen Code,Acute Undifferentiated Leukemia,0
20490,65,Pancreatic carcinoma,0
20491,Following,Metastatic Malignant Neoplasm in the Sellar Region,0
20492,Name,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20493,65,Medulloblastoma,0
20494,Greater,Stage IV Childhood Non-Hodgkin Lymphoma,0
20495,Age at menopause,Mucinous adenocarcinoma,0
20496,Histopathologic Grade differentiation,Kaposi's sarcoma of skin,0
20497,Major <insect>,Undifferentiated Endocervical Sarcoma,0
20498,Epithelioma,gliosarcoma,0
20499,Breaking down,Malignant Neoplasm with Regional Lymph Node Involvement,0
20500,Extraction,Type II Endometrial Adenocarcinoma,0
20501,Hematologic Neoplasms,Hodgkin lymphoma,0
20502,Neck,Localized Askin Tumor,0
20503,Primary malignant neoplasm,Refractory Barrett Esophagus,0
20504,Confirmation,Chest Wall Fibromatosis,0
20505,Child,Childhood Central Nervous System Ganglioneuroblastoma,0
20506,invasive cancer,Clonal Hematopoiesis of Indeterminate Potential,0
20507,Third ventricle structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20508,Problems - What subject filter,Uterine Cancer,0
20509,Electromagnetic Fields,Low Grade Squamous Intraepithelial Neoplasia,0
20510,Anabolism,Angiosarcoma of liver,0
20511,Blood Proteins,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20512,Characterization,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20513,CEL gene,embryonal rhabdomyosarcoma of prostate,0
20514,Macrophage Activation Syndrome,Recurrent Primary Lymphoma of Bone,0
20515,Involvement with,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
20516,Risk,Diffuse malignant mesothelioma,0
20517,Bloating,squamous cell carcinoma of the thyroid gland,0
20518,Mass of body structure,Stage IV Colorectal Cancer AJCC v8,0
20519,Certain (qualifier value),Mucinous adenocarcinoma gastric,0
20520,Geographic Locations,Intestinal Metaplasia of Bladder Urothelium,0
20521,Frequently,Recurrent Primary Lymphoma of Bone,0
20522,Body Excretions,Recurrent Primary Lymphoma of Bone,0
20523,Human papilloma virus infection,Cartilaginous exostosis,0
20524,Plasma Cells,Malignant melanoma of eyelid,0
20525,Rare,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20526,Primary sclerosing cholangitis,Localized Askin Tumor,0
20527,Affecting,Mixed astrocytoma-ependymoma,0
20528,Classification,Stage II Carcinoma of Penis,0
20529,Complete Trisomy 21 Syndrome,Bladder adenocarcinoma stage IV,0
20530,Major,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20531,Disease Outbreaks,Angiosarcoma of liver,0
20532,Either,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
20533,include - SetOperator,Tonsillar Carcinoma,0
20534,Manufactured sign,Benign Carotid Body Paraganglioma,0
20535,Slight (qualifier value),Mixed astrocytoma-ependymoma,0
20536,Colon structure (body structure),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20537,65+,Squamous cell carcinoma of lip,0
20538,Related personal status,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20539,Common Specifications in HL7 V3 Publishing,Childhood Choriocarcinoma,0
20540,Smear - instruction imperative,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20541,Time,Localized Malignant Neoplasm,0
20542,Inflammation,Nasal cavity carcinoma,0
20543,Percent of Abnormal Cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20544,Present,Kaposi's sarcoma of extrahepatic bile duct,0
20545,Cicatrix,Rhabdomyosarcoma with ganglionic differentiation,0
20546,Pap smear,Mixed parotid tumor,0
20547,Related personal status,Diffuse malignant mesothelioma,0
20548,Tryptophanase,Familial Adenomatous Polyposis Associated Medulloblastoma,0
20549,Term (temporal),Diffuse malignant mesothelioma,0
20550,NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology,Uterine Cancer,0
20551,Lymphocyte Count measurement,Fibroadenoma of breast,0
20552,2+ Score,Recurrent Testicular Lymphoma,0
20553,Ewings sarcoma,Tonsillar Carcinoma,0
20554,Precision - second,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20555,Diagnosis Study,Childhood Fibrillary Astrocytoma,0
20556,Malignant Neoplasms,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20557,Experimental Result,Type II Endometrial Adenocarcinoma,0
20558,Numerous,Recurrent Uveal Melanoma,0
20559,One,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20560,shared attribute,malignant lymphoma of pancreatic lymph nodes,0
20561,Discharge,FIGO Stage IVA Ovarian Cancer,0
20562,Data operation - complete,Kaposi's sarcoma of extrahepatic bile duct,0
20563,Rate,Undifferentiated Endocervical Sarcoma,0
20564,lymphatic cancer,Diffuse malignant mesothelioma,0
20565,Childhood Non-Hodgkin Lymphoma,Splenic Manifestation of Hairy Cell Leukemia,0
20566,Poles,Medulloblastoma,0
20567,Change -- procedure,Basal Cell Ameloblastoma,0
20568,high - ActExposureLevelCode,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
20569,Woman,Stage IB Lung Cancer AJCC v7,0
20570,Supportive assistance,Kaposi's sarcoma of skin,0
20571,Very Much,Platinum-Resistant Lung Small Cell Carcinoma,0
20572,Relate - vinyl resin,Stage IV Childhood Non-Hodgkin Lymphoma,0
20573,Bladder Cancer Pathway,FIGO Stage II Ovarian Cancer,0
20574,Tryptophanase,Choroid Necrotic Melanoma,0
20575,Chromosomes,Benign Ovarian Thecoma,0
20576,Body tissue,Undifferentiated Neuroblastoma,0
20577,Result,adenosquamous carcinoma of breast,0
20578,site-specific telomere resolvase activity,Mucinous cystadenofibroma,0
20579,List,Urethral Carcinoma,0
20580,Substance,Metaplastic carcinoma of breast,0
20581,Foreskin of penis,mucinous adenocarcinoma of gallbladder,0
20582,include - SetOperator,Hodgkin Disease,0
20583,Mucoepidermoid Carcinoma,Localized Ewing Sarcoma,0
20584,Aspects of signs,BRCA2 Syndrome,0
20585,Breast Feeding,Angiosarcoma of liver,0
20586,Mutation Abnormality,Acute lymphadenitis,0
20587,CD44 wt Allele,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20588,Cancer Genus,Refractory WHO Grade III Glioma,0
20589,Manufactured form,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20590,Histology aspects,Multiple Skull Base Meningiomas,0
20591,Tests (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
20592,Biopsy,Vaginal Adenoma,0
20593,Precancerous Conditions,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20594,United States,Malignant Testicular Sertoli Cell Tumor,0
20595,Physical shape,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20596,Lymphoid Cell Count,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20597,Bladder Continence Question,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20598,All of the Time,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20599,Pallor,Intraepithelial Melanocytic Hyperplasia,0
20600,Problems - What subject filter,Peripheral primitive neuroectodermal tumor of soft tissue,0
20601,Secretory Vesicles,non-Hodgkin's lymphoma of spleen,0
20602,UV Radiation,Atypical Lobular Breast Hyperplasia,0
20603,General surgery specialty,Hereditary Diffuse Gastric Adenocarcinoma,0
20604,high - ActExposureLevelCode,Unresectable Rhabdomyosarcoma,0
20605,To,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20606,Occur (action),Intraepithelial Melanocytic Hyperplasia,0
20607,Common (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
20608,various antiseptic throat preparations,Mucinous adenocarcinoma,0
20609,Females,BRCA2 Syndrome,0
20610,Classes - encounter,Peripheral primitive neuroectodermal tumor of soft tissue,0
20611,Malignant Neoplasms,Recurrent Testicular Lymphoma,0
20612,800,Methotrexate-Associated Hodgkin Lymphoma,0
20613,N not otherwise specified Antibody,Ovarian germ cell choriocarcinoma stage IV,0
20614,Cell secretion,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20615,Form:Finding:Point in time:{Setting}:Document:{Role},Lipoma of small intestine,0
20616,Apply,Acantholytic squamous cell carcinoma,0
20617,Nevus,Cerebral Primitive Neuroectodermal Tumor,0
20618,competitive advantage,Heavy Chain Deposition Disease,0
20619,Type - attribute,Unicystic ameloblastoma,0
20620,In addition to,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20621,The Sun,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
20622,Medical Drop,Metaplastic carcinoma of breast,0
20623,Genus Axis,Small intestine carcinoma,0
20624,Ductal Breast Carcinoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20625,Therapeutic radiology procedure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20626,diagnostic procedure,Maxillary Sinus Adenoid Cystic Carcinoma,0
20627,Body Fluids,Anaplastic large cell lymphoma,0
20628,Rare Diseases,Testicular cancer metastatic,0
20629,shared attribute,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
20630,Usual Severity Weight Loss,Stage III Cutaneous Melanoma AJCC v6,0
20631,Certain (qualifier value),Familial Hemophagocytic Lymphocytosis,0
20632,Adenolymphoma,Cerebral Primitive Neuroectodermal Tumor,0
20633,Occurrence Indicator,Stage IV Childhood Non-Hodgkin Lymphoma,0
20634,Life,Digestive System Hodgkin Lymphoma,0
20635,Before,Mixed astrocytoma-ependymoma,0
20636,Congenital MeSH qualifier,Pancreatic Intraepithelial Neoplasia-3,0
20637,Pathogenic organism,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20638,Cessation of life,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
20639,Effective,Cartilaginous exostosis,0
20640,Stop (qualifier value),Chest Wall Fibromatosis,0
20641,Black race,Refractory Bladder Carcinoma,0
20642,Call (Instruction),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
20643,Near,Brain Tumor,0
20644,Loss of Appetite question,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20645,Negation,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
20646,Sacrifice,Splenic Manifestation of Hairy Cell Leukemia,0
20647,Nervous system problem,Adenocarcinoma,0
20648,Endoscopy (procedure),Low Grade Squamous Intraepithelial Neoplasia,0
20649,Muscle of arm,Ichthyoses,0
20650,Early disease stage,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20651,active (HL7 RoleLink),Undifferentiated Endocervical Sarcoma,0
20652,Importance Rating Score 0,Gallbladder Adenocarcinoma,0
20653,Type A,Papillary squamous cell carcinoma,0
20654,2+,Digestive System Hodgkin Lymphoma,0
20655,Involvement with,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20656,Occurrence,Advanced Uterine Corpus Carcinosarcoma,0
20657,Formation,Digestive System Hodgkin Lymphoma,0
20658,Frequently,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
20659,How Much Distress Shortness of Breath,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
20660,Known,Childhood Central Nervous System Ganglioneuroblastoma,0
20661,75,Testicular cancer metastatic,0
20662,contextual factors,malignant lymphoma of pancreatic lymph nodes,0
20663,Percent of Abnormal Cells,Stage I Adult Non-Hodgkin Lymphoma,0
20664,Astrocytes,Tubal Hyperplasia,0
20665,Upper arm,Metastatic Carcinoma in the Lung,0
20666,Togo,Nasal cavity carcinoma,0
20667,Characterization,Splenic Manifestation of Hairy Cell Leukemia,0
20668,Patients,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
20669,Thymus <angiosperm>,Human Papillomavirus-Related Carcinoma,0
20670,Adult human body,Trabecular adenocarcinoma,0
20671,Web Site,Maxillary Sinus Adenocarcinoma,0
20672,Occurrence,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
20673,shared attribute,Carcinoma of urinary bladder,0
20674,Slightly (qualifier value),FIGO Stage II Ovarian Cancer,0
20675,Chorioamnionitis,Chest Wall Fibromatosis,0
20676,Germ Cells,Thymic Atypical Carcinoid Tumor,0
20677,Spinal Cord,Bladder adenocarcinoma stage IV,0
20678,Squamous cell carcinoma - category,Platinum-Resistant Lung Small Cell Carcinoma,0
20679,Cerebral hemisphere structure (body structure),Bladder squamous cell carcinoma stage I,0
20680,Main,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20681,Intercellular Junctions,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
20682,various other agents for local oral treatment in ATC,Mastocytosis,0
20683,depend,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20684,Pain,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20685,Solid,Benign squamous cell tumor,0
20686,Immune System Finding,Acute Undifferentiated Leukemia,0
20687,Similarity,Locally Advanced Epithelioid Hemangioendothelioma,0
20688,Back structure,Diffuse malignant mesothelioma,0
20689,Chemotherapy,ROSE Cluster 3,0
20690,evaporation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20691,>40 years,Periosteal Osteosarcoma,0
20692,School Grade,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20693,Morning,Acantholytic squamous cell carcinoma,0
20694,Various patch test substance,Malignant Testicular Sertoli Cell Tumor,0
20695,low confidentiality,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20696,Main,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20697,Contain (action),Non-Metastatic Gestational Trophoblastic Tumor,0
20698,Time,Kaposi's sarcoma of extrahepatic bile duct,0
20699,Covers (device),Stage IV Colorectal Cancer AJCC v8,0
20700,Type - attribute,clear cell adenocarcinoma of gallbladder,0
20701,Version,Liver Lymphangioma,0
20702,Affect (mental function),Intraepithelial Melanocytic Hyperplasia,0
20703,analysis aspect,squamous cell carcinoma of the thyroid gland,0
20704,Order (taxonomic),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20705,Cover (physical object),Malignant Neoplasm with Regional Lymph Node Involvement,0
20706,Neoplastic disease,Anterior Urethral Malignant Neoplasm,0
20707,Metastatic Neoplasm,Undifferentiated Endocervical Sarcoma,0
20708,Name,Gallbladder Adenocarcinoma,0
20709,Diagnosis,Intestinal Metaplasia of Bladder Urothelium,0
20710,Used by,Adult Acute Eosinophilic Leukemia,0
20711,Colon structure (body structure),Female Breast Carcinoma,0
20712,Radiation Ionizing Radiotherapy,Hereditary Diffuse Gastric Adenocarcinoma,0
20713,Bothered by Vomiting,Thymoma malignant recurrent,0
20714,Symptoms aspect,Locally Advanced Epithelioid Hemangioendothelioma,0
20715,Bayer Corneal Epitheliopathy Grade 3,Benign Apocrine Neoplasm,0
20716,Numerous,Female Breast Carcinoma,0
20717,Head and Neck Carcinoma,Mucinous adenocarcinoma gastric,0
20718,International Statistical Classification of Diseases and Related Health Problems,Tubal Hyperplasia,0
20719,Upper Respiratory Infections,Xeroderma pigmentosum,0
20720,With shape,Type II Endometrial Adenocarcinoma,0
20721,Duct (organ) structure,Squamous cell carcinoma of lip,0
20722,Include (action),Benign Anal Granular Cell Tumor,0
20723,Southern Europe,Anterior Urethral Malignant Neoplasm,0
20724,epithelial,Necrotizing Funisitis,0
20725,Primary,sarcoma of spinal cord,0
20726,week,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20727,Very high,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20728,Therapeutic radiology procedure,FIGO Stage II Ovarian Cancer,0
20729,Variety (taxon),Neonatal leukemia,0
20730,Tanning of leather,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20731,follow-up,Refractory Barrett Esophagus,0
20732,Publishing,Benign neoplasm of thorax,0
20733,Eyelash,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20734,Qualitative form,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20735,Etiology aspects,Anterior Urethral Malignant Neoplasm,0
20736,Medical History,Liver Cavernous Hemangioma,0
20737,Most Recent,Colorectal cancer,0
20738,Skin reaction,adenosquamous carcinoma of breast,0
20739,Route,Maxillary Sinus Adenocarcinoma,0
20740,Soft,Microcystic meningioma,0
20741,Improved,Acute Undifferentiated Leukemia,0
20742,Choose (action),Malignant melanoma of eyelid,0
20743,Well,Locally Advanced Squamous Cell Carcinoma,0
20744,BRCA2 protein,Extracranial Neuroblastoma,0
20745,Primary malignant neoplasm,Clonal Hematopoiesis of Indeterminate Potential,0
20746,High Level,Cancer of Urinary Tract,0
20747,Obstruction,Spindle Cell Melanoma,0
20748,Cardiac Lead Procedure,Endometrial Small Cell Carcinoma,0
20749,Surface of skin,Cervical Squamous Intraepithelial Neoplasia,0
20750,Cells,Microcystic meningioma,0
20751,IV number:ID:Pt:^Patient:Nom,Cancer of Urinary Tract,0
20752,Symptoms aspect,FIGO Stage II Ovarian Cancer,0
20753,Flow,Ovarian germ cell choriocarcinoma stage IV,0
20754,Molecular Mass,Spongiotic dermatitis,0
20755,Phimosis,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20756,Common (qualifier value),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20757,Tiredness Visual Analogue Scale,Liver Lymphangioma,0
20758,Negation,Cerebral Primitive Neuroectodermal Tumor,0
20759,Array Feature,clear cell adenocarcinoma of gallbladder,0
20760,Table Cell Horizontal Align - left,Locally Advanced Carcinoma,0
20761,Side of head,Tonsillar Carcinoma,0
20762,Tired,Squamous cell carcinoma of lip,0
20763,Symptoms aspect,BRCA2 Syndrome,0
20764,Occurrence,Acute Undifferentiated Leukemia,0
20765,Concept Attribute,Low Grade Squamous Intraepithelial Neoplasia,0
20766,Mass of body structure,Lipoma of small intestine,0
20767,High Mitosis-Karyorrhexis Index,Locally Advanced Epithelioid Hemangioendothelioma,0
20768,Decision,Recurrent Uveal Melanoma,0
20769,Confirmed by,FIGO Stage II Ovarian Cancer,0
20770,Form:Finding:Point in time:{Setting}:Document:{Role},Nasal cavity carcinoma,0
20771,Pharmacotherapy,Familial Adenomatous Polyposis Associated Medulloblastoma,0
20772,Have Weight Loss,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20773,Diagnosis of exclusion,Cartilaginous exostosis,0
20774,Recent,Kaposi's sarcoma of skin,0
20775,Grade three rank,Stage III Adult Immunoblastic Lymphoma,0
20776,Most,High Grade Glandular Intraepithelial Neoplasia,0
20777,Have Itch,Metastatic Carcinoma in the Lung,0
20778,Including (qualifier),Precursor B-lymphoblastic lymphoma stage II,0
20779,High Mitosis-Karyorrhexis Index,Clinical Stage I Cutaneous Melanoma AJCC v8,0
20780,More common in males,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
20781,Hematopoietic stem cells,Splenic Manifestation of Hairy Cell Leukemia,0
20782,Tooth Wear,Recurrent Testicular Lymphoma,0
20783,Usually,Recurrent Testicular Lymphoma,0
20784,Head,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
20785,Colon <insect>,ROSE Cluster 3,0
20786,Geographic Locations,Recurrent Primary Lymphoma of Bone,0
20787,Extent of disease,Nasal cavity carcinoma,0
20788,Formation,FIGO Stage IVA Ovarian Cancer,0
20789,Malignant Neoplasms,Refractory Barrett Esophagus,0
20790,Sneezing,Anterior Urethral Malignant Neoplasm,0
20791,Precision - second,Bladder squamous cell carcinoma stage I,0
20792,eTMF Content Model Code,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
20793,Primary,squamous cell carcinoma of the thyroid gland,0
20794,removal technique,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20795,High,Mucinous adenocarcinoma gastric,0
20796,Increase,Tubal Hyperplasia,0
20797,oligodendroglioma,Brain Tumor,0
20798,Study Variable,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20799,metastatic qualifier,Childhood Choriocarcinoma,0
20800,Geographic Locations,FIGO Stage IVA Ovarian Cancer,0
20801,Present,Breast Ductal Adenoma,0
20802,*Type - Kind of quantity,sarcoma of spinal cord,0
20803,Cell Device,Diffuse malignant mesothelioma,0
20804,Application procedure,Airway Hemangioma,0
20805,treatment - ActInformationManagementReason,Microcystic meningioma,0
20806,CD44 wt Allele,Adult Acute Eosinophilic Leukemia,0
20807,Known,Familial Adenomatous Polyposis Associated Medulloblastoma,0
20808,Mass,Malignant melanoma of eyelid,0
20809,Elderly (population group),Mixed astrocytoma-ependymoma,0
20810,Head - Component of Device,Non-Metastatic Gestational Trophoblastic Tumor,0
20811,Developed Countries,Childhood Central Nervous System Ganglioneuroblastoma,0
20812,Electromagnetic Fields,Adenocarcinoma,0
20813,Approximate,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
20814,Occurrence Indicator,Clonal Hematopoiesis of Indeterminate Potential,0
20815,Telephone Extension Number,Cartilaginous exostosis,0
20816,Integumentary scale,Undifferentiated Endocervical Sarcoma,0
20817,Disruptive,Localized Askin Tumor,0
20818,In Cerebrospinal Fluid,Colorectal High Grade B-Cell Lymphoma,0
20819,Individual,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
20820,Condition:Find:Pt:^Patient:Nom,Cerebral Primitive Neuroectodermal Tumor,0
20821,Neonatal Abstinence Syndrome,Brain Ependymoma,0
20822,Neuroendocrine Tumors,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20823,Synonym (core metadata concept),Localized Ewing Sarcoma,0
20824,Entity Determiner - specific,Microcystic meningioma,0
20825,Covers (device),Childhood Fibrillary Astrocytoma,0
20826,Estimated,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20827,shared attribute,Benign Apocrine Neoplasm,0
20828,Time (foundation metadata concept),GIANT PIGMENTED HAIRY NEVUS,0
20829,Primary malignant neoplasm,Extra-Adrenal Paraganglioma,0
20830,Biopsy,Mucinous adenocarcinoma gastric,0
20831,Receptors,Microcystic meningioma,0
20832,Dryness of eye,Mixed astrocytoma-ependymoma,0
20833,Pruritus,Basal Cell Ameloblastoma,0
20834,Type - attribute,Kaposi's sarcoma of skin,0
20835,Frequently,Stage IV Colorectal Cancer AJCC v8,0
20836,Scaling,Recurrent Testicular Lymphoma,0
20837,84,Localized Malignant Neoplasm,0
20838,Fluid behavior,Benign Apocrine Neoplasm,0
20839,Evaluation and management note:Finding:Point in time:{Setting}:Document:{Provider},Locally Advanced Epithelioid Hemangioendothelioma,0
20840,Case (situation),Cartilaginous exostosis,0
20841,Togo,Cervical Fibroepithelial Polyp,0
20842,Have Itch,Noninfiltrating Intraductal Carcinoma,0
20843,Somalia,Breast Ductal Adenoma,0
20844,Treating,Refractory Bladder Carcinoma,0
20845,Blood group antibody I,mucinous adenocarcinoma of gallbladder,0
20846,Sometimes,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
20847,Cancer Genus,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
20848,Early,Intraepithelial Melanocytic Hyperplasia,0
20849,described,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20850,Presentation,Extra-Adrenal Paraganglioma,0
20851,With staging,Carcinoma,0
20852,Surgery specialty,Recurrent Uveal Melanoma,0
20853,Hodgkin Disease,Ovarian germ cell choriocarcinoma stage IV,0
20854,Pharmacotherapy,Colorectal Neuroendocrine Tumor G2,0
20855,Hypertensive disease,Larynx carcinoma recurrent,0
20856,Experimental Result,Medulloblastoma,0
20857,biopsy characteristics,Maxillary Sinus Adenoid Cystic Carcinoma,0
20858,Child 7,Pancreatic Endocrine Carcinoma,0
20859,Blood Vessel,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
20860,Major <insect>,Pancreatic carcinoma,0
20861,ethnic european,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20862,Decreasing,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
20863,Include (action),Chronic Myelomonocytic Leukemia-2,0
20864,Occur (action),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
20865,Relationships,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
20866,Down Syndrome,Sarcomatoid Renal Cell Carcinoma,0
20867,Sore skin,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20868,Orchiectomy,Chest Wall Fibromatosis,0
20869,2+,Giant cell angiofibroma,0
20870,Tests (qualifier value),Adult Alveolar Soft Part Sarcoma,0
20871,Lymphatic vessel,Spongiotic dermatitis,0
20872,other medicated shampoos in ATC,Adrenal Rest Tumor,0
20873,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20874,analysis aspect,Liver Lymphangioma,0
20875,include - SetOperator,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
20876,Pharmacotherapy,Digestive System Hodgkin Lymphoma,0
20877,Vaccination,Unicystic ameloblastoma,0
20878,Financial Account,Carcinomatosis of peritoneal cavity,0
20879,Examination finding,Neonatal leukemia,0
20880,Chemotherapy,Liver Lymphangioma,0
20881,Communicable Diseases,Human Papillomavirus-Related Carcinoma,0
20882,Confirmed by,Refractory Barrett Esophagus,0
20883,Sunlight,Malignant Neoplasm of Lung - Multiple Primary Sites,0
20884,World,Acute Undifferentiated Leukemia,0
20885,Germ cell tumor,Recurrent Uveal Melanoma,0
20886,Tumor cells,Giant cell angiofibroma,0
20887,Unintentional,Occult Lung Adenosquamous Carcinoma,0
20888,Ear structure,Ovarian Carcinoid Tumor,0
20889,Age at menopause:Time:Point in time:^Patient:Quantitative,Leiomyoma of Gallbladder,0
20890,Northern Europe,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20891,Cure (remedy),Testicular cancer metastatic,0
20892,High Mitosis-Karyorrhexis Index,Stage III Cutaneous Melanoma AJCC v6,0
20893,Histocompatibility Testing,Kaposi's sarcoma of extrahepatic bile duct,0
20894,Relationships,Primary Cutaneous Plasmablastic Lymphoma,0
20895,Usually Need Help from Another Person for Arising,Malignant melanoma of eyelid,0
20896,Classification of information,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20897,Target Lesion Identification,Microcystic meningioma,0
20898,RBC count low,Extracranial Neuroblastoma,0
20899,Case unit dose,Type II Endometrial Adenocarcinoma,0
20900,Muscle damage,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
20901,Widespread Disease,Congenital hamartoma,0
20902,Referring,Granular Cell Leiomyosarcoma,0
20903,Abdominal colic,Chronic Myelomonocytic Leukemia-2,0
20904,Etiology aspects,Malignant Neoplasm of Lung - Multiple Primary Sites,0
20905,Family member,Recurrent Uveal Melanoma,0
20906,geographic population,Small cell neuroendocrine carcinoma of bladder,0
20907,Out (direction),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20908,No status change,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
20909,cervical cancer,Squamous cell carcinoma of lip,0
20910,Oral region,Blepharal carcinoma,0
20911,Type - attribute,sarcoma of spinal cord,0
20912,Smear - instruction imperative,Benign Anal Granular Cell Tumor,0
20913,pharmacotherapeutic,Intraepithelial Melanocytic Hyperplasia,0
20914,Value Above Reference Range,Stage IV Childhood Non-Hodgkin Lymphoma,0
20915,Obesity,Unfavorable Non-Hodgkin Lymphoma,0
20916,Primary Malignant Liver Neoplasm,Tonsillar Carcinoma,0
20917,Immunotherapy,Kaposi's sarcoma of extrahepatic bile duct,0
20918,Qualitative form,Intracortical osteosarcoma,0
20919,How Often Itching,Acinar cell carcinoma of pancreas,0
20920,Diagnosis,Thymic Atypical Carcinoid Tumor,0
20921,T-Cell Lymphoma,Diffuse malignant mesothelioma,0
20922,Biomaterial Treatment,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
20923,Liver Flavor,sarcoma of spinal cord,0
20924,Smear - instruction imperative,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
20925,How Much Distress Weight Loss,Non-Metastatic Gestational Trophoblastic Tumor,0
20926,Bibliographic Reference,Adenocarcinoma of the prostate metastatic,0
20927,Diffuse Large B-Cell Lymphoma,Botryoid-Type Embryonal Rhabdomyosarcoma,0
20928,Endodermal,Anterior Urethral Malignant Neoplasm,0
20929,Inguinal region,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
20930,Vascular,Neoplasms,0
20931,Adult human body,Non-Metastatic Gestational Trophoblastic Tumor,0
20932,Tobacco,Mucinous adenocarcinoma gastric,0
20933,Chemicals,Larynx carcinoma recurrent,0
20934,To,Childhood Central Nervous System Immature Teratoma,0
20935,gene therapy,Locally Advanced Carcinoma,0
20936,Together,Adult Alveolar Soft Part Sarcoma,0
20937,Infrequent,Intestinal Metaplasia of Bladder Urothelium,0
20938,BONE CARIES,Cartilaginous exostosis,0
20939,Slightly Able,Splenic Manifestation of Hairy Cell Leukemia,0
20940,Non-Small Cell Lung Carcinoma,Stage II Carcinoma of Penis,0
20941,Therapeutic radiology procedure,Tongue Alveolar Soft Part Sarcoma,0
20942,A Codes,Mucosal Melanoma,0
20943,Benign Neoplasm,Localized Ewing Sarcoma,0
20944,Adult,Bladder squamous cell carcinoma stage I,0
20945,Medical Device Emits Smoke,Epithelioid Sarcoma NCI Grade 3,0
20946,Deletion (action),Intraepithelial Melanocytic Hyperplasia,0
20947,Logical Condition,Non-Metastatic Gestational Trophoblastic Tumor,0
20948,Involvement with,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20949,Late,Carcinoma of urinary bladder,0
20950,Relational and Item-Specific Encoding Task,Grade 1 Clear Cell Renal Cell Carcinoma,0
20951,white blood cell type,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20952,operate <remove>,Refractory Bladder Carcinoma,0
20953,Lymphoma,Childhood Anaplastic Large Cell Lymphoma,0
20954,Device system,Endometrial Small Cell Carcinoma,0
20955,Structure of retroorbital region,Stage IB Pancreatic Cancer AJCC v8,0
20956,Old,Acantholytic squamous cell carcinoma,0
20957,diagnosis aspect,Mucinous cystadenofibroma,0
20958,Screening,Squamous cell carcinoma of lip,0
20959,Treating,Refractory Ependymoma,0
20960,Childhood Neuroblastoma,FIGO Stage II Ovarian Cancer,0
20961,Clear fluid,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
20962,Form:Finding:Point in time:{Setting}:Document:{Role},Childhood Lung Non-Small Cell Carcinoma,0
20963,Location,Ovarian Dermoid Cyst with Secondary Carcinoma,0
20964,Moveable,Xeroderma pigmentosum,0
20965,Medications:-:Point in time:^Patient:-,Intraepithelial Melanocytic Hyperplasia,0
20966,Dysplasia,Peripheral primitive neuroectodermal tumor of soft tissue,0
20967,Tryptophanase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
20968,To,Non-Hodgkin Lymphoma During Pregnancy,0
20969,Autosomal recessive inheritance,Metastatic Malignant Neoplasm in the Sellar Region,0
20970,Primary malignant neoplasm,Breast Apocrine Adenoma,0
20971,mast cell,squamous cell carcinoma of the thyroid gland,0
20972,Symptoms,Unfavorable Non-Hodgkin Lymphoma,0
20973,Caucasians,Stage IV Penile Cancer AJCC v7,0
20974,Testis,Astrocytoma of brain,0
20975,Worsening pattern,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
20976,Skin,Granular Cell Leiomyosarcoma,0
20977,Lacking,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
20978,Adenocarcinoma,Malignant Neoplasm with Regional Lymph Node Involvement,0
20979,shared attribute,Metastatic Ductal Breast Carcinoma,0
20980,Status post,Cancer of Urinary Tract,0
20981,+5,FIGO Stage II Ovarian Cancer,0
20982,Recommendation,Cancer of Urinary Tract,0
20983,Specimen Source Codes - Infiltrate,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
20984,Only - dosing instruction fragment,Medulloblastoma,0
20985,H NOS Antibodies,Squamous cell carcinoma of lip,0
20986,Frequently,Intestinal Metaplasia of Bladder Urothelium,0
20987,Beginning,FIGO Stage II Ovarian Cancer,0
20988,survival aspects,Acinar cell carcinoma of pancreas,0
20989,Overall Publication Type,Localized Ewing Sarcoma,0
20990,Referring,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
20991,Percent of Abnormal Cells,Mastocytosis,0
20992,Mental Recall,FIGO Stage II Ovarian Cancer,0
20993,20%,Heavy Chain Deposition Disease,0
20994,Skin,Cervical Fibroepithelial Polyp,0
20995,NCI CTEP SDC Colorectal Cancer Sub-Category Terminology,Fourth Ventricle and Brain Stem Ependymal Tumor,0
20996,Referral placed,Stage IV Colorectal Cancer AJCC v8,0
20997,Adult human body,Chronic Myelomonocytic Leukemia-2,0
20998,Account number:Identifier:Point in time:^Patient:Nominal,Kaposi's sarcoma of skin,0
20999,Part,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21000,Human body structure,Airway Hemangioma,0
21001,Increased,Locally Advanced Squamous Cell Carcinoma,0
21002,Immunotherapy,Papillary squamous cell carcinoma,0
21003,Condyloma,Cervical Adenomyoma,0
21004,54,High Grade Glandular Intraepithelial Neoplasia,0
21005,Bladder Neoplasm,Bladder squamous cell carcinoma stage I,0
21006,Human body structure,Melanomatosis,0
21007,Decreased,Low Grade Squamous Intraepithelial Neoplasia,0
21008,Detectable,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21009,Same,Female Breast Carcinoma,0
21010,Malignant epithelioma,Stage IB Pancreatic Cancer AJCC v8,0
21011,Removed,Cervical Squamous Intraepithelial Neoplasia,0
21012,National origin,Ichthyoses,0
21013,brain cell,Refractory Barrett Esophagus,0
21014,Lymphocyte component of blood,Ichthyoses,0
21015,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
21016,Sarcoma,Atypical Lobular Breast Hyperplasia,0
21017,Smear - instruction imperative,Anterior Urethral Malignant Neoplasm,0
21018,Weight Loss,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21019,Shortness of breath:-:Point in time:^Patient:-,Pilocytic astrocytoma of cerebellum,0
21020,Sometimes,Acute lymphadenitis,0
21021,High Mitosis-Karyorrhexis Index,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21022,Reduction procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21023,Location of Pharyngeal Residue Following Swallowing,Xeroderma pigmentosum,0
21024,Cancer Genus,Carcinoma of urinary bladder,0
21025,Form:Finding:Point in time:{Setting}:Document:{Role},Childhood Anaplastic Large Cell Lymphoma,0
21026,set (group),Childhood Central Nervous System Immature Teratoma,0
21027,Abdominal Cavity,Nasal cavity carcinoma,0
21028,Malignant Neoplasms,Childhood Central Nervous System Ganglioneuroblastoma,0
21029,Condition:Find:Pt:^Patient:Nom,Unfavorable Non-Hodgkin Lymphoma,0
21030,Known,Childhood Choriocarcinoma,0
21031,Chemotherapy Regimen,Mixed astrocytoma-ependymoma,0
21032,therapeutic aspects,Kaposi's sarcoma of skin,0
21033,Standard (qualifier),Recurrent Diffuse Intrinsic Pontine Glioma,0
21034,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Trabecular adenocarcinoma,0
21035,Pathogenic organism,Benign squamous cell tumor,0
21036,Classification of information,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21037,Acute Undifferentiated Leukemia,Werner Syndrome,0
21038,Account number:Identifier:Point in time:^Patient:Nominal,Extra-abdominal fibromatosis,0
21039,include - SetOperator,Cervical Fibroepithelial Polyp,0
21040,Diagnosis,Tumorlet,0
21041,Major <insect>,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21042,Malignant Neoplasms,Trabecular adenocarcinoma,0
21043,Injection procedure,Metaplastic carcinoma of breast,0
21044,radiotherapeutic,Melanomatosis,0
21045,Disease Response,Stage IB Pancreatic Cancer AJCC v8,0
21046,Levels (qualifier value),Gallbladder Adenocarcinoma,0
21047,Derived value,embryonal rhabdomyosarcoma of prostate,0
21048,Case (situation),Ichthyosis,0
21049,NCI CTEP SDC Ewing Sarcoma Sub-Category Terminology,Spermatocytic seminoma,0
21050,Associated with,Hereditary Diffuse Gastric Adenocarcinoma,0
21051,CD34 Measurement,Splenic Manifestation of Hairy Cell Leukemia,0
21052,diagnosis aspect,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21053,Sarcomatous Component Present,Primary Cutaneous Plasmablastic Lymphoma,0
21054,Benign melanocytic nevus,Endometrial Small Cell Carcinoma,0
21055,Patient Reported Outcome Stem,Peripheral primitive neuroectodermal tumor of soft tissue,0
21056,Subject Risk,embryonal rhabdomyosarcoma of prostate,0
21057,Most,mucinous adenocarcinoma of gallbladder,0
21058,Physical findings,Pancreatic carcinoma,0
21059,Healthy,Adult Alveolar Soft Part Sarcoma,0
21060,include - SetOperator,Cervical Squamous Intraepithelial Neoplasia,0
21061,Have Been Vomiting,Nasal cavity carcinoma,0
21062,Very Much,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21063,Dermatologist,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21064,Neoplasms,Benign tumor of eyelid,0
21065,Overall Publication Type,Unicystic ameloblastoma,0
21066,Abdomen,Adult Hepatocellular Carcinoma,0
21067,solid substance,Stage III Cutaneous Melanoma AJCC v6,0
21068,Study Site,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
21069,Adapt (substance),Hereditary corneal dystrophy,0
21070,Monoclonal Gammopathy of Undetermined Significance,Refractory Barrett Esophagus,0
21071,World,Chest Wall Fibromatosis,0
21072,Sepsis,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21073,Adult human body,sarcoma of spinal cord,0
21074,Population Group,squamous cell carcinoma of the thyroid gland,0
21075,Primary operation,Hodgkin lymphoma,0
21076,Changing,Intraepithelial Melanocytic Hyperplasia,0
21077,Australia,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
21078,1+ Score,Stage III Adult Immunoblastic Lymphoma,0
21079,Smear - instruction imperative,Engraftment syndrome,0
21080,Better,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21081,Disease,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21082,Inguinal part of abdomen,Spermatocytic seminoma,0
21083,Squamous cell carcinoma - category,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21084,criteria,Malignant Neoplasm with Regional Lymph Node Involvement,0
21085,regional,FIGO Stage II Ovarian Cancer,0
21086,Substance amount,Recurrent Uveal Melanoma,0
21087,Dental caries,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21088,VARIOUS DRUG CLASSES IN ATC,Central Nervous System Anaplastic Large Cell Lymphoma,0
21089,risk factors,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21090,Severe Extremity Pain,benign mature teratoma of pancreas,0
21091,Specimen Source Codes - Mucus,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
21092,Limited stage (cancer stage),Metaplastic carcinoma of breast,0
21093,Loss of Appetite question,Thyroid Hurthle Cell Carcinoma,0
21094,Characteristics,Localized Askin Tumor,0
21095,mole changes,Fibroadenoma of breast,0
21096,3+ Answer to Question,Benign Carotid Body Paraganglioma,0
21097,Vagina Carcinoma,ALK positive large B-cell lymphoma,0
21098,Area,Cerebral Primitive Neuroectodermal Tumor,0
21099,Females,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21100,N not otherwise specified Antibody,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21101,Etiology aspects,Pancreatic carcinoma,0
21102,Occurrence,Acantholytic squamous cell carcinoma,0
21103,Growth rate,Pleomorphic adenoma of parotid gland,0
21104,high - ActExposureLevelCode,Cerebral hemangioma,0
21105,include - SetOperator,Basal Cell Ameloblastoma,0
21106,What subject filter - Result,Cerebral Primitive Neuroectodermal Tumor,0
21107,Sunscreening Agents,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21108,Neoplasms,Adult Hepatocellular Carcinoma,0
21109,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
21110,Well,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21111,Consistency,Localized Ewing Sarcoma,0
21112,pharmacotherapeutic,Airway Hemangioma,0
21113,Diagnosis,Childhood Fibrillary Astrocytoma,0
21114,Manufactured sign,Cerebral Primitive Neuroectodermal Tumor,0
21115,Attack behavior,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21116,Cicatrix,Periosteal Osteosarcoma,0
21117,Lymphatic,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21118,development aspects,Platinum-Resistant Lung Small Cell Carcinoma,0
21119,shared attribute,Peripheral primitive neuroectodermal tumor of soft tissue,0
21120,International Statistical Classification of Diseases and Related Health Problems,Basal Cell Ameloblastoma,0
21121,Case unit dose,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21122,Form:Finding:Point in time:{Setting}:Document:{Role},Funisitis (disorder),0
21123,Tumor type,FIGO Stage IVA Ovarian Cancer,0
21124,High risk of,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21125,United States,Acute Undifferentiated Leukemia,0
21126,therapeutic aspects,Cancer of Urinary Tract,0
21127,Erythrocytes,mucinous adenocarcinoma of gallbladder,0
21128,Pale color,Tongue Alveolar Soft Part Sarcoma,0
21129,Normal,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21130,Sectioning technique,Malignant neoplasm of gallbladder,0
21131,Urinary Diversion,FIGO Stage IVA Ovarian Cancer,0
21132,Mass of body structure,Childhood Central Nervous System Immature Teratoma,0
21133,Benign Neoplasm,Mucinous adenocarcinoma gastric,0
21134,{Setting},Benign tumor of eyelid,0
21135,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,embryonal rhabdomyosarcoma of prostate,0
21136,Qualitative form,Cancer of Urinary Tract,0
21137,Reported By,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21138,Form:Finding:Point in time:{Setting}:Document:{Role},clear cell adenocarcinoma of gallbladder,0
21139,Relationships,Malignant neoplasm of subglottis,0
21140,Immunosuppression,GIANT PIGMENTED HAIRY NEVUS,0
21141,Occur (action),Thymic Atypical Carcinoid Tumor,0
21142,Gamma globulin,Tonsillar Carcinoma,0
21143,Biomaterial Treatment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21144,Surgery specialty,clear cell adenocarcinoma of gallbladder,0
21145,biomedical tube device,Carcinoma,0
21146,Sunlight,Cervical Fibroepithelial Polyp,0
21147,Often - answer to question,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
21148,Colon <insect>,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21149,low exposure,Refractory Ependymoma,0
21150,Net (qualifier),Malignant neoplasm of choroid,0
21151,Itchiness,Childhood Central Nervous System Ganglioneuroblastoma,0
21152,Numerous,BRCA2 Syndrome,0
21153,What subject filter - Result,ALK positive large B-cell lymphoma,0
21154,Malignant Neoplasms,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
21155,Current (present time),Hemangioma,0
21156,Genetic Marker Expression,Testicular cancer metastatic,0
21157,Damage,Plexosarcoma,0
21158,Tube - unit dose,Stage II Hepatocellular Carcinoma AJCC v8,0
21159,Body Fluids,Rhabdomyosarcoma with ganglionic differentiation,0
21160,Better,Metastatic Lung Small Cell Carcinoma,0
21161,Stomach structure,Ovarian germ cell choriocarcinoma stage IV,0
21162,Process,Childhood Central Nervous System Ganglioneuroblastoma,0
21163,Count of entities,Recurrent Uveal Melanoma,0
21164,Now (temporal qualifier),Recurrent Uveal Melanoma,0
21165,Zone,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
21166,Including (qualifier),Colorectal High Grade B-Cell Lymphoma,0
21167,Decision,Bladder squamous cell carcinoma stage I,0
21168,Form:Finding:Point in time:{Setting}:Document:{Role},Platinum-Resistant Lung Small Cell Carcinoma,0
21169,Metastatic Neoplasm,Stage IB Pancreatic Cancer AJCC v8,0
21170,FAP protein,Placental aromatase deficiency,0
21171,physiological aspects,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21172,Response Likelihood,Malignant neoplasm of olfactory nerve,0
21173,Risk,Unfavorable Non-Hodgkin Lymphoma,0
21174,Easy,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21175,Primary,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21176,Giant Cell Fibroblastoma,Anterior Urethral Malignant Neoplasm,0
21177,Control function,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21178,Fever,Malignant neoplasm of olfactory nerve,0
21179,Adult Liposarcoma,benign mature teratoma of pancreas,0
21180,Malignant neoplasm of skin,Choroid Epithelioid Cell Melanoma,0
21181,Malignant neoplasm of soft tissue,Kaposi's sarcoma of skin,0
21182,CDISC SEND Tumor Findings Results Terminology,Grade 1 Clear Cell Renal Cell Carcinoma,0
21183,Most,Malignant Testicular Sertoli Cell Tumor,0
21184,Eye,BRCA2 Syndrome,0
21185,Coughing,Refractory WHO Grade III Glioma,0
21186,To,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21187,Adenocarcinoma,Squamous cell carcinoma of lip,0
21188,Etiology aspects,Human Papillomavirus-Related Carcinoma,0
21189,Symptomatic,Adult Acute Eosinophilic Leukemia,0
21190,Increased tendency to bruise,Werner Syndrome,0
21191,Condition:Find:Pt:^Patient:Nom,Metastatic Lung Small Cell Carcinoma,0
21192,Approach,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21193,Neoplasms,Splenic Manifestation of Hairy Cell Leukemia,0
21194,Continuance of life,Testicular cancer metastatic,0
21195,Primary,Blood Vessel Tumors,0
21196,Approximate,Bladder adenocarcinoma stage IV,0
21197,PSA Level Less than Two,Trabecular adenocarcinoma,0
21198,Skull,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21199,Body tissue,Locally Advanced Carcinoma,0
21200,Contrast,Breast Apocrine Adenoma,0
21201,disease markers,Undifferentiated Neuroblastoma,0
21202,Risk,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21203,Benign neoplasm of uterus,Carcinomatosis of peritoneal cavity,0
21204,Cell Shape,Nasal cavity carcinoma,0
21205,Numerous,Xeroderma pigmentosum,0
21206,Hair Specimen,Human Papillomavirus-Related Carcinoma,0
21207,Medulla,Malignant melanoma of eyelid,0
21208,Malignant Neoplasms,Stage IB Pancreatic Cancer AJCC v8,0
21209,Inguinal part of abdomen,Splenic Manifestation of Hairy Cell Leukemia,0
21210,Use of,Undifferentiated Endocervical Sarcoma,0
21211,risk factors - observation list,Benign Carotid Body Paraganglioma,0
21212,Linear,Benign neoplasm of eye,0
21213,Male population group,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
21214,Persons,Chondrosarcoma,0
21215,Early,Adult Alveolar Soft Part Sarcoma,0
21216,Organ,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21217,Involvement with,FIGO Stage IVA Ovarian Cancer,0
21218,Retinoic Acid Response Element,Medulloblastoma,0
21219,Most,Acute Undifferentiated Leukemia,0
21220,Hematological Disease,Metaplastic carcinoma of breast,0
21221,Cessation of life,Placental aromatase deficiency,0
21222,Involvement with,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21223,Removing (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21224,CEL gene,benign mature teratoma of pancreas,0
21225,Histopathologic Grade,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21226,Sodium Cation,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21227,Top (position),Undifferentiated Endocervical Sarcoma,0
21228,65+,Pilocytic astrocytoma of cerebellum,0
21229,Thymus Neoplasms,Splenic Manifestation of Hairy Cell Leukemia,0
21230,Breast Feeding,Undifferentiated Endocervical Sarcoma,0
21231,Techniques,FIGO Stage IVA Ovarian Cancer,0
21232,Neoplasms,Malignant neoplasm of olfactory nerve,0
21233,Plasma Cells,Refractory Bladder Carcinoma,0
21234,Stem of Organ,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21235,With shape,Nasal cavity carcinoma,0
21236,Basis - conceptual entity,Melanomatosis,0
21237,Singular,Intracortical osteosarcoma,0
21238,Biomaterial Treatment,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
21239,Pentaerythritol Tetranitrate,Lipoma of small intestine,0
21240,trend,Colorectal High Grade B-Cell Lymphoma,0
21241,Room of building - Study,Chronic Myelomonocytic Leukemia-2,0
21242,50%,Benign Anal Granular Cell Tumor,0
21243,Chemotherapy Drugs Adminstered,Thymic Atypical Carcinoid Tumor,0
21244,Base - General Qualifier,Acantholytic squamous cell carcinoma,0
21245,Permutation,Intraepithelial Melanocytic Hyperplasia,0
21246,Nasal (intended site),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21247,Longitudinal Studies,BRCA2 Syndrome,0
21248,Characteristics,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21249,Widening,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
21250,Observation Interpretation - intermediate,Blepharal carcinoma,0
21251,Cell Count,Stage IB Pancreatic Cancer AJCC v8,0
21252,Leading,Mucinous adenocarcinoma gastric,0
21253,Woman,Chronic Myelomonocytic Leukemia-2,0
21254,Common (qualifier value),Chronic Myelomonocytic Leukemia-2,0
21255,Uncertain - Response,FIGO Stage II Ovarian Cancer,0
21256,Deterioration of status,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21257,Type - attribute,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
21258,High,Trichilemmocarcinoma,0
21259,Beginning,Ovarian germ cell choriocarcinoma stage IV,0
21260,Severe Extremity Pain,Vaginal Adenoid Cystic Carcinoma,0
21261,To,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21262,Type A,clear cell adenocarcinoma of gallbladder,0
21263,Body Site Modifier - Lower,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21264,Malignant neoplasm of lung,Tonsillar Carcinoma,0
21265,Call (Instruction),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21266,Adult human body,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21267,Malignant epithelioma,Squamous cell carcinoma of lip,0
21268,Primary malignant neoplasm,Pancreatic Endocrine Carcinoma,0
21269,Old,Atypical Mesothelial Hyperplasia,0
21270,Linear,Kaposi's sarcoma of extrahepatic bile duct,0
21271,Extension,Blepharal carcinoma,0
21272,Body structure,Peripheral primitive neuroectodermal tumor of soft tissue,0
21273,Aluminum measurement,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21274,Esophagus,Adult Acute Eosinophilic Leukemia,0
21275,65+,Endometrial Small Cell Carcinoma,0
21276,Data Compression,Benign Anal Granular Cell Tumor,0
21277,Body surface,Refractory Ependymoma,0
21278,Childhood Diffuse Large B-Cell Lymphoma,Refractory Bladder Carcinoma,0
21279,Cell surface,Airway Hemangioma,0
21280,Stem of Organ,Larynx carcinoma recurrent,0
21281,Chemotherapy Regimen,Xeroderma pigmentosum,0
21282,Tissue Specimen Code,Unicystic ameloblastoma,0
21283,Childhood Lymphoma,Adenocarcinoma,0
21284,Chemotherapy,Localized Ewing Sarcoma,0
21285,Treated with,High Grade Glandular Intraepithelial Neoplasia,0
21286,Malignant Neoplasms,Refractory Ependymoma,0
21287,Neoplasm of subglottis,Endometrial Small Cell Carcinoma,0
21288,Arising in,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21289,Cover (physical object),Stage IB Pancreatic Cancer AJCC v8,0
21290,unknown vaccine or immune globulin,Stage I Adult Non-Hodgkin Lymphoma,0
21291,Surgery specialty,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21292,Domain (area of knowledge),Stage III Gastric Neuroendocrine Tumor AJCC v8,0
21293,Result,Leptomeningeal sarcoma,0
21294,Aspiration-action,Adult Alveolar Soft Part Sarcoma,0
21295,2+ Score,Cerebral Primitive Neuroectodermal Tumor,0
21296,Type - attribute,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21297,To,Advanced Lung Carcinoma,0
21298,Barite,non-Hodgkin's lymphoma of spleen,0
21299,Skin Erosion,Digestive System Hodgkin Lymphoma,0
21300,CDISC Findings Class,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21301,Hollow shape,FIGO Stage II Ovarian Cancer,0
21302,Resolution,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21303,Structure of lumen of body system,Brain Tumor,0
21304,bony process,FIGO Stage II Ovarian Cancer,0
21305,Manufactured form,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21306,Tryptophanase,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
21307,Fasting,Refractory Ependymoma,0
21308,Blastoma,Blood Vessel Tumors,0
21309,Child,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21310,Primary malignant neoplasm,Placental aromatase deficiency,0
21311,Therapy Object (animal model),Refractory Bladder Carcinoma,0
21312,Feel Tired question,Kaposi's sarcoma of extrahepatic bile duct,0
21313,Type - attribute,Childhood Central Nervous System Ganglioneuroblastoma,0
21314,Most,Kaposi's sarcoma of skin,0
21315,Appearance of breast,Fibroadenoma of breast,0
21316,Lymphatic,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21317,Cessation of life,Childhood Central Nervous System Ganglioneuroblastoma,0
21318,Vaginal Neoplasms,FIGO Stage II Ovarian Cancer,0
21319,Affecting,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21320,common types,Localized Askin Tumor,0
21321,Therapeutic procedure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21322,To,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21323,Leukocytes,Mixed astrocytoma-ependymoma,0
21324,Rare,adenoid cystic carcinoma of lung,0
21325,Granulocytes Product,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21326,Group A (blood group),Pancreatic carcinoma,0
21327,Presentation,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21328,Fatigue,Necrotizing Funisitis,0
21329,Has property,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21330,combination - answer to question,Squamous cell carcinoma of lip,0
21331,Hematochezia,Breast Ductal Adenoma,0
21332,Neoplasms,Mucinous adenocarcinoma gastric,0
21333,Distant,Ichthyoses,0
21334,Count of entities,Pilocytic astrocytoma of cerebellum,0
21335,Benign Neoplasm,Locally Advanced Soft Tissue Sarcoma,0
21336,Metastatic to,Pancreatic Intraepithelial Neoplasia-3,0
21337,Covered (qualifier value),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
21338,Physical Activity Measurement,Benign neoplasm of eye,0
21339,treatment - ActInformationManagementReason,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21340,Leukemia,Ovarian germ cell choriocarcinoma stage IV,0
21341,Growth action,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21342,Statistical Prevalence,Ichthyosis,0
21343,Childhood Acute Megakaryoblastic Leukemia,Carcinoma of submandibular gland,0
21344,Include (action),Intraepithelial Melanocytic Hyperplasia,0
21345,Diagnosis Study,Heavy Chain Deposition Disease,0
21346,Does swallow,Recurrent Primary Lymphoma of Bone,0
21347,Cell Count,Fibroadenoma of breast,0
21348,Present,Intraepithelial Melanocytic Hyperplasia,0
21349,Polypeptide Hormones,Secondary malignant neoplasm of lymph node,0
21350,Reside,Contact dermatitis due to alkali,0
21351,Body tissue,Brain Ependymoma,0
21352,Cells,Small intestine carcinoma,0
21353,Malignant neoplasm of brain,Unicystic ameloblastoma,0
21354,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Rhabdomyosarcoma,0
21355,Neuroectodermal Tumor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21356,Malignant Neoplasms,Undifferentiated Endocervical Sarcoma,0
21357,Mixed (qualifier value),Human Papillomavirus-Related Carcinoma,0
21358,Common Specifications in HL7 V3 Publishing,Diffuse malignant mesothelioma,0
21359,Acral,FIGO Stage IVA Ovarian Cancer,0
21360,Woman,Spermatocytic seminoma,0
21361,IPSS Risk Category Low,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
21362,Neoplasms,Benign Anal Granular Cell Tumor,0
21363,Coding,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21364,National Cancer Institute,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
21365,animal allergen extracts,Childhood Central Nervous System Ganglioneuroblastoma,0
21366,Most,Maxillary Sinus Adenoid Cystic Carcinoma,0
21367,Occurrence,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21368,Biopsy,Breast Apocrine Adenoma,0
21369,Greater,Mucinous cystadenofibroma,0
21370,Primary malignant neoplasm of appendix,Gallbladder Adenocarcinoma,0
21371,Metastatic malignant neoplasm to brain,Spongiotic dermatitis,0
21372,Main,Nasal cavity carcinoma,0
21373,Age,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21374,Sore skin,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21375,Approximate,Stage III Adult Immunoblastic Lymphoma,0
21376,Firstly,Stage 0 Lip Carcinoma,0
21377,Simian virus 40,FIGO Stage IVA Ovarian Cancer,0
21378,Check ligament,Malignant neoplasm of subglottis,0
21379,Neoplasms,Intraepithelial Melanocytic Hyperplasia,0
21380,*Type - Kind of quantity,Stage 0 Penile Cancer AJCC v8,0
21381,Curettage procedure,Ectomesenchymal Chondromyxoid Tumor,0
21382,Normal,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21383,cell type,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21384,include - SetOperator,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
21385,Anatomic Site,Hemangioma,0
21386,Lung,Ampulla of Vater Tubular Adenoma,0
21387,Rate,Intestinal Metaplasia of Bladder Urothelium,0
21388,Woolly hair nevus,Noninfiltrating Intraductal Carcinoma,0
21389,Age at diagnosis:Time:Pt:^Patient:Qn,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21390,Nuclear pleomorphism,Malignant melanoma of eyelid,0
21391,Point in time,FIGO Stage IVA Ovarian Cancer,0
21392,Excision,Heavy Chain Deposition Disease,0
21393,Include (action),Acute lymphadenitis,0
21394,Magnetic Resonance Imaging,Brain Tumor,0
21395,pharmacotherapeutic,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21396,Retinoic Acid Response Element,Stage III Adult Immunoblastic Lymphoma,0
21397,GDF15 protein,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21398,Beginning,Kaposi's sarcoma of skin,0
21399,Mental association,Breast Ductal Adenoma,0
21400,Poor function,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21401,Cessation of life,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
21402,Usual,Locally Advanced Carcinoma,0
21403,Including (qualifier),Childhood Fibrillary Astrocytoma,0
21404,Pruritus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21405,Senility,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21406,Simple,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21407,Chemotherapy Regimen,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21408,Fever symptoms (finding),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21409,Etiology aspects,Xeroderma pigmentosum,0
21410,Variant,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21411,User Group,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21412,Diagnosis Study,Vaginal Adenoid Cystic Carcinoma,0
21413,Pelvic cavity structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21414,Macrophage Activation Syndrome,Unfavorable Non-Hodgkin Lymphoma,0
21415,Etiology aspects,High Grade Glandular Intraepithelial Neoplasia,0
21416,Point,Squamous cell carcinoma of lip,0
21417,risk factors - observation list,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
21418,Squamous cell carcinoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
21419,Easy bleeding,Maxillary Sinus Adenoid Cystic Carcinoma,0
21420,radiotherapeutic,Bladder adenocarcinoma stage IV,0
21421,Smell Perception,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21422,Feature,Carcinomatosis of peritoneal cavity,0
21423,Previous,Digestive System Hodgkin Lymphoma,0
21424,Elbow,Stage IB Lung Cancer AJCC v7,0
21425,Brain Neoplasms,GIANT PIGMENTED HAIRY NEVUS,0
21426,Muscle (organ),Xeroderma pigmentosum,0
21427,Woman,Mucinous adenocarcinoma,0
21428,Leg,Type II Endometrial Adenocarcinoma,0
21429,Term (lexical),Botryoid-Type Embryonal Rhabdomyosarcoma,0
21430,Easy,Stage 0 Penile Cancer AJCC v8,0
21431,Spreading (qualifier value),Stage II Fallopian Tube Cancer,0
21432,Blood group A (finding),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21433,shared attribute,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21434,Congenital Abnormality,Unicystic ameloblastoma,0
21435,>90,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21436,Metastatic Disease Clinical Trial Setting,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21437,lymph nodes,Mixed astrocytoma-ependymoma,0
21438,Smear - instruction imperative,Benign Anal Granular Cell Tumor,0
21439,Marrow plasma cell,Extracranial Neuroblastoma,0
21440,Severe Extremity Pain,Multiple Endocrine Neoplasia,0
21441,Most,Botryoid-Type Embryonal Rhabdomyosarcoma,0
21442,Parotid swelling,Unicystic ameloblastoma,0
21443,combination - answer to question,Neonatal leukemia,0
21444,Adipocytes,embryonal rhabdomyosarcoma of prostate,0
21445,Nasal bone structure,Ovarian Carcinoid Tumor,0
21446,Cell Count,Lipoma of small intestine,0
21447,Symptoms aspect,Refractory Bladder Carcinoma,0
21448,Part,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21449,Cover - action,Advanced Uterine Corpus Carcinosarcoma,0
21450,Call (Instruction),Thymic Clear Cell Carcinoma,0
21451,various allergen extracts,Platinum-Resistant Lung Small Cell Carcinoma,0
21452,Only - dosing instruction fragment,Uterine Cancer,0
21453,Malignant neoplasm of soft tissue,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21454,Neoplasms,Thymic Atypical Carcinoid Tumor,0
21455,Case (situation),Ovarian Dermoid Cyst with Secondary Carcinoma,0
21456,Body structure,High Grade Glandular Intraepithelial Neoplasia,0
21457,Manufactured sign,Human Papillomavirus-Related Carcinoma,0
21458,Close,Stage I Colon Neuroendocrine Tumor AJCC v8,0
21459,Tobacco smoking behavior,Refractory Barrett Esophagus,0
21460,To,Mucinous adenocarcinoma gastric,0
21461,Tumor site,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21462,Aspects of signs,Brain Ependymoma,0
21463,Include (action),Bladder squamous cell carcinoma stage I,0
21464,Leading,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21465,Brain Neoplasms,FIGO Stage IVA Ovarian Cancer,0
21466,Second Primary Cancers,Testicular cancer metastatic,0
21467,Negation,Primary Cutaneous Plasmablastic Lymphoma,0
21468,Slight (qualifier value),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21469,Hepatitis C virus,Advanced Lung Carcinoma,0
21470,Chemotherapy Regimen,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
21471,Inferior,BRCA2 Syndrome,0
21472,French-American-British Classification,ROSE Cluster 3,0
21473,operate <remove>,Mixed astrocytoma-ependymoma,0
21474,Adult,Cancer of Urinary Tract,0
21475,monomer,Pancreatic carcinoma,0
21476,Part,Cervical Adenomyoma,0
21477,Enlargement procedure,Xeroderma pigmentosum,0
21478,radiotherapeutic,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21479,Egg of order Phthiraptera,Vaginal Adenoid Cystic Carcinoma,0
21480,Worsening pattern,High Grade Glandular Intraepithelial Neoplasia,0
21481,Biogenic Amines,Undifferentiated Endocervical Sarcoma,0
21482,Bilateral cataracts (disorder),Placental aromatase deficiency,0
21483,Referral placed,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21484,More,non-Hodgkin's lymphoma of spleen,0
21485,Skin Specimen,Malignant melanoma of eyelid,0
21486,Late,Neonatal leukemia,0
21487,pars nervosa of hypophysis,ROSE Cluster 3,0
21488,Reported Term,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21489,Include (action),Endometrial Small Cell Carcinoma,0
21490,Both ovaries,benign mature teratoma of pancreas,0
21491,Medulloblastoma,Metastatic Malignant Neoplasm in the Sellar Region,0
21492,Therapeutic procedure,Intestinal Metaplasia of Bladder Urothelium,0
21493,CDISC SEND Tumor Findings Results Terminology,Non-Metastatic Gestational Trophoblastic Tumor,0
21494,Contrast,Larynx carcinoma recurrent,0
21495,Ulceration,Lipoma of small intestine,0
21496,Females,Benign squamous cell tumor,0
21497,Benign,Splenic Manifestation of Hairy Cell Leukemia,0
21498,Uterine Corpus Sarcoma,Congenital hamartoma,0
21499,Web Site,Adenocarcinoma of the prostate metastatic,0
21500,Malignant Neoplasms,Microcystic meningioma,0
21501,Squamous cell carcinoma,FIGO Stage IVA Ovarian Cancer,0
21502,Primary operation,Small cell neuroendocrine carcinoma of bladder,0
21503,Area,Stage IB Pancreatic Cancer AJCC v8,0
21504,Used by,Peripheral primitive neuroectodermal tumor of soft tissue,0
21505,Histopathologic Grade,Peripheral primitive neuroectodermal tumor of soft tissue,0
21506,Polyglandular Type I Autoimmune Syndrome,Colorectal High Grade B-Cell Lymphoma,0
21507,ethnic european,Recurrent Primary Lymphoma of Bone,0
21508,Benign,Stage IV Penile Cancer AJCC v7,0
21509,Serum Calcium Level,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21510,Type A,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21511,Requirement,Stage IV Childhood Non-Hodgkin Lymphoma,0
21512,combination of objects,Benign neoplasm of thorax,0
21513,Smear - instruction imperative,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21514,Life,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21515,Linear,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
21516,risk factors - observation list,Refractory Ependymoma,0
21517,Differentiation,Diffuse malignant mesothelioma,0
21518,Operative Surgical Procedures,Cervical Adenomyoma,0
21519,Consortium or Network,FIGO Stage II Ovarian Cancer,0
21520,Rare,Placental aromatase deficiency,0
21521,Term Source,Cervical Fibroepithelial Polyp,0
21522,Skin Specimen,Brain Ependymoma,0
21523,Act Mood - intent,Periosteal Osteosarcoma,0
21524,Therapeutic procedure,Liver Lymphangioma,0
21525,*Type - Kind of quantity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21526,Experimental Result,Locally Advanced Soft Tissue Sarcoma,0
21527,Carcinoma,Multiple Skull Base Meningiomas,0
21528,Classification of information,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21529,Fighting,Kaposi's sarcoma of extrahepatic bile duct,0
21530,Nose,Malignant Neoplasm of Lung - Multiple Primary Sites,0
21531,Spreading (qualifier value),Malignant Neoplasm of Lung - Multiple Primary Sites,0
21532,diagnosis aspect,Endometrial Small Cell Carcinoma,0
21533,Obesity,Stage III Cutaneous Melanoma AJCC v6,0
21534,seen,Localized Ewing Sarcoma,0
21535,Percent of Abnormal Cells,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
21536,Greater,Adult Acute Eosinophilic Leukemia,0
21537,Decision,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21538,Papillomavirus,Advanced Uterine Corpus Carcinosarcoma,0
21539,CLEC4D gene,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21540,Upper surface of body of first segment of coccyx,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21541,Adenocarcinoma of large intestine,Cervical Fibroepithelial Polyp,0
21542,Lymphocyte,Plexosarcoma,0
21543,Sequence Data Type,Squamous cell carcinoma of lip,0
21544,Thyroid hormone (disposition),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21545,Primary operation,BRCA2 Syndrome,0
21546,Clinical,Diffuse malignant mesothelioma,0
21547,Metastatic Disease Clinical Trial Setting,Engraftment syndrome,0
21548,Human body,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21549,Tissue Specimen Code,Cancer of Urinary Tract,0
21550,include - SetOperator,Recurrent Primary Lymphoma of Bone,0
21551,Thymus Gland,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21552,Bloody,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21553,Tract,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21554,Swollen Lymph Node,Adult Acute Eosinophilic Leukemia,0
21555,Interruption,Unicystic ameloblastoma,0
21556,Leading,FIGO Stage II Ovarian Cancer,0
21557,Disease,Hemangioma,0
21558,Pediatrics,BRCA2 Syndrome,0
21559,3+ Score,Squamous cell carcinoma of lip,0
21560,Squamous Epithelial Cells,Maxillary Sinus Adenocarcinoma,0
21561,Tryptophanase,Kaposi's sarcoma of extrahepatic bile duct,0
21562,Woman,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21563,Slightly (qualifier value),Locally Advanced Carcinoma,0
21564,Persistent embryonic structure,Hodgkin lymphoma,0
21565,Malignant Neoplasms,Spermatocytic seminoma,0
21566,Type - attribute,Childhood Central Nervous System Ganglioneuroblastoma,0
21567,Isolate - microorganism,Multiple Skull Base Meningiomas,0
21568,Penetrance,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
21569,Include (action),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21570,Pancreatitis,Gallbladder Adenocarcinoma,0
21571,Chorionic Gonadotropin,Stage III Cutaneous Melanoma AJCC v6,0
21572,Persons,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21573,Esthesia,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21574,Operative Surgical Procedures,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21575,Togo,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21576,Benign Neoplasm,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21577,Retinoic Acid Response Element,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
21578,Young,Benign squamous cell tumor,0
21579,Common Specifications in HL7 V3 Publishing,Xeroderma pigmentosum,0
21580,Condition,Extracranial Neuroblastoma,0
21581,Previous,Methotrexate-Associated Hodgkin Lymphoma,0
21582,Occurrence,Type II Endometrial Adenocarcinoma,0
21583,high - ActExposureLevelCode,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21584,Type A,Childhood Central Nervous System Ganglioneuroblastoma,0
21585,Limited stage (cancer stage),Anaplastic large cell lymphoma,0
21586,<50,Malignant neoplasm of thalamus,0
21587,Hematological Disease,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21588,Excision,Stage IB Pancreatic Cancer AJCC v8,0
21589,majority,Pancreatic Intraepithelial Neoplasia-3,0
21590,Sedentary,Papillary cystic tumor,0
21591,Call (Instruction),Lung squamous cell carcinoma stage I,0
21592,Unmarried person,Chronic Myelomonocytic Leukemia-2,0
21593,30%,Peripheral primitive neuroectodermal tumor of soft tissue,0
21594,90%,Vaginal Adenoid Cystic Carcinoma,0
21595,other medicated shampoos in ATC,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21596,High Level,Squamous cell carcinoma of lip,0
21597,Ovary,Benign neoplasm of eye,0
21598,Upper,Urethral Carcinoma,0
21599,Lower jaw region,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21600,Poor - grade value,Localized Askin Tumor,0
21601,Frequently,Uterine Cancer,0
21602,Tunnel structure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
21603,newly,Extra-abdominal fibromatosis,0
21604,Disease Screening,Malignant neoplasm of gallbladder,0
21605,Pain NOS,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
21606,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Carcinoma of urinary bladder,0
21607,Absent,Refractory Ependymoma,0
21608,N+ (tumor staging),Familial Hemophagocytic Lymphocytosis,0
21609,status - In progress,mucinous adenocarcinoma of gallbladder,0
21610,Form of bone,Bladder Neuroendocrine Neoplasm,0
21611,To,Vaginal Adenoid Cystic Carcinoma,0
21612,Test - temporal region,Pancreatic Endocrine Carcinoma,0
21613,Etiology aspects,Hereditary Diffuse Gastric Adenocarcinoma,0
21614,Areas <moth>,Lipoma of small intestine,0
21615,Lymphoma,Locally Advanced Squamous Cell Carcinoma,0
21616,subscriber - self,Refractory Ependymoma,0
21617,Cancer Genus,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21618,Condition:Find:Pt:^Patient:Nom,Locally Advanced Epithelioid Hemangioendothelioma,0
21619,Transection (procedure),Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21620,Continuance of life,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21621,Forecast of outcome,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21622,Diabetes Mellitus,Kaposi's sarcoma of extrahepatic bile duct,0
21623,Elements,Ovarian germ cell choriocarcinoma stage IV,0
21624,Bilateral salpingectomy with oophorectomy,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21625,Include (action),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21626,Disease,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21627,Mucous Membrane,Intestinal Neuroendocrine Carcinoma,0
21628,various allergen extracts,Mucinous adenocarcinoma,0
21629,Vaginal (intended site),Familial Hemophagocytic Lymphocytosis,0
21630,epithelial,Splenic Manifestation of Hairy Cell Leukemia,0
21631,high - ActExposureLevelCode,clear cell adenocarcinoma of gallbladder,0
21632,Tryptophanase,Basal Cell Ameloblastoma,0
21633,Group A (blood group),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
21634,Genetic Markers,clear cell adenocarcinoma of gallbladder,0
21635,BRCA2 protein,Cancer of Urinary Tract,0
21636,Experimental Result,Benign neoplasm of thorax,0
21637,year,Bladder Neuroendocrine Neoplasm,0
21638,Inguinal part of abdomen,Malignant neoplasm of choroid,0
21639,Entity Determiner - specific,Refractory Barrett Esophagus,0
21640,Blood Cells,Female Breast Carcinoma,0
21641,Family (taxonomic),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
21642,Taxonomic,Astrocytoma of brain,0
21643,Benign,Epithelioid Sarcoma NCI Grade 3,0
21644,Food allergenic extracts,Ovarian Dermoid Cyst with Secondary Carcinoma,0
21645,Togo,Small cell neuroendocrine carcinoma of bladder,0
21646,Phenotype determination,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
21647,Diagnostic Imaging,Engraftment syndrome,0
21648,Structure of parenchyma of lung,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21649,Observation of reflex,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
21650,Known,High Grade Glandular Intraepithelial Neoplasia,0
21651,Sarcoma,Microcystic meningioma,0
21652,depend,Nasal cavity carcinoma,0
21653,Evidence,Endometrial Small Cell Carcinoma,0
21654,Human body,Type II Endometrial Adenocarcinoma,0
21655,Aggressive course,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
21656,Crystal Present Or Absent (lab procedure),Type II Endometrial Adenocarcinoma,0
21657,One,Giant cell angiofibroma,0
21658,Head,Intraepithelial Melanocytic Hyperplasia,0
21659,Usual,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
21660,Males,Metastatic Lung Small Cell Carcinoma,0
21661,Patient Condition Code - Stable,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21662,Shoulder,Refractory Ependymoma,0
21663,Complete excision,Noninfiltrating Intraductal Carcinoma,0
21664,therapeutic aspects,Uterine Cancer,0
21665,Cerebral Cavernous Hemangioma,Breast Ductal Adenoma,0
21666,bony process,Colorectal High Grade B-Cell Lymphoma,0
21667,Meningeal cluster,Mixed astrocytoma-ependymoma,0
21668,Classification of information,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21669,treatment - ActInformationManagementReason,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
21670,Very high,Congenital hamartoma,0
21671,Back,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21672,Cancer Genus,Adenocarcinoma,0
21673,Subject -direct target,Testicular cancer metastatic,0
21674,Weight decreased,Digestive System Hodgkin Lymphoma,0
21675,Five,mucinous adenocarcinoma of gallbladder,0
21676,Vomiting,Mucosal Melanoma,0
21677,One,Xeroderma pigmentosum,0
21678,Massive,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
21679,Spreading (qualifier value),Primary Cutaneous Plasmablastic Lymphoma,0
21680,Combined,Stage III Cutaneous Melanoma AJCC v6,0
21681,Logical Condition,Mixed astrocytoma-ependymoma,0
21682,shared attribute,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21683,Treating,Stage IV Penile Cancer AJCC v7,0
21684,BRCA2 protein,Childhood Fibrillary Astrocytoma,0
21685,Offspring,Human Papillomavirus-Related Carcinoma,0
21686,Term Birth,Gallbladder Adenocarcinoma,0
21687,Nursing interventions,Diffuse malignant mesothelioma,0
21688,Common (qualifier value),Maxillary Sinus Adenoid Cystic Carcinoma,0
21689,diagnosis aspect,Giant cell angiofibroma,0
21690,Form:Finding:Point in time:{Setting}:Document:{Role},Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21691,Spreading (qualifier value),non-Hodgkin's lymphoma of spleen,0
21692,Leading,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21693,Malignant - descriptor,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
21694,Persons,Trichilemmocarcinoma,0
21695,International Statistical Classification of Diseases and Related Health Problems,Cervical Squamous Intraepithelial Neoplasia,0
21696,Different,Cancer of Urinary Tract,0
21697,Positron-Emission Tomography,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21698,Negation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
21699,Tryptophanase,Recurrent Uveal Melanoma,0
21700,To,Stage III Cutaneous Melanoma AJCC v6,0
21701,Expiration,Mucinous adenocarcinoma gastric,0
21702,Combined,Mucinous adenocarcinoma gastric,0
21703,Cutaneous Melanoma,Cervical Adenomyoma,0
21704,Severe Extremity Pain,Cerebral Primitive Neuroectodermal Tumor,0
21705,Advanced phase,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21706,Pharmaceutical Preparations,Neonatal leukemia,0
21707,Localized,Fibroadenoma of breast,0
21708,T-Lymphocyte,Thymic Clear Cell Carcinoma,0
21709,Cystoscopy,FIGO Stage II Ovarian Cancer,0
21710,Human Cells,Refractory Glioma,0
21711,Give - dosing instruction imperative,Blepharal carcinoma,0
21712,Vaginal neoplasia,Transitional cell carcinoma,0
21713,Coitus,Platinum-Resistant Lung Small Cell Carcinoma,0
21714,Chemotherapy,Mucosal Melanoma,0
21715,United States,Refractory Ependymoma,0
21716,Usual,Tongue Alveolar Soft Part Sarcoma,0
21717,Intraocular,Pilocytic astrocytoma of cerebellum,0
21718,Lymphocyte,Engraftment syndrome,0
21719,Family (taxonomic),Carcinoma ex pleomorphic adenoma of parotid gland,0
21720,CEL gene,mucinous adenocarcinoma of gallbladder,0
21721,Thickened,Female Breast Carcinoma,0
21722,Publications,Thymic Clear Cell Carcinoma,0
21723,Subject Risk,Cervical Squamous Intraepithelial Neoplasia,0
21724,Part of,Methotrexate-Associated Hodgkin Lymphoma,0
21725,dendritic spine neck,Cartilaginous exostosis,0
21726,Back structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21727,Malignant neoplasm of urinary bladder,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21728,Partial larynx,Intraepithelial Melanocytic Hyperplasia,0
21729,Cardiovascular system,Cherubism,0
21730,Name (property) (qualifier value),Localized Askin Tumor,0
21731,100%,Microcystic meningioma,0
21732,To,Human Papillomavirus-Related Carcinoma,0
21733,Blood Cells,Malignant melanoma of eyelid,0
21734,Ependymoma,Bladder Neuroendocrine Neoplasm,0
21735,Two,Splenic Manifestation of Hairy Cell Leukemia,0
21736,Present,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
21737,Smear - instruction imperative,Squamous cell carcinoma of lip,0
21738,Distant,Adult Hepatocellular Carcinoma,0
21739,Measurement,Metaplastic carcinoma of breast,0
21740,Measured Tumor Identification,Small cell neuroendocrine carcinoma of bladder,0
21741,Cervical Squamous Cell Carcinoma,Familial Hemophagocytic Lymphocytosis,0
21742,Secondary Neoplasm,Kaposi's sarcoma of skin,0
21743,Swollen Lymph Node,Ovarian germ cell choriocarcinoma stage IV,0
21744,Related personal status,Peripheral primitive neuroectodermal tumor of soft tissue,0
21745,Version,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21746,Array Feature,Engraftment syndrome,0
21747,Primitive,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
21748,Tissue Type Code - Basal cell carcinoma,Thyroid Hurthle Cell Carcinoma,0
21749,STS gene,Stage II Carcinoma of Penis,0
21750,Appearance Distress Question,Female Breast Carcinoma,0
21751,Grouped (foundation metadata concept),Low Grade Squamous Intraepithelial Neoplasia,0
21752,Location of Oral Residue Following Swallowing,Periosteal Osteosarcoma,0
21753,Sore skin,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21754,Concept History,Adult Alveolar Soft Part Sarcoma,0
21755,Vitamin supplementation,Benign tumor of eyelid,0
21756,Pediculus humanus capitis (eukaryote),Chronic Myelomonocytic Leukemia-2,0
21757,Glioblastoma Multiforme,Trabecular adenocarcinoma,0
21758,Accepted,Pancreatic Intraepithelial Neoplasia-3,0
21759,Present,Adult Alveolar Soft Part Sarcoma,0
21760,General surgery specialty,Acute Undifferentiated Leukemia,0
21761,Small,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
21762,Control function,Benign tumor of eyelid,0
21763,Diarrhea,Metastatic Lung Small Cell Carcinoma,0
21764,Best Case Imputation Technique,Low Grade Squamous Intraepithelial Neoplasia,0
21765,survival aspects,Benign Apocrine Neoplasm,0
21766,Asians,ROSE Cluster 3,0
21767,Condition:Find:Pt:^Patient:Nom,Intestinal Metaplasia of Bladder Urothelium,0
21768,Recurrence,Trabecular adenocarcinoma,0
21769,Pharmacotherapy,Childhood Lung Non-Small Cell Carcinoma,0
21770,Condylomata Acuminata,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21771,Chemotherapy,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21772,Often - answer to question,ROSE Cluster 3,0
21773,Moveable,Cancer of Urinary Tract,0
21774,Eating,Childhood Fibrillary Astrocytoma,0
21775,survival aspects,Nasal cavity carcinoma,0
21776,Apply (instruction),FIGO Stage II Ovarian Cancer,0
21777,section sample,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21778,Age of onset of symptoms:Time:Pt:^Patient:Qn,Contact dermatitis due to alkali,0
21779,Name (property) (qualifier value),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21780,Linear,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21781,Arsenic,Colorectal cancer,0
21782,Human body structure,Undifferentiated Endocervical Sarcoma,0
21783,Aspects of disease screening,Benign squamous cell tumor,0
21784,Fatigue,Melanomatosis,0
21785,Table Rules - groups,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21786,diagnosis aspect,Stage III Cutaneous Melanoma AJCC v6,0
21787,Aberrant,Malignant neoplasm of olfactory nerve,0
21788,Therapeutic radiology procedure,Chronic Myelomonocytic Leukemia-2,0
21789,Usually Need Help from Another Person for Arising,FIGO Stage II Ovarian Cancer,0
21790,Antibodies,Melanomatosis,0
21791,Name (property) (qualifier value),Small Intestinal Villous Adenoma,0
21792,Life,adenosquamous carcinoma of breast,0
21793,treatment - ActInformationManagementReason,High Grade Glandular Intraepithelial Neoplasia,0
21794,Pain,Squamous cell carcinoma of lip,0
21795,800,Intestinal Metaplasia of Bladder Urothelium,0
21796,Case Study,Pleomorphic adenoma of parotid gland,0
21797,Probable diagnosis,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
21798,Difficulty walking,Acute Undifferentiated Leukemia,0
21799,Esophagitis,Chondrosarcoma,0
21800,Operative Surgical Procedures,Cervical Squamous Intraepithelial Neoplasia,0
21801,Organ,Thymic Atypical Carcinoid Tumor,0
21802,Manual pelvic examination (procedure),Acute Undifferentiated Leukemia,0
21803,Leukemic Cells Measurement,Human Papillomavirus-Related Carcinoma,0
21804,Skeletal bone,Collecting Duct Carcinoma of the Kidney,0
21805,Older Population,Mucinous adenocarcinoma gastric,0
21806,Child,Fibroadenoma of breast,0
21807,Infection,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21808,Feelings,clear cell adenocarcinoma of gallbladder,0
21809,Cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21810,Pain,Breast Ductal Adenoma,0
21811,Metastasis,Malignant Neoplasm with Regional Lymph Node Involvement,0
21812,Intrinsic origin,Advanced Uterine Corpus Carcinosarcoma,0
21813,Human body,Pancreatic carcinoma,0
21814,To,Metastatic Lung Neuroendocrine Neoplasm,0
21815,Cell Count,Stage IB Pancreatic Cancer AJCC v8,0
21816,International Classification of Disease for Oncology,Stage II Carcinoma of Penis,0
21817,Cell Communication,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21818,Exact (qualifier),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21819,Secondary to,Refractory Bladder Carcinoma,0
21820,Form:Finding:Point in time:{Setting}:Document:{Role},Acute Undifferentiated Leukemia,0
21821,Disease,Vaginal Adenoid Cystic Carcinoma,0
21822,Volume Measurement,Adult Anaplastic Oligodendroglioma,0
21823,Observed,Nasal cavity carcinoma,0
21824,Limited (extensiveness),Colorectal High Grade B-Cell Lymphoma,0
21825,100%,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21826,Decision,Intestinal Metaplasia of Bladder Urothelium,0
21827,granulocyte,Recurrent Primary Lymphoma of Bone,0
21828,Frequently,Cervical Squamous Intraepithelial Neoplasia,0
21829,Palmitic Acid,Fourth Ventricle and Brain Stem Ependymal Tumor,0
21830,Administration type,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21831,Dysgerminoma,Hereditary Diffuse Gastric Adenocarcinoma,0
21832,Greater than one,Ichthyoses,0
21833,Possibly Related to Intervention,Mixed parotid tumor,0
21834,Relationships,Endometrial Small Cell Carcinoma,0
21835,Scientific Study,Astrocytoma of brain,0
21836,Room of building - Study,Stage IV Childhood Non-Hodgkin Lymphoma,0
21837,Type A,Unfavorable Non-Hodgkin Lymphoma,0
21838,Persons,Benign Anal Granular Cell Tumor,0
21839,Borg Category-Ratio 10 Perceived Exertion Score 5,Stage 0 Penile Cancer AJCC v8,0
21840,Professional Occupation,Hodgkin Disease,0
21841,Human body,Refractory Glioma,0
21842,Childhood Leukemia,Refractory Barrett Esophagus,0
21843,Chemotherapy,Localized Ewing Sarcoma,0
21844,Include (action),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21845,physiological aspects,Maxillary Sinus Adenocarcinoma,0
21846,CDISC SDTM Route of Administration Terminology,Childhood Central Nervous System Ganglioneuroblastoma,0
21847,Count of entities,Locally Advanced Squamous Cell Carcinoma,0
21848,Neoplasm Metastasis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21849,Benzene,Mixed astrocytoma-ependymoma,0
21850,What subject filter - Result,Mixed astrocytoma-ependymoma,0
21851,ABCB1 protein,Childhood Fibrillary Astrocytoma,0
21852,Blood Cells,Melanomatosis,0
21853,Type A,Maxillary Sinus Adenocarcinoma,0
21854,Adenocarcinoma,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21855,Carcinoma,Stage IB Pancreatic Cancer AJCC v8,0
21856,leukemia,BRCA2 Syndrome,0
21857,Defense,Refractory Bladder Carcinoma,0
21858,Ameloblasts,Benign Anal Granular Cell Tumor,0
21859,Subtype (attribute),adenoid cystic carcinoma of lung,0
21860,Chemotherapy Regimen,FIGO Stage II Ovarian Cancer,0
21861,Classification of information,Low Grade Squamous Intraepithelial Neoplasia,0
21862,Squamous cell carcinoma,Clonal Hematopoiesis of Indeterminate Potential,0
21863,Sensation quality,Bladder adenocarcinoma stage IV,0
21864,Benign Neoplasm,Squamous cell carcinoma of lip,0
21865,Common Specifications in HL7 V3 Publishing,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
21866,Egg of order Phthiraptera,Cervical Fibroepithelial Polyp,0
21867,Currarino triad,Uterine Cancer,0
21868,Togo,Mucinous adenocarcinoma gastric,0
21869,Abdomen,Cartilaginous exostosis,0
21870,shared attribute,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
21871,Unspecified,Chronic Myelomonocytic Leukemia-2,0
21872,Asia,clear cell adenocarcinoma of gallbladder,0
21873,Anatomic Site,Malignant neoplasm of subglottis,0
21874,Symptoms aspect,Vaginal Adenoid Cystic Carcinoma,0
21875,Numerous,Stage III Adult Immunoblastic Lymphoma,0
21876,Call (Instruction),Benign squamous cell tumor,0
21877,Dura Mater,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21878,Embryonic Development,Pancreatic Intraepithelial Neoplasia-3,0
21879,Benign Neoplasm,Malignant neoplasm of gallbladder,0
21880,Coitus,Splenic Manifestation of Hairy Cell Leukemia,0
21881,Bloating,Acute Undifferentiated Leukemia,0
21882,Skin Specimen,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21883,various antiinfectives and antiseptics for local oral treatment,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21884,Cell Count,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21885,Antifungal Antibiotics,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21886,Full,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
21887,Does play,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
21888,High Level,Neoplasms,0
21889,Morphology,Childhood Central Nervous System Immature Teratoma,0
21890,Count of entities,Hodgkin lymphoma,0
21891,Scientific Publication,Endometrial Small Cell Carcinoma,0
21892,Ichthyosis,Extra-Adrenal Paraganglioma,0
21893,Used by,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
21894,Point,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
21895,Persons,Benign neoplasm of thorax,0
21896,CYREN gene,Gallbladder Adenocarcinoma,0
21897,European race,Malignant neoplasm of olfactory nerve,0
21898,Overall,Stage I Colon Neuroendocrine Tumor AJCC v8,0
21899,International Classification of Diseases for Oncology,Ectomesenchymal Chondromyxoid Tumor,0
21900,Including (qualifier),Locally Advanced Carcinoma,0
21901,Glioma,Testicular cancer metastatic,0
21902,Human body structure,Leptomeningeal sarcoma,0
21903,Person Observer,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
21904,Use of,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
21905,Malignant Neoplasms,Type II Endometrial Adenocarcinoma,0
21906,Woman,Nasal cavity carcinoma,0
21907,Olfactory Epithelium,Advanced Uterine Corpus Carcinosarcoma,0
21908,Neoplasms,Angiosarcoma of liver,0
21909,Recurrent infections,Refractory Barrett Esophagus,0
21910,Malignant neoplasm of large intestine,Blepharal carcinoma,0
21911,2+ Score,Recurrent Uveal Melanoma,0
21912,Transection (procedure),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21913,Tumor type,FIGO Stage II Ovarian Cancer,0
21914,Nervous system structure,Refractory Barrett Esophagus,0
21915,shared attribute,Pilocytic astrocytoma of cerebellum,0
21916,Both ovaries,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
21917,Confirmed by,Diffuse malignant mesothelioma,0
21918,Containing (qualifier),Lipoma of small intestine,0
21919,Location of Oral Residue Following Swallowing,GIANT PIGMENTED HAIRY NEVUS,0
21920,Procedural approach,FIGO Stage IVA Ovarian Cancer,0
21921,Impaired skin integrity,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
21922,Arising in,Cerebral Primitive Neuroectodermal Tumor,0
21923,Used by,Placental aromatase deficiency,0
21924,risk factors - observation list,Blepharal carcinoma,0
21925,More,Brain Tumor,0
21926,Tumor cells,Blepharal carcinoma,0
21927,Tryptophanase,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
21928,Have Weight Loss,Stage IV Childhood Non-Hodgkin Lymphoma,0
21929,Beginning,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
21930,PREVENT (product),benign mature teratoma of pancreas,0
21931,Patient Reported Outcome Stem,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
21932,Analysis of substances,FIGO Stage IVA Ovarian Cancer,0
21933,Volume (publication),Human Papillomavirus-Related Carcinoma,0
21934,eTMF Content Model Code,Adult Alveolar Soft Part Sarcoma,0
21935,Chronic inflammation,Kaposi's sarcoma of extrahepatic bile duct,0
21936,In Blood,FIGO Stage II Ovarian Cancer,0
21937,Cancer Genus,Stage I Adult Non-Hodgkin Lymphoma,0
21938,Obese build,Childhood Thyroid Gland Follicular Carcinoma,0
21939,Occur (action),Human Papillomavirus-Related Carcinoma,0
21940,Manufactured sign,Stage IV Penile Cancer AJCC v7,0
21941,per second,Locally Advanced Carcinoma,0
21942,Symptoms aspect,Angiosarcoma of liver,0
21943,Reported Term,FIGO Stage IVA Ovarian Cancer,0
21944,Call (Instruction),Undifferentiated Endocervical Sarcoma,0
21945,Malignant - descriptor,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
21946,Highest,Malignant melanoma of eyelid,0
21947,Formations,Xeroderma pigmentosum,0
21948,Subject Risk,Atypical Mesothelial Hyperplasia,0
21949,Prognosis:Find:Pt:^Patient:Nom,Recurrent Testicular Lymphoma,0
21950,Melanoma Pathway,Atypical Lobular Breast Hyperplasia,0
21951,Thinking,Gallbladder Adenocarcinoma,0
21952,Negation,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
21953,Tryptophanase,clear cell adenocarcinoma of gallbladder,0
21954,Variant,Cerebral Primitive Neuroectodermal Tumor,0
21955,False Discovery Rate,Adult Hepatocellular Carcinoma,0
21956,Subtype (attribute),Cervical Fibroepithelial Polyp,0
21957,include - SetOperator,Hereditary Diffuse Gastric Adenocarcinoma,0
21958,Poor - qualifier,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
21959,Severe Extremity Pain,Human Papillomavirus-Related Carcinoma,0
21960,Affect (mental function),Astrocytoma of brain,0
21961,More,Mucinous adenocarcinoma gastric,0
21962,Pharmacologic Substance,Stage III Cutaneous Melanoma AJCC v6,0
21963,Evidence,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
21964,Basis - conceptual entity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
21965,Feelings,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
21966,Smear - instruction imperative,Acute Undifferentiated Leukemia,0
21967,Malignant Female Reproductive System Neoplasm,Locally Advanced Epithelioid Hemangioendothelioma,0
21968,Screening - general NOS (finding),Metaplastic carcinoma of breast,0
21969,Percent of Abnormal Cells,Heavy Chain Deposition Disease,0
21970,Linear,Malignant melanoma of eyelid,0
21971,Most,Papillary squamous cell carcinoma,0
21972,site-specific telomere resolvase activity,Benign Carotid Body Paraganglioma,0
21973,OVARIAN SWELLING,Stage IB Pancreatic Cancer AJCC v8,0
21974,Common (qualifier value),Type II Endometrial Adenocarcinoma,0
21975,week,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
21976,Administration procedure,Angiosarcoma of liver,0
21977,Due to,Diffuse malignant mesothelioma,0
21978,Usual Severity Shortness of Breath,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
21979,Reference Object,Undifferentiated Endocervical Sarcoma,0
21980,Rare Diseases,Hodgkin lymphoma,0
21981,Associated with,Gallbladder Adenocarcinoma,0
21982,Case unit dose,Hodgkin Disease,0
21983,65,Thyroid Hurthle Cell Carcinoma,0
21984,Pain,Acantholytic squamous cell carcinoma,0
21985,To,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
21986,Internal,BRCA2 Syndrome,0
21987,Laparotomy,Adult Alveolar Soft Part Sarcoma,0
21988,Form:Finding:Point in time:{Setting}:Document:{Role},Intracortical osteosarcoma,0
21989,Dysuria,Thyroid Hurthle Cell Carcinoma,0
21990,survive,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
21991,year,ROSE Cluster 3,0
21992,Pelvis,Digestive System Hodgkin Lymphoma,0
21993,Body tissue,Unicystic ameloblastoma,0
21994,Laser Device Component,Primary Cutaneous Plasmablastic Lymphoma,0
21995,Call (Instruction),Chondrosarcoma,0
21996,Common Specifications in HL7 V3 Publishing,gliosarcoma,0
21997,Academic degree,Tonsillar Carcinoma,0
21998,Fusion procedure,Carcinomatosis of peritoneal cavity,0
21999,Condition,Kaposi's sarcoma of skin,0
22000,Specimen,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22001,Morphology,Carcinoma of urinary bladder,0
22002,Unknown,Refractory Bladder Carcinoma,0
22003,Chemotherapy,Stage III Adult Immunoblastic Lymphoma,0
22004,Science of Morphology,Cancer of Urinary Tract,0
22005,Diagnosis Study,Ovarian Carcinoid Tumor,0
22006,Hyperlink,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
22007,English [International Organization for Standardization 639-1 code en] language reference set,Malignant melanoma of eyelid,0
22008,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22009,Term Birth,Nasal cavity carcinoma,0
22010,Percent of Abnormal Cells,Cartilaginous exostosis,0
22011,Have Itch,Cervical Squamous Intraepithelial Neoplasia,0
22012,Very Much,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
22013,Personal appearance,Xeroderma pigmentosum,0
22014,Relationships,Recurrent Uveal Melanoma,0
22015,Type - attribute,Pancreatic carcinoma,0
22016,100%,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22017,chapter,Childhood Choriocarcinoma,0
22018,Skeletal bone,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
22019,Formation,Stage I Adult Non-Hodgkin Lymphoma,0
22020,Appearance,Localized Askin Tumor,0
22021,Shortened,Refractory Barrett Esophagus,0
22022,Administration occupational activities,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
22023,Malignant neoplasm of large intestine,Metaplastic carcinoma of breast,0
22024,Medical Device Emits Smoke,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22025,Carcinoma,Childhood Fibrillary Astrocytoma,0
22026,Average,Carcinoma of urinary bladder,0
22027,Factor,Necrotizing Funisitis,0
22028,Surface,Deep Leiomyoma,0
22029,Hypotension,Refractory Ependymoma,0
22030,Nine,Adrenal Rest Tumor,0
22031,Oral cavity,Small cell neuroendocrine carcinoma of bladder,0
22032,Pain,Adult Hepatocellular Carcinoma,0
22033,Basis - conceptual entity,Adenocarcinoma of the prostate metastatic,0
22034,MALIGNANT benign,Benign tumor of eyelid,0
22035,Pelvic Pain,Noninfiltrating Intraductal Carcinoma,0
22036,Physical findings,Blood Vessel Tumors,0
22037,Occurrence Indicator,Spermatocytic seminoma,0
22038,Parameterized Data Type - Set,FIGO Stage II Ovarian Cancer,0
22039,Contain (action),Intraepithelial Melanocytic Hyperplasia,0
22040,Cell Count,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
22041,>90,Undifferentiated Endocervical Sarcoma,0
22042,Intraventricular,Thymic Clear Cell Carcinoma,0
22043,Neoplasm Metastasis,Peripheral primitive neuroectodermal tumor of soft tissue,0
22044,Clinical Trials,Peripheral primitive neuroectodermal tumor of soft tissue,0
22045,Biological Response Modifier Therapy,adenoid cystic carcinoma of lung,0
22046,second (number),Type II Endometrial Adenocarcinoma,0
22047,31,Thymic Clear Cell Carcinoma,0
22048,1+ Score,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22049,Dangerousness,Trichilemmocarcinoma,0
22050,Solid,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22051,Tryptophanase,Benign Anal Granular Cell Tumor,0
22052,Age,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22053,Malignant Neoplasms,Metastatic Ductal Breast Carcinoma,0
22054,Pharmacotherapy,Extra-Adrenal Paraganglioma,0
22055,Normal tissue morphology,Kaposi's sarcoma of extrahepatic bile duct,0
22056,Lymphocyte production,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
22057,Occurrence Indicator,Ovarian germ cell choriocarcinoma stage IV,0
22058,Medical History,Squamous cell carcinoma of lip,0
22059,Singular,Acute Undifferentiated Leukemia,0
22060,Pressure- physical agent,adenoid cystic carcinoma of lung,0
22061,Late,Malignant melanoma of eyelid,0
22062,Known,Childhood Fibrillary Astrocytoma,0
22063,research subject screening,Fibroadenoma of breast,0
22064,diagnosis aspect,Congenital hamartoma,0
22065,Symptoms aspect,Stage IB Pancreatic Cancer AJCC v8,0
22066,Pressure (property),Clonal Hematopoiesis of Indeterminate Potential,0
22067,Abdominal wall structure,Benign Carotid Body Paraganglioma,0
22068,Uterine Corpus Sarcoma,Multiple Skull Base Meningiomas,0
22069,Medical Devices,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22070,Malignant lymphoma,sarcoma of spinal cord,0
22071,Low Risk,Tonsillar Carcinoma,0
22072,Occurrence Indicator,Rhabdomyosarcoma with ganglionic differentiation,0
22073,Slightly (qualifier value),Intestinal Metaplasia of Bladder Urothelium,0
22074,Benign Neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
22075,Neurofibromatosis 1,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
22076,Use of,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22077,Frequently,Primary Cutaneous Plasmablastic Lymphoma,0
22078,Subtype (attribute),Adult Acute Eosinophilic Leukemia,0
22079,Cell Count,Sarcomatoid Renal Cell Carcinoma,0
22080,Role,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
22081,Icterus,Benign Apocrine Neoplasm,0
22082,Male population group,Acute Undifferentiated Leukemia,0
22083,Part,Stage III Cutaneous Melanoma AJCC v6,0
22084,Have Weight Loss,Type II Endometrial Adenocarcinoma,0
22085,Childhood Lymphoma,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
22086,Type A,Metastatic Lung Neuroendocrine Neoplasm,0
22087,Aspects of disease screening,Spindle Cell Melanoma,0
22088,Antimicrobial Intermediate Susceptibility Result,Splenic Manifestation of Hairy Cell Leukemia,0
22089,Biomaterial Treatment,Stage IV Childhood Non-Hodgkin Lymphoma,0
22090,+2,Carcinoma of urinary bladder,0
22091,Numerous,Adrenal Rest Tumor,0
22092,What subject filter - Result,Blood Vessel Tumors,0
22093,Lung,Trichilemmocarcinoma,0
22094,Less Than,Adenocarcinoma of duodenum,0
22095,Medications:-:Point in time:^Patient:-,Carcinoma of urinary bladder,0
22096,Firstly,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22097,Diagnosis Study,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22098,Neoplasm Metastasis,clear cell adenocarcinoma of gallbladder,0
22099,Growth action,Adult Acute Eosinophilic Leukemia,0
22100,Usually Need Help from Another Person for Arising,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22101,Body tissue,Bladder Neuroendocrine Neoplasm,0
22102,Ability,Cherubism,0
22103,Including (qualifier),Hodgkin Disease,0
22104,Comment,Mixed astrocytoma-ependymoma,0
22105,27,Childhood Central Nervous System Ganglioneuroblastoma,0
22106,Primary malignant neoplasm,Intestinal Metaplasia of Bladder Urothelium,0
22107,In Urine,Localized Askin Tumor,0
22108,Used by,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
22109,combination - answer to question,Unfavorable Non-Hodgkin Lymphoma,0
22110,Blood group antibody I,Chest Wall Fibromatosis,0
22111,Diagnosis,Lung squamous cell carcinoma stage I,0
22112,Name,Anaplastic large cell lymphoma,0
22113,Sunscreening Agents,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22114,Tryptophanase,Malignant neoplasm of subglottis,0
22115,Worsening pattern,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22116,Occur (action),Undifferentiated Endocervical Sarcoma,0
22117,Used by,Liver Lymphangioma,0
22118,Orbital region,Cervical Fibroepithelial Polyp,0
22119,Breast,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22120,Present,Adult Alveolar Soft Part Sarcoma,0
22121,Absent,Stage III Adult Immunoblastic Lymphoma,0
22122,Immune,Malignant neoplasm of olfactory nerve,0
22123,Associated with,Childhood Thyroid Gland Follicular Carcinoma,0
22124,Lung,Adult Alveolar Soft Part Sarcoma,0
22125,Body tissue,Unfavorable Non-Hodgkin Lymphoma,0
22126,Sequence Arm,Primary Cutaneous Plasmablastic Lymphoma,0
22127,Type A,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22128,Only - dosing instruction fragment,Tonsillar Carcinoma,0
22129,Transection (procedure),benign mature teratoma of pancreas,0
22130,Area,Stage IB Lung Cancer AJCC v7,0
22131,nonspecific,Cervical Adenomyoma,0
22132,Neuroblastoma,Uterine Cancer,0
22133,Gastrointestinal Stromal Tumors,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22134,Neoplasms,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22135,Frequently,Testicular cancer metastatic,0
22136,Including (qualifier),Urethral Carcinoma,0
22137,Back structure,Lipoma of small intestine,0
22138,Platelet Glycoprotein 4,Unicystic ameloblastoma,0
22139,Diagnosis,Malignant neoplasm of subglottis,0
22140,Skin symptom,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22141,Spreading (qualifier value),Collecting Duct Carcinoma of the Kidney,0
22142,Dermoid Cyst,Placental aromatase deficiency,0
22143,Mutation,de novo Myelodysplastic Syndrome,0
22144,ovarian neoplasm,Cancer of Urinary Tract,0
22145,Cells,Malignant Neoplasm of Lung - Multiple Primary Sites,0
22146,Chemotherapy,Neonatal leukemia,0
22147,Weight Loss,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22148,Embryonic Development,Cervical Squamous Intraepithelial Neoplasia,0
22149,Lung,Pancreatic Intraepithelial Neoplasia-3,0
22150,Better than Others,Thymoma malignant recurrent,0
22151,Biological Response Modifiers,Central Nervous System Anaplastic Large Cell Lymphoma,0
22152,Lymphadenopathy,Refractory Ependymoma,0
22153,Child,Human Papillomavirus-Related Carcinoma,0
22154,Usually,Cervical Squamous Intraepithelial Neoplasia,0
22155,Tryptophanase,Trichilemmocarcinoma,0
22156,Human Papilloma Virus Vaccine,Benign squamous cell tumor,0
22157,Killing,Refractory Ependymoma,0
22158,Average of Value Derivation Technique,Stage II Carcinoma of Penis,0
22159,analysis aspect,Pleomorphic adenoma of parotid gland,0
22160,Science of Etiology,High Grade Glandular Intraepithelial Neoplasia,0
22161,Combined,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22162,Personal appearance,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
22163,Intestines,Spongiotic dermatitis,0
22164,metaplastic cell transformation,Acantholytic squamous cell carcinoma,0
22165,Tryptophanase,malignant lymphoma of pancreatic lymph nodes,0
22166,research,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22167,Males,Gallbladder Adenocarcinoma,0
22168,Location of Pharyngeal Residue Following Swallowing,Metastatic Lung Neuroendocrine Neoplasm,0
22169,3+ Answer to Question,Periosteal Osteosarcoma,0
22170,Biopsy,Malignant Testicular Sertoli Cell Tumor,0
22171,Make - Instruction Imperative,Undifferentiated Endocervical Sarcoma,0
22172,In Blood,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
22173,various allergen extracts,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22174,<50,Small intestine carcinoma,0
22175,Function Axis,Localized Ewing Sarcoma,0
22176,Malignant neoplasm of skin,Recurrent Diffuse Intrinsic Pontine Glioma,0
22177,More,Cartilaginous exostosis,0
22178,Disruptive,Thymic Clear Cell Carcinoma,0
22179,Male population group,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
22180,Most,Tubal Hyperplasia,0
22181,Carcinoma of lung,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22182,Causing,mucinous adenocarcinoma of gallbladder,0
22183,Etiology aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22184,Human Papillomavirus Positive,Funisitis (disorder),0
22185,Noma,Metastatic Neoplasm to the Gallbladder,0
22186,Colorectal Cancer,Locally Advanced Soft Tissue Sarcoma,0
22187,Face (spatial concept),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22188,Two,Breast Ductal Adenoma,0
22189,Infection,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22190,Back structure,Cerebral Primitive Neuroectodermal Tumor,0
22191,Essential,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22192,Term (lexical),adenosquamous carcinoma of breast,0
22193,Source,Refractory Bladder Carcinoma,0
22194,Hollow shape,Refractory Ependymoma,0
22195,South,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22196,Antibiotics for systemic use,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22197,Including (qualifier),Stage II Hepatocellular Carcinoma AJCC v8,0
22198,Approximate,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22199,Anemia,Epithelioid Sarcoma NCI Grade 3,0
22200,Occur (action),Localized Ewing Sarcoma,0
22201,+2,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22202,Removed,Non-Metastatic Gestational Trophoblastic Tumor,0
22203,Aluminum measurement,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22204,BRCA1 protein,Localized Ewing Sarcoma,0
22205,Operative Surgical Procedures,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22206,Administration procedure,Cystadenocarcinoma,0
22207,Dyspnea,Cervical Fibroepithelial Polyp,0
22208,Age at diagnosis,Liver Cavernous Hemangioma,0
22209,mast cell,Cancer of Urinary Tract,0
22210,Additional,Benign Carotid Body Paraganglioma,0
22211,Occurrence Indicator,Blepharal carcinoma,0
22212,Ovarian Carcinoma,Benign tumor of eyelid,0
22213,Area,Digestive System Hodgkin Lymphoma,0
22214,Entity Determiner - specific,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22215,Area,Human Papillomavirus-Related Carcinoma,0
22216,Lung,BRCA2 Syndrome,0
22217,Capsule (unit of presentation),Thyroid Hurthle Cell Carcinoma,0
22218,Classification of information,Basal Cell Ameloblastoma,0
22219,Tired,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22220,In Blood,Acantholytic squamous cell carcinoma,0
22221,Removed,Tonsillar Carcinoma,0
22222,Have Weight Loss,Female Breast Carcinoma,0
22223,Publications,Intestinal Metaplasia of Bladder Urothelium,0
22224,Carcinoma,Colorectal Neuroendocrine Tumor G2,0
22225,To,Angiosarcoma of liver,0
22226,risk factors,FIGO Stage IVA Ovarian Cancer,0
22227,Core needle biopsy,Benign tumor of eyelid,0
22228,Skin tanning,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22229,Occurrence,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22230,Appearance,Squamous cell carcinoma of lip,0
22231,PSA Level Less than Two,Benign Anal Granular Cell Tumor,0
22232,Better than Others,Adult Anaplastic Oligodendroglioma,0
22233,Name,Splenic Manifestation of Hairy Cell Leukemia,0
22234,Occur (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22235,95,Malignant melanoma of eyelid,0
22236,Reduced,Kaposi's sarcoma of extrahepatic bile duct,0
22237,Balance,non-Hodgkin's lymphoma of spleen,0
22238,Borg Category-Ratio 10 Perceived Exertion Score 5,Stage III Cutaneous Melanoma AJCC v6,0
22239,second (number),ROSE Cluster 3,0
22240,Acquired phimosis,Blepharal carcinoma,0
22241,High,Squamous cell carcinoma of lip,0
22242,Immune system,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22243,Related personal status,Adult Alveolar Soft Part Sarcoma,0
22244,Lifetime Risk,Secondary malignant neoplasm of lymph node,0
22245,Bone Marrow,Recurrent Rhabdomyosarcoma,0
22246,Reverse,gliosarcoma,0
22247,include - SetOperator,Colorectal High Grade B-Cell Lymphoma,0
22248,Benign Neoplasm,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22249,Time,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22250,Elderly (population group),Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
22251,Cause of death:Find:Pt:^Patient:Nom,Benign squamous cell tumor,0
22252,Worsening pattern,Refractory Ependymoma,0
22253,Unknown GENC,Malignant neoplasm of gallbladder,0
22254,Occur (action),Cartilaginous exostosis,0
22255,Metastasis,Parathyroid Gland Adenocarcinoma,0
22256,Average,Squamous cell carcinoma of lip,0
22257,Childhood Extracranial Germ Cell Tumor,Stage II Hepatocellular Carcinoma AJCC v8,0
22258,Goiter,Cancer of Urinary Tract,0
22259,Organ,Metaplastic carcinoma of breast,0
22260,Manufactured sign,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22261,soft tissue,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22262,Standard of Care,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
22263,*Type - Kind of quantity,clear cell adenocarcinoma of gallbladder,0
22264,Specific qualifier value,Rhabdomyosarcoma with ganglionic differentiation,0
22265,Disease,Parathyroid Gland Adenocarcinoma,0
22266,Breast tissue sample,Childhood Extragonadal Malignant Germ Cell Tumor,0
22267,Lymphangitis,Pancreatic Endocrine Carcinoma,0
22268,Damage,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22269,health and disease,Thyroid Hurthle Cell Carcinoma,0
22270,Generations,Undifferentiated Endocervical Sarcoma,0
22271,Basal Cell Carcinoma Pathway,Gallbladder adenoma,0
22272,*Type - Kind of quantity,Maxillary Sinus Adenoid Cystic Carcinoma,0
22273,Duodenal Cancer,Stage III Cutaneous Melanoma AJCC v6,0
22274,Pelvic Pain,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22275,Source,Stage I Colon Neuroendocrine Tumor AJCC v8,0
22276,Bone structure of rib,Ichthyosis,0
22277,West Haven Hepatic Encephalopathy Grade 3,Mixed astrocytoma-ependymoma,0
22278,Dyspnea,Parathyroid Gland Adenocarcinoma,0
22279,GDF15 protein,Stage 0 Penile Cancer AJCC v8,0
22280,Catch - Finding of sensory dimension of pain,Type II Endometrial Adenocarcinoma,0
22281,Two,Spindle Cell Melanoma,0
22282,Lymphocyte,Tongue Alveolar Soft Part Sarcoma,0
22283,Malignant Cell Count,Cystadenocarcinoma,0
22284,cell growth,Contact dermatitis due to alkali,0
22285,Togo,Childhood Central Nervous System Ganglioneuroblastoma,0
22286,Including (qualifier),Endometrial Small Cell Carcinoma,0
22287,Gases,Mucosal Melanoma,0
22288,Frequently,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22289,Occur (action),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22290,CHURC1 gene,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22291,Probability,Recurrent Testicular Lymphoma,0
22292,Dorsal,Intestinal Metaplasia of Bladder Urothelium,0
22293,Spreading (qualifier value),Mastocytosis,0
22294,Course,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
22295,radiotherapeutic,Plexosarcoma,0
22296,SLC35G1 gene,Metaplastic carcinoma of breast,0
22297,Cell Count,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
22298,Oral (intended site),Childhood Central Nervous System Ganglioneuroblastoma,0
22299,Greater,Giant cell angiofibroma,0
22300,breast.duct,adenosquamous carcinoma of breast,0
22301,Chemotherapy Regimen,Engraftment syndrome,0
22302,Lower (action),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22303,American College of Cardiology/American Heart Association Lesion Complexity Score C,Advanced Uterine Corpus Carcinosarcoma,0
22304,Childhood diseases,Carcinoma of urinary bladder,0
22305,Therapeutic procedure,Stage I Adult Non-Hodgkin Lymphoma,0
22306,Certain (qualifier value),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22307,6/3,benign mature teratoma of pancreas,0
22308,Malignant Neoplasms,Melanomatosis,0
22309,Mathematical Factor,Localized Malignant Neoplasm,0
22310,treatment - ActInformationManagementReason,Acute lymphadenitis,0
22311,Rare,Cerebral Primitive Neuroectodermal Tumor,0
22312,Biogenic Amines,sarcoma of spinal cord,0
22313,International Statistical Classification of Diseases and Related Health Problems,Undifferentiated Endocervical Sarcoma,0
22314,Lacking,Childhood Lung Non-Small Cell Carcinoma,0
22315,Rating (action),Clinical Stage I Cutaneous Melanoma AJCC v8,0
22316,Headache,Acute lymphadenitis,0
22317,>5,Stage III Cutaneous Melanoma AJCC v6,0
22318,To,squamous cell carcinoma of the thyroid gland,0
22319,Treatment Epoch,Methotrexate-Associated Hodgkin Lymphoma,0
22320,Occurrence Indicator,embryonal rhabdomyosarcoma of prostate,0
22321,Disease,Kaposi's sarcoma of skin,0
22322,Result,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
22323,Anatomic Site,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22324,Increased risk for cancer,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22325,combination of objects,Extra-Adrenal Paraganglioma,0
22326,Operative Surgical Procedures,Malignant melanoma of eyelid,0
22327,Place - dosing instruction imperative,Recurrent Uveal Melanoma,0
22328,Base - General Qualifier,Diffuse malignant mesothelioma,0
22329,Reciprocal translocation,Endometrial Small Cell Carcinoma,0
22330,Occurrence,Refractory Barrett Esophagus,0
22331,Growth action,Refractory Ependymoma,0
22332,treatment - ActInformationManagementReason,Stage 0 Lip Carcinoma,0
22333,ovarian,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22334,structure,Recurrent Testicular Lymphoma,0
22335,Cessation of life,Kaposi's sarcoma of extrahepatic bile duct,0
22336,Diagnosis Study,Metastatic Ductal Breast Carcinoma,0
22337,Lymphangioma,Stage IB Lung Cancer AJCC v7,0
22338,Infant,Adult Alveolar Soft Part Sarcoma,0
22339,Line Specimen,Maxillary Sinus Adenocarcinoma,0
22340,Occurrence,Childhood Central Nervous System Ganglioneuroblastoma,0
22341,Anaplastic astrocytoma,Recurrent Uveal Melanoma,0
22342,Agreement,Benign squamous cell tumor,0
22343,Providing presence (regime/therapy),Childhood Cerebellar Neoplasm,0
22344,Used by,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
22345,Pedunculated Lesion,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22346,Epithelial proliferation,Carcinoma ex pleomorphic adenoma of parotid gland,0
22347,Heart failure,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22348,Substance,Familial Adenomatous Polyposis Associated Medulloblastoma,0
22349,Due to,Endometrial Small Cell Carcinoma,0
22350,Subject is Randomized,malignant lymphoma of pancreatic lymph nodes,0
22351,Science of Etiology,Localized Askin Tumor,0
22352,Hemorrhage,Engraftment syndrome,0
22353,fluid - substance,Acantholytic squamous cell carcinoma,0
22354,Diagnosis,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
22355,Seventh,Lung Mucinous Cystadenoma,0
22356,Central,Testicular cancer metastatic,0
22357,Menopause,Undifferentiated Endocervical Sarcoma,0
22358,dendritic spine neck,Thymic Clear Cell Carcinoma,0
22359,newly,Splenic Manifestation of Hairy Cell Leukemia,0
22360,65,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22361,Coitus,mucinous adenocarcinoma of gallbladder,0
22362,Cancer Genus,Female Breast Carcinoma,0
22363,Neoplasms,Mixed parotid tumor,0
22364,Occurrence Indicator,Localized Ewing Sarcoma,0
22365,Upper,Kaposi's sarcoma of extrahepatic bile duct,0
22366,Extraction,Intraepithelial Melanocytic Hyperplasia,0
22367,How Often Weight Loss,Stage III Cutaneous Melanoma AJCC v6,0
22368,Entire endocrine gland,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
22369,Manufactured form,Acantholytic squamous cell carcinoma,0
22370,Carcinoid Tumor,Tonsillar Carcinoma,0
22371,Late,Testicular cancer metastatic,0
22372,Body structure,Blepharal carcinoma,0
22373,Abdominal bloating,Undifferentiated Endocervical Sarcoma,0
22374,Management Occupations,Brain Tumor,0
22375,Iodides,Undifferentiated Neuroblastoma,0
22376,Personal appearance,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22377,Malignant neoplasm of ampulla of Vater,Malignant Neoplasm of Lung - Multiple Primary Sites,0
22378,shared attribute,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22379,True primary (qualifier value),Ovarian Dermoid Cyst with Secondary Carcinoma,0
22380,Involvement with,Childhood Central Nervous System Ganglioneuroblastoma,0
22381,Percent (qualifier value),Thyroid Hurthle Cell Carcinoma,0
22382,Halitosis,BRCA2 Syndrome,0
22383,memory b cell,Stage IV Childhood Non-Hodgkin Lymphoma,0
22384,Neoplasm Metastasis,Refractory Ependymoma,0
22385,Use of,Maxillary Sinus Adenocarcinoma,0
22386,Germ-Line Mutation,Mucinous adenocarcinoma gastric,0
22387,respiratory gaseous exchange in organisms,Tongue Alveolar Soft Part Sarcoma,0
22388,Lymphoid,Peripheral primitive neuroectodermal tumor of soft tissue,0
22389,Body tissue,Recurrent Primary Lymphoma of Bone,0
22390,Person Name,Angiosarcoma of liver,0
22391,Risk,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22392,Two,Giant cell angiofibroma,0
22393,Changing,Locally Advanced Squamous Cell Carcinoma,0
22394,Biomaterial Treatment,Cerebral hemangioma,0
22395,Second edition,Pleomorphic adenoma of parotid gland,0
22396,Childhood Atypical Teratoid/Rhabdoid Tumor,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
22397,90%,Granular Cell Leiomyosarcoma,0
22398,Persistent embryonic structure,Childhood Central Nervous System Ganglioneuroblastoma,0
22399,bony process,Cerebral Primitive Neuroectodermal Tumor,0
22400,Cells,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22401,Plasma,Stage III Adult Immunoblastic Lymphoma,0
22402,Spreading (qualifier value),Brain Ependymoma,0
22403,Therapeutic procedure,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
22404,Good,Blepharal carcinoma,0
22405,Several,Cerebral Primitive Neuroectodermal Tumor,0
22406,Anatomic Site,Type II Endometrial Adenocarcinoma,0
22407,Occurrence Indicator,Splenic Manifestation of Hairy Cell Leukemia,0
22408,Skin Specimen,Advanced Lung Carcinoma,0
22409,Time (foundation metadata concept),Lung Mucinous Cystadenoma,0
22410,Frequently,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22411,Basal cell carcinoma,Stage II Hepatocellular Carcinoma AJCC v8,0
22412,Pancreas part,Spongiotic dermatitis,0
22413,A Codes,gliosarcoma,0
22414,Lack of exercise finding,Intestinal Metaplasia of Bladder Urothelium,0
22415,Prior Chemotherapy,Hyperplasia of pituitary gland,0
22416,Exposure to radiation,Acantholytic squamous cell carcinoma,0
22417,Malignant neoplasm of larynx,Low Grade Squamous Intraepithelial Neoplasia,0
22418,parent,Female Breast Carcinoma,0
22419,Hormonal,Tongue Alveolar Soft Part Sarcoma,0
22420,Therapeutic procedure,Blepharal carcinoma,0
22421,Malignant Neoplasms,Gallbladder Adenocarcinoma,0
22422,Pharmacotherapy,Occult Lung Adenosquamous Carcinoma,0
22423,Squamous cell carcinoma - category,Human Papillomavirus-Related Carcinoma,0
22424,Staging:Finding:Point in time:Cancer.To be specified in another part of the message:Narrative,Pilocytic astrocytoma of cerebellum,0
22425,Organ,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22426,Immune System Finding,Extra-Adrenal Paraganglioma,0
22427,Definitive,Childhood Fibrillary Astrocytoma,0
22428,various other nasal preparations in ATC,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22429,Blood,Pancreatic Intraepithelial Neoplasia-3,0
22430,Nature,Small cell neuroendocrine carcinoma of bladder,0
22431,General surgery specialty,Kaposi's sarcoma of extrahepatic bile duct,0
22432,Importance Rating Score 0,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22433,Treating,non-Hodgkin's lymphoma of spleen,0
22434,More,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22435,Removal of bladder,Unicystic ameloblastoma,0
22436,Financial Account,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22437,United States Military Commissioned Officer O4,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22438,Malignant Childhood Neoplasm,Adult Acute Eosinophilic Leukemia,0
22439,Ingestible alcohol,Undifferentiated Endocervical Sarcoma,0
22440,spinal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22441,Location of Pharyngeal Residue Following Swallowing,Localized Askin Tumor,0
22442,Cells,Toxic Epidermal Necrolysis,0
22443,Insect Bite Specimen Code,Extra-Adrenal Paraganglioma,0
22444,Pruritus,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22445,Derivative,Thymic Clear Cell Carcinoma,0
22446,Following,Gallbladder Adenocarcinoma,0
22447,Classical Hodgkin's Lymphoma,Malignant melanoma of eyelid,0
22448,Location,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22449,white blood cell type,Digestive System Hodgkin Lymphoma,0
22450,Lymphoma,Splenic Manifestation of Hairy Cell Leukemia,0
22451,Much,Testicular cancer metastatic,0
22452,Myoepithelial,Intraepithelial Melanocytic Hyperplasia,0
22453,Smear - instruction imperative,Stage III Adult Immunoblastic Lymphoma,0
22454,leukemia,Recurrent Uveal Melanoma,0
22455,Limited stage (cancer stage),Microcystic meningioma,0
22456,Immunotherapy,Primary Cutaneous Plasmablastic Lymphoma,0
22457,brain cell,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22458,Sequence Arm,Benign neoplasm of eye,0
22459,Developed Countries,Colorectal Mucin Poor Hyperplastic Polyp,0
22460,Bone structure of coccyx,Choroid Epithelioid Cell Melanoma,0
22461,1+ Score,Malignant Testicular Sertoli Cell Tumor,0
22462,Neoplasm Metastasis,Extra-abdominal fibromatosis,0
22463,Qualitative form,adenoid cystic carcinoma of lung,0
22464,Duct (organ) structure,Placental aromatase deficiency,0
22465,Event-Free Survival,Benign Anal Granular Cell Tumor,0
22466,Compress (Compression Algorithm),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22467,Tooth root structure,Bladder adenocarcinoma stage IV,0
22468,Tryptophanase,Metastatic Ductal Breast Carcinoma,0
22469,Human body structure,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22470,Treating,Benign squamous cell tumor,0
22471,Affecting,Clonal Hematopoiesis of Indeterminate Potential,0
22472,Group A (blood group),Colorectal cancer,0
22473,Others - Allergy,Cervical Adenomyoma,0
22474,Offspring,Non-Metastatic Gestational Trophoblastic Tumor,0
22475,20%,Trichilemmocarcinoma,0
22476,Fasciola hepatica infection,Engraftment syndrome,0
22477,Ancestry-Informative Marker,Atypical Mesothelial Hyperplasia,0
22478,Skin,Carcinoma of urinary bladder,0
22479,Experimental Result,Cartilaginous exostosis,0
22480,Endocrine system,Mucosal Melanoma,0
22481,Menstruation,Stage I Colon Neuroendocrine Tumor AJCC v8,0
22482,Night sweats,Anterior Urethral Malignant Neoplasm,0
22483,Group A (blood group),Malignant neoplasm of gallbladder,0
22484,Hematopoietic Neoplasms,Stage III Cutaneous Melanoma AJCC v6,0
22485,Common Specifications in HL7 V3 Publishing,Stage IV Childhood Non-Hodgkin Lymphoma,0
22486,Protocol Agent,Trabecular adenocarcinoma,0
22487,Shapes,Atypical Mesothelial Hyperplasia,0
22488,Tryptophanase,Thymic Clear Cell Carcinoma,0
22489,Stem cells,Colorectal cancer,0
22490,Dangerousness,Breast Ductal Adenoma,0
22491,Subject Risk,Benign neoplasm of eye,0
22492,Cancer Genus,Stage II Carcinoma of Penis,0
22493,Facial swelling (finding),Recurrent Testicular Lymphoma,0
22494,Tryptophanase,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22495,biopsy characteristics,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22496,Cancer Genus,Mastocytosis,0
22497,95,FIGO Stage II Ovarian Cancer,0
22498,Broken skin,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22499,Qualitative form,ICHTHYOSIS,0
22500,Manufactured sign,Splenic Manifestation of Hairy Cell Leukemia,0
22501,Recommendation,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22502,Primary,Liver Cavernous Hemangioma,0
22503,Mode of inheritance,Kaposi's sarcoma of extrahepatic bile duct,0
22504,Fibrosis Assessment,Neonatal leukemia,0
22505,P450-aromatase Deficiency,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
22506,Pruritus,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22507,Occurrence,Localized Askin Tumor,0
22508,Term Birth,Locally Advanced Soft Tissue Sarcoma,0
22509,Vagina Carcinoma,Metaplastic carcinoma of breast,0
22510,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Xeroderma pigmentosum,0
22511,High Level,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22512,Dental Enamel,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22513,Histologic,Maxillary Sinus Adenoid Cystic Carcinoma,0
22514,Singular,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22515,Childhood Lymphoma,Refractory Bladder Carcinoma,0
22516,Kidney Infection,Grade 3a Malignant Neoplasm,0
22517,Infiltration (procedure),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22518,Malignant neoplasm of large intestine,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22519,Body structure,Ovarian germ cell choriocarcinoma stage IV,0
22520,Taxonomic,Ovarian germ cell choriocarcinoma stage IV,0
22521,International Classification of Disease for Oncology,Placental aromatase deficiency,0
22522,Five,Hereditary Diffuse Gastric Adenocarcinoma,0
22523,English [International Organization for Standardization 639-1 code en] language reference set,Type II Endometrial Adenocarcinoma,0
22524,history (of) disease family,FIGO Stage II Ovarian Cancer,0
22525,Childhood Ependymoma,Angiosarcoma of liver,0
22526,Container status - Identified,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
22527,Aspects of signs,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22528,trophoblast,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22529,Diameter (qualifier value),embryonal rhabdomyosarcoma of prostate,0
22530,Healthy,Locally Advanced Squamous Cell Carcinoma,0
22531,Brain part,Anterior Urethral Malignant Neoplasm,0
22532,Bone structure of cranium,clear cell adenocarcinoma of gallbladder,0
22533,Common Specifications in HL7 V3 Publishing,Transitional cell carcinoma,0
22534,Specific qualifier value,Kaposi's sarcoma of skin,0
22535,Imaging Techniques,FIGO Stage II Ovarian Cancer,0
22536,Tumor cells,Primary Cutaneous Plasmablastic Lymphoma,0
22537,Platelet Glycoprotein 4,Intestinal Metaplasia of Bladder Urothelium,0
22538,Greater,Plexosarcoma,0
22539,Sternum,Malignant neoplasm of thalamus,0
22540,Presence (property),Testicular cancer metastatic,0
22541,Adult Hodgkin Lymphoma,Granular Cell Leiomyosarcoma,0
22542,Primary malignant neoplasm,Chest Wall Fibromatosis,0
22543,Mass of body region,Cervical Squamous Intraepithelial Neoplasia,0
22544,Often - answer to question,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22545,Persons,Stage IB Lung Cancer AJCC v7,0
22546,Bladder Continence Question,Digestive System Hodgkin Lymphoma,0
22547,Laboratory Procedures,Carcinomatosis of peritoneal cavity,0
22548,<50,Benign neoplasm of eye,0
22549,Often - answer to question,Carcinoma of urinary bladder,0
22550,One,FIGO Stage II Ovarian Cancer,0
22551,One,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22552,Known,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22553,Adapt (substance),Lipoma of small intestine,0
22554,Malignant Neoplasms,Locally Advanced Epithelioid Hemangioendothelioma,0
22555,Intersex,Mixed astrocytoma-ependymoma,0
22556,Smear - instruction imperative,Collecting Duct Carcinoma of the Kidney,0
22557,Appearance,Locally Advanced Squamous Cell Carcinoma,0
22558,Fever,Parathyroid Gland Adenocarcinoma,0
22559,Dominant,Childhood Fibrillary Astrocytoma,0
22560,TNM Staging System,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22561,Radiotherapy Research,embryonal rhabdomyosarcoma of prostate,0
22562,50%,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
22563,Pediculus (eukaryote),Human Papillomavirus-Related Carcinoma,0
22564,Usage,Cancer of Urinary Tract,0
22565,vascular transport,Familial Adenomatous Polyposis Associated Medulloblastoma,0
22566,Call (Instruction),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22567,Negation,embryonal rhabdomyosarcoma of prostate,0
22568,Approximate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22569,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22570,Providing (action),mucinous adenocarcinoma of gallbladder,0
22571,Accounting (activity),Pancreatic carcinoma,0
22572,Australia,Stage III Cutaneous Melanoma AJCC v6,0
22573,Cell Count,Acute Undifferentiated Leukemia,0
22574,year,Heavy Chain Deposition Disease,0
22575,Indication of (contextual qualifier),Localized Askin Tumor,0
22576,Vagina,Cancer of Urinary Tract,0
22577,various antiinfectives and antiseptics for local oral treatment,Acantholytic squamous cell carcinoma,0
22578,Surrounding (qualifier value),Congenital hamartoma,0
22579,Term (lexical),Recurrent Uveal Melanoma,0
22580,Chief complaint (finding),Mixed astrocytoma-ependymoma,0
22581,National origin,Hereditary Diffuse Gastric Adenocarcinoma,0
22582,Group A (blood group),Benign neoplasm of thorax,0
22583,Aggressive behavior,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22584,Abnormal Cell Count,Adenocarcinoma,0
22585,classical example,Cerebral Primitive Neuroectodermal Tumor,0
22586,Myasthenia Gravis,Undifferentiated Endocervical Sarcoma,0
22587,Stage,Pancreatic Endocrine Carcinoma,0
22588,Painless,Spongiotic dermatitis,0
22589,Psyche structure,Malignant melanoma of eyelid,0
22590,Intestines,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22591,Congenital defects,Malignant Testicular Sertoli Cell Tumor,0
22592,described,sarcoma of spinal cord,0
22593,Admission Level of Care Code - Improved,Splenic Manifestation of Hairy Cell Leukemia,0
22594,Choriocarcinoma,Vaginal Adenoid Cystic Carcinoma,0
22595,United States Military Commissioned Officer O4,Diffuse malignant mesothelioma,0
22596,Adult human body,Pancreatic carcinoma,0
22597,Vaccinated at,Epithelioid Sarcoma NCI Grade 3,0
22598,Ascites,Atypical Lobular Breast Hyperplasia,0
22599,*Type - Kind of quantity,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22600,Entity Determiner - specific,Brain Tumor,0
22601,Type A,Intraepithelial Melanocytic Hyperplasia,0
22602,Science of Etiology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22603,diagnosis aspect,Choroid Necrotic Melanoma,0
22604,Health,Uterine Cancer,0
22605,How Often Itching,Benign Carotid Body Paraganglioma,0
22606,Ability,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22607,Alpha-fetoprotein level - finding,Stage III Cutaneous Melanoma AJCC v6,0
22608,Endoscopy (procedure),Advanced Uterine Corpus Carcinosarcoma,0
22609,Lesion,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22610,Radiofrequency Ablation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22611,Carcinoma of lung,Squamous cell carcinoma of lip,0
22612,Skin,clear cell adenocarcinoma of gallbladder,0
22613,Human Papillomavirus,Uterine Cancer,0
22614,Confirmed by,Mucinous adenocarcinoma gastric,0
22615,United States,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22616,Birth,Peripheral primitive neuroectodermal tumor of soft tissue,0
22617,Tumor cells,Hereditary Diffuse Gastric Adenocarcinoma,0
22618,Out (direction),squamous cell carcinoma of the thyroid gland,0
22619,Occur (action),Diffuse malignant mesothelioma,0
22620,Intestines,Female Breast Carcinoma,0
22621,Population Mean,Childhood Fibrillary Astrocytoma,0
22622,Melanocytic nevus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22623,Cartilage,Nasal cavity carcinoma,0
22624,International Aspects,Diffuse malignant mesothelioma,0
22625,How Much Distress Weight Loss,Benign tumor of eyelid,0
22626,More,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
22627,Syphilis,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22628,40%,Diffuse malignant mesothelioma,0
22629,35,Multiple Skull Base Meningiomas,0
22630,Case unit dose,sarcoma of spinal cord,0
22631,Physical Medical Procedure,Carcinoma of urinary bladder,0
22632,Dominant,Acantholytic squamous cell carcinoma,0
22633,Surgery specialty,Kaposi's sarcoma of skin,0
22634,CDISC SDTM Procedure Terminology,embryonal rhabdomyosarcoma of prostate,0
22635,Array Feature,Testicular cancer metastatic,0
22636,Blood,Localized Ewing Sarcoma,0
22637,70%,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22638,Male,Acantholytic squamous cell carcinoma,0
22639,Cosmetic surgery specialty,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
22640,Cell (compartment),High Grade Salivary Gland Mucoepidermoid Carcinoma,0
22641,Including (qualifier),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
22642,Togo,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22643,United States,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
22644,Direct (qualifier),Localized Malignant Neoplasm,0
22645,Medical service,BRCA2 Syndrome,0
22646,Contain (action),Adult Alveolar Soft Part Sarcoma,0
22647,Chemicals,Cervical Fibroepithelial Polyp,0
22648,Human papilloma virus infection,Periosteal Osteosarcoma,0
22649,Skin,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
22650,Obese build,Stage I Adult Non-Hodgkin Lymphoma,0
22651,risk factors - observation list,Benign Anal Granular Cell Tumor,0
22652,Neuroglia,Metastatic Neoplasm to the Gallbladder,0
22653,Human Papillomavirus,Cancer of Urinary Tract,0
22654,Specific qualifier value,Stage III Cutaneous Melanoma AJCC v6,0
22655,Time (foundation metadata concept),Stage 0 Penile Cancer AJCC v8,0
22656,Precision - temporal,Stage 0 Penile Cancer AJCC v8,0
22657,Body tissue,Mucinous adenocarcinoma,0
22658,Cerebral hemisphere structure (body structure),Kaposi's sarcoma of skin,0
22659,Sun Exposure,Cherubism,0
22660,General surgery specialty,Stage II Hepatocellular Carcinoma AJCC v8,0
22661,Array Feature,Recurrent Testicular Lymphoma,0
22662,Occurrence Indicator,Cervical Squamous Intraepithelial Neoplasia,0
22663,Disease,Giant cell angiofibroma,0
22664,Second edition,Localized Malignant Neoplasm,0
22665,Flowers,Stage I Colon Neuroendocrine Tumor AJCC v8,0
22666,Increase,Liver Lymphangioma,0
22667,70%,Engraftment syndrome,0
22668,Tobacco smoking behavior,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22669,Bacteria,Acantholytic squamous cell carcinoma,0
22670,Tryptophanase,Benign squamous cell tumor,0
22671,Preventable,Xeroderma pigmentosum,0
22672,Subgroup A Nepoviruses,Adult Acute Eosinophilic Leukemia,0
22673,include - SetOperator,Spongiotic dermatitis,0
22674,Primary malignant neoplasm,FIGO Stage IVA Ovarian Cancer,0
22675,IPSS Risk Category Low,Contact dermatitis due to alkali,0
22676,To,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22677,Cell Count,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22678,Cervical dysplasia,Kaposi's sarcoma of skin,0
22679,Divide,Hyperplasia of pituitary gland,0
22680,Categories,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
22681,How Often Felt Normal question,FIGO Stage IVA Ovarian Cancer,0
22682,Penis carcinoma,Stage IV Colorectal Cancer AJCC v8,0
22683,Little NOS,Childhood Fibrillary Astrocytoma,0
22684,Compression - action,Kaposi's sarcoma of extrahepatic bile duct,0
22685,PODXL protein,Type II Endometrial Adenocarcinoma,0
22686,Uterine Cancer,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22687,Continuance of life,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22688,Site of,Uterine Cancer,0
22689,Sometimes,Stage III Adult Immunoblastic Lymphoma,0
22690,Experimental Result,Melanomatosis,0
22691,Administration procedure,Childhood Lung Non-Small Cell Carcinoma,0
22692,In Urine,Adult Hepatocellular Carcinoma,0
22693,Child,embryonal rhabdomyosarcoma of prostate,0
22694,Cell Count,Atypical Lobular Breast Hyperplasia,0
22695,Tumor Subtype,Astrocytoma of brain,0
22696,Abdomen+,Childhood Fibrillary Astrocytoma,0
22697,Immunization,Tonsillar Carcinoma,0
22698,Helper-Inducer T-Lymphocyte,Maxillary Sinus Adenocarcinoma,0
22699,regional,adenoid cystic carcinoma of lung,0
22700,Aging,Localized Ewing Sarcoma,0
22701,Asia,Anaplastic large cell lymphoma,0
22702,Specimen Source Codes - tumor,adenosquamous carcinoma of breast,0
22703,Malignant neoplasm of oropharynx,Airway Hemangioma,0
22704,Fever,Methotrexate-Associated Hodgkin Lymphoma,0
22705,Consistency,Clonal Hematopoiesis of Indeterminate Potential,0
22706,Structure of parenchyma of lung,Contact dermatitis due to alkali,0
22707,include - SetOperator,Undifferentiated Endocervical Sarcoma,0
22708,Sacrifice,Recurrent Testicular Lymphoma,0
22709,N+ (tumor staging),adenoid cystic carcinoma of lung,0
22710,Central Nervous System,Carcinomatosis of peritoneal cavity,0
22711,Changed status,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
22712,Offspring,Familial Adenomatous Polyposis Associated Medulloblastoma,0
22713,Often - answer to question,Neonatal leukemia,0
22714,More,Malignant melanoma of eyelid,0
22715,Fever,Chest Wall Fibromatosis,0
22716,Metastatic Disease Clinical Trial Setting,Stage 0 Lip Carcinoma,0
22717,Petal,Carcinoma of urinary bladder,0
22718,Dyspareunia,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
22719,SHORT STATURE,Giant cell angiofibroma,0
22720,Oral (intended site),Advanced Uterine Corpus Carcinosarcoma,0
22721,Extrinsic,Human Papillomavirus-Related Carcinoma,0
22722,Nausea,Female Breast Carcinoma,0
22723,Urinary Bladder,Digestive System Hodgkin Lymphoma,0
22724,Excretory function,Vaginal Adenoid Cystic Carcinoma,0
22725,Area,Xeroderma pigmentosum,0
22726,Food allergenic extracts,Vaginal Adenoma,0
22727,Loss of Appetite question,Grade 1 Clear Cell Renal Cell Carcinoma,0
22728,Negation,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
22729,Adverse effects,Adult Alveolar Soft Part Sarcoma,0
22730,Location of Oral Residue Following Swallowing,Vaginal Adenoma,0
22731,Stomach structure,Brain Ependymoma,0
22732,Glioma,Choroid Epithelioid Cell Melanoma,0
22733,Medical Device Emits Smoke,Liver Lymphangioma,0
22734,Data Transformation,Anterior Urethral Malignant Neoplasm,0
22735,include - SetOperator,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22736,Eyelid structure,Benign squamous cell tumor,0
22737,Pelvic Pain,Unicystic ameloblastoma,0
22738,Most,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22739,Diabetes Mellitus,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
22740,Name,Stage II Hepatocellular Carcinoma AJCC v8,0
22741,Sometimes,Localized Malignant Neoplasm,0
22742,During,Maxillary Sinus Adenocarcinoma,0
22743,Retinoic Acid Response Element,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22744,Class (taxonomic),Intestinal Metaplasia of Bladder Urothelium,0
22745,Mass of body region,non-Hodgkin's lymphoma of spleen,0
22746,risk factors,Unicystic ameloblastoma,0
22747,Universal - VocabularyDomainQualifier,Pancreatic carcinoma,0
22748,Anus,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
22749,research subject screening,Engraftment syndrome,0
22750,Similarity,Human Papillomavirus-Related Carcinoma,0
22751,Malignant Neoplasms,Locally Advanced Epithelioid Hemangioendothelioma,0
22752,Inguinal part of abdomen,clear cell adenocarcinoma of gallbladder,0
22753,A Codes,High Grade Glandular Intraepithelial Neoplasia,0
22754,Secretory Vesicles,Acantholytic squamous cell carcinoma,0
22755,Painful intercourse female,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22756,Squamocolumnar junction of cervix,Intracortical osteosarcoma,0
22757,Brain Neoplasms,Anterior Urethral Malignant Neoplasm,0
22758,Common (qualifier value),Granular Cell Leiomyosarcoma,0
22759,majority,Childhood Lymphoma,0
22760,Dermatitis,Cerebral Primitive Neuroectodermal Tumor,0
22761,Usual Severity Weight Loss,Carcinoma ex pleomorphic adenoma of parotid gland,0
22762,Decision,Refractory WHO Grade III Glioma,0
22763,eTMF Content Model Code,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
22764,2+ Score,Chondrosarcoma,0
22765,Five-year Survival Rate,Extra-Adrenal Paraganglioma,0
22766,Early,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22767,High risk of,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22768,Neoplasm Metastasis,Ovarian Dermoid Cyst with Secondary Carcinoma,0
22769,Malignant Neoplasms,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22770,Minor (person),Recurrent Primary Lymphoma of Bone,0
22771,How Much Distress Nausea,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22772,Including (qualifier),Testicular cancer metastatic,0
22773,Woman,FIGO Stage IVA Ovarian Cancer,0
22774,Human embryo,Malignant melanoma of eyelid,0
22775,Common Specifications in HL7 V3 Publishing,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
22776,Unit of Measure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22777,1960s,Breast Apocrine Adenoma,0
22778,Mass,Benign tumor of eyelid,0
22779,Tissue Specimen Code,Neoplasms,0
22780,Loss of Appetite question,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22781,mesenchymal,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
22782,Medications,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
22783,How Much Distress Pain,Malignant Testicular Sertoli Cell Tumor,0
22784,Cessation of life,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22785,Western World,Acantholytic squamous cell carcinoma,0
22786,Slow,Refractory Bladder Carcinoma,0
22787,Firstly,Cancer of Urinary Tract,0
22788,Statistical mean,Cervical Fibroepithelial Polyp,0
22789,Most Recent,Locally Advanced Soft Tissue Sarcoma,0
22790,Affect (mental function),Tumorlet,0
22791,90%,Contact dermatitis due to alkali,0
22792,Plants,Mixed parotid tumor,0
22793,Blood Platelets,Tonsillar Carcinoma,0
22794,Risk,Cancer of Urinary Tract,0
22795,How Often Shortness of Breath,Diffuse malignant mesothelioma,0
22796,Case unit dose,Anaplastic large cell lymphoma,0
22797,>90,Multiple Skull Base Meningiomas,0
22798,Include (action),Lung Inflammatory Myofibroblastic Tumor,0
22799,Function (attribute),Malignant neoplasm of subglottis,0
22800,Image Feature,Refractory Barrett Esophagus,0
22801,Diagnosis Study,Stage IB Lung Cancer AJCC v7,0
22802,Long-term,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22803,Appearance,Neonatal leukemia,0
22804,Neck,Unfavorable Non-Hodgkin Lymphoma,0
22805,depend,Benign squamous cell tumor,0
22806,Form:Finding:Point in time:{Setting}:Document:{Role},FIGO Stage II Ovarian Cancer,0
22807,Probability,Localized Askin Tumor,0
22808,Metastasis,Intraepithelial Melanocytic Hyperplasia,0
22809,Subject Risk,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
22810,Tired,Recurrent Testicular Lymphoma,0
22811,Africa,Cancer of Urinary Tract,0
22812,Megakaryoblast Cell Count,Multiple Endocrine Neoplasia,0
22813,Thickened,Intraepithelial Melanocytic Hyperplasia,0
22814,Body structure,Childhood Anaplastic Large Cell Lymphoma,0
22815,Call (Instruction),Intestinal Metaplasia of Bladder Urothelium,0
22816,Including (qualifier),Acute Undifferentiated Leukemia,0
22817,Membrane Glycoproteins,Ichthyosis,0
22818,Basis - conceptual entity,Nasal cavity carcinoma,0
22819,status - In progress,sarcoma of spinal cord,0
22820,Direct type of relationship,embryonal rhabdomyosarcoma of prostate,0
22821,Worse,Metastatic Ductal Breast Carcinoma,0
22822,mucus layer,Female Breast Carcinoma,0
22823,Dyspnea,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22824,Process (qualifier value),Mucinous adenocarcinoma,0
22825,Pediatric,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22826,Tobacco smoking behavior,Stage 0 Penile Cancer AJCC v8,0
22827,Fibroid Tumor,Stage IV Penile Cancer AJCC v7,0
22828,geographic population,Tongue Alveolar Soft Part Sarcoma,0
22829,Manufactured form,Lipoma of small intestine,0
22830,Near,Cervical Squamous Intraepithelial Neoplasia,0
22831,Location,mucinous adenocarcinoma of gallbladder,0
22832,Sclera,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
22833,National origin,Mastocytosis,0
22834,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Acute Undifferentiated Leukemia,0
22835,Common Specifications in HL7 V3 Publishing,Stage IB Pancreatic Cancer AJCC v8,0
22836,Greeks,Stage 0 Lip Carcinoma,0
22837,Posterior Pituitary Hormone Drug Class,Splenic Manifestation of Hairy Cell Leukemia,0
22838,Form:Finding:Point in time:{Setting}:Document:{Role},Recurrent Diffuse Intrinsic Pontine Glioma,0
22839,Mean Percent of Normal,Adult Hepatocellular Carcinoma,0
22840,Infection,Squamous cell carcinoma of lip,0
22841,Simpson Grade 3,FIGO Stage IVA Ovarian Cancer,0
22842,Malignancy,Pancreatic Intraepithelial Neoplasia-3,0
22843,Occur (action),Metastatic Ductal Breast Carcinoma,0
22844,Decrease,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22845,Embryonic tissue,embryonal rhabdomyosarcoma of prostate,0
22846,Late,Medulloblastoma,0
22847,Anaplastic thyroid carcinoma,Anaplastic large cell lymphoma,0
22848,Main,Chest Wall Fibromatosis,0
22849,Associated with,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22850,Primary malignant neoplasm,Carcinoma of urinary bladder,0
22851,Parenchyma,Engraftment syndrome,0
22852,ADCY10 gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22853,Vaginal (intended site),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
22854,Sexual Partners,Cancer of Urinary Tract,0
22855,Manufactured form,Mucinous adenocarcinoma gastric,0
22856,Specimen Source Codes - tumor,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22857,Continuance of life,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22858,Presentation,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22859,Adrenal Gland Neoplasms,Anterior Urethral Malignant Neoplasm,0
22860,Dilated,Transitional cell carcinoma,0
22861,Screening - general (procedure),benign mature teratoma of pancreas,0
22862,AKR1A1 wt Allele,Benign Anal Granular Cell Tumor,0
22863,Abnormally high,Benign Anal Granular Cell Tumor,0
22864,Version,Metaplastic carcinoma of breast,0
22865,West Haven Hepatic Encephalopathy Grade 3,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
22866,Squamous Epithelial Cells,Intracortical osteosarcoma,0
22867,Usual,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
22868,CDISC SEND Tumor Findings Results Terminology,Metastatic Lung Neuroendocrine Neoplasm,0
22869,Dilated,Type II Endometrial Adenocarcinoma,0
22870,Vagina,Cervical Fibroepithelial Polyp,0
22871,Aggressive behavior,Engraftment syndrome,0
22872,Component object,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
22873,Thymus Gland,Thyroid Hurthle Cell Carcinoma,0
22874,shared attribute,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
22875,Usual Severity Weight Loss,Heavy Chain Deposition Disease,0
22876,Subtype (attribute),Botryoid-Type Embryonal Rhabdomyosarcoma,0
22877,Cancer Genus,Anterior Urethral Malignant Neoplasm,0
22878,Formation,non-Hodgkin's lymphoma of spleen,0
22879,Experimental Result,Locally Advanced Soft Tissue Sarcoma,0
22880,Cancer Genus,carcinoma of middle ear,0
22881,Associated with,Diffuse malignant mesothelioma,0
22882,Probable diagnosis,Adult Acute Eosinophilic Leukemia,0
22883,Reporting,Recurrent Primary Lymphoma of Bone,0
22884,Skin lesion,Ovarian germ cell choriocarcinoma stage IV,0
22885,Operation excision,Adult Acute Eosinophilic Leukemia,0
22886,65,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
22887,Lacrimal sac,squamous cell carcinoma of the thyroid gland,0
22888,More,High Grade Glandular Intraepithelial Neoplasia,0
22889,per second,Acantholytic squamous cell carcinoma,0
22890,Used by,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
22891,Malignant Central Nervous System Neoplasm,Malignant melanoma of eyelid,0
22892,Obesity,Rhabdomyosarcoma with ganglionic differentiation,0
22893,Cancer of Lip,Mucinous adenocarcinoma gastric,0
22894,Often - answer to question,Childhood Anaplastic Large Cell Lymphoma,0
22895,>90,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
22896,Characteristics,Recurrent Uveal Melanoma,0
22897,Platelet Glycoprotein 4,Undifferentiated Endocervical Sarcoma,0
22898,Negation,Brain Tumor,0
22899,Cover (physical object),Intraepithelial Melanocytic Hyperplasia,0
22900,More,Acute Undifferentiated Leukemia,0
22901,Progress,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22902,Immunotherapy,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22903,Further,Carcinoma of urinary bladder,0
22904,Smoking,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22905,Tryptophanase,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
22906,Body part,Recurrent Testicular Lymphoma,0
22907,Include (action),embryonal rhabdomyosarcoma of prostate,0
22908,Involvement with,High Grade Glandular Intraepithelial Neoplasia,0
22909,Pituitary Gland,Liver Lymphangioma,0
22910,diagnosis aspect,Stage IB Pancreatic Cancer AJCC v8,0
22911,Approach,Rhabdomyosarcoma with ganglionic differentiation,0
22912,Specimen Source Codes - tumor,Uterine Cancer,0
22913,High,Adult Alveolar Soft Part Sarcoma,0
22914,Subject Risk,Type II Endometrial Adenocarcinoma,0
22915,Personal appearance,Neonatal leukemia,0
22916,N+ (tumor staging),Botryoid-Type Embryonal Rhabdomyosarcoma,0
22917,Diabetes Mellitus,Malignant melanoma of eyelid,0
22918,Hidrocystoma,Adult Alveolar Soft Part Sarcoma,0
22919,Formation,Mastocytosis,0
22920,Process (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22921,spindle assembly checkpoint,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
22922,Childhood Neuroblastoma,Tongue Alveolar Soft Part Sarcoma,0
22923,More,Hereditary Diffuse Gastric Adenocarcinoma,0
22924,*Type - Kind of quantity,Lipoma of small intestine,0
22925,metaplastic,Thyroid Hurthle Cell Carcinoma,0
22926,various antiinfectives and antiseptics for local oral treatment,Benign Anal Granular Cell Tumor,0
22927,Pleural effusion fluid,Neoplasms,0
22928,Techniques,Advanced Uterine Corpus Carcinosarcoma,0
22929,Fever,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22930,Orbital region,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22931,Scientific Control,Transitional cell carcinoma,0
22932,Usual Severity Itching,Stage IB Lung Cancer AJCC v7,0
22933,Strong,Splenic Manifestation of Hairy Cell Leukemia,0
22934,Classification,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22935,Science of Etiology,Xeroderma pigmentosum,0
22936,Occurrence,Gallbladder Adenocarcinoma,0
22937,Type - attribute,FIGO Stage IVA Ovarian Cancer,0
22938,Severe (severity modifier),Malignant Testicular Sertoli Cell Tumor,0
22939,Only - dosing instruction fragment,Atypical Lobular Breast Hyperplasia,0
22940,Pressure - action,Noninfiltrating Intraductal Carcinoma,0
22941,Sometimes,Trabecular adenocarcinoma,0
22942,Including (qualifier),Parathyroid Gland Adenocarcinoma,0
22943,Age,Clinical Stage I Cutaneous Melanoma AJCC v8,0
22944,Include (action),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
22945,70%,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22946,Specific qualifier value,Maxillary Sinus Adenocarcinoma,0
22947,Followed by,Recurrent Testicular Lymphoma,0
22948,Capillary Action,GIANT PIGMENTED HAIRY NEVUS,0
22949,Neoplasms,Extracranial Neuroblastoma,0
22950,Group A (qualifier value),Medulloblastoma,0
22951,Primary,Fibroadenoma of breast,0
22952,Primary malignant neoplasm,Thymic Atypical Carcinoid Tumor,0
22953,Gait normal,Multiple Skull Base Meningiomas,0
22954,Dyspnea,Intestinal Metaplasia of Bladder Urothelium,0
22955,Primary malignant neoplasm,Refractory Bladder Carcinoma,0
22956,Death Rate,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
22957,Age of Onset,Vaginal Adenoma,0
22958,Neurofibromatosis 1,Unresectable Rhabdomyosarcoma,0
22959,Central Nervous System Embryonal Neoplasm,Ovarian germ cell choriocarcinoma stage IV,0
22960,North America,Chondrosarcoma,0
22961,Immune system,Unresectable Rhabdomyosarcoma,0
22962,Leukemia (category),Ovarian germ cell choriocarcinoma stage IV,0
22963,Indexes,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
22964,Formation,Low Grade Squamous Intraepithelial Neoplasia,0
22965,Anterior,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
22966,Representation (action),Splenic Manifestation of Hairy Cell Leukemia,0
22967,Hemorrhage,Basal Cell Ameloblastoma,0
22968,Organ,Carcinoma of urinary bladder,0
22969,Platelet-Derived Growth Factor Receptor Alpha,Cervical Fibroepithelial Polyp,0
22970,Type A,Botryoid-Type Embryonal Rhabdomyosarcoma,0
22971,Primary operation,Extra-Adrenal Paraganglioma,0
22972,Descent,Microcystic meningioma,0
22973,Protection Element Attribute,Acantholytic squamous cell carcinoma,0
22974,Miss - Title,Medulloblastoma,0
22975,Body Fluids,adenoid cystic carcinoma of lung,0
22976,Classification,Uterine Cancer,0
22977,Third revision,Hyperplasia of pituitary gland,0
22978,Oral,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
22979,Mass of body structure,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
22980,Usual Severity Weight Loss,Peripheral primitive neuroectodermal tumor of soft tissue,0
22981,week,Mucosal Melanoma,0
22982,Genetic,Lipoma of small intestine,0
22983,Stem cell transplant,Werner Syndrome,0
22984,Vascular,Recurrent Uveal Melanoma,0
22985,3+ Score,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
22986,Drug Administration Routes,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
22987,Malignant Neoplasms,Angiosarcoma of liver,0
22988,Etiology aspects,Stage III Cutaneous Melanoma AJCC v6,0
22989,Anogenital region,Mixed astrocytoma-ependymoma,0
22990,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Childhood Lung Non-Small Cell Carcinoma,0
22991,Skin,Cartilaginous exostosis,0
22992,Proliferation (morphologic abnormality),Ovarian germ cell choriocarcinoma stage IV,0
22993,Melanoma Pathway,Localized Askin Tumor,0
22994,Cancer Genus,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
22995,Administration procedure,Hereditary Diffuse Gastric Adenocarcinoma,0
22996,Prophylactic treatment,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
22997,Treating,Atypical Lobular Breast Hyperplasia,0
22998,Personal appearance,Cervical Adenomyoma,0
22999,Cause of Death,Mucinous cystadenofibroma,0
23000,Involvement with,Larynx carcinoma recurrent,0
23001,Initially,Human Papillomavirus-Related Carcinoma,0
23002,Widening,Adult Alveolar Soft Part Sarcoma,0
23003,Include (action),Acute Undifferentiated Leukemia,0
23004,CEL gene,Kaposi's sarcoma of extrahepatic bile duct,0
23005,Therapeutic radiology procedure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
23006,Lung,Melanomatosis,0
23007,shared attribute,Low Grade Squamous Intraepithelial Neoplasia,0
23008,biologic degeneration,Malignant neoplasm of thalamus,0
23009,Include (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
23010,Ki-1+ Anaplastic Large Cell Lymphoma,Endometrial Small Cell Carcinoma,0
23011,Monitor Device,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23012,Mass of body region,Melanomatosis,0
23013,Chemotherapy Regimen,Thyroid carcinoma,0
23014,Site,Hodgkin lymphoma,0
23015,Cancer Genus,Cerebral Primitive Neuroectodermal Tumor,0
23016,Two,Hyperplasia of pituitary gland,0
23017,Conventional Treatment,Malignant neoplasm of olfactory nerve,0
23018,SERPINA3 wt Allele,Peripheral primitive neuroectodermal tumor of soft tissue,0
23019,Nasal turbinate bone structure,Recurrent Uveal Melanoma,0
23020,Used by,Kaposi's sarcoma of skin,0
23021,Decrease,Neonatal leukemia,0
23022,Affecting,Acantholytic squamous cell carcinoma,0
23023,Fever,Leptomeningeal sarcoma,0
23024,active (HL7 RoleLink),Acute Undifferentiated Leukemia,0
23025,Affecting,Adenocarcinoma of duodenum,0
23026,Specimen Type - Genital,Human Papillomavirus-Related Carcinoma,0
23027,Human body structure,clear cell adenocarcinoma of gallbladder,0
23028,Solid Dose Form,Acantholytic squamous cell carcinoma,0
23029,Common (qualifier value),Type II Endometrial Adenocarcinoma,0
23030,Due to,Malignant Testicular Sertoli Cell Tumor,0
23031,Exposure to toxin,Malignant melanoma of eyelid,0
23032,Age,Carcinoma of urinary bladder,0
23033,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Intraepithelial Melanocytic Hyperplasia,0
23034,Tissue Specimen Code,Metaplastic carcinoma of breast,0
23035,Family history,Melanomatosis,0
23036,Chemical or Textual Reference to Actual Test or Parameter,Vaginal Adenoma,0
23037,Human body,Digestive System Hodgkin Lymphoma,0
23038,Tumor type,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23039,Primary malignant neoplasm,Childhood Choriocarcinoma,0
23040,Fifth,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23041,Caucasians,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23042,chance,Benign tumor of eyelid,0
23043,structure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
23044,Pelvic Pain,Undifferentiated Neuroblastoma,0
23045,Line Specimen,Endometrial Small Cell Carcinoma,0
23046,Height / growth measure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23047,Disease,embryonal rhabdomyosarcoma of prostate,0
23048,Frequently,Granular Cell Leiomyosarcoma,0
23049,Precision - second,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23050,Qualitative form,Engraftment syndrome,0
23051,Lifetime,Basal Cell Ameloblastoma,0
23052,Diagnosis,Recurrent Rhabdomyosarcoma,0
23053,Entity Determiner - specific,Digestive System Hodgkin Lymphoma,0
23054,Similarity,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
23055,Pelvis,Localized Ewing Sarcoma,0
23056,APC gene,Occult Lung Adenosquamous Carcinoma,0
23057,per year,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23058,Geographic Locations,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23059,PSA Level Less than Five,Bladder squamous cell carcinoma stage I,0
23060,Painless,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23061,Bothered by Night Sweats,Vaginal Adenoma,0
23062,Type - attribute,Localized Ewing Sarcoma,0
23063,To,Xeroderma pigmentosum,0
23064,Intestines,Benign tumor of eyelid,0
23065,Low Mitosis-Karyorrhexis Index,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
23066,BRCA1 protein,Maxillary Sinus Adenocarcinoma,0
23067,Tissue of central nervous system,Blepharal carcinoma,0
23068,Operative Surgical Procedures,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23069,Class,Metastatic Carcinoma in the Lung,0
23070,survival aspects,Splenic Manifestation of Hairy Cell Leukemia,0
23071,Spinal Cord,Hodgkin Disease,0
23072,Artificial cardiac pacemaker,Grade 3a Malignant Neoplasm,0
23073,Cessation of life,Nasal cavity carcinoma,0
23074,Occur (action),Acute Undifferentiated Leukemia,0
23075,Affecting,Digestive System Hodgkin Lymphoma,0
23076,epithelial,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
23077,Usual,Platinum-Resistant Lung Small Cell Carcinoma,0
23078,General surgery specialty,Recurrent Primary Lymphoma of Bone,0
23079,Numerous,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23080,Show,malignant lymphoma of pancreatic lymph nodes,0
23081,Genetic Markers,Female Breast Carcinoma,0
23082,Varies,Spermatocytic seminoma,0
23083,Time (foundation metadata concept),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23084,Manufactured sign,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23085,Science of Statistics,Transitional cell carcinoma,0
23086,Impaired skin integrity,Cervical Fibroepithelial Polyp,0
23087,include - SetOperator,Heavy Chain Deposition Disease,0
23088,White Blood Cell Count procedure,Small cell neuroendocrine carcinoma of bladder,0
23089,During,Recurrent Primary Lymphoma of Bone,0
23090,Mean Percent of Normal,Malignant neoplasm of olfactory nerve,0
23091,Location,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23092,Trial Screening,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23093,Involvement with,Recurrent Testicular Lymphoma,0
23094,Major <insect>,adenoid cystic carcinoma of lung,0
23095,Account number:Identifier:Point in time:^Patient:Nominal,Acantholytic squamous cell carcinoma,0
23096,Others - Allergy,Cartilaginous exostosis,0
23097,Neutral pH,Lipoma of small intestine,0
23098,Frequently,Vaginal Adenoma,0
23099,Due to,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
23100,Risk,FIGO Stage II Ovarian Cancer,0
23101,Lymphadenopathy,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23102,Associated with,Bladder adenocarcinoma stage IV,0
23103,Coding,Nasal cavity carcinoma,0
23104,melanoma,Pancreatic carcinoma,0
23105,Poverty,Cervical Squamous Intraepithelial Neoplasia,0
23106,SPINK5 gene,adenoid cystic carcinoma of lung,0
23107,Tears - SpecimenType,Stage IB Lung Cancer AJCC v7,0
23108,Exist,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23109,Acute Undifferentiated Leukemia,Carcinoma of urinary bladder,0
23110,PELVIS irradiation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
23111,60%,Stage III Cutaneous Melanoma AJCC v6,0
23112,Glycation End Products,Cancer of Urinary Tract,0
23113,Diagnosis,Vaginal Adenoid Cystic Carcinoma,0
23114,European Union Notified Body,Bladder squamous cell carcinoma stage I,0
23115,Malignant Neoplasms,Squamous cell carcinoma of lip,0
23116,dendritic spine neck,Refractory Barrett Esophagus,0
23117,Dual,Benign Ovarian Thecoma,0
23118,Bloating,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23119,Conditioning (Psychology),Diffuse malignant mesothelioma,0
23120,Pancreatic Hormones,Granular Cell Leiomyosarcoma,0
23121,Enneking High Surgical Grade,Pancreatic carcinoma,0
23122,Coating (film),Stage IV Penile Cancer AJCC v7,0
23123,Ulcer,Localized Askin Tumor,0
23124,Childhood Germ Cell Tumor,Pancreatic Intraepithelial Neoplasia-3,0
23125,400,Trabecular adenocarcinoma,0
23126,Skin,Benign squamous cell tumor,0
23127,Decision,Malignant Neoplasm with Regional Lymph Node Involvement,0
23128,Skeletal bone,Nasal cavity carcinoma,0
23129,Aggressive course,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23130,Primary malignant neoplasm,Intraepithelial Melanocytic Hyperplasia,0
23131,Tumor Mass,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23132,Nasal (intended site),Botryoid-Type Embryonal Rhabdomyosarcoma,0
23133,Previous,Metastatic Ductal Breast Carcinoma,0
23134,Rapid,Childhood Lymphoma,0
23135,Therapeutic radiology procedure,Testicular cancer metastatic,0
23136,Supernumerary,Stage IB Pancreatic Cancer AJCC v8,0
23137,Initial (abbreviation),Familial Hemophagocytic Lymphocytosis,0
23138,Common Specifications in HL7 V3 Publishing,Tongue Alveolar Soft Part Sarcoma,0
23139,Volume,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23140,Filter (function),Clinical Stage I Cutaneous Melanoma AJCC v8,0
23141,biopsy characteristics,Ichthyoses,0
23142,Urine,Breast Apocrine Adenoma,0
23143,Name (property) (qualifier value),Gallbladder adenoma,0
23144,Histocompatibility Testing,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23145,Presentation,Granular Cell Leiomyosarcoma,0
23146,Dyspnea,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
23147,Occurrence,Fibroadenoma of breast,0
23148,Grade IV Childhood Astrocytic Neoplasm,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23149,Enneking High Surgical Grade,Choroid Necrotic Melanoma,0
23150,removal technique,Advanced Uterine Corpus Carcinosarcoma,0
23151,Deeply - dosing instruction fragment,papillary carcinoma of penis,0
23152,Lead,Cervical Adenomyoma,0
23153,Most,Carcinoma,0
23154,Associated with,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23155,Cell Count,Locally Advanced Squamous Cell Carcinoma,0
23156,Collection (action),malignant lymphoma of pancreatic lymph nodes,0
23157,curettage specimen,Stage III Adult Immunoblastic Lymphoma,0
23158,Primary malignant neoplasm,Stage IV Penile Cancer AJCC v7,0
23159,melanoma,Pancreatic Intraepithelial Neoplasia-3,0
23160,Benign,Recurrent Uveal Melanoma,0
23161,Young,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23162,Participation Type - origin,Childhood Central Nervous System Ganglioneuroblastoma,0
23163,Stem cell transplant,Thymoma malignant recurrent,0
23164,Parotid salivary apparatus,Hodgkin Disease,0
23165,Malignant Central Nervous System Neoplasm,Pilocytic astrocytoma of cerebellum,0
23166,survival aspects,ICHTHYOSIS,0
23167,Connect,Acute Undifferentiated Leukemia,0
23168,Infrequent,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23169,Onset of Action,Mucinous adenocarcinoma gastric,0
23170,Case unit dose,Leptomeningeal sarcoma,0
23171,To,Heavy Chain Deposition Disease,0
23172,SLC6A2 protein,Childhood Lung Non-Small Cell Carcinoma,0
23173,PIMREG gene,Mucinous cystadenofibroma,0
23174,Kilosecond,Cervical Fibroepithelial Polyp,0
23175,PSA Level Less than Five,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23176,Ephrin Type-B Receptor 1,Neonatal leukemia,0
23177,Symptoms aspect,Refractory Ependymoma,0
23178,Heart,Acute lymphadenitis,0
23179,3+ Score,Familial Adenomatous Polyposis Associated Medulloblastoma,0
23180,Platelet Glycoprotein 4,Stage 0 Penile Cancer AJCC v8,0
23181,Feel Tired question,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23182,Ultraviolet Rays,Colorectal High Grade B-Cell Lymphoma,0
23183,risk factors,Intraepithelial Melanocytic Hyperplasia,0
23184,>65 years,Locally Advanced Squamous Cell Carcinoma,0
23185,Occurrence,Thyroid carcinoma,0
23186,Categories,Cerebral Primitive Neuroectodermal Tumor,0
23187,Ratio,Undifferentiated Neuroblastoma,0
23188,Proteins,Childhood Anaplastic Large Cell Lymphoma,0
23189,How Often Weight Loss,Refractory Barrett Esophagus,0
23190,Extra-location,Undifferentiated Endocervical Sarcoma,0
23191,Paintings,Mixed astrocytoma-ependymoma,0
23192,Metastatic Neoplasm,Non-Metastatic Gestational Trophoblastic Tumor,0
23193,Common (qualifier value),Colorectal Neuroendocrine Tumor G2,0
23194,Targeted Therapy,Cancer of Urinary Tract,0
23195,Compleat Liquid Nutrition,Ovarian Carcinoid Tumor,0
23196,Primary,Anterior Urethral Malignant Neoplasm,0
23197,Adverse Event by CTCAE Category,Tongue Alveolar Soft Part Sarcoma,0
23198,Consistency,Uterine Cancer,0
23199,Survival Rate,Medulloblastoma,0
23200,Involvement with,Choroid Epithelioid Cell Melanoma,0
23201,Physical shape,Cervical Squamous Intraepithelial Neoplasia,0
23202,Experimental Organism Anal Sac Gland,Splenic Manifestation of Hairy Cell Leukemia,0
23203,Aspects of signs,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23204,Fasting,Human Papillomavirus-Related Carcinoma,0
23205,Repair,Medulloblastoma,0
23206,Adult human body,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23207,Benign,Benign Carotid Body Paraganglioma,0
23208,Often - answer to question,Lung squamous cell carcinoma stage I,0
23209,Full,Cervical Fibroepithelial Polyp,0
23210,Application Context,Testicular cancer metastatic,0
23211,Treated with,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23212,How Much Distress Weight Loss,Ichthyosis,0
23213,Fragment of (qualifier value),Malignant neoplasm of subglottis,0
23214,Upon - dosing instruction fragment,Unicystic ameloblastoma,0
23215,Have Been Vomiting,Choroid Necrotic Melanoma,0
23216,How Much Distress Vomiting,Liver Lymphangioma,0
23217,Name (property) (qualifier value),Neonatal leukemia,0
23218,Metastatic Disease Clinical Trial Setting,Primary Cutaneous Plasmablastic Lymphoma,0
23219,Infrequent,Benign Anal Granular Cell Tumor,0
23220,Infant,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
23221,Tumor cells,Digestive System Hodgkin Lymphoma,0
23222,Carcinoma,High Grade Glandular Intraepithelial Neoplasia,0
23223,VARIOUS DRUG CLASSES IN ATC,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23224,Specimen Source Codes - tumor,Carcinomatosis of peritoneal cavity,0
23225,North America,Childhood Central Nervous System Ganglioneuroblastoma,0
23226,Eyelid Diseases,Multiple Skull Base Meningiomas,0
23227,Linear,Adenocarcinoma of the prostate metastatic,0
23228,Frequently,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
23229,1+ Score,Adenocarcinoma of duodenum,0
23230,Make - Instruction Imperative,Refractory Bladder Carcinoma,0
23231,Prevalence aspects,Kaposi's sarcoma of extrahepatic bile duct,0
23232,Pelvis+,Bladder adenocarcinoma stage IV,0
23233,Face (spatial concept),Multiple Skull Base Meningiomas,0
23234,Medical,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23235,Epithelial ovarian cancer,de novo Myelodysplastic Syndrome,0
23236,Anemia,Digestive System Hodgkin Lymphoma,0
23237,Problems - What subject filter,adenoid cystic carcinoma of lung,0
23238,Overall,Refractory WHO Grade III Glioma,0
23239,3+ Score,Stage IV Childhood Non-Hodgkin Lymphoma,0
23240,Type - attribute,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
23241,Weight decreased,Stage IB Pancreatic Cancer AJCC v8,0
23242,Symptoms,carcinoma of middle ear,0
23243,Call (Instruction),Adenocarcinoma,0
23244,growth aspects,adenosquamous carcinoma of breast,0
23245,Mammal liver preparation,Fibroadenoma of breast,0
23246,Include (action),Spongiotic dermatitis,0
23247,Bone structure of cranium,Small Intestinal Villous Adenoma,0
23248,Scientific Publication,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23249,Support,Stage III Cutaneous Melanoma AJCC v6,0
23250,Diagnosis,Recurrent Testicular Lymphoma,0
23251,+2,Childhood Fibrillary Astrocytoma,0
23252,Appearance,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
23253,Oncogene Fusion,Diffuse malignant mesothelioma,0
23254,Back Pain,Extracranial Neuroblastoma,0
23255,Capecitabine/Cisplatin Regimen,Methotrexate-Associated Hodgkin Lymphoma,0
23256,Redness,Bladder Neuroendocrine Neoplasm,0
23257,Often - answer to question,Angiosarcoma of liver,0
23258,Offspring,Bladder adenocarcinoma stage IV,0
23259,Plasma,Neoplasms,0
23260,Imaging Techniques,Intraepithelial Melanocytic Hyperplasia,0
23261,Diagnosis,Ovarian germ cell choriocarcinoma stage IV,0
23262,Changing,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23263,Cancer Other,Acute Undifferentiated Leukemia,0
23264,Descending,Recurrent Primary Lymphoma of Bone,0
23265,Line Unit of Length,Female Breast Carcinoma,0
23266,Body part,Kaposi's sarcoma of extrahepatic bile duct,0
23267,various other intestinal adsorbents in ATC,Malignant melanoma of eyelid,0
23268,CD69 wt Allele,Splenic Manifestation of Hairy Cell Leukemia,0
23269,Include (action),Undifferentiated Endocervical Sarcoma,0
23270,Genetic syndrome,embryonal rhabdomyosarcoma of prostate,0
23271,Pap smear,Advanced Uterine Corpus Carcinosarcoma,0
23272,Asia,Diffuse malignant mesothelioma,0
23273,Feature,Malignant neoplasm of gallbladder,0
23274,Presence (property),Kaposi's sarcoma of skin,0
23275,Type A,Stage IB Pancreatic Cancer AJCC v8,0
23276,Result,Benign tumor of eyelid,0
23277,Reflex motion descriptor,Adult Hepatocellular Carcinoma,0
23278,Patients,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23279,Progress,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23280,melanocyte,Benign squamous cell tumor,0
23281,Tryptophanase,Endometrial Small Cell Carcinoma,0
23282,Negation,Mucinous adenocarcinoma gastric,0
23283,Either,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23284,Often - answer to question,mucinous adenocarcinoma of gallbladder,0
23285,Abnormal result,Blepharal carcinoma,0
23286,International Medical Terminology,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23287,Urinary Bladder,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23288,Following,Childhood Fibrillary Astrocytoma,0
23289,Less often,Acantholytic squamous cell carcinoma,0
23290,combination - answer to question,Stage IV Penile Cancer AJCC v7,0
23291,control aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23292,Sharing (Social Behavior),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23293,Include (action),Precursor B-lymphoblastic lymphoma stage II,0
23294,Beginning,Tonsillar Carcinoma,0
23295,Parenchyma,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
23296,International Classification of Disease for Oncology,Refractory Ependymoma,0
23297,Firstly,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23298,research subject screening,Mucinous adenocarcinoma gastric,0
23299,Radiation,Childhood Fibrillary Astrocytoma,0
23300,Increased,Breast Ductal Adenoma,0
23301,Twice (Numerical Qualifier),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23302,Range,Human Papillomavirus-Related Carcinoma,0
23303,Uterus,Stage I Adult Non-Hodgkin Lymphoma,0
23304,Ulcerative Colitis,Metaplastic carcinoma of breast,0
23305,Finding related to focusing,Lung squamous cell carcinoma stage I,0
23306,Follow,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23307,Disease Screening,Mucinous adenocarcinoma gastric,0
23308,Cells,Cancer of Urinary Tract,0
23309,Pharmacotherapy,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23310,Beginning,Locally Advanced Carcinoma,0
23311,Known,Engraftment syndrome,0
23312,Infected,Thymoma malignant recurrent,0
23313,Breast tissue sample,Low Grade Squamous Intraepithelial Neoplasia,0
23314,Lung,Spermatocytic seminoma,0
23315,Kininogenase,Childhood Choriocarcinoma,0
23316,Packaging Case,BRCA2 Syndrome,0
23317,Usual Severity Sweats,Nasal cavity carcinoma,0
23318,Five,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
23319,Classification,Peripheral primitive neuroectodermal tumor of soft tissue,0
23320,Treating,Platinum-Resistant Lung Small Cell Carcinoma,0
23321,Brain Neoplasms,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23322,Play,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23323,Estimated,ROSE Cluster 3,0
23324,Taxonomic,Vaginal Adenoma,0
23325,Most,Maxillary Sinus Adenoid Cystic Carcinoma,0
23326,Normal,Placental aromatase deficiency,0
23327,status - In progress,Blepharal carcinoma,0
23328,Age at menopause:Time:Point in time:^Patient:Quantitative,Digestive System Hodgkin Lymphoma,0
23329,Squamous cell carcinoma - category,Chronic Myelomonocytic Leukemia-2,0
23330,Primary malignant neoplasm,Kaposi's sarcoma of extrahepatic bile duct,0
23331,One,Undifferentiated Endocervical Sarcoma,0
23332,Retinoic Acid Response Element,Carcinoma of urinary bladder,0
23333,Antibiotics,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23334,shared attribute,Stage IV Penile Cancer AJCC v7,0
23335,Space - property,Malignant neoplasm of choroid,0
23336,Blood group A (finding),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23337,Cryptorchidism,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23338,Structure of arteriole,FIGO Stage II Ovarian Cancer,0
23339,Occurrence,Carcinoma of urinary bladder,0
23340,Secondary Neoplasm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23341,Lower (action),Pilocytic astrocytoma of cerebellum,0
23342,Compression - action,Benign neoplasm of eye,0
23343,cell type,Extra-Adrenal Paraganglioma,0
23344,Therapeutic procedure,Benign squamous cell tumor,0
23345,Severe Extremity Pain,Malignant melanoma of eyelid,0
23346,Malignant Neoplasms,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23347,Common (qualifier value),Grade 3a Malignant Neoplasm,0
23348,Specimen Source Codes - Tears,Type II Endometrial Adenocarcinoma,0
23349,Finding of hormone level,Splenic Manifestation of Hairy Cell Leukemia,0
23350,Primary,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23351,2+ Score,Collecting Duct Carcinoma of the Kidney,0
23352,status - In progress,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23353,Experimental Result,Locally Advanced Epithelioid Hemangioendothelioma,0
23354,True primary (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23355,include - SetOperator,Neoplasms,0
23356,Corner Plus,Stage III Cutaneous Melanoma AJCC v6,0
23357,Symptoms,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23358,Screening procedure,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
23359,Internal medicine specialty,Cerebral Primitive Neuroectodermal Tumor,0
23360,Dental caries,Carcinoma of submandibular gland,0
23361,Fusion procedure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23362,Hematology (discipline),Ovarian germ cell choriocarcinoma stage IV,0
23363,Treating,Adult Hepatocellular Carcinoma,0
23364,System,Multiple Skull Base Meningiomas,0
23365,Immune,Stage II Carcinoma of Penis,0
23366,Known,Non-Metastatic Gestational Trophoblastic Tumor,0
23367,consideration,Astrocytoma of brain,0
23368,Therapeutic procedure,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
23369,Sufficiently defined concept definition status (core metadata concept),Melanomatosis,0
23370,CD5L wt Allele,Kaposi's sarcoma of skin,0
23371,Congenital Abnormality,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23372,Etiology aspects,Kaposi's sarcoma of skin,0
23373,Back structure,Chondrosarcoma,0
23374,Common Specifications in HL7 V3 Publishing,Vaginal Adenoma,0
23375,Type - attribute,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23376,Due to,Localized Ewing Sarcoma,0
23377,Primary malignant neoplasm,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23378,Occurrence Indicator,High Grade Glandular Intraepithelial Neoplasia,0
23379,Beginning,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23380,300,Malignant Neoplasm of Lung - Multiple Primary Sites,0
23381,Cell Count,Fibroadenoma of breast,0
23382,Abnormal cell,Tonsillar Carcinoma,0
23383,Enlarged,Localized Ewing Sarcoma,0
23384,Goes <invertebrate>,adenoid cystic carcinoma of lung,0
23385,operate <remove>,non-Hodgkin's lymphoma of spleen,0
23386,Less Than,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23387,Secretory Vesicles,Stage 0 Penile Cancer AJCC v8,0
23388,One,Tubal Hyperplasia,0
23389,Intestines,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23390,Indication of (contextual qualifier),BRCA2 Syndrome,0
23391,One,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23392,3+ Answer to Question,Ichthyosis,0
23393,Study,Childhood Central Nervous System Ganglioneuroblastoma,0
23394,Negative Surgical Margin,Colorectal High Grade B-Cell Lymphoma,0
23395,Initial Usage,Hereditary Diffuse Gastric Adenocarcinoma,0
23396,Therapeutic procedure,Pancreatic Intraepithelial Neoplasia-3,0
23397,Biopsy,Kaposi's sarcoma of extrahepatic bile duct,0
23398,Patients,Bladder squamous cell carcinoma stage I,0
23399,Similarity,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23400,Including (qualifier),Cerebral Primitive Neuroectodermal Tumor,0
23401,DUOXA1 gene,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23402,Sarcoma of soft tissue,Pancreatic Endocrine Carcinoma,0
23403,include - SetOperator,Unicystic ameloblastoma,0
23404,Manufactured form,Adult Alveolar Soft Part Sarcoma,0
23405,Scientific Publication,Astrocytoma of brain,0
23406,Obesity,Colorectal cancer,0
23407,Include (action),Astrocytoma of brain,0
23408,United States,Localized Ewing Sarcoma,0
23409,Coughing,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23410,Abnormally high,Primary Cutaneous Plasmablastic Lymphoma,0
23411,Occurrence,Bladder adenocarcinoma stage IV,0
23412,Formation,FIGO Stage II Ovarian Cancer,0
23413,biopsy characteristics,Extracranial Neuroblastoma,0
23414,Associated with,FIGO Stage IVA Ovarian Cancer,0
23415,Germ cell tumor,Acute Undifferentiated Leukemia,0
23416,Body tissue,Pilocytic astrocytoma of cerebellum,0
23417,Malignant neoplasm of lung,Childhood Extragonadal Malignant Germ Cell Tumor,0
23418,Age at menopause,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
23419,Chemotherapy Regimen,Type II Endometrial Adenocarcinoma,0
23420,Near,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23421,How Often Felt Normal question,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23422,Chicken laying egg for human food,Stage III Adult Immunoblastic Lymphoma,0
23423,gastrointestinal,Heavy Chain Deposition Disease,0
23424,Include (action),Malignant Testicular Sertoli Cell Tumor,0
23425,Basis - conceptual entity,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
23426,Comparison,FIGO Stage II Ovarian Cancer,0
23427,Urinary Bladder,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
23428,Common Specifications in HL7 V3 Publishing,Kaposi's sarcoma of extrahepatic bile duct,0
23429,<50,Thyroid Hurthle Cell Carcinoma,0
23430,Irritation - emotion,Melanomatosis,0
23431,Late,Familial Hemophagocytic Lymphocytosis,0
23432,Including (qualifier),Extra-Adrenal Paraganglioma,0
23433,Manufactured form,Vaginal Adenoid Cystic Carcinoma,0
23434,Including (qualifier),Clonal Hematopoiesis of Indeterminate Potential,0
23435,Body part,Vaginal Adenoma,0
23436,Etiology aspects,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23437,Loss of appetite (finding),Metaplastic carcinoma of breast,0
23438,Skeletal bone,Adult Anaplastic Oligodendroglioma,0
23439,various other nasal preparations in ATC,Carcinoma of submandibular gland,0
23440,Ultrasonic Shockwave,Undifferentiated Endocervical Sarcoma,0
23441,2+ Score,Tonsillar Carcinoma,0
23442,survive,Bladder Neuroendocrine Neoplasm,0
23443,Blood,Chest Wall Fibromatosis,0
23444,Symptoms aspect,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23445,Illness: Cannot describe symptoms,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23446,Blast (physical force),Stage IV Childhood Non-Hodgkin Lymphoma,0
23447,genome sequencing,Mucinous adenocarcinoma gastric,0
23448,Cell Differentiation process,GIANT PIGMENTED HAIRY NEVUS,0
23449,*Type - Kind of quantity,Blood Vessel Tumors,0
23450,hand - unit of measure,Benign tumor of eyelid,0
23451,risk factors,Giant cell angiofibroma,0
23452,Pancreatic carcinoma,Childhood Extragonadal Malignant Germ Cell Tumor,0
23453,Study,Anterior Urethral Malignant Neoplasm,0
23454,Probability,Refractory Barrett Esophagus,0
23455,Treating,Endometrial Small Cell Carcinoma,0
23456,cell growth,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23457,Unknown,Prostate Lymphoma,0
23458,Teens,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23459,cell transformation,Localized Malignant Neoplasm,0
23460,Oral cavity,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23461,filter information process,Bladder adenocarcinoma stage IV,0
23462,Suspected qualifier,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23463,risk factors - observation list,Familial Hemophagocytic Lymphocytosis,0
23464,Overall Well Being,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23465,Supportive assistance,Intestinal Neuroendocrine Carcinoma,0
23466,Malignant Neoplasms,squamous cell carcinoma of the thyroid gland,0
23467,Known,Unfavorable Non-Hodgkin Lymphoma,0
23468,Importance Weight,Pilocytic astrocytoma of cerebellum,0
23469,Relationships,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
23470,Involvement with,Methotrexate-Associated Hodgkin Lymphoma,0
23471,Skeletal system,Undifferentiated Endocervical Sarcoma,0
23472,Patient currently pregnant,Cerebral hemangioma,0
23473,Nearly,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
23474,Growth action,Engraftment syndrome,0
23475,Present,Primary Cutaneous Plasmablastic Lymphoma,0
23476,Drink (dietary substance),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23477,Macrophage count,Thymic Clear Cell Carcinoma,0
23478,Ultrasonic,FIGO Stage IVA Ovarian Cancer,0
23479,Lung,Locally Advanced Squamous Cell Carcinoma,0
23480,Central,Malignant neoplasm of choroid,0
23481,Usually Need Help from Another Person for Arising,Heavy Chain Deposition Disease,0
23482,Osteosarcoma of bone,Mucinous adenocarcinoma,0
23483,Sufficient,Serous cystadenocarcinoma ovary,0
23484,Immune System Finding,malignant lymphoma of pancreatic lymph nodes,0
23485,Interventional procedure,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23486,include - SetOperator,Splenic Manifestation of Hairy Cell Leukemia,0
23487,3+ Score,Type II Endometrial Adenocarcinoma,0
23488,Increased,Bladder adenocarcinoma stage IV,0
23489,Neoplastic disease,Kaposi's sarcoma of skin,0
23490,Array Feature,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
23491,Childhood Lymphoma,FIGO Stage IVA Ovarian Cancer,0
23492,Targeted Therapy,Intestinal Neuroendocrine Carcinoma,0
23493,Acute Undifferentiated Leukemia,Lipoma of small intestine,0
23494,Classification,gliosarcoma,0
23495,List,Splenic Manifestation of Hairy Cell Leukemia,0
23496,Activation action,Acantholytic squamous cell carcinoma,0
23497,dependent,Ampulla of Vater Tubular Adenoma,0
23498,Urethra part,Benign Ovarian Thecoma,0
23499,Reduced,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23500,Spreading (qualifier value),embryonal rhabdomyosarcoma of prostate,0
23501,Order (action),Airway Hemangioma,0
23502,Condition,Colorectal Neuroendocrine Tumor G2,0
23503,Malignant neoplasm of thyroid,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
23504,To,Blood Vessel Tumors,0
23505,Large,Kaposi's sarcoma of extrahepatic bile duct,0
23506,incidence of cases,Undifferentiated Endocervical Sarcoma,0
23507,Irregular,Ectomesenchymal Chondromyxoid Tumor,0
23508,factor A,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23509,radiotherapeutic,Metastatic Carcinoma in the Lung,0
23510,Case (situation),Kaposi's sarcoma of skin,0
23511,10%,Bladder Neuroendocrine Neoplasm,0
23512,Administration procedure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23513,Uterine Fibroids,Occult Lung Adenosquamous Carcinoma,0
23514,Experimental Result,Cervical Fibroepithelial Polyp,0
23515,Reduced,Maxillary Sinus Adenoid Cystic Carcinoma,0
23516,Togo,Vaginal Adenoid Cystic Carcinoma,0
23517,Malignant neoplasm of pancreas,Occult Lung Adenosquamous Carcinoma,0
23518,Communicable Diseases,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
23519,Colon <insect>,Papillary squamous cell carcinoma,0
23520,Communication Contact,Precursor B-lymphoblastic lymphoma stage II,0
23521,Include (action),Mastocytosis,0
23522,Abnormal coordination,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23523,Digestive Enzymes,Childhood Fibrillary Astrocytoma,0
23524,Firstly,Placental aromatase deficiency,0
23525,Skin Specimen,Secondary malignant neoplasm of lymph node,0
23526,Malignant Neoplasms,Stage 0 Lip Carcinoma,0
23527,Clone,Small cell neuroendocrine carcinoma of bladder,0
23528,Therapeutic procedure,Astrocytoma of brain,0
23529,Type A,Breast Ductal Adenoma,0
23530,multiple pathologies,Multiple Endocrine Neoplasia,0
23531,Referring,Liver Cavernous Hemangioma,0
23532,Entity,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23533,Obesity,Non-Hodgkin Lymphoma During Pregnancy,0
23534,World Health Organization,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23535,Northern Europe,Pilocytic astrocytoma of cerebellum,0
23536,Disease Screening,Lipoma of small intestine,0
23537,Combined,Deep Leiomyoma,0
23538,Hepatitis,Mucinous adenocarcinoma gastric,0
23539,Location of Pharyngeal Residue Following Swallowing,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23540,Type A,Platinum-Resistant Lung Small Cell Carcinoma,0
23541,Magnetic Resonance Imaging,embryonal rhabdomyosarcoma of prostate,0
23542,Supine Position,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23543,Disease,Human Papillomavirus-Related Carcinoma,0
23544,Fever symptoms (finding),Fibroadenoma of breast,0
23545,Cirrhosis,Mucinous adenocarcinoma gastric,0
23546,Healthy,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23547,During,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23548,Lymphoid neoplasm,ICHTHYOSIS,0
23549,Complete Pharyngeal Contraction,Neoplasms,0
23550,Most,Gallbladder Adenocarcinoma,0
23551,risk factors,Familial Adenomatous Polyposis Associated Medulloblastoma,0
23552,Similarity,Mucosal Melanoma,0
23553,Thyroid Gland,Bladder Neuroendocrine Neoplasm,0
23554,Malignant Neoplasms,Transitional cell carcinoma,0
23555,Species,Rhabdomyosarcoma with ganglionic differentiation,0
23556,physiological aspects,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
23557,Age,Type II Endometrial Adenocarcinoma,0
23558,Cancer Genus,Cartilaginous exostosis,0
23559,Skin cell,Thyroid Hurthle Cell Carcinoma,0
23560,Count of entities,Metaplastic carcinoma of breast,0
23561,Severe (severity modifier),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23562,status - In progress,Refractory Barrett Esophagus,0
23563,Accidental Falls,Carcinoma of submandibular gland,0
23564,Formations,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
23565,century,mucinous adenocarcinoma of gallbladder,0
23566,Areas <moth>,Malignant neoplasm of subglottis,0
23567,Term (temporal),Female Breast Carcinoma,0
23568,Nausea,Kaposi's sarcoma of skin,0
23569,described,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
23570,Surface of skin,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23571,Occurrence Indicator,Adrenal Rest Tumor,0
23572,Prognostic Factors,FIGO Stage IVA Ovarian Cancer,0
23573,Glandular stomach,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23574,Established,Recurrent Primary Lymphoma of Bone,0
23575,Spreading (qualifier value),Childhood Central Nervous System Immature Teratoma,0
23576,Cell Device,Hemangioma,0
23577,Persons,Medulloblastoma,0
23578,Smoking,Kaposi's sarcoma of skin,0
23579,Dietary Lead,Mixed astrocytoma-ependymoma,0
23580,Tissue Specimen Code,Locally Advanced Carcinoma,0
23581,Experimental Result,Malignant melanoma of eyelid,0
23582,What subject filter - Result,Fibroadenoma of breast,0
23583,Multiple Myeloma,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23584,Cell Device,Localized Askin Tumor,0
23585,Negation,squamous cell carcinoma of the thyroid gland,0
23586,Malignant Neoplasms,Familial Adenomatous Polyposis Associated Medulloblastoma,0
23587,Carbohydrate nutrients,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
23588,Well Differentiated,Diffuse malignant mesothelioma,0
23589,Greater,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23590,Several,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
23591,System - kit,Colorectal cancer,0
23592,Base - General Qualifier,Grade 3a Malignant Neoplasm,0
23593,Unknown,Refractory Barrett Esophagus,0
23594,True primary (qualifier value),Small cell neuroendocrine carcinoma of bladder,0
23595,Poor function,Mixed parotid tumor,0
23596,In addition to,Melanomatosis,0
23597,Abnormally high,Cervical Adenomyoma,0
23598,Smaller,Localized Askin Tumor,0
23599,Designated,Recurrent Rhabdomyosarcoma,0
23600,Spread by direct extension,Recurrent Primary Lymphoma of Bone,0
23601,mucosa-associated lymphoid tissue,Collecting Duct Carcinoma of the Kidney,0
23602,Rate,Bladder Neuroendocrine Neoplasm,0
23603,Widening,Cervical Squamous Intraepithelial Neoplasia,0
23604,Smear - instruction imperative,Plexosarcoma,0
23605,active (HL7 RoleLink),Mucinous adenocarcinoma gastric,0
23606,Intergroup Rhabdomyosarcoma Clinical Group Extent of Disease,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
23607,Body tissue,Xeroderma pigmentosum,0
23608,True Control Status,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23609,Use of,Female Breast Carcinoma,0
23610,Tissue Specimen Code,embryonal rhabdomyosarcoma of prostate,0
23611,Surgical aspects,Breast Apocrine Adenoma,0
23612,Treating,Mixed astrocytoma-ependymoma,0
23613,Distention of blood vessel,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23614,Capillary Action,Anterior Urethral Malignant Neoplasm,0
23615,Abdominal Cavity,Engraftment syndrome,0
23616,Entity Determiner - specific,Primary Cutaneous Plasmablastic Lymphoma,0
23617,General surgery specialty,Granular Cell Leiomyosarcoma,0
23618,Including (qualifier),Metastatic Lung Neuroendocrine Neoplasm,0
23619,Pharyngeal structure,Splenic Manifestation of Hairy Cell Leukemia,0
23620,disease history,Epithelioid Sarcoma NCI Grade 3,0
23621,Tobacco smoking behavior,Recurrent Uveal Melanoma,0
23622,60%,Brain Tumor,0
23623,associated disease,Stage IB Lung Cancer AJCC v7,0
23624,Survival Rate,Localized Askin Tumor,0
23625,2+ Score,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23626,peritoneal,Malignant neoplasm of olfactory nerve,0
23627,Breast tissue sample,Recurrent Uveal Melanoma,0
23628,chance,Intestinal Metaplasia of Bladder Urothelium,0
23629,soft tissue,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23630,Have Pain,Malignant Testicular Sertoli Cell Tumor,0
23631,alone - group size,Acantholytic squamous cell carcinoma,0
23632,tumor growth,Childhood Central Nervous System Ganglioneuroblastoma,0
23633,Type - attribute,papillary carcinoma of penis,0
23634,Neuroglia,Hereditary Diffuse Gastric Adenocarcinoma,0
23635,Malignant Neoplasms,Stage I Adult Non-Hodgkin Lymphoma,0
23636,Neoplasms,Adenocarcinoma of duodenum,0
23637,Structure of Wharton's jelly,Gallbladder adenoma,0
23638,Diagnosis Study,Extracranial Neuroblastoma,0
23639,Derivation,Engraftment syndrome,0
23640,Cancer Genus,Metastatic Carcinoma in the Lung,0
23641,Buildup,Platinum-Resistant Lung Small Cell Carcinoma,0
23642,Entity Determiner - specific,Breast Ductal Adenoma,0
23643,Main,Medulloblastoma,0
23644,Malignant Neoplasms,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
23645,/40,Grade 1 Clear Cell Renal Cell Carcinoma,0
23646,Country number:Find:Pt:^Patient:Nom,Cancer of Urinary Tract,0
23647,What subject filter - Result,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23648,Occur (action),Endometrial Small Cell Carcinoma,0
23649,Neoplasm Metastasis,FIGO Stage II Ovarian Cancer,0
23650,Myoepithelial,Liver Lymphangioma,0
23651,Tonsil,Locally Advanced Soft Tissue Sarcoma,0
23652,Mesenchymal Stem Cells,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23653,Most,FIGO Stage IVA Ovarian Cancer,0
23654,Treating,Malignant neoplasm of choroid,0
23655,Specimen Source Codes - tumor,Stage IB Lung Cancer AJCC v7,0
23656,Dysuria,Heavy Chain Deposition Disease,0
23657,Major <insect>,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
23658,LATS1 gene,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
23659,Body tissue,Malignant Neoplasm with Regional Lymph Node Involvement,0
23660,How Often Constipation,Type II Endometrial Adenocarcinoma,0
23661,Term (lexical),Squamous cell carcinoma of lip,0
23662,Night sweats,Precursor B-lymphoblastic lymphoma stage II,0
23663,Mutation,Human Papillomavirus-Related Carcinoma,0
23664,Confirm,Stage IB Lung Cancer AJCC v7,0
23665,Special,Mucosal Melanoma,0
23666,Assortment,Refractory Ependymoma,0
23667,Salivary Gland Neoplasms,Pleomorphic adenoma of parotid gland,0
23668,Cosmetic procedure,benign mature teratoma of pancreas,0
23669,RMS,Malignant neoplasm of gallbladder,0
23670,Order (record artifact),Mixed astrocytoma-ependymoma,0
23671,Dropping,Astrocytoma of brain,0
23672,Females,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23673,Malignant Carcinoid Syndrome,Benign neoplasm of thorax,0
23674,Stage Grouping,Kaposi's sarcoma of skin,0
23675,Biomaterial Treatment,Ichthyosis,0
23676,30%,Uterine Cancer,0
23677,Result,Familial Hemophagocytic Lymphocytosis,0
23678,Term Birth,Malignant melanoma of eyelid,0
23679,Before values,Leptomeningeal sarcoma,0
23680,Killing,Type II Endometrial Adenocarcinoma,0
23681,Gene Mutation,Astrocytoma of brain,0
23682,Pharyngeal structure,clear cell adenocarcinoma of gallbladder,0
23683,Disease,Metastatic Ductal Breast Carcinoma,0
23684,Precipitating Factors,Testicular cancer metastatic,0
23685,shared attribute,Clonal Hematopoiesis of Indeterminate Potential,0
23686,Upper Respiratory Infections,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23687,Retinoic Acid Response Element,Blepharal carcinoma,0
23688,Decision,Mixed parotid tumor,0
23689,Pleomorphic,Chondrosarcoma,0
23690,Malignant neoplasm of lung,Maxillary Sinus Adenocarcinoma,0
23691,Lobe of cerebellum,Congenital hamartoma,0
23692,Ability,Intraepithelial Melanocytic Hyperplasia,0
23693,Type A,Neoplasms,0
23694,Location of Oral Residue Following Swallowing,Non-Hodgkin Lymphoma During Pregnancy,0
23695,Stromal Invasion,Bladder adenocarcinoma stage IV,0
23696,Tests (qualifier value),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
23697,Astrocytoma,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
23698,Surgical aspects,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23699,Call (Instruction),benign mature teratoma of pancreas,0
23700,Abdomen,FIGO Stage IVA Ovarian Cancer,0
23701,Common (qualifier value),Childhood Lymphoma,0
23702,Spreading (qualifier value),Childhood Thyroid Gland Follicular Carcinoma,0
23703,Hematopoietic Neoplasms,Endometrial Small Cell Carcinoma,0
23704,Male population group,Trichilemmocarcinoma,0
23705,Fallopian Tubes,Vaginal Adenoid Cystic Carcinoma,0
23706,Lymphocyte,Gallbladder Adenocarcinoma,0
23707,Left,Low Grade Squamous Intraepithelial Neoplasia,0
23708,Species,Transitional cell carcinoma,0
23709,Alleles,Adenocarcinoma,0
23710,Abnormal Reference Range,Multiple Skull Base Meningiomas,0
23711,Face (spatial concept),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23712,Neoplasm Metastasis,Neonatal leukemia,0
23713,Adult Anaplastic Oligodendroglioma,Undifferentiated Endocervical Sarcoma,0
23714,Part of,Refractory Bladder Carcinoma,0
23715,Obese build,Benign Anal Granular Cell Tumor,0
23716,Congenital MeSH qualifier,Chronic Myelomonocytic Leukemia-2,0
23717,Multiple sexual contacts,Cerebral Primitive Neuroectodermal Tumor,0
23718,Lung,Unresectable Rhabdomyosarcoma,0
23719,Primary,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23720,Severe (severity modifier),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
23721,Contain (action),Childhood Fibrillary Astrocytoma,0
23722,Chemotherapy,Splenic Manifestation of Hairy Cell Leukemia,0
23723,Sunlight,Ovarian Carcinoid Tumor,0
23724,Adenocarcinoma,Adult Alveolar Soft Part Sarcoma,0
23725,Abnormal Reference Range,Carcinoma ex pleomorphic adenoma of parotid gland,0
23726,Neuroendocrine Tumors,Peripheral primitive neuroectodermal tumor of soft tissue,0
23727,Used by,Locally Advanced Squamous Cell Carcinoma,0
23728,Administration procedure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
23729,Neoplasm Metastasis,Thymic Clear Cell Carcinoma,0
23730,Usually,Mucosal Melanoma,0
23731,Fever,Refractory Bladder Carcinoma,0
23732,Diabetes Mellitus,Carcinomatosis of peritoneal cavity,0
23733,Surrounding (qualifier value),Testicular cancer metastatic,0
23734,Species,Metastatic Malignant Neoplasm in the Sellar Region,0
23735,Component object,Benign Carotid Body Paraganglioma,0
23736,Hematology+Oncology,Pancreatic Endocrine Carcinoma,0
23737,Milliampere second,Choroid Necrotic Melanoma,0
23738,Cells,Neoplasms,0
23739,Junonia,Advanced Lung Carcinoma,0
23740,Specific qualifier value,Localized Askin Tumor,0
23741,American College of Cardiology/American Heart Association Lesion Complexity Score C,Low Grade Squamous Intraepithelial Neoplasia,0
23742,Thymoma,Acute Undifferentiated Leukemia,0
23743,Administration procedure,Kaposi's sarcoma of skin,0
23744,Neurofibromatosis 1,Stage II Carcinoma of Penis,0
23745,Logical Condition,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
23746,Aggressive course,Localized Askin Tumor,0
23747,Condition,Malignant neoplasm of subglottis,0
23748,Usual,Intestinal Metaplasia of Bladder Urothelium,0
23749,development aspects,Intestinal Metaplasia of Bladder Urothelium,0
23750,clinical aspects,Uterine Cancer,0
23751,Common (qualifier value),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
23752,Known,FIGO Stage IVA Ovarian Cancer,0
23753,100%,papillary carcinoma of penis,0
23754,Elements,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23755,Divide,Malignant Testicular Sertoli Cell Tumor,0
23756,Advanced phase,Carcinomatosis of peritoneal cavity,0
23757,glottis,Hodgkin lymphoma,0
23758,Rate,Pancreatic carcinoma,0
23759,Etiology aspects,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23760,Interferes with,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23761,Malignant neoplasm of lung,Atypical Lobular Breast Hyperplasia,0
23762,Acinar Cell Carcinoma,Benign Apocrine Neoplasm,0
23763,Capsule Dosing Unit,Adult Brain Stem Mixed Glioma,0
23764,Cancer Genus,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23765,Occurrence,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23766,63,Stage III Cutaneous Melanoma AJCC v6,0
23767,Followed by,Acantholytic squamous cell carcinoma,0
23768,Lymphocyte,Grade 1 Clear Cell Renal Cell Carcinoma,0
23769,Main,Undifferentiated Endocervical Sarcoma,0
23770,Estrogen (disposition),Diffuse malignant mesothelioma,0
23771,Occurrence,Adult Hepatocellular Carcinoma,0
23772,Infection,malignant lymphoma of pancreatic lymph nodes,0
23773,MOSTLY,Cervical Squamous Intraepithelial Neoplasia,0
23774,Usual,Primary Cutaneous Plasmablastic Lymphoma,0
23775,Possible,Metastatic Kidney Carcinoma,0
23776,Primary malignant neoplasm,Benign neoplasm of thorax,0
23777,Within,adenosquamous carcinoma of breast,0
23778,Death (finding),Recurrent Testicular Lymphoma,0
23779,Age,Thymoma malignant recurrent,0
23780,Type - attribute,Malignant neoplasm of subglottis,0
23781,Times,Anterior Urethral Malignant Neoplasm,0
23782,Name (property) (qualifier value),Precursor B-lymphoblastic lymphoma stage II,0
23783,Medical,Benign Anal Granular Cell Tumor,0
23784,Self,Colorectal cancer,0
23785,Malaise,Bladder Neuroendocrine Neoplasm,0
23786,Acquired phimosis,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23787,Containing (qualifier),GIANT PIGMENTED HAIRY NEVUS,0
23788,History of previous events,Diffuse malignant mesothelioma,0
23789,Have Weight Loss,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23790,Bone marrow biopsy,Cerebral Primitive Neuroectodermal Tumor,0
23791,Device system,Malignant Neoplasm of Lung - Multiple Primary Sites,0
23792,Code,Clonal Hematopoiesis of Indeterminate Potential,0
23793,Logical Condition,Spongiotic dermatitis,0
23794,Factor,Kaposi's sarcoma of skin,0
23795,Infiltrative Tumor Margin,Xeroderma pigmentosum,0
23796,Dilate procedure,Medulloblastoma,0
23797,Traumatic injury,Thyroid Hurthle Cell Carcinoma,0
23798,Anorexia,Adenocarcinoma of the prostate metastatic,0
23799,Two,de novo Myelodysplastic Syndrome,0
23800,Tumor grade G3,Benign Ovarian Thecoma,0
23801,Second Suffix,Bladder adenocarcinoma stage IV,0
23802,year,Multiple Endocrine Neoplasia,0
23803,Screening procedure,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23804,Table Cell Horizontal Align - left,adenosquamous carcinoma of breast,0
23805,Intracranial Hypertension,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
23806,Alcohol consumption,Hodgkin Disease,0
23807,Male population group,gliosarcoma,0
23808,Genitalia,Gallbladder Adenocarcinoma,0
23809,Family history,Adenocarcinoma of the prostate metastatic,0
23810,Negative Charge,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23811,Ectodermal,Human Papillomavirus-Related Carcinoma,0
23812,T-Lymphocytopenia,Locally Advanced Epithelioid Hemangioendothelioma,0
23813,Tetraploidy,Bladder Neuroendocrine Neoplasm,0
23814,Nose,Chondrosarcoma,0
23815,Feelings,Bladder Neuroendocrine Neoplasm,0
23816,Vomiting,clear cell adenocarcinoma of gallbladder,0
23817,Including (qualifier),malignant lymphoma of pancreatic lymph nodes,0
23818,Cancer Genus,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
23819,Including (qualifier),Locally Advanced Epithelioid Hemangioendothelioma,0
23820,protein body,Hair nevus,0
23821,Occurrence Indicator,Familial Adenomatous Polyposis Associated Medulloblastoma,0
23822,Retinoic acid syndrome,Diffuse malignant mesothelioma,0
23823,Rate,Cervical Adenomyoma,0
23824,Primary malignant neoplasm,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23825,Dorsal,Airway Hemangioma,0
23826,Chemotherapy,Carcinoma ex pleomorphic adenoma of parotid gland,0
23827,Family history,Intestinal Metaplasia of Bladder Urothelium,0
23828,Female Phenotype,High Grade Glandular Intraepithelial Neoplasia,0
23829,Immune System Finding,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23830,Can Do Very Little,Splenic Manifestation of Hairy Cell Leukemia,0
23831,Female Reproductive System,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
23832,CD5L wt Allele,Locally Advanced Squamous Cell Carcinoma,0
23833,Occurrence Indicator,Anterior Urethral Malignant Neoplasm,0
23834,Aim (idea),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
23835,Occurrence,Cystadenocarcinoma,0
23836,Range,Cerebral hemangioma,0
23837,Increase,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
23838,Stem cell transplant,Intraepithelial Melanocytic Hyperplasia,0
23839,Weight Loss,Hodgkin lymphoma,0
23840,Retinoic Acid Response Element,Type II Endometrial Adenocarcinoma,0
23841,Persons,Acute Undifferentiated Leukemia,0
23842,Skin,Cerebral hemangioma,0
23843,peripheral blood,Mastocytosis,0
23844,Intravascular line,Benign neoplasm of eye,0
23845,Initially,Acantholytic squamous cell carcinoma,0
23846,XK wt Allele,Cervical Squamous Intraepithelial Neoplasia,0
23847,Following,Locally Advanced Squamous Cell Carcinoma,0
23848,treatment options,Brain Tumor,0
23849,Geographic Locations,Breast Ductal Adenoma,0
23850,Symptoms,Intestinal Metaplasia of Bladder Urothelium,0
23851,Sometimes,malignant lymphoma of pancreatic lymph nodes,0
23852,Related personal status,Breast Ductal Adenoma,0
23853,Array Feature,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
23854,/40,Mucinous adenocarcinoma gastric,0
23855,Take,Botryoid-Type Embryonal Rhabdomyosarcoma,0
23856,Hodgkin Disease,Benign Apocrine Neoplasm,0
23857,Endocrine Gland Neoplasms,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
23858,Cause of death.underlying,Female Breast Carcinoma,0
23859,Deterioration of status,Kaposi's sarcoma of skin,0
23860,Antiretroviral Therapy,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
23861,Optical filter,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23862,Trial Screening,Human Papillomavirus-Related Carcinoma,0
23863,Definition,Chronic Myelomonocytic Leukemia-2,0
23864,Singular,Transitional cell carcinoma,0
23865,Derivation,Pancreatic carcinoma,0
23866,Occurrence,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23867,Body part,Clonal Hematopoiesis of Indeterminate Potential,0
23868,Location of Oral Residue Following Swallowing,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
23869,Diagnosis,Hyperplasia of pituitary gland,0
23870,Adenocarcinoma,Stage III Adult Immunoblastic Lymphoma,0
23871,Fever symptoms (finding),Spongiotic dermatitis,0
23872,Part Dosing Unit,Mixed parotid tumor,0
23873,Half,Bladder adenocarcinoma stage IV,0
23874,Body part,embryonal rhabdomyosarcoma of prostate,0
23875,Malignant Neoplasms,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
23876,Group A (qualifier value),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
23877,Precision - second,BRCA2 Syndrome,0
23878,Referring,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23879,Adult Hodgkin Lymphoma,Splenic Manifestation of Hairy Cell Leukemia,0
23880,bony process,Localized Ewing Sarcoma,0
23881,Genetic Risk,Stage III Cutaneous Melanoma AJCC v6,0
23882,Have Sweats,Giant cell angiofibroma,0
23883,Number of birth,Granular Cell Leiomyosarcoma,0
23884,Time,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
23885,Generic Role,Childhood Lymphoma,0
23886,Body tissue,Kaposi's sarcoma of extrahepatic bile duct,0
23887,Tests (qualifier value),Testicular cancer metastatic,0
23888,Cancer Genus,Squamous cell carcinoma of lip,0
23889,Risk,Anterior Urethral Malignant Neoplasm,0
23890,Property (attribute),Childhood Central Nervous System Immature Teratoma,0
23891,Due to,Breast Ductal Adenoma,0
23892,Bilateral salpingectomy with oophorectomy,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23893,Chemotherapy,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
23894,Lung,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
23895,Exogenous Factors,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23896,Red color,Blepharal carcinoma,0
23897,Surgical repair,Intraepithelial Melanocytic Hyperplasia,0
23898,Filters,Astrocytoma of brain,0
23899,Event Seriousness - Significant,Cerebral hemangioma,0
23900,Hormonal Contraception,Kaposi's sarcoma of skin,0
23901,radiotherapeutic,Ichthyosis,0
23902,Approach,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23903,Firstly,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
23904,Financial Account,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23905,Cardiovascular System Part,Mixed astrocytoma-ependymoma,0
23906,Fourth ventricle structure,Prostate Lymphoma,0
23907,Patient Condition Code - Stable,Intracortical osteosarcoma,0
23908,Specimen,Squamous cell carcinoma of lip,0
23909,Time (foundation metadata concept),Stage I Colon Neuroendocrine Tumor AJCC v8,0
23910,NCI CTEP SDC Melanoma Sub-Category Terminology,Benign neoplasm of thorax,0
23911,Areas <moth>,Stage III Cutaneous Melanoma AJCC v6,0
23912,Red Blood Cell Count measurement,Cervical Squamous Intraepithelial Neoplasia,0
23913,Infection,Cancer of Urinary Tract,0
23914,Connect,Acute Undifferentiated Leukemia,0
23915,Long-term,Stage III Adult Immunoblastic Lymphoma,0
23916,Formation,High Grade Glandular Intraepithelial Neoplasia,0
23917,Removed,Ichthyosis,0
23918,Most,Transitional cell carcinoma,0
23919,Morphology,Mixed astrocytoma-ependymoma,0
23920,Gastric (qualifier value),Ovarian germ cell choriocarcinoma stage IV,0
23921,year,Pancreatic carcinoma,0
23922,Packed cell volume increased,Benign Anal Granular Cell Tumor,0
23923,Symptoms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
23924,Extent of disease,Localized Askin Tumor,0
23925,Hormonal,Intracortical osteosarcoma,0
23926,Notable,Ovarian Dermoid Cyst with Secondary Carcinoma,0
23927,Appearance Distress Question,Intracortical osteosarcoma,0
23928,Males,Gallbladder Adenocarcinoma,0
23929,Act Reason - Error,Thyroid Hurthle Cell Carcinoma,0
23930,cardiovascular disorder risk,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23931,Pale feces (finding),mucinous adenocarcinoma of gallbladder,0
23932,Homo sapiens,Sarcomatoid Renal Cell Carcinoma,0
23933,Weight measurement scales,Malignant neoplasm of subglottis,0
23934,NCI CTEP SDC Rhabdomyosarcoma Sub-Category Terminology,Benign squamous cell tumor,0
23935,Child,Bladder squamous cell carcinoma stage I,0
23936,Tryptophanase,Unicystic ameloblastoma,0
23937,Most,Recurrent Uveal Melanoma,0
23938,Location of Oral Residue Following Swallowing,Benign neoplasm of thorax,0
23939,Scientific Control,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
23940,Pregnancy,Clinical Stage I Cutaneous Melanoma AJCC v8,0
23941,Five-year Survival Rate,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
23942,Precancerous Conditions,Benign squamous cell tumor,0
23943,60%,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23944,Four,Liver Lymphangioma,0
23945,Mass of body structure,Primary Cutaneous Plasmablastic Lymphoma,0
23946,>90,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
23947,Primary malignant neoplasm,Astrocytoma of brain,0
23948,More,Werner Syndrome,0
23949,Frequently,Pleomorphic adenoma of parotid gland,0
23950,Hematologic Neoplasms,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
23951,Prognosis:Find:Pt:^Patient:Nom,Childhood Cerebellar Neoplasm,0
23952,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
23953,Fever symptoms (finding),embryonal rhabdomyosarcoma of prostate,0
23954,Patch Dosing Unit,Childhood Thyroid Gland Follicular Carcinoma,0
23955,size,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
23956,Call (Instruction),Carcinoma of urinary bladder,0
23957,Flushing,Funisitis (disorder),0
23958,Retinoic Acid Response Element,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
23959,Surgical reduction,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
23960,Prognosis:Find:Pt:^Patient:Nom,Kaposi's sarcoma of extrahepatic bile duct,0
23961,Night sweats,Anaplastic large cell lymphoma,0
23962,Genetic Heterogeneity,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
23963,Time,Cervical Squamous Intraepithelial Neoplasia,0
23964,Mucous Membrane,Benign squamous cell tumor,0
23965,Human Study Subject,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
23966,Only - dosing instruction fragment,Clonal Hematopoiesis of Indeterminate Potential,0
23967,Long Variable,Adult Brain Stem Mixed Glioma,0
23968,Type - attribute,Colorectal Neuroendocrine Tumor G2,0
23969,Presentation,Acantholytic squamous cell carcinoma,0
23970,Average of Value Derivation Technique,Endometrial Small Cell Carcinoma,0
23971,Result,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23972,PGAP3 gene,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23973,Contrast Media,Benign tumor of eyelid,0
23974,Pain Distress Question,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
23975,Healthy,benign mature teratoma of pancreas,0
23976,Males,Vaginal Adenoma,0
23977,Weight decreased,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
23978,Local disease,Adenocarcinoma,0
23979,Leads (device),Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
23980,Malignant neoplasm of skin,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
23981,Highest,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
23982,Skin,Benign squamous cell tumor,0
23983,size,Angiosarcoma of liver,0
23984,Location of Oral Residue Following Swallowing,Cerebral Primitive Neuroectodermal Tumor,0
23985,Specimen Source Codes - Macrophages,Cervical Fibroepithelial Polyp,0
23986,Often - answer to question,Stage IB Pancreatic Cancer AJCC v8,0
23987,Cancer Remission,Thymic Clear Cell Carcinoma,0
23988,Genetic Risk,Adult Alveolar Soft Part Sarcoma,0
23989,Midline (qualifier value),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
23990,Sodium Tetradecyl Sulfate,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
23991,Occur (action),Platinum-Resistant Lung Small Cell Carcinoma,0
23992,Usual Severity Vomiting,Mixed parotid tumor,0
23993,Base - General Qualifier,Stage I Adult Non-Hodgkin Lymphoma,0
23994,Together,Kaposi's sarcoma of extrahepatic bile duct,0
23995,Office Visits,Astrocytoma of brain,0
23996,Code,embryonal rhabdomyosarcoma of prostate,0
23997,pharmacotherapeutic,Lung Mucinous Cystadenoma,0
23998,leukemia,Hair nevus,0
23999,Therapeutic radiology procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24000,Asians,Acantholytic squamous cell carcinoma,0
24001,cell activation,squamous cell carcinoma of the thyroid gland,0
24002,Tissue Specimen Code,embryonal rhabdomyosarcoma of prostate,0
24003,Moved from,Ovarian germ cell choriocarcinoma stage IV,0
24004,Gestational,Childhood Cerebellar Neoplasm,0
24005,Neuroendocrine Tumors,Bladder adenocarcinoma stage IV,0
24006,Deficiency of sulfatase,Malignant Neoplasm of Lung - Multiple Primary Sites,0
24007,Symptoms aspect,Spermatocytic seminoma,0
24008,Second Suffix,Botryoid-Type Embryonal Rhabdomyosarcoma,0
24009,Upper,Refractory Barrett Esophagus,0
24010,dendritic spine neck,Precursor B-lymphoblastic lymphoma stage II,0
24011,Result,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24012,Result,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24013,Ectodermal,Female Breast Carcinoma,0
24014,Place,Carcinomatosis of peritoneal cavity,0
24015,Endoscopy of stomach,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24016,Snake bite (morphologic abnormality),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24017,Immunoglobulin M,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24018,Specimen Source Codes - Lesion,Periosteal Osteosarcoma,0
24019,Two,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24020,Malignant - descriptor,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
24021,Manufactured form,Airway Hemangioma,0
24022,Pancreas,Tubal Hyperplasia,0
24023,Treatment Epoch,Pancreatic carcinoma,0
24024,Divide,Angiosarcoma of liver,0
24025,Antineoplastic Agents,Pancreatic carcinoma,0
24026,Gland,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24027,Term Birth,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24028,Negative Finding,Airway Hemangioma,0
24029,biopsy characteristics,Stage IV Colorectal Cancer AJCC v8,0
24030,Symptoms aspect,Bladder adenocarcinoma stage IV,0
24031,Classification of information,Lipoma of small intestine,0
24032,Slow Growing,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24033,Contain (action),Airway Hemangioma,0
24034,Completely Able,Localized Ewing Sarcoma,0
24035,Active,Vaginal Adenoid Cystic Carcinoma,0
24036,Mathematical Factor,Neonatal leukemia,0
24037,Inflammatory cell,Refractory Ependymoma,0
24038,Multiple Myeloma,gliosarcoma,0
24039,Occurrence Indicator,Benign Anal Granular Cell Tumor,0
24040,Nose,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24041,Beginning,Metastatic Kidney Carcinoma,0
24042,Antibodies,Type II Endometrial Adenocarcinoma,0
24043,Abdominal Cavity,Digestive System Hodgkin Lymphoma,0
24044,Tumor cells,Refractory Barrett Esophagus,0
24045,Scientist,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24046,Rare,Engraftment syndrome,0
24047,macrophage,Hodgkin Disease,0
24048,Frequently,Tongue Alveolar Soft Part Sarcoma,0
24049,Financial Account,Testicular cancer metastatic,0
24050,2+ Score,Xeroderma pigmentosum,0
24051,include - SetOperator,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24052,Nevus,Brain Ependymoma,0
24053,Firstly,Type II Endometrial Adenocarcinoma,0
24054,Diagnosis,Stage IV Childhood Non-Hodgkin Lymphoma,0
24055,Loss of appetite (finding),Liver Lymphangioma,0
24056,Location of Pharyngeal Residue Following Swallowing,Collecting Duct Carcinoma of the Kidney,0
24057,Group A (qualifier value),Neoplasms,0
24058,Tumor Mass,Localized Ewing Sarcoma,0
24059,Separate,Melanomatosis,0
24060,Cell Count,Blood Vessel Tumors,0
24061,Tumor grade G3,Breast Ductal Adenoma,0
24062,Family,Locally Advanced Soft Tissue Sarcoma,0
24063,Often - answer to question,Astrocytoma of brain,0
24064,Diagnosis,Malignant neoplasm of gallbladder,0
24065,Night sweats,Xeroderma pigmentosum,0
24066,potential,Bladder squamous cell carcinoma stage I,0
24067,Mass of body structure,Splenic Manifestation of Hairy Cell Leukemia,0
24068,Most,Benign neoplasm of thorax,0
24069,Surgery specialty,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
24070,Mesenchymal Stem Cells,Splenic Manifestation of Hairy Cell Leukemia,0
24071,Lead,Nasal cavity carcinoma,0
24072,General surgery specialty,Digestive System Hodgkin Lymphoma,0
24073,estrogen receptor alpha,Adult Hepatocellular Carcinoma,0
24074,Relationships,Colorectal Neuroendocrine Tumor G2,0
24075,therapeutic aspects,Intraepithelial Melanocytic Hyperplasia,0
24076,Togo,Vaginal Adenoid Cystic Carcinoma,0
24077,Feet,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24078,84,Cerebral Primitive Neuroectodermal Tumor,0
24079,Present,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24080,Agenesis of corpus callosum,Secondary malignant neoplasm of lymph node,0
24081,Primary malignant neoplasm,Childhood Fibrillary Astrocytoma,0
24082,Divide,Vaginal Adenoma,0
24083,Science of Etiology,Benign neoplasm of eye,0
24084,pharmacotherapeutic,Acantholytic squamous cell carcinoma,0
24085,Occurrence,Refractory Barrett Esophagus,0
24086,Woman,Malignant melanoma of eyelid,0
24087,Birth,Refractory Barrett Esophagus,0
24088,Abdomen,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24089,Exist,Metastatic Kidney Carcinoma,0
24090,Area,Chest Wall Fibromatosis,0
24091,3+ Score,Malignant melanoma of eyelid,0
24092,Poor - qualifier,Brain Tumor,0
24093,Manufactured form,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
24094,Symptoms,Pleomorphic adenoma of parotid gland,0
24095,Malignant neoplasm of endometrium,Cervical Squamous Intraepithelial Neoplasia,0
24096,Short Value,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
24097,failed,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24098,Pathway (interactions),Ovarian Dermoid Cyst with Secondary Carcinoma,0
24099,Adenocarcinoma,Recurrent Testicular Lymphoma,0
24100,Widening,Recurrent Testicular Lymphoma,0
24101,Childhood Neuroblastoma,Pleomorphic adenoma of parotid gland,0
24102,Common (qualifier value),Hereditary Diffuse Gastric Adenocarcinoma,0
24103,Nervous system structure,Childhood Anaplastic Large Cell Lymphoma,0
24104,59,Bladder Neuroendocrine Neoplasm,0
24105,Line Unit of Length,Human Papillomavirus-Related Carcinoma,0
24106,Representation (action),Germinoma,0
24107,General surgery specialty,Vaginal Adenoma,0
24108,shared attribute,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
24109,physiological aspects,clear cell adenocarcinoma of gallbladder,0
24110,Overgrowth,Benign Apocrine Neoplasm,0
24111,Carcinoma of bladder,Benign Apocrine Neoplasm,0
24112,primary tumor,Cancer of Urinary Tract,0
24113,General surgery specialty,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24114,FAT1 wt Allele,Small cell neuroendocrine carcinoma of bladder,0
24115,Distant,Familial Hemophagocytic Lymphocytosis,0
24116,New,Recurrent Uveal Melanoma,0
24117,Occurrence,Engraftment syndrome,0
24118,Fibrosis,Splenic Manifestation of Hairy Cell Leukemia,0
24119,Secondary Neoplasm,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24120,Smell Perception,Nasal cavity carcinoma,0
24121,Early,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24122,PREVENT (product),Acantholytic squamous cell carcinoma,0
24123,Physical findings,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24124,Cutaneous Melanoma,Refractory Barrett Esophagus,0
24125,Antibodies,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24126,Waldeyer's ring,Undifferentiated Endocervical Sarcoma,0
24127,Malignant - descriptor,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24128,Adult Germ Cell Tumor,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24129,Type - attribute,Choroid Necrotic Melanoma,0
24130,Genes,Neonatal leukemia,0
24131,Slight (qualifier value),Acute Undifferentiated Leukemia,0
24132,Primary,Thyroid Hurthle Cell Carcinoma,0
24133,Malignant Neoplasms,FIGO Stage II Ovarian Cancer,0
24134,Female Reproductive System,Lipoma of small intestine,0
24135,Tumor grade G3,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
24136,types of infections,Refractory Ependymoma,0
24137,Room of building - Study,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24138,Apply (administration method),Bladder adenocarcinoma stage IV,0
24139,Extrinsic,Tubal Hyperplasia,0
24140,Death NOS,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24141,Lacrimal gland structure,Acute Undifferentiated Leukemia,0
24142,Certain (qualifier value),Kaposi's sarcoma of skin,0
24143,Tryptophanase,Cervical Fibroepithelial Polyp,0
24144,Records,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24145,controversy,ROSE Cluster 3,0
24146,Including (qualifier),Thymic Clear Cell Carcinoma,0
24147,Microcyst,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24148,Mathematical Operator,Tonsillar Carcinoma,0
24149,Immature Platelet,Occult Lung Adenosquamous Carcinoma,0
24150,Diagnostic Neoplasm Staging,Type II Endometrial Adenocarcinoma,0
24151,Case (situation),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24152,General surgery specialty,Intraepithelial Melanocytic Hyperplasia,0
24153,Death (finding),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
24154,Immune system,Intestinal Metaplasia of Bladder Urothelium,0
24155,Ovulation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24156,Type A,embryonal rhabdomyosarcoma of prostate,0
24157,Cure (remedy),Chondrosarcoma,0
24158,Multifocal,Spongiotic dermatitis,0
24159,Skin Specimen,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
24160,Role,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24161,Logical Condition,Undifferentiated Endocervical Sarcoma,0
24162,Immune System Finding,Pilocytic astrocytoma of cerebellum,0
24163,Prior Medication Usage,Locally Advanced Epithelioid Hemangioendothelioma,0
24164,Malignant Neoplasms,Metastatic Lung Neuroendocrine Neoplasm,0
24165,Negation,Ovarian germ cell choriocarcinoma stage IV,0
24166,contextual factors,Refractory Bladder Carcinoma,0
24167,Qualitative form,Stage II Carcinoma of Penis,0
24168,Circulating Tumor Cell Count,Mixed parotid tumor,0
24169,Bruising,Recurrent Uveal Melanoma,0
24170,Ovarian Carcinoma,Female Breast Carcinoma,0
24171,Alcohol consumption,Cerebral hemangioma,0
24172,Spreading (qualifier value),Botryoid-Type Embryonal Rhabdomyosarcoma,0
24173,Cauda Equina,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24174,Complication Aspects,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24175,Fatigue,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24176,Sometimes,Advanced Uterine Corpus Carcinosarcoma,0
24177,Tumor type,Childhood Fibrillary Astrocytoma,0
24178,Together,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24179,Live - Specimen Condition,Cervical Fibroepithelial Polyp,0
24180,Smear - instruction imperative,Stage III Cutaneous Melanoma AJCC v6,0
24181,Specimen Source Codes - tumor,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24182,98,Peripheral primitive neuroectodermal tumor of soft tissue,0
24183,One,Trabecular adenocarcinoma,0
24184,Spreading (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
24185,Epidemiology,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24186,What subject filter - Result,Gallbladder Adenocarcinoma,0
24187,Manufactured form,Adenocarcinoma,0
24188,A Codes,Childhood Fibrillary Astrocytoma,0
24189,Gram per Deciliter,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24190,Excision,Digestive System Hodgkin Lymphoma,0
24191,Pleural Effusion,Non-Metastatic Gestational Trophoblastic Tumor,0
24192,Auditory pitch,Carcinoma,0
24193,Make - Instruction Imperative,Undifferentiated Endocervical Sarcoma,0
24194,Decision,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24195,chance,Precursor B-lymphoblastic lymphoma stage II,0
24196,Male population group,Refractory Barrett Esophagus,0
24197,Stratified squamous epithelium,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24198,Young,adenosquamous carcinoma of breast,0
24199,Blood Products Laboratory Testing,Unfavorable Non-Hodgkin Lymphoma,0
24200,Swollen Lymph Node,Recurrent Testicular Lymphoma,0
24201,Often - answer to question,Choroid Necrotic Melanoma,0
24202,Analysis,Uterine Cancer,0
24203,Variety (taxon),Unicystic ameloblastoma,0
24204,Sacrifice,Refractory Ependymoma,0
24205,Progestins,Cervical Adenomyoma,0
24206,Usual,Hemangioma,0
24207,TP53 wt Allele,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24208,Biopsy,Melanomatosis,0
24209,One,Localized Ewing Sarcoma,0
24210,Symptoms,Chest Wall Fibromatosis,0
24211,Bone Marrow,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
24212,Immunoglobulin complex location,Locally Advanced Epithelioid Hemangioendothelioma,0
24213,Environment,Squamous cell carcinoma of lip,0
24214,Aggressive malignancies,Malignant neoplasm of subglottis,0
24215,Partial,Placental aromatase deficiency,0
24216,Definitely Related to Intervention,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24217,therapeutic aspects,Giant cell angiofibroma,0
24218,3+ Answer to Question,sarcoma of spinal cord,0
24219,Benign,Breast Ductal Adenoma,0
24220,Subject Risk,Bladder adenocarcinoma stage IV,0
24221,various other nasal preparations in ATC,Trabecular adenocarcinoma,0
24222,Age,Childhood Central Nervous System Ganglioneuroblastoma,0
24223,Blood Vessel,Testicular cancer metastatic,0
24224,Genetic syndrome,Ovarian germ cell choriocarcinoma stage IV,0
24225,United States,Acantholytic squamous cell carcinoma,0
24226,aromatase activity,Ovarian germ cell choriocarcinoma stage IV,0
24227,Superkingdom (taxonomic category),Metastatic Neoplasm to the Gallbladder,0
24228,contact exposure to arsenic (history),Unfavorable Non-Hodgkin Lymphoma,0
24229,Location of Oral Residue Following Swallowing,Tonsillar Carcinoma,0
24230,Certainties,Acute Undifferentiated Leukemia,0
24231,Qualitative form,Small Intestinal Villous Adenoma,0
24232,Diagnostic Imaging,Engraftment syndrome,0
24233,Old age,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24234,include - SetOperator,Stage I Colon Neuroendocrine Tumor AJCC v8,0
24235,Increased,Adult Hepatocellular Carcinoma,0
24236,eTMF Content Model Code,Localized Ewing Sarcoma,0
24237,Decreasing,Peripheral primitive neuroectodermal tumor of soft tissue,0
24238,Frequently,Metaplastic carcinoma of breast,0
24239,Operative Surgical Procedures,Recurrent Testicular Lymphoma,0
24240,Angiomatous,Thymic Clear Cell Carcinoma,0
24241,Talpidae,Lipoma of small intestine,0
24242,Carcinoma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24243,Togo,Benign squamous cell tumor,0
24244,Enhance (action),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24245,Cells,Localized Ewing Sarcoma,0
24246,Lymphoproliferation,Medulloblastoma,0
24247,Liver and Intrahepatic Biliary Tract Carcinoma,Cystadenocarcinoma,0
24248,Malignant - descriptor,Neoplasms,0
24249,chronic,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24250,Anatomic Site,Anterior Urethral Malignant Neoplasm,0
24251,Formation,Uterine Cancer,0
24252,Aggressive course,Refractory Barrett Esophagus,0
24253,Blood Vessel,Cerebral Primitive Neuroectodermal Tumor,0
24254,foreign,Hodgkin lymphoma,0
24255,Destruction (action),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24256,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24257,Body tissue,Tongue Alveolar Soft Part Sarcoma,0
24258,Procedure (set of actions),Multiple Endocrine Neoplasia,0
24259,per year,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24260,Cystic duct structure,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24261,Pediculus humanus capitis (eukaryote),Adenocarcinoma,0
24262,Body tissue,Angiosarcoma of liver,0
24263,Australia,Digestive System Hodgkin Lymphoma,0
24264,Bone pain,Low Grade Squamous Intraepithelial Neoplasia,0
24265,Left,Non-Metastatic Gestational Trophoblastic Tumor,0
24266,Obese build,Cerebral Primitive Neuroectodermal Tumor,0
24267,Point Name,Pilocytic astrocytoma of cerebellum,0
24268,Drop British,de novo Myelodysplastic Syndrome,0
24269,Varicella Virus Vaccine Live (Oka-Merck) strain,Bladder adenocarcinoma stage IV,0
24270,Carcinoma in Situ,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
24271,Data Compression,Cancer of Urinary Tract,0
24272,Follow-up status,Benign Apocrine Neoplasm,0
24273,Exhibits as Topic,Choroid Necrotic Melanoma,0
24274,FAT1 wt Allele,Choroid Necrotic Melanoma,0
24275,Often - answer to question,Malignant Testicular Sertoli Cell Tumor,0
24276,Cell secretion,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24277,Web Site,Colorectal High Grade B-Cell Lymphoma,0
24278,Disease,Astrocytoma of brain,0
24279,Cough Frequency,Recurrent Uveal Melanoma,0
24280,Vomiting,Vaginal Adenoma,0
24281,Palatine Tonsil,squamous cell carcinoma of the thyroid gland,0
24282,research subject screening,Acute Undifferentiated Leukemia,0
24283,Enlarged,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24284,Chemotherapy,Carcinoma of urinary bladder,0
24285,Increase,Mucinous adenocarcinoma gastric,0
24286,Malignant neoplasm of lung,Metaplastic carcinoma of breast,0
24287,In Blood,Cystadenocarcinoma,0
24288,Aggressive behavior,Pancreatic Intraepithelial Neoplasia-3,0
24289,radiotherapeutic,Heavy Chain Deposition Disease,0
24290,Health,Melanomatosis,0
24291,Brain,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
24292,Often - answer to question,Pancreatic carcinoma,0
24293,Diagnosis Study,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
24294,Bruising,Unicystic ameloblastoma,0
24295,Categories,FIGO Stage II Ovarian Cancer,0
24296,Add - instruction imperative,Chronic Myelomonocytic Leukemia-2,0
24297,seconds,clear cell adenocarcinoma of gallbladder,0
24298,Treating,Recurrent Testicular Lymphoma,0
24299,China,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24300,Well,Extracranial Neuroblastoma,0
24301,Oral,Anterior Urethral Malignant Neoplasm,0
24302,treatment - ActInformationManagementReason,Benign Carotid Body Paraganglioma,0
24303,65+,Small cell neuroendocrine carcinoma of bladder,0
24304,Parenchyma,Keratoderma,0
24305,intent,Choroid Necrotic Melanoma,0
24306,Radiating to,Refractory Bladder Carcinoma,0
24307,Decision,Mucosal Melanoma,0
24308,HLA Class II Histocompatibility Antigen Gamma Chain,Malignant neoplasm of choroid,0
24309,Infrequent,Acantholytic squamous cell carcinoma,0
24310,Organ,Malignant melanoma of eyelid,0
24311,True primary (qualifier value),Pleomorphic adenoma of parotid gland,0
24312,Chronic myeloproliferative disorder,Fibroadenoma of breast,0
24313,PSA Level Less than Five,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24314,Condition:Find:Pt:^Patient:Nom,Endometrial Small Cell Carcinoma,0
24315,Therapy Object (animal model),Adenocarcinoma,0
24316,Approved,Cervical Squamous Intraepithelial Neoplasia,0
24317,Most,Carcinomatosis of peritoneal cavity,0
24318,Hematopoietic stem cells,Benign Apocrine Neoplasm,0
24319,Division (surgical procedure),Cervical Squamous Intraepithelial Neoplasia,0
24320,Classical Hodgkin's Lymphoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
24321,Ibrutinib,Peripheral primitive neuroectodermal tumor of soft tissue,0
24322,Persons,Benign Anal Granular Cell Tumor,0
24323,Stomach structure,Cervical Fibroepithelial Polyp,0
24324,Hemangioma,Pancreatic Intraepithelial Neoplasia-3,0
24325,Type - attribute,Rhabdomyosarcoma with ganglionic differentiation,0
24326,Percent normal,Adult Acute Eosinophilic Leukemia,0
24327,Foreskin of penis,Grade 3a Malignant Neoplasm,0
24328,Changed status,Clonal Hematopoiesis of Indeterminate Potential,0
24329,Evaluation procedure,Digestive System Hodgkin Lymphoma,0
24330,Contain (action),Unfavorable Non-Hodgkin Lymphoma,0
24331,Woman,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24332,Frequently,Low Grade Squamous Intraepithelial Neoplasia,0
24333,Two,Stage III Adult Immunoblastic Lymphoma,0
24334,Bilateral complete salpingectomy,Refractory Barrett Esophagus,0
24335,Mandible,adenoid cystic carcinoma of lung,0
24336,treatment - ActInformationManagementReason,Secondary malignant neoplasm of lymph node,0
24337,combination - answer to question,Recurrent Uveal Melanoma,0
24338,Diagnostic Imaging,Pilocytic astrocytoma of cerebellum,0
24339,Thrombocythemia,Cherubism,0
24340,Group A (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
24341,Active License,Primary Cutaneous Plasmablastic Lymphoma,0
24342,Leading,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24343,Blood Platelets,Liver Cavernous Hemangioma,0
24344,Feature,Malignant melanoma of eyelid,0
24345,High,Heavy Chain Deposition Disease,0
24346,Moved to,Localized Askin Tumor,0
24347,Color,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24348,Anterior mediastinum,Malignant melanoma of eyelid,0
24349,include - SetOperator,BRCA2 Syndrome,0
24350,Veins,Tonsillar Carcinoma,0
24351,Histology,Adult Alveolar Soft Part Sarcoma,0
24352,1+,Gallbladder Adenocarcinoma,0
24353,Standard (document),Childhood Central Nervous System Ganglioneuroblastoma,0
24354,64,Recurrent Rhabdomyosarcoma,0
24355,2+,Blepharal carcinoma,0
24356,More,Female Breast Carcinoma,0
24357,Persons,BRCA2 Syndrome,0
24358,Area,gliosarcoma,0
24359,Type A,Spermatocytic seminoma,0
24360,Statistical Significance,Astrocytoma of brain,0
24361,Offspring,Kaposi's sarcoma of extrahepatic bile duct,0
24362,various other nasal preparations in ATC,Benign Anal Granular Cell Tumor,0
24363,Extreme,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24364,Sustained,Xeroderma pigmentosum,0
24365,Pediculus humanus capitis (eukaryote),Thyroid Hurthle Cell Carcinoma,0
24366,Medical Imaging,Refractory Ependymoma,0
24367,DNA,Metaplastic carcinoma of breast,0
24368,patient is female,Multiple Endocrine Neoplasia,0
24369,therapeutic aspects,Malignant Neoplasm with Regional Lymph Node Involvement,0
24370,Usually,Malignant melanoma of eyelid,0
24371,Ovarian Carcinoma,Lung squamous cell carcinoma stage I,0
24372,Feature,Hereditary Diffuse Gastric Adenocarcinoma,0
24373,Down Syndrome,Liver Lymphangioma,0
24374,Primary malignant neoplasm,Cerebral Primitive Neuroectodermal Tumor,0
24375,Rare,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
24376,Distention of blood vessel,Choroid Epithelioid Cell Melanoma,0
24377,BRCA2 gene,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24378,pharmacotherapeutic,High Grade Glandular Intraepithelial Neoplasia,0
24379,Family (taxonomic),Spermatocytic seminoma,0
24380,Stem cell transplant,Mucinous adenocarcinoma,0
24381,Infrequent,Childhood Anaplastic Large Cell Lymphoma,0
24382,Bloating,Pancreatic carcinoma,0
24383,Infrequent,Mucinous adenocarcinoma gastric,0
24384,Dietary Arsenic,Childhood Central Nervous System Ganglioneuroblastoma,0
24385,Common Specifications in HL7 V3 Publishing,Vaginal Adenoid Cystic Carcinoma,0
24386,Fever,Bladder adenocarcinoma stage IV,0
24387,Common Specifications in HL7 V3 Publishing,Cerebral Primitive Neuroectodermal Tumor,0
24388,Primary malignant neoplasm,Adult Anaplastic Oligodendroglioma,0
24389,Transformation,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
24390,Hematuria,Chronic Myelomonocytic Leukemia-2,0
24391,Result,Xeroderma pigmentosum,0
24392,Pentaerythritol Tetranitrate,Gallbladder Adenocarcinoma,0
24393,Surgical aspects,Peripheral primitive neuroectodermal tumor of soft tissue,0
24394,Case unit dose,Spindle Cell Melanoma,0
24395,Act Mood - intent,Transitional cell carcinoma,0
24396,Including (qualifier),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24397,IPSS Risk Category High,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24398,per day,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24399,Togo,Recurrent Testicular Lymphoma,0
24400,Dorsal,Acute lymphadenitis,0
24401,Death (finding),Gallbladder Adenocarcinoma,0
24402,Widening,Mastocytosis,0
24403,Geographic Locations,Cervical Squamous Intraepithelial Neoplasia,0
24404,Methods,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24405,Malignant Neoplasms,Chronic Myelomonocytic Leukemia-2,0
24406,diagnosis aspect,Vaginal Adenoid Cystic Carcinoma,0
24407,Left,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
24408,Pale color saturation,Uterine Cancer,0
24409,Survival Rate,Epithelioid Sarcoma NCI Grade 3,0
24410,Mother (person),Metastatic Carcinoma in the Lung,0
24411,treatment - ActInformationManagementReason,Vaginal Adenoma,0
24412,Taken,Stage 0 Lip Carcinoma,0
24413,Group Object,Stage IV Childhood Non-Hodgkin Lymphoma,0
24414,Anorectal,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
24415,Neoplastic disease,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24416,Occurrence,Localized Askin Tumor,0
24417,Macrophage Activation Syndrome,Malignant Testicular Sertoli Cell Tumor,0
24418,Area,Periosteal Osteosarcoma,0
24419,Person Observer,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24420,Formation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24421,Dyspareunia,Testicular cancer metastatic,0
24422,Inflammatory Breast Carcinoma,Metaplastic carcinoma of breast,0
24423,Several,Cervical Fibroepithelial Polyp,0
24424,Infantile Colic,Kaposi's sarcoma of extrahepatic bile duct,0
24425,bony process,Diffuse malignant mesothelioma,0
24426,Unit of radiation dose,High Grade Glandular Intraepithelial Neoplasia,0
24427,Endocervical epithelium,Anaplastic large cell lymphoma,0
24428,Burkina Faso,FIGO Stage II Ovarian Cancer,0
24429,Dento-alveolar joint,Undifferentiated Endocervical Sarcoma,0
24430,Obese build,Ovarian germ cell choriocarcinoma stage IV,0
24431,Smaller,Pleomorphic adenoma of parotid gland,0
24432,Similarity,Female Breast Carcinoma,0
24433,Type - attribute,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24434,Better,Unicystic ameloblastoma,0
24435,Term Birth,Mucinous cystadenofibroma,0
24436,One,Colorectal High Grade B-Cell Lymphoma,0
24437,Well,Cervical Squamous Intraepithelial Neoplasia,0
24438,83,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24439,Egg of order Phthiraptera,Low Grade Squamous Intraepithelial Neoplasia,0
24440,Diabetes Mellitus,Nasal cavity carcinoma,0
24441,treatment - ActInformationManagementReason,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24442,Mathematical Operator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24443,Most,Stage III Adult Immunoblastic Lymphoma,0
24444,Approximate,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24445,Cholangiocarcinoma,Endometrial Small Cell Carcinoma,0
24446,Probability,Bladder adenocarcinoma stage IV,0
24447,Referral placed,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24448,Genes,Thymoma malignant recurrent,0
24449,Type - attribute,Benign Apocrine Neoplasm,0
24450,Squamous cell carcinoma,Unresectable Rhabdomyosarcoma,0
24451,PSA Level Greater than Fifty,Congenital hamartoma,0
24452,Classification,Unresectable Rhabdomyosarcoma,0
24453,Plasma,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
24454,Clavien-Dindo Grade III,Refractory Bladder Carcinoma,0
24455,Common (qualifier value),Adult Alveolar Soft Part Sarcoma,0
24456,pharmacotherapeutic,Uterine Cancer,0
24457,Daily Living,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24458,Form:Finding:Point in time:{Setting}:Document:{Role},Cervical Squamous Intraepithelial Neoplasia,0
24459,morphological,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
24460,Proteins,Placental aromatase deficiency,0
24461,Malignant Childhood Neoplasm,ROSE Cluster 3,0
24462,Tumor stage,Localized Malignant Neoplasm,0
24463,Problems - What subject filter,Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
24464,Tissue Specimen Code,Childhood Thyroid Gland Follicular Carcinoma,0
24465,Disease Management,Childhood Anaplastic Large Cell Lymphoma,0
24466,Code,Stage IB Pancreatic Cancer AJCC v8,0
24467,Togo,ROSE Cluster 3,0
24468,Type A,Recurrent Uveal Melanoma,0
24469,Due to,Nasal cavity carcinoma,0
24470,Chemotherapy,Benign Apocrine Neoplasm,0
24471,PSA Level Greater than Fifty,Chest Wall Fibromatosis,0
24472,Malignant tumor of colon,Refractory Barrett Esophagus,0
24473,Malignant Neoplasms,Advanced Uterine Corpus Carcinosarcoma,0
24474,SMG1 wt Allele,Tubal Hyperplasia,0
24475,shared attribute,Intraepithelial Melanocytic Hyperplasia,0
24476,MYOT gene,Occult Lung Adenosquamous Carcinoma,0
24477,Acute monocytic leukemia,Adenocarcinoma,0
24478,Endocrine Cells,Childhood Lymphoma,0
24479,Often - answer to question,Adult Acute Eosinophilic Leukemia,0
24480,Coding,Familial Adenomatous Polyposis Associated Medulloblastoma,0
24481,Occurrence Indicator,Gallbladder Adenocarcinoma,0
24482,Compleat Liquid Nutrition,malignant lymphoma of pancreatic lymph nodes,0
24483,Throat,Gallbladder Adenocarcinoma,0
24484,chronic,Benign Apocrine Neoplasm,0
24485,Simpson Grade 3,Mucinous adenocarcinoma gastric,0
24486,Common Specifications in HL7 V3 Publishing,Stage IV Penile Cancer AJCC v7,0
24487,Hormonal,Vaginal Adenoma,0
24488,How Much Distress Sweats,Type II Endometrial Adenocarcinoma,0
24489,Burkina Faso,Hereditary Diffuse Gastric Adenocarcinoma,0
24490,Person 1,Engraftment syndrome,0
24491,Dependent - ability,Cervical Squamous Intraepithelial Neoplasia,0
24492,Minor salivary gland structure,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24493,Intrinsic origin,Intraepithelial Melanocytic Hyperplasia,0
24494,Account number:Identifier:Point in time:^Patient:Nominal,adenosquamous carcinoma of breast,0
24495,Universities,Human Papillomavirus-Related Carcinoma,0
24496,Case unit dose,Malignant melanoma of eyelid,0
24497,Basis - conceptual entity,Stage IB Pancreatic Cancer AJCC v8,0
24498,Qualitative form,sarcoma of spinal cord,0
24499,United States,ROSE Cluster 3,0
24500,Cerebellum,Breast Ductal Adenoma,0
24501,Two,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24502,Abnormal Reference Range,Childhood Central Nervous System Ganglioneuroblastoma,0
24503,Biological Response Modifiers,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24504,Constant (qualifier),Colorectal High Grade B-Cell Lymphoma,0
24505,Non-Small Cell Lung Carcinoma,Atypical Lobular Breast Hyperplasia,0
24506,Progress,Adult Alveolar Soft Part Sarcoma,0
24507,apply - action,Malignant Neoplasm with Regional Lymph Node Involvement,0
24508,Filter - medical device,Astrocytoma of brain,0
24509,Mechanism (attribute),Nasal cavity carcinoma,0
24510,Malignant neoplasm of soft tissue,Stage IV Childhood Non-Hodgkin Lymphoma,0
24511,Probability,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24512,Africa,Mucinous adenocarcinoma gastric,0
24513,Component object,Cartilaginous exostosis,0
24514,Half,Squamous cell carcinoma of lip,0
24515,Manufactured sign,Spongiotic dermatitis,0
24516,Five,Digestive System Hodgkin Lymphoma,0
24517,Eating,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24518,Retinoic Acid Response Element,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24519,Case unit dose,clear cell adenocarcinoma of gallbladder,0
24520,Consortium for Molecular and Cellular Characterization of Screen-Detected Lesions,Intestinal Metaplasia of Bladder Urothelium,0
24521,Structure of spermatogenic epithelium,clear cell adenocarcinoma of gallbladder,0
24522,immunoglobulin activity,Giant cell angiofibroma,0
24523,Broken skin,Refractory WHO Grade III Glioma,0
24524,Alphabet,Engraftment syndrome,0
24525,Immune System Processes,Refractory Ependymoma,0
24526,Moll's gland cyst,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24527,Melanoma Pathway,Pancreatic Intraepithelial Neoplasia-3,0
24528,Lung,Malignant Neoplasm with Regional Lymph Node Involvement,0
24529,Immature Lymphocytes Measurement,Tonsillar Carcinoma,0
24530,biopsy characteristics,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24531,Leg,clear cell adenocarcinoma of gallbladder,0
24532,white blood cell type,FIGO Stage II Ovarian Cancer,0
24533,other medicated shampoos in ATC,Kaposi's sarcoma of skin,0
24534,Most,Botryoid-Type Embryonal Rhabdomyosarcoma,0
24535,Multiple Myeloma,Childhood Thyroid Gland Follicular Carcinoma,0
24536,Southern Europe,Diffuse malignant mesothelioma,0
24537,One,Locally Advanced Carcinoma,0
24538,Pelvic Pain,adenosquamous carcinoma of breast,0
24539,Marketing basis - Transitional,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24540,MOSTLY,Metastatic Ductal Breast Carcinoma,0
24541,Breast Cancer Type 1 Susceptibility Protein Measurement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24542,Primary,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24543,site,mucinous adenocarcinoma of gallbladder,0
24544,Three,Giant cell angiofibroma,0
24545,Covers (device),Platinum-Resistant Lung Small Cell Carcinoma,0
24546,Usual,Botryoid-Type Embryonal Rhabdomyosarcoma,0
24547,Immature,Brain Tumor,0
24548,Have Been Coughing,Squamous cell carcinoma of lip,0
24549,Proton pump inhibitors for peptic ulcer and GORD,Nasal cavity carcinoma,0
24550,Common (qualifier value),Recurrent Uveal Melanoma,0
24551,Smear - instruction imperative,Leptomeningeal sarcoma,0
24552,Appearance,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24553,Agreement,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24554,N not otherwise specified Antibody,Cervical Fibroepithelial Polyp,0
24555,Triggered by,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24556,Cell Device,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
24557,Main,Medulloblastoma,0
24558,Life Expectancy Less than Five Years,Locally Advanced Soft Tissue Sarcoma,0
24559,Cell (compartment),FIGO Stage IVA Ovarian Cancer,0
24560,Present,Pancreatic Intraepithelial Neoplasia-3,0
24561,Weather,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
24562,Neonatal Abstinence Syndrome,FIGO Stage IVA Ovarian Cancer,0
24563,Lymphatic Spread,Stage II Hepatocellular Carcinoma AJCC v8,0
24564,Classical Hodgkin's Lymphoma,Localized Ewing Sarcoma,0
24565,Science of Etiology,Intestinal Metaplasia of Bladder Urothelium,0
24566,Bladder Continence Question,Breast Apocrine Adenoma,0
24567,Major <insect>,Stage III Cutaneous Melanoma AJCC v6,0
24568,Base - General Qualifier,Pancreatic carcinoma,0
24569,Line Unit of Length,Hodgkin Disease,0
24570,ETV5 gene,Breast Ductal Adenoma,0
24571,Tears - SpecimenType,Pilocytic astrocytoma of cerebellum,0
24572,Preoperative,Bladder squamous cell carcinoma stage I,0
24573,Primary malignant neoplasm,Chest Wall Fibromatosis,0
24574,Symptoms aspect,Carcinoma of submandibular gland,0
24575,Removed,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24576,Used by,Blood Vessel Tumors,0
24577,Human Cells,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24578,Diabetes Mellitus,Intracortical osteosarcoma,0
24579,Characteristics,Endometrial Small Cell Carcinoma,0
24580,Clinical Observation,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24581,2+ Score,Locally Advanced Soft Tissue Sarcoma,0
24582,Formed,Astrocytoma of brain,0
24583,Nearly,Pancreatic carcinoma,0
24584,biopsy characteristics,Anaplastic large cell lymphoma,0
24585,Classification,clear cell adenocarcinoma of gallbladder,0
24586,Common Specifications in HL7 V3 Publishing,Refractory Barrett Esophagus,0
24587,Neither Satisfied nor Dissatisfied,Malignant neoplasm of thalamus,0
24588,Carcinoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24589,Beds,Benign Carotid Body Paraganglioma,0
24590,Extrinsic,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24591,Alphabet,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24592,Form:Finding:Point in time:{Setting}:Document:{Role},Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24593,Common (qualifier value),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
24594,Congenital ichthyosis,Human Papillomavirus-Related Carcinoma,0
24595,Digital Content Category,Angiosarcoma of liver,0
24596,Tryptophanase,Maxillary Sinus Adenoid Cystic Carcinoma,0
24597,Ovary,Pilocytic astrocytoma of cerebellum,0
24598,Report (document),Childhood Anaplastic Large Cell Lymphoma,0
24599,How Much Distress Shortness of Breath,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24600,Adapt (substance),Mucosal Melanoma,0
24601,Main,Small Intestinal Villous Adenoma,0
24602,Fever symptoms (finding),Mixed parotid tumor,0
24603,cancer immunology,Precursor B-lymphoblastic lymphoma stage II,0
24604,Type - attribute,Vaginal Adenoid Cystic Carcinoma,0
24605,health and disease,Localized Malignant Neoplasm,0
24606,Cancer Etiology,mucinous adenocarcinoma of gallbladder,0
24607,Metastatic Disease Clinical Trial Setting,FIGO Stage IVA Ovarian Cancer,0
24608,Embryonic Development,Low Grade Squamous Intraepithelial Neoplasia,0
24609,Usually,Transitional cell carcinoma,0
24610,70%,Sarcomatoid Renal Cell Carcinoma,0
24611,Bayer Visual Acuity Changes Grade 3,Recurrent Uveal Melanoma,0
24612,contact exposure to arsenic (history),Recurrent Rhabdomyosarcoma,0
24613,family of origin,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24614,Highest,Non-Metastatic Gestational Trophoblastic Tumor,0
24615,subscriber - self,Neonatal leukemia,0
24616,transmission process,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24617,shared attribute,Anterior Urethral Malignant Neoplasm,0
24618,Special,Vaginal Adenoid Cystic Carcinoma,0
24619,polyps,Advanced Lung Carcinoma,0
24620,High,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24621,Long-term,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
24622,Sex Cord-Stromal Tumor,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
24623,migrated,Lipoma of small intestine,0
24624,CDH1 gene,Mucinous adenocarcinoma gastric,0
24625,How Much Distress Sweats,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
24626,second (number),Mucinous adenocarcinoma gastric,0
24627,Covers (device),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24628,Diffuse,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24629,Tobacco smoking behavior,FIGO Stage IVA Ovarian Cancer,0
24630,Derivative,High Grade Glandular Intraepithelial Neoplasia,0
24631,Communicable Diseases,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24632,Age,Squamous cell carcinoma of lip,0
24633,Sometimes,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
24634,Call (Instruction),Peripheral primitive neuroectodermal tumor of soft tissue,0
24635,Rate,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
24636,Surgery specialty,Epithelioid Sarcoma NCI Grade 3,0
24637,peripheral blood,Pleomorphic adenoma of parotid gland,0
24638,Unlikely,Mixed parotid tumor,0
24639,Symptoms aspect,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24640,treatment - ActInformationManagementReason,Female Breast Carcinoma,0
24641,Diagnosis,Xeroderma pigmentosum,0
24642,Specimen Source Codes - Tube,Childhood Thyroid Gland Follicular Carcinoma,0
24643,Type - attribute,Maxillary Sinus Adenoid Cystic Carcinoma,0
24644,Common (qualifier value),Clinical Stage I Cutaneous Melanoma AJCC v8,0
24645,Surrounding (qualifier value),Endometrial Small Cell Carcinoma,0
24646,Nursing interventions,Angiosarcoma of liver,0
24647,Class,Atypical Lobular Breast Hyperplasia,0
24648,Eating,Angiosarcoma of liver,0
24649,Cardiac Lead Procedure,Medulloblastoma,0
24650,Including (qualifier),Extra-Adrenal Paraganglioma,0
24651,Most,Leptomeningeal sarcoma,0
24652,Body tissue,Vaginal Adenoid Cystic Carcinoma,0
24653,Mucoepidermoid Carcinoma,Locally Advanced Epithelioid Hemangioendothelioma,0
24654,Neoplasms,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
24655,Major <insect>,Heavy Chain Deposition Disease,0
24656,Treating,Stage II Hepatocellular Carcinoma AJCC v8,0
24657,therapeutic aspects,Metastatic Carcinoma in the Lung,0
24658,Delight,Female Breast Carcinoma,0
24659,Fatigue,Childhood Central Nervous System Immature Teratoma,0
24660,Oral region,Ovarian germ cell choriocarcinoma stage IV,0
24661,Reported Term,Unicystic ameloblastoma,0
24662,combination - answer to question,Unfavorable Non-Hodgkin Lymphoma,0
24663,Pharmaceutical Preparations,Thyroid Hurthle Cell Carcinoma,0
24664,To,Mixed astrocytoma-ependymoma,0
24665,Radiological Exposure Device,FIGO Stage IVA Ovarian Cancer,0
24666,Large,Engraftment syndrome,0
24667,Pale color saturation,FIGO Stage II Ovarian Cancer,0
24668,Mechanism Component of Device,Gallbladder Adenocarcinoma,0
24669,Bladder Continence Question,Metaplastic carcinoma of breast,0
24670,Descent,Methotrexate-Associated Hodgkin Lymphoma,0
24671,Both ovaries,Malignant Neoplasm with Regional Lymph Node Involvement,0
24672,Heightened,Acute Undifferentiated Leukemia,0
24673,Resolution,Cervical Fibroepithelial Polyp,0
24674,Secondary Neoplasm,Trichilemmocarcinoma,0
24675,Offspring,ROSE Cluster 3,0
24676,Increased,Diffuse malignant mesothelioma,0
24677,Frequently,Localized Malignant Neoplasm,0
24678,To,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24679,See,Kaposi's sarcoma of extrahepatic bile duct,0
24680,Smaller,Refractory Bladder Carcinoma,0
24681,Treating,Liver Cavernous Hemangioma,0
24682,Skin Erosion,Pancreatic Intraepithelial Neoplasia-3,0
24683,Age of onset of symptoms:Time:Pt:^Patient:Qn,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24684,New,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
24685,Yolk Sac Tumor,FIGO Stage II Ovarian Cancer,0
24686,More,Malignant melanoma of eyelid,0
24687,Merkel cell carcinoma,non-Hodgkin's lymphoma of spleen,0
24688,Qualitative form,Stage II Carcinoma of Penis,0
24689,Include (action),Adenocarcinoma of the prostate metastatic,0
24690,Cell Count,embryonal rhabdomyosarcoma of prostate,0
24691,Diagnostic Imaging,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
24692,seen,Intraepithelial Melanocytic Hyperplasia,0
24693,Invasive Ductal Breast Carcinoma,Recurrent Uveal Melanoma,0
24694,Collections (publication),Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24695,High Grade Ovarian Serous Adenocarcinoma,Small Intestinal Villous Adenoma,0
24696,Cerebral hemisphere structure (body structure),Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
24697,active (HL7 RoleLink),Recurrent Uveal Melanoma,0
24698,To,Ectomesenchymal Chondromyxoid Tumor,0
24699,ovarian,Placental aromatase deficiency,0
24700,Ethanol,BRCA2 Syndrome,0
24701,Taxonomic,Cartilaginous exostosis,0
24702,Cancer Genus,Locally Advanced Soft Tissue Sarcoma,0
24703,Operative Surgical Procedures,Intestinal Neuroendocrine Carcinoma,0
24704,Occurrence Indicator,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
24705,status - In progress,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24706,Rectum,Cerebral hemangioma,0
24707,Favorable,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24708,Mammal liver preparation,Carcinoma,0
24709,include - SetOperator,Childhood Thyroid Gland Follicular Carcinoma,0
24710,Abnormally high,Localized Ewing Sarcoma,0
24711,Treating,Botryoid-Type Embryonal Rhabdomyosarcoma,0
24712,Specimen Source Codes - tumor,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24713,Tissue Specimen Code,Engraftment syndrome,0
24714,Color,Pilocytic astrocytoma of cerebellum,0
24715,Tumor cells,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24716,Diagnosis Study,Basal Cell Ameloblastoma,0
24717,Center of town,Unresectable Rhabdomyosarcoma,0
24718,Sequence Data Type,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24719,Smaller,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24720,Body tissue,Locally Advanced Epithelioid Hemangioendothelioma,0
24721,year,Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma,0
24722,Phenomenon,Kaposi's sarcoma of extrahepatic bile duct,0
24723,Chronic inflammation,Mucinous cystadenofibroma,0
24724,Specific qualifier value,Deep Leiomyoma,0
24725,Lymphadenopathy,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24726,Cancer Genus,Breast Ductal Adenoma,0
24727,other medicated shampoos in ATC,Thymoma malignant recurrent,0
24728,Term Source,Congenital hamartoma,0
24729,Carcinoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
24730,Only - dosing instruction fragment,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24731,Central,FIGO Stage IVA Ovarian Cancer,0
24732,Cells,non-Hodgkin's lymphoma of spleen,0
24733,Inguinal part of abdomen,Malignant neoplasm of gallbladder,0
24734,Toxic Epidermal Necrolysis,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24735,Adult Lymphoma,Testicular cancer metastatic,0
24736,Epithelial ovarian cancer,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24737,Edema,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24738,Primary malignant neoplasm,Benign Ovarian Thecoma,0
24739,Symptoms aspect,Anaplastic large cell lymphoma,0
24740,Primary malignant neoplasm,Refractory Barrett Esophagus,0
24741,*Type - Kind of quantity,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
24742,Irregular,Choroid Necrotic Melanoma,0
24743,Loss of Appetite question,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
24744,year,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24745,Soft,Cervical Fibroepithelial Polyp,0
24746,CD69 protein,Larynx carcinoma recurrent,0
24747,Neoplasm Metastasis,Unresectable Rhabdomyosarcoma,0
24748,International Classification of Disease for Oncology,Benign Anal Granular Cell Tumor,0
24749,Breast tissue sample,Xeroderma pigmentosum,0
24750,Physical findings,Angiosarcoma of liver,0
24751,Third revision,Benign squamous cell tumor,0
24752,Confirmed by,Larynx carcinoma recurrent,0
24753,Sweat Glands,Astrocytoma of brain,0
24754,In Blood,Adult Alveolar Soft Part Sarcoma,0
24755,Targeted Therapy,Pancreatic Endocrine Carcinoma,0
24756,Catch - Finding of sensory dimension of pain,Bladder Neuroendocrine Neoplasm,0
24757,Fluid behavior,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
24758,Primary malignant neoplasm,Lipoma of small intestine,0
24759,Disruptive,Unicystic ameloblastoma,0
24760,Embryo,Funisitis (disorder),0
24761,System - kit,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24762,Type A,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24763,Severe Extremity Pain,Adult Acute Eosinophilic Leukemia,0
24764,Specimen Source Codes - Genital,Recurrent Uveal Melanoma,0
24765,Trial Screening,Advanced Uterine Corpus Carcinosarcoma,0
24766,phosphoethanolamine,Recurrent Testicular Lymphoma,0
24767,mesenchymal,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24768,Value Above Reference Range,Malignant melanoma of eyelid,0
24769,1+,Cervical Squamous Intraepithelial Neoplasia,0
24770,Basal cell carcinoma,FIGO Stage II Ovarian Cancer,0
24771,High Mitosis-Karyorrhexis Index,Tubal Hyperplasia,0
24772,3+ Answer to Question,Small intestine carcinoma,0
24773,Rare,Recurrent Primary Lymphoma of Bone,0
24774,lymph nodes,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
24775,VARIOUS DRUG CLASSES IN ATC,non-Hodgkin's lymphoma of spleen,0
24776,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Stage II Hepatocellular Carcinoma AJCC v8,0
24777,Intellectual scale,Malignant neoplasm of subglottis,0
24778,Much,Anterior Urethral Malignant Neoplasm,0
24779,Interferes with,Human Papillomavirus-Related Carcinoma,0
24780,Organ,FIGO Stage IVA Ovarian Cancer,0
24781,Prophylactic behavior,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24782,Latin America,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
24783,Frequently,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
24784,Historical - ParameterizedDataType,Locally Advanced Carcinoma,0
24785,Cardiovascular system,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24786,Pith - plant part,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
24787,Folded structure,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24788,Carcinoid Tumor,FIGO Stage IVA Ovarian Cancer,0
24789,Ameloblastoma,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24790,Ovarian Carcinoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
24791,Case (situation),Thymic Atypical Carcinoid Tumor,0
24792,Web Site,gliosarcoma,0
24793,Cells,Stage 0 Penile Cancer AJCC v8,0
24794,Togo,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
24795,Due to,Thyroid Hurthle Cell Carcinoma,0
24796,Upper back structure,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
24797,Usual,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24798,Fishes,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24799,Medical service,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24800,Age Factors,Undifferentiated Endocervical Sarcoma,0
24801,Make - Instruction Imperative,Adenocarcinoma of the prostate metastatic,0
24802,Type A,Nasal cavity carcinoma,0
24803,Togo,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24804,lymph nodes,Childhood Central Nervous System Ganglioneuroblastoma,0
24805,Congenital Abnormality,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24806,Embryonal Rhabdomyosarcoma,Acantholytic squamous cell carcinoma,0
24807,Aggressive course,Recurrent Testicular Lymphoma,0
24808,Confusion,Gallbladder Adenocarcinoma,0
24809,31,Malignant neoplasm of thalamus,0
24810,Including (qualifier),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24811,Bone Pain,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
24812,Version,Nasal cavity carcinoma,0
24813,Referring,Choroid Epithelioid Cell Melanoma,0
24814,Dorsal,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24815,Geographic Locations,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24816,Beginning,Primary Cutaneous Plasmablastic Lymphoma,0
24817,Virus,Stage IB Pancreatic Cancer AJCC v8,0
24818,Occurrence Indicator,Cervical Squamous Intraepithelial Neoplasia,0
24819,To,Cerebral Primitive Neuroectodermal Tumor,0
24820,Physical findings,Stage III Adult Immunoblastic Lymphoma,0
24821,VARIOUS DRUG CLASSES IN ATC,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
24822,Human papilloma virus infection,Intraepithelial Melanocytic Hyperplasia,0
24823,Malignant Vaginal Neoplasm,Localized Ewing Sarcoma,0
24824,Image Feature,Diffuse malignant mesothelioma,0
24825,Tryptophanase,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
24826,Adult Lymphoma,Acantholytic squamous cell carcinoma,0
24827,Squamous,Human Papillomavirus-Related Carcinoma,0
24828,Symptoms aspect,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
24829,Vaginal intraepithelial neoplasia,Maxillary Sinus Adenoid Cystic Carcinoma,0
24830,Before,Mixed astrocytoma-ependymoma,0
24831,Five,Stage III Cutaneous Melanoma AJCC v6,0
24832,Woman,Thymic Clear Cell Carcinoma,0
24833,Manufactured form,Nasal cavity carcinoma,0
24834,Trimethoprim-Sulfamethoxazole Combination,gliosarcoma,0
24835,Nicotiana tabacum,adenoid cystic carcinoma of lung,0
24836,Name,Gallbladder Adenocarcinoma,0
24837,Pharyngeal structure,Refractory Barrett Esophagus,0
24838,XK wt Allele,FIGO Stage II Ovarian Cancer,0
24839,include - SetOperator,Parathyroid Gland Adenocarcinoma,0
24840,Renal Cell Carcinoma,Hereditary corneal dystrophy,0
24841,Time (foundation metadata concept),Recurrent Testicular Lymphoma,0
24842,Removed,Adult Brain Stem Mixed Glioma,0
24843,Fever,Cervical Squamous Intraepithelial Neoplasia,0
24844,Dryness (characteristic),Digestive System Hodgkin Lymphoma,0
24845,Urinary Bladder,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24846,NCI CTEP SDC Astrocytoma,Pancreatic Intraepithelial Neoplasia-3,0
24847,Infertility,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24848,Low Level,Metastatic Ductal Breast Carcinoma,0
24849,1980s,Collecting Duct Carcinoma of the Kidney,0
24850,Ulceration,Uterine Cancer,0
24851,How Much Distress Weight Loss,Refractory Bladder Carcinoma,0
24852,Type - attribute,Secondary malignant neoplasm of lymph node,0
24853,Age,Cervical Fibroepithelial Polyp,0
24854,Fallopian Tubes,Stage II Carcinoma of Penis,0
24855,Singular,Low Grade Squamous Intraepithelial Neoplasia,0
24856,Known,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
24857,Associated with,Localized Askin Tumor,0
24858,Usual Severity Shortness of Breath,Acute Undifferentiated Leukemia,0
24859,Tryptophanase,Methotrexate-Associated Hodgkin Lymphoma,0
24860,shared attribute,Cervical Fibroepithelial Polyp,0
24861,Weight decreased,Clinical Stage I Cutaneous Melanoma AJCC v8,0
24862,Initially,Stage II Carcinoma of Penis,0
24863,Partial,Hereditary corneal dystrophy,0
24864,Factor,Type II Endometrial Adenocarcinoma,0
24865,Common (qualifier value),Chronic Myelomonocytic Leukemia-2,0
24866,Back structure,Cerebral Primitive Neuroectodermal Tumor,0
24867,Morbidity - disease rate,Acute Undifferentiated Leukemia,0
24868,Body tissue,Heavy Chain Deposition Disease,0
24869,Have Shortness of Breath question,Benign Anal Granular Cell Tumor,0
24870,Sensation quality,Liver Cavernous Hemangioma,0
24871,Basis - conceptual entity,Vaginal Adenoma,0
24872,brain shape,Colorectal High Grade B-Cell Lymphoma,0
24873,Term (temporal),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
24874,Clonality,FIGO Stage IVA Ovarian Cancer,0
24875,Fever,Fibroadenoma of breast,0
24876,Cartilage,adenoid cystic carcinoma of lung,0
24877,Classification,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24878,10%,Larynx carcinoma recurrent,0
24879,Individual,Stage III Adult Immunoblastic Lymphoma,0
24880,Account number:Identifier:Point in time:^Patient:Nominal,Advanced Uterine Corpus Carcinosarcoma,0
24881,Cerebellum,Maxillary Sinus Adenocarcinoma,0
24882,Nevus,Xeroderma pigmentosum,0
24883,member,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
24884,Major,Cancer of Urinary Tract,0
24885,Therapeutic radiology procedure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
24886,ovarian,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24887,Malignant Neoplasms,Vaginal Adenoma,0
24888,Treating,Benign Anal Granular Cell Tumor,0
24889,Clinical,Stage I Adult Non-Hodgkin Lymphoma,0
24890,Mathematical Operator,Stage III Cutaneous Melanoma AJCC v6,0
24891,Sex Behavior,Locally Advanced Carcinoma,0
24892,Secondary Neoplasm,Localized Askin Tumor,0
24893,Along edge (qualifier value),Mastocytosis,0
24894,Affecting,Diffuse malignant mesothelioma,0
24895,Examination,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24896,Primary malignant neoplasm,Mucinous cystadenofibroma,0
24897,Urinary Bladder,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
24898,Dietary Factors,Cerebral Primitive Neuroectodermal Tumor,0
24899,/40,Germinoma,0
24900,Smear - instruction imperative,Malignant neoplasm of olfactory nerve,0
24901,Cure (remedy),Extra-abdominal fibromatosis,0
24902,Including (qualifier),Contact dermatitis due to alkali,0
24903,Corner Minus,Medulloblastoma,0
24904,Type - attribute,Localized Malignant Neoplasm,0
24905,Body tissue,Ovarian Dermoid Cyst with Secondary Carcinoma,0
24906,Histology Procedure,Xeroderma pigmentosum,0
24907,Appearance,Giant cell angiofibroma,0
24908,Social group,Mucinous adenocarcinoma gastric,0
24909,Reported Term,Testicular cancer metastatic,0
24910,Two,Pilocytic astrocytoma of cerebellum,0
24911,Body Fluids,Cerebral Primitive Neuroectodermal Tumor,0
24912,Special,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
24913,Concept model domain,ROSE Cluster 3,0
24914,Structure of Wharton's jelly,Intestinal Neuroendocrine Carcinoma,0
24915,Contain (action),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24916,Point Name,squamous cell carcinoma of the thyroid gland,0
24917,Needs,Refractory Barrett Esophagus,0
24918,Disease,Benign Apocrine Neoplasm,0
24919,Aromatase deficiency,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
24920,Very Much,mucinous adenocarcinoma of gallbladder,0
24921,Two,Neonatal leukemia,0
24922,Tobacco use,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
24923,site-specific telomere resolvase activity,Female Breast Carcinoma,0
24924,Common Cold,Atypical Lobular Breast Hyperplasia,0
24925,Unmarried,Hereditary Diffuse Gastric Adenocarcinoma,0
24926,Deoxyribonucleic Acid Measurement,Recurrent Uveal Melanoma,0
24927,various antiseptic throat preparations,Lipoma of small intestine,0
24928,Abdominal bloating,Childhood Anaplastic Large Cell Lymphoma,0
24929,Papillomaviridae,Malignant Neoplasm with Regional Lymph Node Involvement,0
24930,Numerous,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
24931,Human body structure,Pancreatic carcinoma,0
24932,Consistent with,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24933,Therapeutic procedure,Mucinous adenocarcinoma gastric,0
24934,Abdomen,Type II Endometrial Adenocarcinoma,0
24935,Second Suffix,Refractory Bladder Carcinoma,0
24936,Type 3,embryonal rhabdomyosarcoma of prostate,0
24937,Hematoxylin and eosin stain method,Fibroadenoma of breast,0
24938,Loss of Appetite question,Cancer of Urinary Tract,0
24939,No Application Type,Intraepithelial Melanocytic Hyperplasia,0
24940,1+ Score,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
24941,Cells,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
24942,Erythropoietin,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
24943,BRCA2 gene,Testicular cancer metastatic,0
24944,Biogenic Amines,Astrocytoma of brain,0
24945,Incidental Findings,Malignant Neoplasm with Regional Lymph Node Involvement,0
24946,oncology field,Kaposi's sarcoma of skin,0
24947,Bone neoplasms,Carcinoma of submandibular gland,0
24948,risk factors,Vaginal Adenoma,0
24949,include - SetOperator,Diffuse malignant mesothelioma,0
24950,Organ,Vaginal Adenoma,0
24951,Therapeutic procedure,Childhood Central Nervous System Ganglioneuroblastoma,0
24952,Breast Carcinoma,Advanced Uterine Corpus Carcinosarcoma,0
24953,Common Specifications in HL7 V3 Publishing,Epithelioid Sarcoma NCI Grade 3,0
24954,Apply,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
24955,Reported Term,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
24956,Childhood Hodgkin Lymphoma,Xeroderma pigmentosum,0
24957,Ursidae Family,Metastatic Lung Neuroendocrine Neoplasm,0
24958,Growth action,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
24959,Treated with,Diffuse malignant mesothelioma,0
24960,Smear - instruction imperative,Colorectal Neuroendocrine Tumor G2,0
24961,Physical assessment findings,Hereditary Diffuse Gastric Adenocarcinoma,0
24962,PSA Level Greater than Fifty,Splenic Manifestation of Hairy Cell Leukemia,0
24963,Including (qualifier),Recurrent Rhabdomyosarcoma,0
24964,IGHV@ gene cluster,Angiosarcoma of liver,0
24965,Individual,Acute Undifferentiated Leukemia,0
24966,use of ultrasonography,Mucinous adenocarcinoma gastric,0
24967,combination of objects,FIGO Stage IVA Ovarian Cancer,0
24968,Shell - Animal skin appendage,Splenic Manifestation of Hairy Cell Leukemia,0
24969,Lesion,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
24970,23,Carcinoma,0
24971,Patient Outcome - Died,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
24972,Blood,Acute Undifferentiated Leukemia,0
24973,Unknown GENC,Adult Hepatocellular Carcinoma,0
24974,Moved from,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
24975,Common (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
24976,Over (spatial),Locally Advanced Carcinoma,0
24977,year,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
24978,A Codes,Stage IB Pancreatic Cancer AJCC v8,0
24979,Smoking,Giant cell angiofibroma,0
24980,radioactive iodine,Mixed parotid tumor,0
24981,Cyst,Carcinomatosis of peritoneal cavity,0
24982,Simple,Benign Anal Granular Cell Tumor,0
24983,Asthma Control Test Questionnaire,Breast Ductal Adenoma,0
24984,Occurrence Indicator,Stage III Cutaneous Melanoma AJCC v6,0
24985,Malignant neoplasm of larynx,Cancer of Urinary Tract,0
24986,Five-year Survival Rate,FIGO Stage II Ovarian Cancer,0
24987,Sarcoma - category (morphologic abnormality),Type II Endometrial Adenocarcinoma,0
24988,newly,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
24989,Therapeutic radiology procedure,Anterior Urethral Malignant Neoplasm,0
24990,CYREN gene,embryonal rhabdomyosarcoma of prostate,0
24991,Following,Endometrial Small Cell Carcinoma,0
24992,Increase,Thymic Clear Cell Carcinoma,0
24993,Brain Stem,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
24994,Aspects of signs,Congenital hamartoma,0
24995,Injury of integument,Angiosarcoma of liver,0
24996,Benign neoplasm of paraganglion,Cancer of Urinary Tract,0
24997,Adult human body,Primary Cutaneous Plasmablastic Lymphoma,0
24998,Pharyngitis,Unresectable Rhabdomyosarcoma,0
24999,Numbers,Adult Acute Eosinophilic Leukemia,0
25000,75,Trabecular adenocarcinoma,0
25001,Mass of body structure,Adult Anaplastic Oligodendroglioma,0
25002,Togo,Cerebral hemangioma,0
25003,Human Cells,Refractory Ependymoma,0
25004,Cover (physical object),Mucinous adenocarcinoma,0
25005,Including (qualifier),Trabecular adenocarcinoma,0
25006,User Group,Thymic Clear Cell Carcinoma,0
25007,Occur (action),Granular Cell Leiomyosarcoma,0
25008,Punctum,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25009,cell growth pattern,Kaposi's sarcoma of skin,0
25010,Absent,Breast Ductal Adenoma,0
25011,Tissue Specimen Code,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25012,curettage specimen,Blepharal carcinoma,0
25013,Improvement,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25014,Hemoptysis,Nasal cavity carcinoma,0
25015,Surgical aspects,Brain Ependymoma,0
25016,Enneking Low Surgical Grade,FIGO Stage II Ovarian Cancer,0
25017,Procedure (set of actions),Thymic Clear Cell Carcinoma,0
25018,Spreading (qualifier value),Tongue Alveolar Soft Part Sarcoma,0
25019,Before,Airway Hemangioma,0
25020,Person Name,Brain Tumor,0
25021,Common Specifications in HL7 V3 Publishing,Refractory Bladder Carcinoma,0
25022,Males,Stage III Cutaneous Melanoma AJCC v6,0
25023,Blood Cells,Locally Advanced Epithelioid Hemangioendothelioma,0
25024,Asia,Anterior Urethral Malignant Neoplasm,0
25025,{Setting},Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
25026,Human body,Adult Alveolar Soft Part Sarcoma,0
25027,Malignant neoplasm of skin,Tumorlet,0
25028,Kidney Tubules,Diffuse malignant mesothelioma,0
25029,Fever symptoms (finding),Botryoid-Type Embryonal Rhabdomyosarcoma,0
25030,Neoplasms,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
25031,Consistency,Intestinal Metaplasia of Bladder Urothelium,0
25032,Palmitic Acid,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25033,Known,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25034,Etiology aspects,Localized Ewing Sarcoma,0
25035,Histamine H2 Receptor Antagonists [MoA],Engraftment syndrome,0
25036,Population Group,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25037,Ductal,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25038,Provide (product),Lipoma of small intestine,0
25039,Most,Malignant melanoma of eyelid,0
25040,Aspects of signs,Cancer of Urinary Tract,0
25041,40%,Chronic Myelomonocytic Leukemia-2,0
25042,Precision - temporal,Carcinomatosis of peritoneal cavity,0
25043,Process,Ovarian Carcinoid Tumor,0
25044,Seminoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25045,Intestines,Endometrial Small Cell Carcinoma,0
25046,Case (situation),Carcinoma of urinary bladder,0
25047,Very good,Adult Fibrolamellar Carcinoma,0
25048,Medications,Digestive System Hodgkin Lymphoma,0
25049,3+ Score,Endometrial Small Cell Carcinoma,0
25050,Mean Percent of Normal,Cervical Fibroepithelial Polyp,0
25051,Rare,Childhood Fibrillary Astrocytoma,0
25052,How Much Distress Weight Loss,Mucinous adenocarcinoma gastric,0
25053,Covers (device),Grade 3a Malignant Neoplasm,0
25054,Hypothalamic structure,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
25055,Small cell carcinoma of lung,Benign neoplasm of eye,0
25056,Germ Cells,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25057,Type 3,Gallbladder Adenocarcinoma,0
25058,depend,Papillary squamous cell carcinoma,0
25059,Laser-generated electromagnetic radiation,Leiomyoma of Gallbladder,0
25060,Stomach structure,Childhood Central Nervous System Ganglioneuroblastoma,0
25061,X-Ray Computed Tomography,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25062,Therapeutic radiology procedure,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25063,Asleep,Extra-Adrenal Paraganglioma,0
25064,Disease Screening,Human Papillomavirus-Related Carcinoma,0
25065,Malignant Childhood Neoplasm,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25066,Classic Histology,Hemangioma,0
25067,Structure of mucous membrane of nose,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25068,Categories,Carcinoma ex pleomorphic adenoma of parotid gland,0
25069,Brain part,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25070,Kidney,Childhood Lymphoma,0
25071,CD5L wt Allele,Angiosarcoma of liver,0
25072,Hereditary,Benign neoplasm of thorax,0
25073,Diagnosis Study,Liver Cavernous Hemangioma,0
25074,Feelings,Digestive System Hodgkin Lymphoma,0
25075,high - ActExposureLevelCode,Vaginal Adenoid Cystic Carcinoma,0
25076,High Grade Astrocytic Tumor,Cerebral hemangioma,0
25077,Melanoma Pathway,embryonal rhabdomyosarcoma of prostate,0
25078,Humoralism,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25079,Index,Locally Advanced Carcinoma,0
25080,Histology Procedure,Thymic Atypical Carcinoid Tumor,0
25081,Include (action),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25082,Cover (physical object),Colorectal High Grade B-Cell Lymphoma,0
25083,Common Specifications in HL7 V3 Publishing,Thymic Clear Cell Carcinoma,0
25084,Participation Type - origin,Neonatal leukemia,0
25085,Males,Chest Wall Fibromatosis,0
25086,Endothelial Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25087,Tumor type,Congenital hamartoma,0
25088,Type A,Benign Carotid Body Paraganglioma,0
25089,Type A,Intraepithelial Melanocytic Hyperplasia,0
25090,How Much Distress Difficulty Swallowing,Stage I Colon Neuroendocrine Tumor AJCC v8,0
25091,Neuroendocrine Tumors,Multiple Skull Base Meningiomas,0
25092,Benign Neoplasm,Occult Lung Adenosquamous Carcinoma,0
25093,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Airway Hemangioma,0
25094,diagnosis aspect,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25095,Characteristics,malignant lymphoma of pancreatic lymph nodes,0
25096,Type - attribute,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25097,Sufficiently defined concept definition status (core metadata concept),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25098,Due to,Recurrent Testicular Lymphoma,0
25099,Diagnosis,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25100,Qualitative form,Splenic Manifestation of Hairy Cell Leukemia,0
25101,Poor - grade value,Stage II Carcinoma of Penis,0
25102,Recurrent fevers,Endometrial Small Cell Carcinoma,0
25103,Common (qualifier value),Familial Adenomatous Polyposis Associated Medulloblastoma,0
25104,Case unit dose,adenoid cystic carcinoma of lung,0
25105,Treating,Stage III Cutaneous Melanoma AJCC v6,0
25106,Old,Localized Malignant Neoplasm,0
25107,Racial group,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25108,Entity Determiner - specific,Gallbladder adenoma,0
25109,Epithelial cell count (procedure),Ovarian germ cell choriocarcinoma stage IV,0
25110,Cystoscopy,Refractory Bladder Carcinoma,0
25111,various other agents for local oral treatment in ATC,Primary Cutaneous Plasmablastic Lymphoma,0
25112,Performed,Childhood Choriocarcinoma,0
25113,Gastrointestinal tract structure,Recurrent Testicular Lymphoma,0
25114,Divide,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
25115,Diagnosis,Undifferentiated Endocervical Sarcoma,0
25116,Deterioration of status,Anterior Urethral Malignant Neoplasm,0
25117,Death NOS,Recurrent Rhabdomyosarcoma,0
25118,Removal of bladder,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
25119,Metastatic to,Metaplastic carcinoma of breast,0
25120,Transmitted by,embryonal rhabdomyosarcoma of prostate,0
25121,Administration procedure,Melanomatosis,0
25122,Physical findings,Leiomyoma of Gallbladder,0
25123,Worsening pattern,Adenocarcinoma,0
25124,Symptoms aspect,Engraftment syndrome,0
25125,Human papilloma virus infection,Acute Undifferentiated Leukemia,0
25126,Direct Extension,Benign squamous cell tumor,0
25127,Numbers,Multiple Skull Base Meningiomas,0
25128,radiotherapeutic,Thyroid Hurthle Cell Carcinoma,0
25129,Benign Neoplasm,Stage IB Pancreatic Cancer AJCC v8,0
25130,Life Expectancy Less than Ten Years,Blood Vessel Tumors,0
25131,Formation,Hereditary Diffuse Gastric Adenocarcinoma,0
25132,Testing,Pancreatic carcinoma,0
25133,Lower urinary tract,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25134,English Language,Granular Cell Leiomyosarcoma,0
25135,Term Birth,Acantholytic squamous cell carcinoma,0
25136,Extrinsic,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25137,Negation,Recurrent Uveal Melanoma,0
25138,per second,Endometrial Small Cell Carcinoma,0
25139,Include (action),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25140,Representation (action),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25141,Secondary malignant neoplasm of lymph nodes of neck,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25142,Togo,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25143,Precancerous Conditions,Type II Endometrial Adenocarcinoma,0
25144,Primitive,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
25145,Body tissue,adenoid cystic carcinoma of lung,0
25146,Skeletal bone,Recurrent Testicular Lymphoma,0
25147,Plasma Product,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25148,Retinoic Acid Response Element,Uterine Cancer,0
25149,Negation,Carcinoma of urinary bladder,0
25150,Fourth ventricle structure,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25151,Adult Lymphoma,Prostate Lymphoma,0
25152,In Urine,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25153,Occurrence Indicator,Malignant Neoplasm of Lung - Multiple Primary Sites,0
25154,Pharmaceutical Preparations,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25155,Operation excision,Malignant melanoma of eyelid,0
25156,80%,Malignant Neoplasm of Lung - Multiple Primary Sites,0
25157,Fetal Tissue,Uterine Cancer,0
25158,Physical shape,Metastatic Malignant Neoplasm in the Sellar Region,0
25159,CDISC ADAS-Cog - Commands Summary Score,Vaginal Adenoid Cystic Carcinoma,0
25160,Inspiration function,Type II Endometrial Adenocarcinoma,0
25161,Sometimes,Thyroid Hurthle Cell Carcinoma,0
25162,Forecast of outcome,Peripheral primitive neuroectodermal tumor of soft tissue,0
25163,At risk of disease,Type II Endometrial Adenocarcinoma,0
25164,Thyroid cancer,Kaposi's sarcoma of extrahepatic bile duct,0
25165,Removed,Benign Anal Granular Cell Tumor,0
25166,Affect (mental function),Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
25167,Lymphoid Tissue,Malignant melanoma of eyelid,0
25168,Known,Cartilaginous exostosis,0
25169,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Stage III Cutaneous Melanoma AJCC v6,0
25170,Pain NOS,FIGO Stage IVA Ovarian Cancer,0
25171,*Type - Kind of quantity,Breast Apocrine Adenoma,0
25172,Fever,Breast Ductal Adenoma,0
25173,Domain (area of knowledge),Transitional cell carcinoma,0
25174,Secondary Neoplasm,Uterine Cancer,0
25175,2+,Xeroderma pigmentosum,0
25176,How Much Distress Shortness of Breath,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25177,High Risk Acute Leukemia,Microcystic meningioma,0
25178,Weight decreased,Ovarian Carcinoid Tumor,0
25179,Including (qualifier),Epithelioid Sarcoma NCI Grade 3,0
25180,peripheral blood,Ovarian germ cell choriocarcinoma stage IV,0
25181,Surgical aspects,Type II Endometrial Adenocarcinoma,0
25182,Rating (action),Contact dermatitis due to alkali,0
25183,lymph nodes,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25184,High risk,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25185,treatment - ActInformationManagementReason,Cancer of Urinary Tract,0
25186,Fresh Water,Endometrial Small Cell Carcinoma,0
25187,Percent normal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
25188,International Classification of Diseases for Oncology,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25189,Type of device,Tubal Hyperplasia,0
25190,Two,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25191,growth aspects,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25192,Pleomorphism (morphologic abnormality),Refractory Bladder Carcinoma,0
25193,Accumulation,Benign tumor of eyelid,0
25194,Contain (action),Maxillary Sinus Adenocarcinoma,0
25195,Common Specifications in HL7 V3 Publishing,Cervical Fibroepithelial Polyp,0
25196,Overall Publication Type,benign mature teratoma of pancreas,0
25197,Nicotiana,Breast Ductal Adenoma,0
25198,Circulating,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25199,diagnosis aspect,Vaginal Adenoid Cystic Carcinoma,0
25200,Established,Benign Anal Granular Cell Tumor,0
25201,Regular,Giant cell angiofibroma,0
25202,Treatment Epoch,Stage IB Pancreatic Cancer AJCC v8,0
25203,Organ,Airway Hemangioma,0
25204,Infrequent,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
25205,Removed,Leiomyoma of Gallbladder,0
25206,Skin lesion,Carcinomatosis of peritoneal cavity,0
25207,Empty (qualifier),Uterine Cancer,0
25208,Array Feature,FIGO Stage IVA Ovarian Cancer,0
25209,Usual Severity Weight Loss,Cervical Adenomyoma,0
25210,Term Birth,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25211,Precision - second,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25212,Diagnosis,Recurrent Primary Lymphoma of Bone,0
25213,Remetinostat,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
25214,Keratoderma,Testicular cancer metastatic,0
25215,HLA Complex,Leiomyoma of Gallbladder,0
25216,Reduction procedure,Pancreatic Intraepithelial Neoplasia-3,0
25217,Supernumerary,Digestive System Hodgkin Lymphoma,0
25218,various allergen extracts,Stage I Colon Neuroendocrine Tumor AJCC v8,0
25219,Neoplasms,Malignant melanoma of eyelid,0
25220,Disease,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25221,Fatigue,Malignant neoplasm of subglottis,0
25222,Removed,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25223,Trial Screening,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25224,10%,Atypical Mesothelial Hyperplasia,0
25225,Name,Intraepithelial Melanocytic Hyperplasia,0
25226,Occurrence Indicator,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25227,Beginning,Bladder adenocarcinoma stage IV,0
25228,high - ActExposureLevelCode,Neoplasms,0
25229,Pelvis,Recurrent Diffuse Intrinsic Pontine Glioma,0
25230,100%,Mucinous neoplasm,0
25231,Male population group,Malignant Testicular Sertoli Cell Tumor,0
25232,Body tissue,Xeroderma pigmentosum,0
25233,Tissue Specimen Code,Grade 3a Malignant Neoplasm,0
25234,Post Device,Pancreatic Intraepithelial Neoplasia-3,0
25235,Specimen Type - Macrophages,Acantholytic squamous cell carcinoma,0
25236,Merkel cell carcinoma,Recurrent Uveal Melanoma,0
25237,Cell (compartment),Benign Carotid Body Paraganglioma,0
25238,Specialized Stand Alone Plan - Vision,papillary carcinoma of penis,0
25239,Cancer Genus,Diffuse malignant mesothelioma,0
25240,biopsy characteristics,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25241,More,Benign squamous cell tumor,0
25242,Aggressive behavior,Kaposi's sarcoma of extrahepatic bile duct,0
25243,Electromagnetic Radiation,Bladder adenocarcinoma stage IV,0
25244,Subject Risk,Cervical Squamous Intraepithelial Neoplasia,0
25245,Biologic Development,Hodgkin Disease,0
25246,Specimen Source Codes - Respiratory,Leiomyoma of Gallbladder,0
25247,symbol - solid dosage form,Benign squamous cell tumor,0
25248,Manufactured form,Stage IV Colorectal Cancer AJCC v8,0
25249,Malignant - descriptor,Advanced Uterine Corpus Carcinosarcoma,0
25250,Beginning,Intestinal Metaplasia of Bladder Urothelium,0
25251,Surface,Acute Undifferentiated Leukemia,0
25252,How Often Felt Normal question,Thymic Clear Cell Carcinoma,0
25253,Infrequent,Cancer of Urinary Tract,0
25254,Primitive Streak,Mixed astrocytoma-ependymoma,0
25255,pharmacotherapeutic,Parathyroid Gland Adenocarcinoma,0
25256,Hyperviscosity syndrome,Adrenal Rest Tumor,0
25257,Tumor Mass,Acinar cell carcinoma of pancreas,0
25258,Occurrence Indicator,Ichthyosis,0
25259,Disseminated Malignant Neoplasm,Papillary cystic tumor,0
25260,Capillary Leak Syndrome,Anaplastic large cell lymphoma,0
25261,Preventive monitoring,Malignant neoplasm of olfactory nerve,0
25262,Immunotherapy,Malignant Testicular Sertoli Cell Tumor,0
25263,Asians,Familial Hemophagocytic Lymphocytosis,0
25264,white blood cell type,BRCA2 Syndrome,0
25265,Hematopoietic stem cells,Melanomatosis,0
25266,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
25267,Spreading (qualifier value),Neonatal leukemia,0
25268,Time (foundation metadata concept),Recurrent Uveal Melanoma,0
25269,NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology,Undifferentiated Endocervical Sarcoma,0
25270,Oncologists,Stage IB Lung Cancer AJCC v7,0
25271,Hematopoietic Neoplasms,Rhabdomyosarcoma with ganglionic differentiation,0
25272,Common Specifications in HL7 V3 Publishing,Papillary squamous cell carcinoma,0
25273,Toilet seat,Hereditary corneal dystrophy,0
25274,Cone-Rod Dystrophy 2,Recurrent Testicular Lymphoma,0
25275,Duct (organ) structure,Malignant Testicular Sertoli Cell Tumor,0
25276,Process,Vaginal Adenoid Cystic Carcinoma,0
25277,Ultrasonic Shockwave,FIGO Stage IVA Ovarian Cancer,0
25278,Epidermis,Malignant melanoma of eyelid,0
25279,Person Name,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25280,Disruptive,Type II Endometrial Adenocarcinoma,0
25281,American College of Cardiology/American Heart Association Lesion Complexity Score C,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25282,1+ Score,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
25283,Feel Tired question,Bladder squamous cell carcinoma stage I,0
25284,Orbit (brand of fungicide),benign mature teratoma of pancreas,0
25285,Pelvic Pain,Cerebral hemangioma,0
25286,per year,Carcinoma of urinary bladder,0
25287,Before,Malignant neoplasm of thalamus,0
25288,1+ Score,Gallbladder Adenocarcinoma,0
25289,Help document,Epithelioid Sarcoma NCI Grade 3,0
25290,Interventional procedure,Stage IV Childhood Non-Hodgkin Lymphoma,0
25291,Tryptophanase,Plexosarcoma,0
25292,Thinking,Gallbladder adenoma,0
25293,Clinical Trials,Localized Askin Tumor,0
25294,Including (qualifier),Advanced Uterine Corpus Carcinosarcoma,0
25295,Prognosis:Find:Pt:^Patient:Nom,Transitional cell carcinoma,0
25296,To,Lung squamous cell carcinoma stage I,0
25297,Human body structure,Acute Undifferentiated Leukemia,0
25298,Experimental Result,Childhood Cerebellar Neoplasm,0
25299,Second Suffix,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25300,CEL gene,Malignant melanoma of eyelid,0
25301,How Much Distress Weight Loss,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
25302,NIN gene,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25303,Neoplasms,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25304,combination of objects,Refractory Ependymoma,0
25305,shared attribute,Acantholytic squamous cell carcinoma,0
25306,Gram per Deciliter,non-Hodgkin's lymphoma of spleen,0
25307,Area,Mucinous adenocarcinoma,0
25308,shared attribute,Stage IB Pancreatic Cancer AJCC v8,0
25309,Knowledge,Recurrent Rhabdomyosarcoma,0
25310,Treating,Hereditary Diffuse Gastric Adenocarcinoma,0
25311,Symptoms,Benign squamous cell tumor,0
25312,Treatment Epoch,Thymic Clear Cell Carcinoma,0
25313,Major <insect>,Leptomeningeal sarcoma,0
25314,Malignant neoplasm of thymus,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25315,Gallbladder Carcinoma,Angiosarcoma of liver,0
25316,Always (frequency),High Grade Glandular Intraepithelial Neoplasia,0
25317,Tissue Specimen Code,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
25318,development aspects,Mastocytosis,0
25319,IPSS Risk Category Low,Malignant Testicular Sertoli Cell Tumor,0
25320,Divide,FIGO Stage II Ovarian Cancer,0
25321,Certainties,Grade 3a Malignant Neoplasm,0
25322,Mechanism (attribute),Plexosarcoma,0
25323,Histogenic Process,Acinar cell carcinoma of pancreas,0
25324,Science of Morphology,Childhood Extragonadal Malignant Germ Cell Tumor,0
25325,Visual Analog Scale,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25326,Surgical aspects,Clonal Hematopoiesis of Indeterminate Potential,0
25327,Vagina,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
25328,Used by,Lipoma of small intestine,0
25329,Dust,Adult Fibrolamellar Carcinoma,0
25330,Symptoms aspect,ALK positive large B-cell lymphoma,0
25331,Bladder Continence Question,Localized Malignant Neoplasm,0
25332,Togo,Childhood Cerebellar Neoplasm,0
25333,Abnormal Reference Range,Basal Cell Ameloblastoma,0
25334,Referring,Ovarian germ cell choriocarcinoma stage IV,0
25335,*Relative,Unresectable Rhabdomyosarcoma,0
25336,Chemotherapy Regimen,Digestive System Hodgkin Lymphoma,0
25337,Physical findings,Lipoma of small intestine,0
25338,month,Cervical Fibroepithelial Polyp,0
25339,Feelings,Diffuse malignant mesothelioma,0
25340,Microscopes,Mucinous adenocarcinoma gastric,0
25341,structure,Advanced Lung Carcinoma,0
25342,Known,Malignant Testicular Sertoli Cell Tumor,0
25343,Symptom severity level,Intraepithelial Melanocytic Hyperplasia,0
25344,Personal appearance,Lipoma of small intestine,0
25345,Occurrence Indicator,Stage III Adult Immunoblastic Lymphoma,0
25346,low exposure,Locally Advanced Epithelioid Hemangioendothelioma,0
25347,Adult,Liver Cavernous Hemangioma,0
25348,Either,Neonatal leukemia,0
25349,Cessation of life,Cancer of Urinary Tract,0
25350,Including (qualifier),Thymic Clear Cell Carcinoma,0
25351,Hereditary Diseases,Benign squamous cell tumor,0
25352,Skeletal bone,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25353,Occurrence Indicator,Intraepithelial Melanocytic Hyperplasia,0
25354,Anatomic Site,Unicystic ameloblastoma,0
25355,Malignant Neoplasms,Malignant neoplasm of subglottis,0
25356,Smear - instruction imperative,Airway Hemangioma,0
25357,GUCY2C protein,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
25358,More,Stage III Cutaneous Melanoma AJCC v6,0
25359,Life Threatening,Acantholytic squamous cell carcinoma,0
25360,Role,Childhood Thyroid Gland Follicular Carcinoma,0
25361,Obese build,Mucinous cystadenofibroma,0
25362,Primary malignant neoplasm of endometrium,Cancer of Urinary Tract,0
25363,Polypeptide Hormones,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
25364,During,Diffuse malignant mesothelioma,0
25365,BRCA2 gene,Squamous cell carcinoma of lip,0
25366,Vomiting,Mastocytosis,0
25367,To,Blepharal carcinoma,0
25368,Back structure,Malignant neoplasm of subglottis,0
25369,Skin Pigmentation,Childhood Fibrillary Astrocytoma,0
25370,More common in women,Colorectal Neuroendocrine Tumor G2,0
25371,Classification,Adult Alveolar Soft Part Sarcoma,0
25372,Sex Behavior,Mucinous adenocarcinoma gastric,0
25373,Retinoic Acid Response Element,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
25374,Characteristics,Maxillary Sinus Adenocarcinoma,0
25375,majority,FIGO Stage II Ovarian Cancer,0
25376,How Much Distress Pain,Childhood Central Nervous System Ganglioneuroblastoma,0
25377,Cover - action,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25378,pharmacotherapeutic,Carcinoma,0
25379,Cardiomyopathy,Hereditary corneal dystrophy,0
25380,Agent,Unfavorable Non-Hodgkin Lymphoma,0
25381,Hematopoietic stem cells,FIGO Stage II Ovarian Cancer,0
25382,Treating,Placental aromatase deficiency,0
25383,Diagnosis Study,Heavy Chain Deposition Disease,0
25384,research,adenoid cystic carcinoma of lung,0
25385,shared attribute,Adult Alveolar Soft Part Sarcoma,0
25386,Oral region,Non-Metastatic Gestational Trophoblastic Tumor,0
25387,Referring,Childhood Fibrillary Astrocytoma,0
25388,Symptoms,Precursor B-lymphoblastic lymphoma stage II,0
25389,Artificial Airways,Fibroadenoma of breast,0
25390,Make - Instruction Imperative,Heavy Chain Deposition Disease,0
25391,Support,Refractory Ependymoma,0
25392,Symptoms aspect,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
25393,Offspring,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25394,Mutation Abnormality,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25395,Emotions,Chest Wall Fibromatosis,0
25396,Include (action),Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
25397,Treatment Epoch,Pancreatic Endocrine Carcinoma,0
25398,Natural History,Cervical Fibroepithelial Polyp,0
25399,Skeletal muscle structure,Acute lymphadenitis,0
25400,Ichthyoses,Benign squamous cell tumor,0
25401,Slight (qualifier value),Stage IB Pancreatic Cancer AJCC v8,0
25402,Malignant epithelioma,Unfavorable Non-Hodgkin Lymphoma,0
25403,Change -- procedure,Locally Advanced Squamous Cell Carcinoma,0
25404,Cancer Genus,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25405,Occurrence Indicator,Platinum-Resistant Lung Small Cell Carcinoma,0
25406,Skin Specimen,Familial Adenomatous Polyposis Associated Medulloblastoma,0
25407,Suspected qualifier,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25408,bony process,Splenic Manifestation of Hairy Cell Leukemia,0
25409,Filter (function),Medulloblastoma,0
25410,biopsy characteristics,Tumorlet,0
25411,Weight decreased,Cartilaginous exostosis,0
25412,Surgical patch,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25413,Abnormal cell,Stage IB Lung Cancer AJCC v7,0
25414,Analysis of substances,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25415,Average of Value Derivation Technique,Intestinal Metaplasia of Bladder Urothelium,0
25416,Neoplasms,Mixed astrocytoma-ependymoma,0
25417,Pigment cell,Localized Ewing Sarcoma,0
25418,Spreading (qualifier value),Cystadenocarcinoma,0
25419,control substance,Colorectal Neuroendocrine Tumor G2,0
25420,Childhood Hodgkin Lymphoma,Acantholytic squamous cell carcinoma,0
25421,teratologic,Brain Ependymoma,0
25422,Concept History,Cervical Adenomyoma,0
25423,High risk of,BRCA2 Syndrome,0
25424,Stomach,Metastatic Carcinoma in the Lung,0
25425,Sahara,Endometrial Small Cell Carcinoma,0
25426,Aggressive course,Cystadenocarcinoma,0
25427,Firstly,Breast Ductal Adenoma,0
25428,Epidermis,Basal Cell Ameloblastoma,0
25429,Symptoms aspect,adenosquamous carcinoma of breast,0
25430,Elevated,Engraftment syndrome,0
25431,Sex Cord-Stromal Tumor,Colorectal Neuroendocrine Tumor G2,0
25432,Areas <moth>,Recurrent Testicular Lymphoma,0
25433,Logical Condition,non-Hodgkin's lymphoma of spleen,0
25434,Publications,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25435,Categories,Testicular cancer metastatic,0
25436,How Often Shortness of Breath,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25437,Account number:Identifier:Point in time:^Patient:Nominal,Adult Brain Stem Mixed Glioma,0
25438,Neuroendocrine Tumors,Mucinous adenocarcinoma gastric,0
25439,Administration procedure,Adult Acute Eosinophilic Leukemia,0
25440,Carcinoid Tumor,Collecting Duct Carcinoma of the Kidney,0
25441,Patient need for (contextual qualifier),Localized Askin Tumor,0
25442,diagnosis aspect,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25443,Thymus <angiosperm>,Contact dermatitis due to alkali,0
25444,Present,Splenic Manifestation of Hairy Cell Leukemia,0
25445,Solid Dose Form,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25446,Histology Procedure,Neonatal leukemia,0
25447,Philadelphia Chromosome,Advanced Lung Carcinoma,0
25448,Base - General Qualifier,BRCA2 Syndrome,0
25449,Bayer Corneal Epitheliopathy Grade 3,Endometrial Small Cell Carcinoma,0
25450,Childhood Diffuse Large B-Cell Lymphoma,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25451,respiratory,Mucinous adenocarcinoma gastric,0
25452,Localized,Cancer of Urinary Tract,0
25453,chance,Intestinal Metaplasia of Bladder Urothelium,0
25454,Ancestry-Informative Marker,Stage III Cutaneous Melanoma AJCC v6,0
25455,Precursor Cell Lymphoblastic Leukemia Lymphoma,Squamous cell carcinoma of lip,0
25456,Oropharyngeal,Malignant melanoma of eyelid,0
25457,application of research,Mixed parotid tumor,0
25458,Metastasis,Ovarian germ cell choriocarcinoma stage IV,0
25459,Slow,embryonal rhabdomyosarcoma of prostate,0
25460,Adult Medulloblastoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25461,Known,Leptomeningeal sarcoma,0
25462,Decision,Benign tumor of eyelid,0
25463,Common Specifications in HL7 V3 Publishing,Hodgkin lymphoma,0
25464,Homo sapiens,Vaginal Adenoid Cystic Carcinoma,0
25465,Age of Onset,Benign Anal Granular Cell Tumor,0
25466,Most,Benign Anal Granular Cell Tumor,0
25467,Breast Carcinoma,Pancreatic Intraepithelial Neoplasia-3,0
25468,Early,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25469,Arising,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
25470,Case (situation),Breast Ductal Adenoma,0
25471,Episodic,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25472,Usually Need Help from Another Person for Arising,Small cell neuroendocrine carcinoma of bladder,0
25473,Congenital melanocytic nevus,Contact dermatitis due to alkali,0
25474,Therapeutic procedure,Localized Ewing Sarcoma,0
25475,Pediculus (eukaryote),Malignant Neoplasm with Regional Lymph Node Involvement,0
25476,Malignant neoplasm of ovary,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
25477,Exertion,Serous cystadenocarcinoma ovary,0
25478,Net (qualifier),Stage IV Childhood Non-Hodgkin Lymphoma,0
25479,Subject Risk,Locally Advanced Carcinoma,0
25480,Males,Brain Tumor,0
25481,Current (present time),Childhood Lung Non-Small Cell Carcinoma,0
25482,Derivation,Kaposi's sarcoma of extrahepatic bile duct,0
25483,Spreading (qualifier value),Benign tumor of eyelid,0
25484,Medulla Oblongata,Nasal cavity carcinoma,0
25485,Replacement - supply,Bladder adenocarcinoma stage IV,0
25486,Arsenic measurement,Stage IB Pancreatic Cancer AJCC v8,0
25487,Neuromuscular,Extracranial Neuroblastoma,0
25488,Human papillomavirus typing (procedure),Female Breast Carcinoma,0
25489,Binding action,Precursor B-lymphoblastic lymphoma stage II,0
25490,SLC5A5 protein,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
25491,depend,Transitional cell carcinoma,0
25492,Condition,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25493,DNA index 2,Bladder squamous cell carcinoma stage I,0
25494,Internal,Collecting Duct Carcinoma of the Kidney,0
25495,Relationships,Peripheral primitive neuroectodermal tumor of soft tissue,0
25496,Common Cold,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25497,Ulceration,Mixed astrocytoma-ependymoma,0
25498,Including (qualifier),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25499,chapter,Contact dermatitis due to alkali,0
25500,Relationships,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25501,Usually,Bladder Neuroendocrine Neoplasm,0
25502,Macrophage count,Thymic Clear Cell Carcinoma,0
25503,How Often Nausea,embryonal rhabdomyosarcoma of prostate,0
25504,Feature,FIGO Stage II Ovarian Cancer,0
25505,Slight (qualifier value),Occult Lung Adenosquamous Carcinoma,0
25506,Obesity,Stage IB Pancreatic Cancer AJCC v8,0
25507,Milliampere second,Malignant Testicular Sertoli Cell Tumor,0
25508,treatment - ActInformationManagementReason,Xeroderma pigmentosum,0
25509,Surrounding (qualifier value),Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
25510,Togo,Larynx carcinoma recurrent,0
25511,Operative Surgical Procedures,Botryoid-Type Embryonal Rhabdomyosarcoma,0
25512,Head and neck structure,Mucinous cystadenofibroma,0
25513,Taxonomic,Malignant Testicular Sertoli Cell Tumor,0
25514,Pruritus,Peripheral primitive neuroectodermal tumor of soft tissue,0
25515,Blood,Atypical Mesothelial Hyperplasia,0
25516,Internal,Hodgkin Disease,0
25517,Case unit dose,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25518,Certainties,Engraftment syndrome,0
25519,Visible,Tonsillar Carcinoma,0
25520,Tryptophanase,Diffuse malignant mesothelioma,0
25521,Specimen Source Codes - tumor,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,0
25522,Label (document),Pancreatic Intraepithelial Neoplasia-3,0
25523,Peeling of skin,Thymic Atypical Carcinoid Tumor,0
25524,Ulcer,Malignant neoplasm of thalamus,0
25525,Divide,Benign neoplasm of thorax,0
25526,Malignant neoplasm of brain,FIGO Stage II Ovarian Cancer,0
25527,Fever,Ampulla of Vater Tubular Adenoma,0
25528,Used by,Malignant melanoma of eyelid,0
25529,Sharing (Social Behavior),clear cell adenocarcinoma of gallbladder,0
25530,New,Digestive System Hodgkin Lymphoma,0
25531,combination of objects,Acantholytic squamous cell carcinoma,0
25532,One,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25533,Medical History,Acute Undifferentiated Leukemia,0
25534,Chemotherapy,Metaplastic carcinoma of breast,0
25535,Discover,Anterior Urethral Malignant Neoplasm,0
25536,Skin,Pancreatic Intraepithelial Neoplasia-3,0
25537,Site,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25538,Human gene,squamous cell carcinoma of the thyroid gland,0
25539,Abnormally high,Stage I Adult Non-Hodgkin Lymphoma,0
25540,How Often Felt Normal question,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25541,Similarity,Stage III Cutaneous Melanoma AJCC v6,0
25542,DNA,Endometrial Small Cell Carcinoma,0
25543,Optical filter,Benign neoplasm of thorax,0
25544,Have Itch,Acantholytic squamous cell carcinoma,0
25545,Ultrasonic Shockwave,Acantholytic squamous cell carcinoma,0
25546,1960s,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25547,Nervous system structure,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
25548,Decision,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25549,Tryptophanase,Adult Anaplastic Oligodendroglioma,0
25550,Anterior mediastinum,Childhood Central Nervous System Ganglioneuroblastoma,0
25551,Used by,Carcinoma of urinary bladder,0
25552,Exophytic,sarcoma of spinal cord,0
25553,status - In progress,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25554,Providing (action),Adult Alveolar Soft Part Sarcoma,0
25555,shared attribute,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25556,Mucous body substance,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
25557,Human body,Carcinomatosis of peritoneal cavity,0
25558,Genetic Markers,Malignant melanoma of eyelid,0
25559,leukemia,Benign Carotid Body Paraganglioma,0
25560,Central African Republic,Colorectal High Grade B-Cell Lymphoma,0
25561,Telephone Extension Number,Unfavorable Non-Hodgkin Lymphoma,0
25562,Usual Severity Pain,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25563,Infiltration Route of Drug Administration,Refractory WHO Grade III Glioma,0
25564,High Level,Advanced Uterine Corpus Carcinosarcoma,0
25565,Mumps,Refractory Barrett Esophagus,0
25566,Urinary Diversion,Stage III Adult Immunoblastic Lymphoma,0
25567,Entity Determiner - specific,ROSE Cluster 3,0
25568,Epithelium,Type II Endometrial Adenocarcinoma,0
25569,Lower (action),Refractory Bladder Carcinoma,0
25570,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Recurrent Uveal Melanoma,0
25571,N not otherwise specified Antibody,Childhood Lymphoma,0
25572,Specimen Source Codes - tumor,Non-Metastatic Gestational Trophoblastic Tumor,0
25573,World,Unresectable Rhabdomyosarcoma,0
25574,Milliampere second,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25575,Risk,Anaplastic large cell lymphoma,0
25576,Result,FIGO Stage IVA Ovarian Cancer,0
25577,Approximate,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
25578,Hematologic Tests,Hereditary corneal dystrophy,0
25579,Negation,Childhood Lymphoma,0
25580,Tubular adenoma,Hereditary Diffuse Gastric Adenocarcinoma,0
25581,Low Mitosis-Karyorrhexis Index,Unresectable Rhabdomyosarcoma,0
25582,Changed status,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
25583,Stomach Diseases,Funisitis (disorder),0
25584,Adult human body,Thyroid Hurthle Cell Carcinoma,0
25585,Both ovaries,Breast Ductal Adenoma,0
25586,Manufactured form,Basal Cell Ameloblastoma,0
25587,30%,Spermatocytic seminoma,0
25588,Telephone Extension Number,Intraepithelial Melanocytic Hyperplasia,0
25589,Relationships,Benign Anal Granular Cell Tumor,0
25590,Chronic Lymphocytic Leukemia,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
25591,Rare,Squamous cell carcinoma of lip,0
25592,Increase,Vaginal Adenoid Cystic Carcinoma,0
25593,Common Specifications in HL7 V3 Publishing,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25594,Psyche structure,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
25595,Good,Anaplastic large cell lymphoma,0
25596,Skin tag,Methotrexate-Associated Hodgkin Lymphoma,0
25597,Spleen,Thyroid Hurthle Cell Carcinoma,0
25598,Most,Malignant melanoma of eyelid,0
25599,2+,Pleomorphic adenoma of parotid gland,0
25600,Term (lexical),Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
25601,Cancer Genus,Adult Hepatocellular Carcinoma,0
25602,Feature,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
25603,Water,Melanomatosis,0
25604,Africa,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
25605,80%,Benign squamous cell tumor,0
25606,Treating,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25607,Term (lexical),Undifferentiated Endocervical Sarcoma,0
25608,Cutaneous Route of Drug Administration,Recurrent Uveal Melanoma,0
25609,Prostate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25610,Rare,Metastatic Malignant Neoplasm in the Sellar Region,0
25611,Derived value,Ovarian Carcinoid Tumor,0
25612,Papillary transitional cell neoplasm of low malignant potential,Malignant neoplasm of thalamus,0
25613,Anorexia,Diffuse malignant mesothelioma,0
25614,Distant,Malignant neoplasm of gallbladder,0
25615,Therapeutic procedure,FIGO Stage IVA Ovarian Cancer,0
25616,Avitaminosis,Metastatic Lung Neuroendocrine Neoplasm,0
25617,Imaging Techniques,Vaginal Adenoid Cystic Carcinoma,0
25618,Science of Etiology,FIGO Stage II Ovarian Cancer,0
25619,Occurrence,Refractory Ependymoma,0
25620,General surgery specialty,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25621,Screening procedure,Type II Endometrial Adenocarcinoma,0
25622,rituximab,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
25623,Reduced,Cervical Squamous Intraepithelial Neoplasia,0
25624,Very large,Recurrent Primary Lymphoma of Bone,0
25625,Childhood Non-Hodgkin Lymphoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25626,Females,Undifferentiated Neuroblastoma,0
25627,Contain (action),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25628,Pediatric,High Grade Glandular Intraepithelial Neoplasia,0
25629,General surgery specialty,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25630,Analysis,Female Breast Carcinoma,0
25631,Brain part,Adrenal Rest Tumor,0
25632,chronic,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25633,Manufactured sign,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25634,True primary (qualifier value),squamous cell carcinoma of the thyroid gland,0
25635,Reported Term,Placental aromatase deficiency,0
25636,Replaced by,Leiomyoma of Gallbladder,0
25637,Type A,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
25638,polyps,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25639,Posterior Spinal Artery Syndrome,Larynx carcinoma recurrent,0
25640,Vegetables,Bladder adenocarcinoma stage IV,0
25641,IPSS Risk Category High,Kaposi's sarcoma of skin,0
25642,Skin,Kaposi's sarcoma of extrahepatic bile duct,0
25643,Chemotherapy,Squamous cell carcinoma of lip,0
25644,Pleomorphic,Cerebral Primitive Neuroectodermal Tumor,0
25645,New,Basal Cell Ameloblastoma,0
25646,common types,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25647,100%,Stage IB Lung Cancer AJCC v7,0
25648,Result,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25649,To,Heavy Chain Deposition Disease,0
25650,Qualitative form,Pilocytic astrocytoma of cerebellum,0
25651,<3 (qualifier value),Cancer of Urinary Tract,0
25652,N+ (tumor staging),Stage I Gastric Neuroendocrine Tumor AJCC v8,0
25653,Michigan alcoholism screening test,Liver Cavernous Hemangioma,0
25654,Sacrococcygeal teratoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25655,A1CF wt Allele,adenosquamous carcinoma of breast,0
25656,How Much Distress Itching,Malignant melanoma of eyelid,0
25657,stage,Benign neoplasm of thorax,0
25658,Concept model range (foundation metadata concept),Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
25659,Dysuria,Diffuse malignant mesothelioma,0
25660,Drop measurement,Benign squamous cell tumor,0
25661,Science of Statistics,FIGO Stage II Ovarian Cancer,0
25662,Progress,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25663,Characteristics,Engraftment syndrome,0
25664,Separate,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
25665,Smoking,Lung squamous cell carcinoma stage I,0
25666,Mediate,Malignant Testicular Sertoli Cell Tumor,0
25667,Disease,Refractory Barrett Esophagus,0
25668,Ascites,Tonsillar Carcinoma,0
25669,Lipomatosis,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
25670,Vascular,Childhood Extragonadal Malignant Germ Cell Tumor,0
25671,SLC6A2 protein,gliosarcoma,0
25672,Retinoic Acid Response Element,Blepharal carcinoma,0
25673,International Aspects,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25674,Persons,Congenital hamartoma,0
25675,Subtype (attribute),Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
25676,Drop measurement,Non-Metastatic Gestational Trophoblastic Tumor,0
25677,Cough Frequency,Intracortical osteosarcoma,0
25678,Used by,de novo Myelodysplastic Syndrome,0
25679,Child,Stage IB Lung Cancer AJCC v7,0
25680,Subgroup A Nepoviruses,Serous cystadenocarcinoma ovary,0
25681,Frequently,Stage III Cutaneous Melanoma AJCC v6,0
25682,ultrasound device,Stage IB Lung Cancer AJCC v7,0
25683,Anorexia,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25684,Common (qualifier value),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25685,Prophylactic behavior,Undifferentiated Endocervical Sarcoma,0
25686,Most,Clinical Stage I Cutaneous Melanoma AJCC v8,0
25687,Abnormal,Benign Anal Granular Cell Tumor,0
25688,Human body,Non-Metastatic Gestational Trophoblastic Tumor,0
25689,Cell Count,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25690,trauma qualifier,Kaposi's sarcoma of extrahepatic bile duct,0
25691,combination of objects,Adult Hepatocellular Carcinoma,0
25692,Flattened,Malignant neoplasm of subglottis,0
25693,Combined,Non-Metastatic Gestational Trophoblastic Tumor,0
25694,Sufficiently defined concept definition status (core metadata concept),Medulloblastoma,0
25695,Completely - dosing instruction fragment,Breast Ductal Adenoma,0
25696,Skeletal,Leptomeningeal sarcoma,0
25697,History of present illness,Malignant neoplasm of subglottis,0
25698,Weight decreased,Pancreatic Intraepithelial Neoplasia-3,0
25699,Abnormal cell,Anaplastic large cell lymphoma,0
25700,Abdomen+,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
25701,Rare Diseases,Noninfiltrating Intraductal Carcinoma,0
25702,Aggressive behavior,Breast Ductal Adenoma,0
25703,Case (situation),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25704,Skin,High Grade Glandular Intraepithelial Neoplasia,0
25705,treatment - ActInformationManagementReason,Breast Ductal Adenoma,0
25706,Secondary Neoplasm,Benign Anal Granular Cell Tumor,0
25707,Age of Onset,Astrocytoma of brain,0
25708,Therapeutic procedure,Mucinous adenocarcinoma,0
25709,Age,Malignant neoplasm of gallbladder,0
25710,CDISC SEND Tumor Findings Results Terminology,Diffuse malignant mesothelioma,0
25711,Early stage,Unicystic ameloblastoma,0
25712,Tumor Mass,Liver Lymphangioma,0
25713,Call (Instruction),Intraocular Malignant Peripheral Nerve Sheath Tumor,0
25714,Pleural effusion fluid,Lipoma of small intestine,0
25715,Retinoic Acid Response Element,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25716,Malignant Neoplasms,Rhabdomyosarcoma with ganglionic differentiation,0
25717,Sequence of Planned Assessment Schedule,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25718,Including (qualifier),Ovarian germ cell choriocarcinoma stage IV,0
25719,Simple,Periosteal Osteosarcoma,0
25720,pharmacotherapeutic,Type II Endometrial Adenocarcinoma,0
25721,59,Heavy Chain Deposition Disease,0
25722,Duplicate,Bladder adenocarcinoma stage IV,0
25723,High Level,Grade 3a Malignant Neoplasm,0
25724,Autoimmune Diseases,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25725,Procedure (set of actions),Malignant neoplasm of subglottis,0
25726,Leads (device),Diffuse malignant mesothelioma,0
25727,Iodides,ICHTHYOSIS,0
25728,Scalp structure,Splenic Manifestation of Hairy Cell Leukemia,0
25729,Chromosomes,Melanomatosis,0
25730,Lung,Cerebral Primitive Neuroectodermal Tumor,0
25731,Common (qualifier value),Heavy Chain Deposition Disease,0
25732,IMPA1 gene,Plexosarcoma,0
25733,contagion,FIGO Stage II Ovarian Cancer,0
25734,Affect (mental function),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25735,Lymphoma,Acute Undifferentiated Leukemia,0
25736,Immune system,Chest Wall Fibromatosis,0
25737,immunoglobulin complex location,Angiosarcoma of liver,0
25738,Breast,Testicular cancer metastatic,0
25739,Clear cell carcinoma of lung,FIGO Stage II Ovarian Cancer,0
25740,Togo,Kaposi's sarcoma of skin,0
25741,Thrombocythemia,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
25742,Treatment Epoch,Cerebral Primitive Neuroectodermal Tumor,0
25743,PSA Level Less than Five,Extra-Adrenal Paraganglioma,0
25744,Rare,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25745,Antibiotic Resistance,Bladder Neuroendocrine Neoplasm,0
25746,To,mucinous adenocarcinoma of gallbladder,0
25747,Smaller,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25748,Pancreas,Intraepithelial Melanocytic Hyperplasia,0
25749,Treating,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
25750,Blue - answer to question,Human Papillomavirus-Related Carcinoma,0
25751,Mechanism Component of Device,Cervical Adenomyoma,0
25752,Bone Pain,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
25753,Stem of plant,Xeroderma pigmentosum,0
25754,Cancer Genus,Acute Undifferentiated Leukemia,0
25755,Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25756,Taxonomic,Placental aromatase deficiency,0
25757,Linear,Human Papillomavirus-Related Carcinoma,0
25758,Reaching,Glomeruloid hemangioma,0
25759,Characteristics,Malignant Testicular Sertoli Cell Tumor,0
25760,Jaw,Stage IV Colorectal Cancer AJCC v8,0
25761,Obese build,Melanomatosis,0
25762,Following,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25763,Loss of appetite (finding),Mixed astrocytoma-ependymoma,0
25764,CDISC SEND Tumor Findings Results Terminology,Malignant Neoplasm of Lung - Multiple Primary Sites,0
25765,Palm thickening,Pleomorphic adenoma of parotid gland,0
25766,Life Expectancy Less than Twenty Years,Locally Advanced Squamous Cell Carcinoma,0
25767,Negation,Engraftment syndrome,0
25768,Person Observer,Liver Lymphangioma,0
25769,Including (qualifier),Angiosarcoma of liver,0
25770,How Much Distress Itching,Secondary malignant neoplasm of lymph node,0
25771,Beginning,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
25772,Diagnosis Study,Thymic Atypical Carcinoid Tumor,0
25773,Absence (morphologic abnormality),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25774,What subject filter - Result,Locally Advanced Squamous Cell Carcinoma,0
25775,True primary (qualifier value),Extra-abdominal fibromatosis,0
25776,Clone,Peripheral primitive neuroectodermal tumor of soft tissue,0
25777,Assisted (qualifier value),Kaposi's sarcoma of extrahepatic bile duct,0
25778,Did not receive therapy or drug for,benign mature teratoma of pancreas,0
25779,site-specific telomere resolvase activity,Angiosarcoma of liver,0
25780,Pain,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25781,Image Feature,FIGO Stage II Ovarian Cancer,0
25782,Poverty,Carcinoma ex pleomorphic adenoma of parotid gland,0
25783,Lymphoma,Gallbladder Adenocarcinoma,0
25784,Condition:Find:Pt:^Patient:Nom,Adult Alveolar Soft Part Sarcoma,0
25785,Grouped (qualifier value),Hodgkin Disease,0
25786,Oral region,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25787,Common Specifications in HL7 V3 Publishing,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25788,Proteins,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25789,Adult human body,Malignant melanoma of eyelid,0
25790,fluid - substance,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
25791,Chronic inflammation,Cartilaginous exostosis,0
25792,Breast,Gallbladder Adenocarcinoma,0
25793,shared attribute,squamous cell carcinoma of the thyroid gland,0
25794,Stroma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25795,Risk,Carcinomatosis of peritoneal cavity,0
25796,Mass of body region,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
25797,Class (taxonomic),Stage III Adult Immunoblastic Lymphoma,0
25798,Lumpectomy of breast,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
25799,Qualitative form,Multiple Skull Base Meningiomas,0
25800,Surgery specialty,Adult Alveolar Soft Part Sarcoma,0
25801,Bothered by Nausea,Undifferentiated Endocervical Sarcoma,0
25802,Encounter,Benign tumor of eyelid,0
25803,Historical - DataType,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25804,Type A,Stage II Hepatocellular Carcinoma AJCC v8,0
25805,Muscle Tissue,Stage IV Penile Cancer AJCC v7,0
25806,Derivation,Giant cell angiofibroma,0
25807,Therapeutic procedure,Diffuse malignant mesothelioma,0
25808,Common (qualifier value),Digestive System Hodgkin Lymphoma,0
25809,Always (frequency),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
25810,Block (unit of presentation),Human Papillomavirus-Related Carcinoma,0
25811,common types,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25812,Increased erythropoietin,Diffuse malignant mesothelioma,0
25813,per year,Pleomorphic adenoma of parotid gland,0
25814,Treating,Kaposi's sarcoma of extrahepatic bile duct,0
25815,Goiter,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
25816,Walls of a building,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
25817,Feature,Stage III Cutaneous Melanoma AJCC v6,0
25818,Usual Severity Shortness of Breath,Advanced Uterine Corpus Carcinosarcoma,0
25819,Subject Risk,Occult Lung Adenosquamous Carcinoma,0
25820,Bothered by Night Sweats,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25821,Multiple Endocrine Neoplasia,Benign Anal Granular Cell Tumor,0
25822,Value Above Reference Range,Giant cell angiofibroma,0
25823,Mass of body structure,Cerebral hemangioma,0
25824,Including (qualifier),Noninfiltrating Intraductal Carcinoma,0
25825,Malignant Neoplasms,Grade 3a Malignant Neoplasm,0
25826,Poor - qualifier,Mixed astrocytoma-ependymoma,0
25827,Genus Cygnus,Bladder adenocarcinoma stage IV,0
25828,85,Medulloblastoma,0
25829,Nature,papillary carcinoma of penis,0
25830,Endometrium,malignant lymphoma of pancreatic lymph nodes,0
25831,Bone pain,Peripheral primitive neuroectodermal tumor of soft tissue,0
25832,Cartilage,Childhood Fibrillary Astrocytoma,0
25833,Confirmed by,benign mature teratoma of pancreas,0
25834,Most,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25835,During,Adult Acute Eosinophilic Leukemia,0
25836,Advance -- medical device,Pilocytic astrocytoma of cerebellum,0
25837,Removed,Mucinous cystadenofibroma,0
25838,Platelets,Type II Endometrial Adenocarcinoma,0
25839,Often - answer to question,Tongue Alveolar Soft Part Sarcoma,0
25840,Subglottis structure,Type II Endometrial Adenocarcinoma,0
25841,Site of,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25842,Tumor Mass,Stage 0 Penile Cancer AJCC v8,0
25843,Ascites,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
25844,control aspects,papillary carcinoma of penis,0
25845,Liver,Blepharal carcinoma,0
25846,Persons,Extra-Adrenal Paraganglioma,0
25847,Specimen Source Codes - tumor,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
25848,Qualitative form,Ampulla of Vater Tubular Adenoma,0
25849,therapeutic aspects,clear cell adenocarcinoma of gallbladder,0
25850,Thymus Neoplasms,Epithelioid Sarcoma NCI Grade 3,0
25851,liposarcoma,FIGO Stage II Ovarian Cancer,0
25852,Biomaterial Treatment,Brain Tumor,0
25853,Constant (qualifier),Uterine Cancer,0
25854,per second,Chronic Myelomonocytic Leukemia-2,0
25855,Frequently,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
25856,filter information process,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
25857,Physical findings,Malignant Neoplasm with Regional Lymph Node Involvement,0
25858,Childhood Non-Hodgkin Lymphoma,Heavy Chain Deposition Disease,0
25859,Cell Count,Childhood Anaplastic Large Cell Lymphoma,0
25860,Injury due to exposure to external cause,Benign Anal Granular Cell Tumor,0
25861,Science of Etiology,Maxillary Sinus Adenoid Cystic Carcinoma,0
25862,Pancreas,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25863,Hormonal,Pancreatic Intraepithelial Neoplasia-3,0
25864,Dorsal,Malignant neoplasm of olfactory nerve,0
25865,Vascular,Gallbladder adenoma,0
25866,Midline (qualifier value),Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
25867,Pancreatitis,Splenic Manifestation of Hairy Cell Leukemia,0
25868,therapeutic aspects,gliosarcoma,0
25869,Primary,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
25870,Usually,Adult Hepatocellular Carcinoma,0
25871,Source,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25872,Serum,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
25873,Skin,Thyroid Hurthle Cell Carcinoma,0
25874,Manufactured form,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
25875,Treatment Epoch,non-Hodgkin's lymphoma of spleen,0
25876,Unexplained weight loss,Childhood Central Nervous System Ganglioneuroblastoma,0
25877,Hodgkin Disease,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25878,Organ,Stage I Adult Non-Hodgkin Lymphoma,0
25879,Most,Diffuse malignant mesothelioma,0
25880,Genetic Risk,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
25881,fluid - substance,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
25882,Skin,Colorectal cancer,0
25883,Togo,Melanomatosis,0
25884,Ultrasonography,Vaginal Adenoid Cystic Carcinoma,0
25885,Object Class,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25886,Thought,Neonatal leukemia,0
25887,Tissue Specimen Code,Tonsillar Carcinoma,0
25888,Rattus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25889,Curative - procedure intent,Malignant Neoplasm of Lung - Multiple Primary Sites,0
25890,treatment - ActInformationManagementReason,Spongiotic dermatitis,0
25891,Pelvic Pain,Cancer of Urinary Tract,0
25892,Symptoms,Uterine Cancer,0
25893,Togo,Ovarian Dermoid Cyst with Secondary Carcinoma,0
25894,Including (qualifier),Localized Askin Tumor,0
25895,Human body structure,Recurrent Testicular Lymphoma,0
25896,Forecast of outcome,Brain Tumor,0
25897,Including (qualifier),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25898,Spinal Cord,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
25899,Endocrine system,malignant lymphoma of pancreatic lymph nodes,0
25900,Sarcoma,Childhood Lung Non-Small Cell Carcinoma,0
25901,Part of,Congenital hamartoma,0
25902,Concept History,Peripheral primitive neuroectodermal tumor of soft tissue,0
25903,Derivation,Mucinous adenocarcinoma gastric,0
25904,SLC6A2 protein,Uterine Cancer,0
25905,More,Lung Inflammatory Myofibroblastic Tumor,0
25906,Cessation of life,Periosteal Osteosarcoma,0
25907,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
25908,Brain,Contact dermatitis due to alkali,0
25909,include - SetOperator,Trabecular adenocarcinoma,0
25910,Lower - spatial qualifier,Gallbladder Adenocarcinoma,0
25911,Asbestos,Ovarian germ cell choriocarcinoma stage IV,0
25912,Myeloid neoplasm,Hodgkin lymphoma,0
25913,National origin,Endometrial Small Cell Carcinoma,0
25914,Lymphocyte,Spindle Cell Melanoma,0
25915,Prognosis:Find:Pt:^Patient:Nom,Chondrosarcoma,0
25916,Unmarried person,Adenocarcinoma,0
25917,Formation,Anterior Urethral Malignant Neoplasm,0
25918,Negation,Cervical Fibroepithelial Polyp,0
25919,treatment - ActInformationManagementReason,Refractory Bladder Carcinoma,0
25920,Poor - grade value,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
25921,per year,Breast Ductal Adenoma,0
25922,Formation,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
25923,Abnormal Reference Range,Stage I Colon Neuroendocrine Tumor AJCC v8,0
25924,Pharmacotherapy,Acute Undifferentiated Leukemia,0
25925,Respiratory tract structure,Intestinal Neuroendocrine Carcinoma,0
25926,Favorable,Hemangioma,0
25927,Ulcer,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
25928,Scientific Study,Childhood Central Nervous System Ganglioneuroblastoma,0
25929,analysis aspect,Vaginal Adenoid Cystic Carcinoma,0
25930,Reduced,Mucinous cystadenofibroma,0
25931,Chemotherapy,Spongiotic dermatitis,0
25932,Tumor cells,Childhood Central Nervous System Ganglioneuroblastoma,0
25933,Death (finding),GIANT PIGMENTED HAIRY NEVUS,0
25934,Skin lesion,Parathyroid Gland Adenocarcinoma,0
25935,white blood cell type,Recurrent Rhabdomyosarcoma,0
25936,Tumor type,Localized Malignant Neoplasm,0
25937,Cell Device,Locally Advanced Carcinoma,0
25938,Specimen Type - Macrophages,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
25939,North America,Refractory Ependymoma,0
25940,adaptive,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
25941,Papillomaviridae,Mucinous adenocarcinoma gastric,0
25942,Offspring,Benign neoplasm of thorax,0
25943,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Acute Undifferentiated Leukemia,0
25944,Microbial anatomical capsule structure,Endometrial Small Cell Carcinoma,0
25945,Motor Neuron and Pancreas Homeobox Protein 1,Bladder adenocarcinoma stage IV,0
25946,inflammatory,clear cell adenocarcinoma of gallbladder,0
25947,Cancer Genus,Vaginal Adenoid Cystic Carcinoma,0
25948,Cancer Other,Digestive System Hodgkin Lymphoma,0
25949,risk factors - observation list,Adult Anaplastic Oligodendroglioma,0
25950,combination - answer to question,Gallbladder Adenocarcinoma,0
25951,AS virus,embryonal rhabdomyosarcoma of prostate,0
25952,Localized,BRCA2 Syndrome,0
25953,Associated with,Childhood Thyroid Gland Follicular Carcinoma,0
25954,2+ Score,Heavy Chain Deposition Disease,0
25955,Small,FIGO Stage II Ovarian Cancer,0
25956,Usual Severity Weight Loss,Spongiotic dermatitis,0
25957,Including (qualifier),Acantholytic squamous cell carcinoma,0
25958,Stem cell transplant,Stage III Cutaneous Melanoma AJCC v6,0
25959,Abnormal increase in number,Cartilaginous exostosis,0
25960,Similarity,Chest Wall Fibromatosis,0
25961,Occurrence,Squamous cell carcinoma of lip,0
25962,Usual,Undifferentiated Endocervical Sarcoma,0
25963,Fever symptoms (finding),Heavy Chain Deposition Disease,0
25964,300,Ampulla of Vater Tubular Adenoma,0
25965,Negation,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
25966,treatment - ActInformationManagementReason,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25967,More,Noninfiltrating Intraductal Carcinoma,0
25968,Painful intercourse female,Thyroid Hurthle Cell Carcinoma,0
25969,Adult Lymphoma,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
25970,Therapeutic radiology procedure,Mucinous cystadenofibroma,0
25971,Promegakaryocytes,Splenic Manifestation of Hairy Cell Leukemia,0
25972,Seventh,Neoplasms,0
25973,Leading,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
25974,Pleomorphic Xanthoastrocytoma,Activated B-cell type diffuse large B-cell lymphoma,0
25975,Worsening pattern,Endometrial Small Cell Carcinoma,0
25976,How Much Distress Vomiting,Adrenal Rest Tumor,0
25977,>5,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
25978,Microplate Well,Malignant Testicular Sertoli Cell Tumor,0
25979,Involvement with,Acute lymphadenitis,0
25980,High grade (lymphoma grade) (finding),Metastatic Malignant Neoplasm in the Sellar Region,0
25981,Human papillomavirus 16,Adenocarcinoma,0
25982,Back structure,Vaginal Adenoma,0
25983,Location,Cervical Squamous Intraepithelial Neoplasia,0
25984,CD244 wt Allele,Endometrial Small Cell Carcinoma,0
25985,Adult Lymphoma,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
25986,Benign,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
25987,liter,Fourth Ventricle and Brain Stem Ependymal Tumor,0
25988,Body surface,Localized Ewing Sarcoma,0
25989,Ovarian Follicle,Intracortical osteosarcoma,0
25990,Rapid,Childhood Extragonadal Malignant Germ Cell Tumor,0
25991,Occurrence,Adult Hepatocellular Carcinoma,0
25992,Contribution,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
25993,Response to treatment,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
25994,Human body structure,Splenic Manifestation of Hairy Cell Leukemia,0
25995,40%,Malignant neoplasm of choroid,0
25996,Early,Acantholytic squamous cell carcinoma,0
25997,Present,squamous cell carcinoma of the thyroid gland,0
25998,History,Breast Ductal Adenoma,0
25999,Only a Little,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
26000,Three,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26001,Referring,Liver Cavernous Hemangioma,0
26002,Testicular Germ Cell Tumor,Malignant neoplasm of subglottis,0
26003,Structure of great blood vessel (organ),Recurrent Testicular Lymphoma,0
26004,System,Non-Metastatic Gestational Trophoblastic Tumor,0
26005,Lower - spatial qualifier,Larynx carcinoma recurrent,0
26006,True primary (qualifier value),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26007,Acute lymphocytic leukemia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26008,red Patches,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26009,White color,Locally Advanced Soft Tissue Sarcoma,0
26010,Response to treatment,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
26011,Post Device,Recurrent Testicular Lymphoma,0
26012,Frequently,Astrocytoma of brain,0
26013,Malignant Neoplasms,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
26014,Rating (action),Liver Lymphangioma,0
26015,eTMF Content Model Code,benign mature teratoma of pancreas,0
26016,Childhood Germ Cell Tumor,Clonal Hematopoiesis of Indeterminate Potential,0
26017,Lateral ventricle structure,Engraftment syndrome,0
26018,High Mitosis-Karyorrhexis Index,Cerebral Primitive Neuroectodermal Tumor,0
26019,Physical findings,Digestive System Hodgkin Lymphoma,0
26020,biopsy characteristics,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
26021,N not otherwise specified Antibody,Ovarian germ cell choriocarcinoma stage IV,0
26022,Block Unit of Distance,Adult Alveolar Soft Part Sarcoma,0
26023,Most,Acute Undifferentiated Leukemia,0
26024,Bladder Continence Question,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
26025,Condition,Congenital hamartoma,0
26026,Breast,Benign Anal Granular Cell Tumor,0
26027,Environmental risk factor,Carcinomatosis of peritoneal cavity,0
26028,Primary,Stage I Colon Neuroendocrine Tumor AJCC v8,0
26029,per year,Intraepithelial Melanocytic Hyperplasia,0
26030,N+ (tumor staging),Peripheral primitive neuroectodermal tumor of soft tissue,0
26031,Chemotherapy,mucinous adenocarcinoma of gallbladder,0
26032,Leading,Papillary cystic tumor,0
26033,Lower (action),Lipoma of small intestine,0
26034,Polymerization,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26035,Sharing (Social Behavior),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26036,Decreasing,Diffuse malignant mesothelioma,0
26037,Name,Intestinal Metaplasia of Bladder Urothelium,0
26038,Adolescent (age group),Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26039,<3 (qualifier value),Chest Wall Fibromatosis,0
26040,Family history,Localized Ewing Sarcoma,0
26041,Human body,Digestive System Hodgkin Lymphoma,0
26042,Type of Form,Malignant Testicular Sertoli Cell Tumor,0
26043,treatment - ActInformationManagementReason,Benign neoplasm of eye,0
26044,Symptoms,Collecting Duct Carcinoma of the Kidney,0
26045,Bone marrow aspiration procedure,Childhood Anaplastic Large Cell Lymphoma,0
26046,treatment options,Neonatal leukemia,0
26047,Mathematical Operator,Diffuse malignant mesothelioma,0
26048,Biospecimen,Stage II Carcinoma of Penis,0
26049,Symptom:Find:Pt:^Patient:Nom,Chest Wall Fibromatosis,0
26050,Participation Type - origin,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
26051,melanoma,ALK positive large B-cell lymphoma,0
26052,Tumor Mass,Carcinoma of urinary bladder,0
26053,Cessation of life,Adult Acute Eosinophilic Leukemia,0
26054,True primary (qualifier value),Ichthyosis,0
26055,Smear - instruction imperative,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
26056,Forecast of outcome,Adult Acute Eosinophilic Leukemia,0
26057,Lung,Stage III Cutaneous Melanoma AJCC v6,0
26058,Negation,Neoplasms,0
26059,Complete Agreement,Angiosarcoma of liver,0
26060,CEL gene,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26061,Old,Bladder squamous cell carcinoma stage I,0
26062,Primary malignant neoplasm,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26063,diagnosis aspect,Malignant Neoplasm with Regional Lymph Node Involvement,0
26064,Smear - instruction imperative,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
26065,MYELODYSPLASTIC SYNDROME,Recurrent Uveal Melanoma,0
26066,Result,Vaginal Adenoma,0
26067,Rapid,Childhood Fibrillary Astrocytoma,0
26068,Death Adverse Event Not Associated with More Specific CTCAE Term NOS,Human Papillomavirus-Related Carcinoma,0
26069,Make - Instruction Imperative,Squamous cell carcinoma of lip,0
26070,Characterization,Stage II Fallopian Tube Cancer,0
26071,Special,Cervical Fibroepithelial Polyp,0
26072,Malignant neoplasm of brain,Secondary malignant neoplasm of lymph node,0
26073,Pruritus,Vaginal Adenoid Cystic Carcinoma,0
26074,To,Basal Cell Ameloblastoma,0
26075,Prior Chemotherapy,Pancreatic Endocrine Carcinoma,0
26076,Togo,Medulloblastoma,0
26077,Internal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26078,Biological Response Modifiers,Kaposi's sarcoma of extrahepatic bile duct,0
26079,English race,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26080,Occurrence,Intraepithelial Melanocytic Hyperplasia,0
26081,size,Pilocytic astrocytoma of cerebellum,0
26082,Development,Malignant neoplasm of thalamus,0
26083,Categories,Localized Ewing Sarcoma,0
26084,Tissue Specimen Code,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
26085,Usual,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26086,Practice Experience,Tonsillar Carcinoma,0
26087,Biological Response Modifier Therapy,Diffuse malignant mesothelioma,0
26088,Areas <moth>,Tonsillar Carcinoma,0
26089,One,Type II Endometrial Adenocarcinoma,0
26090,leukemia,FIGO Stage IVA Ovarian Cancer,0
26091,therapeutic aspects,papillary carcinoma of penis,0
26092,Skin,Human Papillomavirus-Related Carcinoma,0
26093,Spreading (qualifier value),Acute Undifferentiated Leukemia,0
26094,Example,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26095,% volume (qualifier value),Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26096,Type A,ROSE Cluster 3,0
26097,Smear - instruction imperative,Epithelioid Sarcoma NCI Grade 3,0
26098,Color,Pancreatic Intraepithelial Neoplasia-3,0
26099,Lacking,Fibroadenoma of breast,0
26100,Biomaterial Treatment,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
26101,Pharmacotherapy,Heavy Chain Deposition Disease,0
26102,CDISC SEND Body System Terminology,Chest Wall Fibromatosis,0
26103,Sequence Data Type,Chondrosarcoma,0
26104,To,Neoplasms,0
26105,Ephrin Type-B Receptor 1,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
26106,Different,Human Papillomavirus-Related Carcinoma,0
26107,Grouping,Childhood Fibrillary Astrocytoma,0
26108,Age at diagnosis:Time:Pt:^Patient:Qn,papillary carcinoma of penis,0
26109,How Much Distress Weight Loss,Recurrent Uveal Melanoma,0
26110,Adult Soft Tissue Sarcoma,Kaposi's sarcoma of extrahepatic bile duct,0
26111,Five,FIGO Stage II Ovarian Cancer,0
26112,Soft Tissue Neoplasms,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26113,advanced disease,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
26114,Supratentorial,Papillary squamous cell carcinoma,0
26115,Adult Diffuse Large B-Cell Lymphoma,Bladder squamous cell carcinoma stage I,0
26116,3+ Score,Mucinous neoplasm,0
26117,Sex Cord-Stromal Tumor,Intraepithelial Melanocytic Hyperplasia,0
26118,Usual,malignant lymphoma of pancreatic lymph nodes,0
26119,fluid - substance,clear cell adenocarcinoma of gallbladder,0
26120,Percent normal,Familial Adenomatous Polyposis Associated Medulloblastoma,0
26121,N+ (tumor staging),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
26122,Area,Deep Leiomyoma,0
26123,Epithelioma,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
26124,Immunoproliferative Disorders,embryonal rhabdomyosarcoma of prostate,0
26125,CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,Mastocytosis,0
26126,Adrenal Cortical Adenoma,Childhood Central Nervous System Immature Teratoma,0
26127,Pathology,Acantholytic squamous cell carcinoma,0
26128,Classification of information,ROSE Cluster 3,0
26129,Logical Condition,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
26130,Removed,Cancer of Urinary Tract,0
26131,IPSS Risk Category Low,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26132,Increased erythropoietin,Cerebral Primitive Neuroectodermal Tumor,0
26133,Symptoms aspect,Liver Lymphangioma,0
26134,Neoplasms,Microcystic meningioma,0
26135,Often - answer to question,Melanomatosis,0
26136,Tumor Mass,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
26137,Destruction (action),Breast Ductal Adenoma,0
26138,Osteosarcoma,Non-Metastatic Gestational Trophoblastic Tumor,0
26139,Percent of Abnormal Cells,Angiosarcoma of liver,0
26140,Covers (device),Female Breast Carcinoma,0
26141,shared attribute,Hodgkin lymphoma,0
26142,Reaching,Acute lymphadenitis,0
26143,Primary malignant neoplasm,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
26144,status - In progress,Malignant Testicular Sertoli Cell Tumor,0
26145,Swollen Lymph Node,Vaginal Adenoma,0
26146,health and disease,Type II Endometrial Adenocarcinoma,0
26147,Case (situation),non-Hodgkin's lymphoma of spleen,0
26148,Histopathology,Digestive System Hodgkin Lymphoma,0
26149,Representation (action),Intraepithelial Melanocytic Hyperplasia,0
26150,Small Cell Lung Cancer Pathway,Cervical Squamous Intraepithelial Neoplasia,0
26151,Antibiotics,Malignant neoplasm of choroid,0
26152,various antiinfectives and antiseptics for local oral treatment,Bladder squamous cell carcinoma stage I,0
26153,Serious,gliosarcoma,0
26154,Population Group,Malignant melanoma of eyelid,0
26155,Comprehension,Adult Anaplastic Oligodendroglioma,0
26156,Treating,Thymoma malignant recurrent,0
26157,Physical findings,FIGO Stage II Ovarian Cancer,0
26158,MYELODYSPLASTIC SYNDROME,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
26159,Genetic,Childhood Central Nervous System Ganglioneuroblastoma,0
26160,cervical cancer,Low Grade Squamous Intraepithelial Neoplasia,0
26161,Cancer Genus,Mucinous adenocarcinoma gastric,0
26162,1+ Score,Clonal Hematopoiesis of Indeterminate Potential,0
26163,Primary malignant neoplasm,Stage 0 Penile Cancer AJCC v8,0
26164,International Classification of Disease for Oncology,Mucinous adenocarcinoma,0
26165,Abdomen+,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
26166,Mass Effect,Anterior Urethral Malignant Neoplasm,0
26167,Diagnosis,Bladder adenocarcinoma stage IV,0
26168,Adenocarcinoma,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26169,Ovary,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26170,Basis - conceptual entity,FIGO Stage II Ovarian Cancer,0
26171,Infrequent,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26172,More,Anterior Urethral Malignant Neoplasm,0
26173,With shape,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26174,include - SetOperator,Stage III Adult Immunoblastic Lymphoma,0
26175,Type - attribute,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26176,Group A (qualifier value),Diffuse malignant mesothelioma,0
26177,Brain,Stage IB Pancreatic Cancer AJCC v8,0
26178,Tests (qualifier value),Airway Hemangioma,0
26179,Containing (qualifier),Platinum-Resistant Lung Small Cell Carcinoma,0
26180,Partial,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26181,Call (Instruction),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26182,Specimen Source Codes - tumor,Type II Endometrial Adenocarcinoma,0
26183,other medicated shampoos in ATC,Squamous cell carcinoma of lip,0
26184,Transitory,Stage II Carcinoma of Penis,0
26185,Operative Surgical Procedures,Acute Undifferentiated Leukemia,0
26186,Version (morphologic abnormality),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26187,Person Name,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
26188,Cells,Stage I Adult Non-Hodgkin Lymphoma,0
26189,Classification,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
26190,Growth action,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26191,physiological aspects,Non-Hodgkin Lymphoma During Pregnancy,0
26192,Persons,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26193,Concept model range (foundation metadata concept),Endometrial Small Cell Carcinoma,0
26194,Thyroid carcinoma,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
26195,Most,Recurrent Uveal Melanoma,0
26196,Experimental Organism Basal Cell Carcinoma,Leptomeningeal sarcoma,0
26197,Ability,Carcinoma of urinary bladder,0
26198,Raised,ROSE Cluster 3,0
26199,human MUC1 protein,Carcinoma of submandibular gland,0
26200,Inch Unit of Length,Carcinoma of urinary bladder,0
26201,Less Than,Intestinal Neuroendocrine Carcinoma,0
26202,melanoma,Nasal cavity carcinoma,0
26203,Geographic state,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26204,Present,Benign squamous cell tumor,0
26205,Primary,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
26206,Manufactured form,Thymic Clear Cell Carcinoma,0
26207,omit,Liver Lymphangioma,0
26208,pharmacotherapeutic,Malignant Testicular Sertoli Cell Tumor,0
26209,Lymphoma,Type II Endometrial Adenocarcinoma,0
26210,60%,Digestive System Hodgkin Lymphoma,0
26211,solid substance,Stage II Fallopian Tube Cancer,0
26212,Cardiac Lead Procedure,Primary Cutaneous Plasmablastic Lymphoma,0
26213,Occur (action),Malignant Neoplasm with Regional Lymph Node Involvement,0
26214,Greater,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
26215,Togo,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
26216,Medications:Presence or Identity:Duration of the study:^Patient:Nominal,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26217,Epithelial cell count (procedure),Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26218,Palliative Care,Stage III Adult Immunoblastic Lymphoma,0
26219,Negation,Adenocarcinoma,0
26220,Common (qualifier value),Cervical Fibroepithelial Polyp,0
26221,Malignant tumor of cervix,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26222,Have Weight Loss,Tonsillar Carcinoma,0
26223,Smear - instruction imperative,Kaposi's sarcoma of skin,0
26224,Greater,Gallbladder adenoma,0
26225,United States,Larynx carcinoma recurrent,0
26226,To,Acute lymphadenitis,0
26227,Frequently,Advanced Uterine Corpus Carcinosarcoma,0
26228,Used by,embryonal rhabdomyosarcoma of prostate,0
26229,Support,embryonal rhabdomyosarcoma of prostate,0
26230,Involvement with,Nasal cavity carcinoma,0
26231,include - SetOperator,Familial Adenomatous Polyposis Associated Medulloblastoma,0
26232,Splitting,Kaposi's sarcoma of skin,0
26233,Similarity,Multiple Skull Base Meningiomas,0
26234,Have Weight Loss,Non-Metastatic Gestational Trophoblastic Tumor,0
26235,Often - answer to question,Platinum-Resistant Lung Small Cell Carcinoma,0
26236,Cure (remedy),Mixed astrocytoma-ependymoma,0
26237,Neoplasms,Stage IV Childhood Non-Hodgkin Lymphoma,0
26238,Coloring Excipient,Refractory Bladder Carcinoma,0
26239,CDISC SDTM Procedure Terminology,clear cell adenocarcinoma of gallbladder,0
26240,Etiology aspects,Pancreatic Endocrine Carcinoma,0
26241,Count of entities,Benign Carotid Body Paraganglioma,0
26242,Congenital Abnormality,Liver Cavernous Hemangioma,0
26243,Occurrence Indicator,Cerebral Primitive Neuroectodermal Tumor,0
26244,Function Axis,Basal Cell Ameloblastoma,0
26245,More Often than Once a Day,Testicular cancer metastatic,0
26246,status - In progress,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
26247,Spreading (qualifier value),Germinoma,0
26248,Take,Blepharal carcinoma,0
26249,Embryonic tissue,Liver Lymphangioma,0
26250,Experimental Result,Precursor B-lymphoblastic lymphoma stage II,0
26251,Mixed Salivary Gland Tumor,Refractory Barrett Esophagus,0
26252,Genetic Predisposition to Disease,Pancreatic carcinoma,0
26253,Direct (qualifier),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26254,DNA,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26255,Proton Pump Inhibitors,Gallbladder adenoma,0
26256,To,Rhabdomyosarcoma with ganglionic differentiation,0
26257,Lymphocyte,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
26258,Increased frequency of micturition,Childhood Choriocarcinoma,0
26259,Front of neck,Refractory Ependymoma,0
26260,Sebaceous Glands,Deep Leiomyoma,0
26261,Form:Finding:Point in time:{Setting}:Document:{Role},Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26262,Specialized,Funisitis (disorder),0
26263,Two,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26264,Statistical mean,Stage I Adult Non-Hodgkin Lymphoma,0
26265,Asia,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26266,Self,Noninfiltrating Intraductal Carcinoma,0
26267,Frequently,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
26268,Manufactured sign,Adenocarcinoma,0
26269,Immune,Kaposi's sarcoma of skin,0
26270,Neoplasms,Angiosarcoma of liver,0
26271,include - SetOperator,Atypical Lobular Breast Hyperplasia,0
26272,Back Pain,Maxillary Sinus Adenoid Cystic Carcinoma,0
26273,Specimen Source Codes - Respiratory,Stage III Cutaneous Melanoma AJCC v6,0
26274,Tryptophanase,Trichilemmocarcinoma,0
26275,peripheral blood,Xeroderma pigmentosum,0
26276,Call (Instruction),Type II Endometrial Adenocarcinoma,0
26277,Neoplasm Metastasis,Granular Cell Leiomyosarcoma,0
26278,Have Pain,Astrocytoma of brain,0
26279,Negation,Locally Advanced Squamous Cell Carcinoma,0
26280,Less often,Engraftment syndrome,0
26281,Fungus (lab result),Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26282,Human body,Papillary squamous cell carcinoma,0
26283,Including (qualifier),Methotrexate-Associated Hodgkin Lymphoma,0
26284,Not Applicable,Locally Advanced Squamous Cell Carcinoma,0
26285,Physician:Identifier:Point in time:^Patient:Nominal,Testicular cancer metastatic,0
26286,PSA Level Greater than Fifty,non-Hodgkin's lymphoma of spleen,0
26287,Shortened,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
26288,fluid - substance,Childhood Central Nervous System Immature Teratoma,0
26289,Categories,Angiosarcoma of liver,0
26290,Malignant Neoplasms,Adenocarcinoma of the prostate metastatic,0
26291,Homo sapiens,Human Papillomavirus-Related Carcinoma,0
26292,Diagnosis,Mucinous adenocarcinoma gastric,0
26293,Benign,Pancreatic carcinoma,0
26294,Often - answer to question,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,0
26295,Never (frequency),Childhood Lymphoma,0
26296,20%,Leiomyoma of Gallbladder,0
26297,Biological Response Modifiers,Acute Undifferentiated Leukemia,0
26298,Color change,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26299,Spreading (qualifier value),sarcoma of spinal cord,0
26300,Primary malignant neoplasm,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
26301,Spreading (qualifier value),Liver Lymphangioma,0
26302,Obesity,Benign tumor of eyelid,0
26303,Protons,clear cell adenocarcinoma of gallbladder,0
26304,Pressure (finding),Type II Endometrial Adenocarcinoma,0
26305,National origin,Diffuse malignant mesothelioma,0
26306,Cerebrum,de novo Myelodysplastic Syndrome,0
26307,Location of Pharyngeal Residue Following Swallowing,Benign Anal Granular Cell Tumor,0
26308,One,Cerebral hemangioma,0
26309,Frequently,Refractory Barrett Esophagus,0
26310,Affect (mental function),Locally Advanced Soft Tissue Sarcoma,0
26311,size,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26312,Pelvic Pain,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26313,Hypesthesia,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26314,Mass of body structure,squamous cell carcinoma of the thyroid gland,0
26315,Distention of blood vessel,FIGO Stage IVA Ovarian Cancer,0
26316,Neck,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26317,Sharing (Social Behavior),Benign neoplasm of eye,0
26318,Further,Digestive System Hodgkin Lymphoma,0
26319,Make - Instruction Imperative,Hereditary Diffuse Gastric Adenocarcinoma,0
26320,Benign Vascular Neoplasm,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26321,Manufactured form,Digestive System Hodgkin Lymphoma,0
26322,Round shape,Metastatic Neoplasm to the Gallbladder,0
26323,Mammal liver preparation,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26324,Adult Classical Hodgkin Lymphoma,Undifferentiated Endocervical Sarcoma,0
26325,Weight decreased,Hyperplasia of pituitary gland,0
26326,Pisum sativum,Astrocytoma of brain,0
26327,Conventional (Clear Cell) Renal Cell Carcinoma,Bladder adenocarcinoma stage IV,0
26328,Symptoms,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
26329,Woman,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
26330,Pyelonephritis,Thymic Clear Cell Carcinoma,0
26331,Group A (blood group),Recurrent Uveal Melanoma,0
26332,Symptoms aspect,Squamous cell carcinoma of lip,0
26333,Neoplasms,Methotrexate-Associated Hodgkin Lymphoma,0
26334,Treatment Epoch,Mucosal Melanoma,0
26335,Not Applicable,Trichilemmocarcinoma,0
26336,Type A,Thymic Clear Cell Carcinoma,0
26337,Sometimes,Cerebral Primitive Neuroectodermal Tumor,0
26338,Tryptophanase,Carcinoma of submandibular gland,0
26339,Neuroendocrine Tumors,clear cell adenocarcinoma of gallbladder,0
26340,stage,Tumorlet,0
26341,Cancer Genus,Benign Carotid Body Paraganglioma,0
26342,Death (finding),Secondary malignant neoplasm of lymph node,0
26343,Ability,Chest Wall Fibromatosis,0
26344,Recurrent infections,Stage III Cutaneous Melanoma AJCC v6,0
26345,Injury due to exposure to external cause,Cancer of Urinary Tract,0
26346,Sarcoma of soft tissue,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26347,Pediculus humanus capitis (eukaryote),Unicystic ameloblastoma,0
26348,CD69 wt Allele,Childhood Anaplastic Large Cell Lymphoma,0
26349,biopsy characteristics,Leptomeningeal sarcoma,0
26350,Formation,Small Intestinal Villous Adenoma,0
26351,Then,Adenocarcinoma of the prostate metastatic,0
26352,Reported,Benign Anal Granular Cell Tumor,0
26353,Cells,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
26354,Occur (action),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26355,Imaging Techniques,Intraepithelial Melanocytic Hyperplasia,0
26356,Symptoms aspect,mucinous adenocarcinoma of gallbladder,0
26357,biopsy characteristics,Recurrent Primary Lymphoma of Bone,0
26358,General surgery specialty,Airway Hemangioma,0
26359,Severe (severity modifier),Clinical Stage I Cutaneous Melanoma AJCC v8,0
26360,Malignant - descriptor,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26361,Bladder Neoplasm,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26362,Immunotherapy,Squamous cell carcinoma of lip,0
26363,Group A (blood group),Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26364,Process,Giant cell angiofibroma,0
26365,Human Cells,Mucinous adenocarcinoma gastric,0
26366,Operative Surgical Procedures,Malignant melanoma of eyelid,0
26367,Occurrence,Clonal Hematopoiesis of Indeterminate Potential,0
26368,Act Relationship Subset - previous,Hereditary corneal dystrophy,0
26369,Mass of body structure,Type II Endometrial Adenocarcinoma,0
26370,Increase,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26371,First (number),Childhood Central Nervous System Ganglioneuroblastoma,0
26372,Removing (action),Bladder adenocarcinoma stage IV,0
26373,Example,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26374,Decision,ICHTHYOSIS,0
26375,Increased risk for cancer,Mixed astrocytoma-ependymoma,0
26376,Airway structure,Advanced Lung Carcinoma,0
26377,Study Site,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26378,Eye lid,Undifferentiated Endocervical Sarcoma,0
26379,Known,Acute Undifferentiated Leukemia,0
26380,How Often Shortness of Breath,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26381,Patient Reported Outcome Stem,Extra-Adrenal Paraganglioma,0
26382,Viral,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26383,Aspects of disease screening,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26384,Following,Undifferentiated Endocervical Sarcoma,0
26385,Lower (action),Pancreatic carcinoma,0
26386,+5,Intestinal Metaplasia of Bladder Urothelium,0
26387,Highest,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26388,Slightly Agree,Recurrent Uveal Melanoma,0
26389,Biopsy,Recurrent Uveal Melanoma,0
26390,What subject filter - Result,Endometrial Small Cell Carcinoma,0
26391,Two,Thymic Clear Cell Carcinoma,0
26392,Aspect - Kind of quantity,Human Papillomavirus-Related Carcinoma,0
26393,Compresses (device),Airway Hemangioma,0
26394,Rest,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
26395,Fatal,embryonal rhabdomyosarcoma of prostate,0
26396,Most,Familial Adenomatous Polyposis Associated Medulloblastoma,0
26397,Human body structure,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26398,Capillary vessel,Unicystic ameloblastoma,0
26399,Immune system,Testicular cancer metastatic,0
26400,Five-year Survival Rate,embryonal rhabdomyosarcoma of prostate,0
26401,Unique,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26402,Colorectal Cancer Pathway,Ichthyosis,0
26403,Persons,Benign Carotid Body Paraganglioma,0
26404,Long,Tonsillar Carcinoma,0
26405,Sharing (Social Behavior),Carcinomatosis of peritoneal cavity,0
26406,Medical Device Emits Smoke,Familial Adenomatous Polyposis Associated Medulloblastoma,0
26407,Occurrence,Metastatic Carcinoma in the Lung,0
26408,Overall,papillary carcinoma of penis,0
26409,Usually,Adult Hepatocellular Carcinoma,0
26410,Report (document),Rhabdomyosarcoma with ganglionic differentiation,0
26411,pharmacotherapeutic,Acute Undifferentiated Leukemia,0
26412,Evidence,Acute lymphadenitis,0
26413,Clouded consciousness,Childhood Fibrillary Astrocytoma,0
26414,Malignant neoplasm of ovary,Recurrent Testicular Lymphoma,0
26415,Adult Lymphoma,Necrotizing Funisitis,0
26416,Stomach,Refractory Barrett Esophagus,0
26417,Person Observer,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26418,Early,Maxillary Sinus Adenoid Cystic Carcinoma,0
26419,Biomaterial Treatment,Endometrial Small Cell Carcinoma,0
26420,Lymphoma,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26421,Fatal,Stage IB Pancreatic Cancer AJCC v8,0
26422,Malignant Neoplasms,Female Breast Carcinoma,0
26423,Integumentary scale,Astrocytoma of brain,0
26424,European race,Unicystic ameloblastoma,0
26425,Helpful,Malignant neoplasm of thalamus,0
26426,early detection of cervical cancer,squamous cell carcinoma of the thyroid gland,0
26427,Difficulty walking,ROSE Cluster 3,0
26428,Human Age Group,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26429,Classes - encounter,Papillary cystic tumor,0
26430,Third grade in elementary school,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26431,Neck,Undifferentiated Endocervical Sarcoma,0
26432,Consistency,Spermatocytic seminoma,0
26433,Initial (abbreviation),Refractory Ependymoma,0
26434,Deterioration of status,clear cell adenocarcinoma of gallbladder,0
26435,True primary (qualifier value),Transitional cell carcinoma,0
26436,Solid Neoplasm,Xeroderma pigmentosum,0
26437,Melanoma Pathway,Hodgkin Disease,0
26438,Form:Finding:Point in time:{Setting}:Document:{Role},Malignant Neoplasm with Regional Lymph Node Involvement,0
26439,Tryptophanase,Childhood Central Nervous System Ganglioneuroblastoma,0
26440,American College of Cardiology/American Heart Association Lesion Complexity Score C,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
26441,Pathological Dilatation,Precursor B-lymphoblastic lymphoma stage II,0
26442,Complication Aspects,Testicular cancer metastatic,0
26443,Occur (action),Benign squamous cell tumor,0
26444,Retinoic Acid Response Element,Pancreatic Intraepithelial Neoplasia-3,0
26445,Complete Agreement,Refractory Ependymoma,0
26446,Liver Flavor,Colorectal Neuroendocrine Tumor G2,0
26447,Out (direction),Metastatic Kidney Carcinoma,0
26448,Case (situation),Splenic Manifestation of Hairy Cell Leukemia,0
26449,Very,Localized Askin Tumor,0
26450,Sarcoma - category (morphologic abnormality),Precursor B-lymphoblastic lymphoma stage II,0
26451,Poverty,Gallbladder Adenocarcinoma,0
26452,Megakaryoblasts,embryonal rhabdomyosarcoma of prostate,0
26453,Seventh,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26454,Early,Uterine Cancer,0
26455,Trial Screening,Non-Metastatic Gestational Trophoblastic Tumor,0
26456,Morphology,Thymic Clear Cell Carcinoma,0
26457,Estimated,Metastatic Lung Small Cell Carcinoma,0
26458,radiotherapeutic,Metastatic Malignant Neoplasm in the Sellar Region,0
26459,Combined,Thymic Clear Cell Carcinoma,0
26460,dendritic spine neck,Refractory Ependymoma,0
26461,Histopathological aspects,Benign tumor of eyelid,0
26462,Obese build,Pancreatic carcinoma,0
26463,Body structure,Lipoma of small intestine,0
26464,Stress,Lung squamous cell carcinoma stage I,0
26465,combination of objects,Engraftment syndrome,0
26466,Frequently,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
26467,Hardness,Type II Endometrial Adenocarcinoma,0
26468,Adult Lymphoma,embryonal rhabdomyosarcoma of prostate,0
26469,Embryonic Development,Recurrent Rhabdomyosarcoma,0
26470,Common Specifications in HL7 V3 Publishing,Cerebral Primitive Neuroectodermal Tumor,0
26471,Females,Grade 3a Malignant Neoplasm,0
26472,Hereditary Diseases,Ovarian Carcinoid Tumor,0
26473,Chemotherapy,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26474,Solid Dose Form,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
26475,70%,Rhabdomyosarcoma with ganglionic differentiation,0
26476,Malignant neoplasm of thyroid,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26477,Skeletal bone,Medulloblastoma,0
26478,Divide,Rhabdomyosarcoma with ganglionic differentiation,0
26479,Loss of appetite (finding),Malignant melanoma of eyelid,0
26480,Covers (device),Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26481,Relationships,Unicystic ameloblastoma,0
26482,Most,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
26483,Physical Appearance,Benign Carotid Body Paraganglioma,0
26484,Chemotherapy Regimen,Childhood Fibrillary Astrocytoma,0
26485,Divide,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
26486,Throat,Undifferentiated Endocervical Sarcoma,0
26487,Interstitial Fluid,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26488,Surgical aspects,Digestive System Hodgkin Lymphoma,0
26489,Duct (organ) structure,Diffuse malignant mesothelioma,0
26490,Human Papillomavirus Positive,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
26491,Poliosis,Small Intestinal Villous Adenoma,0
26492,Somatic mutation,Locally Advanced Carcinoma,0
26493,Common (qualifier value),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26494,PER1 gene,Kaposi's sarcoma of extrahepatic bile duct,0
26495,Effect,Hodgkin Disease,0
26496,Adult Non-Hodgkin Lymphoma,Cervical Squamous Intraepithelial Neoplasia,0
26497,Growth,non-Hodgkin's lymphoma of spleen,0
26498,Occur (action),Peripheral primitive neuroectodermal tumor of soft tissue,0
26499,Back,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26500,Confirmation,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
26501,Comparison,Acute lymphadenitis,0
26502,Call (Instruction),Refractory Barrett Esophagus,0
26503,Heartburn,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26504,How Much Distress Constipation,Vaginal Adenoid Cystic Carcinoma,0
26505,Sunlight,Bladder adenocarcinoma stage IV,0
26506,More Often than Once a Day,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26507,Most,Transitional cell carcinoma,0
26508,Reclassified,Chest Wall Fibromatosis,0
26509,Histologic type,Refractory Glioma,0
26510,Loss of appetite (finding),Ovarian Dermoid Cyst with Secondary Carcinoma,0
26511,Infrequent,Breast Apocrine Adenoma,0
26512,white blood cell type,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26513,Involvement with,Localized Ewing Sarcoma,0
26514,Stage 3 lower case b,clear cell adenocarcinoma of gallbladder,0
26515,Renal Cell Carcinoma,clear cell adenocarcinoma of gallbladder,0
26516,risk factors,Cerebral Primitive Neuroectodermal Tumor,0
26517,Occurrence Indicator,Stage II Hepatocellular Carcinoma AJCC v8,0
26518,Rare,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26519,Covered (qualifier value),Necrotizing Funisitis,0
26520,predictive factor,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26521,Lesion,Refractory Barrett Esophagus,0
26522,Type - attribute,Acantholytic squamous cell carcinoma,0
26523,Physical findings,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
26524,Elevated,Blepharal carcinoma,0
26525,Tryptophanase,Cancer of Urinary Tract,0
26526,Adult Hodgkin Lymphoma,sarcoma of spinal cord,0
26527,Hemorrhage,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
26528,Top (position),Splenic Manifestation of Hairy Cell Leukemia,0
26529,Age,Intraepithelial Melanocytic Hyperplasia,0
26530,Blood Circulation,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
26531,Late stage,Kaposi's sarcoma of skin,0
26532,Present,Low Grade Squamous Intraepithelial Neoplasia,0
26533,Chest Pain,Mucinous adenocarcinoma gastric,0
26534,Symptoms aspect,Urethral Carcinoma,0
26535,Present,Benign Anal Granular Cell Tumor,0
26536,Complete,Acute Undifferentiated Leukemia,0
26537,include - SetOperator,Atypical Lobular Breast Hyperplasia,0
26538,Slow Growing,Parathyroid Gland Adenocarcinoma,0
26539,Liquid substance,Benign tumor of eyelid,0
26540,Cessation of life,Localized Askin Tumor,0
26541,Tract,Diffuse malignant mesothelioma,0
26542,Large,Type II Endometrial Adenocarcinoma,0
26543,Cessation of life,Diffuse malignant mesothelioma,0
26544,Human body structure,ROSE Cluster 3,0
26545,Retinoic Acid Response Element,Mastocytosis,0
26546,Person Name,Endometrial Small Cell Carcinoma,0
26547,Blood Cells,Thymic Clear Cell Carcinoma,0
26548,Infiltration,Engraftment syndrome,0
26549,Often - answer to question,Ovarian germ cell choriocarcinoma stage IV,0
26550,Primary malignant neoplasm,Childhood Anaplastic Large Cell Lymphoma,0
26551,Often - answer to question,Acute Undifferentiated Leukemia,0
26552,Adipose tissue,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26553,Location of Pharyngeal Residue Following Swallowing,Trichilemmocarcinoma,0
26554,Cultured Cell Line,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
26555,lymphatic cancer,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26556,Financial Account,adenosquamous carcinoma of breast,0
26557,Pharmaceutical Preparations,FIGO Stage II Ovarian Cancer,0
26558,Mass,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26559,Examination of skin,Melanomatosis,0
26560,Affect (mental function),Blepharal carcinoma,0
26561,Primary malignant neoplasm of lung,Clonal Hematopoiesis of Indeterminate Potential,0
26562,Worse,Bladder adenocarcinoma stage IV,0
26563,Morphology,Peripheral primitive neuroectodermal tumor of soft tissue,0
26564,New Zealand,Atypical Lobular Breast Hyperplasia,0
26565,Management Occupations,Recurrent Testicular Lymphoma,0
26566,Device tip (physical object),Kaposi's sarcoma of skin,0
26567,Continuance of life,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26568,ITGBL1 gene,Localized Malignant Neoplasm,0
26569,Groups,Lipoma of small intestine,0
26570,Rate,Occult Lung Adenosquamous Carcinoma,0
26571,Category Type,Kaposi's sarcoma of extrahepatic bile duct,0
26572,Hepatitis B,Multiple Skull Base Meningiomas,0
26573,Internal medicine specialty,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
26574,Has difficulty doing (qualifier value),Locally Advanced Carcinoma,0
26575,Persons,Chondrosarcoma,0
26576,Form:Finding:Point in time:{Setting}:Document:{Role},Carcinoma of urinary bladder,0
26577,Subject Risk,Cartilaginous exostosis,0
26578,Duplicate,Female Breast Carcinoma,0
26579,Referring,Vaginal Adenoma,0
26580,Testis,Stage III Cutaneous Melanoma AJCC v6,0
26581,Body part,squamous cell carcinoma of the thyroid gland,0
26582,Numbers,Collecting Duct Carcinoma of the Kidney,0
26583,Fever,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
26584,Body tissue,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
26585,cell growth,Brain Tumor,0
26586,depend,Ichthyosis,0
26587,Juice,Kaposi's sarcoma of skin,0
26588,Etiology aspects,Stage II Carcinoma of Penis,0
26589,Diagnosis Study,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26590,Frequently,Small cell neuroendocrine carcinoma of bladder,0
26591,Population at Risk,Malignant Testicular Sertoli Cell Tumor,0
26592,Diabetes Mellitus,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26593,Body cavities,Intestinal Neuroendocrine Carcinoma,0
26594,Cure (remedy),Cancer of Urinary Tract,0
26595,Widespread,Malignant Testicular Sertoli Cell Tumor,0
26596,Infrequent,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26597,month,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26598,IV number:ID:Pt:^Patient:Nom,Secondary malignant neoplasm of lymph node,0
26599,Nodule,Benign Carotid Body Paraganglioma,0
26600,SLC6A2 wt Allele,Heavy Chain Deposition Disease,0
26601,Increase,Melanomatosis,0
26602,Race,Microcystic meningioma,0
26603,Increase,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
26604,Occurrence Indicator,Carcinomatosis of peritoneal cavity,0
26605,Hypotension,Malignant Testicular Sertoli Cell Tumor,0
26606,55,Kaposi's sarcoma of skin,0
26607,Mass of body structure,Carcinomatosis of peritoneal cavity,0
26608,survival aspects,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26609,Death (finding),Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26610,Foreskin of penis,Localized Askin Tumor,0
26611,Lymphangioma,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
26612,high - ActExposureLevelCode,Squamous cell carcinoma of lip,0
26613,Damage,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26614,Administration procedure,Refractory Bladder Carcinoma,0
26615,MALIGNANT benign,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26616,Body tissue,Squamous cell carcinoma of lip,0
26617,Local,Stage IB Lung Cancer AJCC v7,0
26618,Eyelash,Angiosarcoma of liver,0
26619,Rare,Stage I Adult Non-Hodgkin Lymphoma,0
26620,Primary malignant neoplasm,Carcinoma of urinary bladder,0
26621,gene therapy,Colorectal High Grade B-Cell Lymphoma,0
26622,Neuroectodermal Tumor,Malignant melanoma of eyelid,0
26623,Domain (area of knowledge),Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
26624,Biomaterial Treatment,Acantholytic squamous cell carcinoma,0
26625,1+ Score,Splenic Manifestation of Hairy Cell Leukemia,0
26626,Examination of pharynx,Type II Endometrial Adenocarcinoma,0
26627,Reproductive History,Non-Metastatic Gestational Trophoblastic Tumor,0
26628,A Codes,Central Nervous System Yolk Sac Tumor,0
26629,Genes,Adult Acute Eosinophilic Leukemia,0
26630,Clinical trial protocol,Adult Hepatocellular Carcinoma,0
26631,Cerebral hemisphere structure (body structure),Recurrent Testicular Lymphoma,0
26632,Result,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26633,Measures,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
26634,Presence of cells,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
26635,photoreactivating enzyme activity,Pancreatic Intraepithelial Neoplasia-3,0
26636,Diagnosis,Colorectal Neuroendocrine Tumor G2,0
26637,Qualitative form,Peripheral primitive neuroectodermal tumor of soft tissue,0
26638,Relationships,Unfavorable Non-Hodgkin Lymphoma,0
26639,CYP19A1 wt Allele,Malignant melanoma of eyelid,0
26640,mouth swelling,Uterine Cancer,0
26641,Indolent Non-Hodgkin Lymphoma,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26642,Negative Selection,Childhood Anaplastic Large Cell Lymphoma,0
26643,68,Botryoid-Type Embryonal Rhabdomyosarcoma,0
26644,Inflammatory Myofibroblastic Tumor,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26645,Departure - action,Non-Metastatic Gestational Trophoblastic Tumor,0
26646,diagnosis aspect,Splenic Manifestation of Hairy Cell Leukemia,0
26647,World Health Organization,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26648,various antiseptic throat preparations,Serous cystadenocarcinoma ovary,0
26649,Hematologic Tests,Blood Vessel Tumors,0
26650,Including (qualifier),Malignant neoplasm of gallbladder,0
26651,Include (action),Childhood Central Nervous System Ganglioneuroblastoma,0
26652,Cure (remedy),Metaplastic carcinoma of breast,0
26653,diagnosis aspect,Pancreatic Intraepithelial Neoplasia-3,0
26654,Have Been Vomiting,Intraepithelial Melanocytic Hyperplasia,0
26655,Very Much,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
26656,Secretory Vesicles,Trabecular adenocarcinoma,0
26657,True primary (qualifier value),Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
26658,Usual,Colorectal High Grade B-Cell Lymphoma,0
26659,Obstructed,Metaplastic carcinoma of breast,0
26660,Orchitis,Childhood Fibrillary Astrocytoma,0
26661,Unknown GENC,Giant cell angiofibroma,0
26662,Both ovaries,Bladder adenocarcinoma stage IV,0
26663,parent,Type II Endometrial Adenocarcinoma,0
26664,Cancer Other,Chest Wall Fibromatosis,0
26665,primary tumor,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
26666,Linear,Benign tumor of eyelid,0
26667,Narrow face,Serous cystadenocarcinoma ovary,0
26668,Skeletal bone,Noninfiltrating Intraductal Carcinoma,0
26669,Negation,Platinum-Resistant Lung Small Cell Carcinoma,0
26670,Include (action),ROSE Cluster 3,0
26671,Internal,Tonsillar Carcinoma,0
26672,Cumulative Survival Rate,High Grade Glandular Intraepithelial Neoplasia,0
26673,Ability,BRCA2 Syndrome,0
26674,Abnormal,Chondrosarcoma,0
26675,Both ovaries,Unfavorable Non-Hodgkin Lymphoma,0
26676,Face,Astrocytoma of brain,0
26677,Central African Republic,Thymic Clear Cell Carcinoma,0
26678,Disease,Tongue Alveolar Soft Part Sarcoma,0
26679,Lymphoma,Chondrosarcoma,0
26680,mucus layer,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26681,Sweat,Adult Hepatocellular Carcinoma,0
26682,Facial swelling (finding),Malignant melanoma of eyelid,0
26683,Common (qualifier value),Benign squamous cell tumor,0
26684,Congenital phimosis,Stage IV Penile Cancer AJCC v7,0
26685,Mucosa-Associated Lymphoid Tissue Lymphoma,Stage III Cutaneous Melanoma AJCC v6,0
26686,Entity Determiner - specific,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
26687,Including (qualifier),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26688,Personal appearance,Stage II Hepatocellular Carcinoma AJCC v8,0
26689,Symptoms,Carcinomatosis of peritoneal cavity,0
26690,Major <insect>,Carcinoma of urinary bladder,0
26691,Therapeutic procedure,Chondrosarcoma,0
26692,Rate,Tonsillar Carcinoma,0
26693,Clinical,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
26694,Affecting,Metaplastic carcinoma of breast,0
26695,Symptoms aspect,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26696,Diagnosis,Adenocarcinoma of duodenum,0
26697,Have Sweats,Malignant Neoplasm with Regional Lymph Node Involvement,0
26698,Numerous,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26699,Account number:Identifier:Point in time:^Patient:Nominal,Blepharal carcinoma,0
26700,Definitive,Female Breast Carcinoma,0
26701,Hemorrhage,Malignant neoplasm of subglottis,0
26702,spinal,Refractory Ependymoma,0
26703,Leg,Heavy Chain Deposition Disease,0
26704,Brain part,Spindle Cell Melanoma,0
26705,Occurrence Indicator,Hemangioma,0
26706,Highest,Localized Askin Tumor,0
26707,Cancer Registry,Acantholytic squamous cell carcinoma,0
26708,Exposure to,Malignant neoplasm of subglottis,0
26709,Array Feature,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26710,Tired,GIANT PIGMENTED HAIRY NEVUS,0
26711,50%,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26712,Carcinoma,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26713,Ultrasonography,Thymic Clear Cell Carcinoma,0
26714,Due to,Non-Metastatic Gestational Trophoblastic Tumor,0
26715,Definitely Related to Intervention,Non-Metastatic Gestational Trophoblastic Tumor,0
26716,Cell Count,Adult Alveolar Soft Part Sarcoma,0
26717,3+ Score,Thyroid Hurthle Cell Carcinoma,0
26718,Malignant neoplasm of urinary bladder,Advanced Lung Carcinoma,0
26719,English race,Choroid Necrotic Melanoma,0
26720,Occurrence Indicator,Spongiotic dermatitis,0
26721,Vitamin Deficiency,Splenic Manifestation of Hairy Cell Leukemia,0
26722,Risk,Recurrent Uveal Melanoma,0
26723,Icterus,Thyroid Hurthle Cell Carcinoma,0
26724,High,Serous cystadenocarcinoma ovary,0
26725,Skin,Refractory Ependymoma,0
26726,Cerebral hemisphere structure (body structure),Malignant Neoplasm of Lung - Multiple Primary Sites,0
26727,Including (qualifier),Splenic Manifestation of Hairy Cell Leukemia,0
26728,Togo,Placental aromatase deficiency,0
26729,structure,Hodgkin lymphoma,0
26730,CDISC SEND Body System Terminology,Angiosarcoma of liver,0
26731,Positron-Emission Tomography,Acantholytic squamous cell carcinoma,0
26732,Definition,Localized Ewing Sarcoma,0
26733,Neuropil,Stage IB Pancreatic Cancer AJCC v8,0
26734,Removed,Cancer of Urinary Tract,0
26735,3+ Score,Undifferentiated Endocervical Sarcoma,0
26736,Folded structure,Medulloblastoma,0
26737,Neoplasms,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
26738,potential,Blood Vessel Tumors,0
26739,Obesity,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
26740,Cancer Genus,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
26741,Entity Determiner - specific,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26742,See,Astrocytoma of brain,0
26743,Biogenic Amines,Refractory Barrett Esophagus,0
26744,Similarity,Hereditary Diffuse Gastric Adenocarcinoma,0
26745,Clinical Study Case,Recurrent Testicular Lymphoma,0
26746,low exposure,Airway Hemangioma,0
26747,criteria,Gallbladder Adenocarcinoma,0
26748,Age-Years,Fourth Ventricle and Brain Stem Ependymal Tumor,0
26749,Togo,Localized Malignant Neoplasm,0
26750,Ethanol,Refractory Bladder Carcinoma,0
26751,Act Mood - intent,Endometrial Small Cell Carcinoma,0
26752,Name,Nasal cavity carcinoma,0
26753,Negative Finding,Cartilaginous exostosis,0
26754,Coughing,Kaposi's sarcoma of skin,0
26755,Sodium Chloride,Stage II Hepatocellular Carcinoma AJCC v8,0
26756,Chemotherapy Regimen,Refractory Barrett Esophagus,0
26757,Cell Count,Nasal cavity carcinoma,0
26758,2+ Score,Intraepithelial Melanocytic Hyperplasia,0
26759,Blood flow,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26760,*Type - Kind of quantity,FIGO Stage IVA Ovarian Cancer,0
26761,diagnosis aspect,Bladder squamous cell carcinoma stage I,0
26762,How Often Weight Loss,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
26763,Glioma,Malignant Neoplasm with Regional Lymph Node Involvement,0
26764,Qualitative form,Epithelioid Sarcoma NCI Grade 3,0
26765,Poor - grade value,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
26766,Normal,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26767,Better than Others,Carcinomatosis of peritoneal cavity,0
26768,How Often Sweats,Digestive System Hodgkin Lymphoma,0
26769,Category Type,Chronic Myelomonocytic Leukemia-2,0
26770,Benign,Bladder Neuroendocrine Neoplasm,0
26771,Biological Response Modifier Therapy,Trichilemmocarcinoma,0
26772,Smaller,Kaposi's sarcoma of skin,0
26773,Only - dosing instruction fragment,Pancreatic carcinoma,0
26774,Pharmaceutical Preparations,Adenocarcinoma of the prostate metastatic,0
26775,Act Class - investigation,Anaplastic large cell lymphoma,0
26776,World Health Organization,benign mature teratoma of pancreas,0
26777,Cell Device,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26778,Prophylactic behavior,Xeroderma pigmentosum,0
26779,Tryptophanase,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26780,Muscle (organ),Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
26781,Eye foreign bodies,Carcinoma of submandibular gland,0
26782,Seventh,Locally Advanced Epithelioid Hemangioendothelioma,0
26783,Symptoms,Bladder squamous cell carcinoma stage I,0
26784,Metastasis,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26785,Specimen Source Codes - tumor,papillary carcinoma of penis,0
26786,Corticosteroid [EPC],Locally Advanced Carcinoma,0
26787,Abnormal size,Refractory Barrett Esophagus,0
26788,risk factors,Thyroid Hurthle Cell Carcinoma,0
26789,Illness: Cannot describe symptoms,Maxillary Sinus Adenoid Cystic Carcinoma,0
26790,Most,Stage III Adult Immunoblastic Lymphoma,0
26791,Common Specifications in HL7 V3 Publishing,Mucinous cystadenofibroma,0
26792,Microscopic description,Placental aromatase deficiency,0
26793,Involvement with,Larynx carcinoma recurrent,0
26794,NCI CTEP SDC Non-Hodgkin Lymphoma Sub-Category Terminology,Chest Wall Fibromatosis,0
26795,Lymphatic Capillaries,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
26796,Symptoms aspect,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
26797,diagnosis aspect,Liver Lymphangioma,0
26798,Closed,Breast Ductal Adenoma,0
26799,Specimen Source Codes - Lesion,Undifferentiated Endocervical Sarcoma,0
26800,site-specific telomere resolvase activity,Thyroid Hurthle Cell Carcinoma,0
26801,Overall,Cervical Fibroepithelial Polyp,0
26802,Gastrointestinal tract structure,Neoplasms,0
26803,Recombinant Erythropoietin,Granular Cell Leiomyosarcoma,0
26804,Life threatening - Event Consequence,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26805,Two,Cervical Fibroepithelial Polyp,0
26806,Surrounding (qualifier value),Childhood Thyroid Gland Follicular Carcinoma,0
26807,Retraction (finding),Refractory Barrett Esophagus,0
26808,Special,Breast Ductal Adenoma,0
26809,Frequently,Mucinous cystadenofibroma,0
26810,Table Cell Vertical Align - middle,Vaginal Adenoid Cystic Carcinoma,0
26811,Therapeutic procedure,Adult Acute Eosinophilic Leukemia,0
26812,Separated from cohabitee,papillary carcinoma of penis,0
26813,Base - General Qualifier,Multiple Skull Base Meningiomas,0
26814,Certain (qualifier value),Brain Tumor,0
26815,Subtype (attribute),ICHTHYOSIS,0
26816,Biological Transport,Choroid Necrotic Melanoma,0
26817,How Often Weight Loss,Medulloblastoma,0
26818,International Statistical Classification of Diseases and Related Health Problems,FIGO Stage IVA Ovarian Cancer,0
26819,Stroma,non-Hodgkin's lymphoma of spleen,0
26820,Negation,Benign Anal Granular Cell Tumor,0
26821,Cervical Intraepithelial Neoplasia,Brain Ependymoma,0
26822,glycosylation,Melanomatosis,0
26823,Shortened,Chronic Myelomonocytic Leukemia-2,0
26824,Science of Statistics,Digestive System Hodgkin Lymphoma,0
26825,Back Pain,Testicular cancer metastatic,0
26826,Category Type,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26827,Edema,Heavy Chain Deposition Disease,0
26828,Common Specifications in HL7 V3 Publishing,Localized Askin Tumor,0
26829,Human body,Extracranial Neuroblastoma,0
26830,Malignant Neoplasms,Cervical Squamous Intraepithelial Neoplasia,0
26831,Science of Etiology,Stage IV Childhood Non-Hodgkin Lymphoma,0
26832,Smear - instruction imperative,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26833,Disease,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
26834,100%,Intraepithelial Melanocytic Hyperplasia,0
26835,Occurrence,Recurrent Rhabdomyosarcoma,0
26836,Examined,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26837,Human Cells,Diffuse malignant mesothelioma,0
26838,chapter,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26839,85,gliosarcoma,0
26840,Sometimes,Unfavorable Non-Hodgkin Lymphoma,0
26841,Neuroblastoma,Childhood Fibrillary Astrocytoma,0
26842,Mental association,Thymic Clear Cell Carcinoma,0
26843,B-Lymphocytes,clear cell adenocarcinoma of gallbladder,0
26844,Occurrence Indicator,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
26845,Color change,Necrotizing Funisitis,0
26846,Lymphocyte,Extra-Adrenal Paraganglioma,0
26847,Brain,Collecting Duct Carcinoma of the Kidney,0
26848,Ovary,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26849,Childhood Embryonal Rhabdomyosarcoma,Microcystic meningioma,0
26850,Biomaterial Treatment,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26851,Neoplasms,Small cell neuroendocrine carcinoma of bladder,0
26852,Serous Membrane,Kaposi's sarcoma of extrahepatic bile duct,0
26853,Including (qualifier),embryonal rhabdomyosarcoma of prostate,0
26854,Togo,Medulloblastoma,0
26855,Posterior cerebral commissure,Acute lymphadenitis,0
26856,Including (qualifier),Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
26857,Followed by,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26858,Cancer Genus,Benign neoplasm of thorax,0
26859,risk factors,Precursor B-lymphoblastic lymphoma stage II,0
26860,Tumor Subtype,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
26861,Bladder Neoplasm,Heavy Chain Deposition Disease,0
26862,Diagnosis Study,Malignant melanoma of eyelid,0
26863,Content Creation Date,Acantholytic squamous cell carcinoma,0
26864,Decrease in appetite,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
26865,Exposure to,Cancer of Urinary Tract,0
26866,Malignant - descriptor,Unicystic ameloblastoma,0
26867,include - SetOperator,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
26868,Childhood Solid Neoplasm,Cerebral Primitive Neuroectodermal Tumor,0
26869,Firstly,Hodgkin lymphoma,0
26870,Main,Benign neoplasm of eye,0
26871,Cancer Genus,Malignant melanoma of eyelid,0
26872,mast-,Squamous cell carcinoma of lip,0
26873,Vagina,Undifferentiated Endocervical Sarcoma,0
26874,Occurrence,Refractory Bladder Carcinoma,0
26875,Location,Testicular cancer metastatic,0
26876,Malignant Epithelial Cell,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26877,Circulatory System Process,FIGO Stage IVA Ovarian Cancer,0
26878,Network Device,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
26879,Hemorrhage,Human Papillomavirus-Related Carcinoma,0
26880,Natural History,Recurrent Primary Lymphoma of Bone,0
26881,Followed by,Noninfiltrating Intraductal Carcinoma,0
26882,Liver Flavor,Transitional cell carcinoma,0
26883,Weight Loss,Thyroid Hurthle Cell Carcinoma,0
26884,Cancer Genus,Acute lymphadenitis,0
26885,Function (attribute),Cervical Adenomyoma,0
26886,Vaginal (intended site),Mucinous adenocarcinoma gastric,0
26887,Integral Membrane Proteins,Stage II Carcinoma of Penis,0
26888,Obese build,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
26889,risk factors - observation list,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26890,Dietary Lead,Childhood Central Nervous System Ganglioneuroblastoma,0
26891,Account number:Identifier:Point in time:^Patient:Nominal,Precursor B-lymphoblastic lymphoma stage II,0
26892,Therapeutic procedure,Cartilaginous exostosis,0
26893,Second Suffix,Stage IV Appendix Neuroendocrine Tumor AJCC v7,0
26894,Usual Severity Itching,Undifferentiated Endocervical Sarcoma,0
26895,Specific qualifier value,Blepharal carcinoma,0
26896,Therapeutic radiology procedure,Human Papillomavirus-Related Carcinoma,0
26897,Probably,Squamous cell carcinoma of lip,0
26898,Glandular stomach,Breast Ductal Adenoma,0
26899,Main,Colorectal Neuroendocrine Tumor G2,0
26900,Chemotherapy,FIGO Stage II Ovarian Cancer,0
26901,Etiology aspects,FIGO Stage IVA Ovarian Cancer,0
26902,Communicable Diseases,Locally Advanced Carcinoma,0
26903,Geographic Locations,Female Breast Carcinoma,0
26904,95,Childhood Lymphoma,0
26905,Malignant neoplasm of skin,Malignant neoplasm of choroid,0
26906,800,Fourth Ventricle and Brain Stem Ependymal Tumor,0
26907,Common (qualifier value),Cherubism,0
26908,Common Specifications in HL7 V3 Publishing,Unfavorable Non-Hodgkin Lymphoma,0
26909,Covered (qualifier value),Xeroderma pigmentosum,0
26910,Cancer Registry,Carcinomatosis of peritoneal cavity,0
26911,Superfamily,Ovarian germ cell choriocarcinoma stage IV,0
26912,combination of objects,Spongiotic dermatitis,0
26913,Contain (action),Undifferentiated Endocervical Sarcoma,0
26914,Lung,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26915,Body tissue,Leiomyoma of Gallbladder,0
26916,Pharmacotherapy,Adenocarcinoma of duodenum,0
26917,Body part,clear cell adenocarcinoma of gallbladder,0
26918,Sex Cord-Stromal Tumor,Hodgkin lymphoma,0
26919,Heart Ventricle,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26920,Closure,Refractory Barrett Esophagus,0
26921,diagnosis aspect,High Grade Glandular Intraepithelial Neoplasia,0
26922,leukemia,Fourth Ventricle and Brain Stem Ependymal Tumor,0
26923,Data operation - complete,Leptomeningeal sarcoma,0
26924,Isolation procedure,Vaginal Adenoid Cystic Carcinoma,0
26925,Disease,Cervical Squamous Intraepithelial Neoplasia,0
26926,Condition:Find:Pt:^Patient:Nom,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
26927,Including (qualifier),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
26928,Knowledge,adenosquamous carcinoma of breast,0
26929,peritoneal,Unicystic ameloblastoma,0
26930,shared attribute,FIGO Stage II Ovarian Cancer,0
26931,Usual Severity Itching,Adult Hepatocellular Carcinoma,0
26932,How Often Weight Loss,Benign Anal Granular Cell Tumor,0
26933,Result,Carcinomatosis of peritoneal cavity,0
26934,Area,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
26935,Precursor Cell Lymphoblastic Leukemia Lymphoma,Bladder adenocarcinoma stage IV,0
26936,Lymphocyte component of blood,Small cell neuroendocrine carcinoma of bladder,0
26937,Have Shortness of Breath question,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26938,Common Specifications in HL7 V3 Publishing,Melanomatosis,0
26939,Back Pain,Intraepithelial Melanocytic Hyperplasia,0
26940,Comparison,Locally Advanced Squamous Cell Carcinoma,0
26941,Qualitative form,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26942,Male population group,embryonal rhabdomyosarcoma of prostate,0
26943,Forecast of outcome,Ichthyosis,0
26944,Neoplastic Glandular Cell,Uterine Cancer,0
26945,Empty (qualifier),BRCA2 Syndrome,0
26946,Glioblastoma Multiforme,Papillary squamous cell carcinoma,0
26947,Similarity,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
26948,Esophagitis,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
26949,Numbness,Stage I Gastric Neuroendocrine Tumor AJCC v8,0
26950,associated disease,Pancreatic carcinoma,0
26951,Mole,Acute Undifferentiated Leukemia,0
26952,Person Name,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
26953,As Much as Desired,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
26954,Usually Need Help from Another Person for Arising,Peripheral primitive neuroectodermal tumor of soft tissue,0
26955,Divide,Childhood Central Nervous System Ganglioneuroblastoma,0
26956,How Much Distress Weight Loss,Adult Fibrolamellar Carcinoma,0
26957,Bothered by Vomiting,Diffuse malignant mesothelioma,0
26958,Cerebral hemisphere structure (body structure),Pancreatic Endocrine Carcinoma,0
26959,Symptoms,Intestinal Metaplasia of Bladder Urothelium,0
26960,Epithelial cell count (procedure),Metastatic Lung Small Cell Carcinoma,0
26961,Decade,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
26962,Hereditary,clear cell adenocarcinoma of gallbladder,0
26963,How Much Distress Pain,Vaginal Adenoma,0
26964,Adult,Benign tumor of eyelid,0
26965,Occur (action),Type II Endometrial Adenocarcinoma,0
26966,Obesity,Clinical Stage I Cutaneous Melanoma AJCC v8,0
26967,Present,Ovarian Dermoid Cyst with Secondary Carcinoma,0
26968,Slightly Agree,Digestive System Hodgkin Lymphoma,0
26969,Form:Finding:Point in time:{Setting}:Document:{Role},Ovarian Dermoid Cyst with Secondary Carcinoma,0
26970,Axilla,Fibroadenoma of breast,0
26971,Glia <plant>,Kaposi's sarcoma of extrahepatic bile duct,0
26972,Similarity,Acute Undifferentiated Leukemia,0
26973,Due to,Adult Acute Eosinophilic Leukemia,0
26974,Diagnosis,Acinar cell carcinoma of pancreas,0
26975,Neck,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
26976,Offspring,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
26977,Automobile Driving,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26978,Patients,Basal Cell Ameloblastoma,0
26979,Blood Circulation,Squamous cell carcinoma of lip,0
26980,Primary malignant neoplasm,Endometrial Small Cell Carcinoma,0
26981,Spreading (qualifier value),Benign Carotid Body Paraganglioma,0
26982,% index,Advanced Uterine Corpus Carcinosarcoma,0
26983,Deoxyribonucleic Acid Measurement,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26984,Pigment cell,Melanomatosis,0
26985,Drug Administration Routes,High Grade Salivary Gland Mucoepidermoid Carcinoma,0
26986,Entity Determiner - specific,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
26987,<50,Malignant melanoma of eyelid,0
26988,Term Birth,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
26989,Child,Squamous cell carcinoma of lip,0
26990,Lymphocyte,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
26991,Malignant neoplasm of breast,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
26992,Bronchoconstriction [PE],Benign Carotid Body Paraganglioma,0
26993,Staging system,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
26994,Carcinoma,Human Papillomavirus-Related Carcinoma,0
26995,Blood,Metastatic Carcinoma in the Lung,0
26996,Abdominal Cavity,Gallbladder Adenocarcinoma,0
26997,Malignant Neoplasms,Hair nevus,0
26998,unknown vaccine or immune globulin,Cancer of Urinary Tract,0
26999,Body part,Ovarian germ cell choriocarcinoma stage IV,0
27000,Linear,Locally Advanced Squamous Cell Carcinoma,0
27001,High Level,Refractory Barrett Esophagus,0
27002,Times,Stage IIIA Colorectal Neuroendocrine Tumor AJCC v8,0
27003,Stomach structure,Acinar cell carcinoma of pancreas,0
27004,Worsening pattern,Malignant melanoma of eyelid,0
27005,Concept model domain,Airway Hemangioma,0
27006,Does stand alone,Choroid Necrotic Melanoma,0
27007,Details,Engraftment syndrome,0
27008,DNA Repair,Medulloblastoma,0
27009,Common (qualifier value),Recurrent Testicular Lymphoma,0
27010,include - SetOperator,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27011,Operative Surgical Procedures,Digestive System Hodgkin Lymphoma,0
27012,Covered (qualifier value),Childhood Lung Non-Small Cell Carcinoma,0
27013,Smoking,Primary Cutaneous Plasmablastic Lymphoma,0
27014,Pharmacotherapy,Refractory Barrett Esophagus,0
27015,Taxonomic,Ovarian germ cell choriocarcinoma stage IV,0
27016,Type - attribute,Cervical Fibroepithelial Polyp,0
27017,Genomics,Vaginal Adenoid Cystic Carcinoma,0
27018,System (unit of presentation),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27019,Superior mediastinum,Benign tumor of eyelid,0
27020,Negative - answer,Locally Advanced Carcinoma,0
27021,Biological Response Modifiers,Tongue Alveolar Soft Part Sarcoma,0
27022,Prognosis bad,Hair nevus,0
27023,Cells,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27024,Malignant Cell Count,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27025,Pelvic pain female,Locally Advanced Epithelioid Hemangioendothelioma,0
27026,Sometimes,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
27027,Cancer Genus,Primary Cutaneous Plasmablastic Lymphoma,0
27028,Digital Content Category,Localized Malignant Neoplasm,0
27029,Tired,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27030,Young Adult,Kaposi's sarcoma of skin,0
27031,How Much Distress Shortness of Breath,Serous cystadenocarcinoma ovary,0
27032,Type - attribute,Localized Askin Tumor,0
27033,Pseudotumor,Small intestine carcinoma,0
27034,Sunlight,gliosarcoma,0
27035,Front of neck,Unicystic ameloblastoma,0
27036,Term (lexical),Diffuse malignant mesothelioma,0
27037,Recommendation,Adult Alveolar Soft Part Sarcoma,0
27038,2+,Xeroderma pigmentosum,0
27039,Congenital chromosomal disease,Multiple Skull Base Meningiomas,0
27040,Column (arrangement),Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
27041,Trial Subject Replacement,Adult Alveolar Soft Part Sarcoma,0
27042,Support,Peripheral primitive neuroectodermal tumor of soft tissue,0
27043,Therapeutic radiology procedure,Multiple Skull Base Meningiomas,0
27044,Throat,Fourth Ventricle and Brain Stem Ependymal Tumor,0
27045,Second edition,Peripheral primitive neuroectodermal tumor of soft tissue,0
27046,lobe,Adenocarcinoma,0
27047,Malignant neoplasm of lung,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
27048,Experimental Result,Uterine Cancer,0
27049,Treatment Epoch,Tonsillar Carcinoma,0
27050,Degree Unit of Plane Angle,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27051,Nodular Lymphocyte Predominant Hodgkin Lymphoma,Maxillary Sinus Adenoid Cystic Carcinoma,0
27052,Occurrence,Childhood Extragonadal Malignant Germ Cell Tumor,0
27053,Diagnosis Study,embryonal rhabdomyosarcoma of prostate,0
27054,Occurrence Indicator,Breast Ductal Adenoma,0
27055,Main,Cervical Adenomyoma,0
27056,diagnosis aspect,Giant cell angiofibroma,0
27057,Sarcoma - category (morphologic abnormality),Stage 0 Lip Carcinoma,0
27058,CDISC SEND Tumor Findings Results Terminology,Extracranial Neuroblastoma,0
27059,Hormone Therapy,FIGO Stage II Ovarian Cancer,0
27060,Sounds device,Necrotizing Funisitis,0
27061,Pelvic pain female,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27062,Manufactured form,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27063,Rare,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27064,survive,Endometrial Small Cell Carcinoma,0
27065,Poverty,Endometrial Small Cell Carcinoma,0
27066,Malignant Childhood Neoplasm,Mixed astrocytoma-ependymoma,0
27067,Intersex,Colorectal cancer,0
27068,How Much Distress Pain,Breast Ductal Adenoma,0
27069,Qualitative form,Female Breast Carcinoma,0
27070,Pelvic pain female,malignant lymphoma of pancreatic lymph nodes,0
27071,Morning,Diffuse malignant mesothelioma,0
27072,Observation Interpretation - intermediate,Cancer of Urinary Tract,0
27073,Area,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
27074,therapeutic aspects,Cervical Fibroepithelial Polyp,0
27075,Version (morphologic abnormality),Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
27076,Operative Surgical Procedures,Choroid Necrotic Melanoma,0
27077,Separate,Digestive System Hodgkin Lymphoma,0
27078,Family history,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27079,Pediculus (eukaryote),Thymic Clear Cell Carcinoma,0
27080,Sunlight,Thymic Clear Cell Carcinoma,0
27081,More Often than Once a Day,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27082,Primary malignant neoplasm,Recurrent Uveal Melanoma,0
27083,set (group),Botryoid-Type Embryonal Rhabdomyosarcoma,0
27084,Operation excision,Childhood Fibrillary Astrocytoma,0
27085,Occur (action),Malignant melanoma of eyelid,0
27086,Html Link Type - index,Malignant melanoma of eyelid,0
27087,Specific qualifier value,Metaplastic carcinoma of breast,0
27088,Hepatitis C Virus Infection,Ovarian germ cell choriocarcinoma stage IV,0
27089,Result,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27090,Often - answer to question,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27091,Form:Finding:Point in time:{Setting}:Document:{Role},Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27092,Atypical,Kaposi's sarcoma of extrahepatic bile duct,0
27093,Most,Melanomatosis,0
27094,Appearance,Cancer of Urinary Tract,0
27095,Main,Blepharal carcinoma,0
27096,body system,Digestive System Hodgkin Lymphoma,0
27097,Biopsy,Mixed astrocytoma-ependymoma,0
27098,combination of objects,papillary carcinoma of penis,0
27099,NCI CTEP SDC Melanoma Sub-Category Terminology,Benign Ovarian Thecoma,0
27100,NCI CTEP SDC Basal Cell Carcinoma Sub-Category Terminology,Brain Tumor,0
27101,Person Name,Non-Hodgkin Lymphoma During Pregnancy,0
27102,Normal,Malignant melanoma of eyelid,0
27103,Cause of death.underlying,Thymoma malignant recurrent,0
27104,Type A,Benign Apocrine Neoplasm,0
27105,Increased Immunologic Activity [PE],Bladder adenocarcinoma stage IV,0
27106,Breaking down,Carcinoma of urinary bladder,0
27107,Endocrine Cells,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27108,Bothered by Vomiting,Malignant Neoplasm with Regional Lymph Node Involvement,0
27109,Neuroectodermal Tumor,Adult Fibrolamellar Carcinoma,0
27110,Headache,Bladder squamous cell carcinoma stage I,0
27111,Mathematical Operator,Ovarian germ cell choriocarcinoma stage IV,0
27112,Derivation,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27113,newly,Cartilaginous exostosis,0
27114,Pilot Projects,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27115,Term (lexical),Unicystic ameloblastoma,0
27116,Immune,Botryoid-Type Embryonal Rhabdomyosarcoma,0
27117,Colon structure (body structure),Pilocytic astrocytoma of cerebellum,0
27118,Prebone tissue,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27119,Weight Loss,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
27120,Tumor cells,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
27121,Ultraviolet Rays,Adult Alveolar Soft Part Sarcoma,0
27122,Operative Surgical Procedures,Metaplastic carcinoma of breast,0
27123,Smear - instruction imperative,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27124,Purple,Intraepithelial Melanocytic Hyperplasia,0
27125,Unified - Type of Agreement,Acute Undifferentiated Leukemia,0
27126,Life Expectancy Less than Twenty Years,Botryoid-Type Embryonal Rhabdomyosarcoma,0
27127,50%,Metastatic Ductal Breast Carcinoma,0
27128,therapeutic aspects,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27129,Cells,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27130,Scientific Publication,Breast Ductal Adenoma,0
27131,operate <remove>,Testicular cancer metastatic,0
27132,Specimen Source Codes - Respiratory,Endometrial Small Cell Carcinoma,0
27133,treatment - ActInformationManagementReason,Nasal cavity carcinoma,0
27134,Version (morphologic abnormality),Stage III Cutaneous Melanoma AJCC v6,0
27135,Distal (qualifier value),Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27136,Change in voice (finding),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27137,Radiotherapy Research,Recurrent Primary Lymphoma of Bone,0
27138,Occur (action),Metastatic Lung Neuroendocrine Neoplasm,0
27139,Most,Gallbladder Adenocarcinoma,0
27140,Science of Etiology,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
27141,consider,Benign squamous cell tumor,0
27142,Skin Specimen,papillary carcinoma of penis,0
27143,Study Control,Nodular Lymphocyte Predominant Hodgkin Lymphoma,0
27144,diagnosis aspect,Medulloblastoma,0
27145,Body tissue,FIGO Stage II Ovarian Cancer,0
27146,Gait normal,malignant lymphoma of pancreatic lymph nodes,0
27147,CD34 gene,Squamous cell carcinoma of lip,0
27148,Type - attribute,Xeroderma pigmentosum,0
27149,Extrinsic,Refractory Glioma,0
27150,65+,Stage III Cutaneous Melanoma AJCC v6,0
27151,Age of Onset,Malignant melanoma of eyelid,0
27152,Adult human body,Stage IB Pancreatic Cancer AJCC v8,0
27153,cell growth,Adult Hepatocellular Carcinoma,0
27154,Observation of attack,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27155,Clear,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
27156,<90,Acantholytic squamous cell carcinoma,0
27157,0%,Extracranial Neuroblastoma,0
27158,antibiotics,Blood Vessel Tumors,0
27159,Chemotherapy Regimen,Platinum-Resistant Lung Small Cell Carcinoma,0
27160,growth aspects,Heavy Chain Deposition Disease,0
27161,Including (qualifier),Metastatic Carcinoma in the Lung,0
27162,20%,Splenic Manifestation of Hairy Cell Leukemia,0
27163,Hodgkin Disease,Acantholytic squamous cell carcinoma,0
27164,Inferior Colliculus,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27165,Malignant neoplasm of submandibular gland,Locally Advanced Carcinoma,0
27166,Occur (action),Adult Anaplastic Oligodendroglioma,0
27167,Clinical Effectiveness,Xeroderma pigmentosum,0
27168,Chemotherapy Regimen,Breast Ductal Adenoma,0
27169,Tumor cells,Choroid Epithelioid Cell Melanoma,0
27170,TRANSCRIPTION FACTOR,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27171,Science of Etiology,Collecting Duct Carcinoma of the Kidney,0
27172,Survival Rate,Type II Endometrial Adenocarcinoma,0
27173,Common (qualifier value),Neonatal leukemia,0
27174,SLC6A2 wt Allele,Childhood Anaplastic Large Cell Lymphoma,0
27175,Feel Tired question,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27176,Cells,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27177,Disease,Diffuse malignant mesothelioma,0
27178,Etiology aspects,Childhood Anaplastic Large Cell Lymphoma,0
27179,Epithelioid and spindle cell nevus,ROSE Cluster 3,0
27180,insensitivity,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27181,Cancer Genus,Stage 0 Penile Cancer AJCC v8,0
27182,year,Stage III Gastric Neuroendocrine Tumor AJCC v8,0
27183,Cancer Genus,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27184,year,Basal Cell Ameloblastoma,0
27185,Cultured Cell Line,Medulloblastoma,0
27186,Tumor cells,Xeroderma pigmentosum,0
27187,Plant Roots,Undifferentiated Endocervical Sarcoma,0
27188,Frequently,Clonal Hematopoiesis of Indeterminate Potential,0
27189,Pruritus,FIGO Stage II Ovarian Cancer,0
27190,Changed status,Unicystic ameloblastoma,0
27191,Breast Carcinoma,Angiosarcoma of liver,0
27192,Acquisition (action),Anterior Urethral Malignant Neoplasm,0
27193,antigen binding,Kaposi's sarcoma of extrahepatic bile duct,0
27194,Persons,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27195,Common (qualifier value),Digestive System Hodgkin Lymphoma,0
27196,Complete Trisomy 21 Syndrome,Human Papillomavirus-Related Carcinoma,0
27197,soft tissue,Pancreatic carcinoma,0
27198,Tryptophanase,Collecting Duct Carcinoma of the Kidney,0
27199,Cancer Genus,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27200,Cells,Thyroid Hurthle Cell Carcinoma,0
27201,Fatigue,Localized Askin Tumor,0
27202,Characteristics,Unfavorable Non-Hodgkin Lymphoma,0
27203,Patient Reported Outcome Stem,Hodgkin Disease,0
27204,Less Than,Malignant melanoma of eyelid,0
27205,Yellow complexion,Medulloblastoma,0
27206,Xeroderma Pigmentosum,Localized Malignant Neoplasm,0
27207,Firm,Atypical Lobular Breast Hyperplasia,0
27208,Behavior,Brain Tumor,0
27209,Surgical aspects,Neoplasms,0
27210,Approximate,Pilocytic astrocytoma of cerebellum,0
27211,Second Suffix,Angiosarcoma of liver,0
27212,brain cell,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
27213,Surgical aspects,Refractory Bladder Carcinoma,0
27214,Both ovaries,Benign tumor of eyelid,0
27215,Lead,Bladder Neuroendocrine Neoplasm,0
27216,Feel Tired question,Melanomatosis,0
27217,Make - Instruction Imperative,Cervical Adenomyoma,0
27218,pharmacotherapeutic,Liver Cavernous Hemangioma,0
27219,Well,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27220,Vaginal,Benign Ovarian Thecoma,0
27221,Injury due to exposure to external cause,Malignant neoplasm of thalamus,0
27222,Sometimes,Bladder squamous cell carcinoma stage I,0
27223,majority,Kaposi's sarcoma of skin,0
27224,Adult,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
27225,Basis - conceptual entity,Carcinoma ex pleomorphic adenoma of parotid gland,0
27226,Affecting,Deep Leiomyoma,0
27227,Neoplasms,Metaplastic carcinoma of breast,0
27228,Salivary Gland Tissue,Kaposi's sarcoma of skin,0
27229,Bone marrow: lymphocytes (finding),Childhood Lymphoma,0
27230,Decision,Lung squamous cell carcinoma stage I,0
27231,Obesity,Kaposi's sarcoma of skin,0
27232,Main,Small intestine carcinoma,0
27233,Occurrence,Carcinoma,0
27234,Dominant,Angiosarcoma of liver,0
27235,Ploidies,Acute Undifferentiated Leukemia,0
27236,Morphology,Testicular cancer metastatic,0
27237,Epithelial ovarian cancer,Placental aromatase deficiency,0
27238,Science of Statistics,Small Intestinal Villous Adenoma,0
27239,Often - answer to question,Female Breast Carcinoma,0
27240,Asia,Astrocytoma of brain,0
27241,Side,Locally Advanced Epithelioid Hemangioendothelioma,0
27242,Symptoms aspect,Mucinous adenocarcinoma gastric,0
27243,Mohs Surgery,Carcinoma of urinary bladder,0
27244,Disease,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27245,Vomiting,Adult Fibrolamellar Carcinoma,0
27246,Negative Surgical Margin,Stage IB Pancreatic Cancer AJCC v8,0
27247,Colon structure (body structure),Childhood Lymphoma,0
27248,Providing presence (regime/therapy),Cervical Adenomyoma,0
27249,Include (action),Benign Anal Granular Cell Tumor,0
27250,Biopsy,Intestinal Metaplasia of Bladder Urothelium,0
27251,various antiseptic throat preparations,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27252,Diabetes,Adult Hepatocellular Carcinoma,0
27253,shared attribute,Malignant Neoplasm with Regional Lymph Node Involvement,0
27254,Myelodysplastic Syndrome,Recurrent Uveal Melanoma,0
27255,indolent,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
27256,Affecting,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27257,Tests (qualifier value),Unfavorable Non-Hodgkin Lymphoma,0
27258,Covers (device),Localized Ewing Sarcoma,0
27259,Borg Category-Ratio 10 Perceived Exertion Score 5,ROSE Cluster 3,0
27260,Death (finding),Splenic Manifestation of Hairy Cell Leukemia,0
27261,Include (action),Mucinous cystadenofibroma,0
27262,Basis - conceptual entity,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27263,include - SetOperator,Cancer of Urinary Tract,0
27264,Include (action),Metaplastic carcinoma of breast,0
27265,gastrointestinal,Diffuse malignant mesothelioma,0
27266,seen,Carcinomatosis of peritoneal cavity,0
27267,Social group,Hyperplasia of pituitary gland,0
27268,Tissue specific,Mucinous adenocarcinoma gastric,0
27269,CDISC SEND Tumor Findings Results Terminology,Locally Advanced Epithelioid Hemangioendothelioma,0
27270,Manual pelvic examination (procedure),Transitional cell carcinoma,0
27271,Entity Name Part Qualifier - birth,Malignant neoplasm of olfactory nerve,0
27272,VARIOUS DRUG CLASSES IN ATC,Mixed parotid tumor,0
27273,X-Ray Computed Tomography,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
27274,classic behavior,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27275,Tissue Specimen Code,Pancreatic carcinoma,0
27276,Treating,Testicular cancer metastatic,0
27277,Malignant neoplasm of skin,Childhood Lung Non-Small Cell Carcinoma,0
27278,Examination of cells,Mastocytosis,0
27279,Acquired Name,Fibroadenoma of breast,0
27280,Adult human body,Intestinal Metaplasia of Bladder Urothelium,0
27281,Group Object,Uterine Cancer,0
27282,photoreactivating enzyme activity,Localized Malignant Neoplasm,0
27283,Epithelial Cells,Hereditary Diffuse Gastric Adenocarcinoma,0
27284,To,Refractory Barrett Esophagus,0
27285,cell type,Pancreatic Intraepithelial Neoplasia-3,0
27286,Increase,Pancreatic carcinoma,0
27287,Science of Etiology,Splenic Manifestation of Hairy Cell Leukemia,0
27288,second (number),Clonal Hematopoiesis of Indeterminate Potential,0
27289,Anatomic Site,Localized Ewing Sarcoma,0
27290,Social group,Acantholytic squamous cell carcinoma,0
27291,Case (situation),Cancer of Urinary Tract,0
27292,Times,GIANT PIGMENTED HAIRY NEVUS,0
27293,Recent,Liver Lymphangioma,0
27294,Presence of cells,Carcinomatosis of peritoneal cavity,0
27295,Deafness,Diffuse malignant mesothelioma,0
27296,Completely - dosing instruction fragment,squamous cell carcinoma of the thyroid gland,0
27297,Time,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
27298,Carcinoma of bladder,Ovarian germ cell choriocarcinoma stage IV,0
27299,Diagnostic Imaging,Recurrent Uveal Melanoma,0
27300,Glioblastoma Multiforme,Heavy Chain Deposition Disease,0
27301,high - ActExposureLevelCode,Secondary malignant neoplasm of lymph node,0
27302,Common Specifications in HL7 V3 Publishing,Cartilaginous exostosis,0
27303,Sodium Cation,sarcoma of spinal cord,0
27304,Case unit dose,Ichthyoses,0
27305,Epithelial cell count (procedure),Pancreatic Intraepithelial Neoplasia-3,0
27306,Increasing,Thyroid Hurthle Cell Carcinoma,0
27307,Case (situation),Mucosal Melanoma,0
27308,How Often Weight Loss,FIGO Stage II Ovarian Cancer,0
27309,63,Lung Mucinous Cystadenoma,0
27310,Initially,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27311,Back,Bladder adenocarcinoma stage IV,0
27312,Endocervical epithelium,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27313,During,Metaplastic carcinoma of breast,0
27314,common types,Stage IB Lung Cancer AJCC v7,0
27315,Diagnosis,Ovarian Carcinoid Tumor,0
27316,Changing,Undifferentiated Endocervical Sarcoma,0
27317,Cirrhosis,Angiosarcoma of liver,0
27318,veterans alcoholism screening test (VAST),FIGO Stage II Ovarian Cancer,0
27319,>90,Blepharal carcinoma,0
27320,combination of objects,Carcinoma of urinary bladder,0
27321,Arising,Deep Leiomyoma,0
27322,Oral Sex,Intraepithelial Melanocytic Hyperplasia,0
27323,Sometimes,Metaplastic carcinoma of breast,0
27324,Therapeutic procedure,Fibroadenoma of breast,0
27325,Area,Astrocytoma of brain,0
27326,Group A (blood group),FIGO Stage II Ovarian Cancer,0
27327,Usual,Melanomatosis,0
27328,Rare,Intracortical osteosarcoma,0
27329,Common (qualifier value),Stage III Cutaneous Melanoma AJCC v6,0
27330,User Group,Undifferentiated Endocervical Sarcoma,0
27331,Gait normal,Stage III Cutaneous Melanoma AJCC v6,0
27332,Event Seriousness - Significant,Non-Hodgkin Lymphoma During Pregnancy,0
27333,Ovarian Carcinoma,Familial Hemophagocytic Lymphocytosis,0
27334,(City) Block,Type II Endometrial Adenocarcinoma,0
27335,Person Observer,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
27336,allowing,Occult Lung Adenosquamous Carcinoma,0
27337,Pharmaceutical Preparations,Leptomeningeal sarcoma,0
27338,Patients,Stage IB Pancreatic Cancer AJCC v8,0
27339,Outlines (document),Thymic Clear Cell Carcinoma,0
27340,cell growth,Splenic Manifestation of Hairy Cell Leukemia,0
27341,Blood Vessel,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27342,Cancer Genus,Advanced Lung Carcinoma,0
27343,+5,Vaginal Adenoid Cystic Carcinoma,0
27344,bony process,Thymoma malignant recurrent,0
27345,Natural Killer Cells,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27346,Shallow,Blepharal carcinoma,0
27347,Irritants,Female Breast Carcinoma,0
27348,Most,Liver Lymphangioma,0
27349,CEL gene,clear cell adenocarcinoma of gallbladder,0
27350,Project,Occult Lung Adenosquamous Carcinoma,0
27351,Administration procedure,Type II Endometrial Adenocarcinoma,0
27352,Percent normal,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27353,Patient Monitoring,Ovarian germ cell choriocarcinoma stage IV,0
27354,Adult Lymphoma,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27355,Specimen Source Codes - tumor,Fibroadenoma of breast,0
27356,Bartholin Glands,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27357,Show,Digestive System Hodgkin Lymphoma,0
27358,Human Papillomavirus,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27359,A Codes,Grade 3a Malignant Neoplasm,0
27360,/40,Digestive System Hodgkin Lymphoma,0
27361,Room of building - Study,Malignant Testicular Sertoli Cell Tumor,0
27362,Occurrence,Neoplasms,0
27363,High risk,Melanomatosis,0
27364,Cartilage,Germinoma,0
27365,Negation,Refractory Bladder Carcinoma,0
27366,melanocyte,Squamous cell carcinoma of lip,0
27367,Type - attribute,FIGO Stage IVA Ovarian Cancer,0
27368,Genes,Astrocytoma of brain,0
27369,Neoplasm Metastasis,Squamous cell carcinoma of lip,0
27370,Central neuroblastoma,Mucinous adenocarcinoma gastric,0
27371,B-Lymphocytes,squamous cell carcinoma of the thyroid gland,0
27372,700,Vaginal Adenoid Cystic Carcinoma,0
27373,Special,BRCA2 Syndrome,0
27374,Treatment Epoch,Ampulla of Vater Tubular Adenoma,0
27375,Malignant tumor of peritoneum,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27376,History of previous events,Locally Advanced Carcinoma,0
27377,Occurrence,Astrocytoma of brain,0
27378,Call (Instruction),Malignant neoplasm of subglottis,0
27379,Septum - general anatomical term,Mixed astrocytoma-ependymoma,0
27380,Timepoint,Serous cystadenocarcinoma ovary,0
27381,Breathing Distress Question,Acute Undifferentiated Leukemia,0
27382,Hormonal,Benign tumor of eyelid,0
27383,Chemotherapy Regimen,Microcystic meningioma,0
27384,Subependymal Giant Cell Astrocytoma,Refractory Ependymoma,0
27385,Body Site Modifier - Lower,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27386,Subcategory,Intraepithelial Melanocytic Hyperplasia,0
27387,incomplete spinal cord injury,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27388,Used by,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27389,Standard Treatment,Intestinal Neuroendocrine Carcinoma,0
27390,Present,Sarcomatoid Renal Cell Carcinoma,0
27391,Chicken laying egg for human food,Malignant melanoma of eyelid,0
27392,Diagnosis,Small intestine carcinoma,0
27393,abnormal growth by tissue,Ovarian Carcinoid Tumor,0
27394,Estrogen [EPC],Childhood Thyroid Gland Follicular Carcinoma,0
27395,Decision,Hereditary Diffuse Gastric Adenocarcinoma,0
27396,Present,Noninfiltrating Intraductal Carcinoma,0
27397,Adult human body,Extracranial Neuroblastoma,0
27398,Cessation of life,Adult Alveolar Soft Part Sarcoma,0
27399,Metastasis,Recurrent Uveal Melanoma,0
27400,Prenatal care,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27401,Major salivary gland structure,Thyroid Hurthle Cell Carcinoma,0
27402,Act Mood - intent,Funisitis (disorder),0
27403,84,Adult Fibrolamellar Carcinoma,0
27404,Physiological Processes,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27405,Treatment Epoch,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27406,How Much Distress Shortness of Breath,Mucinous adenocarcinoma gastric,0
27407,Unmarried,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27408,Togo,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
27409,Help document,Kaposi's sarcoma of extrahepatic bile duct,0
27410,99,FIGO Stage II Ovarian Cancer,0
27411,Mammal liver preparation,Cerebral Primitive Neuroectodermal Tumor,0
27412,epithelial,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27413,Cartilage,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
27414,Abdominal Cavity,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27415,Function Axis,Neonatal leukemia,0
27416,New,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
27417,Feelings,Xeroderma pigmentosum,0
27418,inflammatory,Localized Malignant Neoplasm,0
27419,Slightly Able,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27420,Brain,Hereditary corneal dystrophy,0
27421,Form:Finding:Point in time:{Setting}:Document:{Role},Pancreatic carcinoma,0
27422,Benign Neoplasm,Platinum-Resistant Lung Small Cell Carcinoma,0
27423,german race,Liver Lymphangioma,0
27424,Glioblastoma Multiforme Pathway,Locally Advanced Squamous Cell Carcinoma,0
27425,Condition:Find:Pt:^Patient:Nom,Malignant neoplasm of thalamus,0
27426,Thick,embryonal rhabdomyosarcoma of prostate,0
27427,Occupations,sarcoma of spinal cord,0
27428,Young,Recurrent Rhabdomyosarcoma,0
27429,Human Papillomavirus Positive,Intestinal Metaplasia of Bladder Urothelium,0
27430,Financial Account,Squamous cell carcinoma of lip,0
27431,Cyst,Kaposi's sarcoma of extrahepatic bile duct,0
27432,More,Locally Advanced Soft Tissue Sarcoma,0
27433,Human body,Female Breast Carcinoma,0
27434,Containing (qualifier),Thymic Clear Cell Carcinoma,0
27435,Metastatic Neoplasm,Uterine Cancer,0
27436,Overall,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
27437,Lymphocyte,papillary carcinoma of penis,0
27438,Salivary Glands,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27439,Radiation,Acute lymphadenitis,0
27440,Present,Undifferentiated Neuroblastoma,0
27441,seen,Blood Vessel Tumors,0
27442,Limited stage (cancer stage),Childhood Central Nervous System Immature Teratoma,0
27443,Vomiting,Breast Ductal Adenoma,0
27444,Prognosis:Find:Pt:^Patient:Nom,adenoid cystic carcinoma of lung,0
27445,trauma qualifier,Intraepithelial Melanocytic Hyperplasia,0
27446,Diet poor,Benign Apocrine Neoplasm,0
27447,Infrequent,Botryoid-Type Embryonal Rhabdomyosarcoma,0
27448,Operative Surgical Procedures,Diffuse malignant mesothelioma,0
27449,second (number),Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27450,Including (qualifier),Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
27451,Anterior portion of neck,Medulloblastoma,0
27452,Near,Unfavorable Non-Hodgkin Lymphoma,0
27453,Known,Temporal Lobe Pleomorphic Xanthoastrocytoma,0
27454,Manufactured form,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27455,English Language,Adrenal Rest Tumor,0
27456,Hour Times Percent,FIGO Stage II Ovarian Cancer,0
27457,Goes <invertebrate>,Xeroderma pigmentosum,0
27458,Cover - action,Thymic Atypical Carcinoid Tumor,0
27459,Vaginal intraepithelial neoplasia,Maxillary Sinus Adenocarcinoma,0
27460,Mass of skin,Childhood Lymphoma,0
27461,TRIM33 gene,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27462,Physical Examination,Melanomatosis,0
27463,occurrence characteristics,Refractory Ependymoma,0
27464,Body part,Blood Vessel Tumors,0
27465,Divide,Mixed astrocytoma-ependymoma,0
27466,/40,Undifferentiated Neuroblastoma,0
27467,Benign Neoplasm,Kaposi's sarcoma of skin,0
27468,Fatigue,Leptomeningeal sarcoma,0
27469,Parotid Gland,Squamous cell carcinoma of lip,0
27470,Process,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27471,High Mitosis-Karyorrhexis Index,Recurrent Uveal Melanoma,0
27472,Dysuria,Childhood Fibrillary Astrocytoma,0
27473,1000000,Maxillary Sinus Adenoid Cystic Carcinoma,0
27474,Type - attribute,Fibroadenoma of breast,0
27475,Abdominal Cavity,Digestive System Hodgkin Lymphoma,0
27476,Subtype (attribute),Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27477,Glia <plant>,embryonal rhabdomyosarcoma of prostate,0
27478,Decision,Testicular cancer metastatic,0
27479,Definitely Related to Intervention,carcinoma of middle ear,0
27480,Granuloma,Digestive System Hodgkin Lymphoma,0
27481,Hemangioma,Localized Askin Tumor,0
27482,Medical service,Stage IB Pancreatic Cancer AJCC v8,0
27483,Hollings Cancer Center,Pleomorphic adenoma of parotid gland,0
27484,Specimen Source Codes - Macrophages,Acute Undifferentiated Leukemia,0
27485,Did not receive therapy or drug for,Mucinous neoplasm,0
27486,Melanoma Pathway,Xeroderma pigmentosum,0
27487,General surgery specialty,Diffuse malignant mesothelioma,0
27488,Including (qualifier),Melanomatosis,0
27489,Rare,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
27490,Plasma cell dyscrasia,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
27491,Screening Study,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
27492,Stem cell transplant,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
27493,pharmacotherapeutic,Ovarian germ cell choriocarcinoma stage IV,0
27494,Gait normal,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27495,Body tissue,Dermatofibrosarcoma Protuberans with Giant Cell Fibroblastoma-Like Differentiation,0
27496,Net (qualifier),Splenic Manifestation of Hairy Cell Leukemia,0
27497,Dermatitis,Choroid Necrotic Melanoma,0
27498,Scientific Control,Pleomorphic adenoma of parotid gland,0
27499,Involvement with,Intestinal Neuroendocrine Carcinoma,0
27500,BRCA1 protein,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27501,To,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27502,3+ Answer to Question,Clinical Stage I Cutaneous Melanoma AJCC v8,0
27503,Responsible to,Intraepithelial Melanocytic Hyperplasia,0
27504,Radiotherapy Research,Benign squamous cell tumor,0
27505,Adult Lymphoma,Vaginal Non-Keratinizing Squamous Cell Carcinoma,0
27506,Language Ability - Sign,Cartilaginous exostosis,0
27507,Two,Non-Metastatic Gestational Trophoblastic Tumor,0
27508,Neuroglia,Localized Malignant Neoplasm,0
27509,Different,Undifferentiated Endocervical Sarcoma,0
27510,Males,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27511,A Codes,Refractory Ependymoma,0
27512,various antiseptic throat preparations,Spongiotic dermatitis,0
27513,Exposure to,Colorectal Mucin Poor Hyperplastic Polyp,0
27514,Good,Extracranial Neuroblastoma,0
27515,English [International Organization for Standardization 639-1 code en] language reference set,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27516,NCI CTEP SDC Melanoma Sub-Category Terminology,Pancreatic Intraepithelial Neoplasia-3,0
27517,Mixed (qualifier value),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27518,Prognosis bad,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27519,Tumor cells,mucinous adenocarcinoma of gallbladder,0
27520,Anatomic Site,Hemangioma,0
27521,Antibiotics for systemic use,Chest Wall Fibromatosis,0
27522,Increased risk,ROSE Cluster 3,0
27523,cure of disease,adenoid cystic carcinoma of lung,0
27524,Dairy Cream,Botryoid-Type Embryonal Rhabdomyosarcoma,0
27525,Result,Lung Mucinous Cystadenoma,0
27526,Enneking High Surgical Grade,Undifferentiated Endocervical Sarcoma,0
27527,Congenital Abnormality,Carcinoma,0
27528,Pharmacotherapy,Benign Carotid Body Paraganglioma,0
27529,School Grade,Melanomatosis,0
27530,Symptoms aspect,Engraftment syndrome,0
27531,Adolescent (age group),Collecting Duct Carcinoma of the Kidney,0
27532,Cell Count,Adenocarcinoma,0
27533,Lymphoma,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27534,Complete,Unfavorable Non-Hodgkin Lymphoma,0
27535,survival aspects,Choroid Epithelioid Cell Melanoma,0
27536,Determined by,Mucinous adenocarcinoma gastric,0
27537,Appearance,Stage III Adult Immunoblastic Lymphoma,0
27538,Usual Severity Nausea,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27539,Common Specifications in HL7 V3 Publishing,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27540,Mean Percent of Normal,Carcinoma of urinary bladder,0
27541,Name,Stage IB Pancreatic Cancer AJCC v8,0
27542,Image Feature,Uterine Cancer,0
27543,Base - General Qualifier,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
27544,Different,Thymic Clear Cell Carcinoma,0
27545,Chemotherapy,Childhood Extragonadal Malignant Germ Cell Tumor,0
27546,Homo sapiens,Type II Endometrial Adenocarcinoma,0
27547,International Classification of Diseases for Oncology,Squamous cell carcinoma of lip,0
27548,Breast Cancer Type 1 Susceptibility Protein Measurement,Advanced Lung Carcinoma,0
27549,Inflammatory Bowel Diseases,Occult Lung Adenosquamous Carcinoma,0
27550,Often - answer to question,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27551,Swelling,Endometrial Small Cell Carcinoma,0
27552,KRT17 wt Allele,Thymic Clear Cell Carcinoma,0
27553,Adult Acute Megakaryoblastic Leukemia,Mucinous adenocarcinoma gastric,0
27554,shared attribute,Splenic Manifestation of B-Cell Prolymphocytic Leukemia,0
27555,Process,Intraepithelial Melanocytic Hyperplasia,0
27556,Clear,Thymoma malignant recurrent,0
27557,Case (situation),Low Grade Squamous Intraepithelial Neoplasia,0
27558,Dual,Recurrent Uveal Melanoma,0
27559,Ovary,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27560,Risk,embryonal rhabdomyosarcoma of prostate,0
27561,Carrying,Kaposi's sarcoma of skin,0
27562,Collagen Type I,FIGO Stage IVA Ovarian Cancer,0
27563,Death (finding),Cystadenocarcinoma,0
27564,Occur (action),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27565,Active License,Carcinoma of urinary bladder,0
27566,Brain,Carcinoma of urinary bladder,0
27567,Include (action),Advanced Lung Carcinoma,0
27568,Poor - grade value,Basal Cell Ameloblastoma,0
27569,incidence of cases,Fibroadenoma of breast,0
27570,Cause of death:Find:Pt:^Patient:Nom,Engraftment syndrome,0
27571,Type - attribute,Recurrent Testicular Lymphoma,0
27572,Including (qualifier),Undifferentiated Endocervical Sarcoma,0
27573,Back structure,Adult Hepatocellular Carcinoma,0
27574,Medical History,Epithelioid Sarcoma NCI Grade 3,0
27575,GDF15 protein,Cancer of Urinary Tract,0
27576,Pancreatic carcinoma,Rhabdomyosarcoma with ganglionic differentiation,0
27577,Occurrence,Carcinoma of urinary bladder,0
27578,Body Fluids,Squamous cell carcinoma of lip,0
27579,Group A (qualifier value),Carcinoma,0
27580,ACACA wt Allele,Colorectal Neuroendocrine Tumor G2,0
27581,Diagnosis Study,Primary Cutaneous Plasmablastic Lymphoma,0
27582,veterans alcoholism screening test (VAST),Collecting Duct Carcinoma of the Kidney,0
27583,consider,Cerebral Primitive Neuroectodermal Tumor,0
27584,Fasting Status Indicator,Bladder adenocarcinoma stage IV,0
27585,T-Cell Development,Astrocytoma of brain,0
27586,How Often Felt Normal question,Chondrosarcoma,0
27587,Presentation,Tonsillar Carcinoma,0
27588,Pancreas,ICHTHYOSIS,0
27589,Carcinoma,Stage IV Penile Cancer AJCC v7,0
27590,Anatomic Site,Malignant neoplasm of choroid,0
27591,Operative Surgical Procedures,Childhood Central Nervous System Ganglioneuroblastoma,0
27592,Tissue injury,Metastatic Lung Small Cell Carcinoma,0
27593,Cancer Genus,Peripheral primitive neuroectodermal tumor of soft tissue,0
27594,Surgery specialty,Extracranial Neuroblastoma,0
27595,Present,Stage I Adult Non-Hodgkin Lymphoma,0
27596,Cells,Thyroid Hurthle Cell Carcinoma,0
27597,Pacemaker ECG Assessment,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
27598,diagnosis aspect,Recurrent Testicular Lymphoma,0
27599,Death (finding),Epithelioid Sarcoma NCI Grade 3,0
27600,Cell secretion,Localized Askin Tumor,0
27601,Only - dosing instruction fragment,Hyperplasia of pituitary gland,0
27602,Lead,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27603,Occurrence Indicator,Benign tumor of eyelid,0
27604,device aspects,Uterine Cancer,0
27605,Virus,Chronic Myelomonocytic Leukemia-2,0
27606,Cardiac Lead Procedure,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27607,Malignant Neoplasms,Vaginal Adenoma,0
27608,2+,Secondary malignant neoplasm of lymph node,0
27609,CDISC SEND Tumor Findings Results Terminology,Fibroadenoma of breast,0
27610,Reported Term,Bladder squamous cell carcinoma stage I,0
27611,Percent of Abnormal Cells,Endometrial Small Cell Carcinoma,0
27612,Increase,FIGO Stage IVA Ovarian Cancer,0
27613,Uterine Fibroids,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
27614,Firstly,Transitional cell carcinoma,0
27615,Entire primordial sex cell,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
27616,Human body,Atypical Lobular Breast Hyperplasia,0
27617,Diagnosis Study,Intraepithelial Melanocytic Hyperplasia,0
27618,Lung,non-Hodgkin's lymphoma of spleen,0
27619,shared attribute,Cartilaginous exostosis,0
27620,Analysis of substances,Urethral Carcinoma,0
27621,Related personal status,Uterine Cancer,0
27622,Status post,Metastatic Neoplasm to the Gallbladder,0
27623,Detection,Childhood Anaplastic Large Cell Lymphoma,0
27624,Characteristics,Recurrent Testicular Lymphoma,0
27625,75,Familial Adenomatous Polyposis Associated Medulloblastoma,0
27626,Tumor site:Anat:Pt:Specimen:Nom,Adult Alveolar Soft Part Sarcoma,0
27627,Known,Platinum-Resistant Lung Small Cell Carcinoma,0
27628,First (number),Thymic Atypical Carcinoid Tumor,0
27629,Susceptibility (property) (qualifier value),Colorectal cancer,0
27630,Hematuria,Breast Ductal Adenoma,0
27631,Disease,Breast Ductal Adenoma,0
27632,bony process,FIGO Stage IVA Ovarian Cancer,0
27633,Usually,Cerebral Primitive Neuroectodermal Tumor,0
27634,Intestines,Adult Fibrolamellar Carcinoma,0
27635,Biomaterial Treatment,Recurrent Rhabdomyosarcoma,0
27636,contextual factors,embryonal rhabdomyosarcoma of prostate,0
27637,Pregnancy,Localized Askin Tumor,0
27638,month,Undifferentiated Neuroblastoma,0
27639,Oropharyngeal Carcinoma,Locally Advanced Epithelioid Hemangioendothelioma,0
27640,Neuron spine,malignant lymphoma of pancreatic lymph nodes,0
27641,One,Pilocytic astrocytoma of cerebellum,0
27642,Percent of Bacteria,Mastocytosis,0
27643,<90,Precursor B-lymphoblastic lymphoma stage II,0
27644,Smear test,Adult Alveolar Soft Part Sarcoma,0
27645,Biogenic Amines,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27646,Analysis,Type II Endometrial Adenocarcinoma,0
27647,Togo,Cartilaginous exostosis,0
27648,Growth action,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27649,Birth defects diagnosis:Find:Pt:^Patient:Nar,malignant lymphoma of pancreatic lymph nodes,0
27650,Result,Parathyroid Gland Adenocarcinoma,0
27651,Base - General Qualifier,gliosarcoma,0
27652,various other nasal preparations in ATC,Intestinal Neuroendocrine Carcinoma,0
27653,VIPR1 wt Allele,Unicystic ameloblastoma,0
27654,Involvement with,FIGO Stage II Ovarian Cancer,0
27655,Affect (mental function),Gallbladder Adenocarcinoma,0
27656,Prophylactic behavior,Chest Wall Fibromatosis,0
27657,Skin,Pleomorphic adenoma of parotid gland,0
27658,Fever,Botryoid-Type Embryonal Rhabdomyosarcoma,0
27659,International Classification of Diseases for Oncology,Type II Endometrial Adenocarcinoma,0
27660,Pelvis,Testicular cancer metastatic,0
27661,Feature,Cerebral Primitive Neuroectodermal Tumor,0
27662,Substance amount,Malignant Neoplasm with Regional Lymph Node Involvement,0
27663,Sarcoma - category (morphologic abnormality),BRCA2 Syndrome,0
27664,Present,Hodgkin lymphoma,0
27665,Shapes,Thymic Atypical Carcinoid Tumor,0
27666,Affecting,Cervical Squamous Intraepithelial Neoplasia,0
27667,Human body,Stage IB Lung Cancer AJCC v7,0
27668,Rating (action),Vaginal Adenoma,0
27669,Nodulus cerebelli,Recurrent Uveal Melanoma,0
27670,How Often Vomiting,Refractory Barrett Esophagus,0
27671,Cancer/Testis Antigen,Mucinous adenocarcinoma gastric,0
27672,human AVP protein,Angiosarcoma of liver,0
27673,Syndrome,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
27674,Primary malignant neoplasm,Benign squamous cell tumor,0
27675,Large,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27676,Medications,Granular Cell Leiomyosarcoma,0
27677,Firstly,sarcoma of spinal cord,0
27678,Including (qualifier),Benign Anal Granular Cell Tumor,0
27679,Significant,Childhood Lymphoma,0
27680,Row (arrangement),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27681,Pilocytic Astrocytoma,Diffuse malignant mesothelioma,0
27682,*Type - Kind of quantity,Epithelioid Sarcoma NCI Grade 3,0
27683,fluid - substance,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27684,Rare,Low Grade Squamous Intraepithelial Neoplasia,0
27685,Risk,Epithelioid Sarcoma NCI Grade 3,0
27686,Simple,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27687,Certain (qualifier value),Malignant neoplasm of thalamus,0
27688,Reduced,Plexosarcoma,0
27689,Removing (action),Refractory Bladder Carcinoma,0
27690,Overall Publication Type,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
27691,Set (Psychology),Noninfiltrating Intraductal Carcinoma,0
27692,Thyroid Gland,Maxillary Sinus Adenocarcinoma,0
27693,Hormone replacement therapy,Thymic Atypical Carcinoid Tumor,0
27694,Chemotherapy Regimen,Kaposi's sarcoma of skin,0
27695,Infrequent,Recurrent Rhabdomyosarcoma,0
27696,Decision,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27697,Solitary leiomyoma,Refractory Ependymoma,0
27698,CD69 protein,mucinous adenocarcinoma of gallbladder,0
27699,Squamous cell carcinoma - category,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27700,Sufficiently defined concept definition status (core metadata concept),Airway Hemangioma,0
27701,Used by,Clonal Hematopoiesis of Indeterminate Potential,0
27702,Tryptophanase,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
27703,Oropharyngeal Carcinoma,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
27704,Iris (Eye),Neonatal leukemia,0
27705,Retinoic Acid Response Element,Cervical Squamous Intraepithelial Neoplasia,0
27706,combination of objects,Ovarian germ cell choriocarcinoma stage IV,0
27707,Blood capillaries,Refractory Bladder Carcinoma,0
27708,Life Threatening,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27709,Spreading (qualifier value),Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27710,Recommendation,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27711,Limited Lifting Ability,Childhood Anaplastic Large Cell Lymphoma,0
27712,Limited component (foundation metadata concept),Stage IV Colorectal Cancer AJCC v8,0
27713,Computed Tomography Study File,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27714,Occurrence,Breast Apocrine Adenoma,0
27715,Structure of germinal center of lymph node,embryonal rhabdomyosarcoma of prostate,0
27716,Known,Recurrent Uveal Melanoma,0
27717,Function (attribute),Metastatic Lung Small Cell Carcinoma,0
27718,Personal appearance,adenoid cystic carcinoma of lung,0
27719,Biogenic Amines,Kaposi's sarcoma of skin,0
27720,Spleen,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27721,shared attribute,Small Intestinal Villous Adenoma,0
27722,Aspects of signs,Engraftment syndrome,0
27723,Include (action),Cerebral hemangioma,0
27724,Most,Advanced Uterine Corpus Carcinosarcoma,0
27725,Type - attribute,Chest Wall Fibromatosis,0
27726,Europe,Nasal cavity carcinoma,0
27727,Increase,Nasal cavity carcinoma,0
27728,liposarcoma,Atypical Lobular Breast Hyperplasia,0
27729,Confirmation,Larynx carcinoma recurrent,0
27730,International Classification of Diseases for Oncology,Vaginal Adenoma,0
27731,shared attribute,High Grade Glandular Intraepithelial Neoplasia,0
27732,Exposure to,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27733,Sweating,Refractory Glioma,0
27734,Science of Etiology,Neoplasms,0
27735,Subgroup,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
27736,Common Specifications in HL7 V3 Publishing,Cervical Squamous Intraepithelial Neoplasia,0
27737,Skeletal bone,Benign Anal Granular Cell Tumor,0
27738,Aspects of disease screening,Squamous cell carcinoma of lip,0
27739,Lymphoma,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27740,Microcyst,Collecting Duct Carcinoma of the Kidney,0
27741,Dysplasia,Acute Undifferentiated Leukemia,0
27742,Unknown,Methotrexate-Associated Hodgkin Lymphoma,0
27743,Tumor cells,adenosquamous carcinoma of breast,0
27744,Set of nose hairs,Adenocarcinoma of duodenum,0
27745,Include (action),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27746,treatment options,Intraepithelial Melanocytic Hyperplasia,0
27747,Including (qualifier),Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27748,Plasma,Melanomatosis,0
27749,Human body,Localized Ewing Sarcoma,0
27750,Table Cell Horizontal Align - left,Undifferentiated Endocervical Sarcoma,0
27751,FAT1 wt Allele,Benign Anal Granular Cell Tumor,0
27752,Very high,Precursor B-lymphoblastic lymphoma stage II,0
27753,Presence (property),Ovarian Dermoid Cyst with Secondary Carcinoma,0
27754,combination of objects,High Grade Glandular Intraepithelial Neoplasia,0
27755,System One,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27756,Balance (substance),Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27757,/mm3,Malignant Neoplasm with Regional Lymph Node Involvement,0
27758,CDISC SEND Tumor Findings Results Terminology,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27759,Inguinal region,Low Grade Squamous Intraepithelial Neoplasia,0
27760,Options,Atypical Lobular Breast Hyperplasia,0
27761,Diagnosis Study,Methotrexate-Associated Hodgkin Lymphoma,0
27762,Togo,Recurrent Primary Lymphoma of Bone,0
27763,Fibrous,Bladder Neuroendocrine Neoplasm,0
27764,Abnormal host response,Botryoid-Type Embryonal Rhabdomyosarcoma,0
27765,Regulation,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27766,Rate,Hyperplasia of pituitary gland,0
27767,Arsenic measurement,Necrotizing Funisitis,0
27768,Treating,Cervical Fibroepithelial Polyp,0
27769,Known,Spongiotic dermatitis,0
27770,Infrequent,Serous cystadenocarcinoma ovary,0
27771,Response (communication),Engraftment syndrome,0
27772,Management Occupations,Carcinoma,0
27773,Group A (qualifier value),Low Grade Squamous Intraepithelial Neoplasia,0
27774,Scalp structure,Adrenal Rest Tumor,0
27775,Contusions,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27776,Slow progression,Recurrent Testicular Lymphoma,0
27777,Alcohols,Choroid Necrotic Melanoma,0
27778,Intestines,Carcinoma of urinary bladder,0
27779,Seven-Day Report,Atypical Mesothelial Hyperplasia,0
27780,Digital Content Category,Familial Adenomatous Polyposis Associated Medulloblastoma,0
27781,Complete Agreement,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
27782,Body cavities,Grade 3a Malignant Neoplasm,0
27783,Colorectal Cancer Pathway,Acute lymphadenitis,0
27784,solid substance,Testicular cancer metastatic,0
27785,Including (qualifier),Cancer of Urinary Tract,0
27786,Outlines (document),BRCA2 Syndrome,0
27787,Infrequent,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,0
27788,Imaging Techniques,Prostate Lymphoma,0
27789,Response to treatment,Thymic Clear Cell Carcinoma,0
27790,Detection,Neonatal leukemia,0
27791,Building structure,Trichilemmocarcinoma,0
27792,Abnormal result,Stage II Carcinoma of Penis,0
27793,Healthy,Digestive System Hodgkin Lymphoma,0
27794,Pelvis,Pilocytic astrocytoma of cerebellum,0
27795,30%,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27796,To,Recurrent Testicular Lymphoma,0
27797,various other intestinal adsorbents in ATC,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27798,Levels (qualifier value),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
27799,0%,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27800,diagnosis aspect,squamous cell carcinoma of the thyroid gland,0
27801,Part,Malignant neoplasm of thalamus,0
27802,Bowen's Disease,Stage 0 Penile Cancer AJCC v8,0
27803,Major,FIGO Stage II Ovarian Cancer,0
27804,Lymphocyte component of blood,Acute Undifferentiated Leukemia,0
27805,LATS1 wt Allele,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27806,erythropoietin activity,Refractory Barrett Esophagus,0
27807,Greater,Recurrent Testicular Lymphoma,0
27808,Malignant neoplasm of soft tissue,Low Grade Squamous Intraepithelial Neoplasia,0
27809,newly,Acantholytic squamous cell carcinoma,0
27810,Body tissue,Blepharal carcinoma,0
27811,Rare Diseases,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27812,include - SetOperator,FIGO Stage IVA Ovarian Cancer,0
27813,Smaller,Blood Vessel Tumors,0
27814,Logical Condition,Colorectal High Grade B-Cell Lymphoma,0
27815,Occurrence Indicator,Choroid Epithelioid Cell Melanoma,0
27816,Occurrence Indicator,Recurrent Primary Lymphoma of Bone,0
27817,Diabetes Mellitus,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27818,Absence (morphologic abnormality),Thyroid Hurthle Cell Carcinoma,0
27819,Subgroup A Nepoviruses,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
27820,Small intestine carcinoma,Collecting Duct Carcinoma of the Kidney,0
27821,Blast count procedure,Bladder squamous cell carcinoma stage I,0
27822,Reaction,Tonsillar Carcinoma,0
27823,Tumor tissue sample,Uterine Cancer,0
27824,Problems - What subject filter,Anterior Urethral Malignant Neoplasm,0
27825,History,Adenocarcinoma of the prostate metastatic,0
27826,Late,Grade 3a Malignant Neoplasm,0
27827,0%,Recurrent Testicular Lymphoma,0
27828,Web Site,Mastocytosis,0
27829,SUSPENSORY,Human Papillomavirus-Related Carcinoma,0
27830,Retinoic Acid Response Element,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27831,peripheral blood,FIGO Stage IVA Ovarian Cancer,0
27832,Pancreatic Cyst,Bladder adenocarcinoma stage IV,0
27833,Alternative,BRCA2 Syndrome,0
27834,Non-Small Cell Lung Carcinoma,Mastocytosis,0
27835,chance,Stage I Adult Non-Hodgkin Lymphoma,0
27836,bony process,Metaplastic carcinoma of breast,0
27837,Form:Finding:Point in time:{Setting}:Document:{Role},Stage III Gastric Neuroendocrine Tumor AJCC v8,0
27838,Study,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27839,Average,Cerebral hemangioma,0
27840,Presentation,Pleomorphic adenoma of parotid gland,0
27841,size,Larynx carcinoma recurrent,0
27842,Have Itch,Bladder Neuroendocrine Neoplasm,0
27843,Group A (blood group),Fibroadenoma of breast,0
27844,Occur (action),High Grade Glandular Intraepithelial Neoplasia,0
27845,Leading,Pilocytic astrocytoma of cerebellum,0
27846,Nictitating Membrane,Thyroid Hurthle Cell Carcinoma,0
27847,World,Atypical Lobular Breast Hyperplasia,0
27848,<90,Papillary cystic tumor,0
27849,Treatment Epoch,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
27850,Hereditary Diseases,Childhood Cerebellar Neoplasm,0
27851,System (unit of presentation),Recurrent Testicular Lymphoma,0
27852,shared attribute,Neonatal leukemia,0
27853,Primary,Benign Anal Granular Cell Tumor,0
27854,Hormonal Contraception,Familial Adenomatous Polyposis Associated Medulloblastoma,0
27855,Clouded consciousness,Peripheral primitive neuroectodermal tumor of soft tissue,0
27856,Definitely Related to Intervention,Benign Anal Granular Cell Tumor,0
27857,Ability,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27858,Tumor Mass,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
27859,Infrequent,Multiple Skull Base Meningiomas,0
27860,Concept model range (foundation metadata concept),Giant cell angiofibroma,0
27861,Abdomen,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27862,Intercellular Junctions,Noninfiltrating Intraductal Carcinoma,0
27863,Weight Loss,Thymic Atypical Carcinoid Tumor,0
27864,Singular,Childhood Lung Non-Small Cell Carcinoma,0
27865,Academic degree,Basal Cell Ameloblastoma,0
27866,Human body structure,Carcinoma,0
27867,potential,Cancer of Urinary Tract,0
27868,NCI CTEP SDC Cervical Cancer Sub-Category Terminology,Metastatic Malignant Neoplasm in the Sellar Region,0
27869,Squamous cell carcinoma - category,Chronic Myelomonocytic Leukemia-2,0
27870,Skin,Intestinal Metaplasia of Bladder Urothelium,0
27871,Designated Blood Product Donation,Refractory Ependymoma,0
27872,Pale feces (finding),Cerebral Primitive Neuroectodermal Tumor,0
27873,Plasma,Rhabdomyosarcoma with ganglionic differentiation,0
27874,Shapes,malignant lymphoma of pancreatic lymph nodes,0
27875,Rosette formation,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
27876,High,Digestive System Hodgkin Lymphoma,0
27877,Including (qualifier),Blepharal carcinoma,0
27878,Immunotherapy,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
27879,Within,Astrocytoma of brain,0
27880,*Type - Kind of quantity,Hodgkin Disease,0
27881,High Level,Blepharal carcinoma,0
27882,More,Adenocarcinoma,0
27883,Chemotherapy,Anaplastic large cell lymphoma,0
27884,ovarian,Malignant neoplasm of thalamus,0
27885,Back structure,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27886,Make - Instruction Imperative,sarcoma of spinal cord,0
27887,Fever,Adult Alveolar Soft Part Sarcoma,0
27888,Retinoid [EPC],Astrocytoma of brain,0
27889,Both ovaries,Methotrexate-Associated Hodgkin Lymphoma,0
27890,Turner Syndrome,Acantholytic squamous cell carcinoma,0
27891,Gland,Thyroid Hurthle Cell Carcinoma,0
27892,Known,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27893,Population Group,Clonal Hematopoiesis of Indeterminate Potential,0
27894,Screening,Squamous cell carcinoma of lip,0
27895,Moveable,Breast Ductal Adenoma,0
27896,Fracture,Malignant Neoplasm with Regional Lymph Node Involvement,0
27897,Tobacco user,Ovarian Dermoid Cyst with Secondary Carcinoma,0
27898,Forecast of outcome,High Grade Glandular Intraepithelial Neoplasia,0
27899,To,Nasal cavity carcinoma,0
27900,Present,Squamous cell carcinoma of lip,0
27901,Poor - qualifier,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27902,World Health Organization,FIGO Stage II Ovarian Cancer,0
27903,Change in voice (finding),Central Nervous System Anaplastic Large Cell Lymphoma,0
27904,Odontogenic Epithelium,Cancer of Urinary Tract,0
27905,Most,Bladder adenocarcinoma stage IV,0
27906,Administration procedure,Undifferentiated Neuroblastoma,0
27907,Symptoms,Maxillary Sinus Adenocarcinoma,0
27908,Antigens,Extra-Adrenal Paraganglioma,0
27909,Glioblastoma,Ovarian germ cell choriocarcinoma stage IV,0
27910,Peripheral Nerves,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,0
27911,15-19,Stage III Adult Immunoblastic Lymphoma,0
27912,Occurrence,Type II Endometrial Adenocarcinoma,0
27913,Extension,Neoplasms,0
27914,Cell Device,Anterior Urethral Malignant Neoplasm,0
27915,Fatigue,Papillary squamous cell carcinoma,0
27916,Adolescent (age group),Mucinous adenocarcinoma gastric,0
27917,Frequently,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
27918,Numerous,Thymic Atypical Carcinoid Tumor,0
27919,Disease Screening,Localized Malignant Neoplasm,0
27920,Logical Condition,Plexosarcoma,0
27921,Data Transformation,Thyroid Hurthle Cell Carcinoma,0
27922,Mass of skin,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
27923,melanoma,Pleomorphic adenoma of parotid gland,0
27924,Vaginal Neoplasms,Tongue Alveolar Soft Part Sarcoma,0
27925,Imbrication (procedure),Malignant neoplasm of gallbladder,0
27926,Tumor Mass,Mucosal Melanoma,0
27927,Fatigue,Placental aromatase deficiency,0
27928,Relate - vinyl resin,Melanomatosis,0
27929,radiotherapeutic,Female Breast Carcinoma,0
27930,Intraocular (intended site),Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27931,Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma,Intraepithelial Melanocytic Hyperplasia,0
27932,Intravascular line,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27933,Skin,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27934,Massive,Adult Acute Eosinophilic Leukemia,0
27935,Science of Etiology,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
27936,Specific qualifier value,Chondrosarcoma,0
27937,Low Level,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27938,Use of,Undifferentiated Endocervical Sarcoma,0
27939,photoreactivating enzyme activity,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
27940,Endometrial Carcinoma,Non-Hodgkin Lymphoma During Pregnancy,0
27941,utilization qualifier,Adult Acute Eosinophilic Leukemia,0
27942,Case unit dose,Thymic Atypical Carcinoid Tumor,0
27943,Childhood Lymphoma,Tonsillar Carcinoma,0
27944,+2,Cerebral hemangioma,0
27945,Run-in Period,Malignant Neoplasm with Regional Lymph Node Involvement,0
27946,Malignant tumor of colon,Childhood Lymphoma,0
27947,Prevalence aspects,Airway Hemangioma,0
27948,Germ cell tumor,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
27949,Body Weight,Metastatic Lung Small Cell Carcinoma,0
27950,Cessation of life,Endometrial Small Cell Carcinoma,0
27951,Availability of,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
27952,Feel Pain,Stage III Adult Immunoblastic Lymphoma,0
27953,body system,Contact dermatitis due to alkali,0
27954,Treating,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
27955,Referring,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
27956,Primary malignant neoplasm,Recurrent Testicular Lymphoma,0
27957,Abdominal bloating,Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
27958,Due to,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27959,Malignant - descriptor,Carcinoma ex pleomorphic adenoma of parotid gland,0
27960,*Type - Kind of quantity,Recurrent Testicular Lymphoma,0
27961,Percent (qualifier value),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27962,Neuroglia,Papillary squamous cell carcinoma,0
27963,Malignant Neoplasms,Cervical Fibroepithelial Polyp,0
27964,Malignant Central Nervous System Neoplasm,Choroid Necrotic Melanoma,0
27965,pharmacotherapeutic,Posterior Pharyngeal Wall Squamous Cell Carcinoma,0
27966,Adult Hodgkin Lymphoma,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
27967,Occurrence Indicator,Carcinoma ex pleomorphic adenoma of parotid gland,0
27968,Increase,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,0
27969,Financial Account,Advanced Uterine Corpus Carcinosarcoma,0
27970,WHO Central Nervous System Grade III,Thyroid Hurthle Cell Carcinoma,0
27971,Usual Severity Weight Loss,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
27972,Offspring,Precursor T-lymphoblastic lymphoma/leukemia stage III,0
27973,Recommendation,Bladder squamous cell carcinoma stage I,0
27974,First sign,Recurrent Rhabdomyosarcoma,0
27975,low,Heavy Chain Deposition Disease,0
27976,Collection (action),Nasal cavity carcinoma,0
27977,Anterior,Mucinous adenocarcinoma gastric,0
27978,Science of Etiology,Vaginal Adenoma,0
27979,Post,Lipoma of small intestine,0
27980,Therapeutic radiology procedure,Metaplastic carcinoma of breast,0
27981,Esthesia,Cerebral Primitive Neuroectodermal Tumor,0
27982,Mutation,Intracortical osteosarcoma,0
27983,Cancer Genus,Recurrent Rhabdomyosarcoma,0
27984,Subject Risk,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
27985,Lymphoma,Maxillary Sinus Adenocarcinoma,0
27986,Malignant neoplasm of thymus,Grade 3a Malignant Neoplasm,0
27987,high throughput analysis,Malignant neoplasm of thalamus,0
27988,Treating,Melanomatosis,0
27989,Large,Fibroadenoma of breast,0
27990,Pharmacotherapy,Benign Apocrine Neoplasm,0
27991,Posterolateral,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
27992,intent,ROSE Cluster 3,0
27993,Surgical service,FIGO Stage II Ovarian Cancer,0
27994,Most Recent,Kaposi's sarcoma of skin,0
27995,Loss of appetite (finding),Fourth Ventricle and Brain Stem Ependymal Tumor,0
27996,Most,clear cell adenocarcinoma of gallbladder,0
27997,Chest Pain,Basal Cell Ameloblastoma,0
27998,All of the Time,Glomeruloid hemangioma,0
27999,Genus Homo,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28000,Childhood,Stage I Adult Non-Hodgkin Lymphoma,0
28001,Organ,Type II Endometrial Adenocarcinoma,0
28002,4+ Answer to question,Malignant melanoma of eyelid,0
28003,Erythropoiesis,Chest Wall Fibromatosis,0
28004,Term Birth,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
28005,CDISC SEND Tumor Findings Results Terminology,Thyroid Hurthle Cell Carcinoma,0
28006,Rare,Locally Advanced Epithelioid Hemangioendothelioma,0
28007,Togo,Splenic Manifestation of Hairy Cell Leukemia,0
28008,Smaller,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28009,Usual Severity Weight Loss,Prostate Lymphoma,0
28010,Structure of germinal center of lymph node,Medulloblastoma,0
28011,Occur (action),Cervical Fibroepithelial Polyp,0
28012,Primary malignant neoplasm,Adult Hepatocellular Carcinoma,0
28013,Malignant neoplasm of skin,Splenic Manifestation of Hairy Cell Leukemia,0
28014,Benign,Bladder squamous cell carcinoma stage I,0
28015,Usual Severity Weight Loss,Ovarian Dermoid Cyst with Secondary Carcinoma,0
28016,Pulmonary aspiration,Liver Lymphangioma,0
28017,Membrane,High Grade Glandular Intraepithelial Neoplasia,0
28018,Usually,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28019,Malignancy,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
28020,Treatment Epoch,Maxillary Sinus Adenocarcinoma,0
28021,Primary malignant neoplasm,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
28022,Carcinoma of lung,Astrocytoma of brain,0
28023,Analysis,Metastatic Neoplasm to the Gallbladder,0
28024,Including (qualifier),Recurrent Acute Myeloid Leukemia with t (9;11) (p21.3; q23.3); MLLT3-KMT2A,0
28025,Blood,Hereditary Diffuse Gastric Adenocarcinoma,0
28026,Common (qualifier value),Recurrent Primary Lymphoma of Bone,0
28027,Retained,Ichthyosis,0
28028,Fever,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
28029,Referring,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,0
28030,Comparison,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,0
28031,Areas <moth>,Fibroadenoma of breast,0
28032,Surface,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
28033,Taxonomic,Malignant melanoma of eyelid,0
28034,Sometimes,Refractory Barrett Esophagus,0
28035,Call (Instruction),Stage IV Penile Cancer AJCC v7,0
28036,development aspects,Adult Hepatocellular Carcinoma,0
28037,Extrinsic,Benign Anal Granular Cell Tumor,0
28038,Often - answer to question,Malignant neoplasm of thalamus,0
28039,Hemopoietic tissue,Microcystic meningioma,0
28040,Pigment cell,Benign Apocrine Neoplasm,0
28041,Sunscreening Agents,Clinical Stage I Cutaneous Melanoma AJCC v8,0
28042,Mass of body structure,Intraepithelial Melanocytic Hyperplasia,0
28043,Invasive Ductal Breast Carcinoma,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28044,Squamous,adenoid cystic carcinoma of lung,0
28045,*Type - Kind of quantity,Childhood Fibrillary Astrocytoma,0
28046,One,High Grade Glandular Intraepithelial Neoplasia,0
28047,Version (morphologic abnormality),High Grade Glandular Intraepithelial Neoplasia,0
28048,Treatment Epoch,Stage 0 Penile Cancer AJCC v8,0
28049,Manufactured form,Pleomorphic adenoma of parotid gland,0
28050,incidence of cases,Familial Hemophagocytic Lymphocytosis,0
28051,Biologic Development,Carcinomatosis of peritoneal cavity,0
28052,Human body,Pilocytic astrocytoma of cerebellum,0
28053,Common Specifications in HL7 V3 Publishing,Bladder adenocarcinoma stage IV,0
28054,320,embryonal rhabdomyosarcoma of prostate,0
28055,With texture,Benign neoplasm of eye,0
28056,Body cavities,Melanomatosis,0
28057,Name,Splenic Manifestation of Hairy Cell Leukemia,0
28058,Talpidae,Metastatic Neoplasm to the Gallbladder,0
28059,1+,Clinical Stage I Cutaneous Melanoma AJCC v8,0
28060,Less Than,Melanomatosis,0
28061,Account number:Identifier:Point in time:^Patient:Nominal,Lymphomatous Adult T-Cell Leukemia/Lymphoma,0
28062,Table Rules - groups,Diffuse malignant mesothelioma,0
28063,IPSS Risk Category Low,Choroid Necrotic Melanoma,0
28064,Human body structure,Ovarian germ cell choriocarcinoma stage IV,0
28065,Nicotiana,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
28066,Highest,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,0
28067,85,Extra-abdominal fibromatosis,0
28068,Abdominal bloating,Locally Advanced Squamous Cell Carcinoma,0
28069,Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,0
28070,Cancer Genus,Thymic Clear Cell Carcinoma,0
28071,Tumor size,Benign Anal Granular Cell Tumor,0
28072,Parotid Neoplasms,FIGO Stage II Ovarian Cancer,0
28073,Occurrence,Cerebral hemangioma,0
28074,Mechanism (attribute),adenoid cystic carcinoma of lung,0
28075,severe reaction,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
28076,Derived value,Choroid Necrotic Melanoma,0
28077,AMACR wt Allele,Adult Anaplastic Oligodendroglioma,0
28078,Approximate,Type II Endometrial Adenocarcinoma,0
28079,Childhood Lymphoma,Recurrent Uveal Melanoma,0
28080,Togo,Benign tumor of eyelid,0
28081,Adrenal mass,Anterior Urethral Malignant Neoplasm,0
28082,gene therapy,Ovarian germ cell choriocarcinoma stage IV,0
28083,Surgery specialty,Peripheral primitive neuroectodermal tumor of soft tissue,0
28084,Easy bleeding,Heavy Chain Deposition Disease,0
28085,Carcinoma of lung,Undifferentiated Endocervical Sarcoma,0
28086,Primary malignant neoplasm of lung,Clinical Stage I Cutaneous Melanoma AJCC v8,0
28087,Malignant neoplasm of appendix,Undifferentiated Neuroblastoma,0
28088,Neoplastic disease,Neonatal leukemia,0
28089,Noninvasive,Multiple Skull Base Meningiomas,0
28090,Minor (person),Tubal Hyperplasia,0
28091,Nervous system structure,Heavy Chain Deposition Disease,0
28092,Additional,Refractory Ependymoma,0
28093,Neoplastic disease,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28094,Infarction,Unresectable Rhabdomyosarcoma,0
28095,Malignant neoplasm of oropharynx,Choroid Necrotic Melanoma,0
28096,Contusions,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28097,All of the Time,Stage III Cutaneous Melanoma AJCC v6,0
28098,Progress,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
28099,And/Or,Benign Anal Granular Cell Tumor,0
28100,Associated with,Childhood Central Nervous System Ganglioneuroblastoma,0
28101,Never (frequency),Ichthyoses,0
28102,Approximate,Collecting Duct Carcinoma of the Kidney,0
28103,Circulating blood,Leptomeningeal sarcoma,0
28104,body system,Methotrexate-Associated Hodgkin Lymphoma,0
28105,Time,de novo Myelodysplastic Syndrome,0
28106,shared attribute,Mucinous cystadenofibroma,0
28107,Direct (qualifier),Adult Acute Eosinophilic Leukemia,0
28108,Total,FIGO Stage IVA Ovarian Cancer,0
28109,Disease,Cerebral Primitive Neuroectodermal Tumor,0
28110,Seizures,Engraftment syndrome,0
28111,Tumor Mass,Colorectal cancer,0
28112,Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,0
28113,Complication Aspects,Kaposi's sarcoma of skin,0
28114,Scaling,Carcinoma,0
28115,Child,embryonal rhabdomyosarcoma of prostate,0
28116,Pleomorphic,Stage III Cutaneous Melanoma AJCC v6,0
28117,65+,Melanomatosis,0
28118,What subject filter - Result,Liver Cavernous Hemangioma,0
28119,Sometimes,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
28120,Delta (difference),Medulloblastoma,0
28121,Human body,Carcinoma,0
28122,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Stage III Cutaneous Melanoma AJCC v6,0
28123,Back,Digestive System Hodgkin Lymphoma,0
28124,Tube - unit dose,adenosquamous carcinoma of breast,0
28125,Sample Range,Engraftment syndrome,0
28126,Tryptophanase,Fibroadenoma of breast,0
28127,Metastatic Neoplasm,Congenital hamartoma,0
28128,Morphology,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
28129,Group A (blood group),Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28130,Approximate,Benign tumor of eyelid,0
28131,Newly Diagnosed Childhood Ependymoma,Pathologic Stage III Cutaneous Melanoma AJCC v8,0
28132,Sharing (Social Behavior),Atypical Lobular Breast Hyperplasia,0
28133,metastatic qualifier,FIGO Stage IVA Ovarian Cancer,0
28134,Sometimes,Kaposi's sarcoma of extrahepatic bile duct,0
28135,Measures,Small cell neuroendocrine carcinoma of bladder,0
28136,Symptoms,Stage III Adult Immunoblastic Lymphoma,0
28137,Primary,FIGO Stage IVA Ovarian Cancer,0
28138,Taken,Benign Anal Granular Cell Tumor,0
28139,Data Change Date,Tonsillar Carcinoma,0
28140,Benign,Vaginal Adenoid Cystic Carcinoma,0
28141,Mass of body region,Methotrexate-Associated Hodgkin Lymphoma,0
28142,Case unit dose,Diffuse malignant mesothelioma,0
28143,Mammal liver preparation,Localized Ewing Sarcoma,0
28144,Benign,Benign neoplasm of thorax,0
28145,Percent normal,Transitional cell carcinoma,0
28146,Delta (difference),Toxic Epidermal Necrolysis,0
28147,Age,Testicular cancer metastatic,0
28148,Back Pain,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
28149,Prophylactic behavior,Melanomatosis,0
28150,How Often Shortness of Breath,Hodgkin Disease,0
28151,Areas <moth>,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
28152,Five-year Survival Rate,Benign Anal Granular Cell Tumor,0
28153,Childhood Embryonal Rhabdomyosarcoma,Bladder squamous cell carcinoma stage I,0
28154,Hodgkin Disease,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
28155,Symptoms,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,0
28156,Malignant Neoplasms,Colorectal Neuroendocrine Tumor G2,0
28157,Follicular thyroid carcinoma,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
28158,Person Name,Mixed astrocytoma-ependymoma,0
28159,Patient observation,Mucinous adenocarcinoma gastric,0
28160,83,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
28161,NCI CTEP SDC Hodgkin Lymphoma Sub-Category Terminology,Nasal cavity carcinoma,0
28162,Not Otherwise Specified,Childhood Central Nervous System Ganglioneuroblastoma,0
28163,Complication Aspects,Fibroadenoma of breast,0
28164,radiotherapeutic,Congenital hamartoma,0
28165,Adult Hodgkin Lymphoma,Mucinous adenocarcinoma,0
28166,Congenital Disorders,Locally Advanced Soft Tissue Sarcoma,0
28167,Sharing (Social Behavior),Uterine Cancer,0
28168,Main,Childhood Lung Non-Small Cell Carcinoma,0
28169,Aspect - Kind of quantity,benign mature teratoma of pancreas,0
28170,Adult Lymphoma,Locally Advanced Soft Tissue Sarcoma,0
28171,Smear - instruction imperative,Cancer of Urinary Tract,0
28172,Cancer Genus,Ichthyosis,0
28173,<3 (qualifier value),Medulloblastoma,0
28174,Surgery specialty,Giant cell angiofibroma,0
28175,Less Than,Mucinous adenocarcinoma gastric,0
28176,Enlarged,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
28177,Operative Surgical Procedures,Human Papillomavirus-Related Carcinoma,0
28178,Including (qualifier),clear cell adenocarcinoma of gallbladder,0
28179,Better,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
28180,2+ Score,Refractory Ependymoma,0
28181,Optimistic,Childhood Anaplastic Large Cell Lymphoma,0
28182,Analysis of substances,Thyroid Gland Carcinoma Showing Thymus-Like Differentiation,0
28183,Salivary Gland Neoplasms,Digestive System Hodgkin Lymphoma,0
28184,Time (foundation metadata concept),Refractory Ependymoma,0
28185,Incidence,Methotrexate-Associated Hodgkin Lymphoma,0
28186,Polypeptide Hormones,Localized Ewing Sarcoma,0
28187,Enzymes,Adult Alveolar Soft Part Sarcoma,0
28188,North America,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
28189,Almost All of the Time,Platinum-Resistant Lung Small Cell Carcinoma,0
28190,white blood cell type,Trabecular adenocarcinoma,0
28191,Cellular Debris,Nasal cavity carcinoma,0
28192,Known,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
28193,Occur (action),Stage IB Lung Cancer AJCC v7,0
28194,Damage,Cerebral Primitive Neuroectodermal Tumor,0
28195,cervical cancer,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
28196,Non-small cell carcinoma,Stage IIIB Ovarian Cancer AJCC v6 and v7,0
28197,Large,Platinum-Resistant Lung Small Cell Carcinoma,0
28198,Canis familiaris,Endometrial Small Cell Carcinoma,0
28199,Hemorrhage,Cervical Squamous Intraepithelial Neoplasia,0
28200,Occurrence,Malignant Testicular Non-Seminomatous Germ Cell Tumor,0
28201,Entity Determiner - specific,Localized Askin Tumor,0
28202,NCI CTEP SDC Acute Myeloid Leukemia Sub-Category Terminology,Human Papillomavirus-Related Carcinoma,0
28203,Therapeutic procedure,Adenocarcinoma of the prostate metastatic,0
28204,Rare,Locally Advanced Squamous Cell Carcinoma,0
28205,Control function,Digestive System Hodgkin Lymphoma,0
28206,Ever told by doctor or nurse that you have high blood pressure:Finding:Point in time:^Patient:Ordinal,Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28207,Adamantinoma,Stage II Carcinoma of Penis,0
28208,Male population group,Adult Alveolar Soft Part Sarcoma,0
28209,Enhance (action),FIGO Stage II Ovarian Cancer,0
28210,Benign neoplasm of paraganglion,Engraftment syndrome,0
28211,New Zealand Rabbits,Endometrial Small Cell Carcinoma,0
28212,shared attribute,Malignant melanoma of eyelid,0
28213,Class (taxonomic),Anterior Urethral Malignant Neoplasm,0
28214,Pleura,Stage 0 Penile Cancer AJCC v8,0
28215,2+ Score,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,0
28216,Measured,Spongiotic dermatitis,0
28217,Irritant behavior,Stage 0 Lip Carcinoma,0
28218,Including (qualifier),Intestinal Metaplasia of Bladder Urothelium,0
28219,bony process,Hyperplasia of pituitary gland,0
28220,Source,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
28221,Oral region,Clinical Stage I Cutaneous Melanoma AJCC v8,0
28222,Very Much,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
28223,Adrenal Cortical Adenoma,Childhood Fibrillary Astrocytoma,0
28224,operate <remove>,Cancer of Urinary Tract,0
28225,Invasive Carcinoma,Transitional cell carcinoma,0
28226,Laboratory,Acute Undifferentiated Leukemia,0
28227,Solid,Malignant Neoplasm with Regional Lymph Node Involvement,0
28228,95,Medulloblastoma,0
28229,Cerebrum,Stage III Adult Immunoblastic Lymphoma,0
28230,Effective,Human Papillomavirus-Related Carcinoma,0
28231,Occurrence,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
28232,Is an only child,Kaposi's sarcoma of skin,0
28233,Malignant Squamous Cell Neoplasm,Plexosarcoma,0
28234,Low Grade,Recurrent Testicular Lymphoma,0
28235,Primary,Trabecular adenocarcinoma,0
28236,Minor (person),Adenocarcinoma of the prostate metastatic,0
28237,Group A (qualifier value),Stage IVA Lip and Oral Cavity Cancer AJCC v8,0
28238,adjectives,Bladder squamous cell carcinoma stage I,0
28239,Seminoma,Chest Wall Fibromatosis,0
28240,SLC6A2 wt Allele,Thymic Atypical Carcinoid Tumor,0
28241,Less Than,Adult Alveolar Soft Part Sarcoma,0
28242,Call (Instruction),Locally Advanced Soft Tissue Sarcoma,0
28243,Third,Ovarian Dermoid Cyst with Secondary Carcinoma,0
28244,Five,Mucinous adenocarcinoma gastric,0
28245,Difficulty walking,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,0
28246,Linear,Granular Cell Leiomyosarcoma,0
28247,Doses of vaccine,Cerebral Primitive Neuroectodermal Tumor,0
28248,Absence (morphologic abnormality),Undifferentiated Endocervical Sarcoma,0
28249,Definitely Related to Intervention,Anaplastic large cell lymphoma,0
28250,Include (action),Temporal Lobe Pleomorphic Xanthoastrocytoma,0
28251,Primary malignant neoplasm,Lung Inflammatory Myofibroblastic Tumor,0
28252,Experimental Result,Recurrent Primary Lymphoma of Bone,0
28253,Poor function,Unresectable Rhabdomyosarcoma,0
28254,Symptoms aspect,benign mature teratoma of pancreas,0
28255,Include (action),Malignant Neoplasm with Regional Lymph Node Involvement,0
28256,Use of,Extra-Adrenal Paraganglioma,0
28257,Urinary Diversion,Testicular cancer metastatic,0
28258,Vaginal intraepithelial neoplasia,Localized Askin Tumor,0
28259,Skin condition (observable entity),Grade 3a Malignant Neoplasm,0
28260,Chemicals,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
28261,Brain part,Spongiotic dermatitis,0
28262,Percent (qualifier value),Vaginal Adenoma,0
28263,risk factors,Intestinal Metaplasia of Bladder Urothelium,0
28264,Hematuria,Methotrexate-Associated Hodgkin Lymphoma,0
28265,Condition,Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7,0
28266,Item Collection,Digestive System Hodgkin Lymphoma,0
28267,Asia,Undifferentiated Endocervical Sarcoma,0
28268,Group A (blood group),Astrocytoma of brain,0
28269,device aspects,Colorectal cancer,0
28270,Including (qualifier),ALK positive large B-cell lymphoma,0
28271,Used by,Hodgkin lymphoma,0
28272,Does play,Ann Arbor Stage I Childhood Non-Hodgkin Lymphoma,0
28273,Volume Measurement,Fibroadenoma of breast,0
28274,Chest wall structure,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28275,Presentation,Undifferentiated Endocervical Sarcoma,0
28276,Most,Acute Myeloid Leukemia with t(6;11)(q27;q23); KMT2A-MLLT4,0
28277,Aggressive behavior,Childhood Central Nervous System Immature Teratoma,0
28278,1000000,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,0
28279,66,Stage III Adult Immunoblastic Lymphoma,0
28280,Term Birth,Undifferentiated Neuroblastoma,0
28281,Ultraviolet Rays,Splenic Manifestation of Hairy Cell Leukemia,0
28282,Together,Nasal cavity carcinoma,0
28283,W stress,Basal Cell Ameloblastoma,0
28284,Targeted Therapy,Mucinous adenocarcinoma gastric,0
28285,World,Vaginal Adenoma,0
28286,Normal,Cervical Fibroepithelial Polyp,0
28287,Process,Congenital hamartoma,0
28288,Neoplasms,Metaplastic carcinoma of breast,0
28289,shared attribute,Malignant melanoma of eyelid,0
28290,Procedure (set of actions),Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,0
28291,brain shape,Gallbladder adenoma,0
28292,Cause of death:Find:Pt:^Patient:Nom,Blood Vessel Tumors,0
28293,Case Study,Refractory Barrett Esophagus,0
28294,International Classification of Diseases for Oncology,clear cell adenocarcinoma of gallbladder,0
28295,Bacteria present,Female Breast Carcinoma,0
28296,Problems - What subject filter,Adult Hepatocellular Carcinoma,0
28297,Malignant Neoplasms,Intermediate Soft Tissue Tumor of Uncertain Differentiation,0
28298,Time,Malignant Neoplasm with Regional Lymph Node Involvement,0
28299,Microvolt,Malignant neoplasm of gallbladder,0
28300,Skin lesion,Malignant melanoma of eyelid,0
28301,Togo,Non-Metastatic Gestational Trophoblastic Tumor,0
28302,Administration procedure,Thyroid Hurthle Cell Carcinoma,0
28303,Sleeping Pills,Advanced Lung Carcinoma,0
28304,Case unit dose,Small Lymphocytic Lymphoma with Immunoglobulin Heavy Chain Variable-Region Gene Somatic Hypermutation,0
28305,Scaly skin,Pancreatic carcinoma,0
28306,development aspects,Fibroadenoma of breast,0
28307,Line Specimen,Localized Ewing Sarcoma,0
28308,Neoplasm Metastasis,Splenic Manifestation of Hairy Cell Leukemia,0
28309,Cardiac Lead Procedure,Epipodophyllotoxin-Related Myelodysplastic Syndrome,0
28310,Spreading (qualifier value),Metastatic Neoplasm to the Gallbladder,0
28311,Egg of order Phthiraptera,Cervical Squamous Intraepithelial Neoplasia,0
28312,Biological Transport,Stage IB Lung Cancer AJCC v7,0
28313,Mediate,Colorectal High Grade B-Cell Lymphoma,0
28314,Paraneoplastic Syndromes,gliosarcoma,0
28315,Oral cavity,Acute Undifferentiated Leukemia,0
28316,Extrinsic,Glomeruloid hemangioma,0
28317,Renal Cell Carcinoma Pathway,Benign Anal Granular Cell Tumor,0
28318,World,Botryoid-Type Embryonal Rhabdomyosarcoma,0
28319,Referral placed,Intraocular Malignant Peripheral Nerve Sheath Tumor,0
28320,AKT1S1 gene,Pathologic Stage IA Cutaneous Melanoma AJCC v8,0
28321,Current (present time),Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
28322,Genetic,Breast Ductal Adenoma,0
28323,therapeutic aspects,Ovarian germ cell choriocarcinoma stage IV,0
28324,Tubal Ligation,Recurrent Ph-Like Acute Lymphoblastic Leukemia,0
28325,Advanced phase,Metastatic Lung Neuroendocrine Neoplasm,0
28326,Mass of body structure,Localized Ewing Sarcoma,0
28327,French language,Fibroadenoma of breast,0
28328,Pitch - substance,papillary carcinoma of penis,0
28329,Monitor,Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,0
28330,Fibrotic Stroma Formation,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
28331,Neuroendocrine Differentiation,Ampulla of Vater Neuroendocrine Tumor,1
28332,Regional Disease,Locally Advanced Unresectable Pancreatic Adenocarcinoma,1
28333,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
28334,Malignant Cellular Infiltrate,Malignant Diencephalic Neoplasm,1
28335,Recurrent Lymphoma,EBV-Related Lymphoma,1
28336,Secondary Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,1
28337,Metastatic Lesion,Metastatic Lung Adenosquamous Carcinoma,1
28338,Mild dysplasia,Colorectal Low Grade Intraepithelial Neoplasia,1
28339,Benign Cellular Infiltrate,Benign Childhood Germ Cell Tumor,1
28340,Malignant Germinomatous Cellular Infiltrate,"Seminoma, anaplastic",1
28341,Ineffective hematopoiesis,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
28342,Epithelial Component Present,Adenoid cystic carcinoma of parotid gland,1
28343,Spontaneous Regression,keratoacanthoma,1
28344,Epithelial Component Present,"Carcinoma, Transitional Cell",1
28345,Extensive Stage Lesion,Advanced Favorable Non-Hodgkin Lymphoma,1
28346,Recurrent disease,Recurrent Childhood Lymphomatoid Granulomatosis,1
28347,Osseous Differentiation,Primary Bone Osteosarcoma,1
28348,Epithelial Component Present,Occult Lung Adenocarcinoma,1
28349,Diffuse Pattern,Anaplastic astrocytoma,1
28350,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Brain,1
28351,Dilated Cystic Spaces Present,Tubulocystic renal cell carcinoma,1
28352,Malignant Cellular Infiltrate,Chronic leukemia (category),1
28353,Neuroectodermal Differentiation,Recurrent Olfactory Neuroblastoma,1
28354,Malignant Cellular Infiltrate,Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8,1
28355,Neuroendocrine Differentiation,"Extra-adrenal paraganglioma, malignant",1
28356,Malignant Cellular Infiltrate,Adult Acute Myelomonocytic Leukemia,1
28357,Epithelial Component Present,Gastric Body Carcinoma,1
28358,Primary Lesion,Medullary Hemangioblastoma,1
28359,Epithelial Component Present,Ampulla of Vater Cancer by AJCC v8 Stage,1
28360,Neuronal Differentiation,Extraventricular neurocytoma,1
28361,Epithelial Component Present,Refractory Adrenal Gland Pheochromocytoma,1
28362,Cystic Change,Cystadenocarcinoma of pancreas,1
28363,Poorly Differentiated Neuroendocrine Lesion,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
28364,Malignant Cellular Infiltrate,Malignant Peripheral Nerve Sheath Tumor,1
28365,Cysts Containing Proteinaceous Fluid Present,Serous cystadenocarcinoma of pancreas,1
28366,Adulthood Lesion,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,1
28367,Intestinal metaplasia,Intestinal Metaplasia of Bladder Urachal Epithelium,1
28368,Epithelial Component Present,Non-small cell lung cancer recurrent,1
28369,Benign Cellular Infiltrate,Osteoma,1
28370,Benign Cellular Infiltrate,Benign neoplasm of bladder,1
28371,High Grade Lesion,Proneural Glioblastoma,1
28372,Hereditary Lesion,Familial Paraganglioma-Pheochromocytoma Syndrome,1
28373,Benign Cellular Infiltrate,Tumorlet,1
28374,High Mitotic Activity,Rectal Small Cell Neuroendocrine Carcinoma,1
28375,Hyaline Cartilage Differentiation,Chondroma,1
28376,Papillary Pattern,Papillary mucinous cystadenocarcinoma,1
28377,Angiocentric Pattern,Grade I Lymphomatoid Granulomatosis,1
28378,Anaplasia,Infratentorial Glioblastoma,1
28379,Carcinomatous Component Present,Recurrent Gastroesophageal Junction Adenocarcinoma,1
28380,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
28381,Necrotic changes (finding),MGMT-Unmethylated Glioblastoma,1
28382,Epithelial Component Present,Undifferentiated carcinoma of ovary,1
28383,Stromal Invasion,Recurrent Ovarian Endometrioid Adenocarcinoma,1
28384,Malignant Cellular Infiltrate,mesenchymal chondrosarcoma of bone,1
28385,Papillary Pattern,Urethral Verrucous Carcinoma,1
28386,Malignant Cellular Infiltrate,Non-Metastatic Childhood Soft Tissue Sarcoma,1
28387,Cutaneous Involvement,Stage I Cutaneous Melanoma AJCC v6,1
28388,Exophytic Polypoid Lesion,Fundic gland polyp,1
28389,Lobulated Growth Pattern,Juxta-Articular Myxoma,1
28390,Carcinomatous Component Present,Adult Liver Carcinoma,1
28391,Indolent Clinical Course,Urethral Leiomyoma,1
28392,Perivascular Arrangement of Tumor Cells,Telangiectatic Glomangioma,1
28393,Malignant Cellular Infiltrate,Stage IVB Colon Cancer AJCC v7,1
28394,Syncytial Pattern,Oropharyngeal lymphoepithelioma stage III,1
28395,Neuroendocrine Differentiation,Intestinal Neuroendocrine Neoplasm,1
28396,Benign Cellular Infiltrate,Breast Pleomorphic Adenoma,1
28397,Lesion with Diameter of 10mm or Less,Functioning Pituitary Gland Microadenoma,1
28398,Malignant Cellular Infiltrate,Stage IIIA Anal Cancer AJCC v8,1
28399,Carcinomatous Component Present,solid type ductal carcinoma in situ of breast,1
28400,Hyaline Cartilage Differentiation,Adult Mesenchymal Chondrosarcoma,1
28401,Epithelial Component Present,Recurrent Salivary Duct Carcinoma,1
28402,Refractory Disease,Refractory Mature B-Cell Non-Hodgkin Lymphoma,1
28403,Recurrent disease,Recurrent Adult Spinal Cord Neoplasm,1
28404,Cutaneous Involvement,Carcinoma in situ of skin,1
28405,Recurrent disease,Recurrent Primary Peritoneal Carcinoma,1
28406,Carcinomatous Component Present,Extraocular Cutaneous Sebaceous Carcinoma,1
28407,Nuclear Molding,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
28408,Mild cytologic atypia,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
28409,Absence of Invasion,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
28410,Therapy-Related Toxicity,Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder,1
28411,Carcinomatous Component Present,Central Nervous System Carcinoma,1
28412,Malignant Cellular Infiltrate,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
28413,Nuclear Atypia,Childhood Giant Cell Glioblastoma,1
28414,Epithelial Component Present,Stage I Anal Cancer AJCC v8,1
28415,Papillary Pattern,Fallopian Tube Papillary Adenocarcinoma,1
28416,High Grade Lesion,Recurrent Childhood Giant Cell Glioblastoma,1
28417,Infiltrative Growth Pattern,Malignant Uterine Corpus PEComa,1
28418,Malignant Cellular Infiltrate,Cholangiocarcinoma metastatic,1
28419,Benign Cellular Infiltrate,Infantile digital fibromatosis,1
28420,Extraosseous Lesion,Extraskeletal osteosarcoma non-metastatic,1
28421,Cutaneous Involvement,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
28422,Carcinomatous Component Present,Pancreatic carcinoma,1
28423,Malignant Cellular Infiltrate,Malignant tumor of epididymis,1
28424,Epithelial Component Present,Adenocarcinoma of the rete testis,1
28425,Carcinomatous Component Present,Clinical Stage 0 Gastric Cancer AJCC v8,1
28426,Vascular Channel Formation,Childhood Conventional Osteosarcoma,1
28427,Epithelial Component Present,Carcinoma of larynx,1
28428,Recurrent disease,Recurrent Adult Soft Tissue Sarcoma,1
28429,Poorly Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Carcinoma,1
28430,Metastatic Lesion,Advanced Nasopharyngeal Squamous Cell Carcinoma,1
28431,Adnexal Differentiation,apocrine adenocarcinoma of vulva,1
28432,Monoclonal Cellular Population Present,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease",1
28433,Diffuse Lesion,"Diffuse midline glioma, point mutation K27M in histone H3",1
28434,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Adenocarcinoma,1
28435,Carcinomatous Component Present,Cervix carcinoma recurrent,1
28436,Primary Lesion,Giant Cell Glioblastoma,1
28437,Malignant Cellular Infiltrate,Malignant Ovarian Teratoma,1
28438,Invasive Lesion,Prostate Undifferentiated Carcinoma,1
28439,Well Differentiated Neuroendocrine Lesion,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,1
28440,Cystic Change,Mucinous cystadenoma of ovary,1
28441,Carcinomatous Component Present,Locally Advanced Digestive System Carcinoma,1
28442,Malignant Cellular Infiltrate,Ovarian Lymphoma,1
28443,Benign Cellular Infiltrate,Thyroid Gland Oncocytic Adenoma,1
28444,Hypokalemia,Pancreatic Vipoma,1
28445,Recurrent disease,Recurrent Prostate Acinar Adenocarcinoma,1
28446,Acral Lesion,Primary cutaneous acral CD8 positive T-cell lymphoma,1
28447,Malignant Cellular Infiltrate,small cell carcinoma of larynx,1
28448,Malignant Cellular Infiltrate,Stage IV Merkel Cell Carcinoma AJCC v7,1
28449,Carcinomatous Component Present,Stage III Prostate Cancer AJCC v8,1
28450,Malignant Cellular Infiltrate,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive",1
28451,Secondary Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,1
28452,Well Differentiated Lesion,Laryngeal verrucous carcinoma recurrent,1
28453,Malignant Cellular Infiltrate,Epithelioid Cell Melanoma,1
28454,Epithelial Component Present,Apocrine Breast Carcinoma In Situ,1
28455,Epithelial Component Present,Anal Papillary Hidradenoma,1
28456,CD30-Positive Neoplastic Cells Present,Recurrent Anaplastic Large Cell Lymphoma,1
28457,Mucoid Stroma Formation,mucinous adenocarcinoma of rectum,1
28458,Well-Circumscribed Lesion,Rectal Juvenile Polyp,1
28459,Malignant Cellular Infiltrate,follicular malignant lymphoma of breast,1
28460,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
28461,Malignant Cellular Infiltrate,Vaginal Basaloid Carcinoma,1
28462,Childhood Lesion,Childhood Fibrosarcoma,1
28463,Neuroendocrine Differentiation,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
28464,Carcinomatous Component Present,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
28465,Epithelial Component Present,Advanced Squamous Cell Carcinoma of the Oropharynx,1
28466,Malignant Cellular Infiltrate,Malignant Mixed Tumor of the Major Salivary Gland,1
28467,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v8 Stage,1
28468,Cystic Change,Low Grade Salivary Gland Mucoepidermoid Carcinoma,1
28469,Metastatic/Recurrent Disease,Cardiac Biphasic Synovial Sarcoma,1
28470,Epithelial Component Present,Stage 0 Lip Carcinoma,1
28471,Adulthood Lesion,Stage III Adult Liver Cancer AJCC v7,1
28472,Indolent Clinical Course,Chondroma,1
28473,Rapidly Enlarging Mass,Laryngeal Basaloid Carcinoma,1
28474,Exophytic Polypoid Lesion,Colorectal Tubular Adenoma,1
28475,Carcinomatous Component Present,Stage IIB Esophageal Adenocarcinoma AJCC v7,1
28476,Solitary mass,Sellar Chordoma,1
28477,Malignant Cellular Infiltrate,Sellar Neuroblastoma,1
28478,Malignant Cellular Infiltrate,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,1
28479,Vascular Channel Formation,Superficial angiomyxoma,1
28480,Childhood Lesion,Childhood Choroid Plexus Neoplasm,1
28481,Malignant Cellular Infiltrate,Colorectal Serrated Adenocarcinoma,1
28482,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type",1
28483,Malignant Cellular Infiltrate,Stage I Renal Pelvis and Ureter Cancer AJCC v8,1
28484,Carcinomatous Component Present,Cervical Cancer by AJCC v6 Stage,1
28485,Carcinomatous Component Present,signet ring cell carcinoma of breast,1
28486,Vascular Channel Formation,Vascular Breast Neoplasm,1
28487,Poorly Differentiated Neuroendocrine Lesion,Unresectable Pancreatic Neuroendocrine Carcinoma,1
28488,Metastatic Lesion,Disseminated adenocarcinoma,1
28489,Neoplastic Plasma Cells Present in Bone Marrow,ISS Stage I Plasma Cell Myeloma,1
28490,Preserved Nuclear Polarity,Ureter Inverted Papilloma,1
28491,Immunologic Deficiency Syndromes,AIDS-Related Isosporiasis,1
28492,Poorly Differentiated Neuroendocrine Lesion,Gastric Small Cell Carcinoma,1
28493,Primary Lesion,Adult Brain Stem Astrocytoma,1
28494,Cutaneous Involvement,Verrucous epidermal nevus,1
28495,Calcitonin Positive Neoplastic Cells Present,Stage IV Thyroid Gland Medullary Carcinoma AJCC v8,1
28496,Mild cytologic atypia,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
28497,Epithelial Component Present,External Auditory Canal Ceruminous Adenoma,1
28498,Metastatic Lesion,Meningeal Leukemia,1
28499,Epithelial Component Present,Rectal Neuroendocrine Tumor by AJCC v8 Stage,1
28500,Epithelial Component Present,Basaloid carcinoma,1
28501,Primary Lesion,Localized Resectable Adult Hepatocellular Carcinoma,1
28502,Endophytic Tumor Growth,Subglottic Verrucous Carcinoma,1
28503,Secondary Lesion,Skin squamous cell carcinoma metastatic,1
28504,Malignant Cellular Infiltrate,Ovarian adenocarcinoma,1
28505,Carcinomatous Component Present,Carcinoma of anal canal,1
28506,Malignant Cellular Infiltrate,Distal Urethral Carcinoma,1
28507,Secondary Lesion,Breast Carcinoma Metastatic in the Liver,1
28508,Cutaneous Involvement,Epidermolytic acanthoma,1
28509,Epithelial Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
28510,Malignant Cellular Infiltrate,Stage IVB Cervical Cancer AJCC v6 and v7,1
28511,Metastatic Lesion,Adenocarcinoma of Unknown Primary,1
28512,Carcinomatous Component Present,Metastatic Carcinoma in the Adrenal Medulla,1
28513,Epithelial Component Present,"Vulvar Adenocarcinoma, Intestinal-Type",1
28514,Malignant Cellular Infiltrate,Stage II Colon Cancer,1
28515,Epithelial Component Present,Vulvar Keratoacanthoma,1
28516,Cutaneous Involvement,Balloon cell malignant melanoma,1
28517,Malignant Cellular Infiltrate,"Adenocarcinoma of lung, stage IV",1
28518,Tubular Structures of Glycogen-Rich Non-Ciliated Cells Present,Pulmonary Blastoma,1
28519,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
28520,Malignant Cellular Infiltrate,Corneal Melanoma,1
28521,Papillary Pattern,Gallbladder Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
28522,Epithelial Component Present,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
28523,Metastatic Lesion,Locally Advanced Angiosarcoma,1
28524,Peripheral Blood Involvement,Acute Adult T-Cell Leukemia/Lymphoma,1
28525,Malignant Cellular Infiltrate,Unresectable Leiomyosarcoma,1
28526,Non-Invasive Lesion,Bladder papilloma,1
28527,Malignant Cellular Infiltrate,High Grade Sarcoma,1
28528,Diffuse Pattern,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
28529,Malignant Cellular Infiltrate,Minor Salivary Gland Adenocarcinoma,1
28530,Childhood Lesion,Childhood Gastric Carcinoma,1
28531,High Mitotic Activity,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
28532,Neuroendocrine Differentiation,Small Intestinal Neuroendocrine Carcinoma,1
28533,Non-Invasive Lesion,Stage 0a Ureter Cancer AJCC v7,1
28534,Metastatic Lesion,Secondary malignant neoplasm of vertebral column,1
28535,Metastatic Lesion,Secondary malignant neoplasm of colon,1
28536,High Grade Lesion,Anaplastic astrocytoma,1
28537,Benign Cellular Infiltrate,Benign Teratoma,1
28538,Epithelial Component Present,Stage IIIA Eyelid Carcinoma AJCC v8,1
28539,Carcinomatous Component Present,External Ear Squamous Cell Carcinoma,1
28540,Secondary Lesion,Locally Advanced Chordoma,1
28541,Absence of Invasion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,1
28542,Low Mitotic Activity,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,1
28543,Invasive Lesion,Invasive Malignant Neoplasm,1
28544,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx recurrent,1
28545,Malignant Cellular Infiltrate,Infant Leukemia,1
28546,Ventricular Involvement Only,Ventricular Ependymal Tumor,1
28547,Well Differentiated Neuroendocrine Lesion,Stage I Jejunal Neuroendocrine Tumor AJCC v8,1
28548,Malignant Cellular Infiltrate,Leiomyosarcoma NCI Grade 2,1
28549,Malignant Cellular Infiltrate,Stage IIA Small Intestinal Cancer AJCC v7,1
28550,Malignant Cellular Infiltrate,Stage IIB Gallbladder Cancer AJCC v8,1
28551,Carcinomatous Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
28552,Malignant Cellular Infiltrate,Oropharyngeal squamous cell carcinoma recurrent,1
28553,High Mitotic Activity,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
28554,Dysplasia,Hepatocellular Small Cell Change,1
28555,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage II,1
28556,Blasts of Mixed Phenotype Present,acute biphenotypic leukemia in relapse,1
28557,Acute inflammation,"lymphomatoid papulosis, type A",1
28558,Malignant Cellular Infiltrate,"Carcinoma, Transitional Cell",1
28559,Malignant Cellular Infiltrate,AIDS-Related Diffuse Large B-cell Lymphoma,1
28560,High Mitotic Activity,Pleomorphic Variant Mantle Cell Lymphoma,1
28561,Carcinomatous Component Present,Carcinoma in situ of vagina,1
28562,Cutaneous Involvement,Cutaneous Melanoma by AJCC v6 Stage,1
28563,Epithelial Component Present,Clinical Stage I Gastric Cancer AJCC v8,1
28564,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
28565,Primary Lesion,Refractory Central Nervous System Lymphoma,1
28566,Serotonin Positive Neoplastic Cells Present,Colon Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
28567,Cavernous Vascular Space Formation,Intracranial cavernous hemangioma,1
28568,Epithelial Component Present,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
28569,Metastatic Lesion,Breast Carcinoma Metastatic in the Skin,1
28570,Benign Cellular Infiltrate,Benign fibrohistiocytic neoplasm,1
28571,High Mitotic Activity,Cervical Large Cell Neuroendocrine Carcinoma,1
28572,Low Mitotic Activity,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
28573,Refractory Disease,Refractory Pancreatic Carcinoma,1
28574,Malignant Cellular Infiltrate,Lymphoma stage,1
28575,Pathologic TNM Finding,Pathologic Stage IB Gastric Cancer AJCC v8,1
28576,Malignant Cellular Infiltrate,Stage IIIA Vulvar Cancer AJCC v7,1
28577,Epithelial Component Present,Metastatic gastric adenocarcinoma,1
28578,Indolent Clinical Course,Intermediate Rhabdomyoma,1
28579,Carcinomatous Component Present,Stage IVA Bladder Cancer AJCC v8,1
28580,Malignant Cellular Infiltrate,Refractory Liposarcoma,1
28581,Indolent Clinical Course,Odontogenic myxofibroma,1
28582,Deep Lesion,Deep Hemangioma,1
28583,Transformed Phase of Disease,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,1
28584,Epithelial Component Present,insulinoma,1
28585,Cutaneous Involvement,Malignant vascular tumor of skin,1
28586,Tissue Differentiation Uncertain,Uterine Corpus PEComa,1
28587,Adulthood Lesion,Adult Central Nervous System Neoplasm,1
28588,Carcinomatous Component Present,Small Intestinal Signet Ring Cell Carcinoma,1
28589,Local disease,Adrenal Cortex Adenomatoid Tumor,1
28590,Malignant Cellular Infiltrate,Stage IIIB Uveal Melanoma AJCC v7,1
28591,Unicystic Lesion,intraductal papilloma of salivary gland,1
28592,Metastatic/Recurrent Disease,Extrarenal rhabdoid tumor,1
28593,Cystic Change,Apocrine cystadenoma,1
28594,Primary Lesion,Childhood Conventional Osteosarcoma,1
28595,Nested Pattern,Ovarian gonadoblastoma,1
28596,Cystic Change,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
28597,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gestational choriocarcinoma,1
28598,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage I site unspecified,1
28599,Malignant Cellular Infiltrate,Stage IA Lung Adenosquamous Carcinoma AJCC v7,1
28600,Malignant Cellular Infiltrate,Chondroid chordoma,1
28601,Neuroendocrine Differentiation,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
28602,Well Differentiated Lesion,Glottis Verrucous Carcinoma,1
28603,Carcinomatous Component Present,Ovarian Serous Adenocarcinoma,1
28604,Malignant Cellular Infiltrate,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,1
28605,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Cancer AJCC v8,1
28606,Carcinomatous Component Present,Hereditary Leiomyomatosis and Renal Cell Cancer,1
28607,Resectable Mass,Resectable Renal Cell Carcinoma,1
28608,Carcinomatous Component Present,Small Intestinal Undifferentiated Carcinoma,1
28609,Epithelial Component Present,Infiltrating Bladder Carcinoma,1
28610,Malignant Cellular Infiltrate,"Seminoma, anaplastic",1
28611,Carcinomatous Component Present,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
28612,Local disease,Localized Gastroesophageal Junction Adenocarcinoma,1
28613,Malignant Cellular Infiltrate,Childhood Gliosarcoma,1
28614,Epithelial Component Present,Bladder Urothelial Papilloma,1
28615,Contiguous Disease,Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma,1
28616,Unfavorable Clinical Outcome,Ph-Like Acute Lymphoblastic Leukemia,1
28617,Childhood Lesion,Postsurgical Stage III Hepatoblastoma,1
28618,Carcinomatous Component Present,Helicobacter Pylori-Related Carcinoma,1
28619,Carcinomatous Component Present,Carcinoma breast stage I,1
28620,Malignant Cellular Infiltrate,Salivary Gland Myoepithelial Carcinoma,1
28621,Mesenchymal Component Present,Malignant phyllodes tumor of breast,1
28622,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage,1
28623,Epithelial Component Present,Papillary carcinoma in situ,1
28624,Epithelial Component Present,Anterior Tongue Mucoepidermoid Carcinoma,1
28625,Malignant Cellular Infiltrate,Large cell lung cancer stage III,1
28626,Epithelial Component Present,Stage IVA Lip Cancer AJCC v6 and v7,1
28627,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage I,1
28628,Carcinomatous Component Present,Esophageal Large Cell Neuroendocrine Carcinoma,1
28629,Benign Cellular Infiltrate,Cardiac Capillary Hemangioma,1
28630,Severe dysplasia,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
28631,Recurrent disease,Recurrent Primary Peritoneal Serous Adenocarcinoma,1
28632,Malignant Cellular Infiltrate,Clitoral Carcinoma,1
28633,Malignant Cellular Infiltrate,Ovarian Angiosarcoma,1
28634,Epithelial Component Present,Vaginal Mesonephric Adenocarcinoma,1
28635,Epithelial Component Present,Stage IIIA Esophageal Cancer AJCC v7,1
28636,Malignant Cellular Infiltrate,Leiomyosarcoma of stomach,1
28637,Malignant Cellular Infiltrate,Malignant neoplasm of scrotum,1
28638,Carcinomatous Component Present,Gallbladder Goblet Cell Carcinoid,1
28639,Malignant Cellular Infiltrate,Stage IV Lung Cancer AJCC v8,1
28640,Epithelial Component Present,Stage IVB Laryngeal Cancer AJCC v7,1
28641,Malignant Cellular Infiltrate,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
28642,Diffuse Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
28643,Neuroendocrine Differentiation,Digestive System Large Cell Neuroendocrine Carcinoma,1
28644,Well-Circumscribed Lesion,Adult Type Testicular Granulosa Cell Tumor,1
28645,Benign Cellular Infiltrate,Benign neoplasm of adrenal cortex,1
28646,Fibrotic Stroma Formation,Signet Ring Cell Intrahepatic Cholangiocarcinoma,1
28647,Necrotic changes (finding),Gastric Large Cell Neuroendocrine Carcinoma,1
28648,Mixture of Germ Cell Neoplastic Components Present,Ovarian germ cell tumor mixed,1
28649,Recurrent Lymphoma,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
28650,Childhood Lesion,Childhood Cerebellar Anaplastic Astrocytoma,1
28651,Malignant Cellular Infiltrate,Stage III Cutaneous Melanoma AJCC v6,1
28652,Epithelial Component Present,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
28653,Benign Cellular Infiltrate,Jugular Foramen Schwannoma,1
28654,Non-Hereditary Lesion,Gastric Papillary Adenocarcinoma,1
28655,Malignant Cellular Infiltrate,Stage IIIA Bladder Cancer AJCC v8,1
28656,Epithelial Component Present,Stage I Colon Neuroendocrine Tumor AJCC v8,1
28657,Monoclonal Cellular Population Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
28658,Indolent Clinical Course,Fibromyxolipoma,1
28659,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
28660,Malignant Cellular Infiltrate,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,1
28661,Malignant Cellular Infiltrate,Adult Epithelioid Sarcoma,1
28662,Malignant Cellular Infiltrate,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
28663,Carcinomatous Component Present,Mixed Acinar-Neuroendocrine-Ductal Carcinoma of the Pancreas,1
28664,Epithelial Component Present,Stage IV Colon Carcinoma,1
28665,Tissue Differentiation Uncertain,Childhood Epithelioid Sarcoma,1
28666,Carcinomatous Component Present,Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7,1
28667,Carcinomatous Component Present,Childhood Esophageal Carcinoma,1
28668,Exophytic Polypoid Lesion,Colonic Polyps,1
28669,Epithelial Component Present,Stage I Carcinoma of Bladder,1
28670,Epithelial Component Present,Stage IIIB Thymus Epithelial Neoplasm AJCC v8,1
28671,Mixed Cellular Population,Epithelial Predominant Kidney Wilms Tumor,1
28672,Severe cytologic atypia,Vaginal Undifferentiated Sarcoma,1
28673,Biphasic Pattern,Nephrogenic adenofibroma,1
28674,No Identifiable Line of Differentiation,Malignant fibrous histiocytoma metastatic,1
28675,Malignant Cellular Infiltrate,Gallbladder papillary adenocarcinoma,1
28676,Malignant Cellular Infiltrate,Advanced Head and Neck Squamous Cell Carcinoma,1
28677,Epithelial Component Present,Urothelial cancer of renal pelvis,1
28678,Low Cellularity Present,Adult Pilocytic Astrocytoma,1
28679,Malignant Cellular Infiltrate,Stage IV Ampulla of Vater Cancer AJCC v8,1
28680,Malignant Cellular Infiltrate,High Grade Astrocytic Tumor,1
28681,Malignant Cellular Infiltrate,Pancreatic adenocarcinoma resectable,1
28682,Diffuse Lesion,Kasabach-Merritt syndrome,1
28683,Papillary Pattern,Papillary serous cystadenocarcinoma,1
28684,Malignant Cellular Infiltrate,Hepatoblastoma,1
28685,Biphasic Pattern,Childhood Gliosarcoma,1
28686,Follicular Cell Differentiation,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
28687,Carcinomatous Component Present,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,1
28688,Glomeruloid Vessels Present,Recurrent Childhood Pilocytic Astrocytoma,1
28689,Epithelial Component Present,Sympathetic paraganglioma,1
28690,Exophytic Polypoid Lesion,tubulovillous adenoma of stomach,1
28691,Secondary Lesion,Squamous Cell Carcinoma of Unknown Primary,1
28692,Favorable Clinical Outcome,Hepatocellular Adenoma,1
28693,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,1
28694,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage II Immature Testicular Teratoma AJCC v6 and v7,1
28695,Neuroendocrine Differentiation,Stage III Appendix Neuroendocrine Tumor AJCC v8,1
28696,Malignant Cellular Infiltrate,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
28697,High Grade Lesion,Recurrent Childhood Glioblastoma,1
28698,Multifocal Lesion,Multiple Endocrine Neoplasia Type 1,1
28699,Subcutaneous nodule,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
28700,Malignant Cellular Infiltrate,Thyroid Gland Malignant Peripheral Nerve Sheath Tumor,1
28701,Well-Circumscribed Lesion,Mixed cell adenoma,1
28702,Malignant Cellular Infiltrate,"Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
28703,Carcinomatous Component Present,Hereditary Diffuse Gastric Adenocarcinoma,1
28704,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Biphasic or Triphasic Teratoma,1
28705,Malignant Cellular Infiltrate,Granulomatous slack skin disease,1
28706,Metastatic/Recurrent Disease,Bladder Alveolar Soft Part Sarcoma,1
28707,Adulthood Lesion,Lugano Classification Stage I Adult Lymphoma AJCC v8,1
28708,Neuroectodermal Differentiation,Poorly Differentiated Neuroblastoma,1
28709,Carcinomatous Component Present,Stage IV Esophageal Adenocarcinoma AJCC v7,1
28710,Carcinomatous Component Present,small cell carcinoma of salivary gland,1
28711,Follicular Differentiation,"Acanthoma, Pilar Sheath",1
28712,Invasive Lesion,Metaplastic carcinoma of breast,1
28713,Malignant Cellular Infiltrate,Stage IIB Gastric Cancer AJCC v7,1
28714,High Mitotic Activity,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
28715,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
28716,Carcinomatous Component Present,Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
28717,Papillary Pattern,Paranasal Sinus Schneiderian Papilloma,1
28718,Peripheral Blood Involvement,Leukemic Phase of Non-Hodgkin's Lymphoma,1
28719,Exophytic Polypoid Lesion,Ampulla of Vater Tubulovillous Adenoma,1
28720,Malignant Cellular Infiltrate,Stage IV Bladder Cancer AJCC v8,1
28721,atypia morphology,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
28722,Malignant Cellular Infiltrate,Metastatic Urethral Carcinoma,1
28723,Dysplasia,Tubular adenoma of colon,1
28724,Malignant Cellular Infiltrate,"Thymoma, type A, malignant",1
28725,Malignant Cellular Infiltrate,Squamous cell carcinoma in situ with questionable stromal invasion,1
28726,Somatostatin Positive Neoplastic Cells Present,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
28727,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
28728,Epithelial Component Present,Jejunal Neuroendocrine Tumor by AJCC v8 Stage,1
28729,Malignant Cellular Infiltrate,Stage IIIC Appendix Carcinoma AJCC v8,1
28730,Pathologic TNM Finding,Pathologic Stage IIIC Gastric Cancer AJCC v8,1
28731,Diffuse Lesion,Carcinomatosis,1
28732,Dysplasia,Stage 0 Vaginal Cancer AJCC v7,1
28733,Malignant Cellular Infiltrate,Parasite-Related Carcinoma,1
28734,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of parotid gland,1
28735,Carcinomatous Component Present,Resectable Intrahepatic Cholangiocarcinoma,1
28736,Metastatic/Recurrent Disease,"Ossifying fibromyxoid tumor, malignant",1
28737,More than 10 Mitoses per 10HPF,Metastatic Prostate Small Cell Carcinoma,1
28738,Moderate dysplasia,Anal Intraepithelial Neoplasia 2,1
28739,Indolent Clinical Course,Fibromatosis colli,1
28740,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma,1
28741,Keratin Horn Pearls Formation,Squamous cell carcinoma with horn formation,1
28742,Mixed Cellular Population,Carcinoma ex pleomorphic adenoma,1
28743,Epithelial Component Present,FIGO Stage III Ovarian Cancer,1
28744,Carcinomatous Component Present,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,1
28745,Collagenous Stroma Formation,Palisaded Lymph Node Myofibroblastoma,1
28746,Cutaneous Involvement,Malignant Proliferating Pilar Tumor,1
28747,Infiltrative Growth Pattern,Recurrent Gliosarcoma,1
28748,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
28749,Malignant Cellular Infiltrate,Bartholin Gland Adenoid Cystic Carcinoma,1
28750,Epithelial Component Present,adenocarcinoma of epididymis,1
28751,Malignant Cellular Infiltrate,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
28752,Cutaneous Involvement,Exacerbation of acne,1
28753,Diffuse Pattern,Mesenchymal Glioblastoma,1
28754,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma refractory,1
28755,Malignant Cellular Infiltrate,Secondary malignant neoplasm of epididymis,1
28756,Carcinomatous Component Present,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
28757,Epithelial Component Present,Squamous cell carcinoma of the head and neck,1
28758,Perineural spread,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
28759,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v8,1
28760,Carcinomatous Component Present,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,1
28761,Gyriform Trabecular Pattern,"Gastrinoma, malignant",1
28762,Indolent Clinical Course,Benign neoplasm of mesothelial tissue of pleura,1
28763,Malignant Cellular Infiltrate,Mature T- and NK-Cell Lymphoma by Ann Arbor Stage,1
28764,Refractory Disease,Refractory Chronic Myelomonocytic Leukemia,1
28765,Secondary Lesion,Locally Advanced Head and Neck Carcinoma,1
28766,Secondary Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,1
28767,Diffuse Pattern,Recurrent Childhood Gliosarcoma,1
28768,Benign Cellular Infiltrate,Testicular Large Cell Calcifying Sertoli Cell Tumor,1
28769,Epithelial Component Present,Gastric Cancer by AJCC v7 Stage,1
28770,Immunologic Deficiency Syndromes,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
28771,Secondary Lesion,Advanced Digestive System Neuroendocrine Neoplasm,1
28772,Mixed Cellular Population,Mixed Cell Adrenal Cortical Adenoma,1
28773,Birbeck Granules Present,"Langerhans Cell Histiocytosis, Polystotic",1
28774,Epithelial Component Present,Stage 0 Penile Cancer AJCC v8,1
28775,Indolent Clinical Course,Benign Pericytic Neoplasm,1
28776,Malignant Cellular Infiltrate,B-cell lymphoma unclassifiable with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma,1
28777,Childhood Lesion,Postsurgical Stage IV Hepatoblastoma,1
28778,Malignant Cellular Infiltrate,Pleural Epithelioid Hemangioendothelioma,1
28779,Low Mitotic Activity,Carcinoid tumor of rectum,1
28780,Benign Cellular Infiltrate,Colorectal Benign Granular Cell Tumor,1
28781,Fibrotic Stroma Formation,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
28782,Carcinomatous Component Present,Laryngeal Mucoepidermoid Carcinoma,1
28783,Epithelial Component Present,Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma,1
28784,Epithelial Component Present,Stage 0 Breast Cancer AJCC v6 and v7,1
28785,Cutaneous Involvement,Hutchinson's Melanotic Freckle,1
28786,Malignant Cellular Infiltrate,Primary malignant neoplasm of oculomotor nerve,1
28787,Carcinomatous Component Present,Stage I Lung Cancer AJCC v6,1
28788,Pathologic TNM Finding,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
28789,Malignant Cellular Infiltrate,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
28790,High Grade Lesion,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
28791,Malignant Cellular Infiltrate,Myxosarcoma,1
28792,Solitary mass,Childhood Epithelioid Hemangioendothelioma,1
28793,Invasive Lesion,Low Grade Adenosquamous Breast Carcinoma,1
28794,Malignant Cellular Infiltrate,Sellar Neuroblastoma,1
28795,Local disease,Localized Unresectable Neuroblastoma,1
28796,Childhood Lesion,Pediatric Intraocular Retinoblastoma,1
28797,Malignant Cellular Infiltrate,Acute myeloid leukemia refractory,1
28798,Malignant Cellular Infiltrate,Primary Intestinal Follicular Lymphoma,1
28799,Childhood Lesion,Recurrent Childhood Gliomatosis Cerebri,1
28800,Solitary mass,Sellar Chondroid Chordoma,1
28801,Neuroendocrine Differentiation,Metastatic Jugulotympanic Paraganglioma,1
28802,Recurrent disease,Recurrent Primary Amyloidosis,1
28803,Hyperplastic Tissue Present,Prostatic Basal Cell Hyperplasia,1
28804,Macule,Stage I Acral Lentiginous Melanoma AJCC v7,1
28805,Secondary Lesion,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
28806,Cartilaginous Differentiation,mesenchymal chondrosarcoma of bone,1
28807,Extensive Stage Lesion,Pleural mesothelioma malignant advanced,1
28808,In Situ Lesion,In situ follicular neoplasia,1
28809,HMB-45-Positive Neoplastic Cells Present,"Perivascular epithelioid tumor, benign",1
28810,Fibrotic Stroma Formation,Ovarian Stromal-Leydig Cell Tumor,1
28811,Benign Cellular Infiltrate,Diffuse Lipomatosis,1
28812,Recurrent disease,Recurrent Endometrial Clear Cell Adenocarcinoma,1
28813,Malignant Cellular Infiltrate,Cardiac Fibrosarcoma,1
28814,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7,1
28815,Junctional Proliferation,Spindle cell nevus of Reed,1
28816,Epithelial Component Present,Stage III Fallopian Tube Cancer AJCC v8,1
28817,Malignant Cellular Infiltrate,Stage III Adult Burkitt Lymphoma,1
28818,Recurrent disease,Recurrent Childhood Anaplastic Oligodendroglioma,1
28819,Peripheral Nuclear Palisading,Small cell carcinoma of lung,1
28820,Low Mitotic Activity,Pancreatic Neuroendocrine Tumor G1,1
28821,Vascular proliferation,Nasopharyngeal Angiofibroma,1
28822,Nodular Pattern,Medulloblastoma with extensive nodularity,1
28823,Malignant Cellular Infiltrate,Stage III Mucosal Melanoma of the Head and Neck AJCC v7,1
28824,Malignant Cellular Infiltrate,Recurrent Lip Basal Cell Carcinoma,1
28825,Rapidly Enlarging Mass,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
28826,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Carcinoma,1
28827,Secondary Lesion,Secondary malignant neoplasm of spinal cord,1
28828,Malignant Cellular Infiltrate,Treatment related acute myeloid leukaemia,1
28829,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vertebral column,1
28830,Benign Cellular Infiltrate,Benign fibrohistiocytic neoplasm,1
28831,Infiltrating Tumor Margins Present,Malignant Cystosarcoma Phyllodes,1
28832,Mitotic Activity,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
28833,Malignant Cellular Infiltrate,Stage II Malignant Mediastinal Germ Cell Tumor,1
28834,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Recurrent High Risk Myelodysplastic Syndrome,1
28835,Mucoid Stroma Formation,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
28836,Malignant Cellular Infiltrate,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
28837,Single Cell Necrosis,Stage IB Merkel Cell Carcinoma AJCC v7,1
28838,Immunologic Deficiency Syndromes,Hyperacute allograft rejection,1
28839,Indolent Clinical Course,Cardiac Intramuscular Hemangioma,1
28840,Multinodular Mass,Small Intestinal Angiosarcoma,1
28841,Carcinomatous Component Present,Poorly Differentiated Prostate Adenocarcinoma,1
28842,Malignant Cellular Infiltrate,Medullomyoblastoma,1
28843,Chromogranin A Positive Neoplastic Cells Present,Ovarian Mucinous Carcinoid Tumor,1
28844,Epithelial Component Present,undifferentiated carcinoma of ureter,1
28845,Cutaneous Involvement,Malignant melanoma in precancerous melanosis,1
28846,Carcinomatous Component Present,Recurrent Digestive System Carcinoma,1
28847,Carcinomatous Component Present,Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
28848,Malignant Cellular Infiltrate,Refractory Plasmablastic Lymphoma,1
28849,Carcinomatous Component Present,Diffuse Gastric Adenocarcinoma,1
28850,Lymphoplasmacytic Infiltrate,"Castleman Disease, Hyaline-Vascular Type",1
28851,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with hyperdiploidy,1
28852,Carcinomatous Component Present,Vulvar Clear Cell Hidradenocarcinoma,1
28853,Malignant Cellular Infiltrate,Stage IV Paranasal Sinus Cancer AJCC v7,1
28854,Borderline Lesion,"lymphomatoid papulosis, type C",1
28855,No Identifiable Line of Differentiation,Adult Undifferentiated Pleomorphic Sarcoma,1
28856,Malignant Cellular Infiltrate,Stage IIB Adult Soft Tissue Sarcoma AJCC v7,1
28857,Malignant Cellular Infiltrate,"Liposarcoma, well differentiated",1
28858,Peau d'orange surface of breast,Inflammatory Breast Carcinoma,1
28859,Resectable Mass,Resectable Renal Cell Carcinoma,1
28860,Secondary Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,1
28861,Papillary Pattern,Peritoneal Well Differentiated Papillary Mesothelioma,1
28862,Human Papillomavirus Positive,Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
28863,Secondary Lesion,Locally Advanced Digestive System Carcinoma,1
28864,Nodular lesions,"Adrenal Gland Ganglioneuroblastoma, Nodular",1
28865,Malignant Cellular Infiltrate,Stage 0 Lung Cancer AJCC v8,1
28866,Malignant Cellular Infiltrate,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
28867,High Mitotic Activity,Small Intestinal Small Cell Neuroendocrine Carcinoma,1
28868,Cutaneous Involvement,Outer Hair Sheath and Infundibulum Neoplasm,1
28869,Carcinomatous Component Present,Submandibular Gland Acinic Cell Carcinoma,1
28870,Malignant Cellular Infiltrate,Ameloblastic Carcinoma,1
28871,Hyalinized Stroma Formation,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
28872,Malignant Cellular Infiltrate,Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
28873,Malignant Cellular Infiltrate,Stage II Thyroid Gland Papillary Carcinoma AJCC v8,1
28874,Malignant Cellular Infiltrate,Lung Non-Small Cell Cancer by AJCC v7 Stage,1
28875,Malignant Cellular Infiltrate,Transplant-Related Hepatocellular Carcinoma,1
28876,Secondary Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
28877,Unresectable Mass,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
28878,Well Differentiated Lesion,"Cervical Mucinous Adenocarcinoma, Minimal Deviation Type",1
28879,Epithelial Component Present,Stage III Thymoma AJCC v8,1
28880,Malignant Cellular Infiltrate,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,1
28881,Nuclear Atypia,Recurrent Gliosarcoma,1
28882,Stromal Invasion,squamous cell carcinoma of ovary,1
28883,Epithelial Component Present,Stage IIIA Ovarian Cancer AJCC v6 and v7,1
28884,Metastatic Lesion,Metastatic Digestive System Neuroendocrine Carcinoma,1
28885,Well-Circumscribed Lesion,Epithelial Predominant Kidney Wilms Tumor,1
28886,atypia morphology,"Leydig cell tumor, malignant",1
28887,Cystic Change,Mucinous cystadenofibroma,1
28888,Cutaneous Involvement,Dermatophytosis of groin and perianal area,1
28889,Mild cytologic atypia,Plantar Verrucous Skin Carcinoma,1
28890,Sarcomatous Component Present,Carcinosarcoma,1
28891,Benign Cellular Infiltrate,Benign Anterior Tongue Neoplasm,1
28892,Malignant Cellular Infiltrate,Neuroblastoma recurrent,1
28893,Metastatic/Recurrent Disease,Malignant Lung PEComa,1
28894,Polymorphic Cellular Infiltrate,Refractory Langerhans Cell Histiocytosis,1
28895,Malignant Cellular Infiltrate,Erythroleukemia (Erythroid/Myeloid),1
28896,Edematous Stroma Formation,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
28897,Malignant Cellular Infiltrate,ISS Stage III Plasma Cell Myeloma,1
28898,Epithelial Component Present,Adenocarcinoma of the prostate metastatic,1
28899,Secondary Lesion,Advanced Prostate Adenocarcinoma,1
28900,Diffuse Lesion,Lymphangitis carcinomatosa,1
28901,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Immature Teratoma,1
28902,Peripheral Nuclear Palisading,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
28903,Carcinomatous Component Present,Stage IB Merkel Cell Carcinoma AJCC v7,1
28904,Tissue of Mullerian Origin Present,Mucinous adenofibroma,1
28905,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
28906,Benign Cellular Infiltrate,Parotid Gland Warthin Tumor,1
28907,Cutaneous Involvement,Eczema,1
28908,Malignant Cellular Infiltrate,Metachronous Osteosarcoma,1
28909,Benign Cellular Infiltrate,Pigmented villonodular synovitis,1
28910,Malignant Cellular Infiltrate,Myxoid chondrosarcoma,1
28911,Metastatic Lesion,Secondary malignant neoplasm of large intestine,1
28912,Malignant Cellular Infiltrate,Stage IV Gallbladder Cancer AJCC v7,1
28913,Benign Cellular Infiltrate,Hidrocystoma,1
28914,Micropapillary Pattern,Colon Micropapillary Adenocarcinoma,1
28915,Malignant Cellular Infiltrate,Vaginal Undifferentiated Carcinoma,1
28916,Epithelial Component Present,Stage IV Rectal Carcinoma,1
28917,Carcinomatous Component Present,Stage IIIB Colon Cancer AJCC v8,1
28918,Childhood Lesion,Childhood Gastrointestinal Stromal Tumor,1
28919,Melanin Pigment Present,Melanocytic nevus of skin,1
28920,Pregnancy Complications,Placental polyp,1
28921,Recurrent disease,Malignant neoplasm of nasopharynx recurrent,1
28922,Myeloblasts Under 1 Percent of Peripheral Blood White Cells,Refractory anemia with ringed sideroblasts,1
28923,Metaplasia,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1
28924,Refractory Disease,Refractory Adrenal Gland Pheochromocytoma,1
28925,Recurrent disease,Recurrent Minor Salivary Gland Adenocarcinoma,1
28926,Benign Cellular Infiltrate,Squamous odontogenic tumor,1
28927,Adulthood Lesion,Stage IV Adult Non-Hodgkin Lymphoma,1
28928,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v8,1
28929,In Situ Lesion,Carcinoma in situ of penis,1
28930,Malignant Cellular Infiltrate,Colloid Carcinoma of the Pancreas,1
28931,Carcinomatous Component Present,Stage II Fallopian Tube Cancer AJCC v8,1
28932,Insular Pattern,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
28933,Adulthood Lesion,Adult Medulloblastoma,1
28934,Single Cell Necrosis,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
28935,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,"Amyloidosis, Familial",1
28936,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
28937,Mitotic Activity,Childhood Gliosarcoma,1
28938,Local disease,Locally Recurrent Malignant Neoplasm,1
28939,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
28940,Malignant Cellular Infiltrate,Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement,1
28941,Epithelial Component Present,Recurrent Uterine Corpus Carcinoma,1
28942,Increased Cellularity Present,Retinoblastoma,1
28943,Monomorphic Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
28944,Osseous Differentiation,Central Nervous System Extraskeletal Osteosarcoma,1
28945,Carcinomatous Component Present,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
28946,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Hepatoid Pattern",1
28947,Malignant Cellular Infiltrate,Stage IV Adult Burkitt Lymphoma,1
28948,Benign Cellular Infiltrate,"Cervical Adenomyoma, Endocervical Type",1
28949,Malignant Cellular Infiltrate,papillary carcinoma of renal pelvis,1
28950,Bone Marrow Dysplasia Present,Refractory anemia with ringed sideroblasts,1
28951,Epithelial Component Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
28952,Diffuse Pattern,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
28953,Nuclear Atypia,Pineal parenchymal tumor of intermediate differentiation,1
28954,Malignant Cellular Infiltrate,Stage IIA Colon Cancer AJCC v7,1
28955,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v6 and v7,1
28956,Epithelial Component Present,Stage IA1 Cervical Cancer AJCC v8,1
28957,Diffuse Pattern,Centroblastic lymphoma stage III,1
28958,Malignant Cellular Infiltrate,Invasive Lobular Breast Carcinoma,1
28959,Epithelial Component Present,Stage 0is Renal Pelvis Cancer AJCC v7,1
28960,Malignant Cellular Infiltrate,Basal cell carcinoma - adamantinoid,1
28961,Carcinomatous Component Present,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
28962,Carcinomatous Component Present,lymphoepithelial squamous cell carcinoma of salivary gland,1
28963,Low Grade Lesion,Metastatic Epithelioid Hemangioendothelioma,1
28964,Epithelial Component Present,Peripheral Intrahepatic Cholangiocarcinoma,1
28965,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Ovarian Teratoma,1
28966,Epithelial Component Present,Locally Advanced Unresectable Cervical Carcinoma,1
28967,Disease regression,"Malignant melanoma, regressing",1
28968,Malignant Cellular Infiltrate,Stage IVA Hypopharyngeal Carcinoma AJCC v8,1
28969,Epithelial Component Present,Adult Liver Carcinoma,1
28970,Lobulated Growth Pattern,Dedifferentiated chordoma,1
28971,Malignant Cellular Infiltrate,Stage IV Cutaneous Melanoma AJCC v6 and v7,1
28972,Dermal Involvement,Vaginal Blue Nevus,1
28973,Malignant Cellular Infiltrate,Ameloblastic Carcinoma,1
28974,Carcinomatous Component Present,Pancreatic Cancer by AJCC v6 and v7 Stage,1
28975,Epithelial Component Present,adenocarcinoma of extrahepatic bile duct,1
28976,Squamous metaplasia,Adenolymphoma,1
28977,Childhood Lesion,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
28978,Recurrent disease,Recurrent Anaplastic Large Cell Lymphoma,1
28979,Low Mitotic Activity,Somatostatinoma,1
28980,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v8,1
28981,Invasive Lesion,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,1
28982,Non-Malignant Cellular Infiltrate,Submandibular lymphadenitis,1
28983,Epithelial Component Present,Cervical intraepithelial neoplasia grade 2,1
28984,Exophytic Polypoid Lesion,Polyp of vocal cord,1
28985,Malignant Cellular Infiltrate,Malignant tumor of rectosigmoid junction,1
28986,Follicular Cell Differentiation,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
28987,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gestational choriocarcinoma,1
28988,Epithelial Component Present,Multicentric Thyroid Gland Papillary Carcinoma,1
28989,Follicular Cell Differentiation,Papillary Thyroid Microcarcinoma,1
28990,Malignant Cellular Infiltrate,Recurrent Hepatocellular Carcinoma,1
28991,Malignant Cellular Infiltrate,Schneiderian carcinoma,1
28992,Painless Mass,Soft tissue chondroma,1
28993,Epithelial Component Present,Eosinophilic Variant of Chromophobe Renal Cell Carcinoma,1
28994,Syncytial Pattern,Nasopharyngeal lymphoepithelioma stage III,1
28995,High Grade Lesion,Cervical Alveolar Soft Part Sarcoma,1
28996,Malignant Cellular Infiltrate,Locally Advanced Malignant Neoplasm,1
28997,Carcinomatous Component Present,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
28998,Papillary Pattern,Extrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
28999,Unclassifiable Lesion,primitive neuroectodermal tumor (PNET) of spinal cord,1
29000,Metaplasia,Urinary Bladder Nephrogenic Adenoma,1
29001,Severe dysplasia,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
29002,Tissue Differentiation Uncertain,Pleural Biphasic Synovial Sarcoma,1
29003,Epithelial Component Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
29004,Benign Cellular Infiltrate,Benign neoplasm of supraglottis,1
29005,Malignant Cellular Infiltrate,Disseminated carcinoma,1
29006,Diffuse Pattern,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
29007,Pathologic TNM Finding,Pathologic Stage IIIA Cutaneous Melanoma AJCC v8,1
29008,Sebaceous Differentiation,Sebaceoma,1
29009,Diffuse Pattern,Adult Giant Cell Glioblastoma,1
29010,Rapidly Enlarging Mass,Pelvic Rhabdomyosarcoma,1
29011,Serotonin Positive Neoplastic Cells Present,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
29012,Cutaneous Involvement,Vulvar Keratoacanthoma,1
29013,Malignant Cellular Infiltrate,Acantholytic squamous cell carcinoma,1
29014,Diffuse Pattern,Infratentorial Glioblastoma,1
29015,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
29016,Metastatic/Recurrent Disease,Cardiac Biphasic Synovial Sarcoma,1
29017,Mallory Bodies,Acute alcoholic liver disease,1
29018,Cystic Change,Malignant Brenner Tumor,1
29019,Deep Lesion,Chest Wall Fibromatosis,1
29020,High Mitotic Activity,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
29021,Epithelial Component Present,Eyelid Carcinoma by AJCC v8 Stage,1
29022,Malignant Cellular Infiltrate,Cancer of Lip,1
29023,Malignant Cellular Infiltrate,Vulvar Non-Keratinizing Squamous Cell Carcinoma,1
29024,Epithelial Component Present,Poorly Differentiated Thyroid Carcinoma,1
29025,Invasive Lesion,malignant myoepithelioma of breast,1
29026,Carcinomatous Component Present,Relapsed Hypopharynx Carcinoma,1
29027,Neuronal Differentiation,Adult Ganglioglioma,1
29028,Carcinomatous Component Present,Cervical Cancer by AJCC v8 Stage,1
29029,Malignant Cellular Infiltrate,Retroperitoneal Lymphoma,1
29030,Melanosomes Present,Mediastinal Melanotic Schwannoma,1
29031,Carcinomatous Component Present,Peripheral Intrahepatic Cholangiocarcinoma,1
29032,Neuroendocrine Differentiation,Pathologic Stage III Merkel Cell Carcinoma AJCC v8,1
29033,Thin-Walled Branching Vascular Pattern,Peritoneal Solitary Fibrous Tumor,1
29034,Hyaline Cartilage Differentiation,Enchondromatosis,1
29035,Fibrotic Stroma Formation,Major Salivary Gland Mucoepidermoid Carcinoma,1
29036,More than 10 Mitoses per 10HPF,Stage IA Lung Small Cell Carcinoma AJCC v7,1
29037,Mucoid Stroma Formation,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
29038,Metastatic Lesion,Metastatic Carcinoma in the Lung,1
29039,Secondary Lesion,Advanced Melanoma,1
29040,CD56-Positive Neoplastic Cells Present,childhood nasal type extranodal NK/T-cell lymphoma,1
29041,Epithelial Component Present,Oral Cavity Carcinoma,1
29042,Primary Lesion,Recurrent Peripheral Primitive Neuroectodermal Tumor,1
29043,Fibromyxoid Stroma Formation,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
29044,Carcinomatous Component Present,Squamous cell carcinoma of the parotid gland,1
29045,Nodular Pattern,Skin Nodular Basal Cell Carcinoma,1
29046,Biphasic Pattern,Atypical polypoid adenomyoma,1
29047,Anaplasia,Sarcomatoid Carcinoma of the Penis,1
29048,Diffuse Pattern,Childhood Brain Stem Mixed Glioma,1
29049,Cutaneous Involvement,"Skin Diseases, Infectious",1
29050,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
29051,In Situ Lesion,Stage 0is Urethral Cancer AJCC v8,1
29052,Rapidly Enlarging Mass,Embryonal Rhabdomyosarcoma,1
29053,Recurrent Lymphoma,Recurrent EBV-Related Lymphoma,1
29054,Epithelial Component Present,Stage III Prostate Carcinoma,1
29055,Epithelial Component Present,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
29056,Diffuse Pattern,Adult Malignant Peripheral Nerve Sheath Tumor,1
29057,Malignant Cellular Infiltrate,Eyelid Sebaceous Gland Carcinoma,1
29058,Generalized illness,"Langerhans Cell Histiocytosis, Disseminated",1
29059,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma refractory,1
29060,Mitotic Activity,Testicular Mixed Yolk Sac Tumor and Teratoma,1
29061,Refractory Disease,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
29062,Malignant Cellular Infiltrate,Retinoblastoma bilateral,1
29063,Metaplasia,Barrett's Adenocarcinoma,1
29064,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8,1
29065,Malignant Cellular Infiltrate,Childhood Liposarcoma,1
29066,Epithelial Component Present,Parotid monomorphic adenoma,1
29067,Cutaneous Involvement,Stage III Cutaneous Melanoma AJCC v6,1
29068,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma recurrent,1
29069,Unfavorable Clinical Outcome,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
29070,Epithelial Component Present,Adenoid cystic carcinoma of trachea,1
29071,Indolent Clinical Course,Lipoma of chest wall,1
29072,Malignant Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v7,1
29073,Malignant Cellular Infiltrate,Lugano Classification Childhood Hodgkin Lymphoma by AJCC v8 Stage,1
29074,Well Differentiated Lesion,Vulvar Keratoacanthoma,1
29075,Malignant Cellular Infiltrate,Infiltrating duct and lobular carcinoma,1
29076,Diffuse Pattern,Small Intestinal Diffuse Large B-Cell Lymphoma,1
29077,Epithelial Component Present,Ovarian Microcystic Stromal Tumor,1
29078,Increased Cellularity Present,Anaplastic astrocytoma,1
29079,'Starry-sky' pattern,Stage III Burkitt Lymphoma,1
29080,Mitotic Activity,teratocarcinoma of mediastinum,1
29081,Malignant Cellular Infiltrate,Splenic Small Lymphocytic Lymphoma,1
29082,Non-Hereditary Lesion,Sporadic Diffuse Gastric Adenocarcinoma,1
29083,Epithelial Component Present,Hypopharyngeal Carcinoma by AJCC v6 Stage,1
29084,High Grade Lesion,High Grade Astrocytic Tumor,1
29085,Benign Cellular Infiltrate,Nodular tenosynovitis,1
29086,Benign Cellular Infiltrate,Colorectal Perineurioma,1
29087,Carcinomatous Component Present,Stage IV Rectal Cancer AJCC v8,1
29088,Hyalinized Stroma Formation,Childhood Epithelioid Hemangioendothelioma,1
29089,Carcinomatous Component Present,"Squamous cell carcinoma, metastatic",1
29090,Malignant Cellular Infiltrate,Stage IV Childhood Hepatocellular Carcinoma AJCC v7,1
29091,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
29092,Secondary Lesion,Locally Advanced Unresectable Basal Cell Carcinoma,1
29093,Malignant Cellular Infiltrate,Stage IIB Distal Bile Duct Cancer AJCC v7,1
29094,Childhood Lesion,Childhood Liposarcoma,1
29095,Secondary Lesion,Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia,1
29096,Secondary Lesion,Locally Advanced Urothelial Carcinoma,1
29097,Malignant Cellular Infiltrate,Carcinoma of Male Breast,1
29098,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
29099,Epithelial Component Present,Anal Canal Neuroendocrine Tumor G1,1
29100,Indolent Clinical Course,Cementoma,1
29101,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myelomonocytic, Chronic",1
29102,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
29103,Epithelial Component Present,Malignant basal cell tumor,1
29104,Primary Lesion,Stage I Osteosarcoma AJCC v7,1
29105,Locally Aggressive Lesion,Intermediate Vascular Neoplasm,1
29106,Malignant Cellular Infiltrate,Heavy Chain Deposition Disease,1
29107,Recurrent disease,Recurrent Aggressive NK-Cell Leukemia,1
29108,Diffuse Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma,1
29109,Absence of Invasion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
29110,Borderline Lesion,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
29111,Invasive Lesion,Metastatic Signet Ring Cell Breast Carcinoma,1
29112,Epithelial Component Present,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
29113,Abundance of Small Lymphocytes,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma,1
29114,Severe cytologic atypia,Digestive System Small Cell Neuroendocrine Carcinoma,1
29115,atypia morphology,Borderline Ovarian Transitional Cell Tumor,1
29116,Malignant Cellular Infiltrate,Refractory Colon Carcinoma,1
29117,Extraocular Dissemination of Disease,Extraocular retinoblastoma,1
29118,Epithelial Component Present,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
29119,Castration-Sensitive,Castration-Sensitive Prostate Carcinoma,1
29120,"Undifferentiated ""Fetal-Type"" Tissues Present",Childhood Central Nervous System Immature Teratoma,1
29121,Benign Cellular Infiltrate,Juxtaglomerular tumor,1
29122,Epithelial Component Present,Carcinoma of anal margin,1
29123,Carcinomatous Component Present,Hepatoma resectable,1
29124,Carcinomatous Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
29125,More than 10 Mitoses per 10HPF,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
29126,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
29127,Carcinomatous Component Present,Stage IB Lung Adenosquamous Carcinoma AJCC v7,1
29128,Malignant Cellular Infiltrate,Precursor T-cell lymphoblastic lymphoma,1
29129,Neuroendocrine Differentiation,Stage IIA Digestive System Neuroendocrine Tumor AJCC v7,1
29130,Adulthood Lesion,Adult Anaplastic (Malignant) Meningioma,1
29131,Benign Cellular Infiltrate,Ovarian Clear Cell Cystadenofibroma,1
29132,Recurrent disease,Recurrent Craniopharyngioma,1
29133,Malignant Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v6,1
29134,Epithelial Component Present,Fibroadenoma of breast,1
29135,Carcinomatous Component Present,Pigmented Basal Cell Carcinoma,1
29136,Primary Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
29137,Multifocal Lesion,Synchronous Multifocal Osteosarcoma,1
29138,Malignant Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v6,1
29139,Carcinomatous Component Present,Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v7,1
29140,Hereditary Lesion,Familial Acute Myeloid Leukemia with Mutated Cebpa,1
29141,Carcinomatous Component Present,Small intestine carcinoma,1
29142,Malignant Cellular Infiltrate,Liver Extraskeletal Osteosarcoma,1
29143,Tubular Pattern,Gallbladder Tubular Carcinoid,1
29144,Benign Cellular Infiltrate,Benign Adrenal Gland Composite Pheochromocytoma,1
29145,Recurrent disease,Recurrent Adult Immunoblastic Lymphoma,1
29146,Benign Cellular Infiltrate,Mediastinal Schwannoma,1
29147,Carcinomatous Component Present,Laryngeal Cancer by AJCC v7 Stage,1
29148,Regional Disease,Crohn's disease of large bowel,1
29149,Indolent Clinical Course,Endometrial Polyp,1
29150,Benign Cellular Infiltrate,Epithelioid and spindle cell nevus,1
29151,Cutaneous Involvement,External Ear Actinic Keratosis,1
29152,Malignant Cellular Infiltrate,Neuroendocrine carcinoma of appendix,1
29153,Metastatic Lesion,Lung Carcinoma Metastatic in the Central Nervous System,1
29154,Papillary Pattern,Esophageal squamous papilloma,1
29155,Neuroendocrine Differentiation,Malignant carcinoid tumor of lung,1
29156,Metastatic Lesion,Metastatic Oral Cavity Adenoid Cystic Carcinoma,1
29157,Hemorrhagic,Aortic Angiosarcoma,1
29158,Epithelial Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
29159,Well-Circumscribed Lesion,Tubular adenoma of breast,1
29160,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
29161,Carcinomatous Component Present,pleomorphic carcinoma of breast,1
29162,Malignant Cellular Infiltrate,Clear Cell Variant Thyroid Gland Papillary Carcinoma,1
29163,Poorly Differentiated Lesion,Large cell lung cancer stage IV,1
29164,Epithelial Component Present,Non-small cell lung cancer stage I,1
29165,Malignant Cellular Infiltrate,Refractory Testicular Lymphoma,1
29166,Epithelial Component Present,Rectosigmoid Adenocarcinoma,1
29167,Hyalinized Stroma Formation,malignant epithelioid hemangioendothelioma of liver,1
29168,Childhood Lesion,Cystic Partially Differentiated Nephroblastoma,1
29169,Papillary Pattern,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
29170,More than 5 Mitoses per 50HPF,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
29171,Epithelial Component Present,Stage II Appendix Carcinoma AJCC v8,1
29172,Glucagon-Like Peptide Positive Neoplastic Cells Present,Colon L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
29173,Malignant Cellular Infiltrate,Skin Metatypical Carcinoma,1
29174,Cord-Like Pattern,Vaginal Adenoid Basal Carcinoma,1
29175,Borderline Lesion,Grade III Lymphomatoid Granulomatosis,1
29176,Carcinomatous Component Present,BCLC Stage D Hepatocellular Carcinoma,1
29177,Nuclear Grooves,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
29178,Indolent Clinical Course,Senile angioma,1
29179,Benign Cellular Infiltrate,"Benign neoplasm of brain, unspecified",1
29180,Benign Cellular Infiltrate,Benign neoplasm of mesothelial tissue of pleura,1
29181,Perivascular Arrangement of Tumor Cells,"Perivascular epithelioid tumor, benign",1
29182,Carcinomatous Component Present,"Uterine Carcinosarcoma, Heterologous Type",1
29183,Acanthosis,Warty Carcinoma of the Penis,1
29184,Mixed Cellular Population,Lung Mixed Squamous Cell and Glandular Papilloma,1
29185,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
29186,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Adenocarcinoma,1
29187,Human Papillomavirus Positive,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
29188,Nodular lesions,Malignant carcinoid tumor of lung,1
29189,Epithelial Component Present,Stage II Esophageal Cancer AJCC v7,1
29190,Stromal Invasion,Recurrent Ovarian Endometrioid Adenocarcinoma,1
29191,Dysplasia,Bladder squamous cell carcinoma stage 0,1
29192,Benign Cellular Infiltrate,Benign Adult Cerebral Neoplasm,1
29193,Therapy-Related Toxicity,Treatment related secondary malignancy,1
29194,Necrotic changes (finding),Low Grade Malignant Peripheral Nerve Sheath Tumor,1
29195,Papillary Pattern,Vaginal Mullerian Papilloma,1
29196,Vascular Channel Formation,Small Intestinal Kaposi Sarcoma,1
29197,Neuroectodermal Differentiation,Refractory Neuroblastoma,1
29198,Epithelial Component Present,Stage I Prostate Cancer AJCC v8,1
29199,Endophytic Tumor Growth,Ethmoid Sinus Inverted Papilloma,1
29200,Indolent Clinical Course,Intracranial Benign Fibrous Histiocytoma,1
29201,Recurrent disease,Hodgkin's disease mixed cellularity recurrent,1
29202,Malignant Cellular Infiltrate,Ceruminous adenocarcinoma,1
29203,Diffuse Pattern,Pleural Desmoplastic Mesothelioma,1
29204,Neuroendocrine Differentiation,Recurrent Merkel Cell Carcinoma,1
29205,Malignant Cellular Infiltrate,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
29206,Epithelial Component Present,Cervix carcinoma recurrent,1
29207,Carcinomatous Component Present,Endometrial adenocarcinoma metastatic,1
29208,Infiltrative Growth Pattern,Recurrent Childhood Fibrillary Astrocytoma,1
29209,Ineffective hematopoiesis,Refractory anaemia with excess blasts,1
29210,Therapy-Related Toxicity,Methotrexate-Associated Follicular Lymphoma,1
29211,Tissue of Mullerian Origin Present,Cervical Atypical Polypoid Adenomyoma,1
29212,Childhood Lesion,Recurrent Childhood Liver Cancer,1
29213,Carcinomatous Component Present,Stage II Major Salivary Gland Cancer AJCC v8,1
29214,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
29215,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
29216,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline ETV6 Mutation,1
29217,Papillary Pattern,Warty Carcinoma of the Penis,1
29218,Carcinomatous Component Present,Stage IIIA Lung Large Cell Carcinoma AJCC v7,1
29219,Neuroectodermal Differentiation,Localized Resectable Neuroblastoma,1
29220,Cellular Pseudostratification,cystic mucinous tumor of pancreas with moderate dysplasia,1
29221,Malignant Cellular Infiltrate,Resectable Soft Tissue Sarcoma,1
29222,Malignant Cellular Infiltrate,leiomyosarcoma of liver,1
29223,Epithelial Component Present,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
29224,Invasive Lesion,Oncocytic Breast Carcinoma,1
29225,Malignant Cellular Infiltrate,Stage IIC Merkel Cell Carcinoma AJCC v7,1
29226,Indolent Clinical Course,Fibroma of tendon sheath,1
29227,Malignant Cellular Infiltrate,High grade B-cell lymphoma,1
29228,Epithelial Component Present,"Adenocarcinoma of lung, stage IV",1
29229,Non-Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
29230,Thyroglobulin Positive Neoplastic Cells Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
29231,Cutaneous Involvement,Atrophic lichen planus,1
29232,Syncytial Pattern,lymphoepithelial squamous cell carcinoma of salivary gland,1
29233,Malignant Cellular Infiltrate,Malignant melanoma of vulva,1
29234,Epithelial Component Present,Esophageal Well Differentiated Squamous Cell Carcinoma,1
29235,Nodular lesions,Lung Typical Carcinoid Tumor,1
29236,Drug Exposure,Steroid Lipomatosis,1
29237,Hyperkeratosis,Seborrheic keratosis,1
29238,Malignant Cellular Infiltrate,Stage IV Anal Canal Cancer AJCC v6 and v7,1
29239,High Grade Lesion,Adult Alveolar Soft Part Sarcoma,1
29240,Epithelial Component Present,Gastric Cancer by AJCC v8 Pathologic Stage,1
29241,Metastatic Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
29242,Malignant Cellular Infiltrate,Gastric Mixed Adenocarcinoma,1
29243,Carcinomatous Component Present,Stage III Ovarian Cancer AJCC v8,1
29244,Carcinomatous Component Present,Stage IIA Gastric Cancer AJCC v7,1
29245,Firm mass,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
29246,CD8-Positive Neoplastic Cells Present,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
29247,Absence of Invasion,Intraductal Cribriform Breast Adenocarcinoma,1
29248,Fibrotic Stroma Formation,Acanthomatous ameloblastoma,1
29249,Papillary Pattern,Well-differentiated papillary mesothelioma,1
29250,Epithelial Component Present,Intrapulmonary thymoma,1
29251,Malignant Cellular Infiltrate,Refractory Soft Tissue Sarcoma,1
29252,Single Cell Necrosis,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
29253,Apocrine Differentiation,Malignant Apocrine Neoplasm,1
29254,Malignant Cellular Infiltrate,Malignant lymphoma of testis,1
29255,Epithelial Component Present,Stage III Prostate Cancer AJCC v7,1
29256,Benign Cellular Infiltrate,Solitary Myofibromatosis,1
29257,Malignant Cellular Infiltrate,Refractory anaemia with excess blasts,1
29258,Diffuse Pattern,Recurrent Childhood Gemistocytic Astrocytoma,1
29259,Intraluminal Tumor Growth,Giant Fibrovascular Esophageal Polyp,1
29260,Benign Cellular Infiltrate,"Papilloma, Intraductal",1
29261,Malignant Cellular Infiltrate,FIGO Stage III Ovarian Cancer,1
29262,Malignant Cellular Infiltrate,Pancreatic Ductal Adenocarcinoma,1
29263,Carcinomatous Component Present,squamous cell carcinoma of salivary gland,1
29264,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage I,1
29265,Osseous Differentiation,Small cell osteosarcoma,1
29266,Neuroendocrine Differentiation,Carcinoid Tumor,1
29267,Malignant Cellular Infiltrate,Recurrent Bone Ewing Sarcoma,1
29268,Malignant Cellular Infiltrate,"Hepatocellular carcinoma, scirrhous",1
29269,Nodular Pattern,Grade 2 Cutaneous Follicular Lymphoma,1
29270,Adnexal Differentiation,Malignant Hair Follicle Neoplasm,1
29271,Childhood Lesion,Postsurgical Stage IV Hepatoblastoma,1
29272,Recurrent disease,Recurrent Ampulla of Vater Adenocarcinoma,1
29273,Anaplasia,Plasmacytoma anaplastic,1
29274,Adulthood Lesion,Adult Brain Stem Neoplasm,1
29275,Epithelial Component Present,Stage I Gastric Neuroendocrine Tumor AJCC v8,1
29276,Well-Circumscribed Lesion,Juvenile Polyp of the Small Intestine,1
29277,Malignant Cellular Infiltrate,Cholangiocarcinoma metastatic,1
29278,Diffuse Pattern,"Diffuse Astrocytoma, IDH-Mutant",1
29279,Malignant Cellular Infiltrate,"Retinoblastoma, differentiated",1
29280,Malignant Cellular Infiltrate,Pancreatic Foamy Gland Adenocarcinoma,1
29281,Tubular Pattern,Pancreatic Intraductal Tubulopapillary Neoplasm,1
29282,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v7,1
29283,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
29284,Drug toxicity,Kaposi Sarcoma Related to Immunosuppressive Treatment,1
29285,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage IV,1
29286,'Starry-sky' pattern,Recurrent Burkitt Lymphoma,1
29287,Epithelial Component Present,Stage IIC Colorectal Cancer AJCC v8,1
29288,Malignant Cellular Infiltrate,Recurrent Malignant Endocrine Neoplasm,1
29289,Epithelial Component Present,Stage II Colorectal Cancer AJCC v7,1
29290,Mild cytologic atypia,Plantar Verrucous Skin Carcinoma,1
29291,Nuclear Grooves,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
29292,Benign Cellular Infiltrate,Central Nervous System Myofibroblastoma,1
29293,Non-Invasive Lesion,Ureter Urothelial Papilloma,1
29294,Childhood Lesion,Childhood Brain Germinoma,1
29295,Microvascular Proliferation,MGMT-Methylated Glioblastoma,1
29296,Epithelial Component Present,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
29297,Recurrent disease,Recurrent Malignant Extragonadal Germ Cell Tumor,1
29298,Cutaneous Involvement,Verruciform xanthoma of skin,1
29299,Exophytic Polypoid Lesion,adenoma of extrahepatic bile duct,1
29300,Carcinomatous Component Present,EBV-Related Carcinoma,1
29301,Pseudoalveolar Pattern,Vulvar Alveolar Soft Part Sarcoma,1
29302,Malignant Cellular Infiltrate,Klatskin Tumor,1
29303,Carcinomatous Component Present,Scirrhous carcinoma of breast,1
29304,Epithelial Component Present,BCLC Stage D Adult Hepatocellular Carcinoma,1
29305,Epithelial Component Present,Proliferating Brenner Tumor,1
29306,Epithelial Component Present,Stage II Bladder Cancer AJCC v6 and v7,1
29307,Tubular Structures Present,Malignant Testicular Sertoli Cell Tumor,1
29308,Carcinomatous Component Present,Bile duct clear cell adenocarcinoma,1
29309,Malignant Cellular Infiltrate,Cervical Papillary Squamous Cell Carcinoma,1
29310,Papillary Pattern,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
29311,Recurrent disease,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
29312,Crooke Hyaline Change,Crooke Cell Adenoma,1
29313,Carcinomatous Component Present,undifferentiated carcinoma of larynx,1
29314,Extraosseous Lesion,Kidney Extraskeletal Osteosarcoma,1
29315,Refractory Disease,Refractory Classic Hodgkin Lymphoma,1
29316,Carcinomatous Component Present,Esophageal Poorly Differentiated Squamous Cell Carcinoma,1
29317,Malignant Cellular Infiltrate,Cervical Basaloid Carcinoma,1
29318,Ganglioneuroblastoma Component Present,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
29319,Metastatic Lesion,Prostate Carcinoma Metastatic in the Soft Tissue,1
29320,Slow Growing Mass,Subependymal Giant Cell Astrocytoma,1
29321,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v7,1
29322,Malignant Cellular Infiltrate,Recurrent Medulloblastoma,1
29323,High Mitotic Activity,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
29324,Neuroendocrine Differentiation,Gastric Large Cell Neuroendocrine Carcinoma,1
29325,Biphasic Pattern,Benign mixed epithelial and stromal tumor of kidney,1
29326,Invasive Lesion,Histiocytoid Breast Carcinoma,1
29327,Epithelial Component Present,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
29328,Severe cytologic atypia,Small cell carcinoma of esophagus,1
29329,Papillary Pattern,Common wart,1
29330,Epithelial Component Present,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,1
29331,Primary Lesion,Childhood Cerebellar Astrocytoma,1
29332,Perivascular Arrangement of Tumor Cells,Malignant Pericytic Neoplasm,1
29333,Malignant Cellular Infiltrate,Stage III Pleural Malignant Mesothelioma AJCC v8,1
29334,Well Differentiated Lesion,Esophageal Well Differentiated Squamous Cell Carcinoma,1
29335,Malignant Cellular Infiltrate,High Grade Salivary Gland Carcinoma,1
29336,Epithelial Component Present,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
29337,Epithelial Component Present,Stage IVB Lip and Oral Cavity Cancer AJCC v8,1
29338,Severe dysplasia,Carcinoma in situ of prostate,1
29339,Malignant Cellular Infiltrate,Mantle cell lymphoma stage IV,1
29340,Nodular Pattern,Follicular Bronchitis/Bronchiolitis,1
29341,Perivascular Arrangement of Tumor Cells,Kidney Epithelioid Type Angiomyolipoma,1
29342,Mitotic Activity,Diencephalic Glioblastoma,1
29343,Poorly Differentiated Lesion,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,1
29344,Myeloblasts Under 10 Percent of Peripheral Blood White Cells,Overt Primary Myelofibrosis,1
29345,Epithelial Component Present,Advanced Carcinoid Tumor,1
29346,Benign Cellular Infiltrate,Benign Female Reproductive System Neoplasm,1
29347,Epithelial Component Present,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
29348,Malignant Cellular Infiltrate,Pancreatic Non-Hodgkin Lymphoma,1
29349,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Erythroid Leukemia,1
29350,Mitotic Activity,"Testicular Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
29351,Recurrent disease,Intrahepatic cholangiocarcinoma recurrent,1
29352,Primary Lesion,Recurrent Medulloblastoma,1
29353,Cystic Change,mucoepidermoid carcinoma of lacrimal gland,1
29354,Carcinomatous Component Present,Stage IV Penile Cancer AJCC v8,1
29355,Nuclear Grooves,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
29356,Storiform Growth Pattern,Adult Undifferentiated Pleomorphic Sarcoma,1
29357,Neuroendocrine Differentiation,Stage IIA Colon Neuroendocrine Tumor AJCC v8,1
29358,Low Mitotic Activity,Pancreatic Neuroendocrine Microadenoma,1
29359,Primary Lesion,Stage IV Hepatocellular Carcinoma AJCC v6,1
29360,High Mitotic Activity,Vaginal Large Cell Neuroendocrine Carcinoma,1
29361,Osseous Differentiation,Cementoma,1
29362,Childhood Lesion,Childhood Diffuse Astrocytoma,1
29363,Invasive Lesion,Locally Advanced Prostate Adenocarcinoma,1
29364,Epithelial Component Present,Oropharyngeal Poorly Differentiated Carcinoma,1
29365,Epithelial Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
29366,Exophytic Polypoid Lesion,Villous adenoma of duodenum,1
29367,Malignant Cellular Infiltrate,Metastatic Nasopharyngeal Undifferentiated Carcinoma,1
29368,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage I,1
29369,Malignant Cellular Infiltrate,Malignant neoplasm of endocrine gland,1
29370,Carcinomatous Component Present,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
29371,Increased Cellularity Present,Cellular neurothekeoma,1
29372,Cutaneous Involvement,Trichodiscoma,1
29373,Anaplasia,Recurrent Glioblastoma,1
29374,Malignant Cellular Infiltrate,Stage III Bone Sarcoma AJCC v7,1
29375,Benign Cellular Infiltrate,Metastatic Benign Neoplasm,1
29376,Recurrent disease,Recurrent Ovarian Mucinous Adenocarcinoma,1
29377,Refractory Disease,Refractory Transformed Chronic Lymphocytic Leukemia,1
29378,Carcinomatous Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,1
29379,Primary Lesion,Refractory Primary Vitreoretinal Lymphoma,1
29380,Epithelial Component Present,Atrial Paraganglioma,1
29381,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,1
29382,Well-Circumscribed Lesion,Compact Cell Adrenal Cortical Adenoma,1
29383,Malignant Cellular Infiltrate,Klatskin Tumor,1
29384,Intracanalicular Growth Pattern,Intracanalicular fibroadenoma,1
29385,Malignant Cellular Infiltrate,Locally Advanced Bone Sarcoma,1
29386,Malignant Cellular Infiltrate,Lymphomatous Adult T-Cell Leukemia/Lymphoma,1
29387,Carcinomatous Component Present,Bladder Squamous Cell Carcinoma,1
29388,Epithelial Component Present,Rectosigmoid cancer,1
29389,Neuroendocrine Differentiation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
29390,Well-Circumscribed Lesion,Anal polyp,1
29391,Vascular Channel Formation,Intermediate Blood Vessel Neoplasm,1
29392,Carcinomatous Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
29393,Metastatic/Recurrent Disease,Epithelioid sarcoma metastatic,1
29394,Villous atrophy,Immunoproliferative Small Intestinal Disease,1
29395,Unilineage Dysplasia Present,Refractory Thrombocytopenia,1
29396,Intraductal Lesion,Pancreatic Intraductal Papillary-Mucinous Neoplasm with High Grade Dysplasia,1
29397,Malignant Cellular Infiltrate,Recurrent Burkitt Leukemia,1
29398,Thyroglobulin Positive Neoplastic Cells Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
29399,Metastatic Lesion,Carcinoma Metastatic to the Skin,1
29400,High Mitotic Activity,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
29401,Keratin pearl formation,Spindle cell squamous cell carcinoma,1
29402,Malignant Cellular Infiltrate,Stage IIA Anal Cancer AJCC v8,1
29403,Pseudoglandular Pattern,Acantholytic squamous cell carcinoma,1
29404,Malignant Cellular Infiltrate,Serous cystadenocarcinoma ovary,1
29405,Well-Circumscribed Lesion,Villous adenoma of colon,1
29406,Increased Cellularity Present,Adult Anaplastic Ependymoma,1
29407,Epithelial Component Present,Stage IVC Pharyngeal Carcinoma,1
29408,Carcinomatous Component Present,Stage IVA Hypopharyngeal Carcinoma AJCC v7,1
29409,Malignant Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia,1
29410,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage II,1
29411,Neuroendocrine Differentiation,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
29412,High Grade Lesion,"Glioblastoma, IDH-Wildtype",1
29413,Mitotic Activity,Childhood Brain Stem Gliosarcoma,1
29414,Endophytic Tumor Growth,Ureter Inverted Papilloma,1
29415,Vascular Channel Formation,Anal Kaposi Sarcoma,1
29416,Epithelial Component Present,Stage IIIA Hepatocellular Carcinoma AJCC v8,1
29417,Childhood Lesion,Childhood Testicular Choriocarcinoma,1
29418,High Mitotic Activity,Malignant Solitary Fibrous Tumor,1
29419,Malignant Cellular Infiltrate,Resectable Intrahepatic Cholangiocarcinoma,1
29420,Carcinomatous Component Present,Carcinoma of upper gum,1
29421,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
29422,Malignant Cellular Infiltrate,Stage III Rectosigmoid Cancer AJCC v7,1
29423,Malignant Cellular Infiltrate,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,1
29424,Epithelial Component Present,clear cell adenocarcinoma of urethra,1
29425,Carcinomatous Component Present,Small cell carcinoma of lung,1
29426,Malignant Cellular Infiltrate,Recurrent Ureter Carcinoma,1
29427,Malignant Cellular Infiltrate,Stage IIIA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
29428,Microcystic Change,Fibrillary Astrocytoma,1
29429,Secondary Lesion,Secondary malignant neoplasm of peritoneum,1
29430,Fever,HHV8-Positive Multicentric Castleman Disease,1
29431,Non-Specific Glandular Pattern,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
29432,Metastatic Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
29433,Carcinomatous Component Present,Maxillary Sinus Carcinoma,1
29434,Recurrent disease,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
29435,Biphasic Pattern,Pulmonary Blastoma,1
29436,Indolent Clinical Course,Intravascular fasciitis,1
29437,Hypergammaglobulinemia,Multi-centric Castleman's Disease,1
29438,Recurrent disease,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
29439,Carcinomatous Component Present,Major Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
29440,Malignant Cellular Infiltrate,Malignant Cardiac Germ Cell Tumor,1
29441,Secondary Lesion,Secondary malignant neoplasm of axilla,1
29442,Malignant Cellular Infiltrate,Stage IIIB Uterine Corpus Cancer AJCC v8,1
29443,Malignant Cellular Infiltrate,Tobacco-Related Carcinoma,1
29444,More than 5 Mitoses per 50HPF,"Stage IIIB Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
29445,Carcinomatous Component Present,Stage IVA Cervical Cancer AJCC v8,1
29446,Secondary Lesion,Treatment related leukaemia,1
29447,Immunologic Deficiency Syndromes,AIDS Dementia Complex,1
29448,Malignant Cellular Infiltrate,Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
29449,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q),1
29450,Cutaneous Involvement,Mycosis fungoides/Sezary syndrome recurrent,1
29451,Malignant Cellular Infiltrate,Rectal Serrated Adenocarcinoma,1
29452,Geographic Necrosis,Adult Central Nervous System Embryonal Carcinoma,1
29453,Carcinomatous Component Present,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
29454,Human Papillomavirus Positive,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
29455,Cutaneous Involvement,Old Burn Scar-Related Cutaneous Melanoma,1
29456,Chronic lymphocytic inflammation,"Thymoma, type B2, malignant",1
29457,Epithelial Component Present,Occult Lung Large Cell Carcinoma,1
29458,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor by AJCC v8 Stage,1
29459,Dermal Involvement,Vulvar Eccrine Porocarcinoma,1
29460,Unresectable Mass,Pancreatic carcinoma non-resectable,1
29461,Malignant Cellular Infiltrate,Peripheral primitive neuroectodermal bone tumor,1
29462,Generalized Dysplasia,Filiform Serrated Adenoma,1
29463,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
29464,Carcinomatous Component Present,Gallbladder Goblet Cell Carcinoid,1
29465,Malignant Cellular Infiltrate,Stage II Eyelid Carcinoma AJCC v7,1
29466,Primary Lesion,Primary Lung Meningioma,1
29467,Malignant Cellular Infiltrate,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
29468,Malignant Cellular Infiltrate,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,1
29469,Malignant Cellular Infiltrate,"Childhood Ganglioneuroblastoma, Nodular",1
29470,Malignant Cellular Infiltrate,Multicentric Thyroid Gland Papillary Carcinoma,1
29471,Subcutaneous Involvement,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
29472,Malignant Cellular Infiltrate,Adenocarcinoma of Unknown Primary,1
29473,Epithelial Component Present,Stage III Anal Canal Cancer AJCC v6 and v7,1
29474,Carcinomatous Component Present,Refractory Endometrial Carcinoma,1
29475,Malignant Cellular Infiltrate,Recurrent Grade 1 Follicular Lymphoma,1
29476,Solitary mass,Plasmacytoma,1
29477,Therapy-Related Toxicity,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
29478,Epithelial Component Present,Appendix Villous Adenoma,1
29479,Osseous Differentiation,Stage IIA Osteosarcoma AJCC v7,1
29480,Chromogranin A Positive Neoplastic Cells Present,Pancreatic Neuroendocrine Tumor G1,1
29481,Epithelial Component Present,Adenocarcinoma of the prostate stage IV,1
29482,Carcinomatous Component Present,Stage IIIB Rectal Cancer AJCC v7,1
29483,Carcinomatous Component Present,Stage IIA Lung Squamous Cell Carcinoma AJCC v7,1
29484,Malignant Cellular Infiltrate,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
29485,Primary Lesion,anaplastic large cell lymphoma of central nervous system,1
29486,Single Cell Necrosis,Merkel Cell Carcinoma by AJCC v8 Stage,1
29487,Carcinomatous Component Present,Extrahepatic Bile Duct Mixed Adenoneuroendocrine Carcinoma,1
29488,Epithelial Component Present,Ethmoid Sinus Squamous Cell Carcinoma,1
29489,Carcinomatous Component Present,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
29490,Carcinomatous Component Present,Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
29491,Perineural spread,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
29492,Sarcomatous Component Present,carcinosarcoma of lung,1
29493,Malignant Cellular Infiltrate,Recurrent Pancreatic Cystadenocarcinoma,1
29494,Carcinomatous Component Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
29495,Cribriform Pattern,Colon Cribriform Comedo-Type Adenocarcinoma,1
29496,Dysplasia,Flat adenoma,1
29497,Carcinomatous Component Present,Stage IVA Basal Cell Lip Carcinoma,1
29498,Non-Hereditary Lesion,Sporadic Burkitt's lymphoma,1
29499,Epithelial Component Present,Carcinoma in situ of penis,1
29500,Malignant Cellular Infiltrate,Secondary malignant neoplasm of extrahepatic bile ducts,1
29501,Resectable Mass,Bile duct cancer resectable,1
29502,Adnexal Differentiation,Eccrine spiradenoma,1
29503,High Mitotic Activity,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,1
29504,Intraosseous Lesion,Granular cell ameloblastoma,1
29505,Carcinomatous Component Present,Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
29506,Benign Cellular Infiltrate,Lipoblastoma,1
29507,Malignant Cellular Infiltrate,Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma,1
29508,Carcinomatous Component Present,Skin Sarcomatoid Basal Cell Carcinoma,1
29509,Carcinomatous Component Present,Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
29510,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of ileum,1
29511,Carcinomatous Component Present,Cervical Serous Adenocarcinoma,1
29512,Neuroendocrine Differentiation,Refractory Neuroendocrine Neoplasm,1
29513,Epithelial Component Present,estrogen-producing adrenal cortical adenoma,1
29514,Severe dysplasia,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
29515,High Grade Lesion,Cardiac Monophasic Synovial Sarcoma,1
29516,Epithelial Component Present,Recurrent Combined Thymic Epithelial Neoplasm,1
29517,Neuroendocrine Differentiation,Carcinoid tumor of ileum,1
29518,Fibrosis,Fibrosclerosis of breast,1
29519,Bilateral Disease,Bilateral Carcinoma,1
29520,Malignant Cellular Infiltrate,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
29521,Epithelial Component Present,Bladder cancer recurrent,1
29522,Low Mitotic Activity,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
29523,Carcinomatous Component Present,Fibrolamellar Hepatocellular Carcinoma,1
29524,Malignant Cellular Infiltrate,Stage IIIB Gastric Carcinoma,1
29525,Thin-Walled Branching Vascular Pattern,Peritoneal Solitary Fibrous Tumor,1
29526,Carcinomatous Component Present,Unresectable Skin Squamous Cell Carcinoma,1
29527,Carcinomatous Component Present,ACTH-Producing Pituitary Gland Carcinoma,1
29528,Carcinomatous Component Present,Stage IC Fallopian Tube Cancer AJCC v6 and v7,1
29529,Cutaneous Involvement,Furunculosis,1
29530,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(11;17)(q13;q21),1
29531,Multiple Tumor Masses,"Meningiomas, Multiple",1
29532,Malignant Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v8,1
29533,Malignant Cellular Infiltrate,Pathologic Stage II Retinoblastoma AJCC v8,1
29534,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Erythroid Leukemia,1
29535,Malignant Cellular Infiltrate,Metastatic Fibrolamellar Carcinoma,1
29536,Thin-Walled Branching Vascular Pattern,Angiolipoma,1
29537,Carcinomatous Component Present,Stage IV Colorectal Cancer AJCC v7,1
29538,Epithelial Component Present,Metastatic Digestive System Neuroendocrine Carcinoma,1
29539,High Plasma Renin Activity,Juxtaglomerular tumor,1
29540,Epithelial Component Present,Oropharyngeal lymphoepithelioma stage III,1
29541,Malignant Cellular Infiltrate,alk-positive anaplastic large cell lymphoma,1
29542,Organoid Pattern,Orbital Alveolar Soft Part Sarcoma,1
29543,Carcinomatous Component Present,Combined Lung Small Cell and Squamous Cell Carcinoma,1
29544,Poorly Differentiated Lesion,Gingival Spindle Cell Carcinoma,1
29545,Cysts Containing Proteinaceous Fluid Present,Papillary serous cystadenoma,1
29546,Nuclear Molding,Combined Lung Large Cell Neuroendocrine Carcinoma,1
29547,Papillary Pattern,Papillary transitional cell neoplasm of low malignant potential,1
29548,Benign Cellular Infiltrate,Hemangioma of orbit,1
29549,Tumor Vascular Invasion,Malignant Testicular Sex Cord-Stromal Tumor,1
29550,Misplaced Exocytosis Present,Acidophil Stem Cell Pituitary Gland Adenoma,1
29551,Tissue of Mullerian Origin Present,Adenomyoma,1
29552,Epithelial Component Present,Apocrine breast carcinoma,1
29553,Metastatic Lesion,Locally Advanced Unresectable Bone Sarcoma,1
29554,Mixed Cellular Population,Breast Pleomorphic Adenoma,1
29555,Well Differentiated Lesion,Stage III Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
29556,Malignant Cellular Infiltrate,Ovarian germ cell tumor mixed,1
29557,Exophytic Polypoid Lesion,adenomatous polyp of stomach,1
29558,Carcinomatous Component Present,Clinical Stage IIB Gastric Cancer AJCC v8,1
29559,Epithelial Component Present,Pedunculated conjunctival papilloma,1
29560,Poorly Differentiated Neuroendocrine Lesion,Refractory Pancreatic Neuroendocrine Carcinoma,1
29561,Dysplasia,Colorectal Sessile Serrated Adenoma/Polyp,1
29562,Follicular Cell Differentiation,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
29563,Thin-Walled Branching Vascular Pattern,"Adult Intracranial Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
29564,Childhood Lesion,Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10,1
29565,Dysplasia,Colonic tubulovillous adenoma,1
29566,Fibrotic Stroma Formation,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
29567,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,MYELODYSPLASTIC SYNDROME,1
29568,Indolent Clinical Course,Lipoma,1
29569,Carcinomatous Component Present,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
29570,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
29571,Cutaneous Involvement,Trichilemmoma,1
29572,Malignant Cellular Infiltrate,Stage IIIB Colon Cancer AJCC v7,1
29573,Bone Marrow Dysplasia Present in 50 Percent or More of the Cells of Two Cell Lines,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,1
29574,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Seminoma,1
29575,High Mitotic Activity,large cell neuroendocrine carcinoma of lung,1
29576,Infiltrative Growth Pattern,Frontal Lobe Anaplastic Astrocytoma,1
29577,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage II,1
29578,Epithelial Component Present,Mixed Cell Adrenal Cortical Adenoma,1
29579,Sarcomatous Component Present,"Uterine Carcinosarcoma, Heterologous Type",1
29580,Carcinomatous Component Present,Metastatic Oral Cavity Adenoid Cystic Carcinoma,1
29581,Indolent Clinical Course,"Uterine Corpus Leiomyoma, Mitotically Active Variant",1
29582,Ground Glass Nuclear Inclusion,Columnar Cell Variant Thyroid Gland Papillary Carcinoma,1
29583,Malignant Cellular Infiltrate,Stage IIIB Uterine Sarcoma AJCC v7,1
29584,Anaplasia,Stage III Childhood Anaplastic Large Cell Lymphoma,1
29585,Villous Pattern,tubulopapillary adenoma of extrahepatic bile duct,1
29586,Carcinomatous Component Present,Stage IV Colon Carcinoma,1
29587,Malignant Cellular Infiltrate,Unresectable Soft Tissue Sarcoma,1
29588,Exophytic Polypoid Lesion,Foveolar-Type Adenoma,1
29589,Malignant Cellular Infiltrate,Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
29590,Immunologic Deficiency Syndromes,Acute GVH disease,1
29591,Storiform Growth Pattern,"Histiocytoma, Benign Fibrous",1
29592,Metastatic Lesion,Metastatic gastric adenocarcinoma,1
29593,Refractory Disease,Refractory Sarcoma,1
29594,Exophytic Polypoid Lesion,Rectal Tubular Adenoma,1
29595,Epithelial Component Present,Intrahepatic Bile Duct Papillary Neoplasm,1
29596,Malignant Cellular Infiltrate,Extrarenal Rhabdoid Tumor of the Liver,1
29597,Spindle Cell Component Present,Cardiac Biphasic Synovial Sarcoma,1
29598,Immunosuppression-Related Post-Transplant Toxicity,Neoplastic Post-Transplant Lymphoproliferative Disorder,1
29599,Low Grade Lesion,Childhood Parosteal Osteosarcoma,1
29600,Perivascular Arrangement of Tumor Cells,Malignant Pericytic Neoplasm,1
29601,Monomorphic Cellular Infiltrate,Small cell glioblastoma,1
29602,Neuroendocrine Differentiation,"Gastrinoma, malignant",1
29603,Epithelial Component Present,Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor,1
29604,"Undifferentiated ""Fetal-Type"" Tissues Present",Stage II Immature Testicular Teratoma AJCC v6 and v7,1
29605,Fibrotic Stroma Formation,Testicular Brenner Tumor,1
29606,Primary Lesion,Primary leiomyosarcoma,1
29607,Carcinomatous Component Present,Mucin-producing adenocarcinoma,1
29608,Severe dysplasia,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
29609,Cytoplasmic Eosinophilic Globules Present,Undifferentiated (Embryonal) Sarcoma,1
29610,Malignant Cellular Infiltrate,Retroperitoneal sarcoma,1
29611,Epithelial Component Present,Squamous cell carcinoma of tongue,1
29612,Biphasic Pattern,Ovarian Seromucinous Adenofibroma,1
29613,Neuroendocrine Differentiation,Small Intestinal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
29614,Childhood Lesion,Childhood Cerebellar Neoplasm,1
29615,Well Differentiated Neuroendocrine Lesion,Stage I Ileal Neuroendocrine Tumor AJCC v8,1
29616,Carcinomatous Component Present,carcinoma of middle ear,1
29617,Diffuse Pattern,Glioblastoma,1
29618,Epithelial Component Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
29619,Malignant Cellular Infiltrate,Stage IB Fallopian Tube Cancer AJCC v8,1
29620,Malignant Cellular Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
29621,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v7 Stage,1
29622,Malignant Cellular Infiltrate,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
29623,Cystic Change,Pancreatic Intraductal Neoplasms,1
29624,Chromogranin A Positive Neoplastic Cells Present,Pancreatic Neuroendocrine Tumor G1,1
29625,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IV,1
29626,Cutaneous Involvement,Melanoma recurrent,1
29627,Carcinomatous Component Present,Stage II Adult Liver Cancer AJCC v7,1
29628,Malignant Cellular Infiltrate,Digestive System Small Cell Neuroendocrine Carcinoma,1
29629,Hyalinized Stroma Formation,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,1
29630,Diffuse Pattern,AIDS-Related Diffuse Large B-cell Lymphoma,1
29631,Recurrent disease,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
29632,Epithelial Component Present,Glottic Squamous Cell Carcinoma,1
29633,Malignant Cellular Infiltrate,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
29634,High Mitotic Activity,Bartholin Gland Small Cell Carcinoma,1
29635,Unresectable Mass,Unresectable Esophageal Carcinoma,1
29636,Primary Lesion,Recurrent Childhood Anaplastic Astrocytoma,1
29637,Metastatic Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
29638,Secondary Lesion,Breast Carcinoma Metastatic in the Lung,1
29639,Epithelial Component Present,Vulvar Papillary Hidradenoma,1
29640,Epithelial Component Present,Stage IA Eyelid Carcinoma AJCC v8,1
29641,Carcinomatous Component Present,Stage 0 Renal Pelvis Cancer AJCC v7,1
29642,Clusters and Cords of GFAP Positive Epithelioid Tumor Cells Present,Chordoid Glioma of the Third Ventricle,1
29643,Absence of Invasion,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
29644,Malignant Cellular Infiltrate,Malignant neoplasm of skin of eyelid,1
29645,Malignant Cellular Infiltrate,Stage IIC Ovarian Carcinoma,1
29646,Infiltrative Growth Pattern,Metastatic Kidney Medullary Carcinoma,1
29647,Cutaneous Involvement,Neoplasm of skin with adnexal differentiation,1
29648,Polymorphic Cellular Infiltrate,Letterer-Siwe Disease,1
29649,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage,1
29650,Epithelial Component Present,Stage I Lung Cancer AJCC v6,1
29651,Rapidly Enlarging Mass,Adult Rhabdomyosarcoma,1
29652,Malignant Cellular Infiltrate,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
29653,High Grade Lesion,Refractory Alveolar Rhabdomyosarcoma,1
29654,Epithelial Component Present,Colorectal Large Cell Neuroendocrine Carcinoma,1
29655,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v7 Stage,1
29656,Carcinomatous Component Present,Stage IV Lung Cancer AJCC v8,1
29657,Carcinomatous Component Present,Renal Cell Cancer by AJCC v6 Stage,1
29658,Malignant Cellular Infiltrate,Resectable Pancreatic Acinar Cell Carcinoma,1
29659,Malignant Cellular Infiltrate,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
29660,Follicular Cell Differentiation,"Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive",1
29661,Biphasic Pattern,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
29662,Carcinomatous Component Present,Stage IVB Gallbladder Cancer AJCC v8,1
29663,High Grade Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
29664,Diffuse Pattern,Well Differentiated Oligodendroglioma,1
29665,Cystic Change,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
29666,Malignant Cellular Infiltrate,Poorly Differentiated Angiosarcoma,1
29667,Metastatic Lesion,Advanced Unfavorable Hodgkin Lymphoma,1
29668,Necrotic changes (finding),Recurrent Malignant Peripheral Nerve Sheath Tumor,1
29669,Recurrent Lymphoma,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,1
29670,Adulthood Lesion,Recurrent Adult Spinal Cord Neoplasm,1
29671,Childhood Lesion,Grade III Childhood Astrocytoma,1
29672,Epithelial Component Present,Thoracic Esophagus Adenocarcinoma,1
29673,Microvascular Proliferation,"Glioblastoma, IDH-Wildtype",1
29674,Epithelial Component Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
29675,Epithelial Component Present,Small Intestinal High Grade Intraepithelial Neoplasia,1
29676,Malignant Cellular Infiltrate,Adult Anaplastic Ependymoma,1
29677,Malignant Cellular Infiltrate,Stage II Adrenal Cortex Carcinoma AJCC v8,1
29678,Non-Contiguous Disease,Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma,1
29679,Carcinomatous Component Present,Recurrent Ovarian Transitional Cell Carcinoma,1
29680,Malignant Cellular Infiltrate,malignant ganglioneuroblastoma of adrenal gland,1
29681,Epithelial Component Present,Stage IV Rectal Cancer AJCC v7,1
29682,Indolent Clinical Course,Disseminated Juvenile Xanthogranuloma,1
29683,Malignant Cellular Infiltrate,Unresectable Gallbladder Carcinoma,1
29684,Unresectable Mass,Unresectable Rhabdomyosarcoma,1
29685,Malignant Cellular Infiltrate,Colon Mucosa-Associated Lymphoid Tissue Lymphoma,1
29686,Epithelial Component Present,Stage IV Ureter Cancer AJCC v7,1
29687,Malignant Cellular Infiltrate,Large B-cell lymphoma with IRF4 rearrangement,1
29688,Hypertensive disease,Hypertensive Encephalopathy,1
29689,Cutaneous Involvement,Stage IIIA Cutaneous Melanoma AJCC v7,1
29690,Malignant Cellular Infiltrate,Colorectal Kaposi Sarcoma,1
29691,Carcinomatous Component Present,Recurrent Adult Liver Carcinoma,1
29692,Stromal Invasion,FIGO Stage IIIA1(i) Ovarian Cancer,1
29693,Stromal Invasion,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
29694,Malignant Cellular Infiltrate,Malignant neoplasm of endometrium,1
29695,Neuroendocrine Differentiation,Pancreatic Somatostatinoma,1
29696,Carcinomatous Component Present,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
29697,Malignant Cellular Infiltrate,Sarcoma of breast,1
29698,Primary Site Unspecified,Primary Carcinoma Unspecified Site,1
29699,Malignant Cellular Infiltrate,Liver and Intrahepatic Bile Duct Malignant Non-Epithelial Neoplasm,1
29700,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Neoplasm,1
29701,Recurrent disease,Recurrent Malignant Head and Neck Neoplasm,1
29702,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Carcinosarcoma of ovary,1
29703,Nodular lesions,Thyroid Nodule,1
29704,Carcinomatous Component Present,Hepatic cancer stage IVA,1
29705,Extraosseous Lesion,Liver Extraskeletal Osteosarcoma,1
29706,Epithelial Component Present,Squamous intraepithelial lesion,1
29707,Malignant Cellular Infiltrate,Adult Lymphocyte-Depleted Classical Hodgkin Lymphoma,1
29708,Carcinomatous Component Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
29709,Collagenous Stroma Formation,"Fibromatosis, Abdominal",1
29710,Epithelial Component Present,Stage IIC Fallopian Tube Cancer AJCC v6 and v7,1
29711,Malignant Cellular Infiltrate,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7,1
29712,Malignant Cellular Infiltrate,Stage IA Ovarian Cancer AJCC v8,1
29713,Single Cell Necrosis,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
29714,Malignant Cellular Infiltrate,Parotid Gland Non-Hodgkin Lymphoma,1
29715,Indolent Clinical Course,Benign Notochordal Cell Tumor,1
29716,Malignant Cellular Infiltrate,Lipid-rich carcinoma,1
29717,Intraluminal Tumor Growth,Pulmonary Artery Intimal Sarcoma,1
29718,Necrotic changes (finding),Prostate Stromal Sarcoma,1
29719,Stromal Invasion,FIGO Stage IC2 Ovarian Cancer,1
29720,Multifocal Lesion,Bowenoid papulosis of penis,1
29721,atypia morphology,Prostatic Atypical Adenomatous Hyperplasia,1
29722,Trabecular Pattern,Thyroid Hyalinizing Trabecular Adenoma,1
29723,Tissue Differentiation Uncertain,Superficial angiomyxoma,1
29724,Single Cell Necrosis,Merkel Cell Carcinoma by AJCC v7 Stage,1
29725,Primary Lesion,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor",1
29726,Dysplasia,Biliary Intraepithelial Neoplasia-2,1
29727,Thick-Walled Vessels Present,Childhood Kidney Angiomyolipoma,1
29728,Malignant Cellular Infiltrate,Metastatic Lung Adenosquamous Carcinoma,1
29729,Preserved Nuclear Polarity,Ureter Urothelial Papilloma,1
29730,Carcinomatous Component Present,Stage IVC Nasopharyngeal Carcinoma AJCC v7,1
29731,Benign Cellular Infiltrate,Perineurioma,1
29732,Exophytic Polypoid Lesion,Vaginal Tubular Adenoma,1
29733,Bone Marrow Eosinophilia,"Acute myeloid leukemia, inv(16)(p13q22)",1
29734,Alternative Fascicle (Bundle) Pattern,Liver Leiomyoma,1
29735,Metastatic Lesion,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
29736,Peripheral Nuclear Palisading,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
29737,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with Maturation,1
29738,Adulthood Lesion,Stage II Adult Liver Cancer AJCC v7,1
29739,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
29740,Epithelial Component Present,Actinic keratosis,1
29741,Nuclear Pseudoinclusion,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
29742,Follicular Cell Differentiation,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
29743,Cutaneous Involvement,apocrine adenocarcinoma of vulva,1
29744,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of appendix,1
29745,Storiform Growth Pattern,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
29746,Malignant Cellular Infiltrate,Malignant Intrathoracic Paravertebral Paraganglioma,1
29747,Malignant Cellular Infiltrate,Adult Hodgkin Lymphoma,1
29748,Myeloblasts 90 Percent or More of Bone Marrow Non-Erythroid Cells,Adult Acute Myeloid Leukemia without Maturation,1
29749,Mixed Cellular Population,Stromal Predominant Kidney Wilms Tumor,1
29750,Malignant Cellular Infiltrate,Centroblastic Lymphoma by Ann Arbor Stage,1
29751,Malignant Cellular Infiltrate,Minor Salivary Gland Carcinoma,1
29752,Rapidly Enlarging Mass,Abdominal Rhabdomyosarcoma,1
29753,Exophytic Polypoid Lesion,Gastrointestinal polyps,1
29754,Epithelial Component Present,Bladder Paraganglioma,1
29755,Congenital Lesion,Congenital spondylolysis of lumbosacral region,1
29756,Low Grade Lesion,Subependymal Giant Cell Astrocytoma,1
29757,Malignant Cellular Infiltrate,Follicular T-cell lymphoma,1
29758,Epithelial Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8,1
29759,Tissue of Mullerian Origin Present,Fallopian Tube Serous Adenofibroma,1
29760,Recurrent disease,Recurrent Breast Angiosarcoma,1
29761,Pleural effusion disorder,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
29762,Non-Invasive Lesion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
29763,Epithelial Component Present,Metastatic Well Differentiated Neuroendocrine Neoplasm,1
29764,CD30-Positive Neoplastic Cells Present,Primary cutaneous CD30+ T-cell lymphoproliferative disorder,1
29765,Benign Cellular Infiltrate,Pericardial Leiomyoma,1
29766,Malignant Cellular Infiltrate,Malignant neoplasm of epicardium,1
29767,Epithelial Component Present,Gardner Syndrome,1
29768,Absence of a Hormonal Syndrome,Pituitary Gland Oncocytic Adenoma,1
29769,Red Papular Lesion,Senile angioma,1
29770,Metastatic Lesion,Locally Advanced Salivary Gland Carcinoma,1
29771,Anaplasia,Anaplastic Pleomorphic Xanthoastrocytoma,1
29772,Multilayered Rosette Formation,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
29773,Malignant Cellular Infiltrate,sarcoma of esophagus,1
29774,Immunologic Deficiency Syndromes,"Post-transplant lymphoproliferative disorder, polymorphic",1
29775,Secondary Lesion,Metastatic Penile Cancer,1
29776,Adulthood Lesion,Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8,1
29777,Benign Cellular Infiltrate,Central Nervous System Mature Teratoma,1
29778,Low Mitotic Activity,Lipofibromatosis,1
29779,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
29780,Malignant Cellular Infiltrate,Stage III Distal Bile Duct Cancer AJCC v8,1
29781,Breast Microcalcification,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
29782,Carcinomatous Component Present,Small cell lung cancer extensive stage,1
29783,Carcinomatous Component Present,Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8,1
29784,Neuroendocrine Differentiation,Intestinal Neuroendocrine Carcinoma,1
29785,Epithelial Component Present,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
29786,Neuroectodermal Differentiation,Sellar Neuroblastoma,1
29787,Carcinomatous Component Present,Stage IIB Lung Cancer AJCC v7,1
29788,Malignant Cellular Infiltrate,Metastatic Pancreatic Neuroendocrine Carcinoma,1
29789,Malignant Cellular Infiltrate,Stage II Lip Cancer AJCC v6 and v7,1
29790,Epithelial Component Present,Unresectable Head and Neck Squamous Cell Carcinoma,1
29791,Epithelial Component Present,Sclerosing thymoma,1
29792,Cutaneous Involvement,Recurrent Merkel Cell Carcinoma,1
29793,Indolent Clinical Course,Mediastinal Lymphangioma,1
29794,Carcinomatous Component Present,large cell carcinoma of salivary gland,1
29795,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
29796,Malignant Cellular Infiltrate,MGMT-Methylated Glioblastoma,1
29797,Nodular lesions,"Ganglioneuroblastoma, Nodular",1
29798,Anaplasia,Plasmacytoma anaplastic,1
29799,Malignant Cellular Infiltrate,Stage IV Renal Pelvis and Ureter Cancer AJCC v7,1
29800,Recurrent disease,Recurrent Primary Cutaneous Lymphoma,1
29801,Epithelial Component Present,Grade 3 Colon Adenocarcinoma,1
29802,Malignant Cellular Infiltrate,Refractory Classic Hodgkin Lymphoma,1
29803,Malignant Cellular Infiltrate,Leukemic infiltration of skin,1
29804,Recurrent Lymphoma,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
29805,Cutaneous Involvement,Reactive Cutaneous Fibrous Lesion,1
29806,Epithelial Component Present,undifferentiated carcinoma of urethra,1
29807,Carcinomatous Component Present,Advanced Squamous Cell Carcinoma of the Oropharynx,1
29808,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1",1
29809,Intraductal Lesion,Atypical Breast Papilloma,1
29810,Malignant Cellular Infiltrate,Stage IVA Oropharyngeal Carcinoma AJCC v7,1
29811,Childhood Lesion,Congenital Mesoblastic Nephroma,1
29812,Neuroendocrine Differentiation,Prostate Neuroendocrine Neoplasm,1
29813,Borderline Lesion,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
29814,Malignant Cellular Infiltrate,Pulmonary Vein Leiomyosarcoma,1
29815,Carcinomatous Component Present,"Basal cell carcinoma, micronodular",1
29816,Malignant Cellular Infiltrate,Metastatic osteosarcoma,1
29817,Absence of Invasion,Bowenoid papulosis,1
29818,Epithelial Component Present,Labia Majora Carcinoma,1
29819,Malignant Cellular Infiltrate,HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage,1
29820,High Mitotic Activity,Stage IB Merkel Cell Carcinoma AJCC v7,1
29821,Malignant Cellular Infiltrate,Hepatoid adenocarcinoma,1
29822,Rapidly Enlarging Mass,Central Nervous System Rhabdomyosarcoma,1
29823,Malignant Cellular Infiltrate,Recurrent Thyroid Carcinoma,1
29824,CD8-Positive Neoplastic Cells Present,Hydroa vacciniforme-like lymphoma,1
29825,Epithelial Component Present,Prostate Undifferentiated Carcinoma,1
29826,Epithelial Component Present,Non-small cell lung cancer stage I,1
29827,Malignant Cellular Infiltrate,Stage IVB Pharyngeal Carcinoma,1
29828,Collagenous Stroma Formation,Vulvar Angiomyofibroblastoma,1
29829,Primary Site Unknown,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,1
29830,Recurrent disease,Extra-osseous Ewing's sarcoma recurrent,1
29831,Extensive Stage Lesion,Advanced Melanoma,1
29832,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v7,1
29833,Eosinophil count raised (finding),"Leukemia, Eosinophilic, Acute",1
29834,Congenital Lesion,Small Congenital Melanocytic Nevus,1
29835,Carcinomatous Component Present,Skin Squamous Cell Carcinoma In Situ,1
29836,Nuclear Atypia,Proneural Glioblastoma,1
29837,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Skin Squamous Cell Carcinoma,1
29838,Malignant Cellular Infiltrate,Stage III Soft Tissue Sarcoma AJCC v7,1
29839,Epithelial Component Present,Stage IIB Ampulla of Vater Cancer AJCC v7,1
29840,Adnexal Differentiation,Desmoplastic trichilemmoma,1
29841,Adulthood Lesion,Lugano Classification Stage II Adult Non-Hodgkin Lymphoma AJCC v8,1
29842,Malignant Cellular Infiltrate,FIGO Stage IVA Ovarian Cancer,1
29843,Neuroendocrine Differentiation,Carcinoid tumor of rectum,1
29844,Epithelial Component Present,Sarcomatoid Carcinoma of the Penis,1
29845,Epithelial Component Present,Clinical Stage IVB Gastric Cancer AJCC v8,1
29846,Carcinomatous Component Present,Stage III Rectosigmoid Cancer AJCC v6,1
29847,Carcinomatous Component Present,Vaginal Mesonephric Adenocarcinoma,1
29848,Malignant Cellular Infiltrate,Adult Acute Monocytic Leukemia,1
29849,Carcinomatous Component Present,Undifferentiated carcinoma of stomach,1
29850,Epithelial Component Present,Stage IV Eyelid Carcinoma AJCC v7,1
29851,Absence of Invasion,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
29852,Intracanalicular Growth Pattern,"Phyllodes tumor, benign",1
29853,Malignant Cellular Infiltrate,Prostate Carcinoma Metastatic in the Bone,1
29854,Malignant Cellular Infiltrate,"Invasive Lobular Breast Carcinoma, Tubulolobular Variant",1
29855,Malignant Cellular Infiltrate,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,1
29856,Primary Lesion,Central Nervous System Intravascular Large B-Cell Lymphoma,1
29857,Epithelial Component Present,Prostate cancer stage D,1
29858,Cutaneous Involvement,Vulvar Seborrheic Keratosis,1
29859,Dysplasia,Cervical Squamous Intraepithelial Neoplasia,1
29860,Epithelial Component Present,Colon cancer recurrent,1
29861,Epithelial Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
29862,Carcinomatous Component Present,Stage IV Eyelid Carcinoma AJCC v8,1
29863,Secondary Lesion,Disseminated squamous cell carcinoma,1
29864,Intraductal Lesion,Noninfiltrating intraductal papillary adenocarcinoma,1
29865,Epithelial Component Present,Benign Apocrine Neoplasm,1
29866,Malignant Cellular Infiltrate,Adult Acute Basophilic Leukemia,1
29867,Malignant Cellular Infiltrate,Sarcoma by AJCC Grade,1
29868,Cystic Change,Childhood Cystic Nephroma,1
29869,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
29870,Increased Cellularity Present,Undifferentiated Neuroblastoma,1
29871,Extensive Stage Lesion,Advanced Adult Hepatocellular Carcinoma,1
29872,Carcinomatous Component Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),1
29873,Stromal Invasion,Stage IIIC Ovarian Cancer AJCC v8,1
29874,Epidermotropic Lymphocytic Infiltrate,Stage IA Mycosis Fungoides AJCC v7,1
29875,Malignant Cellular Infiltrate,Burkitt's lymphoma of small intestine,1
29876,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
29877,Malignant Cellular Infiltrate,Retroperitoneal sarcoma,1
29878,Low Mitotic Activity,Duodenal Somatostatin-Producing Neuroendocrine Tumor,1
29879,Poorly Differentiated Lesion,carcinosarcoma of lung,1
29880,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),1
29881,Mild cytologic atypia,Anal Verrucous Carcinoma,1
29882,Multifocal Lesion,Encephalocraniocutaneous lipomatosis,1
29883,Malignant Cellular Infiltrate,Adenocarcinoma of lacrimal gland,1
29884,Carcinomatous Component Present,Stage IV Breast Cancer AJCC v6 and v7,1
29885,Osseous Differentiation,Ivory Exostosis,1
29886,Malignant Cellular Infiltrate,Skin squamous cell carcinoma recurrent,1
29887,Primary Lesion,Meningeal melanomatosis,1
29888,Malignant Cellular Infiltrate,Gingival Squamous Cell Carcinoma,1
29889,Well Differentiated Lesion,Grade 1 Colon Adenocarcinoma,1
29890,Epithelial Component Present,"Lung Squamous Cell Carcinoma, Clear Cell Variant",1
29891,Pain,Subungual exostoses,1
29892,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage III,1
29893,Epithelial Component Present,Stage IIC Ovarian Carcinoma,1
29894,Benign Cellular Infiltrate,Meyerson Nevus,1
29895,Epithelial Component Present,High Grade Appendix Mucinous Adenocarcinoma,1
29896,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v7,1
29897,Perineural spread,adenoid cystic carcinoma of floor of mouth,1
29898,Adulthood Lesion,Adult Desmoplastic Small Round Cell Tumor,1
29899,Hereditary Lesion,Cobb's syndrome,1
29900,Carcinomatous Component Present,Vaginal Mesonephric Adenocarcinoma,1
29901,High Mitotic Activity,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
29902,Papillary Pattern,Papillary adenoma,1
29903,Hemorrhagic Neuroblastic Nodules Present,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
29904,Malignant Cellular Infiltrate,Verrucous carcinoma of oral cavity,1
29905,Aggressive Clinical Course,Digital papillary eccrine carcinoma of skin,1
29906,Pseudoencapsulated Mass,Childhood Malignant Peripheral Nerve Sheath Tumor,1
29907,Malignant Cellular Infiltrate,Grade 2 Diffuse Follicular Lymphoma,1
29908,Perivascular Arrangement of Tumor Cells,Lymphangioleiomyomatosis of skin,1
29909,Thick-Walled Hyalinized Vessels Present,Benign Intraocular Schwannoma,1
29910,Invasive Lesion,Metastatic Prostate Small Cell Carcinoma,1
29911,Mucoid Stroma Formation,mucinous adenocarcinoma of salivary gland,1
29912,Epithelial Component Present,Filiform Serrated Adenoma,1
29913,Malignant Cellular Infiltrate,leiomyosarcoma of liver,1
29914,Malignant Cellular Infiltrate,Grade 3 Endometrial Mucinous Adenocarcinoma,1
29915,Dysplasia,Tubulovillous adenoma,1
29916,Epithelial Component Present,Stage II Rectal Cancer,1
29917,Cutaneous Involvement,Bullous lichen planus,1
29918,Malignant Cellular Infiltrate,"Adenocarcinoma, endocervical type",1
29919,Malignant Cellular Infiltrate,Childhood Leukemia,1
29920,Favorable Clinical Outcome,HNF1alpha-Inactivated Hepatocellular Adenoma,1
29921,Osseous Differentiation,Metastatic osteosarcoma,1
29922,Myxoid Stroma Formation,Ovarian Myxoid Liposarcoma,1
29923,Cutaneous Involvement,Dysplastic Nevus,1
29924,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed stage II,1
29925,Cystic Change,Posterior Tongue Mucoepidermoid Carcinoma,1
29926,atypia morphology,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
29927,Papillary Pattern,"Papillary mucinous cystadenoma, borderline malignancy",1
29928,Epithelial Component Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
29929,Abundance of Small Lymphocytes,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma,1
29930,Benign Cellular Infiltrate,Benign neoplasm of rectum,1
29931,Neuroendocrine Differentiation,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
29932,Hyperkeratosis,Vulvar Seborrheic Keratosis,1
29933,Malignant Cellular Infiltrate,Disseminated neuroblastoma,1
29934,Neoplastic Cells with TFH Cell Phenotype Present,Follicular T-cell lymphoma,1
29935,Diffuse Pattern,Primary mediastinal large B-cell lymphoma stage IV,1
29936,Malignant Cellular Infiltrate,Stage I Ureter Cancer AJCC v8,1
29937,Biphasic Pattern,sialadenoma papilliferum of salivary gland,1
29938,Malignant Cellular Infiltrate,Adenocarcinofibroma,1
29939,Malignant Cellular Infiltrate,Pathologic Stage IV Retinoblastoma AJCC v8,1
29940,Malignant Cellular Infiltrate,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
29941,Malignant Cellular Infiltrate,Malignant neoplasm of cerebrum,1
29942,Well-Circumscribed Lesion,Adult Kidney Wilms Tumor,1
29943,Epithelial Component Present,Stage IVA Fallopian Tube Cancer AJCC v8,1
29944,Well-Circumscribed Lesion,Nephroblastoma,1
29945,Epithelial Component Present,Stage IV Duodenal Neuroendocrine Tumor AJCC v8,1
29946,Biphasic Pattern,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant",1
29947,Epithelial Component Present,Lobular carcinoma in situ of breast,1
29948,Epithelial Component Present,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8",1
29949,Carcinomatous Component Present,Stage IVA Hilar Cholangiocarcinoma AJCC v8,1
29950,Pseudoencapsulated Mass,"Perineurioma, malignant",1
29951,Benign Cellular Infiltrate,Mediastinal Rhabdomyoma,1
29952,Carcinomatous Component Present,Stage IIIC Hepatocellular Carcinoma AJCC v7,1
29953,Malignant Cellular Infiltrate,Squamous cell carcinoma of rectum,1
29954,Neuroendocrine Differentiation,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma,1
29955,Indolent Clinical Course,Fibroid Tumor,1
29956,Epithelial Component Present,Advanced Carcinoid Tumor,1
29957,Carcinomatous Component Present,Stage III Adrenal Cortex Carcinoma AJCC v7,1
29958,Malignant Cellular Infiltrate,Primary Prostate Urothelial Carcinoma,1
29959,Low Mitotic Activity,Gastric Neuroendocrine Tumor G2,1
29960,Malignant Cellular Infiltrate,Malignant Synovial Neoplasm,1
29961,Malignant Cellular Infiltrate,Primary myoepithelial carcinoma of lung,1
29962,Malignant Cellular Infiltrate,carcinoma ex pleomorphic adenoma of salivary gland,1
29963,Firm mass,Childhood Malignant Peripheral Nerve Sheath Tumor,1
29964,Tissue Differentiation Uncertain,Benign Lung PEComa,1
29965,Epithelial Component Present,Papillary adenoma,1
29966,Carcinomatous Component Present,Adenocarcinoma of cecum,1
29967,Epithelial Component Present,Primary Peritoneal Cancer by AJCC v7 Stage,1
29968,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
29969,Hemorrhagic,Mediastinal Angiosarcoma,1
29970,Carcinomatous Component Present,Undifferentiated carcinoma of nasopharynx,1
29971,Carcinomatous Component Present,Stage IIIA Penile Cancer AJCC v8,1
29972,Anaplasia,Recurrent Anaplastic Large Cell Lymphoma,1
29973,Absence of Invasion,Lobular Neoplasia,1
29974,Neuroendocrine Differentiation,Malignant carcinoid tumor of lung,1
29975,Malignant Cellular Infiltrate,Small Intestinal Signet Ring Cell Carcinoma,1
29976,Unresectable Mass,Unresectable Gastrointestinal Stromal Tumor,1
29977,Mitotic Activity,Anaplastic Hemispheric Astrocytoma,1
29978,"Fully Differentiated ""Adult-Type"" Tissues Present",Sellar Mature Teratoma,1
29979,Nodular Pattern,"Hodgkin lymphoma, nodular sclerosis, cellular phase",1
29980,Benign Cellular Infiltrate,Chondroma,1
29981,Malignant Cellular Infiltrate,Stage IIIB Testicular Cancer AJCC v6 and v7,1
29982,Cord-Like Pattern,Clear cell sarcoma of kidney,1
29983,In Situ Lesion,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8",1
29984,Diffuse Pattern,Childhood Brain Stem Gliosarcoma,1
29985,Malignant Cellular Infiltrate,Sarcoma by FNCLCC Grade,1
29986,Non-Invasive Lesion,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
29987,High Grade Lesion,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
29988,Cystic Change,Vulvar Papillary Hidradenoma,1
29989,Carcinomatous Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
29990,atypia morphology,Atypical Endometrial Hyperplasia,1
29991,Dysplasia,Vulval intraepithelial neoplasia,1
29992,High Mitotic Activity,Localized Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
29993,Multifocal Lesion,Refractory Erdheim-Chester Disease,1
29994,Carcinomatous Component Present,Stage III Fallopian Tube Cancer AJCC v7,1
29995,Papillary Pattern,Intraductal papillomatosis,1
29996,Carcinomatous Component Present,Squamous Cell Carcinoma Metastatic in the Neck with Occult Primary,1
29997,Childhood Lesion,Stage III Childhood Anaplastic Large Cell Lymphoma,1
29998,Neuroendocrine Differentiation,Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
29999,Malignant Cellular Infiltrate,Fetal Lung Adenocarcinoma,1
30000,Malignant Cellular Infiltrate,Normal Breast-Like Subtype of Breast Carcinoma,1
30001,Neuroendocrine Differentiation,Familial Paraganglioma,1
30002,Malignant Cellular Infiltrate,Adenocarcinoma with cartilaginous metaplasia,1
30003,Epithelial Component Present,Large cell carcinoma with rhabdoid phenotype,1
30004,Malignant Cellular Infiltrate,Acute promyelocytic leukemia - hypogranular variant,1
30005,Indolent Clinical Course,Adenomatoid Tumor,1
30006,Neuroendocrine Differentiation,Cerebellar Paraganglioma,1
30007,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,1
30008,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory anemias,1
30009,Sebaceous Differentiation,Vulvar Sebaceous Carcinoma,1
30010,Benign Cellular Infiltrate,"Nevus, Intradermal",1
30011,Recurrent Genetic Abnormalities Present,"Acute myeloid leukemia, t(8;21) (q22;q22)",1
30012,Malignant Cellular Infiltrate,Esophageal Neuroendocrine Carcinoma,1
30013,Multilocular Lesion,Childhood Cystic Nephroma,1
30014,Malignant Cellular Infiltrate,Stage II Paranasal Sinus Cancer AJCC v6 and v7,1
30015,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
30016,Cutaneous Involvement,Primary Cutaneous Plasmablastic Lymphoma,1
30017,Biphasic Pattern,Nephrogenic adenofibroma,1
30018,Benign Cellular Infiltrate,Mature Ovarian Teratoma,1
30019,Epithelial Component Present,Stage III Carcinoma of Penis,1
30020,Biphasic Pattern,Ovarian Adenosarcoma,1
30021,Carcinomatous Component Present,Metaplastic carcinoma,1
30022,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage IV,1
30023,Adulthood Lesion,Adult Central Nervous System Germ Cell Tumor,1
30024,Refractory Disease,Refractory Neurofibromatosis Type 1,1
30025,Black Discoloration,Thyroid Gland Black Follicular Adenoma,1
30026,Carcinomatous Component Present,Luminal B Breast Carcinoma,1
30027,Indolent Clinical Course,Hemolymphangioma,1
30028,Diffuse Pattern,Immunoblastic Large-Cell Lymphoma,1
30029,Vascular Channel Formation,Metastatic angiosarcoma,1
30030,Rapidly Enlarging Mass,Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
30031,Refractory Disease,Burkitt's lymphoma refractory,1
30032,Well-Circumscribed Lesion,Multiple polyps,1
30033,Infiltrative Growth Pattern,"Diffuse Astrocytoma, IDH-Wildtype",1
30034,Epithelial Component Present,Adenocarcinoma in Situ,1
30035,Malignant Cellular Infiltrate,Stage IIIB Ovarian Cancer AJCC v6 and v7,1
30036,Indolent Clinical Course,Intramuscular Myxoma,1
30037,Carcinomatous Component Present,Renal Cell Carcinoma Associated with inv(X)(p11;q12),1
30038,Malignant Cellular Infiltrate,Marginal zone lymphoma stage II,1
30039,Severe dysplasia,Gallbladder Mucinous Cystic Neoplasm with High Grade Intraepithelial Neoplasia,1
30040,Intracanalicular Growth Pattern,Malignant Phyllodes Tumor of Prostate,1
30041,Malignant Cellular Infiltrate,Acute myeloid leukemia with recurrent genetic abnormality,1
30042,Epithelial Component Present,Metastatic Lip Carcinoma,1
30043,High Mitotic Activity,small cell carcinoma of gallbladder,1
30044,Childhood Lesion,Stage I Childhood Anaplastic Large Cell Lymphoma,1
30045,Anaplasia,Sarcomatoid Carcinoma of the Penis,1
30046,Thick-Walled Hyalinized Vessels Present,Microcystic/Reticular Schwannoma,1
30047,Epithelial Component Present,"Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified",1
30048,High Mitotic Activity,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
30049,Pathologic TNM Finding,Pathologic Stage IV Cutaneous Melanoma AJCC v8,1
30050,Malignant Cellular Infiltrate,Metastatic Pancreatic Neuroendocrine Carcinoma,1
30051,Carcinomatous Component Present,Stage IIIA Fallopian Tube Cancer AJCC v7,1
30052,Benign Cellular Infiltrate,Benign Glomus Tumor,1
30053,Cutaneous Involvement,Stage IVC Basal Cell Lip Carcinoma,1
30054,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma of parotid gland,1
30055,Malignant Cellular Infiltrate,Stage IIB Gastric Cancer AJCC v7,1
30056,atypia morphology,Atypical hyperplasia,1
30057,Massive Sinusoidal Histiocytic Infiltrate,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,1
30058,Vertical Growth Phase,Nodular melanoma,1
30059,Epithelioid Component Present,Pleural Biphasic Synovial Sarcoma,1
30060,Malignant Cellular Infiltrate,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
30061,Malignant Cellular Infiltrate,Stage III Ureter Cancer AJCC v8,1
30062,Macule,Stage III Acral Lentiginous Melanoma AJCC v7,1
30063,Neuroendocrine Differentiation,Locally Advanced Paraganglioma,1
30064,Epithelial Component Present,Extra-Adrenal Retroperitoneal Paraganglioma,1
30065,Epithelial Component Present,FIGO Stage II Ovarian Cancer,1
30066,Malignant Cellular Infiltrate,RISS Stage II Plasma Cell Myeloma,1
30067,Eccrine Differentiation,Eccrine carcinoma of skin,1
30068,Fibrotic Stroma Formation,mucoepidermoid carcinoma of floor of mouth,1
30069,Epithelial Component Present,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
30070,Papillary Pattern,Intraductal papilloma of breast,1
30071,Malignant Cellular Infiltrate,Extragonadal Seminoma,1
30072,Malignant Cellular Infiltrate,Blastic plasmacytoid dendritic cell neoplasm,1
30073,Papillary Pattern,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
30074,Absence of Invasion,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
30075,Exophytic Papillary Lesion,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
30076,Malignant Cellular Infiltrate,"Refractory NK-Cell Lymphoma, Unclassifiable",1
30077,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1
30078,In Situ Lesion,Carcinoma in situ of trachea,1
30079,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
30080,Below the Diaphragm Disease,Ann Arbor Stage II Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
30081,Malignant Cellular Infiltrate,Childhood Brain Stem Gliosarcoma,1
30082,Epithelial Component Present,Adrenal Cortex Oncocytic Adenoma,1
30083,Malignant Cellular Infiltrate,"Stage 0 Nasal Cavity and Paranasal Sinus Cancer AJCC v6, v7, and v8",1
30084,Refractory Disease,Refractory Pancreatic Carcinoma,1
30085,Locally Aggressive Lesion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1
30086,Poorly Differentiated Lesion,Pleomorphic carcinoma,1
30087,Malignant Cellular Infiltrate,Fallopian Tube Cancer by AJCC v6 Stage,1
30088,Epithelial Component Present,Mucinous Adenocarcinoma,1
30089,Epithelial Component Present,"Carcinoma, Granular Cell",1
30090,Necrotic changes (finding),Adult Brain Glioblastoma,1
30091,Cutaneous Involvement,Aleukemic Acute Lymphoblastic Leukemia Cutis,1
30092,Malignant Cellular Infiltrate,Stage IA1 Lung Cancer AJCC v8,1
30093,Ground Glass Nuclear Inclusion,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
30094,Epithelial Component Present,Bartholin's gland carcinoma,1
30095,Indolent Clinical Course,Spindle cell hemangioma,1
30096,Chronic lymphocytic inflammation,Regressing nevus,1
30097,Epithelial Component Present,Giant fibroadenoma of breast,1
30098,Childhood Lesion,Stage I Childhood Burkitt Lymphoma,1
30099,Rare Lesion,Sex Hormone-Producing Adrenal Cortex Adenoma,1
30100,Epithelial Component Present,Refractory Cholangiocarcinoma,1
30101,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v8,1
30102,Benign Cellular Infiltrate,Benign Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
30103,HMB-45-Positive Neoplastic Cells Present,Angiomyolipoma,1
30104,Metastatic Lesion,Advanced Melanoma,1
30105,Slow Growing Mass,Juvenile Pilocytic Astrocytoma,1
30106,Malignant Cellular Infiltrate,Stage IVA Rectal Cancer AJCC v7,1
30107,Melanosomes Present,Melanotic Schwannoma,1
30108,Papillary Pattern,Papillary Lung Adenocarcinoma,1
30109,Epithelial Component Present,sialadenoma papilliferum of salivary gland,1
30110,Malignant Cellular Infiltrate,Malignant neoplasm of nasopharynx,1
30111,Malignant Cellular Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
30112,Low Mitotic Activity,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
30113,Lymphadenopathy,Ann Arbor Stage IV Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
30114,Obesity,Inflammatory Hepatocellular Adenoma,1
30115,Chronic Inflammatory Infiltrate,Recurrent Lymphomatoid Granulomatosis,1
30116,Epithelial Component Present,Gastrinoma,1
30117,Infantile Lesion,Infant Acute Undifferentiated Leukemia,1
30118,Metastatic Lesion,Metastatic Uveal Melanoma,1
30119,Mixed Cellular Population,Adenomyoma,1
30120,Carcinomatous Component Present,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
30121,Carcinomatous Component Present,Stage III Ampulla of Vater Cancer AJCC v8,1
30122,Carcinomatous Component Present,Paget Disease,1
30123,Carcinomatous Component Present,Advanced Prostate Carcinoma,1
30124,Epithelial Component Present,Luminal B Prostate Carcinoma,1
30125,Intraepithelial Neoplasia,Malignant melanoma in precancerous melanosis,1
30126,Neoplastic Promyelocytes in Bone Marrow Markedly Increased,Childhood Acute Promyelocytic Leukemia with PML-RARA,1
30127,Tubular Pattern,Gallbladder Tubular Carcinoid,1
30128,Malignant Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v8,1
30129,Malignant Cellular Infiltrate,Stage II Childhood Hodgkin Lymphoma,1
30130,Metastatic Lesion,Advanced Urothelial Carcinoma,1
30131,Calcitonin Positive Neoplastic Cells Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7,1
30132,Epithelial Component Present,"Carcinoma, Spindle-Cell",1
30133,Carcinomatous Component Present,basal cell adenocarcinoma of salivary gland,1
30134,Malignant Cellular Infiltrate,Squamous cell carcinoma of the head and neck,1
30135,Epithelial Component Present,Hepatitis C Virus-Related Hepatocellular Carcinoma,1
30136,Secondary Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
30137,Malignant Cellular Infiltrate,mucosa-associated lymphoid tissue (MALT) lymphoma of thyroid,1
30138,Childhood Lesion,Stage II Childhood Anaplastic Large Cell Lymphoma,1
30139,Malignant Cellular Infiltrate,Stage IIIC Fallopian Tube Cancer AJCC v8,1
30140,Precise Histogenesis Unknown,Cerebral Hemangioblastoma,1
30141,Carcinomatous Component Present,Stage II Primary Peritoneal Cancer AJCC v8,1
30142,Benign Cellular Infiltrate,Fallopian Tube Papilloma,1
30143,Epithelial Component Present,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
30144,Childhood Lesion,Recurrent Childhood T Acute Lymphoblastic Leukemia,1
30145,Metastatic/Recurrent Disease,Epithelioid sarcoma non-metastatic,1
30146,Monomorphic Cellular Infiltrate,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",1
30147,Immunologic Deficiency Syndromes,"Post-transplant lymphoproliferative disorder, polymorphic",1
30148,Benign Cellular Infiltrate,Benign tumor of exocrine pancreas,1
30149,Indolent Clinical Course,Solitary Myofibromatosis,1
30150,Ineffective hematopoiesis,Refractory Myelodysplastic Syndrome,1
30151,Carcinomatous Component Present,Pancreatic adenocarcinoma recurrent,1
30152,High Grade Lesion,Adult Brain Glioblastoma,1
30153,Systemic disease,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
30154,Benign Cellular Infiltrate,Intermediate Rhabdomyoma,1
30155,Carcinomatous Component Present,adenoid cystic carcinoma of floor of mouth,1
30156,Malignant Cellular Infiltrate,Stage IS Testicular Cancer AJCC v8,1
30157,Childhood Lesion,Childhood Choroid Plexus Papilloma,1
30158,Childhood Lesion,Recurrent Childhood Hepatocellular Carcinoma,1
30159,Malignant Cellular Infiltrate,Stage I Lung Cancer AJCC v8,1
30160,Malignant Cellular Infiltrate,Papillary renal cell carcinoma type 2,1
30161,Malignant Cellular Infiltrate,Stage IV Eyelid Carcinoma AJCC v7,1
30162,Recurrent disease,Synovial sarcoma recurrent,1
30163,Malignant Cellular Infiltrate,Digestive System Non-Hodgkin Lymphoma,1
30164,More than 10 Mitoses per 10HPF,Metastatic Lung Small Cell Carcinoma,1
30165,Malignant Cellular Infiltrate,Metastatic Ureter Carcinoma,1
30166,Intracytoplasmic Eosinophilic Inclusion,Atypical Teratoid Rhabdoid Tumor,1
30167,Carcinomatous Component Present,Stage IIIC Fallopian Tube Cancer AJCC v8,1
30168,Epithelial Component Present,Stage III Duodenal Neuroendocrine Tumor AJCC v8,1
30169,Mitotic Activity,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7,1
30170,Epithelial Component Present,Stage IVB Vaginal Cancer AJCC v8,1
30171,Immunologic Deficiency Syndromes,Transplant-Related Hepatocellular Carcinoma,1
30172,Schwannian Stroma Predominant Component of the Tumor Volume,Retroperitoneal Ganglioneuroma,1
30173,Mixed Cellular Population,Phyllodes Tumor,1
30174,Epithelial Component Present,Parotid Gland Acinic Cell Carcinoma,1
30175,Precise Histogenesis Unknown,Spinal hemangioblastoma,1
30176,Cystic Change,Adult cystic teratoma,1
30177,Eccrine Differentiation,Eccrine ductal carcinoma,1
30178,Therapy-Related Toxicity,Radiation-Related Angiosarcoma,1
30179,Anaplasia,Refractory Glioblastoma,1
30180,Indolent Clinical Course,Capillary hemangioma of orbit,1
30181,Malignant Cellular Infiltrate,Metastatic Penile Cancer,1
30182,Malignant Cellular Infiltrate,Stage II Esophageal Squamous Cell Carcinoma AJCC v7,1
30183,Geographic Necrosis,Testicular Mixed Choriocarcinoma and Embryonal Carcinoma,1
30184,Epithelial Component Present,Refractory Urothelial Carcinoma,1
30185,Malignant Cellular Infiltrate,Prostate carcinoma,1
30186,Therapy-Related Toxicity,Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders,1
30187,Malignant Cellular Infiltrate,Microcystic adnexal carcinoma,1
30188,Malignant Cellular Infiltrate,EBV-Related Non-Hodgkin Lymphoma,1
30189,Plasma cell inflammation,Lung Inflammatory Myofibroblastic Tumor,1
30190,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Renal Cell Carcinoma,1
30191,Absence of Invasion,Ampulla of Vater Tubular Adenoma,1
30192,Malignant Cellular Infiltrate,adenosquamous carcinoma of pancreas,1
30193,Carcinomatous Component Present,Appendix Carcinoma by AJCC v7 Stage,1
30194,Positive Axillary Lymph Node,Occult Breast Carcinoma,1
30195,High Mitotic Activity,Testicular embryonal carcinoma stage III,1
30196,Recurrent disease,Recurrent Burkitt Leukemia,1
30197,Carcinomatous Component Present,Stage II Renal Cell Cancer,1
30198,Malignant Cellular Infiltrate,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma,1
30199,Secondary Lesion,Pancreatic adenocarcinoma metastatic,1
30200,Secondary Lesion,Metastatic Unresectable Sarcoma,1
30201,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v7,1
30202,Carcinomatous Component Present,Vaginal cancer recurrent,1
30203,Epithelial Component Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
30204,Ineffective hematopoiesis,Refractory Thrombocytopenia,1
30205,Well Differentiated Hyaline Cartilage Present,mesenchymal chondrosarcoma of bone,1
30206,Cutaneous Involvement,Mycosis fungoides stage I,1
30207,Localized Lesion,Peritoneal Well Differentiated Papillary Mesothelioma,1
30208,Moderate dysplasia,Colorectal Adenoma with Moderate Dysplasia,1
30209,Pregnancy Complications,Stage IA Gestational Trophoblastic Tumor AJCC v7,1
30210,Metastatic Lesion,Intermediate Atypical Prostate Carcinoma,1
30211,Metastatic/Recurrent Disease,Adult Extraskeletal Myxoid Chondrosarcoma,1
30212,Neuroectodermal Differentiation,Neuroblastoma,1
30213,Malignant Cellular Infiltrate,Malignant neoplasm of stomach stage II,1
30214,Lymphoplasmacytic Infiltrate,Tonsillar Undifferentiated Carcinoma,1
30215,Epithelial Component Present,Distal Urethral Carcinoma,1
30216,Anaplasia,Childhood Anaplastic Large Cell Lymphoma,1
30217,Necrotic changes (finding),Malignant Peripheral Nerve Sheath Tumor,1
30218,Benign Cellular Infiltrate,hemangioma of mediastinum,1
30219,Hyperplastic Tissue Present,Columnar Cell Hyperplasia of the Breast with Atypia,1
30220,Necrotic changes (finding),Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
30221,Adulthood Lesion,Adult Lymphoblastic Lymphoma,1
30222,Pseudopapillary Pattern,Testicular Mixed Embryonal Carcinoma and Seminoma,1
30223,Malignant Cellular Infiltrate,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8,1
30224,Cytoplasmic Membrane-Bound Granules Present,Merkel cell carcinoma,1
30225,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor,1
30226,Epithelial Component Present,intestinal type adenocarcinoma of gallbladder,1
30227,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia stage II,1
30228,Malignant Cellular Infiltrate,Adrenocortical carcinoma,1
30229,Epithelial Component Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
30230,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v6 Stage,1
30231,High Mitotic Activity,Gastroesophageal Junction Neuroendocrine Carcinoma,1
30232,Anaplasia,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
30233,Malignant Cellular Infiltrate,FNCLCC Sarcoma Grade 3,1
30234,Carcinomatous Component Present,Gastric Carcinoma with Lymphoid Stroma,1
30235,Epithelial Component Present,Stage IIA2 Cervical Cancer AJCC v8,1
30236,Lymphoplasmacytic Infiltrate,Lung Spindle Cell Carcinoma,1
30237,Microvascular Proliferation,MGMT-Unmethylated Glioblastoma,1
30238,Preserved Nuclear Polarity,"Transitional cell papilloma, benign",1
30239,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Carcinoma,1
30240,S-100-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma,1
30241,Malignant Cellular Infiltrate,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
30242,Pathologic TNM Finding,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
30243,Rapidly Enlarging Mass,rhabdomyosarcoma of testis,1
30244,Epithelial Component Present,Poorly Differentiated Prostate Adenocarcinoma,1
30245,Benign Cellular Infiltrate,Recurrent Nevus,1
30246,Carcinomatous Component Present,Non-small cell lung cancer recurrent,1
30247,Carcinomatous Component Present,Small intestine carcinoma non-resectable,1
30248,Well Differentiated Neuroendocrine Lesion,insulinoma,1
30249,Benign Cellular Infiltrate,Hemangioma of spleen,1
30250,Growth Hormone and Prolactin Producing Neoplastic Cells Present,Somatotroph/Lactotroph Adenoma,1
30251,Malignant Cellular Infiltrate,Malignant Lung Hilum Neoplasm,1
30252,In Situ Lesion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,1
30253,Carcinomatous Component Present,Small cell carcinoma of lung,1
30254,Epithelial Component Present,Stage IIB Ovarian Cancer AJCC v8,1
30255,Epithelial Component Present,Breast cancer recurrent,1
30256,Malignant Cellular Infiltrate,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
30257,Well-Circumscribed Lesion,Lung Mucinous Cystadenoma,1
30258,Cystic Lesion,Recurrent Craniopharyngioma,1
30259,Malignant Cellular Infiltrate,"Acute myeloid leukemia, minimal differentiation",1
30260,Chemotherapeutic Agent Toxicity,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
30261,Epithelial Component Present,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
30262,Cartilaginous Differentiation,Chondrosarcoma,1
30263,Neuroendocrine Differentiation,Malignant neoplasm of carotid body,1
30264,Benign Cellular Infiltrate,Myolipoma,1
30265,Benign Cellular Infiltrate,Benign Childhood Supratentorial Neoplasm,1
30266,High Grade Lesion,Endometrial Dedifferentiated Carcinoma,1
30267,Malignant Cellular Infiltrate,Malignant Pineal Region Germ Cell Tumor,1
30268,Bone Marrow Lymphoplasmacytic Infiltrate,Waldenstrom's macroglobulinemia refractory,1
30269,Bilateral Disease,Contralateral Breast Carcinoma,1
30270,Indolent Clinical Course,Juxta-Articular Myxoma,1
30271,Microcystic Change,Childhood Fibrillary Astrocytoma,1
30272,High Grade Lesion,Tongue Alveolar Soft Part Sarcoma',1
30273,Myxoid Stroma Formation,Fibromyxosarcoma,1
30274,Malignant Cellular Infiltrate,Lymphangitis carcinomatosa,1
30275,Indolent Clinical Course,Appendix Leiomyoma,1
30276,Recurrent disease,Nasopharyngeal squamous cell carcinoma recurrent,1
30277,Malignant Cellular Infiltrate,Desmoplastic melanoma,1
30278,Recurrent disease,Recurrent Primary Peritoneal Carcinoma,1
30279,Malignant Cellular Infiltrate,Skin carcinoma,1
30280,Malignant Cellular Infiltrate,Adenocarcinoma in villous adenoma,1
30281,Cartilaginous Differentiation,Bizarre parosteal osteochondromatous proliferation,1
30282,Secondary Lesion,Advanced Laryngeal Squamous Cell Carcinoma,1
30283,Chronic Inflammatory Infiltrate,Childhood Mixed Cellularity Classic Hodgkin Lymphoma,1
30284,Refractory Disease,Refractory Intravascular Large B-Cell Lymphoma,1
30285,Microvascular Proliferation,Refractory Glioblastoma,1
30286,Carcinomatous Component Present,Anatomic Stage II Breast Cancer AJCC v8,1
30287,Malignant Cellular Infiltrate,Asbestos-Related Malignant Mesothelioma,1
30288,Refractory Disease,Refractory Acute Lymphoblastic Leukemia,1
30289,Malignant Cellular Infiltrate,Childhood Angiosarcoma,1
30290,Local disease,benign lipoma of gallbladder,1
30291,Malignant Cellular Infiltrate,Pagetoid reticulosis,1
30292,Carcinomatous Component Present,High Grade Salivary Gland Carcinoma,1
30293,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Epithelioid Leiomyoma,1
30294,Metastatic Lesion,Malignant fibrous histiocytoma metastatic,1
30295,Recurrent disease,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
30296,Absence of Invasion or Limited Invasion Present,Well-differentiated papillary mesothelioma,1
30297,Malignant Cellular Infiltrate,Childhood Bladder Carcinoma,1
30298,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Squamous Cell Carcinoma,1
30299,Necrotic changes (finding),Classical Glioblastoma,1
30300,Neuroendocrine Differentiation,Ovarian Neuroendocrine Neoplasm,1
30301,Firm mass,Esophageal Malignant Peripheral Nerve Sheath Tumor,1
30302,Well-Circumscribed Lesion,Juvenile polyp,1
30303,High Grade Lesion,Anaplastic Embryonal Rhabdomyosarcoma,1
30304,Epithelial Component Present,Stage IV Cervical Cancer AJCC v8,1
30305,Well-Circumscribed Lesion,Polyp of middle ear,1
30306,Well-Circumscribed Lesion,Giant Cell Tumor of Soft Tissue,1
30307,Infiltrating Tumor Margins Present,Stage IVB Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
30308,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
30309,Tissue of Mullerian Origin Present,Clear cell cystadenofibroma,1
30310,Abnormal Eosinophilic Granules Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
30311,Peau d'orange surface of breast,Inflammatory carcinoma of breast recurrent,1
30312,Carcinomatous Component Present,Clitoral Carcinoma,1
30313,In Situ Lesion,Stage 0 Cervical Cancer AJCC v6,1
30314,Epithelial Component Present,Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8,1
30315,Carcinomatous Component Present,Adenocarcinoma with cartilaginous and osseous metaplasia,1
30316,Carcinomatous Component Present,Adenocarcinoma in Situ,1
30317,Well-Circumscribed Lesion,Fibroma of tendon sheath,1
30318,Malignant Cellular Infiltrate,Stage IB Distal Bile Duct Cancer AJCC v7,1
30319,Hyperchromatism,"Perineurioma, malignant",1
30320,Papillary Pattern,papillary carcinoma of renal pelvis,1
30321,Carcinomatous Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
30322,Recurrent disease,Recurrent tumors of the Ewing's family,1
30323,Peripheral Nuclear Palisading,Vaginal Basaloid Carcinoma,1
30324,Mucoid Stroma Formation,Chordoid Glioma of the Third Ventricle,1
30325,Carcinomatous Component Present,Stage IVB Basal Cell Lip Carcinoma,1
30326,Malignant Cellular Infiltrate,Colon Carcinoma Metastatic in the Liver,1
30327,Sonic Hedgehog/Patch Pathway Activated,"Medulloblastoma, SHH-Activated",1
30328,Thyroglobulin Positive Neoplastic Cells Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,1
30329,Epithelial Component Present,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
30330,Neuroectodermal Differentiation,Disseminated neuroblastoma,1
30331,Nidus Formation,Aggressive osteoblastoma,1
30332,Primary Lesion,Recurrent Central Nervous System Non-Hodgkin Lymphoma,1
30333,Multifocal Lesion,Multifocal breast carcinoma,1
30334,Carcinomatous Component Present,Stage IVA Gallbladder Cancer AJCC v8,1
30335,Refractory Disease,Angioimmunoblastic T-cell lymphoma refractory,1
30336,Stromal Invasion,Stage IC Ovarian Cancer AJCC v6 and v7,1
30337,Carcinomatous Component Present,Gastric Neuroendocrine Carcinoma,1
30338,Neuroendocrine Differentiation,"Carcinoma, Neuroendocrine",1
30339,Malignant Cellular Infiltrate,Splenic Manifestation of T-Cell Large Granular Lymphocyte Leukemia,1
30340,Mesenchymal Component Present,Mixed Salivary Gland Tumor,1
30341,Malignant Cellular Infiltrate,Childhood Mesenchymal Chondrosarcoma,1
30342,Mitotic Activity,MGMT-Unmethylated Glioblastoma,1
30343,Perineural spread,Cervical Adenoid Cystic Carcinoma,1
30344,Well-Circumscribed Lesion,Peripheral Hemangioblastoma,1
30345,Intracellular Accumulation of Lipids,Temporal Lobe Pleomorphic Xanthoastrocytoma,1
30346,Eosinophilic inflammation,Breast Epithelioid Hemangioma,1
30347,Chronic Inflammatory Infiltrate,Hodgkin's disease mixed cellularity stage II supradiaphragmatic,1
30348,Epithelial Component Present,Stage IIA Prostate Cancer AJCC v8,1
30349,Well Differentiated Neuroendocrine Lesion,Small Intestinal Gangliocytic Paraganglioma,1
30350,Malignant Cellular Infiltrate,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
30351,Epithelial Component Present,High Grade Fallopian Tube Serous Adenocarcinoma,1
30352,Well-Circumscribed Lesion,Compact Cell Adrenal Cortical Adenoma,1
30353,Epithelial Component Present,Metastatic Prostate Small Cell Carcinoma,1
30354,Metastatic Lesion,Transitional cell cancer of renal pelvis and ureter metastatic,1
30355,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
30356,Vascular Channel Formation,Infantile hemangioma,1
30357,Carcinomatous Component Present,Skin Nodular Basal Cell Carcinoma,1
30358,Therapy-Related Toxicity,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,1
30359,Recurrent Genetic Abnormalities Present,Acute Myeloid Leukemia with t(11;17)(q23;q21),1
30360,Malignant Cellular Infiltrate,Stage III Childhood Hepatocellular Carcinoma AJCC v7,1
30361,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma,1
30362,Cutaneous Involvement,Flexural Skin Nevus,1
30363,Malignant Cellular Infiltrate,Uveal melanoma,1
30364,Malignant Cellular Infiltrate,Cutaneous Melanoma by AJCC v6 Stage,1
30365,Childhood Lesion,Childhood Thyroid Gland Medullary Carcinoma,1
30366,Indolent Clinical Course,Benign Pilar-Associated Mesenchyme Neoplasm,1
30367,Carcinomatous Component Present,Luminal A Breast Carcinoma,1
30368,Mild cytologic atypia,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
30369,Primary Lesion,Anaplastic Hemispheric Astrocytoma,1
30370,Cutaneous Involvement,Amelanotic Skin Melanoma,1
30371,Benign Cellular Infiltrate,Acantholytic acanthoma,1
30372,Malignant Cellular Infiltrate,Stage III Appendix Carcinoma AJCC v8,1
30373,Metastatic Lesion,Metastatic Ureter Carcinoma,1
30374,Epithelial Component Present,squamous cell carcinoma of ovary,1
30375,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
30376,Well Differentiated Lesion,Urethral Verrucous Carcinoma,1
30377,Resectable Mass,Carcinoma duodenum resectable,1
30378,Tobacco Chewing Toxicity,Tobacco Chewing-Related Carcinoma,1
30379,Epithelial Component Present,Tobacco Chewing-Related Carcinoma,1
30380,Malignant Cellular Infiltrate,Ann Arbor Stage IIA Hodgkin Lymphoma,1
30381,Favorable Clinical Outcome,Class 1a Uveal Melanoma,1
30382,Antoni A Pattern,Benign Cardiac Schwannoma,1
30383,Stromal Invasion,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
30384,Glial Differentiation,Childhood Brain Stem Gliosarcoma,1
30385,Cutaneous Involvement,Stage III Acral Lentiginous Melanoma AJCC v7,1
30386,Carcinomatous Component Present,signet ring cell carcinoma of gallbladder,1
30387,Well Differentiated Lesion,Buccal Mucosa Verrucous Carcinoma,1
30388,Perivascular Arrangement of Tumor Cells,"Perivascular epithelioid tumor, malignant",1
30389,Epithelial Component Present,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
30390,Squamous metaplasia of bladder,Bladder squamous cell carcinoma recurrent,1
30391,Epithelial Component Present,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
30392,Malignant Cellular Infiltrate,Stage IVB Uterine Corpus Adenosarcoma AJCC v8,1
30393,Malignant Cellular Infiltrate,Stage I Vulvar Cancer AJCC v8,1
30394,Epithelial Component Present,Plurimorphous Plurihormonal Pituitary Gland Adenoma,1
30395,Epithelial Component Present,Stage IB Cervical Cancer AJCC v8,1
30396,Epithelial Component Present,Basaloid carcinoma,1
30397,Malignant Cellular Infiltrate,Small Intestinal T-Cell Non-Hodgkin Lymphoma,1
30398,Epithelial Component Present,Squamous cell carcinoma of the hypopharynx stage III,1
30399,Increased Cellularity Present,Prostate Stromal Sarcoma,1
30400,Childhood Lesion,Childhood Bladder Carcinoma,1
30401,Monomorphic Cellular Infiltrate,"Adenoma, Basal Cell",1
30402,Cutaneous Involvement,"Dermatofibrosarcoma Protuberans, Myxoid",1
30403,Follicular Cell Differentiation,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
30404,Epithelial Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
30405,Malignant Cellular Infiltrate,Stage IIIC Anal Cancer AJCC v8,1
30406,Malignant Cellular Infiltrate,Methotrexate-Associated Burkitt Lymphoma,1
30407,S-100-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis,1
30408,Well-Circumscribed Lesion,Colon Adenoma with Severe Dysplasia,1
30409,Cystic Change,Kidney Mixed Epithelial and Stromal Tumor Family,1
30410,Malignant Cellular Infiltrate,Hereditary Diffuse Gastric Adenocarcinoma,1
30411,Lobulated Growth Pattern,Clivus Chondroid Chordoma,1
30412,Unresectable Mass,Non-Resectable Malignant Liver Neoplasm,1
30413,Benign Cellular Infiltrate,"Myositis, Proliferative",1
30414,Malignant Cellular Infiltrate,Inflammatory Leiomyosarcoma,1
30415,Indolent Clinical Course,Vulvar Angiomyofibroblastoma,1
30416,Carcinomatous Component Present,large cell neuroendocrine carcinoma of thymus,1
30417,Malignant Cellular Infiltrate,Cerebellar Vermis Medulloblastoma,1
30418,Organoid Pattern,Cervical Alveolar Soft Part Sarcoma,1
30419,atypia morphology,Simple Endometrial Hyperplasia with Atypia,1
30420,Epithelial Component Present,External Ear Actinic Keratosis,1
30421,Epithelial Component Present,Ovarian mucinous tumor,1
30422,Malignant Cellular Infiltrate,Clinical Stage IIA Gastric Cancer AJCC v8,1
30423,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1,1
30424,Hereditary Lesion,"Colorectal cancer, hereditary nonpolyposis, type 1",1
30425,Epithelial Component Present,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
30426,Monomorphic Cellular Infiltrate,Childhood Pineal Parenchymal Tumor of Intermediate Differentiation,1
30427,Lymphoplasmacytic Infiltrate,Central Nervous System Germinoma,1
30428,Mixed Cellular Population,Phyllodes Tumor,1
30429,Malignant Cellular Infiltrate,Malignant neoplasm of bronchus,1
30430,Neuroendocrine Differentiation,Stage IV Appendix Neuroendocrine Tumor AJCC v7,1
30431,Epithelial Component Present,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
30432,Malignant Cellular Infiltrate,Myxoid/Round Cell Liposarcoma,1
30433,Epithelial Component Present,Endometrial Transitional Cell Carcinoma,1
30434,Papillary Pattern,Fallopian Tube Papilloma,1
30435,Extraosseous Lesion,Extraskeletal Osteosarcoma,1
30436,Papillary Pattern,Anal Verrucous Carcinoma,1
30437,Primary Lesion,Cerebral Hodgkin Lymphoma,1
30438,Primary Lesion,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
30439,Toxic effect,Solar Radiation-Related Malignant Neoplasm,1
30440,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
30441,Mixed Cellular Population,Benign mixed epithelial and stromal tumor of kidney,1
30442,Epithelial Component Present,Undifferentiated Carcinoma with Osteoclast-Like Giant Cells,1
30443,Local disease,Localized Ewing Sarcoma,1
30444,Malignant Cellular Infiltrate,Stage IV Nasopharyngeal Carcinoma AJCC v8,1
30445,Perivascular Arrangement of Tumor Cells,Glomus Tumor of Uncertain Malignant Potential,1
30446,Malignant Cellular Infiltrate,Stage III Lip Basal Cell Carcinoma,1
30447,Indolent Clinical Course,Vulvar Superficial Myofibroblastoma,1
30448,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage IV,1
30449,Cutaneous Involvement,Paget's disease of vulva,1
30450,Carcinomatous Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
30451,Malignant Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v7 Stage,1
30452,Well-Circumscribed Lesion,Anal skin tag,1
30453,Exophytic Polypoid Lesion,Rectal Adenoma with Severe Dysplasia,1
30454,Lymphoplasmacytic Infiltrate,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
30455,Mild dysplasia of colon,Colorectal Low Grade Intraepithelial Neoplasia,1
30456,Well Differentiated Lesion,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
30457,Myxoid Stroma Formation,Botryoid-Type Embryonal Rhabdomyosarcoma,1
30458,Geographic Necrosis,Childhood Embryonal Carcinoma,1
30459,Adnexal Differentiation,Pilar-Associated Mesenchyme Neoplasm,1
30460,Biphasic Pattern,carcinosarcoma of fallopian tube,1
30461,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
30462,Benign Cellular Infiltrate,Pancreatic Serous Adenoma,1
30463,Lesion with Diameter Greater than 2cm,Cementoma,1
30464,Carcinomatous Component Present,Stage 0 Ampulla of Vater Cancer AJCC v8,1
30465,Villous Pattern,villous adenoma of stomach,1
30466,Carcinomatous Component Present,Endometrial Small Cell Carcinoma,1
30467,Cutaneous Involvement,Vulvar Inverted Follicular Keratosis,1
30468,Bone marrow reticulin fibrosis,Hairy Cell Leukemia,1
30469,Exophytic Polypoid Lesion,Vaginal Villous Adenoma,1
30470,Birbeck Granules Present,"Histiocytosis, Langerhans-Cell",1
30471,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
30472,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
30473,Epithelial Component Present,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
30474,Cribriform Pattern,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
30475,Cutaneous Involvement,"Xeroderma pigmentosum, variant type",1
30476,Childhood Lesion,Mixed Congenital Mesoblastic Nephroma,1
30477,Malignant Cellular Infiltrate,Anal Lymphoma,1
30478,Neuroendocrine Differentiation,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
30479,Malignant Cellular Infiltrate,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8,1
30480,Cytoplasmic Membrane-Bound Granules Present,Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8,1
30481,Epithelial Component Present,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8,1
30482,Biphasic Pattern,Cystadenofibroma of fallopian tube,1
30483,Cystic Change,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
30484,Mixed Cellular Population,Vaginal Carcinosarcoma,1
30485,Carcinomatous Component Present,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
30486,Secondary Lesion,Hepatic cancer metastatic,1
30487,Peripheral Nuclear Palisading,basaloid carcinoma of anus,1
30488,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma,1
30489,Epithelial Component Present,Esophageal Cancer by AJCC v6 Stage,1
30490,Malignant Cellular Infiltrate,Acute leukemia,1
30491,Malignant Cellular Infiltrate,Stage III Primary Peritoneal Cancer AJCC v7,1
30492,Monomorphic Cellular Infiltrate,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
30493,Pseudopapillary Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
30494,Malignant Cellular Infiltrate,Lymphoma stage,1
30495,Epithelial Component Present,Stage I Nasopharyngeal Carcinoma AJCC v8,1
30496,Immunologic Deficiency Syndromes,Lymphoproliferative Disease Associated with Primary Immune Disorder,1
30497,Polymorphic Cellular Infiltrate,Letterer-Siwe Disease,1
30498,Childhood Lesion,"Childhood Ganglioneuroblastoma, Nodular",1
30499,Mild dysplasia,Mild epithelial dysplasia,1
30500,Immunologic Deficiency Syndromes,AIDS-Related Vulvovaginal Candidiasis,1
30501,Cartilaginous Differentiation,Osteochondromatosis,1
30502,Cutaneous Involvement,Benign Breast Eccrine Spiradenoma,1
30503,Epithelial Component Present,Localized Resectable Adult Hepatocellular Carcinoma,1
30504,Tissue Differentiation Uncertain,Childhood Epithelioid Sarcoma,1
30505,Malignant Cellular Infiltrate,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
30506,Multinodular Mass,"Dermatofibrosarcoma Protuberans, Myxoid",1
30507,Calcinosis,"Ossifying fibromyxoid tumor, malignant",1
30508,Crystal deposition,Alveolar Soft Part Sarcoma,1
30509,Primary Lesion,Recurrent Gliosarcoma,1
30510,Malignant Cellular Infiltrate,Ghost Cell Odontogenic Carcinoma,1
30511,Well-Circumscribed Lesion,Pancreatic Solid Serous Adenoma,1
30512,Monoclonal Cellular Population Present,Cutaneous Mastocytosis,1
30513,Indolent Clinical Course,Soft tissue chondroma,1
30514,Chromogranin A Positive Neoplastic Cells Present,Transverse Colon Neuroendocrine Tumor G1,1
30515,Carcinomatous Component Present,Cervical Adenocarcinoma In Situ,1
30516,Malignant Cellular Infiltrate,"Neuroendocrine carcinoma, metastatic",1
30517,Recurrent disease,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
30518,Malignant Cellular Infiltrate,Adult Erythroleukemia,1
30519,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
30520,Malignant Cellular Infiltrate,Stage IIIB Ovarian Germ Cell Tumor AJCC v6 and 7,1
30521,Metastatic Lesion,Secondary malignant neoplasm of vagina,1
30522,Epithelial Component Present,Stage III Eyelid Carcinoma AJCC v8,1
30523,Spindle Cell Metaplasia,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
30524,Collagenous Stroma Formation,Angiomyofibroblastoma,1
30525,Malignant Cellular Infiltrate,Primary Vitreoretinal Lymphoma,1
30526,Fibrotic Stroma Formation,Scirrhous carcinoma of breast,1
30527,Indolent Clinical Course,Scrotal Hemangioma,1
30528,Dysplasia,Colorectal Adenoma with Moderate Dysplasia,1
30529,Recurrent disease,Recurrent Ampulla of Vater Adenocarcinoma,1
30530,Anaplasia,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
30531,Benign Cellular Infiltrate,Chondroid lipoma,1
30532,Malignant Cellular Infiltrate,Gastric Large Cell Neuroendocrine Carcinoma,1
30533,Tissue Differentiation Uncertain,Lymphangioleiomyomatosis of skin,1
30534,Malignant Cellular Infiltrate,carcinosarcoma of liver,1
30535,Epithelial Component Present,Colorectal cancer recurrent,1
30536,Insular Pattern,"Somatostatinoma, malignant",1
30537,Malignant Cellular Infiltrate,AIDS-Related Burkitt Lymphoma with Plasmacytoid Differentiation,1
30538,Epithelial Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v8,1
30539,Indolent Clinical Course,lipoma of mediastinum,1
30540,Neuroendocrine Differentiation,Colorectal Small Cell Neuroendocrine Carcinoma,1
30541,Sinusoidal Vascular Channel Formation,Anastomosing Hemangioma,1
30542,Cystic Change,Apocrine cystadenoma,1
30543,Secondary Lesion,Metastatic melanoma,1
30544,Primary Lesion,Recurrent Childhood Cerebellar Astrocytoma,1
30545,Recurrent disease,Recurrent Childhood Hodgkin Lymphoma,1
30546,Biphasic Pattern,Advanced Uterine Corpus Carcinosarcoma,1
30547,In Situ Lesion,Stage 0 Pharynx Carcinoma,1
30548,Carcinomatous Component Present,Hepatocellular Carcinoma by AJCC v7 Stage,1
30549,Epithelial Component Present,Opisthorchis Viverrini-Related Cholangiocarcinoma,1
30550,Diffuse Pattern,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,1
30551,Squamous metaplasia of bladder,Schistosoma Hematobium-Related Bladder Squamous Cell Carcinoma,1
30552,Malignant Cellular Infiltrate,Stage IA2 Lung Cancer AJCC v8,1
30553,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma stage I,1
30554,Epithelial Component Present,"Thymoma, type B1",1
30555,Splenomegaly,T-Cell Large Granular Lymphocyte Leukemia,1
30556,Multifocal Lesion,Gardner Syndrome,1
30557,Malignant Cellular Infiltrate,Refractory Childhood Acute Lymphoblastic Leukemia,1
30558,Carcinomatous Component Present,Gallbladder Mixed Adenoneuroendocrine Carcinoma,1
30559,Metaplasia,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
30560,Indolent Clinical Course,Synovial Hemangioma,1
30561,Malignant Cellular Infiltrate,Recurrent Malignant Extragonadal Germ Cell Tumor,1
30562,Epithelial Component Present,Benign Ovarian Seromucinous Tumor,1
30563,Epithelial Component Present,Pituitary Gland Multiple Adenomas,1
30564,Nuclear Expression of STAT6 Protein,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 2",1
30565,In Situ Lesion,Stage 0 Oral Cavity Cancer AJCC v6 and v7,1
30566,Papillary Pattern,Anal Verrucous Carcinoma,1
30567,Tissue Differentiation Uncertain,Pericardial Synovial Sarcoma,1
30568,Dysplasia,Colorectal Intraepithelial Neoplasia,1
30569,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8,1
30570,Encapsulated Mass,Stage II Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
30571,Malignant Cellular Infiltrate,Stage I Osteosarcoma AJCC v7,1
30572,Clinical TNM Finding,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
30573,Epithelial Component Present,Ectopic hamartomatous thymoma,1
30574,Absence of a Hormonal Syndrome,Densely Granulated Non-Functioning Corticotroph Adenoma,1
30575,Malignant Cellular Infiltrate,Metastatic malignant neoplasm to brain,1
30576,HMB-45-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma,1
30577,Hereditary Lesion,Short Limb Dwarfism-Saddle Nose-Spinal Alterations-Metaphyseal Striation Syndrome,1
30578,Benign Cellular Infiltrate,estrogen-producing adrenal cortical adenoma,1
30579,Chronic lymphocytic inflammation,Regressing nevus,1
30580,Abnormal Eosinophilic Granules Present,Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11,1
30581,Adnexal Differentiation,Pilar-Associated Mesenchyme Neoplasm,1
30582,Fibrotic Stroma Formation,Cystadenofibroma of fallopian tube,1
30583,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
30584,Benign Cellular Infiltrate,Benign neoplasm of supraglottis,1
30585,Neuroectodermal Differentiation,Peripheral primitive neuroectodermal tumor of soft tissue,1
30586,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
30587,Malignant Cellular Infiltrate,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
30588,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
30589,Epithelial Component Present,Recurrent Lip and Oral Cavity Carcinoma,1
30590,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1,1
30591,Lesion with Diameter of 10mm or Less,Pituitary Gland Microadenoma,1
30592,Benign Cellular Infiltrate,Benign Ovarian Serous Tumor,1
30593,Tissue of Mullerian Origin Present,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
30594,Malignant Cellular Infiltrate,Stomach Carcinoma,1
30595,Cartilaginous Differentiation,Childhood Myxoid Chondrosarcoma,1
30596,Extensive Stage Lesion,Uveal Melanoma Metastatic in the Liver,1
30597,Malignant Cellular Infiltrate,Recurrent Diffuse Intrinsic Pontine Glioma,1
30598,Carcinomatous Component Present,Resectable Carcinoma,1
30599,Epithelial Component Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
30600,High Mitotic Activity,Stage IA Lung Small Cell Carcinoma AJCC v7,1
30601,Malignant Cellular Infiltrate,Stage II Childhood Anaplastic Large Cell Lymphoma,1
30602,Pathologic TNM Finding,Pathologic Stage 0 Cutaneous Melanoma AJCC v8,1
30603,Carcinomatous Component Present,Adenocarcinoma of the prostate stage III,1
30604,Papillary Pattern,Pleural Well Differentiated Papillary Mesothelioma,1
30605,Severe dysplasia,Stage 0 Vulvar Carcinoma,1
30606,Epithelial Component Present,Gingival Squamous Cell Carcinoma,1
30607,Perineural spread,Recurrent Adenoid Cystic Carcinoma,1
30608,Epithelial Component Present,ductal papilloma of salivary gland,1
30609,Primary Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
30610,Malignant Cellular Infiltrate,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",1
30611,Benign Cellular Infiltrate,neurofibroma of esophagus,1
30612,Malignant Cellular Infiltrate,Secondary malignant neoplasm of extrahepatic bile ducts,1
30613,Well Differentiated Hyaline Cartilage Present,Adult Mesenchymal Chondrosarcoma,1
30614,Malignant Cellular Infiltrate,Stage IIB Colon Cancer AJCC v7,1
30615,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
30616,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
30617,Cartilaginous Differentiation,Cartilaginous exostosis,1
30618,Benign Cellular Infiltrate,Parotid Gland Hemangioma,1
30619,Carcinomatous Component Present,Locally Advanced Thymic Carcinoma,1
30620,Malignant Cellular Infiltrate,Epithelioid sarcoma non-metastatic,1
30621,Nuclear pleomorphism,Uterine Corpus Bizarre Leiomyoma,1
30622,Pushing Tumor Margin,Human Papillomavirus-Related Verrucous Carcinoma,1
30623,Diffuse Pattern,Primary Cutaneous Intravascular Large B-Cell Lymphoma,1
30624,Malignant Cellular Infiltrate,Alkylating Agent-Related Myelodysplastic Syndrome,1
30625,Malignant Cellular Infiltrate,Stage IV Childhood Non-Hodgkin Lymphoma,1
30626,Epithelial Component Present,"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
30627,Well-Circumscribed Lesion,Colorectal Filiform Serrated Adenoma,1
30628,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
30629,Tissue of Mullerian Origin Present,Ovarian Mucinous Adenofibroma,1
30630,Nuclear Pseudoinclusion,Nonencapsulated sclerosing tumor,1
30631,Carcinomatous Component Present,Stage 0 Urethral Cancer AJCC v7,1
30632,Primary Lesion,Childhood Cerebral Astrocytoma,1
30633,High Grade Lesion,Lung Monophasic Synovial Sarcoma,1
30634,Epithelial Component Present,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation,1
30635,Invasive Lesion,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
30636,Malignant Cellular Infiltrate,Stage I Vulvar Cancer,1
30637,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
30638,Malignant Cellular Infiltrate,Stage III Adult Lymphoblastic Lymphoma,1
30639,Benign Cellular Infiltrate,Breast Ductal Adenoma,1
30640,Malignant Cellular Infiltrate,Stromal Predominant Kidney Wilms Tumor,1
30641,Carcinomatous Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,1
30642,Immunologic Deficiency Syndromes,Renal Allograft Thrombosis,1
30643,Epithelial Component Present,Maxillary Sinus Schneiderian Papilloma,1
30644,Carcinomatous Component Present,"Papillary renal cell carcinoma, sporadic",1
30645,Carcinomatous Component Present,Stage II Adrenal Cortex Carcinoma AJCC v8,1
30646,Malignant Cellular Infiltrate,Stage IVA Vaginal Cancer AJCC v8,1
30647,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
30648,Breast Microcalcification,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
30649,Carcinomatous Component Present,Rectal Sarcomatoid Carcinoma,1
30650,Thin-Walled Branching Vascular Pattern,Pericardial Solitary Fibrous Tumor,1
30651,Malignant Cellular Infiltrate,T-Cell Large Granular Lymphocyte Leukemia,1
30652,Epithelial Component Present,Metastatic Carcinoma,1
30653,Tissue Differentiation Uncertain,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
30654,Malignant Cellular Infiltrate,"Pheochromocytoma, malignant",1
30655,Epithelial Component Present,Sebaceous adenoma,1
30656,Pseudoalveolar Pattern,Alveolar soft part sarcoma recurrent,1
30657,Malignant Cellular Infiltrate,Malignant melanoma of ciliary body,1
30658,Adnexal Differentiation,Piloleiomyoma,1
30659,Carcinomatous Component Present,Stage IIB Pancreatic Cancer AJCC v8,1
30660,Chromogranin A Positive Neoplastic Cells Present,Esophageal Neuroendocrine Tumor G1,1
30661,Poorly Differentiated Neuroendocrine Lesion,Esophageal Large Cell Neuroendocrine Carcinoma,1
30662,Recurrent Genetic Abnormalities Present,Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
30663,Acanthosis,inverted follicular keratosis,1
30664,Congenital Lesion,Proliferative dermal lesion in congenital nevus,1
30665,Metastatic/Recurrent Disease,Pleural Monophasic Synovial Sarcoma,1
30666,Carcinomatous Component Present,Undifferentiated Carcinoma of Unknown Primary,1
30667,Epithelial Component Present,Stage 0 Hilar Cholangiocarcinoma AJCC v7,1
30668,Carcinomatous Component Present,Stage IV Oropharyngeal Carcinoma,1
30669,Carcinomatous Component Present,Transitional cell carcinoma of ureter,1
30670,Exophytic Polypoid Lesion,Cecum Villous Adenoma,1
30671,Malignant Cellular Infiltrate,Gastric Intestinal-Type Adenocarcinoma,1
30672,Metastatic Lesion,Secondary malignant neoplasm of pericardium,1
30673,Polymorphic Cellular Infiltrate,Adult Langerhans Cell Histiocytosis,1
30674,Primary Lesion,Primary Effusion Lymphoma,1
30675,Invasive Lesion,Oncocytic Breast Carcinoma,1
30676,Neoplastic Cells with TFH Cell Phenotype Present,Cutaneous Angioimmunoblastic T-Cell Lymphoma,1
30677,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma stage IV,1
30678,Epithelial Component Present,Ampulla of Vater Neuroendocrine Tumor G2,1
30679,Secondary Lesion,Metastatic Uveal Melanoma,1
30680,Epithelial Component Present,Villous adenocarcinoma,1
30681,Indolent Clinical Course,"Hemangioma, Intramuscular",1
30682,Single Cell Necrosis,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
30683,Local disease,Localized Resectable Neuroblastoma,1
30684,Cutaneous Involvement,Eccrine acrospiroma,1
30685,Above the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage II supradiaphragmatic,1
30686,Primary Lesion,Recurrent Diffuse Intrinsic Pontine Glioma,1
30687,Metastatic Lesion,Metastatic Carcinoma in the Adrenal Cortex,1
30688,Below the Diaphragm Disease,Hodgkin's disease of intrapelvic lymph nodes,1
30689,Malignant Cellular Infiltrate,Grade II Chondrosarcoma,1
30690,Estrogen receptor negative,Metastatic Triple-Negative Breast Carcinoma,1
30691,Malignant Cellular Infiltrate,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
30692,Acinar Proliferation,Breast Sclerosing Adenosis,1
30693,Metastatic Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,1
30694,Carcinomatous Component Present,Stage IIA Fallopian Tube Cancer AJCC v6 and v7,1
30695,Thick-Walled Vessels Present,Endometrial Polyp,1
30696,Neoplastic Plasma Cells Present in Bone Marrow,Plasma Cell Myeloma by ISS Stage,1
30697,Deep Lesion,"Vaginal Deep ""Aggressive"" Angiomyxoma",1
30698,Cutaneous Involvement,Trichofolliculoma,1
30699,Sarcomatous Component Present,Testicular Spermatocytic Seminoma with Sarcoma,1
30700,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma In Situ,1
30701,Malignant Cellular Infiltrate,Childhood Acute Monocytic Leukemia,1
30702,Recurrent disease,Recurrent Lobular Breast Carcinoma,1
30703,Increased Cellularity Present,Anaplastic Hemispheric Astrocytoma,1
30704,Osteoid formation,Bone island,1
30705,Benign Cellular Infiltrate,Benign Adult Cerebellar Neoplasm,1
30706,Tissue Differentiation Uncertain,Extra-osseous Ewing's sarcoma,1
30707,Epithelial Component Present,Stage IVA Fallopian Tube Cancer AJCC v8,1
30708,Carcinomatous Component Present,Stage 0 Squamous Cell Lung Carcinoma AJCC v6 and v7,1
30709,Malignant Cellular Infiltrate,Anaplastic Oligodendroglioma,1
30710,Intraductal Lesion,Usual ductal hyperplasia of breast,1
30711,Malignant Component Present,Central Nervous System Teratoma with Malignant Transformation,1
30712,Neuroendocrine Differentiation,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
30713,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v8,1
30714,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8,1
30715,Squamoid Corpuscle,Pancreatoblastoma,1
30716,Carcinomatous Component Present,Carcinoma of lung,1
30717,Tissue Differentiation Uncertain,Ossifying fibromyxoid tumor,1
30718,Epithelial Component Present,Stage III Rectosigmoid Cancer AJCC v7,1
30719,Malignant Cellular Infiltrate,Testicular germ cell tumor mixed stage III,1
30720,Recurrent disease,Recurrent Non-Hodgkin Lymphoma,1
30721,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v8,1
30722,Metastatic Lesion,Locally Advanced Digestive System Carcinoma,1
30723,Carcinomatous Component Present,Adenocarcinoma of rectum,1
30724,Malignant Cellular Infiltrate,Refractory T-Cell Prolymphocytic Leukemia,1
30725,Cutaneous Involvement,Stage II Skin Cancer,1
30726,Local disease,Lipoma of chest wall,1
30727,Tubular Structures Present,Gastric Tubular Adenocarcinoma,1
30728,Low Grade Lesion,Cellular Congenital Mesoblastic Nephroma,1
30729,Perivascular Arrangement of Tumor Cells,Lung Clear Cell Tumor,1
30730,Severe dysplasia,Intraductal Cribriform Breast Adenocarcinoma,1
30731,Monoclonal Langerhans Cells Present,Thyroid Gland Langerhans Cell Histiocytosis,1
30732,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,1
30733,Angiocentric Pattern,Recurrent Grade I Lymphomatoid Granulomatosis,1
30734,Seminomatous Component Present,Testicular Mixed Choriocarcinoma and Seminoma,1
30735,Primary Lesion,Recurrent Childhood Pineoblastoma,1
30736,Dense Collagenized Tissue Present,Desmoplastic mesothelioma,1
30737,Extensive Stage Lesion,Advanced Carcinoma,1
30738,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
30739,Epithelial Component Present,Malignant Granulosa Cell Tumor,1
30740,Polyvesicular Vitelline Pattern,"Ovarian Yolk Sac Tumor, Polyvesicular Vitelline Pattern",1
30741,Human Papillomavirus Negative,Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
30742,Malignant Cellular Infiltrate,Primary Bone Osteosarcoma,1
30743,Malignant Cellular Infiltrate,Endometrial Large Cell Neuroendocrine Carcinoma,1
30744,Dysplasia,adenoma of extrahepatic bile duct,1
30745,Well-Circumscribed Lesion,Adult Kidney Wilms Tumor,1
30746,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,1
30747,Malignant Cellular Infiltrate,rhabdomyosarcoma of mediastinum,1
30748,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
30749,Carcinomatous Component Present,Stage IIIC Vulvar Cancer AJCC v8,1
30750,Carcinomatous Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
30751,Exophytic Papillary Lesion,Condyloma anal,1
30752,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
30753,More than 5 Mitoses per 50HPF,Gastrointestinal Stromal Sarcoma,1
30754,Malignant Cellular Infiltrate,Inflammatory Leiomyosarcoma,1
30755,Nuclear Grooves,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
30756,Polymorphic Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
30757,Unresectable Mass,Unresectable Carcinoma,1
30758,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
30759,Epithelial Component Present,Papilloma of nasal vestibule,1
30760,Anaplasia,Anaplastic Sarcoma of the Kidney,1
30761,Malignant Cellular Infiltrate,Stage IIIB Choroidal and Ciliary Body Melanoma AJCC v8,1
30762,Epithelial Component Present,BCLC Stage D Adult Hepatocellular Carcinoma,1
30763,Neuroendocrine Differentiation,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
30764,Epithelial Component Present,Locally Advanced Prostate Carcinoma,1
30765,Carcinomatous Component Present,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
30766,Carcinomatous Component Present,Anal margin Paget's disease,1
30767,Malignant Cellular Infiltrate,Metastatic Microsatellite Stable Colorectal Carcinoma,1
30768,Epithelial Component Present,large cell carcinoma of salivary gland,1
30769,Therapy-Related Toxicity,Methotrexate-Associated Hodgkin Lymphoma,1
30770,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 1,1
30771,Microcystic Change,Recurrent Childhood Protoplasmic Astrocytoma,1
30772,Malignant Cellular Infiltrate,Human Papillomavirus-Related Verrucous Carcinoma,1
30773,Malignant Cellular Infiltrate,Stage IVB Hepatocellular Carcinoma AJCC v8,1
30774,Multinodular Pattern,Adult Extraskeletal Myxoid Chondrosarcoma,1
30775,Mitotic Activity,Pineal Region Yolk Sac Tumor,1
30776,Malignant Cellular Infiltrate,Gastric Squamous Cell Carcinoma,1
30777,Epithelial Component Present,Gastrointestinal Carcinoid Tumor,1
30778,Metastatic Lesion,Disseminated carcinoma,1
30779,Progressive Disease,"Neurofibromatosis Type 1 with Inoperable, Progressive, Symptomatic Plexiform Neurofibromas",1
30780,Epithelial Component Present,Metastatic Breast Carcinoid Tumor,1
30781,Deep Lesion,Inflammatory liposarcoma,1
30782,Malignant Cellular Infiltrate,Stage IVB Gallbladder Cancer AJCC v8,1
30783,Increased Cellularity Present,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System,1
30784,Epithelial Component Present,Bladder Cancer by AJCC v6 Stage,1
30785,Severe dysplasia,Cervical Squamous Cell Carcinoma In Situ,1
30786,Cystic Change,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
30787,Well-Circumscribed Lesion,Sporadic Thyroid Gland Medullary Carcinoma,1
30788,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
30789,Nuclear Molding,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
30790,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Follicular Carcinoma AJCC v7,1
30791,Carcinomatous Component Present,Stage 0 Distal Bile Duct Cancer AJCC v8,1
30792,Nuclear Atypia,Childhood Cerebellar Anaplastic Astrocytoma,1
30793,Malignant Cellular Infiltrate,Stage IIB Esophageal Carcinoma,1
30794,Plexiform Vasculature Present,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
30795,Malignant Cellular Infiltrate,Refractory Malignant Central Nervous System Neoplasm,1
30796,Malignant Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v6 and v7,1
30797,Rapidly Enlarging Mass,Fusion-Positive Alveolar Rhabdomyosarcoma,1
30798,Invasive Lesion,Invasive Breast Carcinoma by Histologic Grade,1
30799,Carcinomatous Component Present,Carcinoma of Littre Glands,1
30800,High Grade Lesion,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
30801,Epithelial Component Present,Vulvar Papillary Hidradenoma,1
30802,Fibrotic Stroma Formation,Pancreatic Hepatoid Adenocarcinoma,1
30803,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage II,1
30804,Malignant Cellular Infiltrate,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,1
30805,Epithelial Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
30806,Stromal Invasion,Ovarian adenocarcinoma,1
30807,Neuroendocrine Differentiation,Malignant neoplasm of carotid body,1
30808,Fibromuscular Stroma Formation,Bartholin Gland Adenomyoma,1
30809,Dense Intercellular Reticulin Network Present,Childhood Pleomorphic Xanthoastrocytoma,1
30810,Nodular Pattern,Ann Arbor Stage II Follicular Lymphoma,1
30811,Epithelial Component Present,Parotid Gland Undifferentiated Carcinoma,1
30812,Lymphoplasmacytic Infiltrate,Splenic Lymphoplasmacytic Lymphoma,1
30813,Malignant Cellular Infiltrate,Stage I Vaginal Cancer AJCC v6 and v7,1
30814,Metastatic Lesion,Metastatic Pancreatic Neuroendocrine Carcinoma,1
30815,Malignant Cellular Infiltrate,Refractory Breast Carcinoma,1
30816,Neuroendocrine Differentiation,Childhood Carcinoid Tumor,1
30817,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory anemia with ringed sideroblasts,1
30818,Hyperplastic Epithelial Tissue Present,Atypical hyperplasia of breast,1
30819,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
30820,Mild dysplasia,Colorectal Low Grade Intraepithelial Neoplasia,1
30821,Indolent Clinical Course,Fibromyxolipoma,1
30822,Cystic Change,Seminal Vesicle Cystadenoma,1
30823,Xp11.2 Translocations/TFE3 Gene Fusions Present,Renal Cell Carcinoma Associated with t(X;17)(p11.2;q25),1
30824,Single Malignant Cells Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
30825,Epithelial Component Present,verrucous carcinoma of bladder,1
30826,Exophytic Papillary Lesion,Verrucous carcinoma,1
30827,Malignant Cellular Infiltrate,"Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
30828,Epithelial Component Present,Throat cancer,1
30829,Epithelial Component Present,Borderline Fallopian Tube Mucinous Tumor,1
30830,Mesenchymal Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
30831,Chronic Inflammatory Infiltrate,Grade III Lymphomatoid Granulomatosis,1
30832,'Starry-sky' pattern,Stage IV Childhood Burkitt Lymphoma,1
30833,Carcinomatous Component Present,signet ring cell carcinoma of appendix,1
30834,Vascular Channel Formation,Gastric Lymphangioma,1
30835,Invasive Lesion,Medullary carcinoma of breast,1
30836,Favorable Clinical Outcome,Adrenal Gland Ganglioneuroma,1
30837,Carcinomatous Component Present,Occult Lung Non-Small Cell Carcinoma,1
30838,Carcinomatous Component Present,Stage IIIA Cervical Cancer AJCC v8,1
30839,Severe dysplasia,Stage 0 Lung Cancer AJCC v6 and v7,1
30840,Epithelial Component Present,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
30841,Biphasic Pattern,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
30842,Benign Cellular Infiltrate,Hereditary Kidney Oncocytoma,1
30843,Childhood Lesion,Childhood Hematopoietic Neoplasm,1
30844,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Primary Systemic Amyloidosis,1
30845,Clinical TNM Finding,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
30846,Cytopenia,Refractory Cytopenia of Childhood,1
30847,Malignant Cellular Infiltrate,Unresectable Digestive System Neuroendocrine Carcinoma,1
30848,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Carcinoma,1
30849,Stromal Invasion,Stage IIA Ovarian Cancer AJCC V6 and v7,1
30850,Spindle Cell Metaplasia of Malignant Cells Present,adenocarcinoma of breast with spindle cell metaplasia,1
30851,Well Differentiated Neuroendocrine Lesion,Intestinal Neuroendocrine Tumor,1
30852,Pregnancy Complications,Acute Placental Infarction,1
30853,Dysplasia,High-Grade Squamous Intraepithelial Lesions,1
30854,Malignant Cellular Infiltrate,Small Lymphocytic Lymphoma with Plasmacytoid Differentiation,1
30855,Cysts Containing Proteinaceous Fluid Present,Serous papillary cystic tumor of borderline malignancy,1
30856,Recurrent disease,Recurrent Liver Carcinoma,1
30857,Malignant Cellular Infiltrate,Adenoid Cystic Carcinoma,1
30858,Swelling,Mesenchymal Chondrosarcoma,1
30859,High Mitotic Activity,combined small cell carcinoma of lung,1
30860,Non-Hereditary Lesion,Parietal cell carcinoma,1
30861,Biphasic Pattern,Third Ventricle Pilocytic Astrocytoma,1
30862,Hereditary Lesion,Hereditary Kidney Wilms Tumor,1
30863,Malignant Cellular Infiltrate,Plasmablastic Lymphoma of the Oral Mucosa,1
30864,Epithelial Component Present,Lip and Oral Cavity Carcinoma,1
30865,Hyperkeratosis,inverted follicular keratosis,1
30866,Metastatic Lesion,Metastatic Digestive System Carcinoma,1
30867,Benign Cellular Infiltrate,"Chondromatosis, Synovial",1
30868,Carcinomatous Component Present,Thyroid Gland Adenocarcinoma,1
30869,Carcinomatous Component Present,Locally Advanced Pancreatic Ductal Adenocarcinoma,1
30870,Mild cytologic atypia,Human Papillomavirus-Related Verrucous Carcinoma,1
30871,Locally Aggressive Lesion,Inflammatory pseudotumor of liver,1
30872,Malignant Cellular Infiltrate,Leptomeningeal sarcoma,1
30873,Malignant Cellular Infiltrate,Gastrointestinal carcinoma,1
30874,Carcinomatous Component Present,Cervical Papillary Squamous Cell Carcinoma,1
30875,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
30876,Malignant Cellular Infiltrate,Metastatic Bone Ewing Sarcoma,1
30877,Carcinomatous Component Present,Minor Salivary Gland Acinic Cell Carcinoma,1
30878,Malignant Cellular Infiltrate,Recurrent Appendix Mucinous Adenocarcinoma,1
30879,Malignant Cellular Infiltrate,mucoepidermoid carcinoma of accessory sinus,1
30880,Malignant Cellular Infiltrate,Childhood Anaplastic Large Cell Lymphoma,1
30881,Mitotic Activity,Testicular yolk sac tumor stage I,1
30882,Malignant Cellular Infiltrate,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
30883,Carcinomatous Component Present,Nasopharyngeal Differentiated Carcinoma,1
30884,Hereditary Lesion,Peutz-Jeghers Syndrome,1
30885,Drug Exposure,Alkylating Agent-Related Acute Myeloid Leukemia,1
30886,'Starry-sky' pattern,Stage III Adult Burkitt Lymphoma,1
30887,Malignant Cellular Infiltrate,Primary Childhood Soft Tissue Sarcoma,1
30888,Diffuse Pattern,Recurrent Childhood Anaplastic Oligodendroglioma,1
30889,Primary Lesion,Adult Brain Ependymoma,1
30890,Malignant Cellular Infiltrate,Stage I Lip and Oral Cavity Cancer AJCC v6 and v7,1
30891,Malignant Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Hodgkin Lymphoma,1
30892,Cutaneous Involvement,Syringocystadenoma Papilliferum,1
30893,Severe dysplasia,Stage 0 Esophageal Cancer AJCC v7,1
30894,Malignant Cellular Infiltrate,Testicular Spermatocytic Seminoma with Sarcoma,1
30895,Follicular Cell Differentiation,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
30896,Carcinomatous Component Present,Hormone-Resistant Prostate Carcinoma,1
30897,Carcinomatous Component Present,Recurrent Ovarian Carcinosarcoma,1
30898,Childhood Lesion,Stage III Childhood Anaplastic Large Cell Lymphoma,1
30899,Epithelial Component Present,Metastatic Genitourinary System Carcinoma,1
30900,Malignant Cellular Infiltrate,Resectable Pancreatic Acinar Cell Carcinoma,1
30901,Malignant Cellular Infiltrate,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
30902,Malignant Cellular Infiltrate,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
30903,Local disease,Solitary Adult Fibroma,1
30904,Follicular Cell Differentiation,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
30905,Carcinomatous Component Present,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
30906,Epithelial Component Present,Submandibular Gland Acinic Cell Carcinoma,1
30907,Neuroendocrine Differentiation,Pancreatic Vipoma,1
30908,S-100-Positive Neoplastic Cells Present,Angiomyolipoma of kidney,1
30909,Exophytic Papillary Lesion,Urethral Verrucous Carcinoma,1
30910,Hyperplastic Tissue Present,Columnar Cell Hyperplasia of the Breast with Atypia,1
30911,Pathologic TNM Finding,Pathologic Stage IV Gastric Cancer AJCC v8,1
30912,Single Cell Necrosis,Stage IA Merkel Cell Carcinoma AJCC v7,1
30913,Spindle Cell Osteo-Fibrous Component Present,Adamantinoma,1
30914,Alternative Fascicle (Bundle) Pattern,Gastric Leiomyoma,1
30915,Malignant Cellular Infiltrate,Esophageal carcinoma,1
30916,Malignant Cellular Infiltrate,Malignant neoplasm of oropharynx,1
30917,Metastatic Lesion,Metastatic Digestive System Neuroendocrine Tumor G1,1
30918,Well-Circumscribed Lesion,Childhood Pleomorphic Rhabdomyosarcoma,1
30919,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
30920,Adulthood Lesion,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
30921,Malignant Cellular Infiltrate,Recurrent Fallopian Tube Serous Adenocarcinoma,1
30922,Aggressive Clinical Course,Undifferentiated Stromal Sarcoma,1
30923,Carcinomatous Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
30924,Epithelial Component Present,Primary peritoneal carcinoma,1
30925,Cutaneous Involvement,basal cell carcinoma of penis,1
30926,Anaplasia,Rectal Sarcomatoid Carcinoma,1
30927,Abundance of Small Lymphocytes,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
30928,Epithelial Component Present,Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
30929,Malignant Cellular Infiltrate,Pleural Monophasic Synovial Sarcoma,1
30930,Epithelial Component Present,Appendix Low Grade Intraepithelial Neoplasia,1
30931,Necrotic changes (finding),Metastatic Bladder Large Cell Neuroendocrine Carcinoma,1
30932,Refractory Disease,Refractory Alveolar Rhabdomyosarcoma,1
30933,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
30934,Malignant Cellular Infiltrate,embryonal rhabdomyosarcoma of orbit,1
30935,Lobulated Growth Pattern,Vertebral chordoma,1
30936,Diffuse Lesion,Pleural Carcinomatosis,1
30937,Epithelial Component Present,Ovarian Clear Cell Cystadenocarcinoma,1
30938,Metastatic/Recurrent Disease,Synovial sarcoma recurrent,1
30939,Pseudoglandular Pattern,Testicular embryonal carcinoma stage I,1
30940,CD56-Positive Neoplastic Cells Present,Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
30941,Benign Cellular Infiltrate,Cellular Myxoma,1
30942,Carcinomatous Component Present,large cell neuroendocrine carcinoma of gallbladder,1
30943,Benign Cellular Infiltrate,Cutaneous neurofibroma,1
30944,Osseous Differentiation,Osteoma of skull,1
30945,Carcinomatous Component Present,Stage 0 Penile Cancer AJCC v6,1
30946,Metastatic Lesion,Breast Carcinoma Metastatic in the Central Nervous System,1
30947,Epithelial Component Present,Stage II Ureter Cancer AJCC v7,1
30948,Well-Circumscribed Lesion,Rectal hyperplastic polyp,1
30949,Cartilaginous Metaplasia of Malignant Cells Present,Breast Carcinoma with Chondroid Metaplasia,1
30950,Carcinomatous Component Present,Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
30951,Childhood Lesion,Refractory Hepatoblastoma,1
30952,Childhood Lesion,Childhood Grade III Meningioma,1
30953,Epithelial Component Present,Multiple Endocrine Neoplasia,1
30954,Malignant Cellular Infiltrate,Disseminated carcinoma,1
30955,Increased Cellularity Present,Sellar Neuroblastoma,1
30956,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
30957,Malignant Cellular Infiltrate,Pathologic Stage I Esophageal Adenocarcinoma AJCC v8,1
30958,Malignant Cellular Infiltrate,Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7,1
30959,Epithelial Component Present,"Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8",1
30960,Epithelial Component Present,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),1
30961,Epithelial Component Present,Functioning Endocrine Neoplasm,1
30962,Benign Cellular Infiltrate,Adrenal Gland Schwannoma,1
30963,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Teratoma,1
30964,Malignant Cellular Infiltrate,Stage IA Intrahepatic Bile Duct Cancer AJCC v8,1
30965,Severe dysplasia,Stage 0 Colorectal Cancer AJCC v8,1
30966,Benign Cellular Infiltrate,Neurilemmoma,1
30967,Carcinomatous Component Present,cloacogenic carcinoma of rectum,1
30968,Indolent Clinical Course,Epidural Spinal Canal Angiolipoma,1
30969,Locally Aggressive Lesion,Giant Cell Angioblastoma,1
30970,Childhood Lesion,Childhood Anaplastic Oligodendroglioma,1
30971,Benign Cellular Infiltrate,Testicular Large Cell Calcifying Sertoli Cell Tumor,1
30972,Malignant Cellular Infiltrate,Fallopian Tube Serous Adenocarcinoma,1
30973,Carcinomatous Component Present,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
30974,Refractory Disease,Refractory Neurofibromatosis Type 1,1
30975,Benign Cellular Infiltrate,Benign Esophageal Schwannoma,1
30976,Malignant Cellular Infiltrate,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,1
30977,Locally Aggressive Lesion,Dupuytren Contracture,1
30978,Carcinomatous Component Present,Stage III Lung Cancer AJCC v8,1
30979,Well-Circumscribed Lesion,Stage I Thyroid Gland Medullary Carcinoma AJCC v8,1
30980,Tissue of Mullerian Origin Present,serous adenocarcinofibroma of ovary,1
30981,Immunologic Deficiency Syndromes,AIDS-Related Idiopathic Thrombocytopenic Purpura,1
30982,High Mitotic Activity,large cell neuroendocrine carcinoma of appendix,1
30983,Cutaneous Involvement,Hutchinson's Melanotic Freckle,1
30984,Malignant Cellular Infiltrate,Meningeal Carcinomatosis,1
30985,Epithelial Component Present,High Grade Lung Neuroendocrine Neoplasm,1
30986,Cutaneous Involvement,Stage IVA1 Mycosis Fungoides and Sezary Syndrome AJCC v8,1
30987,Epithelial Component Present,Locally Advanced Pancreatic Ductal Adenocarcinoma,1
30988,Hyperplastic Tissue Present,Atypical Mesothelial Hyperplasia,1
30989,Recurrent disease,Recurrent Chronic Leukemia,1
30990,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v7,1
30991,Epithelial Component Present,Gallbladder Goblet Cell Carcinoid,1
30992,Swelling,mesenchymal chondrosarcoma of bone,1
30993,Lobulated Growth Pattern,Juxtacortical chondrosarcoma,1
30994,Cutaneous Involvement,Congenital melanocytic nevus,1
30995,Biphasic Pattern,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
30996,Recurrent disease,Recurrent Adult Brain Neoplasm,1
30997,Epithelial Component Present,"Carcinoma, diffuse type",1
30998,Epithelial Component Present,Breast Solid Neuroendocrine Carcinoma,1
30999,Carcinomatous Component Present,Recurrent Endometrial Serous Adenocarcinoma,1
31000,"Undifferentiated ""Fetal-Type"" Tissues Present",Extragonadal primary malignant teratoma,1
31001,Carcinomatous Component Present,Gastric Cancer by AJCC v7 Stage,1
31002,Tubular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
31003,"Amorphus, Eosinophilic, and Acellular Deposit","Amyloidosis, Familial",1
31004,S-100-Positive Neoplastic Cells Present,Clear-Cell Myomelanocytic Tumors,1
31005,Secondary Lesion,Disseminated adenocarcinoma,1
31006,Abundant Intracytoplasmic Lipofuscin Present,Heavily Pigmented Adrenal Cortical Adenoma,1
31007,Epithelial Component Present,Small Intestinal High Grade Intraepithelial Neoplasia,1
31008,Moderate dysplasia,Squamous intraepithelial neoplasia grade 2,1
31009,Malignant Cellular Infiltrate,Sternal Lymphoma,1
31010,Secondary Lesion,Metastatic Penile Cancer,1
31011,Epithelial Component Present,Stage 0 Eyelid Carcinoma AJCC v8,1
31012,Epithelial Component Present,Acinar cell cystadenocarcinoma,1
31013,atypia morphology,Borderline Uterine Ligament Neoplasm,1
31014,Epithelial Component Present,Refractory Colorectal Carcinoma,1
31015,Malignant Cellular Infiltrate,Stage IIIA Primary Peritoneal Cancer AJCC v8,1
31016,Thyroglobulin Positive Neoplastic Cells Present,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
31017,Adulthood Lesion,Adult Penile Carcinoma,1
31018,Above the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I supradiaphragmatic,1
31019,atypia morphology,Bowenoid papulosis of penis,1
31020,Malignant Cellular Infiltrate,Malignant neoplasm of brain,1
31021,Carcinomatous Component Present,Adenocarcinoma of the prostate stage II,1
31022,Osseous Differentiation,Stage IIB Osteosarcoma AJCC v7,1
31023,Malignant Cellular Infiltrate,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
31024,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
31025,Carcinomatous Component Present,Adenocarcinoma of large intestine,1
31026,Tissue Differentiation Uncertain,Lymphangioleiomyomatosis of skin,1
31027,Malignant Cellular Infiltrate,ALK positive large B-cell lymphoma,1
31028,Unresectable Mass,Unresectable Gallbladder Carcinoma,1
31029,Malignant Cellular Infiltrate,Lung Synovial Sarcoma,1
31030,Neuroendocrine Differentiation,"Pheochromocytoma, Extra-Adrenal",1
31031,Benign Cellular Infiltrate,Periosteal fibroma,1
31032,Well Differentiated Neuroendocrine Lesion,Gastrinoma,1
31033,Radiation Sickness,Radiation-induced myelopathy,1
31034,Mild cytologic atypia,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
31035,Syncytial Pattern,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
31036,Severe cytologic atypia,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
31037,Epithelial Component Present,Adenocarcinoma of salivary gland,1
31038,Malignant Cellular Infiltrate,Leiomyosarcoma recurrent,1
31039,Pathologic TNM Finding,Pathologic Stage IV Retinoblastoma AJCC v8,1
31040,Neuroendocrine Differentiation,Advanced Neuroendocrine Carcinoma,1
31041,Small Lesion,Luteoma,1
31042,Follicular Structures Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
31043,Necrotic changes (finding),Refractory Malignant Peripheral Nerve Sheath Tumor,1
31044,Pregnancy Complications,Stage IV Gestational Trophoblastic Tumor AJCC v7,1
31045,Benign Cellular Infiltrate,Cerebral Hemisphere Lipoma,1
31046,Biphasic Pattern,carcinosarcoma of extrahepatic bile duct,1
31047,Carcinomatous Component Present,Grade 1 Endometrial Endometrioid Adenocarcinoma,1
31048,Nuclear Atypia,Small cell glioblastoma,1
31049,Malignant Cellular Infiltrate,Mycosis fungoides/Sezary syndrome refractory,1
31050,Adulthood Lesion,Adult Liver Carcinoma,1
31051,Carcinomatous Component Present,Small Intestinal Cancer by AJCC v7 Stage,1
31052,Poorly Differentiated Lesion,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
31053,Malignant Cellular Infiltrate,Bartholin Gland Transitional Cell Carcinoma,1
31054,Carcinomatous Component Present,intraductal micropapillary carcinoma of breast,1
31055,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage 0,1
31056,Neuroendocrine Differentiation,Breast Solid Neuroendocrine Carcinoma,1
31057,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Kaposi Sarcoma,1
31058,Indolent Clinical Course,Mucous Membrane Hemangioma,1
31059,Single Cell Necrosis,Pathologic Stage I Merkel Cell Carcinoma AJCC v8,1
31060,Metastatic Lesion,Metastatic Bile Duct Carcinoma,1
31061,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G2,1
31062,No Identifiable Line of Differentiation,Inflammatory malignant fibrous histiocytoma,1
31063,Carcinomatous Component Present,Pituitary carcinoma,1
31064,Collagenous Stroma Formation,Cardiac fibroma,1
31065,Carcinomatous Component Present,Recurrent Parotid Gland Mucoepidermoid Carcinoma,1
31066,Vascular Channel Formation,Colon Kaposi Sarcoma,1
31067,Neuroectodermal Differentiation,Peripheral primitive neuroectodermal tumor of soft tissue,1
31068,High Grade Lesion,Osteoblastic Osteosarcoma,1
31069,Endophytic Tumor Growth,"Schneiderian papilloma, inverted",1
31070,Malignant Cellular Infiltrate,Stage IIB Cutaneous Melanoma AJCC v6 and v7,1
31071,Benign Cellular Infiltrate,Congenital hemangioma,1
31072,Well Differentiated Neuroendocrine Lesion,Rectal Neuroendocrine Tumor by AJCC v8 Stage,1
31073,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Signet Ring Variant",1
31074,Cutaneous Involvement,Anal margin basal cell carcinoma,1
31075,Epithelial Component Present,Recurrent Ovarian Clear Cell Adenocarcinoma,1
31076,Epithelial Component Present,Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8,1
31077,Epithelial Component Present,Ampulla of Vater Neuroendocrine Carcinoma,1
31078,Epithelial Component Present,Contralateral Breast Carcinoma,1
31079,Cystic Change,Rete Ovarii Cystadenofibroma,1
31080,Well-Circumscribed Lesion,Borderline Breast Phyllodes Tumor,1
31081,Indolent Clinical Course,Colon Leiomyoma,1
31082,Mucoid Stroma Formation,Childhood Myxopapillary Ependymoma,1
31083,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
31084,Severe dysplasia,Stage 0is Ureter Cancer AJCC v8,1
31085,Epithelial Component Present,Stage II Hepatocellular Carcinoma AJCC v6 and v7,1
31086,Carcinomatous Component Present,Stage III Vaginal Cancer AJCC v8,1
31087,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma,1
31088,Malignant Cellular Infiltrate,Malignant Pulmonary Artery Neoplasm,1
31089,Benign Cellular Infiltrate,Adenoameloblastoma,1
31090,Low Mitotic Activity,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
31091,Epithelial Component Present,Vaginal adenocarcinoma metastatic,1
31092,Malignant Cellular Infiltrate,carcinosarcoma of salivary gland,1
31093,Malignant Cellular Infiltrate,Metachronous Osteosarcoma,1
31094,Recurrent disease,Recurrent Dedifferentiated Liposarcoma,1
31095,Epithelial Component Present,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
31096,"Fully Differentiated ""Adult-Type"" Tissues Present",Central Nervous System Mature Teratoma,1
31097,Metastatic Lesion,Prostate Carcinoma Metastatic in the Lung,1
31098,Carcinomatous Component Present,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
31099,Carcinomatous Component Present,Rectal Carcinoma,1
31100,Nodular Pattern,follicular lymphoma of spleen,1
31101,Epithelial Component Present,"Uterine Carcinosarcoma, Homologous Type",1
31102,Carcinomatous Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
31103,Indolent Clinical Course,Hemangioma of spleen,1
31104,Biphasic Pattern,Phyllodes Tumor,1
31105,Fibrotic Stroma Formation,Borderline Ovarian Endometrioid Adenofibroma,1
31106,Cystic Change,Broad Ligament Papillary Cystadenoma,1
31107,Malignant Cellular Infiltrate,Liver carcinoma,1
31108,Carcinomatous Component Present,Stage IV Colorectal Cancer AJCC v7,1
31109,Indolent Clinical Course,Colon Lymphangioma,1
31110,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
31111,Capillary Sized Vascular Channel Formation,Kaposiform Hemangioendothelioma,1
31112,Dermal Nodule,Trichodiscoma,1
31113,Malignant Cellular Infiltrate,Secondary Prostate Urothelial Carcinoma,1
31114,Mitotic Activity,"Testicular Yolk Sac Tumor, Endodermal Sinus Pattern",1
31115,Complete Spontaneous Regression,Lymphomatoid Papulosis,1
31116,Dysplasia,Pancreatic Intraepithelial Neoplasia-1B,1
31117,High Grade Lesion,Langerhans Cell Sarcoma,1
31118,Clinical TNM Finding,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
31119,Non-Hereditary Lesion,Gastric Intestinal-Type Adenocarcinoma,1
31120,Carcinomatous Component Present,Penile Cancer by AJCC v6 Stage,1
31121,Low Grade Lesion,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
31122,Cutaneous Involvement,Recurrent Merkel Cell Carcinoma,1
31123,Hepatomegaly,Post polycythaemia vera myelofibrosis,1
31124,Multinodular Mass,hemangioendothelial sarcoma of bone,1
31125,Carcinomatous Component Present,Stage 0 Breast Cancer AJCC v6 and v7,1
31126,Hyperkeratosis,papillary squamous cell carcinoma of larynx,1
31127,High Mitotic Activity,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
31128,Malignant Cellular Infiltrate,Malignant neoplasm of brain,1
31129,Recurrent disease,Recurrent Grade III Lymphomatoid Granulomatosis,1
31130,Hereditary Lesion,Hereditary Glomangioma,1
31131,Epithelial Component Present,Refractory Urothelial Carcinoma,1
31132,Proliferation of Small Ducts Present,Intrahepatic Bile Duct Microcystic Adenoma,1
31133,Recurrent disease,Recurrent Childhood Fibrillary Astrocytoma,1
31134,Malignant Cellular Infiltrate,Squamous cell carcinoma of tongue,1
31135,Refractory Disease,Refractory Breast Lymphoma,1
31136,Mesenchymal Component Present,Malignant Vulvar Phyllodes Tumor,1
31137,Epithelial Component Present,Recurrent Urethral Cancer,1
31138,Severe dysplasia,Carcinoma in situ of prostate,1
31139,Carcinomatous Component Present,Small cell neuroendocrine carcinoma of bladder,1
31140,Malignant Cellular Infiltrate,Malignant Accessory Urethral Gland Neoplasm,1
31141,Carcinomatous Component Present,Stage IIIC Ovarian Cancer AJCC v8,1
31142,Malignant Cellular Infiltrate,Childhood Yolk Sac Tumor,1
31143,Malignant Cellular Infiltrate,Adult Fibrosarcoma,1
31144,Carcinomatous Component Present,Bronchogenic Carcinoma,1
31145,Malignant Cellular Infiltrate,Advanced Uterine Corpus Carcinosarcoma,1
31146,Non-Invasive Lesion,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
31147,Exophytic Polypoid Lesion,Foveolar-Type Adenoma,1
31148,Diffuse Lesion,Pseudomyxoma Peritonei,1
31149,Tubular Pattern,Small Intestinal Tubulovillous Adenoma,1
31150,Epithelial Component Present,Stage III Hepatocellular Carcinoma AJCC v6,1
31151,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Neoplasm,1
31152,Epithelial Component Present,"Mesonephroma, benign",1
31153,Carcinomatous Component Present,Stage IVA Ovarian Cancer AJCC v8,1
31154,Malignant Cellular Infiltrate,Malignant neoplasm of postcricoid region,1
31155,Epithelial Component Present,Colorectal Neuroendocrine Carcinoma,1
31156,Malignant Cellular Infiltrate,Stage IVB Gallbladder Cancer AJCC v8,1
31157,Epithelial Component Present,Clinical Stage II Gastric Cancer AJCC v8,1
31158,Bone marrow reticulin fibrosis,Splenic Manifestation of Hairy Cell Leukemia,1
31159,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
31160,Secondary Lesion,Secondary malignant neoplasm of prostate,1
31161,Carcinomatous Component Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
31162,Malignant Cellular Infiltrate,Metastatic Vulvar Carcinoma,1
31163,Secondary Lesion,Metastatic Endometrial Carcinoma,1
31164,Malignant Cellular Infiltrate,Stage IV Laryngeal Cancer AJCC v7,1
31165,Benign Cellular Infiltrate,Cerebral Hemisphere Lipoma,1
31166,Exophytic Polypoid Lesion,Multiple polyps,1
31167,Benign Cellular Infiltrate,Cavernous hemangioma of the face,1
31168,Carcinomatous Component Present,Locally Advanced Small Intestinal Carcinoma,1
31169,Epithelial Component Present,Disseminated squamous cell carcinoma,1
31170,Secondary Lesion,Locally Advanced Angiosarcoma,1
31171,Carcinomatous Component Present,"Invasive Lobular Breast Carcinoma, Pleomorphic Variant",1
31172,Malignant Cellular Infiltrate,Stage IVB Colorectal Cancer AJCC v7,1
31173,Malignant Cellular Infiltrate,Adult Lymphoma,1
31174,Epithelial Component Present,Apudoma,1
31175,Well-Circumscribed Lesion,Pleomorphic Rhabdomyosarcoma,1
31176,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component,1
31177,Carcinomatous Component Present,Parietal cell carcinoma,1
31178,Absence of Invasion,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
31179,Epithelial Component Present,Borderline Ovarian Serous Cystadenofibroma,1
31180,Carcinomatous Component Present,Penile Cancer by AJCC v6 Stage,1
31181,Epithelial Component Present,Refractory Lung Small Cell Carcinoma,1
31182,Intermediate Grade Neuroendocrine Lesion,Malignant Pancreatic Vipoma,1
31183,Well Differentiated Lesion,Plantar Verrucous Skin Carcinoma,1
31184,Biphasic Pattern,Recurrent Childhood Pilocytic Astrocytoma,1
31185,Malignant Cellular Infiltrate,Stage IIIC Colon Cancer AJCC v8,1
31186,Malignant Cellular Infiltrate,Clinical Stage IIB Gastric Cancer AJCC v8,1
31187,Malignant Cellular Infiltrate,Adult Diffuse Large B-Cell Lymphoma,1
31188,Malignant Cellular Infiltrate,"Spindle cell melanoma, type A",1
31189,Carcinomatous Component Present,Metastatic Prostate Carcinoma,1
31190,Breast Microcalcification,Childhood Brain Oligodendroglioma,1
31191,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma stage I,1
31192,Malignant Cellular Infiltrate,Recurrent Primary Effusion Lymphoma,1
31193,Benign Cellular Infiltrate,Chondroid lipoma,1
31194,Limited Early T-Cell Differentiation,Early T Acute Lymphoblastic Leukemia,1
31195,Carcinomatous Component Present,Clear cell squamous cell carcinoma of skin,1
31196,Epithelial Component Present,Ovarian Granulosa Cell Tumor,1
31197,Epithelial Component Present,Extrapulmonary Small Cell Carcinoma,1
31198,Malignant Cellular Infiltrate,Thyroid Gland Leiomyosarcoma,1
31199,Malignant Cellular Infiltrate,Aleukemic Acute Lymphoblastic Leukemia,1
31200,Intraductal Lesion,Central Breast Papilloma,1
31201,Benign Cellular Infiltrate,"Transitional cell papilloma, benign",1
31202,Carcinomatous Component Present,Anaplastic Carcinoma of the Rectum,1
31203,Carcinomatous Component Present,Vaginal Adenoid Cystic Carcinoma,1
31204,High Grade Lesion,Cardiac Monophasic Synovial Sarcoma,1
31205,Multinodular Mass,Central Nervous System Angiosarcoma,1
31206,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,"Carcinoma, Endometrioid",1
31207,Carcinomatous Component Present,Stage III Ureter Cancer AJCC v7,1
31208,High Mitotic Activity,small cell carcinoma of larynx,1
31209,Malignant Cellular Infiltrate,Stage I Carcinoma of Penis,1
31210,Malignant Cellular Infiltrate,Colon Kaposi Sarcoma,1
31211,Low Mitotic Activity,Small Intestinal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
31212,Regional Disease,Crohn's disease of the ileum,1
31213,Glandular Differentiation,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
31214,Malignant Cellular Infiltrate,"Cranial Nerve Neoplasms, Malignant",1
31215,Well Differentiated Lesion,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
31216,Malignant Cellular Infiltrate,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
31217,Cutaneous Involvement,Benign neoplasm of sweat gland,1
31218,Epithelial Component Present,Colorectal High Grade Intraepithelial Neoplasia,1
31219,Carcinomatous Component Present,Anal margin basal cell carcinoma,1
31220,Malignant Cellular Infiltrate,Secondary malignant neoplasm of nervous system,1
31221,Malignant Cellular Infiltrate,Stage IB Retroperitoneal Sarcoma AJCC v8,1
31222,Carcinomatous Component Present,Stage IVB Colorectal Cancer AJCC v8,1
31223,Epithelial Component Present,Stage II Oropharyngeal Carcinoma,1
31224,Multifocal Lesion,Colon Serrated Polyposis,1
31225,Malignant Cellular Infiltrate,Stage II Adult Lymphoblastic Lymphoma,1
31226,Mixed Cellular Population,Parotid Gland Carcinosarcoma,1
31227,Cutaneous Involvement,Verrucous keratotic hemangioma,1
31228,Mild cytologic atypia,Low Grade Endometrial Stromal Sarcoma,1
31229,Malignant Cellular Infiltrate,Sarcomatoid Hepatocellular Carcinoma,1
31230,Slow Growing Mass,Vertebral chordoma,1
31231,Refractory Disease,"Refractory NK-Cell Lymphoma, Unclassifiable",1
31232,Primary Lesion,Primary cerebral lymphoma,1
31233,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Macrocystic Pattern",1
31234,Malignant Cellular Infiltrate,Ewing's sarcoma of bone,1
31235,Birbeck Granules Present,Letterer-Siwe Disease,1
31236,Childhood Lesion,Refractory Childhood Hodgkin Lymphoma,1
31237,Epithelial Component Present,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,1
31238,Malignant Cellular Infiltrate,Stage I Vaginal Cancer AJCC v6 and v7,1
31239,Marked Bone Marrow Fibrosis,Overt Primary Myelofibrosis,1
31240,Malignant Cellular Infiltrate,Stage III Urethral Cancer AJCC v8,1
31241,Carcinomatous Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
31242,Epithelial Component Present,Recurrent Submandibular Gland Acinic Cell Carcinoma,1
31243,Metastatic Lesion,Secondary malignant neoplasm of esophagus,1
31244,Malignant Cellular Infiltrate,signet ring cell carcinoma of gallbladder,1
31245,Plasma cell inflammation,Urinary Bladder Inflammatory Myofibroblastic Tumor,1
31246,Well-Circumscribed Lesion,tubulopapillary adenoma of extrahepatic bile duct,1
31247,Epithelial Component Present,Adenomatous Polyps,1
31248,Tubular Structures Present,Benign Testicular Sertoli Cell Tumor,1
31249,Carcinomatous Component Present,Intramucosal Adenocarcinoma,1
31250,Recurrent disease,Recurrent Childhood Brain Stem Glioma,1
31251,Intestinal metaplasia,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1
31252,Recurrent disease,Recurrent Childhood Cerebellar Astrocytoma,1
31253,Epithelial Component Present,Anterior Pituitary Gland Endocrine Neoplasm,1
31254,Carcinomatous Component Present,Colorectal Medullary Carcinoma,1
31255,Epithelial Component Present,Hepatoid adenocarcinoma,1
31256,CD56-Positive Neoplastic Cells Present,Blastic plasmacytoid dendritic cell neoplasm,1
31257,Mixed Cellular Population,Oral Cavity Pleomorphic Adenoma,1
31258,Hereditary Lesion,Neurofibromatosis aggravated,1
31259,High Grade Lesion,Esophageal Synovial Sarcoma,1
31260,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,"Acute myeloid leukemia, inv(16)(p13q22)",1
31261,Epithelial Component Present,Unresectable Pancreatic Neuroendocrine Carcinoma,1
31262,Malignant Cellular Infiltrate,Anterior Tongue Carcinoma,1
31263,Malignant Cellular Infiltrate,liposarcoma of kidney,1
31264,Hyperkeratosis,Verrucous carcinoma of oral cavity,1
31265,Adulthood Lesion,BCLC Stage C Adult Hepatocellular Carcinoma,1
31266,Epithelial Component Present,Platinum-Resistant Ovarian Carcinoma,1
31267,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma 55 Years and Older AJCC v8,1
31268,Invasive Lesion,Invasive Cribriform Breast Carcinoma,1
31269,Cystic Change,Mucoepidermoid carcinoma of the oral cavity stage I,1
31270,Malignant Cellular Infiltrate,Mesothelioma malignant localized,1
31271,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
31272,Adulthood Lesion,Adult T-cell lymphoma/leukemia recurrent,1
31273,Juvenile Lesion,Gastric Juvenile Polyp,1
31274,Cystic Change,Ovarian Clear Cell Cystadenofibroma,1
31275,Eosinophil count raised (finding),Myeloid/Lymphoid Neoplasms with PCM1-JAK2,1
31276,Adnexal Differentiation,Piloleiomyoma,1
31277,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Fallopian Tube Endometrioid Adenocarcinoma,1
31278,Childhood Lesion,Childhood Astrocytoma,1
31279,Neuroendocrine Differentiation,Recurrent Digestive System Neuroendocrine Carcinoma,1
31280,Secondary Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
31281,Carcinomatous Component Present,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
31282,Carcinomatous Component Present,Conventional (Clear Cell) Renal Cell Carcinoma,1
31283,Malignant Cellular Infiltrate,leiomyosarcoma of lung,1
31284,Epithelial Component Present,Moderately Differentiated Hepatocellular Carcinoma,1
31285,Diffuse Pattern,Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
31286,Malignant Cellular Infiltrate,Thyroid Gland Leiomyosarcoma,1
31287,Pseudorosette Formation,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
31288,Malignant Cellular Infiltrate,Stage 0 Rectal Cancer AJCC v6 and v7,1
31289,Malignant Cellular Infiltrate,Malignant Ovarian Clear Cell Tumor,1
31290,Poorly Differentiated Lesion,Large cell carcinoma of lung,1
31291,Primary Lesion,Refractory Central Nervous System Lymphoma,1
31292,Fibrotic Stroma Formation,Stage II Intrahepatic Cholangiocarcinoma AJCC v8,1
31293,Malignant Cellular Infiltrate,Malignant myoepithelioma,1
31294,Neuroendocrine Differentiation,Advanced Gastric Large Cell Neuroendocrine Carcinoma,1
31295,Benign Cellular Infiltrate,Ovarian Sclerosing Stromal Tumor,1
31296,Epithelial Component Present,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
31297,Malignant Cellular Infiltrate,Nodal marginal zone B-cell lymphoma refractory,1
31298,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory cytopenia with unilineage dysplasia,1
31299,Low Mitotic Activity,Small Intestinal Neuroendocrine Tumor G2,1
31300,Infiltrative Growth Pattern,Glioblastoma with Primitive Neuronal Component,1
31301,Monocytosis,Juvenile Myelomonocytic Leukemia,1
31302,Precise Histogenesis Unknown,Peripheral Hemangioblastoma,1
31303,Hyaline Cartilage Differentiation,Childhood Myxoid Chondrosarcoma,1
31304,Neuroectodermal Differentiation,"Neuroectodermal Tumor, Melanotic",1
31305,Metastatic Lesion,Stage IV Esophageal Adenocarcinoma,1
31306,Epithelial Component Present,Renal Pelvis Cancer by AJCC v7 Stage,1
31307,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Sarcomatoid Variant",1
31308,Epithelial Component Present,Functioning Pancreatic Neuroendocrine Tumor G2,1
31309,Primary Lesion,Recurrent Gliosarcoma,1
31310,Adnexal Differentiation,Trichilemmoma,1
31311,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline Predisposition Associated with Inherited Bone Marrow Failure Syndromes,1
31312,Indolent Clinical Course,Nuchal-type fibroma,1
31313,Well-Circumscribed Lesion,Benign Brenner Tumor,1
31314,Vascular Channel Formation,Cardiac Kaposi's Sarcoma,1
31315,Carcinomatous Component Present,Carcinoma of soft palate,1
31316,Epithelial Component Present,Recurrent Parotid Gland Carcinoma,1
31317,Epithelial Component Present,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
31318,Dysplasia,Intermediate Grade Ductal Breast Carcinoma In Situ,1
31319,Epithelial Component Present,Stage IVB Basal Cell Lip Carcinoma,1
31320,Epithelial Component Present,Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
31321,Epithelial Component Present,Esophageal Basaloid Carcinoma,1
31322,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
31323,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v7,1
31324,Epithelial Component Present,Paget's disease of penis,1
31325,Malignant Cellular Infiltrate,Intermediate Cell Type Ciliary Body Melanoma,1
31326,Oligodendroglial Component Present,Recurrent Childhood Anaplastic Oligoastrocytoma,1
31327,Epithelial Component Present,Stage I Urethral Cancer AJCC v8,1
31328,Neuroendocrine Differentiation,Stage IIB Lung Small Cell Carcinoma AJCC v7,1
31329,Malignant Cellular Infiltrate,Adenocarcinoma of colon,1
31330,Parakeratosis,Plantar wart,1
31331,Invasive Lesion,"Squamous cell carcinoma, microinvasive",1
31332,Carcinomatous Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
31333,Recurrent disease,Recurrent Skin Carcinoma,1
31334,Epithelial Component Present,Carcinoma Arising from Craniopharyngioma,1
31335,Malignant Cellular Infiltrate,Stage IIIA Eyelid Carcinoma AJCC v7,1
31336,Pathologic TNM Finding,Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8,1
31337,Serrated Glandular Architecture,Colorectal Filiform Serrated Adenoma,1
31338,Tissue Differentiation Uncertain,Childhood Synovial Sarcoma,1
31339,Epithelial Component Present,Stage III Lung Cancer AJCC v8,1
31340,Epithelial Component Present,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
31341,Tissue of Mullerian Origin Present,"Cervical Adenomyoma, Endocervical Type",1
31342,Malignant Cellular Infiltrate,Recurrent Pancreatic Ductal Adenocarcinoma,1
31343,Pushing Tumor Margin,Subglottic Verrucous Carcinoma,1
31344,Metastatic Lesion,Secondary malignant neoplasm of eye,1
31345,Epithelial Component Present,Metastatic Jugulotympanic Paraganglioma,1
31346,Epithelial Component Present,Primary Cutaneous Mucinous Carcinoma,1
31347,Malignant Cellular Infiltrate,Burkitt Lymphoma by Ann Arbor Stage,1
31348,Carcinomatous Component Present,Stage IV Renal Cell Cancer AJCC v8,1
31349,Benign Cellular Infiltrate,leiomyoma of trachea,1
31350,CD8-Positive Neoplastic Cells Present,Primary cutaneous acral CD8 positive T-cell lymphoma,1
31351,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity refractory,1
31352,Indolent Clinical Course,benign neoplasm of floor of mouth,1
31353,Epithelial Component Present,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
31354,Adulthood Lesion,Stage IV Adult Soft Tissue Sarcoma AJCC v7,1
31355,Benign Cellular Infiltrate,Vulvar Angiomyofibroblastoma,1
31356,Cutaneous Involvement,Herpes zoster dermatitis,1
31357,Epithelial Component Present,ACTH-Secreting Pituitary Adenoma,1
31358,Recurrent disease,Recurrent Acute Myeloid Leukemia Not Otherwise Specified,1
31359,Malignant Cellular Infiltrate,Gallbladder Cribriform Carcinoma,1
31360,High Mitotic Activity,"Thyroid Gland Anaplastic Carcinoma, Osteoclastic Variant",1
31361,Epithelial Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v8,1
31362,Acanthosis,Laryngeal verrucous carcinoma stage IV,1
31363,Malignant Cellular Infiltrate,Therapy-related myelodysplastic syndrome,1
31364,Dysplasia,Esophageal Glandular Intraepithelial Neoplasia,1
31365,Anaplasia,Lung Spindle Cell Carcinoma,1
31366,Malignant Cellular Infiltrate,Breast Cancer by AJCC v6 Stage,1
31367,Cutaneous plaque,"Basal cell carcinoma, micronodular",1
31368,Tissue of Mullerian Origin Present,Ovarian Clear Cell Cystadenofibroma,1
31369,Pseudostratified Neuroepithelial Tumor Cells Present,Malignant medulloepithelioma of ciliary body,1
31370,atypia morphology,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
31371,Carcinomatous Component Present,Thyroid carcinoma,1
31372,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell",1
31373,Malignant Cellular Infiltrate,Stage IVB Bone Cancer AJCC v7,1
31374,Low Mitotic Activity,Carcinoid tumor of pancreas,1
31375,High Grade Lesion,Adult Brain Glioblastoma,1
31376,Malignant Cellular Infiltrate,Bladder Mucosa-Associated Lymphoid Tissue Lymphoma,1
31377,Cystic Change,"Papillary mucinous cystadenoma, borderline malignancy",1
31378,Primary Lesion,Benign neoplasm of brain stem,1
31379,Intraocular Lesion,Recurrent Primary Vitreoretinal Lymphoma,1
31380,Epithelial Component Present,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
31381,Malignant Cellular Infiltrate,Refractory anemia with ringed sideroblasts,1
31382,Malignant Cellular Infiltrate,Advanced Bile Duct Carcinoma,1
31383,Benign Cellular Infiltrate,Trichodiscoma,1
31384,Malignant Cellular Infiltrate,Stage 0 Lip Carcinoma,1
31385,Neuroendocrine Differentiation,Colon Neuroendocrine Tumor by AJCC v8 Stage,1
31386,Dysplasia,Flat adenoma,1
31387,Anaplasia,Lung Spindle Cell Carcinoma,1
31388,Well-Circumscribed Lesion,Familial medullary thyroid carcinoma,1
31389,Papillary Pattern,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
31390,Solar Radiation Toxicity,Solar Radiation-Related Malignant Neoplasm,1
31391,Primary Lesion,Primary Effusion Lymphoma,1
31392,Primary Lesion,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
31393,Increased Cellularity Present,Anaplastic Oligodendroglioma,1
31394,Malignant Cellular Infiltrate,Radiation-Related Osteosarcoma,1
31395,Low Mitotic Activity,Esophageal Neuroendocrine Tumor G2,1
31396,Malignant Cellular Infiltrate,Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
31397,Malignant Cellular Infiltrate,Invasive carcinoma of breast,1
31398,Malignant Cellular Infiltrate,Combined Lung Carcinoma,1
31399,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v6,1
31400,Ineffective hematopoiesis,de novo Myelodysplastic Syndrome,1
31401,Hepatomegaly,Overt Primary Myelofibrosis,1
31402,Neuroendocrine Differentiation,Metastatic Breast Neuroendocrine Neoplasm,1
31403,Well Differentiated Neuroendocrine Lesion,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
31404,Malignant Cellular Infiltrate,"Adenocarcinoma, endocervical type",1
31405,Epithelial Component Present,Stage IVB Appendix Carcinoma AJCC v8,1
31406,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH,1
31407,Pathologic TNM Finding,Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8,1
31408,Carcinomatous Component Present,Recurrent Endometrial Serous Adenocarcinoma,1
31409,Malignant Cellular Infiltrate,Refractory Head and Neck Carcinoma,1
31410,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor of the Kidney,1
31411,Malignant Cellular Infiltrate,Stage III Distal Bile Duct Cancer AJCC v7,1
31412,High Mitotic Activity,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
31413,Carcinomatous Component Present,Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
31414,Metaplasia,Barrett's Adenocarcinoma,1
31415,Well-Circumscribed Lesion,Appendix Sessile Serrated Adenoma/Polyp,1
31416,S-100-Positive Neoplastic Cells Present,Lymphangiomyoma,1
31417,Tissue Differentiation Uncertain,Lung Monophasic Synovial Sarcoma,1
31418,Epithelial Component Present,Squamous Lung Dysplasia,1
31419,Childhood Lesion,Childhood Bladder Carcinoma,1
31420,Carcinomatous Component Present,Stage 0is Ureter Cancer AJCC v7,1
31421,Neuroectodermal Differentiation,Recurrent tumors of the Ewing's family,1
31422,Epithelial Component Present,Spindle cell squamous cell carcinoma,1
31423,Malignant Cellular Infiltrate,Vulvar adenocarcinoma,1
31424,Mixed Cellular Population,Adenocarcinoma with cartilaginous and osseous metaplasia,1
31425,Epithelial Component Present,Metastatic Bile Duct Carcinoma,1
31426,Dysplasia,Colorectal Adenoma with Severe Dysplasia,1
31427,Malignant Cellular Infiltrate,Stage II Laryngeal Cancer AJCC v8,1
31428,Perivascular Arrangement of Tumor Cells,Venous Angioleiomyoma,1
31429,High Mitotic Activity,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
31430,Malignant Cellular Infiltrate,Regressing Non-Cutaneous Melanoma,1
31431,Malignant Cellular Infiltrate,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8,1
31432,Carcinomatous Component Present,Stage II Vulva Cancer AJCC v6,1
31433,Low Mitotic Activity,Advanced Pancreatic Neuroendocrine Tumor,1
31434,Cellular Pleomorphism,Malignant Uterine Corpus PEComa,1
31435,Recurrent disease,Recurrent Uterine Corpus Carcinoma,1
31436,Biphasic Pattern,Cardiac Biphasic Synovial Sarcoma,1
31437,Polymorphic Cellular Infiltrate,Refractory Langerhans Cell Histiocytosis,1
31438,Secondary Lesion,Locally Advanced Carcinoma,1
31439,Mitotic Activity,Multifocal Glioblastomas,1
31440,Benign Cellular Infiltrate,Benign neoplasm of middle ear,1
31441,Malignant Cellular Infiltrate,Invasive Lobular Breast Carcinoma,1
31442,Epithelial Component Present,Paranasal Sinus Schneiderian Papilloma,1
31443,Epithelial Component Present,Refractory Hypopharyngeal Squamous Cell Carcinoma,1
31444,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with t(9:11)(p22;q23); MLLT3-MLL,1
31445,High Grade Lesion,"Glioblastoma, IDH-Wildtype",1
31446,Carcinomatous Component Present,Stage I Lung Cancer AJCC v8,1
31447,Epithelial Component Present,Multiple endocrine neoplasia Type 2,1
31448,Mild cytologic atypia,verrucous carcinoma of bladder,1
31449,Recurrent disease,Recurrent Prostate Acinar Adenocarcinoma,1
31450,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Stage,1
31451,Recurrent disease,Recurrent Chronic Myelomonocytic Leukemia,1
31452,Recurrent disease,Recurrent Acute Megakaryoblastic Leukemia,1
31453,Low Cellularity Present,Calcifying Fibrous Pseudotumor,1
31454,Carcinomatous Component Present,Stage 0 Lung Cancer AJCC v6 and v7,1
31455,Edematous Stroma Formation,Vulvar Angiomyofibroblastoma,1
31456,Epithelial Component Present,Rete Ovarii Cystadenoma,1
31457,Epithelial Component Present,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
31458,Myxoid Stroma Formation,Dedifferentiated chordoma,1
31459,Malignant Cellular Infiltrate,Stage IIIB Primary Peritoneal Cancer AJCC v7,1
31460,Vascular Channel Formation,Lymphangioma,1
31461,Secondary Lesion,"Metastatic Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
31462,Epithelial Component Present,Tubular adenoma,1
31463,Malignant Cellular Infiltrate,Vaginal Non-Keratinizing Squamous Cell Carcinoma,1
31464,Microvascular Proliferation,Recurrent Gliosarcoma,1
31465,Epithelial Component Present,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
31466,Malignant Cellular Infiltrate,Extragonadal primary embryonal carcinoma,1
31467,Malignant Cellular Infiltrate,Pituitary carcinoma,1
31468,Epithelial Component Present,Stage I Adrenal Cortex Carcinoma AJCC v8,1
31469,Recurrent disease,Recurrent Childhood Burkitt Lymphoma,1
31470,Epithelial Component Present,Localized Non-Resectable Adult Liver Carcinoma,1
31471,Metastatic Lesion,Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy by AJCC v8 Stage,1
31472,Malignant Cellular Infiltrate,DS Stage III Plasma Cell Myeloma,1
31473,Tissue Differentiation Uncertain,Childhood Epithelioid Sarcoma,1
31474,Anaplasia,anaplastic large cell lymphoma of central nervous system,1
31475,Epithelial Component Present,Thyroid Gland Clear Cell Follicular Adenoma,1
31476,Malignant Cellular Infiltrate,Gonadal Polyembryoma,1
31477,Cystic Change,Clear cell cystadenofibroma,1
31478,Squamous metaplasia of bladder,Bladder Urachal Squamous Cell Carcinoma,1
31479,Capsular Invasion,"Thymoma, type AB, malignant",1
31480,Benign Cellular Infiltrate,Breast Angiomatosis,1
31481,Immunologic Deficiency Syndromes,AIDS-Related Cervical Kaposi Sarcoma,1
31482,Malignant Cellular Infiltrate,Stage III Renal Cell Cancer AJCC v8,1
31483,Adulthood Lesion,Adult Choroid Plexus Neoplasm,1
31484,Favorable Clinical Outcome,Maturing Ganglioneuroma,1
31485,High Mitotic Activity,Advanced Small Intestinal Neuroendocrine Carcinoma,1
31486,Neuroendocrine Differentiation,Stage IV Appendix Neuroendocrine Tumor AJCC v7,1
31487,Hyperkeratosis,Cervical Squamotransitional Carcinoma,1
31488,Carcinomatous Component Present,Eccrine ductal carcinoma,1
31489,Mixed Cellular Population,Carcinosarcoma of cervix uteri,1
31490,Malignant Cellular Infiltrate,Childhood Spindle Cell Rhabdomyosarcoma,1
31491,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage IV,1
31492,Benign Cellular Infiltrate,Uterine Corpus Myxoid Leiomyoma,1
31493,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
31494,Carcinomatous Component Present,Metastatic Salivary Gland Carcinoma,1
31495,Refractory Disease,Refractory B-Cell Prolymphocytic Leukemia,1
31496,Malignant Cellular Infiltrate,undifferentiated carcinoma of larynx,1
31497,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),1
31498,Malignant Cellular Infiltrate,Cutaneous Malignant Melanoma 2,1
31499,Malignant Cellular Infiltrate,Cancer of lymph node,1
31500,Epithelial Component Present,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
31501,Epithelial Component Present,Gonadotroph adenoma,1
31502,Cutaneous Involvement,Chronic Bullous Disease of Childhood,1
31503,Aggressive Clinical Course,ALK positive large B-cell lymphoma,1
31504,Stromal Invasion,Stage IVA Ovarian Cancer AJCC v8,1
31505,Absence of Invasion,Stage 0 Oropharyngeal Carcinoma,1
31506,Malignant Cellular Infiltrate,Posterior Tongue Mucoepidermoid Carcinoma,1
31507,Multifocal Lesion,Erdheim-Chester Disease,1
31508,Malignant Cellular Infiltrate,Bladder cancer stage IV,1
31509,Malignant Cellular Infiltrate,FIGO Stage III Ovarian Cancer,1
31510,Exophytic Polypoid Lesion,Vaginal Villous Adenoma,1
31511,Chromogranin A Positive Neoplastic Cells Present,Colorectal Neuroendocrine Tumor G1,1
31512,Carcinomatous Component Present,Stage I Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7,1
31513,Pseudoencapsulated Mass,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
31514,Mixed Cellular Population,Recurrent Childhood Oligoastrocytoma,1
31515,Epithelial Component Present,Gallbladder Papillary Biliary Intraepithelial Neoplasia,1
31516,Carcinomatous Component Present,Stage IVB Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
31517,Malignant Cellular Infiltrate,Stage IIB Bone Sarcoma AJCC v7,1
31518,Secondary Lesion,Radiation-Related Osteosarcoma,1
31519,Epithelial Component Present,Stage II Ileal Neuroendocrine Tumor AJCC v8,1
31520,CD30-Positive Neoplastic Cells Present,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive",1
31521,atypia morphology,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,1
31522,Malignant Cellular Infiltrate,"Lymphoma, T-Cell, Cutaneous",1
31523,Birbeck Granules Present,"Histiocytosis, Langerhans-Cell",1
31524,Dysplasia,Lung Squamous Cell Carcinoma In Situ,1
31525,Recurrent Genetic Abnormalities Present,"B Acute Lymphoblastic Leukemia, BCR-ABL1-Like",1
31526,Malignant Cellular Infiltrate,Contralateral Breast Carcinoma,1
31527,Mesenchymal Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
31528,Malignant Cellular Infiltrate,Mixed phenotype acute leukemia B/myeloid,1
31529,Cutaneous Involvement,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
31530,Well-Circumscribed Lesion,Colonic tubulovillous adenoma,1
31531,atypia morphology,Malignant Solitary Fibrous Tumor,1
31532,Carcinomatous Component Present,Lower Gingival Verrucous Carcinoma,1
31533,Mixed Cellular Population,Invasive Mixed Breast Carcinoma,1
31534,Angiocentric Pattern,Lymphomatoid Granulomatosis,1
31535,Desmoplastic Stroma Formation,"Adenocarcinoma, Scirrhous",1
31536,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8,1
31537,Cutaneous Involvement,Deep Penetrating Nevus,1
31538,Malignant Cellular Infiltrate,Stage II Osteosarcoma AJCC v7,1
31539,Malignant Cellular Infiltrate,Childhood Parathyroid Gland Carcinoma,1
31540,Epithelial Component Present,Cholangiocarcinoma resectable,1
31541,Epithelial Component Present,Collecting Duct Carcinoma of the Kidney,1
31542,Locally Aggressive Lesion,Inflammatory pseudotumor of liver,1
31543,Malignant Cellular Infiltrate,Recurrent Breast Lymphoma,1
31544,Metastatic Lesion,Carcinomatosis,1
31545,Hypergammaglobulinemia,Multi-centric Castleman's Disease,1
31546,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor G2,1
31547,Neuroendocrine Differentiation,Gastrointestinal Carcinoid Tumor,1
31548,Epithelial Component Present,Pancreatic Serous Adenoma,1
31549,Benign Cellular Infiltrate,Benign Breast Adenomyoepithelioma,1
31550,Childhood Lesion,Childhood Myxopapillary Ependymoma,1
31551,Diffuse Pattern,"Malignant lymphoma centroblastic, diffuse",1
31552,Fever,Thyroid Gland Sinus Histiocytosis with Massive Lymphadenopathy,1
31553,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
31554,Primary Lesion,Stage IIA Osteosarcoma AJCC v7,1
31555,Hyperkeratosis,Cervical Papillary Squamous Cell Carcinoma,1
31556,Epithelial Component Present,Cervical Esophagus Squamous Cell Carcinoma,1
31557,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v8,1
31558,Malignant Cellular Infiltrate,Prognostic Stage 0 Breast Cancer AJCC v8,1
31559,Primary Lesion,Multifocal osteosarcoma,1
31560,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Papillary Pattern",1
31561,Endophytic Tumor Growth,Sphenoid Sinus Inverted Papilloma,1
31562,Capillary Sized Vascular Channel Formation,Peripheral Hemangioblastoma,1
31563,Malignant Cellular Infiltrate,cystadenocarcinoma of salivary gland,1
31564,Epithelial Component Present,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
31565,Malignant Cellular Infiltrate,Stage IIIB Lung Squamous Cell Carcinoma AJCC v7,1
31566,Epithelial Component Present,Gastric Squamous Cell Carcinoma,1
31567,Osteoid formation,Aggressive osteoblastoma,1
31568,Neuroendocrine Differentiation,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",1
31569,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v7 Stage,1
31570,Malignant Cellular Infiltrate,Childhood Central Nervous System Choriocarcinoma,1
31571,Refractory Disease,Refractory Cholangiocarcinoma,1
31572,Malignant Cellular Infiltrate,Stage IIIC Vulvar Cancer AJCC v7,1
31573,Epithelial Component Present,Stage 0a Ureter Cancer AJCC v7,1
31574,Intracanalicular Growth Pattern,Malignant Vulvar Phyllodes Tumor,1
31575,Malignant Cellular Infiltrate,Refractory Central Nervous System Non-Hodgkin Lymphoma,1
31576,No Identifiable Line of Differentiation,Undifferentiated round cell sarcoma,1
31577,Malignant Cellular Infiltrate,Angiocentric lymphoma stage II,1
31578,Malignant Cellular Infiltrate,Refractory Malignant Soft Tissue Neoplasm,1
31579,Carcinomatous Component Present,keratinizing squamous cell carcinoma of vulva,1
31580,Low Mitotic Activity,Appendix Neuroendocrine Tumor by AJCC v7 Stage,1
31581,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Cancer AJCC v8,1
31582,Papillary Pattern,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
31583,Immunologic Deficiency Syndromes,Renal transplant rejection,1
31584,Malignant Cellular Infiltrate,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
31585,Epithelial Component Present,Colorectal High Grade Intraepithelial Neoplasia,1
31586,High Grade Lesion,Childhood Gliosarcoma,1
31587,Epithelial Component Present,Lung Non-Mucinous Adenocarcinoma In Situ,1
31588,Epithelial Component Present,"Squamous cell carcinoma, metastatic",1
31589,Immunosuppression-Related Post-Transplant Toxicity,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
31590,Childhood Lesion,Childhood Testicular Germ Cell Tumor,1
31591,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Uterine Corpus Choriocarcinoma,1
31592,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Cancer AJCC v6 and v7,1
31593,Epithelial Component Present,"Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant",1
31594,Koilocytotic atypia,basaloid carcinoma of penis,1
31595,Neuroendocrine Differentiation,Malignant neoplasm of carotid body,1
31596,Micropapillary Pattern,Papillary serous cystadenocarcinoma,1
31597,Monoclonal Cellular Population Present,Thyroid Gland Hyperfunctioning Adenoma,1
31598,Pushing Tumor Margin,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
31599,Recurrent disease,Recurrent B Acute Lymphoblastic Leukemia,1
31600,Malignant Cellular Infiltrate,Stage III Merkel Cell Carcinoma AJCC v7,1
31601,Benign Cellular Infiltrate,Cervical Blue Nevus,1
31602,Malignant Cellular Infiltrate,Osteoblastic Osteosarcoma,1
31603,Hyperkeratosis,Plantar wart,1
31604,Recurrent disease,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
31605,Dysplasia,Gastrointestinal tract adenoma,1
31606,Recurrent disease,Recurrent Paget Disease of the Anal Canal,1
31607,Carcinomatous Component Present,Duodenal Cancer,1
31608,Epithelial Component Present,Posterior Tongue Mucoepidermoid Carcinoma,1
31609,In Situ Lesion,Stage 0 Pancreatic Cancer AJCC v8,1
31610,Malignant Cellular Infiltrate,Stage IIB Lung Cancer AJCC v7,1
31611,Carcinomatous Component Present,Metastatic Lip Carcinoma,1
31612,Malignant Cellular Infiltrate,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
31613,Biphasic Pattern,Ovarian Clear Cell Cystadenofibroma,1
31614,Epithelial Component Present,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
31615,Childhood Lesion,Macrotrabecular Hepatoblastoma,1
31616,Endobronchial Lesion,Lung Glandular Papilloma,1
31617,Malignant Cellular Infiltrate,Metastatic Neoplasm to the Gallbladder,1
31618,Epithelial Component Present,Stage II Esophageal Cancer AJCC v7,1
31619,Carcinomatous Component Present,Blepharal carcinoma,1
31620,Increased Cellularity Present,Localized Resectable Neuroblastoma,1
31621,Malignant Cellular Infiltrate,Rectal Carcinoma Metastatic in the Liver,1
31622,Epithelial Component Present,Locally Advanced Adrenal Gland Pheochromocytoma,1
31623,Epithelial Component Present,Stage IV Colon Carcinoma,1
31624,Malignant Cellular Infiltrate,Childhood Hodgkin Lymphoma by Ann Arbor Stage,1
31625,Monoclonal Cellular Population Present,"Mastocytosis, Systemic",1
31626,Epithelial Component Present,small cell carcinoma of extrahepatic bile duct,1
31627,Malignant Cellular Infiltrate,Refractory Metastatic Digestive System Carcinoma,1
31628,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type",1
31629,Benign Cellular Infiltrate,Cystadenoma of pancreas,1
31630,Malignant Cellular Infiltrate,Stage IVC Oral Cavity Cancer AJCC v6 and v7,1
31631,Recurrent disease,Recurrent Anal Mucinous Adenocarcinoma,1
31632,Malignant Cellular Infiltrate,Secondary malignant neoplasm of large intestine,1
31633,Childhood Lesion,Childhood Acute Basophilic Leukemia,1
31634,Malignant Cellular Infiltrate,Malignant tumor of extrahepatic bile duct,1
31635,Pseudopapillary Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
31636,Epithelial Component Present,Stage IVB Basal Cell Lip Carcinoma,1
31637,Benign Cellular Infiltrate,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
31638,Neuroendocrine Differentiation,Gallbladder Neuroendocrine Tumor G2,1
31639,Atypical Mitotic Figures,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
31640,Malignant Cellular Infiltrate,Infiltrating Urothelial Carcinoma,1
31641,Osseous Differentiation,Intermediate Osteogenic Neoplasm,1
31642,Epithelial Component Present,High Grade Penile Intraepithelial Neoplasia,1
31643,Epithelial Component Present,Stage IVB Nasopharyngeal Carcinoma AJCC v8,1
31644,Carcinomatous Component Present,Stage IA Esophageal Cancer AJCC v7,1
31645,Malignant Cellular Infiltrate,Acute myeloid leukemia refractory,1
31646,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,1
31647,Metastatic Lesion,Secondary Central Nervous System Hodgkin Lymphoma,1
31648,Rapidly Enlarging Mass,Anal Rhabdomyosarcoma,1
31649,Malignant Cellular Infiltrate,Stage IA1 Cervical Cancer AJCC v8,1
31650,Childhood Lesion,Childhood Acute Lymphoblastic Leukemia,1
31651,Malignant Cellular Infiltrate,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
31652,Cutaneous Involvement,Local infection skin/subcut tissue NOS,1
31653,Adnexal Differentiation,Eccrine mixed tumor of skin,1
31654,Dysplasia,Transitional Cell Intraepithelial Neoplasia,1
31655,Tissue Differentiation Uncertain,Childhood Desmoplastic Small Round Cell Tumor,1
31656,Cutaneous Involvement,inverted follicular keratosis,1
31657,Refractory Disease,Refractory Myxoid Liposarcoma,1
31658,Well Differentiated Neuroendocrine Lesion,Anal Canal Neuroendocrine Tumor G1,1
31659,Cutaneous Involvement,Pigmented Basal Cell Carcinoma,1
31660,Malignant Cellular Infiltrate,Stage I Lung Small Cell Carcinoma AJCC v7,1
31661,Stromal Invasion,mucinous adenocarcinoma of ovary,1
31662,Eosinophil count raised (finding),Childhood Acute Eosinophilic Leukemia,1
31663,Benign Cellular Infiltrate,Benign Intraocular Medulloepithelioma,1
31664,Epithelial Component Present,Nasopharyngeal lymphoepithelioma stage III,1
31665,Abundance of Small Lymphocytes,Childhood Lymphocyte-Rich Classic Hodgkin Lymphoma,1
31666,Epithelial Component Present,Stage II Colorectal Cancer,1
31667,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma stage IV,1
31668,Geographic Necrosis,Ovarian Embryonal Carcinoma,1
31669,Benign Cellular Infiltrate,"Hemangioma, Cavernous, Central Nervous System",1
31670,Oligodendroglial Component Present,Mixed Oligodendroglioma-Astrocytoma,1
31671,Childhood Lesion,Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6,1
31672,Carcinomatous Component Present,Stage IV Oral Cavity Cancer AJCC v6 and v7,1
31673,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
31674,Malignant Cellular Infiltrate,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,1
31675,CD30-Positive Neoplastic Cells Present,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative",1
31676,Malignant Cellular Infiltrate,Lugano Classification Stage III Adult Hodgkin Lymphoma AJCC v8,1
31677,Therapy-Related Toxicity,Monomorphic Post-Transplant Lymphoproliferative Disorder,1
31678,Indolent Clinical Course,Tufted angioma of skin,1
31679,Childhood Lesion,Childhood Acute Basophilic Leukemia,1
31680,Hypertensive disease,Hypertensive episode,1
31681,Poorly Differentiated Lesion,Large cell carcinoma of lung,1
31682,Cutaneous Involvement,Pathologic Stage IA Cutaneous Melanoma AJCC v8,1
31683,Well-Circumscribed Lesion,Cortisol-Producing Adrenal Cortex Adenoma,1
31684,Carcinomatous Component Present,Anal Extramucosal (Perianal) Adenocarcinoma,1
31685,Pseudopapillary Pattern,Adult Papillary Meningioma,1
31686,Rapidly Enlarging Mass,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,1
31687,Diffuse Pattern,Nodal peripheral T-cell lymphoma with T follicular helper phenotype,1
31688,Necrotic changes (finding),Stage III Lung Small Cell Carcinoma AJCC v7,1
31689,Recurrent disease,Breast cancer recurrent,1
31690,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v8 Stage,1
31691,Malignant Cellular Infiltrate,Rectal Kaposi Sarcoma,1
31692,Childhood Lesion,Childhood Gonadal Germ Cell Tumor,1
31693,Indolent Clinical Course,"Histiocytoma, Benign Fibrous",1
31694,Epithelial Component Present,Ethmoid Sinus Squamous Cell Carcinoma,1
31695,Malignant Cellular Infiltrate,Stage B Chronic Lymphocytic Leukemia,1
31696,Carcinomatous Component Present,Squamous cell carcinoma of vagina,1
31697,Malignant Cellular Infiltrate,Stage IA2 Cervical Cancer,1
31698,Breast Implant-Related Lesion,Breast implant-associated anaplastic large cell lymphoma,1
31699,Epithelial Component Present,Glottis Verrucous Carcinoma,1
31700,Carcinomatous Component Present,Recurrent Fibrolamellar Carcinoma,1
31701,Malignant Cellular Infiltrate,Secondary malignant neoplasm of axilla,1
31702,Myxoid Stroma Formation,"Leiomyosarcoma, Myxoid",1
31703,Tumor Vascular Invasion,Malignant Pancreatic Vipoma,1
31704,Malignant Cellular Infiltrate,Thymic Basaloid Carcinoma,1
31705,Malignant Cellular Infiltrate,Osteosarcoma recurrent,1
31706,Epithelial Component Present,Metastatic Breast Carcinoma,1
31707,Malignant Cellular Infiltrate,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
31708,Carcinomatous Component Present,"Carcinoma, Skin Appendage",1
31709,'Starry-sky' pattern,Stage III Adult Burkitt Lymphoma,1
31710,Malignant Cellular Infiltrate,Adult Pleomorphic Hepatocellular Carcinoma,1
31711,Epithelial Component Present,Small cell carcinoma of prostate,1
31712,Malignant Cellular Infiltrate,Marginal Zone Lymphoma by Ann Arbor Stage,1
31713,Malignant Cellular Infiltrate,Metastatic Malignant Neoplasm to the Leptomeninges,1
31714,Immunoglobulin Deposition,Primary amyloidosis,1
31715,Malignant Cellular Infiltrate,Rectal Adenosquamous Carcinoma,1
31716,Malignant Cellular Infiltrate,Recurrent Clear Cell Renal Cell Carcinoma,1
31717,Carcinomatous Component Present,Skin Clear Cell Basal Cell Carcinoma,1
31718,Malignant Cellular Infiltrate,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
31719,Epithelial Component Present,Metastatic Prostate Small Cell Carcinoma,1
31720,Villous atrophy,Immunoproliferative Small Intestinal Disease,1
31721,Recurrent disease,Locally Recurrent Malignant Neoplasm,1
31722,High Mitotic Activity,Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8,1
31723,Malignant Cellular Infiltrate,Squamous cell carcinoma of mouth,1
31724,Pushing Tumor Margin,Lower Gingival Verrucous Carcinoma,1
31725,HMB-45-Positive Neoplastic Cells Present,Benign Lung PEComa,1
31726,Exophytic Papillary Lesion,Buccal Mucosa Verrucous Carcinoma,1
31727,Malignant Cellular Infiltrate,synovial sarcoma,1
31728,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
31729,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
31730,Malignant Cellular Infiltrate,Adult Acute Monocytic Leukemia,1
31731,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage I,1
31732,Indolent Clinical Course,Diffuse Lipomatosis,1
31733,Blue Bone Formation,"Bone Cysts, Aneurysmal",1
31734,Secondary Lesion,Metastatic Esophageal Carcinoma,1
31735,Dysplasia,Esophageal High Grade Intraepithelial Neoplasia,1
31736,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic Lymphadenopathy,1
31737,Carcinomatous Component Present,Stage 0 Esophageal Cancer AJCC v7,1
31738,Carcinomatous Component Present,Cervical Verrucous Carcinoma,1
31739,Malignant Component Present,Sellar Teratoma with Malignant Transformation,1
31740,Epithelial Component Present,Refractory Breast Carcinoma,1
31741,Malignant Cellular Infiltrate,Stage IVA Fallopian Tube Cancer AJCC v8,1
31742,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Adult Non-Hodgkin Lymphoma AJCC v8,1
31743,Epithelial Component Present,Gallbladder squamous cell carcinoma,1
31744,Carcinomatous Component Present,Refractory Head and Neck Carcinoma,1
31745,Carcinomatous Component Present,Skin Nodular Solid Basal Cell Carcinoma,1
31746,Thyroglobulin Positive Neoplastic Cells Present,Papillary thyroid carcinoma,1
31747,Mucocele of appendix,Appendix Mucinous Cystadenoma,1
31748,Malignant Cellular Infiltrate,Adult Acute Promyelocytic Leukemia with PML-RARA,1
31749,progesterone receptor negative,Triple-Negative Breast Carcinoma,1
31750,Cystic Lesion,Unresectable Craniopharyngioma,1
31751,Well Differentiated Neuroendocrine Lesion,Pancreatic Vipoma,1
31752,Delicate Vascular Network Formation,Grade 4 Clear Cell Renal Cell Carcinoma,1
31753,Intermediate Grade Neuroendocrine Lesion,Functioning Pancreatic Neuroendocrine Tumor G2,1
31754,Malignant Cellular Infiltrate,Stage IIB Eyelid Carcinoma AJCC v8,1
31755,Metastatic Lesion,Metastatic Endometrial Carcinoma,1
31756,Malignant Cellular Infiltrate,Orbital lymphoma,1
31757,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor,1
31758,Cystic Change,Vulvar Seborrheic Keratosis,1
31759,Exophytic Polypoid Lesion,Hamartomatous polyposis,1
31760,Adnexal Differentiation,"Acanthoma, Pilar Sheath",1
31761,Tissue Differentiation Uncertain,Alveolar Soft Part Sarcoma,1
31762,Childhood Lesion,Hepatoblastoma resectable,1
31763,Childhood Lesion,Childhood Giant Cell Glioblastoma,1
31764,Epithelial Component Present,Ovarian Insular Carcinoid Tumor,1
31765,Stromal Invasion,Stage IIB Ovarian Cancer AJCC v6 and v7,1
31766,Secondary Lesion,Metastases to abdominal cavity,1
31767,Carcinomatous Component Present,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
31768,Dysplasia,High Grade Gastric Intraepithelial Neoplasia,1
31769,Malignant Cellular Infiltrate,Stage II Oral Cavity Cancer AJCC v6 and v7,1
31770,Carcinomatous Component Present,NUT midline carcinoma,1
31771,Anaplasia,Adult Anaplastic Astrocytoma,1
31772,Well Differentiated Neuroendocrine Lesion,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
31773,Malignant Cellular Infiltrate,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
31774,Epithelial Component Present,Adenomatous polyp of colon,1
31775,Severe dysplasia,Bowen's Disease,1
31776,Exophytic Papillary Lesion,Urethral Verrucous Carcinoma,1
31777,Epithelial Component Present,Masaoka-Koga Stage IIa,1
31778,Malignant Cellular Infiltrate,Stage IVC Colon Cancer AJCC v8,1
31779,Diffuse Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,1
31780,Carcinomatous Component Present,Gastric Mixed Adenoneuroendocrine Carcinoma,1
31781,Malignant Cellular Infiltrate,Stage IV Gallbladder Cancer AJCC v7,1
31782,Epithelial Component Present,Stage IVB Colon Cancer AJCC v7,1
31783,Malignant Cellular Infiltrate,Solid carcinoma,1
31784,Malignant Cellular Infiltrate,Central Nervous System Embryonal Carcinoma,1
31785,Malignant Cellular Infiltrate,Centroblastic lymphoma stage I,1
31786,Epithelial Component Present,Stage II Fallopian Tube Cancer,1
31787,Biphasic Pattern,Cervical Adenofibroma,1
31788,High Grade Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans,1
31789,Perivascular Arrangement of Tumor Cells,Intravascular Angioleiomyoma,1
31790,Adnexal Differentiation,Vulvar Nodular Hidradenoma,1
31791,Well-Circumscribed Lesion,Adenomatous polyp of colon,1
31792,Severe dysplasia,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
31793,Carcinomatous Component Present,Sebaceous Breast Carcinoma,1
31794,Childhood Lesion,Recurrent Childhood Gliosarcoma,1
31795,Epithelial Component Present,"Carcinoma of urinary bladder, superficial",1
31796,Malignant Cellular Infiltrate,Stage III Indolent Adult Non-Hodgkin Lymphoma,1
31797,Low Grade Neuroendocrine Lesion,Small Intestinal Carcinoid Tumor,1
31798,Unresectable Mass,Unresectable Skin Squamous Cell Carcinoma,1
31799,Epithelial Component Present,Stage 0 Rectal Cancer AJCC v6 and v7,1
31800,Malignant Cellular Infiltrate,Mycosis Fungoides by AJCC v7 Stage,1
31801,Slow Growing Painless Mass,calcifying aponeurotic fibroma,1
31802,Epithelial Component Present,Null Cell Pituitary Gland Adenoma,1
31803,Locally Aggressive Lesion,Metastatic Dermatofibrosarcoma Protuberans,1
31804,Carcinomatous Component Present,Stage IV Renal Pelvis Cancer AJCC v8,1
31805,Malignant Cellular Infiltrate,Colorectal Cribriform Comedo-Type Adenocarcinoma,1
31806,Well-Circumscribed Lesion,Ovarian Cystadenoma,1
31807,Epithelial Component Present,Major Salivary Gland Cancer by AJCC v8 Stage,1
31808,Cutaneous Involvement,Recurrent Merkel Cell Carcinoma,1
31809,Carcinomatous Component Present,Childhood Salivary Gland Carcinoma,1
31810,Epithelial Component Present,Luminal A Prostate Carcinoma,1
31811,High Mitotic Activity,Malignant tenosynovial giant cell tumor,1
31812,Diffuse Lesion,Breast Angiomatosis,1
31813,Cutaneous Involvement,Fox Fordyce disease,1
31814,Epithelial Component Present,Adenocarcinoma in situ in adenomatous polyp,1
31815,Dysplasia,Biliary Intraepithelial Neoplasia-3,1
31816,Locally Aggressive Lesion,Inflammatory Myofibroblastic Tumor,1
31817,Benign Cellular Infiltrate,Hamartoma of lung,1
31818,Exophytic Papillary Lesion,Verrucous carcinoma of the oral cavity recurrent,1
31819,Papillary Pattern,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
31820,Borderline Lesion,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
31821,Lytic lesion,Osteoclastic Giant Cell-Rich Tumor of Bone,1
31822,Carcinomatous Component Present,Grade 2 Invasive Breast Carcinoma,1
31823,Nuclear Atypia,Recurrent Childhood Gliosarcoma,1
31824,Monoclonal Cellular Population Present,"Mastocytosis, Systemic",1
31825,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity stage II,1
31826,Malignant Cellular Infiltrate,Favorable Hodgkin Lymphoma,1
31827,Malignant Cellular Infiltrate,Hodgkin's disease lymphocyte depletion type recurrent,1
31828,High Grade Lesion,Childhood Giant Cell Glioblastoma,1
31829,Perivascular Arrangement of Tumor Cells,Solitary Myofibromatosis,1
31830,Mixed Cellular Population,Cystadenofibroma,1
31831,Malignant Cellular Infiltrate,Stage IIIA Cervical Cancer AJCC v8,1
31832,Embryoid Bodies Present,Stage I Ovarian Polyembryoma AJCC v6 and v7,1
31833,Malignant Cellular Infiltrate,Anal Verrucous Carcinoma,1
31834,Organoid Pattern,Alveolar Soft Part Sarcoma,1
31835,Carcinomatous Component Present,Signet-ring cell adenocarcinoma gastric,1
31836,Epithelial Component Present,Stage I Ureter Cancer AJCC v7,1
31837,Carcinomatous Component Present,Metastatic Lung Small Cell Carcinoma,1
31838,Cutaneous Involvement,Acne Keloid,1
31839,Tissue of Mullerian Origin Present,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8,1
31840,Regional Disease,Locally Advanced Squamous Cell Carcinoma,1
31841,Malignant Cellular Infiltrate,Stage IV Penile Cancer AJCC v7,1
31842,Thick-Walled Hyalinized Vessels Present,Benign Mediastinal Psammomatous Schwannoma,1
31843,Epithelial Component Present,Nasal cavity carcinoma,1
31844,Poorly Differentiated Lesion,Sarcomatoid Renal Cell Carcinoma,1
31845,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Black Follicular Adenoma,1
31846,Malignant Cellular Infiltrate,Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
31847,Adulthood Lesion,Stage IV Adult Hodgkin Lymphoma,1
31848,Infiltrative Growth Pattern,Adult Brain Stem Gliosarcoma,1
31849,Carcinomatous Component Present,Stage IIA Appendix Carcinoma AJCC v7,1
31850,Papillary Pattern,Papillary squamous cell carcinoma,1
31851,Malignant Cellular Infiltrate,Hereditary Nonpolyposis Colorectal Cancer,1
31852,Fibrotic Stroma Formation,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
31853,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-3,1
31854,Tissue of Mullerian Origin Present,Broad Ligament Serous Cystadenofibroma,1
31855,Adulthood Lesion,Adult T-Cell Lymphoma/Leukemia,1
31856,Carcinomatous Component Present,Stage IIIA Colon Cancer AJCC v8,1
31857,Epithelial Component Present,Colon Neuroendocrine Neoplasm,1
31858,Carcinomatous Component Present,carcinosarcoma of lung,1
31859,Secondary Lesion,Metastatic Carcinoma in the Adrenal Medulla,1
31860,Lobulated Growth Pattern,Chordoma,1
31861,Malignant Cellular Infiltrate,squamous cell carcinoma of urethra,1
31862,Metastatic/Recurrent Disease,Proximal-Type Epithelioid Sarcoma,1
31863,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage IV,1
31864,Malignant Cellular Infiltrate,Ovarian Lymphoma,1
31865,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Neoplasm,1
31866,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Hypocellular Myelodysplastic Syndrome,1
31867,Epithelial Component Present,Epithelial neoplasm of skin,1
31868,Epithelial Component Present,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
31869,Malignant Cellular Infiltrate,Stage IIA Non-Small Cell Lung Carcinoma AJCC v7,1
31870,Well-Circumscribed Lesion,"Adenoma, Sweat Gland",1
31871,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Smoldering myeloma,1
31872,Invasive Lesion,Invasive Mixed Breast Carcinoma,1
31873,Metaplasia,Bladder squamous cell carcinoma stage IV,1
31874,Carcinomatous Component Present,Human Papillomavirus-Related Cervical Carcinoma,1
31875,Biphasic Pattern,Borderline Ovarian Endometrioid Cystadenofibroma,1
31876,Carcinomatous Component Present,Cloacogenic carcinoma,1
31877,Locally Aggressive Lesion,Atypical Lipoma,1
31878,Carcinomatous Component Present,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
31879,Refractory Disease,Refractory Transformed Non-Hodgkin Lymphoma,1
31880,Malignant Cellular Infiltrate,Laryngeal Mucoepidermoid Carcinoma,1
31881,Biphasic Pattern,Recurrent Childhood Pilocytic Astrocytoma,1
31882,Malignant Cellular Infiltrate,Stage IIA Primary Peritoneal Cancer AJCC v8,1
31883,Malignant Cellular Infiltrate,Stage II Rectosigmoid Cancer AJCC v6,1
31884,Epithelial Component Present,Recurrent Anal Adenocarcinoma,1
31885,Indolent Clinical Course,Cerebral Hemisphere Lipoma,1
31886,Tissue Differentiation Uncertain,Sclerosing PEComa,1
31887,Carcinomatous Component Present,Stage IVC Pharyngeal Carcinoma,1
31888,Angiodestructive Pattern,Pulmonary Lymphomatoid Granulomatosis,1
31889,Low Grade Lesion,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
31890,Histiocytosis,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
31891,Resectable Mass,Bile duct cancer resectable,1
31892,Malignant Cellular Infiltrate,Stage IIIA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
31893,Epithelial Component Present,Benign Sertoli Cell Tumor,1
31894,Vascular Channel Formation,Kaposi's sarcoma of palate,1
31895,Infiltrative Growth Pattern,"Fibromatosis, Aggressive",1
31896,Tissue of Mullerian Origin Present,Stage IIIA Uterine Corpus Adenosarcoma AJCC v8,1
31897,Primary Site Unknown,Carcinoma of unknown primary,1
31898,Epithelial Component Present,Renal Cell Carcinoma,1
31899,Carcinomatous Component Present,Recurrent Endometrial Mixed Cell Adenocarcinoma,1
31900,Epithelial Component Present,Pathologic Stage IA Gastric Cancer AJCC v8,1
31901,Epithelial Component Present,Human Papillomavirus-Related Cervical Squamous Cell Carcinoma,1
31902,Carcinomatous Component Present,large cell neuroendocrine carcinoma of appendix,1
31903,Carcinomatous Component Present,Stage IB Esophageal Cancer AJCC v7,1
31904,Multifocal Lesion,Enchondromatosis,1
31905,Locally Aggressive Lesion,Chest Wall Plexiform Fibrohistiocytic Neoplasm,1
31906,Malignant Cellular Infiltrate,FIGO Stage III Carcinoma of the Fallopian Tube,1
31907,Recurrent disease,Recurrent Childhood Gliosarcoma,1
31908,Carcinomatous Component Present,Stage IV Lung Squamous Cell Carcinoma AJCC v7,1
31909,Epithelial Component Present,Adenocarcinoma of large intestine,1
31910,Malignant Cellular Infiltrate,Small cell lung cancer limited stage,1
31911,Carcinomatous Component Present,Undifferentiated carcinoma of esophagus,1
31912,Intraductal Lesion,High Grade Ductal Breast Carcinoma In Situ,1
31913,Nodular lesions,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
31914,Hyaline Cartilage Differentiation,Grade I Chondrosarcoma,1
31915,In Situ Lesion,Intraductal Cribriform Breast Adenocarcinoma,1
31916,Cutaneous Involvement,Skin Pseudovascular Squamous Cell Carcinoma,1
31917,Malignant Cellular Infiltrate,Malignant Germinative Follicular Epithelium Neoplasm,1
31918,Extensive Stage Lesion,Mesothelioma malignant advanced,1
31919,Adulthood Lesion,Recurrent Adult Acute Lymphoblastic Leukemia,1
31920,Splenomegaly,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
31921,Benign Cellular Infiltrate,Benign neoplasm of appendix,1
31922,Hereditary Lesion,"Neoplastic Syndromes, Hereditary",1
31923,Carcinomatous Component Present,Anal Canal Small Cell Neuroendocrine Carcinoma,1
31924,Adulthood Lesion,Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma,1
31925,High Mitotic Activity,Metastatic Gastric Neuroendocrine Carcinoma,1
31926,Malignant Cellular Infiltrate,adenoid cystic carcinoma of lung,1
31927,Malignant Cellular Infiltrate,Cerebral Hodgkin Lymphoma,1
31928,Epithelial Component Present,Parathyroid Gland Oncocytic Adenoma,1
31929,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma recurrent,1
31930,Malignant Cellular Infiltrate,undifferentiated carcinoma of urethra,1
31931,Neuroectodermal Differentiation,Extracranial Neuroblastoma,1
31932,Recurrent disease,Waldenstrom's macroglobulinemia recurrent,1
31933,Erythroid Precursors 80 Percent or More of Bone Marrow Nucleated Cells,Adult Pure Erythroid Leukemia,1
31934,Malignant Cellular Infiltrate,Stage IIIA Bladder Cancer AJCC v8,1
31935,Malignant Cellular Infiltrate,Squamous cell carcinoma of floor of mouth,1
31936,Mesenchymal Component Present,Breast Phyllodes Tumor,1
31937,Firm mass,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
31938,Malignant Cellular Infiltrate,Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter,1
31939,Malignant Cellular Infiltrate,Papillary serous cystadenocarcinoma,1
31940,Epithelial Component Present,Refractory Primary Peritoneal Carcinoma,1
31941,Immunologic Deficiency Syndromes,HIV-Associated Lymphoproliferative Disorder,1
31942,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Enteric Pattern",1
31943,Mesenchymal Component Present,Carcinoma ex pleomorphic adenoma,1
31944,Dysplasia,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
31945,Papillary Pattern,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
31946,Carcinomatous Component Present,Carcinoma of lung,1
31947,Malignant Cellular Infiltrate,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
31948,Well-Circumscribed Lesion,Gingival fibroepithelial polyp,1
31949,Dysplasia,solid type ductal carcinoma in situ of breast,1
31950,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage II,1
31951,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with High Grade Dysplasia,1
31952,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant",1
31953,Cystic Change,Main Duct Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
31954,Nuclear Pseudoinclusion,Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features,1
31955,Malignant Cellular Infiltrate,Breast Lymphoma,1
31956,Malignant Cellular Infiltrate,Major Salivary Gland Mucoepidermoid Carcinoma,1
31957,Nests of Nevus Cells Resembling Nerve Bundles Present,Neuronevus,1
31958,Malignant Cellular Infiltrate,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
31959,Calcitonin serum level increased,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
31960,Nuclear Atypia,Anaplastic Hemispheric Astrocytoma,1
31961,Malignant Cellular Infiltrate,Pathologic Stage II Esophageal Adenocarcinoma AJCC v8,1
31962,Numerous Stromal Mast Cells Present,Mammary-Type Myofibroblastoma,1
31963,Alternative Fascicle (Bundle) Pattern,leiomyoma of trachea,1
31964,Epithelial Component Present,Benign Ovarian Seromucinous Tumor,1
31965,Epithelial Component Present,Childhood Colorectal Carcinoma,1
31966,Non-Hereditary Lesion,Sporadic Thyroid Gland Medullary Carcinoma,1
31967,Well-Circumscribed Lesion,Serous papillary cystic tumor of borderline malignancy,1
31968,High Mitotic Activity,Central Nervous System Embryonal Carcinoma,1
31969,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Uterine Carcinosarcoma, Heterologous Type",1
31970,Vascular Channel Formation,Cardiac Cavernous Hemangioma,1
31971,Monocytosis,Juvenile Myelomonocytic Leukemia,1
31972,Primary Lesion,Anaplastic Brain Stem Glioma,1
31973,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
31974,Biphasic Pattern,Uterine Corpus Adenosarcoma,1
31975,Human Papillomavirus Negative,Oropharyngeal (p16-Negative) Carcinoma by AJCC v8 Stage,1
31976,Indolent Clinical Course,Steroid Lipomatosis,1
31977,Malignant Cellular Infiltrate,Adult Central Nervous System Choriocarcinoma,1
31978,Hemorrhagic,Cutaneous Radiation-Related Angiosarcoma,1
31979,Papillary Pattern,Papillary tumor of the pineal region,1
31980,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Adrenal Gland Ganglioneuroblastoma, Nodular",1
31981,Mixed Cellular Population,Malignant Mixed Tumor of the Minor Salivary Gland,1
31982,Borderline Lesion,Grade I Lymphomatoid Granulomatosis,1
31983,Exposure to asbestos,Asbestos-Related Lung Disorder,1
31984,Cutaneous Involvement,Basal cell carcinoma - follicular,1
31985,Malignant Cellular Infiltrate,Stage IV Childhood Anaplastic Large Cell Lymphoma,1
31986,Epithelial Component Present,Lung Lymphoepithelioma-Like Carcinoma,1
31987,Secondary Lesion,Metastatic leiomyosarcoma,1
31988,Epithelial Component Present,Pancreatic Solid Serous Adenoma,1
31989,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma,1
31990,Cutaneous Involvement,Lentigo simplex,1
31991,Malignant Cellular Infiltrate,Malignant odontogenic tumor,1
31992,Hypokalemia,Malignant Pancreatic Vipoma,1
31993,Cutaneous Involvement,Benign epithelial neoplasm of skin,1
31994,Malignant Cellular Infiltrate,Large B-cell lymphoma with IRF4 rearrangement,1
31995,Malignant Cellular Infiltrate,Childhood Acute Myelomonocytic Leukemia,1
31996,Cutaneous Involvement,Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
31997,Well-Circumscribed Lesion,Fibrous polyp,1
31998,Adnexal Differentiation,Neoplasm of skin with adnexal differentiation,1
31999,Non-Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
32000,Villous Pattern,Tubulovillous adenoma of rectum,1
32001,Trichoblastic Differentiation,Trichoepithelioma,1
32002,Epithelial Component Present,Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
32003,Vascular Channel Formation,Childhood Conventional Osteosarcoma,1
32004,Malignant Cellular Infiltrate,BCLC Stage B Adult Hepatocellular Carcinoma,1
32005,Malignant Cellular Infiltrate,Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
32006,Indolent Clinical Course,Esophageal hemangioma,1
32007,Lipomatous Component Present,Thymus Lipofibroadenoma,1
32008,Malignant Cellular Infiltrate,Stage III Small Intestinal Adenocarcinoma AJCC v8,1
32009,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer,1
32010,Vascular Channel Formation,Childhood Epithelioid Hemangioendothelioma,1
32011,Malignant Cellular Infiltrate,Disseminated neuroblastoma,1
32012,Malignant Cellular Infiltrate,undifferentiated carcinoma of pancreas,1
32013,Malignant Cellular Infiltrate,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
32014,Malignant Cellular Infiltrate,small cell carcinoma of ureter,1
32015,Increased Cellularity Present,Uterine Corpus Apoplectic Leiomyoma,1
32016,Cutaneous Involvement,Compound nevus of skin,1
32017,Antoni A Pattern,Neurilemmoma,1
32018,Malignant Cellular Infiltrate,Adult Acute Myeloid Leukemia without Maturation,1
32019,Papillary Pattern,Infiltrating papillary adenocarcinoma,1
32020,Refractory Disease,Refractory Aggressive NK-Cell Leukemia,1
32021,Metastatic Lesion,Carcinoma bone,1
32022,Malignant Cellular Infiltrate,Burkitt's tumor of spleen,1
32023,Invasive Lesion,"Invasive Lobular Breast Carcinoma, Signet Ring Variant",1
32024,Malignant Cellular Infiltrate,Marginal zone lymphoma stage III,1
32025,Perineural spread,Adenoid cystic carcinoma of the oral cavity stage II,1
32026,Immunosuppression-Related Post-Transplant Toxicity,Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder,1
32027,Malignant Cellular Infiltrate,Recurrent Giant Cell Glioblastoma,1
32028,Favorable Clinical Outcome,Lymphomatoid Papulosis with Chromosome 6p25 Rearrangement,1
32029,Acquired Lesion,Hemangioma acquired,1
32030,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma,1
32031,Malignant Cellular Infiltrate,Stage 0 Lip Carcinoma,1
32032,Recurrent disease,Plasma cell myeloma recurrent,1
32033,Intracanalicular Growth Pattern,Prostate Phyllodes Tumor,1
32034,Primary Lesion,Childhood Meningeal Melanoma,1
32035,High Grade Lesion,Occult Lung Small Cell Carcinoma,1
32036,Malignant Cellular Infiltrate,Secondary malignant neoplasm of female breast,1
32037,Indolent Clinical Course,"Uterine Corpus Leiomyoma, Mitotically Active Variant",1
32038,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),1
32039,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
32040,Malignant Cellular Infiltrate,Osteosarcoma localised,1
32041,Recurrent disease,Recurrent Ovarian Germ Cell Tumor,1
32042,Hyperplastic Tissue Present,Nodular Bartholin Gland Hyperplasia,1
32043,Carcinomatous Component Present,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
32044,Epithelial Component Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
32045,Pathologic TNM Finding,Pathologic Stage IV Gastric Cancer AJCC v8,1
32046,Malignant Cellular Infiltrate,Malignant neoplasm of retina,1
32047,Epithelial Component Present,Erosive Adenomatosis of the Nipple,1
32048,Well-Circumscribed Lesion,Adenomatoid tumor of epididymis,1
32049,Non-Malignant Cellular Infiltrate,Histiocytic Necrotizing Lymphadenitis,1
32050,Childhood Lesion,Childhood Neuroblastoma,1
32051,Carcinomatous Component Present,Cervical Squamous Cell Carcinoma In Situ,1
32052,Malignant Cellular Infiltrate,Adenocarcinoma in tubulovillous adenoma,1
32053,Angiodestructive Pattern,Cutaneous Lymphomatoid Granulomatosis,1
32054,Malignant Cellular Infiltrate,Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
32055,Malignant Cellular Infiltrate,Refractory Ovarian Carcinoma,1
32056,Carcinomatous Component Present,Stage IIIB Hepatocellular Carcinoma AJCC v7,1
32057,Epithelial Component Present,Stage III Breast Cancer AJCC v6,1
32058,In Situ Lesion,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
32059,Epithelial Component Present,AIDS-Related Carcinoma,1
32060,Benign Cellular Infiltrate,Mature Ganglioneuroma,1
32061,Recurrent disease,Recurrent Childhood T Acute Lymphoblastic Leukemia,1
32062,Anaplasia,"Glioblastoma, IDH-Mutant",1
32063,Radiation Sickness,Cutaneous Radiation-Related Angiosarcoma,1
32064,Biphasic Pattern,Vaginal Adenosarcoma,1
32065,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
32066,Exophytic Polypoid Lesion,tubular adenoma of gallbladder,1
32067,Stromal Invasion,Stage IA Ovarian Cancer,1
32068,Adulthood Lesion,Stage IIIA Adult Liver Cancer AJCC v7,1
32069,Epithelial Component Present,"Carcinoma bladder stage I, without cancer in situ",1
32070,Carcinomatous Component Present,Refractory Hormone Receptor Positive Breast Carcinoma,1
32071,Regional Disease,Locally Advanced Sarcoma,1
32072,Low Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma,1
32073,Malignant Cellular Infiltrate,Prostate cancer stage C,1
32074,Refractory Disease,Refractory Diffuse Intrinsic Pontine Glioma,1
32075,Epithelial Component Present,Parotid Gland Carcinoma,1
32076,Malignant Cellular Infiltrate,Anaplastic small cell lymphoma,1
32077,Childhood Lesion,Childhood Leukemia,1
32078,Benign Cellular Infiltrate,Serous adenofibroma,1
32079,Bone Marrow Lymphoplasmacytic Infiltration of Less than 10%,IgM monoclonal gammopathy of uncertain significance,1
32080,Multinodular Mass,Central Nervous System Angiosarcoma,1
32081,Malignant Cellular Infiltrate,Stage II Thyroid Gland Follicular Carcinoma AJCC v8,1
32082,Perivascular Arrangement of Tumor Cells,Kidney Epithelioid Type Angiomyolipoma,1
32083,Locally Aggressive Lesion,Intermediate (Locally Aggressive) Blood Vessel Neoplasm,1
32084,Histiocytosis,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
32085,Malignant Cellular Infiltrate,Primary malignant neoplasm,1
32086,Carcinomatous Component Present,Cervical Lymphoepithelioma-Like Carcinoma,1
32087,Malignant Cellular Infiltrate,"Adenocarcinoma of lung, stage III",1
32088,"Fully Differentiated ""Adult-Type"" Tissues Present",Sellar Immature Teratoma,1
32089,Malignant Cellular Infiltrate,Locally Advanced Basal Cell Carcinoma,1
32090,Benign Cellular Infiltrate,Ovarian Cellular Fibroma,1
32091,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v8,1
32092,HMB-45-Positive Neoplastic Cells Present,Hepatic Angiomyolipoma,1
32093,Exophytic Polypoid Lesion,Rectal polyp,1
32094,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
32095,Carcinomatous Component Present,Cholangiocarcinoma metastatic,1
32096,Peripheral Blood Involvement,Acute Adult T-Cell Leukemia/Lymphoma,1
32097,Malignant Cellular Infiltrate,Submandibular Gland Undifferentiated Carcinoma,1
32098,Epithelial Component Present,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
32099,Epithelial Component Present,Refractory Lung Small Cell Carcinoma,1
32100,Benign Cellular Infiltrate,Sellar Mature Teratoma,1
32101,Secondary Lesion,Metastatic Malignant Solid Neoplasm,1
32102,Malignant Cellular Infiltrate,Cervical Yolk Sac Tumor,1
32103,Adulthood Lesion,Adult Clear Cell Sarcoma of Soft Parts,1
32104,Malignant Cellular Infiltrate,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8,1
32105,Malignant Cellular Infiltrate,Lip basal cell carcinoma,1
32106,Carcinomatous Component Present,Stage IV Hypopharyngeal Carcinoma AJCC v6,1
32107,Immunoglobulin Deposition,Primary amyloidosis,1
32108,Exophytic Polypoid Lesion,Fundic gland polyp,1
32109,Monomorphic Cellular Infiltrate,Nasopharyngeal Basaloid Squamous Cell Carcinoma,1
32110,Dense Intercellular Reticulin Network Present,Supratentorial Pleomorphic Xanthoastrocytoma,1
32111,Cutaneous Involvement,eccrine adenocarcinoma of vulva,1
32112,Carcinomatous Component Present,Stage IV Oropharyngeal Carcinoma,1
32113,Tubular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
32114,Epithelial Component Present,Metastatic Cervical Carcinoma,1
32115,Primary Lesion,Anaplastic Hemispheric Astrocytoma,1
32116,Keratin pearl formation,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
32117,Cutaneous Involvement,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
32118,Acanthosis,Upper Gingival Verrucous Carcinoma,1
32119,Malignant Cellular Infiltrate,Stage II Acral Lentiginous Melanoma AJCC v6 and v7,1
32120,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1),1
32121,Recurrent disease,Non-small cell lung cancer recurrent,1
32122,Papillary Pattern,Borderline Ovarian Serous Cystadenofibroma,1
32123,Recurrent disease,Recurrent Grade II Lymphomatoid Granulomatosis,1
32124,Malignant Cellular Infiltrate,Lugano Classification Stage IV Adult Non-Hodgkin Lymphoma AJCC v8,1
32125,Secondary Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
32126,Benign Cellular Infiltrate,"Testicular Sertoli Cell Tumor, Lipid Rich Variant",1
32127,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
32128,Carcinomatous Component Present,Stage 0is Ureter Cancer AJCC v8,1
32129,Malignant Cellular Infiltrate,Neonatal leukemia,1
32130,Malignant Cellular Infiltrate,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,1
32131,Metaplasia of Malignant Cells Present,Breast Carcinoma with Chondroid Metaplasia,1
32132,Malignant Cellular Infiltrate,Malignant tumor of exocrine pancreas,1
32133,Exophytic Polypoid Lesion,Neoplastic Polyp,1
32134,Extensive Stage Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
32135,Cutaneous Involvement,"Cutaneous Fibrous Histiocytoma, Epithelioid Variant",1
32136,Dermal Involvement,Deep Penetrating Nevus,1
32137,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Inverted Variant",1
32138,Infiltrative Growth Pattern,Childhood Gemistocytic Astrocytoma,1
32139,Osseous Component Present,Osteochondromyxoma,1
32140,Malignant Cellular Infiltrate,Lugano Classification Adult Lymphoma by AJCC v8 Stage,1
32141,Intermediate Filaments Present,Recurrent Rhabdoid Tumor,1
32142,Systemic disease,Multi-centric Castleman's Disease,1
32143,Epithelial Component Present,Esophageal Neuroendocrine Tumor G1,1
32144,Malignant Cellular Infiltrate,Stage II Anaplastic Large Cell Lymphoma,1
32145,Malignant Cellular Infiltrate,Endometrioid adenocarcinoma recurrent,1
32146,Epithelial Component Present,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,1
32147,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma,1
32148,Benign Cellular Infiltrate,Inner Ear Lipoma,1
32149,Carcinomatous Component Present,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,1
32150,Mesenchymal Differentiation,Mixed epithelial-mesenchymal hepatoblastoma,1
32151,Nuclear Atypia,Diencephalic Glioblastoma,1
32152,Pregnancy Complications,"Placenta, Retained",1
32153,Malignant Cellular Infiltrate,Stage I Diffuse Large B-Cell Lymphoma,1
32154,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
32155,Malignant Cellular Infiltrate,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),1
32156,Malignant Cellular Infiltrate,Vaginal Cancer by AJCC v7 Stage,1
32157,Primary Lesion,Adult Pleomorphic Hepatocellular Carcinoma,1
32158,Mixed Cellular Population,Cystadenofibroma of fallopian tube,1
32159,Malignant Cellular Infiltrate,Advanced Small Intestinal Neuroendocrine Carcinoma,1
32160,Favorable Clinical Outcome,Adrenal Gland Ganglioneuroma,1
32161,Papillary Pattern,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
32162,Carcinomatous Component Present,Acinic cell carcinoma of salivary gland,1
32163,Malignant Cellular Infiltrate,Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
32164,Perivascular Lymphocytic Infiltrate,Cutaneous pseudolymphoma,1
32165,Carcinomatous Component Present,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
32166,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage III,1
32167,Mild cytologic atypia,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
32168,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage 0,1
32169,Glomeruloid Vessels Present,Recurrent Childhood Pilocytic Astrocytoma,1
32170,Pathologic TNM Finding,Pathologic Stage IV Gastric Cancer AJCC v8,1
32171,Severe dysplasia,Carcinoma in Situ,1
32172,Indolent Clinical Course,Degeneration of uterine fibroid,1
32173,Carcinomatous Component Present,Cecum Carcinoma,1
32174,Epithelial Component Present,Stage IVB Vulvar Cancer AJCC v8,1
32175,Cutaneous Involvement,Clinical Stage IIA Cutaneous Melanoma AJCC v8,1
32176,Malignant Cellular Infiltrate,Localized Ewing Sarcoma,1
32177,Cambium Layer,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
32178,Slow Growing Mass,Recurrent Ependymoma,1
32179,Cutaneous Involvement,Cutaneous Leiomyosarcoma,1
32180,Epithelial Component Present,Colorectal Cancer by AJCC v6 Stage,1
32181,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
32182,Malignant Cellular Infiltrate,B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH,1
32183,Cytologic atypia,Anaplastic Astroblastoma,1
32184,Neuroendocrine Differentiation,Stage III Duodenal Neuroendocrine Tumor AJCC v8,1
32185,Malignant Cellular Infiltrate,Treatment related acute myeloid leukaemia,1
32186,Malignant Cellular Infiltrate,Refractory Malignant Brain Neoplasm,1
32187,Absence of a Hormonal Syndrome,Non-Functioning Pituitary Gland Neoplasm,1
32188,Malignant Cellular Infiltrate,Oncocytic Breast Carcinoma,1
32189,Well-Circumscribed Lesion,Bile duct adenoma,1
32190,Malignant Cellular Infiltrate,Malignant Sternal Neoplasm,1
32191,Transformed Phase of Disease,Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma,1
32192,Epithelial Component Present,Carcinoma in situ of vagina,1
32193,Well Differentiated Neuroendocrine Lesion,Colorectal Neuroendocrine Tumor G2,1
32194,High Mitotic Activity,"Endometrial stromal sarcoma, high grade",1
32195,Malignant Cellular Infiltrate,Epithelial Predominant Kidney Wilms Tumor,1
32196,Carcinomatous Component Present,Stage IIB Ovarian Cancer AJCC v6 and v7,1
32197,Secondary Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
32198,Epithelial Component Present,Preinvasive Neoplasm of the Ampullary Region,1
32199,Recurrent disease,Recurrent Transformed Chronic Lymphocytic Leukemia,1
32200,Mixed Cellular Population,Stage I Kidney Wilms Tumor,1
32201,Epithelial Component Present,Refractory Bile Duct Carcinoma,1
32202,Malignant Cellular Infiltrate,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
32203,Malignant Cellular Infiltrate,Cervical Adenocarcinoma,1
32204,Carcinomatous Component Present,Upper Gingival Verrucous Carcinoma,1
32205,Ineffective hematopoiesis,de novo Myelodysplastic Syndrome,1
32206,Neuroendocrine Differentiation,Thymic Small Cell Carcinoma,1
32207,Recurrent disease,Recurrent Digestive System Carcinoma,1
32208,Malignant Cellular Infiltrate,Childhood Undifferentiated Pleomorphic Sarcoma,1
32209,Recurrent disease,Recurrent Childhood Optic Nerve Astrocytoma,1
32210,Carcinomatous Component Present,Gallbladder Cribriform Carcinoma,1
32211,Epithelial Component Present,Extrahepatic Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,1
32212,Malignant Cellular Infiltrate,Intracranial Germinoma,1
32213,Preserved Nuclear Polarity,Renal Pelvis Urothelial Papilloma,1
32214,Well-Circumscribed Lesion,Colon Hyperplastic Polyp,1
32215,Epithelial Component Present,Unresectable Bladder Urothelial Carcinoma,1
32216,High Grade Lesion,Chondroblastic osteosarcoma,1
32217,Mitotic Activity,Recurrent Childhood Pilomyxoid Astrocytoma,1
32218,Secondary Lesion,Secondary Central Nervous System Lymphoma,1
32219,Epithelial Component Present,Biliary Intraepithelial Neoplasia-3,1
32220,Carcinomatous Component Present,Unresectable Renal Pelvis Urothelial Carcinoma,1
32221,Hyaline Cartilage Differentiation,Childhood Mesenchymal Chondrosarcoma,1
32222,Carcinomatous Component Present,Stage IVA Gallbladder Cancer AJCC v8,1
32223,Carcinomatous Component Present,Stage IIIA Ovarian Cancer AJCC v6 and v7,1
32224,High Mitotic Activity,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
32225,Carcinomatous Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
32226,Malignant Cellular Infiltrate,Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
32227,Antoni A Pattern,Degenerated Schwannoma,1
32228,Epithelial Component Present,Stage I Jejunal Neuroendocrine Tumor AJCC v8,1
32229,Malignant Cellular Infiltrate,Choriocarcinoma of ovary,1
32230,Epithelial Component Present,Densely Granulated Somatotroph Adenoma,1
32231,Cartilaginous Differentiation,Intermediate Chondrogenic Neoplasm,1
32232,In Situ Lesion,Intraductal Cribriform Breast Adenocarcinoma,1
32233,Hereditary Lesion,Familial Acute Myeloid Leukemia with Mutated Cebpa,1
32234,Primary Lesion,Meningeal melanomatosis,1
32235,Anaplasia,Brain Glioblastoma,1
32236,Cervical lymphadenopathy,Sinus histiocytosis,1
32237,Malignant Cellular Infiltrate,Stage IIIA Appendix Carcinoma AJCC v7,1
32238,Well-Circumscribed Lesion,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
32239,Malignant Cellular Infiltrate,Adrenocortical carcinoma,1
32240,Epithelial Component Present,squamous cell carcinoma of ovary,1
32241,Epithelial Component Present,Large cell lung cancer stage III,1
32242,Benzene Exposure,Benzene-Related Acute Myeloid Leukemia,1
32243,Epithelial Component Present,Fallopian Tube Squamous Cell Carcinoma,1
32244,Malignant Cellular Infiltrate,Extracranial Neuroblastoma,1
32245,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-cell lymphoma recurrent,1
32246,Malignant Cellular Infiltrate,Clinical Stage 0 Cutaneous Melanoma AJCC v8,1
32247,Papillary Pattern,Glottis Verrucous Carcinoma,1
32248,High Mitotic Activity,Small cell lung cancer extensive stage,1
32249,Malignant Cellular Infiltrate,Stage II Adult Hodgkin Lymphoma,1
32250,Epithelial Component Present,Pyloric Gland Adenoma,1
32251,Malignant Cellular Infiltrate,Stage I Nasal Cavity Cancer AJCC v6 and v7,1
32252,Indolent Clinical Course,Benign neoplasm of body of uterus,1
32253,Carcinomatous Component Present,Stage II Distal Bile Duct Cancer AJCC v8,1
32254,Calcitonin serum level increased,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
32255,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
32256,Epithelial Component Present,Broad Ligament Papillary Cystadenoma,1
32257,Diffuse Pattern,Epithelioid Malignant Peripheral Nerve Sheath Tumor,1
32258,Exophytic Polypoid Lesion,Juvenile Polyp of the Small Intestine,1
32259,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor by AJCC v8 Stage,1
32260,Epithelial Component Present,Chromophobe Renal Cell Carcinoma,1
32261,Epithelial Component Present,Thymoma malignant invasive,1
32262,In Situ Lesion,Stage 0is Urethral Cancer AJCC v8,1
32263,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
32264,Metastatic/Recurrent Disease,Adult Alveolar Soft Part Sarcoma,1
32265,Malignant Cellular Infiltrate,Plasma Cell Myeloma by DS Stage,1
32266,Epithelial Component Present,Stage IIB Vaginal Cancer AJCC v8,1
32267,Carcinomatous Component Present,Ceruminous adenocarcinoma,1
32268,Non-Invasive Lesion,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
32269,Precise Histogenesis Unknown,Spinal hemangioblastoma,1
32270,Resectable Mass,Pancreatic adenocarcinoma resectable,1
32271,Epithelial Component Present,Uterine Ligament Endometrioid Adenocarcinoma,1
32272,Epithelial Component Present,Stage IIIB Colorectal Cancer AJCC v7,1
32273,Carcinomatous Component Present,Stage IVB Basal Cell Lip Carcinoma,1
32274,Well-Circumscribed Lesion,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
32275,Epithelial Component Present,Ovarian adenocarcinoma,1
32276,Absence of Invasion,Lobular Neoplasia Type A,1
32277,Fibrotic Stroma Formation,Granular cell ameloblastoma,1
32278,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant",1
32279,Metastatic Lesion,Transitional cell cancer of renal pelvis and ureter metastatic,1
32280,Anaplasia,Lung Spindle Cell Carcinoma,1
32281,Tissue of Mullerian Origin Present,Uterine Ligament Adenosarcoma,1
32282,High Grade Lesion,Dedifferentiated Dermatofibrosarcoma Protuberans,1
32283,Increased Cellularity Present,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
32284,Epithelial Component Present,"Cystadenocarcinoma, Mucinous",1
32285,Epithelial Component Present,Stage IB Lung Cancer AJCC v8,1
32286,Malignant Cellular Infiltrate,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8,1
32287,Malignant Cellular Infiltrate,Refractory Carcinoma,1
32288,Benign Cellular Infiltrate,Ganglioneuroma of mediastinum,1
32289,Epithelial Component Present,Lipid-rich carcinoma,1
32290,Epithelial Component Present,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
32291,Epithelial Component Present,Papillary carcinoma in situ,1
32292,Epithelial Component Present,Small Intestinal Gangliocytic Paraganglioma,1
32293,Absence of Invasion,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
32294,Benign Cellular Infiltrate,Cellular Blue Nevus,1
32295,Malignant Cellular Infiltrate,Stage IIA Uveal Melanoma AJCC v7,1
32296,Therapy-Related Toxicity,Transplant-Related Hepatocellular Carcinoma,1
32297,Carcinomatous Component Present,Stage IIB Breast Carcinoma,1
32298,Malignant Cellular Infiltrate,Pericardial Angiosarcoma,1
32299,Absence of Invasion,Adenoma of ampulla of Vater,1
32300,Intraductal Lesion,Pancreatic Intraductal Neoplasms,1
32301,Carcinomatous Component Present,Advanced Bile Duct Carcinoma,1
32302,Malignant Cellular Infiltrate,Bladder cancer recurrent,1
32303,Epithelial Component Present,"Carcinoma, diffuse type",1
32304,Malignant Cellular Infiltrate,Malignant Placental Neoplasm,1
32305,Refractory Disease,Refractory WHO Grade III Glioma,1
32306,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
32307,Malignant Cellular Infiltrate,Metastatic Kidney Medullary Carcinoma,1
32308,Carcinomatous Component Present,Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
32309,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II,1
32310,Pushing Tumor Margin,Subglottic Verrucous Carcinoma,1
32311,Epithelial Component Present,Hormone Receptor Positive Breast Carcinoma,1
32312,Acanthosis,Lower Gingival Verrucous Carcinoma,1
32313,Malignant Cellular Infiltrate,Stage II Osteosarcoma AJCC v7,1
32314,Malignant Cellular Infiltrate,Recurrent Clear Cell Renal Cell Carcinoma,1
32315,Benign Cellular Infiltrate,Calcifying Odontogenic Cyst,1
32316,Epithelial Component Present,Breast Carcinoma Metastatic in the Liver,1
32317,Benign Cellular Infiltrate,Aggressive angiomyxoma,1
32318,Tissue of Mullerian Origin Present,"Cervical Adenomyoma, Endometrial Type",1
32319,Malignant Cellular Infiltrate,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
32320,Epithelial Component Present,Gallbladder adenocarcinoma,1
32321,Low Mitotic Activity,Stage IIB Colorectal Neuroendocrine Tumor AJCC v8,1
32322,Secondary Lesion,stage IV pancreatic cancer,1
32323,Malignant Cellular Infiltrate,Acute myeloid leukemia with multilineage dysplasia,1
32324,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma with Papillary Hyperplasia,1
32325,Nuclear pleomorphism,Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
32326,Epithelial Component Present,Stage 0 Penile Cancer AJCC v6,1
32327,Carcinomatous Component Present,Stage IIIC Appendix Carcinoma AJCC v8,1
32328,Epithelial Component Present,Refractory Endometrial Carcinoma,1
32329,Carcinomatous Component Present,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
32330,Firm mass,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
32331,Neuroendocrine Differentiation,Carcinoid tumor of the liver,1
32332,Follicular Cell Differentiation,Familial Nonmedullary Thyroid Gland Carcinoma,1
32333,Epithelial Component Present,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
32334,Skin Papule,Desmoplastic trichoepithelioma,1
32335,High Mitotic Activity,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
32336,Diffuse Pattern,Childhood Brain Glioblastoma,1
32337,Necrotic changes (finding),Neural Glioblastoma,1
32338,Neuroendocrine Differentiation,Malignant carcinoid tumor of lung,1
32339,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia- Modified Rai Staging System,1
32340,Benign Cellular Infiltrate,Subungual exostoses,1
32341,Intracanalicular Growth Pattern,Malignant Cystosarcoma Phyllodes,1
32342,Angiodestructive Pattern,Recurrent Childhood Grade III Lymphomatoid Granulomatosis,1
32343,Malignant Cellular Infiltrate,Carcinoma breast stage I,1
32344,Mass of body structure,Cardiac Myeloid Sarcoma,1
32345,High Grade Lesion,Spindle Cell/Sclerosing Rhabdomyosarcoma,1
32346,Diffuse Pattern,Stage I Diffuse Large B-Cell Lymphoma,1
32347,Well Differentiated Hyaline Cartilage Present,Mesenchymal Chondrosarcoma,1
32348,Well-Circumscribed Lesion,Tubulovillous adenoma of rectum,1
32349,Benign Cellular Infiltrate,Thyroid Gland Follicular Adenoma,1
32350,Hemosiderin pigmentation,"Histiocytoma, Angiomatoid Fibrous",1
32351,Malignant Cellular Infiltrate,Secondary malignant neoplasm of lymph node,1
32352,Fever,Sinus histiocytosis,1
32353,Exophytic Polypoid Lesion,Rectal polyp,1
32354,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma refractory,1
32355,Above the Diaphragm Disease,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
32356,Bone Marrow Dysplasia Present,Therapy-related myelodysplastic syndrome,1
32357,Benign Cellular Infiltrate,Right atrial myxoma,1
32358,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
32359,Monoclonal Cellular Population Present,Clonal Hematopoiesis of Indeterminate Potential,1
32360,Epithelial Component Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
32361,Carcinomatous Component Present,Pathologic Stage 0 Merkel Cell Carcinoma AJCC v8,1
32362,Severe cytologic atypia,Pleomorphic Rhabdomyosarcoma,1
32363,Tissue of Mullerian Origin Present,Ovarian Mucinous Adenofibroma,1
32364,Extensive Stage Lesion,Advanced Adult Hepatocellular Carcinoma,1
32365,Childhood Lesion,Childhood Central Nervous System Mature Teratoma,1
32366,Acquired Lesion,"Nose Deformities, Acquired",1
32367,Malignant Cellular Infiltrate,Recurrent Atypical Teratoid/Rhabdoid Tumor,1
32368,Carcinomatous Component Present,Stage IIIA Ovarian Cancer AJCC v8,1
32369,Immunologic Deficiency Syndromes,Chronic Allograft Arteriopathy,1
32370,Malignant Cellular Infiltrate,Pancreatic Hepatoid Adenocarcinoma,1
32371,Epithelial Component Present,mucinous adenocarcinoma of salivary gland,1
32372,Malignant Cellular Infiltrate,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
32373,High Grade Lesion,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
32374,Recurrent disease,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
32375,Metastatic/Recurrent Disease,Cardiac Synovial Sarcoma,1
32376,Cribriform Pattern,Colon Cribriform Comedo-Type Adenocarcinoma,1
32377,High Mitotic Activity,Stage 0 Merkel Cell Carcinoma AJCC v7,1
32378,Bone Marrow and Blood Involvement,Burkitt Leukemia,1
32379,High Grade Lesion,MGMT-Methylated Glioblastoma,1
32380,Malignant Cellular Infiltrate,Stage IIIB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
32381,High Grade Lesion,rhabdomyosarcoma of liver,1
32382,Cutaneous Involvement,Breast Carcinoma Metastatic in the Skin,1
32383,Proliferation of High Endothelial Venules Present,Angioimmunoblastic T-Cell Lymphoma by Ann Arbor Stage,1
32384,Chromogranin A Positive Neoplastic Cells Present,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",1
32385,Nuclear Atypia,"Anaplastic Astrocytoma, IDH-Mutant",1
32386,Dysplasia,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,1
32387,Alternative Fascicle (Bundle) Pattern,Ureter Leiomyoma,1
32388,High Grade Lesion,Pleural Biphasic Synovial Sarcoma,1
32389,Malignant Cellular Infiltrate,Stage III Kidney Wilms Tumor,1
32390,Primary Lesion,Stage IB Osteosarcoma AJCC v7,1
32391,Malignant Cellular Infiltrate,Stage IA1 Cervical Cancer AJCC v8,1
32392,Carcinomatous Component Present,"Basal cell carcinoma, infundibulocystic",1
32393,Carcinomatous Component Present,Bartholin Gland Adenocarcinoma,1
32394,Nuclear Expression of STAT6 Protein,Thyroid Gland Solitary Fibrous Tumor,1
32395,Malignant Cellular Infiltrate,Malignant Mesothelioma of Peritoneum,1
32396,Metastatic Lesion,Secondary malignant neoplasm of retina,1
32397,Vascular Channel Formation,"Hemangioma, Cavernous",1
32398,Perineural spread,Desmoplastic Neurotropic Melanoma,1
32399,Malignant Cellular Infiltrate,Stage III Soft Tissue Sarcoma AJCC v7,1
32400,Local disease,Pagetoid reticulosis,1
32401,Epithelial Component Present,Rectosigmoid cancer recurrent,1
32402,Malignant Cellular Infiltrate,Stage II Intrahepatic Cholangiocarcinoma AJCC v7,1
32403,Carcinomatous Component Present,Stage IIB Primary Peritoneal Cancer AJCC v8,1
32404,Follicular Cell Differentiation,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
32405,Monomorphic Cellular Infiltrate,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
32406,Malignant Cellular Infiltrate,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
32407,Malignant Cellular Infiltrate,Neuroendocrine cervical carcinoma,1
32408,Thyroglobulin Positive Neoplastic Cells Present,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
32409,Necrotic changes (finding),Refractory Lung Small Cell Carcinoma,1
32410,Epithelial Component Present,Densely Granulated Somatotroph Adenoma,1
32411,Epithelial Component Present,Carcinoma of glottis,1
32412,Epithelial Component Present,Stage 0 Lip and Oral Cavity Cancer AJCC v6 and v7,1
32413,Refractory Disease,Plasma cell myeloma refractory,1
32414,Immunologic Deficiency Syndromes,Hyperacute allograft rejection,1
32415,Carcinomatous Component Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
32416,Primary Lesion,Recurrent Childhood Cerebellar Astrocytoma,1
32417,HMB-45-Positive Neoplastic Cells Present,Malignant Uterine Corpus PEComa,1
32418,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
32419,Lymphoplasmacytic Infiltrate,Nasopharyngeal lymphoepithelioma stage IV,1
32420,Epithelial Component Present,Transverse Colon Neuroendocrine Tumor G1,1
32421,Invasive Lesion,Invasive carcinoma of breast,1
32422,Carcinomatous Component Present,Human Papillomavirus-Related Adenocarcinoma,1
32423,Malignant Cellular Infiltrate,Central Nervous System Extraskeletal Osteosarcoma,1
32424,Adulthood Lesion,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8,1
32425,Well-Circumscribed Lesion,Anal Inflammatory Cloacogenic Polyp,1
32426,Recurrent disease,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
32427,Malignant Cellular Infiltrate,Stage IV Penile Cancer AJCC v7,1
32428,Secondary Lesion,Treatment related acute myeloid leukaemia,1
32429,Malignant Cellular Infiltrate,Stage IIIA Eyelid Carcinoma AJCC v8,1
32430,Immunologic Deficiency Syndromes,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
32431,Invasive Lesion,Squamous cell breast carcinoma,1
32432,Malignant Cellular Infiltrate,Stage IVB Appendix Carcinoma AJCC v8,1
32433,Immunologic Deficiency Syndromes,AIDS-Related Anal Carcinoma,1
32434,Osseous metaplasia,Adenocarcinoma with osseous metaplasia,1
32435,Regional Disease,Locally Advanced Chordoma,1
32436,Epithelial Component Present,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
32437,Primary Site Unknown,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
32438,Carcinomatous Component Present,Small Intestinal Undifferentiated Carcinoma,1
32439,Epithelial Component Present,Stage IVA Cervical Cancer AJCC v8,1
32440,Benign Cellular Infiltrate,Benign neoplasm of ear,1
32441,Malignant Cellular Infiltrate,Anal margin basal cell carcinoma,1
32442,Benign Cellular Infiltrate,Polyp in nasopharynx,1
32443,Epithelial Component Present,Refractory Endometrial Endometrioid Adenocarcinoma,1
32444,Malignant Cellular Infiltrate,Small intestine carcinoma recurrent,1
32445,Nuclear pleomorphism,Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
32446,Malignant Cellular Infiltrate,Inflammatory carcinoma of breast stage IV,1
32447,Vascular Channel Formation,Glomeruloid hemangioma,1
32448,Metastatic Lesion,Metastatic Gastroesophageal Junction Adenocarcinoma,1
32449,Nuclear Pseudoinclusion,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
32450,Nodular Pattern,Ovarian Myxoid Liposarcoma,1
32451,Secondary Lesion,Reactive systemic amyloidosis,1
32452,Cribriform Pattern,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
32453,Well-Circumscribed Lesion,Colorectal Adenoma with Mild Dysplasia,1
32454,Epithelial Component Present,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
32455,Epithelial Component Present,Adenocarcinoma of the prostate stage III,1
32456,High Grade Lesion,Recurrent Alveolar Rhabdomyosarcoma,1
32457,Malignant Cellular Infiltrate,Stromal Predominant Kidney Wilms Tumor,1
32458,Metastatic Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
32459,Mitotic Activity,Supratentorial Glioblastoma,1
32460,Malignant Cellular Infiltrate,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
32461,Carcinomatous Component Present,Childhood Lung Non-Small Cell Carcinoma,1
32462,Epithelial Component Present,Unresectable Carcinoid Tumor,1
32463,Epithelial Component Present,Metastatic Prostate Small Cell Carcinoma,1
32464,Epithelial Component Present,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
32465,Well Differentiated Neuroendocrine Lesion,Jejunal Neuroendocrine Tumor G1,1
32466,Carcinomatous Component Present,Stage IIIA Gallbladder Cancer AJCC v8,1
32467,Necrotic changes (finding),Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
32468,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
32469,Hyalinized Stroma Formation,Malignant Solitary Fibrous Tumor,1
32470,Chromogranin A Positive Neoplastic Cells Present,Metastatic Digestive System Neuroendocrine Tumor G1,1
32471,Mitotic Activity,Endodermal sinus tumor of ovary,1
32472,Unifocal Disease at Presentation,Extracutaneous Mastocytoma,1
32473,Malignant Cellular Infiltrate,Skin Basaloid Carcinoma,1
32474,Malignant Cellular Infiltrate,Stage I Vulvar Cancer,1
32475,Carcinomatous Component Present,Stage IVC Major Salivary Gland Cancer AJCC v7,1
32476,Dysplasia,Gallbladder Papillary Adenoma,1
32477,Carcinomatous Component Present,Advanced Digestive System Carcinoma,1
32478,Papillary Pattern,Laryngeal verrucous carcinoma stage IV,1
32479,Cutaneous Involvement,Large cell acanthoma,1
32480,Low Grade Lesion,Mediastinal Epithelioid Hemangioendothelioma,1
32481,Carcinomatous Component Present,Uterine Ligament Clear Cell Adenocarcinoma,1
32482,Malignant Cellular Infiltrate,Metastatic Sarcomatoid Renal Cell Carcinoma,1
32483,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia refractory,1
32484,Carcinomatous Component Present,High Grade Broad Ligament Serous Adenocarcinoma,1
32485,Malignant Cellular Infiltrate,Stage III Rectosigmoid Cancer AJCC v7,1
32486,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
32487,Papillary Pattern,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
32488,Malignant Cellular Infiltrate,Pathologic Stage IIB Gastric Cancer AJCC v8,1
32489,Childhood Lesion,Childhood Periosteal Osteosarcoma,1
32490,Carcinomatous Component Present,Paget Disease of the Scrotum,1
32491,Megakaryoblasts 50 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Megakaryoblastic Leukemia,1
32492,Carcinomatous Component Present,Stage III Laryngeal Cancer AJCC v6 and v7,1
32493,Nodular Pattern,Benign Breast Eccrine Spiradenoma,1
32494,Microsatellite Stable,Metastatic Microsatellite Stable Colorectal Carcinoma,1
32495,Indolent Clinical Course,Benign Mediastinal Soft Tissue Neoplasm,1
32496,Biphasic Pattern,Recurrent Childhood Pilocytic Astrocytoma,1
32497,Secondary Lesion,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
32498,Epithelial Component Present,Vaginal Tubular Adenoma,1
32499,Unclassifiable Lesion,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified",1
32500,Papillary Pattern,Papilloma,1
32501,Malignant Cellular Infiltrate,Recurrent Ureter Carcinoma,1
32502,Epithelial Component Present,Pilomatrix carcinoma of skin,1
32503,Malignant Cellular Infiltrate,Classical Low Grade Fibromyxoid Sarcoma,1
32504,Low Grade Lesion,Locally Advanced Epithelioid Hemangioendothelioma,1
32505,Childhood Lesion,Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma,1
32506,Epithelial Component Present,Paget's disease of penis,1
32507,Malignant Cellular Infiltrate,Stage IB Lung Large Cell Carcinoma AJCC v7,1
32508,Keratin pearl formation,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
32509,Non-Invasive Lesion,Stage 0is Ureter Cancer AJCC v8,1
32510,Follicular Cell Differentiation,Stage I Differentiated Thyroid Gland Carcinoma AJCC v8,1
32511,Perivascular Pseudorosette Formation,Childhood Anaplastic Ependymoma,1
32512,Varicosity,Phlebitis,1
32513,Malignant Cellular Infiltrate,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",1
32514,Complete Spontaneous Regression,Type E Lymphomatoid Papulosis,1
32515,Malignant Cellular Infiltrate,ROSE Cluster 3,1
32516,Odontogenic Cysts,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
32517,Epithelial Component Present,Oxyphilic Adenoma,1
32518,Epithelial Component Present,Stage III AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
32519,Malignant Cellular Infiltrate,Pharyngeal cancer stage I,1
32520,Diffuse Pattern,Stage I Adult Immunoblastic Lymphoma,1
32521,Malignant Cellular Infiltrate,Stage IB Esophageal Adenocarcinoma AJCC v7,1
32522,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Placental Choriocarcinoma,1
32523,CD4-Positive Neoplastic Cells Present,Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm,1
32524,Locally Aggressive Lesion,Central Nervous System Desmoid-Type Fibromatosis,1
32525,Malignant Cellular Infiltrate,Pancreatic neuroendocrine tumor metastatic,1
32526,Diffuse Pattern,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,1
32527,Aggressive Clinical Course,Vaginal Undifferentiated Sarcoma,1
32528,"Undifferentiated ""Fetal-Type"" Tissues Present",Immature Gastric Teratoma,1
32529,Malignant Cellular Infiltrate,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
32530,Lobulated Growth Pattern,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
32531,Tubular Structures Present,Ovarian Sertoli Cell Tumor,1
32532,Epithelial Component Present,Stage III Vaginal Cancer AJCC v8,1
32533,Tissue of Mullerian Origin Present,serous adenocarcinofibroma of ovary,1
32534,Monomorphic Cellular Infiltrate,Oligodendroglioma of spinal cord,1
32535,Malignant Cellular Infiltrate,Refractory Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
32536,Malignant Cellular Infiltrate,Anaplastic astrocytoma,1
32537,Superficial Lesion,"Fibromatosis, Plantar",1
32538,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Stage,1
32539,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis without Risk Organ Involvement,1
32540,Benign Cellular Infiltrate,Pilocytic astrocytoma of cerebellum,1
32541,Epithelial Component Present,Renal Cell Cancer by AJCC v7 Stage,1
32542,Metastatic/Recurrent Disease,Recurrent Desmoplastic Small Round Cell Tumor,1
32543,Cutaneous Involvement,Non-neoplastic nevus of skin,1
32544,Malignant Cellular Infiltrate,Glottis Verrucous Carcinoma,1
32545,Dysplasia,Gastrointestinal Intraepithelial Neoplasia,1
32546,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor,1
32547,Papillary Pattern,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
32548,Malignant Primitive Cellular Infiltrate,Ovarian germ cell tumor mixed,1
32549,Recurrent disease,Skin squamous cell carcinoma recurrent,1
32550,Adulthood Lesion,Adult Solid Neoplasm,1
32551,Primary Lesion,Metastatic hepatocellular carcinoma,1
32552,Hereditary Lesion,BRCA2 Syndrome,1
32553,Carcinomatous Component Present,Salivary Gland Low Grade Cribriform Cystadenocarcinoma,1
32554,Malignant Cellular Infiltrate,Bone Sarcoma by AJCC v7 Stage,1
32555,Primary Lesion,Recurrent Childhood Pineoblastoma,1
32556,Increased Cellularity Present,Childhood Anaplastic Oligodendroglioma,1
32557,Invasive Lesion,Invasive Prostate Carcinoma,1
32558,Carcinomatous Component Present,Stage IVA Laryngeal Cancer AJCC v7,1
32559,Malignant Cellular Infiltrate,Postcricoid Squamous Cell Carcinoma,1
32560,Carcinomatous Component Present,Endometrial Mucinous Adenocarcinoma,1
32561,Malignant Cellular Infiltrate,Endometrial Mixed Cell Adenocarcinoma,1
32562,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q),1
32563,Carcinomatous Component Present,Meningeal Carcinomatosis,1
32564,Oligodendroglial Component Present,Childhood Anaplastic Oligodendroglioma,1
32565,Papillary Pattern,"Papillary Carcinoma of the Penis, Not Otherwise Specified",1
32566,Epithelial Component Present,Transverse Colon Neuroendocrine Tumor G1,1
32567,Negative Peripheral Blood,Aleukemic leukemia,1
32568,Epithelial Component Present,Cervical intraepithelial neoplasia grade 1,1
32569,Epithelial Component Present,Stage IVC Rectal Cancer AJCC v8,1
32570,Malignant Cellular Infiltrate,Malignant mastocytosis,1
32571,Epithelial Component Present,Scrotal Carcinoma,1
32572,'Starry-sky' pattern,Burkitt Lymphoma by Ann Arbor Stage,1
32573,Oligodendroglial Component Present,Mixed Oligodendroglioma-Astrocytoma,1
32574,Microcystic Change,Adult Subependymoma,1
32575,Low Mitotic Activity,Extrahepatic Bile Duct Neuroendocrine Tumor,1
32576,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Testicular choriocarcinoma stage III,1
32577,Bone Marrow Dysplasia Present,Recurrent Myelodysplastic Syndrome,1
32578,Carcinomatous Component Present,Stage IIIA Small Intestinal Cancer AJCC v7,1
32579,Malignant Cellular Infiltrate,Unclassified Renal Cell Carcinoma,1
32580,Epithelial Component Present,Recurrent Thyroid Gland Medullary Carcinoma,1
32581,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
32582,Malignant Cellular Infiltrate,"High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma",1
32583,Low Cellularity Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 1",1
32584,Vascular Channel Formation,Angiosarcoma NCI Grade 3,1
32585,Malignant Cellular Infiltrate,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
32586,Metastatic Lesion,Breast Carcinoma Metastatic in Lymph Node,1
32587,Microvascular Proliferation,Multifocal Glioblastomas,1
32588,Necrotic changes (finding),Metastatic Malignant Peripheral Nerve Sheath Tumor,1
32589,Carcinomatous Component Present,Bladder cancer stage IV,1
32590,Lobulated Growth Pattern,Primary chondrosarcoma of bone,1
32591,Carcinomatous Component Present,Adenocarcinoma in tubulovillous adenoma,1
32592,Carcinomatous Component Present,Stage IV Pharynx Carcinoma,1
32593,Metastatic Lesion,Metastatic Uveal Melanoma,1
32594,Cutaneous Involvement,Cutaneous Nasal Type Extranodal NK/T-Cell Lymphoma,1
32595,High Grade Lesion,High grade surface osteosarcoma,1
32596,Malignant Cellular Infiltrate,Stage II Carcinoma of Penis,1
32597,Carcinomatous Component Present,Adenosquamous cell lung cancer stage III,1
32598,Dysplasia,Colorectal Tubulovillous Adenoma,1
32599,Malignant Cellular Infiltrate,Colorectal Burkitt Lymphoma,1
32600,Epithelial Component Present,Stage IIB Colorectal Cancer AJCC v8,1
32601,Neuroendocrine Differentiation,Stage IIA Colorectal Neuroendocrine Tumor AJCC v8,1
32602,Cystic Change,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
32603,Bone Marrow Dysplasia Present,"Myelodysplastic syndrome, no ICD-O subtype",1
32604,Carcinomatous Component Present,Vaginal Endometrioid Adenocarcinoma,1
32605,Recurrent Lymphoma,EBV-Related Burkitt Lymphoma,1
32606,Monomorphic Cellular Infiltrate,basaloid squamous cell carcinoma of vulva,1
32607,Malignant Cellular Infiltrate,Fallopian Tube Adenosarcoma,1
32608,Hereditary Lesion,Myeloid Neoplasms with Germline ETV6 Mutation,1
32609,Epithelial Component Present,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
32610,Nodular Pattern,Hodgkin's disease nodular sclerosis recurrent,1
32611,Duct-Like Structures Present,Adenoameloblastoma,1
32612,Indolent Clinical Course,Oral Cavity Adenoma,1
32613,Malignant Cellular Infiltrate,adenosquamous carcinoma of ovary,1
32614,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage I,1
32615,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
32616,Epithelial Component Present,Early Invasive Cervical Adenocarcinoma,1
32617,Erythema,Superficial basal cell carcinoma,1
32618,Chronic Inflammatory Infiltrate,Adult Mixed Cellularity Classical Hodgkin Lymphoma,1
32619,Biphasic Pattern,Parotid Gland Carcinosarcoma,1
32620,Papillary Pattern,Paranasal Sinus Schneiderian Papilloma,1
32621,Extensive Stage Lesion,Advanced B-Cell Neoplasm,1
32622,Benign Cellular Infiltrate,Recurrent Inverted Schneiderian Papilloma,1
32623,Tissue Differentiation Uncertain,Vulvar Proximal-Type Epithelioid Sarcoma,1
32624,Cutaneous Involvement,Pilar-Associated Mesenchyme Neoplasm,1
32625,Recurrent disease,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
32626,Psammoma Body Formation,Melanotic Psammomatous Malignant Peripheral Nerve Sheath Tumor,1
32627,Childhood Lesion,Childhood Lung Non-Small Cell Carcinoma,1
32628,Encapsulated Mass,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
32629,Postneoadjuvant Therapy Pathologic TNM Finding,Esophageal Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
32630,Neuroendocrine Differentiation,Unresectable Pancreatic Neuroendocrine Carcinoma,1
32631,Indolent Clinical Course,Benign neoplasm of spleen,1
32632,Calcinosis,Psammomatous Meningioma,1
32633,Malignant Cellular Infiltrate,Refractory Ovarian Endometrioid Adenocarcinoma,1
32634,Recurrent disease,Recurrent tumor,1
32635,Epithelial Component Present,Stage IVA Vulvar Cancer AJCC v7,1
32636,Stromal Invasion,Lepidic Predominant Adenocarcinoma,1
32637,Carcinomatous Component Present,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
32638,Swelling,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,1
32639,Nuclear pleomorphism,Large Cell Dysplasia,1
32640,Childhood Lesion,Primary Childhood Soft Tissue Sarcoma,1
32641,High Mitotic Activity,small cell carcinoma of breast,1
32642,Epithelial Component Present,Laryngeal Giant Cell Carcinoma,1
32643,Malignant Cellular Infiltrate,Hairy cell leukemia variant,1
32644,Malignant Cellular Infiltrate,Stage IV Colorectal Cancer AJCC v7,1
32645,Neuroendocrine Differentiation,Jejunal Neuroendocrine Tumor,1
32646,Carcinomatous Component Present,"Squamous cell carcinoma, metastatic",1
32647,Carcinomatous Component Present,Metastatic Gastric Carcinoma,1
32648,Epithelial Component Present,"Extra-adrenal paraganglioma, malignant",1
32649,Adulthood Lesion,Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8,1
32650,Malignant Cellular Infiltrate,Childhood Choriocarcinoma,1
32651,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v8 Stage,1
32652,Epithelial Component Present,Invasive carcinoma of breast,1
32653,Carcinomatous Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v7,1
32654,Peripheral Nuclear Palisading,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
32655,Favorable Clinical Outcome,Beta-Catenin-Activated Hepatocellular Adenoma,1
32656,Childhood Lesion,PRETEXT Stage 3 Hepatoblastoma,1
32657,Epithelial Component Present,Esophageal Well Differentiated Squamous Cell Carcinoma,1
32658,Epithelial Component Present,adenocarcinoma of renal pelvis,1
32659,Cutaneous Involvement,Non-neoplastic nevus of skin,1
32660,Malignant Cellular Infiltrate,Stage 0is Renal Pelvis Cancer AJCC v7,1
32661,Malignant Cellular Infiltrate,Lymphoma stage I,1
32662,Blasts of Mixed Phenotype Present,"Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes",1
32663,Malignant Cellular Infiltrate,Stage III Uveal Melanoma AJCC v7,1
32664,Malignant Cellular Infiltrate,Malignant Glioma,1
32665,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) refractory,1
32666,Diffuse Pattern,Protoplasmic astrocytoma,1
32667,Congenital Lesion,Congenital ptosis,1
32668,Malignant Cellular Infiltrate,Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion,1
32669,In Situ Lesion,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
32670,'Starry-sky' pattern,Stage IV Adult Burkitt Lymphoma,1
32671,"Fully Differentiated ""Adult-Type"" Tissues Present",Mediastinal Immature Teratoma,1
32672,Mitotic Activity,Mesenchymal Glioblastoma,1
32673,Malignant Cellular Infiltrate,Eccrine carcinoma of skin,1
32674,Severe cytologic atypia,Metastatic Digestive System Neuroendocrine Carcinoma,1
32675,Epithelial Component Present,Bladder transitional cell carcinoma stage II,1
32676,High Mitotic Activity,Large Cell/Anaplastic Medulloblastoma,1
32677,Absence of Invasion,Stage 0 Pharynx Carcinoma,1
32678,Biphasic Pattern,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
32679,Epithelial Component Present,Stage IV Ovarian Carcinoma,1
32680,Malignant Cellular Infiltrate,"Perivascular epithelioid tumor, malignant",1
32681,Malignant Cellular Infiltrate,Stage IIB Pancreatic Cancer AJCC v8,1
32682,Carcinomatous Component Present,Squamous cell carcinoma in situ with questionable stromal invasion,1
32683,Cutaneous Involvement,Carcinoma in situ of skin,1
32684,Granulocytes Increased in Bone Marrow,Prefibrotic/Early Primary Myelofibrosis,1
32685,Metastatic Lesion,Metastatic Neoplasm to the Bladder,1
32686,Epithelial Component Present,Vulvar Seborrheic Keratosis,1
32687,Malignant Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v8,1
32688,Malignant Cellular Infiltrate,Anatomic Stage IIB Breast Cancer AJCC v8,1
32689,Neuroendocrine Differentiation,"Carcinoid, Goblet Cell",1
32690,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
32691,Malignant Cellular Infiltrate,Pathologic Stage IB Gastric Cancer AJCC v8,1
32692,CD1a-Positive Neoplastic Cells Present,Eosinophilic Granuloma,1
32693,Childhood Lesion,Childhood Classic Hodgkin Lymphoma,1
32694,Severe cytologic atypia,Ampulla of Vater Large Cell Neuroendocrine Carcinoma,1
32695,Well Differentiated Lesion,Well Differentiated Adrenal Cortex Carcinoma,1
32696,Malignant Cellular Infiltrate,Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
32697,Benign Cellular Infiltrate,Benign Breast Eccrine Spiradenoma,1
32698,Secondary Lesion,Locally Advanced Unresectable Carcinoma,1
32699,Recurrent Genetic Abnormalities Present,B Lymphoblastic Leukemia/Lymphoma with Hypodiploidy,1
32700,Well-Circumscribed Lesion,Papillary mucinous cystadenoma,1
32701,Lymphoplasmacytic Infiltrate,Waldenstrom Macroglobulinemia,1
32702,Mixed Cellular Population,Combined Lung Large Cell Neuroendocrine Carcinoma,1
32703,Malignant Cellular Infiltrate,"Urinary bladder carcinoma stage I, with cancer in situ",1
32704,Malignant Primitive Cellular Infiltrate,Stage I Ovarian Polyembryoma AJCC v6 and v7,1
32705,Epithelial Component Present,Stage IVA Bladder Cancer AJCC v8,1
32706,Cutaneous Involvement,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
32707,Epithelial Component Present,Stage IIIB Bladder Cancer AJCC v8,1
32708,Well-Circumscribed Lesion,Vaginal Angiomyofibroblastoma,1
32709,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8,1
32710,Crystal deposition,Childhood Alveolar Soft Part Sarcoma,1
32711,Refractory Disease,Refractory Malignant Thyroid Gland Neoplasm,1
32712,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells,1
32713,Local disease,lipoma of bone,1
32714,Neuroendocrine Differentiation,Stage IV Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
32715,Epithelial Component Present,Advanced Urothelial Carcinoma,1
32716,Malignant Cellular Infiltrate,Stage III renal cell cancer,1
32717,Malignant Cellular Infiltrate,Stage III Kidney Wilms Tumor,1
32718,Carcinomatous Component Present,Mucoepidermoid carcinoma of the oral cavity recurrent,1
32719,Neuroendocrine Differentiation,Paraganglioma,1
32720,Acanthosis,Warty Carcinoma of the Penis,1
32721,Epithelial Component Present,Squamous cell carcinoma of the paranasal sinus,1
32722,Epithelial Component Present,Pituitary Adenoma,1
32723,Malignant Cellular Infiltrate,Stage II Childhood Lymphoblastic Lymphoma,1
32724,Perineural spread,Anterior Tongue Adenoid Cystic Carcinoma,1
32725,Epithelial Component Present,Adenocarcinoma of the prostate stage I,1
32726,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Amyloidosis,1
32727,Malignant Cellular Infiltrate,Malignant Pineal Region Germ Cell Tumor,1
32728,Epithelial Component Present,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
32729,Locally Aggressive Lesion,Metastasizing Chondroblastoma,1
32730,Papillary Pattern,Squamous papillomatosis,1
32731,Primary Lesion,Primary Cutaneous Meningioma,1
32732,Epithelial Component Present,Malignant neoplasm of carotid body,1
32733,Monophasic Pattern,Pleural Monophasic Synovial Sarcoma,1
32734,Odontogenic Cysts,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
32735,Ischemia,Vascular insufficiency of intestine,1
32736,Secondary Lesion,Metastatic Bone Ewing Sarcoma,1
32737,Benign Cellular Infiltrate,Benign Intraocular Schwannoma,1
32738,Epithelial Component Present,Vulval intraepithelial neoplasia,1
32739,Cystic Change,mucoepidermoid carcinoma of lacrimal gland,1
32740,Epithelial Component Present,Stage III Esophageal Cancer,1
32741,Malignant Cellular Infiltrate,Stage II Childhood Burkitt Lymphoma,1
32742,Increased NFkappaB Pathway Activation,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
32743,Cellular Changes Resembling Foveolar Epithelium Cells,"Extrahepatic Bile Duct Adenocarcinoma, Gastric Foveolar Type",1
32744,Papillary Pattern,Papillary Epithelial Neoplasm,1
32745,Epithelial Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v7,1
32746,Carcinomatous Component Present,Adrenal Cortex Carcinoma by AJCC v8 Stage,1
32747,Clinical TNM Finding,Clinical Stage IIA Cutaneous Melanoma AJCC v8,1
32748,Epithelial Component Present,Stage I Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
32749,Epithelial Component Present,Stage IA Fallopian Tube Cancer AJCC v6 and v7,1
32750,Malignant Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
32751,Secondary Lesion,Locally Advanced Adrenal Gland Pheochromocytoma,1
32752,Slow Growing Mass,Venous Angioleiomyoma,1
32753,Exophytic Polypoid Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
32754,Carcinomatous Component Present,Resectable Renal Cell Carcinoma,1
32755,Epithelial Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
32756,Malignant Cellular Infiltrate,Cervical Squamous Cell Carcinoma In Situ,1
32757,Carcinomatous Component Present,Small cell lung cancer limited stage,1
32758,Malignant Cellular Infiltrate,Locally Advanced Thymic Carcinoma,1
32759,Dysplasia,Squamous intraepithelial lesion,1
32760,Absence of Invasion,Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
32761,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
32762,Malignant Cellular Infiltrate,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
32763,Indolent Clinical Course,Leiomyoma of ciliary body,1
32764,Osteoid formation,Duodenal Extraskeletal Osteosarcoma,1
32765,Epithelial Component Present,Stage IIIB Lung Cancer AJCC v8,1
32766,Neuroendocrine Differentiation,Pancreatic Neuroendocrine Tumor G2,1
32767,Epithelial Component Present,Macrofollicular adenoma,1
32768,Epithelial Component Present,"Papilloma, Squamous Cell",1
32769,Cutaneous Involvement,Fibroepithelioma of Pinkus,1
32770,White blood cell count increased (lab result),Juvenile Myelomonocytic Leukemia,1
32771,Exophytic Polypoid Lesion,Foveolar-Type Adenoma,1
32772,Neuroendocrine Differentiation,Adrenal Gland Pheochromocytoma,1
32773,Smooth Muscle Component Present,Clear cell papillary renal cell carcinoma,1
32774,Well-Circumscribed Lesion,Colorectal Adenoma with Moderate Dysplasia,1
32775,Benign Cellular Infiltrate,Uterine Corpus Bizarre Leiomyoma,1
32776,Carcinomatous Component Present,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8,1
32777,Epithelial Component Present,Low grade appendiceal mucinous neoplasm,1
32778,Severe dysplasia,Colon Adenoma with Severe Dysplasia,1
32779,Neoplastic Cells with TFH Cell Phenotype Present,Angioimmunoblastic T-cell lymphoma recurrent,1
32780,Painless Mass,Fibroma of tendon sheath,1
32781,Indolent Clinical Course,benign fibrous histiocytoma of bone,1
32782,Necrotic changes (finding),small cell carcinoma of ureter,1
32783,Carcinomatous Component Present,Stage IVA Hepatocellular Carcinoma AJCC v7,1
32784,Intraosseous Lesion,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
32785,Adulthood Lesion,Adult Pineal Parenchymal Cell Neoplasm,1
32786,Malignant Cellular Infiltrate,Childhood Choroid Plexus Carcinoma,1
32787,Epithelial Component Present,Stage 0 Ampulla of Vater Cancer AJCC v8,1
32788,Malignant Cellular Infiltrate,Low-grade fibromyxoid sarcoma,1
32789,Nodular Pattern,Myxoid liposarcoma metastatic,1
32790,Neuroendocrine Differentiation,Glucagonoma,1
32791,Carcinomatous Component Present,Stage IV Intrahepatic Cholangiocarcinoma AJCC v8,1
32792,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Tumor G1,1
32793,Increased Cellularity Present,Stage 2A Neuroblastoma,1
32794,Metastatic Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,1
32795,Anaplasia,Childhood Systemic Anaplastic Large Cell Lymphoma,1
32796,Epithelial Component Present,Stage II Duodenal Neuroendocrine Tumor AJCC v8,1
32797,Epithelial Component Present,Throat cancer,1
32798,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent,1
32799,Mitotic Activity,Infratentorial Glioblastoma,1
32800,Childhood Lesion,Stage III Childhood Lymphoblastic Lymphoma,1
32801,Malignant Cellular Infiltrate,Pathologic Stage III Retinoblastoma AJCC v8,1
32802,Malignant Germinomatous Cellular Infiltrate,germinoma of brain,1
32803,Malignant Cellular Infiltrate,lymphangiosarcoma,1
32804,Mixed Cellular Population,Adenosarcoma,1
32805,Hereditary Lesion,"Hamartoma Syndrome, Multiple",1
32806,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v6,1
32807,Favorable Clinical Outcome,Type D Lymphomatoid Papulosis,1
32808,Malignant Cellular Infiltrate,malignant myoepithelioma of breast,1
32809,Dysplasia,Colorectal Adenoma with Mild Dysplasia,1
32810,Immunologic Deficiency Syndromes,Transplant-Related Hepatocellular Carcinoma,1
32811,Diffuse Pattern,Immunoblastic lymphoma associated with AIDS,1
32812,Vascular Channel Formation,Skin Cavernous Hemangioma,1
32813,Questionable Invasive Lesion,Thyroid Gland Follicular Tumor of Uncertain Malignant Potential,1
32814,Malignant Cellular Infiltrate,Retroperitoneal Sarcoma by AJCC v8 Stage,1
32815,Dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
32816,Carcinomatous Component Present,Recurrent Childhood Hepatocellular Carcinoma,1
32817,Malignant Cellular Infiltrate,Localized Bone Ewing Sarcoma,1
32818,Clinical TNM Finding,Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8,1
32819,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
32820,Carcinomatous Component Present,Medullary carcinoma of thyroid,1
32821,Biphasic Pattern,Adamantinoma,1
32822,Carcinomatous Component Present,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
32823,Malignant Cellular Infiltrate,Stage IIIB Prostate Cancer AJCC v8,1
32824,Epithelial Component Present,Cystic Oncocytic Neoplasm,1
32825,Increased Cellularity Present,"Childhood Infratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
32826,Recurrent disease,Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,1
32827,Locally Aggressive Lesion,Recurrent Desmoid-Type Fibromatosis,1
32828,Metastatic/Recurrent Disease,"Sarcoma, Epithelioid",1
32829,Polymorphic Cellular Infiltrate,"Langerhans Cell Histiocytosis, Polystotic",1
32830,Metastatic Lesion,stage IV pancreatic cancer,1
32831,Stromal Invasion,Lepidic Predominant Adenocarcinoma,1
32832,Carcinomatous Component Present,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
32833,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
32834,Exophytic Polypoid Lesion,Tubular adenoma,1
32835,Epithelial Component Present,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8,1
32836,Benign Cellular Infiltrate,Fibroma of lung,1
32837,Epithelial Component Present,Prostate Undifferentiated Carcinoma,1
32838,Epithelial Component Present,Gallbladder Papillomatosis,1
32839,Carcinomatous Component Present,Stage IIIA Cervical Carcinoma,1
32840,Keratin pearl formation,Nasopharyngeal squamous cell carcinoma recurrent,1
32841,Carcinomatous Component Present,Esophageal Cancer by AJCC v8 Stage,1
32842,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vagina,1
32843,Epithelial Component Present,Unresectable Hepatocellular Carcinoma,1
32844,Malignant Cellular Infiltrate,Stage IV Bladder Cancer AJCC v6,1
32845,Low Mitotic Activity,Gastrinoma,1
32846,"Fully Differentiated ""Adult-Type"" Tissues Present",Grade 1 Ovarian Teratoma,1
32847,Carcinomatous Component Present,Malignant Breast Eccrine Spiradenoma,1
32848,Malignant Cellular Infiltrate,Luminal A Prostate Carcinoma,1
32849,Epithelial Component Present,Prostate Phyllodes Tumor,1
32850,Nuclear Clearing,Follicular Variant Thyroid Gland Papillary Carcinoma,1
32851,Epithelial Component Present,Malignant Testicular Sex Cord-Stromal Tumor,1
32852,Malignant Cellular Infiltrate,Botryoid-Type Embryonal Rhabdomyosarcoma,1
32853,Mixed Cellular Population,Uterine Corpus Adenofibroma,1
32854,Indolent Clinical Course,Vulvar Superficial Myofibroblastoma,1
32855,Carcinomatous Component Present,High Grade Ovarian Serous Adenocarcinoma,1
32856,Malignant Cellular Infiltrate,Mesothelioma malignant advanced,1
32857,Absence of Invasion,Lung Squamous Cell Carcinoma In Situ,1
32858,Cutaneous Involvement,Pilosebaceous Hamartoma,1
32859,Primary Lesion,Extracavitary Primary Effusion Lymphoma,1
32860,Hereditary Lesion,Hereditary Glomangioma,1
32861,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
32862,Neuroendocrine Differentiation,Thyroid Gland Paraganglioma,1
32863,Cystic Change,Benign mixed epithelial and stromal tumor of kidney,1
32864,Well-Circumscribed Lesion,Breast Phyllodes Tumor,1
32865,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor,1
32866,Epithelial Component Present,Anal Canal Squamous Papilloma,1
32867,Thin Bands of Collagen Present,"Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
32868,Carcinomatous Component Present,Stage IIB Gastric Cancer AJCC v7,1
32869,Micropapillary Pattern,Rectal Micropapillary Adenocarcinoma,1
32870,'Starry-sky' pattern,Burkitt-like lymphoma,1
32871,Perivascular Arrangement of Tumor Cells,Glomus tumor of skin,1
32872,Epithelial Component Present,"Pheochromocytoma, Extra-Adrenal",1
32873,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Adult Acute Basophilic Leukemia,1
32874,Intermediate Grade Neuroendocrine Lesion,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
32875,High Grade Lesion,rhabdomyosarcoma of prostate,1
32876,Neuroendocrine Differentiation,Stage IIB Digestive System Neuroendocrine Tumor AJCC v7,1
32877,Mild dysplasia,Low grade cervical glandular intraepithelial neoplasia,1
32878,Malignant Cellular Infiltrate,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
32879,Well-Circumscribed Lesion,Broad Ligament Papillary Cystadenoma,1
32880,High Mitotic Activity,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
32881,atypia morphology,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
32882,Tissue Differentiation Uncertain,"Vulvar Deep ""Aggressive"" Angiomyxoma",1
32883,Epithelial Component Present,Stage IIIB Fallopian Tube Cancer AJCC v7,1
32884,Epithelial Component Present,Vipoma,1
32885,Non-Invasive Lesion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
32886,Chemotherapeutic Agent Toxicity,Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent,1
32887,Epithelial Component Present,Stage I Cervical Cancer AJCC v8,1
32888,Tissue of Mullerian Origin Present,Fallopian Tube Serous Adenofibroma,1
32889,Indolent Clinical Course,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",1
32890,Carcinomatous Component Present,Throat cancer,1
32891,Well-Circumscribed Lesion,Stage I Kidney Wilms Tumor,1
32892,Neuronal Differentiation,Lhermitte-Duclos disease,1
32893,Carcinomatous Component Present,"Glandular intraepithelial neoplasia, grade III",1
32894,Carcinomatous Component Present,Vulvar Sebaceous Carcinoma,1
32895,Malignant Cellular Infiltrate,Metastatic Epithelioid Hemangioendothelioma,1
32896,Biphasic Pattern,Adenomyoma,1
32897,Recurrent disease,"Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
32898,Slit-Like Stromal Retraction Present,Superficial basal cell carcinoma,1
32899,Tubular Pattern,Pancreatic Somatostatinoma,1
32900,Mesenchymal Differentiation,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
32901,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm,1
32902,Lobulated Growth Pattern,Sellar Chondroid Chordoma,1
32903,Malignant Cellular Infiltrate,Colon Serrated Adenocarcinoma,1
32904,Refractory Disease,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
32905,Epithelial Component Present,Stage IIB Merkel Cell Carcinoma AJCC v7,1
32906,Malignant Cellular Infiltrate,Choroid Mixed Cell Melanoma,1
32907,Oligodendroglial Component Present,Recurrent Childhood Anaplastic Oligoastrocytoma,1
32908,Carcinomatous Component Present,Squamous cell carcinoma of the parotid gland,1
32909,Carcinomatous Component Present,Rectal Small Cell Neuroendocrine Carcinoma,1
32910,Epithelial Component Present,"Stage 0 Epiglottic Carcinoma AJCC v6, v7, and v8",1
32911,Adulthood Lesion,Hodgkin-Like Adult T-Cell Leukemia/Lymphoma,1
32912,Clinical TNM Finding,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
32913,Carcinomatous Component Present,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
32914,Adulthood Lesion,BCLC Stage A Adult Hepatocellular Carcinoma,1
32915,Monomorphic Cellular Infiltrate,"Adenoma, Basal Cell",1
32916,Epithelial Component Present,Stage IIB Esophageal Carcinoma,1
32917,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Ovarian Immature Teratoma,1
32918,Secondary Lesion,Metastatic Malignant Neoplasm to the Thyroid,1
32919,High Grade Lesion,Leiomyosarcoma NCI Grade 3,1
32920,Dermal Involvement,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
32921,Epithelial Component Present,Melanoacanthoma,1
32922,CD30-Positive Neoplastic Cells Present,Stage II Anaplastic Large Cell Lymphoma,1
32923,Recurrent Lymphoma,EBV-Related Lymphoma,1
32924,Carcinomatous Component Present,Occult Breast Carcinoma,1
32925,Benign Cellular Infiltrate,Eccrine acrospiroma,1
32926,Epithelial Component Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
32927,Carcinomatous Component Present,Lung Mucinous Adenocarcinoma In Situ,1
32928,Malignant Cellular Infiltrate,Early Unfavorable Hodgkin Lymphoma,1
32929,Lobulated Growth Pattern,chondroma of lung,1
32930,Severe dysplasia,High Grade Ductal Breast Carcinoma In Situ,1
32931,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
32932,Carcinomatous Component Present,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
32933,Locally Aggressive Lesion,Retiform hemangioendothelioma,1
32934,Secondary Lesion,Metastatic Malignant Neoplasm to the Leptomeninges,1
32935,Childhood Lesion,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1,1
32936,Malignant Cellular Infiltrate,Solid Alveolar Rhabdomyosarcoma,1
32937,Malignant Cellular Infiltrate,Heavy Chain Deposition Disease,1
32938,Cutaneous Involvement,Benign Cutaneous Fibroblastic Neoplasm,1
32939,Tumor Vascular Invasion,Malignant Pancreatic Vipoma,1
32940,Epithelial Component Present,Stage IA Distal Bile Duct Cancer AJCC v7,1
32941,Diffuse Cellular Infiltrate,Lymphoid interstitial pneumonia,1
32942,Carcinomatous Component Present,Platinum-Resistant Ovarian Carcinoma,1
32943,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Minimal Differentiation,1
32944,Cutaneous Involvement,"Connective tissue nevus, NOS",1
32945,Epithelial Component Present,Adenoid cystic breast carcinoma,1
32946,Malignant Germinomatous Cellular Infiltrate,Stage II Testicular Seminoma AJCC v6 and v7,1
32947,Malignant Cellular Infiltrate,B-Cell Lymphomas,1
32948,Severe dysplasia,Adenocarcinoma in Situ,1
32949,Epithelial Component Present,Invasive Lobular Breast Carcinoma with Predominant In Situ Component,1
32950,Biphasic Pattern,Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm,1
32951,Carcinomatous Component Present,Stage I Ureter Cancer AJCC v7,1
32952,Malignant Cellular Infiltrate,Malignant Intrathoracic Paravertebral Paraganglioma,1
32953,BRAF V600E Mutation Present,Recurrent Hairy Cell Leukemia,1
32954,Nodular Pattern,Recurrent Grade 3 Follicular Lymphoma,1
32955,Malignant Cellular Infiltrate,atypical medullary carcinoma of breast,1
32956,Malignant Cellular Infiltrate,Low Grade Endometrioid Stromal Sarcoma of the Cervix,1
32957,Benign Cellular Infiltrate,Cellular Myxoma,1
32958,Solitary mass,Chordoma of clivus,1
32959,Exophytic Polypoid Lesion,tubulopapillary adenoma of extrahepatic bile duct,1
32960,Epithelial Component Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
32961,Vascular Channel Formation,Kaposi's sarcoma classical type,1
32962,Poorly Differentiated Neuroendocrine Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
32963,Malignant Cellular Infiltrate,Resectable Renal Cell Carcinoma,1
32964,Local disease,Pleomorphic Lipoma,1
32965,Carcinomatous Component Present,Stage III Lip Cancer AJCC v6 and v7,1
32966,Neoplastic Growth or Spread,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
32967,Malignant Cellular Infiltrate,Bile duct carcinoma,1
32968,Thick-Walled Hyalinized Vessels Present,Colorectal Schwannoma,1
32969,Malignant Cellular Infiltrate,Stage IA Cervical Cancer AJCC v6 and v7,1
32970,Indolent Clinical Course,Histiocytoma,1
32971,Glucagon-Like Peptide Positive Neoplastic Cells Present,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
32972,Metastatic/Recurrent Disease,Synovial sarcoma non-metastatic,1
32973,Loss of Immunohistochemical Expression of Succinate Dehydrogenase (SDH) B,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
32974,Severe dysplasia,Anal Intraepithelial Neoplasia 3,1
32975,Epithelial Component Present,Stage III Liver Cancer,1
32976,Malignant Cellular Infiltrate,T-cell lymphoma refractory,1
32977,Neuropil Present,Poorly Differentiated Neuroblastoma,1
32978,Benign Cellular Infiltrate,Periosteal fibroma,1
32979,Metastatic Lesion,Metastatic Carcinoma in the Adrenal Cortex,1
32980,Cartilaginous Component Present,Multiple hamartoma of lung,1
32981,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
32982,Mitotic Activity,Testicular yolk sac tumor,1
32983,Human Papillomavirus Positive,Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
32984,Epithelial Component Present,Stage III Carcinoma of Stomach,1
32985,Metastatic Lesion,Locally Advanced Sarcoma,1
32986,Malignant Cellular Infiltrate,Chemotherapy-Related Leukemia,1
32987,Epithelial Component Present,FIGO Stage IIIB Ovarian Cancer,1
32988,Stromal Invasion,Stage IIIA1 Ovarian Cancer AJCC v8,1
32989,Acinar Cell Differentiation,Pancreatic Acinar Cell Neoplasm,1
32990,Invasive Lesion,Acinic Cell Breast Carcinoma,1
32991,Epithelial Component Present,Biliary Intraepithelial Neoplasia,1
32992,Intraductal Lesion,Intraductal breast neoplasm,1
32993,Malignant Cellular Infiltrate,"Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
32994,Epithelial Component Present,Refractory Metastatic Digestive System Carcinoma,1
32995,Cervical lymphadenopathy,Stage IVC Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
32996,Carcinomatous Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7,1
32997,Well-Circumscribed Lesion,Ovarian Myxoid Liposarcoma,1
32998,Epithelial Component Present,Transplant-Related Skin Squamous Cell Carcinoma,1
32999,Epithelial Component Present,Juvenile papillomatosis of breast,1
33000,Epithelial Component Present,Squamous cell carcinoma of penis,1
33001,Epithelial Component Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
33002,Childhood Lesion,Childhood Kidney Wilms Tumor,1
33003,Carcinomatous Component Present,Gastric Mixed Adenocarcinoma,1
33004,Malignant Germinomatous Cellular Infiltrate,Mediastinal seminoma,1
33005,Tissue of Mullerian Origin Present,Ovarian Seromucinous Adenofibroma,1
33006,Papillary Pattern,Sphenoid Sinus Inverted Papilloma,1
33007,Acinar Cell Differentiation,Recurrent Prostate Acinar Adenocarcinoma,1
33008,Metastatic Lesion,Urothelial carcinoma ureter metastatic,1
33009,Lesion Less than 5mm in Diameter,Pancreatic Neuroendocrine Microadenoma,1
33010,Epithelial Component Present,tubulovillous adenoma of stomach,1
33011,Epithelial Component Present,Borderline Ovarian Serous Adenofibroma,1
33012,Epithelial Component Present,Childhood Choroid Plexus Neoplasm,1
33013,Benign Cellular Infiltrate,Recurrent Craniopharyngioma,1
33014,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma in Cervical Lymph Node,1
33015,Absence of Invasion,Intraepithelial Squamous Cell Carcinoma,1
33016,Malignant Cellular Infiltrate,Granulocytic Sarcoma,1
33017,atypia morphology,Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor,1
33018,Carcinomatous Component Present,Stage 0 Anal Cancer AJCC v8,1
33019,Bone Marrow Involvement,Waldenstrom Macroglobulinemia,1
33020,Malignant Cellular Infiltrate,Luminal B Prostate Carcinoma,1
33021,Well-Circumscribed Lesion,Adenomatous Polyps,1
33022,Malignant Cellular Infiltrate,Refractory Alveolar Rhabdomyosarcoma,1
33023,Benign Cellular Infiltrate,Epidermolytic acanthoma,1
33024,Indolent Clinical Course,Cutaneous leiomyoma,1
33025,Epithelial Component Present,Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor,1
33026,Epithelial Component Present,AIDS-Related Anal Carcinoma,1
33027,Epithelial Component Present,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
33028,Malignant Cellular Infiltrate,Bile duct cystadenocarcinoma,1
33029,Epithelial Component Present,Infiltrating Cervical Carcinoma,1
33030,Lymphadenopathy,Ann Arbor Stage I Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
33031,Syncytial Pattern,Metastatic Nasopharyngeal Undifferentiated Carcinoma,1
33032,Necrotic changes (finding),Glandular malignant peripheral nerve sheath tumor,1
33033,Exophytic Polypoid Lesion,Anal polyp,1
33034,More than 10 Mitoses per 10HPF,Refractory Lung Small Cell Carcinoma,1
33035,Malignant Cellular Infiltrate,Adult Brain Medulloblastoma,1
33036,Anaplasia,Cerebellar Glioblastoma,1
33037,Metastatic Lesion,Metastatic Rectal Carcinoma,1
33038,Adulthood Lesion,Adult Immunoblastic Lymphoma,1
33039,Malignant Cellular Infiltrate,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
33040,Carcinomatous Component Present,Stage III Bladder Cancer AJCC v8,1
33041,Low Mitotic Activity,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,1
33042,Hyperplastic Tissue Present,Tubal Hyperplasia,1
33043,Malignant Cellular Infiltrate,Childhood Brain Stem Gliosarcoma,1
33044,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of salivary gland,1
33045,Intraductal Lesion,Intraductal papilloma of breast,1
33046,Primary Lesion,Sellar Ependymoma,1
33047,Carcinomatous Component Present,Stage IIIC Breast Cancer AJCC v6,1
33048,Indolent Clinical Course,Uterine Corpus Adenofibroma,1
33049,Malignant Cellular Infiltrate,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
33050,Epithelial Component Present,Stage IIIC Hilar Cholangiocarcinoma AJCC v8,1
33051,Local disease,Pagetoid reticulosis,1
33052,Epithelial Component Present,Cervical Adenocarcinoma,1
33053,Carcinomatous Component Present,Ovarian Serous Adenocarcinoma,1
33054,Malignant Cellular Infiltrate,Acute Promyelocytic Leukemia,1
33055,Invasive Lesion,Pituitary carcinoma,1
33056,Epithelial Component Present,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
33057,Stromal Invasion,Stage IIB Ovarian Cancer AJCC v6 and v7,1
33058,Polymorphic Cellular Infiltrate,Letterer-Siwe Disease,1
33059,Hereditary Lesion,Familial Neuroblastoma,1
33060,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
33061,Pregnancy Complications,Severe pre-eclampsia,1
33062,Carcinomatous Component Present,Stage IIB Lung Adenosquamous Carcinoma AJCC v7,1
33063,Malignant Cellular Infiltrate,Advanced Carcinoid Tumor,1
33064,Abundance of Small Lymphocytes,Lymphocyte Rich Classical Hodgkin Lymphoma,1
33065,Childhood Lesion,Childhood Central Nervous System Ganglioneuroblastoma,1
33066,Nuclear Molding,combined small cell carcinoma of lung,1
33067,Increased Cellularity Present,Adult Pineoblastoma,1
33068,Alternative Fascicle (Bundle) Pattern,Myxoid leiomyoma,1
33069,Well-Circumscribed Lesion,Vaginal Myofibroblastoma,1
33070,Low Mitotic Activity,Stage IV Jejunal Neuroendocrine Tumor AJCC v8,1
33071,Follicular Cell Differentiation,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
33072,Malignant Cellular Infiltrate,Acute Megakaryoblastic Leukemia with CBFA2T3-GLIS2,1
33073,Cutaneous Involvement,Fibrofolliculoma,1
33074,Locally Aggressive Lesion,"Histiocytoma, Angiomatoid Fibrous",1
33075,Mitotic Activity,teratocarcinoma of mediastinum,1
33076,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Squamous Cell Carcinoma,1
33077,Monomorphic Cellular Infiltrate,Atypical Ductal Breast Hyperplasia,1
33078,Adnexal Differentiation,Benign Apocrine Neoplasm,1
33079,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
33080,Malignant Cellular Infiltrate,Childhood Periosteal Osteosarcoma,1
33081,Neuroendocrine Differentiation,Pituitary Gland Paraganglioma,1
33082,Unresectable Mass,Unresectable Intrahepatic Cholangiocarcinoma,1
33083,Epithelial Component Present,Stage II Colon Cancer,1
33084,Carcinomatous Component Present,Poorly Differentiated Salivary Gland Squamous Cell Carcinoma,1
33085,Cutaneous Involvement,Primary Cutaneous Mucinous Carcinoma,1
33086,Local disease,Localized Extrahepatic Bile Duct Carcinoma,1
33087,Eccrine Differentiation,Vulvar Eccrine Porocarcinoma,1
33088,Slow Growing Mass,Chordoma of clivus,1
33089,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Carcinoma,1
33090,Oligodendroglial Component Present,Recurrent Anaplastic Oligoastrocytoma,1
33091,Chromogranin A Positive Neoplastic Cells Present,Thymic Atypical Carcinoid Tumor,1
33092,Exophytic Polypoid Lesion,villous adenoma of stomach,1
33093,Biphasic Pattern,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
33094,Carcinomatous Component Present,Stage IIC Colorectal Cancer AJCC v7,1
33095,Anaplasia,Anaplastic large cell lymphoma T- and null-cell types refractory,1
33096,Slow Growing Mass,Pineocytoma,1
33097,Malignant Cellular Infiltrate,Stage IVB Liver Cancer,1
33098,Carcinomatous Component Present,Lung Adenocarcinoma In Situ,1
33099,Osteoid formation,Intracortical osteosarcoma,1
33100,Malignant Cellular Infiltrate,Stage II Acral Lentiginous Melanoma AJCC v6 and v7,1
33101,Malignant Cellular Infiltrate,Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q,1
33102,Secondary Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,1
33103,Necrotic changes (finding),Recurrent Glioblastoma,1
33104,Severe dysplasia,"Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8",1
33105,Secondary Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
33106,Carcinomatous Component Present,Asbestos-Related Lung Carcinoma,1
33107,Malignant Cellular Infiltrate,Bartholin Gland Squamous Cell Carcinoma,1
33108,Secondary Lesion,Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma,1
33109,Malignant Cellular Infiltrate,Mucinous carcinoma of breast,1
33110,Epithelial Component Present,Stage 0 Appendix Carcinoma AJCC v8,1
33111,Malignant Cellular Infiltrate,Malignant blue nevus of skin,1
33112,Malignant Cellular Infiltrate,Stage IV Ureter Cancer AJCC v7,1
33113,Epithelial Component Present,Giant cell carcinoma of lung,1
33114,Vascular Channel Formation,Adrenal Gland Angiosarcoma,1
33115,In Situ Lesion,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,1
33116,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity recurrent,1
33117,Cutaneous Involvement,Urticaria Pigmentosa,1
33118,Malignant Cellular Infiltrate,Stage IIB Prostate Cancer AJCC v7,1
33119,Poorly Differentiated Neuroendocrine Lesion,Small Intestinal Neuroendocrine Carcinoma,1
33120,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
33121,Mixed Cellular Population,Gonadoblastoma,1
33122,Malignant Cellular Infiltrate,rhabdomyosarcoma of prostate,1
33123,Carcinomatous Component Present,Cholangiocarcinoma non-resectable,1
33124,Epithelial Component Present,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,1
33125,Low Mitotic Activity,Malignant Pancreatic Vipoma,1
33126,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of skin,1
33127,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
33128,Malignant Cellular Infiltrate,Stage IC Eyelid Carcinoma AJCC v7,1
33129,Carcinomatous Component Present,Stage IV Adrenal Cortex Carcinoma AJCC v8,1
33130,Malignant Cellular Infiltrate,Recurrent Classic Hodgkin Lymphoma,1
33131,Carcinomatous Component Present,Maxillary Sinus Adenoid Cystic Carcinoma,1
33132,In Situ Lesion,Carcinoma in situ in a polyp,1
33133,Low Grade Lesion,Recurrent Childhood Pilocytic Astrocytoma,1
33134,Malignant Cellular Infiltrate,Hereditary Papillary Renal Carcinoma,1
33135,Malignant Cellular Infiltrate,Blastema Predominant Kidney Wilms Tumor,1
33136,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory anemia with ring sideroblasts associated with marked thrombocytosis,1
33137,Cystic Change,Vulvar Seborrheic Keratosis,1
33138,Papillary Pattern,Adult Myxopapillary Ependymoma,1
33139,Malignant Cellular Infiltrate,Infiltrating duct and lobular carcinoma,1
33140,Mild cytologic atypia,Supraglottic Verrucous Carcinoma,1
33141,Carcinomatous Component Present,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
33142,Malignant Cellular Infiltrate,Stage IVB Basal Cell Lip Carcinoma,1
33143,Epithelial Component Present,Stage I Colorectal Cancer AJCC v6 and v7,1
33144,Malignant Cellular Infiltrate,Hereditary clear cell renal cell carcinoma,1
33145,Papillary Pattern,Papillomatosis,1
33146,Epithelial Component Present,Stage IIB Distal Bile Duct Cancer AJCC v7,1
33147,Tissue of Mullerian Origin Present,Vaginal Carcinosarcoma,1
33148,Hyaline Cartilage Differentiation,Childhood Mesenchymal Chondrosarcoma,1
33149,Epithelial Component Present,Sporadic Cylindroma,1
33150,High Grade Lesion,Pericardial Synovial Sarcoma,1
33151,Malignant Cellular Infiltrate,FIGO Stage II Ovarian Cancer,1
33152,Recurrent Genetic Abnormalities Present,Acute myeloid leukemia with abnormal marrow eosinophils,1
33153,Epithelial Component Present,Stage IIIC Hilar Cholangiocarcinoma AJCC v8,1
33154,Malignant Cellular Infiltrate,Cerebellar Papillary Meningioma,1
33155,Malignant Cellular Infiltrate,Malignant tumor of nasal sinuses,1
33156,Indolent Clinical Course,Subglottic Hemangioma,1
33157,Multinodular Mass,Peripheral Intraneural Angiosarcoma,1
33158,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Ovarian germ cell choriocarcinoma stage I,1
33159,Epithelial Component Present,Parathyroid Gland Adenocarcinoma,1
33160,Infiltrative Growth Pattern,Recurrent Childhood Giant Cell Glioblastoma,1
33161,Malignant Cellular Infiltrate,Pancreatic carcinoma resectable,1
33162,Malignant Cellular Infiltrate,Malignant neoplasm of adrenal cortex,1
33163,"Hyperkeratosis, Epidermolytic",Epidermolytic acanthoma,1
33164,Benign Cellular Infiltrate,Pancreatic Acinar Cell Cystadenoma,1
33165,Carcinomatous Component Present,Renal Pelvis Cancer by AJCC v7 Stage,1
33166,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II subdiaphragmatic,1
33167,Malignant Cellular Infiltrate,Tonsillar Undifferentiated Carcinoma,1
33168,Malignant Cellular Infiltrate,Borderline Resectable Carcinoma,1
33169,Secondary Lesion,Metastatic Unresectable Basal Cell Carcinoma,1
33170,Submucosal Tumor Growth,"Carcinoid, Goblet Cell",1
33171,Granulocytes Increased in Bone Marrow,"Leukemia, Myeloid, Chronic-Phase",1
33172,Biphasic Pattern,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
33173,Epithelial Component Present,Laryngeal Acantholytic Squamous Cell Carcinoma,1
33174,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,1
33175,Epithelial Component Present,Refractory Metastatic Digestive System Carcinoma,1
33176,Benign Cellular Infiltrate,Cerebellopontine Angle Schwannoma,1
33177,Intraosseous Lesion,Odontogenic myxoma,1
33178,Epithelial Component Present,Refractory Digestive System Neuroendocrine Neoplasm,1
33179,Dysplasia,adenoma of extrahepatic bile duct,1
33180,Nuclear pleomorphism,Uterine Corpus Bizarre Leiomyoma,1
33181,Epithelial Component Present,Recurrent Pancreatic Neuroendocrine Carcinoma,1
33182,Epithelial Component Present,Paranasal Sinus Cancer,1
33183,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
33184,Primary Lesion,Stage IVA Osteosarcoma AJCC v7,1
33185,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Acute myeloid leukemia, inv(16)(p13q22)",1
33186,Carcinomatous Component Present,Small cell lung cancer extensive stage,1
33187,Carcinomatous Component Present,Basal cell carcinoma - adenoid,1
33188,Toxic effect,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
33189,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
33190,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma stage I,1
33191,Well Differentiated Neuroendocrine Lesion,Intestinal Gangliocytic Paraganglioma,1
33192,Indolent Clinical Course,Endometrial stromal nodule,1
33193,Fibrotic Stroma Formation,High Grade Mucoepidermoid Breast Carcinoma,1
33194,Tissue Differentiation Uncertain,Childhood Desmoplastic Small Round Cell Tumor,1
33195,Malignant Cellular Infiltrate,Stage IVB Nasopharyngeal Carcinoma AJCC v7,1
33196,Exophytic Polypoid Lesion,Urethral Villous Adenoma,1
33197,Neuroendocrine Differentiation,Refractory Lung Small Cell Carcinoma,1
33198,Malignant Cellular Infiltrate,Marginal zone lymphoma refractory,1
33199,Indolent Clinical Course,Cardiac fibroma,1
33200,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vertebral column,1
33201,Carcinomatous Component Present,"Breast Cancer, Familial",1
33202,Epithelial Component Present,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",1
33203,Malignant Cellular Infiltrate,Small Intestinal Kaposi Sarcoma,1
33204,Mitotic Activity,Malignant Ovarian Luteinized Thecoma,1
33205,Well-Circumscribed Lesion,Ureteric polyp,1
33206,Cutaneous Involvement,Cutaneous Fibrous Histiocytoma,1
33207,Metastatic Lesion,Advanced Head and Neck Squamous Cell Carcinoma,1
33208,Refractory Disease,Refractory Undifferentiated Pleomorphic Sarcoma,1
33209,Epithelial Component Present,Anal Canal Squamous Intraepithelial Neoplasia,1
33210,Bilateral Disease,Contralateral Breast Carcinoma,1
33211,Malignant Cellular Infiltrate,Cervical Yolk Sac Tumor,1
33212,Squamous Metaplasia of Malignant Cells Present,adenocarcinoma of breast with squamous metaplasia,1
33213,Borderline Lesion,Borderline Ovarian Endometrioid Cystadenofibroma,1
33214,Cutaneous Involvement,Aleukemic Acute Lymphoblastic Leukemia Cutis,1
33215,Epithelial Component Present,Benign Testicular Sertoli Cell Tumor,1
33216,Multifocal Lesion,Periductal Breast Myoepitheliosis,1
33217,Adulthood Lesion,Adult Soft Tissue Sarcoma,1
33218,Malignant Cellular Infiltrate,Schneiderian carcinoma,1
33219,Malignant Cellular Infiltrate,Immunodeficiency-Related Malignant Neoplasm,1
33220,Carcinomatous Component Present,Grade 2 Clear Cell Renal Cell Carcinoma,1
33221,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Oropharynx,1
33222,Infiltrative Growth Pattern,Adult Gliosarcoma,1
33223,Collagenous Stroma Formation,Sclerosing Epithelioid Fibrosarcoma,1
33224,Tissue Differentiation Uncertain,Angiomyolipoma of kidney,1
33225,Epithelial Component Present,Paraganglioma,1
33226,Primary Lesion,Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma,1
33227,Papillary Pattern,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
33228,Malignant Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v8,1
33229,Cystic Change,Ovarian Endometrioid Cystadenoma,1
33230,Epithelial Component Present,Undifferentiated Fallopian Tube Carcinoma,1
33231,Hydropic Villous Change,Complete hydatidiform mole,1
33232,Epithelial Component Present,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,1
33233,Indolent Clinical Course,Spindle cell hemangioma,1
33234,Epithelial Component Present,Ovarian Carcinoid Tumor,1
33235,Positive Axillary Lymph Node,Occult Breast Carcinoma,1
33236,Papillary Pattern,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
33237,Lymphoplasmacytic Infiltrate,Pineal germinoma,1
33238,Malignant Cellular Infiltrate,Stage III Vaginal Cancer AJCC v6 and v7,1
33239,Low Mitotic Activity,Stage I Appendix Neuroendocrine Tumor AJCC v8,1
33240,Epithelial Component Present,Metanephric Tumor,1
33241,Malignant Cellular Infiltrate,Hepatoblastoma,1
33242,Resectable Mass,Resectable Extrahepatic Bile Duct Adenocarcinoma,1
33243,Malignant Cellular Infiltrate,Stage IIB Appendix Carcinoma AJCC v8,1
33244,Villous Pattern,Colonic tubulovillous adenoma,1
33245,Metastatic Lesion,Metastatic Oral Cavity Carcinoma,1
33246,Carcinomatous Component Present,Stage IV Lip Basal Cell Carcinoma,1
33247,Epithelial Component Present,Clinical Stage 0 Gastric Cancer AJCC v8,1
33248,Mitotic Activity,Epithelioid glioblastoma,1
33249,Carcinomatous Component Present,Recurrent Adult Liver Carcinoma,1
33250,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage I Merkel Cell Carcinoma AJCC v8,1
33251,Malignant Cellular Infiltrate,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
33252,Carcinomatous Component Present,Stage IVB Lung Cancer AJCC v8,1
33253,Cutaneous Involvement,"Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
33254,Secondary Lesion,Carcinomatosis of peritoneal cavity,1
33255,Malignant Cellular Infiltrate,Pineal Region Yolk Sac Tumor,1
33256,Epithelial Component Present,High Grade Salivary Gland Mucoepidermoid Carcinoma,1
33257,Mild cytologic atypia,Cervical Verrucous Carcinoma,1
33258,Epithelial Component Present,Liver and Intrahepatic Biliary Tract Carcinoma,1
33259,Carcinomatous Component Present,Refractory Carcinoma,1
33260,Secondary Lesion,Lung Carcinoma Metastatic in the Bone,1
33261,Nuclear pleomorphism,Hepatocellular Small Cell Change,1
33262,Thin Bands of Collagen Present,Thymus Solitary Fibrous Tumor,1
33263,Epithelial Component Present,Parasympathetic paraganglioma,1
33264,Metastatic Lesion,Metastatic Vulvar Carcinoma,1
33265,Epithelial Component Present,Papillary Renal Cell Carcinoma,1
33266,Multinodular Lesion,Uterine Corpus Dissecting Leiomyoma,1
33267,Malignant Cellular Infiltrate,Metastatic Uveal Melanoma,1
33268,Exophytic Polypoid Lesion,Gastrointestinal polyps,1
33269,Severe dysplasia,Stage 0 Pharynx Carcinoma,1
33270,Carcinomatous Component Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
33271,Malignant Cellular Infiltrate,Lung Pleomorphic Carcinoma,1
33272,Carcinomatous Component Present,Colorectal Cancer by AJCC v8 Stage,1
33273,Monomorphic Cellular Infiltrate,"Adenoma, Monomorphic",1
33274,Necrotic changes (finding),Cerebellar Glioblastoma,1
33275,Invasive Lesion,Moderately Differentiated Prostate Adenocarcinoma,1
33276,Metastatic Lesion,Adenocarcinoma of Unknown Primary,1
33277,Extranodal Extension,Refractory Extranodal Diffuse Large B-cell Lymphoma,1
33278,Well-Circumscribed Lesion,Malignant Cystosarcoma Phyllodes,1
33279,Malignant Cellular Infiltrate,Stage IV Ureter Cancer AJCC v8,1
33280,Malignant Cellular Infiltrate,Nasopharyngeal Carcinoma by AJCC v6 Stage,1
33281,Local disease,Intramuscular lipoma,1
33282,Malignant Cellular Infiltrate,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
33283,Secondary Lesion,Metastatic Gastric Carcinoma,1
33284,Carcinomatous Component Present,Colon cancer recurrent,1
33285,Dysplasia,Stage 0a Renal Pelvis and Ureter Cancer AJCC v7,1
33286,Malignant Cellular Infiltrate,Recurrent B-Cell Prolymphocytic Leukemia,1
33287,Anaplasia,Anaplastic Oligodendroglioma,1
33288,Aggressive Clinical Course,Mast-Cell Sarcoma,1
33289,Epithelial Component Present,Adenosquamous cell lung cancer stage IIIB,1
33290,Mixed Cellular Population,Benign Ovarian Seromucinous Tumor,1
33291,Neuroendocrine Differentiation,"Gastrinoma, malignant",1
33292,Malignant Cellular Infiltrate,Refractory Ewing Sarcoma,1
33293,Carcinomatous Component Present,Fallopian Tube Mucinous Adenocarcinoma,1
33294,Epithelial Component Present,Refractory Thymic Carcinoma,1
33295,Villous Pattern,Villous adenoma of colon,1
33296,Carcinomatous Component Present,Acinar cell carcinoma of pancreas,1
33297,Malignant Cellular Infiltrate,Treatment related leukaemia,1
33298,Benign Cellular Infiltrate,Breast Epithelioid Hemangioma,1
33299,Benign Cellular Infiltrate,Hobnail Hemangioma,1
33300,Malignant Cellular Infiltrate,sarcoma of rectum,1
33301,Benign Cellular Infiltrate,Myxoma of the Endocardium,1
33302,Metastatic Lesion,Metastatic Malignant Neoplasm in the Soft Tissues,1
33303,Adulthood Lesion,Adult Brain Medulloblastoma,1
33304,Childhood Lesion,Infant Leukemia,1
33305,Histiocytosis,T-cell/histiocyte rich large B-cell lymphoma,1
33306,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
33307,Vascular Channel Formation,Strawberry nevus of skin,1
33308,Malignant Cellular Infiltrate,Stage II Laryngeal Cancer AJCC v6 and v7,1
33309,Myxoid Stroma Formation,Chordoid meningioma,1
33310,Epithelial Component Present,Unresectable Lung Non-Small Cell Carcinoma,1
33311,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
33312,Indolent Clinical Course,Endobronchial lipoma,1
33313,Epithelial Component Present,Apudoma,1
33314,Acanthosis,Condyloma acuminata of cervix,1
33315,Benign Cellular Infiltrate,Desmoplastic trichoepithelioma,1
33316,Cystic Change,Pancreatic Intraductal Tubulopapillary Neoplasm,1
33317,Diffuse Pattern,Primary Cutaneous Intravascular Large B-Cell Lymphoma,1
33318,Carcinomatous Component Present,"Adenocarcinoma of lung, stage II",1
33319,Malignant Cellular Infiltrate,Prostate Carcinoma Metastatic in the Bone,1
33320,Hereditary Lesion,Short Limb Dwarfism-Saddle Nose-Spinal Alterations-Metaphyseal Striation Syndrome,1
33321,Malignant Cellular Infiltrate,lymphoma of spinal cord,1
33322,Well-Circumscribed Lesion,Polyp of vagina,1
33323,Epithelial Component Present,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
33324,Eccrine Differentiation,Eccrine carcinoma of skin,1
33325,Malignant Cellular Infiltrate,Childhood Seminoma,1
33326,Storiform Growth Pattern,"Dendritic Cell Sarcoma, Follicular",1
33327,Lymphoplasmacytic Infiltrate,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
33328,Biphasic Pattern,Ovarian Serous Adenofibroma,1
33329,Malignant Cellular Infiltrate,Metastatic carcinoid tumor,1
33330,Cutaneous Involvement,Pilar tumor,1
33331,Benign Cellular Infiltrate,Benign neoplasm of spleen,1
33332,Malignant Cellular Infiltrate,Adult Anaplastic Oligodendroglioma,1
33333,Malignant Cellular Infiltrate,germinoma of brain,1
33334,Cutaneous Involvement,Solar Radiation-Related Cutaneous Melanoma,1
33335,Malignant Cellular Infiltrate,Stage I Bone Cancer AJCC v7,1
33336,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
33337,Childhood Lesion,Childhood Laryngeal Carcinoma,1
33338,Cystic Change,Mucoepidermoid carcinoma of the oral cavity stage II,1
33339,Malignant Cellular Infiltrate,Stage 0 Eyelid Carcinoma AJCC v7,1
33340,Epithelial Component Present,Ovarian Sclerosing Stromal Tumor,1
33341,Malignant Cellular Infiltrate,Cutaneous Precursor Lymphoid Neoplasm,1
33342,Primary Lesion,Stage IVB Osteosarcoma AJCC v7,1
33343,Malignant Cellular Infiltrate,Stage IIIC Rectal Cancer AJCC v7,1
33344,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v7,1
33345,Cutaneous Involvement,"Lymphoma, T-Cell, Cutaneous",1
33346,Immunosuppression-Related Post-Transplant Toxicity,Intestinal Graft Versus Host Disease,1
33347,Malignant Cellular Infiltrate,Familial Nonmedullary Thyroid Gland Carcinoma,1
33348,Epithelial Component Present,Hypopharyngeal Carcinoma by AJCC v8 Stage,1
33349,Skin nodule,Nodulo-ulcerative basal cell carcinoma,1
33350,Epithelial Component Present,Adenosquamous cell lung cancer,1
33351,Malignant Cellular Infiltrate,Cutaneous Mature B-Cell Neoplasm,1
33352,Malignant Cellular Infiltrate,Stage IV Rectosigmoid Cancer AJCC v7,1
33353,Skin nodule,Skin Nodular Solid Basal Cell Carcinoma,1
33354,Cutaneous Involvement,Locally Advanced Skin Squamous Cell Carcinoma,1
33355,Stromal Invasion,Stage IIA Ovarian Cancer AJCC v8,1
33356,Indolent Clinical Course,Bladder Leiomyoma,1
33357,No Identifiable Line of Differentiation,Central Nervous System Undifferentiated Pleomorphic Sarcoma,1
33358,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage II,1
33359,Endophytic Tumor Growth,Subglottic Verrucous Carcinoma,1
33360,Epithelial Component Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
33361,Carcinomatous Component Present,Upper Gingival Verrucous Carcinoma,1
33362,Malignant Cellular Infiltrate,Childhood Leukemia,1
33363,Epithelial Component Present,High Grade Mucoepidermoid Breast Carcinoma,1
33364,Microvascular Proliferation,Adult Gliosarcoma,1
33365,Vascular Channel Formation,Childhood Epithelioid Hemangioendothelioma,1
33366,Malignant Cellular Infiltrate,Colon Cancer by AJCC v6 Stage,1
33367,Glomeruloid Vessels Present,Juvenile Pilocytic Astrocytoma,1
33368,Diffuse Pattern,Anaplastic Brain Stem Astrocytoma,1
33369,Well-Circumscribed Lesion,Polyp of nasal sinus,1
33370,Nuclear Expression of STAT6 Protein,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,1
33371,Malignant Cellular Infiltrate,Stage IV Lip Basal Cell Carcinoma,1
33372,Epithelial Component Present,Esophageal Adenocarcinoma by AJCC v8 Pathologic Stage,1
33373,Malignant Cellular Infiltrate,Ann Arbor Stage IV Aggressive Adult Non-Hodgkin Lymphoma,1
33374,Adnexal Differentiation,Eyelid Sebaceous Gland Carcinoma,1
33375,Nodular lesions,Thyroid Gland Spindle Cell Follicular Adenoma,1
33376,Malignant Cellular Infiltrate,Gastric Pylorus Carcinoma In Situ AJCC v6 and v7,1
33377,Poorly Differentiated Neuroendocrine Lesion,Metastatic Gastric Neuroendocrine Carcinoma,1
33378,Infiltrative Growth Pattern,Gemistocytic astrocytoma,1
33379,No Identifiable Line of Differentiation,Resectable Undifferentiated Pleomorphic Sarcoma,1
33380,Multinodular Mass,Childhood Angiosarcoma,1
33381,Pathologic TNM Finding,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage,1
33382,Papillary Pattern,Epididymal Papillary Cystadenoma,1
33383,Epithelial Component Present,Lung Cancer by AJCC v6 Stage,1
33384,Diffuse Pattern,Anaplastic Hemispheric Astrocytoma,1
33385,Epithelial Component Present,Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor,1
33386,Malignant Cellular Infiltrate,Metastatic Bile Duct Carcinoma,1
33387,Osseous Differentiation,Osteosarcoma by AJCC v7 Stage,1
33388,Local disease,Intramuscular lipoma,1
33389,Epithelial Component Present,squamous cell carcinoma of ureter,1
33390,Refractory Disease,Refractory Lung Carcinoma,1
33391,Malignant Cellular Infiltrate,Clinical Stage II Gastric Cancer AJCC v8,1
33392,Papillary Pattern,Vaginal Warty Carcinoma,1
33393,High Mitotic Activity,Malignant Solitary Fibrous Tumor,1
33394,Epithelial Component Present,"Transitional cell papilloma, inverted",1
33395,Primary Lesion,Adult Brain Stem Glioma,1
33396,Epithelial Component Present,Ampulla of Vater Cancer by AJCC v7 Stage,1
33397,Carcinomatous Component Present,Clear Cell Intrahepatic Cholangiocarcinoma,1
33398,Thyroglobulin Positive Neoplastic Cells Present,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
33399,Regional Disease,Locally Advanced Melanoma,1
33400,Benign Cellular Infiltrate,Benign Uveal Neoplasm,1
33401,Epithelial Component Present,Hereditary Male Breast Carcinoma,1
33402,Metastatic Lesion,Myxoid liposarcoma metastatic,1
33403,Epithelial Component Present,Stage IVA Colorectal Cancer AJCC v7,1
33404,Absence of Invasion,Lobular carcinoma in situ of breast,1
33405,Encapsulated Mass,Parotid Gland Warthin Tumor,1
33406,Secondary Lesion,Advanced Squamous Cell Carcinoma of the Oropharynx,1
33407,Diffuse Pattern,Childhood Immunoblastic Lymphoma,1
33408,Malignant Cellular Infiltrate,Metastatic Thyroid Gland Papillary Carcinoma,1
33409,Refractory Disease,Refractory Urothelial Carcinoma,1
33410,Malignant Cellular Infiltrate,Papillary Meningioma,1
33411,Fibrotic Stroma Formation,Mucoepidermoid carcinoma of the oral cavity stage III,1
33412,Epithelial Component Present,Breast Carcinoma with Melanotic Features,1
33413,Insular Pattern,Pancreatic Somatostatinoma,1
33414,Nodular lesions,Liver Dysplastic Nodule,1
33415,No Identifiable Line of Differentiation,Cardiac Malignant Fibrous Histiocytoma,1
33416,Metastatic Lesion,Good Prognosis Metastatic Gestational Trophoblastic Tumor,1
33417,Epithelial Component Present,Ethmoid Sinus Adenoid Cystic Carcinoma,1
33418,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type I,1
33419,Extracutaneous Dissemination of Disease,Mycosis fungoides stage IV,1
33420,Epithelial Component Present,Glucagonoma,1
33421,Childhood Lesion,Childhood Acute Myeloid Leukemia,1
33422,Absence of Stromal Invasion,Serous Borderline Broad Ligament Tumor/Atypical Proliferative Serous Broad Ligament Tumor,1
33423,Non-Hereditary Lesion,Sporadic Breast Carcinoma,1
33424,Painless Mass,Soft tissue chondroma,1
33425,Malignant Cellular Infiltrate,Malignant Intracranial Neoplasm,1
33426,Epithelial Component Present,Bladder transitional cell carcinoma stage IV,1
33427,Metastatic Lesion,Metastatic Unresectable Basal Cell Carcinoma,1
33428,Epithelial Component Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
33429,Secondary Lesion,Advanced Unfavorable Non-Hodgkin Lymphoma,1
33430,Nuclear pleomorphism,High Grade Ductal Breast Carcinoma In Situ,1
33431,Childhood Lesion,Recurrent Childhood Lymphoblastic Lymphoma,1
33432,Cutaneous Involvement,Chronic Bullous Disease of Childhood,1
33433,Immunologic Deficiency Syndromes,AIDS-Related Herpes Zoster,1
33434,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
33435,Primary Lesion,Childhood Alveolar Rhabdomyosarcoma,1
33436,Malignant Cellular Infiltrate,Salivary Gland Myoepithelial Carcinoma,1
33437,Malignant Cellular Infiltrate,Sporadic Burkitt's lymphoma,1
33438,Low Grade Neuroendocrine Lesion,Carcinoid tumor of appendix,1
33439,Epithelial Component Present,carcinoma of middle ear,1
33440,Dysplasia,Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7,1
33441,Multinodular Mass,Hemangiosarcoma,1
33442,Adulthood Lesion,Stage I Adult Immunoblastic Lymphoma,1
33443,Malignant Cellular Infiltrate,Refractory Thyroid Gland Carcinoma,1
33444,Secondary Lesion,Secondary Prostate Urothelial Carcinoma,1
33445,Childhood Lesion,Diffuse Intrinsic Pontine Glioma,1
33446,Pathologic TNM Finding,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Pathologic Stage,1
33447,Malignant Cellular Infiltrate,Stage III Retroperitoneal Sarcoma AJCC v8,1
33448,Malignant Cellular Infiltrate,Malignant Melanotic Peripheral Nerve Sheath Tumor of the Mediastinum,1
33449,Therapy-Related Toxicity,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,1
33450,Epithelial Component Present,Poorly Differentiated Hepatocellular Carcinoma,1
33451,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of rectum,1
33452,Epithelial Component Present,Pancreatic neuroendocrine tumor metastatic,1
33453,Well Differentiated Neuroendocrine Lesion,Colon Neuroendocrine Tumor by AJCC v8 Stage,1
33454,Cutaneous Involvement,Toxic Epidermal Necrolysis,1
33455,Malignant Cellular Infiltrate,Acinar Prostate Mucinous Adenocarcinoma,1
33456,Cutaneous Involvement,Seborrheic keratosis of eyelid,1
33457,Immunologic Deficiency Syndromes,Transplant-Related Renal Cell Carcinoma,1
33458,Local disease,Localized Malignant Neoplasm,1
33459,Well Differentiated Neuroendocrine Lesion,Appendix L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
33460,Epithelial Component Present,Breast Apocrine Adenoma,1
33461,Myxoid Stroma Formation,Locally Advanced Epithelioid Hemangioendothelioma,1
33462,Epithelial Component Present,Stage IIIC Prostate Cancer AJCC v8,1
33463,Papillary Pattern,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
33464,Metastatic Lesion,Metastatic Prostate Small Cell Carcinoma,1
33465,Unilineage Dysplasia Present,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
33466,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
33467,Malignant Cellular Infiltrate,Parasite-Related Carcinoma,1
33468,Carcinomatous Component Present,Infiltrating Ureter Urothelial Carcinoma with Squamous Differentiation,1
33469,Carcinomatous Component Present,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
33470,Papillary Pattern,Cervical Papillary Squamous Cell Carcinoma,1
33471,Malignant Cellular Infiltrate,Stage II Vulvar Cancer AJCC v7,1
33472,Epithelial Component Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,1
33473,Aggressive Clinical Course,"Leukemia, Mast-Cell",1
33474,Tissue Differentiation Uncertain,Extrarenal Rhabdoid Tumor of the Liver,1
33475,Hyperplastic Tissue Present,Islet Glucagon Cell Hyperplasia,1
33476,Epithelial Component Present,Stage III Lip and Oral Cavity Cancer AJCC v8,1
33477,Dermal Involvement,Compound nevus of skin,1
33478,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma stage IV,1
33479,Well-Circumscribed Lesion,Small Intestinal Tubulovillous Adenoma,1
33480,Malignant Cellular Infiltrate,Temporal Lobe Anaplastic Astrocytoma,1
33481,Carcinomatous Component Present,Stage I Anal Cancer AJCC v8,1
33482,Malignant Cellular Infiltrate,Lung adenocarcinoma recurrent,1
33483,Malignant Cellular Infiltrate,"Hodgkin's disease, nodular sclerosis of lymph nodes of multiple sites",1
33484,Malignant Cellular Infiltrate,Mediastinal seminoma,1
33485,Malignant Cellular Infiltrate,Squamous cell carcinoma of lip,1
33486,Hemorrhagic,Metastatic angiosarcoma,1
33487,Epithelial Component Present,Metastatic Hypopharyngeal Carcinoma,1
33488,Malignant Cellular Infiltrate,ROSE Cluster 8,1
33489,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage I,1
33490,Cutaneous Involvement,Desmoplastic trichoepithelioma,1
33491,Malignant Cellular Infiltrate,Endometrial Mucinous Adenocarcinoma,1
33492,Epithelial Component Present,Cystadenoma of pancreas,1
33493,Epithelial Component Present,Stage IV Thymoma AJCC v8,1
33494,Malignant Cellular Infiltrate,Advanced Oral Cavity Squamous Cell Carcinoma,1
33495,Somatostatin Positive Neoplastic Cells Present,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
33496,Adulthood Lesion,Ann Arbor Stage II Contiguous Adult Non-Hodgkin Lymphoma,1
33497,Benign Cellular Infiltrate,Prostatic Adenoma,1
33498,Low Mitotic Activity,Gastric Gastrin-Producing Neuroendocrine Tumor,1
33499,Biphasic Pattern,carcinosarcoma of fallopian tube,1
33500,Epithelial Component Present,Recurrent Urinary System Carcinoma,1
33501,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v8 Clinical Stage,1
33502,Papillary Pattern,Spindle Cell Variant Thyroid Gland Papillary Carcinoma,1
33503,Ineffective hematopoiesis,Secondary Myelodysplastic Syndrome,1
33504,Dysplasia,High grade cervical glandular intraepithelial neoplasia,1
33505,Benign Cellular Infiltrate,Sellar Mature Teratoma,1
33506,Cartilaginous Differentiation,Subungual exostoses,1
33507,Vascular Channel Formation,Pleural Epithelioid Hemangioendothelioma,1
33508,Geographic Necrosis,Pilomatrix carcinoma of skin,1
33509,Malignant Cellular Infiltrate,Stage IV Adult Liver Cancer AJCC v7,1
33510,Lytic lesion,Malignant Giant Cell Tumor of Bone,1
33511,Papillary Pattern,Buccal Mucosa Verrucous Carcinoma,1
33512,Carcinomatous Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
33513,Absence of Invasion,Carcinoma in situ of prostate,1
33514,Indolent Clinical Course,Desmoplastic fibroblastoma,1
33515,Stromal Invasion,Ovarian adenocarcinoma,1
33516,Malignant Cellular Infiltrate,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
33517,Epithelial Component Present,Stage IIIB Lung Cancer AJCC v7,1
33518,Refractory Disease,Mycosis fungoides refractory,1
33519,Epithelial Component Present,Metastatic Breast Carcinoid Tumor,1
33520,Epithelial Component Present,Penile intraepithelial neoplasia,1
33521,Epithelial Component Present,Distal Esophagus Squamous Cell Carcinoma,1
33522,Malignant Cellular Infiltrate,Recurrent Malignant Extragonadal Germ Cell Tumor,1
33523,Epithelial Component Present,Intraductal Cribriform Breast Adenocarcinoma,1
33524,Pregnancy Complications,Toxemia of pregnancy,1
33525,Peripheral Nuclear Palisading,"Ovarian Small Cell Carcinoma, Pulmonary Type",1
33526,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Adult Acute Monoblastic and Monocytic Leukemia,1
33527,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v6,1
33528,Malignant Cellular Infiltrate,Low Grade Salivary Gland Carcinoma,1
33529,Slow Growing Mass,Adult Pilocytic Astrocytoma,1
33530,Borderline Lesion,Pancreatic Intraepithelial Neoplasia-3,1
33531,Aggressive Clinical Course,"Leukemia, Mast-Cell",1
33532,Epithelial Component Present,Filiform Serrated Adenoma,1
33533,Carcinomatous Component Present,Adenocarcinoma of colon,1
33534,Carcinomatous Component Present,Prostate Carcinoma Metastatic in the Bone,1
33535,Malignant Cellular Infiltrate,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,1
33536,Epithelial Component Present,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
33537,Acanthosis,Condyloma acuminata of vulva,1
33538,CD30-Positive Neoplastic Cells Present,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
33539,Childhood Lesion,Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation,1
33540,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged,1
33541,Epithelial Component Present,Papilloma,1
33542,Metastatic Lesion,Small intestine carcinoma metastatic,1
33543,Malignant Cellular Infiltrate,Stage IVA Uterine Sarcoma AJCC v7,1
33544,Primary Lesion,Childhood Cerebral Astrocytoma,1
33545,Neuroendocrine Differentiation,Stage III Appendix Neuroendocrine Tumor AJCC v8,1
33546,Epithelial Component Present,Stage IV Eyelid Carcinoma AJCC v8,1
33547,Exophytic Polypoid Lesion,Malignant lymphomatous polyposis,1
33548,Malignant Cellular Infiltrate,Prostate Acinar Adenocarcinoma,1
33549,Malignant Cellular Infiltrate,Stage I Adult Soft Tissue Sarcoma AJCC v7,1
33550,Malignant Cellular Infiltrate,Stage IV Renal Cell Cancer AJCC v7,1
33551,Carcinomatous Component Present,Refractory Urothelial Carcinoma,1
33552,Carcinomatous Component Present,Advanced Hypopharyngeal Squamous Cell Carcinoma,1
33553,Cutaneous Involvement,Pemphigoid Gestationis,1
33554,Malignant Cellular Infiltrate,"Salivary Gland Clear Cell Carcinoma, Not Otherwise Specified",1
33555,Malignant Cellular Infiltrate,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
33556,Unresectable Mass,Unresectable Adrenal Cortex Carcinoma,1
33557,Local disease,Fallopian Tube Adenomatoid Tumor,1
33558,"Nodular, Reticulin-Free Zones Present",Desmoplastic Medulloblastoma,1
33559,Diffuse Pattern,Intraocular Malignant Peripheral Nerve Sheath Tumor,1
33560,High Mitotic Activity,Medullary carcinoma of breast,1
33561,Carcinomatous Component Present,Breast Carcinoma Metastatic in the Liver,1
33562,Malignant Cellular Infiltrate,Stage III Cervical Cancer AJCC v6 and v7,1
33563,Malignant Cellular Infiltrate,Sweat gland carcinoma,1
33564,Carcinomatous Component Present,Intraepithelial Squamous Cell Carcinoma,1
33565,Malignant Cellular Infiltrate,Secondary malignant neoplasm of bone,1
33566,Epithelial Component Present,Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7,1
33567,Malignant Cellular Infiltrate,Adult Anaplastic Ependymoma,1
33568,Locally Aggressive Lesion,Gastric Inflammatory Myofibroblastic Tumor,1
33569,Metastatic Lesion,Meningeal Carcinomatosis,1
33570,Hereditary Lesion,Hereditary clear cell renal cell carcinoma,1
33571,Dilated Terminal Duct Lobular Units Present,Columnar Cell Change of the Breast,1
33572,Indolent Clinical Course,Colon Lipoma,1
33573,Malignant Cellular Infiltrate,Malignant neoplasm of prostate,1
33574,Malignant Cellular Infiltrate,Digestive System Hodgkin Lymphoma,1
33575,Malignant Cellular Infiltrate,Malignant Pulmonary Vein Neoplasm,1
33576,Ground Glass Nuclear Inclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
33577,Carcinomatous Component Present,Stage III Gallbladder Cancer AJCC v8,1
33578,Intraosseous Lesion,Odontogenic myxofibroma,1
33579,Malignant Cellular Infiltrate,pineoblastoma,1
33580,Cystic Change,"Papillary mucinous cystadenoma, borderline malignancy",1
33581,Childhood Lesion,Infant T Acute Lymphoblastic Leukemia,1
33582,Epithelial Component Present,Apudoma,1
33583,Exophytic Papillary Lesion,Exophytic Schneiderian Papilloma,1
33584,Malignant Cellular Infiltrate,Metastases to abdominal cavity,1
33585,Epithelial Component Present,Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
33586,Chronic Inflammatory Infiltrate,Stage III Ovarian Dysgerminoma AJCC v6 and v7,1
33587,High Grade Lesion,Grade III Childhood Astrocytoma,1
33588,Cutaneous Involvement,"Nevus, Spindle Cell",1
33589,Malignant Cellular Infiltrate,Stage IIB Rectal Cancer AJCC v7,1
33590,Mixed Cellular Population,Vulvar Ectopic Fibroadenoma,1
33591,Indolent Clinical Course,fibroma of testis,1
33592,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage IV,1
33593,Osteoid formation,Childhood Conventional Osteosarcoma,1
33594,Lymphoplasmacytic Infiltrate,Angiocentric immunoproliferative lesion grade 2,1
33595,Low Grade Lesion,Low Grade Fibromyxoid Sarcoma with Giant Collagen Rosettes,1
33596,Fibrotic Stroma Formation,Borderline Ovarian Clear Cell Cystadenofibroma,1
33597,Congenital Lesion,Congenital melanocytic nevus,1
33598,Diffuse Lesion,Squamous papillomatosis,1
33599,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage III,1
33600,Malignant Cellular Infiltrate,Metastatic Vulvar Carcinoma,1
33601,Exophytic Papillary Lesion,Vaginal Warty Carcinoma,1
33602,Mixed Cellular Population,Mixed parotid tumor,1
33603,Clinical TNM Finding,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
33604,Epithelial Component Present,Apocrine Breast Carcinoma In Situ,1
33605,Lobulated Growth Pattern,Pyogenic granuloma,1
33606,Malignant Component Present,Sellar Teratoma with Malignant Transformation,1
33607,Cutaneous Involvement,Spindle cell nevus of Reed,1
33608,Indolent Clinical Course,Desmoplastic fibroblastoma,1
33609,Lesion with Diameter of 10mm or Less,Non-Functioning Pituitary Gland Microadenoma,1
33610,Carcinomatous Component Present,Metastatic Adenoid Cystic Carcinoma,1
33611,Secondary Lesion,Metastatic Breast Neuroendocrine Neoplasm,1
33612,Invasive Lesion,Inflammatory carcinoma of breast recurrent,1
33613,Epithelial Component Present,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
33614,Malignant Cellular Infiltrate,Childhood Myelodysplastic Syndrome,1
33615,Chromogranin A Positive Neoplastic Cells Present,Childhood Carcinoid Tumor,1
33616,Follicular Cell Differentiation,Stage IV Differentiated Thyroid Gland Carcinoma AJCC v8,1
33617,Epithelial Component Present,Stage IV Hepatocellular Carcinoma AJCC v6,1
33618,Malignant Cellular Infiltrate,Stage IA Ovarian Cancer,1
33619,Systemic disease,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative",1
33620,Tissue of Mullerian Origin Present,Ovarian Adenosarcoma,1
33621,Epithelial Component Present,Lung Enteric Adenocarcinoma,1
33622,Primary Site Unknown,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
33623,High Mitotic Activity,Childhood Choroid Plexus Carcinoma,1
33624,Malignant Cellular Infiltrate,Stage IIIA Esophageal Adenocarcinoma AJCC v7,1
33625,Secondary Lesion,Secondary malignant neoplasm of axilla,1
33626,Epithelial Component Present,Gastric adenoma,1
33627,Epithelial Component Present,undifferentiated carcinoma of salivary gland,1
33628,"Undifferentiated ""Fetal-Type"" Tissues Present",Pineal Region Immature Teratoma,1
33629,Epithelial Component Present,mucinous adenocarcinofibroma of ovary,1
33630,Secondary Lesion,Secondary Supratentorial Anaplastic Astrocytoma,1
33631,Carcinomatous Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
33632,Malignant Cellular Infiltrate,Childhood Ovarian Dysgerminoma,1
33633,Malignant Cellular Infiltrate,Grade 3b Follicular Lymphoma,1
33634,Adnexal Differentiation,Apocrine adenoma,1
33635,'Starry-sky' pattern,Colon Burkitt Lymphoma,1
33636,Carcinomatous Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v7,1
33637,Hemosiderin pigmentation,Hemosiderotic Fibrolipomatous Tumor,1
33638,Indolent Clinical Course,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
33639,Neuroendocrine Differentiation,Refractory Neuroendocrine Neoplasm,1
33640,Diffuse Pattern,Mediastinal (Thymic) Large B-Cell Lymphoma,1
33641,Carcinomatous Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
33642,Carcinomatous Component Present,Thymic Undifferentiated Carcinoma,1
33643,Malignant Cellular Infiltrate,Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8,1
33644,Poorly Differentiated Lesion,Poorly Differentiated Prostate Adenocarcinoma,1
33645,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma by AJCC v7 Stage,1
33646,Carcinomatous Component Present,Colorectal Serrated Adenocarcinoma,1
33647,Neoplastic Monocytes and Precursors 20 Percent or More of Bone Marrow Cells,"Acute myeloid leukemia, t(16;16)(p13;q22)",1
33648,Extraosseous Lesion,Extraskeletal osteosarcoma non-metastatic,1
33649,Epithelial Component Present,Poorly Cohesive Gastric Carcinoma,1
33650,Unresectable Mass,Cholangiocarcinoma non-resectable,1
33651,Well-Circumscribed Lesion,Fibrous polyp,1
33652,Malignant Cellular Infiltrate,Eyelid Carcinoma by AJCC v7 Stage,1
33653,Malignant Cellular Infiltrate,Invasive Mucinous Lung Adenocarcinoma,1
33654,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
33655,Epithelial Component Present,Ovarian Mixed Germ Cell-Sex Cord-Stromal Tumor,1
33656,Carcinomatous Component Present,Castration-Sensitive Prostate Carcinoma,1
33657,Infantile Lesion,Infantile fibrosarcoma,1
33658,Cutaneous Involvement,Reactive Cutaneous Fibrous Lesion,1
33659,Pushing Tumor Margin,Verrucous carcinoma of the oral cavity recurrent,1
33660,Hereditary Lesion,PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA,1
33661,Epithelial Component Present,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
33662,Chromogranin A Positive Neoplastic Cells Present,Advanced Carcinoid Tumor,1
33663,Epithelial Component Present,Malignant phyllodes tumor of breast,1
33664,Epithelial Component Present,Esophageal Neuroendocrine Tumor,1
33665,Malignant Cellular Infiltrate,Oropharyngeal Poorly Differentiated Carcinoma,1
33666,Malignant Cellular Infiltrate,mucinous adenocarcinofibroma of ovary,1
33667,Malignant Cellular Infiltrate,Stage 0 Merkel Cell Carcinoma AJCC v7,1
33668,Benign Cellular Infiltrate,Dermoid cyst of orbit,1
33669,Malignant Cellular Infiltrate,"Intracranial Embryonal Tumor, Not Otherwise Specified",1
33670,Cartilaginous Component Present,Hamartoma of lung,1
33671,Malignant Cellular Infiltrate,"Leukemia, Radiation-Induced",1
33672,Epithelial Component Present,Metaplastic carcinoma of breast,1
33673,Cutaneous Involvement,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
33674,Perineural spread,Minor Salivary Gland Adenoid Cystic Carcinoma,1
33675,Well Differentiated Neuroendocrine Lesion,Stage III Jejunal Neuroendocrine Tumor AJCC v8,1
33676,Indolent Clinical Course,Classic Rhabdomyoma,1
33677,Adnexal Differentiation,Vulvar Trichoepithelioma,1
33678,Benign Cellular Infiltrate,Degenerated Schwannoma,1
33679,Epithelial Component Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,1
33680,Cutaneous Involvement,Skin squamous cell carcinoma recurrent,1
33681,Secondary Lesion,Locally Advanced Melanoma,1
33682,WNT Pathway Activated,"Medulloblastoma, WNT-Activated",1
33683,Refractory Disease,Refractory Lymphoproliferative Disorder,1
33684,Malignant Cellular Infiltrate,Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma,1
33685,Severe cytologic atypia,Advanced Gastric Small Cell Neuroendocrine Carcinoma,1
33686,"Fully Differentiated ""Adult-Type"" Tissues Present","Teratoma, Malignant",1
33687,Carcinomatous Component Present,Vulvar Cancer by AJCC v7 Stage,1
33688,Well Differentiated Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
33689,Thin Bands of Collagen Present,Sellar Solitary Fibrous Tumor/Hemangiopericytoma,1
33690,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,"Leukemia, Prolymphocytic, B-Cell",1
33691,Microcystic Change,Adult Subependymoma,1
33692,Epithelial Component Present,Metastatic Lip and Oral Cavity Carcinoma,1
33693,Cutaneous Involvement,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,1
33694,Immunologic Deficiency Syndromes,Steroid Refractory Graft Versus Host Disease,1
33695,Epithelial Component Present,Bladder adenocarcinoma stage IV,1
33696,Malignant Cellular Infiltrate,Lobular carcinoma in situ of breast,1
33697,Carcinomatous Component Present,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
33698,Endophytic Tumor Growth,Laryngeal verrucous carcinoma stage IV,1
33699,Invasive Lesion,Invasive Malignant Neoplasm,1
33700,Diffuse Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,1
33701,Hyaline Cartilage Differentiation,Mesenchymal Chondrosarcoma,1
33702,Malignant Cellular Infiltrate,polyembryoma of testis,1
33703,Malignant Cellular Infiltrate,FIGO Stage IC1 Ovarian Cancer,1
33704,Malignant Cellular Infiltrate,Recurrent Head and Neck Carcinoma,1
33705,Primary Lesion,Stage IV Hepatocellular Carcinoma AJCC v8,1
33706,Pathologic TNM Finding,Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8,1
33707,Carcinomatous Component Present,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,1
33708,Epithelial Component Present,BCLC Stage D Hepatocellular Carcinoma,1
33709,Carcinomatous Component Present,Malignant neoplasm of stomach stage I,1
33710,Pathologic TNM Finding,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,1
33711,Malignant Cellular Infiltrate,Angiosarcoma NCI Grade 3,1
33712,Invasive Lesion,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
33713,Malignant Cellular Infiltrate,Methotrexate-Associated Burkitt Lymphoma,1
33714,Cutaneous Involvement,Cutaneous Hematopoietic and Lymphoid Cell Neoplasm,1
33715,Adnexal Differentiation,Hidrocystoma,1
33716,Tissue of Mullerian Origin Present,Adenomyoma,1
33717,Malignant Cellular Infiltrate,"Sarcoma, metastatic",1
33718,Dilated Cystic Spaces Present,Tubulocystic renal cell carcinoma,1
33719,Benign Cellular Infiltrate,Serous cystadenoma of ovary,1
33720,Carcinomatous Component Present,Multicentric Breast Carcinoma,1
33721,Epithelial Component Present,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
33722,Primary Lesion,BCLC Stage C Adult Hepatocellular Carcinoma,1
33723,Malignant Cellular Infiltrate,Malignant neoplasm of endocervix,1
33724,Malignant Cellular Infiltrate,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
33725,Tubular Structures Present,"Adenocarcinoma, Tubular",1
33726,Severe dysplasia,Stage 0 Rectosigmoid Cancer AJCC v6 and v7,1
33727,Solitary mass,Cardiac Epithelioid Hemangioendothelioma,1
33728,Squamous Metaplasia of Malignant Cells Present,adenocarcinoma of breast with squamous metaplasia,1
33729,Hyaline Cartilage Differentiation,Grade III Chondrosarcoma,1
33730,Immunologic Deficiency Syndromes,AIDS-Related Retinopathy,1
33731,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Fetiform Teratoma,1
33732,Well Differentiated Lesion,Warty Carcinoma of the Penis,1
33733,Carcinomatous Component Present,Prostate cancer stage B,1
33734,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v7 Stage,1
33735,Benign Cellular Infiltrate,Benign Cardiac Germ Cell Tumor,1
33736,Absence of Invasion,Intraductal Non-Comedo Breast Adenocarcinoma,1
33737,Stromal Invasion,Platinum-Resistant Ovarian Carcinoma,1
33738,Infiltrative Growth Pattern,Anaplastic astrocytoma,1
33739,Epithelial Component Present,Hard Palate Adenoid Cystic Carcinoma,1
33740,Carcinomatous Component Present,Stage IVA Colon Cancer AJCC v7,1
33741,High Grade Lesion,Rhabdomyosarcoma of the orbit,1
33742,Epithelial Component Present,Refractory Lung Carcinoma,1
33743,Nuclear Molding,Metastatic Lung Small Cell Carcinoma,1
33744,Epithelial Component Present,Refractory Bile Duct Carcinoma,1
33745,Cystic Change,Cystadenofibroma,1
33746,Well Differentiated Lesion,mucinous adenocarcinoma of lung,1
33747,Epithelial Component Present,Stage 0 Colorectal Cancer AJCC v6 and v7,1
33748,Primary Lesion,Temporal Lobe Anaplastic Astrocytoma,1
33749,Follicular Cell Differentiation,Stage III Thyroid Gland Papillary Carcinoma AJCC v8,1
33750,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
33751,Recurrent disease,Recurrent Aggressive NK-Cell Leukemia,1
33752,Epithelial Component Present,Recurrent Biliary Tract Carcinoma,1
33753,Benign Cellular Infiltrate,Colorectal Leiomyoma,1
33754,Indolent Clinical Course,benign neoplasm of lymph nodes,1
33755,Endophytic Tumor Growth,Anal Verrucous Carcinoma,1
33756,Recurrent disease,Recurrent Grade II Lymphomatoid Granulomatosis,1
33757,Malignant Cellular Infiltrate,Non-Small Cell Lung Carcinoma,1
33758,Neuroendocrine Differentiation,Neuroendocrine neoplasm of larynx,1
33759,Follicular Cell Differentiation,Childhood Thyroid Gland Papillary Carcinoma,1
33760,Cutaneous Involvement,Digital papillary eccrine carcinoma of skin,1
33761,Papillary Pattern,Serous surface papillary carcinoma,1
33762,Cystic Change,"Cystadenocarcinoma, Serous",1
33763,Ground Glass Nuclear Inclusion,Papillary thyroid carcinoma,1
33764,Epithelial Component Present,"Carcinoma, Basal Cell",1
33765,Carcinomatous Component Present,Stage IIA Colorectal Cancer AJCC v8,1
33766,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Somatostatinoma,1
33767,Single Type of Tissue Derived from One Embryonic Layer Present,Monodermal teratoma,1
33768,Vacuolated Plasma Cells in the Bone Marrow,mu-Chain Disease,1
33769,Chromogranin A Positive Neoplastic Cells Present,Gallbladder Neuroendocrine Tumor G1,1
33770,Malignant Cellular Infiltrate,"Bladder Non-Invasive Papillary Urothelial Carcinoma, Low Grade",1
33771,Mild cytologic atypia,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
33772,Splenomegaly,Hairy Cell Leukemia,1
33773,Carcinomatous Component Present,Stage IVB Laryngeal Cancer AJCC v7,1
33774,Exophytic Polypoid Lesion,Endometrial Polyp,1
33775,Epithelial Component Present,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,1
33776,Carcinomatous Component Present,Squamous cell carcinoma with horn formation,1
33777,Nodular Pattern,Ann Arbor Stage II Grade 1 Follicular Lymphoma,1
33778,Bone Marrow Dysplasia Present,Childhood Myelodysplastic Syndrome,1
33779,Lymphoplasmacytic Infiltrate,Recurrent Grade II Lymphomatoid Granulomatosis,1
33780,Epithelial Component Present,Hereditary Female Breast Carcinoma,1
33781,Epithelial Component Present,Pancreatic Medullary Carcinoma,1
33782,Malignant Cellular Infiltrate,MCD Diffuse Large B-Cell Lymphoma,1
33783,Invasive Lesion,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
33784,Malignant Cellular Infiltrate,Malignant Gastric Gastrointestinal Stromal Tumor,1
33785,Local disease,Endobronchial lipoma,1
33786,Carcinomatous Component Present,Gallbladder Goblet Cell Carcinoid,1
33787,Carcinomatous Component Present,FIGO Stage IVB Ovarian Cancer,1
33788,Localized Lesion,Plasmacytoma,1
33789,Epithelial Component Present,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
33790,Malignant Cellular Infiltrate,Cutaneous Adult T-Cell Leukemia/Lymphoma,1
33791,Transformed Phase of Disease,Recurrent Transformed Chronic Lymphocytic Leukemia,1
33792,Carcinomatous Component Present,Bile duct signet-ring cell carcinoma,1
33793,Immunologic Deficiency Syndromes,Transplant-Related Carcinoma,1
33794,Carcinomatous Component Present,Malignant neoplasm of stomach stage III,1
33795,Severe cytologic atypia,Pancreatic Large Cell Neuroendocrine Carcinoma,1
33796,Carcinomatous Component Present,Squamous cell carcinoma of tongue,1
33797,Epithelial Component Present,Stage III Esophageal Cancer,1
33798,Tobacco Toxicity,Cigarette Smoking-Related Carcinoma,1
33799,Neuroendocrine Differentiation,Pancreatic ACTH-Producing Neuroendocrine Tumor,1
33800,Malignant Cellular Infiltrate,Carcinoma of hard palate,1
33801,Epithelial Component Present,Invasive Mucinous Lung Adenocarcinoma,1
33802,Stromal Invasion,Ovarian Clear Cell Cystadenocarcinoma,1
33803,Cytoplasmic Membrane-Bound Granules Present,Stage IB Merkel Cell Carcinoma AJCC v7,1
33804,Hyperplastic Tissue Present,Adenomatous hyperplasia,1
33805,Pathologic TNM Finding,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
33806,Malignant Cellular Infiltrate,Labia Majora Carcinoma,1
33807,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Alkylating Agent-Related Myelodysplastic Syndrome,1
33808,Cutaneous Involvement,Stage I Lentigo Maligna Melanoma AJCC v7,1
33809,Metastatic Lesion,Metastatic Malignant Neoplasm to the Cervix,1
33810,Carcinomatous Component Present,Bladder adenocarcinoma stage I,1
33811,Malignant Cellular Infiltrate,Oropharyngeal lymphepithelioma,1
33812,Epithelial Component Present,Stage III Esophageal Cancer,1
33813,Epithelial Component Present,"Carcinoma, Giant Cell",1
33814,Malignant Cellular Infiltrate,Refractory Primary Amyloidosis,1
33815,Malignant Cellular Infiltrate,Plasmacytoma,1
33816,High Mitotic Activity,Gallbladder Neuroendocrine Carcinoma,1
33817,Hyperkeratosis,External Ear Actinic Keratosis,1
33818,Hemorrhagic,Uterine Corpus Apoplectic Leiomyoma,1
33819,Malignant Cellular Infiltrate,mucinous adenocarcinoma of ovary,1
33820,Epithelial Component Present,Stage IIB Cervical Cancer AJCC v6 and v7,1
33821,CD1a-Positive Neoplastic Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
33822,Rapidly Enlarging Mass,Adult Rhabdomyosarcoma,1
33823,Benign Cellular Infiltrate,Osteoblastoma,1
33824,Benign Cellular Infiltrate,Inverted Papilloma,1
33825,Mitotic Activity,Adult Gliosarcoma,1
33826,Locally Aggressive Lesion,Intermediate (Locally Aggressive) Blood Vessel Neoplasm,1
33827,Clinical TNM Finding,Clinical Stage III Cutaneous Melanoma AJCC v8,1
33828,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
33829,Intraductal Lesion,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
33830,Cutaneous Involvement,Basal cell nevus with comedones,1
33831,Malignant Cellular Infiltrate,Refractory Liver Carcinoma,1
33832,Anaplasia,Neural Glioblastoma,1
33833,Epithelial Component Present,Papillary tumor of renal pelvis,1
33834,Hyperplastic Tissue Present,Parathyroid hyperplasia,1
33835,Cutaneous Involvement,Malignant eccrine spiradenoma,1
33836,High Mitotic Activity,Extragonadal primary embryonal carcinoma,1
33837,Hypercellular bone marrow,Philadelphia chromosome negative chronic myelogenous leukemia,1
33838,Malignant Cellular Infiltrate,Stage II Acral Lentiginous Melanoma AJCC v6 and v7,1
33839,Metastatic Lesion,Head and neck cancer metastatic,1
33840,Indolent Clinical Course,Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm,1
33841,Well-Circumscribed Lesion,Soft tissue perineurioma,1
33842,Carcinomatous Component Present,Gingival Squamous Cell Carcinoma,1
33843,Malignant Cellular Infiltrate,"Anaplastic large cell lymphoma, ALK negative",1
33844,Epithelial Component Present,Stage 0 Oral Cavity Cancer AJCC v6 and v7,1
33845,Invasive Lesion,High Grade Mucoepidermoid Breast Carcinoma,1
33846,Malignant Cellular Infiltrate,Stage IIA Lung Adenocarcinoma AJCC v7,1
33847,Primary Lesion,"Brain Tumor, Primary",1
33848,Epithelial Component Present,large cell neuroendocrine carcinoma of extrahepatic bile duct,1
33849,Metastatic/Recurrent Disease,Alveolar soft part sarcoma recurrent,1
33850,Malignant Cellular Infiltrate,Chromophobe Renal Cell Carcinoma,1
33851,Well-Circumscribed Lesion,Soft tissue perineurioma,1
33852,Exophytic Polypoid Lesion,Colorectal Tubulovillous Adenoma,1
33853,Biphasic Pattern,Giant fibroadenoma of breast,1
33854,Malignant Cellular Infiltrate,Ovarian Embryonal Carcinoma,1
33855,Epithelial Component Present,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
33856,Pathologic TNM Finding,Pathologic Stage III Retinoblastoma AJCC v8,1
33857,Indolent Clinical Course,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
33858,High Mitotic Activity,small cell carcinoma of larynx,1
33859,Fibrotic Stroma Formation,Cholangiolocellular Carcinoma,1
33860,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma stage III,1
33861,Tissue Differentiation Uncertain,Lung Clear Cell Tumor,1
33862,Malignant Cellular Infiltrate,Recurrent Low Grade Ovarian Serous Adenocarcinoma,1
33863,Adulthood Lesion,Lugano Classification Stage IE Adult Lymphoma AJCC v8,1
33864,Pushing Tumor Margin,Endometrial stromal nodule,1
33865,Adulthood Lesion,Adult Acute Basophilic Leukemia,1
33866,Malignant Cellular Infiltrate,Adult Hodgkin Lymphoma,1
33867,Cutaneous Involvement,Ichthyoses,1
33868,Malignant Cellular Infiltrate,"Carcinoma, Neuroendocrine",1
33869,Necrotic changes (finding),Glandular malignant peripheral nerve sheath tumor,1
33870,Epithelial Component Present,Stage IV Thymoma AJCC v8,1
33871,In Situ Lesion,Lung Mucinous Adenocarcinoma In Situ,1
33872,Trabecular Pattern,Small Intestinal Somatostatin-Producing Neuroendocrine Tumor,1
33873,Malignant Cellular Infiltrate,Carcinosarcoma of cervix uteri,1
33874,Intramucosal Lesion,Colon Intramucosal Adenocarcinoma,1
33875,Infiltrative Growth Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",1
33876,Malignant Cellular Infiltrate,acute undifferentiated leukemia in relapse,1
33877,Carcinomatous Component Present,Uterine Ligament Mucinous Adenocarcinoma,1
33878,Below the Diaphragm Disease,Hodgkin's disease mixed cellularity stage I subdiaphragmatic,1
33879,Increased Cellularity Present,"Childhood Supratentorial Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
33880,Epithelial Component Present,Stage IIB Esophageal Carcinoma,1
33881,Primary Lesion,Childhood Pleomorphic Rhabdomyosarcoma,1
33882,Borderline Lesion,B-Cell Proliferation of Uncertain Malignant Potential,1
33883,Cystic Change,Cystic basal cell carcinoma,1
33884,Junctional Proliferation,Junctional nevus,1
33885,Apocrine Differentiation,Apocrine adenoma,1
33886,Malignant Cellular Infiltrate,Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder,1
33887,Malignant Cellular Infiltrate,BCLC Stage D Hepatocellular Carcinoma,1
33888,Malignant Cellular Infiltrate,Large Cell/Anaplastic Medulloblastoma,1
33889,Carcinomatous Component Present,Stage IV Esophageal Adenocarcinoma AJCC v7,1
33890,Absence of Invasion,Intraductal carcinoma and lobular carcinoma in situ,1
33891,Malignant Cellular Infiltrate,Stage IA Esophageal Cancer AJCC v7,1
33892,Firm mass,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
33893,Epithelial Component Present,Glomerulosa Cell Adrenal Cortical Adenoma,1
33894,Epithelial Component Present,Metastatic Pharyngeal Carcinoma,1
33895,Cauliflower-Like Mass,Childhood Choroid Plexus Papilloma,1
33896,Recurrent disease,Recurrent Anaplastic Oligoastrocytoma,1
33897,Cutaneous Involvement,Refractory Malignant Skin Neoplasm,1
33898,Malignant Cellular Infiltrate,Metachronous Malignant Neoplasm,1
33899,Carcinomatous Component Present,Stage IV Primary Peritoneal Cancer AJCC v8,1
33900,Epithelial Component Present,Stage IA Hepatocellular Carcinoma AJCC v8,1
33901,Carcinomatous Component Present,Multifocal superficial basal cell carcinoma,1
33902,Malignant Cellular Infiltrate,Stage III Childhood Lymphoblastic Lymphoma,1
33903,Malignant Cellular Infiltrate,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
33904,Intracytoplasmic Eosinophilic Inclusion,Rhabdoid Tumor of the Kidney,1
33905,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Testicular Mature Teratoma,1
33906,Carcinomatous Component Present,Breast Carcinoma by Gene Expression Profile,1
33907,"Fully Differentiated ""Adult-Type"" Tissues Present",Pineal Region Mature Teratoma,1
33908,Epithelial Component Present,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,1
33909,Mucoid Stroma Formation,Primary Cutaneous Mucinous Carcinoma,1
33910,Malignant Cellular Infiltrate,Female Breast Carcinoma,1
33911,Epithelial Component Present,Vaginal Mesonephric Adenocarcinoma,1
33912,Epithelial Component Present,Stage IIIB Hilar Cholangiocarcinoma AJCC v8,1
33913,Malignant Cellular Infiltrate,Immunoproliferative Small Intestinal Disease,1
33914,Malignant Cellular Infiltrate,Laryngeal Giant Cell Carcinoma,1
33915,Above the Diaphragm Disease,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
33916,Malignant Cellular Infiltrate,Bone Surface (Peripheral) Osteosarcoma,1
33917,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of the prostate,1
33918,Epithelial Component Present,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
33919,Necrotic changes (finding),Metastatic Bladder Small Cell Carcinoma,1
33920,Malignant Cellular Infiltrate,Stage IIIB Eyelid Carcinoma AJCC v8,1
33921,Malignant Cellular Infiltrate,Leiomyosarcoma NCI Grade 3,1
33922,Malignant Cellular Infiltrate,"Lung Squamous Cell Carcinoma, Papillary Variant",1
33923,Malignant Cellular Infiltrate,Stage IIIB Lung Small Cell Carcinoma AJCC v7,1
33924,Malignant Cellular Infiltrate,Stage III Childhood Lymphoblastic Lymphoma,1
33925,Carcinomatous Component Present,Low Grade Adenosquamous Breast Carcinoma,1
33926,Perineural spread,Major Salivary Gland Adenoid Cystic Carcinoma,1
33927,Hemorrhagic,Adrenal Gland Angiosarcoma,1
33928,Secondary Lesion,Advanced Kaposi Sarcoma,1
33929,Adulthood Lesion,"Adult Supratentorial Embryonal Tumor, Not Otherwise Specified",1
33930,Malignant Cellular Infiltrate,Unresectable Renal Pelvis Urothelial Carcinoma,1
33931,Thyroglobulin Positive Neoplastic Cells Present,Multicentric Thyroid Gland Papillary Carcinoma,1
33932,Tubular Structures Present,Ovarian Sertoli Cell Tumor with Lipid Storage,1
33933,Carcinomatous Component Present,Hereditary Ovarian Carcinoma,1
33934,Cutaneous Involvement,Contact dermatitis due to alkali,1
33935,Epithelial Component Present,Aflatoxins-Related Hepatocellular Carcinoma,1
33936,Malignant Cellular Infiltrate,Lugano Classification Limited Stage Adult Hodgkin Lymphoma AJCC v8,1
33937,Intermediate Grade Lesion,Childhood Periosteal Osteosarcoma,1
33938,Carcinomatous Component Present,Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8,1
33939,Malignant Cellular Infiltrate,Esophageal Squamous Cell Carcinoma by AJCC v8 Pathologic Stage,1
33940,Carcinomatous Component Present,Stage IIIC Ovarian Cancer AJCC v8,1
33941,Rapidly Enlarging Mass,Childhood Spindle Cell Rhabdomyosarcoma,1
33942,Cutaneous Involvement,Furunculosis,1
33943,Malignant Cellular Infiltrate,Metastatic Prostate Small Cell Carcinoma,1
33944,High Grade Lesion,gliosarcoma,1
33945,Low Mitotic Activity,Duodenal Neuroendocrine Tumor by AJCC v8 Stage,1
33946,Carcinomatous Component Present,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
33947,Carcinomatous Component Present,Primary ameloblastic carcinoma,1
33948,Acanthosis,Vaginal Warty Carcinoma,1
33949,Benign Cellular Infiltrate,Adenoameloblastoma,1
33950,Childhood Lesion,Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
33951,Epithelial Component Present,Synchronous Bilateral Breast Carcinoma,1
33952,Carcinomatous Component Present,Solid carcinoma,1
33953,Indolent Clinical Course,Breast Leiomyoma,1
33954,Diffuse Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,1
33955,Malignant Cellular Infiltrate,sarcoma of vagina,1
33956,Cutaneous Involvement,Skin Basal Cell Carcinoma with Sebaceous Differentiation,1
33957,Malignant Cellular Infiltrate,Localized Gallbladder Carcinoma,1
33958,Epithelial Component Present,stage IV pancreatic cancer,1
33959,Primary Lesion,Stage IIA Osteosarcoma AJCC v7,1
33960,Malignant Cellular Infiltrate,epithelial-myoepithelial carcinoma of salivary gland,1
33961,Benign Cellular Infiltrate,Classic Type Trichilemmoma,1
33962,Malignant Cellular Infiltrate,Colorectal Angiosarcoma,1
33963,S-100-Positive Neoplastic Cells Present,Recurrent Langerhans Cell Histiocytosis,1
33964,Carcinomatous Component Present,Stage IIA Ovarian Cancer AJCC v8,1
33965,Pagetoid Proliferation,Stage II Superficial Spreading Melanoma AJCC v6 and v7,1
33966,Epithelial Component Present,adenocarcinoma of breast with squamous metaplasia,1
33967,Malignant Cellular Infiltrate,Malignant melanoma of vulva,1
33968,Non-Invasive Lesion,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
33969,Malignant Cellular Infiltrate,Recurrent Uterine Corpus Carcinoma,1
33970,Malignant Cellular Infiltrate,Trabecular adenocarcinoma,1
33971,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v7 Stage,1
33972,Carcinomatous Component Present,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
33973,Epithelial Component Present,Stage IIIA Ovarian Cancer AJCC v8,1
33974,Malignant Cellular Infiltrate,Colon Cancer by AJCC v6 Stage,1
33975,Carcinomatous Component Present,Stage 0a Urethral Cancer AJCC v7,1
33976,Carcinomatous Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
33977,Keratin pearl formation,Skin Pseudovascular Squamous Cell Carcinoma,1
33978,Malignant Cellular Infiltrate,DS Stage I Plasma Cell Myeloma,1
33979,Carcinomatous Component Present,Borderline Resectable Pancreatic Adenocarcinoma,1
33980,Malignant Cellular Infiltrate,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
33981,Neoplastic Promonocytes in Bone Marrow Markedly Increased,M5b Acute differentiated monocytic leukemia,1
33982,Metastatic/Recurrent Disease,Proximal-Type Epithelioid Sarcoma,1
33983,Malignant Cellular Infiltrate,Intermediate Cell Type Uveal Melanoma,1
33984,Carcinomatous Component Present,Stage III Paranasal Sinus Cancer AJCC v6 and v7,1
33985,Epithelial Component Present,Adenoma of Minor Vestibular Glands,1
33986,Neuroendocrine Differentiation,Pancreatic Large Cell Neuroendocrine Carcinoma,1
33987,Necrotic changes (finding),small cell carcinoma of appendix,1
33988,Epithelial Component Present,Gastroesophageal Junction Neuroendocrine Carcinoma,1
33989,Carcinomatous Component Present,Stage II Adrenal Cortex Carcinoma AJCC v8,1
33990,Childhood Lesion,Childhood Atypical Choroid Plexus Papilloma,1
33991,Well Differentiated Lesion,Vaginal Papillary Carcinoma,1
33992,Malignant Cellular Infiltrate,Secondary malignant neoplasm of urethra,1
33993,Refractory Disease,Refractory Nasopharyngeal Carcinoma,1
33994,Locally Aggressive Lesion,Dermatofibrosarcoma Protuberans,1
33995,Well Differentiated Lesion,Low grade appendiceal mucinous neoplasm,1
33996,Carcinomatous Component Present,Metastatic urothelial carcinoma,1
33997,Malignant Cellular Infiltrate,Recurrent Malignant Extragonadal Germ Cell Tumor,1
33998,Rapidly Enlarging Mass,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
33999,Carcinomatous Component Present,Squamous cell carcinoma,1
34000,Epithelial Component Present,Hormone-Resistant Prostate Carcinoma,1
34001,Recurrent Genetic Abnormalities Present,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
34002,Benign Cellular Infiltrate,Lipoma of breast,1
34003,Severe dysplasia,Stage 0 Pharynx Carcinoma,1
34004,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Tumor,1
34005,Childhood Lesion,Childhood B Lymphoblastic Lymphoma,1
34006,Secondary Lesion,Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
34007,Malignant Cellular Infiltrate,Nasal Type Extranodal NK/T-Cell Lymphoma,1
34008,Hemorrhagic,Hemolymphangioma,1
34009,Monoclonal Gammapathies,Waldenstrom Macroglobulinemia,1
34010,Exophytic Polypoid Lesion,Cyst of Skene's duct,1
34011,Tubular Pattern,tubular adenoma of stomach,1
34012,Hyperkeratosis,Cervical Papillary Squamous Cell Carcinoma,1
34013,Malignant Cellular Infiltrate,Low-grade fibromyxoid sarcoma,1
34014,Multifocal Lesion,"Cerebellar, Fourth Ventricle, and Brain Stem Ependymal Tumor",1
34015,Indolent Clinical Course,Chronic Lymphoproliferative Disorder of NK-Cells,1
34016,Benign Cellular Infiltrate,Thyroid Gland Lipoadenoma,1
34017,Epithelial Component Present,Carcinoma of extrahepatic bile duct,1
34018,Carcinomatous Component Present,Adenocarcinoma in adenomatous polyp,1
34019,Malignant Cellular Infiltrate,Testicular Mixed Choriocarcinoma and Yolk Sac Tumor,1
34020,Malignant Cellular Infiltrate,Grade I Chondrosarcoma,1
34021,Epithelial Component Present,Pathologic Stage IB Gastric Cancer AJCC v8,1
34022,Malignant Cellular Infiltrate,Stage IVB Major Salivary Gland Cancer AJCC v8,1
34023,Focal dysplasia,Sessile Serrated Adenoma/Polyp,1
34024,"Fully Differentiated ""Adult-Type"" Tissues Present",Testicular Dermoid Cyst,1
34025,Increased Cellularity Present,Neuroblastoma of brain,1
34026,VIP Positive Neoplastic Cells Present,Vipoma,1
34027,Malignant Cellular Infiltrate,Refractory Primary Peritoneal Carcinoma,1
34028,Malignant Cellular Infiltrate,Stage IA1 Cervical Cancer AJCC v8,1
34029,Lobulated Growth Pattern,Soft tissue chondroma,1
34030,Epithelial Component Present,Vulvar Large Cell Neuroendocrine Carcinoma,1
34031,Unresectable Mass,Unresectable Synovial Sarcoma,1
34032,Duct-Like Structures Present,Epithelial-myoepithelial carcinoma,1
34033,Epithelial Component Present,squamous cell carcinoma of urethra,1
34034,Carcinomatous Component Present,Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
34035,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
34036,Erythroid hyperplasia,"Polycythemia Vera, Polycythemic Phase",1
34037,Well Differentiated Neuroendocrine Lesion,Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7,1
34038,Carcinomatous Component Present,Thymic Adenocarcinoma,1
34039,Low Mitotic Activity,Stage I Duodenal Neuroendocrine Tumor AJCC v8,1
34040,Vascular Channel Formation,Pyogenic granuloma,1
34041,Carcinomatous Component Present,Recurrent Adenoid Cystic Carcinoma,1
34042,Severe cytologic atypia,Gallbladder Neuroendocrine Carcinoma,1
34043,Below the Diaphragm Disease,Hodgkin's disease mixed cellularity stage II subdiaphragmatic,1
34044,Malignant Cellular Infiltrate,Stage III Oropharyngeal Carcinoma AJCC v7,1
34045,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
34046,Acantholysis,Warty dyskeratoma,1
34047,Metastatic Lesion,Metastatic Non-Cutaneous Melanoma,1
34048,Malignant Cellular Infiltrate,leiomyosarcoma of kidney,1
34049,Epithelial Component Present,Prostate Carcinoma Metastatic in the Bone,1
34050,Carcinomatous Component Present,Minor Salivary Gland Carcinoma ex Pleomorphic Adenoma,1
34051,Exophytic Papillary Lesion,Urethral Condyloma Acuminatum,1
34052,Benign Cellular Infiltrate,"Nevus, Intradermal",1
34053,Pathologic TNM Finding,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
34054,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8,1
34055,Exophytic Polypoid Lesion,Appendix adenoma,1
34056,Epithelial Component Present,Metastatic Squamous Cell Carcinoma of the Larynx,1
34057,Epithelial Component Present,Childhood Lung Small Cell Carcinoma,1
34058,Malignant Cellular Infiltrate,Primary malignant neoplasm of oculomotor nerve,1
34059,Hereditary Lesion,Werner Syndrome,1
34060,Well-Circumscribed Lesion,Gastrointestinal polyps,1
34061,Malignant Cellular Infiltrate,Gastric Papillary Adenocarcinoma,1
34062,Acanthosis,Buschke-Lowenstein Tumor,1
34063,Malignant Cellular Infiltrate,Carcinoma of supraglottis,1
34064,Carcinomatous Component Present,Sporadic Thyroid Gland Micromedullary Carcinoma,1
34065,Epithelial Component Present,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
34066,Malignant Cellular Infiltrate,Endometrioid carcinoma of prostate,1
34067,More than 10 Mitoses per 10HPF,Occult Lung Small Cell Carcinoma,1
34068,Ground Glass Nuclear Inclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
34069,Malignant Cellular Infiltrate,Hereditary Renal Cell Carcinoma,1
34070,Capillary Sized Vascular Channel Formation,Spinal hemangioblastoma,1
34071,Malignant Cellular Infiltrate,Refractory Monomorphic Epitheliotropic Intestinal T-cell Lymphoma,1
34072,Epithelial Component Present,BRCA-Mutated Ovarian Carcinoma,1
34073,Epithelial Component Present,Metastatic Ureter Carcinoma,1
34074,Well Differentiated Neuroendocrine Lesion,Well Differentiated Pancreatic Endocrine Tumor,1
34075,Epithelial Component Present,Metastatic Kidney Carcinoma,1
34076,Nuclear Atypia,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
34077,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
34078,Carcinomatous Component Present,Stage 0 Intrahepatic Cholangiocarcinoma AJCC v7,1
34079,Lymphoplasmacytic Infiltrate,Angiocentric immunoproliferative lesion grade 2,1
34080,Epithelial Component Present,Minor Salivary Gland Mucoepidermoid Carcinoma,1
34081,Well-Circumscribed Lesion,Cecum Villous Adenoma,1
34082,Invasive Lesion,Small cell carcinoma of prostate,1
34083,Glandular Pattern,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
34084,Epithelial Component Present,Colorectal Carcinoma,1
34085,Locally Aggressive Lesion,Gastric Gastrointestinal Stromal Tumor of Uncertain Malignant Potential,1
34086,Epithelial Component Present,Grade 3 Clear Cell Renal Cell Carcinoma,1
34087,Malignant Cellular Infiltrate,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",1
34088,Malignant Cellular Infiltrate,Verrucous carcinoma of penis,1
34089,Low Mitotic Activity,Gastro-enteropancreatic neuroendocrine tumor,1
34090,Progressive Disease,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
34091,Lobulated Growth Pattern,Cellular Myxoma,1
34092,More than 5 Mitoses per 50HPF,"Stage IIIA Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
34093,Indolent Clinical Course,Rectal Lipoma,1
34094,Childhood Lesion,Childhood Undifferentiated Pleomorphic Sarcoma,1
34095,Biphasic Pattern,Recurrent Uterine Corpus Carcinosarcoma,1
34096,Acanthosis,Human Papillomavirus-Related Verrucous Carcinoma,1
34097,Malignant Cellular Infiltrate,Lugano Classification Stage II Bulky Hodgkin Lymphoma AJCC v8,1
34098,Pseudorosette Formation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
34099,Malignant Cellular Infiltrate,Squamous cell carcinoma of the oral cavity stage IV,1
34100,Malignant Cellular Infiltrate,Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
34101,Malignant Cellular Infiltrate,Distal Esophagus Squamous Cell Carcinoma,1
34102,Epithelial Component Present,intraductal micropapillary carcinoma of breast,1
34103,Myeloblasts 5-9 Percent of Bone Marrow Nucleated Cells,Refractory anemia with excess blasts I,1
34104,Malignant Cellular Infiltrate,"Colorectal cancer, hereditary nonpolyposis, type 1",1
34105,Malignant Cellular Infiltrate,Resectable Malignant Liver Neoplasm,1
34106,Epithelial Component Present,Eyelid Carcinoma by AJCC v7 Stage,1
34107,Black Discoloration,Thyroid Gland Black Follicular Adenoma,1
34108,Perivascular fibrosis,Adult Nodular Sclerosis Classical Hodgkin Lymphoma,1
34109,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrial Endometrioid Adenocarcinoma,1
34110,Malignant Cellular Infiltrate,Esophageal Mixed Adenoneuroendocrine Carcinoma,1
34111,Dysplasia,Rectal Tubular Adenoma,1
34112,Epithelial Component Present,Epithelial neoplasm of skin,1
34113,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Monodermal and Highly Specialized Teratoma,1
34114,Multilocular Lesion,Cystic Partially Differentiated Nephroblastoma,1
34115,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma/leukemia,1
34116,Below the Diaphragm Disease,Ann Arbor Stage I Subdiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
34117,Malignant Cellular Infiltrate,mantle cell lymphoma of stomach,1
34118,Ineffective hematopoiesis,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1
34119,Carcinomatous Component Present,Stage IIB Prostate Cancer AJCC v7,1
34120,Presence of a Hormonal Syndrome,"Glucagonoma, malignant",1
34121,Odontogenic Cysts,Ameloblastic Carcinoma Derived From Odontogenic Cyst,1
34122,Malignant Cellular Infiltrate,Cardiac Myxofibrosarcoma,1
34123,Carcinomatous Component Present,Refractory Small Intestinal Carcinoma,1
34124,Epithelial Component Present,Borderline Ovarian Clear Cell Cystadenofibroma,1
34125,Necrotic changes (finding),pleomorphic carcinoma of breast,1
34126,Immunologic Deficiency Syndromes,Acute humoral allograft nephropathy,1
34127,Crystal deposition,Bladder Alveolar Soft Part Sarcoma,1
34128,High Grade Lesion,Childhood Brain Anaplastic Astrocytoma,1
34129,Epithelial Component Present,Locally Advanced Pancreatic Neuroendocrine Carcinoma,1
34130,Carcinomatous Component Present,Stage IB Pancreatic Cancer AJCC v6 and v7,1
34131,Hereditary Lesion,Familial Adrenal Gland Pheochromocytoma,1
34132,Low Mitotic Activity,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,1
34133,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
34134,Anaplasia,Anaplastic Oligodendroglioma,1
34135,In Situ Lesion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,1
34136,Carcinomatous Component Present,Recurrent Parotid Gland Undifferentiated Carcinoma,1
34137,Neuroendocrine Differentiation,Stage IV Pancreatic Neuroendocrine Tumor AJCC v8,1
34138,Benign Cellular Infiltrate,Deep Hemangioma,1
34139,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8,1
34140,Syncytial Pattern,Lymphoepithelial carcinoma,1
34141,Epithelial Component Present,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
34142,Contiguous Disease,Ann Arbor Stage II Contiguous Adult Aggressive Non-Hodgkin Lymphoma,1
34143,Malignant Cellular Infiltrate,Neck Carcinoma,1
34144,Secondary Lesion,Metastatic Ureter Carcinoma,1
34145,Honeycomb Pattern,"Testicular Yolk Sac Tumor, Microcystic Pattern",1
34146,Clinical TNM Finding,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
34147,Mesenchymal Metaplasia of Malignant Cells Present,Breast Carcinoma with Chondroid Metaplasia,1
34148,Malignant Cellular Infiltrate,Childhood Acute Myelomonocytic Leukemia,1
34149,Carcinomatous Component Present,Stage IV Fallopian Tube Cancer AJCC v8,1
34150,Intraductal Lesion,Central Breast Papilloma,1
34151,Pushing Tumor Margin,Verrucous carcinoma of the oral cavity recurrent,1
34152,Nodular lesions,"Childhood Ganglioneuroblastoma, Nodular",1
34153,Malignant Cellular Infiltrate,Stage IIB Gallbladder Cancer AJCC v8,1
34154,Borderline Lesion,Recurrent Adult Grade III Lymphomatoid Granulomatosis,1
34155,Epithelial Component Present,Minimally Invasive Mucinous Lung Adenocarcinoma,1
34156,Carcinomatous Component Present,Intraepithelial Squamous Cell Carcinoma,1
34157,Benign Cellular Infiltrate,Benign neoplasm of scrotum,1
34158,Primary Lesion,Hepatocellular Carcinoma by BCLC Stage,1
34159,Neuroendocrine Differentiation,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
34160,Necrotic changes (finding),Neural Glioblastoma,1
34161,atypia morphology,Pre-Malignant Skin Epithelial Lesion,1
34162,Well Differentiated Lesion,verrucous carcinoma of bladder,1
34163,Recurrent disease,Recurrent Sarcoma,1
34164,Secondary Lesion,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant",1
34165,Epithelial Component Present,Ampulla of Vater Squamous Cell Carcinoma,1
34166,Favorable Clinical Outcome,Benign Liver and Intrahepatic Bile Duct Epithelial Neoplasm,1
34167,atypia morphology,Malignant Ovarian Luteinized Thecoma,1
34168,Carcinomatous Component Present,Breast adenocarcinoma,1
34169,Epithelial Component Present,Infiltrating Ureter Urothelial Carcinoma with Glandular Differentiation,1
34170,Vascular Channel Formation,Histiocytoid hemangioma,1
34171,Malignant Cellular Infiltrate,embryonal carcinoma of mediastinum,1
34172,Malignant Cellular Infiltrate,Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
34173,Therapy-Related Toxicity,Chemotherapy-Related Leukemia,1
34174,Secondary Lesion,Adenocarcinoma of the prostate stage IV,1
34175,Malignant Cellular Infiltrate,Paranasal Sinus Lymphoma,1
34176,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia recurrent,1
34177,Epithelial Component Present,Small cell lung cancer extensive stage,1
34178,Immunologic Deficiency Syndromes,AIDS-Related Enterocolitis,1
34179,Benign Cellular Infiltrate,Left atrial myxoma,1
34180,Refractory Disease,Refractory Childhood Hodgkin Lymphoma,1
34181,Epithelial Component Present,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
34182,Carcinomatous Component Present,Gallbladder Mixed Adenoneuroendocrine Carcinoma,1
34183,Cutaneous Involvement,Vaginal Blue Nevus,1
34184,Malignant Cellular Infiltrate,Stage IIA Cervical Cancer AJCC v6,1
34185,Nodular Pattern,Medulloblastoma with extensive nodularity,1
34186,Malignant Cellular Infiltrate,Malignant Paraganglionic Neoplasm,1
34187,Thyroglobulin Positive Neoplastic Cells Present,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
34188,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,"Carcinoma, Endometrioid",1
34189,Malignant Cellular Infiltrate,Refractory T Acute Lymphoblastic Leukemia,1
34190,Non-Malignant Cellular Infiltrate,Chronic Lymphoproliferative Disorder of NK-Cells,1
34191,Chromogranin A Positive Neoplastic Cells Present,Foregut Carcinoid Tumor,1
34192,Carcinomatous Component Present,Stage I Colon Cancer AJCC v6 and v7,1
34193,Epithelial Component Present,Stage IB Ovarian Cancer AJCC v6 and v7,1
34194,Firm mass,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
34195,Epithelial Component Present,tubulopapillary adenoma of gallbladder,1
34196,Malignant Cellular Infiltrate,Postsurgical Stage II Hepatoblastoma,1
34197,Adulthood Lesion,Benign Adult Brain Stem Neoplasm,1
34198,Childhood Lesion,Childhood Testicular Mature Teratoma,1
34199,Cystic Change,Mucinous cystadenocarcinoma of ovary,1
34200,Fibrotic Stroma Formation,Borderline Ovarian Endometrioid Cystadenofibroma,1
34201,Benign Cellular Infiltrate,Fibroma of prostate,1
34202,Juvenile Lesion,Juvenile Chronic Polyarthritis,1
34203,Dysplasia,Colon Traditional Serrated Adenoma,1
34204,Carcinomatous Component Present,Refractory Head and Neck Squamous Cell Carcinoma,1
34205,Antoni A Pattern,Conventional Schwannoma,1
34206,Malignant Cellular Infiltrate,Stage IB Osteosarcoma AJCC v7,1
34207,Indolent Clinical Course,Lung Clear Cell Tumor,1
34208,Well-Circumscribed Lesion,Myxoid liposarcoma metastatic,1
34209,Epithelial Component Present,Recurrent Skin Carcinoma,1
34210,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Mucinous Follicular Adenoma,1
34211,Malignant Cellular Infiltrate,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,1
34212,Diffuse Pattern,"Glioblastoma, IDH-Mutant",1
34213,Malignant Cellular Infiltrate,Glioblastoma by Gene Expression Profile,1
34214,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
34215,Acinar Cell Differentiation,"Acinar Prostate Adenocarcinoma, Oncocytic Variant",1
34216,Cutaneous Involvement,Contact dermatitis due to dichromate,1
34217,Intraductal Lesion,Ductal Breast Hyperplasia,1
34218,Unresectable Mass,Unresectable Skin Basal Cell Carcinoma,1
34219,Eosinophilic inflammation,Retroperitoneal Inflammatory Myofibroblastic Tumor,1
34220,Recurrent disease,Recurrent Primary Lymphoma of Bone,1
34221,Metastatic Lesion,Metastatic signet ring cell carcinoma,1
34222,Recurrent disease,Recurrent Brain Neoplasm,1
34223,Carcinomatous Component Present,Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8,1
34224,Malignant Cellular Infiltrate,Stage 0 Uterine Corpus Cancer,1
34225,Malignant Cellular Infiltrate,Localized Bone Ewing Sarcoma,1
34226,Malignant Cellular Infiltrate,Medulloblastoma with Leptomeningeal Spread,1
34227,Carcinomatous Component Present,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
34228,Malignant Cellular Infiltrate,Adenocarcinoma with metaplasia,1
34229,Epithelial Component Present,Carcinoma of lung,1
34230,Absence of Invasion,Bladder adenocarcinoma stage 0,1
34231,Malignant Cellular Infiltrate,Stage III Pharynx Carcinoma,1
34232,Epithelial Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v8,1
34233,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Small Cell Carcinoma,1
34234,Malignant Cellular Infiltrate,Diffuse large B-cell lymphoma of central nervous system,1
34235,Neuroendocrine Differentiation,Advanced Digestive System Neuroendocrine Neoplasm,1
34236,Childhood Lesion,Childhood Multilocular Cystic Renal Neoplasm,1
34237,Carcinomatous Component Present,Transitional cell carcinoma of bladder,1
34238,Immunosuppression-Related Post-Transplant Toxicity,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,1
34239,Neuroendocrine Differentiation,Recurrent Adrenal Gland Pheochromocytoma,1
34240,Adnexal Differentiation,Piloleiomyoma,1
34241,Increased Cellularity Present,Frontal Lobe Anaplastic Oligodendroglioma,1
34242,Malignant Cellular Infiltrate,Ph-Like Acute Lymphoblastic Leukemia,1
34243,Metastatic/Recurrent Disease,Clear Cell Sarcoma of Soft Tissue,1
34244,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
34245,Adulthood Lesion,Lymphomatous Adult T-Cell Leukemia/Lymphoma,1
34246,Papillary Pattern,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
34247,Monoclonal Cellular Population Present,Urticaria Pigmentosa,1
34248,Cutaneous Involvement,Atrophic lichen planus,1
34249,Malignant Cellular Infiltrate,Stage IB Hepatocellular Carcinoma AJCC v8,1
34250,Eosinophil count raised (finding),Chronic Myelomonocytic Leukemia with Eosinophilia,1
34251,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage IV,1
34252,Malignant Cellular Infiltrate,Thoracic NUT Carcinoma,1
34253,Cutaneous Involvement,Glomangioma of skin,1
34254,Malignant Germinomatous Cellular Infiltrate,Spermatocytic seminoma,1
34255,Fibrotic Stroma Formation,Hard Palate Mucoepidermoid Carcinoma,1
34256,Tissue of Mullerian Origin Present,Ovarian Mucinous Adenofibroma,1
34257,Angiodestructive Pattern,Angiocentric immunoproliferative lesion grade 2,1
34258,Malignant Cellular Infiltrate,Stage 0 Pancreatic Cancer AJCC v6 and v7,1
34259,Delicate Vascular Network Formation,Grade 1 Clear Cell Renal Cell Carcinoma,1
34260,Malignant Cellular Infiltrate,Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
34261,Well-Circumscribed Lesion,Neoplastic Polyp,1
34262,Syncytial Pattern,Pancreatic Medullary Carcinoma,1
34263,Malignant Cellular Infiltrate,Stage I Adult Immunoblastic Lymphoma,1
34264,Mixed Cellular Population,Borderline Ovarian Endometrioid Adenofibroma,1
34265,Epithelial Component Present,Medullary carcinoma of thyroid,1
34266,Malignant Cellular Infiltrate,Malignant melanoma of eye,1
34267,Carcinomatous Component Present,Cholangiocarcinoma non-resectable,1
34268,Anaplasia,Systemic Anaplastic Large Cell Lymphoma,1
34269,Endophytic Tumor Growth,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
34270,Malignant Cellular Infiltrate,Stage II Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
34271,In Situ Lesion,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
34272,Cutaneous Involvement,Breast Carcinoma Metastatic in the Skin,1
34273,Mitotic Activity,Recurrent Glioblastoma,1
34274,Metastatic Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,1
34275,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of submandibular gland,1
34276,High Grade Lesion,Anaplastic Hemispheric Astrocytoma,1
34277,Vascular Channel Formation,Locally Advanced Epithelioid Hemangioendothelioma,1
34278,BRAF V600E Mutation Present,Splenic Manifestation of Hairy Cell Leukemia,1
34279,Benign Cellular Infiltrate,Bone Leiomyoma,1
34280,Malignant Cellular Infiltrate,Colloid Carcinoma of the Pancreas,1
34281,Extensive Stage Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
34282,Carcinomatous Component Present,Cervical Adenoid Cystic Carcinoma,1
34283,Villous Pattern,Tubulovillous adenoma,1
34284,Malignant Cellular Infiltrate,Choroid Spindle Cell Type A Melanoma,1
34285,EBV-Positive Neoplastic Cells Present,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
34286,Benign Cellular Infiltrate,Conventional Cardiac Rhabdomyoma,1
34287,Epithelial Component Present,Stage II Thyroid Gland Follicular Carcinoma AJCC v7,1
34288,Borderline Lesion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
34289,Unfavorable Clinical Outcome,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,1
34290,Recurrent disease,Recurrent Childhood Oligoastrocytoma,1
34291,Collagenous Stroma Formation,Extra-abdominal fibromatosis,1
34292,Benign Cellular Infiltrate,Thyroid Gland Follicular Adenoma,1
34293,Epithelial Component Present,Stage IIIC Eyelid Carcinoma AJCC v7,1
34294,Malignant Cellular Infiltrate,Stage IIA Ampulla of Vater Cancer AJCC v7,1
34295,High Mitotic Activity,"Leydig cell tumor, malignant",1
34296,Stromal Invasion,Platinum-Resistant Ovarian Carcinoma,1
34297,Malignant Cellular Infiltrate,Distal 1/3 of the Common Bile Duct Adenocarcinoma,1
34298,Malignant Cellular Infiltrate,Resectable Neuroblastoma,1
34299,Necrotic changes (finding),"Ovarian Small Cell Carcinoma, Pulmonary Type",1
34300,Glandular Differentiation,"Carcinoid, Goblet Cell",1
34301,Carcinomatous Component Present,Esophageal squamous cell carcinoma recurrent,1
34302,Secondary Lesion,"Neoplasms, Unknown Primary",1
34303,Peripheral Nuclear Palisading,Small cell lung cancer recurrent,1
34304,Epithelial Component Present,Craniopharyngioma,1
34305,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma,1
34306,High Grade Lesion,Small cell lung cancer recurrent,1
34307,Epithelial Component Present,Stage III Major Salivary Gland Cancer AJCC v8,1
34308,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
34309,Carcinomatous Component Present,Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
34310,Thin-Walled Branching Vascular Pattern,Thyroid Gland Solitary Fibrous Tumor,1
34311,Chronic lymphocytic inflammation,Abdominal Inflammatory Myofibroblastic Tumor,1
34312,Epithelial Component Present,Stage IIA Cervical Cancer AJCC v8,1
34313,Well-Circumscribed Lesion,adenoma of intrahepatic bile duct,1
34314,Exophytic Polypoid Lesion,tubulopapillary adenoma of extrahepatic bile duct,1
34315,Myxoid Stroma Formation,Uterine Corpus Myxoid Leiomyoma,1
34316,Human Papillomavirus Positive,Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
34317,Early Stromal Invasion Present,Early Invasive Cervical Squamous Cell Carcinoma,1
34318,Epithelial Component Present,Tubular adenoma of breast,1
34319,Cutaneous Involvement,Exfoliative dermatitis,1
34320,Anaplasia,Cerebral Glioblastoma,1
34321,Eccrine Differentiation,Papillary Eccrine Carcinoma,1
34322,Increased megakaryocytes (bone marrow),Prefibrotic/Early Primary Myelofibrosis,1
34323,Alternative Fascicle (Bundle) Pattern,Uterine Corpus Dissecting Leiomyoma,1
34324,Metastatic Lesion,Locally Advanced Basal Cell Carcinoma,1
34325,Epithelial Component Present,Encapsulated Thymoma,1
34326,Lymphadenopathy,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
34327,Carcinomatous Component Present,Nasopharyngeal squamous cell carcinoma stage I,1
34328,Intracytoplasmic Eosinophilic Inclusion,Extrarenal Rhabdoid Tumor of the Liver,1
34329,Vascular Channel Formation,Diffuse Pulmonary Lymphangiomatosis,1
34330,Peripheral Nuclear Palisading,Platinum-Resistant Lung Small Cell Carcinoma,1
34331,Epithelial Component Present,Stage III Renal Pelvis Cancer AJCC v7,1
34332,Epithelial Component Present,Luteoma,1
34333,Extensive Stage Lesion,Advanced Small Intestinal Large Cell Neuroendocrine Carcinoma,1
34334,Malignant Cellular Infiltrate,Anatomic Stage IB Breast Cancer AJCC v8,1
34335,Cavernous Vascular Space Formation,Liver Cavernous Hemangioma,1
34336,Adulthood Lesion,Adult Grade II Meningioma,1
34337,Hereditary Lesion,Turcot syndrome (disorder),1
34338,Metaplasia of Malignant Cells Present,Metaplastic carcinoma of breast,1
34339,Platinum Resistance,Platinum-Resistant Ovarian Carcinoma,1
34340,Tubular Pattern,Adenoma of the nipple,1
34341,High Mitotic Activity,Colorectal Neuroendocrine Carcinoma,1
34342,Benign Cellular Infiltrate,Parathyroid transitional clear cell adenoma,1
34343,Metastatic Lesion,Hepatic cancer metastatic,1
34344,Hyaline Cartilage Differentiation,Childhood Myxoid Chondrosarcoma,1
34345,Malignant Cellular Infiltrate,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
34346,Epithelial Component Present,Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v8,1
34347,Tissue Differentiation Uncertain,Mediastinal Synovial Sarcoma,1
34348,Hyperplastic Tissue Present,Circumferential Endothelial Hyperplasia,1
34349,Cystic Change,Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
34350,Anaplasia,Lung Spindle Cell Carcinoma,1
34351,Epithelial Component Present,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
34352,Well-Circumscribed Lesion,Rhabdomyoma,1
34353,Carcinomatous Component Present,Stage IIIB Eyelid Carcinoma AJCC v7,1
34354,Resectable Mass,Resectable Soft Tissue Sarcoma,1
34355,Epithelial Component Present,Stage II Ureter Cancer AJCC v8,1
34356,Carcinomatous Component Present,Vaginal adenocarcinoma metastatic,1
34357,Benign Cellular Infiltrate,Benign neoplasm of peritoneum,1
34358,Epithelial Component Present,Vaginal Villous Adenoma,1
34359,Invasive Lesion,Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma,1
34360,Recurrent disease,Angiocentric lymphoma recurrent,1
34361,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v7 Stage,1
34362,Epithelial Component Present,Benign Outer Hair Sheath and Infundibulum Neoplasm,1
34363,Geographic Necrosis,Testicular embryonal carcinoma stage III,1
34364,Epithelial Component Present,Glucagonoma,1
34365,Epithelial Component Present,Intestinal Gangliocytic Paraganglioma,1
34366,Epithelial Component Present,Recurrent Renal Pelvis Urothelial Carcinoma,1
34367,Malignant Cellular Infiltrate,Lung Squamous Cell Carcinoma by AJCC v7 Stage,1
34368,Birbeck Granules Present,"Histiocytosis, Langerhans-Cell",1
34369,Indolent Clinical Course,Uterine Corpus Hydropic Leiomyoma,1
34370,Fibrotic Stroma Formation,Odontoameloblastoma,1
34371,Epithelial Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
34372,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory anemias,1
34373,Cellular Stratification,Borderline Ovarian Mucinous Adenofibroma,1
34374,Endophytic Tumor Growth,Cervical Verrucous Carcinoma,1
34375,Well-Circumscribed Lesion,Polyp of gallbladder,1
34376,Immunologic Deficiency Syndromes,Transplant-Related Kaposi Sarcoma,1
34377,Malignant Cellular Infiltrate,"Squamous cell carcinoma, microinvasive",1
34378,Indolent Clinical Course,Cutaneous Fibrous Histiocytoma,1
34379,Hyalinized Stroma Formation,malignant epithelioid hemangioendothelioma of liver,1
34380,Follicular Structures Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
34381,Carcinomatous Component Present,Anal Canal Cancer by AJCC v6 and v7 Stage,1
34382,Malignant Cellular Infiltrate,Marginal zone lymphoma stage IV,1
34383,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid tumor,1
34384,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v7 Stage,1
34385,Metastatic Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
34386,Neuroendocrine Differentiation,Refractory Digestive System Neuroendocrine Carcinoma,1
34387,Keratin pearl formation,Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
34388,Primary Lesion,Stage III Hepatocellular Carcinoma AJCC v7,1
34389,Malignant Cellular Infiltrate,Stage IVA Fallopian Tube Cancer AJCC v8,1
34390,Follicular Cell Differentiation,Stage I Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
34391,Absence of Invasion,Stage 0 Esophageal Cancer AJCC v7,1
34392,Mixed Cellular Population,Borderline Ovarian Endometrioid Cystadenofibroma,1
34393,Epithelial Component Present,Stage II Bladder Cancer AJCC v8,1
34394,Malignant Cellular Infiltrate,Malignant lymphoma - lymphoplasmacytic,1
34395,Epithelial Component Present,Stage IIA Pancreatic Cancer AJCC v6 and v7,1
34396,Malignant Cellular Infiltrate,Cecum Lymphoma,1
34397,Carcinomatous Component Present,Adenocarcinoma in situ in tubular adenoma,1
34398,Mitotic Activity,Temporal Lobe Anaplastic Astrocytoma,1
34399,Carcinomatous Component Present,Rectosigmoid Signet Ring Cell Carcinoma,1
34400,Hyperplastic Tissue Present,Papillary Urothelial Hyperplasia,1
34401,Well-Circumscribed Lesion,Hyperplastic Polyp,1
34402,Epithelial Component Present,Pathologic Stage III Gastric Cancer AJCC v8,1
34403,Malignant Cellular Infiltrate,Secondary malignant neoplasm of pancreas,1
34404,Carcinomatous Component Present,Bladder Papillary Clear Cell Adenocarcinoma,1
34405,Benign Cellular Infiltrate,Broad Ligament Serous Adenofibroma,1
34406,Immunologic Deficiency Syndromes,AIDS-Related Anal Non-Hodgkin Lymphoma,1
34407,Malignant Cellular Infiltrate,Extracavitary Primary Effusion Lymphoma,1
34408,Low Mitotic Activity,Duodenal Gastrin-Producing Neuroendocrine Tumor,1
34409,Dysplasia,Esophageal Squamous Intraepithelial Neoplasia,1
34410,Mixed Cellular Population,Stromal Predominant Kidney Wilms Tumor,1
34411,Carcinomatous Component Present,Urethral Cancer by AJCC v8 Stage,1
34412,Neuroendocrine Differentiation,Glomus vagale tumor,1
34413,Indolent Clinical Course,Cardiac Lipoma,1
34414,Epithelial Component Present,Gastric Cancer by AJCC v8 Clinical Stage,1
34415,Epithelial Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
34416,Epithelial Component Present,Squamous cell carcinoma in situ with questionable stromal invasion,1
34417,Indolent Clinical Course,benign lipoma of gallbladder,1
34418,Adulthood Lesion,Adult Favorable Prognosis Hodgkin Lymphoma,1
34419,Carcinomatous Component Present,Invasive micropapillary carcinoma of breast,1
34420,Epithelial Component Present,Adenoid Cystic Carcinoma,1
34421,Carcinomatous Component Present,"Squamous cell carcinoma, clear cell type",1
34422,Malignant Cellular Infiltrate,Occult Lung Adenosquamous Carcinoma,1
34423,Absence of Invasion,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
34424,Epithelial Component Present,Vaginal high grade squamous intraepithelial lesion,1
34425,Bilateral Disease,bilateral breast cancer,1
34426,Malignant Cellular Infiltrate,Relapsed Hypopharynx Carcinoma,1
34427,Blasts of Mixed Phenotype Present,Acute bilineal leukemia,1
34428,Carcinomatous Component Present,Low grade appendiceal mucinous neoplasm,1
34429,Recurrent disease,Recurrent Childhood Cerebellar Astrocytoma,1
34430,Malignant Cellular Infiltrate,Stage IIB Lung Adenocarcinoma AJCC v7,1
34431,Epithelial Component Present,benign myoepithelioma of salivary gland,1
34432,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Acute Monocytic Leukemia,1
34433,Childhood Lesion,Childhood Immunoblastic Lymphoma,1
34434,S-100-Positive Neoplastic Cells Present,Benign Lung PEComa,1
34435,Epithelial Component Present,Mucinous adenocarcinoma of colon,1
34436,Secondary Lesion,Squamous cell carcinoma of head and neck metastatic,1
34437,Low Mitotic Activity,Pancreatic Somatostatinoma,1
34438,Hyperplastic Tissue Present,Inflammatory fibrous hyperplasia of mouth,1
34439,Anaplasia,Adult Giant Cell Glioblastoma,1
34440,Mixed Cellular Population,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8,1
34441,Adulthood Lesion,Adult Acute Promyelocytic Leukemia with PML-RARA,1
34442,Epithelial Component Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,1
34443,Mitotic Activity,Endodermal sinus tumor of ovary,1
34444,Carcinomatous Component Present,Stage IIB Esophageal Carcinoma,1
34445,Epithelial Component Present,Stage IVA Colorectal Cancer AJCC v8,1
34446,Primary Lesion,Central Nervous System Intravascular Large B-Cell Lymphoma,1
34447,Carcinomatous Component Present,Metastatic gastric adenocarcinoma,1
34448,Epithelial Component Present,Recurrent Pancreatic Cystadenocarcinoma,1
34449,Secondary Lesion,Colorectal Carcinoma Metastatic in the Liver,1
34450,Invasive Lesion,Invasive Apocrine Breast Carcinoma,1
34451,Carcinomatous Component Present,Distal Bile Duct Cancer by AJCC v8 Stage,1
34452,Hyperkeratosis,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
34453,Immunosuppression-Related Post-Transplant Toxicity,Graft-vs-Host Disease,1
34454,Secondary Lesion,Stage IV Esophageal Adenocarcinoma,1
34455,Carcinomatous Component Present,Stage I Oropharyngeal Carcinoma,1
34456,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
34457,Perineural spread,Adenoid Cystic Carcinoma,1
34458,Dysplasia,Gastrointestinal Intraepithelial Neoplasia,1
34459,Refractory Disease,Refractory WHO Grade II Glioma,1
34460,Epithelial Component Present,Adenocarcinoma in adenomatous polyp,1
34461,Follicular Cell Differentiation,minimally invasive follicular carcinoma of the thyroid gland,1
34462,Malignant Cellular Infiltrate,Stage IIIC Breast Cancer AJCC v7,1
34463,Primary Lesion,Refractory Primary Peritoneal Carcinoma,1
34464,Vascular Channel Formation,Angiosarcoma recurrent,1
34465,Carcinomatous Component Present,Stage II Lung Small Cell Carcinoma AJCC v7,1
34466,Childhood Lesion,Childhood Fibrosarcoma,1
34467,Epithelial Component Present,Paget Disease,1
34468,Adulthood Lesion,Adult Spinal Cord Neoplasm,1
34469,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline GATA2 Mutation,1
34470,Diffuse Pattern,Recurrent Childhood Protoplasmic Astrocytoma,1
34471,Malignant Cellular Infiltrate,Childhood Breast Carcinoma,1
34472,Malignant Cellular Infiltrate,Recurrent Childhood Medulloblastoma,1
34473,Epithelial Component Present,Thoracic Esophagus Adenocarcinoma,1
34474,Malignant Cellular Infiltrate,"B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative",1
34475,Dysplasia,Bladder squamous cell carcinoma stage 0,1
34476,Immunosuppression-Related Post-Transplant Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
34477,Malignant Cellular Infiltrate,Stage II Uterine Corpus Cancer AJCC v8,1
34478,Immunologic Deficiency Syndromes,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
34479,Malignant Cellular Infiltrate,Stage IV Lung Cancer AJCC v8,1
34480,Seminomatous Component Present,Testicular Mixed Choriocarcinoma and Seminoma,1
34481,Mitotic Activity,Vulvar Yolk Sac Tumor,1
34482,Malignant Cellular Infiltrate,Ocular Sebaceous Carcinoma,1
34483,Microvascular Proliferation,Third Ventricle Pilocytic Astrocytoma,1
34484,Carcinomatous Component Present,cystadenocarcinoma of intrahepatic bile duct,1
34485,Malignant Cellular Infiltrate,Stage IIIA1 Ovarian Cancer AJCC v8,1
34486,atypia morphology,Bowenoid papulosis of penis,1
34487,No Identifiable Line of Differentiation,Malignant fibrous histiocytoma metastatic,1
34488,Calcitonin serum level increased,Stage IV Thyroid Gland Medullary Carcinoma AJCC v7,1
34489,Malignant Cellular Infiltrate,Adenosarcoma,1
34490,Severe dysplasia,Colorectal Adenoma with Severe Dysplasia,1
34491,Clinical TNM Finding,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
34492,Pseudopapillary Pattern,Testicular embryonal carcinoma stage I,1
34493,Well Differentiated Neuroendocrine Lesion,Malignant Pancreatic Somatostatinoma,1
34494,Malignant Cellular Infiltrate,Prostate Basal Cell Carcinoma,1
34495,Papillary Pattern,Urethral Urothelial Papilloma,1
34496,Biphasic Pattern,Juvenile fibroadenoma of breast,1
34497,Secondary Lesion,Castration-Naive Prostate Carcinoma,1
34498,Epithelial Component Present,Stage III renal cell cancer,1
34499,Metastatic Lesion,Advanced Uterine Corpus Carcinosarcoma,1
34500,Calcitonin serum level increased,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8,1
34501,Multifocal Lesion,Recurrent Malignant Neoplasm of Multiple Primary Sites,1
34502,Juvenile Lesion,Scheuermann's Disease,1
34503,Malignant Cellular Infiltrate,Stage IVC Hypopharyngeal Carcinoma AJCC v7,1
34504,Malignant Cellular Infiltrate,Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm,1
34505,Mixed Cellular Population,Broad Ligament Serous Cystadenofibroma,1
34506,Malignant Cellular Infiltrate,Thyroid Gland Leiomyosarcoma,1
34507,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor,1
34508,Malignant Cellular Infiltrate,Lugano Classification Adult Hodgkin Lymphoma by AJCC v8 Stage,1
34509,Carcinomatous Component Present,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
34510,Necrotic changes (finding),Esophageal Malignant Peripheral Nerve Sheath Tumor,1
34511,Biphasic Pattern,Benign mixed epithelial and stromal tumor of kidney,1
34512,Glomerular Hypertrophy,Secondary Focal Segmental Glomerulosclerosis,1
34513,Diffuse Pattern,large B-cell diffuse lymphoma of accessory sinus,1
34514,Malignant Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v7,1
34515,Sinusoidal Growth Pattern,ALK positive large B-cell lymphoma,1
34516,Carcinomatous Component Present,Stage III Intrahepatic Cholangiocarcinoma AJCC v8,1
34517,Epithelial Component Present,"Thymoma, type B3",1
34518,Thick-Walled Vessels Present,Childhood Kidney Angiomyolipoma,1
34519,Malignant Cellular Infiltrate,Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma,1
34520,Adnexal Differentiation,Syringoma,1
34521,Malignant Cellular Infiltrate,Stage III Acral Lentiginous Melanoma AJCC v7,1
34522,Malignant Cellular Infiltrate,Childhood Central Nervous System Ganglioneuroblastoma,1
34523,Malignant Cellular Infiltrate,Stage IA Vulvar Carcinoma AJCC v6,1
34524,Low Grade Neuroendocrine Lesion,Non-Functioning Pancreatic Neuroendocrine Tumor G1,1
34525,Malignant Cellular Infiltrate,Metastatic Carcinoma to the Uterine Cervix,1
34526,Carcinomatous Component Present,Recurrent Head and Neck Carcinoma,1
34527,Malignant Cellular Infiltrate,Cutaneous Radiation-Related Angiosarcoma,1
34528,Epithelial Component Present,Stage IVA Thymus Epithelial Neoplasm AJCC v8,1
34529,Epithelial Component Present,Refractory Head and Neck Carcinoma,1
34530,Carcinomatous Component Present,Infiltrating duct and lobular carcinoma,1
34531,'Starry-sky' pattern,Sporadic Burkitt's lymphoma,1
34532,Epithelial Component Present,Pancreatic Somatostatinoma,1
34533,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Pathologic Stage,1
34534,Fibrotic Stroma Formation,Colloid Carcinoma of the Pancreas,1
34535,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma,1
34536,Cutaneous Involvement,Pigmented hairy epidermal nevus,1
34537,Malignant Cellular Infiltrate,Stage IV Osteosarcoma AJCC v7,1
34538,Absence of Malignant Features,Choroid Plexus Papilloma,1
34539,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v8,1
34540,Carcinomatous Component Present,Hypopharyngeal Carcinoma by AJCC v7 Stage,1
34541,Malignant Cellular Infiltrate,Adenocarcinoma of lung (disorder),1
34542,Malignant Cellular Infiltrate,Seminal Vesicle Adenocarcinoma,1
34543,Local disease,PNET of bone localized,1
34544,Well Differentiated Neuroendocrine Lesion,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
34545,"Fully Differentiated ""Adult-Type"" Tissues Present",benign mature teratoma of pancreas,1
34546,Carcinomatous Component Present,Stage III Anal Canal Cancer AJCC v6 and v7,1
34547,Carcinomatous Component Present,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,1
34548,Malignant Cellular Infiltrate,Papillary mucinous cystadenocarcinoma,1
34549,Carcinomatous Component Present,Stage IIIA Esophageal Cancer AJCC v7,1
34550,Secondary Lesion,Metastatic Bile Duct Carcinoma,1
34551,Enterochromaffin Type Granules Present,Gastric Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
34552,Lymphoplasmacytic Infiltrate,Lymphoepithelial carcinoma,1
34553,Non-Invasive Lesion,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,1
34554,Malignant Cellular Infiltrate,Vaginal Mesonephric Adenocarcinoma,1
34555,Malignant Cellular Infiltrate,Stage IV Uveal Melanoma AJCC v7,1
34556,Recurrent disease,Recurrent Lip and Oral Cavity Carcinoma,1
34557,Low Mitotic Activity,Jejunal Neuroendocrine Tumor,1
34558,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,1
34559,Resectable Mass,Resectable Pancreatic Acinar Cell Carcinoma,1
34560,Secondary Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,1
34561,Neuroendocrine Differentiation,Stage I Colon Neuroendocrine Tumor AJCC v8,1
34562,Epithelial Component Present,Ductal Eccrine Carcinoma with Spindle Cell Elements,1
34563,Carcinomatous Component Present,Endometrial Large Cell Neuroendocrine Carcinoma,1
34564,Carcinomatous Component Present,Stage IV Renal Cell Cancer AJCC v7,1
34565,Epithelial Component Present,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v8,1
34566,Myeloblasts Under 10 Percent of Bone Marrow Nucleated Cells,Primary Myelofibrosis,1
34567,Epithelial Component Present,High Grade Fallopian Tube Serous Adenocarcinoma,1
34568,Cutaneous Involvement,Granular cell tumor of skin,1
34569,Epithelial Component Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
34570,Metastatic Lesion,Secondary malignant neoplasm of sternum,1
34571,Vascular Channel Formation,Intra-Abdominal Lymphangioma,1
34572,Carcinomatous Component Present,Stage IV Breast Cancer AJCC v6 and v7,1
34573,Hypercellular bone marrow,Philadelphia chromosome negative chronic myelogenous leukemia,1
34574,Systemic disease,Smoldering Systemic Mastocytosis,1
34575,Carcinomatous Component Present,Carcinoma ex pleomorphic adenoma of parotid gland,1
34576,Carcinomatous Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
34577,Epithelial Component Present,Parathyroid Gland Adenocarcinoma,1
34578,Recurrent disease,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
34579,Malignant Cellular Infiltrate,Juxtacortical chondrosarcoma,1
34580,Biphasic Pattern,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
34581,Epithelial Component Present,Stage IIA Breast Carcinoma,1
34582,CD56-Positive Neoplastic Cells Present,Angiocentric lymphoma stage IV,1
34583,Well-Circumscribed Lesion,Gastric Cronkhite Canada Polyposis,1
34584,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v6,1
34585,Carcinomatous Component Present,Vaginal Warty Carcinoma,1
34586,Epithelial Component Present,Stage II Lip Cancer AJCC v6 and v7,1
34587,Epithelial Component Present,Squamous Cell Carcinoma In Situ of the Nipple,1
34588,Malignant Cellular Infiltrate,Uveal Melanoma by Gene Expression Profile,1
34589,Epithelial Component Present,Oxyphilic Adenoma,1
34590,Malignant Cellular Infiltrate,Prostate Basal Cell Carcinoma,1
34591,Malignant Cellular Infiltrate,AIDS-Related Anal Carcinoma,1
34592,Metastatic Lesion,Locally Advanced Prostate Carcinoma,1
34593,Carcinomatous Component Present,Diffuse Gastric Adenocarcinoma,1
34594,Cartilaginous Differentiation,Periosteal Osteosarcoma,1
34595,Epithelial Component Present,Stage IA Ovarian Cancer AJCC v8,1
34596,Malignant Cellular Infiltrate,Locally Advanced Microsatellite Stable Colorectal Carcinoma,1
34597,Epithelial Component Present,Stage IIB Colon Cancer AJCC v7,1
34598,Therapy-Related Toxicity,Cutaneous Radiation-Related Angiosarcoma,1
34599,Indolent Clinical Course,Breast Capillary Hemangioma,1
34600,Carcinomatous Component Present,Squamous cell carcinoma in situ with questionable stromal invasion,1
34601,Carcinomatous Component Present,Stage I Carcinoma of Bladder,1
34602,Carcinomatous Component Present,Sporadic Diffuse Gastric Adenocarcinoma,1
34603,Secondary Lesion,Metastatic Malignant Neoplasm in the Thoracic Cavity,1
34604,Neuroectodermal Differentiation,Recurrent tumors of the Ewing's family,1
34605,Malignant Cellular Infiltrate,Neuroendocrine carcinoma of appendix,1
34606,Benign Cellular Infiltrate,Benign Ovarian Transitional Cell Tumor,1
34607,Epithelial Component Present,Ameloblastic Carcinoma,1
34608,Carcinomatous Component Present,Grade 2 Invasive Breast Carcinoma,1
34609,Pain,Aggressive osteoblastoma,1
34610,Malignant Cellular Infiltrate,Adult Grade III Lymphomatoid Granulomatosis,1
34611,Malignant Cellular Infiltrate,Fallopian Tube Adenosarcoma,1
34612,Epithelial Component Present,Papillary Lung Adenocarcinoma,1
34613,Myxoid Stroma Formation,Sellar Dedifferentiated Chordoma,1
34614,Epithelial Component Present,Intraepithelial Squamous Cell Carcinoma,1
34615,Epithelial Component Present,Adenomatous Polyps,1
34616,Secondary Lesion,Stage IVB Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
34617,Malignant Cellular Infiltrate,Malignant neoplasm of stomach recurrent,1
34618,Malignant Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v7,1
34619,High Mitotic Activity,large cell neuroendocrine carcinoma of bladder,1
34620,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
34621,Carcinomatous Component Present,Stage IIB Esophageal Adenocarcinoma AJCC v7,1
34622,Primary Lesion,BCLC Stage A Hepatocellular Carcinoma,1
34623,Firm mass,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,1
34624,Tissue of Mullerian Origin Present,Mucinous adenofibroma,1
34625,Malignant Cellular Infiltrate,Recurrent Chronic Leukemia,1
34626,Subcutaneous Involvement,Subcutaneous panniculitis-like T-cell lymphoma,1
34627,Dysplasia,Stage 0a Renal Pelvis Cancer AJCC v8,1
34628,Hyperplastic Tissue Present,Prostatic Basal Cell Hyperplasia,1
34629,Malignant Cellular Infiltrate,Stage IV Distal Bile Duct Cancer AJCC v8,1
34630,Carcinomatous Component Present,Stage III Ureter Cancer AJCC v7,1
34631,Cavernous Lymphatic Space Formation,Cavernous lymphangioma,1
34632,Malignant Cellular Infiltrate,Childhood Melanoma,1
34633,Skin nodule,Fibroepithelioma of Pinkus,1
34634,Malignant Cellular Infiltrate,Adult Cholangiocarcinoma,1
34635,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma,1
34636,Cavernous Vascular Space Formation,Liver Cavernous Hemangioma,1
34637,Indolent Clinical Course,Leiomyoma of lung,1
34638,Borderline Lesion,Borderline serous tumor of ovary,1
34639,Exophytic Polypoid Lesion,Colorectal hyperplastic polyp,1
34640,Infiltrative Growth Pattern,Metastatic Kidney Medullary Carcinoma,1
34641,Moderately Differentiated Lesion,Moderately Differentiated Hepatocellular Carcinoma,1
34642,Malignant Cellular Infiltrate,Locally Advanced Unresectable Prostate Carcinoma,1
34643,Malignant Cellular Infiltrate,Ethmoid Sinus Adenocarcinoma,1
34644,In Situ Lesion,Carcinoma in Situ,1
34645,Benign Cellular Infiltrate,Fallopian Tube Serous Adenofibroma,1
34646,Epithelial Component Present,Serous cystadenoma of ovary,1
34647,Carcinomatous Component Present,Gastroesophageal Junction Large Cell Neuroendocrine Carcinoma,1
34648,Benign Cellular Infiltrate,Metastasizing Pleomorphic Adenoma of the Salivary Gland,1
34649,Multinodular Mass,Hemangiosarcoma of heart,1
34650,Malignant Cellular Infiltrate,"Childhood Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
34651,Malignant Cellular Infiltrate,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma,1
34652,Recurrent disease,Liposarcoma recurrent,1
34653,Carcinomatous Component Present,Recurrent Merkel Cell Carcinoma,1
34654,Mass of body structure,"Sarcoma, Myeloid",1
34655,Malignant Cellular Infiltrate,Major Salivary Gland Adenoid Cystic Carcinoma,1
34656,Multilocular Lesion,Childhood Cystic Nephroma,1
34657,High Grade Lesion,Glioblastoma with Primitive Neuronal Component,1
34658,Malignant Cellular Infiltrate,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
34659,Dilated Terminal Duct Lobular Units Present,Columnar Cell Change of the Breast with Atypia,1
34660,"Fully Differentiated ""Adult-Type"" Tissues Present",Stage III Immature Testicular Teratoma AJCC v6 and v7,1
34661,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Myelodysplastic Syndrome with Gene Mutation,1
34662,Hyalinized Stroma Formation,Malignant Solitary Fibrous Tumor,1
34663,Indolent Clinical Course,Verrucous keratotic hemangioma,1
34664,Biphasic Pattern,Childhood Pilocytic Astrocytoma,1
34665,Epithelial Component Present,Stage IIIB Thymoma AJCC v8,1
34666,Benign Cellular Infiltrate,Solitary Osteochondroma,1
34667,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia- Binet Staging System,1
34668,Recurrent disease,Recurrent HIV-Associated Lymphoproliferative Disorder,1
34669,Carcinomatous Component Present,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
34670,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline ETV6 Mutation,1
34671,Papillary Pattern,Choroid Plexus Papilloma,1
34672,Epithelial Component Present,Stage IB Esophageal Adenocarcinoma AJCC v7,1
34673,Granulocytes Increased in Bone Marrow,Overt Primary Myelofibrosis,1
34674,Papillary Pattern,Papillary tumor of renal pelvis,1
34675,Papillary Pattern,"Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type",1
34676,Carcinomatous Component Present,Stage IIB Breast Carcinoma,1
34677,Absence of Invasion,Carcinoma in situ of trachea,1
34678,Endophytic Tumor Growth,Inverting papilloma of the paranasal sinus,1
34679,Mixed Cellular Population,"Uterine Carcinosarcoma, Homologous Type",1
34680,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes,1
34681,Collagenous Stroma Formation,Mammary-Type Myofibroblastoma,1
34682,Metastatic Lesion,Krukenberg Tumor,1
34683,Malignant Cellular Infiltrate,Mesenchymal Chondrosarcoma,1
34684,Malignant Cellular Infiltrate,Stage IIIB Testicular Cancer AJCC v8,1
34685,Refractory Disease,Refractory Malignant Soft Tissue Neoplasm,1
34686,Calcitonin Positive Neoplastic Cells Present,Sporadic Thyroid Gland Medullary Carcinoma,1
34687,Non-Hereditary Lesion,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
34688,Adulthood Lesion,Lugano Classification Stage IV Adult Lymphoma AJCC v8,1
34689,Recurrent disease,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
34690,Malignant Cellular Infiltrate,Digestive System Small Cell Neuroendocrine Carcinoma,1
34691,High Mitotic Activity,Stage IB Lung Small Cell Carcinoma AJCC v7,1
34692,Indolent Clinical Course,Genital rhabdomyoma,1
34693,Carcinomatous Component Present,basaloid carcinoma of penis,1
34694,Desmoplastic Stroma Formation,Childhood Desmoplastic Small Round Cell Tumor,1
34695,Epithelial Component Present,Small intestine carcinoma stage I,1
34696,Carcinomatous Component Present,"Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation",1
34697,Cutaneous Involvement,Sarcoma of skin,1
34698,Severe cytologic atypia,Pleomorphic Rhabdomyosarcoma,1
34699,Lobulated Growth Pattern,Myxoma of the Endocardium,1
34700,Non Lipogenic Sarcomatous Stroma Present,Resectable Dedifferentiated Liposarcoma,1
34701,Metastatic Lesion,Hepatic cancer metastatic,1
34702,Dysplasia,Squamous intraepithelial lesion,1
34703,Anaplasia,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
34704,Pain,Giant Cell Tumor of Bone,1
34705,Epithelial Component Present,Anterior Tongue Adenoid Cystic Carcinoma,1
34706,Less than 2 Mitoses per 10HPF,Thymic Typical Carcinoid Tumor,1
34707,Exophytic Papillary Lesion,Condyloma Acuminatum with Dysplasia,1
34708,Cutaneous Involvement,Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm,1
34709,Increased Cellularity Present,Anaplastic Diencephalic Astrocytoma,1
34710,Malignant Cellular Infiltrate,Lugano Classification Stage III Adult Non-Hodgkin Lymphoma AJCC v8,1
34711,Diffuse Pattern,AIDS-Related Plasmablastic Lymphoma,1
34712,Epithelial Component Present,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
34713,Malignant Cellular Infiltrate,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
34714,Carcinomatous Component Present,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
34715,Malignant Cellular Infiltrate,Non-Metastatic Childhood Soft Tissue Sarcoma,1
34716,Syncytial Pattern,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
34717,Malignant Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v6 and v7,1
34718,Adulthood Lesion,Lugano Classification Stage IIE Adult Lymphoma AJCC v8,1
34719,Malignant Cellular Infiltrate,Recurrent Malignant Endocervical Neoplasm,1
34720,Necrotic changes (finding),Glioblastoma multiforme of spinal cord,1
34721,Neuroendocrine Differentiation,Colorectal Neuroendocrine Tumor by AJCC v8 Stage,1
34722,CD1a-Positive Neoplastic Cells Present,Pulmonary Histiocytosis X,1
34723,Malignant Cellular Infiltrate,Stage IA Osteosarcoma AJCC v7,1
34724,Villous Pattern,tubulovillous adenoma of stomach,1
34725,Secondary Lesion,Malignant fibrous histiocytoma metastatic,1
34726,Epithelial Component Present,Stage IVC Pharyngeal Carcinoma,1
34727,Superficial Lesion,Peyronie Disease,1
34728,Benign Cellular Infiltrate,ductal papilloma of salivary gland,1
34729,Primary Lesion,lymphoma of spinal cord,1
34730,Lymphoplasmacytic Infiltrate,Stage IVB Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
34731,Carcinomatous Component Present,Vaginal Large Cell Neuroendocrine Carcinoma,1
34732,Carcinomatous Component Present,Stage IVB Gallbladder Cancer AJCC v8,1
34733,Absence of Stromal Invasion,Borderline Ovarian Mucinous Adenofibroma,1
34734,Pre-existing condition,Myeloid Neoplasms with Germline GATA2 Mutation,1
34735,Malignant Cellular Infiltrate,Plasmablastic Lymphoma of the Oral Mucosa,1
34736,Fibrosis,Primary Mediastinal (Thymic) Large B-Cell Lymphoma by Ann Arbor Stage,1
34737,Neuroendocrine Differentiation,Transverse Colon Neuroendocrine Tumor G1,1
34738,Epithelial Component Present,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,1
34739,Indolent Clinical Course,Vulvar Cellular Angiofibroma,1
34740,Recurrent Lymphoma,EBV-Related Burkitt Lymphoma,1
34741,Multilocular Lesion,"Mesothelioma, Cystic",1
34742,Storiform Growth Pattern,"Cutaneous Fibrous Histiocytoma, Cellular Variant",1
34743,Lipomatous Component Present,Angiomyolipoma,1
34744,Primary Lesion,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
34745,Malignant Cellular Infiltrate,Malignant lymphoma - lymphoplasmacytic,1
34746,Anaplasia,Brain Glioblastoma,1
34747,Malignant Cellular Infiltrate,Adult Grade III Meningioma,1
34748,Malignant Cellular Infiltrate,Ann Arbor Stage III Grade 2 Follicular Lymphoma,1
34749,Malignant Cellular Infiltrate,Stage IB Testicular Cancer AJCC v8,1
34750,Indolent Clinical Course,Lipoma of axilla,1
34751,Benign Cellular Infiltrate,Cavernous lymphangioma,1
34752,Epithelial Component Present,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
34753,Carcinomatous Component Present,Stage III Primary Peritoneal Cancer AJCC v7,1
34754,Metastatic Lesion,Secondary malignant neoplasm of orbit,1
34755,Malignant Cellular Infiltrate,Secondary malignant neoplasm of kidney,1
34756,Malignant Cellular Infiltrate,verrucous carcinoma of bladder,1
34757,Epithelial Component Present,Prostate cancer recurrent,1
34758,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage III,1
34759,Painless Mass,Central Nervous System Chondroma,1
34760,Carcinomatous Component Present,Metastatic Lung Adenocarcinoma,1
34761,Malignant Cellular Infiltrate,Grade 1 Rectal Adenocarcinoma,1
34762,Malignant Cellular Infiltrate,Vaginal Undifferentiated Carcinoma,1
34763,Carcinomatous Component Present,Stage IVA Paranasal Sinus Cancer AJCC v7,1
34764,Malignant Cellular Infiltrate,Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage,1
34765,Biphasic Pattern,Refractory Uterine Corpus Carcinosarcoma,1
34766,Intraductal Lesion,Intraductal papillomatosis,1
34767,Malignant Cellular Infiltrate,Meningeal Gliomatosis,1
34768,Benign Cellular Infiltrate,Benign Extragonadal Germ Cell Tumor,1
34769,Malignant Cellular Infiltrate,Stage IIA Esophageal Squamous Cell Carcinoma AJCC v7,1
34770,Poorly Differentiated Lesion,"Cervical Adenosquamous Carcinoma, Glassy Cell Variant",1
34771,Epithelial Component Present,Stage 0is Urethral Cancer AJCC v8,1
34772,Ground Glass Nuclear Inclusion,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
34773,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage 0,1
34774,Carcinomatous Component Present,Stage III Lung Cancer AJCC v6,1
34775,Malignant Cellular Infiltrate,Intestinal Neuroendocrine Carcinoma,1
34776,Epithelial Component Present,Advanced Uterine Corpus Carcinosarcoma,1
34777,Mild dysplasia,Pancreatic Intraepithelial Neoplasia-1A,1
34778,Lobulated Growth Pattern,Sellar Chondroid Chordoma,1
34779,In Situ Lesion,Pleomorphic lobular carcinoma in situ of breast,1
34780,Malignant Cellular Infiltrate,Bile duct clear cell adenocarcinoma,1
34781,Infiltrative Growth Pattern,Infantile digital fibromatosis,1
34782,Childhood Lesion,Mixed epithelial-mesenchymal hepatoblastoma,1
34783,Malignant Cellular Infiltrate,Acute Lymphoblastic Leukemia by ROSE Cluster,1
34784,Regional Disease,Locally Metastatic Malignant Neoplasm,1
34785,Malignant Cellular Infiltrate,Refractory Urothelial Carcinoma,1
34786,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IV,1
34787,Refractory Disease,Refractory Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
34788,Benign Cellular Infiltrate,Borderline Ovarian Serous Cystadenofibroma,1
34789,Benign Cellular Infiltrate,Sebaceoma,1
34790,Papillary Pattern,Papillary cystic tumor,1
34791,Malignant Cellular Infiltrate,Childhood Mixed Cellularity Classic Hodgkin Lymphoma,1
34792,Refractory Disease,Refractory Barrett Esophagus,1
34793,Carcinomatous Component Present,Stage I Ovarian Cancer AJCC v8,1
34794,Epithelial Component Present,Lung Pleomorphic Carcinoma,1
34795,Poorly Differentiated Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,1
34796,Malignant Cellular Infiltrate,Cholangiocarcinoma resectable,1
34797,Low Mitotic Activity,Malignant Pancreatic Insulinoma,1
34798,Malignant Cellular Infiltrate,Transplant-Related Squamous Cell Carcinoma,1
34799,Carcinomatous Component Present,Minor Salivary Gland Acinic Cell Carcinoma,1
34800,Carcinomatous Component Present,Metastatic Lung Carcinoma,1
34801,Parakeratinized Stratified Squamous Epithelium Present,Keratocystic Odontogenic Tumor,1
34802,Cellular Pleomorphism,Malignant Fibrous Histiocytoma,1
34803,Refractory Disease,Refractory Langerhans Cell Histiocytosis,1
34804,Malignant Cellular Infiltrate,Laryngeal verrucous carcinoma recurrent,1
34805,Refractory Disease,Refractory Ovarian Endometrioid Adenocarcinoma,1
34806,Malignant Cellular Infiltrate,Stage IVA Pharyngeal Carcinoma,1
34807,Mild cytologic atypia,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,1
34808,Epithelial Component Present,Apocrine adenoma,1
34809,Malignant Cellular Infiltrate,Malignant neoplasm of heart,1
34810,Malignant Cellular Infiltrate,Sarcomatoid Hepatocellular Carcinoma,1
34811,Carcinomatous Component Present,Stage 0 Low-Grade Appendiceal Mucinous Neoplasm (LAMN) AJCC v8,1
34812,Malignant Cellular Infiltrate,Testicular Seminoma with Syncytiotrophoblastic Cells,1
34813,Carcinomatous Component Present,Bladder adenocarcinoma stage IV,1
34814,Carcinomatous Component Present,small cell carcinoma of appendix,1
34815,Moderately Differentiated Lesion,Esophageal Moderately Differentiated Squamous Cell Carcinoma,1
34816,Epithelial Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
34817,Malignant Cellular Infiltrate,Malignant neoplasm of sphenoidal sinus,1
34818,Increased Cellularity Present,Extracranial Neuroblastoma,1
34819,Epithelial Component Present,Recurrent Ureter Carcinoma,1
34820,Cutaneous Involvement,Hallopeau-Siemens Disease,1
34821,Primary Lesion,Stage IIA Primary Peritoneal Cancer AJCC v8,1
34822,Stromal Invasion,Recurrent ovarian cancer,1
34823,Papillary Pattern,Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease,1
34824,Malignant Cellular Infiltrate,Centroblastic lymphoma refractory,1
34825,Pseudopapillary Pattern,Solid pseudopapillary tumor of the pancreas,1
34826,Diffuse Pattern,Centroblastic lymphoma recurrent,1
34827,Mitotic Activity,Small cell glioblastoma,1
34828,Low Grade Lesion,Mediastinal Epithelioid Hemangioendothelioma,1
34829,Neuroendocrine Differentiation,Esophageal Neuroendocrine Neoplasm,1
34830,Encapsulated Mass,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
34831,Carcinomatous Component Present,Liver and Intrahepatic Biliary Tract Carcinoma,1
34832,Carcinomatous Component Present,Mediastinal/Thymic NUT Carcinoma,1
34833,Malignant Cellular Infiltrate,Stage IV Hepatocellular Carcinoma AJCC v7,1
34834,Malignant Cellular Infiltrate,"Glioblastoma, IDH-Wildtype",1
34835,Epithelial Component Present,Non-Functioning Adrenal Cortex Adenoma,1
34836,Childhood Lesion,"Diffuse midline glioma, point mutation K27M in histone H3",1
34837,Malignant Cellular Infiltrate,Myeloid Neoplasms with Germline DDX41 Mutation,1
34838,Epithelial Component Present,Mediastinal/Thymic NUT Carcinoma,1
34839,Pagetoid Proliferation,Stage II Superficial Spreading Melanoma AJCC v6 and v7,1
34840,Eosinophil count raised (finding),Hypereosinophilic syndrome,1
34841,Benign Cellular Infiltrate,Benign Bone Schwannoma,1
34842,Recurrent disease,"Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified",1
34843,Hyperkeratosis,Vulvar Seborrheic Keratosis,1
34844,Regional Disease,Locally Advanced Unresectable Bone Sarcoma,1
34845,Well-Circumscribed Lesion,Adenomatous Polyposis Coli,1
34846,Neuroendocrine Differentiation,Gastric Large Cell Neuroendocrine Carcinoma,1
34847,Biphasic Pattern,Serous adenofibroma,1
34848,Carcinomatous Component Present,Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
34849,Malignant Cellular Infiltrate,Localized Resectable Adult Liver Carcinoma,1
34850,Dilated Terminal Duct Lobular Units with Acini Lined by One or Two Layers of Columnar Epithelial Cells Present,Columnar Cell Change of the Breast with Atypia,1
34851,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Neuroendocrine Tumor G1,1
34852,Local disease,Localized Primitive Neuroectodermal Tumor,1
34853,Well-Circumscribed Lesion,Sclerosing Polycystic Adenosis,1
34854,Childhood Lesion,Childhood Craniopharyngioma,1
34855,Adnexal Differentiation,Desmoplastic trichilemmoma,1
34856,Diffuse Pattern,mixed gliomas,1
34857,Cutaneous Involvement,Stage IV Lentigo Maligna Melanoma AJCC v6 and v7,1
34858,Malignant Cellular Infiltrate,Stage IA Vulvar Cancer AJCC v8,1
34859,Carcinomatous Component Present,Stage II Carcinoma of Penis,1
34860,Malignant Cellular Infiltrate,Small Intestinal Adenosquamous Carcinoma,1
34861,Fibrotic Stroma Formation,mucoepidermoid carcinoma of floor of mouth,1
34862,Monoclonal Cellular Population Present,Thyroid Gland Hyperfunctioning Adenoma,1
34863,Malignant Cellular Infiltrate,Resectable Head and Neck Squamous Cell Carcinoma,1
34864,Malignant Cellular Infiltrate,Malignant neoplasm of olfactory nerve,1
34865,Carcinomatous Component Present,Stage IIIB Appendix Carcinoma AJCC v8,1
34866,Refractory Disease,Refractory Liver Carcinoma,1
34867,Carcinomatous Component Present,Vaginal Endometrioid Adenocarcinoma,1
34868,Carcinomatous Component Present,Vaginal Basaloid Carcinoma,1
34869,Cutaneous Involvement,Dermatologic disorders,1
34870,Carcinomatous Component Present,Stage IVB Liver Cancer,1
34871,Carcinomatous Component Present,"Cystadenocarcinoma, Papillary",1
34872,Malignant Cellular Infiltrate,Stage II Soft Tissue Sarcoma AJCC v7,1
34873,Malignant Cellular Infiltrate,Orbital lymphoma,1
34874,'Starry-sky' pattern,Burkitt Lymphoma with Plasmacytoid Differentiation,1
34875,Cystic Change,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
34876,Epithelial Component Present,Breast Solid Neuroendocrine Carcinoma,1
34877,Benign Cellular Infiltrate,Benign Gastric Granular Cell Tumor,1
34878,Diffuse Pattern,Cervical Malignant Peripheral Nerve Sheath Tumor,1
34879,Carcinomatous Component Present,Stage III Cervical Cancer AJCC v8,1
34880,Carcinomatous Component Present,Uterine Corpus Carcinosarcoma,1
34881,Extraosseous Lesion,Mediastinal Extraskeletal Osteosarcoma,1
34882,Malignant Cellular Infiltrate,Primary peritoneal carcinoma,1
34883,Malignant Cellular Infiltrate,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
34884,Malignant Cellular Infiltrate,Adult Papillary Meningioma,1
34885,Estrogen receptor negative,Triple-Negative Breast Carcinoma,1
34886,Invasive Focus of Carcinoma Cells Measuring More Than 5 mm Present,Lepidic Predominant Adenocarcinoma,1
34887,Anaplasia,Infratentorial Glioblastoma,1
34888,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
34889,Secondary Lesion,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
34890,Acanthosis,verrucous carcinoma of bladder,1
34891,Benign Cellular Infiltrate,Central Nervous System Rhabdomyoma,1
34892,Epithelial Component Present,Ductal Breast Carcinoma with Squamous Metaplasia,1
34893,Malignant Cellular Infiltrate,Acute Basophilic Leukemia,1
34894,Benign Cellular Infiltrate,Bone Epithelioid Hemangioma,1
34895,Abundance of Small Lymphocytes,Adult Lymphocyte-Rich Classical Hodgkin Lymphoma,1
34896,Non-Invasive Lesion,Ureter Urothelial Papilloma,1
34897,Neuroendocrine Differentiation,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
34898,Neuroectodermal Differentiation,Olfactory Neuroblastoma,1
34899,High Mitotic Activity,Extrapulmonary Small Cell Carcinoma,1
34900,Multinodular Mass,Cervical Angiosarcoma,1
34901,Malignant Cellular Infiltrate,Childhood Diffuse Large B-Cell Lymphoma,1
34902,Adnexal Differentiation,Malignant Breast Eccrine Spiradenoma,1
34903,Diffuse Pattern,Diffuse follicle center lymphoma,1
34904,High Mitotic Activity,Metastatic Bladder Small Cell Carcinoma,1
34905,1p/19q Codeletion Status Unknown,Anaplastic Oligodendroglioma,1
34906,Epithelial Component Present,Colon Neuroendocrine Tumor by AJCC v8 Stage,1
34907,Epithelial Component Present,Rectal Neuroendocrine Neoplasm,1
34908,High Mitotic Activity,Testicular embryonal carcinoma,1
34909,High Grade Lesion,Platinum-Resistant Lung Small Cell Carcinoma,1
34910,Malignant Cellular Infiltrate,Vaginal Adenosquamous Carcinoma,1
34911,Epithelial Component Present,Parathyroid Gland Lipoadenoma,1
34912,Secondary Lesion,Metastatic Well Differentiated Neuroendocrine Neoplasm,1
34913,Necrotic changes (finding),Stage IIB Lung Small Cell Carcinoma AJCC v7,1
34914,Epithelial Component Present,hepatoid adenocarcinoma of bladder,1
34915,Necrotic changes (finding),Cerebellar Glioblastoma,1
34916,Invasive Lesion,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
34917,Secondary Lesion,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
34918,Malignant Primitive Cellular Infiltrate,Ovarian germ cell tumor mixed,1
34919,Epithelial Component Present,Fallopian Tube Gestational Choriocarcinoma,1
34920,Epithelial Component Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
34921,Benign Cellular Infiltrate,Inner Ear Lipoma,1
34922,Primary Lesion,Medullary Hemangioblastoma,1
34923,Carcinomatous Component Present,Skin Sarcomatoid Basal Cell Carcinoma,1
34924,Absence of Basal Cell Layer,"Acinar Prostate Adenocarcinoma, Pseudohyperplastic Variant",1
34925,Nodular Pattern,Recurrent Myxoid Liposarcoma,1
34926,Mixed Cellular Population,Ovarian Wilms Tumor,1
34927,Malignant Cellular Infiltrate,Stage III Rectal Cancer AJCC v8,1
34928,Cutaneous Involvement,Eccrine Neoplasm,1
34929,Epithelial Component Present,Unresectable Esophageal Carcinoma,1
34930,Malignant Cellular Infiltrate,Refractory Small Intestinal Carcinoma,1
34931,Epithelial Component Present,Adenocarcinoma of lung stage IIIB,1
34932,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Black Follicular Adenoma,1
34933,Peripheral Nuclear Palisading,Nasopharyngeal Basaloid Squamous Cell Carcinoma,1
34934,Carcinomatous Component Present,Retromolar Trigone Squamous Cell Carcinoma,1
34935,Benign Cellular Infiltrate,"Acanthoma, Pilar Sheath",1
34936,Malignant Cellular Infiltrate,Stage II Colorectal Cancer AJCC v7,1
34937,Epithelial Component Present,Pancreatic adenocarcinoma resectable,1
34938,Epithelial Component Present,Sertoli-Leydig cell tumor of ovary,1
34939,Dysplasia,Esophageal dysplasia,1
34940,Mesenchymal Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
34941,Exophytic Papillary Lesion,Supraglottic Verrucous Carcinoma,1
34942,Oligodendroglial Component Present,Mixed Oligodendroglioma-Astrocytoma,1
34943,Epithelial Component Present,"Papillomatosis, glandular",1
34944,Epithelial Differentiation,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
34945,Alternative Fascicle (Bundle) Pattern,Leiomyoma of lung,1
34946,Necrotic changes (finding),Small Intestinal Small Cell Neuroendocrine Carcinoma,1
34947,Epithelial Component Present,Ampulla of Vater Cancer by AJCC v8 Stage,1
34948,Epithelial Component Present,carcinosarcoma of lung,1
34949,Therapy-Related Toxicity,Transplant-Related Lung Carcinoma,1
34950,Adulthood Lesion,Lugano Classification Stage IIE Adult Hodgkin Lymphoma AJCC v8,1
34951,Epithelial Component Present,Stage 0 Vulvar Carcinoma,1
34952,Epithelial Component Present,Stage IV Ovarian Cancer AJCC v8,1
34953,Malignant Cellular Infiltrate,Penile Cancer by AJCC v7 Stage,1
34954,Fried-Egg Appearance of the Bone Marrow,Hairy Cell Leukemia,1
34955,Childhood Lesion,Childhood Choroid Plexus Carcinoma,1
34956,Capillary Sized Vascular Channel Formation,Infantile hemangioma of liver,1
34957,Carcinomatous Component Present,Lung Acinar Adenocarcinoma,1
34958,Neuroendocrine Differentiation,Neuroendocrine Tumors,1
34959,Endophytic Tumor Growth,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
34960,Rapidly Enlarging Mass,Alveolar rhabdomyosarcoma,1
34961,Cutaneous Involvement,Trichofolliculoma,1
34962,Malignant Cellular Infiltrate,Telangiectatic osteosarcoma,1
34963,Metastatic Lesion,Liposarcoma metastatic,1
34964,Syncytial Pattern,Undifferentiated carcinoma of nasopharynx,1
34965,Epithelial Component Present,Stage IA Distal Bile Duct Cancer AJCC v7,1
34966,Carcinomatous Component Present,Laryngeal Basaloid Carcinoma,1
34967,Malignant Cellular Infiltrate,Mixed Squamous Cell Carcinoma of the Penis,1
34968,Necrotic changes (finding),Pancreatic Large Cell Neuroendocrine Carcinoma,1
34969,Malignant Cellular Infiltrate,Stage III Testicular Cancer AJCC v8,1
34970,Epithelial Component Present,Thymic Adenocarcinoma,1
34971,Immunosuppression-Related Post-Transplant Toxicity,Hodgkin-Like Post-Transplant Lymphoproliferative Disorder,1
34972,Slow Growing Mass,Retinal hemangioblastoma,1
34973,Epithelial Component Present,Adenocarcinoma of appendix,1
34974,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Childhood Myelodysplastic Syndrome,1
34975,Malignant Cellular Infiltrate,Kaposi's sarcoma of conjunctiva,1
34976,Malignant Cellular Infiltrate,basal cell adenocarcinoma of salivary gland,1
34977,Carcinomatous Component Present,Stage IA1 Cervical Cancer AJCC v8,1
34978,Low Mitotic Activity,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
34979,Follicular Structures Present,Thyroid Gland Signet Ring Cell Follicular Adenoma,1
34980,Malignant Cellular Infiltrate,Anatomic Stage IIA Breast Cancer AJCC v8,1
34981,Malignant Cellular Infiltrate,Colorectal Cancer by AJCC v8 Stage,1
34982,Metaplasia,Pleomorphic adenoma of lacrimal gland,1
34983,Hereditary Lesion,"Wilms Tumor, Aniridia, Genitourinary Anomalies, Mental Retardation, and Obesity Syndrome",1
34984,Malignant Cellular Infiltrate,Malignant Ovarian Thecoma,1
34985,Biphasic Pattern,Benign mixed epithelial and stromal tumor of kidney,1
34986,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma,1
34987,Infiltrating Tumor Margins Present,Uterine Corpus Low Grade Endometrial Stromal Sarcoma,1
34988,Well-Circumscribed Lesion,Pancreatic Macrocystic Serous Cystadenoma,1
34989,Metastatic Lesion,Metastatic Cervical Carcinoma,1
34990,Osseous Differentiation,Stage IVB Osteosarcoma AJCC v7,1
34991,Benign Cellular Infiltrate,Esophageal squamous papilloma,1
34992,Honeycomb Pattern,Adult Brain Oligodendroglioma,1
34993,Malignant Cellular Infiltrate,Papillary renal cell carcinoma type 2,1
34994,Cutaneous Involvement,Sebaceous Adenocarcinoma,1
34995,Carcinomatous Component Present,large cell neuroendocrine carcinoma of appendix,1
34996,Carcinomatous Component Present,Ductal Eccrine Carcinoma with Abundant Fibromyxoid Stroma,1
34997,Neuroendocrine Differentiation,Clinical Stage IV Merkel Cell Carcinoma AJCC v8,1
34998,Metastatic Lesion,Secondary malignant neoplasm of testis,1
34999,Monomorphic Cellular Infiltrate,Papillary ependymoma,1
35000,Malignant Cellular Infiltrate,Pyriform Fossa Carcinoma,1
35001,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP J",1
35002,Malignant Cellular Infiltrate,Refractory Lymphoblastic Lymphoma,1
35003,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
35004,Carcinomatous Component Present,Oropharyngeal lymphoepithelioma stage I,1
35005,Intraocular Lesion,Intraocular Lymphoma,1
35006,Epithelial Component Present,Metastatic Lobular Breast Carcinoma,1
35007,Epithelial Component Present,Colorectal Micropapillary Adenocarcinoma,1
35008,Trabecular Pattern,Microfollicular adenoma,1
35009,Recurrent disease,Breast cancer recurrent,1
35010,Epithelial Component Present,Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7,1
35011,Benign Cellular Infiltrate,Dermoid Cyst,1
35012,Malignant Cellular Infiltrate,Occult Lung Adenocarcinoma,1
35013,Carcinomatous Component Present,Stage IIIC Esophageal Adenocarcinoma AJCC v7,1
35014,Epithelial Component Present,Stage IV Adult Liver Cancer AJCC v7,1
35015,S-100-Positive Neoplastic Cells Present,Uterine Corpus PEComa,1
35016,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v7,1
35017,Tumor Vascular Invasion,Malignant Testicular Sex Cord-Stromal Tumor,1
35018,Malignant Cellular Infiltrate,signet ring cell carcinoma of breast,1
35019,Malignant Cellular Infiltrate,Childhood Acute Erythroid Leukemia,1
35020,Epithelial Component Present,Thyroid Hurthle Cell Carcinoma,1
35021,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Aleukemic Monocytic Leukemia Cutis,1
35022,Mitotic Activity,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
35023,Malignant Cellular Infiltrate,Adult Cholangiocarcinoma,1
35024,Epithelial Component Present,Adenocarcinoma in villous adenoma,1
35025,Nodular Pattern,Ann Arbor Stage I Follicular Lymphoma,1
35026,Biphasic Pattern,Nephrogenic adenofibroma,1
35027,Locally Aggressive Lesion,Composite hemangioendothelioma,1
35028,Epithelial Component Present,Carcinoma ex pleomorphic adenoma of lacrimal gland,1
35029,Refractory Disease,Refractory Hormone Receptor Positive Breast Carcinoma,1
35030,Metastatic Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
35031,Lymphoplasmacytic Infiltrate,Lung Lymphoepithelioma-Like Carcinoma,1
35032,Epithelial Component Present,Metastatic Unresectable Basal Cell Carcinoma,1
35033,Epithelial Component Present,Stage III Eyelid Carcinoma AJCC v8,1
35034,Secondary Lesion,Advanced Prostate Adenocarcinoma,1
35035,Cystic Change,Cystadenocarcinoma,1
35036,Carcinomatous Component Present,Recurrent Ovarian Transitional Cell Carcinoma,1
35037,Neuroendocrine Differentiation,Malignant Cardiac Paraganglioma,1
35038,Epithelial Component Present,adenomatous polyp of stomach,1
35039,Malignant Cellular Infiltrate,Soft Tissue Sarcoma by AJCC v7 Stage,1
35040,Cysts Containing Proteinaceous Fluid Present,Papillary serous cystadenocarcinoma,1
35041,Absence of Invasion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
35042,Recurrent disease,Recurrent Childhood Rhabdomyosarcoma,1
35043,Cutaneous Involvement,Acantholytic squamous cell carcinoma of skin,1
35044,Primary Lesion,Stage IIIC Primary Peritoneal Cancer AJCC v8,1
35045,Papillary Pattern,Ampulla of Vater Invasive Papillary Adenocarcinoma,1
35046,Neuroendocrine Differentiation,Stage IV Colon Neuroendocrine Tumor AJCC v8,1
35047,Malignant Cellular Infiltrate,Lymphoplasmacytic Lymphoma by Ann Arbor Stage,1
35048,Cystic Lesion,Desmoplastic infantile astrocytoma,1
35049,Metastatic Lesion,Metastatic malignant neoplasm to nasopharynx,1
35050,Carcinomatous Component Present,Non-small cell lung cancer recurrent,1
35051,Malignant Cellular Infiltrate,Pancreatic carcinoma non-resectable,1
35052,Clinical TNM Finding,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
35053,Epithelial Component Present,Fibrolamellar Hepatocellular Carcinoma,1
35054,Carcinomatous Component Present,Adult Salivary Gland Carcinoma,1
35055,Epithelial Component Present,Neuroendocrine neoplasm of lung,1
35056,Carcinomatous Component Present,Stage III Fallopian Tube Cancer AJCC v8,1
35057,Epithelial Component Present,Anterior Tongue Squamous Cell Carcinoma,1
35058,Pseudoencapsulated Mass,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,1
35059,Primary Lesion,Recurrent Peripheral Primitive Neuroectodermal Tumor,1
35060,Metastatic Lesion,Metastatic Unresectable Sarcoma,1
35061,Epithelial Component Present,Colorectal Sarcomatoid Carcinoma,1
35062,Benign Cellular Infiltrate,Juvenile Xanthogranuloma,1
35063,Malignant Cellular Infiltrate,Oropharyngeal lymphoepithelioma stage I,1
35064,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8,1
35065,Epithelial Component Present,High Grade Lung Neuroendocrine Neoplasm,1
35066,Epithelial Component Present,Stage II Liver Cancer,1
35067,Epithelial Component Present,Phyllodes Tumor,1
35068,Refractory Disease,Refractory Hematologic Malignancy,1
35069,Vascular Channel Formation,Soft Tissue Angiosarcoma,1
35070,High Mitotic Activity,Extrapulmonary Small Cell Carcinoma,1
35071,Adulthood Lesion,Adult Kidney Wilms Tumor,1
35072,Malignant Cellular Infiltrate,Stage II Primary Peritoneal Cancer AJCC v8,1
35073,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
35074,Diffuse Pattern,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
35075,Necrotic changes (finding),Colon Small Cell Neuroendocrine Carcinoma,1
35076,Epithelial Component Present,Stage III Ureter Cancer AJCC v7,1
35077,Malignant Cellular Infiltrate,Advanced Small Intestinal Neuroendocrine Carcinoma,1
35078,Malignant Cellular Infiltrate,Metastases to adrenals,1
35079,Epithelial Component Present,Recurrent Liver Carcinoma,1
35080,Neuroendocrine Differentiation,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,1
35081,Malignant Cellular Infiltrate,Grade 1 Endometrial Endometrioid Adenocarcinoma,1
35082,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
35083,Undifferentiated Lesion,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
35084,Pseudoglandular Pattern,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
35085,Malignant Cellular Infiltrate,Vulvar Warty Carcinoma,1
35086,Carcinomatous Component Present,Adrenocortical carcinoma,1
35087,Neuroendocrine Differentiation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
35088,Glandular Pattern,"Somatostatinoma, malignant",1
35089,Benign Cellular Infiltrate,Benign Thalamic Neoplasm,1
35090,Fibrotic Stroma Formation,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8,1
35091,Malignant Cellular Infiltrate,Stage II Kidney Wilms Tumor,1
35092,Malignant Cellular Infiltrate,Refractory Follicular Lymphoma,1
35093,Lymphatic Spread,Inflammatory carcinoma of breast stage III,1
35094,Malignant Cellular Infiltrate,Stage II Rectosigmoid Cancer AJCC v6,1
35095,Microvascular Proliferation,Adult Giant Cell Glioblastoma,1
35096,Epithelial Component Present,Childhood Gastric Carcinoma,1
35097,Refractory Disease,Refractory Mediastinal Lymphoma,1
35098,Epithelial Component Present,Transplant-Related Squamous Cell Carcinoma,1
35099,Lymphadenopathy,Chronic Adult T-Cell Leukemia/Lymphoma,1
35100,Well Differentiated Lesion,Well Differentiated Adrenal Cortex Carcinoma,1
35101,Epithelial Component Present,Anatomic Stage IIA Breast Cancer AJCC v8,1
35102,Carcinomatous Component Present,Neck Carcinoma,1
35103,Therapy-Related Toxicity,Burkitt Lymphoma Post-Transplant Lymphoproliferative Disorder,1
35104,Slow Growing Mass,Central Nervous System Hemangioblastoma,1
35105,Primary Lesion,Hepatocellular Carcinoma by AJCC v7 Stage,1
35106,Malignant Cellular Infiltrate,Colorectal Mucinous Adenocarcinoma,1
35107,Epithelial Component Present,Adenoma of Minor Vestibular Glands,1
35108,Pushing Tumor Margin,Stage I Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
35109,Mixed Cellular Population,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
35110,Dysplasia,Stage 0a Ureter Cancer AJCC v8,1
35111,No Identifiable Line of Differentiation,Malignant Fibrous Histiocytoma,1
35112,Malignant Cellular Infiltrate,Recurrent Ovarian Clear Cell Adenocarcinoma,1
35113,Epithelial Component Present,Childhood Thyroid Gland Papillary Carcinoma,1
35114,Secondary Lesion,Metastatic Digestive System Carcinoma,1
35115,Indolent Clinical Course,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",1
35116,Epithelial Component Present,Nasopharyngeal squamous cell carcinoma recurrent,1
35117,Malignant Cellular Infiltrate,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
35118,Hyperkeratosis,Subglottic Verrucous Carcinoma,1
35119,Secondary Lesion,Carcinoma Arising from Craniopharyngioma,1
35120,Benign Cellular Infiltrate,Benign Extraskeletal Cartilaginous and Osseous Neoplasm,1
35121,Malignant Cellular Infiltrate,leiomyosarcoma of mediastinum,1
35122,Carcinomatous Component Present,Non-Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
35123,Papillary Pattern,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
35124,Epithelial Component Present,Transitional cell carcinoma of bladder,1
35125,Benign Cellular Infiltrate,Bronchial adenoma,1
35126,Systemic disease,Indolent Systemic Mastocytosis,1
35127,Malignant Cellular Infiltrate,Lip Carcinoma,1
35128,Epithelial Component Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v8,1
35129,Necrotic changes (finding),Refractory Lung Small Cell Carcinoma,1
35130,Carcinomatous Component Present,Stage I Lung Cancer AJCC v6,1
35131,Carcinomatous Component Present,Pancreatic Poorly Differentiated Ductal Adenocarcinoma,1
35132,Carcinomatous Component Present,Metastatic Urethral Carcinoma,1
35133,Epithelial Component Present,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
35134,Collagenous Stroma Formation,Pelvic Fibromatosis,1
35135,Carcinomatous Component Present,Aflatoxins-Related Hepatocellular Carcinoma,1
35136,Malignant Cellular Infiltrate,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
35137,Bone Marrow Involvement,Hepatosplenic T-cell lymphoma,1
35138,Epithelial Component Present,Stage II Colorectal Cancer,1
35139,High Grade Lesion,Anaplastic astrocytoma,1
35140,Malignant Cellular Infiltrate,Stage I Hypopharyngeal Carcinoma AJCC v6,1
35141,Cartilaginous Differentiation,Childhood Mesenchymal Chondrosarcoma,1
35142,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7,1
35143,Epithelial Component Present,Esophageal Squamous Cell Carcinoma by AJCC v8 Stage,1
35144,Cutaneous Involvement,Solar lentigo,1
35145,Epithelial Component Present,Recurrent Appendix Mucinous Adenocarcinoma,1
35146,Pregnancy Complications,Pre-Eclampsia,1
35147,Fibrotic Stroma Formation,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
35148,Benign Cellular Infiltrate,Ganglioneuroma,1
35149,Villous Pattern,Colorectal Villous Adenoma,1
35150,High Mitotic Activity,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
35151,Malignant Cellular Infiltrate,Breast implant-associated anaplastic large cell lymphoma,1
35152,Mitotic Activity,Sellar Yolk Sac Tumor,1
35153,Malignant Cellular Infiltrate,Uterine Corpus Cancer,1
35154,Pregnancy Complications,Stage I Gestational Trophoblastic Neoplasm AJCC v8,1
35155,Epithelial Component Present,Recurrent Merkel Cell Carcinoma,1
35156,Invasive Lesion,Well Differentiated Prostate Adenocarcinoma,1
35157,Malignant Cellular Infiltrate,Malignant Phyllodes Tumor of Prostate,1
35158,Neuroendocrine Differentiation,Ampulla of Vater Small Cell Neuroendocrine Carcinoma,1
35159,Acinar Cell Differentiation,Acinar cell carcinoma of pancreas,1
35160,Poorly Differentiated Neuroendocrine Lesion,small cell carcinoma of gallbladder,1
35161,Follicular Cell Differentiation,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
35162,Carcinomatous Component Present,Skin squamous cell carcinoma recurrent,1
35163,Epithelial Component Present,Colorectal Adenoma with Severe Dysplasia,1
35164,Cutaneous Involvement,Ancell-Spiegler cylindromas,1
35165,Carcinomatous Component Present,Platinum-Resistant Lung Small Cell Carcinoma,1
35166,Malignant Cellular Infiltrate,Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
35167,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Nodular amyloidosis,1
35168,Absence of Invasion,Stage 0 Rectal Cancer AJCC v6 and v7,1
35169,Carcinomatous Component Present,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,1
35170,Epithelial Component Present,Thyroid Gland Mixed Medullary and Papillary Carcinoma,1
35171,Thyroglobulin Positive Neoplastic Cells Present,Nonencapsulated sclerosing tumor,1
35172,Nuclear Atypia,Childhood Cerebral Anaplastic Astrocytoma,1
35173,Intramucosal Lesion,Intramucosal Adenocarcinoma,1
35174,Cervical lymphadenopathy,Stage III Unknown Primary Tumor (Except for EBV-Related and HPV-Related Tumors) and Metastatic Cervical Adenopathy AJCC v8,1
35175,Malignant Cellular Infiltrate,AIDS-Related Gastric Kaposi Sarcoma,1
35176,Malignant Cellular Infiltrate,Recurrent Chronic Myelomonocytic Leukemia,1
35177,Malignant Cellular Infiltrate,Pigmented Basal Cell Carcinoma,1
35178,Childhood Lesion,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
35179,Unresectable Mass,Unresectable Thymic Carcinoma,1
35180,Malignant Cellular Infiltrate,Recurrent Thymic Carcinoma,1
35181,Precise Histogenesis Unknown,Hemangioblastoma,1
35182,Epithelial Component Present,Bladder Adenocarcinoma,1
35183,Misplaced Exocytosis Present,Sparsely Granulated Lactotroph Adenoma,1
35184,Epithelial Component Present,Adult Type Granulosa Cell Tumor,1
35185,Indolent Clinical Course,Histiocytoma,1
35186,Epithelial Component Present,Childhood Rectal Carcinoma,1
35187,Malignant Cellular Infiltrate,Stage II Esophageal Squamous Cell Carcinoma AJCC v7,1
35188,Epithelial Component Present,Papillary carcinoma of the breast,1
35189,Diffuse Pattern,Refractory Plasmablastic Lymphoma,1
35190,Well-Circumscribed Lesion,Fibroma of tendon sheath,1
35191,Biphasic Pattern,carcinosarcoma of gallbladder,1
35192,Neuroendocrine Differentiation,Childhood Thyroid Gland Medullary Carcinoma,1
35193,Epithelial Component Present,Locally Advanced Unresectable Prostate Adenocarcinoma,1
35194,Mitotic Activity,Recurrent Glioblastoma,1
35195,Primary Lesion,Hepatoma resectable,1
35196,Carcinomatous Component Present,Stage IVB Vulvar Cancer AJCC v8,1
35197,Epithelial Component Present,Stage III Renal Pelvis Cancer AJCC v8,1
35198,Eosinophil count raised (finding),"Leukemia, Eosinophilic, Acute",1
35199,Primary Lesion,Cerebral Astrocytoma,1
35200,Metaplasia,Bladder squamous cell carcinoma stage 0,1
35201,Bone Marrow Involvement,Waldenstrom's macroglobulinemia recurrent,1
35202,Epithelial Component Present,Stage IA Vulvar Cancer AJCC v8,1
35203,Mixed Cellular Population,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
35204,"Amorphus, Eosinophilic, and Acellular Deposit",Primary Systemic Amyloidosis,1
35205,Epithelial Component Present,Eccrine porocarcinoma,1
35206,Epithelial Component Present,Stage IIIC Vulvar Cancer AJCC v7,1
35207,Vascular proliferation,Vulvar Cellular Angiofibroma,1
35208,Malignant Cellular Infiltrate,Recurrent Anaplastic Astrocytoma,1
35209,Epithelial Component Present,Lung squamous cell carcinoma stage II,1
35210,Monomorphic Cellular Infiltrate,Low Grade Ductal Breast Carcinoma In Situ,1
35211,Epithelial Component Present,Stage IIIA Thymus Epithelial Neoplasm AJCC v8,1
35212,Malignant Cellular Infiltrate,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,1
35213,Refractory Disease,Refractory Malignant Bone Neoplasm,1
35214,Malignant Cellular Infiltrate,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1,1
35215,Epithelial Component Present,Childhood Thyroid Gland Carcinoma,1
35216,Malignant Cellular Infiltrate,Alveolar soft part sarcoma metastatic,1
35217,Cystic Change,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,1
35218,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
35219,Metastatic Lesion,Testicular cancer metastatic,1
35220,Carcinomatous Component Present,Prostate Acinar Adenocarcinoma,1
35221,Malignant Cellular Infiltrate,Synovial sarcoma metastatic,1
35222,Epithelial Component Present,Breast Cancer by AJCC v8 Anatomic Stage,1
35223,Low Mitotic Activity,Intestinal Neuroendocrine Tumor,1
35224,Carcinomatous Component Present,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
35225,Epithelial Component Present,Cervical Adenosquamous Carcinoma,1
35226,Epithelial Component Present,Recurrent Lip and Oral Cavity Carcinoma,1
35227,Malignant Cellular Infiltrate,Bladder Urothelial Carcinoma in Situ,1
35228,Well Differentiated Neuroendocrine Lesion,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
35229,Malignant Cellular Infiltrate,Stage IVA Hypopharyngeal Carcinoma AJCC v7,1
35230,Malignant Cellular Infiltrate,Mixed Germ Cell Tumor,1
35231,Benign Cellular Infiltrate,Central Nervous System Lipoma,1
35232,Secondary Lesion,Malignant Neoplasm with Regional Lymph Node Involvement,1
35233,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
35234,Malignant Cellular Infiltrate,Urothelial carcinoma ureter metastatic,1
35235,Malignant Cellular Infiltrate,Primary hepatic neuroendocrine carcinoma,1
35236,Epithelial Component Present,Stage III Colorectal Cancer AJCC v7,1
35237,Metastatic/Recurrent Disease,Orbital Alveolar Soft Part Sarcoma,1
35238,Malignant Cellular Infiltrate,Adenocarcinoma in tubular adenoma,1
35239,Indolent Clinical Course,Benign neoplasm of mesothelial tissue of pleura,1
35240,Epithelial Component Present,FIGO Stage IIIA1(ii) Ovarian Cancer,1
35241,Childhood Lesion,Childhood Ganglioglioma,1
35242,Epithelial Component Present,Palate carcinoma,1
35243,Malignant Cellular Infiltrate,Blepharal carcinoma,1
35244,Hyalinized Stroma Formation,Thyroid Gland Solitary Fibrous Tumor,1
35245,Local disease,Localized Resectable Neuroblastoma,1
35246,Malignant Cellular Infiltrate,Sarcoma of kidney,1
35247,Well-Circumscribed Lesion,Soft tissue chondroma,1
35248,Malignant Cellular Infiltrate,Stage I Vulvar Cancer AJCC v8,1
35249,Epithelial Component Present,Stage 0 Colon Cancer AJCC v8,1
35250,Nested Pattern,Testicular gonadoblastoma,1
35251,Malignant Cellular Infiltrate,Grade 3 Invasive Breast Carcinoma,1
35252,Well-Circumscribed Lesion,Peutz-Jeghers Polyp of the Stomach,1
35253,Severe dysplasia,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
35254,High Mitotic Activity,Medulloepithelioma,1
35255,Malignant Cellular Infiltrate,Ann Arbor Stage II Childhood Non-Hodgkin Lymphoma,1
35256,Epithelial Component Present,Stage IVA Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
35257,Epithelial Component Present,Stage IVC Oropharyngeal Carcinoma AJCC v7,1
35258,Primary Lesion,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
35259,'Starry-sky' pattern,Small Intestinal Atypical Burkitt/Burkitt-Like Lymphoma,1
35260,Lobulated Growth Pattern,chondroma of lung,1
35261,Osseous Differentiation,Central Nervous System Extraskeletal Osteosarcoma,1
35262,Malignant Cellular Infiltrate,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,1
35263,Cutaneous Involvement,Anal Papillary Hidradenoma,1
35264,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Spine,1
35265,Extraosseous Lesion,Adult Extraskeletal Myxoid Chondrosarcoma,1
35266,Malignant Cellular Infiltrate,Childhood Lymphoma,1
35267,Mild dysplasia,Mild epithelial dysplasia,1
35268,Epithelial Component Present,basal cell carcinoma of scrotum,1
35269,Fibrovascular Stroma Formation,Pterygium Of Conjunctiva And Cornea,1
35270,Malignant Cellular Infiltrate,Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
35271,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(17;17)(q21;q21),1
35272,Epithelial Component Present,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",1
35273,Pregnancy Complications,Placenta Disorders,1
35274,Radiation Sickness,Radiation Pneumonitis,1
35275,Perivascular fibrosis,Hodgkin's disease nodular sclerosis stage II,1
35276,Microvascular Proliferation,Epithelioid glioblastoma,1
35277,Malignant Cellular Infiltrate,Adult T-cell lymphoma/leukemia recurrent,1
35278,Severe dysplasia,Stage 0 Rectal Cancer AJCC v8,1
35279,Carcinomatous Component Present,Major Salivary Gland Mucoepidermoid Carcinoma,1
35280,Benign Cellular Infiltrate,Rhabdomyoma,1
35281,Epithelial Component Present,Neuroendocrine neoplasm of gallbladder,1
35282,Epithelial Component Present,Thoracic Esophagus Adenocarcinoma,1
35283,Alternative Fascicle (Bundle) Pattern,Dartoic myoma,1
35284,Absence of Invasion,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
35285,Malignant Cellular Infiltrate,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
35286,Osteoid formation,Extraskeletal Osteosarcoma,1
35287,Metastatic Lesion,Metastatic Prostate Small Cell Carcinoma,1
35288,Carcinomatous Component Present,Breast cancer recurrent,1
35289,Malignant Cellular Infiltrate,Macrofollicular Variant Thyroid Gland Papillary Carcinoma,1
35290,Epithelial Component Present,Stage III Lung Cancer AJCC v7,1
35291,Well-Circumscribed Lesion,Rectal Adenoma with Severe Dysplasia,1
35292,Malignant Cellular Infiltrate,Lugano Classification Advanced Stage Adult Non-Hodgkin Lymphoma AJCC v8,1
35293,Malignant Cellular Infiltrate,Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
35294,Carcinomatous Component Present,Bartholin's gland carcinoma,1
35295,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Melanocytic Lesion,1
35296,Below the Diaphragm Disease,Hodgkin's disease nodular sclerosis stage I subdiaphragmatic,1
35297,Borderline Lesion,Pancreatic Intraepithelial Neoplasia-3,1
35298,Well Differentiated Hyaline Cartilage Present,Childhood Mesenchymal Chondrosarcoma,1
35299,Malignant Cellular Infiltrate,Peritoneal Desmoplastic Small Round Cell Tumor,1
35300,Refractory Disease,Refractory Breast Lymphoma,1
35301,Childhood Lesion,Childhood T Lymphoblastic Lymphoma,1
35302,Malignant Cellular Infiltrate,Stage IIIA Testicular Cancer AJCC v6 and v7,1
35303,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Cancer AJCC v8,1
35304,Malignant Cellular Infiltrate,Adenocarcinoma of lacrimal gland,1
35305,Malignant Cellular Infiltrate,Malignant neoplasm of soft palate,1
35306,Malignant Cellular Infiltrate,Type II Endometrial Adenocarcinoma,1
35307,Recurrent disease,Hodgkin's disease mixed cellularity recurrent,1
35308,Malignant Cellular Infiltrate,Stage IV Esophageal Squamous Cell Carcinoma,1
35309,Aggressive Clinical Course,"Thymoma, type B2, malignant",1
35310,Pathologic TNM Finding,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
35311,Mucoid Stroma Formation,Rectosigmoid Mucinous Adenocarcinoma,1
35312,Malignant Cellular Infiltrate,Stage II Childhood Hodgkin Lymphoma,1
35313,Storiform Growth Pattern,follicular dendritic cell sarcoma of thyroid gland,1
35314,Carcinomatous Component Present,Stage II Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
35315,Nodular lesions,Thyroid Gland Oncocytic Adenoma,1
35316,Slow Growing Mass,Ependymoma of brain stem,1
35317,Malignant Cellular Infiltrate,Malignant Ovarian Teratoma,1
35318,Epithelial Component Present,Recurrent Ovarian Mucinous Adenocarcinoma,1
35319,Cauliflower-Like Mass,Childhood Choroid Plexus Papilloma,1
35320,Gyriform Trabecular Pattern,Gastrinoma,1
35321,Childhood Lesion,Diffuse Intrinsic Pontine Glioma,1
35322,Epithelial Component Present,Densely Granulated Non-Functioning Corticotroph Adenoma,1
35323,Epithelial Component Present,"Mesonephroma, benign",1
35324,Primary Lesion,Stage IIIA Primary Peritoneal Cancer AJCC v7,1
35325,Primary Lesion,Cerebral Lymphoma in Immunocompetent Host,1
35326,Aggressive Clinical Course,Aggressive Systemic Mastocytosis,1
35327,Exophytic Papillary Lesion,Upper Gingival Verrucous Carcinoma,1
35328,Epithelial Component Present,Stage IA Lung Small Cell Carcinoma AJCC v7,1
35329,Cytoplasmic Membrane-Bound Granules Present,Stage IV Merkel Cell Carcinoma AJCC v7,1
35330,Malignant Cellular Infiltrate,"Leukemia, Myelocytic, Acute",1
35331,Malignant Cellular Infiltrate,Malignant vascular tumor of skin,1
35332,Malignant Cellular Infiltrate,Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8,1
35333,Cystic Change,"Cystadenocarcinoma, Mucinous",1
35334,Nodular Pattern,Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma,1
35335,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage IV,1
35336,Severe dysplasia,Intermediate Grade Ductal Breast Carcinoma In Situ,1
35337,Well Differentiated Neuroendocrine Lesion,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
35338,Neoplastic Plasma Cells Between 10 and 30 Percent of Bone Marrow Nucleated Cells,Smoldering myeloma,1
35339,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent,1
35340,Low Mitotic Activity,Stage IV Gastric Neuroendocrine Tumor AJCC v8,1
35341,Carcinomatous Component Present,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
35342,Hereditary Lesion,"Pyknocytosis, infantile",1
35343,Epithelial Component Present,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
35344,Epithelial Component Present,Stage IA Esophageal Squamous Cell Carcinoma AJCC v7,1
35345,Epithelial Component Present,Pharyngeal cancer recurrent,1
35346,Well-Circumscribed Lesion,"Papillary cystadenoma, borderline malignancy",1
35347,Metastatic Lesion,Locally Advanced Cervical Carcinoma,1
35348,Carcinomatous Component Present,Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
35349,Dysplasia,Stage 0 Vulvar Carcinoma,1
35350,Malignant Cellular Infiltrate,Cervical Warty Carcinoma,1
35351,Epithelial Component Present,Prostate Cancer by Whitmore-Jewett Stage,1
35352,Epithelial Component Present,Ovarian mucinous tumor,1
35353,Sheets of Interfollicular Plasma Cells Present,"Castleman Disease, Plasma Cell Type",1
35354,Cutaneous Involvement,Ichthyosis Vulgaris,1
35355,Benign Cellular Infiltrate,Liver Lipoma,1
35356,Epithelial Component Present,Stage I Eyelid Carcinoma AJCC v8,1
35357,Carcinomatous Component Present,Carcinoma bone,1
35358,Neuroendocrine Differentiation,Colorectal L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor,1
35359,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Erythroid Leukemia,1
35360,Low Mitotic Activity,Non functioning pancreatic endocrine tumor,1
35361,Epithelial Component Present,Stage IA Ampulla of Vater Cancer AJCC v8,1
35362,Nuclear Atypia,Infratentorial Glioblastoma,1
35363,Mixed Cellular Population,Uterine Carcinosarcoma,1
35364,Epithelial Component Present,Anatomic Stage I Breast Cancer AJCC v8,1
35365,Malignant Cellular Infiltrate,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
35366,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage I,1
35367,Benign Cellular Infiltrate,Acoustic Neuroma,1
35368,Epithelial Component Present,Pancreatic Well Differentiated Ductal Adenocarcinoma,1
35369,Sinusoidal Infiltration,Recurrent Hepatosplenic T-Cell Lymphoma,1
35370,Plexiform Growth Pattern,Chest Wall Plexiform Fibrohistiocytic Neoplasm,1
35371,High Mitotic Activity,neuroendocrine carcinoma of anal canal,1
35372,Recurrent disease,Recurrent Childhood Anaplastic Oligodendroglioma,1
35373,High Mitotic Activity,Gallbladder Neuroendocrine Carcinoma,1
35374,Squamous Metaplasia of Malignant Cells Present,Adenocarcinoma with squamous metaplasia,1
